FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Li, HY
   Yang, BS
AF Li, Huayu
   Yang, Bing-Shiou
TI Model evaluation of particle breakage facilitated process
   intensification for Mixed-Suspension-Mixed-Product-Removal (MSMPR)
   crystallization
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Continuous crystallization; Breakage; Wet milling; Population balance
   model; Process intensification
ID POPULATION BALANCE-EQUATIONS; HIGH-RESOLUTION SCHEMES;
   NUMERICAL-METHODS; SCALE-UP; BATCH; AGGREGATION; BEHAVIOR; SIZE;
   PHARMACEUTICALS; NUCLEATION
AB This work studied a system of single stage mixed-suspension-mixed-product-removal (MSMPR) crystallization with particle breakage controlled by wet milling. Conventional single stage MSMPR crystallizer is limited by its degrees of freedom, which makes the process performance largely depend on steady state crystallization rate only tunable by residence time and supersaturation. Breakage brought by wet milling is demonstrated in this work as a supersaturation-independent variable to manipulate steady state conditions. The simulation results show that wet milling can act as a promising process intensification tool that increases process yield and broadens attainable region of particle size. Breakage model is adopted from dry milling and incorporated to high resolution finite volume population balance model. Four cases that cover a wide range of nucleation and growth rates have been tested, and the process yield and particle size are studied as functions of residence time and wet milling tip speeds. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Huayu; Yang, Bing-Shiou] Boehringer Ingelheim Pharmaceut Inc, Mat & Analyt Sci, 900 Ridgebury Rd, Ridgefield, CT 06877 USA.
RP Li, HY (reprint author), Boehringer Ingelheim Pharmaceut Inc, Mat & Analyt Sci, 900 Ridgebury Rd, Ridgefield, CT 06877 USA.
EM huayu.li@boehringer-ingelheim.com
CR Acevedo D, 2017, ORG PROCESS RES DEV, V21, P1069, DOI 10.1021/acs.oprd.7b00192
   Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337
   Alvarez AJ, 2011, CRYST GROWTH DES, V11, P4392, DOI 10.1021/cg200546g
   Bouaswaig AE, 2010, IND ENG CHEM RES, V49, P5911, DOI 10.1021/ie9020057
   CHANG SC, 1995, J COMPUT PHYS, V119, P295, DOI 10.1006/jcph.1995.1137
   Cole KP, 2017, SCIENCE, V356, P1144, DOI 10.1126/science.aan0745
   Di Martino P, 2002, J CRYST GROWTH, V243, P345, DOI 10.1016/S0022-0248(02)01523-3
   Engstrom J, 2013, INT J PHARMACEUT, V456, P261, DOI 10.1016/j.ijpharm.2013.08.084
   Farmer TC, 2016, AICHE J, V62, P3505, DOI 10.1002/aic.15343
   Harter A, 2013, ORG PROCESS RES DEV, V17, P1335, DOI 10.1021/op4001143
   Hounslow Michael J, 2004, AICHE J, V36, P106
   Jiang M, 2014, CRYST GROWTH DES, V14, P851, DOI 10.1021/cg401715e
   Johnson MD, 2012, ORG PROCESS RES DEV, V16, P1017, DOI 10.1021/op200362h
   Koren B., 1993, NOTES NUMERICAL FLUI, V45, P117
   Kumar J, 2009, POWDER TECHNOL, V189, P218, DOI 10.1016/j.powtec.2008.04.014
   Lai TTC, 2015, CRYST GROWTH DES, V15, P3374, DOI 10.1021/acs.cgd.5b00466
   Lai TTC, 2014, ORG PROCESS RES DEV, V18, P1382, DOI 10.1021/op500171n
   Lee SL, 2015, J PHARM INNOV, V10, P191, DOI 10.1007/s12247-015-9215-8
   LeVeque RJ, 2002, FINITE VOLUME METHOD, V31
   Li JC, 2017, CRYST GROWTH DES, V17, P1000, DOI 10.1021/acs.cgd.6b01212
   Li JC, 2016, ORG PROCESS RES DEV, V20, P510, DOI 10.1021/acs.oprd.5b00306
   Luciani CV, 2015, ORG PROCESS RES DEV, V19, P582, DOI 10.1021/acs.oprd.5b00066
   Mascia S, 2013, ANGEW CHEM INT EDIT, V52, P12359, DOI 10.1002/anie.201305429
   Meier M, 2009, POWDER TECHNOL, V188, P301, DOI 10.1016/j.powtec.2008.05.009
   Meier M, 2008, EUR J PHARM SCI, V34, P45, DOI 10.1016/j.ejps.2008.02.120
   Motz S, 2002, CHEM ENG SCI, V57, P4329, DOI 10.1016/S0009-2509(02)00349-4
   Qamar S, 2006, COMPUT CHEM ENG, V30, P1119, DOI 10.1016/j.compchemeng.2006.02.012
   Qamar S, 2007, COMPUT CHEM ENG, V31, P1576, DOI 10.1016/j.compchemeng.2007.01.006
   Qamar S, 2009, CHEM ENG SCI, V64, P2088, DOI 10.1016/j.ces.2009.01.040
   Quon JL, 2012, CRYST GROWTH DES, V12, P3036, DOI 10.1021/cg300253a
   Ranodolph A, 2012, THEORY PARTICULATE P
   Salvatori F, 2018, CRYST GROWTH DES, V18, P5957, DOI 10.1021/acs.cgd.8b00761
   Su QL, 2015, CHEM ENG PROCESS, V89, P41, DOI 10.1016/j.cep.2015.01.001
   Szilagyi B, 2018, CRYST GROWTH DES, V18, P1415, DOI 10.1021/acs.cgd.7b01331
   Vetter T, 2014, CHEM ENG SCI, V106, P167, DOI 10.1016/j.ces.2013.11.008
   Vogel L, 2005, CHEM ENG SCI, V60, P5164, DOI 10.1016/j.ces.2005.03.064
   Wong SY, 2012, CRYST GROWTH DES, V12, P5701, DOI 10.1021/cg301221q
   Yang XC, 2017, ORG PROCESS RES DEV, V21, P1021, DOI 10.1021/acs.oprd.7b00130
   Yang Y, 2017, INT J PHARMACEUT, V533, P49, DOI 10.1016/j.ijpharm.2017.09.050
   Yang Y, 2016, IND ENG CHEM RES, V55, P4987, DOI 10.1021/acs.iecr.5b04956
   Zhang HT, 2014, CRYST GROWTH DES, V14, P2148, DOI 10.1021/cg401571h
   Zhang HT, 2012, ORG PROCESS RES DEV, V16, P915, DOI 10.1021/op2002886
NR 42
TC 0
Z9 0
U1 8
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1175
EP 1186
DI 10.1016/j.ces.2019.07.030
PG 12
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300097
DA 2020-05-12
ER

PT J
AU Mazzelli, A
   Luzzi, DM
   Buonanno, G
   Cicci, A
   Piemonte, V
   Laquaniello, G
AF Mazzelli, A.
   Luzzi, D. M.
   Buonanno, G.
   Cicci, A.
   Piemonte, V
   Laquaniello, G.
TI An optimized separation process of microalgal lipidic products by
   molecular distillation: Techno-economic analysis
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Microalgae; Omega-3; Carotenoids; Molecular distillation; Process
   simulation; RSM
ID WATER; ADSORPTION; COLUMN; FOOD; TOOL
AB Microalgae are a sustainable rich source of high-added value metabolites, as omega-3 and carotenoids, for their ability to grow and accumulate these compounds also in wastewaters or in seawaters. Molecular distillation is a valid techinque respect to conventional distillation for fractionation of these thermosensitive products without affecting their nutritional and biological values. In this work a fractionation process using molecular distillation for separating fatty acids (in part omega-3) as esters and carotenoids from a microalgal lipidic extract, was designed and optimized. A Response Surface Method (RSM) analysis was carried out in order to find the optimal operative conditions of the molecular distiller in terms of temperature, pressure and purification ability. Furthermore, to complete the process scheme, also the design of the other equipments, including in particular the esterification reactor and the dewatering column, was done. In order to complete the feasibility study of the process, an estimation of the Operating Expense (OPEX) and Capital Expenditure (CAPEX), using the results of the simulations in terms of energy and utilities' consumption, was done. All of these informations, both technical and economical, will be the basis for future industrial implementations of the designed process. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mazzelli, A.; Cicci, A.; Laquaniello, G.] BIO P Srl, Via Di Vannina 88, I-00156 Rome, Italy.
   [Mazzelli, A.] Univ Roma La Sapienza, Dipartimento Ingn Chim Mat Ambiente, Via Eudossiana 18, I-00184 Rome, Italy.
   [Luzzi, D. M.; Buonanno, G.; Piemonte, V; Laquaniello, G.] Univ Campus Biomed Roma, Fac Dipartimentale Ingn, Via Alvaro Portillo 21, I-00128 Rome, Italy.
RP Mazzelli, A (reprint author), BIO P Srl, Via Di Vannina 88, I-00156 Rome, Italy.
EM alessio.mazzelli@umroma1.it
OI MAZZELLI, ALESSIO/0000-0003-3878-5643; piemonte,
   vincenzo/0000-0002-2421-3938
CR BARCLAY WR, 1994, J APPL PHYCOL, V6, P123, DOI 10.1007/BF02186066
   Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024
   Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019
   Bogalhos P, 2010, APPL BIOCHEM BIOTECH, V160, P1879, DOI 10.1007/s12010-009-8822-6
   Cicci A., 2017, CHEM ENG T, V57, P1405, DOI [10.3303/CET1757235, DOI 10.3303/CET1757235]
   Cicci A., 2017, CHEM ENG T, V57, P61, DOI DOI 10.3303/CET1757011
   Cicci A, 2018, GREEN CHEM, V20, DOI 10.1039/c8gc01731j
   Cicci A, 2016, CHEM ENGINEER TRANS, V49, P181, DOI 10.3303/CET1649031
   Cicci A, 2015, CHEM ENGINEER TRANS, V43, P235, DOI 10.3303/CET1543040
   Di Paola L, 2015, CHEM ENGINEER TRANS, V43, P1321, DOI 10.3303/CET1543221
   Gabrus E, 2015, CHEM ENG J, V259, P232, DOI 10.1016/j.cej.2014.07.108
   Gironi F, 2011, CHEM ENG RES DES, V89, P857, DOI 10.1016/j.cherd.2010.11.003
   Gorak A, 2014, HBK SEPART SCI, pVII
   Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6
   Ketenoglu O, 2015, ITAL J FOOD SCI, V27, P277, DOI 10.14674/1120-1770%2FIJFS.V269
   Liu ZY, 1999, COMPUT CHEM ENG, V23, pS831, DOI 10.1016/S0098-1354(99)80204-X
   LUTISAN J, 1995, CHEM ENG J BIOCH ENG, V56, P39, DOI 10.1016/0923-0467(94)02857-7
   Maciel W., 2006, ENRICHMENT NATURAL P, V152, P648
   MARCH J, 1992, ADV ORGANIC CHEM
   Mazzelli A, 2018, CHEM ENG T, V64, DOI [10.3303/CET1864115, DOI 10.3303/CET1864115]
   Mazzelli A, 2018, CHEM ENG T, V64, DOI [10.3303/CET1864116, DOI 10.3303/CET1864116]
   Peters M, 2002, PLANT DESIGN EC CHEM
   Piemonte V, 2016, J CLEAN PROD, V111, P62, DOI 10.1016/j.jclepro.2015.07.089
   Ponce GHSF, 2015, CHEM ENG RES DES, V95, P55, DOI 10.1016/j.cherd.2015.01.002
   Sattler K., 1995, THERMAL SEPARATION P
   Simo M, 2009, IND ENG CHEM RES, V48, P9247, DOI 10.1021/ie900446v
   Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87
   Stephan K., 2013, INT SER HEAT MASS TR
   TEO WK, 1986, IND ENG CHEM PROC DD, V25, P17, DOI 10.1021/i200032a003
   Treybal R. E., 1980, MASSTRANSFER OPERATI
   Vigani M, 2015, TRENDS FOOD SCI TECH, V42, P81, DOI 10.1016/j.tifs.2014.12.004
   Wang SR, 2009, FUEL PROCESS TECHNOL, V90, P738, DOI 10.1016/j.fuproc.2009.02.005
   Yamamoto T, 2012, CHEM ENG J, V181, P443, DOI 10.1016/j.cej.2011.11.110
   Zhang GY, 2013, IND ENG CHEM RES, V52, P3918, DOI 10.1021/ie3020044
NR 34
TC 2
Z9 2
U1 9
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1187
EP 1195
DI 10.1016/j.ces.2019.07.043
PG 9
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300098
DA 2020-05-12
ER

PT J
AU Bozorg, M
   Addis, B
   Picciall, V
   Ramirez-Santos, AA
   Castel, C
   Pinnau, I
   Favre, E
AF Bozorg, M.
   Addis, B.
   Picciall, V
   Ramirez-Santos, Alvaro A.
   Castel, C.
   Pinnau, I
   Favre, E.
TI Polymeric membrane materials for nitrogen production from air: A process
   synthesis study
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Nitrogen; Membrane; Process; Synthesis; Optimization; Materials; Cost
ID GAS SEPARATION; OXYGEN-ENRICHMENT; OPTIMIZATION; PERMEATION; CAPTURE
AB Nitrogen production from air by membrane gas separation processes is a mature technology which is applied in numerous industrial sectors (chemical, food, aeronautics, space..). Depending on the nitrogen purity requirements (typically between 90 and 99.9%), single stage or multistage membrane process configurations are used. A very large number of advanced membrane materials have been recently reported, showing increasing permeability and/or selectivity for air separation applications (i.e. trade-off limits of dense polymeric materials for the O-2/N-2 gas pair) compared to the commercially available membranes. The interest of these new materials in terms of nitrogen production cost and their impact in terms of process configuration are reported through a process synthesis study. Based on a tailor made optimization methodology and program, the production cost and associated optimal process configuration are first identified for two standard O-2/N-2 separation membranes at four different levels of N-2 purity (90, 95, 99, 99.9%). The same strategy is then performed with advanced trade-off membrane materials, with the possibility to combine different materials in multistaged systems. The impact in terms of nitrogen production cost for the different purities and the corresponding optimal membrane materials and process configurations are discussed. Surprisingly, a medium membrane selectivity combined to a high permeability is shown to systematically offer the best set of performances, for mono or multistaged sys- tems. Vacuum operation and recycling loops are shown to generate lower N-2 production costs. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bozorg, M.; Addis, B.] Univ Lorraine, CNRS, LORIA, F-54000 Nancy, France.
   [Bozorg, M.; Ramirez-Santos, Alvaro A.; Castel, C.; Favre, E.] Univ Lorraine, CNRS, LRGP, F-54000 Nancy, France.
   [Bozorg, M.; Picciall, V] Univ Roma Tor Vergata, Dipartimento Ingn Civile & Ingn Informat, Viale Politecn 1, I-00133 Rome, Italy.
   [Pinnau, I] King Abdullah Univ Sci & Technol, Adv Membranes & Porous Mat Res Ctr, Thuwal, Saudi Arabia.
RP Favre, E (reprint author), Univ Lorraine, CNRS, LRGP, F-54000 Nancy, France.
EM eric.favre@univ-lorraine.fr
FU King Abdullah University of Science and Technology (KAUST)King Abdullah
   University of Science & Technology [OSR-2016-CPF-2910]
FX Research reported in this publication was supported by King Abdullah
   University of Science and Technology (KAUST # OSR-2016-CPF-2910).
CR Agrawal R, 1996, IND ENG CHEM RES, V35, P3607, DOI 10.1021/ie960160c
   Ajhar M, 2008, J MEMBRANE SCI, V323, P105, DOI 10.1016/j.memsci.2008.06.007
   Baker R W, 2012, MEMBRANE TECHNOLOGY
   Baker RW, 2014, MACROMOLECULES, V47, P6999, DOI 10.1021/ma501488s
   Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088
   BHIDE BD, 1991, J MEMBRANE SCI, V62, P37, DOI 10.1016/0376-7388(91)85003-N
   Bounaceur R, 2017, J MEMBRANE SCI, V523, P77, DOI 10.1016/j.memsci.2016.09.011
   BOZHENKO EI, 1995, GAS SEP PURIF, V9, P31, DOI 10.1016/0950-4214(95)92174-B
   Castle WF, 2002, INT J REFRIG, V25, P158, DOI 10.1016/S0140-7007(01)00003-2
   Ettouney HM, 1998, J MEMBRANE SCI, V148, P105, DOI 10.1016/S0376-7388(98)00144-6
   FAVRE E, 2010, COMPREHENSIVE MEMBRA, V2, P155, DOI DOI 10.1016/B978-0-08-093250-7.00020-7
   Gollan A., 1984, IETC IND EN TECHN C
   Haider S, 2018, SEP PURIF TECHNOL, V205, P251, DOI 10.1016/j.seppur.2018.05.037
   HARAYA K, 1992, J MEMBRANE SCI, V71, P13, DOI 10.1016/0376-7388(92)85002-Z
   Heinz-Wolfgang H., 2008, IND GASES PROCESSING
   Henis J., 1994, POLYM GAS SEPARATION
   Jain R., 1989, GAS SEP PURIF, V3, P123
   Koros WJ, 2017, NAT MATER, V16, P289, DOI [10.1038/NMAT4805, 10.1038/nmat4805]
   Lin HQ, 2013, IND ENG CHEM RES, V52, P10820, DOI 10.1021/ie401464z
   Mahajan R, 2000, IND ENG CHEM RES, V39, P2692, DOI 10.1021/ie990799r
   McConnell S., 2010, 02VTCEGS009 ARG NAT
   Park HB, 2017, SCIENCE, V356, DOI 10.1126/science.aab0530
   PRASAD R, 1994, J MEMBRANE SCI, V94, P225, DOI 10.1016/0376-7388(93)E0193-N
   Prasad R., 1994, POLYM GAS SEPARATION, P531
   Purnomo ISK, 2000, CHEM ENG SCI, V55, P3599, DOI 10.1016/S0009-2509(00)00041-5
   Ramirez-Santos AA, 2018, J MEMBRANE SCI, V566, P346, DOI 10.1016/j.memsci.2018.08.024
   RIGBY GR, 1994, J MEMBRANE SCI, V87, P159, DOI 10.1016/0376-7388(93)E0119-5
   Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030
   SCHELL WJ, 1985, J MEMBRANE SCI, V22, P217, DOI 10.1016/S0376-7388(00)81281-8
   Schmidt S, 2013, DYNAMIC DESIGN CRYOG, P41
   Seider W.D., 2009, PRODUCT PROCESS DESI
   Smith AR, 2001, FUEL PROCESS TECHNOL, V70, P115, DOI 10.1016/S0378-3820(01)00131-X
   SPILLMAN RW, 1989, CHEM ENG PROG, V85, P41
   Thomas S, 2009, J MEMBRANE SCI, V333, P125, DOI 10.1016/j.memsci.2009.02.003
   Yuan MY, 2014, J MEMBRANE SCI, V465, P177, DOI 10.1016/j.memsci.2014.04.026
   Zhu XF, 2008, J MEMBRANE SCI, V323, P221, DOI 10.1016/j.memsci.2008.06.052
NR 36
TC 1
Z9 1
U1 12
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1196
EP 1213
DI 10.1016/j.ces.2019.07.029
PG 18
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300099
DA 2020-05-12
ER

PT J
AU Garcia, A
   Betancourt, F
AF Garcia A, Antonio
   Betancourt C, Fernando
TI Conservative mathematical model and numerical simulation of batch
   gravity settling with coalescence of liquid-liquid dispersions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Liquid-liquid separation; Mathematical modeling; Simulation; Hindered
   settling; Population balance; Coalescence
ID DISCRETIZED POPULATION BALANCE; CRUDE-OIL; SEPARATION; SEDIMENTATION;
   EQUATION; BREAKAGE; SCHEMES; GROWTH
AB Population balance equations (PBE) provide a suitable a framework for dealing with drop breakage and coalescence. In addition, modeling of the solid particle sedimentation process based on Kynch's theory has been successfully used and validated in mineral processing and wastewater treatment. In this work, we present a model that merges the coalescence process with hindered polydisperse sedimentation. The PBE model is projected onto a partial differential equation (PDE) system by discretizing the droplet volume. Because there is loss of mass in the system when the daughter droplets are greater than the larger species considered for the numerical solution, two terms that produce the conservation of the mass or total volume of the dispersed phase are incorporated into the PDE system. The resulting PDE system is split into two systems: homogeneous PDEs and ordinary differential equations (ODEs). The homogeneous PDEs and the ODEs are discretized using a first-order central differencing scheme and the second-order, two-stage Runge-Kutta method, respectively. The model predicts the vertical variation of the composition of the dispersed phase layer that forms at the top or bottom of the gravity settler. The proposed model was calibrated and validated through an experiment with an oil and water system. In particular, simulations illustrate the effects of: the continuity of the dispersion (oil-in-water and water-in-oil) and the standard deviation of the initial droplet volumes on phase separation quality, as well as the influence of the coalescence frequency on the average droplet volume. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Garcia A, Antonio] Univ Catolica Norte, Fac Ingn & Ciencias Geol, Dept Ingn Met & Minas, Antofagasta, Chile.
   [Garcia A, Antonio] CICITEM, Ctr Invest Cient Tecnol Mineria, Antofagasta, Chile.
   [Betancourt C, Fernando] Univ Concepcion, Dept Ingn Met, Concepcion, Chile.
RP Garcia, A (reprint author), Univ Catolica Norte, Fac Ingn & Ciencias Geol, Dept Ingn Met & Minas, Antofagasta, Chile.
EM agarcia@ucn.cl
FU FONDECYT ProjectComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [11085069]; CONICYTComision
   Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
   [REGIONAL/GORE ANTOFAGASTA/CICITEM/R10C1004]; NLHPC (ECM-02); Basal
   project of the PIA Program: Concurso Apoyo a Centros Cientificos y
   Tecnologicos de Excelencia con Financiamiento Basal [AFB170001]; 
   [CONICYT/FONDAP/15130015]
FX AG acknowledges support by FONDECYT Project 11085069 and CONICYT
   REGIONAL/GORE ANTOFAGASTA/CICITEM/R10C1004.; Powered@NLHPC: This
   research was partially supported by the supercomputing infrastructure of
   the NLHPC (ECM-02); FB acknowledges support by CONICYT/FONDAP/15130015
   and Basal project AFB170001 of the PIA Program: Concurso Apoyo a Centros
   Cientificos y Tecnologicos de Excelencia con Financiamiento Basal.
CR Attarakih MM, 2004, CHEM ENG SCI, V59, P2567, DOI 10.1016/j.ces.2004.03.005
   Attarakih MM, 2004, CHEM ENG SCI, V59, P2547, DOI 10.1016/j.ces.2004.03.004
   Berres S, 2004, J COMPUT APPL MATH, V164, P53, DOI 10.1016/S0377-0427(03)00496-5
   Berres S, 2003, INT J SOLIDS STRUCT, V40, P4965, DOI 10.1016/S0020-7683(03)00249-X
   Betancourt F, 2014, HYPERBOLIC CONSERVAT, P23
   Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019
   Boscarino S, 2015, SIAM J SCI COMPUT, V37, pB305, DOI 10.1137/140967544
   Burger R, 2008, COMPUT CHEM ENG, V32, P1173, DOI 10.1016/j.compchemeng.2007.04.019
   Burger R, 2011, J COMPUT PHYS, V230, P2322, DOI 10.1016/j.jcp.2010.12.019
   Burger R, 2008, J ENG MATH, V60, P387, DOI 10.1007/s10665-007-9148-4
   Burger R, 2010, SIAM J APPL MATH, V70, P2186, DOI 10.1137/09076163X
   Gomes EF, 2007, ADV ENG SOFTW, V38, P810, DOI 10.1016/j.advengsoft.2006.08.033
   Grimes BA, 2012, J DISPER SCI TECHNOL, V33, P578, DOI 10.1080/01932691.2011.574946
   Grimes BA, 2012, J DISPER SCI TECHNOL, V33, P591, DOI 10.1080/01932691.2011.574950
   HARTLAND S, 1987, CHEM ENG SCI, V42, P1927, DOI 10.1016/0009-2509(87)80139-2
   Henschke M, 2002, CHEM ENG J, V85, P369, DOI 10.1016/S1385-8947(01)00251-0
   HOUNSLOW MJ, 1988, AICHE J, V34, P1821, DOI 10.1002/aic.690341108
   HULBURT HM, 1964, CHEM ENG SCI, V19, P555, DOI 10.1016/0009-2509(64)85047-8
   KUMAR A, 1985, CAN J CHEM ENG, V63, P368, DOI 10.1002/cjce.5450630303
   Kumar S, 1996, IND ENG CHEM RES, V35, P3155, DOI 10.1021/ie9600147
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   LeVeque R.J., 1992, NUMERICAL METHODS CO
   LITSTER JD, 1995, AICHE J, V41, P591
   Ramkrishna D, 2002, CHEM ENG SCI, V57, P595, DOI 10.1016/S0009-2509(01)00386-4
   RAMKRISHNA D, 2000, POPULATION BALANCES
   ROGERS JR, 1990, METALL TRANS A, V21, P59, DOI 10.1007/BF02656424
   Ruiz MC, 1996, HYDROMETALLURGY, V42, P281, DOI 10.1016/0304-386X(95)00096-Y
   Torfs E, 2017, WATER SCI TECHNOL, V75, P539, DOI 10.2166/wst.2016.485
   VALENTAS KJ, 1966, IND ENG CHEM FUND, V5, P533, DOI 10.1021/i160020a018
   WANG H, 1995, J FLUID MECH, V295, P247, DOI 10.1017/S0022112095001959
   ZHANG XG, 1991, J FLUID MECH, V230, P479, DOI 10.1017/S0022112091000861
   ZHANG XG, 1993, PHYS FLUIDS A-FLUID, V5, P1602, DOI 10.1063/1.858837
NR 32
TC 0
Z9 0
U1 11
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1214
EP 1229
DI 10.1016/j.ces.2019.07.034
PG 16
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300100
DA 2020-05-12
ER

PT J
AU Kimaev, G
   Ricardez-Sandoval, LA
AF Kimaev, Grigoriy
   Ricardez-Sandoval, Luis A.
TI Nonlinear model predictive control of a multiscale thin film deposition
   process using artificial neural networks
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Nonlinear model predictive control; Shrinking horizon optimization;
   Multiscale stochastic system; Machine learning; Artificial neural
   network
ID ATOMIC LAYER DEPOSITION; MONTE-CARLO; CRYSTAL SHAPE; GROWTH-PROCESS;
   OPTIMIZATION; IDENTIFICATION; SYSTEMS; REACTOR; DESIGN; PECVD
AB The purpose of this study was to employ Artificial Neural Networks (ANNs) to develop data-driven models that would enable the shrinking horizon nonlinear model predictive control of a computationally intensive stochastic multiscale system. The system of choice was a simulation of thin film formation by chemical vapour deposition. Two ANNs were trained to estimate the system's observables. The ANNs were subsequently employed in a shrinking horizon optimization scheme to obtain the optimal time-varying profiles of the manipulated variables that would meet the desired thin film properties at the end of the batch. The resulting profiles were validated using the stochastic multiscale system and a good agreement with the predictions of the ANNs was observed. Due to their observed computational efficiency, accuracy, and the ability to reject disturbances, the ANNs seem to be a promising approach for online optimization and control of computationally demanding multiscale process systems. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kimaev, Grigoriy; Ricardez-Sandoval, Luis A.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
RP Ricardez-Sandoval, LA (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM laricard@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
FX The authors would like to gratefully acknowledge the Natural Sciences
   and Engineering Research Council of Canada (NSERC) for the financial
   support.
CR Adomaitis RA, 2003, MATH COMPUT MODEL, V38, P159, DOI 10.1016/S0895-7177(03)00199-7
   Adomaitis RA, 2010, J CRYST GROWTH, V312, P1449, DOI 10.1016/j.jcrysgro.2009.12.041
   Adomaitis Raymond A, 2010, IFAC P VOLUMES, V43, P859
   Akkisetty PK, 2010, J PHARM INNOV, V5, P161, DOI 10.1007/s12247-010-9090-2
   Alexandridis A, 2005, AICHE J, V51, P2495, DOI 10.1002/aic.10505
   Antanasijevic D, 2014, J HYDROL, V519, P1895, DOI 10.1016/j.jhydrol.2014.10.009
   Bach-Andersen M, 2018, WIND ENERGY, V21, P29, DOI 10.1002/we.2142
   Bashir ZA, 2009, IEEE T POWER SYST, V24, P20, DOI 10.1109/TPWRS.2008.2008606
   Bird R. B., 2002, TRANSPORT PHENOMENA
   BORGGAARD C, 1992, ANAL CHEM, V64, P545, DOI 10.1021/ac00029a018
   Chaffart D, 2018, COMPUT CHEM ENG, V119, P465, DOI 10.1016/j.compchemeng.2018.08.029
   Chaffart D, 2016, AICHE J, V62, P2374, DOI 10.1002/aic.15215
   Cheimarios N, 2010, CHEM ENG SCI, V65, P5018, DOI 10.1016/j.ces.2010.06.004
   Chitsazan N, 2015, J HYDROL, V528, P52, DOI 10.1016/j.jhydrol.2015.06.007
   Chow TWS, 1996, IEEE T POWER SYST, V11, P1736, DOI 10.1109/59.544636
   Christofides PD, 2006, COMPUT CHEM ENG, V30, P1670, DOI 10.1016/j.compchemeng.2006.05.025
   Christofides PD, 2009, CONTROL ENG SER BIRK, P1, DOI 10.1007/978-0-8176-4793-3_1
   Crose M, 2018, COMPUT CHEM ENG, V113, P184, DOI 10.1016/j.compchemeng.2018.03.011
   Crose M, 2017, RENEW ENERG, V100, P129, DOI 10.1016/j.renene.2016.06.065
   Crose M, 2015, CHEM ENG SCI, V136, P50, DOI 10.1016/j.ces.2015.02.027
   Dayhoff JE, 2001, CANCER, V91, P1615, DOI 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L
   Ding BC, 2012, J PROCESS CONTR, V22, P1773, DOI 10.1016/j.jprocont.2012.07.011
   Ding YY, 2019, CHEM ENG RES DES, V145, P159, DOI 10.1016/j.cherd.2019.03.004
   Du Tao, P INT C POW SYST TEC, V4, P2331, DOI [10.1109/ICPST.2002.1047201, DOI 10.1109/ICPST.2002.1047201]
   Fausett L., 1993, FUNDAMENTALS NEURAL
   Frenkel D, 2001, UNDERSTANDING MOL SI
   Gandhi AB, 2007, CHEM ENG SCI, V62, P7078, DOI 10.1016/j.ces.2007.07.071
   Garg A, 2017, COMPUT CHEM ENG, V106, P183, DOI 10.1016/j.compchemeng.2017.05.020
   Garg A, 2017, IND ENG CHEM RES, V56, P7491, DOI 10.1021/acs.iecr.7b00682
   HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697
   Hasenauer J, 2015, J COUPLED SYST MULTI, V3, P101, DOI 10.1166/jcsmd.2015.1069
   HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T
   Huang CM, 2001, IEE P-GENER TRANSM D, V148, P222, DOI 10.1049/ip-gtd:20010286
   Huang JQ, 2011, CHEM ENG SCI, V66, P5955, DOI 10.1016/j.ces.2011.08.020
   Huang K, 2003, CHEM ENG SCI, V58, P81, DOI 10.1016/S0009-2509(02)00432-3
   JOSEPH B, 1993, IND ENG CHEM RES, V32, P1951, DOI 10.1021/ie00021a019
   Khanmohammadi S, 2016, PROCEDIA COMPUT SCI, V95, P237, DOI 10.1016/j.procs.2016.09.321
   Kimaev G, 2018, CHEM ENG RES DES, V140, P33, DOI 10.1016/j.cherd.2018.10.006
   Kimaev G, 2017, AICHE J, V63, P3361, DOI 10.1002/aic.15702
   Kleijnen JPC, 2017, EUR J OPER RES, V256, P1, DOI 10.1016/j.ejor.2016.06.041
   Krishnapura VG, 2000, CHEM ENG SCI, V55, P3803, DOI 10.1016/S0009-2509(00)00034-8
   Kumar BS, 2012, BIORESOURCE TECHNOL, V103, P300, DOI 10.1016/j.biortech.2011.10.006
   Kwon JSI, 2015, IND ENG CHEM RES, V54, P11903, DOI 10.1021/acs.iecr.5b02942
   Kwon JSI, 2014, CHEM ENG SCI, V119, P30, DOI 10.1016/j.ces.2014.07.058
   Kwon JSI, 2014, CHEM ENG SCI, V107, P47, DOI 10.1016/j.ces.2013.12.005
   Kwon JSI, 2013, AICHE J, V59, P2317, DOI 10.1002/aic.14039
   Lam R, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.035401
   LANG KJ, 1990, NEURAL NETWORKS, V3, P23, DOI 10.1016/0893-6080(90)90044-L
   Lapedes A., 1987, IEEE INT C NEUR NETW
   Lawrynczuk M, 2016, NONLINEAR DYNAM, V86, P1193, DOI 10.1007/s11071-016-2957-0
   Lee D, 2018, COMPUT CHEM ENG, V118, P283, DOI 10.1016/j.compchemeng.2018.08.011
   Levenberg K., 1944, Quarterly of Applied Mathematics, V2, P164
   Li G, 2018, INT J HYDROGEN ENERG, V43, P5512, DOI 10.1016/j.ijhydene.2018.01.130
   Li JD, 2015, J CATAL, V326, P15, DOI 10.1016/j.jcat.2015.03.010
   Lian C, 2016, IEEE T NEUR NET LEAR, V27, P2683, DOI 10.1109/TNNLS.2015.2512283
   LUO EZ, 1994, PHYS REV B, V49, P4858, DOI 10.1103/PhysRevB.49.4858
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259
   Meidanshahi V, 2017, COMPUT CHEM ENG, V103, P39, DOI 10.1016/j.compchemeng.2017.03.011
   Nandi S, 2001, AICHE J, V47, P126, DOI 10.1002/aic.690470113
   Narasingam A, 2018, COMPUT CHEM ENG, V119, P101, DOI 10.1016/j.compchemeng.2018.08.010
   Oladyshkin S, 2012, RELIAB ENG SYST SAFE, V106, P179, DOI 10.1016/j.ress.2012.05.002
   Oliveira R, 2004, COMPUT CHEM ENG, V28, P755, DOI 10.1016/j.compchemeng.2004.02.014
   Ozkaya B, 2007, ENVIRON MODELL SOFTW, V22, P815, DOI 10.1016/j.envsoft.2006.03.004
   Raimondeau S, 2000, J COMPUT PHYS, V160, P564, DOI 10.1006/jcph.2000.6473
   Rasoulian S, 2016, CHEM ENG SCI, V140, P90, DOI 10.1016/j.ces.2015.10.004
   Rasoulian S, 2015, CHEM ENG SCI, V136, P38, DOI 10.1016/j.ces.2015.02.002
   Rasoulian S, 2014, CHEM ENG SCI, V116, P590, DOI 10.1016/j.ces.2014.05.027
   Rasoulian S, 2015, J PROCESS CONTR, V34, P70, DOI 10.1016/j.jprocont.2015.07.002
   Salciccioli M, 2011, CHEM ENG SCI, V66, P4319, DOI 10.1016/j.ces.2011.05.050
   Sarkar D, 2003, CHEM ENG SCI, V58, P3131, DOI 10.1016/S0009-2509(03)00168-4
   Schroeder, 2007, INTRO THERMAL PHYS
   Seagaran T, 2007, PROGRAMMING COLLECTI
   Shaikh A, 2003, CHEM ENG PROCESS, V42, P599, DOI 10.1016/S0255-2701(02)00209-X
   Sharma H, 2006, AICHE J, V52, P3018, DOI 10.1002/aic.10922
   Siddharnshetty P, 2018, CHEM ENG RES DES, V136, P675, DOI 10.1016/j.cherd.2018.06.015
   Solvason C. C, 2011, INTEGRATED MULTISCAL
   Solvason CC, 2010, COMPUT-AIDED CHEM EN, V28, P1285
   Soni AS, 2004, IND ENG CHEM RES, V43, P3381, DOI 10.1021/ie030535b
   Sundaram A, 2001, AICHE J, V47, P1387, DOI 10.1002/aic.690470615
   Sutskever I, 2010, NEURAL NETWORKS, V23, P239, DOI 10.1016/j.neunet.2009.10.009
   Svozil D, 1997, CHEMOMETR INTELL LAB, V39, P43, DOI 10.1016/S0169-7439(97)00061-0
   THOMAS MM, 1994, PROCEEDINGS OF THE 1994 AMERICAN CONTROL CONFERENCE, VOLS 1-3, P505
   Tiwari MK, 2010, J HYDROL, V382, P20, DOI 10.1016/j.jhydrol.2009.12.013
   VENKATASUBRAMANIAN V, 1989, AICHE J, V35, P1993, DOI 10.1002/aic.690351210
   Venkatasubramanian V, 1992, IFAC S SERIES, P547
   Venkatasubramanian V, 2019, AICHE J, V65, P466, DOI 10.1002/aic.16489
   Venkatasubramanian V, 2009, AICHE J, V55, P2, DOI 10.1002/aic.11756
   Vlachos DG, 2005, ADV CHEM EN, V30, P1, DOI 10.1016/S0065-2377(05)30001-9
   Vlachos DG, 1997, AICHE J, V43, P3031, DOI 10.1002/aic.690431115
   WATANABE K, 1989, AICHE J, V35, P1803, DOI 10.1002/aic.690351106
   Wong WC, 2018, MATHEMATICS-BASEL, V6, DOI 10.3390/math6110242
   Wu Z, 2019, CHEM ENG RES DES, V145, P173, DOI 10.1016/j.cherd.2019.02.016
   Yildiz Z, 2016, BIORESOURCE TECHNOL, V200, P42, DOI 10.1016/j.biortech.2015.09.114
   Yuan S, 2019, IND ENG CHEM RES, V58, P3531, DOI 10.1021/acs.iecr.8b05938
   Zhang YC, 2019, CHEM ENG RES DES, V147, P529, DOI 10.1016/j.cherd.2019.05.049
   Zhao-Yang Dong, 2001, 2001 IEEE Porto Power Tech Proceedings (Cat. No.01EX502), DOI 10.1109/PTC.2001.964731
NR 97
TC 4
Z9 4
U1 12
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1230
EP 1245
DI 10.1016/j.ces.2019.07.044
PG 16
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300101
DA 2020-05-12
ER

PT J
AU Zhang, L
   Wang, W
   Wang, H
   Ma, X
   Bian, ZY
AF Zhang, Lu
   Wang, Wei
   Wang, Hui
   Ma, Xin
   Bian, Zhaoyong
TI Design of inorganic-organic hybrid photocatalytic systems for enhanced
   CO2 reduction under visible light
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Photocatalysis; CO2 reduction; CO; Inorganic-organic binary system;
   H-Bi2WO6
ID BI2WO6 HOLLOW MICROSPHERES; HIGHLY EFFICIENT; TIO2; DEGRADATION;
   CATALYST; COMPLEX; HETEROSTRUCTURES; NANOCOMPOSITES; SEMICONDUCTOR;
   OPTIMIZATION
AB The photocatalytic conversion of CO2 to renewable hydrocarbon fuels by solar energy is important in solving both energy and environmental problems. In this study, highly robust hybrid systems (H-Bi2WO6/MnP, F-Bi2WO6/MnP, and T-Bi2WO6/MnP) for visible-light reduction of CO2 to CO were developed. A Mn complex was anchored to Bi2WO6 particles via bisphosphonate functional groups. Photocatalytic CO2 reduction with this catalytic system under visible-light (lambda > 400 nm) irradiation was investigated. CO was the only product, i.e., no other products were detected in the present system. The addition of water or triethylamine significantly enhanced the CO2 conversion activity of the hybrid photocatalytic system. The addition of 25% (v/v) water enhanced the photocatalytic CO2 reduction efficiency of H-Bi2WO6/MnP. A turnover number of 301 for 8 h was achieved, compared with 255 for F-Bi2WO6/MnP and 212 for T-Bi2WO6/MnP. The Mn complex played an important role in achieving highly selective conversion of CO2 to CO. A possible mechanism, namely a "Z-scheme", for CO2 reduction is proposed. These results confirm that the H-Bi2WO6 semiconductor is an essential component in our heterogeneous hybrid system. It effectively acts as a photosensitizer, an electron reservoir, and an electron transport mediator. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhang, Lu; Wang, Wei; Wang, Hui] Beijing Forestry Univ, Coll Environm Sci & Engn, POB 60,35 Qinghua East Rd, Beijing 100083, Peoples R China.
   [Ma, Xin; Bian, Zhaoyong] Beijing Normal Univ, Coll Water Sci, 19 XinJieKouWai St, Beijing 100875, Peoples R China.
RP Wang, H (reprint author), Beijing Forestry Univ, Coll Environm Sci & Engn, POB 60,35 Qinghua East Rd, Beijing 100083, Peoples R China.; Bian, ZY (reprint author), Beijing Normal Univ, Coll Water Sci, 19 XinJieKouWai St, Beijing 100875, Peoples R China.
EM bian@bnu.edu.cn
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2016ZCQ03]; Beijing
   Forestry University Outstanding Young Talent Cultivation Project
   [2019JQ03007]; Beijing Natural Science FoundationBeijing Natural Science
   Foundation [8172035]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [21872009]
FX This work was supported by the Fundamental Research Funds for the
   Central Universities (No. 2016ZCQ03); Beijing Forestry University
   Outstanding Young Talent Cultivation Project (No. 2019JQ03007); Beijing
   Natural Science Foundation (No. 8172035); and the National Natural
   Science Foundation of China (No. 21872009).
CR Abou Asi M, 2011, CATAL TODAY, V175, P256, DOI 10.1016/j.cattod.2011.02.055
   Adhikari S, 2019, APPL CATAL B-ENVIRON, V244, P11, DOI 10.1016/j.apcatb.2018.11.043
   Adhikari S, 2018, CHEM ENG J, V354, P692, DOI 10.1016/j.cej.2018.08.087
   Ahsaine HA, 2016, CERAM INT, V42, P8552, DOI 10.1016/j.ceramint.2016.02.082
   Alderman NP, 2017, DALTON T, V46, P49, DOI 10.1039/c6dt03658a
   Bae SW, 2007, J KOREAN PHYS SOC, V51, pS22, DOI 10.3938/jkps.51.22
   Bian ZY, 2008, INORG CHEM, V47, P10801, DOI 10.1021/ic801527y
   Bian ZY, 2009, DALTON T, P983, DOI 10.1039/b814340d
   Cheng HF, 2012, CHEM COMMUN, V48, P9729, DOI 10.1039/c2cc35289c
   Choi KM, 2017, J AM CHEM SOC, V139, P356, DOI 10.1021/jacs.6b11027
   Dai WL, 2017, APPL SURF SCI, V403, P230, DOI 10.1016/j.apsusc.2017.01.171
   Gondal MA, 2017, J PHOTOCH PHOTOBIO A, V343, P40, DOI 10.1016/j.jphotochem.2017.04.016
   Hou CX, 2019, J MATER CHEM A, V7, P13460, DOI 10.1039/c9ta03551f
   Jiang ZY, 2017, APPL CATAL B-ENVIRON, V219, P209, DOI 10.1016/j.apcatb.2017.07.023
   Kumar B, 2012, ANNU REV PHYS CHEM, V63, P541, DOI 10.1146/annurev-physchem-032511-143759
   Kuriki R, 2016, J AM CHEM SOC, V138, P5159, DOI 10.1021/jacs.6b01997
   Le K, 2019, DALTON T, V48, P5193, DOI 10.1039/c9dt00615j
   Li CM, 2015, APPL CATAL B-ENVIRON, V163, P415, DOI 10.1016/j.apcatb.2014.07.060
   Li K, 2016, APPL CATAL B-ENVIRON, V180, P130, DOI 10.1016/j.apcatb.2015.06.022
   Lin B, 2019, DALTON T, V48, P8279, DOI 10.1039/c9dt01218d
   Lin L, 2018, APPL CATAL B-ENVIRON, V221, P312, DOI 10.1016/j.apcatb.2017.09.033
   Lin X, 2014, MATER SCI ENG B-ADV, V188, P35, DOI 10.1016/j.mseb.2014.06.005
   Lin ZP, 2019, CHEMCATCHEM, V11, P2217, DOI 10.1002/cctc.201900095
   Liu LJ, 2016, ACS CATAL, V6, P1097, DOI 10.1021/acscatal.5b02098
   Liu X, 2016, ANGEW CHEM INT EDIT, V55, P14924, DOI 10.1002/anie.201600395
   Meng XC, 2017, APPL CATAL B-ENVIRON, V210, P160, DOI 10.1016/j.apcatb.2017.02.083
   Nakada A, 2016, GREEN CHEM, V18, P139, DOI 10.1039/c5gc01720c
   Nikokavoura A, 2017, APPL SURF SCI, V391, P149, DOI 10.1016/j.apsusc.2016.06.172
   Pan D, 2019, IND ENG CHEM RES, V58, P836, DOI 10.1021/acs.iecr.8b04829
   Ramirez A, 2005, CHEM ENG SCI, V60, P4702, DOI 10.1016/j.ces.2005.03.004
   Rosser TE, 2016, ANGEW CHEM INT EDIT, V55, P7388, DOI 10.1002/anie.201601038
   Sekizawa K, 2013, J AM CHEM SOC, V135, P4596, DOI 10.1021/ja311541a
   Shang M, 2009, CRYST GROWTH DES, V9, P991, DOI 10.1021/cg800799a
   Sheng YY, 2019, APPL SURF SCI, V465, P154, DOI 10.1016/j.apsusc.2018.09.137
   Shi ZJ, 2019, GREEN CHEM LETT REV, V12, P235, DOI 10.1080/17518253.2019.1627428
   Shi ZJ, 2019, SCI ADV MATER, V11, P1198, DOI 10.1166/sam.2019.3559
   Shi ZJ, 2019, SCI ADV MATER, V11, P699, DOI 10.1166/sam.2019.3473
   Shi ZJ, 2019, INT J BIOL MACROMOL, V133, P964, DOI 10.1016/j.ijbiomac.2019.04.128
   Shindume HL, 2019, J NANOSCI NANOTECHNO, V19, P839, DOI 10.1166/jnn.2019.15745
   Sinopoli A, 2018, COORDIN CHEM REV, V365, P60, DOI 10.1016/j.ccr.2018.03.011
   Sun HY, 2019, J COLLOID INTERF SCI, V547, P40, DOI 10.1016/j.jcis.2019.03.061
   Takeda H, 2014, CHEM COMMUN, V50, P1491, DOI 10.1039/c3cc48122k
   Tian JY, 2019, J COLLOID INTERF SCI, V541, P18, DOI 10.1016/j.jcis.2019.01.069
   Wang C, 2019, CHEMSUSCHEM, V12, P1576, DOI 10.1002/cssc.201802873
   Wang M, 2017, NANOTECHNOLOGY, V28, P1, DOI 10.1088/1361-6528/aa6bb5
   Wang W, 2016, APPL CATAL A-GEN, V520, P1, DOI 10.1016/j.apcata.2016.04.003
   Wang XJ, 2014, CATAL LETT, V144, P1268, DOI 10.1007/s10562-014-1271-z
   Windle CD, 2015, CHEM-EUR J, V21, P3746, DOI 10.1002/chem.201405041
   Won DI, 2017, FARADAY DISCUSS, V198, P337, DOI 10.1039/c6fd00222f
   Won DI, 2015, J AM CHEM SOC, V137, P13679, DOI 10.1021/jacs.5b08890
   Xu G, 2019, INT J BIOL MACROMOL, V126, P376, DOI 10.1016/j.ijbiomac.2018.12.234
   Zabri H, 2004, J PHOTOCH PHOTOBIO A, V166, P99, DOI 10.1016/j.jphotochem.2004.04.030
   Zhang L, 2013, J PHYS CHEM C, V117, P26316, DOI 10.1021/jp4088783
   Zhang L, 2017, J ELECTROCHEM SOC, V164, pH1086, DOI 10.1149/2.0881714jes
   Zhang L, 2017, J ELECTROCHEM SOC, V164, pH651, DOI 10.1149/2.1531709jes
   Zhang YH, 2013, CHEM SCI, V4, P1820, DOI 10.1039/c3sc50285f
   Zhao W, 2019, NANOSCALE, V11, P50, DOI 10.1039/c8nr08457b
   Zhao ZY, 2019, CHEM REC, V19, P873, DOI 10.1002/tcr.201800153
   Zhou Y, 2011, ACS APPL MATER INTER, V3, P3594, DOI 10.1021/am2008147
   Zhou YX, 2017, MOLECULES, V22, DOI 10.3390/molecules22050859
   Zhu SW, 2017, MOL CATAL, V435, P33, DOI 10.1016/j.mcat.2017.03.016
NR 61
TC 0
Z9 0
U1 39
U2 97
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1246
EP 1255
DI 10.1016/j.ces.2019.07.049
PG 10
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300102
DA 2020-05-12
ER

PT J
AU Felis, F
   Strassl, F
   Laurini, L
   Dietrich, N
   Billet, AM
   Roig, V
   Herres-Pawlis, S
   Loubiere, K
AF Felis, Francisco
   Strassl, Florian
   Laurini, Larissa
   Dietrich, Nicolas
   Billet, Anne-Marie
   Roig, Veronique
   Herres-Pawlis, Sonja
   Loubiere, Karine
TI Using a bio-inspired copper complex to investigate reactive mass
   transfer around an oxygen bubble rising freely in a thin-gap cell
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Reactive bubbly flows; Mass transfer; Bioinspired copper complex;
   Thin-gap cell; Experimental imaging
ID HOMOGENEOUS SWARM; HYDROXYLATION; FLOW; HYDROGENATION; SIMULATIONS;
   SELECTIVITY; TYROSINASE; DYNAMICS
AB The present study describes an original colorimetric method to visualize and quantify the local oxygen mass transfer around a rising bubble in reactive media. This method is based on the use of a colorless bio-inspired copper complex, Cu(btmgp)I, specially tailored for the study, which, dissolved in acetonitrile, oxidizes into an orange copper-complex [Cu2O (2)(btmgp)(2)]I-2. The latter complex, unstable at ambient temperature, decays quite fast into two Cu(II) complexes, leaving a permanent pale-green color as final products. The flow investigated consists in a pure oxygen single bubble rising freely in a confined thingap cell (400 x 200 x 1 mm). A wide range of motion regimes for the bubbles are observed as the Archimedes number ranges from 860 < Ar < 18, 800 and the Reynolds number from 580 < Re < 8200. A high-resolution 16-bit sCMOS camera, combined with specific filters, is used to capture images from a region-of-interest of the cell, illuminated by a white LED backlight panel. An ad hoc calibration protocol is developed to correlate the grey-levels from the colored signal to the equivalent oxygen concentrations. This procedure then allows to measure indirectly the amount of oxygen transferred to the liquid phase. The series of images are also treated to identify the bubble motion and properties. Thanks to this method, equivalent oxygen concentration fields, gap-averaged and time-averaged, can be reached with high precision in the far-field wake of the bubbles, enabling thus to deeply characterize the mass transfer mechanisms under reactive conditions in such confined configuration, and to establish a dimensionless representation in terms of Sherwood number versus Peclet number. At last, thanks to the knowledge of the kinetic rate of the reaction and of the diffusion coefficients, the Hatta number and the enhancement factor are estimated, and thus the intrinsic Sherwood numbers; these results demonstrate that the enhancement of the mass transfer by the reactions involved with the copper-complexes is not negligible (almost 12-15%). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Felis, Francisco; Billet, Anne-Marie; Loubiere, Karine] Univ Toulouse, Lab Genie Chim, CNRS, INPT,UPS, Toulouse, France.
   [Dietrich, Nicolas] Univ Toulouse, Toulouse Biotechnol Inst Bio & Chem Engn TBI, INSA, INRA, Toulouse, France.
   [Roig, Veronique] Univ Toulouse, UPS, INPT, CNRS,IMFT, Toulouse, France.
   [Strassl, Florian; Laurini, Larissa; Herres-Pawlis, Sonja] Rhein Westfal TH Aachen, Inst Anorgan Chem, D-52074 Aachen, Germany.
   [Felis, Francisco] CNRS, Federat Rech FERMAT, Toulouse, France.
RP Loubiere, K (reprint author), Univ Toulouse, Lab Genie Chim, CNRS, INPT,UPS, Toulouse, France.
EM karine.loubiere@ensiacet.fr
RI Billet, Anne-Marie/Y-5082-2019; Dietrich, Nicolas S/E-4971-2017;
   Herres-Pawlis, Sonja/P-3928-2014
OI Billet, Anne-Marie/0000-0002-2589-638X; Dietrich, Nicolas
   S/0000-0001-6169-3101; Herres-Pawlis, Sonja/0000-0002-4354-4353; FELIS,
   Francisco/0000-0002-9103-6281
FU CNRS Research Federation FERMaT in Toulouse [FR 3089]; German Research
   Foundation within the Priority Program "Reactive Bubbly flows" [SPP
   1740]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SPP1740, HE5480/10-2]
FX The authors gratefully acknowledge the financial support provided by the
   CNRS Research Federation FERMaT (FR 3089) in Toulouse and by the German
   Research Foundation within the Priority Program "Reactive Bubbly flows"
   SPP 1740. Sonja Herres-Pawlis thanks the Deutsche Forschungsgemeinschaft
   for generous support (SPP1740, HE5480/10-2).; The authors thank the
   laboratory LCC (CNRS UPR 8241), and especially Dr. Rosa Axet, for
   allowing the use of their glovebox.
CR ACHORD JM, 1980, ANAL CHEM, V52, P601, DOI 10.1021/ac50053a061
   Almeras E, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.074307
   Almeras E, 2016, INT J MULTIPHAS FLOW, V83, P153, DOI 10.1016/j.ijmultiphaseflow.2016.03.011
   Anxionnaz Z, 2008, CHEM ENG PROCESS, V47, P2029, DOI 10.1016/j.cep.2008.06.012
   Aussillous P, 2000, PHYS FLUIDS, V12, P2367, DOI 10.1063/1.1289396
   Bouche E, 2014, J FLUID MECH, V758, P508, DOI 10.1017/jfm.2014.544
   Bouche E, 2012, J FLUID MECH, V704, P211, DOI 10.1017/jfm.2012.233
   Butler C, 2018, INT J MULTIPHAS FLOW, V105, P185, DOI 10.1016/j.ijmultiphaseflow.2018.04.005
   Butler C, 2016, CHEM ENG RES DES, V115, P292, DOI 10.1016/j.cherd.2016.09.001
   Citek C, 2015, ACCOUNTS CHEM RES, V48, P2424, DOI 10.1021/acs.accounts.5b00220
   Dietrich N, 2013, CHEM ENG SCI, V100, P172, DOI 10.1016/j.ces.2013.03.041
   EASTEAL AJ, 1984, J CHEM SOC FARAD T 1, V80, P1287, DOI 10.1039/f19848001287
   Falcone M, 2018, CHEM ENG SCI, V177, P523, DOI 10.1016/j.ces.2017.11.024
   Filella A, 2015, J FLUID MECH, V778, DOI 10.1017/jfm.2015.355
   Hamann JN, 2017, COORDIN CHEM REV, V334, P54, DOI 10.1016/j.ccr.2016.07.009
   Herres S, 2005, INORG CHIM ACTA, V358, P1089, DOI 10.1016/j.ica.2004.10.009
   Herres-Pawlis S, 2005, EUR J INORG CHEM, P3815, DOI 10.1002/ejic.200400822
   Hoffmann A, 2013, ANGEW CHEM INT EDIT, V52, P5398, DOI 10.1002/anie.201301249
   Jimenez M, 2013, CHEM ENG SCI, V100, P160, DOI 10.1016/j.ces.2013.01.036
   Kastens S, 2017, CHEM ENG TECHNOL, V40, P1494, DOI 10.1002/ceat.201700047
   Khinast JG, 2001, AICHE J, V47, P2304, DOI 10.1002/aic.690471015
   Kovats P, 2018, CHEM ENG SCI, V190, P273, DOI 10.1016/j.ces.2018.06.029
   Kroneck P. M. H., 2015, METALS IONS LIFE SCI, V15
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Li Q, 2013, J ELECTROANAL CHEM, V688, P328, DOI 10.1016/j.jelechem.2012.07.039
   Liebhauser P, 2017, CHEM-EUR J, V23, P12171, DOI 10.1002/chem.201700887
   Liebhauser P., 2016, SYNTHESIS SPECTROSCO, DOI [10.1016/B978-0-12-409547-2.11554-9, DOI 10.1016/B978-0-12-409547-2.11554-9]
   Martinez FLD, 2016, CATAL TODAY, V273, P121, DOI 10.1016/j.cattod.2016.04.009
   Oelgemoller M, 2016, CHEM REV, V116, P9664, DOI 10.1021/acs.chemrev.5b00720
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Paul M, 2018, EUR J INORG CHEM, P2101, DOI 10.1002/ejic.201800146
   Pruvost J, 2017, ALGAL RES, V21, P120, DOI 10.1016/j.algal.2016.10.012
   Radl S, 2008, CHEM ENG SCI, V63, P3279, DOI 10.1016/j.ces.2008.03.025
   Rao H, 2017, NATURE, V548, P74, DOI 10.1038/nature23016
   Roig V, 2012, J FLUID MECH, V707, P444, DOI 10.1017/jfm.2012.289
   Roizard C., 1997, TECH ING TRAITE GE J, V1, P1
   Roudet M, 2017, AICHE J, V63, P2394, DOI 10.1002/aic.15562
   Ruttinger S, 2018, CHEMBIOENG REV, V5, P253, DOI 10.1002/cben.201800005
   Schurr D, 2016, REACT CHEM ENG, V1, P485, DOI 10.1039/c6re00119j
   Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t
   Strassl F. Copper, 2019, THESIS
   Thobie C, 2017, CHEM ENG PROCESS, V122, P76, DOI 10.1016/j.cep.2017.10.009
   VANKREVELEN DW, 1948, RECL TRAV CHIM PAY B, V67, P563
   Wilfer C, 2015, CHEM-EUR J, V21, P17639, DOI 10.1002/chem.201501685
   Yang LX, 2017, AICHE J, V63, P2272, DOI 10.1002/aic.15547
NR 45
TC 1
Z9 1
U1 5
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1256
EP 1269
DI 10.1016/j.ces.2019.07.045
PG 14
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300103
OA Green Published, Green Accepted
DA 2020-05-12
ER

PT J
AU Tian, B
   Sakai, VG
   Pappas, C
   van der Goot, AJ
   Bouwman, WG
AF Tian, Bei
   Sakai, Victoria Garcia
   Pappas, Catherine
   van der Goot, Atze Jan
   Bouwman, Wim G.
TI Fibre formation in calcium caseinate influenced by solvent isotope
   effect and drying method - A neutron spectroscopy study
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fibre formation; Calcium caseinate; Protein dynamics; Solvent isotope
   effect; Drying method; Neutron spectroscopy
ID PROTEIN DYNAMICS; FUNCTIONAL-PROPERTIES; THERMAL-DENATURATION;
   GLOBULAR-PROTEINS; HYDRATION WATER; TRANSFER-RNA; AIR BUBBLES;
   SCATTERING; TRANSITION; STABILITY
AB We present an investigation of the dynamics of calcium caseinate as a function of hydration, solvent isotope (H2O and D2O) and drying methods (roller drying and spray drying), using quasi-elastic neutron scattering (QENS). These factors are key to the formation of fibres in this material which makes it a potential candidate as a next-generation meat analogue. Using a phenomenological model, we find that the relaxation times of the dry spray dried powder decrease with increasing temperatures, while they do not change for the roller dried powder. The spectra of the hydrated samples reveal two independent picosecond processes, both reflecting localized re-orientational motions. We hypothesize that the faster motion is due to the external protein groups that are hydrophilic and the slower motion is due to the internal groups that are hydrophobic. The solvent effect of D2O is not limited to the external groups but prevails to the internal groups where less protons are mobile compared to the H2O hydrated samples. Higher temperatures narrow the number difference in mobile protons, possibly by altering the weak interactions inside the protein aggregates. These findings suggest that a harsh and longer drying process contributes to less active protein side-groups and highlight the hydrophobic effect of D2O on the fibre formation in calcium caseinate. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tian, Bei; Pappas, Catherine; Bouwman, Wim G.] Delft Univ Technol, Fac Appl Sci, Dept Radiat Sci & Technol, Mekelweg 15, NL-2629 JB Delft, Netherlands.
   [Sakai, Victoria Garcia] Rutherford Appleton Lab, ISIS Neutron & Muon Facil, Sci & Technol Facil Council, Didcot, Oxon, England.
   [van der Goot, Atze Jan] Wageningen Univ, Food Proc Engn, Wageningen, Netherlands.
RP Bouwman, WG (reprint author), Delft Univ Technol, Fac Appl Sci, Dept Radiat Sci & Technol, Mekelweg 15, NL-2629 JB Delft, Netherlands.
EM w.g.bouwman@tudelft.nl
RI Pappas, Catherine/M-7341-2018; Bouwman, Wim/C-8669-2009
OI Pappas, Catherine/0000-0002-9727-5697; Bouwman, Wim/0000-0002-5331-8085;
   van der Goot, Atze Jan/0000-0001-8005-7864; Garcia Sakai,
   Victoria/0000-0001-6570-4218
FU Netherlands Organisation for Scientific Research (NWO)Netherlands
   Organization for Scientific Research (NWO) [13386]
FX Experiments at the ISIS Pulsed Neutron and Muon Source were supported by
   a beamtime allocation from the Science and Technology Facilities
   Council. This work is part of the research project SSCANFoods (project
   number 13386), which is partly financed by the Netherlands Organisation
   for Scientific Research (NWO). We would like to thank Anton Lefering for
   assisting with the DSC measurements and the sample hydration.
CR Ameseder F, 2018, PHYS CHEM CHEM PHYS, V20, P5128, DOI 10.1039/c7cp08292d
   Anandharamakrishnan C, 2007, DRY TECHNOL, V25, P799, DOI 10.1080/07373930701370175
   Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029
   Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025
   Bu ZM, 2001, J MOL BIOL, V312, P865, DOI 10.1006/jmbi.2001.5006
   Caliskan G, 2006, J AM CHEM SOC, V128, P32, DOI 10.1021/ja056444i
   Caparino OA, 2012, J FOOD ENG, V111, P135, DOI 10.1016/j.jfoodeng.2012.01.010
   CARLILE CJ, 1992, PHYSICA B, V182, P431, DOI 10.1016/0921-4526(92)90047-V
   Chen SH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372491
   Claussen IC, 2007, DRY TECHNOL, V25, P1091, DOI 10.1080/07373930701396444
   Colombo A, 2010, J AGR FOOD CHEM, V58, P4434, DOI 10.1021/jf903426f
   de Kruif CG, 2012, ADV COLLOID INTERFAC, V171, P36, DOI 10.1016/j.cis.2012.01.002
   Dehnad D, 2016, TRENDS FOOD SCI TECH, V57, P116, DOI 10.1016/j.tifs.2016.09.002
   Dekkers BL, 2016, INNOV FOOD SCI EMERG, V36, P193, DOI 10.1016/j.ifset.2016.07.003
   Dhindsa GK, 2014, J PHYS CHEM B, V118, P10821, DOI 10.1021/jp504548w
   DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0
   Doster W, 1999, NATO ADV SCI I A-LIF, V305, P177
   Efimova YM, 2007, BIOPOLYMERS, V85, P264, DOI 10.1002/bip.20645
   Fitter J, 1999, J PHYS CHEM B, V103, P8036, DOI 10.1021/jp9912410
   FRICK B, 1994, MACROMOLECULES, V27, P974, DOI 10.1021/ma00082a014
   Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840
   Gibrat G, 2008, BIOPHYS J, V95, P5247, DOI 10.1529/biophysj.107.120147
   Haque MK, 2004, J FOOD SCI, V69, pE384, DOI 10.1111/j.1365-2621.2004.tb09900.x
   HOLT C, 1992, ADV PROTEIN CHEM, V43, P63, DOI 10.1016/S0065-3233(08)60554-9
   Horne DS, 2003, COLLOID SURFACE A, V213, P255, DOI 10.1016/S0927-7757(02)00518-6
   Horne DS, 2002, CURR OPIN COLLOID IN, V7, P456, DOI 10.1016/S1359-0294(02)00082-1
   Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0
   Ingham B, 2015, SOFT MATTER, V11, P2723, DOI 10.1039/c5sm00153f
   Jansson H, 2006, J PHYS CHEM B, V110, P13786, DOI 10.1021/jp060019+
   Jasnin M, 2008, BIOPHYS J, V95, P857, DOI 10.1529/biophysj.107.124420
   Kealley CS, 2010, BBA-PROTEINS PROTEOM, V1804, P34, DOI 10.1016/j.bbapap.2009.06.027
   Kinsella J. E., 1982, FOOD PROTEINS, P51
   Luck PJ, 2013, J DAIRY SCI, V96, P5522, DOI 10.3168/jds.2013-6617
   Magazu S, 2010, J PHYS CHEM B, V114, P9268, DOI 10.1021/jp102436y
   Manski JM, 2007, TRENDS FOOD SCI TECH, V18, P546, DOI 10.1016/j.tifs.2007.05.002
   Manski JM, 2007, BIOMACROMOLECULES, V8, P1271, DOI 10.1021/bm061008p
   Nickels JD, 2012, BIOPHYS J, V103, P1566, DOI 10.1016/j.bpj.2012.08.046
   Orecchini A, 2002, J PHYS CHEM B, V106, P7348, DOI 10.1021/jp014451x
   Ostrowska-Ligeza E, 2014, J THERM ANAL CALORIM, V118, P911, DOI 10.1007/s10973-014-3846-8
   Perez J, 1999, BIOPHYS J, V77, P454, DOI 10.1016/S0006-3495(99)76903-1
   Perticaroli S, 2014, J PHYS CHEM B, V118, P7317, DOI 10.1021/jp503788r
   Ratti C, 2001, J FOOD ENG, V49, P311, DOI 10.1016/S0260-8774(00)00228-4
   Roh JH, 2006, BIOPHYS J, V91, P2573, DOI 10.1529/biophysj.106.082214
   Roh JH, 2009, BIOPHYS J, V96, P2755, DOI 10.1016/j.bpj.2008.12.3895
   Russo D, 2002, BIOPHYS J, V83, P2792, DOI 10.1016/S0006-3495(02)75288-0
   Sjostrom J, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/415119
   Stadler AM, 2012, BIOPHYS J, V102, P351, DOI 10.1016/j.bpj.2011.12.031
   Tian B, 2018, FOOD HYDROCOLLOID, V83, P287, DOI 10.1016/j.foodhyd.2018.05.006
   VOLINO F, 1980, MOL PHYS, V41, P271, DOI 10.1080/00268978000102761
   Wang ZJ, 2019, FOOD HYDROCOLLOID, V87, P497, DOI 10.1016/j.foodhyd.2018.08.037
   Wood K, 2008, CHEM PHYS, V345, P305, DOI 10.1016/j.chemphys.2007.09.012
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   Zaccai G, 2011, J NON-CRYST SOLIDS, V357, P615, DOI 10.1016/j.jnoncrysol.2010.06.060
NR 53
TC 0
Z9 0
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1270
EP 1277
DI 10.1016/j.ces.2019.07.023
PG 8
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300104
DA 2020-05-12
ER

PT J
AU Rhein, F
   Scholl, F
   Nirschl, H
AF Rhein, Frank
   Scholl, Felix
   Nirschl, Hermann
TI Magnetic seeded filtration for the separation of fine polymer particles
   from dilute suspensions: Microplastics
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Magnetic seeded filtration; Microplastic; Hetero agglomeration;
   Solid-liquid separation
ID WASTE-WATER; NANOPARTICLES; FLOCCULATION; AGGREGATION; REMOVAL
AB Microplastics have become a highly discussed topic: Whether through the decomposition of larger plastic waste or direct usage on a small particle scale, microplastics find their way into the natural ecosystem with uncertain consequences: In particular, the ingestion and therefore the introduction of these particles into the food web (often carrying adsorbed chemicals) poses still not fully understood hazards for mankind. This work focuses on the separation of such particles from aquatic suspensions and evaluates the viability of magnetic seeded filtration in this field. In this study it could be shown that it is generally possible to separate fine polymeric particles from dilute suspensions in a highly effective manner. A broad range of process conditions were investigated with separation efficiencies reaching up to 95%. The pH and ultimately the surface charge of the particles were identified to be the crucial process relevant parameters. More exactly, the surface potentials should be either small or oppositely charged leading to a diminishing or even attractive electrostatic interaction. However, when both agglomeration partners exhibit an electrostatic repulsion, a thorough parameter optimization nevertheless yielded high separation efficiencies. In particular, the ionic strength and magnetic seed concentration proved to be determining factors in this case. Lastly, the process kinetics were investigated and a limited exponential growth character was observed which could be modeled with basic equations from agglomeration theory under simplifying assumptions. This knowledge further assists the selection of an optimal parameter set for a process engineering application. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Rhein, Frank; Scholl, Felix; Nirschl, Hermann] KIT, Inst Mech Proc Engn & Mech, Str Forum 8, D-76131 Karlsruhe, Germany.
RP Rhein, F (reprint author), KIT, Inst Mech Proc Engn & Mech, Str Forum 8, D-76131 Karlsruhe, Germany.
EM frank.rhein@kit.edu
OI Rhein, Frank/0000-0002-7654-3824
FU DFG (German Research Foundation) in the priority program 2045 Highly
   specific and multidimensional fractionation of fine particle systems
   with technical relevanceGerman Research Foundation (DFG)
FX The authors acknowledge the support of the Institute for Technical
   Chemistry and Polymer Chemistry for help with the contact angle
   measurement probe preparation. The research project is funded by the DFG
   (German Research Foundation) in the priority program 2045 Highly
   specific and multidimensional fractionation of fine particle systems
   with technical relevance.
CR Andrady AL, 2015, MARINE ANTHROPOGENIC LITTER, P57, DOI 10.1007/978-3-319-16510-3_3
   Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205
   Berger P. D., 2018, EXPT DESIGN APPL MAN, DOI [10.1007/978-3-319-64583-4, DOI 10.1007/978-3-319-64583-4]
   Browne MA, 2015, MARINE ANTHROPOGENIC LITTER, P229, DOI 10.1007/978-3-319-16510-3_9
   Chin Ching-Ju Monica, 2010, Journal of Environmental Engineering and Management, V20, P145
   Chin CJM, 2006, CHEMOSPHERE, V63, P1809, DOI 10.1016/j.chemosphere.2005.09.035
   Chin CJ, 1998, J COLLOID INTERF SCI, V206, P532, DOI 10.1006/jcis.1998.5737
   Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025
   Elimelech M., 1998, COLLOID SURFACE ENG, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]
   Fang M, 2010, PHYSICA C, V470, P1827, DOI 10.1016/j.physc.2010.05.216
   Galgani F, 2015, MARINE ANTHROPOGENIC LITTER, P29, DOI 10.1007/978-3-319-16510-3_2
   Gouin T, 2011, ENVIRON SCI TECHNOL, V45, P1466, DOI 10.1021/es1032025
   Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352
   Karapinar N, 2003, INT J MINER PROCESS, V71, P45, DOI 10.1016/S0301-7516(03)00029-2
   Kirby BJ, 2004, ELECTROPHORESIS, V25, P203, DOI 10.1002/elps.200305755
   Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733
   Kuhn S, 2015, MARINE ANTHROPOGENIC LITTER, P75, DOI 10.1007/978-3-319-16510-3_4
   Ladislav S., 2000, SOLID LIQUID SEPARAT, DOI [10.1016/B978-0-7506-4568-3.X5023-8, DOI 10.1016/B978-0-7506-4568-3.X5023-8]
   Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038
   Luce H. R., 1955, LIFE, V39, P43
   Menzel K, 2013, SEP PURIF TECHNOL, V105, P114, DOI 10.1016/j.seppur.2012.12.019
   PlasticsEurope, 2018, PLAST FACTS 2018
   Rhein F, 2019, COLLOID SURFACE A, V572, P67, DOI 10.1016/j.colsurfa.2019.03.089
   Rochman CM, 2015, MARINE ANTHROPOGENIC LITTER, P117, DOI 10.1007/978-3-319-16510-3_5
   Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a
   Spelter LE, 2010, CHEM ENG SCI, V65, P4173, DOI 10.1016/j.ces.2010.04.028
   Sun ZX, 1998, J COLLOID INTERF SCI, V197, P151, DOI 10.1006/jcis.1997.5239
   Svoboda J., 2004, MAGNETIC TECHNIQUES, DOI [10.1007/1-4020-2107-0., DOI 10.1007/1-4020-2107-0]
   Taboada-Serrano P, 2005, CURR OPIN COLLOID IN, V10, P123, DOI 10.1016/j.cocis.2005.07.003
   TERASHIMA Y, 1986, WATER RES, V20, P537, DOI 10.1016/0043-1354(86)90017-5
   Tsouris C, 1995, CHEM ENG COMMUN, V137, P147, DOI 10.1080/00986449508936373
   Wan TJ, 2011, WATER RES, V45, P6301, DOI 10.1016/j.watres.2011.08.067
   Wu N., 2013, ENVIRON TECHNOL, P1, DOI DOI 10.1080/09593330.2013.788073
NR 33
TC 2
Z9 1
U1 35
U2 114
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1278
EP 1287
DI 10.1016/j.ces.2019.07.052
PG 10
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300105
DA 2020-05-12
ER

PT J
AU Termuhlen, M
   Strakeljahn, B
   Schembecker, G
   Wohlgemuth, K
AF Termuehlen, Maren
   Strakeljahn, Benedikt
   Schembecker, Gerhard
   Wohlgemuth, Kerstin
TI Characterization of slug formation towards the performance of air-liquid
   segmented flow
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Segmented flow; Hydrodynamics; Slug formation; Slug length distribution;
   Image analysis
ID 2-PHASE FLOW; TAYLOR FLOW; BUBBLE FORMATION; FLUID INJECTION; PART I;
   GAS; REGIMES; CRYSTALLIZATION; MICROCHANNELS; HYDRODYNAMICS
AB The increased attention towards continuous processes in, e.g. reaction or crystallization has put emphasis towards gas-liquid two-phase flow and especially towards slug flow. The segmentation leads to narrow residence time distributions under laminar flow conditions enabling the implementation of kinetically slow processes. Furthermore, mixing inside slugs is ensured without introduction of additional mixing devices. However, such internal mixing is affected by the slug length itself and its distribution formed during slug formation. Therefore, for uniform process conditions inside the slugs, they need to be as homogeneous as possible in length identifying slug formation as one of the crucial steps towards the design of slug flow reactors/crystallizers. In this study, the performance of slug flow with focus on slug lengths' homogeneity is quantified by evaluating characteristic values of a slug length distribution. For that, an automated image based quantification method is developed. Various inlet conditions, including the air supply and the geometry of mixer, are investigated regarding their influence on slug length distribution. Different mixer materials are compared such that finally an improved setup towards homogeneity of slug flow is defined. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Termuehlen, Maren; Strakeljahn, Benedikt; Schembecker, Gerhard; Wohlgemuth, Kerstin] TU Dortmund Univ, Lab Plant & Proc Design, Emil Figge Str 70, D-44227 Dortmund, Germany.
RP Wohlgemuth, K (reprint author), TU Dortmund Univ, Lab Plant & Proc Design, Emil Figge Str 70, D-44227 Dortmund, Germany.
EM kerstin.wohlgemuth@tu-dortmund.de
OI Schembecker, Gerhard/0000-0003-0186-9421; Wohlgemuth,
   Kerstin/0000-0001-7914-4303
CR Abolhasani M, 2012, LAB CHIP, V12, P1611, DOI 10.1039/c2lc21043f
   Amador C., 2004, ICMF 04
   Besenhard MO, 2017, CRYST GROWTH DES, V17, P6432, DOI 10.1021/acs.cgd.7b01096
   BRAUNER N, 1992, INT COMMUN HEAT MASS, V19, P29, DOI 10.1016/0735-1933(92)90061-L
   BRETHERTON FP, 1961, J FLUID MECH, V10, P166, DOI 10.1017/S0022112061000160
   Chen L, 2006, INT J HEAT MASS TRAN, V49, P4220, DOI 10.1016/j.ijheatmasstransfer.2006.03.025
   Cubaud T, 2006, FLUID DYN RES, V38, P772, DOI 10.1016/j.fluiddyn.2005.12.004
   Eder RJP, 2012, CRYST GROWTH DES, V12, P4733, DOI 10.1021/cg201567y
   Fu TT, 2015, CHEM ENG SCI, V135, P343, DOI 10.1016/j.ces.2015.02.016
   Fu TT, 2010, CHEM ENG SCI, V65, P3739, DOI 10.1016/j.ces.2010.03.012
   Haase S, 2017, INT J MULTIPHAS FLOW, V88, P251, DOI 10.1016/j.ijmultiphaseflow.2016.09.002
   Haase S, 2016, INT J MULTIPHAS FLOW, V87, P197, DOI 10.1016/j.ijmultiphaseflow.2016.08.003
   Jiang M, 2018, CHEM ENG TECHNOL, V41, P143, DOI 10.1002/ceat.201600276
   Jiang M, 2015, CRYST GROWTH DES, V15, P2486, DOI 10.1021/acs.cgd.5b00263
   Jiang M, 2014, CRYST GROWTH DES, V14, P851, DOI 10.1021/cg401715e
   Jongen N, 2003, CHEM ENG TECHNOL, V26, P303, DOI 10.1002/ceat.200390046
   Liu H, 2005, IND ENG CHEM RES, V44, P4884, DOI 10.1021/ie049307n
   Mayor TS, 2007, IND ENG CHEM RES, V46, P3794, DOI 10.1021/ie0609923
   Mehta H. B., 2013, ASME 2013 11 INT C N, DOI 10.1115/ICNMM2013-73088
   Mehta HB, 2014, HEAT MASS TRANSFER, V50, P1353, DOI 10.1007/s00231-014-1332-2
   Neugebauer P, 2015, CRYST GROWTH DES, V15, P1089, DOI 10.1021/cg501359h
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Qian DY, 2006, CHEM ENG SCI, V61, P7609, DOI 10.1016/j.ces.2006.08.073
   Rajesh VM, 2012, CHEM ENG J, V207, P832, DOI 10.1016/j.cej.2012.07.082
   Robertson K, 2016, CRYST GROWTH DES, V16, P4759, DOI 10.1021/acs.cgd.6b00885
   Serizawa A, 2002, EXP THERM FLUID SCI, V26, P703, DOI 10.1016/S0894-1777(02)00175-9
   Shao N, 2009, CHEM ENG SCI, V64, P2749, DOI 10.1016/j.ces.2009.01.067
   Shao N, 2011, HEAT TRANSFER ENG, V32, P1117, DOI 10.1080/01457632.2011.562460
   Sobieszuk P, 2010, CHEM ENG RES DES, V88, P263, DOI 10.1016/j.cherd.2009.07.007
   Su M, 2018, IND ENG CHEM RES, V57, P3781, DOI 10.1021/acs.iecr.7b05236
   Suo M, 1964, J BASIC ENG, V86, P576, DOI DOI 10.1115/1.3653176
   Triplett KA, 1999, INT J MULTIPHAS FLOW, V25, P377, DOI 10.1016/S0301-9322(98)00054-8
   Wittering K., 2015, THESIS
NR 33
TC 0
Z9 0
U1 13
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1288
EP 1298
DI 10.1016/j.ces.2019.07.033
PG 11
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300106
DA 2020-05-12
ER

PT J
AU Shang, W
   Zhan, XQ
   Wen, YQ
   Li, YQ
   Zhang, Z
   Wu, F
   Wang, CL
AF Shang, Wei
   Zhan, Xiaoqiang
   Wen, Yuqing
   Li, Yuqing
   Zhang, Zhe
   Wu, Fang
   Wang, Chunlei
TI Deposition mechanism of electroless nickel plating of composite coatings
   on magnesium alloy
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Mg alloy; Composite coatings; Electroless nickel; Deposition mechanism
ID MICRO-ARC OXIDATION; CORROSION-RESISTANCE; FILM
AB To investigate the deposition mechanism of the outermost electroless nickel plating layer in a three-layer composite coatings on the magnesium alloy surface, the electroless nickel plating layers with six different plating times (3, 5, 10, 30, 60, and 90 min) were selected as research targets. The transformations in microcosmic morphology, element composition and material structure of the samples electrolessly plated at six different plating times were characterized by SEM. EDS and XRD. The changes in corrosion resistance of samples with different electroless plating times were measured by polarization curve. It was concluded that the nickel-phosphorus deposition process on the activation composite coatings was a "cell-like three-dimensional" growth judging from the microscopic morphology of coating surface obtained by SEM. The elemental changes obtained from the EDS were consistent with the growth of nickel cells obtained SEM. The XRD results showed that the diffraction peaks of nickel were not detected on the surface at an electroless plating time of 3 min. Nickel peaks appeared after 5 min of electroless plating, and the nickel peak width broadened and the intensity increased as the electroless plating time increased. The corrosion resistance is greatly improved when the electroless plating is performed for 60 min due to the complete nickel coating without defects as shown in the SEM. It can be concluded that the deposition mechanism of electroless plating on the double-layer active surface is an initial ecological reduction [H] autocatalytic reduction deposition process according to the micromorphology and structure of the samples electrolessly plated at six different plating times. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shang, Wei; Zhan, Xiaoqiang; Wen, Yuqing; Li, Yuqing; Zhang, Zhe; Wu, Fang] Guilin Univ Technol, Coll Chem & Bioengn, Guangxi Key Lab Electrochem & Magnetochem Funct M, Guilin 541004, Peoples R China.
   [Wang, Chunlei] Florida Int Univ, Dept Mech & Mat Engn, Coll Engn & Comp, Miami, FL 33199 USA.
RP Wen, YQ (reprint author), Guilin Univ Technol, Coll Chem & Bioengn, Guangxi Key Lab Electrochem & Magnetochem Funct M, Guilin 541004, Peoples R China.; Wang, CL (reprint author), Florida Int Univ, Dept Mech & Mat Engn, Coll Engn & Comp, Miami, FL 33199 USA.
EM 2006027@glut.edu.cn; wangc@fiu.edu
RI Wang, Chunlei/E-5282-2012
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51664011, 51665010]; Project of Guangxi Key
   Laboratory Foundation of China [EMFM20181106]
FX This work was financially supported by National Natural Science
   Foundation of China (No. 51664011 and No. 51665010), and the Project of
   Guangxi Key Laboratory Foundation of China (No. EMFM20181106).
CR Chen MA, 2013, SURF COAT TECH, V232, P726, DOI 10.1016/j.surfcoat.2013.06.087
   Correa E, 2013, SURF COAT TECH, V232, P784, DOI 10.1016/j.surfcoat.2013.06.100
   Duan HP, 2006, ELECTROCHIM ACTA, V51, P2898, DOI 10.1016/j.electacta.2005.08.026
   Elsener B, 2008, J APPL ELECTROCHEM, V38, P1053, DOI 10.1007/s10800-008-9573-8
   Fan XZ, 2013, APPL SURF SCI, V277, P272, DOI 10.1016/j.apsusc.2013.04.044
   Gan R, 2017, CORROS SCI, V123, P147, DOI 10.1016/j.corsci.2017.04.018
   Georgiza E, 2013, SURF COAT TECH, V232, P432, DOI 10.1016/j.surfcoat.2013.05.047
   Gu CD, 2005, J ALLOY COMPD, V391, P104, DOI 10.1016/j.jallcom.2004.07.083
   Guo XH, 2012, CORROS SCI, V65, P367, DOI 10.1016/j.corsci.2012.08.055
   Jian SY, 2016, J TAIWAN INST CHEM E, V68, P496, DOI 10.1016/j.jtice.2016.09.040
   Loto CA, 2016, SILICON-NETH, V8, P177, DOI 10.1007/s12633-015-9367-7
   Luo D, 2018, J ALLOY COMPD, V731, P731, DOI 10.1016/j.jallcom.2017.10.017
   Petro R, 2012, J ELECTROCHEM SOC, V159, pD455, DOI 10.1149/2.069207jes
   Qi H, 2018, CORROS SCI, V138, P170, DOI 10.1016/j.corsci.2018.04.013
   Qin TN, 2011, T NONFERR METAL SOC, V21, P2790, DOI 10.1016/S1003-6326(11)61125-4
   Shang W, 2017, INT J ELECTROCHEM SC, V12, P11875, DOI 10.20964/2017.12.14
   Song GL, 2012, CORROS SCI, V62, P61, DOI 10.1016/j.corsci.2012.04.045
   Song YW, 2008, ELECTROCHIM ACTA, V53, P2135, DOI 10.1016/j.electacta.2007.09.026
   Song ZW, 2015, J ALLOY COMPD, V623, P274, DOI 10.1016/j.jallcom.2014.10.130
   Sudagar J, 2012, PROG ORG COAT, V74, P788, DOI 10.1016/j.porgcoat.2011.10.022
   Tsai TK, 2004, APPL SURF SCI, V233, P180, DOI 10.1016/j.apsusc.2004.03.014
   Wang ML, 2013, T NONFERR METAL SOC, V23, P3629, DOI 10.1016/S1003-6326(13)62910-6
   Wei YK, 2018, CORROS SCI, V138, P105, DOI 10.1016/j.corsci.2018.04.018
   Xiang Y., 2017, T IMF, V79, P30
   Xie ZH, 2012, J COAT TECHNOL RES, V9, P107, DOI 10.1007/s11998-011-9336-z
   Zeng LY, 2010, ELECTROCHIM ACTA, V55, P3376, DOI 10.1016/j.electacta.2010.01.041
   Zhan XQ, 2019, J ALLOY COMPD, V774, P522, DOI 10.1016/j.jallcom.2018.10.059
   Zhang J, 2016, INT J ELECTROCHEM SC, V11, P10053, DOI 10.20964/2016.12.57
   Zucchi F, 2008, MATER CHEM PHYS, V110, P263, DOI 10.1016/j.matchemphys.2008.02.015
   刘永健, 2001, [华东理工大学学报. 自然科学版, Journal of East China University of Science and Technoloy. Natural Sciences Edition], V27, P301
NR 30
TC 1
Z9 1
U1 23
U2 59
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1299
EP 1308
DI 10.1016/j.ces.2019.07.048
PG 10
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300107
DA 2020-05-12
ER

PT J
AU Lee, JW
   Seidel-Morgenstern, A
AF Lee, Ju Weon
   Seidel-Morgenstern, Andreas
TI Solving hyperbolic conservation laws with active counteraction against
   numerical errors: Isothermal fixed-bed adsorption
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Active counteraction scheme; Liquid chromatography; Mixing cell model;
   Simulated moving bed; Generalized Langmuir isotherms; Multi-component
   simulation
ID PARTIAL-DIFFERENTIAL-EQUATIONS; SOLVENT GRADIENT OPERATION;
   MODEL-PREDICTIVE CONTROL; SIMULATED MOVING BEDS; CHROMATOGRAPHY; DESIGN;
   SEPARATION; PROPAGATION; SYSTEMS; BINARY
AB First-order partial differential equations are frequently applied for the simulation of adsorption and reaction processes. The numerous numerical methods available are typically applied without any further modifications despite of various well-known errors caused by, for example, numerical dissipation and crude approximations of certain phenomena. In this work, we analyzed a classical mixing cell model that is capable to simulate isothermal liquid chromatographic separation processes with incompressible mobile phases. This model corresponds to a 1D model of a chromatographic column discretized with a first-order finite volume method. It is our aim to counteract actively two errors, namely numerical dispersion (i.e. the second-order spatial derivative in truncation error) and partition inconsistency related to the nonlinear partition quantified by a competitive adsorption isotherm model. The new numerical method introduced in this article maintains characteristics of the first-order base scheme (non-oscillatory and conditionally stable) and offers enhanced accuracy (smaller numerical errors and improved description of shock waves). Furthermore, the method does not require solving the system of differential-algebraic equations that cause large matrix computations, but rather solves nonlinear equations 'cell-by-cell'. The numerical routines can be easily parallelized to accelerate computation time with multi-core CPUs. To test the method developed, four-zone simulated moving bed adsorption as a challenging example was considered, which causes dynamically changing complex concentration profiles by periodic operation using several columns. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Lee, Ju Weon; Seidel-Morgenstern, Andreas] Max Planck Inst Dynam Complex Tech Syst, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Seidel-Morgenstern, Andreas] Otto von Guericke Univ, Inst Proc Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Lee, JW (reprint author), Max Planck Inst Dynam Complex Tech Syst, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM lee@mpi-magdeburg.apg.de
CR Abel S, 2004, J CHROMATOGR A, V1026, P47, DOI 10.1016/j.chroma.2003.11.054
   Abel S, 2002, J CHROMATOGR A, V944, P23, DOI 10.1016/S0021-9673(01)01087-1
   Alhumaizi K, 2004, COMPUT CHEM ENG, V28, P1759, DOI 10.1016/j.compchemeng.2004.02.032
   Amdahl GM, 1967, P APR 18 20 1967 SPR, V30, P483, DOI DOI 10.1145/1465482.1465560
   Neto ASA, 2016, J CHROMATOGR A, V1470, P42, DOI 10.1016/j.chroma.2016.09.070
   BROUGHTON DB, 1970, CHEM ENG PROG, V66, P70
   BURDEN RL, 1993, NUMERICAL ANAL
   Coimbra MD, 2000, J COMPUT APPL MATH, V115, P169, DOI 10.1016/S0377-0427(99)00171-5
   COURANT R, 1952, COMMUN PUR APPL MATH, V5, P243, DOI 10.1002/cpa.3160050303
   Courant R, 1928, MATH ANN, V100, P32, DOI 10.1007/BF01448839
   Craig LC, 1944, J BIOL CHEM, V155, P519
   Crnjaric-Zic N, 2004, J COMPUT PHYS, V200, P512, DOI 10.1016/j.jcp.2004.04.012
   CZOK M, 1990, COMPUT CHEM ENG, V14, P1435, DOI 10.1016/0098-1354(90)80022-4
   CZOK M, 1990, ANAL CHEM, V62, P189, DOI 10.1021/ac00201a020
   DeVault D, 1943, J AM CHEM SOC, V65, P532, DOI 10.1021/ja01244a011
   Findenegg GH, 2007, J CHROMATOGR A, V1150, P236, DOI 10.1016/j.chroma.2007.01.073
   HEUER C, 1995, CHEM ENG SCI, V50, P1115, DOI 10.1016/0009-2509(94)00498-G
   Jiang GS, 1996, J COMPUT PHYS, V126, P202, DOI 10.1006/jcph.1996.0130
   John V, 2012, J COMPUT PHYS, V231, P1570, DOI 10.1016/j.jcp.2011.10.025
   Kim KM, 2017, CHEM ENG TECHNOL, V40, P2163, DOI 10.1002/ceat.201700206
   Klatt KU, 2002, J PROCESS CONTR, V12, P203, DOI 10.1016/S0959-1524(01)00005-1
   KRAMERS H, 1953, CHEM ENG SCI, V2, P173, DOI 10.1016/0009-2509(53)80039-4
   LAX P, 1960, COMMUN PUR APPL MATH, V13, P217, DOI 10.1002/cpa.3160130205
   Leao CP, 2004, COMPUT CHEM ENG, V28, P1725, DOI 10.1016/j.compchemeng.2004.01.007
   Lee JW, 2018, IFAC PAPERSONLINE, V51, P530, DOI 10.1016/j.ifacol.2018.09.370
   Lee JW, 2014, CHEM ENG J, V251, P355, DOI 10.1016/j.cej.2014.04.043
   LeVeque Randall J., 2002, FINITE VOLUME METHOD
   LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839
   LIU XD, 1994, J COMPUT PHYS, V115, P200, DOI 10.1006/jcph.1994.1187
   LOUREIRO JM, 1991, CHEM ENG SCI, V46, P3259, DOI 10.1016/0009-2509(91)85027-U
   Martin AJP, 1941, BIOCHEM J, V35, P1358, DOI 10.1042/bj0351358
   Mazzotti M, 2006, J CHROMATOGR A, V1126, P311, DOI 10.1016/j.chroma.2006.06.022
   Migliorini C, 1999, IND ENG CHEM RES, V38, P2400, DOI 10.1021/ie980262y
   Rhee H.-K., 1989, 1 ORDER PARTIAL DIFF, VII
   ROUCHON P, 1987, SEPAR SCI TECHNOL, V22, P1793, DOI 10.1080/01496398708057614
   STORTI G, 1993, AICHE J, V39, P471, DOI 10.1002/aic.690390310
   VILLERMAUX J, 1987, J CHROMATOGR, V406, P11, DOI 10.1016/S0021-9673(00)94014-7
   von Lieres E, 2010, COMPUT CHEM ENG, V34, P1180, DOI 10.1016/j.compchemeng.2010.03.008
   Wu DJ, 1998, IND ENG CHEM RES, V37, P4023, DOI 10.1021/ie9801711
   Zhong GM, 1996, CHEM ENG SCI, V51, P4307, DOI 10.1016/0009-2509(96)00262-X
NR 40
TC 0
Z9 0
U1 3
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1309
EP 1330
DI 10.1016/j.ces.2019.07.053
PG 22
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300108
DA 2020-05-12
ER

PT J
AU Abiev, RS
   Butler, C
   Cid, E
   Lalanne, B
   Billet, AM
AF Abiev, R. Sh
   Butler, C.
   Cid, E.
   Lalanne, B.
   Billet, A-M
TI Mass transfer characteristics and concentration field evolution for
   gas-liquid Taylor flow in milli channels
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Taylor flow; Milli channels; Mass transfer; Taylor vortex; T-mixer
ID SLUG FLOW; BUBBLES; SQUARE; CIRCULATION; VELOCITY; FILM; WALL
AB The results of the recent experimental work performed by Butler et al. (2016, 2018) are analysed based on the dominant phenomena: (i) small scale convection by means of Taylor vortices in the liquid slugs and (ii) diffusion in lubrication film. A main result shown here is that the Taylor circulation frequency is able to reflect the global mass transfer rate in gas-liquid Taylor flow through an almost linear relationship, which emphasizes the interest of the circulating motion in the slug, and gives a very simple correlation to predict the k(L)a value (at large Schmidt number). A mechanism of flow behavior during the bubble formation at the T-mixer is proposed as a possible explanation of unexpected concentration areas (called "islands"). However, despite of these unusual concentration field structures in these cases, the mass transfer rate coefficient k(L)a is still accurately predicted by the Taylor circulation frequency in the slug. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Abiev, R. Sh] St Petersburg State Inst Technol Tech Univ, Dept Optimizat Chem & Biotechnol Equipment, 26 Moskovskii Pr, St Petersburg 190013, Russia.
   [Butler, C.; Cid, E.; Lalanne, B.; Billet, A-M] Univ Toulouse, Lab Genie Chim, CNRS, INPT,UPS, Toulouse, France.
   [Butler, C.; Cid, E.; Lalanne, B.; Billet, A-M] Univ Toulouse, FERMAT, CNRS, INP,INSA,UPS, Toulouse, France.
RP Abiev, RS (reprint author), St Petersburg State Inst Technol Tech Univ, Dept Optimizat Chem & Biotechnol Equipment, 26 Moskovskii Pr, St Petersburg 190013, Russia.
EM abiev.rufat@gmail.com
RI Billet, Anne-Marie/Y-5082-2019; cid, emmanuel/Y-4762-2019; Abiev,
   Rufat/AAF-2556-2019; Lalanne, Benjamin/Y-7208-2019; Abiev,
   Rufat/J-4139-2013
OI Billet, Anne-Marie/0000-0002-2589-638X; cid,
   emmanuel/0000-0003-0564-4596; Lalanne, Benjamin/0000-0002-1074-0219;
   Butler, Colin/0000-0002-6431-5947; Abiev, Rufat/0000-0003-3571-5770
FU Russian Foundation for Basic ResearchRussian Foundation for Basic
   Research (RFBR) [N2 18-03-00206-a]
FX The work was partially financially supported by the Russian Foundation
   for Basic Research according to the research project N2 18-03-00206-a.
   There are no other potential conflicts of interest.
CR Abiev RS, 2013, CHEM ENG J, V227, P66, DOI 10.1016/j.cej.2012.10.009
   Abiev RS, 2012, CHEM ENG SCI, V74, P59, DOI 10.1016/j.ces.2012.02.024
   Abiev RS, 2010, THEOR FOUND CHEM EN+, V44, P86, DOI 10.1134/S0040579510010112
   Abiev RS, 2009, THEOR FOUND CHEM EN+, V43, P298, DOI 10.1134/S0040579509030099
   Bercic G, 1997, CHEM ENG SCI, V52, P3709, DOI 10.1016/S0009-2509(97)00217-0
   Butler C, 2018, INT J MULTIPHAS FLOW, V105, P185, DOI 10.1016/j.ijmultiphaseflow.2018.04.005
   Butler C, 2016, CHEM ENG RES DES, V115, P292, DOI 10.1016/j.cherd.2016.09.001
   Dietrich N, 2013, CHEM ENG SCI, V100, P172, DOI 10.1016/j.ces.2013.03.041
   Kovats P, 2018, CHEM ENG SCI, V190, P273, DOI 10.1016/j.ces.2018.06.029
   Kreutzer MT, 2001, CHEM ENG SCI, V56, P6015, DOI 10.1016/S0009-2509(01)00271-8
   Leung SSY, 2012, IND ENG CHEM RES, V51, P2010, DOI 10.1021/ie200610k
   Matsuoka A, 2016, CHEM ENG SCI, V155, P306, DOI 10.1016/j.ces.2016.08.021
   Sattari-Najafabadi M, 2018, CHEM ENG PROCESS, V127, P213, DOI 10.1016/j.cep.2018.03.012
   Sattari-Najafabadi M, 2017, CHEM ENG PROCESS, V117, P9, DOI 10.1016/j.cep.2017.03.011
   Svetlov SD, 2016, THEOR FOUND CHEM EN+, V50, P975, DOI 10.1134/S0040579516060166
   TAYLOR GI, 1961, J FLUID MECH, V10, P161, DOI 10.1017/S0022112061000159
   Thulasidas TC, 1997, CHEM ENG SCI, V52, P2947, DOI 10.1016/S0009-2509(97)00114-0
   van Baten JM, 2004, CHEM ENG SCI, V59, P2535, DOI 10.1016/j.ces.2004.03.010
   Wang K, 2017, CHEM ENG SCI, V169, P18, DOI 10.1016/j.ces.2016.10.025
   Yang L, 2017, CHEM ENG SCI, V165, P192, DOI 10.1016/j.ces.2017.03.007
   Yue J, 2009, CHEM ENG SCI, V64, P3697, DOI 10.1016/j.ces.2009.05.026
   Zhang JZ, 2016, INT J HEAT MASS TRAN, V103, P45, DOI 10.1016/j.ijheatmasstransfer.2016.07.007
NR 22
TC 2
Z9 2
U1 16
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1331
EP 1340
DI 10.1016/j.ces.2019.07.046
PG 10
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300109
OA Green Published
DA 2020-05-12
ER

PT J
AU Sharma, A
   Patwardhan, A
   Dasgupta, K
   Joshi, JB
AF Sharma, Anita
   Patwardhan, Ashwin
   Dasgupta, Kinshuk
   Joshi, Jyeshtharaj B.
TI Kinetic study of boron doped carbon nanotubes synthesized using chemical
   vapour deposition
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Boron; Carbon nanotubes; Doping; Kinetics; Chemical vapour deposition;
   Mechanism
ID GROWTH MECHANISMS; STEP
AB Boron doped carbon nanotubes were synthesized using chemical vapour deposition using acetylene as carbon source, boric acid as boron source and Ferrocene/MgO as catalyst/support. Boric acid was directly used as a solid precursor for doping boron in the CNT lattice. A kinetic model was established by varying the temperature of the reactor, partial pressure of reactants, flow rates and catalyst concentration. The rate controlling steps were studied and the optimal reaction conditions were established so as to synthesize the desired quantity and quality of boron doped carbon nanotubes. Boron doping of 6.31-6.71 at.% was obtained. Two different mechanisms were found to control the rate of reaction at different range of temperatures. The activation energy for the two mechanisms was found to be 18.21 kJ/mol and 6.73 kJ/mol respectively. A mechanism was proposed and validated using the experimental data so as to understand the growth of B-CNTs. The synthesized B-CNTs were purified using concentrated hydrochloric acid and characterized by using SEM, TEM to understand the surface characteristics; FTIR and XPS to detect and quantify the boron present in the sample, Raman spectroscopy and TGA analysis to determine the purity of the product. (C) 2019 Published by Elsevier Ltd.
C1 [Sharma, Anita; Patwardhan, Ashwin; Joshi, Jyeshtharaj B.] Inst Chem Technol, Dept Chem Engn, Nathalal Parekh Marg, Mumbai 400019, Maharashtra, India.
   [Dasgupta, Kinshuk] Bhabha Atom Res Ctr, Mat Grp, Mumbai 400085, Maharashtra, India.
   [Joshi, Jyeshtharaj B.] Homi Bhabha Natl Inst, Mumbai 400094, Maharashtra, India.
RP Joshi, JB (reprint author), Inst Chem Technol, Dept Chem Engn, Nathalal Parekh Marg, Mumbai 400019, Maharashtra, India.
EM jbjoshi@gmail.com
RI Dasgupta, Kinshuk/D-7418-2011
OI Dasgupta, Kinshuk/0000-0002-5742-7799; Patwardhan,
   Ashwin/0000-0001-9893-1249
FU DAE-ICT centre
FX The authors acknowledge DAE-ICT centre for supporting the project. The
   authors would also like to acknowledge the Sophisticated Analytical
   Instrument Facility (SAIF) department of IIT Bombay for providing the
   TEM and HRTEM images for B-CNTs. The authors would also like to
   acknowledge Central Surface Analytical Facility (ESCA), Department of
   Physics, IIT Bombay for providing the XPS results.
CR Ayala P, 2008, J MATER CHEM, V18, P5676, DOI 10.1039/b809050e
   Chen CF, 2003, DIAM RELAT MATER, V12, P1500, DOI 10.1016/S0925-9635(03)00181-X
   Daothong S, 2009, PHYS STATUS SOLIDI B, V246, P2518, DOI 10.1002/pssb.200982358
   Dasgupta K, 2014, AICHE J, V60, P2882, DOI 10.1002/aic.14482
   Ebbesen T. W., 1996, CARBON NANOTUBES PRE
   Ewels C., 2007, DOPED NANOMATER NANO, V3
   Ewels C., 2010, DOPED NANOMATER NANO, P1
   Fogler HS, 1999, ELEMENTS CHEM REACTI
   Handuja S, 2009, NANOSCALE RES LETT, V4, P789, DOI 10.1007/s11671-009-9315-9
   Hodkiewicz J., 2010, CHARACTERIZATION CAR
   Huang JQ, 2012, CATAL TODAY, V186, P83, DOI 10.1016/j.cattod.2011.10.021
   Keru G, 2015, MATER CHEM PHYS, V153, P323, DOI 10.1016/j.matchemphys.2015.01.020
   Koos AA, 2010, CARBON, V48, P3033, DOI 10.1016/j.carbon.2010.04.026
   Kumar M, 2010, J NANOSCI NANOTECHNO, V10, P3739, DOI 10.1166/jnn.2010.2939
   Lyu SC, 2011, CARBON, V49, P1532, DOI 10.1016/j.carbon.2010.12.012
   MacKenzie KJ, 2010, IND ENG CHEM RES, V49, P5323, DOI 10.1021/ie9019787
   Mitri SP, 2005, REV ADV MATER SCI, V10, P314
   Mohammad SN, 2014, CARBON, V75, P133, DOI 10.1016/j.carbon.2014.03.045
   Monteiro FH, 2012, J PHYS CHEM C, V116, P3281, DOI 10.1021/jp209494z
   Panchakarla LS, 2010, INORG CHIM ACTA, V363, P4163, DOI 10.1016/j.ica.2010.07.057
   Preston C, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/44/445601
   Redlich P, 1996, CHEM PHYS LETT, V260, P465, DOI 10.1016/0009-2614(96)00817-2
   RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5
   Saito R., 1998, PHYS PROPERTIES CARB
   Sevim F, 2006, KOREAN J CHEM ENG, V23, P736, DOI 10.1007/BF02705920
   Sharma A, 2017, CHEM ENG SCI, V170, P756, DOI 10.1016/j.ces.2017.03.017
   Susi T, 2011, PHYS CHEM CHEM PHYS, V13, P11303, DOI 10.1039/c1cp20454h
   Terrones M, 2003, ANNU REV MATER RES, V33, P419, DOI 10.1146/annurev.matsci.33.012802.100255
   Tetana ZN, 2017, DIAM RELAT MATER, V74, P70, DOI 10.1016/j.diamond.2017.02.005
   Trasobares S, 2002, J CHEM PHYS, V116, P8966, DOI 10.1063/1.1473195
   Wang Z, 2007, VACUUM, V81, P579, DOI 10.1016/j.vacuum.2006.05.012
   Watanabe T, 2010, PHYSICA C, V470, pS608, DOI 10.1016/j.physc.2010.01.037
   Zhang M, 2014, J MATER CHEM A, V2, P16268, DOI 10.1039/c4ta02623c
NR 33
TC 0
Z9 0
U1 15
U2 53
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1341
EP 1352
DI 10.1016/j.ces.2019.06.030
PG 12
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300110
DA 2020-05-12
ER

PT J
AU Guldena, SJ
   Riedele, C
   Mueller, S
   Kopf, MH
   Nirschl, H
AF Guldena, S. J.
   Riedele, C.
   Mueller, S.
   Kopf, M-H
   Nirschl, H.
TI Combining small-scale screening methods to predict microorganism
   floatability
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Flotation; Small-scale screening; Microorganism; Particle size;
   Hydrophobicity; Bubble-particle interaction forces
ID CELL-SURFACE HYDROPHOBICITY; BUBBLE-PARTICLE ATTACHMENT;
   SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; CONTINUOUS FLOTATION;
   AIR FLOTATION; FORCES; ALGAE; YEAST; RECOVERY
AB Flotation is a common physico-chemical solid-liquid separation technology. It is applied in classical fields like minerals processing, pulp deinking and wastewater treatment and novel fields like biotechnology. The success of flotation is influenced by flotation key parameters. The aim of this study was to present a set of small-scale screening methods for the key flotation parameters particle size, particle hydrophobicity, bubble size and direct particle-bubble interaction. Experiments were performed with the model microorganism S. cerevisiae. Flotation was done in complex fermentation media and in isotonic saline, at varying pH and after flocculant addition. The goal, to combine small-scale laboratory methods to explain, predict and optimize yeast flotation results was achieved. Combining the methods can be used prospectively for wide screening of potential flotation additives, such as collectors, frothers and flocculants and to optimize microorganism floatability. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Guldena, S. J.; Riedele, C.; Mueller, S.; Kopf, M-H] BASF SE, Proc Res Ind Biotechnol, Ludwigshafen, Germany.
   [Guldena, S. J.; Nirschl, H.] KIT, Inst Mech Proc Engn & Mech Proc Machines, Karlsruhe, Germany.
RP Nirschl, H (reprint author), KIT, Inst Mech Proc Engn & Mech Proc Machines, Karlsruhe, Germany.
EM susanne.gulden@cordenbiochem.com; hermann.mrschl@kit.edu
FU BASF SE
FX The authors thank Patrick Graefen for the development of the LabVIEW
   bubble size analysis application and Dr. Peter Baumann and Lisa
   Ditscherlein for their contribution in developing the bubble-yeast
   adhesion force analysis technology. This study was funded by BASF SE.
CR Ahimou F, 2001, J MICROBIOL METH, V45, P119, DOI 10.1016/S0167-7012(01)00240-8
   AHMED N, 1985, INT J MINER PROCESS, V14, P195, DOI 10.1016/0301-7516(85)90003-1
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   BAHR KH, 1991, ENZYME MICROB TECH, V13, P747, DOI 10.1016/0141-0229(91)90054-E
   BAHR KH, 1992, CHEM ENG SCI, V47, P11, DOI 10.1016/0009-2509(92)80195-I
   BOYLES WA, 1958, APPL MICROBIOL, V6, P327, DOI 10.1128/AEM.6.5.327-334.1958
   BUSSCHER HJ, 1995, COLLOID SURFACE B, V5, P111, DOI 10.1016/0927-7765(95)01224-7
   BUTT HJ, 1994, J COLLOID INTERF SCI, V166, P109, DOI 10.1006/jcis.1994.1277
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4
   Chapman DL, 1913, PHILOS MAG, V25, P475, DOI 10.1080/14786440408634187
   Chen YM, 1998, COLLOID SURFACE B, V12, P49, DOI 10.1016/S0927-7765(98)00059-9
   CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0
   Cui X, 2017, CHEM-ASIAN J, V12, P1568, DOI 10.1002/asia.201700388
   Dai ZF, 2000, ADV COLLOID INTERFAC, V85, P231, DOI 10.1016/S0001-8686(99)00030-5
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L
   deSousa SR, 2003, COLLOID SURFACE B, V29, P309, DOI 10.1016/S0927-7765(03)00019-5
   DEY A, 1989, INT J MINER PROCESS, V26, P73, DOI 10.1016/0301-7516(89)90044-6
   Ditscherlein L, 2018, COLLOIDS SURF B
   Dognon A., 1941, REV SCI, V79, P613
   Dognon A., 1941, B SOC CHIM FR, P249
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   DUCKER WA, 1994, LANGMUIR, V10, P3279, DOI 10.1021/la00021a061
   EDZWALD JK, 1993, WATER SCI TECHNOL, V27, P67
   Fielden ML, 1996, LANGMUIR, V12, P3721, DOI 10.1021/la960145c
   Gaudin A.M., 1957, FLOTATION
   GAUDIN AM, 1960, APPL MICROBIOL, V8, P91, DOI 10.1128/AEM.8.2.91-97.1960
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   GEHLE R, 1991, J BIOTECHNOL, V17, P147, DOI 10.1016/0168-1656(91)90005-G
   GEHLE RD, 1984, APPL MICROBIOL BIOT, V20, P133
   Gorain BK, 1998, MINER ENG, V11, P627, DOI 10.1016/S0892-6875(98)00047-8
   Gouy M., 1910, J PHYS-PARIS, V9, P457, DOI DOI 10.1051/JPHYSTAP:019100090045700
   Guibal E, 2006, SEP SCI TECHNOL, V41, P2487, DOI 10.1080/01496390600742807
   Gulden SJ, 2018, CHEM ENG SCI, V185, P168, DOI 10.1016/j.ces.2018.04.009
   Gulden S.J, 2018, SEP PURIF TECHNOL
   Hanotu J, 2014, BIOCHEM ENG J, V82, P174, DOI 10.1016/j.bej.2013.10.019
   Hansen C.A, 1943, SEWAGE WORK J, V15, P212
   Hopper S.H, 1945, J AWWA, V37, P302
   Hopper S.H, 1952, J AM WATER WORKS ASS, V44, P719
   Hu W, 2013, CHEM ENG SCI, V102, P32, DOI 10.1016/j.ces.2013.07.045
   HUSBAND DL, 1994, CAN J CHEM ENG, V72, P840, DOI 10.1002/cjce.5450720510
   Jameson GJ, 2010, MINER ENG, V23, P835, DOI 10.1016/j.mineng.2010.04.001
   Johnson DJ, 2006, ADV COLLOID INTERFAC, V127, P67, DOI 10.1016/j.cis.2006.11.005
   Jones DS, 1996, INT J PHARM, V131, P83, DOI 10.1016/0378-5173(95)04368-3
   LEVIN GV, 1962, APPL MICROBIOL, V10, P169, DOI 10.1128/AEM.10.2.169-175.1962
   Ma J, 2002, WATER RES, V36, P871, DOI 10.1016/S0043-1354(01)00282-2
   Mehdinejad M. Hadi, 2009, EFFECTIVENESS CHITOS
   MEHROTRA SP, 1974, SEPAR SCI, V9, P167, DOI 10.1080/00372367408057055
   National Instrument, 2016, IMAQ FIND EDG 6
   Ndikubwimana T, 2016, BIOTECHNOL J, V11, P315, DOI 10.1002/biot.201500175
   Neethling SJ, 2003, INT J MINER PROCESS, V72, P267, DOI 10.1016/S0301-7516(03)00104-2
   Nguyen AV, 1998, INT J MINER PROCESS, V53, P225, DOI 10.1016/S0301-7516(97)00073-2
   Oliveira C., 2014, Bubble Science, Engineering & Technology, V5, P15, DOI 10.1179/1758897914Y.0000000011
   Ometto F, 2014, WATER RES, V53, P168, DOI 10.1016/j.watres.2014.01.012
   Open CV, 2016, HOUGH CIRCL TRANSF
   OVERBEEK JTG, 1984, POWDER TECHNOL, V37, P195, DOI 10.1016/0032-5910(84)80017-0
   Palmieri MC, 1996, BIOTECHNOL BIOENG, V50, P248, DOI 10.1002/(SICI)1097-0290(19960505)50:3<248::AID-BIT3>3.0.CO;2-G
   Phoochinda W, 2003, ENVIRON TECHNOL, V24, P87, DOI 10.1080/09593330309385539
   REAY D, 1973, CAN J CHEM ENG, V51, P178, DOI 10.1002/cjce.5450510207
   Rodrigues RT, 2007, INT J MINER PROCESS, V82, P1, DOI 10.1016/j.minpro.2006.07.019
   RUBIN AJ, 1966, BIOTECHNOL BIOENG, V8, P135, DOI 10.1002/bit.260080112
   Savassi ON, 1998, MINER ENG, V11, P243, DOI 10.1016/S0892-6875(98)00003-X
   SCHUBERT H, 1978, INT J MINER PROCESS, V5, P131, DOI 10.1016/0301-7516(78)90010-8
   Schugerl K, 2000, ADV BIOCHEM ENG BIOT, V68, P191
   Smith P. G., 1989, MINER PROCESS EXTR M, V5, P123, DOI DOI 10.1080/08827508908952647
   Smith R. W., 1989, MINER PROCESS EXTR M, V4, P277, DOI DOI 10.1080/
   Stern O, 1924, Z ELKTROCHEM ANGEW P, V30, P508
   STUMM W, 1992, CHEM SOLID WATER INT
   Tabor RF, 2012, J COLLOID INTERF SCI, V371, P1, DOI 10.1016/j.jcis.2011.12.047
   TYBUSSEK R, 1994, APPL MICROBIOL BIOT, V41, P13, DOI 10.1007/s002530050100
   Vakarelski IU, 2008, LANGMUIR, V24, P603, DOI 10.1021/la7032059
   Verwey E.J.W., 1948, THEORY STABILITY LYO
   VIEHWEG H, 1983, EUR J APPL MICROBIOL, V17, P96, DOI 10.1007/BF00499858
   Wang W, 2015, ADV COLLOID INTERFAC, V225, P88, DOI 10.1016/j.cis.2015.08.005
   Weir S., 1993, Biotechnology Techniques, V7, P199, DOI 10.1007/BF02566147
   Xing YW, 2017, ADV COLLOID INTERFAC, V246, P105, DOI 10.1016/j.cis.2017.05.019
   Yoon R.H., 1989, MINER PROCESS EXTR M, V5, P101, DOI DOI 10.1080/
   YOON RH, 1993, MINER ENG, V6, P619, DOI 10.1016/0892-6875(93)90116-5
   YOON RH, 1991, J COLLOID INTERF SCI, V141, P374, DOI 10.1016/0021-9797(91)90333-4
NR 80
TC 1
Z9 1
U1 3
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 1353
EP 1363
DI 10.1016/j.ces.2019.07.027
PG 11
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300111
DA 2020-05-12
ER

PT J
AU Kokubun, MAE
   Muntean, A
   Radu, FA
   Kumar, K
   Pop, IS
   Keilegavlen, E
   Spildo, K
AF Kokubun, M. A. Endo
   Muntean, A.
   Radu, F. A.
   Kumar, K.
   Pop, I. S.
   Keilegavlen, E.
   Spildo, K.
TI A pore-scale study of transport of inertial particles by water in porous
   media
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Porous medium; Particles transport; Clogging; Flow diversion; Inertial
   particles
ID HEAVY-PARTICLES; FINES MIGRATION; FLOW; DETACHMENT; EQUATIONS; MOTION;
   MODELS
AB We study the transport of inertial particles in water flow in porous media. Our interest lies in understanding the accumulation of particles including the possibility of clogging. We propose that accumulation can be a result of hydrodynamic effects: the tortuous paths of the porous medium generate regions of dominating strain, which favour the accumulation of particles. Numerical simulations show that essentially two accumulation regimes are identified: for low and for high flow velocities. When particles accumulate at the entrance of a pore throat (high-velocity region), a clog is formed. This significantly modifies the flow, as the partial blockage of the pore causes a local redistribution of pressure, which diverts the upstream water flow into neighbouring pores. Moreover, we show that accumulation in high velocity regions occurs in heterogeneous media, but not in homogeneous media, where we refer to homogeneity with respect to the distribution of the pore throat diameters. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kokubun, M. A. Endo; Spildo, K.] Univ Bergen, Dept Chem, Bergen, Norway.
   [Radu, F. A.; Pop, I. S.; Keilegavlen, E.] Univ Bergen, Dept Math, Bergen, Norway.
   [Pop, I. S.] Univ Hasselt, Fac Sci, Hasselt, Belgium.
   [Muntean, A.; Kumar, K.] Univ Karlstad, Dept Math & Comp Sci, Karlstad, Sweden.
RP Kokubun, MAE (reprint author), Univ Bergen, Dept Chem, Bergen, Norway.
EM max.kokubun@uib.no; adrian.muntean@kau.se; florin.radu@uib.no;
   kundan.kumar@kau.se; sorin.pop@uhasselt.he; eirik.keilegavlen@uib.no;
   kristine.spildo@uib.no
RI Kokubun, Max A Endo/G-2600-2019; Pop, Iuliu Sorin/E-1895-2011
OI Kokubun, Max A Endo/0000-0003-2944-1777; Pop, Iuliu
   Sorin/0000-0001-9647-4347
FU Equinor through the VISTA AdaSim project [6367]; Research
   Foundation-Flanders (FWO)FWO [GOG1316N]; Research Council of Norway
   (NFR)Research Council of Norway [811716 LAB2FIELD, 810857 MICAP];
   MultiBarr (KK Foundation) [20180036]; Equinor; Norwegian Academy of
   Science and Letters
FX MAEK, EK and KS are supported by Equinor through the Akademia agreement.
   The work of AM is partially supported via MultiBarr (KK Foundation,
   project nr. 20180036). FAR was partially supported by the Norwegian
   Academy of Science and Letters and Equinor through the VISTA AdaSim
   project #6367. ISP was supported by the Research Foundation-Flanders
   (FWO) through the Odysseus programme (project GOG1316N) and by Equinor
   through the Akademia agreement. KK work was partially funded by the
   Research Council of Norway (NFR) Projects 811716 LAB2FIELD and 810857
   MICAP.
CR Bjorsvik M, 2008, COLLOID SURFACE A, V317, P504, DOI 10.1016/j.colsurfa.2007.11.025
   Blunt MJ, 2002, ADV WATER RESOUR, V25, P1069, DOI 10.1016/S0309-1708(02)00049-0
   Boffetta G, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/14001
   Bolandtaba S. F., 2009, 15 EUR S IMPR REC
   Borazjani S, 2017, TRANSPORT POROUS MED, V116, P213, DOI 10.1007/s11242-016-0771-2
   Bowen R, 1976, MIXTURE EM FIELD THE, VIII
   Bringedal C, 2017, TRANSPORT POROUS MED, V120, P553, DOI 10.1007/s11242-017-0940-y
   Chequer L, 2019, CHEM ENG SCI, V198, P16, DOI 10.1016/j.ces.2018.12.033
   de Anna P, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.124103
   Dodin Z, 2004, PHYS FLUIDS, V16, P3231, DOI 10.1063/1.1763946
   DRUZHININ OA, 1995, J FLUID MECH, V297, P49, DOI 10.1017/S0022112095003004
   El-Amin M., 2013, 164333 SPE
   Esmaily-Moghadam M, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.084202
   Falkovich G, 2004, PHYS FLUIDS, V16, pL47, DOI 10.1063/1.1755722
   FESSLER JR, 1994, PHYS FLUIDS, V6, P3742, DOI 10.1063/1.868445
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   GRUESBECK C, 1982, SOC PETROL ENG J, V22, P847, DOI 10.2118/8430-PA
   Jackson R, 1997, CHEM ENG SCI, V52, P2457, DOI 10.1016/S0009-2509(97)00065-1
   Jegatheesan V, 2005, CRIT REV ENV SCI TEC, V35, P515, DOI 10.1080/10643380500326432
   Keller AA, 2007, ADV WATER RESOUR, V30, P1392, DOI 10.1016/j.advwatres.2006.05.013
   Kleinstreuer C, 2003, 2 PHASE FLOW THEORY, P82
   Kokubun MAE, 2019, TRANSPORT POROUS MED, V126, P501, DOI 10.1007/s11242-018-1175-2
   Kutsovsky YE, 1996, PHYS FLUIDS, V8, P863, DOI 10.1063/1.868867
   Landa-Marban D, 2019, TRANSPORT POROUS MED, V127, P643, DOI 10.1007/s11242-018-1218-8
   Lawless J, 1982, STAT MODELS METHODS
   Li Y, 2011, TRANSPORT POROUS MED, V90, P333, DOI 10.1007/s11242-011-9788-8
   Mack J.C., 1994, 27780 SPE
   Marliere C, 2015, AICHE J, V61, P3923, DOI 10.1002/aic.14920
   MAXEY MR, 1990, PHILOS T ROY SOC A, V333, P289, DOI 10.1098/rsta.1990.0162
   MAXEY MR, 1987, J FLUID MECH, V174, P441, DOI 10.1017/S0022112087000193
   MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602
   Mitra D, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.044303
   Nasr-El-Din H.A, 2014, 154334 SPE
   NOORDEN TL, 2009, EUR J APPL MATH, V20, P69
   Peker SM, 2008, SOLID-LIQUID TWO PHASE FLOW, P1
   Persson PO, 2004, SIAM REV, V46, P329, DOI 10.1137/S0036144503429121
   Rezakazemi M, 2018, ENVIRON CHEM LETT, V16, P367, DOI 10.1007/s10311-017-0693-4
   Russell T, 2018, CHEM ENG SCI, V190, P98, DOI 10.1016/j.ces.2018.05.062
   Schulz R, 2019, ZAMM-Z ANGEW MATH ME, V99, DOI 10.1002/zamm.201800123
   Shi JT, 2011, ENERG FUEL, V25, P5033, DOI 10.1021/ef200408u
   Spildo K., 2010, 129927 SPE
   Spildo K., 2009, 113460 SPE
   Xiong QR, 2016, J CONTAM HYDROL, V192, P101, DOI 10.1016/j.jconhyd.2016.07.002
   Zeinijahromi A, 2016, FUEL, V176, P222, DOI 10.1016/j.fuel.2016.02.066
NR 44
TC 0
Z9 0
U1 4
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 2
PY 2019
VL 207
BP 397
EP 409
DI 10.1016/j.ces.2019.06.036
PG 13
WC Engineering, Chemical
SC Engineering
GA IR7TR
UT WOS:000481644300031
DA 2020-05-12
ER

PT J
AU Chen, TH
   Liu, WC
   Chen, IC
   Liu, CC
   Huang, MH
   Jan, JT
   Wu, SC
AF Chen, Ting-Hsuan
   Liu, Wen-Chun
   Chen, I-Chen
   Liu, Chia-Chyi
   Huang, Ming-Hsi
   Jan, Jia-Tsrong
   Wu, Suh-Chin
TI Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO)
   stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit
   vaccine development
SO VACCINE
LA English
DT Article
DE CHO cells; Hemagglutinin; H7N9 vaccine; PELC/CpC adjuvant
ID INFLUENZA-A VIRUS; HUMAN INFECTIONS; IMMUNE-RESPONSE; MF59 ADJUVANT; 5TH
   EPIDEMIC; IMMUNOGENICITY; PROTEIN; PROTECTION; INDUCTION; MECHANISM
AB The novel H7N9 avian influenza A virus has caused human infections in China since 2013; some isolates from the fifth wave of infections have emerged as highly pathogenic avian influenza viruses. Recombinant hemagglutinin proteins of H7N9 viruses can be rapidly and efficiently produced with low-level biocontainment facilities. In this study, recombinant H7 antigen was obtained from engineered stable clones of Chinese Hamster Ovary (CHO) cells for subsequent large-scale production. The stable CHO cell clones were also adapted to grow in serum-free suspension cultures. To improve the immunogenicity of the recombinant H7 antigens, we evaluated the use of a novel combination adjuvant of PELC and CpG (PELC/CpG) to augment the anti-H7N9 immune responses in mice. We compared the effects with other adjuvants such as alum, AddaVax (MF59-like), and several Toll-like receptor ligands such as R848, CpG, and poly (I:C). With the PELC/CpG combination adjuvant, CHO cell-expressed rH7 antigens containing terminally sialylated complex type N-glycans were able to induce high titers of neutralizing antibodies in sera and conferred protection following live virus challenges. These data indicate that the CHO cell-expressed recombinant H7 antigens and a PELC/CpG combination adjuvant can be used for H7N9 subunit vaccine development. (C) 2019 The Authors, Published by Elsevier Ltd.
C1 [Chen, Ting-Hsuan; Liu, Wen-Chun; Chen, I-Chen; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.
   [Liu, Chia-Chyi; Huang, Ming-Hsi] Natl Inst Infect Dis & Vaccinol, Natl Hlth Res Inst, Zhunan, Taiwan.
   [Jan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.
   [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan.
RP Wu, SC (reprint author), Natl Tsing Hua Univ, Inst Biotechnol, Dept Med Sci, Hsinchu 30013, Taiwan.
EM scwu@mx.nthu.edu.tw
RI Huang, Ming-Hsi/E-3872-2010
OI Huang, Ming-Hsi/0000-0002-9670-3821; Wu, Suh-Chin/0000-0002-1672-5255
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST107-2321-B-007-003, MOST107 -2321-B-002-011]
FX The authors wish to thank Ken J. Ishii of the National Institute of
   Biomedical Innovation and Osaka University, Japan for providing us with
   the CpG K3 ODN used in this research. This work was supported by the
   Ministry of Science and Technology, Taiwan (MOST107-2321-B-007-003,
   MOST107 -2321-B-002-011).
CR Bale S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01116
   Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761
   Byrne G, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005817
   Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007
   Cao WP, 2016, CELL IMMUNOL, V304, P55, DOI 10.1016/j.cellimm.2016.04.004
   Chen TH, 2019, BIOTECHNOL BIOENG, V116, P598, DOI 10.1002/bit.26810
   Chen TH, 2017, ANTIVIR RES, V146, P213, DOI 10.1016/j.antiviral.2017.09.014
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208
   Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279
   Huo X, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.13.30496
   Iuliano AD, 2017, MMWR-MORBID MORTAL W, V66, P254, DOI 10.15585/mmwr.mm6609e2
   Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916
   Khurana S, 2014, VACCINE, V32, P6421, DOI 10.1016/j.vaccine.2014.09.049
   Kile JC, 2017, MMWR-MORBID MORTAL W, V66, P928, DOI 10.15585/mmwr.mm6635a2
   Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13
   Lin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066719
   Lin SC, 2010, BIOTECHNOL PROGR, V26, P1733, DOI 10.1002/btpr.480
   Liu WC, 2016, J VIROL, V90, P6085, DOI 10.1128/JVI.00452-16
   Madan A, 2016, J INFECT DIS, V214, P1717, DOI 10.1093/infdis/jiw414
   Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403
   Matthews CB, 2017, BIOTECHNOL BIOENG, V114, P2432, DOI 10.1002/bit.26378
   Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854
   Nyon MP, 2018, VACCINE, V36, P1853, DOI 10.1016/j.vaccine.2018.02.065
   O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061
   O'Rourke SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197656
   Ou HL, 2016, VACCINE, V34, P2362, DOI 10.1016/j.vaccine.2016.03.037
   Pan WQ, 2014, ANTIVIR RES, V107, P1, DOI 10.1016/j.antiviral.2014.04.003
   Quan CS, 2018, J VIROL, V92, DOI [10.1128/JVI.00301-18, 10.1128/jvi.00301-18]
   Romanova N, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700232
   Ruwona TB, 2016, VACCINE, V34, P3059, DOI 10.1016/j.vaccine.2016.04.081
   Song L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150678
   Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008
   Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109
   Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054
   Wang DY, 2016, J VIROL, V90, P5561, DOI 10.1128/JVI.03173-15
   Wang L, 2017, NANOMED-NANOTECHNOL, V13, P253, DOI 10.1016/j.nano.2016.09.001
   Wong SS, 2015, J INFECT DIS, V212, P542, DOI 10.1093/infdis/jiv099
   Wu CY, 2014, VACCINE, V32, P4485, DOI 10.1016/j.vaccine.2014.06.043
   Wu UI, 2017, VACCINE, V35, P4099, DOI 10.1016/j.vaccine.2017.06.044
   Zhou L, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/wpsar.2017.8.1.001, 10.5365/WPSAR.2017.8.1.001]
   Zhu XY, 2013, P NATL ACAD SCI USA, V110, P1458, DOI 10.1073/pnas.1218509110
NR 42
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6933
EP 6941
DI 10.1016/j.vaccine.2019.02.040
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100002
PM 31383491
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Lehrer, AT
   Wong, TAS
   Lieberman, MM
   Johns, L
   Medina, L
   Feldmann, F
   Feldmann, H
   Marzi, A
AF Lehrer, Axel T.
   Wong, Teri-Ann S.
   Lieberman, Michael M.
   Johns, Lisa
   Medina, Liana
   Feldmann, Friederike
   Feldmann, Heinz
   Marzi, Andrea
TI Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus
   challenge
SO VACCINE
LA English
DT Article
DE Zaire ebolavirus; Recombinant protein; Glycoprotein; VP24; VP40
ID PATHOGENESIS; EFFICACY
AB Ebola virus (EBOV) is among the deadliest pathogens known to man causing infrequent outbreaks of hemorrhagic disease. In humans, the case fatality rates in the outbreaks can reach 90%. During the West African epidemic almost 30,000 people were infected and of these over 11,000 fatalities were reported. Currently, we are facing an uncontained larger outbreak in the Democratic Republic of the Congo. Even though EBOV was discovered in 1976, extensive efforts to develop countermeasures, particularly therapeutics and vaccines, started late and there is still no FDA-approved product available. Nevertheless, one candidate vaccine, the rVSV-ZEBOV, is being used in clinical trials during the current outbreak with the hope of ending the human transmission chains. However, adverse reactions to administration of some EBOV vaccines have been reported; therefore, we have developed a safe and efficacious formulation of insect-cell derived adjuvanted protein vaccines. Vaccine candidates containing the EBOV glycoprotein with or without matrix proteins VP24 and VP40 formulated with one of three different adjuvants were tested in guinea pigs for immunogenicity and efficacy against lethal EBOV challenge. The results demonstrated that these vaccine candidates engendered high titers of antigen-specific antibodies in immunized animals and two of these vaccine candidates afforded complete or nearly complete protection against lethal challenge. Interestingly, we found a sex bias in partially protected immunized groups with male guinea pigs succumbing to disease and females surviving. In summary, we developed a safe and immunogenic adjuvanted subunit vaccine uniformly protective against EBOV disease in guinea pigs. (C) 2019 Elsevier Ltd.
C1 [Lehrer, Axel T.; Wong, Teri-Ann S.; Johns, Lisa] PanThera Biopharma LLC, Aiea, HI 96701 USA.
   [Lehrer, Axel T.; Wong, Teri-Ann S.; Lieberman, Michael M.; Johns, Lisa; Medina, Liana] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96813 USA.
   [Feldmann, Friederike] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT 59840 USA.
   [Feldmann, Heinz; Marzi, Andrea] NIAID, Lab Virol, Div Intramural Res, NIH, Hamilton, MT 59840 USA.
RP Lehrer, AT (reprint author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med, 651 Ilalo St, Honolulu, HI 96813 USA.; Marzi, A (reprint author), Rocky Mt Labs, Lab Virol, 903 South 4th St, Hamilton, MT 59840 USA.
EM lehrer@hawaii.edu; marzia@niaid.nih.gov
FU Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R43AI066616]; PanThera Biopharma, LLC.
FX The authors are grateful to the BSL4 animal care and veterinary staff of
   the Rocky Mountain Veterinary Branch for their support of this study.
   The immunogenicity portion of the first study was performed via DMID
   Preclinical Services (NIH/NIAID). This work was funded in part by the
   Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, by a grant from
   NIH/NIAID (1R43AI066616), and through corporate funds from PanThera
   Biopharma, LLC. We also greatly acknowledge the gift of adjuvants
   CoVaccine HTTM from BTG International (London, UK) and GPI -0100 from
   Hawaii Biotech, Inc. (Honolulu, USA).
CR Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305
   Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247
   Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hilgers LA, 2006, VACCINE S2, V24
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Konduru K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162446
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lehrer AT, 2018, VACCINE, V36, P3090, DOI 10.1016/j.vaccine.2017.01.068
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Liu H, 2011, VACCINE, V29, P2037, DOI 10.1016/j.vaccine.2011.01.012
   Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X
   Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3
   Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6
   Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510
   Medina LO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02464
   Mellquist-Riemenschneider JL, 2003, VIRUS RES, V92, P187, DOI 10.1016/S0168-1702(02)00338-6
   Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005
   Organization WH, 2016, EB SIT REP
   Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998
   Schieffelin JS, 2017, LANCET INFECT DIS, V17, P1224, DOI 10.1016/S1473-3099(17)30575-3
   Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Warfield KL, 2018, J INFECT DIS, V218, pS553, DOI 10.1093/infdis/jiy316
   Wilson JA, 2001, VIROLOGY, V286, P384, DOI 10.1006/viro.2001.1012
   Wong G, 2018, EXPERT OPIN BIOL TH, V18, P159, DOI 10.1080/14712598.2018.1404572
NR 30
TC 3
Z9 3
U1 6
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6942
EP 6950
DI 10.1016/j.vaccine.2019.06.035
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100003
PM 31324500
OA Other Gold
DA 2020-05-12
ER

PT J
AU Fedosyuk, S
   Merritt, T
   Peralta-Alvarez, MP
   Morris, SJ
   Lam, A
   Laroudie, N
   Kangokar, A
   Wright, D
   Warimwe, GM
   Angell-Manning, P
   Ritchie, AJ
   Gilbert, SC
   Xenopoulos, A
   Boumlic, A
   Douglas, AD
AF Fedosyuk, Sofiya
   Merritt, Thomas
   Peralta-Alvarez, Marco Polo
   Morris, Susan J.
   Lam, Ada
   Laroudie, Nicolas
   Kangokar, Anilkumar
   Wright, Daniel
   Warimwe, George M.
   Angell-Manning, Phillip
   Ritchie, Adam J.
   Gilbert, Sarah C.
   Xenopoulos, Alex
   Boumlic, Anissa
   Douglas, Alexander D.
TI Simian adenovirus vector production for early-phase clinical trials: A
   simple method applicable to multiple serotypes and using entirely
   disposable product-contact components
SO VACCINE
LA English
DT Article
DE Simian adenovirus; GMP; Clinical trials; Single-use; Biomanufacturing;
   Bioreactor; Purification
ID PURIFICATION; IMMUNOGENICITY; QUANTITATION; VACCINES; SAFETY
AB A variety of Good Manufacturing Practice (GMP) compliant processes have been reported for production of non-replicating adenovirus vectors, but important challenges remain. Most clinical development of adenovirus vectors now uses simian adenoviruses or rare human serotypes, whereas reported manufacturing processes mainly use serotypes such as AdHu5 which are of questionable relevance for clinical vaccine development. Many clinically relevant vaccine transgenes interfere with adenovirus replication, whereas most reported process development uses selected antigens or even model transgenes such as fluorescent proteins which cause little such interference. Processes are typically developed for a single adenovirus serotype - transgene combination, requiring extensive further optimization for each new vaccine.
   There is a need for rapid production platforms for small GMP batches of non-replicating adenovirus vectors for early-phase vaccine trials, particularly in preparation for response to emerging pathogen outbreaks. Such platforms must be robust to variation in the transgene, and ideally also capable of producing adenoviruses of more than one serotype. It is also highly desirable for such processes to be readily implemented in new facilities using commercially available single-use materials, avoiding the need for development of bespoke tools or cleaning validation, and for them to be readily scalable for later-stage studies.
   Here we report the development of such a process, using single-use stirred-tank bioreactors, a transgene-repressing HEK293 cell - promoter combination, and fully single-use filtration and ion exchange components. We demonstrate applicability of the process to candidate vaccines against rabies, malaria and Rift Valley fever, each based on a different adenovirus serotype. We compare performance of a range of commercially available ion exchange media, including what we believe to be the first published use of a novel media for adenovirus purification (NatriFlo (R) HD-Q Merck). We demonstrate the need for minimal process individualization for each vaccine, and that the product fulfils regulatory quality expectations. Cell-specific yields are at the upper end of those previously reported in the literature, and volumetric yields are in the range 1 x 10(13) - 5 x 10(13) purified virus particles per litre of culture, such that a 2-4 L process is comfortably adequate to produce vaccine for early-phase trials. The process is readily transferable to any GMP facility with the capability for mammalian cell culture and aseptic filling of sterile products. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Fedosyuk, Sofiya; Peralta-Alvarez, Marco Polo; Morris, Susan J.; Wright, Daniel; Ritchie, Adam J.; Gilbert, Sarah C.; Douglas, Alexander D.] Univ Oxford, Jenner Inst, Roosevelt Dr, Oxford OX3 7BN, England.
   [Merritt, Thomas; Angell-Manning, Phillip] Univ Oxford, Clin Biomfg Facil, Roosevelt Dr, Oxford OX3 7JT, England.
   [Lam, Ada; Kangokar, Anilkumar] Millipore UK Ltd Bedfont Cross, Stanwell Rd, Feltham 7W14 8NX, England.
   [Laroudie, Nicolas; Boumlic, Anissa] Millipore SAS, 39 Route Ind Hardt, F-67120 Molsheim, France.
   [Warimwe, George M.] Univ Oxford, Ctr Trop Med & Global Hlth, Roosevelt Dr, Oxford OX3 7FZ, England.
   [Warimwe, George M.] KEMRI Wellcome Trust Res Programme, PO 230-80108, Kilifi, Kenya.
   [Xenopoulos, Alex] EMD Millipore Corp, 80 Ashby Rd, Bedford, MA 01730 USA.
RP Douglas, AD (reprint author), Univ Oxford, Jenner Inst, Roosevelt Dr, Oxford OX3 7BN, England.
EM sandy.douglas@ndm.ox.ac.uk
RI Douglas, Alexander/E-7040-2012
OI Douglas, Alexander/0000-0002-5410-7562; Wright,
   Daniel/0000-0002-8114-1838
FU Merck KGaA; UK Medical Research CouncilMedical Research Council UK (MRC)
   [MR/P017339/1]; UK Engineering and Physical Sciences Research
   CouncilEngineering & Physical Sciences Research Council (EPSRC)
   [EP/R013756/1]; Wellcome TrustWellcome Trust [201477/Z/16/Z,
   204826/Z/16/Z]
FX This work was supported by Merck KGaA, the UK Medical Research Council
   (grant MR/P017339/1), and the UK Engineering and Physical Sciences
   Research Council (grant EP/R013756/1). ADD is supported by the Wellcome
   Trust [grants 201477/Z/16/Z and 204826/Z/16/Z] and is a Jenner
   Investigator. The study was performed in collaboration between the
   University of Oxford and Merck KGaA; both partners reviewed the
   manuscript prior to submission. The other funders had no input to the
   design of the study or decision to publish. Correspondence and requests
   for materials can be addressed to sandy.douglas@ndm.ox.ac.uk.
CR Afolabi MO, 2016, MOL THER, V24, P1470, DOI 10.1038/mt.2016.83
   Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670
   Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025
   Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925
   Cottingham MG, 2012, BIOTECHNOL BIOENG, V109, P719, DOI 10.1002/bit.24342
   Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236
   Dicks MDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040385
   Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615
   Ewer K, 2017, HUM VACC IMMUNOTHER, V13, P3020, DOI 10.1080/21645515.2017.1383575
   Ewer KJ, 2016, CURR OPIN IMMUNOL, V41, P47, DOI 10.1016/j.coi.2016.05.014
   Fernandes P, 2013, GENE THER, V20, P353, DOI 10.1038/gt.2012.52
   Gilbert SC, 2017, VACCINE, V35, P4461, DOI 10.1016/j.vaccine.2017.04.085
   Goerke AR, 2005, BIOTECHNOL BIOENG, V91, P12, DOI 10.1002/bit.20406
   Green AP, 2002, HUM GENE THER, V13, P1921, DOI 10.1089/10430340260355338
   Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503
   Konz JO, 2005, HUM GENE THER, V16, P1346, DOI 10.1089/hum.2005.16.1346
   Konz John O., 2008, V434, P13, DOI 10.1007/978-1-60327-248-3_2
   Luitjens A, 2011, US patent, Patent No. [10,041,049, 10041049]
   MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9
   Morris SJ, 2016, FUTURE VIROL, V11, P649, DOI 10.2217/fvl-2016-0070
   Nadeau I, 2003, BIOTECHNOL ADV, V20, P475, DOI 10.1016/S0734-9750(02)00030-7
   Nestola P, 2015, J CHROMATOGR A, V1426, P91, DOI 10.1016/j.chroma.2015.11.037
   Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726
   Payne RO, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96381
   Peixoto C, 2008, BIOTECHNOL PROGR, V24, P1290, DOI 10.1002/btpr.25
   RAGHUNATH B, 2012, [No title captured], V11, P30
   Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09
   Riske F, 2013, BIOTECHNOL BIOENG, V110, P848, DOI 10.1002/bit.24742
   Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993
   Takahashi E, 2006, ANAL BIOCHEM, V349, P208, DOI 10.1016/j.ab.2005.11.014
   Vellinga J, 2014, HUM GENE THER, V25, P318, DOI 10.1089/hum.2014.007
   Vitelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055435
   Wang C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006870
   Warimwe GM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-349
   Weggeman M, 2012, US patent, Patent No. [8,574,595, 8574595]
   Zhang W, 2014, J PHARMACEUT BIOMED, V100, P145, DOI 10.1016/j.jpba.2014.07.037
NR 36
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6951
EP 6961
DI 10.1016/j.vaccine.2019.04.056
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100004
PM 31047679
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Pastor, AR
   Gonzalez-Dominguez, G
   Diaz-Salinas, MA
   Ramirez, OT
   Palomares, LA
AF Ruth Pastor, Ana
   Gonzalez-Dominguez, Gonzalo
   Diaz-Salinas, Marco A.
   Ramirez, Octavio T.
   Palomares, Laura A.
TI Defining the multiplicity and time of infection for the production of
   Zaire Ebola virus-like particles in the insect cell-baculovirus
   expression system
SO VACCINE
LA English
DT Article
DE Ebola virus disease; Virus-like particles; ZEBOV-VLP; Design of
   experiments
ID GLYCOPROTEINS; PROTECTION; PROTEINS
AB The Ebola virus disease is a public health challenge. To date, the only available treatments are medical support or the emergency administration of experimental drugs. The absence of licensed vaccines against Ebola virus impedes the prevention of infection. Vaccines based on recombinant virus-like particles (VLP) are a promising alternative. The Zaire Ebola virus serotype (ZEBOV) is the most aggressive with the highest mortality rates. Production of ZEBOV-VLP has been accomplished in mammalian and insect cells by the recombinant coexpression of three structural proteins, the glycoprotein (GP), the matrix structural protein VP40, and the nucleocapsid protein (NP). However, specific conditions to manipulate protein concentrations and improve assembly into VLP have not been determined to date. Here, we used a design of experiments (DoE) approach to determine the best MOI and TOI for three recombinant baculoviruses: bac-GP, bac-VP40 and bac-NP, each coding for one of the main structural proteins of ZEBOV. We identified two conditions where the simultaneous expression of the three recombinant proteins was observed. Interestingly, a temporal and stoichiometric interplay between the three structural proteins was observed. VP40 was required for the correct assembly of ZEBOV-VLP. High NP concentrations reduced the accumulation of GP, which has been reported to be necessary for inducing a protective immune response. Electron microscopy showed that the ZEBOV-VLP produced were morphologically similar to the native virus micrographs previously reported in the literature. A strategy for producing ZEBOV in insect cells, which consists in using a high MOI of bac-VP40 and bac-GP, and reducing expression of NP, either by delaying infection or reducing the MOI of bac-NP, was the most adequate for the production of VLP. (C) 2019 Elsevier Ltd.
C1 [Ruth Pastor, Ana; Gonzalez-Dominguez, Gonzalo; Ramirez, Octavio T.; Palomares, Laura A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.
   [Gonzalez-Dominguez, Gonzalo] Univ Autonoma Estado Morelos, Fac Farm, Cuernavaca, Morelos, Mexico.
   [Diaz-Salinas, Marco A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.
RP Palomares, LA (reprint author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.
EM rpastor@ibt.unam.mx; gonzalo030793@gmail.com; marcoadiazs@gmail.com;
   tonatiuh@ibt.unam.mx; laura@ibt.unam.mx
OI Palomares, Laura/0000-0002-2811-8102
FU CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [P-364]
FX This project was partially funded by CONACyT P-364. The funding agency
   had no involvement in the execution of the research or preparation of
   this article. Technical assistance by Vanessa Hernandez, Guadalupe
   Zavala, Martha Contreras, and the Unidad de Microscopia Electronica
   IBT-UNAM is acknowledged. We thank Alejandro Olvera for providing the
   purified recombinant EBOV proteins that were used as standards.
CR Aucoin MG, 2006, BIOTECHNOL BIOENG, V95, P1081, DOI 10.1002/bit.21069
   Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/erv.12.153, 10.1586/ERV.12.153]
   Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001
   Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31
   Jun SR, 2015, FEMS MICROBIOL REV, V39, P764, DOI 10.1093/femsre/fuv031
   Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]
   Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004
   Martin B, 2016, ANTIVIR RES, V135, P1, DOI 10.1016/j.antiviral.2016.09.001
   Mena JA, 2003, BIOTECHNIQUES, V34, P260, DOI 10.2144/03342bm05
   Mena JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-39
   Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002
   Palomares LA, 2002, BIOTECHNOL BIOENG, V78, P635, DOI 10.1002/bit.10243
   Palomares LA, 2015, CELL ENG, V9, P501, DOI 10.1007/978-3-319-10320-4_15
   Palomares LA, 2009, BIOCHEM ENG J, V45, P158, DOI 10.1016/j.bej.2009.02.006
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Sun YL, 2009, VIROLOGY, V383, P12, DOI 10.1016/j.virol.2008.09.020
   Tsao EI, 1996, BIOTECHNOL BIOENG, V49, P130, DOI 10.1002/(SICI)1097-0290(19960120)49:2&lt;130::AID-BIT2&gt;3.0.CO;2-R
   Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI.79.4.2413-2419.2005
   Warfield KL, 2007, J INFECT DIS, V196, pS421, DOI 10.1086/520612
   Ye L, 2006, VIROLOGY, V351, P260, DOI 10.1016/j.virol.2006.03.021
NR 20
TC 3
Z9 3
U1 4
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6962
EP 6969
DI 10.1016/j.vaccine.2019.06.029
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100005
PM 31262589
OA Other Gold
DA 2020-05-12
ER

PT J
AU Alvim, RGF
   Itabaiana, I
   Castilho, LR
AF Alvim, Renata G. F.
   Itabaiana Jr, Ivaldo
   Castilho, Leda R.
TI Zika virus-like particles (VLPs): Stable cell lines and continuous
   perfusion processes as a new potential vaccine manufacturing platform
SO VACCINE
LA English
DT Article
DE Virus-like particles (VLPs); Zika virus; HEK293 cells; Stable
   expression; Perfusion; Upstream process
ID SECRETION; OUTBREAK; ANTIBODY; FUSION; REGION
AB Zika virus (ZIKV) was first detected in Brazil in 2015 and then rapidly spread to more than 80 countries in Africa, Asia and the Americas. ZIKV infection was correlated with severe congenital malformations in newborns from infected mothers, as well as with Guillain-Barre syndrome in adults. Although the number of infected people has declined in the affected countries lately, the development of a vaccine for ZIKV is of great importance to avoid the future resurgence of the virus in endemic areas or the future spread to currently non-endemic regions. Among many different platforms currently under study, virus-like particles (VLPs) are a promising alternative for the development of vaccines, since tridimensional particles mimicking the virus - but lacking its genome - can be produced and present the antigen in a repetitive way, potentially eliciting robust immune responses. In this work, we demonstrated the generation of stably transfected HEK293 cells constitutively expressing Zika VLPs. Small-scale shake flask studies using a stable cell pool enriched by Fluorescence-Activated Cell Sorting (FACS) showed that daily medium exchange (intermittent perfusion) significantly enhances viable cell density and VLP production (similar to 4-fold) over batch cultures. Continuous perfusion in a controlled bioreactor coupled to an ATF-2 cell retention device resulted in maximum VLP titers similar to those obtained under small-scale intermittent perfusion. Our results show that the use of cell lines constitutively expressing Zika VLPs, cultured in stirred-tank perfusion bioreactors, represents a promising system for the production of a VLP-based Zika vaccine candidate. (C) 2019 Elsevier Ltd.
C1 [Alvim, Renata G. F.; Castilho, Leda R.] Fed Univ Rio de Janeiro UFRJ, Cell Culture Engn Lab, COPPE, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
   [Alvim, Renata G. F.; Itabaiana Jr, Ivaldo] Fed Univ Rio de Janeiro UFRJ, Sch Chem EQ, Dept Biochem Engn, BR-21941909 Rio De Janeiro, RJ, Brazil.
RP Castilho, LR (reprint author), Fed Univ Rio de Janeiro UFRJ, Cell Culture Engn Lab, COPPE, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
EM leda@peq.coppe.ufrj.br
RI Junior, Ivaldo/A-6308-2014
OI Junior, Ivaldo/0000-0003-0725-0881
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Janssen Brazil; JLabs
FX The authors wish to acknowledge financial support from the Brazilian
   funding agencies CNPq, CAPES and FAPERJ; financial support granted by
   JLabs and Janssen Brazil in the context of the "Latin-America Quick Fire
   Challenge 2016"; reagents and media donated by GE Healthcare, Xell AG
   and Merck Millipore; and the HEK293-3F6 cell line provided by NRC
   Canada. The authors also thank T. Brunswick and T. Gonsalves (CENABIO,
   Federal University of Rio de Janeiro) for technical help during cell
   sorting experiments, and B. S. Graham (Vaccine Research Center, NIH) for
   sharing analytical reagents.; All authors attest they meet the ICMJE
   criteria for authorship.
CR Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castilho LR, 2015, CONTINUOUS PROCESSING IN PHARMACEUTICAL MANUFACTURING, P115
   Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381
   Chang G.J.J., 1998, Patent, Patent No. [US8221768132, 8221768132]
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   Fontana D, 2015, VACCINE, V33, P4238, DOI 10.1016/j.vaccine.2015.03.088
   Fuenmayor J, 2017, NEW BIOTECHNOL, V39, P174, DOI 10.1016/j.nbt.2017.07.010
   Fuenmayor J, 2019, J CHEM TECHNOL BIOT, V94, P302, DOI 10.1002/jctb.5777
   Goudar CT, 2015, J BIOTECHNOL, V213, P1, DOI 10.1016/j.jbiotec.2015.08.015
   Gutierrez-Granados S, 2018, CURR OPIN CHEM ENG, V22, P107, DOI 10.1016/j.coche.2018.09.009
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima TM, 2019, VACCINE, V37, P7071
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Nikolay A, 2018, APPL MICROBIOL BIOT, V102, P8725, DOI 10.1007/s00253-018-9275-z
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okumura T, 2015, J BIOSCI BIOENG, V120, P340, DOI 10.1016/j.jbiosc.2015.01.007
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036
   Report S, 2017, ZIK VIR MICR GUILL B
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI 10.1586/ERV.10.115
   Song M, 2011, J CHEM TECHNOL BIOT, V86, P935, DOI 10.1002/jctb.2618
   Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033
   Venereo-Sanchez A, 2017, VACCINE, V35, P4220, DOI 10.1016/j.vaccine.2017.06.024
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   World Health Organization, WHO ZIK VIR COMPL 20
NR 37
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6970
EP 6977
DI 10.1016/j.vaccine.2019.05.064
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100006
PM 31164305
OA Other Gold
DA 2020-05-12
ER

PT J
AU Gerritzen, MJH
   Salverda, MLM
   Martens, DE
   Wijffels, RH
   Stork, M
AF Gerritzen, Matthias J. H.
   Salverda, Merijn L. M.
   Martens, Dirk E.
   Wijffels, Rene H.
   Stork, Michiel
TI Spontaneously released Neisseria meningitidis outer membrane vesicles as
   vaccine platform: production and purification
SO VACCINE
LA English
DT Article
DE Outer membrane vesicles; Vaccine; Vaccine platform; Tangential flow
   filtration; Neisseria meningitidis; Lyme disease
ID LYME-DISEASE; PROTEIN; LIPOPOLYSACCHARIDE; IMMUNOGENICITY; MUTANTS;
   STRAINS; SAFETY
AB Outer membrane vesicles (OMVs) are nanoparticles produced by Gram-negative bacteria that can be used as vaccines. The application of OMVs as vaccine component can be expanded by expressing heterologous antigens on OMVs, creating an OMV-based antigen presenting platform. This study aims to develop a production process for such OMV-based vaccines and studies a production method based on meningococcal OMVs that express heterologous antigens on their surface. As a proof of concept, the Borrelia burgdorferi antigens OspA and OspC were expressed on Neisseria meningitidis OMVs to create a concept anti-Lyme disease vaccine. Production of OMVs released in the culture supernatant was induced by high dissolved oxygen concentrations and purification was based on scalable unit operations. A crude recovery of 90 mg OMV protein could be obtained per liter culture. Expressing heterologous antigens on the OMVs did result in minor reduction of bacterial growth, while OMV production remained constant. The antigen expression did not alter the OMV characteristics. This study shows that production of well characterized OMVs containing heterologous antigens is possible with high yields by combining high oxygen concentrations with an optimized purification process. It is concluded that heterologous OMVs show potential as a vaccine platform. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Gerritzen, Matthias J. H.; Stork, Michiel] Inst Translat Vaccinol Intravacc, Proc Dev Bacterial Vaccines, POB 450, NL-3720 AL Bilthoven, Netherlands.
   [Gerritzen, Matthias J. H.; Martens, Dirk E.; Wijffels, Rene H.] Wageningen Univ, Bioproc Engn, POB 16, NL-6700 AA Wageningen, Netherlands.
   [Wijffels, Rene H.] Nord Univ, Fac Biosci & Aquaculture, POB 1409, N-8049 Bodo, Norway.
   [Salverda, Merijn L. M.] Inst Translat Vaccinol Intravacc, Exploratory & Clin Res, POB 450, NL-3720 AL Bilthoven, Netherlands.
RP Stork, M (reprint author), Inst Translat Vaccinol Intravacc, Proc Dev Bacterial Vaccines, POB 450, NL-3720 AL Bilthoven, Netherlands.
EM michiel.stork@intravacc.nl
RI ; Stork, Michiel/C-4867-2008
OI Gerritzen, Matthias/0000-0001-9741-9956; Stork,
   Michiel/0000-0003-4801-7875
FU Ministry for Health, Welfare and Sports (The Netherlands)Netherlands
   Government
FX The authors thank Lilli Stangowez and Lonneke van Keulen for their help
   in performing the sOMV productions, Joost Uittenbogaard and Alex de Haan
   for the Mass Spectroscopy and phospholipid analysis, and Gideon Kersten
   and Leo van der Pol for critical reading of the manuscript. This work
   has been funded by the Ministry for Health, Welfare and Sports (The
   Netherlands).
CR Baart GJE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r136
   Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1
   Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181
   Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5
   Comstedt P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184357
   Dehottay PMH, 2014, Patent No. [WO2014/001261 A1, 2014001261]
   Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09
   Fantappie L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24015
   FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67
   FREDRIKSEN JH, 1991, NIPH ANN, V14, P79
   Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478
   Gerritzen MJH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41233-x
   Gerritzen MJH, 2017, BIOTECHNOL ADV, V35, P565, DOI 10.1016/j.biotechadv.2017.05.003
   Gerritzen MJH, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1333883
   Gnopo YMD, 2017, ADV DRUG DELIVER REV, V114, P132, DOI 10.1016/j.addr.2017.05.003
   Grandi A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00253
   Hinton HJ, 2008, CURR TOP MICROBIOL, V319, P1
   HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186
   JANTZEN E, 1974, ACTA PATH MICRO IM B, VB 82, P785
   Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837
   Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200
   Lappann M, 2013, J BACTERIOL
   Lastre M, 2006, VACCINE, V24, pS34, DOI 10.1016/j.vaccine.2005.01.110
   Maharjan S, 2016, MICROBIOL-SGM, V162, P364, DOI 10.1099/mic.0.000227
   Malloy A, 2006, PART PART SYST CHAR, V23, P197, DOI 10.1002/ppsc.200601031
   Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F
   Mitra S, 2013, VACCINE, V31, P3163, DOI 10.1016/j.vaccine.2013.05.001
   Muralinath M, 2011, INFECT IMMUN, V79, P887, DOI 10.1128/IAI.00950-10
   Pajon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066536
   Pritsch M, 2016, J IMMUNOL RES, DOI 10.1155/2016/3576028
   Reiser ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00555-4
   Salverda MLM, 2016, VACCINE, V34, P1025, DOI 10.1016/j.vaccine.2016.01.019
   Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08
   Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616
   Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033
   Sikand VK, 2001, PEDIATRICS, V108, P123, DOI 10.1542/peds.108.1.123
   Singleton TE, 2005, J IMMUNOL, V174, P3545, DOI 10.4049/jimmunol.174.6.3545
   Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x
   Steere AC, 2018, PLOTKINS VACCINES
   Tang Bo, 2018, Nan Fang Yi Ke Da Xue Xue Bao, V38, P334
   TOMMASSEN J, 1990, INFECT IMMUN, V58, P1355, DOI 10.1128/IAI.58.5.1355-1359.1990
   van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065157
   van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054314
   van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082
   van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001
   WELCH DF, 1991, CLIN MICROBIOL REV, V4, P422, DOI 10.1128/CMR.4.4.422-438.1991
   Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
   Zariri A, 2015, EXPERT REV VACCINES, V14, P861, DOI 10.1586/14760584.2015.1026808
NR 49
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6978
EP 6986
DI 10.1016/j.vaccine.2019.01.076
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100007
PM 31383485
OA Other Gold
DA 2020-05-12
ER

PT J
AU Rourou, S
   Ben Zakkour, M
   Kallel, H
AF Rourou, Samia
   Ben Zakkour, Meriem
   Kallel, Hela
TI Adaptation of Vero cells to suspension growth for rabies virues
   production in different serum free media
SO VACCINE
LA English
DT Article
DE Vero cells; Suspension growth; Rabies virus production; Serum free
   medium
ID VACCINES CURRENT STATUS; COMPONENT FREE MEDIUM; CULTURE PROCESS;
   MICROCARRIERS; OPTIMIZATION; BIOREACTOR; PROTEIN; LINES
AB Vero cells are nowadays widely used in the production of human vaccines. They are considered as one of the most productive and flexible continuous cell lines available for vaccine manufacturing. However, these cells are anchorage dependent, which greatly complicates upstream processing and process scale-up. Moreover, there is a recognized need to reduce the costs of vaccine manufacturing to develop vaccines that are affordable worldwide. The use of cell lines adapted to suspension growth contributes to reach this objective.
   The current work describes the adaptation of Vero cells to suspension culture in different serum free media according to multiple protocols based on subsequent passages. The best one that relies on cell adaption to IPT-AFM an in-house developed animal component free medium was then chosen for further studies. Besides, as aggregates have been observed, the improvement of IPT-AFM composition and mechanical dissociation were also investigated.
   In addition to IPT-AFM, three chemically defined media (CD293, Hycell CHO and CD-U5) and two serum free media (293SEMII and SFM4CHO) were tested to set up a serum free culture of the suspension-adapted Vero cells (VeroS) in shake flasks. Cell density levels higher than 2 x 10(6) cells/mL were obtained in the assessed conditions. The results were comparable to those obtained in spinner culture of adherent Vero cells grown on Cytodex 1 microcarriers.
   Cell infection with LP-2061 rabies virus strain at an MOI (Multiplicity of Infection) of 0.1 and a cell density of 8 +/- 0.5 x 10(5) cells/mL resulted in a virus titer higher than 10(7) FFU/mL in all media tested. Nevertheless, the highest titer equal to 5.2 +/- 0.5 x 10(7) FFU/mL, was achieved in IPT-AFM containing a reduced amount of Ca++ and Mg++. Our results demonstrate the suitability of the obtained VeroS cells to produce rabies virus at a high titer, and pave the way to develop VeroS cells bioreactor process for rabies vaccine production. (C) 2019 Elsevier Ltd.
C1 [Rourou, Samia; Ben Zakkour, Meriem; Kallel, Hela] Univ Tunis El Manar, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Grp Biotechnol Dev, Inst Pasteur Tunis, 13 Pl Pasteur,BP 74, Tunis 1002, Tunisia.
RP Kallel, H (reprint author), Univ Tunis El Manar, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Grp Biotechnol Dev, Inst Pasteur Tunis, 13 Pl Pasteur,BP 74, Tunis 1002, Tunisia.
EM hela.kallel@pasteur.tn
OI Rourou, Samia/0000-0002-4853-9422
FU Tunisian Ministry of Higher Education and Scientific Research
   (Laboratory of Molecular Microbiology, Vaccinology and Biotechnology
   Development) [LR11IPT01]
FX This research was funded by a grant from the Tunisian Ministry of Higher
   Education and Scientific Research (grant LR11IPT01 Laboratory of
   Molecular Microbiology, Vaccinology and Biotechnology Development).
CR Abraham S., 2017, INT J CURR MICROBIOL, V6, P2064
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P77
   [Anonymous], 2018, WHO WEEKLY EPIDEMIOL, P201
   Aubrit F, 2015, VACCINE, V33, P5905, DOI 10.1016/j.vaccine.2015.06.110
   Barrett PN, 2017, EXPERT REV VACCINES, V16, P883, DOI 10.1080/14760584.2017.1357471
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]
   Biaggio RT, 2015, BIOPROC BIOSYST ENG, V38, P1495, DOI 10.1007/s00449-015-1392-9
   Caron AL, 2018, METHODS MOL BIOL, V1674, P75, DOI 10.1007/978-1-4939-7312-5_6
   EARLE WR, 1954, J NATL CANCER I, V14, P1159
   ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85
   Fooks AR, 2019, VACCINE, V37, pA140, DOI 10.1016/j.vaccine.2018.08.039
   Gallo-Ramirez LE, 2015, EXPERT REV VACCINES, V14, P1181, DOI 10.1586/14760584.2015.1067144
   GARNIER A, 1994, CYTOTECHNOLOGY, V15, P145, DOI 10.1007/BF00762389
   Gupta V, 2017, INDIAN J MICROBIOL, V57, P75, DOI 10.1007/s12088-016-0624-2
   Hacker DL, 2013, PROTEIN EXPRES PURIF, V92, P67, DOI 10.1016/j.pep.2013.09.001
   Haldankar R, 1999, BIOTECHNOL PROGR, V15, P336, DOI 10.1021/bp9900460
   Jordan I, 2014, VIRUSES-BASEL, V6, P1672, DOI 10.3390/v6041672
   Kallel H, 2003, APPL MICROBIOL BIOT, V61, P441, DOI 10.1007/s00253-003-1245-3
   Kallel H, 2002, J BIOTECHNOL, V95, P195, DOI 10.1016/S0168-1656(02)00009-3
   LITWIN J, 1992, CYTOTECHNOLOGY, V10, P169, DOI 10.1007/BF00570893
   Liu C, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065716500428
   [刘红 LIU Hong], 2006, [生物工程学报, Chinese Journal of Biotechnology], V22, P101, DOI 10.1016/S1872-2075(06)60007-1
   Liu J, 2010, VACCINE, V28, P1285, DOI 10.1016/j.vaccine.2009.11.023
   Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004
   Lohr V, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-79
   Merten O-W, 2014, IND SCALE SUSPENSION, P503, DOI 10.1002/9783527683321.ch14
   MERTEN OW, 1994, CYTOTECHNOLOGY, V14, P47, DOI 10.1007/BF00772195
   MOORE GE, 1965, J SURG RES, V5, P270, DOI 10.1016/S0022-4804(65)80017-8
   Moorkens E, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00314
   Munzert S, 2015, AUTOMATED DATA COLLECTION WITH R: A PRACTICAL GUIDE TO WEB SCRAPING AND TEXT MINING, P196
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   O'Brien KL, 2019, VACCINE, V37, pA85, DOI 10.1016/j.vaccine.2018.10.014
   O'Brien S, 2018, CELL CULTURE TECHNOL, P1, DOI [10.1007/978-3-319-74854-21, DOI 10.1007/78-3-319-74854-2]
   Owens OVH, 1953, P AM ASSOC CANC RES, V1, P41
   Paillet C, 2011, VACCINE, V29, P7212, DOI 10.1016/j.vaccine.2011.07.016
   Paillet C, 2009, VACCINE, V27, P6464, DOI 10.1016/j.vaccine.2009.06.020
   PERRIN P, 1995, VACCINE, V13, P1244, DOI 10.1016/0264-410X(94)00022-F
   RADLETT PJ, 1985, DEV BIOL STAND, V60, P163
   Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086
   Rourou S, 2014, VACCINE, V32, P2767, DOI 10.1016/j.vaccine.2014.02.040
   Rourou S, 2009, BIOTECHNOL PROGR, V25, P1752, DOI 10.1002/btpr.279
   Rourou S, 2009, APPL MICROBIOL BIOT, V85, P53, DOI 10.1007/s00253-009-2064-y
   Rupprecht CE, 2018, LAB TECHNIQUES RABIE
   Rupprecht CE, 2016, EXPERT REV VACCINES, V15, P731, DOI 10.1586/14760584.2016.1140040
   Sanchez-Garcia L, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0437-3
   Smith J S, 1973, Monogr Ser World Health Organ, P354
   Souza MCO, 2009, VACCINE, V27, P6420, DOI 10.1016/j.vaccine.2009.06.023
   Starodubova ES, 2015, MOL BIOL+, V49, P513, DOI 10.1134/S0026893315040172
   Trabelsi K, 2006, J BIOTECHNOL, V121, P261, DOI 10.1016/j.jbiotec.2005.07.018
   Trabelsi K, 2005, ENZYME MICROB TECH, V36, P514, DOI 10.1016/j.enzmictec.2004.11.008
   van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029
   World Health Organization, 1987, WHO TECH REP SER, V760, P167
   World Health Organization, 2018, TECHNICAL REPORT SER, V1012
   World Health Organization, 1987, WHO TECH REP SER, V745, P99
   World Hlth Org, 2018, VACCINE, V36, P5500, DOI 10.1016/j.vaccine.2018.06.061
   Yao T, 2017, REPROD MED BIOL, V16, P99, DOI 10.1002/rmb2.12024
   Yasunura Y., 1963, NIPPON RINSHO, V21, P1201
   Zahoor MA, 2016, FUTURE VIROL, V11, P549, DOI 10.2217/fvl-2016-0006
   2013, WHO TECHN REP SER, V978, P1
NR 59
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6987
EP 6995
DI 10.1016/j.vaccine.2019.05.092
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100008
PM 31201054
OA Other Gold
DA 2020-05-12
ER

PT J
AU Shen, CF
   Guilbault, C
   Li, XL
   Elahi, SM
   Ansorge, S
   Kamen, A
   Gilbert, R
AF Shen, Chun Fang
   Guilbault, Claire
   Li, Xiuling
   Elahi, S. Mehdy
   Ansorge, Sven
   Kamen, Amine
   Gilbert, Renald
TI Development of suspension adapted Vero cell culture process technology
   for production of viral vaccines
SO VACCINE
LA English
DT Article
DE Vero cell culture; Viral vaccine; Cell adaptation; Culture media
ID YIELDS; VIRUS
AB Vero cells are considered as the most widely accepted continuous cell line by the regulatory authorities (such as WHO) for the manufacture of viral vaccines for human use. The growth of Vero cells is anchorage-dependent. Scale-up and manufacturing in adherent cultures are labor intensive and complicated. Adaptation of Vero cells to grow in suspension will simplify subcultivation and process scale-up significantly, and therefore reduce the production cost.
   Here we report on a successful adaptation of adherent Vero cells to grow in suspension in a serum-free and animal component-free medium (IHM03) developed in-house. The suspension adapted Vero cell cultures in IHM03 grew to similar or better maximum cell density as what was observed for the adherent Vero cells grown in commercial serum-free media and with a cell doubling time of 40-44 h. Much higher cell density (8 x 10(6) cells/mL) was achieved in a batch culture when three volume of the culture medium was replaced during the batch culture process.
   Both adherent and suspension Vero cells from various stages were tested for their authenticity using short tandem repeat analysis. Testing result indicates that all Vero cell samples had 100% concordance with the Vero DNA control sample, indicating the suspension cells maintained their genetic stability. Furthermore, suspension Vero cells at a passage number of 163 were assayed for tumorigenicity, and were not found to be tumorigenic.
   The viral productivity of suspension Vero cells was evaluated by using vesicular stomatitis virus (VSV) as a model. The suspension cell culture showed a better productivity of VSV than the adherent Vero cell culture. In addition, the suspension culture could be infected at higher cell densities, thus improving the volumetric virus productivity. More than one log of increase in the VSV productivity was achieved in a 3L bioreactor perfusion culture infected at a cell density of 6.8 x 10(6) cells/L. Crown Copyright (C) 2019 Published by Elsevier Ltd.
C1 [Shen, Chun Fang; Guilbault, Claire; Elahi, S. Mehdy; Ansorge, Sven; Kamen, Amine; Gilbert, Renald] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 6100 Royalmt Ave, Montreal, PQ H4P 2R2, Canada.
   [Li, Xiuling] China Natl Biotec Grp Co Ltd, Beijing, Peoples R China.
   [Kamen, Amine] McGill Univ, Dept Bioengn, Montreal, PQ, Canada.
RP Shen, CF (reprint author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 6100 Royalmt Ave, Montreal, PQ H4P 2R2, Canada.
EM chunfang.shen@nrc-cnrc.gc.ca
OI Kamen, Amine/0000-0001-9110-8815
CR Almeida JL, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-102
   Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3
   Chen A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-81
   Delagrave D, 2014, United States Patent, Patent No. [8,877,492 B2, 8877492]
   Elahi SM, 2019, J BIOTECHNOL, V289, P144, DOI 10.1016/j.jbiotec.2018.11.023
   FDA, 1993, POINTS CONS CHAR CEL
   Genzel Y, 2015, BIOTECHNOL J, V10, P728, DOI 10.1002/biot.201400388
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019
   Kolell K, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P583, DOI 10.1007/978-1-4020-5476-1_102
   Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083
   Logan M, 2018, P VACC TECHN 7 C JUN
   Madeline B, 2015, BIOPROCESS INT S1, V13, P26
   Morrow KJ, 2013, REV ARTICLE
   NAHAPETIAN AT, 1986, J CELL SCI, V81, P65
   Peschel B, 2013, VACCINE, V31, P5693, DOI 10.1016/j.vaccine.2013.09.051
   Rourou S, 2018, P VACC TECHN 7 C JUN
   Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086
   Souza MCO, 2009, VACCINE, V27, P6420, DOI 10.1016/j.vaccine.2009.06.023
   Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1
   Thomassen YE, 2014, VACCINE, V32, P2782, DOI 10.1016/j.vaccine.2014.02.022
   Yang JJ, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0794-5
NR 22
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6996
EP 7002
DI 10.1016/j.vaccine.2019.07.003
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100009
PM 31288997
OA Other Gold
DA 2020-05-12
ER

PT J
AU Bissinger, T
   Fritsch, J
   Mihut, A
   Wu, YX
   Liu, XP
   Genzel, Y
   Tan, WS
   Reichl, U
AF Bissinger, Thomas
   Fritsch, Johannes
   Mihut, Adrian
   Wu, Yixiao
   Liu, Xuping
   Genzel, Yvonne
   Tan, Wen-Song
   Reichl, Udo
TI Semi-perfusion cultures of suspension MDCK cells enable high cell
   concentrations and efficient influenza A virus production
SO VACCINE
LA English
DT Article
DE MDCK suspension; High cell density; Influenza A virus production;
   Process intensification; Semi-perfusion; Cell culture-based vaccine
   manufacturing
ID DENSITY CULTIVATIONS; VACCINE; LINE; SYSTEM; GROWTH; SERUM; ADHERENT;
   OPTIMIZATION; ADAPTATION; APOPTOSIS
AB Control and prevention of rapid influenza spread among humans depend on the availability of efficient and safe seasonal and pandemic vaccines, made primarily from inactivated influenza virus particles. Current influenza virus production processes rely heavily on embryonated chicken eggs or on cell culture as substrate for virus propagation. Today's efforts towards process intensification in animal cell culture could innovate viral vaccine manufacturing using high-yield suspension cells in high cell density perfusion processes. In this work, we present a MDCK cell line adapted to grow as single cell suspension with a doubling time of less than 20 h, achieving cell concentrations over 1 x 10(7) cells/mL in batch mode. Influenza A virus titer obtained in batch infections were 3.6 log(10)(HAU/100 mu L) for total- and 10(9) virions/mL for infectious virus particles (TCID50), respectively. In semi-perfusion mode concentrations up to 6 x 10(7) cells/mL, accumulated virus titer of 4.5 log(10)(HAU/100 mu L) aud infectious titer of almost 10(10 )virions/mL (TCID50) were possible. This exceeds results reported previously for cell culture-based influenza virus propagation by far and suggests perfusion cultures as the preferred method in viral vaccine manufacturing. (C) 2019 Published by Elsevier Ltd.
C1 [Bissinger, Thomas; Fritsch, Johannes; Mihut, Adrian; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn Grp, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Wu, Yixiao; Liu, Xuping; Tan, Wen-Song] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China.
   [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Bissinger, T (reprint author), Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn Grp, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM bissinger@mpi-magdeburg.mpg.de
CR Audsley JM, 2004, EXPERT OPIN BIOL TH, V4, P709, DOI 10.1517/14712598.4.5.709
   Barr IG, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0079-z
   Bernal V, 2009, BIOTECHNOL BIOENG, V104, P162, DOI 10.1002/bit.22364
   Bielser JM, 2018, BIOTECHNOL ADV, V36, P1328, DOI 10.1016/j.biotechadv.2018.04.011
   Bock A, 2009, BIOTECHNOL PROGR, V25, P1717, DOI 10.1002/btpr.262
   Castro R, 2015, APPL MICROBIOL BIOT, V99, P7059, DOI 10.1007/s00253-015-6636-8
   Chotteau V, 2015, CELL ENG, V9, P407, DOI 10.1007/978-3-319-10320-4_13
   Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106
   Cox MMJ, 2008, INFLUENZA OTHER RESP, V2, P211, DOI 10.1111/j.1750-2659.2008.00053.x
   EATON MD, 1961, VIROLOGY, V13, P300, DOI 10.1016/0042-6822(61)90149-0
   EATON MD, 1962, VIROLOGY, V18, P102, DOI 10.1016/0042-6822(62)90182-4
   EATON MD, 1967, ARCH GES VIRUSFORSCH, V20, P411, DOI 10.1007/BF01275221
   Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023
   Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019
   Genzel Y, 2007, ANIMAL CELL BIOTECHN, P457
   Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016
   Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2
   Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI 10.1586/ERV.09.128
   Gregersen JP, 2011, FUTURE MICROBIOL, V6, P143, DOI 10.2217/FMB.10.161
   Groner A, 1996, European Patent Office, Patent No. [EP0891420B1, 0891420]
   Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015
   Huang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141686
   Huang Ding, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P645
   Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002
   Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Kluge S, 2015, VACCINE, V33, P4269, DOI 10.1016/j.vaccine.2015.02.077
   Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312
   Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004
   Mercier SM, 2015, BIOTECHNOL BIOENG, V112, P569, DOI 10.1002/bit.25459
   Milian E, 2015, BIOMED RES INT, DOI 10.1155/2015/504831
   Nikolay A, 2018, APPL MICROBIOL BIOT, V102, P8725, DOI 10.1007/s00253-018-9275-z
   Onions D, 2010, BIOLOGICALS, V38, P544, DOI 10.1016/j.biologicals.2010.04.003
   Ozturk SS, 1996, CYTOTECHNOLOGY, V22, P3, DOI 10.1007/BF00353919
   Palache A, 2017, VACCINE, V35, P4681, DOI 10.1016/j.vaccine.2017.07.053
   Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9
   Perdue ML, 2011, EXPERT REV VACCINES, V10, P1183, DOI [10.1586/ERV.11.82, 10.1586/erv.11.82]
   Peschel B, 2013, VACCINE, V31, P5693, DOI 10.1016/j.vaccine.2013.09.051
   Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84
   Schuind A, 2015, J INFECT DIS, V212, P531, DOI 10.1093/infdis/jiv091
   Spearman C., 1909, PSYCHOL BULL, V6, P27, DOI DOI 10.1037/H0063767
   Tapia F, 2016, APPL MICROBIOL BIOT, V100, P2121, DOI 10.1007/s00253-015-7267-9
   Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   U.S. Food & Drug Administration, 2018, APPR PROD FLUBL
   van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029
   Vazquez-Ramirez D, 2018, VACCINE, V36, P3124, DOI 10.1016/j.vaccine.2017.10.112
   Wang HL, 2017, ARCH VIROL, V162, P3051, DOI 10.1007/s00705-017-3460-8
   WHO, 2017, 650000 PEOPL DIE RES
NR 49
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7003
EP 7010
DI 10.1016/j.vaccine.2019.04.054
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100010
PM 31047676
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Coronel, J
   Behrendt, I
   Burgin, T
   Anderlei, T
   Sandig, V
   Reichl, U
   Genzel, Y
AF Coronel, Juliana
   Behrendt, Ilona
   Burgin, Tim
   Anderlei, Tibor
   Sandig, Volker
   Reichl, Udo
   Genzel, Yvonne
TI Influenza A virus production in a single-use orbital shaken bioreactor
   with ATF or TFF perfusion systems
SO VACCINE
LA English
DT Article
DE Orbital shaken bioreactor; Perfusion; Hollow-fiber; High cell density;
   Viral vaccine production; Influenza A virus
ID HIGH-CELL-DENSITY; VACCINE PRODUCTION; INFECTION DYNAMICS; CULTIVATIONS;
   ACTIVATION; APOPTOSIS; KINETICS
AB Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGELCR.pIX avian suspension cells grew to 50 x 10(6) cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h(-1) (doubling time = 32 h). Maximum virus titers in the range of 3.28-3.73 log(10) (HA units/100 mu L) were achieved, corresponding to cell-specific virus yields of 1000-3500 virions/cell and productivities of 0.5-2.2 x 10(12) virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log(10) (HA Units/100 mu L);1286 virions/cell and 1.4 x 10(12) virions/L/D respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Coronel, Juliana; Behrendt, Ilona; Reichl, Udo; Genzel, Yvonne] Max Planck Inst Dynam Complex Tech Syst, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Burgin, Tim; Anderlei, Tibor] Adolf Kuhner AG, Dinkelbergstr 1, CH-4127 Birsfelden, Switzerland.
   [Sandig, Volker] ProBioGen AG, Goethestr 54, D-13086 Berlin, Germany.
   [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Coronel, J (reprint author), Max Planck Inst Dynam Complex Tech Syst, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM coronel@mpi-magdeburg.mpg.de
OI Coronel de Lima Lages, Juliana/0000-0002-1349-2310
FU Adolf Kiihner AG
FX The authors thank Carolin Heinemann, Claudia Best, Marie Dorn, Nancy
   Wynserski, Sara Grone and Susanne Konig for the technical support and
   Adolf Kiihner AG for the support.
CR Adolf kuhner AG, 2017, US MAN ORBSHAKE BIOR
   Bielser JM, 2018, BIOTECHNOL ADV, V36, P1328, DOI 10.1016/j.biotechadv.2018.04.011
   Castilho LR, 2015, CONTINUOUS PROCESSING IN PHARMACEUTICAL MANUFACTURING, P115
   Centers for Disease Control and Prevention, 2016, CELL BAS FLU VACC SE
   Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D
   Clincke MF, 2013, BIOTECHNOL PROGR, V29, P754, DOI 10.1002/btpr.1704
   EATON MD, 1962, VIROLOGY, V18, P102, DOI 10.1016/0042-6822(62)90182-4
   Frensing T, 2016, APPL MICROBIOL BIOT, V100, P7181, DOI 10.1007/s00253-016-7542-4
   Galliher PM, 2018, BIOPHARM PROCESS, P557, DOI [10.1016/B978-0-08-100623-8.00029-3, DOI 10.1016/B978-0-08-100623-8.00029-3]
   Gallo-Ramirez LE, 2015, EXPERT REV VACCINES, V14, P1181, DOI 10.1586/14760584.2015.1067144
   Genzel Y, 2007, ANIMAL CELL BIOTECHN, P457
   Genzel Y, 2015, BIOTECHNOL J, V10, P728, DOI 10.1002/biot.201400388
   Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016
   Gupta SK, 2017, CONTIN BIOMANUFACTUR, P201, DOI [10.1002/9783527699902.ch8, DOI 10.1002/9783527699902.CH8]
   Henry O, 2004, BIOTECHNOL BIOENG, V86, P765, DOI 10.1002/bit.20074
   Isken B, 2012, VACCINE, V30, P5253, DOI 10.1016/j.vaccine.2012.05.065
   Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002
   Karst DJ, 2016, BIOCHEM ENG J, V110, P17, DOI 10.1016/j.bej.2016.02.003
   Klockner W, 2014, ADV BIOCHEM ENG BIOT, V138, P45, DOI 10.1007/10_2013_188
   Lohr V., 2014, CHARACTERIZATION AVI
   Lohr V, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-72
   Ludwig S, 1999, VIRAL IMMUNOL, V12, P175, DOI 10.1089/vim.1999.12.175
   Manceur AP, 2017, HUM GENE THER METHOD, V28, P330, DOI 10.1089/hgtb.2017.086
   Minow B, 2014, ENG LIFE SCI, V14, P272, DOI 10.1002/elsc.201300130
   Nienow AW, 2006, CYTOTECHNOLOGY, V50, P9, DOI 10.1007/s10616-006-9005-8
   Nikolay A, 2018, APPL MICROBIOL BIOT, V102, P8725, DOI 10.1007/s00253-018-9275-z
   Olsen CW, 1996, J VIROL, V70, P663, DOI 10.1128/JVI.70.1.663-666.1996
   Ozturk SS, 1996, CYTOTECHNOLOGY, V22, P3, DOI 10.1007/BF00353919
   Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84
   Portner R, 2015, CELL ENG, V9, P89, DOI 10.1007/978-3-319-10320-4_4
   Pollock J, 2013, BIOTECHNOL BIOENG, V110, P206, DOI 10.1002/bit.24608
   Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4
   Schulze-Horsel J, 2009, VACCINE, V27, P2712, DOI 10.1016/j.vaccine.2009.02.027
   Singh V, 1999, CYTOTECHNOLOGY, V30, P149, DOI 10.1023/A:1008025016272
   Tapia F, 2016, APPL MICROBIOL BIOT, V100, P2121, DOI 10.1007/s00253-015-7267-9
   Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044
   Tissot S, 2010, BIOCHEM ENG J, V52, P181, DOI 10.1016/j.bej.2010.08.005
   Vazquez-Ramirez D, 2019, APPL MICROBIOL BIOT, V103, P3025, DOI 10.1007/s00253-019-09694-2
   Vazquez-Ramirez D, 2018, VACCINE, V36, P3124, DOI 10.1016/j.vaccine.2017.10.112
   Wang S, 2017, J BIOTECHNOL, V246, P52, DOI 10.1016/j.jbiotec.2017.01.020
   Wright B, 2015, BIOPROCESS INT, V13
   Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279
   Zhang X, 2010, J NEUROCHEM, V115, P36
NR 43
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7011
EP 7018
DI 10.1016/j.vaccine.2019.06.005
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100011
PM 31266669
OA Other Gold
DA 2020-05-12
ER

PT J
AU Granicher, G
   Coronel, J
   Pralow, A
   Marichal-Gallardo, P
   Wolff, M
   Rapp, E
   Karlas, A
   Sandig, V
   Genzel, Y
   Reichl, U
AF Graenicher, Gwendal
   Coronel, Juliana
   Pralow, Alexander
   Marichal-Gallardo, Pavel
   Wolff, Michael
   Rapp, Erdmann
   Karlas, Alexander
   Sandig, Volker
   Genzel, Yvonne
   Reichl, Udo
TI Efficient influenza A virus production in high cell density using the
   novel porcine suspension cell line PBG.PK2.1
SO VACCINE
LA English
DT Article
DE High titer influenza virus; Cell metabolism; Porcine suspension cells;
   Bioreactor; hollow-fiber ATF perfusion
ID HEMAGGLUTININ N-GLYCOSYLATION; VACCINE PRODUCTION; GLYCAN ANALYSIS;
   CULTURE; METABOLISM; LACTATE; AMMONIA; DESIGN; GROWTH; CULTIVATIONS
AB Seasonal and pandemic influenza respiratory infections are still a major public health issue. Vaccination is the most efficient way to prevent influenza infection. One option to produce influenza vaccines is cell-culture based virus propagation. Different host cell lines, such as MDCK, Vero, AGE1.CR or PER.C6 cells have been shown to be a good substrate for influenza virus production. With respect to the ease of scale-up, suspension cells should be preferred over adherent cells. Ideally, they should replicate different influenza virus strains with high cell-specific yields. Evaluation of new cell lines and further development of processes is of considerable interest, as this increases the number of options regarding the design of manufacturing processes, flexibility of vaccine production and efficiency.
   Here. PBG.PK2.1. a new mammalian cell line that was developed by ProBioGen AG (Germany) for virus production is presented. The cells derived from immortal porcine kidney cells were previously adapted to growth in suspension in a chemically-defined medium. Influenza virus production was improved after virus adaptation to PBG.PK2.1 cells and optimization of infection conditions, namely multiplicity of infection and trypsin concentration. Hemagglutinin titers up to 3.24 log(10)(HA units/100 mu L) were obtained in fed-batch mode in bioreactors (700 mL working volume). Evaluation of virus propagation in high cell density culture using a hollow-fiber based system (ATF2) demonstrated promising performance: Cell concentrations of up to 50 x 10(6) cells/mL with viabilities exceeding 95%, and a maximum HA titer of 3.93 log(10) (HA units/100 mu L). Analysis of glycosylation of the viral HA antigen expressed showed clear differences compared to HA produced in MDCK or Vero cell lines. With an average cell-specific productivity of 5000 virions/cell, we believe that PBG.PK2.1 cells are a very promising candidate to be considered for next-generation influenza virus vaccine production. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Graenicher, Gwendal; Coronel, Juliana; Pralow, Alexander; Marichal-Gallardo, Pavel; Wolff, Michael; Rapp, Erdmann; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Wolff, Michael] Univ Appl Sci Mittelhessen, Inst Bioproc Engn & Pharmaceut Technol, Wiesenstr 14, D-35390 Giessen, Germany.
   [Karlas, Alexander; Sandig, Volker] ProBioGen AG, Goethestr 54, D-13086 Berlin, Germany.
   [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Granicher, G (reprint author), Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM graenicher@mpi-magdeburg.mpg.de
OI Karlas, Alexander/0000-0002-2187-2057; Coronel de Lima Lages,
   Juliana/0000-0002-1349-2310; Marichal-Gallardo,
   Pavel/0000-0002-5540-4454; Wolff, Michael/0000-0001-7443-3122
CR [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Aubrit F, 2015, VACCINE, V33, P5905, DOI 10.1016/j.vaccine.2015.06.110
   Cruz HJ, 2000, ENZYME MICROB TECH, V27, P43, DOI 10.1016/S0141-0229(00)00151-4
   de Vries RP, 2012, J VIROL
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   EMA, 2017, GUID INFL VACC QUAL
   EMA, 2013, GUID DEV PROD CHAR S
   Ferreira TB, 2005, J BIOTECHNOL, V119, P272, DOI 10.1016/j.jbiotec.2005.03.009
   Fortuna AR, 2018, ENG LIFE SCI, V18, P29, DOI 10.1002/elsc.201700108
   Frensing T, 2016, APPL MICROBIOL BIOT, V100, P7181, DOI 10.1007/s00253-016-7542-4
   Genzel Y, 2007, ANIMAL CELL BIOTECHN, P457
   Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016
   Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2
   Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9
   Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI 10.1586/ERV.09.128
   Harding AT, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6020019
   Harvey DJ, 2018, EXPERT REV PROTEOMIC, V15, P391, DOI 10.1080/14789450.2018.1468756
   HASSELL T, 1991, APPL BIOCHEM BIOTECH, V30, P29, DOI 10.1007/BF02922022
   Hennig Rene, 2015, Methods Mol Biol, V1331, P123, DOI 10.1007/978-1-4939-2874-3_8
   Hoffmann M, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800282
   Huang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141686
   Huang D, 2014, VACCINE, V32, P7091, DOI 10.1016/j.vaccine.2014.10.067
   Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060
   Kalbfuss B, 2014, VACCINE DEV MANUF, P97, DOI DOI 10.1002/9781118870914.CH5
   Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002
   King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034
   Konstantinov K, 2006, ADV BIOCHEM ENG BIOT, V101, P75, DOI 10.1007/10_016
   Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529
   Ru A, 2010, VACCINE, V28, P3661, DOI 10.1016/j.vaccine.2010.03.029
   LINDSAY DA, 1992, BIOTECHNOL BIOENG, V39, P614, DOI 10.1002/bit.260390605
   Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004
   Lohr V, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-72
   Marichal-Gallardo P, 2017, J CHROMATOGR A, V1483, P110, DOI 10.1016/j.chroma.2016.12.076
   Marks DM, 2003, CYTOTECHNOLOGY, V42, P21, DOI 10.1023/A:1026103405618
   Milian E, 2015, BIOMED RES INT, DOI 10.1155/2015/504831
   Nikolay A, 2018, APPL MICROBIOL BIOTE
   OZTURK SS, 1992, BIOTECHNOL BIOENG, V39, P418, DOI 10.1002/bit.260390408
   Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9
   Petiot E, 2018, VACCINE, V36, P3101, DOI 10.1016/j.vaccine.2017.03.102
   Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84
   Pioch M, 2018, ANAL CHEM
   Pohscheidt M, 2008, VACCINE, V26, P1552, DOI 10.1016/j.vaccine.2008.01.032
   Pralow A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11668-1
   Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4
   Schwarzer J, 2008, ELECTROPHORESIS, V29, P4203, DOI 10.1002/elps.200800042
   Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076
   Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116
   Tapia F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182553
   Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044
   Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294
   Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261
   Vazquez-Ramirez D, 2019, APPL MICROBIOL BIOTE
   Vazquez-Ramirez D, 2018, VACCINE, V36, P3124, DOI 10.1016/j.vaccine.2017.10.112
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   Yanming A, 2019, J VIROL, V93
NR 55
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7019
EP 7028
DI 10.1016/j.vaccine.2019.04.030
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100012
PM 31005427
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Haq, K
   Jia, YM
   Elahi, SM
   MacLean, S
   Akache, B
   Gurnani, K
   Chattopadhyay, A
   Nazemi-Moghaddam, N
   Gilbert, R
   McCluskie, MJ
   Weeratna, RD
AF Haq, Kamran
   Jia, Yimei
   Elahi, S. Mehdy
   MacLean, Susanne
   Akache, Bassel
   Gurnani, Komal
   Chattopadhyay, Anindita
   Nazemi-Moghaddam, Nazila
   Gilbert, Renald
   McCluskie, Michael J.
   Weeratna, Risini D.
TI Evaluation of recombinant adenovirus vectors and adjuvanted protein as a
   heterologous prime-boost strategy using HER2 as a model antigen
SO VACCINE
LA English
DT Article
DE Adenoviral vector; Adjuvants; Archaeosomes; Sulfated lactosylarchaeol
   SLA; Human epidermal growth factor-2 (HER2); BALB/c mice
ID BREAST-CANCER; VIRAL VECTORS; POTENTIAL APPLICATIONS; GENE-THERAPY;
   VACCINE; IMMUNOGENICITY; INDUCTION; NEU; AMPLIFICATION; IMMUNIZATION
AB Induction of strong antigen-specific cell-mediated and humoral responses are critical to developing a successful therapeutic vaccine. Herein, using HER2 as a model antigen, we aim to evaluate a therapeutic vaccine protocol that elicits anti-tumor antibody and cytotoxic T cells to HER2/neu antigen. Replicationcompetent (Delta PS AdV) and non-replicating recombinant adenoviral vectors (AdV) expressing a rat HER2/neu (ErbB2) oncogene, were generated and compared for four different doses and over four time points for their ability to induce antigen-specific T and B cell responses in mice. Although Delta PS AdV:Her2 vector was shown to induce more durable antigen-specific CD8(+) T cell responses, overall, the AdV:Her2 vector induced broader T and B cell responses. Hence the AdV:Her2 vector was used to evaluate a heterologous prime-boost vaccination regimen using rat HER2 protein encapsulated in archaeosomes composed of a semi-synthetic glycolipid (sulfated S-lactosylarchaeol, SLA; and lactosylarchaeol, LA) (SLA/LA:HER2enc) or admixed with archaeosomes composed of SLA alone (SLA:HER2adm). We first tested AdV:Her2 using a prime-boost approach with SLA/LA:HER2enc, and thereafter evaluated a sub-optimal AdV:Her2 dose in a heterologous prime-boost approach with SLA:HER2adm. A single administration of AdV:Her2 alone induced strong cell-mediated immune responses, whereas SLA/LA:HER2enc alone induced strong antigen-specific IgG titers. In mice primed with a suboptimal dose of AdV:Her2, strong CD8(+) T-cell responses were observed after a single dose which were not further augmented by protein boost. AdV: Her2 induced CD4(+) specific T-cell responses were augmented by SLA:HER2adm. Homologous vaccination using SLA:HER2adm induced strong antigen-specific antibody responses. However, the overall magnitude of the responses was similar with three doses of SLA:HER2adm or Ad:HER2 prime followed by two doses of SLA:HER2adm.
   We demonstrate that AdV:Her2 is capable of inducing strong antigen-specific CD8(+) T cell responses, even at a low dose, and that these responses can be broadened to include antigen-specific antibody responses by boosting with SLA adjuvanted proteins without compromising CD8 T cell responses elicited by AdV priming. (C) 2019 Published by Elsevier Ltd.
C1 [Haq, Kamran; Jia, Yimei; MacLean, Susanne; Akache, Bassel; Gurnani, Komal; Chattopadhyay, Anindita; McCluskie, Michael J.; Weeratna, Risini D.] Natl Res Council Canada, Ottawa, ON, Canada.
   [Elahi, S. Mehdy; Nazemi-Moghaddam, Nazila; Gilbert, Renald] Natl Res Council Canada, Montreal, PQ, Canada.
RP Weeratna, RD (reprint author), Natl Res Council Canada, Ottawa, ON, Canada.
EM Risini.Weeratna@nrc-cnrc.gc.ca
OI Haq, Kamran/0000-0001-6751-9657
CR Akache B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208067
   Akache B, 2018, HUM VACC IMMUNOTHER, V14, P1746, DOI 10.1080/21645515.2017.1423154
   AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781
   Arlen PM, 2005, SEMIN ONCOL, V32, P549, DOI 10.1053/j.seminoncol.2005.09.006
   Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27
   Bourbeau D, 2007, CANCER RES, V67, P3387, DOI 10.1158/0008-5472.CAN-06-4317
   Choi IK, 2013, CANCER GENE THER, V20, P70, DOI 10.1038/cgt.2012.95
   Crosby CM, 2017, J VIROL, V91, DOI 10.1128/JVI.00720-16
   Datta J, 2016, JAMA ONCOL, V2, P242, DOI 10.1001/jamaoncol.2015.5482
   Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045
   Ewer KJ, 2016, CURR OPIN IMMUNOL, V41, P47, DOI 10.1016/j.coi.2016.05.014
   Gagliato DD, 2016, ONCOTARGET, V7, P64431, DOI 10.18632/oncotarget.7043
   Gilbert R, 2014, J VIROL METHODS, V208, P177, DOI 10.1016/j.jviromet.2014.08.013
   Girard A, 2014, MOL BIOTECHNOL, V56, P394, DOI 10.1007/s12033-013-9723-z
   Haq K, 2016, EXPERT REV VACCINES, V15, P1557, DOI 10.1080/14760584.2016.1195265
   Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008
   Jia Y, 2019, INT J PHARMACEUT, V561, P187, DOI 10.1016/j.ijpharm.2019.02.041
   Kass E, 1999, CANCER RES, V59, P676
   Katoh M, 2003, INT J ONCOL, V23, P831
   Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324
   Krishnan L, 2008, VACCINE, V26, P2043, DOI 10.1016/j.vaccine.2008.02.026
   Lee CS, 2017, GENES DIS, V4, P43, DOI 10.1016/j.gendis.2017.04.001
   Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016
   Malherbe DC, 2018, J VIROL, V92, DOI 10.1128/JVI.01092-17
   Masuelli L, 2007, INT J ONCOL, V30, P381
   McCluskie MJ, 2017, HUM VACC IMMUNOTHER, V13, P2772, DOI 10.1080/21645515.2017.1316912
   McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232
   Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43
   Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290
   Nocera NF, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00356
   Oualikene W, 2000, HUM GENE THER, V11, P1341, DOI 10.1089/10430340050032438
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Ponde N, 2018, CANCER TREAT REV, V67, P10, DOI 10.1016/j.ctrv.2018.04.016
   Quaglino Elena, 2008, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2009s82
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010
   Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230
   SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0
   Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141
   SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106
   Sprott GD, 2003, METHOD ENZYMOL, V373, P155
   Stark FC, 2019, VACCINE, V37, P7108, DOI 10.1016/j.vaccine.2019.07.010
   Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013
   Vergati M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/596432
   Viani GA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-153
   Whitfield DM, 2010, CARBOHYD RES, V345, P214, DOI 10.1016/j.carres.2009.10.011
   Whitfield DM, 2016, WO, Patent No. [2016/ 004512, 2016004512]
   Wold WSM, 2013, CURR GENE THER, V13, P421
   Young KG, 2018, J VIRAL HEPATITIS, V25, P649, DOI 10.1111/jvh.12856
   Zamarin D, 2015, HUM GENE THER, V26, P538, DOI 10.1089/hum.2015.055
   Zhang C, 2016, HUM VACC IMMUNOTHER, V12, P2064, DOI 10.1080/21645515.2016.1165908
   Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278
NR 52
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7029
EP 7040
DI 10.1016/j.vaccine.2019.08.079
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100013
PM 31506193
OA Other Gold
DA 2020-05-12
ER

PT J
AU Sousa, M
   Fenge, C
   Rupprecht, J
   Tappe, A
   Greller, G
   Alves, P
   Carrondo, M
   Roldao, A
AF Sousa, Marcos
   Fenge, Christel
   Rupprecht, Jens
   Tappe, Alexander
   Greller, Gerhard
   Alves, Paula
   Carrondo, Manuel
   Roldao, Antonio
TI Process intensification for Peste des Petites Ruminants Virus vaccine
   production
SO VACCINE
LA English
DT Article
DE Vero cells; Microcarrier technology; In-situ cell detachment; Perfusion;
   Scal-up
ID CELL-CULTURE; VERO CELLS; STEM-CELLS; BIOREACTOR; GROWTH; MICROCARRIERS;
   SUSPENSION; PARTICLES; EXPANSION; AGITATION
AB Process intensification for Peste des Petites Ruminants Virus (PPRV) vaccine production in anchorage dependent Vero cells is challenging, involving substantial amount of bioprocess development.
   In this study, we describe the implementation of a new, scalable bioprocess for PPRV vaccine production in Vero cells using serum-free medium (SFM), microcarrier technology in stirred-tank bioreactors (STB), in-situ cell detachment from microcarriers and perfusion. Vero cells were successfully adapted to ProVere (TM)-1 SFM, reaching growth rates similar to serum-containing cultures (0.030 1/h vs 0.026 1/h, respectively). An in-situ cell detachment method was successfully implemented, with efficiencies above 85%. Up to 2.5-fold increase in maximum cell concentration was obtained using perfusion when compared to batch culture. Combining perfusion with the in-situ cell detachment method enabled the scale-up to 20 L STB directly from a 2 L STB, surpassing the need for a mid-scale platform (i.e. 5 L STB) and thus redueing seed tfaiff thitatiOti. Head-to-head Comparison of cell growth and PPRV production in the 2 L and 20 L STB was performed, and no significant differences could be observed. Estimated infectious PPRV titers in Tissue Culture Infection Dose (TCID50) (TCID50/mL = 5 x 10(6) and TCID50/cell = 5) are within the log-range reported in literature for PPRV production in STB and SFM by Silva et al. (2008), thus confirming the feasibility and scalability of the seed train designed [1].
   The novel and scalable vaccine production process herein proposed has the potential to assist the upcoming Peste des Petites Ruminants (PPR) Global Eradication Program (targeted by FAAO for 2030) by providing African local and/or regional manufacturers with a platform capable of generating over 25,000 doses of Nigeria 75/1 strain in just 19 days using a 20 L STB. (C) 2019 Published by Elsevier Ltd.
C1 [Sousa, Marcos; Alves, Paula; Carrondo, Manuel; Roldao, Antonio] Inst Biol Expt & Tecnol, Apartado 12, P-2780901 Oeiras, Portugal.
   [Sousa, Marcos; Alves, Paula; Roldao, Antonio] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Av Republ, P-2780157 Oeiras, Portugal.
   [Fenge, Christel; Rupprecht, Jens; Tappe, Alexander; Greller, Gerhard] Sartorius Stedim Biotech GmbH, August Spindler Str 11, D-37079 Gottingen, Germany.
RP Roldao, A (reprint author), Inst Biol Expt & Tecnol, Apartado 12, P-2780901 Oeiras, Portugal.
EM aroldao@ibet.pt
RI Roldao, Antonio/J-2396-2013; Alves, Paula/C-1070-2008
OI Roldao, Antonio/0000-0003-0414-4899; Sousa, Marcos/0000-0003-3766-3900;
   Alves, Paula/0000-0003-1445-3556
FU Sartorius Stedim Biotech; Fundacao para a Ciencia e Tecnologia through
   the Investigador FCT programme 2014 [IF/01704/2014,
   IF/01704/2014/CP1229/CT0001]; iNOVA4 Health Research Unit - Fundacao
   para a Ciencia e Tecnologia/Ministerio da Ciencia e do Ensino Superior
   [LISBOA-01-0145-FEDER-007344]; FEDER under the PT2020 Partnership
   Agreement
FX This work was supported by Sartorius Stedim Biotech and received
   financial support from Fundacao para a Ciencia e Tecnologia through the
   Investigador FCT programme 2014 (project IF/01704/2014 and
   IF/01704/2014/CP1229/CT0001) and from iNOVA4 Health Research Unit
   (LISBOA-01-0145-FEDER-007344), which is cofunded by Fundacao para a
   Ciencia e Tecnologia/Ministerio da Ciencia e do Ensino Superior, through
   national funds, and by FEDER under the PT2020 Partnership Agreement. The
   authors wish to thank Carina Silva, Margarida Serra and Joao Clemente
   for technical and scientific support. The authors are also grateful to
   Dr. Genevieve Libeau (CIRAD-EMVT, France) for providing the PPR vaccine
   strain. The authors express their gratitude to Dr. Carlos Augusto for
   the fruitful discussions during the setup of this work. Conflict of
   interest: all authors declare no conflict of interest and agree with the
   submission of the manuscript, which was not submitted for publication
   elsewhere.
CR Abecasis B, 2017, J BIOTECHNOL, V246, P81, DOI 10.1016/j.jbiotec.2017.01.004
   Atiemo-Obeng VA, 2004, SOILD LIQUID MIXING, P543, DOI 10.1002/0471451452.ch10
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]
   Bielser JM, 2018, BIOTECHNOL ADV, V36, P1328, DOI 10.1016/j.biotechadv.2018.04.011
   Bora Mousumi, 2018, VirusDisease, V29, P285, DOI 10.1007/s13337-018-0455-3
   Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+
   Castilho LR, 2002, CELL RETENTION DEVIC, P129, DOI [10.1007/3-540-45736-4_7, DOI 10.1007/3-540-45736-4_7]
   CHERRY RS, 1988, BIOTECHNOL BIOENG, V32, P1001, DOI 10.1002/bit.260320808
   CHERRY RS, 1989, BIOPROCESS ENG, V4, P81, DOI 10.1007/BF00373735
   Clapp KP, 2018, BIOPHARM PROCESS DEV, P457, DOI [10.1016/B978-0-08-100623-8.00024-4, DOI 10.1016//B978-0-08-100623-8.00024-4]
   Clincke MF, 2013, BIOTECHNOL PROGR, V29, P754, DOI 10.1002/btpr.1704
   CROUGHAN MS, 1988, BIOTECHNOL BIOENG, V32, P975, DOI 10.1002/bit.260320805
   CROUGHAN MS, 1987, BIOTECHNOL BIOENG, V29, P130, DOI 10.1002/bit.260290117
   Cruz PE, 1998, BIOTECHNOL BIOENG, V60, P408, DOI 10.1002/(SICI)1097-0290(19981120)60:4<408::AID-BIT2>3.3.CO;2-C
   de Haan J, 2015, FINANCIAL MARKETS AND INSTITUTIONS: A EUROPEAN PERSPECTIVE, 3RD EDITION, P195
   Dhinakar Raj G, 2015, STRATEGIES FUTURE GL, P227, DOI [10.1007/978-3-662-45165-6_13, DOI 10.1007/978-3-662-45165-6_13]
   Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013
   Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311
   Diallo A, 2004, PESTE PETITS RUMINAN, VI
   Diallo A., 2004, PESTE PETITS RUMINAN, VII
   Falkner E, 2006, TOXICOL IN VITRO, V20, P395, DOI 10.1016/j.tiv.2005.09.006
   Fernandes P, 2013, GENE THER, V20, P353, DOI 10.1038/gt.2012.52
   Gallo-Ramirez LE, 2015, EXPERT REV VACCINES, V14, P1181, DOI 10.1586/14760584.2015.1067144
   George M, 2010, BIOTECHNOL BIOENG, V106, P906, DOI 10.1002/bit.22753
   Giangaspero M., 2013, SURGERY, V1, P1, DOI [DOI 10.4172/2329-9088.1000153, 10.4172/2329-9088]
   GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044
   Ibrahim S, 2004, CHEM ENG RES DES, V82, P1082, DOI 10.1205/cerd.82.9.1082.44161
   Kaiser Stephan C., 2011, Computational Fluid Dynamics Technologies and Applications, P97
   Li BY, 2015, J ORTHOP TRANSL, V3, P51, DOI 10.1016/j.jot.2015.02.003
   Maranga L, 2004, J BIOTECHNOL, V107, P55, DOI 10.1016/j.jbiotec.2003.09.012
   Marcelino I, 2006, VACCINE, V24, P1716, DOI 10.1016/j.vaccine.2005.08.109
   Mariner JC, 2016, J IMMUNOL, V196, P3499, DOI 10.4049/jimmunol.1502625
   MCMANAMEY WJ, 1979, CHEM ENG SCI, V34, P432, DOI 10.1016/0009-2509(79)85081-2
   Merten O-W, 2003, ENCY CELL TECHNOL, P1, DOI [10.1002/0471250570.spi036, DOI 10.1002/0471250570.SPI036]
   Merten OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0040
   MONTAGNON BJ, 1984, CLIN INFECT DIS, V6, pS341, DOI DOI 10.1093/CLINIDS/6SUPPLEMENT2.S341
   Nienow A.W., 1998, APPL MECH REV, V51, P3, DOI DOI 10.1115/1.3098990
   Nienow AW, 2016, BIOCHEM ENG J, V108, P24, DOI 10.1016/j.bej.2015.08.003
   Nienow AW, 2014, BIOCHEM ENG J, V85, P79, DOI 10.1016/j.bej.2014.02.005
   Pacek AW, 1999, CHEM ENG SCI, V54, P4211, DOI 10.1016/S0009-2509(99)00156-6
   Parida S, 2015, VET MICROBIOL, V181, P90, DOI 10.1016/j.vetmic.2015.08.009
   Peste Des FAO, 2009, PET RUM PPR CHALL SM
   Petiot E, 2012, CYTOTECHNOLOGY, V64, P429, DOI 10.1007/s10616-011-9421-2
   PLACEK J, 1985, AICHE J, V31, P1113, DOI 10.1002/aic.690310709
   Quesney S, 2003, CYTOTECHNOLOGY, V42, P1, DOI 10.1023/A:1026185615650
   Rafiq QA, 2018, BIOCHEM ENG J, V135, P11, DOI 10.1016/j.bej.2017.11.005
   Rappaport C, 2003, IN VITRO CELL DEV-AN, V39, P187
   Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086
   Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015
   Silva AC, 2008, VACCINE, V26, P3305, DOI 10.1016/j.vaccine.2008.03.077
   Singh RK, 2009, VET ITAL, V45, P449
   Sousa MFQ, 2015, BIOTECHNOL PROGR, V31, P1600, DOI 10.1002/btpr.2158
   TAYLOR WP, 1979, RES VET SCI, V26, P94
   Varley J, 1999, CYTOTECHNOLOGY, V29, P177, DOI 10.1023/A:1008008021481
   Wang Y, 1999, BIOPROCESS ENG, V21, P211, DOI 10.1007/s004490050665
   Zeng AP, 1998, BIOTECHNOL PROGR, V14, P434, DOI 10.1021/bp9800337
NR 56
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7041
EP 7051
DI 10.1016/j.vaccine.2019.07.009
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100014
PM 31402239
OA Other Gold
DA 2020-05-12
ER

PT J
AU Trabelsi, K
   Ben Zakour, M
   Kallel, H
AF Trabelsi, Khaled
   Ben Zakour, Meriem
   Kallel, Hela
TI Purification of rabies virus produced in Vero cells grown in serum free
   medium
SO VACCINE
LA English
DT Article
DE Vero cells; Rabies vaccine; Purification; Membrane chromatography
ID INFLUENZA-A; VACCINE; DNA; CHROMATOGRAPHY; PROTEINS; CHINA; STEP
AB Rabies is a viral zoonosis caused by negative-stranded RNA viruses of the Lyssavirus genus. It can affect all mammals including humans. Dogs are the main source of human rabies deaths, contributing up to 99% of all rabies transmissions to humans. Vaccination against rabies is still the sole efficient way to fight against the disease.
   Cell culture vaccines are recommended by World Health Organization (WHO) for pre and post exposure prophylaxis; among them Vero cell rabies vaccines which are used worldwide. In this work we studied the purification of inactivated rabies virus produced in Vero cells grown in animal component free conditions, using different methods. Cells were grown in VP-SFM medium in stirred bioreactor, then infected at an MOI of 0.05 with the LP2061 rabies virus strain. Collected harvests were purified by zonal centrifugation, and by chromatography supports, namely the Capto Core 700 and the monolithic CIM-QA column. Generated data were compared in terms of residual DNA level, host cell proteins (HCP) level and the overall recovery yield.
   Rabies virus purification using the monolithic column resulted in the highest antigen recovery yield, equal to 94%. Capto Core 700 showed a lower yield, about 84%; whereas the purification yield by zonal centrifugation was equal to 60%. In terms of host cell residual DNA removal, zonal centrifugation was the most efficient method; the removal yield was equal to 88.5%; elimination of host cell DNA was slightly lower when using the monolithic CIM-QA (equal to 73%). Whereas Capto Core 700 showed the lowest level (49.2%). Host cell protein removal varied between 92.6% for the monolithic column and 78.6% for the zonal centrifugation. Capto Core 700 eliminated 86.5% of HCP. (C) 2019 Elsevier Ltd.
C1 [Trabelsi, Khaled; Ben Zakour, Meriem; Kallel, Hela] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Grp Biotechnol Dev, Pl Pasteur,BP 74, Tunis 1002, Tunisia.
RP Kallel, H (reprint author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Grp Biotechnol Dev, Pl Pasteur,BP 74, Tunis 1002, Tunisia.
EM hela.kallel@pasteur.tn
FU Tunisian Ministry of Higher Education and Scientific Research
   [LR11IPT01]
FX This research was funded by a grant from the Tunisian Ministry of Higher
   Education and Scientific Research (grant LR11IPT01 Laboratory of
   Molecular Microbiology, Vaccinology and Biotechnology Development).
CR ATANASIU P, 1979, ANN INST PASTEUR MIC, VA130, P85
   Banjac M, 2014, VACCINE, V32, P2487, DOI 10.1016/j.vaccine.2014.02.086
   Chtioui M, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P629, DOI 10.1007/978-1-4020-5476-1_114
   Fooks AR, 2019, VACCINE, V37, pA140, DOI 10.1016/j.vaccine.2018.08.039
   GE Healthcare Life Sciences, 29000334 GE HEALTHC
   Gijsbers L, 2005, HUM GENE THER, V16, P393, DOI 10.1089/hum.2005.16.393
   Kulkarni PS, 2017, EXPERT REV VACCINES, V16, P303, DOI 10.1080/14760584.2017.1294068
   Kumar AAP, 2005, MICROBES INFECT, V7, P1110, DOI 10.1016/j.micinf.2005.03.034
   Kumar AAP, 2002, J BIOSCI BIOENG, V94, P375, DOI 10.1016/S1389-1723(02)80212-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lagoutte P, 2016, J VIROL METHODS, V232, P8, DOI 10.1016/j.jviromet.2016.02.011
   Li RC, 2013, VACCINE, V31, P5940, DOI 10.1016/j.vaccine.2013.10.043
   Li SM, 2014, BIOLOGICALS, V42, P271, DOI 10.1016/j.biologicals.2014.06.005
   Mattos DA, 2015, VACCINE, V33, P4288, DOI 10.1016/j.vaccine.2015.04.050
   Meslin F.-X., 1996, LAB TECHNIQUES RABIE
   O'Brien KL, 2019, VACCINE, V37, pA85, DOI 10.1016/j.vaccine.2018.10.014
   Oksanen HM, 2012, VIROLOGY, V434, P271, DOI 10.1016/j.virol.2012.09.019
   Pato TP, 2014, VACCINE, V32, P2789, DOI 10.1016/j.vaccine.2014.02.036
   Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086
   Shen X, 2013, BIOLOGICALS, V41, P201, DOI 10.1016/j.biologicals.2012.12.001
   Sheng-Fowler L, 2009, BIOLOGICALS, V37, P190, DOI 10.1016/j.biologicals.2009.02.015
   SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535
   Thomassen YE, 2014, VACCINE, V32, P2782, DOI 10.1016/j.vaccine.2014.02.022
   TORDO N, 1993, ONDERSTEPOORT J VET, V60, P263
   Trabelsi K, 2006, J BIOTECHNOL, V121, P261, DOI 10.1016/j.jbiotec.2005.07.018
   Trabelsi K, 2005, ENZYME MICROB TECH, V36, P514, DOI 10.1016/j.enzmictec.2004.11.008
   Venkatachalam ARK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-99
   World Hlth Org, 2018, VACCINE, V36, P5500, DOI 10.1016/j.vaccine.2018.06.061
   Wu XF, 2011, EXPERT REV VACCINES, V10, P1597, DOI [10.1586/erv.11.140, 10.1586/ERV.11.140]
   Yu PC, 2012, HUM VACC IMMUNOTHER, V8, P1230, DOI 10.4161/hv.20985
   Zhang YZ, 2006, VIRUS RES, V121, P179, DOI 10.1016/j.virusres.2006.05.010
NR 31
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7052
EP 7060
DI 10.1016/j.vaccine.2019.06.072
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100015
PM 31300287
OA Other Gold
DA 2020-05-12
ER

PT J
AU Lima, TM
   Souza, MO
   Castilho, LR
AF Lima, Tulio M.
   Souza, Matheus O.
   Castilho, Leda R.
TI Purification of flavivirus VLPs by a two-step chomatographic process
SO VACCINE
LA English
DT Article
DE Virus-like particles (VLPs); Yellow fever virus; Zika virus; Downstream
   processing; Chromatographic purification
ID VIRUS-LIKE PARTICLES; EXCHANGE MEMBRANE CHROMATOGRAPHY; YELLOW-FEVER;
   OUTBREAK
AB Flaviviruses are enveloped viruses with positive-sense, single-stranded RNA, which are most commonly transmitted by infected mosquitoes. Zika virus (ZIKV) and yellow fever virus (YFV) are flaviviruses that have caused significant outbreaks in the last few years. Since there is no approved vaccine against ZIKV, and since the existing YF attenuated vaccine presents disadvantages related to limited supply and to rare, but fatal adverse effects, there is an urgent need for new vaccines to control these diseases. Virus-like particles (VLPs) represent a recombinant platform to produce safe and immunogenic vaccines. Thus, based on our experience of expressing in recombinant mammalian cells VLPs of most flaviviruses circulating in the Americas, this work focused on the evaluation of chromatographic purification processes for zika and yellow-fever VLPs. The clarified cell culture supernatant was processed by a membrane-based anion-exchange chromatography and then a multimodal chromatographic step. With this process, it was possible to obtain the purified VLPs with a yield (including the clarification step) of 66.4% for zika and 68.1% for yellow fever. DNA clearance was in the range of 99.8-99.9%, providing VLP preparations that meet the WHO limit for this critical contaminant. Correct size and morphology of the purified VLPs were confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). The promising results obtained for both zika and yellow fever VLPs indicate that this process could be potentially applied also to VLPs of other flaviviruses. (C) 2019 Elsevier Ltd.
C1 [Lima, Tulio M.; Souza, Matheus O.; Castilho, Leda R.] Fed Univ Rio Janeiro UFRJ, COPPE, Cell Culture Engn Lab, Av Horacio Macedo,2030 Sl G115,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
   [Lima, Tulio M.] Fed Univ Rio Janeiro UFRJ, EQ, EPQB Grad Program, Av Horacio Macedo,2030 Sl E206,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
   [Souza, Matheus O.] Univ Kansas, Dept Pharmaceut Chem, Immune Engn Lab, 2095 Constant Ave, Lawrence, KS 66047 USA.
RP Castilho, LR (reprint author), Fed Univ Rio Janeiro UFRJ, COPPE, Cell Culture Engn Lab, Av Horacio Macedo,2030 Sl G115,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
EM leda@peq.coppe.ufrj.br
FU Brazilian research funding agency CNPq; Brazilian research funding
   agency CapesCAPES; Brazilian research funding agency Faperj
FX Financial support from the Brazilian research funding agencies CNPq,
   Capes and Faperj is gratefully acknowledged.
CR Alvim RGF, 2019, VACCINE, V37, P6970, DOI 10.1016/j.vaccine.2019.05.064
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Soler JC, 2009, GAC SANIT, V23, P295, DOI 10.1016/j.gaceta.2008.09.008
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen Y, 2015, VACCINE, V33, P4300, DOI 10.1016/j.vaccine.2015.03.078
   DAI S, 2018, J IMMUNOL SCI, V2, P36, DOI DOI 10.29245/2578-3009/2018/2.1118
   Effio CL, 2016, J CHROMATOGR A, V1429, P142, DOI 10.1016/j.chroma.2015.12.006
   ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Foster KR, 1998, SCI AM, V279, P88, DOI 10.1038/scientificamerican0898-88
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018
   Hughson MD, 2017, BIOTECHNOL PROGR, V33, P931, DOI 10.1002/btpr.2501
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   Litvoc MN, 2018, REV ASSOC MED BRAS, V64, P106, DOI 10.1590/1806-9282.64.02.106
   Martins RD, 2018, VACCINE, V36, P4112, DOI 10.1016/j.vaccine.2018.05.041
   Middelberg PJA, 2013, PHARM BIOPROCESS, V1, P407
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Native Antigen Company (NAC), 2019, ZIK VIR VLP CERT AN
   Native Antigen Company (NAC), 2019, DENG VIR SER 2 ENV P
   Nestola P, 2015, J CHROMATOGR A, V1426, P91, DOI 10.1016/j.chroma.2015.11.037
   O'Higgins T, 2014, ECOL SOC, V19, DOI 10.5751/ES-06507-190446
   Ohtaki N, 2011, J VIROL METHODS, V174, P131, DOI 10.1016/j.jviromet.2011.03.021
   PAHO/WHO, 2015, ZIK CAS CONG SYNDR A
   Pato TP, 2019, VACCINE, V37, P3214, DOI 10.1016/j.vaccine.2019.04.077
   Pato TP, 2014, VACCINE, V32, P2789, DOI 10.1016/j.vaccine.2014.02.036
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI 10.1586/ERV.10.115
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Vicente T, 2008, J MEMBRANE SCI, V311, P270, DOI 10.1016/j.memsci.2007.12.021
   Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004
   Vogel JH, 2012, BIOTECHNOL BIOENG, V109, P3049, DOI 10.1002/bit.24578
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   World Health Organization, 2007, WHO STUD GROUP CELL
   World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069
   Zhao D, 2015, J APPL MICROBIOL, V119, P1196, DOI 10.1111/jam.12922
NR 41
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7061
EP 7069
DI 10.1016/j.vaccine.2019.05.066
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100016
PM 31201056
OA Other Gold
DA 2020-05-12
ER

PT J
AU Aguilar, PP
   Schneider, TA
   Wetter, V
   Maresch, D
   Ling, WL
   Tover, A
   Steppert, P
   Jungbauer, A
AF Aguilar, Patricia Pereira
   Schneider, Tobias Amadeus
   Wetter, Viktoria
   Maresch, Daniel
   Ling, Wai Li
   Tover, Andres
   Steppert, Petra
   Jungbauer, Alois
TI Polymer-grafted chromatography media for the purification of enveloped
   virus-like particles, exemplified with HIV-1 gag VLP
SO VACCINE
LA English
DT Article
DE Fractogel (R); Dynamic binding capacity; HIV-1 gag variants;
   Nanoparticle tracking analysis; Multi-angle light scattering
ID EXTRACELLULAR VESICLES; PROTEIN ADSORPTION; VACCINES; SEPARATION;
   TRANSPORT; EXCHANGERS; DELIVERY; BEHAVIOR; VECTORS; RNA
AB Polymer-grafted chromatography media, especially ion exchangers, are high performance materials for protein purification. However, due to the pore size limitation, conventional chromatography beads are usually not considered for the downstream processing of large biomolecules such as virus-like particles (VLPs). Contrariwise, since the outer surface of the chromatography beads provides satisfactory binding capacity for VLPs and impurities of smaller size can bind inside of the beads, conventional porous beads should be considered for VLP capture and purification. We used HIV-1 gag VLPs with a diameter of 100-200 nm as a model to demonstrate that polymer-grafted anion exchangers are suitable for the purification of bionanoparticles. The equilibrium binding capacity was 1 x 10(13) part/mL resin. Moderate salt concentration up to 100 mM NaCl did not affect binding, allowing direct loading of cell culture supernatant onto the column for purification. Dynamic binding capacity at 10% breakthrough, when loading cell culture supernatant, was approximately 6 x 10(11) part/mL column; only 1-log lower than for monoliths. Endonuclease treatment of the cell culture supernatant did not increase the dynamic binding capacity, suggesting that dsDNA does not compete for the binding sites of VLPs. Nevertheless, due to simultaneous elution of particles and dsDNA, endonuclease treatment is required to reduce dsDNA contamination in the product. Proteomic analysis revealed that HIV-1 gag VLPs contain different host cell proteins in their cargo. This cargo is composed of conserved proteins and other proteins that vary from one particle population to another, as well as from batch to batch. This process allowed the separation of different particle populations. HIV-1 gag VLPs were directly captured and purified from cell culture supernatant with a total particle recovery in the elution of about 35%. Columns packed with beads can be scaled to practically any dimension and therefore a tailored design of the process is possible. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Aguilar, Patricia Pereira; Maresch, Daniel; Steppert, Petra; Jungbauer, Alois] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.
   [Schneider, Tobias Amadeus; Wetter, Viktoria; Jungbauer, Alois] Austrian Ctr Ind Biotechnol, Vienna, Austria.
   [Ling, Wai Li] Univ Grenoble Alpes, IBS, CNRS, CEA, F-38000 Grenoble, France.
   [Tover, Andres] Icosagen AS, Tartumaa, Estonia.
RP Jungbauer, A (reprint author), Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.
EM alois.jungbauer@boku.ac.at
OI Pereira Aguilar, Patricia/0000-0003-3346-4832; Jungbauer,
   Alois/0000-0001-8182-7728
FU Austrian Science Fund (project BioToP)Austrian Science Fund (FWF) [FWF
   W1224]; Austrian BMWD; BMVIT; SFG; Standortagentur Tirol; Government of
   Lower Austria; Business Agency Vienna through the Austrian
   FFG-COMET-Funding Program; FRISBI within the Grenoble Partnership for
   Structural Biology (PSB) [ANR-10-INSB-05-02]; GRAL within the Grenoble
   Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]; Auvergne
   Rhone-Alpes Region; Fondation Recherche Medicale (FRM)Fondation pour la
   Recherche Medicale; fonds FEDER; GIS-Infrastrutures en Biologie Sante et
   Agronomie, France (IBISA)
FX This project has been supported by the Austrian Science Fund (project
   BioToP; FWF W1224). Schneider and Wetter have been supported by the
   Austrian BMWD, BMVIT, SFG, Standortagentur Tirol, Government of Lower
   Austria and Business Agency Vienna through the Austrian
   FFG-COMET-Funding Program. This work used the platforms of the Grenoble
   Instruct-ERIC Center (ISBG: UMS 3518 CNRS-CEA-UGA-EMBL) with support
   from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the
   Grenoble Partnership for Structural Biology (PSB). The electron
   microscope facility is supported by the Auvergne Rhone-Alpes Region, the
   Fondation Recherche Medicale (FRM), the fonds FEDER and the
   GIS-Infrastrutures en Biologie Sante et Agronomie, France (IBISA). The
   funding agencies had no influence on the conduct of this research. The
   authors would like to specially thank Professor Giorgio Carta for the
   great scientific collaboration and Preston Fuks for the help in the
   laboratory, especially regarding the imaging of resin beads.
CR Abdulrahman A, 2018, ANAL CHIM ACTA, V1025, P41, DOI 10.1016/j.aca.2018.04.001
   Almodovar EXP, 2011, BIOTECHNOL PROGR, V27, P1264, DOI 10.1002/btpr.643
   Bowes BD, 2011, J CHROMATOGR A, V1218, P7180, DOI 10.1016/j.chroma.2011.08.039
   Bowes BD, 2009, J CHROMATOGR A, V1216, P7774, DOI 10.1016/j.chroma.2009.09.014
   Braas G, 1996, BIOSEPARATION, V6, P211
   Brune KD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01432
   Carta GA, 2010, JUNGBAUER PROTEIN CH
   Diedrich J, 2017, J CHROMATOGR A, V1525, P60, DOI 10.1016/j.chroma.2017.09.039
   Ding XW, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700324
   Donaldson B, 2018, EXPERT REV VACCINES, V17, P833, DOI 10.1080/14760584.2018.1516552
   Effio CL, 2015, BIOTECHNOL J, V10, P715, DOI 10.1002/biot.201400392
   Gerster P, 2013, J CHROMATOGR A, V1290, P36, DOI 10.1016/j.chroma.2013.03.047
   Ghosh R, 2002, J CHROMATOGR A, V952, P13, DOI 10.1016/S0021-9673(02)00057-2
   Gutierrez-Granados S, 2013, J VIROL METHODS, V193, P85, DOI 10.1016/j.jviromet.2013.05.010
   Hardcastle N, 2018, EXPERT OPIN BIOL TH, V18, P293, DOI 10.1080/14712598.2018.1416089
   Jungbauer A, 2005, J CHROMATOGR A, V1065, P3, DOI 10.1016/j.chroma.2004.08.162
   Kramberger P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-265
   Kurg R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29425
   Lenhoff AM, 2011, J CHROMATOGR A, V1218, P8748, DOI 10.1016/j.chroma.2011.06.061
   Marcus RK, 2009, J SEP SCI, V32, P695, DOI 10.1002/jssc.200800645
   McCraw DM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28700-7
   Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x
   Muller E, 2005, CHEM ENG TECHNOL, V28, P1295, DOI 10.1002/ceat.200500161
   MULLER W, 1990, J CHROMATOGR, V510, P133, DOI 10.1016/S0021-9673(01)93746-X
   Nestola P, 2015, BIOTECHNOL BIOENG, V112, P843, DOI 10.1002/bit.25545
   Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113
   Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306
   Pitoiset F, 2015, EXPERT REV VACCINES, V14, P913, DOI 10.1586/14760584.2015.1046440
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Schupbach J, 2006, J MED VIROL, V78, P1003, DOI 10.1002/jmv.20655
   Shirbaghaee Z, 2016, BIOPOLYMERS, V105, P113, DOI 10.1002/bip.22759
   Steppert P, 2017, J CHROMATOGR A, V1487, P89, DOI 10.1016/j.chroma.2016.12.085
   Steppert P, 2017, J SEP SCI, V40, P979, DOI 10.1002/jssc.201600765
   Steppert P, 2016, J CHROMATOGR A, V1455, P93, DOI 10.1016/j.chroma.2016.05.053
   Tang VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18227-8
   Tengattini S, 2019, CHROMATOGRAPHIA, V82, P415, DOI 10.1007/s10337-018-3637-7
   Thompson CM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-141
   Trilisky EI, 2007, J CHROMATOGR A, V1142, P2, DOI 10.1016/j.chroma.2006.12.094
   Turnbull J, 2019, BIOTECHNOL BIOENG, V116, P1698, DOI 10.1002/bit.26972
   [US. Department of Health and Humans Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)], 2001, BIOAN METH VAL
   Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004
   Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07
   Wang QQ, 2016, J CHROMATOGR A, V1443, P118, DOI 10.1016/j.chroma.2016.03.033
   Watson DS, 2012, VACCINE, V30, P2256, DOI 10.1016/j.vaccine.2012.01.070
   Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060
   Wolff MW, 2011, EXPERT REV VACCINES, V10, P1451, DOI [10.1586/ERV.11.111, 10.1586/erv.11.111]
   Wu YG, 2013, J CHROMATOGR A, V1297, P96, DOI 10.1016/j.chroma.2013.04.062
   Yamamoto S, 1999, J CHROMATOGR A, V852, P25, DOI 10.1016/S0021-9673(99)00594-4
   Yu MR, 2014, J CHROMATOGR A, V1331, P69, DOI 10.1016/j.chroma.2014.01.027
   Zhu MM, 2018, J CHEM TECHNOL BIOT, V93, P1948, DOI 10.1002/jctb.5410
   Zochling A, 2004, J SEP SCI, V27, P819, DOI 10.1002/jssc.200401777
NR 51
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7070
EP 7080
DI 10.1016/j.vaccine.2019.07.001
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100017
PM 31300289
OA Other Gold
DA 2020-05-12
ER

PT J
AU Suarez-Zuluaga, DA
   Borchert, D
   Driessen, NN
   Bakker, WAM
   Thomassen, YE
AF Suarez-Zuluaga, Diego A.
   Borchert, Daniel
   Driessen, Nicole N.
   Bakker, Wilfried A. M.
   Thomassen, Yvonne E.
TI Accelerating bioprocess development by analysis of all available data: A
   USP case study
SO VACCINE
LA English
DT Article
DE Multivariate data analysis; Comprehensive data gathering; Cause and
   effect analysis; Inactivated poliovirus vaccine; Design of experiments
ID MULTIVARIATE DATA-ANALYSIS; VERO-CELL GROWTH; D-ANTIGEN; CULTURE;
   OPTIMIZATION; BACULOVIRUS; GLUCOSE; IPV
AB Bioprocess development generates extensive datasets from different unit operations and sources (e.g. time series, quality measurements). The development of such processes can be accelerated by evaluating all data generated during the experimental design. This can only be achieved by having a clearly defined data logging and analysis strategy. The latter is described in this manuscript. It consists in a combination of a feature based approach along with principal component analysis and partial least square regression.
   Application of this combined strategy is illustrated by applying it in an upstream processing (USP) case study. Data from the development and optimization of an animal component free USP of Sabin inactivated poliovirus vaccine (sIPV) was evaluated. During process development, 26 bioreactor runs at scales ranging from 2.3 to 16 L were performed. Several operational parameters were varied, and data was routinely analyzed following a design of experiments (DoE) methodology.
   With the strategy described here, it became possible to scrutinize all data from the 26 runs in a single data study. This included the DoE response parameters, all data generated by the bioreactor control systems, all offline data, and its derived calculations. This resulted in a more detailed, reliable and exact view on the most important parameters affecting bioreactor performance.
   In this case study, the strategy was applied for the analysis of previously produced data. Further development will use this data analysis methodology for continuous enhancing and accelerating process development, intensified DoE and integrated process modelling. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Suarez-Zuluaga, Diego A.; Driessen, Nicole N.; Bakker, Wilfried A. M.; Thomassen, Yvonne E.] Intravacc, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands.
   [Borchert, Daniel] Exputec GmbH, Mariahilferstr 147-2-2D, A-1150 Vienna, Austria.
   [Borchert, Daniel] Vienna Univ Technol, Res Area Biochem Engn, Gumpendorferstr 1a, A-1060 Vienna, Austria.
RP Thomassen, YE (reprint author), Intravacc, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands.
EM yvonne.thomassen@intravacc.nl
OI Borchert, Daniel/0000-0002-0067-7965
FU Dutch Ministry of Economic Affairs under PPP-Allowance under the
   TKI-programme Life Sciences Health
FX This project has received funding from the Dutch Ministry of Economic
   Affairs under PPP-Allowance under the TKI-programme Life Sciences &
   Health.
CR Bakker WAM, 2011, VACCINE, V29, P7188, DOI 10.1016/j.vaccine.2011.05.079
   Borchert D, 2019, BIOPROC BIOSYST ENG, V42, P245, DOI 10.1007/s00449-018-2029-6
   Charaniya S, 2008, TRENDS BIOTECHNOL, V26, P690, DOI 10.1016/j.tibtech.2008.09.003
   Cruz HJ, 1999, APPL MICROBIOL BIOT, V51, P579, DOI 10.1007/s002530051435
   Golabgir A, 2016, BIOTECHNOL ADV, V34, P621, DOI 10.1016/j.biotechadv.2016.02.011
   Hu X, 2017, IEEE INT SYMP NANO, P61, DOI 10.1109/NANOARCH.2017.8053711
   Huang HY, 2006, PROCESS BIOCHEM, V41, P2386, DOI 10.1016/j.procbio.2006.06.018
   Kirdar AO, 2008, BIOTECHNOL PROGR, V24, P720, DOI 10.1021/bp0704384
   Knowlson S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005316
   Kozma B, 2018, J PHARMACEUT BIOMED, V158, P269, DOI 10.1016/j.jpba.2018.06.005
   Kumamaru H, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0047-x
   Multicollinearity Least, 2015, INT J STAT APPL, P6
   NAHAPETIAN AT, 1986, J CELL SCI, V81, P65
   PAVLIDIS VF, 2017, [No title captured], P649, DOI DOI 10.1016/B978-0-12-410501-0.00021-6
   Petiot E, 2010, BIOTECHNOL BIOENG, V107, P143, DOI 10.1002/bit.22783
   POWER JF, 1994, BIOTECHNOL BIOENG, V44, P710, DOI 10.1002/bit.260440607
   Quesney S, 2003, CYTOTECHNOLOGY, V42, P1, DOI 10.1023/A:1026185615650
   Rathore AS, 2018, CURR OPIN BIOTECH, V53, P99, DOI 10.1016/j.copbio.2017.12.022
   Sagmeister Patrick, 2012, PDA J Pharm Sci Technol, V66, P526, DOI 10.5731/pdajpst.2012.00889
   Sawatzki Annina, 2018, Bioengineering (Basel), V5, DOI 10.3390/bioengineering5040101
   Sokolov M, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700461
   ten Have R, 2012, BIOLOGICALS, V40, P84, DOI 10.1016/j.biologicals.2011.11.004
   Thomassen YE, 2015, VACCINE, V33, P4307, DOI 10.1016/j.vaccine.2015.03.076
   Thomassen YE, 2014, VACCINE, V32, P2782, DOI 10.1016/j.vaccine.2014.02.022
   Thomassen YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083374
   Thomassen YE, 2013, BIOTECHNOL BIOENG, V110, P1354, DOI 10.1002/bit.24798
   Thomassen YE, 2010, BIOTECHNOL BIOENG, V107, P96, DOI 10.1002/bit.22788
   Ursache RV, 2015, BIOPROC BIOSYST ENG, V38, P543, DOI 10.1007/s00449-014-1294-2
   Veerasamy R., 2011, INT J DRUG DES DIS, V2, P511, DOI DOI 10.1016/J.FEBSLET.2005.06.031
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Wong KTK, 1996, BIOTECHNOL BIOENG, V49, P659, DOI 10.1002/(SICI)1097-0290(19960320)49:6&lt;659::AID-BIT7&gt;3.0.CO;2-N
NR 31
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7081
EP 7089
DI 10.1016/j.vaccine.2019.07.026
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100018
PM 31337593
OA Other Gold
DA 2020-05-12
ER

PT J
AU Logan, M
   Manalil, J
   Notte, C
   Kearse, C
   George, S
   Zeiser, A
   Farrell, P
   Aucoin, MG
AF Logan, Megan
   Manalil, Julia
   Notte, Christina
   Kearse, Craig
   George, Steve
   Zeiser, Arno
   Farrell, Patrick
   Aucoin, Marc G.
TI A flow cytometric granularity assay for the quantification of infectious
   virus
SO VACCINE
LA English
DT Article
DE Side-scatter; Flow cytometry; Herpes simplex virus; Recombinant HSV-2;
   ALVAC; Granularity
ID HERPES-SIMPLEX-VIRUS; GREEN FLUORESCENT PROTEIN; TITRATION ASSAY; CELLS
AB A flow cytometry-based assay was developed to assess the infective titer of two recombinant viruses: a recombinant herpes simplex type 2 (rHSV-2) and a recombinant canary pox (rALVAC.gfp). This method uses granularity of infected Vero and QT-35 cells, respectively, and correlates this to the infectious titer of virus samples. The percent of the cell populations with a high level of granularity could accurately be correlated to viral titers obtained through a traditional plaque assay, with R-2 values greater than 0.8 using a semi-logarithmic scale. This approach offers a rapid, high-throughput method for infectious virus titration with similar accuracy to a traditional plaque assay. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Logan, Megan; Manalil, Julia; Aucoin, Marc G.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
   [Notte, Christina; Kearse, Craig; George, Steve; Zeiser, Arno; Farrell, Patrick] Sanofi Pasteur, 1755 Steeles Ave West, Toronto, ON M2R 3T4, Canada.
RP Aucoin, MG (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM maucoin@uwaterloo.ca
OI Aucoin, Marc/0000-0001-9393-5558
FU NSERC of Canada through Engage [EGP-451558-2013]; Sanofi Pasteur [CDPJ
   444171-2012]
FX The authors acknowledge funding support to MGA by the NSERC of Canada
   through Engage [grant number EGP-451558-2013]; and Collaborative
   Research and Development Grants with Sanofi Pasteur [grant number CDPJ
   444171-2012]. The authors also thank Prof. Maud Gorbet and Brian Ingalls
   for allowing access to their labs.
CR [Anonymous], 2005, INT C HARM TECH REQ
   Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000
   Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330
   Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714
   Foster TP, 1998, J VIROL METHODS, V75, P151, DOI 10.1016/S0166-0934(98)00107-4
   Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653
   Grigorov B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024135
   Kung SH, 2000, J VIROL METHODS, V90, P205, DOI 10.1016/S0166-0934(00)00234-2
   LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0
   Li ZJ, 2010, J VIROL METHODS, V169, P87, DOI 10.1016/j.jviromet.2010.07.003
   Lonsdale R, 2003, J VIROL METHODS, V110, P67, DOI 10.1016/S0166-0934(03)00102-2
   McSharry JJ, 2000, METHODS, V21, P249, DOI 10.1006/meth.2000.1005
   Morris T, 2013, USP PHARMACOPEIAL CO, V36, P986
   Nordstrom T, 1999, CYTOMETRY, V37, P238, DOI 10.1002/(SICI)1097-0320(19991101)37:3<238::AID-CYTO11>3.0.CO;2-9
   Qi J, 2015, ANAL CHIM ACTA, V879, P58, DOI 10.1016/j.aca.2015.04.007
   Roizman B., 2013, FIELDS VIROLOGY, V2, P1824
   Sandhu KS, 2008, BIOTECHNOL PROGR, V24, P250, DOI 10.1021/bp070198s
   Shapiro H. M., 2003, PRACTICAL FLOW CYTOM, DOI [10.1002/0471722731, DOI 10.1002/0471722731]
   Shrivastava A., 2011, CHRON YOUNG SCI, V2, P21, DOI DOI 10.4103/2229-5186.79345
   Tsai YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0137-z
   Vengatesan D, 2006, CYTOM PART B-CLIN CY, V70B, P335, DOI 10.1002/cyto.b.20104
   Weli SC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-49
   Xin X, 2018, J VIROL, V92, DOI [10.1128/JVI.00179-18, 10.1128/jvi.00179-18]
NR 23
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7090
EP 7099
DI 10.1016/j.vaccine.2019.02.059
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100019
PM 31630940
OA Other Gold
DA 2020-05-12
ER

PT J
AU Venereo-Sanchez, A
   Fulton, K
   Koczka, K
   Twine, S
   Chahal, P
   Ansorge, S
   Gilbert, R
   Henry, O
   Kamen, A
AF Venereo-Sanchez, Alina
   Fulton, Kelly
   Koczka, Krisztina
   Twine, Susan
   Chahal, Parminder
   Ansorge, Sven
   Gilbert, Renald
   Henry, Olivier
   Kamen, Amine
TI Characterization of influenza H1N1 Gag virus-like particles and
   extracellular vesicles co-produced in HEK-293SF
SO VACCINE
LA English
DT Article
DE Virus-like particles; Influenza vaccine; nLC-MS/MS; Extracellular
   vesicles; Exosomes; HEK-293SF
ID ELONGATION-FACTOR 1-ALPHA; CELL-DERIVED EXOSOMES; PROTEOMIC ANALYSIS;
   PROTEIN; TYPE-1; NUCLEOLIN; HEMAGGLUTININ; TRANSLATION; LEVEL;
   TUMORIGENICITY
AB One of the concerns associated with the use of influenza virus-like particles (VLPs) as vaccine candidate or delivery system is their heterogeneous composition. Enveloped VLPs take up the host cell membrane at the budding site carrying out not only the viral antigenic proteins but also host proteins. In addition, the intrinsic nature of cells to produce membrane derived vesicles or extracellular vesicles (EVs), which have similar size to the VLPs, makes VLP purification process challenging. To further characterize these particles and identify proteins that are unique to each population, comparative proteomic analyses were completed to ultimately provide guidance for rational design of separation protocols. The VLPs were produced in suspension and serum free media by transient transfection of an inducible clone of a Human Embryonic Kidney (HEK-293SF) cells expressing HA and NA (H1N1/A/Puerto Rico/8/34), with a plasmid containing the gag gene of HIV-1 fused to GFP. EVs were produced independently from the non-transformed HEK-293SF cell line as a control for comparative studies. Both preparations were characterized for total nucleic acids and protein concentrations and extensively analyzed by nanoLC-MS/MS for their protein compositions. The proteomic analyses showed that aside from the recombinant VLP proteins, nucleolin was the most abundant host cell protein uniquely identified within VLPs (considering the MASCOT score value) while lactotransferrin and heat shock protein 90 were the most abundant proteins in EVs. Overall, this comparative study identifies potential target proteins as specific markers to guide VLP purification and discusses the biogenesis of enveloped particles released in HEK-293 cell suspension cultures emphasizing on the biological functions of host cell proteins identified. Crown Copyright (C) 2019 Published by Elsevier Ltd.
C1 [Venereo-Sanchez, Alina; Gilbert, Renald; Kamen, Amine] McGill Univ, Dept Bioengn, Montreal, PQ, Canada.
   [Venereo-Sanchez, Alina; Henry, Olivier] Ecole Polytech Montreal, Dept Chem Engn, Montreal, PQ, Canada.
   [Venereo-Sanchez, Alina; Fulton, Kelly; Twine, Susan; Chahal, Parminder; Ansorge, Sven; Gilbert, Renald] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada.
   [Koczka, Krisztina] ACIB, Vienna, Austria.
RP Kamen, A (reprint author), McGill Univ, Dept Bioengn, Montreal, PQ, Canada.
EM amine.kamen@mcgill.ca
OI Kamen, Amine/0000-0001-9110-8815
FU Natural Sciences and Engineering Research Council of government of
   Canada [NSERC STPGP 462995-14]; Canada Research Chair of government of
   Canada [CRC/240394]
FX This work has been supported by grants from Natural Sciences and
   Engineering Research Council (NSERC STPGP 462995-14) and Canada Research
   Chair (CRC/240394) of government of Canada. The authors also thank Nasha
   Nassoury and Sabo Hrapovic for providing the TEM analysis of the
   particles. Also Authors would like to thank the support of Reingard
   Grabherr from BOKU and the continuing support of NRC technical teams.
CR Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005
   Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8
   Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442
   Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002
   Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000
   Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999
   CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7
   D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x
   Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227
   Dobbelaer R, 2005, WHO TECHN REP SER
   Dumont J, 2016, CRIT REV BIOTECHNOL, V36, P1110, DOI 10.3109/07388551.2015.1084266
   Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9
   EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978
   Farquhar MJ, 2011, BIOCHEM SOC T, V39, P532, DOI 10.1042/BST0390532
   Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299
   Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002
   Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001
   Haynes JR, 2009, EXPERT REV VACCINES, V8, P435, DOI 10.1586/ERV.09.8
   Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X
   Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787
   Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015
   Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019
   KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031
   Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622
   KUBOTA H, 1995, EUR J BIOCHEM, V230, P3, DOI 10.1111/j.1432-1033.1995.tb20527.x
   LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6
   Marsman G, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.410
   Monette A, 2011, REMODELLING NUCL POR
   Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058
   Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522
   Nwasike C, 2016, ANN NY ACAD SCI
   Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x
   Overbye A, 2015, ONCOTARGET, V6, P30357, DOI 10.18632/oncotarget.4851
   Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005
   Pushko P, 2011, VACCINE, V29, P5911, DOI 10.1016/j.vaccine.2011.06.068
   Richter-Landsberg C., 2009, HEAT SHOCK PROTEINS, P1
   ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134
   SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026
   Segura MM, 2008, J VIROL, V82, P1107, DOI 10.1128/JVI.01909-07
   Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085
   Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002
   Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065
   Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014
   TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0
   Thali M, 2011, TETRASPANIN FUNCTION
   Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309
   Thompson CM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0152-x
   Ueno T, 2004, MICROBIOL IMMUNOL, V48, P111, DOI 10.1111/j.1348-0421.2004.tb03496.x
   Venereo-Sanchez A, 2017, VACCINE, V35, P4220, DOI 10.1016/j.vaccine.2017.06.024
   Venereo-Sanchez A, 2016, VACCINE, V34, P3371, DOI 10.1016/j.vaccine.2016.04.089
   Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004
   Wu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009784
   ZAIDI SHE, 1995, J BIOL CHEM, V270, P17292, DOI 10.1074/jbc.270.29.17292
NR 55
TC 3
Z9 3
U1 4
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7100
EP 7107
DI 10.1016/j.vaccine.2019.07.057
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100020
PM 31358407
OA Other Gold
DA 2020-05-12
ER

PT J
AU Stark, FC
   Akache, B
   Ponce, A
   Dudani, R
   Deschatelets, L
   Jia, YM
   Sauvageau, J
   Williams, D
   Jamshidi, MP
   Agbayani, G
   Wachholz, K
   Harrison, BA
   Li, XG
   Krishnan, L
   Chen, WX
   McCluskie, MJ
AF Stark, Felicity C.
   Akache, Bassel
   Ponce, Amalia
   Dudani, Renu
   Deschatelets, Lise
   Jia, Yimei
   Sauvageau, Janelle
   Williams, Dean
   Jamshidi, Mohammad P.
   Agbayani, Gerard
   Wachholz, Kristina
   Harrison, Blair A.
   Li, Xuguang
   Krishnan, Lakshmi
   Chen, Wangxue
   McCluskie, Michael J.
TI Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific
   immune responses through direct immunization in young and aged mice or
   through passive maternal immunization
SO VACCINE
LA English
DT Article
DE Vaccine; Adjuvant; Glycolipid; Archaeosome; SLA
ID VIRUS INFECTION; CELL RESPONSE; TH1 IMMUNITY; T-CELLS; HEMAGGLUTININ;
   ARCHAEOSOMES; PROTECTION; HOSPITALIZATIONS; IMMUNOGENICITY; ILLNESS
AB Vaccine induced responses are often weaker in those individuals most susceptible to infection, namely the very young and the elderly, highlighting the need for safe and effective vaccine adjuvants. Herein we evaluated different archaeosome formulations as an adjuvant to the H1N1 influenza hemagglutinin protein and compared immune responses (anti-HA IgG and hemagglutination inhibition assay titers) as well as protection to an influenza A virus (strain A/Puerto Rico/8/1934 H1N1) homologous challenge to those generated using a squalene-based oil-in-water nano-emulsion, AddaVax (TM) in a murine model. The impact of age (young adult vs aged) on vaccine induced immune responses as well as the protection in pups due to the transfer of maternal antibodies was measured. Overall, we show that archaeal lipid based adjuvants can induce potent anti-HA responses in young and aged mice that can also be passed from vaccinated mothers to pups. Furthermore, young and aged mice immunized with archaeal lipid adjuvants as well as pups from immunized mothers were protected from challenge with influenza. In addition, we show that a simple admixed archaeosome formulation composed of a single sulfated glycolipid namely sulfated lactosylarchaeol (SLA; 6'-sulfate-beta-D-Galp-(1,4)-beta-D-Glcp-(1,1)-archaeol) can give equal or better protection compared to AddaVax (TM) or the traditional antigen-encapsulated archaeosome formulations. Crown Copyright (C) 2019 Published by Elsevier Ltd.
C1 [Stark, Felicity C.; Akache, Bassel; Ponce, Amalia; Dudani, Renu; Deschatelets, Lise; Jia, Yimei; Sauvageau, Janelle; Williams, Dean; Jamshidi, Mohammad P.; Agbayani, Gerard; Wachholz, Kristina; Harrison, Blair A.; Krishnan, Lakshmi; McCluskie, Michael J.] Natl Res Council Canada, Human Hlth Therapeut, 1200 Montreal Rd, Montreal, ON K1T 0H1, Canada.
   [Li, Xuguang; Chen, Wangxue] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0K9, Canada.
RP McCluskie, MJ (reprint author), Natl Res Council Canada, Human Hlth Therapeut, 1200 Montreal Rd, Montreal, ON K1T 0H1, Canada.
EM Michael.McCluskie@nrc-cnrc.gc.ca
OI Stark, Felicity/0000-0002-7547-8493
FU National Research Council an intramural research agency of the
   Government of Canada
FX This research was funded by the National Research Council an intramural
   research agency of the Government of Canada.
CR Agbayani G, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12742
   Akache B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208067
   Akache B, 2018, HUM VACC IMMUNOTHER, V14, P1746, DOI 10.1080/21645515.2017.1423154
   Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875
   Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889
   Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09
   Chow EJ, 2018, MMWR-MORBID MORTAL W, V67, P1178, DOI 10.15585/mmwr.mm6742a3
   Conlan JW, 2001, VACCINE, V19, P3509, DOI 10.1016/S0264-410X(01)00041-X
   Cruz-Valdez A, 2018, HUM VACC IMMUNOTHER, V14, P386, DOI 10.1080/21645515.2017.1373227
   Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001
   Ghosh MK, 2017, J IMMUNOL, V199, P1729, DOI 10.4049/jimmunol.1601375
   Ghosh MK, 2016, J IMMUNOL, V197, P2290, DOI 10.4049/jimmunol.1502483
   Gurnani K, 2004, J IMMUNOL, V173, P566, DOI 10.4049/jimmunol.173.1.566
   Higa LH, 2013, HUM VACC IMMUNOTHER, V9, P409, DOI 10.4161/hv.22780
   Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8
   Influenza ANZIC, 2010, BMJ-BRIT MED J, V18, pc1279
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jia Y, 2019, INT J PHARMACEUT, V561, P187, DOI 10.1016/j.ijpharm.2019.02.041
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Krishnan L, 2000, J IMMUNOL, V165, P5177, DOI 10.4049/jimmunol.165.9.5177
   Krishnan L, 2007, J IMMUNOL, V178, P2396, DOI 10.4049/jimmunol.178.4.2396
   Krishnan L, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/578432
   Kumar A, 2017, HUM VACC IMMUNOTHER, V13, P2048, DOI 10.1080/21645515.2017.1337615
   Landi A, 2017, VACCINE, V35, P6949, DOI 10.1016/j.vaccine.2017.10.072
   Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7
   Ma LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003562
   Matias G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4177-z
   McCluskie MJ, 2017, HUM VACC IMMUNOTHER, V13, P2772, DOI 10.1080/21645515.2017.1316912
   McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019
   Mertz D, 2017, VACCINE, V35, P521, DOI 10.1016/j.vaccine.2016.12.012
   Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032
   Mooney AJ, 2013, J VIROL, V87, P363, DOI 10.1128/JVI.02330-12
   Nelson CS, 2016, J VIROL, V90, P4951, DOI 10.1128/JVI.00335-16
   Nunes MC, 2016, JAMA PEDIATR, V170, P840, DOI 10.1001/jamapediatrics.2016.0921
   Public Health Agency of Canada, 2015, LIT REV PED FLUAD IN
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3
   Shen XF, 2012, VACCINE, V30, P6946, DOI 10.1016/j.vaccine.2012.02.071
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Sprott GD, 2012, ARCHAEA, V2012, DOI 10.1155/2012/513231
   Stark FC, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040038
   Stark FC, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040044
   Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145
   Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333
   Venereo-Sanchez A, 2016, VACCINE, V34, P3371, DOI 10.1016/j.vaccine.2016.04.089
   Wang SC, 2019, VIROLOGY, V526, P125, DOI 10.1016/j.virol.2018.10.005
   Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x
   Whitfield DM, 2010, CARBOHYD RES, V345, P214, DOI 10.1016/j.carres.2009.10.011
   WHO, MAN LAB DIAGN VIR SU
   Wilcox CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01548
   Wilkins AL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01760
   Zhang Y, 2018, EMERG INFECT DIS, V24, P2098, DOI 10.3201/eid2411.171410
NR 51
TC 4
Z9 4
U1 3
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7108
EP 7116
DI 10.1016/j.vaccine.2019.07.010
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100021
PM 31383490
OA Other Gold
DA 2020-05-12
ER

PT J
AU Tzeng, TT
   Lai, CC
   Weng, TC
   Cyue, MH
   Tsai, SY
   Tseng, YF
   Sung, WC
   Lee, MS
   Hu, AYC
AF Tzeng, Tsai-Teng
   Lai, Chia-Chun
   Weng, Tsai-Chuan
   Cyue, Ming-Hong
   Tsai, Shin-Yi
   Tseng, Yu-Fen
   Sung, Wang-Chou
   Lee, Min-Shi
   Hu, Alan Yung-Chih
TI The stability and immunogenicity of inactivated MDCK cell-derived
   influenza H7N9 viruses
SO VACCINE
LA English
DT Article
DE Inactivated influenza vaccine; Stability; Suspension MDCK; H7N9
ID CULTURE; VACCINE; LINE
AB In recent years, cell-based influenza vaccines have gained a great interest over the egg-based vaccines. Several inactivated H7N9 vaccines have been evaluated in clinical trials, including whole-virion vaccines, split vaccines and subunit vaccines. Recently, we developed a new suspension MDCK (sMDCK) cell line for influenza viruses production. However, the properties of purified antigen from sMDCK cells remain unclear. In this study, the stability of influenza H7N9 vaccine bulk derived from sMDCK cells was investigated, and the data were compared with the vaccine antigen derived from our characterized adhesion MDCK (aMDCK) cells in serum-free medium. The influenza H7N9 bulks derived from sMDCK and aMDCK cells were stored at 2-8 degrees C for different periods of time, and a number of parameters selected to monitor the H7N9 vaccine antigen stability were evaluated at each interval (1,3 and 12 months). The monitored parameters included virus morphology, hemagglutinin (HA) activity, HA concentration, antigenicity, and immunogenicity. The sMDCK-derived H7N9 bulk showed similar morphology to that of the aMDCK-derived H7N9 bulk, and there were no obvious changes after the extended storage periods. Furthermore, the HA titer, HA concentration, and antigenicity of sMDCK-derived H7N9 bulk were stable after 28 months of storage. Finally, the results of hemagglutination inhibition and neutralization tests showed that sMDCK- and aMDCK-derived H7N9 vaccines had comparable immunogenicity. These results indicated that sMDCK-derived H7N9 bulk has good stability compared to that of aMDCK-derived H7N9 bulk. Thus, the newly developed suspension MDCK cell line shows a great alternative for manufacturing cell-based influenza vaccines. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Tzeng, Tsai-Teng; Lai, Chia-Chun; Weng, Tsai-Chuan; Cyue, Ming-Hong; Tsai, Shin-Yi; Tseng, Yu-Fen; Sung, Wang-Chou; Lee, Min-Shi; Hu, Alan Yung-Chih] Inst NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan.
   [Lai, Chia-Chun] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan.
RP Hu, AYC (reprint author), Inst NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan.
EM alanhu@nhri.org.tw
FU NHRINational Health Research Institutes - Taiwan [IV-107-PP-24]
FX The authors would like to thank the UK NIBSC for supplying the
   egg-derived vaccine strain, the UK NIBSC for providing standard reagents
   for the SRID assay, and team members from the Bioproduction Plant at the
   NHRI. The authors gratefully acknowledge Dr. Shang-Rung Wu from the
   Instrument Development Center of the National Cheng Kung University for
   the SEM imaging. This research was financially supported by the NHRI
   (grant no. IV-107-PP-24).
CR [Anonymous], 2009, BIOLOGICALS, V37, P424, DOI 10.1016/j.biologicals.2009.08.017
   Centers of Disease Control and Prevention (CDC), IMM EFF EFF INFL VAC
   Chia MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120793
   Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106
   Dobbelaer R, 2009, BIOL J INT ASS BIOL, V37, P1, DOI DOI 10.1016/J.BI0L0GICALS.2009.08.017
   Farnsworth A, 2011, VACCINE, V29, P1529, DOI 10.1016/j.vaccine.2010.12.120
   Hegde NR, 2015, HUM VACC IMMUNOTHER, V11, P1223, DOI 10.1080/21645515.2015.1016666
   Hu AYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014578
   Huang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141686
   Isakova-Sivak I, 2017, EXPERT REV VACCINES, V16, P709, DOI 10.1080/14760584.2017.1333907
   Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916
   Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002
   Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004
   Pan SC, 2013, J MICROBIOL IMMUNOL, V46, P448, DOI 10.1016/j.jmii.2012.08.002
   Tseng YF, 2018, VACCINE, V36, P3146, DOI 10.1016/j.vaccine.2017.03.016
   van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029
   WHO, 2018, ANT GEN CHAR ZOON IN
   WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5
   World Health Organization, 2002, WHO MAN AN INFL DIAG
   World Health Organization, 2017, ANT GEN CHAR ZOON IN
   Wu UI, 2017, VACCINE, V35, P4099, DOI 10.1016/j.vaccine.2017.06.044
   Yang L., 2017, J VIROL, V91
NR 22
TC 3
Z9 3
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7117
EP 7122
DI 10.1016/j.vaccine.2019.03.024
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100022
PM 31383484
OA Other Gold
DA 2020-05-12
ER

PT J
AU Garg, H
   Mehmetoglu-Gurbuz, T
   Ruddy, GM
   Joshi, A
AF Garg, Himanshu
   Mehmetoglu-Gurbuz, Tugba
   Ruddy, Gregory M.
   Joshi, Anjali
TI Capsid containing virus like particle vaccine against Zika virus made
   from a stable cell line
SO VACCINE
LA English
DT Article
DE Zika; Vaccine; CprME; prME; NS2B-3; Virus like particle
ID ROUND INFECTIOUS PARTICLES; DNA VACCINE; PROTECTION; IMMUNOGENICITY;
   DETERMINANTS; CLEAVAGE
AB Zika virus infection during pregnancy is associated with severe birth defects including microcephaly in the new born. The lack of specific treatment calls for the development of a safe and effective vaccine for use in pregnant women. We recently tested the efficacy of a Virus Like Particle (VLP) vaccine for Zika virus in mice and found that Capsid-preMembrane-Env (CprME) VLPs generated a better neutralizing antibody response than preMembrane-Env (prME) VLPs. The superiority of CprME VLPs suggested that inclusion of capsid in the vaccine may enhance the immune response. However, production of CprME VLPs requires co-expression of NS2B-3 protease, which creates a major hurdle for generation of stable cell lines. To overcome this limitation, we generated a bicistronic vector that expresses CprME and NS2B-3 using an IRES sequence. This bicistronic expression cassette, in a lentiviral vector, was used to create a stable cell line that constitutively secretes CprME VLPs. The expression of NS2B-3, presence of capsid in the secreted VLPs, efficiency of VLP release, and stability of the cell line was extensively tested. Antigen sparing studies in mice using prME and CprME VLPs, both derived from stable cell lines, confirmed the superiority of CprME VLPs in generation of neutralizing antibody response. Capsid specific antibodies were detected in CprME VLP immunized mice providing mechanistic insights into the superiority of these VLPs. Challenge of CprME VLP immunized mice with Zika PRVABC59 showed complete protection against day 3 viremia further validating the efficacy of the vaccine. Our study is the first to generate a stable cell line secreting Zika CprME VLPs via natural NS2B-3 cleavage, demonstrate incorporation of capsid in CprME VLPs and complete protection in challenge studies. This is a major advancement for the Zika vaccine platform that is safe for use in pregnant women and readily scalable for use in developing countries. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Garg, Himanshu; Mehmetoglu-Gurbuz, Tugba; Ruddy, Gregory M.; Joshi, Anjali] Texas Tech Univ, Hlth Sci Ctr, Ctr Emphasis Infect Dis, Dept Mol & Translat Med, El Paso, DC USA.
RP Garg, H; Joshi, A (reprint author), Texas Tech Univ, Hlth Sci Ctr, Dept Mol & Translat Med, 5001 El Paso Dr, El Paso, DC 79905 USA.
EM Himanshu.garg@ttuhsc.edu; anjali.joshi@ttuhsc.edu
OI Mehmetoglu-Gurbuz, Tugba/0000-0003-1417-9446
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Basu R, 2018, VACCINE, V36, P1256, DOI 10.1016/j.vaccine.2018.01.056
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brien JD, 2013, CURR PROTOCOLS MICRO, V31, DOI [10.1002/9780471729259.mcl5d03s31, DOI 10.1002/9780471729259.MCL5D03S31]
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Garg H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-197
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Jeong H., 2017, MICROBIOL, V55, P220, DOI DOI 10.1007/S12275-017-7056-1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
NR 37
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7123
EP 7131
DI 10.1016/j.vaccine.2019.09.093
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300001
PM 31607605
DA 2020-05-12
ER

PT J
AU Wilkinson, K
   Righolt, CH
   Kwong, JC
   Schwartz, KL
   Russell, ML
   Crowcroft, NS
   Mahmud, SM
AF Wilkinson, Krista
   Righolt, Christiaan H.
   Kwong, Jeffrey C.
   Schwartz, Kevin L.
   Russell, Margaret L.
   Crowcroft, Natasha S.
   Mahmud, Salaheddin M.
TI A nested case-control study measuring pertussis vaccine effectiveness
   and duration of protection in Manitoba, Canada, 1992-2015: A Canadian
   Immunization Research Network Study
SO VACCINE
LA English
DT Article
DE Bordetella pertussis; Whooping cough; Pertussis vaccine; Vaccination;
   Vaccine effectiveness
ID UNITED-STATES; POPULATION
AB Background: Pertussis persists in Manitoba despite the universal availability of pertussis vaccines. Recent cases have included previously vaccinated individuals, raising concerns about declining vaccine effectiveness (VE). We measured pertussis VE and duration of protection using Manitoba's provincial immunization and communicable disease registries.
   Methods: Using a nested case-control design, individuals with laboratory-confirmed pertussis in Manitoba diagnosed between April 1, 1992, and March 31, 2015, were matched to up to five population-based controls on age, gender, geography, and case physician or number of physician visits. Conditional logistic regression was used to estimate VE against pertussis for both the whole-cell (wP) and acellular (aP) pertussis vaccines. Duration of protection was assessed using time since last dose.
   Results: Data on 534 eligible cases and 2614 controls were available for analysis. The adjusted VE estimate for aP-containing vaccines was 85% (95%CI: 74-91%); VE was 89% (66-96%) one to three years after the last vaccination. The adjusted VE of wP-containing vaccines was -15% (-91-31%) during a large outbreak in 1994 and 1995 compared to 35% (-26-66%) during non-outbreak years.
   Conclusions: Our estimates suggest that the aP vaccine was effective in preventing pertussis since its introduction in Manitoba. VE was lower during a large outbreak, highlighting the importance of separately analyzing outbreak periods when estimating pertussis VE over time. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.
C1 [Wilkinson, Krista; Righolt, Christiaan H.; Mahmud, Salaheddin M.] Univ Manitoba, Vaccine & Drug Evaluat Ctr, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Kwong, Jeffrey C.; Schwartz, Kevin L.; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Schwartz, Kevin L.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Kwong, Jeffrey C.; Schwartz, Kevin L.; Crowcroft, Natasha S.] ICES, Toronto, ON, Canada.
   [Russell, Margaret L.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.
   [Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
RP Mahmud, SM (reprint author), Univ Manitoba, Vaccine & Drug Evaluat Ctr, Dept Community Hlth Sci, Winnipeg, MB, Canada.
EM Salah.Mahmud@umanitoba.ca
OI Crowcroft, Natasha/0000-0002-6761-8783
FU Manitoba Centre for Health Policy [2016-013, 2015/2016-37, H2015:366]
FX The authors acknowledge the Manitoba Centre for Health Policy for the
   use of data contained in the Population Health Research Data Repository
   under project #2016-013 (HIPC #2015/2016-37; REB #H2015:366). The
   results and conclusions are those of the authors and no official
   endorsement by the Manitoba Centre for Health Policy, Manitoba Health,
   or other data providers is intended or should be inferred. Data used in
   this study are from the Population Health Research Data Repository
   housed at the Manitoba Centre for Health Policy, University of Manitoba
   and were derived from data provided by Manitoba Health.
CR Al-Tawfiq JA, 2007, J INFECTION, V55, P249, DOI 10.1016/j.jinf.2007.04.008
   Barlow RS, 2014, CLIN INFECT DIS, V58, P1523, DOI 10.1093/cid/ciu156
   BentsiEnchill AD, 1997, VACCINE, V15, P301, DOI 10.1016/S0264-410X(96)00176-4
   Blume S, 2006, SOC SCI MED, V63, P1825, DOI 10.1016/j.socscimed.2006.04.014
   de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404
   Dempsey AF, 2009, PREV MED, V48, P500, DOI 10.1016/j.ypmed.2009.02.020
   Fulton TR, 2016, CLIN INFECT DIS, V62, P1100, DOI 10.1093/cid/ciw051
   Government of Canada, 2017, NOT DIS ONL
   Government of Manitoba, 2011, MIMS US MAN 3 ED APR
   Government of Manitoba, 2013, MAN ANN SUMM COMM DI
   Government of Manitoba, MIMS TAR QUICK REF H
   Government of Manitoba MH, 2015, MAN ANN IMM SURV REP
   Guris D, 1997, J INFECT DIS, V176, P456, DOI 10.1086/514064
   HALPERIN SA, 1989, J PEDIATR-US, V115, P686, DOI 10.1016/S0022-3476(89)80643-2
   Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2
   Klein NP, 2017, VACCINE, V35, P3395, DOI 10.1016/j.vaccine.2017.05.008
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   McGirr A, 2015, PEDIATRICS, V135, P331, DOI 10.1542/peds.2014-1729
   National Advisory Committee on Immunization, 1997, CANADA COMMUNICABLE, P23
   Ntezayabo B, 2003, PEDIAT INFECT DIS J, V22
   Public Health Agency of Canada, 2017, VACC COV CAN CHILDR
   RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X
   Riffelmann M, 2014, EUR J CLIN MICROBIOL, V33, P805, DOI 10.1007/s10096-013-2016-4
   ROBERTS JD, 1994, AM J PUBLIC HEALTH, V84, P1666, DOI 10.2105/AJPH.84.10.1666
   Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006
   ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002
   Schwartz KL, 2016, CAN MED ASSOC J, V188, pE399, DOI 10.1503/cmaj.160193
   Smith T, PERTUSSIS SURVEILLAN
   Wolff G, 2015, VACCINE, V33, P3228, DOI 10.1016/j.vaccine.2015.04.084
   Zerbo O, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3466
NR 30
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7132
EP 7137
DI 10.1016/j.vaccine.2019.09.064
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300002
PM 31564453
DA 2020-05-12
ER

PT J
AU Manca, TA
   Graham, JE
   Dube, E
   Kervin, M
   Castillo, E
   Crowcroft, NS
   Fell, DB
   Hadskis, M
   Mannerfeldt, JM
   Greyson, D
   MacDonald, NE
   Top, KA
   Baylis, F
   Campbell, K
   Dakin, P
   Diaz, KW
   Dribnenki, C
   Driedger, M
   Deeks, S
   Ehman, W
   Esteghamati, A
   Faour, D
   Harmon, S
   Kanters, M
   Loh, L
   Mann, C
   Njie, B
   Pham-Huy, A
   Pless, R
   Poliquin, V
   Slayter, K
   Steffen, C
   Tomovici, A
   Toth, E
AF Manca, Terra A.
   Graham, Janice E.
   Dube, Eve
   Kervin, Melissa
   Castillo, Eliana
   Crowcroft, Natasha S.
   Fell, Deshayne B.
   Hadskis, Michael
   Mannerfeldt, Jaelene M.
   Greyson, Devon
   MacDonald, Noni E.
   Top, Karina A.
   Baylis, F.
   Campbell, K.
   Dakin, P.
   Diaz, K. -W
   Dribnenki, C.
   Driedger, M.
   Deeks, S.
   Ehman, W.
   Esteghamati, A.
   Faour, D.
   Harmon, S.
   Kanters, M.
   Loh, L.
   Mann, C.
   Njie, B.
   Pham-Huy, A.
   Pless, R.
   Poliquin, V
   Slayter, K.
   Steffen, C.
   Tomovici, A.
   Toth, E.
CA Canadian Vaccine Product
TI Developing product label information to support evidence-informed use of
   vaccines in pregnancy
SO VACCINE
LA English
DT Article
DE Consensus methods; Immunization; Influenza; Pertussis; Pregnancy;
   Vaccination
ID INFLUENZA VACCINATION; PERTUSSIS-VACCINE; IMMUNIZATION; DELPHI; WOMEN;
   CONSENSUS; PACKAGE; SAFETY; RISK
AB Background: Product labelling information describing the use of vaccines in pregnancy continues to contain cautionary language even after clinical and epidemiological evidence of safety becomes available. This language raises safety concerns among healthcare providers who may hesitate to recommend vaccines during pregnancy.
   Purpose: To develop clear evidence-based language about vaccine safety and effectiveness in pregnancy for inclusion in vaccine product labels.
   Methods: We conducted a three-stage consensus-methods project with stakeholders, including: healthcare providers, vaccine regulators, industry representatives, and experts in public health, communication, law, ethics, and social sciences. Using qualitative and quantitative methods, we held a nominal group technique (NGT) meeting, followed by a Delphi survey, and then a consensus workshop with a subset of Delphi participants. We developed a methodological tool to analyse data for consensus.
   Principal results: Stakeholders (N = 14) at the NGT meeting drafted product label statements for evaluation in the Delphi survey. Survey participants (N = 41) provided feedback on statements for five hypothetical vaccines. Workshop participants (N = 27) initiated discussions that demonstrated a lack of awareness that the regulatory purpose of product labels is to provide a scientific summary of product-specific preclinical and clinical trial data. Each stage of this project built on earlier stages until we achieved strong consensus on the language, structure, and types of data that stakeholders wanted to include in inactivated influenza vaccine (IIV) and tetanus-diphtheria-acellular pertussis (Tdap) vaccine product labels in Canada.
   Conclusions: The revised statements for IIV and Tdap aligned with workshop participants' goals that the product label be evidence-based, with a consistent structure and language that is easily understood by healthcare providers. Emergent methods uncovered stakeholder concerns about the regulatory purpose, content, and evidence used in product labels. Involving healthcare providers in the development and regular updating of product information could prevent interpretations of that information that contribute to vaccine hesitancy. (C) 2019 The Author(s). Published by Elsevier Ltd.
C1 [Manca, Terra A.; Graham, Janice E.; Kervin, Melissa; MacDonald, Noni E.; Top, Karina A.] Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS B3K 6R8, Canada.
   [Manca, Terra A.; Graham, Janice E.; Kervin, Melissa; MacDonald, Noni E.; Top, Karina A.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.
   [Dube, Eve] Univ Laval, Laval Univ Pavillon Charles De Koninck, Dept Anthropol, 1030 Ave Sci Humaines,Bur 3431, Quebec City, PQ G1V 0A6, Canada.
   [Castillo, Eliana] Univ Calgary, Dept Med, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
   [Castillo, Eliana; Mannerfeldt, Jaelene M.] Univ Calgary, Dept Obstet & Gynecol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
   [Crowcroft, Natasha S.] Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5G 1V2, Canada.
   [Crowcroft, Natasha S.] Inst Clin Evaluat Sci G1 06, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
   [Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St 6F, Toronto, ON M5T 3M7, Canada.
   [Fell, Deshayne B.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Alta Vista Campus,Room 101, Ottawa, ON K1G 5Z3, Canada.
   [Fell, Deshayne B.] Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada.
   [Hadskis, Michael] Dalhousie Univ, Sch Hlth Adm, Weldon Law Bldg,6061 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.
   [Hadskis, Michael] Dalhousie Univ, Schulich Sch Law, Weldon Law Bldg,6061 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.
   [Mannerfeldt, Jaelene M.] Univ Calgary, Dept Family Med, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
   [Greyson, Devon] Univ Massachusetts Amherst, Dept Commun, N308 Integrat Learning Ctr,650 N Pleasant St, Amherst, MA 01003 USA.
   [Baylis, F.] Dalhousie Univ, Halifax, NS, Canada.
   [Campbell, K.] Univ British Columbia, Vancouver, BC, Canada.
   [Dakin, P.] Univ Kings Coll, London, England.
   [Diaz, K. -W] Medicago Inc, Quebec City, PQ, Canada.
   [Dribnenki, C.] Alberta Hlth Serv, Edmonton, AB, Canada.
   [Driedger, M.] Univ Manitoba, Winnipeg, MB, Canada.
   [Deeks, S.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Ehman, W.] Nanaimo Matern Family Physicians Network, Nanaimo, BC, Canada.
   [Esteghamati, A.; Tomovici, A.] WHO, Geneva, Switzerland.
   [Faour, D.; Harmon, S.] Dalhousie Univ, Halifax, NS, Canada.
   [Kanters, M.] Pfizer Canada Inc, Quebec City, PQ, Canada.
   [Loh, L.] Peel Publ Hlth, Mississauga, ON, Canada.
   [Mann, C.; Slayter, K.] IWK Hlth Ctr, Halifax, NS, Canada.
   [Njie, B.] Hlth Canada, BGTD, Toronto, ON, Canada.
   [Pham-Huy, A.] CHEO Res Inst, Toronto, ON, Canada.
   [Pless, R.] Hlth Canada, MHPD, Toronto, ON, Canada.
   [Poliquin, V] Univ Manitoba, Winnipeg, MB, Canada.
   [Tomovici, A.] Sanofi Pasteur, Lyon, France.
   [Toth, E.] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.
RP Top, KA (reprint author), IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS B3K 6R8, Canada.
EM tmanca@ualberta.ca; janice.graham@dal.ca; eve.dube@inspq.qc.ca;
   Melissa.Kervin@iwk.nshealth.ca; castillo@ucalgary.ca;
   natasha.crowcroft@oahpp.ca; dfell@cheo.on.ca; Michael.Hadskis@dal.ca;
   dgreyson@umass.edu; Noni.MacDonald@dal.ca; karina.top@dal.ca
OI Greyson, Devon/0000-0003-4860-384X; Crowcroft,
   Natasha/0000-0002-6761-8783; Top, Karina/0000-0002-9981-368X
FU Public Health Agency of Canada; Society of Obstetricians and
   Gynaecologists of Canada
FX This project was funded by the Public Health Agency of Canada, in
   collaboration with the Society of Obstetricians and Gynaecologists of
   Canada.
CR Amirthalingam G, 2016, CLIN INFECT DIS, V63, pS236, DOI 10.1093/cid/ciw559
   Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3
   Baxter R, 2017, PEDIATRICS, P139, DOI [10.1542/peds.2016-4091e20164091, DOI 10.1542/PEDS.2016-4091E20164091]
   Bettinger JA, 2016, J OBSTET GYNAECOL CA, V38, P1045, DOI 10.1016/j.jogc.2016.08.004
   Black N, 1999, J Health Serv Res Policy, V4, P236
   Brady SR, 2015, INT J QUAL METH, V14, DOI 10.1177/1609406915621381
   CDC (Centers for Disease Control and Prevention), 2017, GUID VACC PREGN WOM
   Chamberlain AT, 2015, VACCINE, V33, P3571, DOI 10.1016/j.vaccine.2015.05.048
   Desjardins M, 2017, OFFICIAL J ASS MED M, V2, P1, DOI 10.3138/jammi.2.1.001
   Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002
   Donaldson B, 2015, VACCINE, V33, P5822, DOI 10.1016/j.vaccine.2015.08.093
   Dube E, 2017, CLIN MICROBIOL INFEC, V23, P279, DOI 10.1016/j.cmi.2016.11.007
   European Commission, 2009, GUID SUMM PROD CHAR
   Fell DB, 2017, VACCINE, V35, P5738, DOI 10.1016/j.vaccine.2017.08.037
   GACVS (Global Advisory Committee on Vaccine Safety), 2014, SAF IMM PREGN REV EV
   Giles ML, 2019, HUM VACC IMMUNOTHER, V15, P687, DOI 10.1080/21645515.2018.1540807
   GlaxoSmithKline Inc, 2018, PROD MON BOOSTR COMB
   GlaxoSmithKline Inc, 2018, PROD MON FLULAVAL TE
   Government of Canada, 2014, FREQ ASK QUEST PROD
   Gruber MF, 2015, VACCINE, V33, P6499, DOI 10.1016/j.vaccine.2015.05.107
   Henninger ML, 2015, J WOMENS HEALTH, V24, P394, DOI 10.1089/jwh.2014.5105
   Krubiner CB, 2019, VACCINE, DOI [10.1016/j.vacine2019.01.011, DOI 10.1016/J.VACINE2019.01.011]
   Landeta J, 2011, TECHNOL FORECAST SOC, V78, P1629, DOI 10.1016/j.techfore.2011.03.009
   Lyerly AD, 2009, HASTINGS CENT REP, V39, P34
   MacDonald NE, 2018, CLIN INVEST MED, V41, P35, DOI 10.25011/cim.v41i2.31440
   McDonald K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S5-S5
   McDougal JA, 2005, EVAL HEALTH PROF, V28, P428, DOI 10.1177/0163278705281076
   McMillan M, 2017, OBSTET GYNECOL, V129, P560, DOI 10.1097/AOG.0000000000001888
   McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x
   Meeting of the Strategic Advisory Group of Experts on Immunization, 2014, WKLY EPIDEMIOL REC, V89, P1
   Neels P, 2017, VACCINE, V35, P2329, DOI 10.1016/j.vaccine.2017.02.056
   Noh Y, 2018, J WOMENS HEALTH, V27, P1086, DOI 10.1089/jwh.2017.6792
   Omer SB, 2017, NEW ENGL J MED, V376, P1256, DOI 10.1056/NEJMra1509044
   Pasteur Sanofi, 2016, PRODUCT MONOGRAPH FL
   PHAC (Public Health Agency of Canada), 2018, UPD IMM PREGN TET TO
   PHAC (Public Health Agency of Canada), CAN IMM GUID CHAPT I
   Proveaux T, 2016, VACCINE, V34, P5406, DOI 10.1016/j.vaccine.2016.08.042
   Steinhoff MC, 2017, LANCET INFECT DIS, V17, P981, DOI 10.1016/S1473-3099(17)30252-9
   Tapio P, 2011, TECHNOL FORECAST SOC, V78, P1616, DOI 10.1016/j.techfore.2011.03.016
   Thompson MG, 2019, CLIN INFECT DIS, V68, P1444, DOI 10.1093/cid/ciy737
   Top K A, 2018, Can Commun Dis Rep, V44, P134, DOI 10.14745/ccdr.v44i06a03
   Top KA, 2016, LANCET GLOB HEALTH, V4, pE690, DOI 10.1016/S2214-109X(16)30182-6
   Vojtek I, 2018, ANN MED, V50, P193, DOI 10.1080/07853890.2017.1421320
   WHO, 2017, WHO TECH REP SER, V1004, P488
   Wiley KE, 2013, VACCINE, V31, P3972, DOI 10.1016/j.vaccine.2013.06.015
NR 45
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7138
EP 7146
DI 10.1016/j.vaccine.2019.09.063
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300003
PM 31594709
OA Other Gold
DA 2020-05-12
ER

PT J
AU de Noronha, TG
   Maia, MDD
   Ribeiro, JGL
   Lemos, JAC
   de Lima, SMB
   Martins-Filho, OA
   Campi-Azevedo, AC
   Freire, MD
   Martins, RD
   Camacho, LAB
AF de Noronha, Tatiana Guimardes
   de Sousa Maia, Maria de Lourdes
   Leite Ribeiro, Jose Geraldo
   Campos Lemos, Jandira Aparecida
   Barbosa de Lima, Sheila Maria
   Martins-Filho, Olindo Assis
   Campi-Azevedo, Ana Carolina
   Freire, Marcos da Silva
   Martins, Reinaldo de Menezes
   Bastos Camacho, Luiz Antonio
CA Collaborative Grp Studies
TI Duration of post-vaccination humoral immunity against yellow fever in
   children
SO VACCINE
LA English
DT Article
DE Yellow fever vaccine; Immunogenicity; Vaccination policy; Duration of
   immunity in children
ID DOUBLE-BLIND; IMMUNOGENICITY; VACCINATION; VACCINES
AB Introduction: Vaccination is the most important measure for prevention and control of yellow fever. It is recommended by the World Health Organization (WHO) for residents of endemic areas and travelers to risk areas. In 2013, the WHO discontinued the recommendation of booster doses every 10 years, indicating a single dose as sufficient for lifelong protection.
   Objective: Considering the lower immune response to YF vaccine in children compared to adults, this study was set out to assess the duration of immunity to YF in children vaccinated in the first two years of life.
   Methods: This cross-sectional study involved children aged 9 months to 12 years with accessible vaccination records recruited in primary care units from a metropolitan area in Southeast Brazil. The serologic status (negative, indeterminate and positive), and geometric mean titers (GMT, inverse dilution) of neutralizing antibodies against YF obtained by Plaque Reduction Neutralization Test was assessed across categories of time after YF vaccination. The strength of association of seropositivity with time was assessed by the odds ratio (OR) taking recent vaccination (1-6 months) as reference.
   Results: A total of 824 children recruited from August 2010 to July 2011 were tested. The proportion of seropositivity (95% C.I.) and GMT (95% C.I.) dropped markedly across time periods: from 86.7% (80.5-91.4%), GMT 47.9 (38.3-59.9) in newly vaccinated to 59.0% (49.7-67.8%), GMT 14.8 (11.6-19.1) and 42.2% (33.8-51.0), GMT 8.6 (7.1-12.1), respectively in the subgroups vaccinated 31-72 months and 73-100 months before.
   Conclusions: Analogous to previous findings in adults, these data support the need for revaccination of children living in areas with yellow fever virus circulation in humans or in other primates. The data also supported the change of a booster dose to 4 years of age for those primarily vaccinated for yellow fever in the first two years of life. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [de Noronha, Tatiana Guimardes; de Sousa Maia, Maria de Lourdes; Barbosa de Lima, Sheila Maria; Freire, Marcos da Silva; Martins, Reinaldo de Menezes] Fiocruz MS, Inst Technol Imunobiol Biomanguinhos, Ave Brasil 4365,CTV,ASCLIN Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Leite Ribeiro, Jose Geraldo; Campos Lemos, Jandira Aparecida] State Dept Hlth Minas Gerais, Divinopolis, MG, Brazil.
   [Martins-Filho, Olindo Assis; Campi-Azevedo, Ana Carolina] Fiocruz MS, Rene Rachou Res Ctr, Rio De Janeiro, RJ, Brazil.
   [Bastos Camacho, Luiz Antonio] Fiocruz MS, Brazilian Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil.
RP de Noronha, TG (reprint author), Fiocruz MS, Inst Technol Imunobiol Biomanguinhos, Ave Brasil 4365,CTV,ASCLIN Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM tnoronha@bio.fiocruz.br
OI Barbosa de Lima, Sheila Maria/0000-0001-9234-1678; Campi-Azevedo, Ana
   Carolina/0000-0001-6306-3605; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889
FU Health Surveillance Department, Ministry of Health; Institute of
   Technology for Immunobiologicals of Bio-Manguinhos - FIOCRUZ; Brazilian
   National Research Council-CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ);
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)CAPES [001]
FX Health Surveillance Department, Ministry of Health; Institute of
   Technology for Immunobiologicals of Bio-Manguinhos - FIOCRUZ; Brazilian
   National Research Council-CNPq; FAPERJ (Acronym for the Foundation of
   support to scientific research in the State of Rio de Janeiro); FAPEMIG
   (Acronym for the Foundation of support to scientific research in the
   State of Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) Finance Code 001.
CR ANDERSON CR, 1947, AM J HYG, V45, P302, DOI 10.1093/oxfordjournals.aje.a119138
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   [Anonymous], 2013, 64 WMA GEN ASS FORT
   Camacho LAB, 2007, VACCINE, V25, P3118, DOI 10.1016/j.vaccine.2007.01.053
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Brasil. Ministerio da Saude, 2018, B EPIDEMIOLOGICO
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Camara FP, 2013, T ROY SOC TROP MED H, V107, P324, DOI 10.1093/trstmh/trt014
   Campi-Azevedo AC, 2017, J IMMUNOL METHODS, V448, P9, DOI 10.1016/j.jim.2017.05.002
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Development Core Team R, 2008, R LANG ENV STAT COMP
   Fox JP, 1943, AM J HYG, V37, P93, DOI 10.1093/oxfordjournals.aje.a118845
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Grupo Colaborativo do Programa Nacional de Imunizacoes para o Estudo da Soroconversao pela Vacina contra Febre Amarela, 2003, 7 C BRAS SAUD COL BR
   Hepburn MJ, 2006, VACCINE, V24, P2843, DOI 10.1016/j.vaccine.2005.12.055
   IBM.Corp, 2011, IBM SPSS STAT WIND V
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2014, B EPIDEMIOL, V45, P1
   Monath T, 2008, VACCINES, P959
   Simoes M, 2012, BIOLOGICALS, V40, P399, DOI 10.1016/j.biologicals.2012.09.005
   VASCONCELOS PFC, 2003, REV SOC BRAS MED TRO, V36, P275, DOI DOI 10.1590/S0037-86822003000200012
   WHO, 2019, YELLOW FEVER
   World Health Organisation (WHO), 2005, INT HLTH REG
   World Health Organization, COUNTR RISK YELL FEV
NR 25
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7147
EP 7154
DI 10.1016/j.vaccine.2019.09.051
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300004
PM 31590934
DA 2020-05-12
ER

PT J
AU Kaiser, JA
   Luo, HL
   Widen, SG
   Wood, TG
   Huang, CYH
   Wang, T
   Barrett, ADT
AF Kaiser, Jaclyn A.
   Luo, Huanle
   Widen, Steven G.
   Wood, Thomas G.
   Huang, Claire Y. -H.
   Wang, Tian
   Barrett, Alan D. T.
TI Genotypic and phenotypic characterization of West Nile virus NS5
   methyltransferase mutants
SO VACCINE
LA English
DT Article
DE Flavivirus; West Nile virus; Attenuation; Methyltransferase; NS5 protein
ID CRYSTAL-STRUCTURE; PROTEIN; VACCINE; TRAFFICKING; DEFICIENCY; SEQUENCE;
   STRAIN; REGION; BRAIN; RISK
AB Although West Nile virus (WNV) causes annual cases of neurological disease and deaths in humans, a vaccine has not been licensed for human use. Several WNV genes have been targeted for mutagenesis in attempts to generate live attenuated vaccine candidates, including the non-structural protein NS5. Specifically, mutation of WNV NS5-K61A or NS5-E218A in the catalytic tetrad of the methyltransferase decreases enzyme activity of the NS5 protein and correspondingly attenuates the virus in mice. In this report, NS5-K61A, NS5-E218A, and a double mutant encoding both mutations (NS5-K61A/E218A) were compared both in vitro and in vivo. Each single mutant was strongly attenuated in highly susceptible out-bred mice, whereas the double mutant unexpectedly was not attenuated. Sequencing analysis demonstrated that the double mutant was capable of reversion at both residues NS5-61 and NS5-218, whereas the genotype of the single mutants did not show evidence of reversion. Overall, either NS5-K61A or NS5-E218A methyltransferase mutations could be potential mutations to include in a candidate live WNV vaccine; however, multiple mutations in the catalytic tetrad of the methyltransferase are not tolerated. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kaiser, Jaclyn A.; Luo, Huanle; Wang, Tian; Barrett, Alan D. T.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Widen, Steven G.; Wood, Thomas G.] Univ Texas Med Branch, Mol Genom Core Facil, Galveston, TX 77555 USA.
   [Wang, Tian; Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Wang, Tian; Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Huang, Claire Y. -H.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
RP Barrett, ADT (reprint author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM abarrett@utmb.edu
FU Gillson Longenbaugh Foundation; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI099123,
   T32 AI 7526-16]; Sealy Institute for Vaccine Sciences at UTMB
FX This work was funded by a grant from Gillson Longenbaugh Foundation to
   ADTB. JAK was funded in part by NIH grant T32 AI 7526-16. T.W. is
   supported in part by NIH grant R01 AI099123 and a grant from the Sealy
   Institute for Vaccine Sciences at UTMB.
CR [Anonymous], 2018, INT TRAV HLTH VACC
   Barrett A., J TRAVEL MED, V25
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Centers for Disease Control and Prevention, W NIL VIR STAT MAPS
   Collins ND, 2018, MBIO, V9, DOI 10.1128/mBio.01871-18
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691
   Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012
   NI HL, 1994, J GEN VIROL, V75, P1505, DOI 10.1099/0022-1317-75-6-1505
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Qian F, 2015, CLIN VACCINE IMMUNOL, V22, P6, DOI 10.1128/CVI.00508-14
   Qin CF., 2014, NOVEL ATTENUATED DEN
   Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641
   Zhang SL, 2006, VIROLOGY, V353, P35, DOI 10.1016/j.virol.2006.05.025
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2017, PLOS ONE, V13, P1
NR 37
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7155
EP 7164
DI 10.1016/j.vaccine.2019.09.045
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300005
PM 31611100
DA 2020-05-12
ER

PT J
AU Grantz, KH
   Claudot, P
   Kambala, M
   Kouyate, M
   Soumah, A
   Bourn, Y
   Juan-Giner, A
   Jemmy, JP
   Cummings, DAT
   Grais, RF
AF Grantz, Kyra H.
   Claudot, Pauline
   Kambala, Micky
   Kouyate, Mariama
   Soumah, Aboubacar
   Bourn, Yap
   Juan-Giner, Aitana
   Jemmy, Jean-Paul
   Cummings, Derek A. T.
   Grais, Rebecca F.
TI Factors influencing participation in an Ebola vaccine trial among
   front-line workers in Guinea
SO VACCINE
LA English
DT Article
DE Ebola virus disease; rVSV vaccine; Guinea; Healthcare workers; Research
   design; Qualitative
ID INFORMED-CONSENT; PERCEPTIONS; KNOWLEDGE; ATTITUDES; BELIEFS; SCIENCE;
   GAMBIA; TRUST; BLOOD; HPV
AB Background: Alongside the clinical aspects of the immunogenicity and safety trial of an Ebola vaccine deployed among front-line workers, a qualitative study was conducted to describe motivations behind individuals' decisions to participate - or not to participate - in the study.
   Methods: In July and August 2015, focus group discussions and semi-structured individual interviews were conducted in Conakry, Guinea. Individuals were eligible for the qualitative study if they met the inclusion criteria of the immunogenicity and safety study irrespective of their participation. Surveys were also conducted among several institution and department heads of staff included in the study as well as vaccine trial staff members. Discussion and interview transcripts were analyzed using content thematic analysis.
   Results: Interviews and focus groups were conducted among 110 persons, of whom about two-thirds (67%) participated in the vaccine trial. There was at least one group interview conducted at each participating trial site, along with numerous formal and informal interviews and conversations through the enrollment period. Participants were often motivated by a desire to save and protect themselves and others, contribute to scientific progress, or lead by example. Non-participants expressed concerns regarding the risk and costs of participation, particularly the fear of unknown side effects following vaccination, and distrust or fear of stigmatization.
   Conclusions: Despite the unique nature of the 2014-2015 Ebola outbreak, front-line workers employed much of the same logic when choosing to participate as in other clinical trials in similar settings. Special consideration should be given to addressing perceived inequity, misunderstanding, and mistrust among the target populations in future trials. (C) 2019 The Author(s). Published by Elsevier Ltd.
C1 [Grantz, Kyra H.; Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Grantz, Kyra H.; Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Claudot, Pauline] Ecole Normale Super Lyon, Lyon, France.
   [Kambala, Micky; Jemmy, Jean-Paul] Med Sans Frontieres Operat Ctr, Brussels, Belgium.
   [Kouyate, Mariama; Soumah, Aboubacar; Bourn, Yap; Juan-Giner, Aitana; Grais, Rebecca F.] Epictr, 8 Rue St Sabin, F-75011 Paris, France.
RP Grais, RF (reprint author), 8 Rue St Sabin, F-75011 Paris, France.
EM Rebecca.Grais@epicentre.msf.org
OI Freeman Grais, Rebecca/0000-0002-5037-8218
FU Medecins Sans Frontieres - Operational Center Brussels; MSF
FX This study was financed by Medecins Sans Frontieres - Operational Center
   Brussels. Epicentre received core funding from MSF.
CR Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288
   [Anonymous], 2019, PREL RES EFF RVSV ZE
   Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8
   Bond L, 1998, AUST NZ J PUBL HEAL, V22, P441, DOI 10.1111/j.1467-842X.1998.tb01411.x
   Casillas Adrian M, 2003, Biol Res Nurs, V4, P268, DOI 10.1177/1099800403252603
   Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2
   Denzin N. K., 2005, SAGE HDB QUALITATIVE
   Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413
   Ebola ca suffit ring vaccination trial consortium, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h3740h3740, DOI 10.1136/BMJ.H3740H3740]
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Enria L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3799-x
   Fairhead J, 2006, J BIOSOC SCI, V38, P103, DOI 10.1017/S0021932005000945
   Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018
   Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116
   Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003
   Grietens KP, 2014, AM J TROP MED HYG, V91, P213, DOI 10.4269/ajtmh.13-0630
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hewlett Bonnie L, 2005, J Transcult Nurs, V16, P289, DOI 10.1177/1043659605278935
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073
   Kalenga OI, 2019, NEW ENGL J MED, V381, P373, DOI 10.1056/NEJMsr1904253
   Kasereka MC, 2019, VACCINE, V37, P2174, DOI 10.1016/j.vaccine.2019.03.004
   Kass Nancy E, 2005, IRB, V27, P1, DOI 10.2307/3563534
   Katz IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072094
   Kieny MP, 2016, LANCET, V387, P1509, DOI 10.1016/S0140-6736(16)00686-3
   Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa
   Leach A, 1999, SOC SCI MED, V48, P139, DOI 10.1016/S0277-9536(98)00317-7
   Mfutso-Bengo J, 2008, MALAWI MED J, V20, P37
   Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002
   Mohammadi D, 2015, LANCET, V385, P214, DOI 10.1016/S0140-6736(15)60035-6
   Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073
   Moodley K, 2005, J MED ETHICS, V31, P727, DOI 10.1136/jme.2004.009910
   Obilade T, 2015, INT ARCH MED, V8, DOI [10.3823/1613, DOI 10.3823/1613]
   Ogoina D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165271
   Ogoina D, 2016, INT HEALTH, V8, P5, DOI 10.1093/inthealth/ihv065
   Oladimeji AM, 2015, TROP MED INT HEALTH, V20, P1162, DOI 10.1111/tmi.12528
   Preziosi M, 1997, ENGL J
   Priest Helena, 2002, Nurse Res, V10, P30
   Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025
   ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B
   Strauss RP, 2001, J ACQ IMMUN DEF SYND, V26, P63, DOI 10.1097/00126334-200101010-00010
   Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800
   WHO, 2016, HLTH WORK EB INF GUI
   WHO Clinical Response Team, 2016, EB SIT REP
   Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245
   World Health Organization, 2019, 54 WHO
   Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077
NR 47
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7165
EP 7170
DI 10.1016/j.vaccine.2019.09.094
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300006
PM 31623917
OA Other Gold
DA 2020-05-12
ER

PT J
AU Juan-Giner, A
   Tchaton, M
   Jemmy, JP
   Soumah, A
   Bourn, Y
   Faga, EM
   Cisse, M
   Grais, RF
AF Juan-Giner, Aitana
   Tchaton, Marie
   Jemmy, Jean-Paul
   Soumah, Aboubacar
   Bourn, Yap
   Faga, Elisabetta Maria
   Cisse, Mohamed
   Grais, Rebecca F.
TI Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline
   workers in Guinea
SO VACCINE
LA English
DT Article
DE Ebola virus disease; rVSV vaccine; Safety; Guinea; Health-care workers;
   Surveillance
ID DOUBLE-BLIND; HEALTHY-ADULTS; IMMUNOGENICITY; CANDIDATE; TRIAL
AB Background: As part of the ring vaccination trial in Guinea, Front Line Workers were invited to participate in a sub-study to provide additional information on the immunogenicity and safety of rVSV Delta G/ZEBOV-GP. Here we summarize the information on the safety follow-up.
   Methods: An open-label, non-randomized, immunogenicity evaluation of one dose of rVSV Delta G/ZEBOV-GP was conducted in Conakry, Guinea between March 2015 and July 2016. Front-line workers refusing vaccination were invited to participate as a control group. Participants were followed for 3 months with a subset followed-up for 6 months after vaccination. Women becoming pregnant during the follow-up were followed until pregnancy outcome. Solicited and unsolicited adverse events were monitored at each contact with participants using standardized study forms.
   Results: 2016 vaccinated participants and 99 controls were included in the safety cohort. On the 3 days post-vaccination visit adverse events were very common, with over 70% of participants reporting at least one adverse event. The most frequently reported symptoms were headache, fatigue, arthralgia, subjective fever and myalgia. Among participants that completed fever diaries (n = 887), post-vaccination fever was reported by 15.22%. Comparing to the unvaccinated group, local reaction, fatigue, headache, arthralgia, myalgia and subjective fever occurring within the first 3 days post-vaccination were statistically significantly different in the vaccinated group compared to the unvaccinated. A total of 8 Serious Adverse Events were identified during follow-up. 2 SAES were related to pregnancy.
   Conclusions: Results confirm that adverse events 3 days after vaccination with the rVSV candidate vaccine are common. The occurrence of fever is of particular concern in the context of ongoing Ebola transmission. Additional studies should address important data gaps regarding the use of the vaccine in pregnancy and other vulnerable populations. (C) 2018 The Authors. Published by Elsevier Ltd.
C1 [Juan-Giner, Aitana; Tchaton, Marie; Soumah, Aboubacar; Bourn, Yap; Grais, Rebecca F.] Epictr, 8 Rue St Sabin, F-75011 Paris, France.
   [Jemmy, Jean-Paul; Faga, Elisabetta Maria] Med Sans Frontieres Operat Ctr, Brussels, Belgium.
   [Cisse, Mohamed] Ctr Hosp Univ Donka, Conakry, Guinea.
RP Grais, RF (reprint author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.
EM Rebecca.Grais@epicentre.msf.org
OI Freeman Grais, Rebecca/0000-0002-5037-8218
FU Medecins Sans Frontieres - Operational Center Brussels; MSF
FX This study was financed by Medecins Sans Frontieres - Operational Center
   Brussels. Epicentre received core funding from MSF.
CR Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Agnandji ST, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002402
   Aly HAA, 2015, WHO TECH REP SER, V994, P1
   Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354
   Caluwaerts S, 2016, CLIN INFECT DIS, V62, P903, DOI 10.1093/cid/civ1024
   De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7
   Dolzhikova IV, 2017, ACTA NATURAE, V9, P4, DOI 10.32607/20758251-2017-9-3-4-11
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Henao-restrepo AM, 2016, LANCET, V6737, P32621
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Heppner DG, 2017, LANCET INFECT DIS, V17, P854, DOI 10.1016/S1473-3099(17)30313-4
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052
   Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067
   Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   WHO, 2015, EB SIT REP
   World Health Organization, 2015, HLTH WORK EB INF GUI
   Wu LH, 2017, HUM VACC IMMUNOTHER, V13, P2078, DOI 10.1080/21645515.2017.1342021
NR 19
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7171
EP 7177
DI 10.1016/j.vaccine.2018.09.009
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300007
PM 30266489
OA Other Gold
DA 2020-05-12
ER

PT J
AU Wolfe, DN
   Zarrabian, AG
   Disbrow, GL
   Espeland, EM
AF Wolfe, Daniel N.
   Zarrabian, Amanda G.
   Disbrow, Gary L.
   Espeland, Eric M.
TI Progress towards a vaccine against Ebola to meet emergency medical
   countermeasure needs
SO VACCINE
LA English
DT Article
DE Ebola; Filovirus; Vaccine
ID DOUBLE-BLIND; NONHUMAN-PRIMATES; RANDOMIZED-TRIAL; VIRUS DISEASE;
   SAFETY; IMMUNOGENICITY; PROTECTS; CHALLENGE; ADULTS
AB The Ebola virus epidemic in West Africa proved to be the largest in the history of filovirus outbreaks, causing the World Health Organization to declare a public health emergency of international concern in August of 2014. In collaboration with domestic and international partners, the Biomedical Advanced Research and Development Authority (BARDA) initiated several vaccine development projects in support of the overall response efforts. The urgency associated with the epidemic triggered the clinical evaluation of lead vaccine candidates starting in late 2014. Here we will discuss development of the lead vaccine candidates for Ebola virus, specifically Zaire ebolavirus. Published by Elsevier Ltd.
C1 [Wolfe, Daniel N.; Zarrabian, Amanda G.; Disbrow, Gary L.; Espeland, Eric M.] HHS, ASPR, BARDA, Thomas P ONeill Fed Bldg FOBS,200 C St SW, Washington, DC 20024 USA.
RP Wolfe, DN (reprint author), HHS, ASPR, BARDA, Thomas P ONeill Fed Bldg FOBS,200 C St SW, Washington, DC 20024 USA.
EM daniel.wolfe2@hhs.gov
CR Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Alpren C, 2016, MMWR-MORBID MORTAL W, V65, P681, DOI 10.15585/mmwr.mm6526a4
   [Anonymous], 2016, OUTBREAKS CHRONOLOGY
   De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10
   Henao-Restrepo A M, 2016, LANCET, V6736, P32621, DOI DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Herbert AS, 2013, J VIROL, V87, P4952, DOI 10.1128/JVI.03361-12
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042
   Krauer F, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004867
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Ledgerwood JE, 2015, LANCET INFECT DIS, V15, P1117, DOI 10.1016/S1473-3099(15)00222-4
   Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06
   Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218
   Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428
   Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567
   Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09
   Regules JA, 2015, N ENGL J MED
   Rose J, 1987, THABDOVIRUSES, P129
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X
   Warfield KL, 2011, J INFECT DIS, V204, pS1053, DOI 10.1093/infdis/jir346
NR 30
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7178
EP 7182
DI 10.1016/j.vaccine.2017.10.111
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300008
PM 29199040
DA 2020-05-12
ER

PT J
AU Hossmann, S
   Haynes, AG
   Spoerri, A
   Diatta, ID
   Aboubacar, B
   Egger, M
   Rintelen, F
   Trelle, S
AF Hossmann, Stefanie
   Haynes, Alan G.
   Spoerri, Adrian
   Diatta, Ibrahima Dina
   Aboubacar, Barry
   Egger, Matthias
   Rintelen, Felix
   Trelle, Sven
TI Data management of clinical trials during an outbreak of Ebola virus
   disease
SO VACCINE
LA English
DT Article
DE Clinical trial; Data management; Data management centre; Electronic data
   capturing system; REDCap
AB Introduction: Clinical trial data management (DM) conducted during outbreaks like that of Ebola virus disease (EVD) in West Africa, 2014-2016, has to adapt to specific, unique circumstances. CTU Bern was asked to set up a safe data capture/management system that could be launched within a few weeks and cover two different vaccine trials. This article describes some of the challenges we faced and our solutions during the two different trials.
   Methods: Setting up a DM system was split into four phases/tasks: (1) quick set-up of the (electronic) data capture system (EDC) and mobile infrastructure in Bern, (2) moving the EDC and infrastructure to Conakry, Guinea and implementation of a local data management centre (DMC), (3) running the DMC, and (4) data cleaning. The DMC had to meet the following criteria: (1) quick implementation, (2) efficient maintenance and handling of data, and (3) procedures to guarantee data quality. The EDC (REDCap) was setup as a local area network. In order to ensure high data quality, double data entry, and then review of inconsistencies and offline plausibility checks were implemented.
   Results: From the start of CTU Bern's involvement to the productive EDC took 11 weeks. It was necessary to adapt processes for dealing with data continuously throughout the trial conduct phase. The data management team processed 171,794 case report form pages from a total of 14,203 participants in the period between March and December 2015.
   Conclusion: Data management is a key task supporting trial conduct. For trials in emergency situations, many of our approaches are suitable, but we also provide a list of aspects that might be done differently. (C) 2017 Published by Elsevier Ltd.
C1 [Hossmann, Stefanie; Haynes, Alan G.; Diatta, Ibrahima Dina; Rintelen, Felix; Trelle, Sven] Univ Bern, CTU Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.
   [Spoerri, Adrian; Egger, Matthias; Trelle, Sven] Univ Bern, ISPM, Finkenhubelweg 11, CH-3012 Bern, Switzerland.
   [Aboubacar, Barry] WHO, Conakry, Guinea.
RP Trelle, S (reprint author), Univ Bern, CTU Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.
EM stefanie.hossmann@ctu.unibe.ch; alan.haynes@ctu.unibe.ch;
   adrian.spoerri@ispm.unibe.ch; iddiatta@gmail.com; barrynews1@gmail.com;
   matthias.egger@ispm.unibe.ch; felix.rintelen@ctu.unibe.ch;
   sven.trelle@ctu.unibe.ch
OI Hossmann, Stefanie/0000-0003-1600-5925; Haynes, Alan
   G/0000-0003-1374-081X; Trelle, Sven/0000-0002-8162-8910; Diatta,
   Ibrahima Dina/0000-0002-9342-0252; Spoerri, Adrian/0000-0001-5016-9822
FU World Health OrganizationWorld Health Organization [001]
CR Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Kuchinke W, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-79
   Ohmann C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-97
   Thriemer Kamala, 2012, BMC Res Notes, V5, P113, DOI 10.1186/1756-0500-5-113
   Van den Broeck J, 2007, CLIN TRIALS, V4, P572, DOI 10.1177/1740774507084106
   WHO, 2015, EB SIT REP
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7183
EP 7189
DI 10.1016/j.vaccine.2017.09.094
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300009
PM 29074200
DA 2020-05-12
ER

PT J
AU Walldorf, JA
   Cloessner, EA
   Hyde, TB
   MacNeil, A
AF Walldorf, Jenny A.
   Cloessner, Emily A.
   Hyde, Terri B.
   MacNeil, Adam
CA CDC Emergency Ebola Vaccine
TI Considerations for use of Ebola vaccine during an emergency response
SO VACCINE
LA English
DT Review
DE Ebola infection; Ebola virus vaccines; Emergencies; Outbreaks; Strategic
   planning; Vaccination
ID HEALTH-CARE WORKERS; PROTECTS NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER;
   VIRUS DISEASE; RISK-FACTORS; WEST-AFRICA; TRANSMISSION; CONGO; KIKWIT;
   INFECTION
AB Vaccination against Ebola virus disease is a tool that may limit disease transmission and deaths in future outbreaks, integrated within traditional Ebola outbreak prevention and control measures. Although a licensed Ebolavirus vaccine (EV) is not yet available, the 2014-2016 West African Ebola outbreak has accelerated EV clinical trials and given public health authorities in Guinea, Liberia, and Sierra Leone experience with implementation of emergency ring vaccination. As evidence supporting the use of EV during an outbreak response has become available, public health authorities in at-risk countries are considering how to integrate EV into future emergency Ebola responses and for prevention in high-risk groups, such as healthcare workers and frontline workers (HCW/FLWs), even before an EV is licensed. This review provides an overview of Ebola epidemiology, immunology, and evidence to inform regional and country-level decisions regarding EV delivery during an emergency response and to at-risk populations before a licensed vaccine is available and beyond. Countries or regions planning to use EV will need to assess factors such as the likelihood of a future Ebolavirus outbreak, the most likely species to cause an outbreak, the availability of a safe and effective EV (unlicensed or licensed) for the affected population, capacity to implement Ebola vaccination in conjunction with standard Ebola outbreak control measures, and availability of minimum essential resources and regulatory requirements to implement emergency Ebola vaccination. Potential emergency vaccination strategies for consideration include ring or geographically targeted community vaccination, HCW/FLW vaccination, and mass vaccination. The development of guidelines and protocols for Ebola vaccination will help ensure that activities are standardized, evidence-based, and well-coordinated with overall Ebola outbreak response efforts in the future. Published by Elsevier Ltd.
C1 [Walldorf, Jenny A.; Cloessner, Emily A.; Hyde, Terri B.; MacNeil, Adam] Ctr Dis Control & Prevent, Ctr Global Hlth, Global Immunizat Div, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.
   [Cloessner, Emily A.] Assoc Sch & Programs Publ Hlth, 1900 M St NW Suite 710, Washington, DC 20036 USA.
RP Walldorf, JA (reprint author), Ctr Dis Control & Prevent, Ctr Global Hlth, Global Immunizat Div, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.
EM jwalldorf@cdc.gov; ecloessner@cdc.gov; thyde@cdc.gov; amacneil1@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   Althaus CL, 2015, LANCET INFECT DIS, V15, P507, DOI 10.1016/S1473-3099(15)70135-0
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P681
   [Anonymous], 2017, RELEVE EPIDEMIOLOGIQ, V92, P241
   Ansari AA, 2014, J AUTOIMMUN, V55, P1, DOI 10.1016/j.jaut.2014.09.001
   Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Billioux BJ, 2017, JAMA NEUROL
   Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   Centers for Disease Control and Prevention, OUTBR CHRON EB VIR D
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Davey RT., 2016, 8 INT S FIL SEPT 12
   Deen GF, 2015, N ENGL J MED
   Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284
   Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109
   Esangbedo DO, 2016, AM J TROP MED HYG, V95, P654, DOI 10.4269/ajtmh.16-0206
   Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27
   Forrester JD, 2014, MMWR-MORBID MORTAL W, V63, P925
   Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09
   Glynn JR, 2015, LANCET, V386, P432, DOI 10.1016/S0140-6736(15)61446-5
   Heeney JL, 2015, NATURE, V527, P453, DOI 10.1038/527453a
   Henao-Restrepo AM, 2016, LANCET
   Henao-Restrepo AM, 2016, CURR OPIN VIROL, V17, P138, DOI 10.1016/j.coviro.2016.03.008
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904
   Huo X, 2016, VACCINE, V34, P1767, DOI 10.1016/j.vaccine.2016.02.046
   Irwin KL, 2017, VACCINE
   Kamali A, 2016, EMERG INFECT DIS, V22, P1156, DOI 10.3201/eid2207.160269
   Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320
   Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306
   Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168
   Kozak RA, 2016, EXPERT REV VACCINES, V15, P1093, DOI 10.1586/14760584.2016.1170597
   Kucharski AJ, 2016, EMERG INFECT DIS, V22, P105, DOI 10.3201/eid2201.151410
   Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114
   LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7
   MacNeil A, 2011, J INFECT DIS, V204, pS761, DOI 10.1093/infdis/jir294
   MacNeil A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001175
   MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Martins KA, 2016, EXPERT REV VACCINES, V15, P1101, DOI 10.1080/14760584.2016.1187566
   Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841
   Matanock A, 2014, MMWR-MORBID MORTAL W, V63, P1077
   Mate SE, 2015, N ENGL J MED
   Mennechet FJD, 2015, EXPERT REV VACCINES, V14, P1471, DOI 10.1586/14760584.2015.1083429
   Merler S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005093
   Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218
   Mire CE, 2016, EXP REV VACCINES
   Moreau M, 2015, EURO SURVEILL, V20
   Nordenstedt H, 2016, EMERG INFECT DIS, V22, P759, DOI 10.3201/eid2204.151880
   O'Brien KL, 2016, LANCET, V387, P1887, DOI 10.1016/S0140-6736(16)30394-4
   Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949
   Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311
   Samai M, 2016, AM SOC TROP MED HYG
   Shen MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15818
   Skrip LA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004802
   Sonnenberg P, 2015, CLIN INFECT DIS, V60, P974, DOI 10.1093/cid/ciu981
   Sow MS, 2016, J INFECT DIS
   Sridhar Saranya, 2015, Ther Adv Vaccines, V3, P125, DOI 10.1177/2051013615611017
   Tomori O, 1999, J INFECT DIS, V179, pS98, DOI 10.1086/514307
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Ughasoro MD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003838
   Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Velasquez GE, 2015, CLIN INFECT DIS, V61, P1135, DOI 10.1093/cid/civ531
   Victory KR, 2015, MMWR-MORBID MORTAL W, V64, P386
   Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525
   Warfield KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118881
   Wells C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003794
   WHO, 2016, GLOB MAN SURV ADV EV
   WHO, 2016, INT COORD GROUP ICG
   WHO. Global Ebola Vaccine Implementation Team (GEVIT), 2016, PRACT GUID US EB VAC
   Winslow RL, 2017, JAMA-J AM MED ASSOC, V317, P1074, DOI 10.1001/jama.2016.20644
   World Health Organization (WHO), 2015, GUID IMM PROGR AFR R
   Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255
NR 86
TC 4
Z9 4
U1 11
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7190
EP 7200
DI 10.1016/j.vaccine.2017.08.058
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300010
PM 28890191
DA 2020-05-12
ER

PT J
AU Sauvageau, C
   Gilca, V
   Donken, R
   Fan, SY
   Ogilvie, G
   Dobson, S
AF Sauvageau, Chantal
   Gilca, Vladimir
   Donken, Robine
   Fan, Shu Yu
   Ogilvie, Gina
   Dobson, Simon
TI The immune response to a two-dose schedule of quadrivalent HPV vaccine
   in 9-13 year-old girls: Is it influenced by age, menarche status or body
   mass index?
SO VACCINE
LA English
DT Article
DE Human Papillomavirus; Vaccine; Immunogenicity; Two-dose
ID HUMAN-PAPILLOMAVIRUS TYPE-6; IMMUNOGENICITY; IMPACT; ADOLESCENTS
AB HPV vaccines are highly immunogenic. A two-dose schedule for 9-14 year-old is recommended. However, no data exist regarding the impact of age, menarche status and body mass index (BMI) on the immune response to a two-dose schedule. In this post-hoc analysis, we present antibody titers to HPV6/11 /16/18 in 9-13 year-old girls participating in a randomized clinical trial and assigned to receive two doses of quadrivalent HPV vaccine at 6 months interval (NCT00501137). Antibody titers were measured at month 7 and 24 of the study by using a competitive Luminex immunoassay (cLIA). Both, at Month 7 and 24 the GMTs for four HPV genotypes were similar across the age bands, and did not vary significantly by menarche status. Overweight and obese girls had lower GMTs. More than 99% of girls remained seropositive for HPV 6/11/16 and 89% for HPV18 at month 24. Comprehensive data in overweight and obese vaccines are warranted. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sauvageau, Chantal; Gilca, Vladimir] Quebec Natl Publ Hlth Inst, Quebec City, PQ, Canada.
   [Sauvageau, Chantal; Gilca, Vladimir] Laval Univ, Quebec City, PQ, Canada.
   [Sauvageau, Chantal; Gilca, Vladimir] CHU Quebec Res Ctr, Quebec City, PQ, Canada.
   [Donken, Robine; Fan, Shu Yu] BC Childrens Hosp, Vaccine Evaluat Ctr, Res Inst, Vancouver, BC, Canada.
   [Donken, Robine; Ogilvie, Gina] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Donken, Robine; Ogilvie, Gina] Womens Hlth Res Inst, Vancouver, BC, Canada.
   [Dobson, Simon] BC Childrens Hosp, Vancouver, BC, Canada.
RP Sauvageau, C (reprint author), Inst Natl Sante Publ Quebec, 2400 Ave Estimauville, Quebec City, PQ G1E 7G9, Canada.
EM chantal.sauvageau@inspq.qc.ca
FU Merck Laboratories Inc; Canadian Immunization Research Network (CIRN);
   Michael Smith Foundation for Health ResearchMichael Smith Foundation for
   Health Research
FX This analysis did not receive any specific grant from funding agencies
   in the public, commercial, or not-for-profit sectors. Ministries of
   Health in the provinces of British Columbia, Nova Scotia, and Quebec
   provided the funding for the source project. The HPV DNA assays were
   conducted by Provincial Health Services Authority. Merck Laboratories
   Inc conducted the antibody assays at no cost to the study. RD was
   granted fellowships from the Canadian Immunization Research Network
   (CIRN) and the Michael Smith Foundation for Health Research.
CR Basu P, 2019, PAPILLOMAVIRUS RES, V7, P75, DOI 10.1016/j.pvr.2019.01.004
   Brotherton JML, 2018, BEST PRACT RES CL OB, V47, P42, DOI 10.1016/j.bpobgyn.2017.08.010
   Center for Disease Control and Prevention, DAT TABL BMI FOR AG
   Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625
   Donken R, 2016, HUM VACC IMMUNOTHER, V12, P1381, DOI 10.1080/21645515.2016.1160978
   European Medicine Agency, 2014, ASS REP VAR
   European Medicine Agency, 2014, ASS REP GARD
   European Medicines Agency, 2018, GARD 9 PROC STEPS TA
   Giuliano AR, 2007, J INFECT DIS, V196, P1153, DOI 10.1086/521679
   Joura EA, 2008, VACCINE, V26, P6844, DOI 10.1016/j.vaccine.2008.09.073
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5
   Ogilvie GS, 2015, 30 INT PAP C CLIN PU
   Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003
   Painter SD, 2015, VACCINE, V33, P4422, DOI 10.1016/j.vaccine.2015.06.101
   Petersen LK, 2017, PAPILLOMAVIRUS RES, V3, P105, DOI 10.1016/j.pvr.2017.03.002
   Plotkin SA, 2012, VACCINES
   Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a
NR 18
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7203
EP 7206
DI 10.1016/j.vaccine.2019.09.089
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900002
PM 31648910
DA 2020-05-12
ER

PT J
AU Knodlseder, JM
   Fell, SF
   Straubinger, RK
AF Knoedlseder, Jasmin M.
   Fell, Shari F.
   Straubinger, Reinhard K.
TI A study with a commercial vaccine against Lyme borreliosis in horses
   using two different vaccination schedules: Characterization of the
   humoral immune response
SO VACCINE
LA English
DT Article
DE Borrelia burgdorferi; Lyme borreliosis; EquiLyme (R); Vaccination;
   Horses; OspA
ID DISEASE; BURGDORFERI; DOGS; INFECTION
AB A total of 143 horses were included in a study to test a commercial vaccine against Lyme borreliosis. The vaccine contained three different antigens (outer surface protein A, OspA) to prevent the infection with spirochetes - B. burgdorferi sensu stricto, B. afzelii and B. garinii. Horses in Group A (49 animals) received two vaccinations on days 0 and 14 and a booster on day 365, whereas 50 horses in Group B received an additional booster vaccination on day 180. Group C (44 animals) was not immunized. Total antibody levels and specific OspA antibody responses were assessed quantitatively and qualitatively in two-month intervals over 13-month period. Vaccinees in Groups A and B developed high OspA antibodies levels, whereas horses in Group C did not show specific antibody responses. The additional vaccination applied in Group B enhanced the specific OspA antibody response significantly and prevented its rapid decline. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Knoedlseder, Jasmin M.; Fell, Shari F.; Straubinger, Reinhard K.] Ludwig Maximilians Univ Munchen, Fac Vet Med, Dept Vet Sci, Inst Infect Dis & Zoonoses,Bacteriol & Mycol, Vet Str 13, D-80539 Munich, Germany.
RP Straubinger, RK (reprint author), Ludwig Maximilians Univ Munchen, Fac Vet Med, Dept Vet Sci, Inst Infect Dis & Zoonoses,Bacteriol & Mycol, Vet Str 13, D-80539 Munich, Germany.
EM R.Straubinger@lmu.de
FU Hanns-Seidel-Stiftung e.V.
FX This research did not receive any specific grant from funding agencies
   in the public, commercial or not-for-profit sectors. The
   Hanns-Seidel-Stiftung e.V. provided financial support.
CR APPEL MJG, 1993, J INFECT DIS, V167, P651, DOI 10.1093/infdis/167.3.651
   BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737
   CHANG YF, 1995, INFECT IMMUN, V63, P3543, DOI 10.1128/IAI.63.9.3543-3549.1995
   Chang YF, 1999, VACCINE, V18, P540, DOI 10.1016/S0264-410X(99)00187-5
   Comstedt P, 2015, VACCINE, V33, P5982, DOI 10.1016/j.vaccine.2015.07.095
   Gern L, 1997, VACCINE, V15, P1551, DOI 10.1016/S0264-410X(97)00066-2
   Gipson CL, 2005, INFECT IMMUN, V73, P1644, DOI 10.1128/IAI.73.3.1644-1647.2005
   Golde WT, 1997, INFECT IMMUN, V65, P882, DOI 10.1128/IAI.65.3.882-889.1997
   Guarino C, 2017, VACCINE, V35, P4140, DOI 10.1016/j.vaccine.2017.06.052
   Hahn CN, 1996, EQUINE VET J, V28, P84, DOI 10.1111/j.2042-3306.1996.tb01595.x
   Jacobson RH, 1996, SEMIN VET MED SURG, V11, P172, DOI 10.1016/S1096-2867(96)80030-2
   Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09
   Passamonti F, 2015, ANN AGR ENV MED, V22, P247, DOI 10.5604/12321966.1152074
   Sears KP, 2012, VET DERMATOL, V23, P153, DOI 10.1111/j.1365-3164.2011.01013.x
   Topfer KH, 2007, VACCINE, V25, P314, DOI 10.1016/j.vaccine.2006.07.031
   Van Hoecke C, 1999, CLIN INFECT DIS, V28, P1260, DOI 10.1086/514779
   Wilske B, 2001, QUALITATSSTANDARDS M, P23
NR 17
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7207
EP 7212
DI 10.1016/j.vaccine.2019.09.087
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900003
PM 31635975
DA 2020-05-12
ER

PT J
AU Friedman, L
   Renaud, A
   Hines, D
   Winter, A
   Bolotin, S
   Johnstone, J
   Kwong, JC
   McGeer, AJ
   Crowcroft, NS
   Warshawsky, BF
AF Friedman, Lindsay
   Renaud, Ariane
   Hines, Delaney
   Winter, Anne
   Bolotin, Shelly
   Johnstone, Jennie
   Kwong, Jeffrey C.
   McGeer, Allison J.
   Crowcroft, Natasha S.
   Warshawsky, Bryna F.
TI Exploring indirect protection associated with influenza immunization - A
   systematic review of the literature
SO VACCINE
LA English
DT Review
DE Indirect protection; Vaccine effectiveness; Influenza vaccine; Seasonal
   influenza
ID LABORATORY-CONFIRMED INFLUENZA; VACCINE EFFECTIVENESS; HERD-IMMUNITY;
   PRIMARY-CARE; CHILDREN; EFFICACY; IMPACT; AGE; TRIVALENT; ADULTS
AB Background: Influenza causes significant annual morbidity and mortality, particularly in older adults, for whom influenza vaccine effectiveness (VE) is also lower. Immunizing one group (e.g., children) against influenza may indirectly protect another group (e.g., older adults) against influenza and its complications.
   Methods: We updated previous systematic reviews on indirect protection against influenza by searching MEDLINE and EMBASE for relevant human studies published until January 4, 2017. We abstracted and critically appraised English language publications that reported or provided information to calculate indirect VE against influenza, as a percentage, in non-institutional settings.
   We developed a term called 'estimated actual protection' to explore the relationship between indirect protection and the product of direct VE and relative vaccine coverage. We calculated estimated actual protection for a subset of studies that reported coverage and indirect VE for: laboratory-confirmed influenza; outpatient care for respiratory illness; influenza-associated emergency visits; or influenza-associated hospitalizations. We ran linear mixed models to compare estimated actual protection against indirect VE for the four outcomes, and graphed the data.
   Results: Of 2320 unique records identified, we abstracted and appraised 26 articles describing 24 studies. The majority of included studies reported at least one outcome suggesting that immunizing one group reduced influenza-related outcomes in another group. Critical appraisal of the abstracted studies identified recurring methodological weaknesses, such as lack of laboratory-confirmed influenza.
   Our exploratory analyses of 18 studies indicated a positive but not statistically significant relationship between estimated actual protection and indirect protection for each of the four outcomes.
   Conclusions: Our systematic review and exploratory analyses suggest influenza immunization provides some level of indirect protection. However, our critical appraisal highlights the need for a standardized and consistently applied approach to measuring indirect protection against influenza to fill existing knowledge gaps. Additionally, the concept of estimated actual protection requires validation. Crown Copyright (C) 2019 Published by Elsevier Ltd.
C1 [Friedman, Lindsay; Renaud, Ariane; Hines, Delaney; Winter, Anne; Bolotin, Shelly; Johnstone, Jennie; Kwong, Jeffrey C.; Crowcroft, Natasha S.; Warshawsky, Bryna F.] Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5G 1V2, Canada.
   [Bolotin, Shelly; Johnstone, Jennie; Kwong, Jeffrey C.; McGeer, Allison J.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.
   [Johnstone, Jennie; McGeer, Allison J.; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
   [Johnstone, Jennie; McGeer, Allison J.] Mt Sinai Hosp, Dept Microbiol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.
   [Kwong, Jeffrey C.; Crowcroft, Natasha S.] ICES, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
   [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, 500 Univ Ave,5th Floor, Toronto, ON M5G 1V7, Canada.
   [Kwong, Jeffrey C.] Toronto Western Hosp, Toronto Western Family Hlth Team, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.
   [Warshawsky, Bryna F.] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, 1151 Richmond St, London, ON N6A 5C1, Canada.
RP Friedman, L (reprint author), Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5G 1V2, Canada.
EM lindsay.friedman@oahpp.ca; shelly.bolotin@oahpp.ca;
   jennie.johnstone@oahpp.ca; jeff.kwong@utoronto.ca;
   allison.mcgeer@sinaihealthsystem.ca; natasha.crowcroft@utoronto.ca;
   bryna.warshawsky@oahpp.ca
RI McGeer, Allison/AAB-6885-2020
OI McGeer, Allison/0000-0001-5647-6137; Crowcroft,
   Natasha/0000-0002-6761-8783
CR Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009
   ANDERSON RM, 1992, VACCINE, V10, P928, DOI 10.1016/0264-410X(92)90327-G
   Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527
   Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8
   Better Value Healthcare Ltd, 2017, CRIT APPR SKILLS PRO
   Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480
   Canadian Influenza Sentinel Practitioner Surveillance Network, 2017, SPSN INFL VACC EFF E
   Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases (NCIRD), 2017, TABL ADJ VACC EFF IN
   Charu V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026282
   Cromer D, 2014, J INFECTION, V68, P363, DOI 10.1016/j.jinf.2013.11.013
   Demicheli V, 2018, COCHRANE DB SYST REV, P2
   DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084
   Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6
   Fine P, 2018, PLOTKINS VACCINES, P1512
   Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
   Fleming DM, 2010, J EPIDEMIOL COMMUN H, V64, P1062, DOI 10.1136/jech.2009.093450
   Ghendon YZ, 2006, EPIDEMIOL INFECT, V134, P71, DOI 10.1017/S0950268805005650
   Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089
   Goncalves G, 2008, EXPERT REV VACCINES, V7, P1493, DOI 10.1586/14760584.7.10.1493
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105
   Graitcer SB, 2012, VACCINE, V30, P4835, DOI 10.1016/j.vaccine.2012.05.008
   Grijalva Carlos G, 2010, PLoS One, V5, pe15097, DOI 10.1371/journal.pone.0015097
   Halloran ME, 2010, STAT BIOL HEALTH, P19, DOI 10.1007/978-0-387-68636-3_2
   HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884
   Hardelid P, 2009, EFFECTIVENESS PANDEM
   Hardelid P, 2012, VACCINE, V30, P1371, DOI 10.1016/j.vaccine.2011.12.038
   Hull HF, 2010, PROCEDIA VACCINOL, V2, P92, DOI 10.1016/j.provac.2010.03.017
   Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677
   Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4
   King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414
   King JC, 2010, VACCINE, V28, P7737, DOI 10.1016/j.vaccine.2010.09.064
   King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301
   Loeb M, 2011, VACCINE, V30, P1, DOI 10.1016/j.vaccine.2011.10.069
   Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250
   McBean M, 2011, PROCEDIA VACCINOL, V4, DOI 10.1016/j.provac.2011.07.009
   McMenamin J, 2013, EUROSURVEILLANCE, V18, P2
   Mertz D, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.42.30378
   Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008
   MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16
   MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537
   Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X
   Pannaraj PS, 2014, CLIN INFECT DIS, V59, P325, DOI 10.1093/cid/ciu340
   Pebody RG, 2015, EUROSURVEILLANCE, V20, P37, DOI 10.2807/1560-7917.ES.2015.20.39.30029
   Pebody RG, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.22.20823
   Pebody RG, 2013, EPIDEMIOL INFECT, V141, P620, DOI 10.1017/S0950268812001148
   Pebody RG, 2013, EUROSURVEILLANCE, V18, P25
   Penttinen P, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.22.21148
   PHE Influenza Surveillance Section Respiratory Diseases Department Centre of Infectious Disease Surveillance and Control, 2015, INFL IMM PROGR ENGL
   PHE Influenza Surveillance Section Respiratory Diseases Department Centre of Infectious Disease Surveillance and Control, 2014, INFL IMM PROGR ENGL
   Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025
   Piedra PA, 2007, PEDIATRICS, V120, pE553, DOI 10.1542/peds.2006-2836
   Plans P, 2013, EUR J CLIN MICROBIOL, V32, P961, DOI 10.1007/s10096-013-1836-6
   Poehling KA, 2009, VACCINE, V27, P2695, DOI 10.1016/j.vaccine.2009.02.043
   Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4
   Public Health Agency of Canada, 2018, 2016 17 SEAS INFL VA
   Public Health England, 2016, INFL VACC EFF AD CHI
   Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256
   Santibanez TA, 2014, PUBLIC HEALTH REP, V129, P417, DOI 10.1177/003335491412900505
   Simpson C. R., 2015, Eurosurveillance, V20, P21043
   Taksler GB, 2015, CLIN INFECT DIS, V61, P1495, DOI 10.1093/cid/civ630
   Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108
   Tran C, 2014, CTS-CLIN TRANSL SCI, V7, P240
   Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012
   Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317
   Yin JK, 2017, CLIN INFECT DIS, V65, P719, DOI 10.1093/cid/cix420
NR 65
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7213
EP 7232
DI 10.1016/j.vaccine.2019.09.086
PG 20
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900004
PM 31648907
OA Other Gold
DA 2020-05-12
ER

PT J
AU Cowley, D
   Sari, RM
   Handley, A
   Watts, E
   Bachtiar, NS
   At Thobari, J
   Satria, CD
   Bogdanovic-Sakran, N
   Nirwati, H
   Orsini, F
   Lee, KJ
   Kirkwood, CD
   Soenarto, Y
   Bines, JE
AF Cowley, Daniel
   Sari, Rini Mulia
   Handley, Amanda
   Watts, Emma
   Bachtiar, Novilia S.
   At Thobari, Jarir
   Satria, Cahya Dewi
   Bogdanovic-Sakran, Nada
   Nirwati, Hera
   Orsini, Francesca
   Lee, Katherine J.
   Kirkwood, Carl D.
   Soenarto, Yati
   Bines, Julie E.
TI Immunogenicity of four doses of oral poliovirus vaccine when
   co-administered with the human neonatal rotavirus vaccine (RV3-BB)
SO VACCINE
LA English
DT Article
DE Rotavirus; Poliovirus; Neonatal; Vaccine
ID HOSPITALIZATIONS; MONOVALENT; MORTALITY; IMPACT
AB Background: The RV3-BB human neonatal rotavirus vaccine was developed to provide protection from severe rotavirus disease from birth. The aim of this study was to investigate the potential for mutual interference in the immunogenicity of oral polio vaccine (OPV) and RV3-BB.
   Methods: A randomized, placebo-controlled trial involving 1649 participants was conducted from January 2013 to July 2016 in Central Java and Yogyakarta, Indonesia. Participants received three doses of oral RV3-BB, with the first dose given at 0-5 days (neonatal schedule) or similar to 8 weeks (infant schedule), or placebo. Two sub-studies assessed the immunogenicity of RV3-BB when co-administered with either trivalent OPV (OPV group, n = 282) or inactivated polio vaccine (IPV group, n = 333). Serum samples were tested for antibodies to poliovirus strains 1, 2 and 3 by neutralization assays following doses 1 and 4 of OPV.
   Results: Sero-protective rates to poliovirus type 1, 2 or 3 were similar (range 0.96-1.00) after four doses of OPV co-administered with RV3-BB compared with placebo. Serum IgA responses to RV3-BB were similar when co-administered with either OPV or IPV (difference in proportions OPV vs IPV: sIgA responses; neonatal schedule 0.01, 95% CI -0.12 to 0.14; p = 0.847; infant schedule -0.10, 95% CI -0.21 to -0.001; p = 0.046: sIgA GMT ratio: neonatal schedule 1.23, 95% CI 0.71-2.14, p = 0.463 or infant schedule 1.20, 95% CI 0.74-1.96, p = 0.448).
   Conclusions: The co-administration of OPV with RV3-BB rotavirus vaccine in a birth dose strategy did not reduce the immunogenicity of either vaccine. These findings support the use of a neonatal RV3-BB vaccine where either OPV or IPV is used in the routine vaccination schedule. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Cowley, Daniel; Handley, Amanda; Watts, Emma; Bogdanovic-Sakran, Nada; Kirkwood, Carl D.; Bines, Julie E.] Murdoch Childrens Res Inst, Enter Dis, Parkville, Vic, Australia.
   [Cowley, Daniel; Lee, Katherine J.; Kirkwood, Carl D.; Bines, Julie E.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.
   [Sari, Rini Mulia; Bachtiar, Novilia S.] Bio Farma PT, Bandung, Indonesia.
   [Handley, Amanda] Med Dev Global Hlth, Melbourne, Vic, Australia.
   [At Thobari, Jarir] Univ Gadjah Mada, Dept Pharmacol & Therapy, Yogyakarta, Indonesia.
   [At Thobari, Jarir; Nirwati, Hera] Univ Gadjah Mada, Dept Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Nirwati, Hera] Univ Gadjah Mada, Dept Microbiol, Yogyakarta, Indonesia.
   [At Thobari, Jarir; Satria, Cahya Dewi; Soenarto, Yati] Univ Gadjah Mada, Dept Paediat, Paediat Res Off, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.
   [Orsini, Francesca; Lee, Katherine J.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic, Australia.
   [Orsini, Francesca; Lee, Katherine J.] Murdoch Childrens Res Inst, Melbourne Childrens Trials Ctr, Parkville, Vic, Australia.
   [Kirkwood, Carl D.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Bines, Julie E.] Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Parkville, Vic, Australia.
RP Bines, JE (reprint author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM jebines@unimelb.edu.au
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia; Bill and Melinda Gates
   FoundationGates Foundation; NHMRC CDA fellowshipNational Health and
   Medical Research Council of Australia [607347]; Victorian Government's
   Operational Infrastructure Support Program; Murdoch Children's Research
   Institute; PT Bio Farma
FX This trial was funded by the Australian National Health and Medical
   Research Council, the Bill and Melinda Gates Foundation, PT Bio Farma.
   C.D.K was supported by an NHMRC CDA fellowship (607347). This research
   at Murdoch Children's Research Institute was supported by the Victorian
   Government's Operational Infrastructure Support Program. The Faculty of
   Medicine, Public Health and Nursing, Universitas Gadjah Mada received
   funds as part of a clinical trial agreement with Murdoch Children's
   Research Institute and PT Bio Farma.
CR [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49
   Bines JE, 2018, NEW ENGL J MED, V378, P719, DOI 10.1056/NEJMoa1706804
   Bines JE, 2015, LANCET INFECT DIS, V15, P1389, DOI 10.1016/S1473-3099(15)00227-3
   Burnett E, 2017, J INFECT DIS, V215, P1666, DOI 10.1093/infdis/jix186
   Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087
   Chandola TR, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00302
   Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780
   Danchin M, 2013, VACCINE, V31, P2610, DOI 10.1016/j.vaccine.2013.04.008
   Emperador DM, 2016, CLIN INFECT DIS, V62, P150, DOI 10.1093/cid/civ807
   Kirkwood CD, 2017, VACCINE
   Lewis I, 2017, J INFECT DIS, V216, pS33, DOI 10.1093/infdis/jiw550
   Parashar UD, 2016, CLIN INFECT DIS, V62, pS91, DOI 10.1093/cid/civ1015
   Patel M, 2012, VACCINE, V30, pA30, DOI 10.1016/j.vaccine.2011.11.093
   Sanchez-Uribe E, 2016, CLIN INFECT DIS, V62, pS133, DOI 10.1093/cid/civ1205
   Siegrist CA, 2017, VACCINE IMMUNOLOGY, P16
   Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034
   Tregnaghi MW, 2011, PEDIATR INFECT DIS J, V30, pE103, DOI 10.1097/INF.0b013e3182138278
   Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P118, DOI 10.1097/01.inf.0000199288.98370.71
   Wahjuhono G, 2014, J INFECT DIS, V210, pS347, DOI 10.1093/infdis/jiu060
   Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8
   World Health Organization (WHO), 2013, POL ER ENDG STRAT PL
   Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059
NR 22
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7233
EP 7239
DI 10.1016/j.vaccine.2019.09.071
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900005
PM 31607604
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU McGirr, A
   Fisman, DN
   Tuite, AR
AF McGirr, Ashleigh
   Fisman, David N.
   Tuite, Ashleigh R.
TI The health and economic burden of pertussis in Canada: A microsimulation
   study
SO VACCINE
LA English
DT Article
DE Bordetella pertussis; Pertussis; Whooping cough; Burden of disease;
   Health economics; Epidemiology
ID EPIDEMIOLOGIC FEATURES; BACTERIAL SINUSITIS; UNITED-STATES; COSTS;
   ADOLESCENTS; PROGRAM; STRATEGIES; MORBIDITY; DIAGNOSIS; VACCINE
AB Background: Despite excellent vaccine coverage, pertussis persists in Canada, with high incidence during recent outbreaks and non-negligible incidence in non-outbreak years. While Canadian pertussis incidence is well-characterized, the full health and economic impact of pertussis have not been examined in Canada. We estimated age-specific life years (LYs) and quality-adjusted life years (QALYs) lost, and costs due to pertussis in Ontario, Canada, using a model-based approach.
   Methods: We developed a microsimulation model to simulate pertussis natural history. Daily probabilities of pertussis complications, hospitalizations, and disease sequelae as well as utilities and costs for health states were literature-derived. A healthcare payer perspective was used with a lifetime time horizon. Model outcomes were compared to those from a model with no pertussis health states. Probabilistic sensitivity analyses were used to generate distributions for estimates. Economic burden was estimated by multiplying case cost estimates by annual age-specific incidence.
   Results: Overall, LYs lost per pertussis case was low, with negligible LYs lost in those aged >4 years. Infants (<6 months) had the greatest mean QALY loss per case (0.58), while adults lost only 0.05 QALYs per case. Infants experienced the greatest mean cost per case of $22,768 (95% CI: 21,144-23,406). Case costs generally declined with age, but increased in seniors (aged 65+) with mean cost of $1920 (95% CI: 1800-2033). Based on historic age-specific incidence, pertussis costs the Ontario healthcare system approximately $7.6-$21.5 M annually. In total economic cost estimates with QALYs valued at 1 xGDP (3xGDP) per capita, the net impact of pertussis in Ontario was estimated at $21.7-$66.5 M annually ($50.0-$156.3 M). For all of Canada, total economic costs were estimated at $79.6-$241.3 M ($187.5-$580.5 M) annually.
   Conclusion: The health and economic consequences of pertussis persistence are substantial and highlight the need for improved control strategies. (C) 2019 Published by Elsevier Ltd.
C1 [McGirr, Ashleigh; Fisman, David N.; Tuite, Ashleigh R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Fisman, David N.] Univ Toronto, Fac Med, Dept Med, Div Infect Dis, Toronto, ON, Canada.
RP Fisman, DN (reprint author), 155 Coll St,Room 686, Toronto, ON M5T 3M7, Canada.
EM david.fisman@utoronto.ca
FU Canadian Immunization Research Network - CIRN
FX This work was supported by doctoral funding (to Dr. McGirr) from the
   Canadian Immunization Research Network - CIRN.
CR Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082
   [Anonymous], 2016, PROTR
   Balk EM, 2001, J GEN INTERN MED, V16, P701, DOI 10.1111/j.1525-1497.2001.00429.x
   Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P73
   Cohen E, 2012, PEDIATRICS, V130, pE1463, DOI 10.1542/peds.2012-0175
   Cortese MM, 2008, PEDIATRICS, V121, P484, DOI 10.1542/peds.2007-1393
   Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X
   Crowcroft NS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195984
   De Serres G, 2000, J INFECT DIS, V182, P174, DOI 10.1086/315648
   Deeks S, 1999, CLIN INFECT DIS, V28, P840, DOI 10.1086/515203
   FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708
   Forsyth K, 2015, PEDIATRICS, V135, pE1475, DOI 10.1542/peds.2014-3925
   Galanis E, 2006, CAN MED ASSOC J, V174, P451, DOI 10.1503/cmaj.050379
   Government of Ontario, SCHED BEN PHYS SERV
   Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792
   Hamborsky J, 2015, EPIDEMIOLOGY PREVENT
   Hutubessy R, 2003, COST EFFECT RESOUR A, V1, P8, DOI DOI 10.1186/1478-7547-1-8
   Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025
   Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009
   Iskedjian Michael, 2005, Paediatr Drugs, V7, P123, DOI 10.2165/00148581-200507020-00005
   Iskedjian M, 2010, VACCINE, V28, P714, DOI 10.1016/j.vaccine.2009.10.079
   Kwong J, 2010, ONTARIO BURDEN INFEC
   Laudano MA, 2013, BJU INT, V112, pE151, DOI 10.1111/bju.12180
   Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006
   Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17
   Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989
   Marti M., 2015, VACCINE
   Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
   McGirr AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083850
   Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004
   O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57
   Oh PI, 1996, CLIN THER, V18, P160, DOI 10.1016/S0149-2918(96)80188-3
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, REP DIS TRENDS ONT 2
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, REP DIS TRENDS ONT 2
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2014, REP DIS TRENDS ONT 2
   Ontario Ministry of Health and Long-Term Care, APP B PROV CAS DEF D
   Ontario Ministry of Health and Long-Term Care-Health Data Branch, 2002, ONT CAS COST IN
   Pichichero ME, 1997, ARCH PEDIAT ADOL MED, V151, P35, DOI 10.1001/archpedi.1997.02170380039006
   Public Health Agency of Canada, 2014, NOT DIS ON LIN
   Public Health Ontario, 2013, MONTHL INF DIS SURV
   Public Health Ontario, 2014, MONTHL INF DIS SURV
   Public Health Ontario, 2012, MONTHL INF DIS SURV
   R Core Team, 2018, R LANG ENV STAT COMP
   Raguckas SE, 2007, PHARMACOTHERAPY, V27, P41, DOI 10.1592/phco.27.1.41
   Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097
   Sande MA, 2004, CLIN INFECT DIS, V39, pS151, DOI 10.1086/421353
   Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010
   Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256
   Smith T, 2014, Can Commun Dis Rep, V40, P21
   Statistics Canada, 2015, TABL 051 0002 EST DE
   Stefanoff P, 2014, EPIDEMIOL INFECT, V142, P714, DOI 10.1017/S0950268813001684
   Thampi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119271
   World Health Organization, HLTH STAT INF SYST
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7240
EP 7247
DI 10.1016/j.vaccine.2019.09.070
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900006
PM 31585727
DA 2020-05-12
ER

PT J
AU Bao, YM
   Wang, Q
   Yao, KH
   Xie, G
   Gao, W
   Huang, L
   Liu, XL
   Zhu, CQ
   Chen, HY
   Wang, HP
   Shen, KL
   Zheng, YJ
   Yang, YH
AF Bao, Yanmin
   Wang, Qing
   Yao, Kaihu
   Xie, Gan
   Gao, Wei
   Huang, Lu
   Liu, Xiaoli
   Zhu, Chunqin
   Chen, Hongyu
   Wang, Heping
   Shen, Kungling
   Zheng, Yuejie
   Yang, Yonghong
TI The changing phenotypes and genotypes of invasive pneumococcal isolates
   from children in Shenzhen during 2013-2017
SO VACCINE
LA English
DT Article
DE Streptococcus pneumoniae; Serotypes; Antibiotic resistance; Genotype;
   Invasive pneumococcal diseases
ID RESISTANT STREPTOCOCCUS-PNEUMONIAE; SEROTYPE 19A; ANTIMICROBIAL
   RESISTANCE; ANTIBIOTIC-RESISTANCE; CONJUGATE VACCINES; DISEASE;
   EMERGENCE; EXPANSION; INCREASE; PATTERN
AB Background: The phenotypes and genotypes of Streptococcus pneumoniae isolated from invasive pneumococcal diseases (IPDs) were changing all the time. To monitor these changes of phenotypes and genotypes of S. pneumoniae isolates from children, we examined antibiotic susceptibility, serotype distribution and sequence types (STs) of S. pneumoniae, which were isolated before the 13-valent pneumococcal conjugate vaccine (PCV13) introduced into China.
   Methods: Strains were isolated from children less than 14 years old between January 2013 and May 2017 from Shenzhen Children's Hospital. Serotypes, antibiotic resistance, and genotypes of these isolates were determined using capsular swelling, E-test, and multi-locus sequence typing, respectively.
   Results: A total of 94 S. pneumoniae strains were isolated, which belonged to 15 serotypes. The five most prevalent serotypes were 19F (25.5%), 19A (19%), 14 (17%), 23F (7.5%), and 6B (9.6%). We found 42 STs for these isolates. The most abundant STs were ST271 (24.4%), ST876 (17%), and ST320 (10.6%), mainly related to 19F, 14, and 19A, respectively. The potential coverage of PCV13 was 87.2%. Among non-meningitis isolates, the resistance rates to penicillin and ceftriaxone were 0% and 2%. However, the meningitis isolates showed high resistance to penicillin (80%) and ceftriaxone (20%). Most of these isolates (95.7%) were resistant to erythromycin, and 66 (70.2%) strains carried the ermB gene and 24 (25.5%) strains carried both the ermB and mefA/E genes. Serotype 19A showed the highest mean minimum inhibitory concentration (MIC) for penicillin (MIC = 1.486) than the other serotypes, but no significant difference in penicillin MIC among the three main STs (ST271, ST320, and ST876).
   Conclusions: The phenotypes and genotypes of invasive pneumococcal isolates from Shenzhen Children's Hospital have changed with the passage of time. Compared with PCV7, PCV13 can more effectively protect Chinese children from IPDs. To some extent, these changes are possibly related to the usage of antibiotics and vaccines. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bao, Yanmin; Wang, Qing; Yao, Kaihu; Xie, Gan; Gao, Wei; Shen, Kungling; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, 56 Nan Li Shi Rd, Beijing 100045, Peoples R China.
   [Bao, Yanmin; Xie, Gan; Huang, Lu; Liu, Xiaoli; Zhu, Chunqin; Chen, Hongyu; Wang, Heping; Zheng, Yuejie; Yang, Yonghong] Shenzhen Childrens Hosp, 7019 Yitian Rd, Shenzhen 518026, Guangdong, Peoples R China.
RP Yang, YH (reprint author), Capital Med Univ, Beijing Childrens Hosp, 56 Nan Li Shi Rd, Beijing 100045, Peoples R China.; Zheng, YJ; Yang, YH (reprint author), Shenzhen Childrens Hosp, 7019 Yitian Rd, Shenzhen 518026, Guangdong, Peoples R China.
EM yuejiez@sina.com; yyh628628@sina.com
FU Shenzhen Science and Technology Project [JCYJ20180228175330567]; Sanming
   Project of Medicine in Shenzhen [SZSM201512030]
FX This work was supported by Shenzhen Science and Technology Project
   (grant No. JCYJ20180228175330567) and Sanming Project of Medicine in
   Shenzhen (SZSM201512030).
CR Arushothy R, 2019, INT J INFECT DIS, V80, P129, DOI 10.1016/j.ijid.2018.12.009
   Baek JY, 2018, DIAGN MICR INFEC DIS, V91, P287, DOI 10.1016/j.diagmicrobio.2018.02.010
   Bao L, 2015, PLOS ONE, V10, DOI [10.1371/journalpone.0118868e0118868, DOI 10.1371/JOURNALPONE.0118868E0118868]
   Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052
   Cassiolato AP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208211
   Cho YC, 2017, PEDIATR INFECT DIS J, V36, pE334, DOI [10.1097/INF.0000000000001664, 10.1097/inf.0000000000001664]
   Crook DWM, 1998, BRIT MED BULL, V54, P595
   Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044
   Del Grosso M, 2013, J MED MICROBIOL, V62, P1220, DOI 10.1099/jmm.0.061242-0
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Golden AR, 2018, J ANTIMICROB CHEMOTH, V73, DOI [10.1093/jac/d1ty157, DOI 10.1093/JAC/D1TY157]
   Ho PL, 2011, VACCINE, V29, P3270, DOI 10.1016/j.vaccine.2011.02.025
   Htar MTT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1147-x
   Hulten KG, 2013, J CLIN MICROBIOL, V51, P1294, DOI 10.1128/JCM.00058-13
   Ikuse T, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818002133
   Janoir C, 2016, INSIGHT RESISTANCE P
   Jiang H, 2017, PLOS ONE, V12, DOI [10.1371/joumal.pone.0180161e0180161, DOI 10.1371/JOUMAL.PONE.0180161E0180161]
   Karlowsky JA, 2018, J ANTIMICROB CHEMOTH, V73, P5, DOI 10.1093/jac/dky156
   Kawaguchiya M, 2017, MICROB DRUG RESIST, V23, P206, DOI 10.1089/mdr.2016.0054
   Kelly LM, 1999, J CLIN MICROBIOL, V37, P3296, DOI 10.1128/JCM.37.10.3296-3299.1999
   Lee NY, 2001, CLIN INFECT DIS, V32, P1463, DOI 10.1086/320165
   Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054254
   Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004
   Liyanapathirana V, 2015, DIAGN MICR INFEC DIS, V81, P66, DOI 10.1016/j.diagmicrobio.2014.09.028
   Ma X, 2013, EPIDEMIOL INFECT, V141, P1690, DOI 10.1017/S0950268812002269
   Ma X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067507e67507, DOI 10.1371/JOURNAL.PONE.0067507E67507]
   Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582
   Olarte L, 2017, J CLIN MICROBIOL, V55, P724, DOI 10.1128/JCM.01778-16
   Principi N, 2018, EXPERT OPIN BIOL TH, V18, P7, DOI 10.1080/14712598.2018.1384462
   Schmitz J, 2017, INT J MED MICROBIOL, V307, P216, DOI 10.1016/j.ijmm.2017.04.003
   Sheppard C, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.50.30423
   Shi W, 2019, EXPERT REV VACCINES, V18, P89, DOI 10.1080/14760584.2019.1557523
   Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048
   Singh J, 2017, VACCINE, V35, P4501, DOI 10.1016/j.vaccine.2017.06.079
   SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097
   Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562
   Ubukata K, 2018, EMERG INFECT DIS, V24, P2010, DOI 10.3201/eid2411.180326
   Vestrheim DF, 2012, CLIN VACCINE IMMUNOL, V19, P443, DOI 10.1128/CVI.05563-11
   Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X
   Wayne P, 2015, M100S25 CLIN LAB STA
   Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603
   Xue L, 2011, CHINESE MED J-PEKING, V124, P1769, DOI 10.3760/cma.j.issn.0366-6999.2011.12.002
   Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534
   Zhang QL, 2011, PEDIATR INFECT DIS J, V30, P7, DOI 10.1097/INF.0b013e3181ec6245
   Zhang ZG, 2017, J CLIN PHARM THER, V42, P579, DOI 10.1111/jcpt.12544
NR 45
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7248
EP 7255
DI 10.1016/j.vaccine.2019.09.069
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900007
PM 31635974
DA 2020-05-12
ER

PT J
AU Jimenez-Chavez, AD
   Moreno-Fierros, L
   Bustos-Jaimes, I
AF de Jesus Jimenez-Chavez, Angel
   Moreno-Fierros, Leticia
   Bustos-Jaimes, Ismael
TI Therapy with multi-epitope virus-like particles of B19 parvovirus reduce
   tumor growth and lung metastasis in an aggressive breast cancer mouse
   model
SO VACCINE
LA English
DT Article
DE Virus-like particles; Neoepitopes; Vaccine; Triple negative breast
   cancer
ID T-CELLS; ANTIGEN; PROTOXIN; IMMUNOTHERAPY; ACTIVATION; PROTECTION;
   ANTIBODY; CARRIERS; SUBSETS; VACCINE
AB Triple-negative breast cancer is a major health problem that lacks molecular targets for therapy. Neoepitopes represent a viable option to induce antitumor immune responses, but they have limitations, such as low immunogenicity and tolerance induction. Parvovirus B19 virus-like particles may be used to deliver neoepitopes to prime cellular immunity. We designed and evaluated the therapeutic effect of VP2 B19-virus-like particles, with multi-neoepitopes, in a 4T1 breast cancer model. Balb/c mice received four therapeutic immunizations with multi-neoepitopes-virus-like, wild type-virus-like, vehicle, or virus-like plus Cry1Ac adjuvant particles, intraperitoneally and peritumorally. Tumor growth, lung macro-metastasis, and specific immune responses were evaluated. Therapeutic administration of multi-epitopes virus-like particles significantly delayed tumor growth and decreased the lung macrometastasis number, in comparison to treatment with wild type-virus-like particles, which surprisingly also elicited antitumoral effects that were improved with the adjuvant. Only treatments with multiepitope virus-like particles induced specific proliferative responses of CD8 and CD4 T lymphocytes and Granzyme-B production in lymphatic nodes local to the tumor. Treatment with recombinant multiple neoepitopes-virus-like particles induced specific cellular responses, inhibited tumor growth and macro-metastasis, thus B19-virus-like particles may function as an effective delivery system for neoepitopes for personalized immunotherapy. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [de Jesus Jimenez-Chavez, Angel; Moreno-Fierros, Leticia] Univ Nacl Autonoma Mexico, Fac Higher Studies Iztacala, Biomed Unit, Ave los Barrios 1, Tlalnepantla 54090, Estado De Mexic, Mexico.
   [Bustos-Jaimes, Ismael] Natl Autonomous Univ Mexico UNAM, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.
RP Moreno-Fierros, L (reprint author), UNAM, FES Iztacala, Biomed Unit, Lab 9, Av De los Barrios 1, Tlalnepantla 54090, Estado De Mexic, Mexico.
EM lemofi@unam.mx
OI Jimenez Chavez, Angel de Jesus/0000-0003-1652-3140
FU Programa de Apoyo a Proyectos de Investigation e InnovaciOn Tecnologica
   (PAPIIT)Programa de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT) [1N2233319]; Consejo Nacional de Ciencia y
   Tecnologia (CONACYT)Consejo Nacional de Ciencia y Tecnologia (CONACyT)
   [CB283319]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [CVU 659430]
FX This work was supported by Grants from Programa de Apoyo a Proyectos de
   Investigation e InnovaciOn Tecnologica (PAPIIT) 1N2233319 and Consejo
   Nacional de Ciencia y Tecnologia (CONACYT) CB283319. Angel de Jesus
   Jimenez Chavez is a doctoral student from Programa de Doctorado en
   Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and
   was supported by CONACYT (CVU 659430).
CR Abraham M, 2008, J AUTOIMMUN, V30, P21, DOI 10.1016/j.jaut.2007.11.007
   Amexis G, 2006, J INFECT DIS, V194, P790, DOI 10.1086/506361
   Ao ZJ, 2019, CANCER BIOTHER RADIO, V34, P33, DOI 10.1089/cbr.2018.2566
   Blackburn HL, 2017, BREAST CANCER-BASIC, V11, P1, DOI 10.1177/1178223417691246
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Brennick CA, 2017, IMMUNOTHERAPY-UK, V9, P361, DOI 10.2217/imt-2016-0146
   BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117
   Bustos-Jaimes I, 2017, J BIOTECHNOL, V263, P55, DOI 10.1016/j.jbiotec.2017.09.014
   Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405
   Gilbert L, 2005, BIOCHEM BIOPH RES CO, V331, P527, DOI 10.1016/j.bbrc.2005.03.208
   Gonzalez-Gonzalez E, 2015, VET MICROBIOL, V175, P382, DOI 10.1016/j.vetmic.2014.11.021
   Gregorio AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165817
   Jaiswal PK, 2015, INDIAN J MED RES, V141, P389, DOI 10.4103/0971-5916.159250
   Jia CC, 2018, ACS APPL MATER INTER, V10, P35745, DOI 10.1021/acsami.8b11556
   Khong H, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0160-y
   Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111
   Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426
   Li KY, 2013, J IMMUNOTHER, V36, P11, DOI 10.1097/CJI.0b013e3182787f5e
   Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572
   Lin MC, 2019, CANCER GENE THER, V26, P208, DOI 10.1038/s41417-019-0083-0
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Marqus S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0328-x
   Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685
   Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985
   Moreno-Fierros L, 2013, INT IMMUNOPHARMACOL, V17, P1051, DOI 10.1016/j.intimp.2013.10.005
   Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930
   Ogasawara Y, 2006, IN VIVO, V20, P319
   Ong HK, 2017, PEERJ, V5, DOI 10.7717/peerj.4053
   Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991
   Palladini A, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1408749
   Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074
   Petrovsky N, 2015, DRUG SAFETY, V38, P1059, DOI 10.1007/s40264-015-0350-4
   Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39
   Rahman M, 2015, ONCOL LETT, V10, P1233, DOI 10.3892/ol.2015.3486
   Rojas-Hernandez S, 2004, INFECT IMMUN, V72, P4368, DOI 10.1128/IAI.72.8.4368-4375.2004
   Roman J, 2010, AM J RESP CELL MOL, V43, P684, DOI 10.1165/rcmb.2009-0375OC
   Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003
   Sanchez-Rodriguez SP, 2012, BIOCHIMIE, V94, P870, DOI 10.1016/j.biochi.2011.12.006
   Seung-Yeol P, 2012, BBA, V1820, P1141, DOI [10.1016/j.bbagen.2012.04.008, DOI 10.1016/J.BBAGEN.2012.04.008]
   Shirota H, 2015, VACCINES-BASEL, V3, P390, DOI 10.3390/vaccines3020390
   Tomita Y, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25801
   Tsubaki Takuya, 2018, Oncotarget, V9, P11209, DOI 10.18632/oncotarget.24359
   Umansky V, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040036
   Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030
   Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522
   Yavari B, 2018, CURR PROTEIN PEPT SC, V19, P759, DOI 10.2174/1389203719666180111150008
   Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791
   Zanetti M, 2015, J IMMUNOL, V194, P2049, DOI 10.4049/jimmunol.1402669
   Zdanowicz M, 2016, ACTA BIOCHIM POL, V63, P469, DOI 10.18388/abp.2016_1275
   Zheng K, 2017, BIOTECHNOL J INT, V19, P1, DOI [10.9734/BJI/2017/36382, DOI 10.9734/BJI/2017/36382]
   Zimmerman T, 2006, J IMMUNOL METHODS, V314, P67, DOI 10.1016/j.jim.2006.05.012
NR 51
TC 0
Z9 0
U1 8
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7256
EP 7268
DI 10.1016/j.vaccine.2019.09.068
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900008
PM 31570181
DA 2020-05-12
ER

PT J
AU Vitoriano-Souza, J
   Mathias, FAS
   Moreira, ND
   Aguiar-Soares, RDD
   Vieira, PMD
   Teixeira-Carvalho, A
   Carneiro, CM
   Giunchetti, RC
   de Brito, RCF
   Fujiwara, RT
   Roatt, BM
   Melo, MN
   Reis, AB
AF Vitoriano-Souza, Juliana
   Siqueira Mathias, Fernando Augusto
   Moreira, Nadia das Dores
   de Oliveira Aguiar-Soares, Rodrigo Dian
   de Abreu Vieira, Paula Melo
   Teixeira-Carvalho, Andrea
   Carneiro, Claudia Martins
   Giunchetti, Rodolfo Cordeiro
   Fortes de Brito, Rory Cristiane
   Fujiwara, Ricardo Toshio
   Roatt, Bruno Mendes
   Melo, Maria Norma
   Reis, Alexandre Barbosa
TI Effect on cellular recruitment and the innate immune response by
   combining saponin, monophosphoryl lipid-A and Incomplete Freund's
   Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine
   formulation
SO VACCINE
LA English
DT Article
DE Adjuvants; Saponin; Monophosphoryl lipid; Incomplete Freund Adjuvant;
   Cellular infiltration; Cytokines; Immune response
ID MACROPHAGES; MIGRATION; CYTOKINES; DERMIS
AB The poor immunogenicity displayed by some antigens has encouraged the development of strategies to improve the immune response and safety of vaccine candidates, resulting in an intense search for substances that potentiate vaccine response. Adjuvants have these properties helping vaccine candidates to induce a strong, durable, and fast immune response. In this study, we evaluated the specific immune response of adjuvants alone, Saponin (SAP), Incomplete Freund's Adjuvant (IFA) and Monophosphoryl lipid-A SE (MPL-SE (R)) and in combination with total antigen of L. braziliensis (LB): LBSAP, LBIFA and LBMPL. The specific immune response induced by these compositions demonstrated that they were powerfully immunogenic, increasing cellular infiltration in the skin. Draining lymph nodes cultures showed that LBIFA and LBMPL have higher ability to increase the capacity of APCs to present antigens, with increased frequency of CD11c(+)CD86(+)cells. SAP, MPL, LBSAP, LBIFA and LBMPL could activate lymphocytes increasing expression of CD69 and CD25. LBSAP group was an excellent inducer of pro-inflammatory cytokines at 24 h. At 48 h, higher cytokines production was observed in IFA, LBIFA, MPL and LBMPL groups. Our data demonstrate that LBSAP and LBMPL are potential formulations to be tested in other experimental models. Also, the data obtained could expand the knowledge about immune response after sensitization and also contribute to the development of safe, immunogenic and effective vaccines. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Vitoriano-Souza, Juliana; Siqueira Mathias, Fernando Augusto; Moreira, Nadia das Dores; de Oliveira Aguiar-Soares, Rodrigo Dian; de Abreu Vieira, Paula Melo; Fortes de Brito, Rory Cristiane; Roatt, Bruno Mendes; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Imunopatol, Ouro Preto, MG, Brazil.
   [Vitoriano-Souza, Juliana; Carneiro, Claudia Martins; Giunchetti, Rodolfo Cordeiro; Fujiwara, Ricardo Toshio; Melo, Maria Norma; Reis, Alexandre Barbosa] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, BR-30190002 Belo Horizonte, MG, Brazil.
   [Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Dept Analises Clin, Ouro Preto, MG, Brazil.
   [Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.
   [de Abreu Vieira, Paula Melo] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Morfopatol, Ouro Preto, MG, Brazil.
   [de Oliveira Aguiar-Soares, Rodrigo Dian] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Multiusuario Citometria Fluxo, Ouro Preto, MG, Brazil.
   [Roatt, Bruno Mendes; Reis, Alexandre Barbosa] INCT DT, Salvador, BA, Brazil.
   [Roatt, Bruno Mendes] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Ciencias Biol, Ouro Preto, MG, Brazil.
RP Reis, AB (reprint author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Imunopatol, BR-35400000 Ouro Preto, MG, Brazil.
EM alexreis@ufop.edu.br
RI ; De Brito, Rory Cristiane Fortes/N-3147-2018
OI Vieira, Paula/0000-0001-7033-7686; Siqueira Mathias, Fernando
   Augusto/0000-0003-2071-0344; De Brito, Rory Cristiane
   Fortes/0000-0002-7591-5331
FU Brazilian agencies: Fundacao de Amparo a Pesquisa de Minas Gerais
   -FAPEMIG, Brazil [APQ-01373-14, APQ-02638-17]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq, BrazilNational Council
   for Scientific and Technological Development (CNPq) [435224/2018-2];
   Instituto Nacional de Ciencia e Tecnologia em Doencas Tropicais -
   INCT-DT, Brazil; Universidade Federal de Ouro Preto (UFOP), Brazil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES [001]
FX This study was funded by Brazilian agencies: Fundacao de Amparo a
   Pesquisa de Minas Gerais -FAPEMIG, Brazil (grants ID: APQ-01373-14,
   APQ-02638-17), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq, Brazil (grant ID: 435224/2018-2), Instituto Nacional
   de Ciencia e Tecnologia em Doencas Tropicais - INCT-DT, Brazil and
   Universidade Federal de Ouro Preto (UFOP), Brazil. This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Brazil - Finance Code 001.
CR Apostolico JD, 2016, J IMMUNOL RES, DOI 10.1155/2016/1459394
   Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114
   Das S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008222
   Vieira PMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032912
   Detienne S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39475
   Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474
   Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296
   Fox CB, 2008, COLLOID SURFACE B, V65, P98, DOI 10.1016/j.colsurfb.2008.03.003
   Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x
   Garcon N, 2017, HUM VACC IMMUNOTHER, V13, P19, DOI 10.1080/21645515.2016.1225635
   Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009
   Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681
   HARMSEN AG, 1985, SCIENCE, V230, P1277, DOI 10.1126/science.4071052
   Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0
   Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618
   Lee CH, 2017, J MICROBIOL BIOTECHN, V27, P709, DOI 10.4014/jmb.1611.11072
   Mayrink W, 1996, MEM I OSWALDO CRUZ, V91, P695, DOI 10.1590/S0074-02761996000600006
   Michel G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156363
   Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100
   Moreira ND, 2009, VET IMMUNOL IMMUNOP, V128, P418, DOI 10.1016/j.vetimm.2008.11.030
   Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0
   Murtaugh MP, 2002, VET IMMUNOL IMMUNOP, V87, P109, DOI 10.1016/S0165-2427(02)00042-9
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x
   Roatt BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049780
   ROSEN H, 1990, EUR J IMMUNOL, V20, P1251, DOI 10.1002/eji.1830200609
   Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006
   Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5
   Shen SS, 2012, VACCINE, V30, P1560, DOI 10.1016/j.vaccine.2011.12.120
   Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Thakur A, 2015, IMMUNOBIOLOGY, V220, P1031, DOI 10.1016/j.imbio.2015.05.014
   van Aalst S, 2017, VACCINE, V35, P1622, DOI 10.1016/j.vaccine.2017.02.005
   Vitoriano-Souza J, 2008, VACCINE, V26, P3922, DOI 10.1016/j.vaccine.2008.04.084
   Vitoriano-Souza J, 2013, MOL IMMUNOL, V56, P540, DOI 10.1016/j.molimm.2013.05.231
   Vitoriano-Souza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040745
   Weilhammer D, 2017, VACCINE, V35, P1475, DOI 10.1016/j.vaccine.2017.02.004
NR 37
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7269
EP 7279
DI 10.1016/j.vaccine.2019.09.067
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900009
PM 31575491
DA 2020-05-12
ER

PT J
AU Pasmans, H
   Schurink-van't Klooster, TM
   Bogaard, MJM
   van Rooijen, DM
   de Melker, HE
   Welters, MJP
   van der Burg, SH
   van der Klis, FRM
   Buisman, AM
AF Pasmans, Hella
   Schurink-van't Klooster, Tessa M.
   Bogaard, Marjan J. M.
   van Rooijen, Debbie M.
   de Melker, Hester E.
   Welters, Marij J. P.
   van der Burg, Sjoerd H.
   van der Klis, Fiona R. M.
   Buisman, Anne-Marie
TI Long-term HPV-specific immune response after one versus two and three
   doses of bivalent HPV vaccination in Dutch girls
SO VACCINE
LA English
DT Article
DE HPV; Vaccines; Immunology; Antibodies; B-cells; T-cells; Cytokines
ID (HPV)-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS; QUADRIVALENT
   VACCINE; ADOLESCENT GIRLS; DOUBLE-BLIND; T-CELLS; IMMUNOGENICITY;
   INFECTION; SCHEDULE; EFFICACY
AB Background: In view of further reduction of HPV vaccination schedules, gaining more insight into humoral and cellular immune responses after a single HPV vaccine is of great interest. Therefore, these responses were evaluated after different doses of the bivalent (2v) HPV-vaccine in girls.
   Methods: Blood was collected yearly up to seven years post-vaccination with one-, two- or three-doses of the 2vHPV vaccine (N = 890). HPV-type-specific IgG and IgA-antibody levels, IgG-isotypes and avidity indexes were measured by a virus-like-particle-based multiplex-immuno-assay for two vaccine and five non-vaccine HPV types. HPV-type-specific memory B-cell numbers- and T-cell cytokine responses were determined in a subpopulation.
   Results: HPV-type-specific antibody concentrations were significantly lower in one- than in two- and three-dose vaccinated girls but remained stable over seven years. The lower antibody response coincided with reduced HPV-type-specific B- and T-cell responses. There were no differences in both the IgG subtypes and the avidity of the HPV16-specific antibodies between the groups.
   Conclusions: One-dose of the 2vHPV vaccine is immunogenic, but results in less B- and T-cell memory and considerable lower antibody responses when compared with more doses. Therefore, at least of some of girls receiving the one-dose of the vaccination might be at higher risk for waning immunity to HPV in the long-term. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Pasmans, Hella; Schurink-van't Klooster, Tessa M.; Bogaard, Marjan J. M.; van Rooijen, Debbie M.; de Melker, Hester E.; van der Klis, Fiona R. M.; Buisman, Anne-Marie] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Antonie van Leeuwenhoeklaan 9, NL-3720 MA Bilthoven, Netherlands.
   [Pasmans, Hella; Welters, Marij J. P.; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Med Oncol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.
RP Pasmans, H (reprint author), Natl Inst Publ Hlth & Environm RIVM, POB 41, NL-3720 BA Bilthoven, Netherlands.
EM hella.pasmans@rivm.nl
FU Dutch Ministry of Health, Welfare and Sports
FX This work was funded by the Dutch Ministry of Health, Welfare and
   Sports.
CR Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016
   [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P465, DOI DOI 10.1186/1750-9378-2-15
   Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102
   Carollo M, 2013, VACCINE, V31, P506, DOI 10.1016/j.vaccine.2012.11.029
   de Rond L, 2015, CLIN VACCINE IMMUNOL, V22, P561, DOI 10.1128/CVI.00695-14
   Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493
   Donken R, 2017, J INFECT DIS, V215, P359, DOI 10.1093/infdis/jiw588
   Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117
   Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760
   Heijstek MW, 2014, ANN RHEUM DIS, V73, P1500, DOI 10.1136/annrheumdis-2013-203429
   Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503
   Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044
   Kreimer AR, 2018, VACCINE, V36, P4774, DOI 10.1016/j.vaccine.2017.12.078
   Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55
   Matsui K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137195
   Mollers M, 2012, CANCER EPIDEMIOL, V36, P519, DOI 10.1016/j.canep.2012.07.006
   Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5
   Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4
   Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300
   Pinto LA, 2005, VACCINE, V23, P3555, DOI 10.1016/j.vaccine.2005.01.146
   Romanowski B, 2016, HUM VACC IMMUNOTHER, V12, P20, DOI 10.1080/21645515.2015.1065363
   Safaeian M, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx158
   Sankaranarayanan R, 2018, VACCINE, V36, P4783, DOI 10.1016/j.vaccine.2018.02.087
   Scherer EM, 2018, J INFECT DIS, V217, P572, DOI 10.1093/infdis/jix566
   Scherpenisse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074797
   Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068
   Schiller J, 2018, VACCINE, V36, P4768, DOI 10.1016/j.vaccine.2017.12.079
   Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046
   Smith KM, 2006, VACCINE, V24, P3035, DOI 10.1016/j.vaccine.2005.10.027
   Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640
   Smith KM, 2003, J IMMUNOL, V170, P2310, DOI 10.4049/jimmunol.170.5.2310
   Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051
   Toh ZQ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy147
   van der Lee S, 2018, VACCINE, V36, P220, DOI 10.1016/j.vaccine.2017.11.066
   van der Maas NA, 2014, EUROSURVEILLANCE, V19, P21, DOI 10.2807/1560-7917.ES2014.19.7.20705
   van Poelgeest MIE, 2016, CLIN CANCER RES, V22, P2342, DOI 10.1158/1078-0432.CCR-15-2594
   Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741
   Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010
   zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046
NR 40
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 20
PY 2019
VL 37
IS 49
BP 7280
EP 7288
DI 10.1016/j.vaccine.2019.09.066
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JP5YM
UT WOS:000498339900010
PM 31575492
DA 2020-05-12
ER

PT J
AU Azizi, S
   Yaday, A
   Lau, YM
   Hampel, U
   Roy, S
   Schubert, M
AF Azizi, S.
   Yaday, A.
   Lau, Y. M.
   Hampel, U.
   Roy, S.
   Schubert, M.
TI Hydrodynamic correlations for bubble columns from complementary UXCT and
   RPT measurements in identical geometries and conditions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Bubble columns; Hydrodynamic correlations; Ultrafast X-ray computed
   tomography; Radioactive particle tracking
ID GAS HOLD-UP; MASS-TRANSFER COEFFICIENT; 2-PHASE FLOW; REACTORS; SIZE;
   PREDICTION; PRESSURE; PATTERNS; VELOCITY; DENSITY
AB Many correlations have been developed to predict the hydrodynamics of bubble columns. Often, these studies are performed for incomparable systems in terms of column and sparger dimensions as well as physical fluid properties. In this work, a different approach is proposed comprising interrelated correlations for liquid velocity, gas holdup and bubble size. The correlations are developed on the basis of complementary experiments with non-invasive measurement techniques, namely, Ultrafast X-ray Computed Tomography (UXCT) and Radioactive Particle Tracking (RPT). The experimental setup consists of a bubble column equipped with a needle sparger. The developed correlations consider sparger dimensions, operating conditions and bubble size. The bubble size is applied as the characteristic length in the Reynolds and the Eotvos numbers, which are utilized for the gas holdup and liquid velocity correlations. In comparison with previous approaches, the developed correlations show better agreement with experimental data from this study as well as from the literature. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Azizi, S.; Lau, Y. M.; Hampel, U.; Schubert, M.] Helmholtz Zentrum Dresden Rossendorf, Inst Fluid Dynam, Bautzner Landstr 400, D-01328 Dresden, Germany.
   [Yaday, A.; Roy, S.] Indian Inst Technol Delhi, Dept Chem Engn, Delhi 110016, India.
   [Hampel, U.] Tech Univ Dresden, Chair Imaging Tech Energy & Proc Engn, D-01062 Dresden, Germany.
RP Schubert, M (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Fluid Dynam, Bautzner Landstr 400, D-01328 Dresden, Germany.
EM m.schubert@hzdr.de
OI YADAV, ASHUTOSH/0000-0002-1733-3579
FU European Research Council (ERC)European Research Council (ERC) [307360]
FX The authors gratefully acknowledge the financial support of the European
   Research Council (ERC Starting Grant, Grant Agreement No. 307360). Salar
   Azizi would like to thank the Indian Institute of Technology Delhi
   (IITD) and the technicians (Brahm Prakash Arya and Naresh Kumar) for the
   support during the visit at the Institute.
CR AKITA K, 1973, IND ENG CHEM PROC DD, V12, P76, DOI 10.1021/i260045a015
   Azizi S, 2017, CHEM ENG SCI, V170, P320, DOI 10.1016/j.ces.2017.02.015
   Basha OM, 2015, INT J CHEM REACT ENG, V13, P201, DOI 10.1515/ijcre-2014-0146
   Behkish A, 2006, CHEM ENG J, V115, P157, DOI 10.1016/j.cej.2005.10.006
   BHAVARAJU SM, 1978, AICHE J, V24, P1063, DOI 10.1002/aic.690240618
   Bieberle A, 2011, NUCL ENG DES, V241, P2086, DOI 10.1016/j.nucengdes.2011.03.028
   CURTIS WD, 1982, LINEAR ALGEBRA APPL, V47, P117, DOI 10.1016/0024-3795(82)90229-4
   Deen N., 2010, BUBBLE COLUMNS
   Degaleesan S, 2001, AICHE J, V47, P1913, DOI 10.1002/aic.690470904
   Degaleesan S., 1997, THESIS
   DUDLEY J, 1995, WATER RES, V29, P1129, DOI 10.1016/0043-1354(94)00253-4
   Dudukovic M.P., 1984, CHEM CATALYTIC REACT
   Fischer F, 2010, NUCL ENG DES, V240, P2254, DOI 10.1016/j.nucengdes.2009.11.016
   Fischer F, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/9/094002
   Gandhi AB, 2009, IND ENG CHEM RES, V48, P4216, DOI 10.1021/ie8003489
   GEARY NW, 1991, AICHE J, V37, P161, DOI 10.1002/aic.690370202
   Gotz M, 2017, CHEM ENG J, V308, P1209, DOI 10.1016/j.cej.2016.09.101
   HIKITA H, 1980, CHEM ENG J BIOCH ENG, V20, P59, DOI 10.1016/0300-9467(80)85006-4
   Hooshyar N, 2010, CAN J CHEM ENG, V88, P533, DOI 10.1002/cjce.20338
   HUGHMARK GA, 1967, IND ENG CHEM PROC DD, V6, P218, DOI 10.1021/i260022a011
   Jamialahmadi M, 2000, CHEM ENG TECHNOL, V23, P919, DOI 10.1002/1521-4125(200010)23:10<919::AID-CEAT919>3.0.CO;2-R
   JAMIALAHMADI M, 1992, CHEM ENG J BIOCH ENG, V50, P47, DOI 10.1016/0300-9467(92)80005-U
   Kalaga DV, 2017, CHEM ENG SCI, V170, P332, DOI 10.1016/j.ces.2017.02.022
   Kantarci N, 2005, PROCESS BIOCHEM, V40, P2263, DOI 10.1016/j.procbio.2004.10.004
   KAWASE Y, 1992, CHEM ENG J BIOCH ENG, V50, P1, DOI 10.1016/0300-9467(92)80001-Q
   Krishna R, 1996, AICHE J, V42, P2627, DOI 10.1002/aic.690420923
   KRISHNA R, 1991, CHEM ENG SCI, V46, P2491, DOI 10.1016/0009-2509(91)80042-W
   KUMAR A, 1976, CAN J CHEM ENG, V54, P503
   Kumar SB, 1997, AICHE J, V43, P1414, DOI 10.1002/aic.690430605
   LEIBSON I, 1956, AICHE J, V2, P296, DOI 10.1002/aic.690020305
   Letzel HM, 1999, CHEM ENG SCI, V54, P2237, DOI 10.1016/S0009-2509(98)00418-7
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Liao YX, 2010, CHEM ENG SCI, V65, P2851, DOI 10.1016/j.ces.2010.02.020
   Liao YX, 2009, CHEM ENG SCI, V64, P3389, DOI 10.1016/j.ces.2009.04.026
   Luo XK, 1999, AICHE J, V45, P665, DOI 10.1002/aic.690450402
   MILLER DN, 1974, AICHE J, V20, P445, DOI 10.1002/aic.690200303
   Moo-Young M, 1981, ADV BIOCHEM ENG, V19, P1, DOI DOI 10.1007/3-540-10464-X_16
   Nedeltchev S, 2008, J CHEM ENG JPN, V41, P744, DOI 10.1252/jcej.08we005
   Nottenkaemper R., 1983, GER CHEM ENG, V6, P147
   Polli M, 2002, CHEM ENG SCI, V57, P197, DOI 10.1016/S0009-2509(01)00301-3
   REILLY IG, 1986, CAN J CHEM ENG, V64, P705, DOI 10.1002/cjce.5450640501
   Riquarts H.P, 1981, GER CHEM ENG, V4, P18
   Roy S, 2002, APPL RADIAT ISOTOPES, V56, P485, DOI 10.1016/S0969-8043(01)00142-7
   Sal S, 2013, CHEM ENG PROCESS, V70, P259, DOI 10.1016/j.cep.2013.03.012
   Schafer R, 2002, EXP THERM FLUID SCI, V26, P595, DOI 10.1016/S0894-1777(02)00189-9
   SHAH YT, 1982, AICHE J, V28, P353, DOI 10.1002/aic.690280302
   Shimada N, 2012, J CHEM ENG JPN, V45, P632, DOI 10.1252/jcej.12we021
   Sommerfeld M, 2009, IND ENG CHEM RES, V48, P330, DOI 10.1021/ie800838u
   TSUGE H, 1978, J CHEM ENG JPN, V11, P173, DOI 10.1252/jcej.11.173
   UEYAMA K, 1979, AICHE J, V25, P258, DOI 10.1002/aic.690250207
   Upadhyay RK, 2013, CHEM ENG SCI, V96, P152, DOI 10.1016/j.ces.2013.03.045
   WALTER JF, 1983, CHEM ENG COMMUN, V19, P243, DOI 10.1080/00986448308956344
   WILKINSON PM, 1994, CHEM ENG SCI, V49, P1417, DOI 10.1016/0009-2509(93)E0022-5
   WILKINSON PM, 1990, CHEM ENG SCI, V45, P2309, DOI 10.1016/0009-2509(90)80110-Z
   Wu CT, 2008, AICHE J, V54, P1203, DOI 10.1002/aic.11459
   Wu YX, 2001, CHEM ENG SCI, V56, P1127, DOI 10.1016/S0009-2509(00)00330-4
   Wu YX, 2001, CHEM ENG SCI, V56, P1207, DOI 10.1016/S0009-2509(00)00341-9
   Yadav A, 2017, AICHE J, V63, P2850, DOI 10.1002/aic.15596
   Zehner P., 1982, VERFAHRENSTECHNIK MA, V16, P347
NR 59
TC 0
Z9 0
U1 3
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115099
DI 10.1016/j.ces.2019.07.017
PG 19
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900003
DA 2020-05-12
ER

PT J
AU Bartsch, C
   Wiedmeyer, V
   Lakdawala, Z
   Patterson, RIA
   Voigt, A
   Sundmacher, K
   John, V
AF Bartsch, Clemens
   Wiedmeyer, Viktoria
   Lakdawala, Zahra
   Patterson, Robert I. A.
   Voigt, Andreas
   Sundmacher, Kai
   John, Volker
TI Stochastic-deterministic population balance modeling and simulation of a
   fluidized bed crystallizer experiment
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fluidized bed crystallizer; Potassium aluminum sulfate dodecahydrate;
   Agglomeration; Population balance system; Stochastic-deterministic
   simulation method; Size separation
ID IDENTIFICATION
AB The crystallization of potassium aluminum sulfate dodecahydrate (potash alum) in a fluidized bed crystallizer is studied both with experiments and simulations. A population balance system with three spatial coordinates and one internal coordinate (mass) is utilized as our model. The simulations are performed with a stochastic-deterministic method with novel extensions, where the fluid dynamics of the crystallizer (flow field, temperature, concentration) are solved deterministically and the particles are simulated with a stochastic method. In experiments of 30 min duration, the average crystal diameter increases by growth and agglomeration from about 130 mu m to 210 mu m. This observation agrees qualitatively well with our simulation results. A quantitative difference between simulation and experiment leaves room for future improvements in modeling. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bartsch, Clemens; Lakdawala, Zahra; Patterson, Robert I. A.; John, Volker] Weierstrass Inst Appl Anal & Stochast WIAS, Mohrenstr 39, D-10117 Berlin, Germany.
   [Wiedmeyer, Viktoria] Swiss Fed Inst Technol, Inst Proc Engn, Sonneggstr 3, CH-8092 Zurich, Switzerland.
   [Voigt, Andreas; Sundmacher, Kai] Otto von Guericke Univ, Dept Proc Syst Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
   [Sundmacher, Kai] Max Planck Inst Dynam Complex Tech Syst, Proc Syst Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [John, Volker] Free Univ Berlin, Dept Math & Comp Sci, Arnimallee 6, D-14195 Berlin, Germany.
RP John, V (reprint author), Weierstrass Inst Appl Anal & Stochast WIAS, Mohrenstr 39, D-10117 Berlin, Germany.
EM bartsch@wias-berlin.de; wiedmeyv@ipe.mavt.ethz.ch;
   lakdawala@wias-berlin.de; patterson@wias-berlin.de;
   andreas.voigt@ovgu.de; sundmacher@mpi-magdeburg.mpg.de;
   John@wias-berlin.de
FU DFG priority programme 1679: Dynamic simulation of interconnected solid
   processes [Jo329/10-3, SU189/6-3]; Deutsche Forschungsgemeinschaft
   (DFG)German Research Foundation (DFG) [CRC 1114]
FX The work of V. John and K. Sundmacher was supported by grants Jo329/10-3
   and SU189/6-3 within the DFG priority programme 1679: Dynamic simulation
   of interconnected solid processes. R. Patterson has been partially
   supported by the Deutsche Forschungsgemeinschaft (DFG) through grant CRC
   1114 "Scaling Cascades in Complex Systems", Project C08. We would also
   like to acknowledge the support of Hang Si for assisting in the mesh
   generation using TETGEN.
CR Ahmed N, 2018, COMPUT METHOD APPL M, V331, P492, DOI 10.1016/j.cma.2017.12.004
   Anker F, 2015, COMPUT CHEM ENG, V75, P95, DOI 10.1016/j.compchemeng.2015.01.010
   Bartsch C., 2018, THESIS
   Bartsch C, 2019, COMPUT CHEM ENG, V124, P350, DOI 10.1016/j.compchemeng.2019.01.012
   Beckmann W., 2013, CRYSTALLIZATION BASI
   Berg HC, 1983, RANDOM WALKS BIOL
   Binev D., 2015, THESIS
   Boettcher R, 2017, INT J SOLIDS STRUCT, V106, P229, DOI 10.1016/j.ijsolstr.2016.11.016
   Borchert C, 2014, CRYST GROWTH DES, V14, P952, DOI 10.1021/cg401098x
   Celnik M, 2007, COMBUST FLAME, V148, P158, DOI 10.1016/j.combustflame.2006.10.007
   Davis TA, 2004, ACM T MATH SOFTWARE, V30, P196, DOI 10.1145/992200.992206
   Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04
   Ganesan S, 2016, 2016 23RD IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING WORKSHOPS (HIPCW 2016), P106, DOI [10.1109/HiPCW.2016.023, 10.1109/HiPCW.2016.19]
   Garcia-Gutierrez LM, 2017, CHEM ENG J, V321, P175, DOI 10.1016/j.cej.2017.03.109
   HOFFMANN AC, 1993, CHEM ENG SCI, V48, P1583, DOI 10.1016/0009-2509(93)80118-A
   Howley MA, 2002, CHEM ENG SCI, V57, P4209
   John V, 2012, J COMPUT PHYS, V231, P1570, DOI 10.1016/j.jcp.2011.10.025
   John V, 2008, COMPUT METHOD APPL M, V198, P475, DOI 10.1016/j.cma.2008.08.016
   Kerst K, 2017, CHEM ENG SCI, V165, P1, DOI 10.1016/j.ces.2017.01.068
   Kuzmin D, 2009, J COMPUT PHYS, V228, P2517, DOI 10.1016/j.jcp.2008.12.011
   Lewis A., 2015, IND CRYSTALLIZATION
   Lin WG, 2003, CHEM ENG J, V96, P171, DOI 10.1016/j.cej.2003.08.008
   NIENOW AW, 1980, T I CHEM ENG-LOND, V58, P181
   Park GI, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.044301
   Patterson RIA, 2011, J COMPUT PHYS, V230, P7456, DOI 10.1016/j.jcp.2011.06.011
   RUBINO SM, 2016, SPRINGER SERIES COMP, V57
   Russell A, 2014, AICHE J, V60, P4037, DOI 10.1002/aic.14572
   SAAD Y, 1993, SIAM J SCI COMPUT, V14, P461, DOI 10.1137/0914028
   Sander M, 2011, P COMBUST INST, V33, P675, DOI 10.1016/j.proci.2010.06.156
   Seckler MM, 1996, WATER RES, V30, P1585, DOI 10.1016/0043-1354(96)00018-8
   Shekar S, 2012, J AEROSOL SCI, V44, P83, DOI 10.1016/j.jaerosci.2011.09.004
   Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697
   Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)091, 10.1175/1520-0493(1963)091<less than>0099:GCEWTP<greater than>2.3.CO;2]
   Tavare N.S., 1995, PLENUM CHEM ENG SERI
   Temmel E, 2016, CRYST GROWTH DES, V16, P6743, DOI 10.1021/acs.cgd.6b00787
   Wilbrandt U, 2017, COMPUT MATH APPL, V74, P74, DOI 10.1016/j.camwa.2016.12.020
   Zhang Y, 2009, INT J CHEM REACT ENG, V7
NR 37
TC 0
Z9 0
U1 8
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115102
DI 10.1016/j.ces.2019.07.020
PG 14
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900004
DA 2020-05-12
ER

PT J
AU Beigi, BHM
   Thorpe, RB
   Ouki, S
   Winter, P
   Waalkens, A
AF Beigi, B. H. M.
   Thorpe, R. B.
   Ouki, S.
   Winter, P.
   Waalkens, A.
TI Hydrogen sulphide and VOC removal in biotrickling filters: Comparison of
   data from a full-scale, low-emission unit with kinetic models
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Biotrickling Filter; Biofiltration; H2S; VOC; Model; Odour
ID ORGANIC-COMPOUNDS; EXPANDED SCHIST; WASTE GASES; ODOR; BIOFILTRATION;
   H2S; BIOTREATMENT; VOLATILE
AB In this paper, data is published on the removal of H2S and VOCs by a biotrickling filter (BTF) demonstration plant, namely a SULPHUS (TM), which was installed by Thames Water in late 2015. These data, along with some data already published by Sempere et al. (2018), were compared to the predictions of a number of existing and novel models for the removal of a single pollutant by a biofilm.
   The two widely used models of Ottengraf and van den Oever (1983) were found to be inadequate with sum of squares of errors of 11 and 41 mg(2) m(-6) respectively. These models are based on zero-order kinetics in the biofilm which according to the M-M kinetic model, are likely to be inaccurate at low pollutant concentration. The odour control unit was designed to produce low emission levels of less than 1 mg m(-3) of H2S, rendering the zero-order assumption unlikely to be accurate. A model based on first-order kinetics, which also has some support in the literature, was found to be a better, but not a good, fit to the data with a sum of squares of errors of 4.7 mg(2) m(-6). A novel model for the BTF based on M-M kinetics was found to be a good fit to the shape of the data with the lowest sum of squares of errors of 2.5 mg(2) m(-6). This novel M-M model was also identified as the best fit for VOC data from the same unit. Other publications support the M-M approach with a product of saturation constant and Henry's Law constant of about 50 mg m(-3), which is equivalent to an H2S level in the gas phase of about 40 ppmv. Broad agreement was found between the SULPHUS (TM) experiments and data in the literature for other BTFs destroying H2S under the zero-order regime, at V-max value of about 0.3 g/m(3)/s. This paper represents an attempt to harmonise a literature that was previously disparate, which has not previously been attempted. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Beigi, B. H. M.; Thorpe, R. B.; Ouki, S.] Univ Surrey, Dept Chem & Proc Engn, Guildford GU2 7XH, Surrey, England.
   [Winter, P.] Thames Water, Innovat Ctr, Reading RG2 0RP, Berks, England.
   [Waalkens, A.] Pure Air Solut, POB 135, NL-8440 AC Heerenveen, Netherlands.
RP Beigi, BHM; Thorpe, RB (reprint author), Univ Surrey, Dept Chem & Proc Engn, Guildford GU2 7XH, Surrey, England.
EM behzad_hmb@hotmail.co.uk; rex.thorpe@surrey.ac.uk
FU Thames Water Ltd; Pure Air Solutions; EPSRCEngineering & Physical
   Sciences Research Council (EPSRC) [EP/G037612]
FX The views expressed in the paper are those of the authors and not
   necessarily those of Thames Water. The authors gratefully acknowledge
   the support and funding of Thames Water Ltd, Pure Air Solutions and the
   EPSRC (grant number EP/G037612, provided via the SEES doctoral training
   programme based at the University of Surrey Centre for the Environment
   and Sustainability. They would also like to thank F. Sempere and I.
   Cranshaw for their support during the SULPHUS (TM) trials that led this
   paper.
CR Alfonsin C, 2015, J ENVIRON MANAGE, V149, P77, DOI 10.1016/j.jenvman.2014.10.011
   AZI, 2014, JER 631 X HYDR SULF
   BAILEY J, 1986, BIOCH ENG FUNDAMENTA
   Ben Jaber M, 2016, BIOCHEM ENG J, V112, P153, DOI 10.1016/j.bej.2016.04.020
   Chung YC, 2000, CHEMOSPHERE, V41, P329, DOI 10.1016/S0045-6535(99)00490-7
   Courtois A, 2015, J CHEM TECHNOL BIOT, V90, P50, DOI 10.1002/jctb.4456
   Coy JD, 2000, AM IND HYG ASSOC J, V61, P268, DOI 10.1080/15298660008984536
   Deshusses MA, 1997, CURR OPIN BIOTECH, V8, P335, DOI 10.1016/S0958-1669(97)80013-4
   Dincer F, 2008, J ENVIRON SCI HEAL A, V43, P1569, DOI 10.1080/10934520802293776
   Dumont E, 2017, J ENVIRON CHEM ENG, V5, P2668, DOI 10.1016/j.jece.2017.05.022
   Estrada JM, 2012, BIOTECHNOL ADV, V30, P1354, DOI 10.1016/j.biotechadv.2012.02.010
   Estrada JM, 2011, ENVIRON SCI TECHNOL, V45, P1100, DOI 10.1021/es103478j
   Fan J, 2009, ENVIRON TECHNOL, V30, P641, DOI 10.1080/09593330902850408
   Frederickson J., 2013, EVIDENCE BIOFILTER P
   Gabriel D, 2004, WATER SCI TECHNOL, V50, P309
   Ghorbani M, 2011, ENVIRON TECHNOL, V32, P1923, DOI 10.1080/09593330.2011.568974
   HAIMOUR N, 1984, J CHEM ENG DATA, V29, P20, DOI 10.1021/je00035a009
   Haji Mirza Beigi B., 2019, THESIS
   Henri V., 1903, LOIS GEN ACTION DIAS
   HIRAI M, 1990, J FERMENT BIOENG, V70, P334, DOI 10.1016/0922-338X(90)90145-M
   Kennes C, 1998, J CHEM TECHNOL BIOT, V72, P303
   Kim S, 2003, ENVIRON PROG, V22, P119, DOI 10.1002/ep.670220214
   Kotowska U, 2012, ENVIRON MONIT ASSESS, V184, P2893, DOI 10.1007/s10661-011-2158-8
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Mathur AK, 2008, J HAZARD MATER, V152, P1027, DOI 10.1016/j.jhazmat.2007.07.112
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   Morgan-Sagastume JM, 2003, J AIR WASTE MANAGE, V53, P1011, DOI 10.1080/10473289.2003.10466249
   Onda K., 1968, J CHEM ENG JPN, V1, P56, DOI DOI 10.1252/JCEJ.1.56
   OTTENGRAF SPP, 1983, BIOTECHNOL BIOENG, V25, P3089, DOI 10.1002/bit.260251222
   Ottengraf SPP, 1986, BIOTECHNOLOGY, V8, P425
   Perry R.H., 1997, PERRYS CHEM ENG HDB
   RAE Systems, 2018, GUID PID INSTR RESP
   Rahul, 2013, BIORESOURCE TECHNOL, V142, P9, DOI 10.1016/j.biortech.2013.05.005
   Hernandez ACR, 2013, NEW BIOTECHNOL, V30, P210, DOI 10.1016/j.nbt.2012.07.003
   Schafer P.L., 1995, WATER ENV FEDERAT, V22
   Schoonhoven A., 2014, SULPHUS BIOL TREATME
   Sempere F., 2018, TREATMENT DISCONTINU, P2482
   Sinnott R.K., 2009, CHEM ENG DESIGN
   Sivil D, 2009, WATER SCI TECHNOL, V59, P1377, DOI 10.2166/wst.2009.109
   Stuetz R.M., 2001, ODOURS WASTEWATER TR
   Van Harreveld A.P., 2007, 2 INT C BIOT AIR POL
   Vincent A., 1998, CIWEM MONOGRAPHS BES, P31
   Vinegar E., 1984, INFORM EXCHANGE GAS, V1
   YANG YH, 1994, J AIR WASTE MANAGE, V44, P1315, DOI 10.1080/10473289.1994.10467328
   Zarra T, 2008, WATER SCI TECHNOL, V58, P89, DOI 10.2166/wst.2008.330
   Zarra T., 2008, CHEM ENG T, V15, P63
NR 46
TC 0
Z9 0
U1 57
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115033
DI 10.1016/j.ces.2019.06.012
PG 18
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900002
DA 2020-05-12
ER

PT J
AU Boyce, CM
   Penn, A
   Lehnert, M
   Pruessmann, KP
   Muller, CR
AF Boyce, C. M.
   Penn, A.
   Lehnert, M.
   Pruessmann, K. P.
   Mueller, C. R.
TI Magnetic resonance imaging of interaction and coalescence of two bubbles
   injected consecutively into an incipiently fluidized bed
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fluidization; Bubbles; Coalescence; Magnetic resonance imaging
ID SOLIDS MOTION; GAS; EQUATIONS
AB Rapid magnetic resonance imaging (MRI) was used to visualize and quantify the interaction of two bubbles injected into an incipiently fluidized bed. The particle size, bubble sizes and the vertical and horizontal separations between bubbles were varied to understand their effects on bubble behavior. Image analysis quantified the size, shape and position of the bubbles over time. Bubbles were found to either (a) coalesce, (b) influence one another without coalescing or (c) have a collapse of a lower bubble due to influence from the upper bubble. In all cases, the lower bubbles were much more influenced in their rise by the upper bubbles than vice-versa, as lower bubbles accelerated toward the wakes of upper bubbles. Upper bubbles developed spherical cap shapes, while lower bubbles elongated vertically elongated as they rose. The experimental data provided here will serve as excellent benchmarks to challenge the assumptions made in computational and theoretical models. (C) 2019 Published by Elsevier Ltd.
C1 [Boyce, C. M.; Penn, A.; Lehnert, M.; Mueller, C. R.] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Zurich, Switzerland.
   [Boyce, C. M.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   [Penn, A.; Pruessmann, K. P.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland.
   [Penn, A.; Pruessmann, K. P.] Univ Zurich, Zurich, Switzerland.
RP Boyce, CM (reprint author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
EM cmb2302@columbia.edu
RI Penn, Alexander/E-9692-2013; Muller, Christoph R/J-6025-2016
OI Penn, Alexander/0000-0001-5596-6310; Muller, Christoph
   R/0000-0003-2234-6902
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200020_182692]
FX This work was supported by the Swiss National Science Foundation under
   grant number 200020_182692.
CR Boyce CM, 2019, PHYS REV FLUIDS, V4, DOI 10.1103/PhysRevFluids.4.034303
   Boyce CM, 2019, CHEM ENG SCI, V200, P147, DOI 10.1016/j.ces.2019.01.047
   Boyce CM, 2019, POWDER TECHNOL, V343, P813, DOI 10.1016/j.powtec.2018.11.091
   Boyce CM, 2018, AICHE J, V64, P2958, DOI 10.1002/aic.16036
   Boyce CM, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.074201
   Boyce CM, 2014, CHEM ENG SCI, V116, P611, DOI 10.1016/j.ces.2014.05.041
   Boyce C.M., 2019, POWDER TECHNOL
   Boyce CM, 2015, IND ENG CHEM RES, V54, P10684, DOI 10.1021/acs.iecr.5b03186
   CALLAGHAN PT, 1991, PRINCIPLES NUCL MAGN
   Candela D, 2007, GRANUL MATTER, V9, P331, DOI 10.1007/s10035-007-0045-3
   CARAM HS, 1986, CHEM ENG SCI, V41, P1445, DOI 10.1016/0009-2509(86)85230-7
   CLIFT R, 1972, J FLUID MECH, V51, P187, DOI 10.1017/S0022112072001144
   CLIFT R, 1985, CONTINUOUS BUBBLING
   Davidson J.F., 1963, FLUIDISED PARTICLES
   DAVIES RM, 1950, PROC R SOC LON SER-A, V200, P375, DOI 10.1098/rspa.1950.0023
   de Korte RJ, 2001, AICHE J, V47, P851, DOI 10.1002/aic.690470409
   Fabich HT, 2016, J MAGN RESON, V273, P113, DOI 10.1016/j.jmr.2016.10.016
   Fischer F, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/9/094002
   GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3
   GRACE JR, 1970, CAN J CHEM ENG, V48, P30, DOI 10.1002/cjce.5450480106
   HALOW JS, 1992, POWDER TECHNOL, V69, P255, DOI 10.1016/0032-5910(92)80017-Q
   Hoffmann M, 2007, STUD CLASS DATA ANAL, P75, DOI 10.1007/978-3-540-70981-7_9
   HORIO M, 1987, AICHE J, V33, P1865, DOI 10.1002/aic.690331113
   Huan C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041302
   Lasic S, 2006, EUROPHYS LETT, V75, P887, DOI 10.1209/epl/i2006-10193-6
   Lim EWC, 2007, IND ENG CHEM RES, V46, P1375, DOI 10.1021/ie060864e
   Mudde RF, 2010, POWDER TECHNOL, V199, P55, DOI 10.1016/j.powtec.2009.04.021
   Muller CR, 2007, IND ENG CHEM RES, V46, P1642, DOI 10.1021/ie0611397
   Muller CR, 2007, CHEM ENG SCI, V62, P82, DOI 10.1016/j.ces.2006.08.019
   Muller CR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154504
   MURRAY JD, 1965, J FLUID MECH, V21, P465, DOI 10.1017/S0022112065000277
   Olaofe OO, 2011, CHEM ENG SCI, V66, P2764, DOI 10.1016/j.ces.2011.03.030
   PARKER DJ, 1993, NUCL INSTRUM METH A, V326, P592, DOI 10.1016/0168-9002(93)90864-E
   Pavlin T, 2007, APPL MAGN RESON, V32, P93, DOI 10.1007/s00723-007-0002-7
   Penn A, 2018, IND ENG CHEM RES, V57, P9674, DOI 10.1021/acs.iecr.8b00932
   Penn A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701879
   ROWE PN, 1971, CHEM ENG SCI, V26, P923, DOI 10.1016/0009-2509(71)83052-X
   Santana D, 2005, POWDER TECHNOL, V150, P1, DOI 10.1016/j.powtec.2004.11.013
   Savelsberg R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.020301
   SINGH B, 1972, POWDER TECHNOL, V6, P239, DOI 10.1016/0032-5910(72)83018-3
   SIT SP, 1981, CHEM ENG SCI, V36, P327, DOI 10.1016/0009-2509(81)85012-9
   STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560
NR 42
TC 1
Z9 1
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115152
DI 10.1016/j.ces.2019.08.010
PG 19
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900024
DA 2020-05-12
ER

PT J
AU Chen, Q
   Pan, DW
   Qi, XB
   Liu, XD
   Li, B
AF Chen, Qiang
   Pan, Dawei
   Qi, Xiaobo
   Liu, Xiangdong
   Li, Bo
TI Controlled fabrication of solid-shelled capsules with designed geometry
   sphericity
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Microfluidic; Microencapsulation; W1-O-W2 double droplets; Solid-shelled
   capsules; Deformation
ID INTERFACIAL POLYMERIZATION; MICROENCAPSULATION; SIMULATION; PARTICLES;
   EMULSIONS
AB The high degree of control afforded by microfluidic techniques enables the generation of monodisperse water-in-oil-in-water (W1-O-W2) double droplets, which are transformed to solid-shelled capsules through solvent-evaporation-based microencapsulation. Experimental investigations and numerical simulations are combined to explore the developments for controlled fabrication of solid-shelled capsules with designed geometry sphericity. The designed geometry sphericity arises from the competition between solidification and shear stress generated by the shear flow field. An increasing viscosity of continuous phase resists the solidification, which contributes to improve the sphericity of the solid-shelled capsules, but intensifies the shear stress of the flow filed, which promotes the deformation of the droplets. Therefore, the continuous phase viscosity exerts a parabolic effect on the deformation of double droplets and the sphericity of the resulting capsules. Accordingly, spherical and non-spherical such as oval and ellipsoid jujube core like solid-shelled capsules can be obtained by controlling the viscosity of the shear flow field. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Chen, Qiang; Pan, Dawei; Qi, Xiaobo; Li, Bo] China Acad Engn Phys, Laser Fus Res Ctr, Mianyang 621900, Sichuan, Peoples R China.
   [Chen, Qiang] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.
   [Liu, Xiangdong] Yangzhou Univ, Coll Elect Energy & Power Engn, Yangzhou 225127, Jiangsu, Peoples R China.
RP Li, B (reprint author), China Acad Engn Phys, Laser Fus Res Ctr, Mianyang 621900, Sichuan, Peoples R China.; Liu, XD (reprint author), Yangzhou Univ, Coll Elect Energy & Power Engn, Yangzhou 225127, Jiangsu, Peoples R China.
EM liuxd@yzu.edu.cn; lb67.11@163.com
FU NSAF Foundation [U1530260]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [51876184]; Natural
   Science Foundation of Jiangsu ProvinceJiangsu Planned Projects for
   Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20180102]; Six-talent Peak Project of Jiangsu Province
   [JNHB-074]
FX This work is supported by the NSAF Foundation [No. U1530260], National
   Natural Science Foundation of China [No. 51876184], Natural Science
   Foundation of Jiangsu Province [No. BK20180102] and Six-talent Peak
   Project of Jiangsu Province [No. JNHB-074].
CR Arpagaus C., 2018, INT J PHARM
   AUTON TR, 1988, J FLUID MECH, V197, P241, DOI 10.1017/S0022112088003246
   Bhandarkar S, 2016, FUSION SCI TECHNOL, V70, P127, DOI 10.13182/FST15-245
   Chen Q, 2019, COLLOID SURFACE A, V563, P350, DOI 10.1016/j.colsurfa.2018.12.011
   Chen Q, 2018, COLLOID SURFACE A, V554, P1, DOI 10.1016/j.colsurfa.2018.06.004
   Chen Q, 2018, RSC ADV, V8, P3687, DOI 10.1039/c7ra09799a
   Chen YP, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4916623
   Chen YP, 2015, LAB CHIP, V15, P1255, DOI 10.1039/c4lc01231c
   Chen YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141159
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Dallas P, 2007, POLYMER, V48, P2007, DOI 10.1016/j.polymer.2007.01.058
   Datta SS, 2014, ADV MATER, V26, P2205, DOI 10.1002/adma.201305119
   Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949
   Gupta S, 2006, NANO LETT, V6, P2066, DOI 10.1021/nl061336v
   Hwang DK, 2008, LAB CHIP, V8, P1640, DOI 10.1039/b805176c
   Lee TY, 2016, LAB CHIP, V16, P3415, DOI 10.1039/c6lc00809g
   [梁丰收 Liang Fengshou], 2018, [高分子材料科学与工程, Polymer Materials Science & Engineering], V34, P150
   Liu MF, 2017, NUCL FUSION, V56, DOI 10.1088/0029-5515/57/1/016018
   Liu MF, 2014, CHEM ENG J, V241, P466, DOI 10.1016/j.cej.2013.08.120
   Moreau L, 2009, LASER PART BEAMS, V27, P537, DOI 10.1017/S0263034609000317
   Paulo F, 2017, MAT SCI ENG C-MATER, V77, P1327, DOI 10.1016/j.msec.2017.03.219
   Pozzetti G, 2018, INT J MULTIPHAS FLOW, V99, P186, DOI 10.1016/j.ijmultiphaseflow.2017.10.008
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Shang LR, 2017, CHEM REV, V117, P7964, DOI 10.1021/acs.chemrev.6b00848
   Shao T, 2013, CHEM ENG SCI, V104, P55, DOI 10.1016/j.ces.2013.09.001
   Shum HC, 2010, MACROMOL RAPID COMM, V31, P108, DOI 10.1002/marc.200900590
   Tucker-Schwartz AK, 2010, LANGMUIR, V26, P18606, DOI 10.1021/la103719z
   Wang ZF, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.066402
   YAMAMOTO S, 1994, J CHEM PHYS, V100, P3317, DOI 10.1063/1.466423
   Yang YP, 2017, EXP BIOL MED, V242, P286, DOI 10.1177/1535370216673746
   Zhang FL, 2016, CHEM ENG J, V303, P48, DOI 10.1016/j.cej.2016.05.145
   Zhao YJ, 2015, SMALL, V11, P151, DOI 10.1002/smll.201401600
   Zuo J., 2017, ADV POWDER TECHNOL, V28
NR 34
TC 0
Z9 0
U1 10
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115153
DI 10.1016/j.ces.2019.08.011
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900025
DA 2020-05-12
ER

PT J
AU Donaubauer, PJ
   Schmalhorst, L
   Hinrichsen, O
AF Donaubauer, Philipp J.
   Schmalhorst, Leonhard
   Hinrichsen, Olaf
TI 2D flow fields in fixed-bed reactor design: a robust methodology for
   continuum models
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fixed-bed reactor; Continuum model; Fluid flow; Inlet boundary
   condition; Radial porosity profile
ID HEAT-TRANSFER; FLUID-FLOW; BOUNDARY-CONDITIONS; CHEMICAL-REACTION; CFD
   SIMULATIONS; PACKED-BEDS; MASS; TRANSPORT; CATALYST; COEFFICIENTS
AB In combination with computationally demanding, but steadily developing discrete particle simulation techniques, new areas of application for the fixed-bed continuum models, like in silico determination of transport parameters, become accessible. Within this study, we present a pseudo-homogeneous continuum model fully accounting for 2D fluid flow, heat and species dispersion in axial and radial direction and apply it to four configurations of packed beds. Application of different discretization techniques for fluid flow as well as heat and species transport provide an efficient and robust solution strategy. Beds of ideal spheres exhibited deviating conversion behavior due to strong oscillation in the radial flow profile. Moreover, the importance of adequate coupling of fluid flow and chemical reaction is highlighted by a variation of reaction stoichiometry. This theoretical evaluation of the continuum approach provides valuable insights on the interplay of fluid flow and chemical reaction in fixed-bed reactors. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hinrichsen, Olaf] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany.
   Tech Univ Munich, Catalysis Res Ctr, Ernst Otto Fischer Str 1, D-85748 Garching, Germany.
RP Hinrichsen, O (reprint author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany.
EM olaf.hinrichsen@ch.tum.de
FU Bavarian Ministry of Economic Affairs, Energy and Technology
   [47-3665g/1075/1-NW-1501-0003]; TUM Graduate School
FX We gratefully acknowledge the financial support of the Bavarian Ministry
   of Economic Affairs, Energy and Technology (Project number:
   47-3665g/1075/1-NW-1501-0003) and the fruitful environment within the
   framework of MuniCat. P. Donaubauer is thankful for support from TUM
   Graduate School.
CR BAUER R, 1978, INT CHEM ENG, V18, P189
   Bauer R., 1977, VDI FORSCHUNGSHEFTE, V582
   Behnam M, 2013, IND ENG CHEM RES, V52, P15244, DOI 10.1021/ie4000568
   Bey O, 1997, CHEM ENG SCI, V52, P1365, DOI 10.1016/S0009-2509(96)00509-X
   CAREY GF, 1975, CHEM ENG SCI, V30, P587, DOI 10.1016/0009-2509(75)80031-5
   Che-Galicia G, 2015, CHEM ENG J, V280, P682, DOI 10.1016/j.cej.2015.05.128
   DANCKWERTS PV, 1953, CHEM ENG SCI, V2, P1, DOI 10.1016/0009-2509(53)80001-1
   Das S, 2017, CHEM ENG SCI, V160, P1, DOI 10.1016/j.ces.2016.11.008
   DASZKOWSKI T, 1992, CHEM ENG SCI, V47, P2245, DOI 10.1016/0009-2509(92)87042-O
   Dixon A.G., 2006, ADV CHEM ENG, P307, DOI [10.1016/S0065-2377(06) 31005-8., DOI 10.1016/S0065-2377(06)31005-8]
   Dixon AG, 2017, FLUIDS, V2, DOI 10.3390/fluids2040056
   Dixon AG, 2017, CHEM ENG SCI, V168, P156, DOI 10.1016/j.ces.2017.04.039
   Dixon AG, 2012, CAN J CHEM ENG, V90, P507, DOI 10.1002/cjce.21630
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   FAIRBANKS DF, 1950, IND ENG CHEM, V42, P471, DOI 10.1021/ie50483a022
   Ferziger J.H., 2002, COMPUTATIONAL METHOD, DOI [10.1007/978-3-642-56026-7, DOI 10.1007/978-3-642-56026-7]
   Finlayson B. A., 1980, Mathematics and Computers in Simulation, V22, P11, DOI 10.1016/0378-4754(80)90097-X
   Froment G. F., 2011, CHEM REACTOR ANAL DE
   FULLER EN, 1969, J PHYS CHEM-US, V73, P3679, DOI 10.1021/j100845a020
   FULLER EN, 1966, IND ENG CHEM, V58, P19, DOI 10.1021/ie50677a007
   Giese M, 1998, AICHE J, V44, P484, DOI 10.1002/aic.690440225
   Giese M, 1998, THESIS
   HAIDEGGER E, 1989, CHEM-ING-TECH, V61, P647, DOI 10.1002/cite.330610822
   Hamzah AB, 2019, CHEM ENG RES DES, V141, P93, DOI 10.1016/j.cherd.2018.10.022
   HEIN S, 1995, Z NATURFORSCH A, V50, P568, DOI 10.1515/zna-1995-0608
   Hlavacek V., 2014, ULLMANNS ENCY IND CH, DOI [10.1002/14356007.b04_121, DOI 10.1002/14356007.B04_121]
   Karthik GM, 2017, AICHE J, V63, P366, DOI 10.1002/aic.15542
   Kleiber M., 2013, VDI WARMEATLAS, V1, P137, DOI [10.1007/978-3-642-19981-3_11, DOI 10.1007/978-3-642-19981-3_11]
   Kleiber M., 2006, VDI WARMEATLAS, P103, DOI [10.1007/978-3-540-32218-4_10, DOI 10.1007/978-3-540-32218-4_10]
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   MARTIN H, 1980, CHEM-ING-TECH, V52, P199, DOI 10.1002/cite.330520303
   Maussner J, 2017, CHEM ENG SCI, V171, P495, DOI 10.1016/j.ces.2017.06.005
   Nijemeisland M, 2001, CHEM ENG J, V82, P231, DOI 10.1016/S1385-8947(00)00360-0
   NOVY RA, 1990, CHEM ENG SCI, V45, P1515, DOI 10.1016/0009-2509(90)80003-W
   Partopour B, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.08.124
   Partopour B, 2018, CAN J CHEM ENG, V96, P1946, DOI 10.1002/cjce.23130
   Partopour B, 2016, COMPUT CHEM ENG, V88, P126, DOI 10.1016/j.compchemeng.2016.02.015
   Reimann J, 2017, POWDER TECHNOL, V318, P471, DOI 10.1016/j.powtec.2017.05.033
   SALMI T, 1995, CHEM ENG PROCESS, V34, P359, DOI 10.1016/0255-2701(94)00531-1
   Schlereth D, 2014, CHEM ENG RES DES, V92, P702, DOI 10.1016/j.cherd.2013.11.014
   Tsotsas E., 2013, VDI WARMEATLAS M, V6, P1499, DOI [10.1007/978-3-642-19981-3_x, DOI 10.1007/978-3-642-19981-3_X]
   Tsotsas E., 2013, VDI WARMEATLAS, P1517, DOI [10.1007/978-3-642-19981-3_102, DOI 10.1007/978-3-642-19981-3_102]
   VORTMEYER D, 1983, CHEM ENG SCI, V38, P1691, DOI 10.1016/0009-2509(83)85026-X
   Wehinger GD, 2015, CHEM ENG SCI, V122, P197, DOI 10.1016/j.ces.2014.09.007
   WEHNER JF, 1956, CHEM ENG SCI, V6, P89, DOI 10.1016/0009-2509(56)80014-6
   Winterberg M, 2000, CHEM ENG SCI, V55, P967, DOI 10.1016/S0009-2509(99)00379-6
   Winterberg M, 2000, CHEM ENG SCI, V55, P5937, DOI 10.1016/S0009-2509(00)00198-6
   ZEHNER P, 1972, CHEM-ING-TECH, V44, P1303, DOI 10.1002/cite.330442305
   Zhang MH, 2018, CHEM ENG RES DES, V132, P149, DOI 10.1016/j.cherd.2018.01.006
   ZOU RP, 1995, CHEM ENG SCI, V50, P1504, DOI 10.1016/0009-2509(94)00483-8
NR 50
TC 0
Z9 0
U1 5
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115137
DI 10.1016/j.ces.2019.07.055
PG 13
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900009
DA 2020-05-12
ER

PT J
AU Hakansson, A
AF Hakansson, Andreas
TI An analytical solution to the fixed pivot fragmentation population
   balance equation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Population balance equation; Population balance model; Emulsification;
   Fragmentation; Break-up
ID DROP SIZE DISTRIBUTIONS; THEORETICAL-MODEL; QUADRATURE METHOD; BUBBLE
   BREAKUP; TURBULENT; EMULSIFICATION; COALESCENCE; AGGREGATION;
   PREDICTION; PRESSURE
AB Drop breakup in high-energy emulsification is often modelled using a population balance equation (PBE) framework. For cases with high emulsifier to disperse phase concentration, the PBE is dominated by the fragmentation term. Since there are no analytical solutions to the continuous PBE for physically reasonable fragmentation rate expressions, a discretization is often needed to evaluate the PBE, turning it into a set of ordinary differential equations that can be solved numerically. The fixed pivot technique (Kumar and Ramkrishna, 1996) is one of the most often applied class discretization methods. This contribution suggests an analytical solution to the fixed pivot technique fragmentation equation, that can be used instead of the traditional numerical approach provided that the fragmentation rate is constant over time. The proposed solution compares favorably to two special cases where analytical solutions for the continuous PBE are available, and to two more realistic PBE emulsification problems (with varying fragmentation intensity and varying number of fragments formed per breakup), while offering a substantial reduction in computational time compared to the traditional approach of solving the discretized equations numerically. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hakansson, Andreas] Lund Univ, LTH, Dept Food Technol Engn & Nutr, Lund, Sweden.
RP Hakansson, A (reprint author), Lund Univ, LTH, Dept Food Technol Engn & Nutr, Lund, Sweden.
EM andreas.hakansson@food.lth.se
FU Swedish Research council (VR)Swedish Research Council [2018-03820]
FX This study was financed by the Swedish Research council (VR), grant
   number 2018-03820.
CR Andersson R, 2006, AICHE J, V52, P2031, DOI 10.1002/aic.10832
   Becker PJ, 2014, CHEM ENG SCI, V109, P326, DOI 10.1016/j.ces.2014.02.008
   COULALOGLOU CA, 1977, CHEM ENG SCI, V32, P1289, DOI 10.1016/0009-2509(77)85023-9
   Hakansson A, 2019, ANNU REV FOOD SCI T, V10, P239, DOI 10.1146/annurev-food-032818-121501
   Hakansson A, 2016, J FOOD ENG, V178, P47, DOI 10.1016/j.jfoodeng.2016.01.006
   Hakansson A, 2011, CHEM ENG SCI, V66, P1790, DOI 10.1016/j.ces.2011.01.026
   Hakansson A, 2009, CHEM ENG SCI, V64, P2915, DOI 10.1016/j.ces.2009.03.034
   Han LC, 2011, CHEM ENG SCI, V66, P766, DOI 10.1016/j.ces.2010.11.041
   Henry JVL, 2009, J COLLOID INTERF SCI, V338, P201, DOI 10.1016/j.jcis.2009.05.077
   Jafari SM, 2008, FOOD HYDROCOLLOID, V22, P1191, DOI 10.1016/j.foodhyd.2007.09.006
   Janssen JJM, 2014, CAN J CHEM ENG, V92, P198, DOI 10.1002/cjce.21942
   Kumar J, 2009, POWDER TECHNOL, V189, P218, DOI 10.1016/j.powtec.2008.04.014
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   Lasheras JC, 2002, INT J MULTIPHAS FLOW, V28, P247, DOI 10.1016/S0301-9322(01)00046-5
   Liao YX, 2009, CHEM ENG SCI, V64, P3389, DOI 10.1016/j.ces.2009.04.026
   Lobo L, 2002, J COLLOID INTERF SCI, V253, P409, DOI 10.1006/jcis.2002.8560
   Luo H, 1996, AICHE J, V42, P1225, DOI 10.1002/aic.690420505
   Maindarkar SN, 2015, COLLOID SURFACE A, V467, P18, DOI 10.1016/j.colsurfa.2014.11.032
   Marchisio DL, 2003, J COLLOID INTERF SCI, V258, P322, DOI 10.1016/S0021-9797(02)00054-1
   McGraw R, 1997, AEROSOL SCI TECH, V27, P255, DOI 10.1080/02786829708965471
   Mohan S, 1997, J COLLOID INTERF SCI, V192, P1, DOI 10.1006/jcis.1997.5012
   Mortensen HH, 2018, CHEM ENG RES DES, V130, P52, DOI 10.1016/j.cherd.2017.12.006
   Raikar NB, 2011, IND ENG CHEM RES, V50, P6089, DOI 10.1021/ie101818h
   Raikar NB, 2010, COLLOID SURFACE A, V361, P96, DOI 10.1016/j.colsurfa.2010.03.020
   Raikar NB, 2009, CHEM ENG SCI, V64, P2433, DOI 10.1016/j.ces.2009.01.062
   RAMKRISHNA D, 2000, POPULATION BALANCES
   REID KJ, 1965, CHEM ENG SCI, V20, P953, DOI 10.1016/0009-2509(65)80093-8
   Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424
   Solsvik J, 2016, CHEM ENG SCI, V149, P249, DOI 10.1016/j.ces.2016.04.037
   Taisne L, 1996, J COLLOID INTERF SCI, V184, P378, DOI 10.1006/jcis.1996.0632
   Vankova N, 2007, J COLLOID INTERF SCI, V313, P612, DOI 10.1016/j.jcis.2007.04.064
   Walstra P, 2005, FUNDAMENTALS INTERFA
   ZIFF RM, 1991, J PHYS A-MATH GEN, V24, P2821, DOI 10.1088/0305-4470/24/12/020
   ZIFF RM, 1985, J PHYS A-MATH GEN, V18, P3027, DOI 10.1088/0305-4470/18/15/026
NR 34
TC 0
Z9 0
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115150
DI 10.1016/j.ces.2019.08.008
PG 8
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900022
DA 2020-05-12
ER

PT J
AU Hu, GQ
   Li, W
   Li, S
AF Hu, Guoqing
   Li, Wei
   Li, Song
TI Effects of functionalization on the performance of metal-organic
   frameworks for adsorption-driven heat pumps by molecular simulations
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Functionalization; Adsorption; Ethanol; Hierarchical pores; Coefficient
   of performance
ID ISOBARIC STAGES; CARBON-DIOXIDE; WATER; MOFS; TRANSFORMATION; CYCLE
AB Metal-organic frameworks (MOFs) are promising adsorbents for adsorption-driven heat pumps (AHPs) due to their outstanding adsorption performance. However, the role of functionality in tuning the AHP performance has not been elucidated. In this work, the ethanol adsorption behaviors and AHP performance of Zr-based MOFs in three topologies (i.e. csq, ftw and scu) functionalized by -NH2 and -CF3 exhibiting different affinities towards ethanol working fluid were investigated by grand canonical Monte Carlo simulations (GCMC). It was revealed that functionalization not only affected the adsorption capacity but also shifted the steps of isotherms to the low pressure upon functionalization by -NH2. scu-MOFs exhibited the higher coefficient of performance for cooling (COPC) than csq-MOFs and ftw-MOFs. Moreover, functionalization reduced the COPC of ftw-MOFs and scu-MOFs due to the lower working capacity resulting from the reduced pore volumes. On the contrary, the COPC of csq-MOFs can be improved upon functionalization by -NH2. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Song] Huazhong Univ Sci & Technol, Sch Energy & Power Engn, State Key Lab Coal Combust, Wuhan 430074, Hubei, Peoples R China.
   Huazhong Univ Sci & Technol, Nano Interface Ctr Energy, Sch Energy & Power Engn, Wuhan 430074, Hubei, Peoples R China.
RP Li, S (reprint author), Huazhong Univ Sci & Technol, Sch Energy & Power Engn, State Key Lab Coal Combust, Wuhan 430074, Hubei, Peoples R China.
EM songli@hust.edu.cn
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [51606081]; China-EU Institute for Clean and
   Renewable Energy [ICARE-RP-2018-HYDRO-001]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) under Project No. 51606081 and double first-class research
   funding of China-EU Institute for Clean and Renewable Energy (No.
   ICARE-RP-2018-HYDRO-001). This work was carried out at National
   Su-percomputer Center in Shenzhen.
CR Akiyama G, 2012, MICROPOR MESOPOR MAT, V157, P89, DOI 10.1016/j.micromeso.2012.01.015
   Aristov YI, 2013, APPL THERM ENG, V50, P1610, DOI 10.1016/j.applthermaleng.2011.09.003
   Bai Y, 2016, CHEM SOC REV, V45, P2327, DOI 10.1039/c5cs00837a
   Banerjee D., 2011, ENCY INORGANIC BIOIN, P1
   Benjamin T.E.O.H.W., 2018, T JAPAN SOC REFRIGER
   Berry C., 2015, RESIDENTIAL ENERGY C
   Chen HY, 2019, CHEM MATER, V31, P2702, DOI 10.1021/acs.chemmater.9b00062
   Clarke L, 2018, ENERG ECON, V72, P667, DOI 10.1016/j.eneco.2018.01.003
   de Lange MF, 2015, CHEM REV, V115, P12205, DOI 10.1021/acs.chemrev.5b00059
   Demir H, 2008, RENEW SUST ENERG REV, V12, P2381, DOI 10.1016/j.rser.2007.06.005
   Dubbeldam D, 2016, MOL SIMULAT, V42, P81, DOI 10.1080/08927022.2015.1010082
   Erdos M, 2018, ACS APPL MATER INTER, V10, P27074, DOI 10.1021/acsami.8b09343
   Glaznev IS, 2009, INT J HEAT MASS TRAN, V52, P1774, DOI 10.1016/j.ijheatmasstransfer.2008.09.031
   Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057
   Henning HM, 2007, APPL THERM ENG, V27, P1734, DOI 10.1016/j.applthermaleng.2006.07.021
   Henninger SK, 2012, ENRGY PROCED, V30, P279, DOI 10.1016/j.egypro.2012.11.033
   Henninger SK, 2009, J AM CHEM SOC, V131, P2776, DOI 10.1021/ja808444z
   Jeremias F, 2013, DALTON T, V42, P15967, DOI 10.1039/c3dt51471d
   Khutia A, 2013, CHEM MATER, V25, P790, DOI 10.1021/cm304055k
   Li S, 2017, J PHYS CHEM LETT, V8, P6135, DOI 10.1021/acs.jpclett.7b02700
   Li W, 2019, J MATER CHEM A, V7, P7470, DOI 10.1039/c8ta07909a
   Li W, 2018, CHEM ENG SCI, V189, P65, DOI 10.1016/j.ces.2018.05.042
   Lin CK, 2012, INORG CHEM, V51, P9039, DOI 10.1021/ic301189m
   Majer V., 1985, ENTHALPIES VAPORIZAT, P104
   Nalaparaju A, 2010, J PHYS CHEM C, V114, P11542, DOI 10.1021/jp1033273
   Okunev BN, 2013, APPL THERM ENG, V53, P89, DOI 10.1016/j.applthermaleng.2013.01.018
   Potoff JJ, 2001, AICHE J, V47, P1676, DOI 10.1002/aic.690470719
   RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040
   Rezk A, 2013, APPL ENERG, V112, P1025, DOI 10.1016/j.apenergy.2013.06.041
   SEGALL M, 2002, MAT STUDIO CASTEP VE
   Serre C, 2012, ANGEW CHEM INT EDIT, V51, P6048, DOI 10.1002/anie.201201440
   Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272
   Wade CR, 2013, ENERG ENVIRON SCI, V6, P2172, DOI 10.1039/c3ee40876k
   Wang CH, 2014, J PHYS CHEM C, V118, P19723, DOI 10.1021/jp502867v
   Willems TF, 2012, MICROPOR MESOPOR MAT, V149, P134, DOI 10.1016/j.micromeso.2011.08.020
   Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x
NR 36
TC 0
Z9 0
U1 11
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115143
DI 10.1016/j.ces.2019.08.001
PG 9
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900015
DA 2020-05-12
ER

PT J
AU Huang, PN
   Dong, GP
   Pan, MQ
AF Huang, Pingnan
   Dong, Guanping
   Pan, Minqiang
TI The velocity distribution of a cutting microchannel plate based on the
   resistance network method
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cutting microchannel; Velocity distribution; Resistance network; Heat
   and mass transfer; Simulation
ID FAN-SHAPED RIBS; HEAT-TRANSFER; LAMINAR-FLOW; HYDRAULIC CHARACTERISTICS;
   OPTIMAL-DESIGN; PRESSURE-DROP; FLUID-FLOW; SINK; PERFORMANCE; UNIFORMITY
AB Velocity distribution has a very important influence on the performance of microchannel devices. In this paper, a cutting microchannel plate was proposed, and the velocity distribution was investigated based on the resistance network method. The results showed that the asymmetric cutting microchannel plate had the most uniform velocity distribution. Finally, the optimal results were further confirmed via ANSYS Fluent simulation and the heat and mass transfer efficiencies were also investigated. Taken together, the present findings provide direct evidence that uniform velocity distribution results in the higher performance of microchannel devices. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Huang, Pingnan; Dong, Guanping; Pan, Minqiang] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510640, Guangdong, Peoples R China.
RP Pan, MQ (reprint author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510640, Guangdong, Peoples R China.
EM mqpan@scut.edu.cn
FU Science and Technology Planning Project of Guangdong Province, China
   [2016A050503019]; National Natural Science Foundation of Guangdong,
   China [1714050000297]; Science and Technology Program of Guangzhou,
   China [201804010137, 201807010074]; Fundamental Research Funds for the
   Central UniversitiesFundamental Research Funds for the Central
   Universities [2018ZD28]
FX This research was supported by the Science and Technology Planning
   Project of Guangdong Province, China, Project No. 2016A050503019, and
   National Natural Science Foundation of Guangdong, China, No.
   1714050000297, and Science and Technology Program of Guangzhou, China,
   Project Nos. 201804010137 and 201807010074, and the Fundamental Research
   Funds for the Central Universities, Project No. 2018ZD28.
CR Cao J, 2018, INT COMMUN HEAT MASS, V93, P60, DOI 10.1016/j.icheatmasstransfer.2017.04.017
   Chai L, 2016, INT J HEAT MASS TRAN, V97, P1081, DOI 10.1016/j.ijheatmasstransfer.2016.02.076
   Chai L, 2016, INT J HEAT MASS TRAN, V97, P1069, DOI 10.1016/j.ijheatmasstransfer.2016.02.077
   Commenge JM, 2002, AICHE J, V48, P345, DOI 10.1002/aic.690480218
   Feng ZF, 2017, APPL THERM ENG, V116, P597, DOI 10.1016/j.applthermaleng.2017.01.091
   Jones BJ, 2008, INT J HEAT MASS TRAN, V51, P1877, DOI 10.1016/j.ijheatmasstransfer.2007.06.034
   Khodabandeh E, 2019, J THERM ANAL CALORIM, V136, P1333, DOI 10.1007/s10973-018-7826-2
   Mei DQ, 2014, INT J HYDROGEN ENERG, V39, P17690, DOI 10.1016/j.ijhydene.2014.08.114
   Mei DQ, 2013, INT J HYDROGEN ENERG, V38, P15488, DOI 10.1016/j.ijhydene.2013.09.105
   Pan MQ, 2008, CHEM ENG J, V137, P339, DOI 10.1016/j.cej.2007.05.012
   Pan MQ, 2018, CHEM ENG PROCESS, V131, P178, DOI 10.1016/j.cep.2018.07.018
   Pan MQ, 2017, CHEM ENG TECHNOL, V40, P2283, DOI 10.1002/ceat.201700189
   Pan MQ, 2017, CHEM ENG TECHNOL, V40, P1774, DOI 10.1002/ceat.201700291
   Pan MQ, 2015, CHEM ENG TECHNOL, V38, P336, DOI 10.1002/ceat.201400447
   Pan MQ, 2013, CHEM ENG TECHNOL, V36, P1067, DOI 10.1002/ceat.201200496
   Pan MQ, 2010, CHEM ENG J, V164, P238, DOI 10.1016/j.cej.2010.08.024
   Pan MQ, 2009, AICHE J, V55, P1969, DOI 10.1002/aic.11817
   Qiu J, 2019, INT J NEUROSCI, V129, P438, DOI 10.1080/00207454.2018.1538988
   Sarafraz MM, 2018, EXP THERM FLUID SCI, V91, P509, DOI 10.1016/j.expthermflusci.2017.11.007
   Siddique W, 2013, HEAT MASS TRANSFER, V49, P679, DOI 10.1007/s00231-013-1111-5
   Siddique W, 2012, HEAT MASS TRANSFER, V48, P735, DOI 10.1007/s00231-011-0926-1
   Sun KK, 2019, IEEE T FUZZY SYST, V27, P1587, DOI 10.1109/TFUZZ.2018.2883374
   Sun XY, 2019, APPL THERM ENG, V150, P1159, DOI 10.1016/j.applthermaleng.2019.01.071
   Wu GW, 2019, CHEM ENG SCI, V201, P386, DOI 10.1016/j.ces.2019.02.015
   Zhao J, 2016, APPL THERM ENG, V93, P1347, DOI 10.1016/j.applthermaleng.2015.08.105
NR 25
TC 0
Z9 0
U1 8
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115140
DI 10.1016/j.ces.2019.07.058
PG 9
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900012
DA 2020-05-12
ER

PT J
AU Jirasek, F
   Burger, J
   Hasse, H
AF Jirasek, Fabian
   Burger, Jakob
   Hasse, Hans
TI Application of NEAT for determining the composition dependence of
   activity coefficients in poorly specified mixtures
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE NEAT; NMR spectroscopy; Activity coefficients; Unknown composition;
   Varying composition
ID WASTE-WATER; PREDICTION
AB Poorly specified mixtures, of which the composition is only partially known, are important in many fields. In a recent work of our group, the method NEAT for estimating activity coefficients of target components in such mixtures was introduced. In the present work, it is shown that based on a single NMR analysis of a poorly specified mixture not only the activity coefficient of the target component in that mixture but also its composition dependence can be predicted with NEAT. Hence, based on a single NMR analysis, the activity coefficient of the target component in many mixtures can be predicted with NEAT. This is possible, if the unknown part of the mixture remains unchanged, which is the case e.g. when the target component is selectively removed or when a known solvent is added or removed. The approach is successfully tested using several aqueous test mixtures. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jirasek, Fabian; Hasse, Hans] Tech Univ Kaiserslautern, Lab Engn Thermodynam LTD, Erwin Schrodinger Str 44, D-67663 Kaiserslautern, Germany.
   [Burger, Jakob] Tech Univ Munich, Chair Chem Proc Engn, Campus Straubing Biotechnol & Sustainabil, D-94315 Straubing, Germany.
RP Jirasek, F (reprint author), Tech Univ Kaiserslautern, Lab Engn Thermodynam LTD, Erwin Schrodinger Str 44, D-67663 Kaiserslautern, Germany.
EM fabian.jrasek@mv.uni-kl.de
RI Hasse, Hans/B-6439-2008
OI Hasse, Hans/0000-0003-4612-5995
FU European CommunityEuropean Community (EC) [637077]
FX The authors gratefully acknowledge financial support from the European
   Community's Framework Program for Research and Innovation Horizon 2020
   (2014-2020) under grant agreement No. 637077.
CR ABRAMS DS, 1975, AICHE J, V21, P116, DOI 10.1002/aic.690210115
   ALEXANDER GL, 1985, IND ENG CHEM FUND, V24, P301, DOI 10.1021/i100019a005
   CARREONCALDERON B, 2012, IND ENG CHEM RES, V51, P14188
   Constantinescu D, 2016, J CHEM ENG DATA, V61, P2738, DOI 10.1021/acs.jced.6b00136
   DARWISH E, 1995, FLUID PHASE EQUILIBR, V105, P229, DOI 10.1016/0378-3812(94)02619-C
   DIEBOLD JP, 2000, NRELSR57027613
   FAHIM MA, 1992, CAN J CHEM ENG, V70, P335, DOI 10.1002/cjce.5450700218
   FREDENSLUND A, 1975, AICHE J, V21, P1086, DOI 10.1002/aic.690210607
   FREDENSLUND AA, 1977, VAPOR LIQUID EQUILIB
   Guellil A, 2001, WATER RES, V35, P143, DOI 10.1016/S0043-1354(00)00240-2
   Jirasek F, 2019, IND ENG CHEM RES, V58, P9155, DOI 10.1021/acs.iecr.9b01269
   Jirasek F, 2018, IND ENG CHEM RES, V57, P7310, DOI 10.1021/acs.iecr.8b00917
   KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062
   Klamt A, 1998, J PHYS CHEM A, V102, P5074, DOI 10.1021/jp980017s
   MAURER G, 1978, FLUID PHASE EQUILIBR, V2, P91, DOI 10.1016/0378-3812(78)85002-X
   NIELSEN PH, 1992, WATER SCI TECHNOL, V25, P17
   Pasetka CJ, 2010, INT J ANTIMICROB AG, V35, P182, DOI 10.1016/j.ijantimicag.2009.10.013
   Patle S, 2008, BIOMASS BIOENERG, V32, P596, DOI 10.1016/j.biombioe.2007.12.008
   RENON H, 1968, AICHE J, V14, P135, DOI 10.1002/aic.690140124
NR 19
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115161
DI 10.1016/j.ces.2019.115161
PG 9
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900032
DA 2020-05-12
ER

PT J
AU Li, BY
   Dobosz, KM
   Zhang, HT
   Schiffman, JD
   Saranteas, K
   Henson, MA
AF Li, Boyang
   Dobosz, Kerianne M.
   Zhang, Haitao
   Schiffman, Jessica D.
   Saranteas, Kostas
   Henson, Michael A.
TI Predicting the performance of pressure filtration processes by coupling
   computational fluid dynamics and discrete element methods
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Pressure filtration; Particle technology; Discrete element methods;
   Computational fluid dynamics
ID CFD-DEM SIMULATION; ROLLING FRICTION; CAKE FORMATION; BED; MODEL; SHAPE;
   SIZE; FLOW
AB To obtain a fundamental understanding of the various factors affecting pressure filtration performance, we developed a coupled computational fluid dynamics (CFD) and discrete element method (DEM) model for simulating the effect of solvent flow through the solid particle cake. The model was validated using data collected by filtering mixtures of spherical glass beads and deionized water through a dead-end cell over a range of applied pressures. Numerical experiments were performed to study the effects of particle properties, liquid properties and operating conditions on filtration performance. The model predicted that the filtrate flow rate could be strongly affected by the mean size of the particles, the presence of small particles (i.e. fines) in the particle distribution, the viscosity of the liquid, and particle deformation leading to cake compression. Our study demonstrated that CFD-DEM modeling is a powerful approach for understanding cake filtration processes and predicting filtration performance. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Boyang; Dobosz, Kerianne M.; Schiffman, Jessica D.; Henson, Michael A.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Li, Boyang; Dobosz, Kerianne M.; Schiffman, Jessica D.; Henson, Michael A.] Univ Massachusetts, Inst Appl Life Sci, Amherst, MA 01003 USA.
   [Zhang, Haitao; Saranteas, Kostas] Sunovion Pharmaceut Inc, Chem Proc Res & Dev, Marlborough, MA 01752 USA.
RP Henson, MA (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.; Henson, MA (reprint author), Univ Massachusetts, Inst Appl Life Sci, Amherst, MA 01003 USA.
EM mhenson@umass.edu
FU Sunovion Pharmaceuticals; University of Massachusetts, Biotechnology
   Training Program (National Research Service Award) [T32 GM108556]
FX We acknowledge Sunovion Pharmaceuticals for funding this project and Dr.
   David Schmidt (UMass Amherst) for guidance on OpenFOAM (R). This work
   was supported in part by a Fellowship from the University of
   Massachusetts to KMD as part of the Biotechnology Training Program
   (National Research Service Award T32 GM108556).
CR Bourcier D, 2016, CHEM ENG SCI, V144, P176, DOI 10.1016/j.ces.2016.01.023
   Brilliantov NV, 1998, EUROPHYS LETT, V42, P511, DOI 10.1209/epl/i1998-00281-7
   Bruckard WJ, 2009, INT J MINER PROCESS, V93, P1, DOI 10.1016/j.minpro.2009.05.002
   Burger R, 2001, CHEM ENG SCI, V56, P4537, DOI 10.1016/S0009-2509(01)00115-4
   Dong KJ, 2009, MINER ENG, V22, P921, DOI 10.1016/j.mineng.2009.03.018
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   Faber S, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-016-2309-x
   Farr RS, 2013, POWDER TECHNOL, V245, P28, DOI 10.1016/j.powtec.2013.04.009
   Foley G, 2006, J MEMBRANE SCI, V274, P38, DOI 10.1016/j.memsci.2005.12.008
   Goniva C, 2012, PARTICUOLOGY, V10, P582, DOI 10.1016/j.partic.2012.05.002
   Hager A, 2014, J COMPUTATIONAL MULT, V6, P13, DOI DOI 10.1260/1757-482X.6.1.13
   He AD, 2014, SOFT MATTER, V10, P2264, DOI 10.1039/c3sm53063a
   Kloss C, 2012, PROG COMPUT FLUID DY, V12, P140, DOI 10.1504/PCFD.2012.047457
   Lichtenegger T, 2018, POWDER TECHNOL, V325, P698, DOI 10.1016/j.powtec.2017.11.058
   Lu WM, 2001, SEPAR SCI TECHNOL, V36, P2355, DOI 10.1081/SS-100106098
   Lu X, 2018, CHEM ENG SCI, V189, P123, DOI 10.1016/j.ces.2018.04.074
   Luding S, 1998, NATO ADV SCI I E-APP, V350, P285
   MacLeod CS, 2012, ORG PROCESS RES DEV, V16, P425, DOI 10.1021/op200279m
   Mattsson T, 2012, SEP PURIF TECHNOL, V96, P139, DOI 10.1016/j.seppur.2012.05.029
   Min FL, 2013, TUNN UNDERGR SP TECH, V38, P423, DOI 10.1016/j.tust.2013.07.024
   Murugesan S., 2010, CHEM ENG PHARM IND R, P315, DOI 10.1002/9780470882221.ch17
   Murugesan S, 2012, ORG PROCESS RES DEV, V16, P42, DOI 10.1021/op2001468
   Peng ZB, 2014, AICHE J, V60, P2000, DOI 10.1002/aic.14421
   Qian FP, 2014, COMPUT CHEM ENG, V71, P478, DOI 10.1016/j.compchemeng.2014.09.018
   Sen M, 2014, PROCESSES, V2, P89, DOI 10.3390/pr2010089
   Sigma-Aldrich Inc, GLASS BEADS AC WASH
   Soren S, 2012, INT J MECH ENG MECHA, V1, P28, DOI [10.11159/ijmem.2012.004, DOI 10.11159/IJMEM.2012.004]
   Sorensen PB, 1996, CHEM ENG SCI, V51, P967, DOI 10.1016/0009-2509(95)00339-8
   Suzzi D, 2012, CHEM ENG SCI, V69, P107, DOI 10.1016/j.ces.2011.10.009
   Tien C, 2003, CHEM ENG SCI, V58, P1323, DOI 10.1016/S0009-2509(02)00655-3
   Tien C, 2002, POWDER TECHNOL, V127, P1, DOI 10.1016/S0032-5910(02)00063-3
   Volk A, 2018, POWDER TECHNOL, V325, P519, DOI 10.1016/j.powtec.2017.11.051
   Volk A, 2017, POWDER TECHNOL, V311, P137, DOI 10.1016/j.powtec.2017.01.088
   Walzel P., 2012, ULLMANNS ENCY IND CH, V25, P40, DOI [10.1002/14356007.b02, DOI 10.1002/14356007.B02]
   WEN CY, 1966, AICHE J, V12, P610, DOI 10.1002/aic.690120343
   Yue C, 2016, J AEROSOL SCI, V101, P174, DOI 10.1016/j.jaerosci.2016.08.004
   Zhang ZL, 2019, INT J PROD RES, V57, P2327, DOI 10.1080/00207543.2018.1516904
   Zhou YC, 1999, PHYSICA A, V269, P536, DOI 10.1016/S0378-4371(99)00183-1
   Zhu HP, 2007, CHEM ENG SCI, V62, P3378, DOI 10.1016/j.ces.2006.12.089
NR 39
TC 1
Z9 1
U1 5
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115162
DI 10.1016/j.ces.2019.115162
PG 10
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900033
PM 31579324
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Li, W
   Wang, HF
   Li, ZY
   Wang, T
   Zhao, CX
AF Li, Wei
   Wang, Hao-Fei
   Li, Zhi-Yong
   Wang, Tong
   Zhao, Chun-Xia
TI Numerical investigation of drug transport from blood vessels to tumour
   tissue using a Tumour-Vasculature-on-a-Chip
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Drug transport; Numerical investigation; Tumour-Vasculature-on-a-Chip;
   Species transport model
ID DELIVERY; RESISTANCE; SIMULATION; CANCER; FLOW; SINGLE
AB Delivery of adequate amount of anticancer drugs to tumour sites is critical to achieve effective therapeutic treatment, but it remains challenging to observe drug transport and investigate the spatial distribution of the drug in tumour microenvironment experimentally. In this study, we investigated the drug transport from a blood vessel to a tumour tissue, and explored the effect of tumour size, tumour numbers and positioning on drug concentration distribution using a numerical method in combination with a microfluidic Tumour-Vasculature-on-a-Chip (TVOC) model. The TVOC model is composed of a blood vessel channel, and a tumour channel sandwiched with a porous membrane. A species transport model based on computational fluid dynamics was adopted to investigate drug transport. The numerical simulation was firstly validated using experimental data, and then used to analyse the spatial-temporal structure of the flow, and to investigate the effect of tumour size and positioning on drug transport and drug concentration heterogeneity. We found the drug concentration surrounding the tumour was highly heterogeneous, with the most downstream point the most difficult for drugs to transport and the nearest point to the blood vessel the easiest. Moreover, tumour size and positioning contributed significantly to this drug concentration heterogeneity on tumour surface, which was dramatically augmented in large and downstream-positioned tumours. These studies established the relationship between solid tumour size/positioning and drug concentration heterogeneity in the tumour microenvironment, which could help to understand heterogeneous drug distribution in tumour microenvironment. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Wei; Li, Zhi-Yong] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld, Australia.
   [Wang, Hao-Fei; Wang, Tong; Zhao, Chun-Xia] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
RP Wang, T; Zhao, CX (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
EM z.chunxia@uq.edu.au
RI Wang, Tong/AAJ-9949-2020; Zhao, Chun-Xia/I-4224-2012; Li,
   Zhi-Yong/G-9701-2011
OI Wang, Tong/0000-0002-3680-8189; Zhao, Chun-Xia/0000-0002-3365-3759; Li,
   Zhi-Yong/0000-0002-6814-9165
FU High Performance Computing of Queensland University of Technology;
   Australian Research Council (ARC)Australian Research Council
   [FT140100726]; Australian Research CouncilAustralian Research Council
   [DE170100546]
FX We acknowledge the supports from High Performance Computing of
   Queensland University of Technology. C.-X Zhao acknowledges financial
   support from the award of the Australian Research Council (ARC) Future
   Fellowship (FT140100726). TW acknowledges financial support from the
   award of the Australian Research Council DECRA Fellow (DE170100546).
   This work was performed in part at the Queensland node of the Australian
   National Fabrication Facility (ANFF-Q), a company established under the
   National Collaborative Research Infrastructure Strategy to provide nano
   and micro-fabrication facilities for Australia's researchers.
CR Altrock P., 2018, BIORXIV
   Barisam M, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9030094
   Chen HM, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.24
   Dewhirst MW, 2017, NAT REV CANCER, V17, P738, DOI 10.1038/nrc.2017.93
   Fu F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004142
   Fuso Nerini I, 2014, Clin Pharmacol Ther, V96, P224, DOI 10.1038/clpt.2014.105
   Gao BJ, 2015, PROCEDIA ENGINEER, V130, P1246, DOI 10.1016/j.proeng.2015.12.206
   Habib MA, 2013, J MEMBRANE SCI, V446, P230, DOI 10.1016/j.memsci.2013.06.035
   Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599
   Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769
   Jensen MM, 2015, COMP MATER SCI, V105, P75, DOI 10.1016/j.commatsci.2015.04.023
   Kathawate J, 2008, INT J HEAT MASS TRAN, V51, P5598, DOI 10.1016/j.ijheatmasstransfer.2008.04.053
   Kavousanakis ME, 2014, CHEM ENG SCI, V108, P203, DOI 10.1016/j.ces.2014.01.005
   Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514
   Kolandavel MK, 2006, ANN BIOMED ENG, V34, P1820, DOI 10.1007/s10439-006-9188-3
   Kwak B, 2014, J CONTROL RELEASE, V194, P157, DOI 10.1016/j.jconrel.2014.08.027
   Li W, 2018, MICROFLUID NANOFLUID, V22, DOI 10.1007/s10404-018-2165-y
   Linninger AA, 2008, J THEOR BIOL, V250, P125, DOI 10.1016/j.jtbi.2007.09.009
   Lominadze D, 1999, MICROVASC RES, V58, P187, DOI 10.1006/mvre.1999.2160
   Longest PW, 2010, J AEROSOL SCI, V41, P805, DOI 10.1016/j.jaerosci.2010.04.006
   Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714
   Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z
   Nguyen NT, 2013, ADV DRUG DELIVER REV, V65, P1403, DOI 10.1016/j.addr.2013.05.008
   Pal S, 2014, INT J HEAT MASS TRAN, V69, P285, DOI 10.1016/j.ijheatmasstransfer.2013.10.023
   Park J, 2005, J CONTROL RELEASE, V105, P279, DOI 10.1016/j.jconrel.2005.03.010
   Ran R, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201900015
   Sanjay ST, 2018, ADV DRUG DELIVER REV, V128, P3, DOI 10.1016/j.addr.2017.09.013
   Steuperaert M, 2017, DRUG DELIV, V24, P491, DOI 10.1080/10717544.2016.1269848
   Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135
   Vyskocil L, 2014, NUCL ENG DES, V279, P147, DOI 10.1016/j.nucengdes.2014.02.014
   Walsh CL, 2009, LAB CHIP, V9, P545, DOI 10.1039/b810571e
   Wang HF, 2018, ACS NANO, V12, P11600, DOI 10.1021/acsnano.8b06846
   Wen ZQ, 2015, CHEM PROCESS ENG-INZ, V36, P21, DOI 10.1515/cpe-2015-0002
   Zhan WB, 2013, J DRUG DELIV, DOI 10.1155/2013/172529
   Zhao CX, 2013, ADV DRUG DELIVER REV, V65, P1420, DOI 10.1016/j.addr.2013.05.009
NR 35
TC 0
Z9 0
U1 14
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115155
DI 10.1016/j.ces.2019.115155
PG 10
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900027
DA 2020-05-12
ER

PT J
AU Luyben, WL
AF Luyben, William L.
TI Temperature setpoint-ramp control structure for batch reactors
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Batch reactor control; Setpoint ramp; Reactor instability; Reactor
   runaway
ID ONLINE RUNAWAY DETECTION; STABILITY-CRITERION
AB Batch reactors can present challenging dynamic control problems because of the large nonlinear changes in process parameters during the batch cycle. Large reactant concentrations at the beginning of the batch produce fast reaction rates and large heat-transfer duties if the reactor temperature is increased too rapidly from its low initial temperature. Exothermic reactions can lead to reactor runaways that exceed maximum temperature/pressure safety constraints. Several papers have studied sophisticated techniques for detecting the potential of an impending runaway and taking corrective action. A complex stability criterion embedded in a model predictive control structure is a recent suggestion for handling the problem.
   This paper discusses a simple practical technique that has been used in industry for decades. The set-point of a temperature/pressure controller is ramped up at a reasonable rate, but if the demand for coolant increases too much, the ramp is stopped until the demand for control effort drops down to a normal level. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Luyben, William L.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA.
RP Luyben, WL (reprint author), Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA.
EM WLL0@Lehigh.edu
CR Bosch J, 2004, COMPUT CHEM ENG, V28, P527, DOI 10.1016/j.compchemeng.2003.08.005
   Copelli S, 2014, J LOSS PREVENT PROC, V28, P92, DOI 10.1016/j.jlp.2013.05.004
   Hub L., 1986, PLANT OPER PROG, V5, P221, DOI DOI 10.1002/PRSB.720050408
   Juba M.R., 1986, P CHEM PROC CONTR CP, V3, P139
   Kahm W, 2018, CHEM ENG RES DES, V138, P292, DOI 10.1016/j.cherd.2018.08.017
   Kahm W, 2018, CHEM ENG SCI, V188, P192, DOI 10.1016/j.ces.2018.05.032
   ROTSTEIN GE, 1992, COMPUT CHEM ENG, V16, P27, DOI 10.1016/0098-1354(92)80003-R
   Strozzi F, 1999, AICHE J, V45, P2429, DOI 10.1002/aic.690451116
NR 8
TC 0
Z9 0
U1 7
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115124
DI 10.1016/j.ces.2019.07.042
PG 8
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900005
DA 2020-05-12
ER

PT J
AU Ma, YL
   Liu, MY
   Zhou, XH
   Javed, A
AF Ma, Yongli
   Liu, Mingyan
   Zhou, Xiuhong
   Javed, Areej
TI Axial meso-scale modeling of gas-liquid-solid circulating fluidized beds
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Model; Gas-liquid-solid fluidization; Circulating; Axial model;
   Meso-scale
ID BUBBLE; FLOW; SIMULATION; HOLDUP; WAKE; REGIMES
AB This paper has established an axial meso-scale model based on the Energy-Minimization Multiscale (EMMS) principle for the gas-liquid-solid circulating fluidized bed. Comparisons made with the experimental data show that the established model is able to predict the axial hydrodynamics of the system under study. Model studies demonstrate that the dynamic formation and decomposition of the particle-clusters can illustrate the mechanism of the axial distribution. For the first time, the model predicts the transition points between the expanding fluidization mode, the circulating fluidization mode, and the liquid transporting mode. The maximum value of the solid particles' acceleration in the particle-cluster phase can be an indicator of a change to the length of the transition section. And the particle-clusters gradually form as the bubbles grow. In the pseudo steady state, the solid particles' acceleration in the liquid-solid suspension phase tends to be -9.8 m/s(2), and that of the bubbles tends to be 0 m/s(2). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ma, Yongli; Liu, Mingyan; Zhou, Xiuhong; Javed, Areej] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China.
   [Liu, Mingyan] Tianjin Univ, State Key Lab Chem Engn, Tianjin 300350, Peoples R China.
RP Liu, MY (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China.
EM myliu@tju.edu.cn
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [91434204, 91834303]
FX We would like to thank financial supports from the National Nature
   Science Foundation of China (No. 91434204; No. 91834303). Thanks to Karo
   Itimi-Elo from the University of Ottawa for helping to modify the
   language of this study.
CR Arjmandi-Tash O, 2015, CAN J CHEM ENG, V93, P942, DOI 10.1002/cjce.22143
   Clift R., 1978, BUBBLES DROPS PARTIC
   ELTEMTAMY SA, 1978, INT J MULTIPHAS FLOW, V4, P19, DOI 10.1016/0301-9322(78)90022-8
   Fan L.S., 1989, GAS LIQUID SOLID FLU
   FAN LS, 1990, BUBBLE WAKE DYNAMICS
   Ge W, 2002, CHEM ENG SCI, V57, P3993, DOI 10.1016/S0009-2509(02)00234-8
   GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   Han S.J., 1997, J CHEM ENG CHIN U, P53
   HESKETH RP, 1987, AICHE J, V33, P663, DOI 10.1002/aic.690330414
   HINZE JO, 1955, AICHE J, V1, P289, DOI 10.1002/aic.690010303
   Jin GD, 2006, CHEM ENG J, V117, P1, DOI 10.1016/j.cej.2005.12.009
   KATO Y, 1985, J CHEM ENG JPN, V18, P308, DOI 10.1252/jcej.18.308
   Kreischer B.E., 1989, BUBBLE BUBBLE WAKE C
   LEE SLP, 1987, AICHE J, V33, P1359, DOI 10.1002/aic.690330813
   Levich V.G., 1966, PRIKL MAT MEKH, V30, P467
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   Li HL, 2013, APPL MECH MATER, V433-435, P1988, DOI 10.4028/www.scientific.net/AMM.433-435.1988
   Li J., 1994, METALLURG
   Li J., 1987, THESIS
   Li JH, 2014, SPRINGERBR APPL SCI, P51, DOI 10.1007/978-3-642-41790-0_6
   LIANG W, 1995, CAN J CHEM ENG, V73, P656, DOI 10.1002/cjce.5450730509
   LIANG WG, 1995, AICHE J, V41, P267, DOI 10.1002/aic.690410209
   Liu MY, 2001, CHEM ENG SCI, V56, P6805, DOI 10.1016/S0009-2509(01)00318-9
   Ma YL, 2019, CHEM ENG SCI, V196, P188, DOI 10.1016/j.ces.2018.11.005
   Ma YL, 2018, CHEM ENG SCI, V179, P243, DOI 10.1016/j.ces.2018.01.002
   MATSUMOTO T, 1989, AICHE J, V35, P1701, DOI 10.1002/aic.690351015
   Razzak SA, 2010, POWDER TECHNOL, V199, P77, DOI 10.1016/j.powtec.2009.05.014
   RICHARDSON JF, 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8
   SONG GH, 1991, CHEM ENG SCI, V46, P2933, DOI 10.1016/0009-2509(91)85162-Q
   Tsuchiya K, 1997, CHEM ENG SCI, V52, P3053, DOI 10.1016/S0009-2509(97)00127-9
   TSUTSUMI A, 1992, CHEM ENG SCI, V47, P3411, DOI 10.1016/0009-2509(92)85052-D
   Wang W, 2007, CHEM ENG SCI, V62, P208, DOI 10.1016/j.ces.2006.08.017
   Zhou RT, 2017, POWDER TECHNOL, V314, P466, DOI 10.1016/j.powtec.2016.09.083
NR 34
TC 0
Z9 0
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115139
DI 10.1016/j.ces.2019.07.057
PG 16
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900011
DA 2020-05-12
ER

PT J
AU Mesa, S
   Arboleda, J
   Echavarria, A
   Lopez-Suarez, FE
AF Mesa, S.
   Arboleda, J.
   Echavarria, A.
   Lopez-Suarez, F. E.
TI Ferrierite zeolite passivation and its catalytic application in toluene
   disproportionation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Ferrierite zeolites; Passivation process; Acidic properties; Toluene
   disproportionation
ID TEMPERATURE-PROGRAMMED DESORPTION; SHAPE-SELECTIVE CATALYSTS; EXTERNAL
   SURFACE; SKELETAL ISOMERIZATION; LIQUID DEPOSITION; ACID SITES; HZSM-5;
   BETA
AB Ferrierite zeolites have been prepared, characterized and evaluated in toluene disproportionation. The materials were synthesized using a hydrothermal method. A passivation process (chemical liquid deposition, CLD) was applied in order to modify the acidic properties of parent zeolite and the shape-selective performance in the production of p-xylene by the disproportionation of toluene. The catalyst structures and chemical compositions were characterized by SEM, XRD, XRF, TGA, DTA, nitrogen adsorption/desorption, and NH3-TPD measurements. Textural properties and acidity of ferrierite zeolites were changed by the passivation procedure. The strength and amount of acid sites on the materials diminished with increasing the modification cycles in the passivation process. In toluene disproportionation, the passivated materials were substantially more para-selective (56% at 648 K and 689.5 KPa) than the parent zeolite (H-form). Overall, the temperature and pressure ranges evaluated were from 689.5 to 2757.9 KPa and 648-698 K. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mesa, S.; Arboleda, J.; Echavarria, A.] Univ Antioquia, Inst Quim, Grp Catalizadores & Adsorbentes, Calle 70 52-21, Medellin, Colombia.
   [Lopez-Suarez, F. E.] Univ Bogota Jorge Tadeo Lozano, Dept Chem Engn, IPSI Grp, St 4 22-61, Bogota 110311, Colombia.
RP Lopez-Suarez, FE (reprint author), Univ Bogota Jorge Tadeo Lozano, Dept Chem Engn, IPSI Grp, St 4 22-61, Bogota 110311, Colombia.
EM santiago.mesa@udea.edu.co; johana.arboleda@udea.edu.co;
   adriana.echavarria@udea.edu.co; franzedwin@gmail.com
OI Lopez-Suarez, Franz Edwin/0000-0003-4129-1329
FU University of Antioquia under "CODI fellowship" [2014-1052];
   COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [1115-669-4663]; University de Bogota Jorge Tadeo
   Lozano under "DICE convocatoria de investigacion" [15 de 2017]
FX The authors thank financial support of University of Antioquia under
   "CODI fellowship 2014-1052", COLCIENCIAS under contract 1115-669-4663
   and University de Bogota Jorge Tadeo Lozano under "DICE convocatoria de
   investigacion No 15 de 2017".
CR Al-Khattaf S, 2006, ENERG FUEL, V20, P946, DOI 10.1021/ef050415b
   Baduraig A, 2010, TOP CATAL, V53, P1446, DOI 10.1007/s11244-010-9605-6
   Belhekar AA, 2003, CATAL COMMUN, V4, P295, DOI 10.1016/S1566-7367(03)00056-6
   Bhavani AG, 2005, CATAL LETT, V103, P89, DOI 10.1007/s10562-005-6508-4
   Bonilla A, 2009, J CATAL, V265, P170, DOI 10.1016/j.jcat.2009.04.022
   Burzo E., 2013, TECTOSILICATES, P1
   Caro J, 2009, ADV NANOPOR MAT, V1, P1, DOI 10.1016/S1878-7959(09)00101-7
   Cejka J, 1996, ZEOLITES, V17, P265, DOI 10.1016/0144-2449(96)00006-1
   CORMA A, 1995, CHEM REV, V95, P559, DOI 10.1021/cr00035a006
   Coskun Z., 2003, THESIS
   DAS J, 1994, APPL CATAL A-GEN, V116, P71, DOI 10.1016/0926-860X(94)80280-7
   GIANNETTI JP, 1975, IND ENG CHEM PROC DD, V14, P86, DOI 10.1021/i260053a015
   Gogebakan Z, 2007, IND ENG CHEM RES, V46, P2006, DOI 10.1021/ie061013+
   Janardhan HL, 2014, APPL CATAL A-GEN, V471, P12, DOI 10.1016/j.apcata.2013.11.029
   KARGE HG, 1991, J PHYS CHEM-US, V95, P283, DOI 10.1021/j100154a053
   Katada N, 2004, CATAL SURV ASIA, V8, P161, DOI 10.1023/B:CATS.0000038534.37849.16
   KIBBY CL, 1974, J CATAL, V35, P256, DOI 10.1016/0021-9517(74)90204-8
   Kotrel S, 2001, J PHYS CHEM B, V105, P3917, DOI 10.1021/jp002161v
   Kunieda T, 1999, J CATAL, V188, P431, DOI 10.1006/jcat.1999.2686
   Kunkeler PJ, 1997, MICROPOROUS MATER, V11, P313, DOI 10.1016/S0927-6513(97)00053-9
   Liu N, 2016, CATAL COMMUN, V77, P60, DOI 10.1016/j.catcom.2016.01.027
   MOOIWEER HH, 1994, STUD SURF SCI CATAL, V84, P2327
   Moreau P, 2008, STUD SURF SCI CATAL, V174, P1179
   O'Connor CT, 2007, KONA, V25, P230, DOI 10.14356/kona.2007020
   Pinar AB, 2010, MICROPOR MESOPOR MAT, V129, P164, DOI 10.1016/j.micromeso.2009.09.012
   Pinar AB, 2007, COLLECT CZECH CHEM C, V72, P666, DOI 10.1135/cccc20070666
   Qian B, 2001, LANGMUIR, V17, P1119, DOI 10.1021/la000835n
   Ren XQ, 2006, J POROUS MAT, V13, P353, DOI 10.1007/s10934-006-8030-5
   SCHERZER J, 1993, STUD SURF SCI CATAL, V76, P145
   VAUGHAN PA, 1966, ACTA CRYSTALLOGR, V21, P983, DOI 10.1107/S0365110X66004298
   Weber RW, 1998, MICROPOR MESOPOR MAT, V23, P179, DOI 10.1016/S1387-1811(98)00061-4
   XU WQ, 1995, J PHYS CHEM-US, V99, P9443, DOI 10.1021/j100023a022
   Zheng S., 2002, SURFACE MODIFICATION
   Zheng SR, 2003, J CATAL, V219, P310, DOI 10.1016/S0021-9517(03)00234-3
NR 34
TC 0
Z9 0
U1 14
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115147
DI 10.1016/j.ces.2019.08.005
PG 7
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900019
DA 2020-05-12
ER

PT J
AU Mirfendereski, SM
AF Mirfendereski, Seyed Mojtaba
TI Development of a multi-step hybrid method to synthesize highly-permeable
   and well-oriented SAPO-34 membranes for CO2 removal applications
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE SAPO-34; CO2 removal; Well-oriented; Highly-permeable; Hybrid synthesis
ID T-TYPE ZEOLITE; GEL CONVERSION METHOD; GAS PERMEATION; MOLECULAR-SIEVE;
   SYNTHESIS PARAMETERS; PHYSICAL ADSORPTION; CH4 PERMEATION; SEPARATION;
   SILICALITE-1; CO2/CH4
AB In this study a multi-step method was proposed to synthesize thin, high-permeable and well-oriented SAPO-34 membranes. The advantages of the different binary to quinary combinations of the available effective methods including support-masking, ionic-linkage, chemical-functionalization, dip-coating, hydrothermal and dry-gel on the structure and performance of SAPO-34 membranes in CO2/CH4 gas separation process were investigated.
   We applied for the first time, the crystallographic preferred orientation index (CPO) for comparative evaluation of proposed methods on the performance of membranes. The adsorption properties of supported membranes were also estimated and compared with those of SAPO-34 powder and of alumina support for better understanding of the effect of CPO on the mass transfer mechanism.
   It was found that the CO2 adsorption capacity is sensitive to CPO. Lower diffusion resistance, shorter diffusion path and less tortuosity were achieved at higher CPO, which made the penetration rate overcome on the absorption rate, and consequently enhanced the selectivity. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mirfendereski, Seyed Mojtaba] Shahid Beheshti Univ, Fac Mech & Energy Engn, Tehran, Iran.
RP Mirfendereski, SM (reprint author), Shahid Beheshti Univ, Fac Mech & Energy Engn, Tehran, Iran.
EM m_mirfendereski@sbu.ac.ir
RI Mirfendereski, Seyed Mojtaba/Y-7597-2019
OI Mirfendereski, Seyed Mojtaba/0000-0002-6859-0655
CR Alfaro S, 2009, J POROUS MAT, V16, P337, DOI 10.1007/s10934-008-9205-z
   Avila AM, 2009, J MEMBRANE SCI, V335, P32, DOI 10.1016/j.memsci.2009.02.028
   Bai L, 2017, MICROPOR MESOPOR MAT, V241, P392, DOI 10.1016/j.micromeso.2016.12.019
   Bons AJ, 2003, MICROPOR MESOPOR MAT, V62, P9, DOI 10.1016/S1387-1811(03)00384-6
   Boudreau LC, 1999, J MEMBRANE SCI, V152, P41, DOI 10.1016/S0376-7388(98)00166-5
   Bux H, 2011, CHEM MATER, V23, P2262, DOI 10.1021/cm200555s
   Cai R, 2010, J AM CHEM SOC, V132, P12776, DOI 10.1021/ja101649b
   Caro J, 2005, ADSORPTION, V11, P215, DOI 10.1007/s10450-005-5394-9
   Carreon MA, 2008, J AM CHEM SOC, V130, P5412, DOI 10.1021/ja801294f
   Carreon MA, 2008, ADV MATER, V20, P729, DOI 10.1002/adma.200701280
   Chang N, 2018, J MEMBRANE SCI, V552, P13, DOI 10.1016/j.memsci.2018.01.066
   Chen Y, 2017, J CO2 UTIL, V18, P30, DOI 10.1016/j.jcou.2017.01.005
   Chiche D, 2008, J PHYS CHEM C, V112, P8524, DOI 10.1021/jp710664h
   Das JK, 2014, ACS APPL MATER INTER, V6, P20717, DOI 10.1021/am5045345
   Das JK, 2013, J MATER CHEM A, V1, P4966, DOI 10.1039/c3ta01095c
   Das JK, 2012, INT J HYDROGEN ENERG, V37, P10354, DOI 10.1016/j.ijhydene.2012.03.102
   Fan DQ, 2018, CHEM ENG SCI, V176, P285, DOI 10.1016/j.ces.2017.10.032
   Funke HH, 2012, J MEMBRANE SCI, V409, P212, DOI 10.1016/j.memsci.2012.03.058
   Hammond KD, 2007, J POROUS MAT, V14, P409, DOI 10.1007/s10934-006-9034-x
   Hammond KD, 2007, LANGMUIR, V23, P8371, DOI 10.1021/la063256c
   Hedlund J, 1999, MICROPOR MESOPOR MAT, V28, P185, DOI 10.1016/S1387-1811(98)00300-X
   Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5
   Hedlund J, 1997, CHEM COMMUN, P1193, DOI 10.1039/a702616a
   Hedlund J, 2003, J MEMBRANE SCI, V222, P163, DOI 10.1016/S0376-7388(03)00285-0
   Hirota Y, 2010, MATER CHEM PHYS, V123, P507, DOI 10.1016/j.matchemphys.2010.05.005
   Hrabanek P, 2013, MICROPOR MESOPOR MAT, V174, P154, DOI 10.1016/j.micromeso.2013.03.007
   Huang AS, 2010, CHEM MATER, V22, P4353, DOI 10.1021/cm1016189
   Kim E., 2013, ANGEW CHEM INT EDIT, V125, P5388
   Korelskiy D, 2013, J MEMBRANE SCI, V427, P381, DOI 10.1016/j.memsci.2012.10.016
   Kornic S, 2002, CHEM COMMUN, P1700, DOI 10.1039/b204042e
   Lara-Medina JJ, 2012, INT J GREENH GAS CON, V10, P494, DOI 10.1016/j.ijggc.2012.07.014
   Li M, 2016, MICROPOR MESOPOR MAT, V225, P261, DOI 10.1016/j.micromeso.2015.11.056
   Li S, 2004, J AM CHEM SOC, V126, P4122, DOI 10.1021/ja031985y
   Li SG, 2004, J MEMBRANE SCI, V241, P121, DOI 10.1016/j.memsci.2004.04.027
   Li SG, 2007, IND ENG CHEM RES, V46, P3904, DOI 10.1021/ie0610703
   Li SG, 2006, ADV MATER, V18, P2601, DOI 10.1002/adma.200601147
   Liu YY, 2011, J MEMBRANE SCI, V379, P46, DOI 10.1016/j.memsci.2011.05.041
   Masuda T, 2003, CHEM ENG SCI, V58, P649, DOI 10.1016/S0009-2509(02)00591-2
   Mirfendereski M, 2008, INT J GREENH GAS CON, V2, P531, DOI 10.1016/j.ijggc.2008.03.001
   Mirfendereski SM, 2008, SEP PURIF TECHNOL, V61, P317, DOI 10.1016/j.seppur.2007.11.007
   Mirfendereski SM, 2019, J AUST CERAM SOC, V55, P103, DOI 10.1007/s41779-018-0216-1
   Mohammadi T, 2012, SEP SCI TECHNOL, V47, P2320, DOI 10.1080/01496395.2012.677924
   Nian P, 2016, J MATER SCI, V51, P3257, DOI 10.1007/s10853-015-9638-0
   Rad MD, 2012, CHEM ENG RES DES, V90, P1687, DOI 10.1016/j.cherd.2012.01.010
   Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030
   Sjoberg E, 2013, J MEMBRANE SCI, V443, P131, DOI 10.1016/j.memsci.2013.05.008
   Song JW, 2008, J PHYS CHEM C, V112, P8609, DOI 10.1021/jp800598p
   Tian YY, 2009, J MATER CHEM, V19, P7698, DOI 10.1039/b907237c
   van den Bergh J, 2008, J MEMBRANE SCI, V316, P35, DOI 10.1016/j.memsci.2007.12.051
   Venna SR, 2011, LANGMUIR, V27, P2888, DOI 10.1021/la105037n
   Wang Q, 2017, J MEMBRANE SCI, V540, P50, DOI 10.1016/j.memsci.2017.06.009
   Wondraczek L, 2013, J NON-CRYST SOLIDS, V360, P36, DOI 10.1016/j.jnoncrysol.2012.10.001
   Xu MX, 2017, CHEM ENG SCI, V158, P117, DOI 10.1016/j.ces.2016.10.001
   Yao JF, 2010, J MATER CHEM, V20, P9827, DOI 10.1039/c0jm01003k
   Zhang YF, 2010, J MEMBRANE SCI, V363, P29, DOI 10.1016/j.memsci.2010.06.054
   Zhong ZX, 2015, J MATER CHEM A, V3, P15715, DOI 10.1039/c5ta03707g
   Zhou M, 2008, CHINESE SCI BULL, V53, P801, DOI 10.1007/s11434-008-0021-2
   Zhou RF, 2013, J MEMBRANE SCI, V444, P384, DOI 10.1016/j.memsci.2013.05.048
   Zhou RF, 2013, MICROPOR MESOPOR MAT, V174, P81, DOI 10.1016/j.micromeso.2013.02.019
NR 59
TC 0
Z9 0
U1 18
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115157
DI 10.1016/j.ces.2019.115157
PG 17
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900029
DA 2020-05-12
ER

PT J
AU Mirzaeifard, S
   Servio, P
   Rey, AD
AF Mirzaeifard, Sina
   Servio, Phillip
   Rey, Alejandro D.
TI Molecular dynamics characterization of the water-methane, ethane, and
   propane gas mixture interfaces
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Water-natural gas mixture interface; Gas hydrates; Surface physics;
   Interfacial tension; Molecular dynamics simulation; NPNAT ensemble
ID SURFACE-TENSION; HOMOGENEOUS NUCLEATION; COMPUTER-SIMULATION; LIQUID;
   HYDRATE; TEMPERATURE; SOLUBILITY; COMPONENTS; PRESSURE; SYSTEM
AB The co-existing natural gas and water bulk phases arise in a wide range of technological and environmental processes. The liquid-gas mixture is separated by an interface which plays a crucial role in mass transport across the phases. In this work, we use the molecular dynamics (MD) technique to investigate the molecular organization, solubility, density, and compositions of natural gas-water interfaces. We apply the NP(N)AT ensemble which is an appropriate statistical methodology to dodge the defects of the conventional ensembles in surface physics, and ultimately, to characterize the interfacial thermodynamics and mechanics. High interfacial density, excess, and radial pair distribution function of the gas components in order of propane, ethane, and methane, respectively, suggest the interfacial adsorption as per favorable interactions with a dense hydrogen bonding network near the surface in the liquid water phase. It is also found that the gas components solubility is negligible. Nevertheless, methane molecules present in natural gas can further dissolve in water, comparing to pure methane. We lastly conclude a heterogeneous formation of structure II hydrate from the adsorption and composition results. Moreover, we systematically increase the pressure from 1 MPa to 50 MPa and the temperature from 273.15 K to 303.15 K to calculate the interfacial tension using the mechanical approach. We observe a decrease in the interfacial tension along with an increase in both pressure and temperature. Given the remarkable hydrocarbon adsorption acting as a surfactant, this interfacial tension attenuation is more highlighted in a natural gas-water system compared to the pure liquid-vapor water or water-pure methane systems at the same temperature and pressure. We employ MD combined with fundamental thermodynamics to predict the interfacial tension via its independent relations with pressure and temperature which agrees with the classical scaling laws, namely, the Eotvos rule. The corresponding molecular mechanisms captured by the microscopic and macroscopic properties at the interfacial regions prospectively demonstrate a sensitivity to both temperature and pressure, which contributes to the developing understanding and applications of the imperative water-natural gas interface. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mirzaeifard, Sina; Servio, Phillip; Rey, Alejandro D.] McGill Univ, Dept Chem Engn, Montreal, PQ H3A 0C5, Canada.
RP Rey, AD (reprint author), McGill Univ, Dept Chem Engn, Montreal, PQ H3A 0C5, Canada.
EM alejandro.rey@mcgill.ca
RI Mirzaeifard, Sina/M-4961-2015
OI Mirzaeifard, Sina/0000-0002-5919-7341
FU McGill Engineering Doctoral Awards (MEDA) Grad Excellence Award program
   [90025]; Natural Sciences and Engineering Research Council
   (NSERC)Natural Sciences and Engineering Research Council of Canada
   [RGPAS 446194, RGPIN 42069-0]; McGill University
FX SM appreciates the financial support of the McGill Engineering Doctoral
   Awards (MEDA) Grad Excellence Award-90025 program. This research is
   supported by the Natural Sciences and Engineering Research Council
   (NSERC) RGPAS 446194 & RGPIN 42069-0 through the Discovery Grants
   Program. We are grateful to Compute Canada and Calcul Quebec for the
   access to HPC facilities and the technical supports. ADR is grateful to
   McGill University for financial support through the James McGill
   Professorship appointment.
CR Aman ZM, 2016, CHEM SOC REV, V45, P1678, DOI 10.1039/c5cs00791g
   Bagherzadeh SA, 2012, J PHYS CHEM C, V116, P24907, DOI 10.1021/jp305529d
   Bai DS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12747
   Bai XM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1931661
   Binks BP, 2002, LANGMUIR, V18, P1270, DOI 10.1021/la011420k
   Biscay F, 2009, J PHYS CHEM B, V113, P14277, DOI 10.1021/jp906953a
   Biscay F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3236390
   BLOKHUIS EM, 1995, MOL PHYS, V85, P665, DOI 10.1080/00268979500101371
   Busch A, 2013, MAR PETROL GEOL, V45, P208, DOI 10.1016/j.marpetgeo.2013.05.005
   Carroll J., 2014, NATURAL GAS HYDRATES
   Chandrasekhar S., 1992, LIQ CRYST, P80
   CHAPELA GA, 1977, J CHEM SOC FARAD T 2, V73, P1133, DOI 10.1039/f29777301133
   Chaplin M., 2009, WATER, V1, P1, DOI DOI 10.14294/WATER.2009.2
   DEMIRBAS A, 2010, [No title captured], P1
   Eisenberg D., 2005, STRUCTURE PROPERTIES
   Faramawy S, 2016, J NAT GAS SCI ENG, V34, P34, DOI 10.1016/j.jngse.2016.06.030
   Ghadar Y, 2014, PHYS CHEM CHEM PHYS, V16, P12475, DOI 10.1039/c4cp00602j
   Ghoufi A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3676056
   Grest G.S., 2006, SUBSTRUCTURED MULTIB
   Grimvall G., 1999, THERMOPHYSICAL PROPE, P79
   Hatriss RC, 1988, GLOBAL BIOGEOCHEM CY, V2, P231, DOI 10.1029/GB002i003p00231
   Hayama H, 2017, J CHEM THERMODYN, V108, P71, DOI 10.1016/j.jct.2017.01.007
   Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509
   Hockney R. W., 1988, COMPUTER SIMULATION
   Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075
   Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402
   Isele-Holder RE, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764089
   Jacobson LC, 2009, J PHYS CHEM B, V113, P10298, DOI 10.1021/jp903439a
   Jendi ZM, 2015, CRYST GROWTH DES, V15, P5301, DOI 10.1021/acs.cgd.5b00829
   JORGENSEN WL, 1984, J AM CHEM SOC, V106, P6638, DOI 10.1021/ja00334a030
   Kashchiev D, 2003, J CRYST GROWTH, V250, P499, DOI 10.1016/S0022-0248(02)02461-2
   Kashchiev D, 2002, J CRYST GROWTH, V243, P476, DOI 10.1016/S0022-0248(02)01576-2
   KASHCHIEV D, 2000, NUCL BASIC THEORY AP
   Khadem SA, 2015, IND ENG CHEM RES, V54, P10768, DOI 10.1021/acs.iecr.5b01681
   Khadem SA, 2014, J NAT GAS SCI ENG, V20, P407, DOI 10.1016/j.jngse.2014.07.010
   KIRKWOOD JG, 1949, J CHEM PHYS, V17, P338, DOI 10.1063/1.1747248
   Klauda JB, 2005, ENERG FUEL, V19, P459, DOI 10.1021/ef049798o
   Knott BC, 2012, J AM CHEM SOC, V134, P19544, DOI 10.1021/ja309117d
   Koh CA, 2011, ANNU REV CHEM BIOMOL, V2, P237, DOI 10.1146/annurev-chembioeng-061010-114152
   Kvamme B., 2006, COMPUTATIONAL METHOD
   Liang S, 2015, CAN J CHEM, V93, P791, DOI 10.1139/cjc-2014-0443
   Lupi L, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4961652
   McCain W. D., 1990, PROPERTIES PETROLEUM
   Mirzaeifard S, 2018, COLLOID INTERFAC SCI, V24, P75, DOI 10.1016/j.colcom.2018.04.004
   Vazquez UOM, 2009, J MATH CHEM, V45, P161, DOI 10.1007/s10910-008-9374-7
   Nourbakhsh A., 2012, DETERMINATION CAPILL
   Noya EG, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2901172
   Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Rey AD, 2000, LANGMUIR, V16, P845, DOI 10.1021/1a9902542
   Rowlinson J. S., 2013, MOL THEORY CAPILLARI
   Sakamaki R, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3579480
   Sarupria S, 2012, J PHYS CHEM LETT, V3, P2942, DOI 10.1021/jz3012113
   Scharlin P, 1998, PURE APPL CHEM, V70, P1895, DOI 10.1351/pac199870101895
   Schmidt KAG, 2007, FLUID PHASE EQUILIBR, V261, P230, DOI 10.1016/j.fluid.2007.07.045
   Sloan E.D., 2007, CLATHRATE HYDRATES N
   Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135
   Speight JG, 2017, ENVIRONMENTAL ORGANIC CHEMISTRY FOR ENGINEERS, P203, DOI 10.1016/B978-0-12-804492-6.00005-8
   TOLMAN RC, 1948, J CHEM PHYS, V16, P758, DOI 10.1063/1.1746994
   Udeagbara S.G., 2010, EFFECT TEMPERATURE I
   Vlasic TM, 2017, CRYST GROWTH DES, V17, P6407, DOI 10.1021/acs.cgd.7b01072
   Vlasic TM, 2016, AIP ADV, V6, DOI 10.1063/1.4961728
   Wang LK, 2003, FLUID PHASE EQUILIBR, V207, P143, DOI 10.1016/S0378-3812(03)00009-8
   Warrier P, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4968590
NR 64
TC 5
Z9 5
U1 31
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 114769
DI 10.1016/j.ces.2019.01.051
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900001
DA 2020-05-12
ER

PT J
AU Mohammadi, MH
   Sotiropoulos, F
   Brinkerhoff, JR
AF Mohammadi, Mohammad Haji
   Sotiropoulos, Fotis
   Brinkerhoff, Joshua R.
TI Eulerian-Eulerian large eddy simulation of two-phase dilute bubbly flows
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Large eddy simulation; Two-phase dynamical modeling; Two-fluid
   Eulerian/Eulerian; Bubble column
ID GAS-LIQUID FLOW; EPSILON TURBULENCE MODEL; NUMERICAL-SIMULATION; DYNAMIC
   SIMULATION; LIFT FORCE; MASS-TRANSFER; LARGE-SCALE; COLUMN;
   APPLICABILITY; COALESCENCE
AB An efficient mathematical model is presented for conducting large eddy simulation (LES) of turbulent bubbly flows at low gas hold-ups. The mathematical model is based on the filtered multi-fluid equations derived by application of the component-weighted volume-averaging process of each phase. A two-fluid model is applied to the filtered set of equations, yielding a more computationally tractable set of filtered equations. The filtered equations are formulated in generalized curvilinear coordinates to simulate turbulent gas-liquid bubbly flows in complex geometries. The Germano model is used to account for subgrid turbulent stresses. The gas and liquid momentum equations are discretized with the hybrid staggered/non-staggered method. The performance of the developed mathematical model is demonstrated by simulating the benchmark test case of a turbulent gas-liquid bubbly flow in a rectangular bubble column. The accuracy of the proposed method is assessed via comparison with the experimental data and other numerical results in the literature. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mohammadi, Mohammad Haji; Brinkerhoff, Joshua R.] Univ British Columbia Okanagan, Sch Engn, 1137 Alumni Ave, Kelowna, BC V1V 1V7, Canada.
   [Sotiropoulos, Fotis] SUNY Stony Brook, Coll Engn & Appl Sci, Stony Brook, NY 11794 USA.
RP Brinkerhoff, JR (reprint author), Univ British Columbia Okanagan, Sch Engn, 1137 Alumni Ave, Kelowna, BC V1V 1V7, Canada.
EM joshua.brinkerhoff@ubc.ca
FU Office of Energy Efficiency and Renewable Energy (EERE), U.S. Department
   of EnergyUnited States Department of Energy (DOE) [DEEE0002668]; Hydro
   Research Foundation
FX The information, data, or work presented herein was funded in part by
   the Office of Energy Efficiency and Renewable Energy (EERE), U.S.
   Department of Energy, under Award Number DEEE0002668 and the Hydro
   Research Foundation. Computational resources provided by Compute Canada
   are gratefully acknowledged.
CR Alletto M, 2012, INT J MULTIPHAS FLOW, V45, P70, DOI 10.1016/j.ijmultiphaseflow.2012.05.005
   Bai W, 2011, IND ENG CHEM RES, V50, P4320, DOI 10.1021/ie1017805
   Besagni G, 2017, CHEM ENG SCI, V170, P270, DOI 10.1016/j.ces.2017.03.043
   Bombardelli F., 2004, THESIS
   Bombardelli F.A., 2006, MECANICA COMPUT, VXXIII, P1969
   BOMBARDELLI FA, 2003, P 2003 WORLD WAT ENV
   Bombardelli F, 2009, ENVIRON FLUID MECH, V9, P207, DOI 10.1007/s10652-008-9091-6
   Borchers O, 1999, CHEM ENG SCI, V54, P5927, DOI 10.1016/S0009-2509(99)00181-5
   Bove S, 2004, INT J CHEM REACT ENG, V2
   Bunea F, 2010, IOP C SER EARTH ENV, V12, DOI 10.1088/1755-1315/12/1/012035
   Buscaglia GC, 2002, INT J MULTIPHAS FLOW, V28, P1763, DOI 10.1016/S0301-9322(02)00075-7
   Cabot W, 2000, FLOW TURBUL COMBUST, V63, P269, DOI 10.1023/A:1009958917113
   Carrica PM, 1999, INT J MULTIPHAS FLOW, V25, P257, DOI 10.1016/S0301-9322(98)00047-0
   Clift R., 2005, BUBBLES DROPS PARTIC
   DEBERTODANO ML, 1994, J FLUID ENG-T ASME, V116, P128
   Deen N.G., 2000, P 10 INT S APPL LAS, V38
   Deen NG, 2001, CHEM ENG SCI, V56, P6341, DOI 10.1016/S0009-2509(01)00249-4
   Delnoij E, 1997, CHEM ENG SCI, V52, P1429, DOI 10.1016/S0009-2509(96)00515-5
   Dhotre M., 2013, INT J CHEM ENG, V2013
   Dhotre MT, 2008, CHEM ENG J, V136, P337, DOI 10.1016/j.cej.2007.04.016
   Diaz ME, 2008, CHEM ENG J, V139, P363, DOI 10.1016/j.cej.2007.08.015
   Drew D.A., 1999, THEORY MULTICOMPONEN
   DREW DA, 1987, INT J MULTIPHAS FLOW, V13, P113, DOI 10.1016/0301-9322(87)90011-5
   Druzinec D, 2015, CHEM ENG SCI, V126, P160, DOI 10.1016/j.ces.2014.12.020
   Fayolle Y, 2007, CHEM ENG SCI, V62, P7163, DOI 10.1016/j.ces.2007.08.082
   Ge L, 2007, J COMPUT PHYS, V225, P1782, DOI 10.1016/j.jcp.2007.02.017
   GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955
   Hibiki T, 2007, CHEM ENG SCI, V62, P6457, DOI 10.1016/j.ces.2007.07.034
   ISHII M, 1979, AICHE J, V25, P843, DOI 10.1002/aic.690250513
   Kang S, 2011, ADV WATER RESOUR, V34, P98, DOI 10.1016/j.advwatres.2010.09.018
   Karn A, 2015, INT J HEAT MASS TRAN, V87, P512, DOI 10.1016/j.ijheatmasstransfer.2015.04.021
   Laborde-Boutet C, 2009, CHEM ENG SCI, V64, P4399, DOI 10.1016/j.ces.2009.07.009
   Lakehal D, 2002, J TURBUL, V3
   Lau YM, 2014, CHEM ENG SCI, V108, P9, DOI 10.1016/j.ces.2013.12.034
   Lau YM, 2011, CHEM ENG SCI, V66, P3309, DOI 10.1016/j.ces.2011.01.053
   Liao YX, 2019, CHEM ENG SCI, V202, P55, DOI 10.1016/j.ces.2019.03.007
   Liu ZQ, 2018, CHEM ENG J, V338, P465, DOI 10.1016/j.cej.2018.01.051
   Lopez de Bertodano M., 1994, International Journal of Multiphase Flow, V20, P805, DOI 10.1016/0301-9322(94)90095-7
   Lu JC, 2006, INT J MULTIPHAS FLOW, V32, P643, DOI 10.1016/j.ijmultiphaseflow.2006.02.003
   Lucas D, 2011, INT J MULTIPHAS FLOW, V37, P1178, DOI 10.1016/j.ijmultiphaseflow.2011.05.009
   Ma T, 2016, NUCL ENG DES, V299, P146, DOI 10.1016/j.nucengdes.2015.08.010
   Masterov MV, 2018, INT J MULTIPHAS FLOW, V107, P275, DOI 10.1016/j.ijmultiphaseflow.2018.06.006
   Milelli M., 2002, THESIS
   Milelli M., 2001, DIRECT LARGE EDDY SI, VIV, P461
   Mudde RF, 1999, CHEM ENG SCI, V54, P5061, DOI 10.1016/S0009-2509(99)00234-1
   Nauha EK, 2018, CHEM ENG J, V334, P2319, DOI 10.1016/j.cej.2017.11.182
   Niceno B, 2008, CHEM ENG SCI, V63, P3923, DOI 10.1016/j.ces.2008.04.050
   Niceno B, 2009, SCI TECHNOL NUCL INS, V2009, DOI 10.1155/2009/410272
   Rzehak R, 2017, CHEM ENG SCI, V157, P147, DOI 10.1016/j.ces.2016.04.056
   Rzehak R, 2012, NUCL ENG DES, V253, P41, DOI 10.1016/j.nucengdes.2012.07.009
   SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058
   SATO Y, 1981, INT J MULTIPHAS FLOW, V7, P167, DOI 10.1016/0301-9322(81)90003-3
   Simiano M, 2006, INT J MULTIPHAS FLOW, V32, P1160, DOI 10.1016/j.ijmultiphaseflow.2006.05.014
   Smith B., 1998, P 3 INT C MULT FLOW, P8
   Sokolichin A, 1997, CHEM ENG SCI, V52, P611, DOI 10.1016/S0009-2509(96)00425-3
   Sokolichin A, 2004, AICHE J, V50, P24, DOI 10.1002/aic.10003
   Sokolichin A, 1999, CHEM ENG SCI, V54, P2273, DOI 10.1016/S0009-2509(98)00420-5
   Sungkorn R, 2011, CHEM ENG SCI, V66, P2745, DOI 10.1016/j.ces.2011.03.032
   Tryggvason G., 2011, DIRECT NUMERICAL SIM
   Tryggvason G, 2006, FLUID DYN RES, V38, P660, DOI 10.1016/j.fluiddyn.2005.08.006
   UNVERDI SO, 1992, J COMPUT PHYS, V100, P25, DOI 10.1016/0021-9991(92)90307-K
   Vaidheeswaran A, 2017, INT J HEAT MASS TRAN, V115, P741, DOI 10.1016/j.ijheatmasstransfer.2017.08.075
   van den Hengel EIV, 2005, IND ENG CHEM RES, V44, P5233, DOI 10.1021/ie0492449
   Zhang D, 2006, CHEM ENG SCI, V61, P7593, DOI 10.1016/j.ces.2006.08.053
   Ziegenhein T, 2017, CAN J CHEM ENG, V95, P170, DOI 10.1002/cjce.22647
NR 65
TC 1
Z9 1
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115156
DI 10.1016/j.ces.2019.115156
PG 15
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900028
DA 2020-05-12
ER

PT J
AU Mottaghi, M
   Kuhn, S
AF Mottaghi, M.
   Kuhn, S.
TI Numerical investigation of well-structured porous media in a milli-scale
   tubular reactor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Milli-scale reactor; Porous medium; CFD; Mixing; Scale-up
ID OPEN CELLULAR STRUCTURES; RESIDENCE TIME DISTRIBUTION; PRESSURE-DROP
   MEASUREMENTS; METAL FOAMS; FLOW; CHANNEL; CFD; INTENSIFICATION;
   PERFORMANCE; TRANSPORT
AB Despite the many advantages of micro-reactors their application in industry is still limited due to their low throughput. To address this issue, micro-scale porous media are used as inserts in milli-scale tubular reactors. In this work, six different well-structured porous media (WSPM) consisting of cylindrical rods with an outer diameter of 250 mu m are characterized with computational fluid dynamics (CFD). The individual WSPM differ in the rotation of rod layers around the main flow direction, and the orientation of rod layers against the flow direction. The simulation results show that changing the rod layer orientation influences the flow heterogeneity, while the rod layer rotation affects the pore alignment resulting in connected fluid paths. Scalar transport simulations reveal that the WSPM result in a considerable mixing enhancement. This study underlines the potential of integrating WSPM in milli-scale reactors as scale-up approach, and how their geometry affects mixing. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mottaghi, M.; Kuhn, S.] Katholieke Univ Leuven, Dept Chem Engn, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
RP Kuhn, S (reprint author), Katholieke Univ Leuven, Dept Chem Engn, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
EM simon.kuhn@kuleuven.be
RI Kuhn, Simon/C-6177-2015
OI Kuhn, Simon/0000-0002-2816-0060
FU FWO (Odysseus II Grant)FWO [G0E6314N]
FX S. K. acknowledges financial support from FWO (Odysseus II Grant No.
   G0E6314N).
CR Boomsma K, 2002, J FLUID ENG-T ASME, V124, P263, DOI 10.1115/1.1429637
   Bothe D, 2010, HEAT MASS TRANSF, P17, DOI 10.1007/978-3-642-04549-3_2
   Busse C, 2018, CHEM ENG PROCESS, V124, P199, DOI 10.1016/j.cep.2018.01.023
   Code_aster, 2018, SALOME PLATF JUL 201
   DANCKWERTS PV, 1952, APPL SCI RES, V3, P279, DOI 10.1007/BF03184936
   de Barros FPJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051302
   Della Torre A, 2016, COMPUT CHEM ENG, V92, P55, DOI 10.1016/j.compchemeng.2016.04.031
   Della Torre A, 2014, INT J HEAT FLUID FL, V50, P72, DOI 10.1016/j.ijheatfluidflow.2014.05.005
   Giani L, 2005, IND ENG CHEM RES, V44, P9078, DOI 10.1021/ie050598p
   Giani L, 2005, IND ENG CHEM RES, V44, P4993, DOI 10.1021/ie0490886
   Hafeli R, 2016, CHEM ENG SCI, V143, P86, DOI 10.1016/j.ces.2015.12.022
   HALL MJ, 1994, PHYS FLUIDS, V6, P469, DOI 10.1063/1.868344
   Haller G, 2001, PHYSICA D, V149, P248, DOI 10.1016/S0167-2789(00)00199-8
   Harnby N., 1997, MIXING PROCESS IND
   Hutter C, 2011, CHEM ENG SCI, V66, P1132, DOI 10.1016/j.ces.2010.12.016
   Hutter C, 2011, CHEM ENG SCI, V66, P519, DOI 10.1016/j.ces.2010.11.015
   Hutter C, 2010, CHEM ENG SCI, V65, P3169, DOI 10.1016/j.ces.2010.02.002
   Huu TT, 2009, CHEM ENG SCI, V64, P5131, DOI 10.1016/j.ces.2009.08.028
   Inayat A, 2011, CHEM ENG SCI, V66, P2758, DOI 10.1016/j.ces.2011.03.031
   Klumpp M, 2014, CHEM ENG J, V242, P364, DOI 10.1016/j.cej.2013.12.060
   Krishnan S, 2006, J HEAT TRANS-T ASME, V128, P793, DOI 10.1115/1.2227038
   Kumar P, 2014, CHEM ENG SCI, V116, P793, DOI 10.1016/j.ces.2014.06.009
   Lacroix M, 2007, CHEM ENG SCI, V62, P3259, DOI 10.1016/j.ces.2007.03.027
   Lammermann M, 2018, CHEM ENG PROCESS, V126, P178, DOI 10.1016/j.cep.2018.02.027
   Lammermann M, 2016, CATAL TODAY, V273, P161, DOI 10.1016/j.cattod.2016.02.049
   Lang C, 2017, ENERG FUEL, V31, P12932, DOI 10.1021/acs.energyfuels.7b01765
   Lester DR, 2016, J FLUID MECH, V803, P144, DOI 10.1017/jfm.2016.486
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Lukens S, 2010, CHAOS, V20, DOI 10.1063/1.3271340
   Ortega-Casanova J, 2017, CHEM ENG PROCESS, V117, P18, DOI 10.1016/j.cep.2017.03.012
   Ottino J.M., 1989, KINEMATICS MIXING ST
   Ottino JM, 2004, PHILOS T R SOC A, V362, P923, DOI 10.1098/rsta.2003.1355
   OTTINO JM, 1991, PHYS FLUIDS A-FLUID, V3, P1417, DOI 10.1063/1.858020
   Podyacheva OY, 1997, REACT KINET CATAL L, V60, P243, DOI 10.1007/BF02475685
   Potdar A, 2019, CHEM-ING-TECH, V91, P592, DOI 10.1002/cite.201800128
   Potdar A, 2019, CHEM ENG J, V363, P337, DOI 10.1016/j.cej.2019.01.082
   Potdar A, 2017, REACT CHEM ENG, V2, P137, DOI 10.1039/c6re00185h
   Rahimi M, 2015, COMPUT CHEM ENG, V73, P172, DOI 10.1016/j.compchemeng.2014.12.007
   Razza S, 2016, CATAL TODAY, V273, P187, DOI 10.1016/j.cattod.2016.02.058
   Serres M, 2018, CHEM ENG SCI, V190, P149, DOI 10.1016/j.ces.2018.05.004
   Serres M, 2016, INT J MULTIPHAS FLOW, V85, P157, DOI 10.1016/j.ijmultiphaseflow.2016.06.003
   Suranani S, 2018, CHEM ENG PROCESS, V126, P62, DOI 10.1016/j.cep.2018.02.013
   Tourvieille JN, 2015, CHEM ENG J, V267, P332, DOI 10.1016/j.cej.2014.11.084
   Tourvieille JN, 2015, CHEM ENG SCI, V126, P406, DOI 10.1016/j.ces.2014.11.059
   Twigg MV, 2007, IND ENG CHEM RES, V46, P4166, DOI 10.1021/ie061122o
   Versteeg H. K., 2007, INTRO COMPUTATIONAL
   Weeks SW, 1998, WATER RESOUR RES, V34, P3315, DOI 10.1029/98WR02535
   Weller H., 2019, OPENFOAM FREE CFD SO
   Woldemariam M, 2016, CHEM ENG SCI, V152, P26, DOI 10.1016/j.ces.2016.05.030
   YANG HH, 1992, POLYM ENG SCI, V32, P1411, DOI 10.1002/pen.760321903
   Zhang JS, 2017, ANNU REV CHEM BIOMOL, V8, P285, DOI 10.1146/annurev-chembioeng-060816-101443
NR 51
TC 1
Z9 1
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115146
DI 10.1016/j.ces.2019.08.004
PG 12
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900018
DA 2020-05-12
ER

PT J
AU Naukkarinen, T
   Nikku, M
   Turunen-Saaresti, T
AF Naukkarinen, Tomi
   Nikku, Markku
   Turunen-Saaresti, Teemu
TI CFD-DEM simulations of hydrodynamics of combined ion exchange-membrane
   filtration
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE CFD-DEM; Combined-filtration; Wastewater; Resin beads
ID DISCRETE PARTICLE SIMULATION; ENDOCRINE DISRUPTING CHEMICALS; LARGE-EDDY
   SIMULATION; NUMERICAL-SIMULATION; BISPHENOL-A; ROLLING FRICTION;
   FLUIDIZED-BED; FLOW; MODEL; WATER
AB The combined ion exchange-membrane filtration system, whereby an active filtration layer is formed using a slurry flow of resin beads and water, has the potential to reduce energy usage and increase the quality of purified wastewater. The hydrodynamic design of these systems is in its infancy and there is a need for numerical methods to analyze such systems. In this work, computational fluid dynamics coupled with the discrete element method (CFD-DEM) is utilized to analyse the hydrodynamics of the combined ion exchange-membrane filtration system, and the formation of the filtrating bed and the parameters affecting it are studied by varying the flow conditions. As a result, the details of the bed formation with insights on the parameters affecting these phenomena and suggestions for an improved hydrodynamic design of the combined ion exchange-membrane filtration system are presented. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Naukkarinen, Tomi; Nikku, Markku; Turunen-Saaresti, Teemu] Lappeenranta Univ Technol, Sch Energy Syst, Lappeenranta, Finland.
RP Naukkarinen, T (reprint author), Lappeenranta Univ Technol, Sch Energy Syst, Lappeenranta, Finland.
EM Tomi.Naukkarinen@lut.fi
RI Turunen-Saaresti, Teemu/AAE-5413-2020
OI Turunen-Saaresti, Teemu/0000-0001-6560-5762; Nikku,
   Markku/0000-0001-5418-5328
CR Abdulgader H.A., 2013, SEP PURIF TECHNOL, V116, P253, DOI DOI 10.1016/J.SEPPUR.2013.05.052
   Ai J, 2011, POWDER TECHNOL, V206, P269, DOI 10.1016/j.powtec.2010.09.030
   Al-Sammarraee M, 2009, CHEM ENG J, V152, P307, DOI 10.1016/j.cej.2009.04.062
   Alobaid F, 2013, ADV POWDER TECHNOL, V24, P403, DOI 10.1016/j.apt.2012.09.003
   ANDERSON TB, 1967, IND ENG CHEM FUND, V6, P527, DOI 10.1021/i160024a007
   Annaland MS, 2005, CHEM ENG SCI, V60, P6188, DOI 10.1016/j.ces.2005.04.038
   Arolla SK, 2015, INT J MULTIPHAS FLOW, V75, P1, DOI 10.1016/j.ijmultiphaseflow.2015.04.010
   Belfroid AC, 1999, SCI TOTAL ENVIRON, V225, P101, DOI 10.1016/S0048-9697(98)00336-2
   Bell R.A., 2000, NUMERICAL MODELLING
   Biegert E, 2017, J COMPUT PHYS, V340, P105, DOI 10.1016/j.jcp.2017.03.035
   Blais B, 2017, CHEM ENG RES DES, V123, P388, DOI 10.1016/j.cherd.2017.05.021
   Blais B, 2015, COMPUT FLUIDS, V114, P121, DOI 10.1016/j.compfluid.2015.03.002
   Capecelatro J, 2013, INT J MULTIPHAS FLOW, V55, P64, DOI 10.1016/j.ijmultiphaseflow.2013.04.006
   Chu KW, 2008, POWDER TECHNOL, V179, P104, DOI 10.1016/j.powtec.2007.06.017
   Crowe C.T., 2011, MULTIPHASE FLOWS DRO
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Dallali M, 2015, ADV WATER RESOUR, V81, P33, DOI 10.1016/j.advwatres.2014.12.004
   DAVIS RH, 1986, J FLUID MECH, V163, P479, DOI 10.1017/S0022112086002392
   de Jong JF, 2012, POWDER TECHNOL, V230, P93, DOI 10.1016/j.powtec.2012.06.059
   Deen NG, 2007, CHEM ENG SCI, V62, P28, DOI 10.1016/j.ces.2006.08.014
   Deshpande R, 2019, AICHE J, V65, P1294, DOI 10.1002/aic.16529
   Di Renzo A, 2004, CHEM ENG SCI, V59, P525, DOI 10.1016/j.ces.2003.09.037
   Di Renzo A, 2007, CHEM ENG SCI, V62, P116, DOI 10.1016/j.ces.2006.08.009
   Dong KJ, 2012, AICHE J, V58, P1409, DOI 10.1002/aic.12682
   Dufresne M, 2009, COMPUT FLUIDS, V38, P1042, DOI 10.1016/j.compfluid.2008.01.011
   Durand R., 1953, P MINN INT HYDR CONV, P89
   Elghannay H, 2018, INT J SEDIMENT RES, V33, P137, DOI 10.1016/j.ijsrc.2017.09.006
   Elghannay HA, 2016, INT J MULTIPHAS FLOW, V85, P284, DOI 10.1016/j.ijmultiphaseflow.2016.06.019
   ELGHOBASHI S, 1994, APPL SCI RES, V52, P309, DOI 10.1007/BF00936835
   Elghobashi S., 2006, UPDATED CLASSIFICATI
   GILLIES RG, 1994, PARTICUL SCI TECHNOL, V12, P45, DOI 10.1080/02726359408906641
   Gondret P, 2002, PHYS FLUIDS, V14, P643, DOI 10.1063/1.1427920
   Goniva C, 2012, PARTICUOLOGY, V10, P582, DOI 10.1016/j.partic.2012.05.002
   Huggins DL, 2005, AQUACULT ENG, V33, P167, DOI 10.1016/j.aquaeng.2005.01.008
   Kabay N, 2006, DESALINATION, V198, P158, DOI 10.1016/j.desal.2006.09.011
   Kalitzin G, 2005, J COMPUT PHYS, V204, P265, DOI 10.1016/j.jcp.2004.10.018
   Ketterhagen WR, 2008, POWDER TECHNOL, V179, P126, DOI 10.1016/j.powtec.2007.06.023
   Kidanemariam AG, 2014, INT J MULTIPHAS FLOW, V67, P174, DOI 10.1016/j.ijmultiphaseflow.2014.08.008
   Kidanemariam AG, 2014, J FLUID MECH, V750, DOI 10.1017/jfm.2014.284
   Kloss C, 2012, PROG COMPUT FLUID DY, V12, P140, DOI 10.1504/PCFD.2012.047457
   Koch DL, 2001, ANNU REV FLUID MECH, V33, P619, DOI 10.1146/annurev.fluid.33.1.619
   Kuch HM, 2001, ENVIRON SCI TECHNOL, V35, P3201, DOI 10.1021/es010034m
   Laatikainen K, 2014, SEP SCI TECHNOL, V49, P763, DOI 10.1080/01496395.2013.860462
   Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, P269, DOI 10.1016/0045-7825(74)90029-2
   Legendre D, 2006, CHEM ENG SCI, V61, P3543, DOI 10.1016/j.ces.2005.12.028
   Lohaus J, 2018, J MEMBRANE SCI, V553, P90, DOI 10.1016/j.memsci.2018.02.023
   Loth E, 2009, ENVIRON FLUID MECH, V9, P187, DOI [10.1007/s10652-009-9123-X, 10.1007/s10652-009-9123-x]
   Ma WF, 2015, J ENVIRON SCI-CHINA, V31, P154, DOI 10.1016/j.jes.2014.12.006
   Ozel A, 2016, CHEM ENG SCI, V155, P258, DOI 10.1016/j.ces.2016.08.014
   Peng ZB, 2014, CHEM ENG SCI, V116, P49, DOI 10.1016/j.ces.2014.04.040
   Poschel T, 2005, COMPUTATIONAL GRANUL, DOI [10.1007/3-540-27720-X, DOI 10.1007/3-540-27720-X]
   Potic B, 2005, CHEM ENG SCI, V60, P5982, DOI 10.1016/j.ces.2005.04.047
   SAFFMAN PG, 1965, J FLUID MECH, V22, P385, DOI 10.1017/S0022112065000824
   Schiller R. E., 1991, HDB DREDGING
   Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052
   Sun R, 2016, COMPUT GEOSCI-UK, V89, P207, DOI 10.1016/j.cageo.2016.01.011
   Sun Y, 2013, ENVIRON POLLUT, V180, P339, DOI 10.1016/j.envpol.2013.05.006
   Tarpagkou R, 2013, APPL MATH MODEL, V37, P3478, DOI 10.1016/j.apm.2012.08.011
   Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9
   Tiihonen J, 2001, J APPL POLYM SCI, V82, P1256, DOI 10.1002/app.1959
   Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064
   TSUJI Y, 1992, POWDER TECHNOL, V71, P239, DOI 10.1016/0032-5910(92)88030-L
   TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7
   Uzi A, 2018, POWDER TECHNOL, V326, P302, DOI 10.1016/j.powtec.2017.11.067
   Wang Q, 1997, INT J MULTIPHAS FLOW, V23, P749, DOI 10.1016/S0301-9322(97)00014-1
   Wang RQ, 2014, INT J MULTIPHAS FLOW, V67, P65, DOI 10.1016/j.ijmultiphaseflow.2014.08.004
   Wensrich CM, 2012, POWDER TECHNOL, V217, P409, DOI 10.1016/j.powtec.2011.10.057
   Wolska J, 2014, SEP SCI TECHNOL, V49, P1643, DOI 10.1080/01496395.2014.906459
   Worster R.C., 1955, P I MECH ENG, V169, P563
   Yoon Y, 2007, DESALINATION, V202, P16, DOI 10.1016/j.desal.2005.12.033
   Yoon YM, 2003, WATER RES, V37, P3530, DOI 10.1016/S0043-1354(03)00239-2
   ZHANG DZ, 1994, J FLUID MECH, V267, P185, DOI 10.1017/S0022112094001151
   Zhang JP, 2000, POWDER TECHNOL, V113, P310, DOI 10.1016/S0032-5910(00)00314-4
   Zhang JP, 1999, POWDER TECHNOL, V106, P98, DOI 10.1016/S0032-5910(99)00053-4
   Zhao T, 2014, GRANUL MATTER, V16, P921, DOI 10.1007/s10035-014-0534-0
   Zhou ZY, 2010, J FLUID MECH, V661, P482, DOI 10.1017/S002211201000306X
   Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006
NR 77
TC 0
Z9 0
U1 8
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115151
DI 10.1016/j.ces.2019.08.009
PG 13
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900023
DA 2020-05-12
ER

PT J
AU Russell, AW
   Kahouadji, L
   Mirpuri, K
   Quarmby, A
   Piccione, PM
   Matar, OK
   Luckham, PF
   Markides, CN
AF Russell, Andrew W.
   Kahouadji, Lyes
   Mirpuri, Karan
   Quarmby, Andrew
   Piccione, Patrick M.
   Matar, Omar K.
   Luckham, Paul F.
   Markides, Christos N.
TI Mixing viscoplastic fluids in stirred vessels over multiple scales: A
   combined experimental and CFD approach
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Caverns; Mixing; Scaling; Stirred vessel; Viscoplastic; Visualisation
ID SHEAR-THINNING FLUIDS; NON-NEWTONIAN FLUIDS; LASER-INDUCED FLUORESCENCE;
   HERSCHEL-BULKLEY FLUIDS; POSSESSING YIELD-STRESS; PSEUDOPLASTIC FLUIDS;
   CAVERN SIZES; RHEOLOGICAL PROPERTIES; CARBOPOL GELS; FLOW VISUALIZATION
AB Dye visualisation techniques and CFD are used to characterise the flow of viscoplastic Carbopol (TM) solutions in stirred vessel systems over multiple scales. Centrally-mounted, geometrically-similar Rushton turbine (RT) impellers are used to agitate various Carbopol 980 (C980) fluids. The dimensionless cavern diameters, D-c/D, are scaled against a combination of dimensionless parameters: Re-m (-0.3)Re(y)(0.6)n (-0.1)k(s)(-1), where Re-m, Re-y, n and k(s) are the modified power-law Reynolds number, yield stress Reynolds number, flow behaviour index and impeller geometry constant, respectively. Excellent collapse of the data is demonstrated for the fluids and range of flows investigated. Additional data are collected using a pitched-blade turbine (PBT) with cavern size similarity being shown between the RT and PBT datasets. These results are important in the context of scale-up/scale-down mixing processes in stirred vessels containing complex fluids and can be used to show that flow similarity can be achieved in these systems if the processes are scaled appropriately. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Russell, Andrew W.; Kahouadji, Lyes; Mirpuri, Karan; Matar, Omar K.; Luckham, Paul F.; Markides, Christos N.] Imperial Coll London, Dept Chem Engn, London SW7 2AZ, England.
   [Quarmby, Andrew; Piccione, Patrick M.] Syngenta, Proc Studies Grp, Technol & Engn, Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England.
   [Piccione, Patrick M.] Syngenta, Technol & Engn, Proc Studies Grp, Breitenloh 5, CH-4333 Munchwilen, Switzerland.
   [Piccione, Patrick M.] F Hoffmann La Roche & Cie AG, Grenzacherstr 124, CH-4070 Basel, Switzerland.
   [Quarmby, Andrew] Solenis Ltd, Cleckheaton Rd, Bradford BD12 0JZ, W Yorkshire, England.
RP Markides, CN (reprint author), Imperial Coll London, Dept Chem Engn, London SW7 2AZ, England.
EM c.markides@imperial.ac.uk
RI Markides, Christos N./D-3162-2015; Luckham, Paul F/B-1325-2015
OI Markides, Christos N./0000-0002-4219-1867; Luckham, Paul
   F/0000-0002-8191-540X
FU Syngenta Ltd; UK Engineering and Physical Sciences Research Council
   (EPSRC)Engineering & Physical Sciences Research Council (EPSRC)
   [EP/M507878/1, EP/K003976/1]
FX The authors would like to thank Syngenta Ltd for funding this work
   through a PhD CASE studentship. This work was also supported by the UK
   Engineering and Physical Sciences Research Council (EPSRC) [grant
   numbers EP/M507878/1, EP/K003976/1]. Special thanks to Patricia Carry
   for granting permission for use of the Anton Paar MCR 302 and to John
   Hone for his rheology expertise and assistance throughout this work. We
   thank with gratitude Damir Juric, Jalel Chergui, Seungwon Shin and
   Richard Craster for helpful numerical discussions. The numerical
   simulations were performed with code BLUE and run using the
   high-performance computing resources provided by the Research Computing
   Service (RCS) of Imperial College London. Data supporting this
   publication can be obtained on request from cep-lab@imperial.ac.uk.
CR Adams LW, 2007, CHEM ENG RES DES, V85, P598, DOI 10.1205/cherd06170
   Amanullah A, 1998, BIOTECHNOL BIOENG, V57, P95, DOI 10.1002/(SICI)1097-0290(19980105)57:1<95::AID-BIT12>3.0.CO;2-7
   Amanullah A, 1998, CHEM ENG SCI, V53, P455, DOI 10.1016/S0009-2509(97)00200-5
   Amanullah A, 1997, FOOD BIOPROD PROCESS, V75, P232, DOI 10.1205/096030897531630
   Ameur H, 2015, ENERGY, V93, P1980, DOI 10.1016/j.energy.2015.10.084
   Arratia PE, 2006, AICHE J, V52, P2310, DOI 10.1002/aic.10847
   Aubin J, 2000, CHEM ENG RES DES, V78, P1105, DOI 10.1205/026387600528382
   Balmforth NJ, 2014, ANNU REV FLUID MECH, V46, P121, DOI 10.1146/annurev-fluid-010313-141424
   BARRY BW, 1979, INT J PHARMACEUT, V2, P1, DOI 10.1016/0378-5173(79)90025-5
   Bertrand F, 1996, J CHEM ENG JPN, V29, P51, DOI 10.1252/jcej.29.51
   Bonacucina G, 2004, INT J PHARM, V282, P115, DOI 10.1016/j.ijpharm.2004.06.012
   Charogiannis A, 2019, INT J MULTIPHAS FLOW, V118, P193, DOI 10.1016/j.ijmultiphaseflow.2019.06.002
   Cherdantsev AV, 2019, INT J MULTIPHAS FLOW, V119, P237, DOI 10.1016/j.ijmultiphaseflow.2019.07.013
   CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575
   Cortada-Garcia M, 2018, CHEM ENG SCI, V179, P133, DOI 10.1016/j.ces.2018.01.010
   Cortada-Garcia M, 2017, CHEM ENG RES DES, V119, P171, DOI 10.1016/j.cherd.2017.01.018
   Curran SJ, 2000, IND ENG CHEM RES, V39, P195, DOI 10.1021/ie990468e
   Dinkgreve M, 2016, J NON-NEWTON FLUID, V238, P233, DOI 10.1016/j.jnnfm.2016.11.001
   Edwards M.F., 1985, MIXING PROCESS IND, P131
   Ein-Mozaffari F, 2009, CHEM ENG RES DES, V87, P515, DOI 10.1016/j.cherd.2008.12.020
   Elson T.P., 1988, 6TH P EUR C MIX PAV, P485
   ELSON TP, 1986, CHEM ENG SCI, V41, P2555, DOI 10.1016/0009-2509(86)80041-0
   ELSON TP, 1990, CHEM ENG COMMUN, V94, P143, DOI 10.1080/00986449008911461
   Fadlun EA, 2000, J COMPUT PHYS, V161, P35, DOI 10.1006/jcph.2000.6484
   Galindo E, 1996, CHEM ENG TECHNOL, V19, P315, DOI 10.1002/ceat.270190405
   GALINDO E, 1992, BIOTECHNOL PROGR, V8, P233, DOI 10.1021/bp00015a009
   GALINDO E, 1993, CHEM ENG TECHNOL, V16, P102, DOI DOI 10.1002/CEAT.270160206
   GODA K, 1979, J COMPUT PHYS, V30, P76, DOI 10.1016/0021-9991(79)90088-3
   HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178
   Herschel WH, 1926, KOLLOID Z, V39, P291, DOI 10.1007/BF01432034
   HIRATA Y, 1994, J CHEM ENG JPN, V27, P235, DOI 10.1252/jcej.27.235
   Hui LK, 2009, CHEM ENG SCI, V64, P509, DOI 10.1016/j.ces.2008.09.021
   Ibarra R, 2018, INT J MULTIPHAS FLOW, V101, P47, DOI 10.1016/j.ijmultiphaseflow.2017.12.018
   Ihejirika I, 2007, CHEM ENG TECHNOL, V30, P606, DOI 10.1002/ceat.200700006
   Islam MT, 2004, PHARM RES-DORDR, V21, P1192, DOI 10.1023/B:PHAM.0000033006.11619.07
   JAWORSKI Z, 1994, CHEM ENG SCI, V49, P3321, DOI 10.1016/0009-2509(94)E0075-2
   Kazemzadeh A, 2017, CHEM ENG PROCESS, V111, P101, DOI 10.1016/j.cep.2016.10.019
   Kazemzadeh A, 2016, CAN J CHEM ENG, V94, P2394, DOI 10.1002/cjce.22601
   Kazemzadeh A, 2016, CHEM ENG RES DES, V114, P202, DOI 10.1016/j.cherd.2016.08.017
   Kim JY, 2003, COLLOID POLYM SCI, V281, P614, DOI 10.1007/s00396-002-0808-7
   Letellier B, 2002, CHEM ENG SCI, V57, P4617, DOI 10.1016/S0009-2509(02)00371-8
   Malkin A, 2017, RHEOL ACTA, V56, P177, DOI 10.1007/s00397-016-0963-2
   Mavros P, 2001, CHEM ENG RES DES, V79, P113, DOI 10.1205/02638760151095926
   METZNER AB, 1961, AICHE J, V7, P3, DOI 10.1002/aic.690070103
   METZNER AB, 1957, AICHE J, V3, P3, DOI 10.1002/aic.690030103
   Oppong FK, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041405
   Pakzad L, 2008, CHEM ENG SCI, V63, P2508, DOI 10.1016/j.ces.2008.02.009
   Pakzad L, 2013, CHEM ENG SCI, V101, P642, DOI 10.1016/j.ces.2013.07.027
   Pakzad L, 2013, CHEM ENG COMMUN, V200, P1553, DOI 10.1080/00986445.2012.751380
   Pakzad L, 2013, CHEM ENG RES DES, V91, P761, DOI 10.1016/j.cherd.2012.09.008
   Pakzad L, 2008, CHEM ENG PROCESS, V47, P2218, DOI 10.1016/j.cep.2007.12.003
   Pakzad L, 2008, CHEM ENG TECHNOL, V31, P1838, DOI 10.1002/ceat.200800362
   PAPANASTASIOU TC, 1987, J RHEOL, V31, P385, DOI 10.1122/1.549926
   Patel D, 2015, CHEM ENG RES DES, V100, P126, DOI 10.1016/j.cherd.2015.05.010
   Patel D, 2012, CHEM ENG RES DES, V90, P514, DOI 10.1016/j.cherd.2011.08.022
   Piau JM, 2007, J NON-NEWTON FLUID, V144, P1, DOI 10.1016/j.jnnfm.2007.02.011
   Piccione PM, 2017, J CHEM EDUC, V94, P726, DOI 10.1021/acs.jchemed.6b00633
   Saeed S, 2008, IND ENG CHEM RES, V47, P7465, DOI 10.1021/ie800496x
   Saeed S, 2008, J CHEM TECHNOL BIOT, V83, P559, DOI 10.1002/jctb.1833
   Saeed S, 2007, IND ENG CHEM RES, V46, P2172, DOI 10.1021/ie0607548
   SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2
   Solomon J, 1981, CHEM ENG COMMUN, V11, P143, DOI 10.1080/00986448108910992
   Sossa-Echeverria J, 2015, CHEM ENG PROCESS, V93, P66, DOI 10.1016/j.cep.2015.04.009
   Sossa-Echeverria J, 2014, AICHE J, V60, P1156, DOI 10.1002/aic.14309
   Sussman M, 1998, COMPUT FLUIDS, V27, P663, DOI 10.1016/S0045-7930(97)00053-4
   TEMAM R, 1968, B SOC MATH FR, V96, P115
   Wichterle K., 1975, CHISA 75
   Wichterle K, 1981, INT CHEM ENG, V21, P116
   Wright SF, 2017, EXP FLUIDS, V58, DOI 10.1007/s00348-017-2386-y
   Xiao Q, 2014, AICHE J, V60, P3057, DOI 10.1002/aic.14470
   Zhang LP, 2014, BIOCHEM ENG J, V90, P324, DOI 10.1016/j.bej.2014.06.018
NR 71
TC 2
Z9 2
U1 17
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115129
DI 10.1016/j.ces.2019.07.047
PG 16
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900006
DA 2020-05-12
ER

PT J
AU de Menezes, DES
   Sum, AK
   Desmedt, A
   Pessoa, PD
   Fuentes, MDR
AF Sanches de Menezes, Davi Eber
   Sum, Amadeu K.
   Desmedt, Arnaud
   Pessoa Filho, Pedro de Alcantara
   Robustillo Fuentes, Maria Dolores
TI Coexistence of sI and sII in methane-propane hydrate former systems at
   high pressures
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Methane propane hydrate; Metastable structure; High pressure
   calorimetry; Isochoric method
ID PHASE-EQUILIBRIUM DATA; DIFFERENTIAL SCANNING CALORIMETRY; GAS;
   DISSOCIATION; DSC; STABILITY; KINETICS; WATER; MIXTURES; ACCURACY
AB The hydrate-former system composed of methane-propane-water was studied through HP-mu DSC and a PVT cell. New equilibrium data were obtained. Results reveal evidence of the simultaneous formation of structures I and II, although only sII is expected at such conditions at equilibrium. Most of sI is present as a metastable structure, but a small fraction of it seems to provide a more stable system, mainly at excess methane conditions. The effect of heating rate, mixing, multiple cycles and initial gas phase composition on the formation of both structures was evaluated. These factors affect the formation kinetics, the type and the proportion of each hydrate structure and hence the thermodynamic profile during dissociation. Raman spectroscopy was applied for studying ex situ single and double hydrates, suggesting a higher fraction of sII than sI for all gas phase compositions studied, and higher occupancy of large cavities by methane molecules as methane content increases. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sanches de Menezes, Davi Eber; Pessoa Filho, Pedro de Alcantara; Robustillo Fuentes, Maria Dolores] Univ Sao Paulo, Engn Sch, Dept Chem Engn, Caixa Postal 61548, BR-05424970 Sao Paulo, SP, Brazil.
   [Sum, Amadeu K.] Colorado Sch Mines, Chem & Biol Engn Dept, Phases Flow Lab, Golden, CO 80401 USA.
   [Desmedt, Arnaud] Univ Bordeaux, CNRS, UMR5255, Grp Spectroscopie Mol,Inst Sci Mol, Bordeaux, France.
RP Fuentes, MDR (reprint author), Univ Sao Paulo, Engn Sch, Dept Chem Engn, Caixa Postal 61548, BR-05424970 Sao Paulo, SP, Brazil.
EM mrobustillof@gmail.com
RI de Alcantara Pessoa Filho, Pedro/B-5681-2008; FUENTES, MARIA DOLORES
   ROBUSTILLO/A-7962-2013
OI de Alcantara Pessoa Filho, Pedro/0000-0003-4315-7238; FUENTES, MARIA
   DOLORES ROBUSTILLO/0000-0001-7148-8443; Sum, Amadeu/0000-0003-1903-4537
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/02140-7, 2014/25740-0, 2015/23148-9, 2017/01351-2]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [306184/2017-6]; FEDEREuropean Union (EU); Region AquitaineRegion
   Nouvelle-Aquitaine
FX The group thank to FAPESP (Processes 2014/02140-7, 2014/25740-0,
   2015/23148-9, 2017/01351-2) and CNPq (Process 306184/2017-6) for
   financial support. All Raman experiments have been performed at the
   platform SIV ("Spectroscopie et Imagerie Vibrationnelle") at University
   of Bordeaux, funded by the FEDER and the Region Aquitaine.
CR Aladko E.Ya., 2002, J SUPRAMOL CHEM, V2, P369
   Broseta D., 2017, GAS HYDRATES
   Cha MJ, 2016, FLUID PHASE EQUILIBR, V413, P2, DOI 10.1016/j.fluid.2015.08.010
   Chazallon B., 2017, GAS HYDRATES FUNDAME, V1, P63
   Chong Z.R., 2016, APPL ENERGY, V162
   Chu CK, 2016, FLUID PHASE EQUILIBR, V413, P57, DOI 10.1016/j.fluid.2015.10.007
   Dalmazzone C., 2000, SPE ANN TECHN C EXH
   Dalmazzone D, 2002, J THERM ANAL CALORIM, V70, P493, DOI 10.1023/A:1021632709287
   Dalmazzone D, 2009, CHEM ENG SCI, V64, P2020, DOI 10.1016/j.ces.2009.01.028
   Daraboina N, 2011, ENERG FUEL, V25, P4392, DOI 10.1021/ef200812m
   Davies SR, 2010, IND ENG CHEM RES, V49, P12319, DOI 10.1021/ie1017173
   Davies SR, 2009, CHEM ENG SCI, V64, P370, DOI 10.1016/j.ces.2008.10.017
   Gupta A, 2008, CHEM ENG SCI, V63, P5848, DOI 10.1016/j.ces.2008.09.002
   Hu Y, 2017, J NAT GAS SCI ENG, V46, P750, DOI 10.1016/j.jngse.2017.08.004
   Hu Y, 2017, FLUID PHASE EQUILIBR, V450, P24, DOI 10.1016/j.fluid.2017.07.003
   Kang SP, 2001, J CHEM THERMODYN, V33, P513, DOI 10.1006/jcht.2000.0765
   Klapproth A, 2019, J PHYS CHEM C, V123, P2703, DOI 10.1021/acs.jpcc.8b06693
   Koh CA, 2011, ANNU REV CHEM BIOMOL, V2, P237, DOI 10.1146/annurev-chembioeng-061010-114152
   Kumar A, 2019, ISCIENCE, V14, P136, DOI 10.1016/j.isci.2019.03.020
   Kumar R, 2008, AICHE J, V54, P2132, DOI 10.1002/aic.11527
   Lachance JW, 2008, CHEM ENG SCI, V63, P3942, DOI 10.1016/j.ces.2008.04.049
   Le Parlouer P, 2004, J THERM ANAL CALORIM, V78, P165, DOI 10.1023/B:JTAN.0000042164.19602.7e
   Lin W, 2014, FLUID PHASE EQUILIBR, V372, P63, DOI 10.1016/j.fluid.2014.03.026
   Lin W, 2013, J CHEM THERMODYN, V61, P132, DOI 10.1016/j.jct.2013.02.005
   MAK TCW, 1965, J CHEM PHYS, V42, P2732, DOI 10.1063/1.1703229
   Masoudi R, 2004, FLUID PHASE EQUILIBR, V219, P157, DOI 10.1016/j.fluid.2004.01.031
   MCLEOD HO, 1961, T SOC PETROL EN AIME, V222, P590
   MCMULLAN RK, 1965, J CHEM PHYS, V42, P2725, DOI 10.1063/1.1703228
   Mohammad-Taheri M, 2013, FLUID PHASE EQUILIBR, V338, P257, DOI 10.1016/j.fluid.2012.10.010
   Mohammadi AH, 2005, AICHE J, V51, P2825, DOI 10.1002/aic.10526
   Nixdorf J, 1997, FLUID PHASE EQUILIBR, V139, P325, DOI 10.1016/S0378-3812(97)00141-6
   Petuya C, 2018, CRYSTALS, V8, DOI 10.3390/cryst8040145
   Petuya C, 2018, CHEM COMMUN, V54, P4290, DOI [10.1039/c8cc00538a, 10.1039/C8CC00538A]
   Petuya C, 2018, J PHYS CHEM C, V122, P566, DOI 10.1021/acs.jpcc.7b10151
   Petuya C, 2017, J PHYS CHEM C, V121, P13798, DOI 10.1021/acs.jpcc.7b04947
   Sabil KM, 2015, J CHEM THERMODYN, V84, P7, DOI 10.1016/j.jct.2014.12.017
   Sami NA, 2013, INT J SCI ENG RES, V4
   de Menezes DES, 2018, BRAZ J CHEM ENG, V35, P403, DOI 10.1590/0104-6632.20180352s20160329
   Schicks JM, 2013, SPECTROCHIM ACTA A, V115, P528, DOI 10.1016/j.saa.2013.06.065
   Shin W, 2012, CHEM-ASIAN J, V7, P2235, DOI 10.1002/asia.201200040
   Sloan ED, 2008, CHEM IND-SER, V119, pXIX
   Sloan ED, 2010, ENERGIES, V3, P1991, DOI 10.3390/en3121991
   Sloan ED, 2011, NATURAL GAS HYDRATES IN FLOW ASSURANCE, P1
   Sloan ED, 1998, ENERG FUEL, V12, P191, DOI 10.1021/ef970164+
   Subramanian S, 2000, CHEM ENG SCI, V55, P5763, DOI 10.1016/S0009-2509(00)00162-7
   Sum AK, 1997, J PHYS CHEM B, V101, P7371, DOI 10.1021/jp970768e
   Sum AK, 2009, IND ENG CHEM RES, V48, P7457, DOI 10.1021/ie900679m
   Tohidi B, 2000, ANN NY ACAD SCI, V912, P924
   Uchida T, 2004, AICHE J, V50, P518, DOI 10.1002/aic.10045
   Wang LJ, 2013, ADV MATER RES-SWITZ, V616-618, P1202, DOI 10.4028/www.scientific.net/AMR.616-618.1202
   Ward ZT, 2015, J CHEM ENG DATA, V60, P424, DOI 10.1021/je5007423
   Xu CG, 2013, ENERGY, V59, P719, DOI 10.1016/j.energy.2013.07.056
   Zhang YF, 2004, J PHYS CHEM B, V108, P16717, DOI 10.1021/jp047421d
   Zhu JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5128
NR 54
TC 3
Z9 3
U1 21
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115149
DI 10.1016/j.ces.2019.08.007
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900021
DA 2020-05-12
ER

PT J
AU Senapati, A
   Singh, G
   Lakkaraju, R
AF Senapati, Arahata
   Singh, Gaurav
   Lakkaraju, Rajaram
TI Numerical simulations of an inline rising unequal-sized bubble pair in a
   liquid column
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Two phase flow; Computational fluid dynamics; Bubble coalescence;
   Coefficient of pressure; Drag force; Liquid fluctuation; Vortex
   structures; Hairpin structures
ID GAS-BUBBLES; AIR BUBBLES; MOTION; FLUID; DYNAMICS; VOLUME; WAKE;
   MECHANICS; FLOWS; RISE
AB We have studied the motion of a pair of unequal-sized bubbles rising inline in a quiescent liquid column, using the Volume of Fluid (VOF) method. In our work, a wide range of Archimedes numbers (400 < Ar < 5000) is used to study the bubbles' shape, rise-velocities, and the wake region. We found that the leading bubble is unaffected by the proximity of the trailing bubble and moves with its terminal speed, whereas, the trailing bubble shows an acceleration with an increase in its speed as it approaches the leading bubble. We have also examined the wake behaviour behind the bubbles using the pressure distribution and extracted the vortex structures using the Q-criterion. Our work has unveiled two dominant vortex structures in the wake: (1) a toroidal ring on the bubble surface near the maximum diameter plane which occasionally detaches, and (2) a set of hairpin-like structures near the rear stagnation point, which grows by diffusion. The interaction between the toroidal ring and the hairpins determine the overall wake features. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Senapati, Arahata; Singh, Gaurav; Lakkaraju, Rajaram] Indian Inst Technol Kharagpur, Dept Mech Engn, Computat Mech Grp, West Midnapore 721302, Bengal, India.
RP Lakkaraju, R (reprint author), Indian Inst Technol Kharagpur, Dept Mech Engn, Computat Mech Grp, West Midnapore 721302, Bengal, India.
EM rajaram.lv@gmail.com
FU Innovation in Science in Pursuit of Research (INSPIRE), Government of
   India; Department of Science and Technology, Government of
   IndiaDepartment of Science & Technology (India); BRNS-BARC, Department
   of Atomic Energy, Government of India
FX We are thankful to Innovation in Science in Pursuit of Research
   (INSPIRE) and Department of Science and Technology, Government of India
   for generously providing a research grant to understand two-phase flows.
   We are also grateful to Yada Nandukumar for his generous help in
   preparing the manuscript. RL is thankful to BRNS-BARC, Department of
   Atomic Energy, Government of India for their research grant support, and
   to Sharmila Lakkaraju for her encouragement regarding multiphase flow
   work.
CR Anna SL, 2016, ANNU REV FLUID MECH, V48, P285, DOI 10.1146/annurev-fluid-122414-034425
   Berberovic E, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036306
   BESSLER WF, 1987, J FLUID MECH, V185, P137, DOI 10.1017/S0022112087003112
   BHAGA D, 1981, J FLUID MECH, V105, P61, DOI 10.1017/S002211208100311X
   BHAGA D, 1980, CHEM ENG SCI, V35, P2467, DOI 10.1016/0009-2509(80)85059-7
   BIESHEUVEL A, 1982, J ENG MATH, V16, P349, DOI 10.1007/BF00037735
   BRENNEN CE, 1995, CAVITATION BUBBLE DY
   Chan DYC, 2011, SOFT MATTER, V7, P2235, DOI 10.1039/c0sm00812e
   Chen L, 1997, NUMER HEAT TR A-APPL, V31, P629, DOI 10.1080/10407789708914057
   Chen L, 1999, J FLUID MECH, V387, P61, DOI 10.1017/S0022112099004449
   Clift R., 1978, BUBBLES DROPS PARTIC
   Del Castillo LA, 2011, J COLLOID INTERF SCI, V356, P316, DOI 10.1016/j.jcis.2010.12.057
   FORTES AF, 1987, J FLUID MECH, V177, P467, DOI 10.1017/S0022112087001046
   Gerlach D, 2006, INT J HEAT MASS TRAN, V49, P740, DOI 10.1016/j.ijheatmasstransfer.2005.07.045
   HARPER JF, 1970, J FLUID MECH, V41, P751, DOI 10.1017/S0022112070000897
   HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5
   Huisman SG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.027302
   JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462
   Joshi JB, 2001, CHEM ENG SCI, V56, P5893, DOI 10.1016/S0009-2509(01)00273-1
   Kantarci N, 2005, PROCESS BIOCHEM, V40, P2263, DOI 10.1016/j.procbio.2004.10.004
   Katz J, 1996, INT J MULTIPHAS FLOW, V22, P239, DOI 10.1016/0301-9322(95)00081-X
   Kelley E, 1997, PHYS REV LETT, V79, P1265, DOI 10.1103/PhysRevLett.79.1265
   KEVLAHAN NKR, 1994, APPL SCI RES, V53, P339, DOI 10.1007/BF00849109
   Klostermann J, 2013, INT J NUMER METH FL, V71, P960, DOI 10.1002/fld.3692
   Kok J.B.W., 1989, THESIS
   KOMASAWA I, 1980, J CHEM ENG JPN, V13, P103, DOI 10.1252/jcej.13.103
   Krishna R, 1999, INT COMMUN HEAT MASS, V26, P781, DOI 10.1016/S0735-1933(99)00066-4
   KUMAGAI T, 1983, B JSME, V26, P1900, DOI 10.1299/jsme1958.26.1900
   Kumar P, 2015, INT J MULTIPHAS FLOW, V77, P32, DOI 10.1016/j.ijmultiphaseflow.2015.06.014
   LAFAURIE B, 1994, J COMPUT PHYS, V113, P134, DOI 10.1006/jcph.1994.1123
   LAZAREK GM, 1974, J FLUID MECH, V66, P673, DOI 10.1017/S0022112074000449
   Lohse D, 2003, PHYS TODAY, V56, P36, DOI 10.1063/1.1564347
   Lunde K., 1997, P ASME FLUIDS ENG DI, V97-3530, P97
   Ma D, 2012, CHEM ENG SCI, V72, P61, DOI 10.1016/j.ces.2012.01.013
   Maxworthy T, 1996, J FLUID MECH, V321, P421, DOI 10.1017/S0022112096007781
   MONSON LA, 2012, COMPUT SCI DISCOV, V7
   Mougin G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.014502
   Mukundakrishnan K, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036308
   Piedra S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.063013
   RAGHUNATHAN K, 1992, INT J MULTIPHAS FLOW, V18, P41, DOI 10.1016/0301-9322(92)90005-2
   Ramirez-Munoz J, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4822183
   Rusche H., 2002, THESIS
   SANGANI AS, 1993, J FLUID MECH, V250, P307, DOI 10.1017/S0022112093001478
   Sunol F, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.053009
   SWEBY PK, 1984, SIAM J NUMER ANAL, V21, P995, DOI 10.1137/0721062
   Tagawa Y, 2014, J FLUID MECH, V738, P124, DOI 10.1017/jfm.2013.571
   Wang X, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4948931
   Watanabe M, 2006, JSME INT J B-FLUID T, V49, P410, DOI 10.1299/jsmeb.49.410
   Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744
   YUAN H, 1994, J FLUID MECH, V278, P325, DOI 10.1017/S0022112094003733
   Zenit R, 2018, PHYS TODAY, V71, P45, DOI 10.1063/PT.3.4069
   Zhou J, 1999, J FLUID MECH, V387, P353, DOI 10.1017/S002211209900467X
NR 52
TC 0
Z9 0
U1 7
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115159
DI 10.1016/j.ces.2019.115159
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900031
DA 2020-05-12
ER

PT J
AU Shi, PY
   Rzehak, R
AF Shi, Pengyu
   Rzehak, Roland
TI Lift forces on solid spherical particles in unbounded flows
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Review
DE Lift force; Particles; Shear flow; Particle rotation; Correlation
ID LINEAR SHEAR-FLOW; TRANSVERSELY ROTATING SPHERE; PROLATE SPHEROIDAL
   PARTICLE; MACROSCOPIC RIGID SPHERES; LOW-REYNOLDS-NUMBER; SPINNING
   SPHERE; NONSPHERICAL PARTICLES; INERTIAL LIFT; TORQUE COEFFICIENTS;
   HYDRODYNAMIC-FORCES
AB The present work is concerned with the lift forces acting on particles immersed in an unbounded fluid. Both mechanisms due to rotation of the particle and vorticity of the fluid flow are considered. Focus is on solid spherical particles at Reynolds numbers up to 10(3) which are relevant for particulate flows in chemical and minerals engineering. A comprehensive review of existing results from analytical, numerical, and experimental studies is given. In particular in the simulation area many new data have appeared in the past 10 years since the earlier review of Loth [AIAA Journal 46 (2008), 801-809]. The available correlations are critically assessed by comparison to data from experiment and direct numerical simulation. Based on the comparison new correlations are proposed and gaps or inconsistencies in the data are identified. The case of wall-bounded flows will be considered in a sequel. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shi, Pengyu; Rzehak, Roland] Helmholtz Zentrum Dresden Rossendorf, Inst Fluid Dynam, Bautzner Landstr 400, D-01328 Dresden, Germany.
   [Shi, Pengyu] Tech Univ Dresden, Fac Mech Engn, Inst Power Engn, D-01062 Dresden, Germany.
RP Shi, PY (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Fluid Dynam, Bautzner Landstr 400, D-01328 Dresden, Germany.
EM p.shi@hzdr.de
RI SHI, Pengyu/AAD-2500-2019
OI SHI, Pengyu/0000-0001-6402-4720
FU Chinese Scholarship Council (CSC)China Scholarship Council
FX This work was supported by the Chinese Scholarship Council (CSC). We
   wish to thank Professor Jacques Magnaudet for helpful discussions on the
   negative shear-lift in the low epsilon region and Professor David Fabre
   for discussion on the bifurcation lift.
CR Andersson HI, 2019, ACTA MECH, V230, P431, DOI 10.1007/s00707-018-2325-x
   Asmolov E. S., 1990, Fluid Dynamics, V25, P886
   Asmolov ES, 1999, INT J MULTIPHAS FLOW, V25, P739, DOI 10.1016/S0301-9322(98)00063-9
   AUTON TR, 1987, J FLUID MECH, V183, P199, DOI 10.1017/S002211208700260X
   Bagchi P, 2002, J FLUID MECH, V473, P379, DOI 10.1017/S0022112002002628
   Bagchi P, 2002, J FLUID MECH, V466, P365, DOI 10.1017/S0022112002001490
   Bagchi P, 2002, PHYS FLUIDS, V14, P2719, DOI 10.1063/1.1487378
   Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435
   Ben Salem M, 1998, INT J MULTIPHAS FLOW, V24, P563, DOI 10.1016/S0301-9322(97)00082-7
   Bluemink JJ, 2008, J FLUID MECH, V600, P201, DOI 10.1017/S0022112008000438
   Bluemink JJ, 2010, J FLUID MECH, V643, P1, DOI 10.1017/S0022112009991881
   Candelier F, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.067301
   Candelier F, 2008, J FLUID MECH, V608, P319, DOI 10.1017/S0022112008002152
   Candelier F, 2019, J FLUID MECH, V864, P554, DOI 10.1017/jfm.2019.23
   Charru F, 2013, ANNU REV FLUID MECH, V45, P469, DOI 10.1146/annurev-fluid-011212-140806
   Cherukat P, 1999, INT J MULTIPHAS FLOW, V25, P15, DOI 10.1016/S0301-9322(98)00034-2
   CHERUKAT P, 1994, INT J MULTIPHAS FLOW, V20, P339, DOI 10.1016/0301-9322(94)90086-8
   CHILDRESS S, 1964, J FLUID MECH, V20, P305, DOI 10.1017/S0022112064001227
   Citro V, 2016, J FLUID MECH, V807, P62, DOI 10.1017/jfm.2016.596
   Clift R., 2005, BUBBLES DROPS PARTIC
   Coimbra CFM, 2002, J FLUID MECH, V469, P257, DOI 10.1017/S0022112002001829
   Constantinescu G., 1999, P 38 AER SCI M EXH N
   Cui Y, 2019, INT J MULTIPHAS FLOW, V111, P232, DOI 10.1016/j.ijmultiphaseflow.2018.12.003
   Cui Y, 2018, INT J MULTIPHAS FLOW, V104, P103, DOI 10.1016/j.ijmultiphaseflow.2018.03.007
   DANDY DS, 1990, J FLUID MECH, V216, P381, DOI 10.1017/S0022112090000477
   Dobson J, 2014, COMPUT FLUIDS, V102, P170, DOI 10.1016/j.compfluid.2014.07.001
   Dong S, 2014, J COMPUT PHYS, V261, P83, DOI 10.1016/j.jcp.2013.12.042
   DREW DA, 1983, ANNU REV FLUID MECH, V15, P261, DOI 10.1146/annurev.fl.15.010183.001401
   DREW DA, 1978, J FLUID MECH, V88, P393, DOI 10.1017/S0022112078002177
   Fabre D, 2017, THEOR COMP FLUID DYN, V31, P475, DOI 10.1007/s00162-016-0405-x
   Fabre D, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2909609
   Fukada T, 2014, INT J MULTIPHAS FLOW, V58, P292, DOI 10.1016/j.ijmultiphaseflow.2013.10.006
   Giacobello M, 2009, J FLUID MECH, V621, P103, DOI 10.1017/S0022112008004655
   HARPER EY, 1968, J FLUID MECH, V33, P209, DOI 10.1017/S0022112068001254
   HERRON IH, 1975, J FLUID MECH, V68, P209, DOI 10.1017/S0022112075000778
   HINCH E. J., 1991, PERTURBATION METHODS
   Holzer A, 2008, POWDER TECHNOL, V184, P361, DOI 10.1016/j.powtec.2007.08.021
   Holzer A, 2009, COMPUT FLUIDS, V38, P572, DOI 10.1016/j.compfluid.2008.06.001
   Homann H, 2013, J FLUID MECH, V721, P155, DOI 10.1017/jfm.2013.66
   Ivanov S. G., 1980, Fluid Dynamics, V15, P449, DOI 10.1007/BF01089985
   Johnson TA, 1999, J FLUID MECH, V378, P19, DOI 10.1017/S0022112098003206
   KAPLUN S, 1957, J MATH MECH, V6, P585
   Kim D, 2002, J FLUID MECH, V461, P365, DOI 10.1017/S0022112002008509
   Kim D, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2090327
   Kim D, 2009, J MECH SCI TECHNOL, V23, P578, DOI 10.1007/s12206-008-1001-9
   Kim I, 2006, INT J COMPUT FLUID D, V20, P137, DOI 10.1080/10618560600731869
   Kim J, 2014, J FLUID MECH, V754, DOI 10.1017/jfm.2014.428
   Kray T, 2012, J WIND ENG IND AEROD, V110, P1, DOI 10.1016/j.jweia.2012.07.005
   Kurose R, 1999, J FLUID MECH, V384, P183, DOI 10.1017/S0022112099004164
   Lee H, 2010, J FLUID MECH, V657, P89, DOI 10.1017/S0022112010001382
   Lee SS, 2000, FLUID DYN RES, V27, P1, DOI 10.1016/S0169-5983(99)00040-4
   Legendre D, 1997, PHYS FLUIDS, V9, P3572, DOI 10.1063/1.869466
   Legendre D, 1998, J FLUID MECH, V368, P81, DOI 10.1017/S0022112098001621
   Lim EA, 2005, J FLUID MECH, V535, P101, DOI 10.1017/S0022112005004908
   LIN CJ, 1970, J FLUID MECH, V44, P1, DOI 10.1017/S0022112070001659
   Liu N, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2998449
   Loth E, 2008, AIAA J, V46, P801, DOI 10.2514/1.29159
   Magnaudet J, 2003, J FLUID MECH, V485, P115, DOI 10.1017/S0022112003004464
   Magnaudet J, 2003, J FLUID MECH, V476, P115, DOI 10.1017/S0022112002002902
   Magnaudet J, 2011, J FLUID MECH, V689, P564, DOI 10.1017/jfm.2011.363
   Mando M, 2010, POWDER TECHNOL, V202, P1, DOI 10.1016/j.powtec.2010.05.001
   MCLAUGHLIN JB, 1991, J FLUID MECH, V224, P261, DOI 10.1017/S0022112091001751
   MEI R, 1992, INT J MULTIPHAS FLOW, V18, P145, DOI 10.1016/0301-9322(92)90012-6
   Meibohm J, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.084203
   Mikulencak DR, 2004, J FLUID MECH, V520, P215, DOI 10.1017/S0022112004001648
   Mittal R, 1999, INT J NUMER METH FL, V30, P921, DOI 10.1002/(SICI)1097-0363(19990815)30:7<921::AID-FLD875>3.0.CO;2-3
   Mittal R, 2002, AIAA J, V40, P579, DOI 10.2514/2.1686
   MIYAZAKI K, 1995, J FLUID MECH, V296, P373, DOI 10.1017/S0022112095002163
   Niazmand H, 2005, J FLUID ENG-T ASME, V127, P163, DOI 10.1115/1.1852471
   Niazmand H, 2003, COMPUT FLUIDS, V32, P1405, DOI 10.1016/S0045-7930(02)00115-9
   NIRSCHL H, 1995, J FLUID MECH, V283, P273, DOI 10.1017/S002211209500231X
   Oesterle B, 1998, EXP FLUIDS, V25, P16, DOI 10.1007/s003480050203
   Ouchene R, 2016, POWDER TECHNOL, V303, P33, DOI 10.1016/j.powtec.2016.07.067
   POE GG, 1975, J FLUID MECH, V72, P605, DOI 10.1017/S0022112075003187
   Poon EKW, 2014, J FLUID MECH, V759, DOI 10.1017/jfm.2014.570
   Poon EKW, 2013, INT J HEAT FLUID FL, V42, P278, DOI 10.1016/j.ijheatfluidflow.2013.02.005
   Poon EKW, 2010, INT J HEAT FLUID FL, V31, P961, DOI 10.1016/j.ijheatfluidflow.2010.04.005
   PROUDMAN I, 1957, J FLUID MECH, V2, P237, DOI 10.1017/S0022112057000105
   Rabha S, 2013, AICHE J, V59, P1709, DOI 10.1002/aic.13920
   RUBINOW SI, 1961, J FLUID MECH, V11, P447, DOI 10.1017/S0022112061000640
   SAFFMAN PG, 1965, J FLUID MECH, V22, P385, DOI 10.1017/S0022112065000824
   Sanjeevi SKP, 2018, INT J MULTIPHAS FLOW, V106, P325, DOI 10.1016/j.ijmultiphaseflow.2018.05.011
   Santarelli C, 2016, INT J MULTIPHAS FLOW, V81, P27, DOI 10.1016/j.ijmultiphaseflow.2016.01.004
   Santarelli C, 2015, INT J MULTIPHAS FLOW, V75, P174, DOI 10.1016/j.ijmultiphaseflow.2015.05.007
   SEGRE G, 1962, J FLUID MECH, V14, P136, DOI 10.1017/S0022112062001111
   SEGRE G, 1962, J FLUID MECH, V14, P115, DOI 10.1017/S002211206200110X
   Shampine LF, 2008, J COMPUT APPL MATH, V211, P131, DOI 10.1016/j.cam.2006.11.021
   SINGH SN, 1975, Z ANGEW MATH PHYS, V26, P415, DOI 10.1007/BF01590779
   SRIDHAR G, 1995, PHYS FLUIDS, V7, P389, DOI 10.1063/1.868637
   Subramaniam S, 2013, PROG ENERG COMBUST, V39, P215, DOI 10.1016/j.pecs.2012.10.003
   Takagi S., 1998, P 3 INT C MULT FLOW
   TRI BD, 1990, CR ACAD SCI II, V311, P27
   TSUJI Y, 1985, J FLUID ENG-T ASME, V107, P484, DOI 10.1115/1.3242517
   Vadlakonda B, 2018, SEP PURIF TECHNOL, V203, P274, DOI 10.1016/j.seppur.2018.04.039
   Volkov AN, 2009, FLUID DYNAM+, V44, P141, DOI 10.1134/S0015462809010153
   Wakaba L, 2005, INT J MULTIPHAS FLOW, V31, P996, DOI 10.1016/j.ijmultiphaseflow.2005.05.009
   WANG CT, 1972, AIAA J, V10, P713, DOI 10.2514/3.50192
   Wang J, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5029944
   Weidman PD, 2004, PHYS FLUIDS, V16, pL9, DOI 10.1063/1.1633265
   You CF, 2003, ACTA MECH SINICA, V19, P300
   Yow HN, 2005, ADV POWDER TECHNOL, V16, P363, DOI 10.1163/1568552054194221
   Zastawny M, 2012, INT J MULTIPHAS FLOW, V39, P227, DOI 10.1016/j.ijmultiphaseflow.2011.09.004
NR 102
TC 3
Z9 3
U1 10
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115145
DI 10.1016/j.ces.2019.08.003
PG 18
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900017
DA 2020-05-12
ER

PT J
AU Simone, G
   van de Donk, O
AF Simone, Giuseppina
   van de Donk, Oole
TI On demand coalescence in microchannel: Viscosity matters
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Coalescence; Surface destabilization; Mixing; Viscosity; Microfluidics
ID ELECTROSTATIC ENHANCEMENT; DROPLET FORMATION; SURFACE-TENSION; WATER
   DROPLETS; OIL; INTERFACE; STABILITY; DYNAMICS; SPEED
AB Here, the coalescence of similar and dissimilar droplets has been investigated in microfluidics while varying the rheological and physical properties (e.g. viscosity, density) of the fluids.
   Our data indicate that in early regimes, the dynamics of coalescence depends on the properties of the inner fluid, which can generate a dominant viscous or inertial regime, while the outer fluid controls the activation or inhibition of the merging droplets. Besides, the models describing the mechanism in vacuum or in a very low viscous outer fluid become invalid when one of those conditions fails. An accurate modification resulted from accounting for the viscosity ratio of the inner and outer fluid. A phase diagram showing the crossovers into the different possible late-time dynamics identifies that, depending on the ratio of the viscosities of the inner and outer fluid, the coalescence develops by an inertial limited viscous, pure viscous or inertial regime. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Simone, Giuseppina; van de Donk, Oole] Northwestern Polytech Univ, Sch Mech Engn, Key Lab Micro Nano Syst Aerosp, Minist Educ, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China.
   [van de Donk, Oole] Avans Univ Appl Sci, Dept Mech Engn, Lovensdijkstr 61-63, NL-4818 AJ Breda Noord Brabant, Breda, Netherlands.
RP Simone, G (reprint author), Northwestern Polytech Univ, Sch Mech Engn, Key Lab Micro Nano Syst Aerosp, Minist Educ, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China.
EM giuseppina.simone@nwpu.edu.cn
FU "Fundamental Research Funds for the Central Universities", Northwestern
   Polytechnical University, Xi'an, China [31020190503007]; Northwestern
   Polytechnical University Xi'an, China; Avans University, AJ Breda,
   Netherlands
FX This work is supported by "the Fundamental Research Funds for the
   Central Universities" (Number: 31020190503007), Northwestern
   Polytechnical University, Xi'an, China. The authors thank the support
   from the Foreigner Students Exchanging Program between the Northwestern
   Polytechnical University Xi'an, China and Avans University, AJ Breda,
   Netherlands.
CR Baroud CN, 2010, LAB CHIP, V10, P2032, DOI 10.1039/c001191f
   Berry JD, 2017, J COLLOID INTERF SCI, V487, P513, DOI 10.1016/j.jcis.2016.10.040
   Brenn G, 2001, PHYS FLUIDS, V13, P2463, DOI 10.1063/1.1384892
   D'Errico G, 2004, J CHEM ENG DATA, V49, P1665, DOI 10.1021/je049917u
   Deng SB, 2002, COLLOID SURFACE A, V211, P275, DOI 10.1016/S0927-7757(02)00281-9
   Denn M.M., 1980, PROCESS FLUID MECH
   DICKINSON E, 1988, J CHEM SOC FARAD T 1, V84, P871, DOI 10.1039/f19888400871
   Eggers J, 1999, J FLUID MECH, V401, P293, DOI 10.1017/S002211209900662X
   Eow JS, 2002, CHEM ENG J, V85, P357, DOI 10.1016/S1385-8947(01)00250-9
   Eow JS, 2001, CHEM ENG J, V84, P173, DOI 10.1016/S1385-8947(00)00386-7
   Finotello G, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4984081
   Garstecki P., 2005, Bulletin of the Polish Academy of Sciences, Technical Sciences, V53, P361
   Garstecki P, 2006, LAB CHIP, V6, P693
   Harkins WD, 1916, J AM CHEM SOC, V38, P242, DOI 10.1021/ja02259a006
   Harpur IG, 1997, J ELECTROSTAT, V40-1, P135, DOI 10.1016/S0304-3886(97)00027-2
   Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988
   JAYARATNE OW, 1964, PROC R SOC LON SER-A, V280, P545, DOI 10.1098/rspa.1964.0161
   Kavehpour HP, 2015, ANNU REV FLUID MECH, V47, P245, DOI 10.1146/annurev-fluid-010814-014720
   Lai YH, 2010, LAB CHIP, V10, P3149, DOI 10.1039/c003729j
   Liu D, 2013, INT J HEAT MASS TRAN, V57, P421, DOI 10.1016/j.ijheatmasstransfer.2012.10.023
   Mazutis L, 2012, LAB CHIP, V12, P1800, DOI 10.1039/c2lc40121e
   Oh J. M., 2012, EPL, V98, P1
   Paulsen JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4182
   Paulsen JD, 2012, P NATL ACAD SCI USA, V109, P6857, DOI 10.1073/pnas.1120775109
   Paulsen JD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.114501
   PELOFSKY AH, 1966, J CHEM ENG DATA, V11, P394, DOI 10.1021/je60030a031
   Pepe A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06512-5
   Qian J, 1997, J FLUID MECH, V331, P59, DOI 10.1017/S0022112096003722
   Ray B, 2010, J FLUID MECH, V655, P72, DOI 10.1017/S0022112010000662
   Rekvig L, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2780865
   Sadeghi HM, 2018, J COLLOID INTERF SCI, V532, P363, DOI 10.1016/j.jcis.2018.08.001
   Shang LR, 2017, CHEM REV, V117, P7964, DOI 10.1021/acs.chemrev.6b00848
   Simone G, 2015, RSC ADV, V5, P56848, DOI 10.1039/c5ra10207c
   Sommerfeld M, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2249-y
   Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653
   Thoroddsen ST, 2005, J FLUID MECH, V527, P85, DOI 10.1017/S0022112004003076
   Tice JD, 2004, ANAL CHIM ACTA, V507, P73, DOI 10.1016/j.aca.2003.11.024
   van de Donk O., 2019, BIOSENS, V13
   Weheliye WH, 2017, CHEM ENG SCI, V161, P215, DOI 10.1016/j.ces.2016.12.009
   Xu JH, 2006, LAB CHIP, V6, P131, DOI 10.1039/b509939k
   Yarranton HW, 2007, J COLLOID INTERF SCI, V310, P253, DOI 10.1016/j.jcis.2007.01.098
   Zhang XM, 2019, CHEM ENG J, V356, P516, DOI 10.1016/j.cej.2018.09.038
NR 42
TC 0
Z9 0
U1 12
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115173
DI 10.1016/j.ces.2019.115173
PG 8
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900034
DA 2020-05-12
ER

PT J
AU Sun, CZ
   Zheng, XZ
   Bai, BF
AF Sun, Chengzhen
   Zheng, Xiuzhi
   Bai, Bofeng
TI Hydrogen purification using nanoporous graphene membranes and its
   economic analysis
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Separation membrane; Nanoporous graphene; Hydrogen purification;
   Economic analysis; Molecular dynamics
ID MULTICOMPONENT GAS SEPARATION; CARBON-DIOXIDE CAPTURE; POROUS GRAPHENE;
   CO2/N-2 SEPARATION; NATURAL-GAS; PERMEATION; INSIGHTS; SIMULATION;
   TRANSPORT; CH4/CO2
AB We show from molecular dynamics insights that the nanoporous graphene (NPG) is an efficient membrane in hydrogen purification for separating gaseous H-2/CH4 mixtures with a high permeance and selectivity. The H-2 permeance is as high as 106 GPU, extremely higher than those of polymer membranes; the selectivity of H-2 over CH4 is up to 225, in the same order with those of polymer membranes. An economic analysis is performed from the aspects of compression energy consumption and required membrane area; it is shown that the NPG membrane requires less membrane area but a bit more compression energy compared with the polymer membranes. However, the slightly higher compression energy consumption can be totally offset by the remarkably smaller membrane area. In summary, the NPG membranes for hydrogen purification present an excellent separation performance with a high H-2 permeance, ultimately resulting in an impressive economic index comparing to the polymer membranes. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sun, Chengzhen; Zheng, Xiuzhi; Bai, Bofeng] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian, Shaanxi, Peoples R China.
RP Sun, CZ; Bai, BF (reprint author), Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian, Shaanxi, Peoples R China.
EM sun-cz@xjtu.edu.cn; bfbai@mail.xjtu.edu.cn
FU National Natural Science Foundation of China, ChinaNational Natural
   Science Foundation of China [51876169, 51425603]
FX The supports from National Natural Science Foundation of China, China
   for project No. 51876169 and Distinguished Young Scientists No. 51425603
   are highly appreciated. The great help from a graduate student, Shaohua
   Zhu, and Dr. Fei Liu in the calculation of PMF profiles are highly
   appreciated.
CR Azamat J, 2015, CHEM ENG SCI, V127, P285, DOI 10.1016/j.ces.2015.01.048
   Baker RW, 2008, IND ENG CHEM RES, V47, P2109, DOI 10.1021/ie071083w
   Belaissaoui B, 2012, CHEM ENG J, V211, P122, DOI 10.1016/j.cej.2012.09.012
   Bernardo P, 2009, IND ENG CHEM RES, V48, P4638, DOI 10.1021/ie8019032
   Bounaceur R, 2006, ENERGY, V31, P2556, DOI 10.1016/j.energy.2005.10.038
   Boutilier MSH, 2017, ACS NANO, V11, P5726, DOI 10.1021/acsnano.7b01231
   Boutilier MSH, 2014, ACS NANO, V8, P841, DOI 10.1021/nn405537u
   Chowdhury MHM, 2005, CHEM ENG TECHNOL, V28, P773, DOI 10.1002/ceat.200500077
   Dasgupta T, 2015, CHEM ENG SCI, V121, P279, DOI 10.1016/j.ces.2014.07.057
   Dincer I, 2015, INT J HYDROGEN ENERG, V40, P11094, DOI 10.1016/j.ijhydene.2014.12.035
   Energy U.S.D.o., 2017, SMALL BUS INN RES SB
   Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999
   Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946
   Kaldis SP, 2000, J MEMBRANE SCI, V173, P61, DOI 10.1016/S0376-7388(00)00353-7
   Khakpay A, 2017, J PHYS CHEM C, V121, P12308, DOI 10.1021/acs.jpcc.7b03728
   Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/nnano.2012.162, 10.1038/NNANO.2012.162]
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lei GP, 2014, CHEM PHYS LETT, V599, P127, DOI 10.1016/j.cplett.2014.03.040
   Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686
   Liu HJ, 2013, NANOSCALE, V5, P9984, DOI 10.1039/c3nr02852f
   O'Hern SC, 2014, NANO LETT, V14, P1234, DOI 10.1021/nl404118f
   Ockwig NW, 2007, CHEM REV, V107, P4078, DOI 10.1021/cr0501792
   PAN CY, 1978, CAN J CHEM ENG, V56, P197, DOI 10.1002/cjce.5450560207
   Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030
   SALTONSTALL CW, 1987, J MEMBRANE SCI, V32, P185, DOI 10.1016/S0376-7388(00)85005-X
   Schrier J, 2012, ACS APPL MATER INTER, V4, P3745, DOI 10.1021/am300867d
   Schrier J, 2010, J PHYS CHEM LETT, V1, P2284, DOI 10.1021/jz100748x
   Shan MX, 2012, NANOSCALE, V4, P5477, DOI 10.1039/c2nr31402a
   Stuart SJ, 2000, J CHEM PHYS, V112, P6472, DOI 10.1063/1.481208
   Sun CZ, 2018, J PHYS CHEM C, V122, P6178, DOI 10.1021/acs.jpcc.8b00181
   Sun CZ, 2017, SCI BULL, V62, P554, DOI 10.1016/j.scib.2017.03.004
   Sun CZ, 2017, CHEM ENG SCI, V165, P186, DOI 10.1016/j.ces.2017.02.042
   Sun CZ, 2015, SCI BULL, V60, P1807, DOI 10.1007/s11434-015-0914-9
   Sun CZ, 2015, CHEM ENG SCI, V138, P616, DOI 10.1016/j.ces.2015.08.049
   Sun CZ, 2014, LANGMUIR, V30, P675, DOI 10.1021/la403969g
   WELLER S, 1950, J APPL PHYS, V21, P279, DOI 10.1063/1.1699653
   Wen BY, 2015, PHYS CHEM CHEM PHYS, V17, P23619, DOI 10.1039/c5cp03195h
   Wu TT, 2014, J PHYS CHEM C, V118, P7369, DOI 10.1021/jp4096776
   Yeo ZY, 2012, J NAT GAS CHEM, V21, P282, DOI 10.1016/S1003-9953(11)60366-6
   Zheng HX, 2017, INT J HYDROGEN ENERG, V42, P30653, DOI 10.1016/j.ijhydene.2017.10.134
NR 40
TC 0
Z9 0
U1 17
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115141
DI 10.1016/j.ces.2019.07.059
PG 7
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900013
DA 2020-05-12
ER

PT J
AU Sun, YX
   Yang, DH
   He, LM
   Luo, XM
   Lu, YL
AF Sun, Yongxiang
   Yang, Donghai
   He, Limin
   Luo, Xiaoming
   Lu, Yuling
TI Influence of alkali concentration, electric waveform, and frequency on
   the critical electric field strength of droplet-interface partial
   coalescence
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Critical electric field strength; Droplet-interface coalescence; Alkali;
   Waveform; Frequency
ID WATER-IN-OIL; PULSED DC; ELECTROSTATIC COALESCENCE; AQUEOUS DROPS;
   ELECTROCOALESCENCE; DEMULSIFICATION; DEHYDRATION; SEPARATION
AB During the process of electro-dehydration, the electric field strength should be set below a critical value (E-crit) to inhibit droplet-interface partial coalescence. The alkali present in alkaline-surfactant-polymer flooding may affect E-crit because they change the electrical properties of produced liquids. In view of this, this study investigated the effects of Na2CO3 solution concentration, electric field waveform, and frequency on the root mean square (RMS) values of E-crit. The results show that elevated Na2CO3 concentrations increase E-crit, owing to the enhanced solution conductivity which may affect the charge transfer during coalescence. The convection of ions is associated with penetration of fluid into the bulk phase and an increase in Na2CO3 concentration decreases the penetration velocity. Moreover, increasing the AC or pulsed electric field frequency can increase E-crit, and the optimal waveform (i.e., with the largest E-crit) varies with frequency. These findings will be useful for optimizing electro-coalescence systems. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yang, Donghai] China Univ Petr, Coll Pipeline & Civil Engn, Qingdao 266580, Shandong, Peoples R China.
   China Univ Petr, Shandong Prov Key Lab Oil & Gas Storage & Transpo, Qingdao 266580, Shandong, Peoples R China.
RP Yang, DH (reprint author), China Univ Petr, Coll Pipeline & Civil Engn, Qingdao 266580, Shandong, Peoples R China.
EM yangdonghai@upc.edu.cn
RI 罗, 小明/AAC-7450-2019
OI 罗, 小明/0000-0003-1797-9924; Sun, Yongxiang/0000-0002-6597-168X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51704318, 51674281]; Natural Science Foundation of
   Shandong Province, ChinaNatural Science Foundation of Shandong Province
   [ZR2017BEE008]; Fundamental Research Funds for the Central Universities
   of ChinaFundamental Research Funds for the Central Universities
   [19CX02033A]; Introduction of Talent Research Start-up Fund
   [YJ201601016]; Scientific and Technology Planning Project of Gansu
   Province of China [18YF1GA006]
FX This work is supported by grants from the National Natural Science
   Foundation of China (Grant No. 51704318, 51674281), the Natural Science
   Foundation of Shandong Province, China (Grant No. ZR2017BEE008), the
   Fundamental Research Funds for the Central Universities of China (Grant
   No. 19CX02033A), Introduction of Talent Research Start-up Fund (Grant
   No. YJ201601016), and the Scientific and Technology Planning Project of
   Gansu Province of China (Grant No. 18YF1GA006).
CR Arihara N, 1999, SPE AS PAC OIL GAS C, DOI [10.2118/54330-MS, DOI 10.2118/54330-MS]
   Aryafar H, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2227435
   Aryafar H, 2009, LANGMUIR, V25, P12460, DOI 10.1021/la902758u
   BAILES PJ, 1981, T I CHEM ENG-LOND, V59, P229
   Berry JD, 2013, J COMPUT PHYS, V251, P209, DOI 10.1016/j.jcp.2013.05.026
   Blanchette F, 2006, NAT PHYS, V2, P254, DOI 10.1038/nphys268
   Bortolotti V., 2009, EUROPEC EAGE C EXH A, DOI [10.2118/121832-MS, DOI 10.2118/121832-MS]
   Bortolotti V., 2009, AS PAC OIL GAS C EXH, DOI [10.2118/122499-MS, DOI 10.2118/122499-MS]
   Bryan J, 2007, SPE ANN TECHN C EXH, DOI [10.2118/110738-MS, DOI 10.2118/110738-MS]
   Bryan J.L., 2008, INT THERM OP HEAV OI, DOI [10.2118/117649-MS, DOI 10.2118/117649-MS]
   Charles G.E., 1960, Journal of Colloid Science, V15, P236, DOI 10.1016/0095-8522(60)90026-X
   Charles G.E., 1960, Journal of Colloid Science, V15, P105, DOI 10.1016/0095-8522(60)90012-X
   CHEN T, 2013, HEAVY OIL ADV PET EX, V5, P106
   Chen XP, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2201470
   DRELICH J, 1992, FUEL PROCESS TECHNOL, V31, P105, DOI 10.1016/0378-3820(92)90014-H
   Eow JS, 2003, COLLOID SURFACE A, V219, P253, DOI 10.1016/S0927-7757(03)00051-7
   Eow JS, 2003, CHEM ENG PROCESS, V42, P259, DOI 10.1016/S0255-2701(02)00036-3
   Eow JS, 2002, CHEM ENG PROCESS, V41, P649, DOI 10.1016/S0255-2701(01)00183-0
   Eow JS, 2002, CHEM ENG J, V85, P357, DOI 10.1016/S1385-8947(01)00250-9
   Eow JS, 2001, CHEM ENG J, V84, P173, DOI 10.1016/S1385-8947(00)00386-7
   Galvin C.P., 1986, ICHEME S SER, V88, P101, DOI 10.1016/B978-0-08-031439-6.50012-X
   Hamlin BS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.094501
   HIRATO T, 1991, MATER T JIM, V32, P257, DOI 10.2320/matertrans1989.32.257
   Karunanayake KPDJ, 2010, J ELECTROSTAT, V68, P91, DOI 10.1016/j.elstat.2009.11.004
   Lee CM, 2001, J ELECTROSTAT, V53, P1, DOI 10.1016/S0304-3886(01)00029-8
   Lesaint C, 2009, COLLOID SURFACE A, V352, P63, DOI 10.1016/j.colsurfa.2009.09.051
   Liu R.H., 2008, ELECT ELECT ENG
   Lundgaard L., 2002, P 14 INT C DIEL LIQ, DOI [10.1109/ICDL.2002.1022733, DOI 10.1109/ICDL.2002.1022733]
   Midtgard OM, 2009, CHEM ENG J, V151, P168, DOI 10.1016/j.cej.2009.02.014
   Mohammadi M, 2013, CHEM ENG RES DES, V91, P904, DOI 10.1016/j.cherd.2012.09.002
   Mousavi SH, 2014, CHEM ENG SCI, V120, P130, DOI 10.1016/j.ces.2014.08.055
   Mousavichoubeh M, 2011, CHEM ENG PROCESS, V50, P338, DOI 10.1016/j.cep.2010.09.017
   Mousavichoubeh M, 2011, CHEM ENG SCI, V66, P5330, DOI 10.1016/j.ces.2011.07.019
   Noik C., 2002, SPE ANN TECHN C EXH, DOI [10.2118/77492-MS, DOI 10.2118/77492-MS]
   Paulsen JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4182
   Pena-Polo F, 2014, ENVIRON SCI ENG, P307, DOI 10.1007/978-3-319-00191-3_17
   Pillai R, 2017, CHEM ENG SCI, V169, P273, DOI 10.1016/j.ces.2016.07.022
   Pillai R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.013007
   Pillai R, 2016, SOFT MATTER, V12, P3310, DOI 10.1039/c6sm00047a
   Ray B., 2013, ASME 2013 HEAT TRANS, DOI [10.1115/HT2013-17711, DOI 10.1115/HT2013-17711]
   Rondon M, 2006, ENERG FUEL, V20, P1600, DOI 10.1021/ef060017o
   Sams G.W., 1996, United States Patents, No, Patent No. 5565078
   Taylor SE, 1996, CHEM ENG RES DES, V74, P526
   Techaumnat B, 2016, POWDER TECHNOL, V301, P153, DOI 10.1016/j.powtec.2016.06.008
   Vivacqua V, 2016, CHEM ENG RES DES, V114, P180, DOI 10.1016/j.cherd.2016.08.019
   Vivacqua V, 2015, CHEM ENG RES DES, V104, P658, DOI 10.1016/j.cherd.2015.10.006
   Warren K.W., 2002, SPE PS CIM CHOA INT, DOI [10.2118/78944-MS, DOI 10.2118/78944-MS]
   Yang DH, 2018, CHEM ENG PROCESS, V132, P89, DOI 10.1016/j.cep.2018.08.018
   Yang DH, 2018, CHEM ENG RES DES, V136, P83, DOI 10.1016/j.cherd.2018.05.004
   Yue PT, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2364144
   Zhang YZ, 2011, COLLOID SURFACE A, V386, P185, DOI 10.1016/j.colsurfa.2011.07.010
   Zhang YZ, 2011, COLLOID SURFACE A, V373, P130, DOI 10.1016/j.colsurfa.2010.10.043
   Zolfaghari R, 2016, SEP PURIF TECHNOL, V170, P377, DOI 10.1016/j.seppur.2016.06.026
NR 53
TC 0
Z9 0
U1 21
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115136
DI 10.1016/j.ces.2019.07.054
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900008
DA 2020-05-12
ER

PT J
AU Watamura, T
   Kitagawa, A
   Murai, Y
AF Watamura, Tomoaki
   Kitagawa, Atsuhide
   Murai, Yuichi
TI Cloud structuring of microbubbles ascending along a vertical wall
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fluid dynamics; Bubbly flow; Ultrasonic velocity profiling; Flow
   visualization
ID DIRECT NUMERICAL SIMULATIONS; 2 SPHERICAL BUBBLES; NATURAL-CONVECTION;
   HEAT-TRANSFER; IN-LINE; PART 1; MOTION; FLOWS; MECHANICS; SWARM
AB To elucidate the motion of spatiotemporally developing flow structures driven by densely concentrated microbubbles, we experimentally investigated the distribution and motion of microbubbles rising along a vertical plane wall. We performed optical measurements and an ultrasonic velocity profiling to determine the distribution and motion of microbubbles. We found that the microbubbles form clouds (fluid blobs containing rich microbubbles) with a three-dimensional structure, the spatial patterns of which become more periodic in the streamwise direction than in the spanwise direction. In addition, owing to the coalescence of neighboring microbubble clouds caused by the hydrodynamic interaction between them, the separation length of the buoyant force distribution of microbubbles increases with increasing the distance from the bottom of the tank. According to the Reynolds number of the microbubbles cloud presented here, we conclude that the unsteady motion of microbubble clouds can be analogously modeled as an interacting motion of moving bodies in flow. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Watamura, Tomoaki] Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.
   [Kitagawa, Atsuhide] Kyoto Inst Technol, Dept Mech Engn, Sakyo Ku, Kyoto 6068585, Japan.
   [Murai, Yuichi] Hokkaido Univ, Fac Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.
RP Watamura, T (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.
EM tomoaki.watamura@me.es.osaka-u.ac
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP18K13686]
FX Part of this study was funded by JSPS KAKENHI JP18K13686.
CR ACHENBACH E, 1974, J FLUID MECH, V62, P209, DOI 10.1017/S0022112074000644
   ALAM M, 1993, J FLUID MECH, V254, P363, DOI 10.1017/S0022112093002174
   Baines PG, 1996, J FLUID MECH, V312, P107, DOI 10.1017/S0022112096001930
   Brucker C, 1999, PHYS FLUIDS, V11, P1781, DOI 10.1063/1.870043
   Bunner B., 2002, J FLUID MECH, V466, P313
   Ceccio SL, 2010, ANNU REV FLUID MECH, V42, P183, DOI 10.1146/annurev-fluid-121108-145504
   Cheng W, 2005, FLOW MEAS INSTRUM, V16, P35, DOI 10.1016/j.flowmeasinst.2004.08.002
   Clift R., 1979, BUBBLES DROPS PARTIC
   CRAIG VSJ, 1993, NATURE, V364, P317, DOI 10.1038/364317a0
   Esmaeeli A, 1998, J FLUID MECH, V377, P313, DOI 10.1017/S0022112098003176
   Esmaeeli A, 1996, J FLUID MECH, V314, P315, DOI 10.1017/S002211209600033X
   Esmaeeli A, 1999, J FLUID MECH, V385, P325, DOI 10.1017/S0022112099004310
   Figueroa- Espinoza B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2055487
   Fujiwara A., 2006, ECO IND, V11, P27
   Gordiychuk A, 2016, EXP THERM FLUID SCI, V70, P51, DOI 10.1016/j.expthermflusci.2015.08.014
   Hallez Y, 2011, J FLUID MECH, V673, P406, DOI 10.1017/S002211201000635X
   Happel J., 1965, LOW REYNOLDS NUMBER
   Hara K, 2011, EXP FLUIDS, V50, P715, DOI 10.1007/s00348-010-0970-5
   Harkins WD, 1925, J AM CHEM SOC, V47, P2083, DOI 10.1021/ja01685a002
   Huisman SG, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.074204
   Kitagawa A, 2008, EXP FLUIDS, V45, P473, DOI 10.1007/s00348-008-0490-8
   Kitagawa A, 2014, CHEM ENG SCI, V116, P694, DOI 10.1016/j.ces.2014.06.001
   Kitagawa A, 2013, J VISUAL-JAPAN, V16, P313, DOI 10.1007/s12650-013-0184-z
   Kitagawa A, 2013, CHEM ENG SCI, V99, P215, DOI 10.1016/j.ces.2013.05.027
   Kitagawa A, 2011, EXP FLUIDS, V51, P701, DOI 10.1007/s00348-011-1089-z
   Kundu P., 2015, FLUID MECH
   Legendre D, 2003, J FLUID MECH, V497, P133, DOI 10.1017/S0022112003006463
   Levitsky I, 2016, CHEM ENG TECHNOL, V39, P1537, DOI 10.1002/ceat.201500492
   Lide D.R., 2005, CRC HDB CHEM PHYS IN
   Lindau O, 2003, J FLUID MECH, V479, P327, DOI 10.1017/S0022112002003695
   Martinez-Bazan C, 1999, J FLUID MECH, V401, P157, DOI 10.1017/S0022112099006680
   Murai Y, 2006, EXP FLUIDS, V41, P343, DOI 10.1007/s00348-006-0142-9
   Murai Y, 2000, J FLUID ENG-T ASME, V122, P754, DOI 10.1115/1.1313245
   Murai Y, 2018, EXP FLUIDS, V59, DOI 10.1007/s00348-018-2620-2
   NARAYANAN S, 1974, CHEM ENG SCI, V29, P2071, DOI 10.1016/0009-2509(74)80221-6
   Nukiyama S., 1939, T SOC MECH ENG JPN, V5, P62
   Ogasawara T, 2018, NUCL ENG DES, V337, P141, DOI 10.1016/j.nucengdes.2018.06.019
   Park HJ, 2018, EXP FLUIDS, V59, DOI 10.1007/s00348-018-2621-1
   Parmar R., 2013, JAPANESE J MULTIPHAS, V64, p79 
   Riboux G, 2010, J FLUID MECH, V643, P509, DOI 10.1017/S0022112009992084
   SANGANI AS, 1993, J FLUID MECH, V250, P307, DOI 10.1017/S0022112093001478
   So S, 2002, EXP FLUIDS, V33, P135, DOI 10.1007/s00348-002-0459-y
   Stimson M, 1926, P R SOC LOND A-CONTA, V111, P110, DOI 10.1098/rspa.1926.0053
   Takagi S, 2011, ANNU REV FLUID MECH, V43, P615, DOI 10.1146/annurev-fluid-122109-160756
   Takahashi M., 2005, CAN J CHEM ENG, V109, P21858
   Takeda Y, 2012, ULTRASONIC DOPPLER V
   Terasaka K, 2011, CHEM ENG SCI, V66, P3172, DOI 10.1016/j.ces.2011.02.043
   VANWIJNGAARDEN L, 1993, J FLUID MECH, V251, P55, DOI 10.1017/S0022112093003337
   WINNIKOW S, 1966, PHYS FLUIDS, V9, P50, DOI 10.1063/1.1761532
   Yang C, 2003, AICHE J, V49, P1024, DOI 10.1002/aic.690490419
   YUAN H, 1994, J FLUID MECH, V278, P325, DOI 10.1017/S0022112094003733
   Yurkovetsky Y, 1996, PHYS FLUIDS, V8, P881, DOI 10.1063/1.868869
   Zenit R, 2001, J FLUID MECH, V429, P307, DOI 10.1017/S0022112000002743
NR 53
TC 1
Z9 1
U1 3
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115132
DI 10.1016/j.ces.2019.07.050
PG 13
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900007
DA 2020-05-12
ER

PT J
AU Xu, L
   Qiu, Z
   Gong, HJ
   Zhu, CF
   Sang, Q
   Li, YJ
   Dong, MZ
AF Xu, Long
   Qiu, Zhe
   Gong, Houjian
   Zhu, Chaofan
   Sang, Qian
   Li, Yajun
   Dong, Mingzhe
TI Synergy of microbial polysaccharides and branched-preformed particle gel
   on thickening and enhanced oil recovery
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Rheology; Polysaccharides; Branched-preformed particle gel; Synergy;
   Temperature/salt tolerance; Enhanced oil recovery
ID LOCUST BEAN GUM; PARTIALLY HYDROLYZED POLYACRYLAMIDE; ANIONIC MICELLAR
   SOLUTIONS; RHEOLOGICAL PROPERTIES; HIGH-TEMPERATURE; XANTHAN; GELATION;
   CONFORMATION; WELAN; MICROSTRUCTURE
AB A novel combination consisting of microbial polysaccharide (diutan gum or xanthan gum) and branchedpreformed particle gel (B-PPG) was systematically investigated by rheological method. Polysaccharide/B-PPG suspensions exhibit pseudoplastic fluid characteristics. Synergy occurs between polysaccharides and B-PPG on thickening the suspensions. The salt tolerance is improved by combining xanthan gum and B-PPG, and both of the temperature tolerance and salt tolerance are enhanced by combining diutan gum and B-PPG. The combination of diutan gum and B-PPG contributes to the formation of strong particle gel networks based on double helices and gel particles by van der Waals force and hydrogen bonding, improving the stability in high-temperature and high-salinity environments. It was confirmed that the heavy oil recovery efficiencies of diutan/B-PPG composite (17.4% original oil in place (OOIP)) and xanthan/B-PPG composite (8.2% OOIP) were higher than that of B-PPG alone (5.3% OOIP) at 90 degrees C and 244,121 mg.L-1 salinity. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Xu, Long; Qiu, Zhe; Gong, Houjian; Zhu, Chaofan; Sang, Qian; Li, Yajun; Dong, Mingzhe] China Univ Petr East China, Minist Educ, Key Lab Unconvent Oil & Gas Dev, Qingdao 266580, Shandong, Peoples R China.
   [Xu, Long; Qiu, Zhe; Gong, Houjian; Dong, Mingzhe] China Univ Petr East China, Sch Petr Engn, Shandong Key Lab Oilfield Chem, Qingdao 266580, Shandong, Peoples R China.
   [Dong, Mingzhe] Univ Calgary, Dept Chem & Petr Engn, Calgary, AB T2N 1N4, Canada.
RP Xu, L; Gong, HJ (reprint author), China Univ Petr East China, Minist Educ, Key Lab Unconvent Oil & Gas Dev, Qingdao 266580, Shandong, Peoples R China.
EM xulong@upc.edu.cn; gonghoujian@upc.edu.cn
OI Gong, Houjian/0000-0002-3304-1605; Xu, Long/0000-0003-1859-6538
FU Natural Science Foundation of China, ChinaNational Natural Science
   Foundation of China [51774310]; Fundamental Research Funds for the
   Central Universities, ChinaFundamental Research Funds for the Central
   Universities [17CX05005, 18CX02165A]; Applied Basic Research Program of
   Qingdao [17-1-1-27-jch]
FX We gratefully acknowledge financial supports from the Natural Science
   Foundation of China, China (Grant No. 51774310), the Fundamental
   Research Funds for the Central Universities, China (Grant No. 17CX05005,
   18CX02165A), and the Applied Basic Research Program of Qingdao (Grant
   No. 17-1-1-27-jch).
CR Bai B., 2008, SPE DOE S IMPR OIL R
   Banerjee P, 2009, LANGMUIR, V25, P11647, DOI 10.1021/la901259e
   BREWER CF, 1973, BIOCHEMISTRY-US, V12, P4448, DOI 10.1021/bi00746a023
   Chagas BS, 2004, J APPL POLYM SCI, V91, P3686, DOI 10.1002/app.13628
   Cheng SW, 2017, ACS NANO, V11, P752, DOI 10.1021/acsnano.6b07172
   Choppe E, 2010, CARBOHYD POLYM, V82, P1228, DOI 10.1016/j.carbpol.2010.06.056
   de Jong S, 2007, FOOD HYDROCOLLOID, V21, P1172, DOI 10.1016/j.foodhyd.2006.09.004
   Denis M., 2008, OPEN CONSTRUCTION BU, V2, P15, DOI DOI 10.2174/1874836800802010015
   Gong HJ, 2017, ENERG FUEL, V31, P7904, DOI 10.1021/acs.energyfuels.7b01012
   Gong HJ, 2017, RSC ADV, V7, P39564, DOI 10.1039/c7ra04347c
   GOYCOOLEA FM, 1995, MACROMOLECULES, V28, P8308, DOI 10.1021/ma00128a047
   Hamcerencu M, 2009, BIOMACROMOLECULES, V10, P1911, DOI 10.1021/bm900318g
   HEMBER MWN, 1995, CARBOHYD POLYM, V27, P23, DOI 10.1016/0144-8617(95)00026-4
   Jin WG, 2014, FOOD HYDROCOLLOID, V40, P245, DOI 10.1016/j.foodhyd.2014.03.004
   Kamal MS, 2015, CAN J CHEM ENG, V93, P1194, DOI 10.1002/cjce.22204
   Khouryieh HA, 2007, FOOD RES INT, V40, P883, DOI 10.1016/j.foodres.2007.03.001
   Kurt A, 2017, INT J BIOL MACROMOL, V102, P1035, DOI 10.1016/j.ijbiomac.2017.04.081
   Li YJ, 2017, ENERG FUEL, V31, P3960, DOI 10.1021/acs.energyfuels.6b02923
   LOPES L, 1992, CARBOHYD POLYM, V17, P121, DOI 10.1016/0144-8617(92)90105-Y
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775
   Moreira ASP, 2011, J AGR FOOD CHEM, V59, P10078, DOI 10.1021/jf2021072
   Morris ER, 1996, CARBOHYD POLYM, V30, P165, DOI 10.1016/S0144-8617(96)00059-8
   MORRIS ER, 1977, J MOL BIOL, V110, P1, DOI 10.1016/S0022-2836(77)80095-8
   Mu JH, 2002, J PHYS CHEM B, V106, P11685, DOI 10.1021/jp014096a
   Mu JH, 2001, COLLOID POLYM SCI, V279, P872, DOI 10.1007/s003960100508
   Mukherjee I, 2010, LANGMUIR, V26, P17906, DOI 10.1021/la102717v
   Nitta Y, 2010, BIOMACROMOLECULES, V11, P187, DOI 10.1021/bm901063k
   Oh MH, 1999, J COLLOID INTERF SCI, V216, P320, DOI 10.1006/jcis.1999.6325
   Ojinnaka C, 1997, CARBOHYD RES, V305, P101, DOI 10.1016/S0008-6215(97)00277-2
   PAUL F, 1986, BIOTECHNOL ADV, V4, P245, DOI 10.1016/0734-9750(86)90311-3
   Rodd AB, 2000, CARBOHYD POLYM, V42, P159, DOI 10.1016/S0144-8617(99)00156-3
   Samanta A, 2010, J CHEM ENG DATA, V55, P4315, DOI 10.1021/je100458a
   Sang Q, 2014, FUEL, V136, P295, DOI 10.1016/j.fuel.2014.07.065
   Schulte J, 1999, COLLOID POLYM SCI, V277, P827, DOI 10.1007/s003960050459
   Tako M, 2009, COLLOID POLYM SCI, V287, P1445, DOI 10.1007/s00396-009-2112-2
   Tam KC, 1998, MACROMOLECULES, V31, P4149, DOI 10.1021/ma980148r
   Wang W, 2003, COLLOID POLYM SCI, V281, P1046, DOI 10.1007/s00396-003-0873-6
   Xin X, 2008, COLLOID SURFACE A, V326, P1, DOI 10.1016/j.colsurfa.2008.05.009
   Xu L, 2015, CARBOHYD POLYM, V132, P620, DOI 10.1016/j.carbpol.2015.06.083
   Xu L, 2015, CARBOHYD POLYM, V121, P147, DOI 10.1016/j.carbpol.2014.12.030
   Zhang J, 2010, CEMENT CONCRETE RES, V40, P1023, DOI 10.1016/j.cemconres.2010.03.014
   Zhu DW, 2014, ENERGIES, V7, P3858, DOI 10.3390/en7063858
NR 43
TC 0
Z9 0
U1 24
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115138
DI 10.1016/j.ces.2019.07.056
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900010
DA 2020-05-12
ER

PT J
AU Xu, ZL
   Jin, ZJ
   Liu, BQ
   Bengt, S
AF Xu, Zilong
   Jin, Zhijiang
   Liu, Baoqing
   Bengt, Sunden
TI Experimental investigation on solid suspension performance of coaxial
   mixer in viscous and high solid loading systems
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Coaxial mixer; High solid loading; Solid suspension; Cloud height
ID ELECTRICAL-RESISTANCE TOMOGRAPHY; YIELD-PSEUDOPLASTIC FLUIDS;
   POWER-CONSUMPTION; MASS-TRANSFER; CLOUD HEIGHT; LIQUID; IMPELLER;
   AGITATION; HOMOGENIZATION; EFFICIENCY
AB The coaxial mixers consisting of an inner Rushton turbine or propeller and an outer anchor were combined first with the just off-bottom suspension in viscous and high solid loading systems. In this study, a new method based on RGB brightness analysis was proposed to determine the cloud height, and the measures to promote cloud height were also discussed. In addition, the effects of rotation modes, pumping modes and solid loading on the just-suspension power were investigated. The results showed that the co-rotation coaxial mixers with an up-pumping inner impeller could achieve the just suspension at lower power consumption and were recommended. The combination of anchor and up-pumping propeller was the most energy efficient among the investigated mixers, whereas its cloud height was relatively low. The high off-bottom clearance and the combined inner impeller could promote the cloud height with little power variation, but the enlargement of inner impeller had no obvious effect. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Xu, Zilong; Jin, Zhijiang; Liu, Baoqing] Zhejiang Univ, Inst Proc Equipment, Hangzhou 310027, Zhejiang, Peoples R China.
   [Liu, Baoqing; Bengt, Sunden] Lund Univ, Dept Energy Sci, SE-22100 Lund, Sweden.
RP Liu, BQ (reprint author), Zhejiang Univ, Inst Proc Equipment, Hangzhou 310027, Zhejiang, Peoples R China.; Bengt, S (reprint author), Lund Univ, Dept Energy Sci, SE-22100 Lund, Sweden.
EM baoqingliu@zju.edu.cn; bengt.sunden@energy.lth.se
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21776246]; Fundamental Research Funds for the
   Central UniversitiesFundamental Research Funds for the Central
   Universities [2019QNA4020]; China Scholarship CouncilChina Scholarship
   Council [201806325014]
FX This work was financially supported by the National Natural Science
   Foundation of China (21776246), Fundamental Research Funds for the
   Central Universities (2019QNA4020) and China Scholarship Council
   (201806325014).
CR Bittorf KJ, 2003, CHEM ENG RES DES, V81, P568, DOI 10.1205/026387603765444519
   Bubbico R, 1998, CAN J CHEM ENG, V76, P428, DOI 10.1002/cjce.5450760312
   Bujalski W, 1999, CHEM ENG RES DES, V77, P241, DOI 10.1205/026387699526151
   Drewer GR, 2000, MIXING AND CRYSTALLIZATION, P83
   Foucault S, 2004, CHEM ENG TECHNOL, V27, P324, DOI 10.1002/ceat.200401996
   HARRIOTT P, 1962, AICHE J, V8, P93, DOI 10.1002/aic.690080122
   Hashemi N, 2016, CHEM ENG SCI, V151, P25, DOI 10.1016/j.ces.2016.05.003
   Hashemi N, 2016, CHEM ENG RES DES, V109, P734, DOI 10.1016/j.cherd.2016.03.028
   Hashemi N, 2016, CHEM ENG J, V289, P402, DOI 10.1016/j.cej.2015.12.077
   Hicks MT, 1997, CHEM ENG COMMUN, V160, P137, DOI 10.1080/00986449708936610
   Hosseini S, 2010, CHEM ENG SCI, V65, P1374, DOI 10.1016/j.ces.2009.10.007
   Ibrahim S, 1999, CHEM ENG RES DES, V77, P721, DOI 10.1205/026387699526863
   Kazemzadeh A, 2017, CHEM ENG COMMUN, V204, P453, DOI 10.1080/00986445.2016.1277520
   Kuzmanic N, 2008, CHEM ENG PROCESS, V47, P663, DOI 10.1016/j.cep.2006.12.010
   Liu BQ, 2019, CHINESE J CHEM ENG, V27, P2325, DOI 10.1016/j.cjche.2019.01.031
   Liu BQ, 2018, CHINESE J CHEM ENG, V26, P1785, DOI 10.1016/j.cjche.2018.02.009
   Liu BQ, 2018, CHEM ENG RES DES, V133, P335, DOI 10.1016/j.cherd.2018.03.035
   Liu BQ, 2013, IND ENG CHEM RES, V52, P17285, DOI 10.1021/ie401499f
   Liu BQ, 2013, IND ENG CHEM RES, V52, P6862, DOI 10.1021/ie4002266
   Myers KJ, 1998, CAN J CHEM ENG, V76, P433, DOI 10.1002/cjce.5450760313
   Oldshue J.Y., 1992, AICHE S SER, V88, P72
   Pakzad L, 2013, CHEM ENG RES DES, V91, P1715, DOI 10.1016/j.cherd.2013.02.027
   Pakzad L, 2013, CHEM ENG COMMUN, V200, P1553, DOI 10.1080/00986445.2012.751380
   Pakzad L, 2013, CHEM ENG RES DES, V91, P761, DOI 10.1016/j.cherd.2012.09.008
   RAO KSMSR, 1988, AICHE J, V34, P1332
   Rivera C, 2006, CHEM ENG SCI, V61, P2895, DOI 10.1016/j.ces.2005.11.045
   Stoian D, 2017, IND ENG CHEM RES, V56, P7021, DOI 10.1021/acs.iecr.7b00435
   Takenaka K, 2005, J CHEM ENG JPN, V38, P309, DOI 10.1252/jcej.38.309
   Wang S, 2012, CHEM ENG SCI, V74, P233, DOI 10.1016/j.ces.2012.02.035
   Wang S, 2012, AICHE J, V58, P1291, DOI 10.1002/aic.12657
   Wu J, 2011, AICHE J, V57, P2316, DOI 10.1002/aic.12468
   Wu J, 2002, AICHE J, V48, P1349, DOI 10.1002/aic.690480620
   Wu J, 2010, CAN J CHEM ENG, V88, P447, DOI 10.1002/cjce.20278
   Wu J, 2010, CAN J CHEM ENG, V88, P287, DOI 10.1002/cjce.20274
   ZWIETERING TN, 1958, CHEM ENG SCI, V8, P244, DOI 10.1016/0009-2509(58)85031-9
NR 35
TC 0
Z9 0
U1 10
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115144
DI 10.1016/j.ces.2019.08.002
PG 11
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900016
DA 2020-05-12
ER

PT J
AU Yang, JF
   Bhagat, RK
   Fernandes, RR
   Nordkvist, M
   Gernaey, KV
   Kruhne, U
   Wilson, DI
AF Yang, Jifeng
   Bhagat, Rajesh K.
   Fernandes, Rubens R.
   Nordkvist, Mikkel
   Gernaey, Krist, V
   Kruhne, Ulrich
   Wilson, D. Ian
TI Cleaning of toothpaste from vessel walls by impinging liquid jets and
   their falling films: Quantitative modelling of soaking effects
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cleaning; Impinging jet; Falling film; Soaking; Toothpaste
ID WATER JETS; FLOW PATTERNS; SOIL LAYERS; SURFACES; DEPOSITS
AB The cleaning of thin toothpaste soiling layers from vertical glass surfaces by horizontal impinging water jets and the falling films created by the draining liquid were studied. The effect of soaking time on the rheological properties of the soil material, the force required to remove it, and the cleaning behaviour were determined. The adhesive removal model reported by Wilson et al. (2014, Chem. Eng. Sci., Vol. 109, 183-195) and Bhagat et al. (2017, Food Bioprod. Proc., Vol. 102, 31-54) gave a good description of the cleaning behaviour, including the shape of the cleaning front generated by jets from static and moving nozzles. This model was also applied to removal by the falling liquid film: when soaking kinetics are taken into consideration, it gives a good description of this process as well. This is the first study considering the effect of soil soaking on cleaning by water jets and falling films. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yang, Jifeng; Gernaey, Krist, V; Kruhne, Ulrich] Tech Univ Denmark, Dept Chem & Biochem Engn, Bldg 229, DK-2800 Lyngby, Denmark.
   [Bhagat, Rajesh K.; Fernandes, Rubens R.; Wilson, D. Ian] Dept Chem Engn & Biotechnol, Philippa Fawcett Dr, Cambridge CB3 0AS, England.
   [Nordkvist, Mikkel] Alfa Laval Copenhagen AS, Maskinvej 5, DK-2860 Soborg, Denmark.
RP Wilson, DI (reprint author), Dept Chem Engn & Biotechnol, Philippa Fawcett Dr, Cambridge CB3 0AS, England.
EM diw11@cam.ac.uk
RI Fernandes, Rubens R./AAE-9815-2019; Gernaey, Krist V./J-1759-2018;
   Bhagat, Rajesh/AAE-3106-2020
OI Gernaey, Krist V./0000-0002-0364-1773; Kruhne,
   Ulrich/0000-0001-7774-7442
FU DRIP (Danish partnership for Resource and water efficient Industrial
   food Production) - Innovation Fund Denmark (IFD) [5107-00003B];
   Technical University of Denmark (DTU); Commonwealth Scholarship
   Commission; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   - Brasil (CAPES)CAPES [001]; Otto Monsteds Fond [18-70-0448]
FX A PhD studentship and project support for JY from DRIP (Danish
   partnership for Resource and water efficient Industrial food
   Production), partly funded by the Innovation Fund Denmark (IFD) under
   contract No. 5107-00003B, and by the Technical University of Denmark
   (DTU), is gratefully acknowledged, as are PhD scholarships for RKB and
   RRF from the Commonwealth Scholarship Commission and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance
   Code 001, respectively. Financial support for JY's research at Cambridge
   was provided by the Otto Monsteds Fond (award No. 18-70-0448). Melissa
   Chee helped with the measurement of falling film thickness.
CR Ahuja A, 2018, J NON-NEWTON FLUID, V258, P1, DOI 10.1016/j.jnnfm.2018.04.003
   Ahuja A, 2018, RHEOL ACTA, V57, P459, DOI 10.1007/s00397-018-1090-z
   American Society of Mechanical Engineers, 2016, ASME BPE BIOPR EQ
   Aouad W, 2016, EXP THERM FLUID SCI, V74, P429, DOI 10.1016/j.expthermflusci.2015.12.010
   Bhagat RK, 2017, FOOD BIOPROD PROCESS, V102, P31, DOI 10.1016/j.fbp.2016.11.011
   Bhagat RK, 2016, CHEM ENG SCI, V152, P606, DOI 10.1016/j.ces.2016.06.011
   Bhagat RK, 2018, J FLUID MECH, V851, DOI 10.1017/jfm.2018.558
   Chee MWL, 2019, FOOD BIOPROD PROCESS, V113, P142, DOI 10.1016/j.fbp.2018.10.005
   Cuckston GL, 2019, J FOOD ENG, V243, P22, DOI 10.1016/j.jfoodeng.2018.08.018
   Damkjaer NF, 2017, FOOD BIOPROD PROCESS, V101, P145, DOI 10.1016/j.fbp.2016.11.001
   Gerhards C, 2019, J FOOD ENG, V253, P21, DOI 10.1016/j.jfoodeng.2019.02.011
   Glover HW, 2016, J FOOD ENG, V178, P95, DOI 10.1016/j.jfoodeng.2015.12.021
   Hsu TYT, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3567215
   Kohler H, 2016, TEH VJESN, V23, P349, DOI 10.17559/TV-20140213152946
   Magens OM, 2017, J FOOD ENG, V197, P48, DOI 10.1016/j.jfoodeng.2016.11.004
   Mertens K, 2005, J FLUID MECH, V531, P49, DOI 10.1017/S0022112005003873
   Micro-Epsilon, 2016, INSTR MAN CONFOCALDT
   Morison KR, 2002, FOOD BIOPROD PROCESS, V80, P270, DOI 10.1205/096030802321154763
   Nusselt W, 1916, Z VER DTSCH ING, V60, P541
   Palabiyik I, 2014, CHEM ENG RES DES, V92, P2201, DOI 10.1016/j.cherd.2014.01.001
   PORTALSKI S, 1963, CHEM ENG SCI, V18, P787, DOI 10.1016/0009-2509(63)85046-0
   Rodgers A, 2019, FOOD BIOPROD PROCESS, V113, P118, DOI 10.1016/j.fbp.2018.11.003
   Wang T, 2013, CHEM ENG SCI, V102, P585, DOI 10.1016/j.ces.2013.08.054
   Wang T, 2013, CHEM ENG SCI, V88, P79, DOI 10.1016/j.ces.2012.11.009
   Wang T, 2015, FOOD BIOPROD PROCESS, V93, P333, DOI 10.1016/j.fbp.2014.09.006
   Wilson DI, 2015, CHEM ENG SCI, V123, P450, DOI 10.1016/j.ces.2014.11.006
   Wilson DI, 2014, CHEM ENG SCI, V109, P183, DOI 10.1016/j.ces.2014.01.034
   Wilson DI, 2012, CHEM ENG SCI, V68, P449, DOI 10.1016/j.ces.2011.10.003
   Yang JF, 2019, FOOD BIOPROD PROCESS, V113, P154, DOI 10.1016/j.fbp.2018.10.007
NR 29
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115148
DI 10.1016/j.ces.2019.08.006
PG 15
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900020
DA 2020-05-12
ER

PT J
AU Yang, YX
   Qiao, LQ
   Hao, JS
   Shi, H
   Lv, GQ
AF Yang, Yongxing
   Qiao, Liuqi
   Hao, Junsheng
   Shi, Hu
   Lv, Guangqiang
TI Hydrodeoxygenation upgrading of bio-oil on Ni-based catalysts with low
   Ni loading
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Catalyst; Ni; Hydrogenation; Bio-fuel; Upgrading
ID METAL-SUPPORT INTERACTION; PHASE HYDRODEOXYGENATION;
   AROMATIC-HYDROCARBONS; LIGNIN; PHENOL; CONVERSION; FRACTION; MODEL
AB Ni/gamma-Al2O3, Ni/AlSBA-15 and Ni/HZSM-5 catalyst with small amount of active metal of 1 wt% Ni loading were prepared. The performance for hydrodeoxygenation upgrading of a model bio-oil was evaluated under different reaction conditions. It was found that Ni/gamma-Al2O3 displays the highest anisole conversion 60% at WHSV = 81.6 h(-1) and nearly 100% at WHSV = 20.4 h(-1) as compared with Ni/AlSBA-15 and Ni/HZSM-5. Toluene, a premium aromatic product, could form and the maximum toluene selectivity 20% could be obtained at WHSV = 20.4 h(-1) at 3 bars over Ni/HZSM-5. 10% n-hexane selectivity could be obtained over Ni/HZSM-5 at WHSV = 20.4 h(-1) at 3 bars. 70% arene selectivity could be obtained at WHSV = 81.6 h(-1) at 3 bars over Ni/HZSM-5. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yang, Yongxing; Qiao, Liuqi; Hao, Junsheng; Shi, Hu] Shanxi Univ, Sch Chem & Chem Engn, Natl Demonstrat Ctr Expt Chem Educ, Wucheng Rd 92, Taiyuan 030006, Shanxi, Peoples R China.
   [Lv, Guangqiang] Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Mol Engn, Shandong Acad Sci, Jinan 250353, Shandong, Peoples R China.
RP Yang, YX (reprint author), Shanxi Univ, Sch Chem & Chem Engn, Natl Demonstrat Ctr Expt Chem Educ, Wucheng Rd 92, Taiyuan 030006, Shanxi, Peoples R China.; Lv, GQ (reprint author), Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Mol Engn, Shandong Acad Sci, Jinan 250353, Shandong, Peoples R China.
EM yangyongxing@sxu.edu.cn; lvguangqiang@qlu.edu.cn
FU National Natural Science Foundation of China (NNSFC)National Natural
   Science Foundation of China [U1610108, 21805145]; Scientific and
   Technological Innovation Programs of High Education Institutions in
   Shanxi [201802001-1]; Department of Human Resource and Social Security
   of Shanxi Province [Y6SW9613B1]; Department of Science and Technology of
   Shanxi Province [201705D211001]
FX This work was financially supported by the National Natural Science
   Foundation of China (NNSFC) (U1610108 & 21805145), Scientific and
   Technological Innovation Programs of High Education Institutions in
   Shanxi (201802001-1), the Department of Human Resource and Social
   Security of Shanxi Province (Y6SW9613B1) and the Department of Science
   and Technology of Shanxi Province (201705D211001).
CR Broglia F, 2019, FUEL, V243, P501, DOI 10.1016/j.fuel.2019.01.157
   Chen ZH, 2018, NEW CARBON MATER, V33, P417, DOI 10.1016/S1872-5805(18)30008-8
   Cheng SY, 2016, NEW BIOTECHNOL, V33, P440, DOI 10.1016/j.nbt.2016.02.004
   Dongil AB, 2016, FUEL, V172, P65, DOI 10.1016/j.fuel.2016.01.002
   Echeandia S, 2010, APPL CATAL B-ENVIRON, V101, P1, DOI 10.1016/j.apcatb.2010.08.018
   HARDENBERG TAJ, 1992, ZEOLITES, V12, P685, DOI 10.1016/0144-2449(92)90116-7
   Long JX, 2015, ENERG CONVERS MANAGE, V105, P570, DOI 10.1016/j.enconman.2015.08.016
   Mortensen PM, 2013, ACS CATAL, V3, P1774, DOI 10.1021/cs400266e
   Ochoa-Hernandez C, 2013, CATAL TODAY, V210, P81, DOI 10.1016/j.cattod.2012.12.002
   Yang FF, 2018, ACS CATAL, V8, P1672, DOI 10.1021/acscatal.7b04097
   Yang KX, 2018, CHEMISTRYSELECT, V3, P11398, DOI 10.1002/slct.201802490
   Yang YX, 2016, APPL CATAL B-ENVIRON, V197, P206, DOI 10.1016/j.apcatb.2016.01.001
   Yang YX, 2014, APPL CATAL B-ENVIRON, V145, P91, DOI 10.1016/j.apcatb.2013.03.038
   Yang YX, 2012, ACS CATAL, V2, P592, DOI 10.1021/cs200659r
   Yin W, 2018, FUEL PROCESS TECHNOL, V169, P258, DOI 10.1016/j.fuproc.2017.10.006
   Yu ZQ, 2018, IND ENG CHEM RES, V57, P10216, DOI 10.1021/acs.iecr.8b01606
   Yu ZQ, 2018, GREEN CHEM, V20, P609, DOI 10.1039/c7gc03262e
   Yung MM, 2018, CATAL TODAY, V302, P151, DOI 10.1016/j.cattod.2017.03.014
   Zhang XH, 2018, J ANAL APPL PYROL, V135, P60, DOI 10.1016/j.jaap.2018.09.020
   Zhang XH, 2019, CATAL TODAY, V319, P41, DOI 10.1016/j.cattod.2018.03.068
   Zhang XH, 2018, APPL ENERG, V227, P73, DOI 10.1016/j.apenergy.2017.08.078
   Zhang XH, 2018, FUEL, V215, P825, DOI 10.1016/j.fuel.2017.11.111
   Zhang XH, 2014, ENERG FUEL, V28, P2562, DOI 10.1021/ef402421j
   Zhang XH, 2013, APPL ENERG, V112, P533, DOI 10.1016/j.apenergy.2013.04.077
   Zhao XY, 2018, CHEMISTRYSELECT, V3, P10364, DOI 10.1002/slct.201801147
   Zhou X, 2018, ASIA-PAC J CHEM ENG, V13, DOI 10.1002/apj.2228
   Zhu GH, 2018, ACS SUSTAIN CHEM ENG, V6, P10078, DOI 10.1021/acssuschemeng.8b01419
NR 27
TC 0
Z9 0
U1 24
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115154
DI 10.1016/j.ces.2019.08.012
PG 7
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900026
DA 2020-05-12
ER

PT J
AU Zhou, H
   Zhu, CY
   Fu, TT
   Ma, YG
   Li, HZ
AF Zhou, Hao
   Zhu, Chunying
   Fu, Taotao
   Ma, Youguang
   Li, Huai Z.
TI Dynamics and interfacial evolution for bubble breakup in shear-thinning
   non-Newtonian fluid in microfluidic T-junction
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Microfluidics; Interfacial dynamics; Bubble; Shear-thinning fluid;
   Breakup
ID DROPLET FORMATION; FLOWS; OBSTRUCTION
AB The dynamics and interfacial evolution for bubble breakup in shear-thinning non-Newtonian fluids in microfluidic T-junction were investigated. The bubble breakup process includes three stages: squeezing, transition and rapid pinch-off stages. The minimum widths of the bubble neck in three stages exhibit a power-law relationship with the time or remaining time. Compared to bubble breakup in Newtonian fluid, the squeezing stage shortens in non-Newtonian fluid, and the power-law exponent of the rapid pinch-off stage increases with the decrease of the flow index of the CMC solutions. The length of the bubble tip is linearly stretched with time, and the elongation rate increases with the concentration of CMC solution. The results show that the rheological property of the CMC solution could significantly affect the bubble breakup process in the microfluidic T-junction. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhou, Hao; Zhu, Chunying; Fu, Taotao; Ma, Youguang] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
   [Li, Huai Z.] Univ Lorraine, Lab React & Proc Engn, CNRS, 1 Rue Grandville,BP 20451, F-54001 Nancy, France.
RP Zhu, CY; Ma, YG (reprint author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
EM zhchy971@tju.edu.cn; ygma@tju.edu.cn
RI Li, Huai/S-2162-2019
OI Li, Huai/0000-0001-7129-6660; Fu, Taotao/0000-0003-1881-1509
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [21776200, 21576186, 91634105]; aid of Opening
   Project of State Key Laboratory of Chemical Engineering of China
   [SKL-ChE-17B02]
FX The financial supports from the National Nature Science Foundation of
   China (No. 21776200, 21576186, 91634105), the aid of Opening Project of
   State Key Laboratory of Chemical Engineering of China (No.
   SKL-ChE-17B02).
CR Basaran OA, 2002, AICHE J, V48, P1842, DOI 10.1002/aic.690480902
   Bergmann R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154505
   Chen YP, 2017, J FLUID MECH, V819, P401, DOI 10.1017/jfm.2017.181
   Chen YP, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789865
   Dai CL, 2017, COLLOID SURFACE A, V535, P130, DOI 10.1016/j.colsurfa.2017.09.037
   De Menech M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031505
   Dollet B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.034504
   Fu TT, 2016, CHEM ENG TECHNOL, V39, P987, DOI 10.1002/ceat.201500620
   Fu TT, 2016, CHEM ENG SCI, V144, P75, DOI 10.1016/j.ces.2015.12.031
   Fu TT, 2012, AICHE J, V58, P3560, DOI 10.1002/aic.13723
   Fu TT, 2011, CHEM ENG SCI, V66, P4184, DOI 10.1016/j.ces.2011.06.003
   Garstecki P, 2006, LAB CHIP, V6, P693
   Garstecki P, 2004, APPL PHYS LETT, V85, P2649, DOI 10.1063/1.1796526
   Gordillo JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.194501
   Han WB, 2019, CHEM ENG RES DES, V145, P213, DOI 10.1016/j.cherd.2019.03.002
   Han WB, 2018, J MICRO-NANOLITH MEM, V17, DOI 10.1117/1.JMM.17.2.025502
   Hoang DA, 2013, J FLUID MECH, V717, DOI 10.1017/jfm.2013.18
   Ingremeau F, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041002
   Jiang XF, 2017, CHEM ENG SCI, V170, P98, DOI 10.1016/j.ces.2016.12.057
   Jullien MC, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3170983
   Leshansky AM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.264502
   Leshansky AM, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3078515
   Li HAZ, 1999, CHEM ENG SCI, V54, P2247, DOI 10.1016/S0009-2509(98)00294-2
   Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503
   Lu YT, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022802
   Ma PC, 2019, KOREAN J CHEM ENG, V36, P21, DOI 10.1007/s11814-018-0165-y
   Ma R, 2018, J IND ENG CHEM, V65, P272, DOI 10.1016/j.jiec.2018.04.038
   Ma YL, 2018, CHEM ENG SCI, V179, P104, DOI 10.1016/j.ces.2018.01.011
   Mansour MH, 2015, INT J MULTIPHAS FLOW, V72, P263, DOI 10.1016/j.ijmultiphaseflow.2015.02.019
   Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b
   Muller-Fischer N, 2008, EXP FLUIDS, V45, P917, DOI 10.1007/s00348-008-0509-1
   Ren Y, 2015, LAB CHIP, V15, P121, DOI 10.1039/c4lc00798k
   Sontti SG, 2018, J IND ENG CHEM, V65, P82, DOI 10.1016/j.jiec.2018.04.016
   Sontti SG, 2017, CHEM ENG J, V330, P245, DOI 10.1016/j.cej.2017.07.097
   Sun X, 2018, CHEM ENG SCI, V188, P158, DOI 10.1016/j.ces.2018.05.027
   Thoroddsen ST, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2710269
   Wang XD, 2015, CHEM ENG SCI, V132, P128, DOI 10.1016/j.ces.2015.04.038
   Wang XD, 2015, AICHE J, V61, P1081, DOI 10.1002/aic.14704
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Yuan D, 2018, LAB CHIP, V18, P551, DOI 10.1039/c7lc01076a
NR 40
TC 1
Z9 1
U1 32
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115158
DI 10.1016/j.ces.2019.115158
PG 10
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900030
DA 2020-05-12
ER

PT J
AU Zhou, KH
   Tang, DM
   Li, WL
   Han, Y
   Wu, HY
   Diao, GW
   Chen, M
AF Zhou, Kehan
   Tang, Dongmei
   Li, Wenlong
   Han, Yue
   Wu, Huayu
   Diao, Guowang
   Chen, Ming
TI Synergetic lithium storage of bimetallic sulfide Co8FeS8/N-C
   dodecahedral nanocages with enhanced lithium-ion battery performance
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Co8FeS8; Bimetallic sulfide; Synergy effect; Lithium-ion batteries;
   ZIF-67
ID METAL-ORGANIC-FRAMEWORKS; IN-SITU FORMATION; OXYGEN REDUCTION; COBALT
   PHOSPHIDE; CARBON NANOCUBES; FACILE SYNTHESIS; ANODE MATERIAL;
   EVOLUTION; NANOPARTICLES; ELECTRODES
AB In this paper, bimetallic sulfide Co8FeS8/N-C dodecahedral nanocages (DNCs) were synthesized by using ZIF-67 as a template through subsequent pyrolysis and sulfuration process. Co8FeS8 nanoparticles are embedded carbon framework, which has porous hollow interior and conductive N-doped carbon matrix. When the Co8FeS8/N-C DNCs were applied as anode materials in lithium-ion battery, the bimetallic sulfide composites realize high reversible capacity (396 mA h g(-1) at 0.5 A g(-1) after 400 cycles) and excellent rate capability (349 mA h g(-1) at 5.0 A g(-1)). Meanwhile, Co8FeS8/N-C DNCs also have superior cycle performance (308 mA h g(-1) at 5.0 A g(-1) after 1000 cycles). The remarkable properties are attributed to the synergy effect of bimetallic sulfide and the special polyhedral hollow structure with the conductive N-dopped mesoporous carbon. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhou, Kehan; Tang, Dongmei; Li, Wenlong; Han, Yue; Wu, Huayu; Diao, Guowang; Chen, Ming] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou 225002, Jiangsu, Peoples R China.
RP Chen, M (reprint author), Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou 225002, Jiangsu, Peoples R China.
EM chenming@yzu.edu.cn
RI Zhou, Kehan/AAL-8261-2020; , D.W./AAH-8097-2020
OI Chen, Ming/0000-0002-6436-4765
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21773203]; Natural Science Foundation of Jiangsu
   ProvinceJiangsu Planned Projects for Postdoctoral Research FundsNatural
   Science Foundation of Jiangsu Province [BK20161329]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions
FX The funding support from the National Natural Science Foundation of
   China (Grant No. 21773203), Natural Science Foundation of Jiangsu
   Province (BK20161329), and a Project Funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions is
   acknowledged.
CR Amiinu IS, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702300
   Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411
   Chen J., 2019, ADV FUNCT MAT, V29
   Chen J., 2017, ADV ENERGY MAT, V7
   Chen YZ, 2015, ADV MATER, V27, P5010, DOI 10.1002/adma.201502315
   Feng LL, 2016, J MATER CHEM A, V4, P6860, DOI 10.1039/c5ta08611f
   Ganesan V, 2017, INT J HYDROGEN ENERG, V42, P5985, DOI 10.1016/j.ijhydene.2016.12.060
   Gao S, 2016, NATURE, V529, P68, DOI 10.1038/nature16455
   Gao X, 2019, ENERGY STORAGE MATER, V16, P46, DOI 10.1016/j.ensm.2018.04.027
   Gao XJ, 2017, J MATER CHEM A, V5, P25625, DOI 10.1039/c7ta06849b
   Gomez-Camer JL, 2008, J ELECTROCHEM SOC, V155, pA189, DOI 10.1149/1.2825137
   Goodenough JB, 2014, ENERG ENVIRON SCI, V7, P14, DOI 10.1039/c3ee42613k
   Hou CT, 2012, RSC ADV, V2, P12696, DOI 10.1039/c2ra21848h
   Hu H, 2016, ENERG ENVIRON SCI, V9, P107, DOI 10.1039/c5ee02903a
   Huang M, 2017, J MATER CHEM A, V5, P266, DOI 10.1039/c6ta09030c
   Kim JH, 2017, NANO RES, V10, P3178, DOI 10.1007/s12274-017-1535-1
   Kong SF, 2014, J PHYS CHEM C, V118, P25355, DOI 10.1021/jp508698q
   Li SJ, 2019, ENERGY STORAGE MATER, V16, P267, DOI 10.1016/j.ensm.2018.06.006
   Li WL, 2019, J MATER CHEM A, V7, P8443, DOI 10.1039/c9ta00054b
   Lin YM, 2018, ENERGY STORAGE MATER, V11, P67, DOI 10.1016/j.ensm.2017.06.001
   Liu J, 2016, SMALL, V12, P2354, DOI 10.1002/smll.201503821
   Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045
   Recham N, 2010, NAT MATER, V9, P68, DOI [10.1038/nmat2590, 10.1038/NMAT2590]
   Salunkhe RR, 2017, ACS NANO, V11, P5293, DOI 10.1021/acsnano.7b02796
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Shang L, 2016, ADV MATER, V28, P1668, DOI 10.1002/adma.201505045
   Shen LF, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400977
   Shi WH, 2012, ACS APPL MATER INTER, V4, P2999, DOI 10.1021/am3003654
   Sun YW, 2016, CHEMISTRYSELECT, V1, P5129, DOI 10.1002/slct.201601147
   Tsumori N, 2018, CHEM-US, V4, P845, DOI 10.1016/j.chempr.2018.03.009
   Wang L, 2016, ELECTROCHIM ACTA, V219, P592, DOI 10.1016/j.electacta.2016.10.050
   Wang LL, 2019, ENERGY STORAGE MATER, V16, P37, DOI 10.1016/j.ensm.2018.04.025
   Wang QF, 2015, SMALL, V11, P2511, DOI 10.1002/smll.201403579
   Wu QH, 2019, ENERGY STORAGE MATER, V19, P69, DOI 10.1016/j.ensm.2018.10.018
   Wu RB, 2015, ADV MATER, V27, P3038, DOI 10.1002/adma.201500783
   Xi JB, 2015, CHEM COMMUN, V51, P10479, DOI 10.1039/c5cc03946k
   Xia GL, 2017, J MATER CHEM A, V5, P10321, DOI 10.1039/c7ta02600e
   Xu QT, 2018, ELECTROCHIM ACTA, V292, P1, DOI 10.1016/j.electacta.2018.09.135
   Xu X, 2014, NANO TODAY, V9, P604, DOI 10.1016/j.nantod.2014.09.005
   Yan Y, 2012, CHEM COMMUN, V48, P10663, DOI 10.1039/c2cc36234a
   Yang HC, 2015, NANO LETT, V15, P7616, DOI 10.1021/acs.nanolett.5b03446
   Yang SB, 2012, ADV FUNCT MATER, V22, P3634, DOI 10.1002/adfm.201200186
   Yang YQ, 2014, J MATER CHEM A, V2, P9111, DOI 10.1039/c4ta01222d
   Yu L, 2016, ANGEW CHEM INT EDIT, V55, P13422, DOI 10.1002/anie.201606776
   Yu X, 2018, ELECTROCHIM ACTA, V272, P119, DOI 10.1016/j.electacta.2018.03.201
   Zeng PY, 2017, CHEM-EUR J, V23, P9517, DOI 10.1002/chem.201700881
   Zeng YP, 2012, SEP PURIF TECHNOL, V95, P149, DOI 10.1016/j.seppur.2012.04.032
   Zhang L, 2013, J AM CHEM SOC, V135, P10664, DOI 10.1021/ja401727n
   Zhang XE, 2018, J MATER CHEM A, V6, P19004, DOI 10.1039/c8ta05584j
   Zhang X, 2017, ACS NANO, V11, P8429, DOI 10.1021/acsnano.7b04078
   Zhang YF, 2015, NANOSCALE, V7, P3155, DOI 10.1039/c4nr06286h
   Zhong X, 2016, J MATER CHEM A, V4, P10575, DOI 10.1039/c6ta03820d
   Zhou YX, 2010, CHEM-EUR J, V16, P12000, DOI 10.1002/chem.200903263
NR 53
TC 0
Z9 0
U1 46
U2 53
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD NOV 23
PY 2019
VL 208
AR UNSP 115142
DI 10.1016/j.ces.2019.07.060
PG 9
WC Engineering, Chemical
SC Engineering
GA JD5AV
UT WOS:000489992900014
DA 2020-05-12
ER

PT J
AU Poston, TB
   Gottlieb, SL
   Darville, T
AF Poston, Taylor B.
   Gottlieb, Sami L.
   Darville, Toni
TI Status of vaccine research and development of vaccines for Chlamydia
   trachomatis infection
SO VACCINE
LA English
DT Article
DE Chlamydia; Vaccine; Pathogenesis
ID PELVIC-INFLAMMATORY-DISEASE; SEXUALLY-TRANSMITTED INFECTIONS;
   GENITAL-INFECTION; PROTECTIVE IMMUNITY; T-CELLS; COST-EFFECTIVENESS;
   UNITED-STATES; FIELD TRIAL; FOLLOW-UP; WOMEN
AB Genital infection with Chlamydia trachomatis, a gram-negative obligate intracellular bacterium, is the most common bacterial sexually transmitted infection globally. Ascension of chlamydial infection to the female upper genital tract can cause acute pelvic inflammatory disease, tubal factor infertility, ectopic pregnancy, and chronic pelvic pain. Shortcomings of current chlamydia control strategies, especially for low- and middle-income countries, highlight the need for an effective vaccine. Evidence from animal models, human epidemiological studies, and early trachoma vaccine trials suggest that a C trachomatis vaccine is feasible. Vaccine development for genital chlamydial infection has been in the preclinical phase of testing for many years, but the first Phase I trials of chlamydial vaccine candidates are underway, and scientific advances hold promise for additional candidates to enter clinical evaluation in the coming years. We describe the clinical and public health need for a C trachomatis vaccine, provide art overview of Chlamydia vaccine development efforts, and summarize current vaccine candidates in the development pipeline. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Poston, Taylor B.; Darville, Toni] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA.
   [Gottlieb, Sami L.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
RP Darville, T (reprint author), Univ N Carolina, 8340B MBRB,CB 7509,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.
EM toni.darville@unc.edu
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI084024, R01 AI119164]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (Grants U19 AI084024 and R01 AI119164).
CR ADAMS EJ, 2007, [No title captured], V83, P74
   Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364
   Aghaizu A, 2011, SEX TRANSM INFECT, V87, P312, DOI 10.1136/sti.2010.048694
   [Anonymous], 2015, VACCINE, V33, P4383, DOI 10.1016/j.vaccine.2014.12.002
   ARNO JN, 1994, SEX TRANSM DIS, V21, P47, DOI 10.1097/00007435-199401000-00010
   Bailey R, P 13 INT S HUM CHLAM, P485
   Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400
   Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734
   Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5
   BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994
   Bietti G, 1967, TRACHOMA PREVENTION
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Boje S, 2016, IMMUNOL CELL BIOL, V94, P185, DOI 10.1038/icb.2015.79
   Brady LJ, 2005, INFECT IMMUN, V73, P671, DOI 10.1128/IAI.73.2.671-678.2005
   Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053
   Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3
   Buckner LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146663
   Cabeza J, 2015, SEX TRANSM INFECT, V91, P7, DOI 10.1136/sextrans-2014-051531
   CATES W, 1985, LANCET, V2, P596
   CDC (Centers for Disease Control and Prevention) ASRM (American Society for Reproductive Medicine) and SART (Society for Assisted Reproductive Technology), 2015, 2013 ASS REPR TECHN
   Collier L, 1963, ORIENT ARCHS OPHTHAL, V1, P67
   Darville T, 2013, SEX TRANSM INFECT, V89, pA27, DOI 10.1136/sextrans-2013-051184.0086
   Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7
   Derrick T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/791847
   DHIR SP, 1967, AM J OPHTHALMOL, V63, P1639, DOI 10.1016/0002-9394(67)94157-8
   Dhont N, 2011, TROP DOCT, V41, P96, DOI 10.1258/td.2011.100410
   Dodet B, 2014, VACCINE, V32, P1624, DOI 10.1016/j.vaccine.2013.08.032
   Durber L, 2010, INT J STD AIDS, V21, P449, DOI 10.1258/ijsa.2010.010093
   Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006
   Feinberg EC, 2006, FERTIL STERIL, V85, P888, DOI 10.1016/j.fertnstert.2005.10.028
   Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108
   Garmory HS, 2005, INFECT IMMUN, V73, P2005, DOI 10.1128/IAI.73.4.2005-2011.2005
   Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094
   Gift TL, 2008, SEX TRANSM DIS, V35, pS66, DOI 10.1097/OLQ.0b013e31818b64ac
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Gottlieb SL, 2013, SEX TRANSM DIS, V40, P97, DOI 10.1097/OLQ.0b013e31827bd637
   Goyaux N, 2003, ACTA OBSTET GYN SCAN, V82, P305, DOI 10.1034/j.1600-0412.2003.00175.x
   Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983
   Grayston J, 1971, TRACHOMA RELATED DIS, P377
   GRAYSTON JT, 1978, SEX TRANSM DIS, V5, P73, DOI 10.1097/00007435-197804000-00011
   GRAYSTON JT, 1963, P SOC EXP BIOL MED, V112, P589, DOI 10.3181/00379727-112-28112
   Heijne JCM, 2010, AM J PREV MED, V39, P243, DOI 10.1016/j.amepre.2010.05.011
   Hu V, P 13 INT S HUM CHLAM, P489
   IGIETSEME JU, 1991, INFECT IMMUN, V59, P1346, DOI 10.1128/IAI.59.4.1346-1351.1991
   Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530
   Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266
   Karunakaran KP, 2015, VACCINE, V33, P2159, DOI 10.1016/j.vaccine.2015.02.055
   LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981
   Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375
   Lorenzen E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00628
   Lorenzen E, 2015, VET RES, V46, DOI 10.1186/s13567-015-0241-9
   Mabey DCW, 2014, VACCINE, V32, P1572, DOI 10.1016/j.vaccine.2013.10.016
   Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229
   NanoBio Corporation, 2015, NAN CHLAM VACC IMPR
   Ness RB, 1998, CONTROL CLIN TRIALS, V19, P499, DOI 10.1016/S0197-2456(98)00022-1
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027
   Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642
   Oakeshott Pippa, 2008, Trials, V9, P73, DOI 10.1186/1745-6215-9-73
   Olivares-Zavaleta N, 2014, J IMMUNOL, V192, P4648, DOI 10.4049/jimmunol.1400120
   Olsen AW, 2015, J INFECT DIS, V212, P978, DOI 10.1093/infdis/jiv137
   Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2
   Picard MD, 2015, CLIN VACCINE IMMUNOL, V22, P1206, DOI 10.1128/CVI.00247-15
   Poston TB, 2016, CURR TOP MICROBIOL I
   Qu YY, 2015, INFECT IMMUN, V83, P4056, DOI 10.1128/IAI.00841-15
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   RANK RG, 1985, INFECT IMMUN, V48, P847, DOI 10.1128/IAI.48.3.847-849.1985
   Rank RG, 2010, J INFECT DIS, V201, pS168, DOI 10.1086/652399
   Russell AN, 2016, J INFECT DIS, V213, P523, DOI 10.1093/infdis/jiv438
   Russell ANZX, 2016, J INFECT DIS
   Rutstein SO, 2004, INFECUNDITY INFERTIL, P20705
   Sexton J, 2005, SEX TRANSM DIS, V32, P351, DOI 10.1097/01.olq.0000154504.54686.d1
   SOWA S, 1969, J HYG-CAMB, V67, P699, DOI 10.1017/S0022172400042157
   Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205
   Tukeva TA, 1999, RADIOLOGY, V210, P209, DOI 10.1148/radiology.210.1.r99ja04209
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001
   Wiesenfeld HC, 2005, SEX TRANSM DIS, V32, P400, DOI 10.1097/01.olq.0000154508.26532.6a
   WOOLRIDGE RL, 1967, AM J OPHTHALMOL, V63, P1650, DOI 10.1016/0002-9394(67)94159-1
   Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952
NR 80
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7289
EP 7294
DI 10.1016/j.vaccine.2017.01.023
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100001
PM 28111145
DA 2020-05-12
ER

PT J
AU Sutton, P
   Boag, JM
AF Sutton, Philip
   Boag, Joanne M.
TI Status of vaccine research and development for Helicobacter pylori
SO VACCINE
LA English
DT Article
DE Helicobacter pylori; Vaccine; Research and development
ID THERAPEUTIC IMMUNIZATION; GASTRIC-CANCER; INFECTION; ERADICATION;
   INFLAMMATION; IMMUNITY; IMMUNOGENICITY; EPIDEMIOLOGY; VOLUNTEERS;
   PROTECTION
AB Gastric adenocarcinoma is globally the third leading cause of death due to malignancy, with the bulk of this disease burden being suffered by low and middle income countries (LMIC), especially in Asia. The majority of these cancers develop as a result of a chronic gastritis that arises in response to infection with the stomach-dwelling bacterium, Helicobacter pylori. A vaccine against this pathogen would therefore be a powerful tool for preventing gastric adenocarcinoma. However, notwithstanding a proof-of-concept that vaccination can protect children from acquisition of H. pylori infection, there are currently no advanced vaccine candidates with only a single vaccine in Phase I clinical trial. Further, the development of a vaccine against H. pylori is not a current strategic priority of major pharmaceutical companies despite the large global disease burden. Given the involvement of such companies is likely to be critical for late stage development, there is therefore a need for an increased appreciation of the burden of this disease in LMIC and more investment to reinvigorate research in H. pylori vaccine Research and Development. (C) 2018 Elsevier Ltd.
C1 [Sutton, Philip; Boag, Joanne M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Sutton, Philip] Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia.
   [Sutton, Philip] Univ Melbourne, Dept Paediat, Parkville, Vic 3010, Australia.
RP Sutton, P (reprint author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Mucosal Immunol, Parkville, Vic 3052, Australia.
EM phil.sutton@mcri.edu.au
OI Sutton, Philip/0000-0003-3129-1800
CR Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839
   [Anonymous], 2012, GLOBOCAN 2012 EST CA
   Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621
   Castano-Rodriguez N, 2017, GUT, V66, P235, DOI 10.1136/gutjnl-2015-310545
   Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821
   Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1
   D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156
   den Hoed CM, 2011, HELICOBACTER, V16, P405, DOI 10.1111/j.1523-5378.2011.00854.x
   DOIDGE C, 1994, LANCET, V343, P914, DOI 10.1016/S0140-6736(94)90032-9
   Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277
   Gasbarrini A, 1998, LANCET, V352, P878, DOI 10.1016/S0140-6736(05)60004-9
   Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499
   Herrero R, 2014, BEST PRACT RES CL GA, V28, P1107, DOI 10.1016/j.bpg.2014.10.003
   Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022
   Konno M, 2008, PEDIATR INFECT DIS J, V27, P999, DOI 10.1097/INF.0b013e31817d756e
   Lee YC, 2016, GASTROENTEROLOGY, V150, P1113, DOI 10.1053/j.gastro.2016.01.028
   Leja M, 2016, HELICOBACTER, V21, P3, DOI 10.1111/hel.12332
   Li XY, 2014, PATHOG DIS, V72, P78, DOI 10.1111/2049-632X.12173
   Li Y, 2016, HELICOBACTER, V21, P234, DOI 10.1111/hel.12268
   Malaty HM, 1999, CLIN INFECT DIS, V28, P279, DOI 10.1086/515105
   Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054
   Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084
   Mirzaei N, 2017, CRIT REV MICROBIOL, V43, P631, DOI 10.1080/1040841X.2017.1291578
   MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149
   Moss SF, 2011, VACCINE, V29, P2085, DOI 10.1016/j.vaccine.2010.12.130
   Murdoch Children's Research Institute, 2016, Patent WO/, Patent No. [2016/000022, 000022]
   Nagy P, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0091-7
   Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110
   Pan KF, 2016, GUT, V65, P9, DOI 10.1136/gutjnl-2015-309197
   Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240
   Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999
   Rupnow MFT, 2009, J INFECT DIS, V200, P1311, DOI 10.1086/605845
   Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031
   Solnick JV, 2000, INFECT IMMUN, V68, P2560, DOI 10.1128/IAI.68.5.2560-2565.2000
   Stasi R, 2009, BLOOD, V113, P1231, DOI 10.1182/blood-2008-07-167155
   Sutton P, 2000, ALIMENT PHARM THERAP, V14, P1107
   Sutton P, 2003, DIGEST LIVER DIS, V35, P675, DOI 10.1016/S1590-8658(03)00414-6
   Sutton P, 2000, IMMUNOL CELL BIOL, V78, P28, DOI 10.1046/j.1440-1711.2000.00881.x
   Sutton P, 2015, LANCET, V386, P1424, DOI 10.1016/S0140-6736(15)60579-7
   Sutton P, 2013, EXPERT REV VACCINES, V12, P433, DOI [10.1586/erv.13.20, 10.1586/ERV.13.20]
   Tobias J, 2017, MICROB PATHOGENESIS, V105, P177, DOI 10.1016/j.micpath.2017.02.021
   Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999
   Velin D, 2016, HELICOBACTER, V21, P26, DOI 10.1111/hel.12336
   Walduck A, 2015, HELICOBACTER, V20, P17, DOI 10.1111/hel.12252
   Wustner S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14028-1
   WYATT JI, 1986, J CLIN PATHOL, V39, P863, DOI 10.1136/jcp.39.8.863
   Xie TT, 2013, EUR J GASTROEN HEPAT, V25, P1195, DOI 10.1097/MEG.0b013e328363e2c7
   Yang J, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv026
   Zeng M, 2015, LANCET, V386, P1457, DOI 10.1016/S0140-6736(15)60310-5
NR 49
TC 10
Z9 11
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7295
EP 7299
DI 10.1016/j.vaccine.2018.01.001
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100002
PM 29627231
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Riley, TV
   Lyras, D
   Douce, GR
AF Riley, T. V.
   Lyras, D.
   Douce, G. R.
TI Status of vaccine research and development for Clostridium difficile
SO VACCINE
LA English
DT Article
DE Clostridium difficile; Toxin based vaccines; Protection; Shedding;
   Dysbiotic gut
ID FECAL MICROBIOTA TRANSPLANTATION; TOXIN-B; MOLECULAR EPIDEMIOLOGY;
   PROTECTIVE EFFICACY; ECONOMIC BURDEN; TOXOID VACCINE; INFECTION;
   COMMUNITY; IMMUNOGENICITY; CANDIDATE
AB Clostridium difficile associated disease is fundamentally associated with dysbiosis of the gut microbiome as a consequence of antibiotic use. This is because this sporulating, obligate anaerobe germinates and proliferates rapidly in the dysbiotic gut, which is an indirect consequence of their use. During its growth, C difficile produces two toxins, toxin A (TcdA) and toxin B (TcdB), which are responsible for the majority of clinical symptoms associated with the disease. Three parenterally delivered vaccines, based on detoxified or recombinant forms of these toxins, have undergone or are undergoing clinical trials. Each offers the opportunity to generate high titres of toxin neutralising antibodies. Whilst these data suggest these vaccines may reduce primary symptomatic disease, they do not in their current form reduce the capacity of the organism to persist and shed from the vaccinated host. The current progress of vaccine development is considered with advantages and limitations of each highlighted. In addition, several alternative approaches are described that seek to limit C. difficile germination, colonisation and persistence. It may yet prove that the most effective treatments to limit infection, disease and spread of the organism will require a combination of therapeutic approaches. The potential use and efficacy of these vaccines in low and middle income countries will be depend on the development of a cost effective vaccine and greater understanding of the distribution and extent of disease in these countries. (C) 2019 Elsevier Ltd.
C1 [Riley, T. V.] Edith Cowan Univ, Joondalup, WA, Australia.
   [Riley, T. V.] Murdoch Univ, Murdoch, WA, Australia.
   [Riley, T. V.] PathWest Lab Med, Nedlands, WA, Australia.
   [Lyras, D.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.
   [Lyras, D.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
   [Douce, G. R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Sir Graham Davies Bldg,Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
RP Douce, GR (reprint author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Sir Graham Davies Bldg,Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
EM Gillian.Douce@glasgow.ac.uk
OI Douce, Gillian/0000-0002-6654-7346
CR Banks A, 2016, ANAEROBE, V37, P49, DOI 10.1016/j.anaerobe.2015.12.008
   Bertolo L, 2012, CARBOHYD RES, V354, P79, DOI 10.1016/j.carres.2012.03.032
   Bezay N, 2016, VACCINE, V34, P2585, DOI 10.1016/j.vaccine.2016.03.098
   Brouwer MSM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3601
   Bruxelle JF, 2016, ANAEROBE, V37, P78, DOI 10.1016/j.anaerobe.2015.10.010
   Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15
   Chandrasekaran R, 2017, FEMS MICROBIOL REV, V41, P723, DOI 10.1093/femsre/fux048
   Choi HY, 2015, BIOMED RES INT, DOI 10.1155/2015/510386
   Collins D. A., 2017, New Microbes and New Infections, V18, P34, DOI 10.1016/j.nmni.2017.04.006
   Cowardin CA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.108, 10.1038/nmicrobiol.2016.108]
   Cozar-Llisto A, 2016, INFECT DIS THER, V5, P253, DOI 10.1007/s40121-016-0124-z
   Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106
   de Bruyn G, 2016, VACCINE, V34, P2170, DOI 10.1016/j.vaccine.2016.03.028
   Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418
   Dingle KE, 2017, LANCET INFECT DIS, V17, P411, DOI 10.1016/S1473-3099(16)30514-X
   Donald RGK, 2013, MICROBIOL-SGM, V159, P1254, DOI 10.1099/mic.0.066712-0
   Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P57, DOI 10.1086/592981
   Dutta SK, 2014, CLIN GASTROENTEROL H, V12, P1572, DOI 10.1016/j.cgh.2013.12.032
   Eidhin DBN, 2008, FEMS IMMUNOL MED MIC, V52, P207, DOI 10.1111/j.1574-695X.2007.00363.x
   Eyre DW, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21059
   Forrester JD, 2017, TROP MED INT HEALTH, V22, P1223, DOI 10.1111/tmi.12937
   Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017
   Furuya-Kanamori L, 2015, INFECT CONT HOSP EP, V36, P132, DOI 10.1017/ice.2014.39
   Gallagher JC, 2015, ANTIMICROB AGENTS CH, V59, P7007, DOI 10.1128/AAC.00939-15
   Ganeshapillai J, 2008, CARBOHYD RES, V343, P703, DOI 10.1016/j.carres.2008.01.002
   Gebhart D, 2015, MBIO, V6, DOI 10.1128/mBio.02368-14
   Gerding DN, 2015, JAMA-J AM MED ASSOC
   Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368
   Ghose C, 2016, ANAEROBE, V37, P85, DOI 10.1016/j.anaerobe.2015.12.001
   Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8
   Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13
   He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478
   Hong HA, 2017, INFECT IMMUN, V85
   Huang H, 2009, CLIN MICROBIOL INFEC, V15, P1170, DOI 10.1111/j.1469-0691.2009.02992.x
   Hung YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166159
   Hutton ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03982-5
   Janezic S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-48
   Janezic S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-173
   Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004
   Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88
   Keeley AJ, 2016, MALAWI MED J, V28, P66, DOI 10.4314/mmj.v28i2.8
   Keller JM, 2014, CLIN GERIATR MED, V30, P79, DOI 10.1016/j.cger.2013.10.008
   Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398
   Kim H, 2010, KOREAN J LAB MED, V30, P491, DOI 10.3343/kjlm.2010.30.5.491
   Kirk JA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6813
   Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954
   Kotila SM, 2016, EMERG INFECT DIS, V22, P1747, DOI 10.3201/eid2210.151492
   Krutova M, 2016, INT J MED MICROBIOL, V306, P479, DOI 10.1016/j.ijmm.2016.07.003
   Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397
   Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604
   Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995
   Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144
   Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]
   Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12
   Li YT, 2016, ALIMENT PHARM THER, V43, P445, DOI 10.1111/apt.13492
   Lim SK, 2014, CLIN INFECT DIS, V58, P1723, DOI 10.1093/cid/ciu203
   LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988
   Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635
   Lynch T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053757
   May M, 2013, TOXINS, V5, P106, DOI 10.3390/toxins5010106
   MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913
   McGlone SM, 2012, CLIN MICROBIOL INFEC, V18, P282, DOI 10.1111/j.1469-0691.2011.03571.x
   Monot M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15023
   Nale JY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01383
   Nale JY, 2016, ANTIMICROB AGENTS CH, V60, P968, DOI 10.1128/AAC.01774-15
   Oberli MA, 2011, CHEM BIOL, V18, P580, DOI 10.1016/j.chembiol.2011.03.009
   Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29
   Orenstein R, 2016, CLIN INFECT DIS, V62, P596, DOI 10.1093/cid/civ938
   Pechine S, 2011, FEMS IMMUNOL MED MIC, V63, P73, DOI 10.1111/j.1574-695X.2011.00832.x
   Permpoonpattana P, 2013, J BACTERIOL, V195, P1492, DOI 10.1128/JB.02104-12
   POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988
   Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028
   Putsathit P, 2015, INT J ANTIMICROB AG, V45, P1, DOI 10.1016/j.ijantimicag.2014.09.005
   Ramakrishnan N, 2015, NUTRITION, V31, P1052, DOI 10.1016/j.nut.2015.02.002
   Romano MR, 2014, TOXINS, V6, P1385, DOI 10.3390/toxins6041385
   Rupnik M, 2016, J CLIN MICROBIOL, V54, P13, DOI 10.1128/JCM.02083-15
   SCHWAN A, 1984, SCAND J INFECT DIS, V16, P211, DOI 10.3109/00365548409087145
   Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626
   Secore S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170640
   Sheldon E, 2016, VACCINE, V34, P2082, DOI 10.1016/j.vaccine.2016.03.010
   Shetty N, 2011, J HOSP INFECT, V77, P1, DOI 10.1016/j.jhin.2010.07.024
   Spencer J, 2014, GUT MICROBES, V5, P225, DOI 10.4161/gmic.27712
   Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669
   Tenover FC, 2011, J CLIN MICROBIOL, V49, P1831, DOI 10.1128/JCM.02446-10
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Vohra P, 2011, J MED MICROBIOL, V60, P1218, DOI 10.1099/jmm.0.030288-0
   Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12
   Wieczorkiewicz JT, 2016, ANTIMICROB AGENTS CH, V60, P418, DOI 10.1128/AAC.01820-15
   Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615
   Worth LJ, 2016, J HOSP INFECT, V93, P280, DOI 10.1016/j.jhin.2016.03.014
   Zainul NH, 2017, EPIDEMIOL INFECT, V145, P3012, DOI [10.1017/s0950268817002011, 10.1017/S0950268817002011]
NR 93
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7300
EP 7306
DI 10.1016/j.vaccine.2019.02.052
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100003
PM 30902484
OA Green Published, Green Accepted
DA 2020-05-12
ER

PT J
AU Kobayashi, M
   Schrag, SJ
   Alderson, MR
   Madhi, SA
   Baker, CJ
   Sobanjo-ter Meulen, A
   Kaslow, DC
   Smith, PG
   Moorthy, VS
   Vekemans, J
AF Kobayashi, Miwako
   Schrag, Stephanie J.
   Alderson, Mark R.
   Madhi, Shabir A.
   Baker, Carol J.
   Sobanjo-ter Meulen, Ajoke
   Kaslow, David C.
   Smith, Peter G.
   Moorthy, Vasee S.
   Vekemans, Johan
TI WHO consultation on group B Streptococcus vaccine development: Report
   from a meeting held on 27-28 April 2016
SO VACCINE
LA English
DT Article
DE Group B Streptococcus; Maternal vaccination; Phase III trial; Vaccine
   licensure
ID MATERNAL ANTIBODY; UNITED-STATES; CONJUGATE VACCINE; PREGNANT-WOMEN;
   RISK-FACTORS; DISEASE; PREVENTION; PROTEIN; COLONIZATION; EPIDEMIOLOGY
AB Globally, group B Streptococcus (GBS) remains a leading cause of sepsis and meningitis in infants in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at increased risk of transmitting GBS to their newborns has been effective in reducing part, but not all, of the GBS disease burden in many high income countries (HICs). In low- and middle-income countries (LMICs), IAP use is low. Immunization of pregnant women with a GBS vaccine represents an alternative strategy to protecting newborns and young infants, through transplacental antibody transfer and potentially by reducing new vaginal colonization. This vaccination strategy was first suggested in the 1970s and several potential GBS vaccines have completed phase I/II clinical trials. During the 2015 WHO Product Development for Vaccines Advisory Committee meeting, GBS was identified as a high priority for the development of a vaccine for maternal immunization because of the major public health burden posed by GBS in LMICs, and the high technical feasibility for successful development. Following this meeting, the first WHO technical consultation on GBS vaccines was held on the 27th and 28th of April 2016, to consider development pathways for such vaccines, focused on their potential role in reducing newborn and young infant deaths and possibly stillbirths in LMICs. Discussion topics included: (1) pathophysiology of disease; (2) current gaps in the knowledge of global disease burden and serotype distribution; (3) vaccine candidates under development; (4) design considerations for phase III trials; and (5) pathways to licensure, policy recommendations and use. Efforts to address gaps identified in each of these areas are needed to establish the public health need for, the development and deployment of, efficacious GBS vaccines. In particular, more work is required to understand the global disease burden of GBS-associated stillbirths, and to develop quality-assured standardized antibody assays to identify correlates of protection. (C) 2016 The Author(s). Published by Elsevier Ltd.
C1 [Kobayashi, Miwako; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Atlanta, GA 30329 USA.
   [Kobayashi, Miwako] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Alderson, Mark R.; Kaslow, David C.] PATH, Ctr Vaccine Innovat & Access, Seattle, WA 98121 USA.
   [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa.
   [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Baker, Carol J.] Baylor Coll Med, Dept Pediat Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Sobanjo-ter Meulen, Ajoke] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.
   [Smith, Peter G.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England.
   [Moorthy, Vasee S.; Vekemans, Johan] WHO, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland.
RP Vekemans, J (reprint author), WHO, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland.
EM vekemansj@who.int
OI Moorthy, Vasee/0000-0002-6535-2854; Smith, Peter/0000-0003-0080-7560
FU Bill & Melinda Gates Foundation, Seattle, WAGates Foundation
   [OPP1134011]
FX This work was supported by the Bill & Melinda Gates Foundation, Seattle,
   WA [Global Health Grant OPP1134011].
CR Akanmori B, 2015, WHO DRUG INFORM, V29, P127
   ANCONA RJ, 1979, INFECT IMMUN, V26, P599, DOI 10.1128/IAI.26.2.599-603.1979
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P341
   [Anonymous], 2015, MAT MORT
   Baker CJ, 2014, J INFECT DIS, V209, P781, DOI 10.1093/infdis/jit549
   BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404
   Baker CJ, INF DIS SOC AM 47 AN
   Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3
   Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605
   Boslego JW, 2012, HUM VACC IMMUNOTHER, V8, P700, DOI 10.4161/hv.21033
   Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562
   Dangor Z, 2015, VACCINE, V33, P6793, DOI 10.1016/j.vaccine.2015.10.019
   Dellepiane N, 2015, CLIN INFECT DIS, V61, pS428, DOI 10.1093/cid/civ491
   Dellepiane N, 2015, VACCINE, V33, P52, DOI 10.1016/j.vaccine.2013.11.066
   Deutscher M, 2011, CLIN INFECT DIS, V53, P114, DOI 10.1093/cid/cir325
   Donders GGG, 2016, OBSTET GYNECOL, V127, P213, DOI 10.1097/AOG.0000000000001190
   Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6
   Edwards MS, 2016, REMINGTON KLEINS INF, P411
   Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183
   Giersing BK, 2016, VACCINE, V34, P2865, DOI 10.1016/j.vaccine.2016.02.078
   Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040
   Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8
   Gravekamp C, 1997, INFECT IMMUN, V65, P5216, DOI 10.1128/IAI.65.12.5216-5221.1997
   Heyderman RS, 2016, LANCET INFECT DIS
   Islam MS, 2016, PEDIAT INFECT DIS J
   Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9
   Kim SY, 2014, VACCINE, V32, P1954, DOI 10.1016/j.vaccine.2014.01.062
   Larsson C, 2006, ARCH DIS CHILD-FETAL, V91, pF403, DOI 10.1136/adc.2005.090472
   Larsson C, 1999, VACCINE, V17, P454, DOI 10.1016/S0264-410X(98)00218-7
   Le Doare K, 2016, J INFECTION, V72, P283, DOI 10.1016/j.jinf.2015.12.014
   Leroux-Roels G, 2016, VACCINE, V34, P1786, DOI 10.1016/j.vaccine.2016.02.044
   Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756
   Lin FYC, 2001, J INFECT DIS, V184, P1022, DOI 10.1086/323350
   Madhi SA, 2016, LANCET INFECT DIS
   Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029
   McDuffie RS, 1996, AM J OBSTET GYNECOL, V175, P402, DOI 10.1016/S0002-9378(96)70153-9
   Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012
   Nan C, 2015, BJOG-INT J OBSTET GY, V122, P1437, DOI 10.1111/1471-0528.13527
   O'Brien KL, 2016, LANCET, V387, P1887, DOI 10.1016/S0140-6736(16)30394-4
   O'Sullivan C, 2016, ARCH DIS CHILD, V101, P1, DOI [10.1136/archdischild-2016-310863.3, DOI 10.1136/ARCHDISCHILD-2016-310863.3]
   Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514
   Paoletti Lawrence C, 2002, Semin Neonatol, V7, P315, DOI 10.1053/siny.2002.0114
   Paoletti LC, 2000, J INFECT DIS, V181, P653, DOI 10.1086/315285
   Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056
   Randis TM, 2014, J INFECT DIS, V210, P265, DOI 10.1093/infdis/jiu067
   Roberts JN, 2015, VACCINE, V33, P966, DOI 10.1016/j.vaccine.2014.12.068
   Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056
   Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a
   Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497
   Seale AC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.67, 10.1038/nmicrobiol.2016.67]
   Sinha A, 2016, PEDIAT INFECT DIS J
   Turrentine MA, 2008, OBSTET GYNECOL, V112, P259, DOI 10.1097/AOG.0b013e31817f5cb9
   U.S. Food and Drug Administration, 2015, CLIN DEV REQ LIC VAC
   UNICEF, 2016, ANT CAR COV
   White A, 2015, VACCINE, V33, P6396, DOI 10.1016/j.vaccine.2015.07.108
   WHO, 2013, POCK BOOK HOSP CAR C
   World Health Organization, 2012, DEV COUNTR VACC REG
   World Health Organization, 2015, WHO REC PREV TREATM
NR 58
TC 22
Z9 24
U1 4
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7307
EP 7314
DI 10.1016/j.vaccine.2016.12.029
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100004
PM 28017431
OA Green Accepted, Green Published, Other Gold
HC Y
HP N
DA 2020-05-12
ER

PT J
AU Giersing, BK
   Vekemans, J
   Nava, S
   Koslow, DC
   Moorthy, V
   Abdulla, S
   Bavdekar, A
   Cichutek, K
   Cravioto, A
   Fritzell, B
   Graham, BS
   Karron, RA
   Lanata, CF
   Shao, YM
   Smith, PG
AF Giersing, Birgitte K.
   Vekemans, Johan
   Nava, Samantha
   Koslow, David C.
   Moorthy, Vasee
   Abdulla, Salim
   Bavdekar, Ashish
   Cichutek, Klaus
   Cravioto, Alejandro
   Fritzell, Bernard
   Graham, Barney S.
   Karron, Ruth A.
   Lanata, Claudio F.
   Shao, Yiming
   Smith, Peter G.
CA WHO Prod Dev Vaccines Advisory
TI Report from the World Health Organization's third Product Development
   for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June
   2016
SO VACCINE
LA English
DT Article
DE Vaccine; Product development; LMICs; Bacterial; Viral; PDVAC; SAGE
ID CLOSTRIDIUM-DIFFICILE INFECTION; RESEARCH-AND-DEVELOPMENT; ENTEROVIRUS
   71 VACCINE; IMMUNOGENICITY; SAFETY; CHILDREN; CANDIDATE; MORTALITY;
   EFFICACY; ROADMAP
AB The third meeting of WHO's Product Development for Vaccines Advisory Committee (PDVAC) was held in June 2016, with a remit to revisit the pathogen areas for which significant progress has occurred since recommendations from the 2015 meeting, as well as to consider new advances in the development of vaccines against other pathogens. Since the previous meeting, significant progress has been made with regulatory approvals of the first malaria and dengue vaccines, and the first phase III trials of a respiratory syncytial virus (RSV) vaccine candidate has started in the elderly and pregnant women. In addition, PDVAC has also supported vaccine development efforts against important emerging pathogens, including Middle Eastern Coronavirus (MERS CoV) and Zika virus. Trials of HIV and tuberculosis vaccine candidates are steadily progressing towards pivotal data points, and the leading norovirus vaccine candidate has entered a phase lib efficacy study. WHO's Immunization, Vaccine and Biologicals (IVB) department is actively working in several pathogen areas on the recommendation of PDVAC, as well as continuing horizon scanning for advances in the development of vaccines that may benefit low and middle income countries (LMICs), such as the recent licensure of the enterovirus 71 (EV71) vaccine in China. Following on from discussions with WHO's Strategic Advisory Group of Experts (SAGE) on Immunization, PDVAC will also look beyond licensure and consider data needs for vaccine recommendation and implementation to reduce the delay between vaccine approval and vaccine impact. (C) 2017 World Health Organization; licensee Elsevier Ltd.
C1 [Giersing, Birgitte K.; Vekemans, Johan; Moorthy, Vasee] WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Nava, Samantha] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Koslow, David C.] PATH, Seattle, WA 98109 USA.
   [Abdulla, Salim] Ifakara Hlth Inst, Ifakara, Tanzania.
   [Bavdekar, Ashish] Kem Hosp & Res Ctr, Pune, Maharashtra, India.
   [Cichutek, Klaus] Paul Ehrlich Inst, Langen, Germany.
   [Cravioto, Alejandro] Global Evaluat Sci Inc, Seattle, WA USA.
   [Graham, Barney S.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru.
   [Shao, Yiming] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
   [Smith, Peter G.] London Sch Hyg & Trop Med, London, England.
RP Moorthy, V (reprint author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM moorthyv@who.int
OI Moorthy, Vasee/0000-0002-6535-2854
FU World Health OrganizationWorld Health Organization [001]
CR Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872
   Bezay N, 2016, VACCINE, V34, P2585, DOI 10.1016/j.vaccine.2016.03.098
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   CATES W, 1985, FAM PLANN PERSPECT, V17, P175, DOI 10.2307/2135243
   de Bruyn G, 2016, VACCINE, V34, P2170, DOI 10.1016/j.vaccine.2016.03.028
   Evans TG, 2016, VACCINE, V34, P2911, DOI 10.1016/j.vaccine.2016.02.079
   Giersing BK, 2016, VACCINE, V34, P2865, DOI 10.1016/j.vaccine.2016.02.078
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Henao-Restrepo AM, 2016, CURR OPIN VIROL, V17, P138, DOI 10.1016/j.coviro.2016.03.008
   Kayvon Modjarrad, WHO PRODUCT DEV VACC, V34, P2863
   Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111
   Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010
   Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319
   Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224
   Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999
   Miwako Kobayashia, 2016, M HELD 27 28 A UNPUB
   Modjarrad K, 2016, NAT MED, V22, P701, DOI 10.1038/nm.4131
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Nesin M., ADV MATERNAL IMMUNIZ, V33, P6371
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   O'Brien KL, 2016, LANCET, V387, P1887, DOI 10.1016/S0140-6736(16)30394-4
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358
   Sheldon E, 2016, VACCINE, V34, P2082, DOI 10.1016/j.vaccine.2016.03.010
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6
   Zeng M, 2015, LANCET, V386, P1457, DOI 10.1016/S0140-6736(15)60310-5
   Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923
NR 32
TC 7
Z9 7
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7315
EP 7327
DI 10.1016/j.vaccine.2016.10.090
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100005
PM 28262332
OA Green Published, Bronze
DA 2020-05-12
ER

PT J
AU Kirkwood, CD
   Ma, LF
   Carey, ME
   Steele, AD
AF Kirkwood, Carl D.
   Ma, Lyou-Fu
   Carey, Megan E.
   Steele, A. Duncan
TI The rotavirus vaccine development pipeline
SO VACCINE
LA English
DT Article
DE Rotavirus; Vaccines; Non-replicating
ID ATTENUATED HUMAN ROTAVIRUS; DEVELOPING-COUNTRIES; DOUBLE-BLIND;
   PARENTERAL VACCINE; INDIAN CHILDREN; 2ND YEAR; SAFETY; IMMUNOGENICITY;
   EFFICACY; IMPACT
AB Rotavirus disease is a leading global cause of mortality and morbidity in children under 5 years of age. The effectiveness of the two globally used oral rotavirus vaccines quickly became apparent when introduced into both developed and developing countries, with significant reductions in rotavirus-associated mortality and hospitalizations. However, the effectiveness and impact of the vaccines is reduced in developing country settings, where the burden and mortality is highest.
   New rotavirus vaccines, including live oral rotavirus candidates and non-replicating approaches continue to be developed, with the major aim to improve the global supply of rotavirus vaccines and for local implementation, and to improve vaccine effectiveness in developing settings. This review provides an overview of the new rotavirus vaccines in development by developing country manufacturers and provides a rationale why newer candidates continue to be explored. It describes the new live oral rotavirus vaccine candidates as well as the non-replicating rotavirus vaccines that are furthest along in development. (C) 2017 The Author(s). Published by Elsevier Ltd.
C1 [Kirkwood, Carl D.; Ma, Lyou-Fu; Carey, Megan E.; Steele, A. Duncan] Bill & Melinda Gates Fdn, Global Hlth, Enter & Diarrheal Dis, POB 23350, Seattle, WA 98102 USA.
RP Kirkwood, CD (reprint author), Bill & Melinda Gates Fdn, Global Hlth, Enter & Diarrheal Dis, POB 23350, Seattle, WA 98102 USA.
EM carl.kirkwood@gatesfoundation.org
OI Steele, Andrew Duncan/0000-0002-4946-037X
CR Anh DD, 2011, VACCINE, V29, P2029, DOI 10.1016/j.vaccine.2011.01.018
   Armah G, 2016, CLIN INFECT DIS, V62, pS200, DOI 10.1093/cid/ciw014
   Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6
   Azevedo MSP, 2010, CLIN VACCINE IMMUNOL, V17, P420, DOI 10.1128/CVI.00395-09
   BAI Z, 1994, CHINESE J BIOL, V7, P49
   Bai ZS, 2003, 1 ROTAVIRUS VACCINES
   Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111
   Bar-Zeev N, 2016, CLIN INFECT DIS, V62, pS213, DOI 10.1093/cid/civ1183
   Barnes GL, 2002, VACCINE, V20, P2950, DOI 10.1016/S0264-410X(02)00235-9
   Bertolotti-Ciarlet A, 2003, VACCINE, V21, P3885, DOI 10.1016/S0264-410X(03)00308-6
   Bhan MK, 2014, LANCET, V383, P2180, DOI 10.1016/S0140-6736(14)60191-4
   BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282
   Bhandari N, 2014, VACCINE, V32, pA110, DOI 10.1016/j.vaccine.2014.04.079
   Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6
   Bines JE, 2015, LANCET INFECT DIS, V15, P1389, DOI 10.1016/S1473-3099(15)00227-3
   BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203
   Blazevic V, 2011, VACCINE, V29, P8126, DOI 10.1016/j.vaccine.2011.08.026
   Clements-Mann ML, 1999, VACCINE, V17, P2715, DOI 10.1016/S0264-410X(98)00497-6
   Clements-Mann ML, 2001, VACCINE, V19, P4676, DOI 10.1016/S0264-410X(01)00242-0
   Danchin M, 2013, VACCINE, V31, P2610, DOI 10.1016/j.vaccine.2013.04.008
   Anh DD, 2012, VACCINE, V30, pA114, DOI 10.1016/j.vaccine.2011.07.118
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   Dhingra MS, 2014, VACCINE, V32, pA117, DOI 10.1016/j.vaccine.2014.03.069
   Estes M, 2014, GLOBAL VACCINE IMMUN
   Fang ZY, 2005, J INFECT DIS, V192, pS94, DOI 10.1086/431505
   Fix AD, 2015, VACCINE, V33, P3766, DOI 10.1016/j.vaccine.2015.05.024
   Flewett TH, 1982, VIRUS INFECTIONS GAS, P125
   Fu CX, 2012, VACCINE, V31, P154, DOI 10.1016/j.vaccine.2012.10.078
   Fu CX, 2010, HUM VACCINES, V6, P953, DOI 10.4161/hv.6.11.12847
   GASTANADUY PA, 2016, [No title captured], V62, pS16, DOI DOI 10.1093/CID/CIV1207
   Gheorghita S, 2016, CLIN INFECT DIS, V62, pS140, DOI 10.1093/cid/civ1209
   Glass RI, 2005, J INFECT DIS, V192, pS30, DOI 10.1086/431498
   Groome MJ, 2016, 12 INT ROT S MELB AU
   Hoshino Y, 1997, J MED VIROL, V51, P319
   do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024
   Jiang BM, 2013, HUM VACC IMMUNOTHER, V9, P1634, DOI 10.4161/hv.24958
   Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008
   Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278
   Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031
   Kapikian AZ, 2005, J INFECT DIS, V192, pS22, DOI 10.1086/431510
   Karafillakis E, 2015, VACCINE, V33, P2097, DOI 10.1016/j.vaccine.2015.03.016
   Kollaritsch H, 2015, CLIN MICROBIOL INFEC, V21, P735, DOI 10.1016/j.cmi.2015.01.027
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lamberti LM, 2016, PEDIATR INFECT DIS J, V35, P992, DOI 10.1097/INF.0000000000001232
   Lappalainen S, 2015, ARCH VIROL, V160, P2075, DOI 10.1007/s00705-015-2461-8
   Le LT, 2009, VACCINE, V27, pF130, DOI 10.1016/j.vaccine.2009.08.086
   Li T, 2014, VACCINE, V32, P1921, DOI 10.1016/j.vaccine.2014.01.093
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Luna EJA, 2013, VACCINE, V31, P1100, DOI 10.1016/j.vaccine.2012.12.020
   Madhi SA, 2016, MALAWI MED J, V28, P108, DOI 10.1056/NEJMoa0904797
   Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea
   Moon S, 2013, VACCINE, V31, P3396, DOI 10.1016/j.vaccine.2012.11.027
   Mpabalwani EM, 2016, CLIN INFECT DIS, V62, pS183, DOI 10.1093/cid/civ1027
   Nordgren J, 2014, CLIN INFECT DIS, V59, P1567, DOI 10.1093/cid/ciu633
   O'Ryan M, 2009, EXPERT REV VACCINES, V8, P1627, DOI [10.1586/erv.09.136, 10.1586/ERV.09.136]
   Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562
   Parashar UD, 2016, CLIN INFECT DIS, V62, pS91, DOI 10.1093/cid/civ1015
   Patel M, 2016, CLIN INFECT DIS, V62, pS127, DOI 10.1093/cid/civ1017
   Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035
   Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4
   Patel MM, 2009, VACCINE, V27, P2916, DOI 10.1016/j.vaccine.2009.03.016
   PATH foundation, PROGR WEBS ROT VACC
   Patnaik B, 2016, 12 INT ROT S MELB AU
   Pringle KD, 2016, CLIN INFECT DIS, V62, pS115, DOI 10.1093/cid/civ1026
   RODRIGUEZ WJ, 1977, J PEDIATR-US, V91, P188, DOI 10.1016/S0022-3476(77)80810-X
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Russer JA, 2016, EMC EUR, P12, DOI 10.1109/EMCEurope.2016.7739292
   Santos VS, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0173-2
   Tan M, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.2
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Tate JE, 2016, CLIN INFECT DIS, V62, pS208, DOI 10.1093/cid/civ1016
   Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334
   Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664
   Vesikari T, 2006, J INFECT DIS, V194, P370, DOI 10.1086/505151
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Wang YH, 2010, VACCINE, V28, P5432, DOI 10.1016/j.vaccine.2010.06.006
   Ward RL, 2010, J INFECT DIS, V202, pS101, DOI 10.1086/653556
   Wen XB, 2015, HUM VACC IMMUNOTHER, V11, P2483, DOI 10.1080/21645515.2015.1054583
   Wen XB, 2012, VACCINE, V30, P6121, DOI 10.1016/j.vaccine.2012.07.078
   WHO, 2016, HLTH TOP ROT INF
   WHO, 2000, M REP FUT DIR ROT VA
   WHO, 2009, WKLY EPIDEMIOL REC, V2009, P213
   Yen C, 2016, HUM VACC IMMUNOTHER, P1
   Zade JK, 2014, VACCINE, V32, pA124, DOI 10.1016/j.vaccine.2014.03.003
   Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6
   Zhen SS, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.64
NR 88
TC 18
Z9 18
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7328
EP 7335
DI 10.1016/j.vaccine.2017.03.076
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100006
PM 28396207
OA Green Published, Other Gold
HC Y
HP N
DA 2020-05-12
ER

PT J
AU Gottlieb, SL
   Giersing, B
   Boily, MC
   Chesson, H
   Looker, KJ
   Schiffer, J
   Spicknall, I
   Hutubessy, R
   Broutet, N
   Deal, C
   Gift, T
   Mogasale, V
   Moorthy, V
   Ndowa, F
   Teerawattananon, Y
   Vickerman, P
   Williams, B
AF Gottlieb, Sami L.
   Giersing, Birgitte
   Boily, Marie-Claude
   Chesson, Harrell
   Looker, Katharine J.
   Schiffer, Joshua
   Spicknall, Ian
   Hutubessy, Raymond
   Broutet, Nathalie
   Deal, Carolyn
   Gift, Thomas
   Mogasale, Vittal
   Moorthy, Vasee
   Ndowa, Francis
   Teerawattananon, Yot
   Vickerman, Peter
   Williams, Brian
CA WHO HSV Vaccine Impact Modell
TI Modelling efforts needed to advance herpes simplex virus (HSV) vaccine
   development: Key findings from the World Health Organization
   Consultation on HSV Vaccine Impact Modelling
SO VACCINE
LA English
DT Article
DE Herpes simplex virus; Sexually transmitted infections; HSV vaccines;
   Modelling
ID SEXUALLY-TRANSMITTED INFECTIONS; COST-EFFECTIVENESS; GENITAL HERPES;
   ANTIVIRAL THERAPY; HIV ACQUISITION; TYPE-2; TRANSMISSION; WOMEN;
   EPIDEMIOLOGY; PREVENTION
AB Development of a vaccine against herpes simplex virus (HSV) is an important goal for global sexual and reproductive health. In order to more precisely define the health and economic burden of HSV infection and the theoretical impact and cost-effectiveness of an HSV vaccine, in 2015 the World Health Organization convened an expert consultation meeting on HSV vaccine impact modelling. The experts reviewed existing model-based estimates and dynamic models of HSV infection to outline critical future modelling needs to inform development of a comprehensive business case and preferred product characteristics for an HSV vaccine. This article summarizes key findings and discussions from the meeting on modelling needs related to HSV burden, costs, and vaccine impact, essential data needs to carry out those models, and important model components and parameters. (C) 2017 Published by Elsevier Ltd.
C1 [Gottlieb, Sami L.; Giersing, Birgitte; Hutubessy, Raymond; Broutet, Nathalie; Moorthy, Vasee] WHO, Geneva, Switzerland.
   [Boily, Marie-Claude] Imperial Coll, London, England.
   [Chesson, Harrell; Spicknall, Ian] Ctr Dis Control & Prevent, CDC, Atlanta, GA USA.
   [Looker, Katharine J.; Vickerman, Peter] Univ Bristol, Bristol, Avon, England.
   [Schiffer, Joshua] Univ Washington, Seattle, WA 98195 USA.
   [Deal, Carolyn] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Gift, Thomas] CDC, Atlanta, GA 30333 USA.
   [Mogasale, Vittal] Int Vaccine Inst, Seoul, South Korea.
   [Ndowa, Francis] Skin & GU Med Clin, Harare, Zimbabwe.
   [Teerawattananon, Yot] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Bangkok, Thailand.
   [Williams, Brian] South African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa.
   [Williams, Brian] Univ Witwatersrand, Wits Reprod Hlth Inst, Johannesburg, South Africa.
RP Gottlieb, SL (reprint author), WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM gottliebs@who.int
OI Boily, Marie-Claude/0000-0003-3919-006X
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01 AI030731]; World Health
   OrganizationWorld Health Organization [001]
CR Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230
   Alsallaq RA, 2010, SEX TRANSM DIS, V37, P290, DOI 10.1097/OLQ.0b013e3181d3d023
   Baker D, 2004, AM J OBSTET GYNECOL, V191, P2074, DOI 10.1016/j.ajog.2004.05.034
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891
   Boily MC, 2012, VACCINOLOGY PRINCIPL
   Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A
   Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331
   Corey Lawrence, 2004, Herpes, V11 Suppl 3, p170A
   Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015
   Fisman DN, 2005, SEX TRANSM INFECT, V81, P267, DOI 10.1136/sti.2004.011619
   Fisman DN, 2002, SEX TRANSM DIS, V29, P608, DOI 10.1097/00007435-200210000-00008
   Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134
   Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7
   Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549
   Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074
   Garnett GP, 2014, VACCINE, V32, P1536, DOI 10.1016/j.vaccine.2013.11.007
   Garnett GP, 2004, SEX TRANSM INFECT, V80, P24, DOI 10.1136/sti.2002.003848
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087
   Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4
   Institute of Medicine, 2000, VACCINES 21 CENTURY
   James SH, 2015, CLIN PERINATOL, V42, P47, DOI 10.1016/j.clp.2014.10.005
   Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076
   Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904
   Leelahavarong P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-534
   Little SE, 2005, AM J OBSTET GYNECOL, V193, P1274, DOI 10.1016/j.ajog.2005.05.042
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Lou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046027
   Masese L, 2015, AIDS, V29, P1077, DOI 10.1097/QAD.0000000000000646
   Mennemeyer ST, 1997, AM J MANAG CARE, V3, P1551
   MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197
   Nakagawa F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125018
   Newton EAC, 2000, SEX TRANSM DIS, V27, P363, DOI 10.1097/00007435-200008000-00001
   Owusu-Edusei K, 2015, J PEDIATR NURS, V30, P346, DOI 10.1016/j.pedn.2014.08.004
   Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2
   Podder CN, 2010, IMA J APPL MATH, V75, P75, DOI 10.1093/imamat/hxp030
   Schiffer JT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0160
   Schiffer JT, 2015, MANDELL DOUGLAS BENN, P1713
   Schwartz EJ, 2005, J INFECT DIS, V191, P1734, DOI 10.1086/429299
   Schwartz EJ, 2007, HUM VACCINES, V3, P231, DOI 10.4161/hv.4529
   Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915
   Szucs TD, 2001, BMC INFECT DIS, V1, part. no., DOI 10.1186/1471-2334-1-5
   Tuffaha Haitham W, 2016, MDM Policy Pract, V1, p2381468316642238, DOI 10.1177/2381468316642238
   Tuite AR, 2011, SEX TRANSM INFECT, V87, P141, DOI 10.1136/sti.2010.045559
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007
   Whitley Richard J, 2005, Semin Pediatr Infect Dis, V16, P17, DOI 10.1053/j.spid.2004.09.007
NR 51
TC 10
Z9 11
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7336
EP 7345
DI 10.1016/j.vaccine.2017.03.074
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100007
PM 28647165
DA 2020-05-12
ER

PT J
AU Zhong, GM
   Brunham, RC
   de la Maza, LM
   Darville, T
   Deal, C
AF Zhong, Guangming
   Brunham, Robert C.
   de la Maza, Luis M.
   Darville, Toni
   Deal, Carolyn
TI National Institute of Allergy and Infectious Diseases workshop report:
   "Chlamydia vaccines: The way forward"
SO VACCINE
LA English
DT Article
DE Chlamydia trachomatis; Chlamydia vaccine; Vaccine development
ID OUTER-MEMBRANE PROTEIN; GENITAL-TRACT INFECTION;
   PELVIC-INFLAMMATORY-DISEASE; BIVALENT TRACHOMA VACCINE; HUMORAL
   IMMUNE-RESPONSE; CD4(+) T-CELLS; GAMMA-INTERFERON; FIELD TRIAL;
   VIRULENCE FACTOR; ANTICHLAMYDIAL ACTIVITY
AB Chlamydia trachomatis (Ct), an intracellular pathogen, is the most common bacterial sexually transmitted infection. In addition to acute cervicitis and urethritis, Ct can lead to serious sequelae of significant public health burden including pelvic inflammatory disease (PID) and infertility. Ct control efforts have not resulted in desired outcomes such as reduced incidence and reinfection, and this highlights the need for the development of an effective Ct vaccine. To this end, NIAID organized a workshop to consider the current status of Ct vaccine research and address critical questions in Ct vaccine design and clinical testing. Topics included the goal(s) of a vaccine and the feasibility of achieving these goals, animal models of infection including mouse and nonhuman primate (NHP) models, and correlates of protection to guide vaccine design. Decades of research have provided both whole cell-based and subunit vaccine candidates for development. At least one is currently in clinical development and efforts now need to be directed toward further development of the most attractive candidates. Overall, the discussions and presentations from the workshop highlighted optimism about the current status of Ct vaccine research and detailed the remaining gaps and questions needed to move vaccines forward. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA.
   [Brunham, Robert C.] Univ British Columbia, UBC Ctr Dis Control, Vaccine Res Lab, Vancouver, BC V5Z 4R4, Canada.
   [de la Maza, Luis M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA.
   [Darville, Toni] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA.
   [Deal, Carolyn] NIAID, Div Microbiol & Infect Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Zhong, GM (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA.
EM Zhongg@UTHSCSA.edu
FU NIAID, a part of the US National Institutes of Health (NIH)
FX The organization of this meeting was supported by NIAID, a part of the
   US National Institutes of Health (NIH). We thank Harlan Caldwell (NIAID)
   for participation in the workshop planning committee, Thomas Hiltke
   (NIAID) for his efforts in planning and logistic support of the meeting,
   and all those who attended and presented. The views expressed are those
   of the authors and do not necessarily represent the position of the
   NIAID or NIH.
CR ALLEN JE, 1991, J IMMUNOL, V147, P674
   BAILEY RL, 1995, INFECT IMMUN, V63, P389, DOI 10.1128/IAI.63.2.389-392.1995
   Bailey RL, 2014, CHLAMYDIAL INFECT, P485
   BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998
   Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103
   Boje S, 2016, IMMUNOL CELL BIOL, V94, P185, DOI 10.1038/icb.2015.79
   Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005
   Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426
   Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326
   Burton MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003763
   Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11
   BYRNE GI, 1986, J INTERFERON RES, V6, P389, DOI 10.1089/jir.1986.6.389
   BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986
   CALDWELL HD, 1982, INFECT IMMUN, V38, P745, DOI 10.1128/IAI.38.2.745-754.1982
   CDC, 2014, CHLAM SCREEN PERC RE
   Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14
   Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15
   Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997
   Derrick T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/791847
   Donati M, 2003, VACCINE, V21, P1089, DOI 10.1016/S0264-410X(02)00631-X
   Dong F, 2004, INFECT IMMUN, V72, P3869, DOI 10.1128/IAI.72.7.3869-3875.2004
   Eko Francis O, 2014, BMC Immunol, V15, P584, DOI 10.1186/s12865-014-0056-x
   Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10
   Galaleldeen A, 2013, J BIOL CHEM, V288, P22068, DOI 10.1074/jbc.M113.475012
   Grassly NC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000341
   GRAYSTON JT, 1963, P SOC EXP BIOL MED, V112, P589, DOI 10.3181/00379727-112-28112
   GRAYSTON JT, 1962, J EXP MED, V115, P1009, DOI 10.1084/jem.115.5.1009
   Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395
   Hou SP, 2015, INFECT IMMUN, V83, P4701, DOI 10.1128/IAI.00746-15
   Hu VH, 2012, INFECT IMMUN, V80, P121, DOI 10.1128/IAI.05965-11
   Huang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124840
   Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005
   Ifere Godwin O., 2007, Journal of Microbiology Immunology and Infection, V40, P188
   Jayarapu K, 2010, J IMMUNOL, V185, P6911, DOI 10.4049/jimmunol.1002596
   Jayarapu K, 2009, INFECT IMMUN, V77, P4469, DOI 10.1128/IAI.00491-09
   Johnson RM, 2012, INFECT IMMUN, V80, P2204, DOI 10.1128/IAI.06339-11
   Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764
   Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375
   Karunakaran KP, 2016, METHODS MOL BIOL, V1403, P419, DOI 10.1007/978-1-4939-3387-7_23
   Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13
   Li WD, 2010, INFECT IMMUN, V78, P3942, DOI 10.1128/IAI.00346-10
   Li ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032997
   Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14
   Lu CX, 2013, MICROBES INFECT, V15, P329, DOI 10.1016/j.micinf.2013.02.001
   McClarty G, 2007, CURR OPIN MICROBIOL, V10, P47, DOI 10.1016/j.mib.2006.12.003
   Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814
   Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002
   MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995
   Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000
   Morrison SG, 2001, INFECT IMMUN, V69, P2643, DOI 10.1128/IAI.69.4.2643-2649.2001
   Murthy AK, 2006, INFECT IMMUN, V74, P6722, DOI 10.1128/IAI.01119-06
   Murthy AK, 2011, VACCINE, V29, P2519, DOI 10.1016/j.vaccine.2011.01.074
   Natividad A, 2007, GENES IMMUN, V8, P288, DOI 10.1038/sj.gene.6364384
   Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10
   Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   NICHOLS RL, 1966, AM J TROP MED HYG, V15, P639, DOI 10.4269/ajtmh.1966.15.639
   NICHOLS RL, 1969, AM J TROP MED HYG, V18, P723, DOI 10.4269/ajtmh.1969.18.723
   O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027
   Olsen AW, 2015, J INFECT DIS, V212, P978, DOI 10.1093/infdis/jiv137
   Owusu-Edusei K, 2015, EMERG INFECT DIS, V21, P960, DOI 10.3201/eid2106.141270
   Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074
   Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005
   Patton DL, 2015, SEX TRANSM INFECT, V91, pA133, DOI 10.1136/sextrans-2015-052270.350
   Price MJ, 2016, J INFECT DIS, V214, P617, DOI 10.1093/infdis/jiw178
   Qu YY, 2015, INFECT IMMUN, V83, P4056, DOI 10.1128/IAI.00841-15
   Ramsey K, 1990, ROLE T CELL SUBPOPUL, P241
   RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983
   RANK RG, 1992, INFECT IMMUN, V60, P4427, DOI 10.1128/IAI.60.10.4427-4429.1992
   Roan NR, 2006, P NATL ACAD SCI USA, V103, P12069, DOI 10.1073/pnas.0603866103
   Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98
   Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021
   Russell AN, 2016, J INFECT DIS, V214, P1884, DOI 10.1093/infdis/jiw485
   Russell AN, 2016, J INFECT DIS, V213, P523, DOI 10.1093/infdis/jiv438
   SCHACHTER J, 1978, NEW ENGL J MED, V298, P428, DOI 10.1056/NEJM197802232980805
   Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11
   Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004
   Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8
   SOWA S, 1969, J HYG-CAMB, V67, P699, DOI 10.1017/S0022172400042157
   Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205
   STEPHENS RS, 1988, J EXP MED, V167, P817, DOI 10.1084/jem.167.3.817
   Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10
   SU H, 1990, J EXP MED, V172, P203, DOI 10.1084/jem.172.1.203
   Sun X, 2015, INFECT IMMUN, V83, P2327, DOI 10.1128/IAI.00154-15
   Tang L, 2015, ENVIRON SCI TECH LET, V2, P59, DOI 10.1021/acs.estlett.5b00008
   Taylor BD, 2017, SEX TRANSM DIS, V44, P36, DOI 10.1097/OLQ.0000000000000533
   Tifrea DF, 2014, J IMMUNOL, V192, P5201, DOI 10.4049/jimmunol.1303392
   Tukeva TA, 1999, RADIOLOGY, V210, P209, DOI 10.1148/radiology.210.1.r99ja04209
   Wali S, 2017, IMMUNOL CELL BIOL, V95, P454, DOI 10.1038/icb.2016.122
   Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240
   WANG SP, 1967, AM J OPHTHALMOL, V63, P1133, DOI 10.1016/0002-9394(67)94095-0
   WOOLRIDGE RL, 1967, AM J OPHTHALMOL, V63, P1645, DOI 10.1016/0002-9394(67)94158-X
   WOOLRIDGE RL, 1967, AM J OPHTHALMOL, V63, P1650, DOI 10.1016/0002-9394(67)94159-1
   Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3
   Yang ZS, 2016, MICROBES INFECT, V18, P669, DOI 10.1016/j.micinf.2016.07.002
   Yang ZS, 2016, INFECT IMMUN, V84, P2697, DOI 10.1128/IAI.00280-16
   Yang ZS, 2015, INFECT IMMUN, V83, P2234, DOI 10.1128/IAI.00275-15
   Yu H, 2014, ACCIDENT ANAL PREV, V66, P80, DOI 10.1016/j.aap.2014.01.017
   Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952
   Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935
   ZHONG GM, 1990, INFECT IMMUN, V58, P1450, DOI 10.1128/IAI.58.5.1450-1455.1990
   ZHONG GM, 1993, J IMMUNOL, V151, P3728
   Zhong GM, 2017, TRENDS MICROBIOL, V25, P141, DOI 10.1016/j.tim.2016.09.006
NR 103
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7346
EP 7354
DI 10.1016/j.vaccine.2017.10.075
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100008
PM 29097007
OA Green Published
DA 2020-05-12
ER

PT J
AU Giersing, BK
   Karron, RA
   Vekemans, J
   Kaslow, DC
   Moorthy, VS
AF Giersing, Birgitte K.
   Karron, Ruth A.
   Vekemans, Johan
   Kaslow, David C.
   Moorthy, Vasee S.
TI Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV)
   vaccine development, Geneva, 25-26 April 2016
SO VACCINE
LA English
DT Article
DE Respiratory Syncytial Virus; Vaccine; Monoclonal antibody; Lower
   respiratory tract infection (LTRI); Acute lower respiratory illness
   (ALRI); Wheezing; Licensure; SAGE
ID INFANTS; DISEASE; INFECTION; MOTAVIZUMAB; CHALLENGES; PREVENTION; RISK
AB Respiratory syncytial virus (RSV) is a leading viral cause of respiratory morbidity and mortality in infants and young children worldwide. Low and middle income countries (LMICs) account for approximately 99% of the global mortality estimates in this population, with up to 200,000 RSV deaths per year. The vaccine product development pipeline is diverse with the most advanced clinical candidate currently in phase III efficacy testing in pregnant women. In addition, a long-acting RSV-neutralizing monoclonal antibody (mAb) to be administered at birth to prevent serious RSV-related respiratory disease is in late stage clinical development, as are additional conventional mAb for use in high-risk infants. Thus, there is a realistic possibility that an effective new intervention to prevent RSV disease will be available in the next 5-10 year horizon. In anticipation of this outcome, the Strategic Advisory Group of Experts for Immunization (SAGE), WHO's vaccine policy recommendation body, reviewed the status of RSV vaccine and monoclonal antibody development in April 2016. Although substantial progress towards licensure has broadened the research agenda to consider intervention impact and cost effectiveness, significant gaps remain in the data that will be needed to inform and support a policy recommendation for implementation. These aspects were the focus of WHO's second consultation on RSV vaccines and single dosage extended half-life mAb for prophylaxis.
C1 [Giersing, Birgitte K.; Vekemans, Johan; Moorthy, Vasee S.] WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Kaslow, David C.] PATH, Seattle, WA 98109 USA.
RP Moorthy, VS (reprint author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM moorthyv@who.int
OI Moorthy, Vasee/0000-0002-6535-2854
FU Bill & Melinda Gates FoundationGates Foundation [OPP1114766]
FX This meeting was funded by the Bill & Melinda Gates Foundation (Global
   Health Grant OPP1114766). The views, findings, and conclusions contained
   within are those of the authors and should not be construed to represent
   the positions or policies of the Bill & Melinda Gates Foundation, the US
   Department of Defence or the World Health Organization.
CR [Anonymous], 2016, WHO WEEKLY EPIDEMIOL, V91, P265
   Berry CE, 2016, AM J RESP CRIT CARE, V194, P607, DOI 10.1164/rccm.201604-0753OC
   Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917
   Caballero MT, 2016, PEDIATR INFECT DIS J, V35, P821, DOI 10.1097/INF.0000000000001167
   Connor E, 1997, PEDIATRICS, V99, P93
   FDA, 2015, BRIEF DOC VACC REL B
   Geoghegan S, 2017, AM J RESP CRIT CARE, V195, P96, DOI [10.1164/rccm.201603-0658OC, 10.1164/rccm.201603-0658oc]
   GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3
   Griffin MP, 2016, ANTIMICROB AGENTS CH
   Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515
   Humphreys G, 2015, B WORLD HEALTH ORGAN, V93, P290, DOI 10.2471/BLT.15.020515
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955
   Kinyanjui TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138018
   Mochizuki H, 2017, AM J RESP CRIT CARE, V196, P29, DOI [10.1164/rccm.201609-1812OC, 10.1164/rccm.201609-1812oc]
   Modjarrad K, 2016, VACCINE, V34, P190, DOI 10.1016/j.vaccine.2015.05.093
   Munywoki PK, 2015, J INFECT DIS, V212, P1711, DOI 10.1093/infdis/jiv263
   Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9
   Pan-Ngum W, 2017, VACCINE, V35, P403, DOI 10.1016/j.vaccine.2016.10.073
   Poletti P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0283-x
   Roberts JN, 2016, VACCINE, V34, P4843, DOI 10.1016/j.vaccine.2016.07.057
   Shi T, 2015, J GLOB HEALTH, V5, P203, DOI 10.7189/jogh.05.020416
   Simoes EAF, 2016, LANCET INFECT DIS, V16, P639, DOI 10.1016/S1473-3099(16)30059-7
   Wegzyn C, 2014, INFECT DIS THER, V3, P133, DOI 10.1007/s40121-014-0046-6
   Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014
   Zanone SM, 2016, LANCET RESP MED, V4, P345, DOI 10.1016/S2213-2600(16)30042-X
NR 27
TC 4
Z9 4
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7355
EP 7362
DI 10.1016/j.vaccine.2017.02.068
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100009
PM 28302410
OA Bronze
DA 2020-05-12
ER

PT J
AU Schiffer, JT
   Gottlieb, SL
AF Schiffer, Joshua T.
   Gottlieb, Sami L.
TI Biologic interactions between HSV-2 and HIV-1 and possible implications
   for HSV vaccine development
SO VACCINE
LA English
DT Article
DE HSV vaccine; HIV; Sexually transmitted infection
ID HERPES-SIMPLEX-VIRUS; MEMORY T-CELLS; SUBUNIT ANTIGEN VACCINE; PLASMID
   DNA VACCINE; GENITAL HERPES; THERAPEUTIC VACCINE; TYPE-2 INFECTION;
   DOUBLE-BLIND; IMMUNE SURVEILLANCE; RISK-FACTORS
AB Development of a safe and effective vaccine against herpes simplex virus type 2 (HSV-2) has the potential to limit the global burden of HSV-2 infection and disease, including genital ulcer disease and neonatal herpes, and is a global sexual and reproductive health priority. Another important potential benefit of an HSV-2 vaccine would be to decrease HIV infections, as HSV-2 increases the risk of HIV-1 acquisition several-fold. Acute and chronic HSV-2 infection creates ulcerations and draws dendritic cells and activated CD4+ T cells into genital mucosa. These cells are targets for HIV entry and replication. Prophylactic HSV-2 vaccines (to prevent infection) and therapeutic vaccines (to modify or treat existing infections) are currently under development. By preventing or modifying infection, an effective HSV-2 vaccine could limit HSV-associated genital mucosal inflammation and thus HIV risk. However, a vaccine might have competing effects on HIV risk depending on its mechanism of action and cell populations generated in the genital mucosa. In this article, we review biologic interactions between HSV-2 and HIV-1, consider HSV-2 vaccine development in the context of HIV risk, and discuss implications and research needs for future HSV vaccine development. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Schiffer, Joshua T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Schiffer, Joshua T.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Schiffer, Joshua T.] Univ Washington, Dept Med, Seattle, WA USA.
   [Gottlieb, Sami L.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
RP Schiffer, JT (reprint author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
EM jschiffe@fredhutch.org
FU NIH National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P01 AI030731, R01AI121129]; NIH/NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI108543]
FX JTS acknowledges funding from the NIH National Institute of Allergy and
   Infectious Diseases (NIAID; P01 AI030731 and R01AI121129). SLG
   acknowledges support from NIH/NIAID (U01 AI108543). SLG is a staff
   member of the World Health Organization (WHO). The views expressed are
   those of the authors and do not necessarily represent the decisions,
   policies, or views of WHO.
CR Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230
   Anipindi VC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005589
   Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803
   Aubert M, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.75
   Awasthi S, 2014, J VIROL, V88, P8421, DOI 10.1128/JVI.01130-14
   Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177
   Awasthi S, 2014, J VIROL, V88, P2000, DOI 10.1128/JVI.03163-13
   Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888
   Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11
   Barnabas RV, 2011, JAIDS-J ACQ IMM DEF, V57, P238, DOI 10.1097/QAI.0b013e31821acb5
   Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106
   Bernstein DI, 2017, J INFECT DIS, V215, P856, DOI 10.1093/infdis/jix004
   Bohl DD, 2011, SEX TRANSM DIS, V38, P617, DOI 10.1097/OLQ.0b013e31820a8c10
   Botting RA, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1923
   Boukhvalova M, 2015, J VIROL, V89, P9825, DOI 10.1128/JVI.01387-15
   Bright H, 2012, VACCINE, V30, P7529, DOI 10.1016/j.vaccine.2012.10.046
   Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Carbone FR, 2015, J IMMUNOL, V195, P17, DOI 10.4049/jimmunol.1500515
   Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031
   Carnegie NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043048
   Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4
   Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020
   Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b
   Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144
   CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678
   Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22
   Diaz FM, 2016, VIROLOGY, V488, P61, DOI 10.1016/j.virol.2015.10.033
   Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948
   Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342
   Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298
   Dutton JL, 2016, HUM VACC IMMUNOTHER, V12, P3079, DOI 10.1080/21645515.2016.1221872
   Dutton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076407
   El-Haddad D, 2016, ANTIVIR RES, V134, P58, DOI 10.1016/j.antiviral.2016.08.024
   Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015
   Flechtner JB, 2016, VACCINE, V34, P5314, DOI 10.1016/j.vaccine.2016.09.001
   Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7
   Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074
   Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32
   Gottlieb SL, 2017, CURR OPIN INFECT DIS, V30, P77, DOI 10.1097/QCO.0000000000000343
   Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087
   Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706
   Halford WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145228
   Henning TR, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0320-6
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007
   Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645
   Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530
   Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108
   Jing LC, 2012, J CLIN INVEST, V122, P654, DOI 10.1172/JCI60556
   Johnson KE, 2011, J INFECT DIS, V203, P602, DOI 10.1093/infdis/jiq091
   Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1
   Johnston C, 2014, J VIROL, V88, P4921, DOI 10.1128/JVI.03285-13
   Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066
   Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9
   Kahle EM, 2015, J INFECT DIS, V211, P1451, DOI 10.1093/infdis/jiu621
   Kim M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004812
   LeGoff J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-2
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Looker KJE, 2017, LANCET
   Low AJ, 2016, J INFECT DIS, V213, P731, DOI 10.1093/infdis/jiv495
   Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510
   Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109
   Mackay LK, 2012, J IMMUNOL, V188, P2173, DOI 10.4049/jimmunol.1102719
   Mammen M., 2016, THERAPEUTIC DNA VACC
   Marsden V, 2015, J IMMUNOL, V194, P4438, DOI 10.4049/jimmunol.1401706
   Marshak JO, 2014, METHODS MOL BIOL, V1144, P305, DOI 10.1007/978-1-4939-0428-0_21
   McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200
   MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197
   Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011
   Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297
   Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012
   O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991
   Odegard JM, 2016, VACCINE, V34, P101, DOI 10.1016/j.vaccine.2015.10.137
   Ouwendijk WJD, 2013, CURR OPIN VIROL, V3, P452, DOI 10.1016/j.coviro.2013.04.004
   Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2
   Petro C, 2015, ELIFE, V4, DOI 10.7554/eLife.06054
   Phipps W, 2016, J INFECT DIS, V213, P439, DOI 10.1093/infdis/jiv451
   Posavad CM, 2015, MUCOSAL IMMUNOL, V8, P115, DOI 10.1038/mi.2014.47
   Prodger JL, 2012, AIDS, V26, P1319, DOI 10.1097/QAD.0b013e328354675c
   Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303
   Rajagopal S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu043
   RONG R, 2009, [No title captured], V6, DOI DOI 10.1371/JOURNAL.PPATP1000274
   Rouzine IM, 2015, CELL, V160, P1002, DOI 10.1016/j.cell.2015.02.017
   Roxby AC, 2013, AIDS RES HUM RETROV, V29, P94, DOI [10.1089/AID.2012.0071, 10.1089/aid.2012.0071]
   Rubbo PA, 2011, JAIDS-J ACQ IMM DEF, V58, P9, DOI 10.1097/QAI.0b013e318224d0ad
   Sato A, 2014, J VIROL, V88, P13699, DOI 10.1128/JVI.02279-14
   Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486
   Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007
   Schiffer JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155124
   Schiffer JT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0160
   Schiffer JT, 2013, ELIFE, V2, DOI 10.7554/eLife.00288
   Schiffer JT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00209
   Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314
   Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107
   Schiffer Joshua T, 2009, Curr Infect Dis Rep, V11, P457, DOI 10.1007/s11908-009-0066-7
   Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193
   Shannon B, 2014, J IMMUNOL, V192, P5074, DOI 10.4049/jimmunol.1302916
   Shin H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13346
   Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522
   Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0
   Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12
   St Leger AJ, 2013, J IMMUNOL, V191, P2258, DOI 10.4049/jimmunol.1300585
   Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915
   Steukers L, 2014, J INFECT DIS, V210, P209, DOI 10.1093/infdis/jiu036
   Tyring S, 2012, J INFECT DIS, V205, P1100, DOI 10.1093/infdis/jis019
   van Velzen M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003547
   Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104
   Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057
   Visalli RJ, 2014, VACCINE, V32, P1398, DOI 10.1016/j.vaccine.2013.10.079
   Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47
   WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205
   Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231
   Wald A, 2014, NEW ENGL J MED, V370, P201, DOI 10.1056/NEJMoa1301150
   Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260
   Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c
   Weiss H, 2004, HERPES S, V11, p24A
   Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041
   Yan Y, 2015, J IMMUNOL, V195, P329, DOI 10.4049/jimmunol.1500198
   Yi TJ, 2014, J INFECT DIS, V210, P708, DOI 10.1093/infdis/jiu163
   Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111
   Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100
   Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792
   Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110
   Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006
NR 128
TC 7
Z9 7
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7363
EP 7371
DI 10.1016/j.vaccine.2017.09.044
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100010
PM 28958807
DA 2020-05-12
ER

PT J
AU Hosangadi, D
   Smith, PG
   Giersing, BK
AF Hosangadi, Divya
   Smith, Peter G.
   Giersing, Birgitte K.
TI Considerations for using ETEC and Shigella disease burden estimates to
   guide vaccine development strategy
SO VACCINE
LA English
DT Article
ID ENTEROTOXIGENIC ESCHERICHIA-COLI; EARLY-CHILDHOOD DIARRHEA; MEDIATED
   ISOTHERMAL AMPLIFICATION; GLOBAL ENTERIC MULTICENTER;
   RESEARCH-AND-DEVELOPMENT; LIFE YEARS DALYS; SYSTEMATIC ANALYSIS;
   DEVELOPING-COUNTRIES; CHILDREN; MORTALITY
AB Enterotoxigenic E. coli (ETEC) and Shigella are enteropathogens causing significant global morbidity and mortality, partieularly in low-income countries. No licensed vaccine exists for either pathogen, but candidates are in development, with the most advanced candidates potentially approaching pivotal efficacy testing within the next few years.
   A positive policy recommendation for introduction of any vaccine, following licensure, depends on evidence of vaccine cost-effectiveness and impact on morbidity and mortality. The mortality estimates for these two pathogens have fluctuated over recent years, which has led to uncertainty in the assessment of their relative public health importance for use in low and middle-income countries.
   This paper summarizes the various ETEC and Shigella disease burden estimates, based on a review of current literature and informal consultations with leading stakeholders in enteric disease modelling. We discuss the factors that underpin the variability, including differences in the modelling methodology; diagnostic tools used to ascertain diarrheal etiology; epidemiological setting; the data that are available to incorporate; and absolute changes in the total number of diarrheal deaths over time. We consider the further work that will strengthen the evidence needed to support future decision making with respect to recommendations on the relative utility of these vaccines. (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Hosangadi, Divya] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Smith, Peter G.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England.
   [Giersing, Birgitte K.] WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RP Giersing, BK (reprint author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM giersingb@who.int
OI Smith, Peter/0000-0003-0080-7560
FU Bill & Melinda Gates FoundationGates Foundation [OPP1135836]
FX ' This work was supported by the Bill & Melinda Gates Foundation
   (OPP1135836). The views, findings, and conclusions contained within are
   those of the authors and should not be construed to represent the
   positions or policies of the Bill & Melinda Gates Foundation or the
   World Health Organization.
CR Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653
   Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096
   Barker DJP, 2005, ARCH DIS CHILD, V90, P272, DOI 10.1136/adc.2003.033464
   Bartsch SM, 2014, HUM VACC IMMUNOTHER, V10, P1568, DOI 10.4161/hv.28885
   BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193
   Bolin I, 2006, J CLIN MICROBIOL, V44, P3872, DOI 10.1128/JCM.00790-06
   Bourgeois AL, 2016, VACCINE, V34, P2880, DOI 10.1016/j.vaccine.2016.02.076
   Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI [10.1016/S2214-109X(16)30212-1, 10.1016/s2214-109x(16)30212-1]
   Colombara DV, 2016, AM J GASTROENTEROL S, V3, P4, DOI DOI 10.1038/AJGSUP.2016.9
   De la Cabada Bauche J, 2011, GASTROENTEROL HEPATO, V7, P88
   Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280
   Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787
   Fischer Walker Christa L, 2012, BMC Public Health, V12, P220, DOI 10.1186/1471-2458-12-220
   Galbadage T, 2009, AM J TROP MED HYG, V80, P20, DOI 10.4269/ajtmh.2009.80.20
   [GBD Mortality and Causes of Death Collaborators], 2016, LANCET, V388
   GBD, 2015, LANCET, V385, P117, DOI DOI 10.1016/S0140-6736(14)61682-2
   George CM, 2015, EMERG INFECT DIS, V21, P2006, DOI 10.3201/eid2111.150333
   Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x
   Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239
   Houpt E, 2014, CLIN INFECT DIS, V59, pS225, DOI 10.1093/cid/ciu413
   Camacho AI, 2013, EXPERT REV VACCINES, V12, P43, DOI [10.1586/ERV.12.135, 10.1586/erv.12.135]
   Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084
   Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485
   Keusch GT, 2006, THESIS
   Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001421, DOI 10.1371/JOURNAL.PONE.1001921]
   Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10
   Kosek M, 2010, CURR OPIN INFECT DIS, V23, P475, DOI 10.1097/QCO.0b013e32833da204
   Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036
   Kotloff KL, 2017, PEDIATR CLIN N AM, V64, P799, DOI 10.1016/j.pcl.2017.03.006
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4
   Lamberti LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002705
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Legros D, 2004, J Health Popul Nutr, V22, P445
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4
   Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12
   Liu J, 2012, J CLIN MICROBIOL, V50, P98, DOI 10.1128/JCM.05416-11
   Liu L, 2015, LANCET, V385, P2461, DOI 10.1016/S0140-6736(15)61132-1
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468
   Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075
   Mekata T, 2009, LETT APPL MICROBIOL, V48, P25, DOI 10.1111/j.1472-765X.2008.02479.x
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142
   Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x
   PATH, 2011, CAS INV ENT ESCH COL
   Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252
   Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072
   Pinkerton R, 2016, AM J TROP MED HYG, V95, P1004, DOI 10.4269/ajtmh.16-0150
   Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927
   Platts-Mills JA, 2013, MUCOSAL IMMUNOL, V6, P876, DOI 10.1038/mi.2013.50
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439
   Porter C, 2016, AM J GASTROENTEROL, V3
   Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005
   Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07
   Rachwal PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035971
   RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994
   Rheingans R, 2012, CLIN INFECT DIS, V55, pS317, DOI 10.1093/cid/cis763
   Rheingans R, 2012, CLIN INFECT DIS, V55, pS327, DOI 10.1093/cid/cis764
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Soleimani M, 2013, J APPL MICROBIOL, V115, P828, DOI 10.1111/jam.12290
   Taniuchi M, 2012, DIAGN MICR INFEC DIS, V73, P121, DOI 10.1016/j.diagmicrobio.2012.03.008
   Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1
   Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.02.016, 10.1016/j.cmi.2015.03.014]
   van den Beld MJC, 2016, J MICROBIOL METH, V131, P10, DOI 10.1016/j.mimet.2016.09.023
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145
   von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Walker CLF, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010402
   Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768
   Walker RI, 2015, VACCINE, V33, P946, DOI 10.1016/j.vaccine.2014.11.048
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   WHO, 2015, WHO PRINC CONS ADD V
   Zhang WP, 2015, CLIN VACCINE IMMUNOL, V22, P983, DOI 10.1128/CVI.00224-15
NR 86
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7372
EP 7380
DI 10.1016/j.vaccine.2017.09.083
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100011
PM 29031690
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Hosangadi, D
   Smith, PG
   Kaslow, DC
   Giersing, BK
   Armah, G
   Black, R
   Chilengi, R
   Guerrant, DL
   Houpt, E
   Khalil, I
   Kirkwood, C
   Kotloff, K
   Lamberti, L
   Mok, W
   Muhib, F
   de Silva, CP
   Rheingans, R
   Riddle, M
   Walker, R
AF Hosangadi, Divya
   Smith, Peter G.
   Kaslow, David C.
   Giersing, Birgitte K.
   Armah, George
   Black, Robert
   Chilengi, Roma
   Guerrant, Dick L.
   Houpt, Eric
   Khalil, Ibrahim
   Kirkwood, Carl
   Kotloff, Karen
   Lamberti, Laura
   Mok, Wilson
   Muhib, Farzana
   de Silva, Carmem Pessoa
   Rheingans, Richard
   Riddle, Mark
   Walker, Richard
CA WHO ETEC Shigella Vaccine Cons
TI WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th
   April 2017: Meeting report
SO VACCINE
LA English
DT Article
DE Enterotoxigenic E. coli; ETEC; Shigella; Vaccine; Mortality; Burden of
   disease
ID MULTIEPITOPE FUSION ANTIGEN; GLOBAL ENTERIC MULTICENTER; CAUSE-SPECIFIC
   MORTALITY; RESEARCH-AND-DEVELOPMENT; SYSTEMATIC ANALYSIS;
   DEVELOPING-COUNTRIES; ALL-CAUSE; DIARRHEA; VACCINE; COLI
AB According to the 2015 Global Burden of Disease Study, diarrhea ranked ninth among causes of death for all ages, and fourth among children under 5 years old, accounting for an estimated 499,000 deaths in this young age group. It was also the second most common cause of years lived with disability (2.39 billion YLDs). The goal of the WHO/UNICEF Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) is to reduce deaths from diarrhea in children under 5 years of age to less than 1 per 1000 live births, by 2025. Development of new and improved vaccines against diarrheal infections is a fundamental element of the strategy towards achieving this goal.Enterotoxigenic Escherichia coli (ETEC) and Shigella are enteropathogens that cause significant global mortality and morbidity, particularly in low- and middle-income countries. In 2016, WHO's Product Development for Vaccines Advisory Committee (PDVAC) recommended that the WHO's Initiative for Vaccine Research (IVR) engage in this area, based on PDVAC's criteria of prioritizing the development of vaccines against pathogens that will address a major unmet public health need, and for which clinical candidates with a good probability of technical success are in the pipeline. As a first step, WHO's IVR convened global subject matter experts to discuss the current global ETEC and Shigella disease burden estimates, including the current understanding of the long-term indirect effects of ETEC and Shigella infection, and how these data may affect future decision making on vaccine development for both pathogens.
   The available global burden estimates for ETEC and Shigella differ with respect to the relative importance of these two pathogens. The mortality estimates vary between iterations published by the same group, as well as between estimates of different groups, although the uncertainty intervals are broad and overlapping. These variances are attributable to differences in the data available and incorporated in the models; the methods used to detect the pathogens; the modelling methodologies; and, to actual changes in the total number of diarrheal deaths over time. The changes in the most recently reported mortality estimates for these pathogens, as compared to previous iterations, has led to debate as to whether investment in development of stand-alone vaccines, rather than combined vaccines, is warranted from cost-effectiveness and vaccine impact perspectives. Further work will be needed to understand better the variances and uncertainties in the reported mortality estimates to support investment decision making, and ultimately policy recommendations for vaccine use. In addition, a comprehensive assessment of the value proposition for vaccines against these pathogens is needed and will be strengthened if the long-term health consequences associated with diarrhea and dysentery due to these pathogens are better defined. (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Hosangadi, Divya] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Smith, Peter G.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England.
   [Kaslow, David C.; Muhib, Farzana; Walker, Richard] PATH, Seattle, WA 98109 USA.
   [Giersing, Birgitte K.] WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Armah, George] Univ Ghana, Accra, Ghana.
   [Black, Robert] Johns Hopkins Univ, Baltimore, MD USA.
   [Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia.
   [Guerrant, Dick L.; Houpt, Eric] Univ Virginia, Charlottesville, VA USA.
   [Khalil, Ibrahim] Univ Washington, Seattle, WA 98195 USA.
   [Kirkwood, Carl; Lamberti, Laura] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Kotloff, Karen] Univ Maryland, Baltimore, MD 21201 USA.
   [de Silva, Carmem Pessoa] WHO, Geneva, Switzerland.
   [Rheingans, Richard] Appalachian State Univ, Boone, NC 28608 USA.
   [Riddle, Mark] US Naval, Med Res Ctr, Silver Spring, MD USA.
RP Giersing, BK (reprint author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM giersingb@who.int
FU Bill & Melinda Gates FoundationGates Foundation [OPP1135836]; US
   Department of DefenseUnited States Department of Defense
FX We gratefully acknowledge funding from the Bill & Melinda Gates
   Foundation to support the consultation reported here (OPP1135836). The
   views, findings, and conclusions contained within are those of the
   authors and should not be construed to represent the positions or
   policies of the Bill & Melinda Gates Foundation, the US Department of
   Defense, the US National Institutes of Health, or the World Health
   Organization. We are very grateful to all participants at the meeting
   (Table 4).
CR Administration U.S.F.a.D, 1997, GUID IND EV COMB VAC
   [Anonymous], 2017, LANCET INFECT DIS
   [Anonymous], 2015, TACKLING DRUG RESIST
   [Anonymous], 2015, GLOBAL ANTIMICROBIAL
   [Anonymous], 2013, LANCET, V88, P1545
   [Anonymous], 2017, WHOS PREFERRED PRODU
   Bourgeois AL, 2016, VACCINE, V34, P2880, DOI 10.1016/j.vaccine.2016.02.076
   Chakraborty S, 2016, CLIN VACCINE IMMUNOL, V23, P315, DOI 10.1128/CVI.00608-15
   Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099
   Colombara DV, 2016, AM J GASTROENTEROL S, V3, P4, DOI DOI 10.1038/AJGSUP.2016.9
   Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113
   Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12
   Das JK, 2014, CURR OPIN INFECT DIS, V27, P451, DOI 10.1097/QCO.0000000000000096
   DuPont HL, 2016, JAMA-J AM MED ASSOC, V315, P2712, DOI 10.1001/jama.2016.7833
   Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x
   Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239
   Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084
   Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]
   Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549
   Kotloff KL, 2017, PEDIATR CLIN N AM, V64, P799, DOI 10.1016/j.pcl.2017.03.006
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lamberti LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002705
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Luiz WB, 2015, INFECT IMMUN, V83, P4555, DOI 10.1128/IAI.00858-15
   Lundgren A, 2014, VACCINE, V32, P7077, DOI 10.1016/j.vaccine.2014.10.069
   Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075
   McKenzie R, 2006, VACCINE, V24, P3735, DOI 10.1016/j.vaccine.2005.07.014
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nandre RM, 2016, VACCINE, V34, P3620, DOI 10.1016/j.vaccine.2016.04.003
   Nataro JP, 2017, VACCINE, V35, P6807, DOI 10.1016/j.vaccine.2017.05.035
   Neuzil KM, 2015, LANCET GLOB HEALTH, V3, pE510, DOI 10.1016/S2214-109X(15)00052-2
   Operario DJ, 2017, J INFECT DIS, V216, P220, DOI 10.1093/infdis/jix294
   Ouyang-Latimer J, 2011, ANTIMICROB AGENTS CH, V55, P874, DOI 10.1128/AAC.00739-10
   Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Porter CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149358
   Porter CK, 2016, AM J GASTROENTEROL S, V3, P12
   Rausch D, 2017, VET MICROBIOL, V202, P79, DOI 10.1016/j.vetmic.2016.02.002
   Richard SA, 2013, AM J EPIDEMIOL, V178, P1129, DOI 10.1093/aje/kwt094
   Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891
   Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609
   Sincock SA, 2016, VACCINE, V34, P284, DOI 10.1016/j.vaccine.2015.11.017
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
   Tribble DR, 2017, J TRAVEL MED, V24, pS6, DOI 10.1093/jtm/taw090
   Venkatesan MM, 2015, HUM VACC IMMUNOTHER, V11, P1434, DOI 10.4161/21645515.2014.986984
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145
   W.H. Organization, 2016, NEW CHECKL MAK HLTH
   Walker R, 2017, VACCINE, V35, P6790, DOI 10.1016/j.vaccine.2017.06.076
   Walker RI, 2015, VACCINE, V33, P946, DOI 10.1016/j.vaccine.2014.11.048
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   WHO, 2005, TREATM DIARRH MAN PH
NR 55
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7381
EP 7390
DI 10.1016/j.vaccine.2017.10.011
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100012
PM 29352598
DA 2020-05-12
ER

PT J
AU Vekemans, J
   Moorthy, V
   Friede, M
   Alderson, MR
   Sobanjo-Ter Meulen, A
   Baker, CJ
   Heath, PT
   Madhi, SA
   Mehring-Le Doare, K
   Saha, SK
   Schrag, S
   Kaslow, DC
AF Vekemans, Johan
   Moorthy, Vasee
   Friede, Martin
   Alderson, Mark R.
   Sobanjo-Ter Meulen, Ajoke
   Baker, Carol J.
   Heath, Paul T.
   Madhi, Shabir A.
   Mehring-Le Doare, Kirsty
   Saha, Samir K.
   Schrag, Stephanie
   Kaslow, David C.
TI Maternal immunization against Group B streptococcus: World Health
   Organization research and development technological roadmap and
   preferred product characteristics
SO VACCINE
LA English
DT Article
DE Group B streptococcus; Vaccine; Maternal immunization
AB Group B streptococcus, found in the vagina or lower gastrointestinal tract of about 10-40% of women of reproductive age, is a leading cause of early life invasive bacterial disease, potentially amenable to prevention through maternal immunization during pregnancy. Following a consultation process with global stakeholders, the World Health Organization is herein proposing priority research and development pathways and preferred product characteristics for GBS vaccines, with the aim to facilitate and accelerate vaccine licensure, policy recommendation for wide scale use and implementation. (C) 2018 The Authors. Published by Elsevier Ltd.
C1 [Vekemans, Johan; Moorthy, Vasee; Friede, Martin] World Hlth Org, Geneva, Switzerland.
   [Alderson, Mark R.; Kaslow, David C.] PATH, Seattle, WA USA.
   [Sobanjo-Ter Meulen, Ajoke] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Baker, Carol J.] Baylor Coll Med, Houston, TX 77030 USA.
   [Heath, Paul T.] St Georges Univ London, Vaccine Inst, London, England.
   [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Mehring-Le Doare, Kirsty] Imperial Coll Fac Med, London, England.
   [Saha, Samir K.] Dhaka Shishu Hosp, Inst Child Hlth, Child Hlth Res Fdn, Dhaka, Bangladesh.
   [Schrag, Stephanie] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Vekemans, J (reprint author), World Hlth Org, Geneva, Switzerland.
EM vekemansj@who.int
OI Heath, Paul/0000-0002-7540-7433; Madhi, Shabir/0000-0002-7629-0636; le
   doare, kirsty/0000-0002-5104-085X; Moorthy, Vasee/0000-0002-6535-2854
FU Bill & Melinda Gates Foundation, Seattle, WAGates Foundation
   [OPP1134011]
FX This work was supported by the Bill & Melinda Gates Foundation, Seattle,
   WA [Global Health Grant OPP1134011].
CR BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404
   Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3
   Heath PT, 2017, LANCET INFECT DIS, V17, pE223, DOI 10.1016/S1473-3099(17)30232-3
   Heath PT, 2016, VACCINE, V34, P2876, DOI 10.1016/j.vaccine.2015.12.072
   Kobayashi M, 2019, VACCINE, V37, P7307, DOI 10.1016/j.vaccine.2016.12.029
   Kobayashi Miwako, 2016, F1000Res, V5, P2355
   O'Sullivan CLT, 2016, ARCH DIS CHILD, V101, pA2, DOI DOI 10.1136/ARCHDISCHILD-2016-310863.3
   Vornhagen J, 2017, TRENDS MICROBIOL
NR 8
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7391
EP 7393
DI 10.1016/j.vaccine.2017.09.087
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100013
PM 29398277
OA Other Gold, Green Published, Green Accepted
DA 2020-05-12
ER

PT J
AU Vekemans, J
   Moorthy, V
   Giersing, B
   Friede, M
   Hombach, J
   Arora, N
   Modjarrad, K
   Smith, PG
   Karron, R
   Graham, B
   Kaslow, DC
AF Vekemans, Johan
   Moorthy, Vasee
   Giersing, Brigitta
   Friede, Martin
   Hombach, Joachim
   Arora, Narendra
   Modjarrad, Kayvon
   Smith, Peter G.
   Karron, Ruth
   Graham, Barney
   Kaslow, David C.
TI Respiratory syncytial virus vaccine research and development: World
   Health Organization technological roadmap and preferred product
   characteristics
SO VACCINE
LA English
DT Article
DE Respiratory syncytial virus; Vaccines; Maternal immunization; Research
   and development
ID DISEASE
AB The respiratory syncytial virus causes a considerable respiratory disease burden globally, most markedly in young infants, in low and middle income countries. A diverse product pipeline illustrates the recent intensification of research and development activities for vaccines and monoclonal antibodies against RSV. With the aim to ensure that product development activities are directed to address the public health needs, the World Health Organization has developed a research and development technical roadmap and articulated product characteristics preferences. (C) 2017 Published by Elsevier Ltd.
C1 [Vekemans, Johan; Moorthy, Vasee; Giersing, Brigitta; Friede, Martin; Hombach, Joachim] World Hlth Org, Geneva, Switzerland.
   [Arora, Narendra] INCLEN Inst Global Hlth, New Delhi, India.
   [Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Smith, Peter G.] London Sch Hyg & Trop Med, London, England.
   [Karron, Ruth] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Graham, Barney] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Kaslow, David C.] PATH, Seattle, WA USA.
RP Vekemans, J (reprint author), World Hlth Org, Geneva, Switzerland.
EM vekemansj@who.int
CR Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1
   Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]
NR 4
TC 8
Z9 8
U1 6
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7394
EP 7395
DI 10.1016/j.vaccine.2017.09.092
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100014
DA 2020-05-12
ER

PT J
AU Spicknall, IH
   Looker, KJ
   Gottlieb, SL
   Chesson, HW
   Schiffer, JT
   Elmes, J
   Boily, MC
AF Spicknall, Ian H.
   Looker, Katharine J.
   Gottlieb, Sami L.
   Chesson, Harrell W.
   Schiffer, Joshua T.
   Elmes, Jocelyn
   Boily, Marie-Claude
TI Review of mathematical models of HSV-2 vaccination: Implications for
   vaccine development
SO VACCINE
LA English
DT Review
DE Mathematical models; Vaccine impact; Herpes simplex
ID HERPES-SIMPLEX-VIRUS; HIV-1 TRANSMISSION; TYPE-2; VALACYCLOVIR;
   INFECTION; IMPACT; LEVEL; ACQUISITION; WOMEN
AB Development of a vaccine against herpes simplex virus type 2 (HSV-2), a life-long sexually-transmitted infection (STI), would be a major step forward in improving global sexual and reproductive health. In this review, we identified published literature of dynamic mathematical models assessing the impact of either prophylactic or therapeutic HSV-2 vaccination at the population level. We compared each study's model structure and assumptions as well as predicted vaccination impact. We examined possible causes of heterogeneity across model predictions, key gaps, and the implications of these findings for future modelling efforts. Only eight modelling studies have assessed the potential public health impact of HSV-2 vaccination, with the majority focusing on impact of prophylactic vaccines. The studies showed that even an imperfect prophylactic HSV-2 vaccine could have an important public health impact on HSV-2 incidence, and could also impact HIV indirectly in high HIV prevalence settings. Therapeutic vaccines also may provide public health benefits, though they have been explored less extensively. However, there was substantial variation in predicted population-level impact for both types of vaccine, reflecting differences in assumptions between model scenarios. Importantly, many models did not account for heterogeneity in infection rates such as by age, sex and sexual activity. Future modelling work to inform decisions on HSV vaccine development and implementation should consider cost-effectiveness, account for additional HSV-2 sequelae such as neonatal transmission, and model greater heterogeneity in infection rates between individuals, more realistic vaccine deployment, and more thorough sensitivity and uncertainty analyses. Published by Elsevier Ltd.
C1 [Spicknall, Ian H.; Chesson, Harrell W.] Ctr Dis Control & Prevent CDC, Div STD Prevent, Atlanta, GA USA.
   [Looker, Katharine J.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.
   [Gottlieb, Sami L.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Schiffer, Joshua T.] Univ Washington, Seattle, WA 98195 USA.
   [Schiffer, Joshua T.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Elmes, Jocelyn; Boily, Marie-Claude] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
RP Spicknall, IH (reprint author), CDC, Div STD Prevent, 1600 Clifton Rd NE,MS E80, Atlanta, GA 30329 USA.
EM xfu0@cdc.gov
OI Boily, Marie-Claude/0000-0003-3919-006X; Elmes,
   Jocelyn/0000-0003-2097-5465
FU UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP); U.S.
   National Institutes of Health through HPTNUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH
   UM1AI068617]; NIH/NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01 AI108543]; NIH National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [NIAID: P01
   AI030731, R01 AI121129]; Genocea an HSV vaccine manufacturer; Sexual
   Health 24
FX The HSV vaccine expert consultation on HSV-2 vaccine impact modeling was
   supported by the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of
   Research, Development and Research Training in Human Reproduction (HRP),
   a cosponsored program executed by the World Health Organization (WHO).
   KJL received separate funding from Sexual Health 24 during the course of
   this study. This funder had no role in the writing of the manuscript nor
   the decision to submit it for publication. MCB and JE thank the HPTN
   Modelling Centre, which is funded by the U.S. National Institutes of
   Health (NIH UM1AI068617) through HPTN, for partial funding of this work.
   SLG acknowledges support from NIH/NIAID (U01 AI108543). JTS acknowledges
   funding from the NIH National Institute of Allergy and Infectious
   Diseases (NIAID: P01 AI030731, R01 AI121129). He also has received
   research support from Genocea an HSV vaccine manufacturer.
CR Alsallaq RA, 2010, SEX TRANSM DIS, V37, P290, DOI 10.1097/OLQ.0b013e3181d3d023
   Anderson RM, 1992, INFECT DIS HUMANS DY
   Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78
   AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006
   Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156
   Basanez MG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001548
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Boily M-C, 2012, ROLE MATH MODELS VAC, P480
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144
   Corey L., 2007, SEXUALLY TRANSMITTED
   Davenport MP, 2004, J VIROL, V78, P11340, DOI 10.1128/JVI.78.20.11340-11351.2004
   Feng ZL, 2013, MATH BIOSCI, V245, P171, DOI 10.1016/j.mbs.2013.07.003
   Foss AM, 2011, SEX TRANSM INFECT, V87, P22, DOI 10.1136/sti.2009.041699
   Foss AM, 2009, B MATH BIOL, V71, P720, DOI 10.1007/s11538-008-9379-1
   Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7
   Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074
   Garnett GP, 2004, SEX TRANSM INFECT, V80, P24, DOI 10.1136/sti.2002.003848
   GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209
   Gottlieb SL, 2019, VACCINE, V37, P7408, DOI 10.1016/j.vaccine.2017.10.084
   Gottlieb SL, 2019, VACCINE, V37, P7336, DOI 10.1016/j.vaccine.2017.03.074
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519
   Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4
   Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076
   Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904
   Looker KJ, 2017, LANCET INFECT DIS, V17, P1303, DOI 10.1016/S1473-3099(17)30405-X
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Lou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046027
   Mark H, 2009, JOGNN-J OBST GYN NEO, V38, P320, DOI 10.1111/j.1552-6909.2009.01026.x
   Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913
   MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075
   Michael E, 2007, ADV PARASIT, V65, P191, DOI 10.1016/S0065-308X(07)65003-9
   Newton EAC, 2000, SEX TRANSM DIS, V27, P363, DOI 10.1097/00007435-200008000-00001
   Pinninti SG, 2013, AM J PERINAT, V30, P113, DOI 10.1055/s-0032-1332802
   Podder CN, 2010, IMA J APPL MATH, V75, P75, DOI 10.1093/imamat/hxp030
   Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486
   Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314
   Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193
   Schwartz EJ, 2005, J INFECT DIS, V191, P1734, DOI 10.1086/429299
   Schwartz EJ, 2007, HUM VACCINES, V3, P231, DOI 10.4161/hv.4529
   Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915
   Todd J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059037
   WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205
   Wald A, 2002, J INFECT DIS, V186, pS34, DOI 10.1086/342969
   Wald A, 2016, JAMA-J AM MED ASSOC, V316, P2495, DOI 10.1001/jama.2016.18189
   Wells C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003794
   White RG, 2008, SEX TRANSM INFECT, V84, pII12, DOI 10.1136/sti.2008.029918
   *WHO, 2003, GUID MAN SEX TRANSM
NR 51
TC 2
Z9 2
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7396
EP 7407
DI 10.1016/j.vaccine.2018.02.067
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100015
PM 29625767
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Gottlieb, SL
   Giersing, BK
   Hickling, J
   Jones, R
   Deal, C
   Kaslow, DC
   Boily, MC
   Brady, M
   Broutet, N
   Chirenje, ZM
   Delany-Moretlwe, S
   Johnston, C
   Koelle, DM
   Leone, P
   Looker, K
   Low, N
   Madhivanan, P
   Mugo, N
   Nagot, N
   Schillinger, J
   Southem, J
   Toledo, JP
   Wald, A
   Zhou, PY
AF Gottlieb, Sami L.
   Giersing, Birgitte K.
   Hickling, Julian
   Jones, Rebecca
   Deal, Carolyn
   Kaslow, David C.
   Boily, Marie-Claude
   Brady, Martha
   Broutet, Nathalie
   Chirenje, Z. Mike
   Delany-Moretlwe, Sinead
   Johnston, Christine
   Koelle, David M.
   Leone, Peter
   Looker, Katharine
   Low, Nicola
   Madhivanan, Purnima
   Mugo, Nelly
   Nagot, Nicolas
   Schillinger, Julie
   Southem, James
   Toledo, Joao Paulo
   Wald, Anna
   Zhou, Pingyu
CA HSV Vaccine Expert Consultation
TI Meeting report: Initial World Health Organization consultation on herpes
   simplex virus (HSV) vaccine preferred product characteristics, March
   2017
SO VACCINE
LA English
DT Article
DE Herpes simplex virus; Sexually transmitted infections; Vaccines; HSV
   vaccines; Preferred product characteristics; Genital herpes
ID HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMID DNA VACCINE; GENITAL HERPES;
   THERAPEUTIC VACCINE; HIV-1 TRANSMISSION; TYPE-2 INFECTION; T-CELLS;
   WOMEN; IMMUNOGENICITY; ACQUISITION
AB The development of vaccines against herpes simplex virus (HSV) is an important global goal for sexual and reproductive health. A key priority to advance development of HSV vaccines is the definition of preferred product characteristics (PPCs), which provide strategic guidance on World Health Organization (WHO) preferences for new vaccines, specifically from a low- and middle-income country (LMIC) perspective. To start the PPC process for HSV vaccines, the WHO convened a global stakeholder consultation in March 2017, to define the priority public health needs that should be addressed by HSV vaccines and discuss the key considerations for HSV vaccine PPCs, particularly for LMICs. Meeting participants outlined an initial set of overarching public health goals for HSV vaccines in LMICs, which are: to reduce the acquisition of HIV associated with HSV-2 infection in high HIV-prevalence populations and to reduce the burden of HSV-associated disease, including mortality and morbidity due to neonatal herpes and impacts on sexual and reproductive health. Participants also considered the role of prophylactic versus therapeutic vaccines, whether both HSV-2 and HSV-1 should be targeted, important target populations, and infection and disease endpoints for clinical trials. This article summarizes the main discussions from the consultation.
C1 [Gottlieb, Sami L.; Giersing, Birgitte K.; Broutet, Nathalie] WHO, Geneva, Switzerland.
   [Hickling, Julian; Jones, Rebecca] Tandem Ltd, Cambridge, England.
   [Deal, Carolyn] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Kaslow, David C.] PATH, Seattle, WA USA.
   [Boily, Marie-Claude] Imperial Coll, London, England.
   [Brady, Martha] PATH, Washington, DC USA.
   [Chirenje, Z. Mike] Univ Zimbabwe, Harare, Zimbabwe.
   [Delany-Moretlwe, Sinead] Univ Witwatersrand, Johannesburg, South Africa.
   [Johnston, Christine; Koelle, David M.; Wald, Anna] Univ Washington, Seattle, WA 98195 USA.
   [Leone, Peter] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Looker, Katharine; Low, Nicola] Univ Bristol, Bristol, Avon, England.
   [Madhivanan, Purnima] Florida Int Univ, Miami, FL 33199 USA.
   [Mugo, Nelly] KEMRI, Nairobi, Kenya.
   [Nagot, Nicolas] Univ Montpellier, Montpellier, France.
   [Schillinger, Julie] Ctr Dis Control & Prevent, New York, NY USA.
   [Schillinger, Julie] New York City Dept Hlth & Mental Hyg, New York, NY USA.
   [Southem, James] Med Control Council, Pretoria, South Africa.
   [Toledo, Joao Paulo] Minist Hlth, Brasilia, DF, Brazil.
   [Zhou, Pingyu] Shanghai Skin Dis & STD Hosp, Shanghai, Peoples R China.
RP Gottlieb, SL (reprint author), WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM gottliebs@who.int
FU National Institutes of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI108543]
FX The WHO HSV vaccine PPC expert consultation was supported by the
   National Institutes of Allergy and Infectious Diseases (U01 AI108543).
CR Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177
   Baccari A, 2016, VACCINE, V34, P3901, DOI 10.1016/j.vaccine.2016.05.033
   Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156
   Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bernard MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121518
   Bernstein DI, 2017, J INFECT DIS, V215, P856, DOI 10.1093/infdis/jix004
   Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458
   Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Burrel S, 2017, MOL BIOL EVOL, V34, P1713, DOI 10.1093/molbev/msx113
   Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447
   Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849
   Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4
   Cohen JI, 2017, J INFECT DIS, DOI [10.1093/infdis/jix006, DOI 10.1093/INFDIS/JIX006]
   Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331
   Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714
   Delaney S, 2014, JAMA-J AM MED ASSOC, V312, P746, DOI 10.1001/jama.2014.4359
   Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217
   Dutton JL, 2016, HUM VACC IMMUNOTHER, V12, P3079, DOI 10.1080/21645515.2016.1221872
   Dutton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076407
   Fisman DN, 2005, SEX TRANSM INFECT, V81, P267, DOI 10.1136/sti.2004.011619
   Flechtner JB, 2016, VACCINE, V34, P5314, DOI 10.1016/j.vaccine.2016.09.001
   Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074
   Giersing BK, 2019, VACCINE, V37, P7315, DOI 10.1016/j.vaccine.2016.10.090
   Gottlieb SL, 2019, VACCINE, V37, P7336, DOI 10.1016/j.vaccine.2017.03.074
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   Johnson KE, 2011, J INFECT DIS, V203, P602, DOI 10.1093/infdis/jiq091
   Johnston C, 2016, VACCINE, V34, P2948, DOI 10.1016/j.vaccine.2015.12.076
   Johnston C, 2016, CLIN MICROBIOL REV, V29, P149, DOI 10.1128/CMR.00043-15
   Khan AA, 2015, J VIROL, V89, P3776, DOI 10.1128/JVI.03419-14
   Knipe DM, 2014, VACCINE, V32, P1561, DOI 10.1016/j.vaccine.2014.01.052
   Long D, 2014, VIROLOGY, V464, P296, DOI 10.1016/j.virol.2014.07.018
   Looker KJ, 2017, LANCET INFECT DIS, V17, P1303, DOI 10.1016/S1473-3099(17)30405-X
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913
   MERTZ GJ, 1988, J INFECT DIS, V157, P1169, DOI 10.1093/infdis/157.6.1169
   MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197
   MERTZ GJ, 1985, SEX TRANSM DIS, V12, P33, DOI 10.1097/00007435-198501000-00007
   Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011
   Mujugira A, 2011, SEX TRANSM INFECT, V87, P238, DOI 10.1136/sti.2010.047415
   Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0
   Mundle ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057224
   Nagot N, 2008, J INFECT DIS, V198, P241, DOI 10.1086/589621
   Newman RM, 2015, J VIROL, V89, P8219, DOI 10.1128/JVI.01303-15
   Odegard JM, 2016, VACCINE, V34, P101, DOI 10.1016/j.vaccine.2015.10.137
   Organization WH, 2016, GLOB HLTH SECT STRAT
   Phipps W, 2016, J INFECT DIS, V213, P439, DOI 10.1093/infdis/jiv451
   Rajagopal S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu043
   Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896
   Schiffer JT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0160
   Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193
   Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0
   Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12
   Song LB, 2017, IEEE ANN INT CONF CY, P886
   Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915
   Stanberry LR, 2004, HERPES, V11, P161
   Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103
   Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420
   Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057
   Wald A, 2011, VACCINE, V29, P8520, DOI 10.1016/j.vaccine.2011.09.046
   Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260
   World Health Organization, 2013, GLOB VACC ACT PLAN 2
   Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110
NR 66
TC 4
Z9 4
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7408
EP 7418
DI 10.1016/j.vaccine.2017.10.084
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100016
PM 29224963
DA 2020-05-12
ER

PT J
AU Vincent, LR
   Jerse, AE
AF Vincent, Leah R.
   Jerse, Ann E.
TI Biological feasibility and importance of a gonorrhea vaccine for global
   public health
SO VACCINE
LA English
DT Article
DE Gonorrhea; Vaccine; Antibiotic resistance; Pelvic inflammatory disease;
   Ophthalmia neonatorum; Infertility
ID SEXUALLY-TRANSMITTED INFECTIONS; RESISTANT NEISSERIA-GONORRHOEAE;
   PELVIC-INFLAMMATORY-DISEASE; GENITAL-TRACT INFECTION;
   CHLAMYDIA-TRACHOMATIS; GONOCOCCAL-INFECTION; UNITED-STATES;
   ANTIMICROBIAL RESISTANCE; OPHTHALMIA NEONATORUM; HUMAN-EXPERIMENTATION
AB There is a growing public health interest in controlling sexually transmitted infections (STIs) through vaccination due to increasing recognition of the global disease burden of STIs and the role of STIs in women's reproductive health, adverse pregnancy outcomes, and the health and well-being of neonates. Neisseria gonorrhoeae has historically challenged vaccine development through the expression of phase and antigenically variable surface molecules and its capacity to cause repeated infections without inducing protective immunity. An estimated 78 million new N. gonorrhoeae infections occur annually and the greatest disease burden is carried by low- and middle-income countries (LMIC). Current control measures are clearly inadequate and threatened by the rapid emergence of antibiotic resistance. The gonococcus now holds the status of "super-bug" as there is currently no single reliable monotherapy for empirical treatment of gonorrhea. The problem of antibiotic resistance has elevated treatment costs and necessitated the establishment of large surveillance programs to track the spread of resistant strains. Here we review the need for a gonorrhea vaccine with respect to global disease burden and related socioeconomic and treatment costs, with an emphasis on the impact of gonorrhea on women and newborns. We also highlight the challenge of estimating the impact of a gonorrhea vaccine due to the need for more data on the burden of gonococcal pelvic inflammatory disease and related sequelae and of gonorrhea-associated adverse pregnancy outcomes and the problem of empirical diagnosis and treatment of STIs in LMIC. There is also a lack of clinical and basic science research in the area of gonococcal/chlamydia coinfection, which occurs in a high percentage of individuals with gonorrhea and should be considered when testing the efficacy of gonorrhea vaccines. Finally, we review recent research that suggests a gonorrhea vaccine is feasible and discuss challenges and research gaps in gonorrhea vaccine development. Published by Elsevier Ltd.
C1 [Vincent, Leah R.] NIAID, 5601 Fishers Lane, Rockville, MD 20852 USA.
   [Jerse, Ann E.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Herbert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20854 USA.
RP Jerse, AE (reprint author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM leah.vincent@nih.gov; ann.jerse1@usuhs.edu
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI113170]
FX This work was supported by NIH/NIAID grant U19 AI113170 (AEJ).
CR Alirol E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002366
   Allan-Blitz LT, 2017, INT J STD AIDS, V28, P138, DOI 10.1177/0956462416630909
   Araoye Margaret O, 2003, West Afr J Med, V22, P190
   ARKO RJ, 1976, J INFECT DIS, V133, P441, DOI 10.1093/infdis/133.4.441
   Ashshi AM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1313-1
   Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837
   Borges-Costa J, 2012, J EUR ACAD DERMATOL, V26, P972, DOI 10.1111/j.1468-3083.2011.04194.x
   BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X
   BRITIGAN BE, 1985, NEW ENGL J MED, V312, P1683, DOI 10.1056/NEJM198506273122606
   Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426
   Brunner A, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0166-9
   Butali Azeez, 2016, Pan Afr Med J, V24, P1, DOI 10.11604/pamj.2016.24.1.8382
   Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662
   Cha S, 2017, MMWR-MORBID MORTAL W, V66, P644, DOI 10.15585/mmwr.mm6624a4
   Chesson HW, 2017, SEX TRANSM DIS  0922
   Chisholm SA, 2016, SEX TRANSM INFECT, V92, P365, DOI 10.1136/sextrans-2015-052312
   Christian P, 2005, SEX TRANSM INFECT, V81, P254, DOI 10.1136/sti.2004.011817
   COHEN MS, 1994, J INFECT DIS, V169, P532, DOI 10.1093/infdis/169.3.532
   Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9
   Cohen MS, 1999, J INFECT DIS, V179, pS375, DOI 10.1086/513847
   Craig AP, 2015, VACCINE, V33, P4520, DOI 10.1016/j.vaccine.2015.07.015
   Das BB, 2016, INFECT DRUG RESIST, V9, P191, DOI 10.2147/IDR.S91260
   de Curraize C, 2016, ANTIMICROB AGENTS CH, V60, P6962, DOI 10.1128/AAC.01568-16
   DeRocco A SH, 2014, 19 INT PATH NEISS C
   Dhont N, 2011, TROP DOCT, V41, P96, DOI 10.1258/td.2011.100410
   Dillon JAR, 2013, SEX TRANSM INFECT, V89, P36, DOI 10.1136/sextrans-2012-050905
   Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004
   Ekeroma AJ, 2012, NEW ZEAL MED J, V125, P23
   Ermert D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005043
   Feinen B, 2010, MUCOSAL IMMUNOL, V3, P312, DOI 10.1038/mi.2009.139
   Feinen B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00011
   Fifer H, 2016, NEW ENGL J MED, V374, P2504, DOI 10.1056/NEJMc1512757
   Gagliardi MC, 2011, FEMS IMMUNOL MED MIC, V61, P129, DOI 10.1111/j.1574-695X.2010.00759.x
   Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402
   Gianecini R, 2016, EMERG INFECT DIS, V22, P1139, DOI 10.3201/eid2206.152091
   GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181
   GREENBERG L, 1974, CAN J PUBLIC HEALTH, V65, P29
   GREENBERG L, 1975, J REPROD MED, V14, P34
   Gulati S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003559
   HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7
   Hanson Claudia, 2013, BMC Res Notes, V6, P435, DOI 10.1186/1756-0500-6-435
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999
   Heumann CL, 2017, SEX TRANSM DIS, V44, P266, DOI [10.1097/olq.0000000000000592, 10.1097/OLQ.0000000000000592]
   Hobbs MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00123
   HOLMES KH, 1971, ANN INTERN MED, V74, P979, DOI 10.7326/0003-4819-74-6-979
   HOOK EW, 1999, SEXUALLY TRANSMITTED, P451
   Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016
   Islam EA, 2016, MUCOSAL IMMUNOL, V9, P1051, DOI 10.1038/mi.2015.122
   Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999
   Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067
   Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107
   Katz AR, 2017, CLIN INFECT DIS, V65, P918, DOI 10.1093/cid/cix485
   Khauv Phara, 2014, BMC Res Notes, V7, P784, DOI 10.1186/1756-0500-7-784
   Khin-Nwe-Oo, 2011, SE ASIAN J TROP MED, V42, P347
   Knight E, 2014, J OBSTET GYNAECOL CA, V36, P216, DOI 10.1016/S1701-2163(15)30629-0
   Korenromp EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170773
   Kunz AN, 2012, J INFECT DIS, V205, P1821, DOI 10.1093/infdis/jis277
   LAGA M, 1986, LANCET, V2, P1145
   LAGA M, 1989, B WORLD HEALTH ORGAN, V67, P471
   Lewis LA, 2015, MBIO, V6, DOI 10.1128/mBio.02465-14
   Liu Y, 2014, MUCOSAL IMMUNOL, V7, P165, DOI 10.1038/mi.2013.36
   Liu Y, 2012, MUCOSAL IMMUNOL, V5, P320, DOI 10.1038/mi.2012.12
   Liu Y, 2017, MUCOSAL IMMUNOL
   Liu YR, 2013, J INFECT DIS, V208, P1821, DOI 10.1093/infdis/jit354
   Liu YR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00052
   Marai W, 2001, East Afr Med J, V78, P581
   Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229
   Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298
   MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1
   Ndowa F, 2012, REPROD HEALTH MATTER, V20, P76, DOI 10.1016/S0968-8080(12)40653-X
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   Nsuami M, 2004, SEX TRANSM DIS, V31, P424, DOI [10.1097/01.OLQ.0000130535.96576.D3, 10.1097/01.olq.0000130535.96576.D3]
   O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525
   Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11
   Ong KJ, 2017, SEX TRANSM INFECT, V93, P18, DOI 10.1136/sextrans-2016-052597
   Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38
   Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14
   Packiam M, 2010, INFECT IMMUN, V78, P433, DOI 10.1128/IAI.00711-09
   Pajon R, 2015, VACCINE, V33, P1317, DOI 10.1016/j.vaccine.2015.01.057
   Palafox SKV, 2011, CLIN EXP OPHTHALMOL, V2, P1
   Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184
   Petousis-Harris H, 2017, LANCET, V390, P1603, DOI 10.1016/S0140-6736(17)31449-6
   Plante M, 2000, J INFECT DIS, V182, P848, DOI 10.1086/315801
   PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040
   PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159
   PLUMMER FA, 1993, J CLIN INVEST, V91, P339, DOI 10.1172/JCI116190
   Polis CB, 2017, HUM REPROD, V32, P1064, DOI 10.1093/humrep/dex025
   Pouyanfard S, 2017, BIOL CHEM, V398, P871, DOI 10.1515/hsz-2017-0105
   Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005
   RAMSEY KH, 1994, ANN NY ACAD SCI, V730, P322, DOI 10.1111/j.1749-6632.1994.tb44280.x
   Ranjit R, 2014, MIDDLE EAST AFR J OP, V21, P240, DOI 10.4103/0974-9233.134684
   Rank RG, 2010, J INFECT DIS, V201, pS168, DOI 10.1086/652399
   Reekie J, CLIN INFECT DIS
   Reekie J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094361
   Regnier SA, 2014, HUM VACC IMMUNOTHER, V10, P3737, DOI 10.4161/hv.36221
   Rice PA, 2017, ANNU REV MICROBIOL, V71, P665, DOI 10.1146/annurev-micro-090816-093530
   Rosenvinge MM, 2009, INT J STD AIDS, V20, P571, DOI 10.1258/ijsa.2008.008472
   Sanchez JL, 2013, MIL MED, V178, P1271, DOI 10.7205/MILMED-D-13-00137
   Schmitt DM, 2016, INT J ANTIMICROB AG, V48, P367, DOI 10.1016/j.ijantimicag.2016.06.009
   SCHNEIDER H, 1984, INFECT IMMUN, V45, P544, DOI 10.1128/IAI.45.3.544-549.1984
   Schneider H, 1996, J INFECT DIS, V173, P1422, DOI 10.1093/infdis/173.6.1422
   SCHNEIDER H, 1991, J EXP MED, V174, P1601, DOI 10.1084/jem.174.6.1601
   Semchenko EA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00898-16
   Shaughnessy J, 2016, J IMMUNOL, V196, P1732, DOI 10.4049/jimmunol.1500292
   Shewell LK, 2013, BIOCHEM BIOPH RES CO, V431, P215, DOI 10.1016/j.bbrc.2012.12.132
   Song WX, 2008, VACCINE, V26, P5741, DOI 10.1016/j.vaccine.2008.08.020
   Spencer SE, 2004, J INFECT DIS, V189, P410, DOI 10.1086/381125
   Stankowski RV, 2012, SEX TRANSM DIS, V39, P238, DOI 10.1097/OLQ.0b013e3182471974
   Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336
   Stupiansky NW, 2011, SEX TRANSM DIS, V38, P750, DOI 10.1097/OLQ.0b013e31820ff9a4
   SWANSON J, 1987, J EXP MED, V165, P1016, DOI 10.1084/jem.165.4.1016
   Tapsall J., 2005, WHAT IS EC BURDEN IM
   Templeton DJ, 2012, SEX HEALTH, V9, P392, DOI 10.1071/SH11146
   TRAMONT EC, 1985, VACCINE, V3, P3, DOI 10.1016/0264-410X(85)90003-9
   Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008
   Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/S1473-3099(17)30310-9, 10.1016/s1473-3099(17)30310-9]
   Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14
   VEALE DR, 1979, J GEN MICROBIOL, V113, P383, DOI 10.1099/00221287-113-2-383
   WARD ME, 1972, J INFECT DIS, V126, P601, DOI 10.1093/infdis/126.6.601
   Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x
   Watts DH, 1999, SEXUALLY TRANSMITTED, P1089
   Wetzler LM, 2016, CLIN VACCINE IMMUNOL, V23, P656, DOI 10.1128/CVI.00230-16
   Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07
   Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010
   Zhu WY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00124
   Zielke RA, 2016, MOL CELL PROTEOMICS, V15, P2338, DOI 10.1074/mcp.M116.058800
NR 129
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7419
EP 7426
DI 10.1016/j.vaccine.2018.02.081
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100017
PM 29680200
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Milligan, GN
   Schnierle, BS
   McAuley, AJ
   Beasley, DWC
AF Milligan, Gregg N.
   Schnierle, Barbara S.
   McAuley, Alexander J.
   Beasley, David W. C.
TI Defining a correlate of protection for chikungunya virus vaccines
SO VACCINE
LA English
DT Article
DE Arbovirus; Vaccine; Neutralizing antibodies; Assays; Animal models;
   Clinical trial
ID HUMAN MONOCLONAL-ANTIBODIES; MOUSE MODEL; COMPARATIVE IMMUNOGENICITIES;
   NEUTRALIZING ANTIBODIES; NONHUMAN-PRIMATES; ACUTE-PHASE; T-CELLS;
   INFECTION; DISEASE; ARTHRITIS
AB Chikungunya virus infection causes a debilitating febrile illness that in many affected individuals is associated with long-term sequelae that can persist for months or years. Over the past decade a large number of candidate vaccines have been developed, several of which have now entered clinical trials. The rapid and sporadic nature of chikungunya outbreaks poses challenges for planning of large clinical efficacy trials suggesting that licensure of chikungunya vaccines may utilize non-traditional approval pathways based on identification of immunological endpoint(s) predictive of clinical benefit. This report reviews the current status of nonclinical and clinical testing and potential challenges for defining a suitable surrogate or correlate of protection. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Milligan, Gregg N.; Beasley, David W. C.] Univ Texas Med Branch, WHO Collaborating Ctr Vaccine Res Evaluat & Train, Galveston, TX 77555 USA.
   [Milligan, Gregg N.; Beasley, David W. C.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Milligan, Gregg N.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [McAuley, Alexander J.; Beasley, David W. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Schnierle, Barbara S.] Paul Ehrlich Inst, WHO Collaborating Ctr Standardizat & Evaluat Vacc, Langen, Germany.
   [Schnierle, Barbara S.] Paul Ehrlich Inst, Virol Div, Sect AIDS New & Emerging Pathogens, D-152018 Langen, Germany.
   [McAuley, Alexander J.] CSIRO Australian Anim Hlth Lab, 5 Portarlington Rd, Geelong, Vic 3219, Australia.
RP Beasley, DWC (reprint author), Univ Texas Med Branch, WHO Collaborating Ctr Vaccine Res Evaluat & Train, Galveston, TX 77555 USA.; Beasley, DWC (reprint author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Beasley, DWC (reprint author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM dwbeasle@utmb.edu
OI McAuley, Alexander/0000-0002-7632-9633
CR Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   BINN LN, 1967, AM J TROP MED HYG, V16, P782, DOI 10.4269/ajtmh.1967.16.782
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Broeckel R, 2015, PATHOGENS, V4, P662, DOI 10.3390/pathogens4030662
   Burrack KS, 2015, J IMMUNOL, V194, P678, DOI 10.4049/jimmunol.1401833
   Carletti F, 2017, GENOME ANNOUNC, V5, P1
   Chaaithanya IK, 2014, INDIAN J MED RES, V140, P142
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   DeMeio J L, 1979, Asian J Infect Dis, V3, P119
   ECDC, 2017, CLUST AUT CHIK CAS F
   ECDC, 2017, COMM DIS THREATS REP
   ECDC, 2017, COMM DIS THREATS REP
   ECKELS KH, 1970, APPL MICROBIOL, V19, P321, DOI 10.1128/AEM.19.2.321-325.1970
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674
   Galatas B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004281
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Glasker S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-235
   Goo L, 2016, J INFECT DIS, V214, P1487, DOI 10.1093/infdis/jiw431
   Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   HARRISON VR, 1971, J IMMUNOL, V107, P643
   HARRISON VR, 1967, AM J TROP MED HYG, V16, P786, DOI 10.4269/ajtmh.1967.16.786
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   HAZELTON RA, 1985, AUST NZ J MED, V15, P336, DOI 10.1111/j.1445-5994.1985.tb04048.x
   Hoarau JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084695
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089
   IGARASHI A, 1970, BIKEN J, V13, P229
   Jain J, 2017, CLIN INFECT DIS
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   KAWANO Y, 1994, J IMMUNOL, V153, P4948
   Khan M, 2012, VIRUS RES, V167, P236, DOI 10.1016/j.virusres.2012.05.004
   Kistner O, 2007, VACCINE, V25, P4845, DOI 10.1016/j.vaccine.2007.01.103
   Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072
   La Linn M, 1998, J VIROL, V72, P5146, DOI 10.1128/JVI.72.6.5146-5153.1998
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   Long F, 2015, P NATL ACAD SCI USA, V112, P13898, DOI 10.1073/pnas.1515558112
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Mallhi T H, 2017, New Microbes New Infect, V19, P13, DOI 10.1016/j.nmni.2017.05.008
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240
   Metz SW, 2013, VACCINE, V31, P6092, DOI 10.1016/j.vaccine.2013.09.045
   Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060
   Muthumani K, 2016, J INFECT DIS, V214, P369, DOI 10.1093/infdis/jiw111
   NAKAO E, 1973, B WORLD HEALTH ORGAN, V48, P559
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183
   PAHO, 2017, NUMB REP CAS CHIK FE
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pierro A., 2015, New Microbes and New Infections, V7, P23, DOI 10.1016/j.nmni.2015.04.002
   Piper A, 2013, J VIROL, V87, P6748, DOI 10.1128/JVI.03357-12
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Prow TW, 2010, SMALL, V6, P1776, DOI 10.1002/smll.201000331
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rauf M, 2017, LANCET INFECT DIS, V17, P258, DOI 10.1016/S1473-3099(17)30074-9
   Roques P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.83527
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Rudd PA, 2015, VACCINE, V33, P5172, DOI 10.1016/j.vaccine.2015.07.099
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Saraswat S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004782
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simarmata D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26097
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Taylor A, 2017, MBIO, V8, DOI 10.1128/mBio.01970-16
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062
   Treanor J, 2003, Dev Biol (Basel), V115, P97
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   van den Doel P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003101
   van Els C, 2014, HUM VACC IMMUNOTHER, V10, P1935, DOI 10.4161/hv.28639
   Verma P, 2014, CLIN CHEM LAB MED, V52, P297, DOI 10.1515/cclm-2013-0363
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Wang EY, 2011, J VIROL, V85, P9249, DOI 10.1128/JVI.00844-11
   Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Weber C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003684
   Weber C, 2014, J VIROL METHODS, V201, P7, DOI 10.1016/j.jviromet.2014.02.001
   Weger-Lucarelli J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002970
   WHITE A, 1972, APPL MICROBIOL, V23, P951, DOI 10.1128/AEM.23.5.951-952.1972
   WHO, 2017, WHO TECHN REP SER, P75
   WHO, 2017, CHIK FACT SHEET
   Wressnigg N, 2015, CLIN VACCINE IMMUNOL, V22, P267, DOI 10.1128/CVI.00546-14
   Yang SX, 2017, VACCINE, V35, P4851, DOI 10.1016/j.vaccine.2017.07.065
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yun NE, 2009, VACCINE, V27, P4064, DOI 10.1016/j.vaccine.2009.04.015
NR 119
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7427
EP 7436
DI 10.1016/j.vaccine.2018.10.033
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100018
PM 30448337
DA 2020-05-12
ER

PT J
AU Plotkin, SA
   Boppana, SB
AF Plotkin, Stanley A.
   Boppana, Suresh B.
TI Vaccination against the human cytomegalovirus
SO VACCINE
LA English
DT Article
DE CMV; Congenital infection; Deafness; Pentamer; Reinfection
ID POLYMERASE-CHAIN-REACTION; TRANSPLANT RECIPIENTS; HEARING-LOSS;
   INTRAUTERINE TRANSMISSION; CELL TRANSPLANTATION; IMMUNE-RESPONSES;
   VIRUS-VACCINE; T-CELLS; INFECTION; CMV
AB The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far advanced, with numerous candidate vaccines being tested, both live and inactivated. This article summarizes the status of the candidate vaccines. (C) 2018 The Authors. Published by Elsevier Ltd.
C1 [Plotkin, Stanley A.] Univ Penn, Vaxconsult, 4650 Wismer Rd, Doylestown, PA 18902 USA.
   [Boppana, Suresh B.] UAB Sch Med, CHB 114,1600 7th Ave South, Birmingham, AL 35233 USA.
RP Plotkin, SA (reprint author), Univ Penn, Vaxconsult, 4650 Wismer Rd, Doylestown, PA 18902 USA.
EM Stanley.plotkin@vaxconsult.com; sboppana@peds.uab.edu
CR Adler SP, 2016, J INFECT DIS, V214, P1341, DOI 10.1093/infdis/jiw365
   BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433
   Berencsi K, 2001, J INFECT DIS, V183, P1171, DOI 10.1086/319680
   Bernstein DI, 2016, VACCINE, V34, P313, DOI 10.1016/j.vaccine.2015.11.056
   Bernstein DI, 2009, VACCINE, V28, P484, DOI 10.1016/j.vaccine.2009.09.135
   Boeckh M, 2015, BIOL BLOOD MARROW TR, V21, pS19, DOI 10.1016/j.bbmt.2014.12.034
   Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560
   BOPPANA SB, 1995, J INFECT DIS, V171, P1115, DOI 10.1093/infdis/171.5.1115
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   BOPPANA SB, 1992, J CLIN MICROBIOL, V30, P721, DOI 10.1128/JCM.30.3.721-723.1992
   Boppana SB, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P1
   Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561
   Britt WJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02392-16
   Camargo JF, 2017, HEMATOL ONCOL STEM C
   Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002
   Cayatte C, 2013, J VIROL, V87, P11107, DOI 10.1128/JVI.01554-13
   Chan ST, 2017, BLOOD REV, V31, P173, DOI 10.1016/j.blre.2017.01.002
   Dar L, 2017, PEDIATR INFECT DIS J, V36, P670, DOI [10.1097/INF.0000000000001527, 10.1097/inf.0000000000001527]
   Davis NL, 2017, BIRTH DEFECTS RES, V109, P336, DOI 10.1002/bdra.23601
   de Vries JJC, 2013, REV MED VIROL, V23, P241, DOI 10.1002/rmv.1744
   DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   ELEK SD, 1974, LANCET, V1, P1
   Fehr T, 2015, TRANSPL INT, V28, P1351, DOI 10.1111/tri.12629
   Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104
   Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016
   FOWLER KB, 1991, J INFECT DIS, V164, P259, DOI 10.1093/infdis/164.2.259
   Fu TM, 2014, VACCINE, V32, P2525, DOI 10.1016/j.vaccine.2014.03.057
   Furione M, 2013, J MED VIROL, V85, P1960, DOI 10.1002/jmv.23691
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kirchmeier M, 2014, CLIN VACCINE IMMUNOL, V21, P174, DOI 10.1128/CVI.00662-13
   La Rosa C, 2017, BLOOD, V129, P114, DOI 10.1182/blood-2016-07-729756
   La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107
   Lanzieri TM, 2014, VACCINE, V32, P3780, DOI 10.1016/j.vaccine.2014.05.014
   Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010
   Leruez-Ville M, 2017, CLIN INFECT DIS, V65, P398, DOI 10.1093/cid/cix337
   Lilleri D, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1921
   Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863
   Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668
   Lumbreras C, 2014, CLIN MICROBIOL INFEC, V20, P19, DOI 10.1111/1469-0691.12594
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Nakamura R, 2016, LANCET HAEMATOL, V3, pE87, DOI 10.1016/S2352-3026(15)00246-X
   Nigro G, 2013, CLIN INFECT DIS, V57, pS193, DOI 10.1093/cid/cit586
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   PLOTKIN SA, 1994, TRANSPLANTATION, V58, P1176, DOI 10.1097/00007890-199412150-00006
   PLOTKIN SA, 1989, J INFECT DIS, V159, P860, DOI 10.1093/infdis/159.5.860
   PLOTKIN SA, 1975, INFECT IMMUN, V12, P521, DOI 10.1128/IAI.12.3.521-527.1975
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903
   Schleiss MR, 2007, J INFECT DIS, V195, P789, DOI 10.1086/511982
   Simonazzi G, 2017, FETAL DIAGN THER
   Smith LR, 2013, VACCINES-BASEL, V1, DOI 10.3390/vaccines1040398
   STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   Stratton KR, 2000, VACCINES 21 CENTURY
   Torre-Cisneros J, 2016, TRANSPLANT REV-ORLAN, V30, P119, DOI 10.1016/j.trre.2016.04.001
   van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492
   Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085
   Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102
   WILLIAMSON WD, 1992, PEDIATRICS, V90, P862
   Wilson SR, 2008, COMPARATIVE MED, V58, P129
   Wloch MK, 2008, J INFECT DIS, V197, P1634, DOI 10.1086/588385
   Yadav SK, 2017, J CLIN EXP HEPATOL, V7, P144, DOI 10.1016/j.jceh.2017.05.011
   Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640
   Zhong J, 2010, J GEN VIROL, V91, P2994, DOI 10.1099/vir.0.025742-0
NR 68
TC 18
Z9 19
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7437
EP 7442
DI 10.1016/j.vaccine.2018.02.089
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100019
PM 29622379
OA Green Published, Other Gold
HC Y
HP N
DA 2020-05-12
ER

PT J
AU Vannice, KS
   Giersing, BK
   Kaslow, DC
   Griffiths, E
   Meyer, H
   Barrett, A
   Durbin, AP
   Wood, D
   Hombach, J
AF Vannice, K. S.
   Giersing, B. K.
   Kaslow, D. C.
   Griffiths, E.
   Meyer, H.
   Barrett, A.
   Durbin, A. P.
   Wood, D.
   Hombach, J.
TI Meeting Report: WHO consultation on considerations for regulatory
   expectations of Zika virus vaccines for use during an emergency
SO VACCINE
LA English
DT Article
DE Zika virus; Zika vaccines; Vaccine regulation
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; CROSS-REACTIVITY; PROTECTION;
   INFECTION; TRANSMISSION; CHALLENGE; EPIDEMIC; RISK
AB On 1 February 2016, in the context of the ongoing Zika virus epidemic, the WHO declared that the recently reported clusters of microcephaly and other neurological disorders constituted a Public Health Emergency of International Concern (PHEIC). In response, WHO in collaboration with UNICEF and a working group of independent subject matter experts developed a Zika virus vaccine Target Product Profile (TPP) for use in an emergency, or in a future outbreak scenario. The drafting process of the Zika virus vaccine TPP included the opportunity for public comment, as well as consultation with epidemiologists, flavivirus vaccine subject matter experts, vaccine developers and global regulators to consider the regulatory expectations and potential emergency use pathways for a vaccine with the characteristics described in the TPP. This report summarizes an expert consultation held 6-7 June 2016 on the regulatory considerations for a Zika vaccine for emergency use. (C) 2017 Elsevier Ltd.
C1 [Vannice, K. S.; Giersing, B. K.; Hombach, J.] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.
   [Kaslow, D. C.] PATH, Seattle, WA 98109 USA.
   [Griffiths, E.] The Farthings, Kingston Upon Thames KT2 7PT, Surrey, England.
   [Meyer, H.] Paul Ehrlich Inst, D-63225 Langen, Germany.
   [Barrett, A.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Barrett, A.] Univ Texas Med Branch, World Hlth Org, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA.
   [Durbin, A. P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Wood, D.] WHO, Dept Essential Med & Hlth Prod, CH-1211 Geneva 27, Switzerland.
RP Hombach, J (reprint author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.
EM hombachj@who.int
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.18655, 10.1001/jama.2016.19328]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Brasil P, 2016, N ENGL J MED
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dodd CN, 2013, VACCINE, V31, P4448, DOI 10.1016/j.vaccine.2013.06.032
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   JACKSON N, 2014, [No title captured], V91, P172
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, 2016, CAS DEF
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun W, 2013, J INFECT DIS, V207, P700, DOI 10.1093/infdis/jis744
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   WHO, 2014, SAF IMM PREGN REV EV
   WHO, 2016, WHO STAT 1 M INT HLT
   WHO Expert Committee on Biological Standardization, 2015, WHO TECHN REP SER
   World Health Organization, 2016, WHO VACC PIP TRACK
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   World Health Organization, 2016, ZIK VIR VACC PROD DE
   World Health Organization, 2016, WHO CONS CONS REG EX
   World Health Organization, 2015, EM US ASS LIST PROC
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 56
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7443
EP 7450
DI 10.1016/j.vaccine.2016.10.034
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100020
PM 27916410
DA 2020-05-12
ER

PT J
AU Aguilar-Hernandez, GA
   Siguenza-Sanchez, CP
   Donati, F
   Merciai, S
   Schmidt, J
   Rodrigues, JF
   Tukker, A
AF Aguilar-Hernandez, Glenn A.
   Siguenza-Sanchez, Carlos Pablo
   Donati, Franco
   Merciai, Stefano
   Schmidt, Jannick
   Rodrigues, Joao Fd
   Tukker, Arnold
TI The circularity gap of nations: A multiregional analysis of waste
   generation, recovery, and stock depletion in 2011
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Multiregional hybrid-units input-output tables;
   Material-based metrics; Circularity interventions; Resource efficiency
ID INPUT-OUTPUT-ANALYSIS; GLOBAL ECONOMY; MONITORING FRAMEWORK; RESOURCE
   EXTRACTION; LAND APPROPRIATION; FLOWS; CHINA; FOOTPRINTS; INDICATOR;
   LOSSES
AB Due to increased policy attention on circular economy strategies, many studies have quantified material use and recovery at national and global scales. However, there has been no quantitative analysis of the unrecovered waste that can be potentially reintegrated into the economy as materials or products. This can be interpreted as the gap of material circularity. In this paper we define the circularity gap of a country as the generated waste, plus old materials removed from stocks and durable products disposed (i.e. stock depletion), minus recovered waste. We estimated the circularity gap of 43 nations and 5 rest of the world regions in 2011, using the global, multiregional hybrid-units input-output database EXIOBASE v3.3. Our results show the trends of circularity gap in accordance to each region. For example, the circularity gaps of Europe and North America were between 1.6-2.2 tonnes per capita (t/cap), which are more than twice the global average gap (0.8 t/cap). Although these regions presented the major amount of material recovery, their circularity gaps were mostly related to the levels of stock depletion. In Africa and Asia-Pacific regions, the circularity gap was characterized by a low degree of recovery and stock depletion, with high levels of generated waste. Moreover, we discuss which intervention types can be implemented to minimize the circularity gap of nations.
C1 [Aguilar-Hernandez, Glenn A.; Siguenza-Sanchez, Carlos Pablo; Donati, Franco; Rodrigues, Joao Fd; Tukker, Arnold] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.
   [Merciai, Stefano; Schmidt, Jannick] 2 0 LCA Consultants, Aalborg, Denmark.
RP Aguilar-Hernandez, GA (reprint author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.
EM g.a.aguilar@cml.leidenuniv.nl
OI Donati, Franco/0000-0002-8287-2413; Aguilar-Hernandez, Glenn
   Alonso/0000-0003-3740-8221
FU European Commission under the Horizon 2020 Marie Sktodowska Curie Action
   2016 [721909]
FX Glenn A. Aguilar-Hernandez is part of the Circular European Economy
   Innovative Training Network (CircEuit), funded by the European
   Commission under the Horizon 2020 Marie Sktodowska Curie Action 2016
   (Grant Agreement Number 721909).
CR Aguilar-Hernandez G.A., 2018, J EC STRUCT, V7, P14, DOI [10.1186/s40008-018-0113-3, DOI 10.1186/S40008-018-0113-3]
   Bastein T., 2013, TECHNICAL REPORT
   Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034
   Blomsma F, 2017, J IND ECOL, V21, P603, DOI 10.1111/jiec.12603
   Bocken NMP, 2016, J IND PROD ENG, V33, P308, DOI 10.1080/21681015.2016.1172124
   Cullen JM, 2017, J IND ECOL, V21, P483, DOI 10.1111/jiec.12599
   de Koning A., 2018, CREATING GLOBAL SCEN
   de Wit M., 2018, TECHNICAL REPORT
   Dietzenbacher E, 2005, ECOL ECON, V55, P11, DOI 10.1016/j.ecolecon.2005.04.009
   Duchin F, 2013, J IND ECOL, V17, P65, DOI 10.1111/j.1530-9290.2012.00498.x
   EC, 2001, TECHNICAL REPORT
   EC, 2000, TECHNICAL REPORT
   EMF, 2013, TECHNICAL REPORT
   EMF SUN SYSTEMIQ, 2017, TECHNICAL REPORT
   Eurostat, 2008, EUR MAN SUPPL US INP
   Eurostat, 2013, EC WID MAT FLOW ACC
   Eurostat, 2013, MAN WAST STAT HDB DA
   Fellner J, 2017, J IND ECOL, V21, P494, DOI 10.1111/jiec.12582
   Figge F, 2018, ECOL ECON, V150, P297, DOI 10.1016/j.ecolecon.2018.04.030
   Franklin-Johnson E, 2016, J CLEAN PROD, V133, P589, DOI 10.1016/j.jclepro.2016.05.023
   Geerken T, 2019, J CLEAN PROD, V227, P683, DOI 10.1016/j.jclepro.2019.04.120
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Giljum S, 2015, J IND ECOL, V19, P792, DOI 10.1111/jiec.12214
   Gujarati D.N., 2003, BASIC ECONOMETRICS, P17
   Haas W, 2015, J IND ECOL, V19, P765, DOI 10.1111/jiec.12244
   Haupt M, 2017, J IND ECOL, V21, P615, DOI 10.1111/jiec.12506
   Homrich AS, 2018, J CLEAN PROD, V175, P525, DOI 10.1016/j.jclepro.2017.11.064
   Hubacek K, 2003, ECOL ECON, V44, P137, DOI 10.1016/S0921-8009(02)00257-4
   Iacovidou E, 2017, J CLEAN PROD, V166, P910, DOI 10.1016/j.jclepro.2017.07.100
   Jacobi N, 2018, RESOUR CONSERV RECY, V137, P156, DOI 10.1016/j.resconrec.2018.05.022
   Kirchherr J., 2017, CONCEPTUALIZING CIRC, DOI [10.1016/j.resconrec.2017.09.005, DOI 10.1016/J.RESCONREC.2017.09.005]
   Kovanda J, 2014, RESOUR CONSERV RECY, V92, P78, DOI 10.1016/j.resconrec.2014.08.006
   Krausmann F, 2018, GLOBAL ENVIRON CHANG, V52, P131, DOI 10.1016/j.gloenvcha.2018.07.003
   Krausmann F, 2017, P NATL ACAD SCI USA, V114, P1880, DOI 10.1073/pnas.1613773114
   Mayer A, 2019, J IND ECOL, V23, P62, DOI 10.1111/jiec.12809
   McDowall W, 2017, J IND ECOL, V21, P651, DOI 10.1111/jiec.12597
   Merciai S, 2018, J IND ECOL, V22, P516, DOI 10.1111/jiec.12713
   Murray A., 2015, J BUS ETHICS, P1, DOI [10.1007/s10551-015-2693-2, DOI 10.1007/S10551-015-2693-2]
   Nakamura S, 2017, ENVIRON SCI TECHNOL, V51, P9469, DOI 10.1021/acs.est.7b01683
   Nuss P., 2017, TECHNICAL REPORT
   Pauliuk S, 2018, RESOUR CONSERV RECY, V129, P81, DOI 10.1016/j.resconrec.2017.10.019
   Pauliuk S, 2017, RESOUR CONSERV RECY, V116, P84, DOI 10.1016/j.resconrec.2016.09.029
   Schandl H, 2016, DECOUPLING GLOBAL EN, DOI [10.1016/j.jclepro.2015.06.100, DOI 10.1016/J.JCLEPRO.2015.06.100]
   Schmidt J., 2017, PHYS HYBRID SUPPLY U
   Schmidt J., 2013, RECOMMENDATION TERMI
   Schmidt J. H., 2010, DOCUMENTATION FINAL
   Stadler K, 2018, J IND ECOL, V22, P502, DOI 10.1111/jiec.12715
   Stanhel W.R., 2015, TAKING STOCK IND ECO, P137
   Su B, 2013, J CLEAN PROD, V42, P215, DOI 10.1016/j.jclepro.2012.11.020
   Suh S, 2004, ECOL ECON, V48, P9, DOI 10.1016/j.ecolecon.2003.09.003
   Suh S, 2010, J IND ECOL, V14, P335, DOI 10.1111/j.1530-9290.2010.00235.x
   Tisserant A, 2017, J IND ECOL, V21, P628, DOI 10.1111/jiec.12562
   Tukker A, 2018, J IND ECOL, V22, P489, DOI 10.1111/jiec.12736
   Tukker A, 2016, GLOBAL ENVIRON CHANG, V40, P171, DOI 10.1016/j.gloenvcha.2016.07.002
   Tukker A, 2013, ECON SYST RES, V25, P50, DOI 10.1080/09535314.2012.761952
   Van Eygen E, 2017, RESOUR CONSERV RECY, V117, P183, DOI 10.1016/j.resconrec.2016.10.017
   Weisz H, 2006, ECOL ECON, V57, P534, DOI 10.1016/j.ecolecon.2005.05.011
   Weisz H, 2006, ECOL ECON, V58, P676, DOI 10.1016/j.ecolecon.2005.08.016
   Wiedenhofer D, 2019, ECOL ECON, V156, P121, DOI 10.1016/j.ecolecon.2018.09.010
   Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110
   Winans K, 2017, RENEW SUST ENERG REV, V68, P825, DOI 10.1016/j.rser.2016.09.123
   Wood R, 2018, J IND ECOL, V22, P553, DOI 10.1111/jiec.12735
   Wood R, 2015, SUSTAINABILITY-BASEL, V7, P138, DOI 10.3390/su7010138
   World Bank, 2019, WORLD BANK COUNTR LE
   World Bank, 2019, WORLD BANK OP DAT
   Yuan ZW, 2006, J IND ECOL, V10, P4, DOI 10.1162/108819806775545321
   Zhu JM, 2019, J IND ECOL, V23, P110, DOI 10.1111/jiec.12754
NR 69
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104452
DI 10.1016/j.resconrec.2019.104452
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700006
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Althaf, S
   Babbitt, CW
   Chen, R
AF Althaf, Shahana
   Babbitt, Callie W.
   Chen, Roger
TI Forecasting electronic waste flows for effective circular economy
   planning
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Electronic waste; Circular economy; Logistic forecasting; Emerging
   technology; E-waste policy; Material flow analysis (MFA); Industrial
   ecology
ID ENVIRONMENTAL ASSESSMENT; SUCCESSIVE GENERATIONS; SUBSTITUTION MODEL;
   MOBILE PHONES; TECHNOLOGY; MANAGEMENT; COMPUTERS; DIFFUSION; PRODUCTS;
   QUANTITIES
AB Rapid evolution in the consumer electronics sector has created new resource and waste challenges that are inadequately managed in the current linear product system. Circular economy (CE) strategies offer potential to close the Loop on electronic products and materials, but often lack the future-oriented perspective needed to keep pace with this dynamic sector. The present study addresses this challenge by developing a logistic forecasting material flow model that can predict future resource and waste flows for products with abundant historic sales data (mature products) as well as for products that have just entered the market (emerging products). One of the key trends observed across current and legacy electronics is the steadily shrinking innovation cycle, where the time between a product's market entry and peak sales is decreasing over time. This trend, coupled with extensive historic and modem product sales data, was used to create adoption scenario forecasts for emerging products, like fitness trackers, smart thermostats, and drones. Findings show that these devices are likely to have rapid uptake in the market, but may be quickly replaced by subsequent product innovations. In contrast, waste flow forecasts for mature products like CRTs, desktops, monitors and flat panel TVs showed their declining contribution to the U.S. e-waste stream. This study contributes a modeling framework that can be used to inform CE strategies in electronics by identifying near term opportunities and risks in end-of-life management of products to extend product life and close the loop on key materials.
C1 [Althaf, Shahana; Babbitt, Callie W.; Chen, Roger] Rochester Inst Technol, Golisano Inst Sustainabil, Rochester, NY 14623 USA.
RP Babbitt, CW (reprint author), Golisano Inst Sustainabil, Rochester, NY 14623 USA.
EM cwbgis@rit.edu
RI Althaf, Shahana/AAF-1157-2019
FU National Science FoundationNational Science Foundation (NSF)
   [CBET-1236447, CBET-1254688]; Consumer Technology Association; Staples
   Sustainable Innovation Lab at Rochester Institute of Technology
FX The authors gratefully acknowledge and thank Hema Madaka, Mosunmola
   Odulate, and Dr. Erinn Ryen for their assistance in electronic product
   disassembly and data collection. This article is based upon work
   supported by the National Science Foundation (CBET-1236447 and
   CBET-1254688), the Consumer Technology Association, and the Staples
   Sustainable Innovation Lab at Rochester Institute of Technology.
   Findings and conclusions reported here are those of the authors and do
   not necessarily reflect the views of the funding organizations.
CR Anshassi M, 2018, ENVIRON SCI TECHNOL, V52, P6544, DOI 10.1021/acs.est.7b06007
   Babbitt C.W., 2017, SUSTAINABLE MAT MANA
   Babbitt CW, 2009, ENVIRON SCI TECHNOL, V43, P5106, DOI 10.1021/es803568p
   Bagher A. M., 2017, INT J ADV RES PHYS S, V4, P48
   Bakker C, 2014, J CLEAN PROD, V69, P10, DOI 10.1016/j.jclepro.2014.01.028
   Balde C.P., 2017, GLOBAL E WASTE MONIT
   Bocken NMP, 2016, J IND PROD ENG, V33, P308, DOI 10.1080/21681015.2016.1172124
   Boks C, 2007, INT J PROD RES, V45, P4021, DOI 10.1080/00207540701439909
   Brunner PH, 2004, PRACTICAL HDB MAT FL
   Buchert M, 2012, RECYCLING CRITICAL R
   Chen AM, 2011, ENVIRON HEALTH PERSP, V119, P431, DOI 10.1289/ehp.1002452
   Cho Y, 2016, FORESIGHT, V18, P117, DOI 10.1108/FS-08-2015-0043
   Chopra SS, 2017, ENVIRON SCI-NANO, V4, P244, DOI 10.1039/c6en00326e
   Consumer Technology Association, 2017, 19 ANN CONS TECHN OW
   Cucchiella F, 2015, RENEW SUST ENERG REV, V51, P263, DOI 10.1016/j.rser.2015.06.010
   Dutta T, 2016, ENVIRON RES, V150, P182, DOI 10.1016/j.envres.2016.05.052
   Electronics TakeBack Coalition, 2015, SCOP PROD E WAST LAW
   FISHER JC, 1971, TECHNOL FORECAST SOC, V3, P75, DOI 10.1016/S0040-1625(71)80005-7
   Gaustad G, 2018, RESOUR CONSERV RECY, V135, P24, DOI 10.1016/j.resconrec.2017.08.002
   Gu Y., 2018, J CLEAN PROD, V127, P331, DOI [10.1016/j.jclepro.2016.04, DOI 10.1016/J.JCLEPRO.2016.04]
   Gusukuma M, 2018, RESOUR CONSERV RECY, V138, P142, DOI 10.1016/j.resconrec.2018.07.014
   Habuer, 2014, WASTE MANAGE, V34, P489, DOI 10.1016/j.wasman.2013.11.004
   Isildar A, 2018, RESOUR CONSERV RECY, V135, P296, DOI 10.1016/j.resconrec.2017.07.031
   Islam T, 1997, TECHNOL FORECAST SOC, V56, P49, DOI 10.1016/S0040-1625(97)00030-9
   Kahhat R, 2012, RESOUR CONSERV RECY, V67, P67, DOI 10.1016/j.resconrec.2012.07.008
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Kasulaitis BV, 2019, J IND ECOL, V23, P119, DOI 10.1111/jiec.12756
   Kiddee P, 2013, WASTE MANAGE, V33, P1237, DOI 10.1016/j.wasman.2013.01.006
   Kohler A, 2004, HUM ECOL RISK ASSESS, V10, P831, DOI 10.1080/10807030490513856
   Kucharavy Dmitry, 2015, Procedia Engineering, V131, P280, DOI 10.1016/j.proeng.2015.12.390
   Kucharavy D., 2011, PROCEDIA ENG, V9, P402, DOI DOI 10.1016/J.PROENG.2011.03.129
   LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348
   Li B, 2015, WASTE MANAGE, V35, P247, DOI 10.1016/j.wasman.2014.09.008
   Lu B, 2015, J CLEAN PROD, V89, P148, DOI 10.1016/j.jclepro.2014.11.004
   Marchetti C., 1979, DYNAMICS ENERGY SYST
   Mars C., 2016, ELECT RECYCLING LAND
   Meyer P.S., 1999, TECHNOL FORECAST SOC, V61, P1
   Miller T.R., 2016, ENVIRON SCI TECHNOL, DOI [10.1021/acs.est6b00079, DOI 10.1021/ACS.EST6B00079]
   NORTON JA, 1987, MANAGE SCI, V33, P1069, DOI 10.1287/mnsc.33.9.1069
   O'Connor MP, 2016, ACS SUSTAIN CHEM ENG, V4, P5879, DOI 10.1021/acssuschemeng.6b01954
   Oguchi M, 2008, RESOUR CONSERV RECY, V52, P463, DOI 10.1016/j.resconrec.2007.06.001
   Perera C, 2015, IEEE T EMERG TOP COM, V3, P585, DOI 10.1109/TETC.2015.2390034
   Petridis NE, 2016, J CLEAN PROD, V112, P3072, DOI 10.1016/j.jclepro.2015.09.119
   Quaglia R, 2018, GER MICROW CONF, P1, DOI 10.23919/GEMIC.2018.8335013
   Rahmani M, 2014, RESOUR CONSERV RECY, V87, P21, DOI 10.1016/j.resconrec.2014.03.009
   Reike D, 2018, RESOUR CONSERV RECY, V135, P246, DOI 10.1016/j.resconrec.2017.08.027
   Ryen EG, 2014, J IND ECOL, V18, P708, DOI 10.1111/jiec.12130
   Scalbi S, 2017, J CLEAN PROD, V142, P3702, DOI 10.1016/j.jclepro.2016.10.098
   Tansel B, 2017, ENVIRON INT, V98, P35, DOI 10.1016/j.envint.2016.10.002
   Tsai BH, 2013, TECHNOVATION, V33, P345, DOI 10.1016/j.technovation.2013.05.002
   Tseng FM, 2009, TECHNOL FORECAST SOC, V76, P897, DOI 10.1016/j.techfore.2009.02.003
   U S Environmental Protection Agency, 2011, EL WAST MAN US
   U.S. Environmental Protection Agency (U.S. EPA), 2016, EL PROD GEN REC US 2
   Vanegas P, 2018, RESOUR CONSERV RECY, V135, P323, DOI 10.1016/j.resconrec.2017.06.022
   Wang F, 2013, WASTE MANAGE, V33, P2397, DOI 10.1016/j.wasman.2013.07.005
   Wang X, 2012, WASTE MANAGE, V32, P1903, DOI 10.1016/j.wasman.2012.05.005
   Yang Y, 2009, TECHNOL FORECAST SOC, V76, P1105, DOI 10.1016/j.techfore.2009.03.004
   Yu JL, 2010, ENVIRON SCI TECHNOL, V44, P3232, DOI 10.1021/es903350q
   Zeng XL, 2018, ENVIRON SCI TECHNOL, V52, P4835, DOI 10.1021/acs.est.7b04909
   Zlamparet GI, 2018, WASTE MANAGE, V73, P78, DOI 10.1016/j.wasman.2017.11.053
   Zlamparet GI, 2017, J CLEAN PROD, V149, P126, DOI 10.1016/j.jclepro.2017.02.004
NR 61
TC 0
Z9 0
U1 13
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104362
DI 10.1016/j.resconrec.2019.05.038
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700025
DA 2020-05-12
ER

PT J
AU Amirudin, N
   Gim, THT
AF Amirudin, Nurlin
   Gim, Tae-Hyoung Tommy
TI Impact of perceived food accessibility on household food waste
   behaviors: A case of the Klang Valley, Malaysia
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Perceived food accessibility; Household food waste behavior; Food
   access; Food waste Partial least squares structural equation modeling
ID BUILT ENVIRONMENT; ACCESS; CONSUMERS; CITIES
AB Food waste is a global issue that is currently gaining attention in light of food security problems and related environmental issues. Studies related to household food waste have looked at consumer behavior in attempting to explain household food waste behaviors. However, standing for material infrastructure, food accessibility has been suspected to indirectly impact household food waste behaviors. This study therefore looks at perceived food accessibility, measured in terms of perceived time and perceived effort, and its impact on household food waste. A conceptual model is formed through a review of the literature and data obtained from a survey conducted at two locations in the Klang Valley, Malaysia. The collected data are then analyzed using partial least squares structural equation modeling. Three significant paths are found in the model connecting food waste with effort levels, environmental concern, and price importance.
C1 [Amirudin, Nurlin; Gim, Tae-Hyoung Tommy] Seoul Natl Univ, Gwanak Ro 1, Seoul 08826, South Korea.
RP Gim, THT (reprint author), Seoul Natl Univ, Gwanak Ro 1, Seoul 08826, South Korea.
EM taehyoung.gim@snu.ac.kr
CR Aschemann-Witzel J, 2018, GLOBAL ENVIRON CHANG, V49, P85, DOI 10.1016/j.gloenvcha.2018.02.002
   Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457
   Babbie E, 2004, PRACTICE SOCIAL RES
   Caldwell EM, 2009, PUBLIC HEALTH NUTR, V12, P1743, DOI 10.1017/S1368980008004308
   Cao XY, 2007, ENVIRON PLANN A, V39, P830, DOI 10.1068/a37437
   Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006
   Department of Statistics Malaysia, 2018, POP DEM AGE GROUP ET
   Diaz-Ruiz R, 2018, J CLEAN PROD, V172, P1140, DOI 10.1016/j.jclepro.2017.10.148
   Farr-Wharton G, 2014, J CONSUM BEHAV, V13, P393, DOI 10.1002/cb.1488
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Hair Jr J.F., 2017, PRIMER PARTIAL LEAST
   Hebrok M, 2017, J CLEAN PROD, V151, P380, DOI 10.1016/j.jclepro.2017.03.069
   Ilyuk V, 2018, J RETAIL CONSUM SERV, V41, P20, DOI 10.1016/j.jretconser.2017.11.003
   Jarv O, 2018, APPL GEOGR, V95, P101, DOI 10.1016/j.apgeog.2018.04.009
   Kruger J, 2007, AM J PREV MED, V32, P500, DOI 10.1016/j.amepre.2007.02.003
   Lee KCL, 2018, J CLEAN PROD, V172, P325, DOI 10.1016/j.jclepro.2017.10.085
   Lipinski B., 2013, WORKING PAPER
   Maas J, 2012, PSYCHOL HEALTH, V27, P59, DOI 10.1080/08870446.2011.565341
   Ministry of Domestic Trade and Consumer Affairs, 2018, SCHED CONTR GOODS LI
   Neff RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127881
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009
   Porpino G, 2015, INT J CONSUM STUD, V39, P619, DOI 10.1111/ijcs.12207
   Quested TE, 2013, RESOUR CONSERV RECY, V79, P43, DOI 10.1016/j.resconrec.2013.04.011
   Roca J., 2017, PREVENTING WASTE REC
   Roodhuyzen DMA, 2017, TRENDS FOOD SCI TECH, V68, P37, DOI 10.1016/j.tifs.2017.07.009
   Russell SV, 2017, RESOUR CONSERV RECY, V125, P107, DOI 10.1016/j.resconrec.2017.06.007
   Shannon J, 2017, GEOJOURNAL, V82, P769, DOI 10.1007/s10708-016-9716-0
   Stancu V, 2016, APPETITE, V96, P7, DOI 10.1016/j.appet.2015.08.025
   Stefan V, 2013, FOOD QUAL PREFER, V28, P375, DOI 10.1016/j.foodqual.2012.11.001
   The World Biogas Associaton, 2018, GLOB FOOD WAST MAN I
   Visschers VHM, 2016, J ENVIRON PSYCHOL, V45, P66, DOI 10.1016/j.jenvp.2015.11.007
   Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013
   Wang D, 2015, LANDSCAPE URBAN PLAN, V133, P53, DOI 10.1016/j.landurbplan.2014.09.007
   Widener MJ, 2018, PHYSIOL BEHAV, V193, P257, DOI 10.1016/j.physbeh.2018.02.032
   Widener MJ, 2014, HEALTH PLACE, V30, P1, DOI 10.1016/j.healthplace.2014.07.011
NR 35
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104335
DI 10.1016/j.resconrec.2019.05.011
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700001
DA 2020-05-12
ER

PT J
AU Arthur, M
   Liu, GY
   Hao, Y
   Zhang, LX
   Liang, S
   Asamoah, EF
   Lombardi, GV
AF Arthur, Mercy
   Liu, Gengyuan
   Hao, Yan
   Zhang, Lixiao
   Liang, Sai
   Asamoah, Ernest Frimpong
   Lombardi, Ginevra Virginia
TI Urban food-energy-water nexus indicators: A review
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Food-water-energy; Nexus indicators; Resources security; Policy
   coherence
ID SUSTAINABLE DEVELOPMENT; POLLUTION NEXUS; SYSTEMS; CARBON; METABOLISM;
   MANAGEMENT; EMISSIONS; MODEL; PERSPECTIVE; ENVIRONMENT
AB The unprecedented surge in urbanization and population growth rates is generating multiple impacts, affecting food, energy and water (FEW hereafter) demands. Moreover, the adverse effects are extending to climate, as well as to human and ecosystem health. Coordinated efforts are often deemed critical to minimize the trade-offs while maximizing the synergies in the use and the effective analysis of the interlinkages among food, energy, and water within urban ecosystems. Data are collected and transformed into useful information through different indicators, which are often applied to guide several policies in the urban domain. However, their different nature now asks for a critical reanalysis to collate them into different groups, understanding their guiding principles and identifying possible gaps for further policy- and design-oriented studies. This paper reviews the state-of-the-art on existing urban FEW nexus indicators. Indicators were found to belong to four main distinct groups, measuring resource fluxes (52%); quantifying environmental impacts (13%), and efficiency aspects (29%). Results highlight a need to develop new indicators, considering the inclusion of all involved factors within new integrated metrics. However, prior to developing an overall sustainability indicator system is presented, it would be vital to incorporate as many flows as possible to represent the entire urban systems.
C1 [Arthur, Mercy; Liu, Gengyuan; Hao, Yan; Zhang, Lixiao; Liang, Sai] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.
   [Liu, Gengyuan; Hao, Yan; Zhang, Lixiao; Liang, Sai] Beijing Engn Res Ctr Watershed Environm Restorat, Beijing 100875, Peoples R China.
   [Asamoah, Ernest Frimpong] Macquarie Univ, Fac Sci & Engn, Dept Environm Sci, Sydney, NSW, Australia.
   [Lombardi, Ginevra Virginia] Univ Florence, Dept Econ & Management, Florence, Italy.
RP Liu, GY; Hao, Y (reprint author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.
EM liugengyuan@bnu.edu.cn; haoyan@bnu.edu.cn
OI Liang, Sai/0000-0002-6306-5800; Asamoah, Ernest
   Frimpong/0000-0003-0712-5642
FU Projects of International Cooperation of National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [51661125010]; National Key R&D Program of China [2016YFC0502800];
   Beijing Science and Technology Planning Project [Z181100009618030];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71673029]; 111 ProjectMinistry of Education, China
   - 111 Project [B17005]
FX This work is supported by the Projects of International Cooperation of
   National Natural Science Foundation of China (No. 51661125010), National
   Key R&D Program of China (No. 2016YFC0502800), Beijing Science and
   Technology Planning Project (No. Z181100009618030), National Natural
   Science Foundation of China (No. 71673029) and the 111 Project (No.
   B17005).
CR Ajanovic A, 2011, ENERGY, V36, P2070, DOI 10.1016/j.energy.2010.05.019
   Albrecht T.R., 2018, ENVIRON RES LETT, V13, P1748
   [Anonymous], 2003, IND MEAS SUST URB WA
   Aquastat F.A.O, 2011, FAOS INF SYST WAT AG
   Bazilian M, 2011, ENERG POLICY, V39, P7896, DOI 10.1016/j.enpol.2011.09.039
   Bellezoni RA, 2018, BIOMASS BIOENERG, V115, P108, DOI 10.1016/j.biombioe.2018.04.017
   Berardy A, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5e6d
   Biggs EM, 2015, ENVIRON SCI POLICY, V54, P389, DOI 10.1016/j.envsci.2015.08.002
   Birol E, 2010, J ENVIRON MANAGE, V91, P2163, DOI 10.1016/j.jenvman.2010.05.008
   Bizikova L., 2013, WATER ENERGY FOOD SE
   Bulkeley H, 2014, URBAN STUD, V51, P1471, DOI 10.1177/0042098013500089
   Restrepo JDC, 2018, RESOUR CONSERV RECY, V131, P216, DOI 10.1016/j.resconrec.2017.12.023
   Chang Y, 2016, ENERGIES, V9, DOI 10.3390/en9020065
   Chen SQ, 2017, APPL ENERG, V194, P774, DOI 10.1016/j.apenergy.2016.10.069
   Chen SQ, 2016, APPL ENERG, V184, P905, DOI 10.1016/j.apenergy.2016.03.042
   Chhipi-Shrestha G, 2017, J WATER RES PLAN MAN, V143, DOI [10.1061/(asce)wr.1943-5452.0000765, 10.1061/(ASCE)WR.1943-5452.0000765]
   Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025
   Cottee J, 2016, SMART INNOV SYST TEC, V52, P613, DOI 10.1007/978-3-319-32098-4_52
   de Bruijn K, 2017, ENVIRON SCI POLICY, V70, P21, DOI 10.1016/j.envsci.2017.02.001
   de Vito R, 2017, ADV WATER RESOUR, V110, P423, DOI 10.1016/j.advwatres.2017.10.027
   EL-Gafy I, 2017, WATER RESOUR MANAG, V31, P4971, DOI 10.1007/s11269-017-1789-0
   El-Gafy I, 2017, APPL WATER SCI, V7, P2857, DOI 10.1007/s13201-017-0551-3
   Engstrom RE, 2017, SUSTAIN CITIES SOC, V31, P83, DOI 10.1016/j.scs.2017.02.007
   FAO, 2014, STAT WORLD FISH AQ O
   FAO, 2009, FEED WORLD 2050
   Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1
   Finley JW, 2014, J AGR FOOD CHEM, V62, P6255, DOI 10.1021/jf501496r
   Food and Agriculture Agency of the United Nations (FAO), 2017, STAT FOOD SEC NUTR W
   Gao Y, 2018, ECOL MODEL, V379, P22, DOI 10.1016/j.ecolmodel.2018.04.004
   Garcia DJ, 2016, COMPUT CHEM ENG, V91, P49, DOI 10.1016/j.compchemeng.2016.03.003
   Giampietro M., 2013, 56 FAO ENV NAT RES M
   Guidotti TL, 2010, ARCH ENVIRON OCCUP H, V65, P54, DOI 10.1080/19338240903400435
   Hanson LL, 2014, RES URBAN SOCIOL, V14, P191, DOI 10.1108/S1047-004220140000014009
   Helmstedt KJ, 2018, J ENVIRON MANAGE, V209, P17, DOI 10.1016/j.jenvman.2017.12.026
   Hiremath RB, 2013, ENERGY SUSTAIN DEV, V17, P555, DOI 10.1016/j.esd.2013.08.004
   Hodson M., 2011, GEOGR HELV, V66, P108
   Karabulut AA, 2018, J CLEAN PROD, V172, P3874, DOI 10.1016/j.jclepro.2017.05.092
   Karnib A, 2017, EUROPEAN WATER, V60, P89
   Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107
   Kenway SJ, 2015, ENVIRON MODELL SOFTW, V73, P272, DOI 10.1016/j.envsoft.2015.08.009
   Kibler KM, 2018, WASTE MANAGE, V74, P52, DOI 10.1016/j.wasman.2018.01.014
   Kumar P, 2014, URBAN CLIM, V10, P846, DOI 10.1016/j.uclim.2014.07.004
   Leck H, 2015, GEOGR COMPASS, V9, P445, DOI 10.1111/gec3.12222
   Lee M, 2017, APPL ENERG, V205, P589, DOI 10.1016/j.apenergy.2017.08.002
   Li JR, 2017, PROCEEDINGS OF THE 20TH INTERNATIONAL SYMPOSIUM ON ADVANCEMENT OF CONSTRUCTION MANAGEMENT AND REAL ESTATE, P1101, DOI 10.1007/978-981-10-0855-9_97
   Liu GY, 2018, J CLEAN PROD, V197, P1056, DOI 10.1016/j.jclepro.2018.06.194
   Liu GY, 2017, APPL ENERG, V186, P96, DOI 10.1016/j.apenergy.2016.06.132
   Liu LR, 2018, J CLEAN PROD, V200, P922, DOI 10.1016/j.jclepro.2018.07.298
   Liu YT, 2017, ENRGY PROCED, V142, P3108, DOI 10.1016/j.egypro.2017.12.452
   Lu Y, 2016, ENRGY PROCED, V88, P212, DOI 10.1016/j.egypro.2016.06.150
   Miller-Robbie L, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6bfe
   Mohammadi A, 2014, RENEW SUST ENERG REV, V30, P724, DOI 10.1016/j.rser.2013.11.012
   Mohtar R.H., 2016, J ENV STUD SCI, V5, P192, DOI DOI 10.1007/S13412-016-0378-5
   Moioli E, 2018, ADV WATER RESOUR, V121, P22, DOI 10.1016/j.advwatres.2018.07.007
   Moss R. H., 2008, NEW SCENARIOS ANAL E
   Moumouni Y., 2014, INT J ENERGY POWER E, V3, P308, DOI [10.11648/j.ijepe.20140306.14, DOI 10.11648/J.IJEPE.20140306.14]
   OECD-FAO, 2010, OECD FAO AGR OUTL 20
   Pittock J, 2015, AQUAT PR, V5, P58, DOI 10.1016/j.aqpro.2015.10.008
   Pupphachai U, 2017, ECOL INDIC, V72, P784, DOI 10.1016/j.ecolind.2016.09.016
   Rasul G, 2014, ENVIRON SCI POLICY, V39, P35, DOI 10.1016/j.envsci.2014.01.010
   Ren DD, 2018, SCI TOTAL ENVIRON, V626, P11, DOI 10.1016/j.scitotenv.2018.01.071
   Saladini F, 2018, ECOL INDIC, V91, P689, DOI 10.1016/j.ecolind.2018.04.035
   SEI (Stockholm environment institute), 2011, BONN 2011 NEX C STOC, P1
   Shao JP, 2006, AQUACULTURE, V252, P289, DOI 10.1016/j.aquaculture.2005.06.050
   Sherwood J, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa83f0
   Shi GM, 2010, ENERG POLICY, V38, P6172, DOI 10.1016/j.enpol.2010.06.003
   Silalertruksa T, 2018, J CLEAN PROD, V182, P521, DOI 10.1016/j.jclepro.2018.02.085
   Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010
   Tidwell V, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094008
   Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111
   UN, 2016, CLIM CHANG RES OPP R
   United Nations, 2015, INTR PROP GOALS TARG
   United Nations, 2014, WORLD URB PROSP 2014
   US EPA, 2017, CLIM CHANG IMP CLIM
   Vanham D, 2017, ECOL INDIC, V74, P119, DOI 10.1016/j.ecolind.2016.11.019
   Venkatesh G, 2014, ENERGY, V75, P153, DOI 10.1016/j.energy.2014.06.111
   Villarroel Walker R, 2012, FRONT ENV SCI ENG, V6, P596, DOI 10.1007/s11783-012-0445-4
   Walker RV, 2014, J ENVIRON MANAGE, V141, P104, DOI 10.1016/j.jenvman.2014.01.054
   Wang SG, 2017, APPL ENERG, V196, P208, DOI 10.1016/j.apenergy.2017.02.011
   Wang SG, 2016, APPL ENERG, V178, P773, DOI 10.1016/j.apenergy.2016.06.112
   [邬建国 Wu Jianguo], 2014, [地球科学进展, Advance in Earth Sciences], V29, P1315
   Xiao LQ, 2015, PLOS ONE, V10, P1
   Yang XC, 2018, APPL ENERG, V228, P2298, DOI 10.1016/j.apenergy.2018.07.090
   Zhang HJ, 2013, APPL MECH MATER, V409-410, P143, DOI 10.4028/www.scientific.net/AMM.409-410.143
   Zhang PP, 2019, RESOUR CONSERV RECY, V142, P215, DOI 10.1016/j.resconrec.2018.11.018
   Zhao JZ, 1999, ACTA ECOLOGICA SINIC, V19, P393
   Zhao R., 2018, LAND USE POLICY, V72, P2017
   Zhao RQ, 2018, LAND USE POLICY, V72, P480, DOI 10.1016/j.landusepol.2017.12.029
   Zhao X, 2017, ECOL MODEL, V348, P25, DOI 10.1016/j.ecolmodel.2017.01.006
NR 89
TC 1
Z9 1
U1 58
U2 58
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104481
DI 10.1016/j.resconrec.2019.104481
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700026
DA 2020-05-12
ER

PT J
AU Civancik-Uslu, D
   Puig, R
   Voigt, S
   Walter, D
   Fullana-i-Palmer, P
AF Civancik-Uslu, Didem
   Puig, Rita
   Voigt, Stephan
   Walter, Dieter
   Fullana-i-Palmer, Pere
TI Improving the production chain with LCA and eco-design: application to
   cosmetic packaging
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Mineral fillers; Post-consumer-recycled plastic; Cosmetic tubes;
   Packaging; End of life allocation (EoL)
ID LIFE-CYCLE ASSESSMENT; CIRCULAR ECONOMY; INDUSTRIAL-WASTE; SYSTEMS;
   MANAGEMENT; EFFICIENCY; MODELS; IMPACT
AB One of the main drivers for companies to perform environmental improvements is economic benefit, either by obtaining a more valuable product or gaining new customers. Circular economy combines environmental improvements with these drivers to achieve higher and quicker benefits. This paper is a case study on packaging eco-design aligned with circular economy strategy along the production chain. Life cycle assessment (LCA) was used to identify the product life cycle stages where the application of eco-design strategies would be more efficient (in this case, raw materials production from virgin petrochemicals). To improve the environmental profile of this packaging, virgin petrochemicals were partially replaced by mineral fillers (calcium carbonate based) or/and post-consumer recycled plastics. Different technically compliant cosmetic tubes were produced by collaboration between a company producing the plastic granulates with mineral fillers and a company producing the cosmetic tubes and cradle-to-gate LCA were performed. The replacement of virgin petrochemicals by mineral fillers helped to reduce the environmental impacts by an average of 12% and the use of post-consumer recycled plastic further decreased emissions up to 29% for 6 out of the 9 evaluated impact categories. The option with better environmental performance was also the one with lower economic costs.
   According to the involved companies, LCA combined with ecodesign helped to achieve efficient environmental and economic savings. The findings are important for the plastic packaging sector because they tackle with prime concerns, like plastic debris, climate change and resource depletion. They are of main interest for industrial activities where brand positioning is a priority (ie. cosmetics).
C1 [Civancik-Uslu, Didem; Puig, Rita; Fullana-i-Palmer, Pere] UNESCO Chair Life Cycle & Climate Change ESCI UPF, Pg Pujades 1, Barcelona 08003, Spain.
   [Puig, Rita] Univ Lleida, Dept Comp Sci & Ind Engn, Pla Massa 8, Igualada 08700, Spain.
   [Voigt, Stephan] GCR Grp, Carrer Boters S-N, Tarragona 43717, Spain.
   [Walter, Dieter] Linhardt & Co GmbH, Weiherer Str 41, D-76707 Hambrucken, Germany.
RP Fullana-i-Palmer, P (reprint author), UNESCO Chair Life Cycle & Climate Change ESCI UPF, Pg Pujades 1, Barcelona 08003, Spain.
EM didem.civancik@esci.upf.edu; rita.puig@udl.cat;
   stephan.voigt@gcrgroup.es; dieter.walter@linhardt.com;
   pere.fullana@esci.upf.edu
RI Fullana-i-Palmer, Pere/J-6174-2013
OI Fullana-i-Palmer, Pere/0000-0003-0013-5098; Civancik-Uslu,
   Didem/0000-0003-4798-6658
FU plastic granulates company GCR Group, Spain; subdivision Granic
FX This study is part of the PhD thesis of one of the authors (Civancik)
   and she wishes to thank the plastic granulates company GCR Group, Spain
   and its subdivision Granic for their financial support and the tube
   manufacturer Linhardt for providing field data.
CR Albrecht S, 2013, INT J LIFE CYCLE ASS, V18, P1549, DOI 10.1007/s11367-013-0590-4
   Allacker K, 2017, INT J LIFE CYCLE ASS, V22, P1441, DOI 10.1007/s11367-016-1244-0
   [Anonymous], 2006, 14040 ISO
   [Anonymous], 2006, 14044 ISO
   Babbitt CW, 2018, RESOUR CONSERV RECY, V135, P1, DOI 10.1016/j.resconrec.2018.04.012
   Balaguera A, 2019, SCI TOTAL ENVIRON, V651, P1272, DOI 10.1016/j.scitotenv.2018.09.306
   Baumann H., 2004, HITCH HIKERS GUIDE L
   Borghi V., 2004, 34 CED ANN M
   Borghi V., 2003, SETAC EUR 13 ANN M
   Brezet H, 1997, ECODESIGN PROMISING
   Chkanikova O, 2018, INT J LIFE CYCLE ASS, V23, P1383, DOI 10.1007/s11367-015-0865-z
   Civancik-Uslu D, 2019, SCI TOTAL ENVIRON, V685, P621, DOI 10.1016/j.scitotenv.2019.05.372
   Civancik-Uslu D, 2019, J CLEAN PROD, V212, P925, DOI 10.1016/j.jclepro.2018.12.076
   Civancik-Uslu D, 2018, SCI TOTAL ENVIRON, V626, P927, DOI 10.1016/j.scitotenv.2018.01.149
   Cleary J, 2013, J CLEAN PROD, V44, P143, DOI 10.1016/j.jclepro.2013.01.009
   Crippa M., 2019, CIRCULAR EC PLASTICS
   da Luz LM, 2018, J CLEAN PROD, V193, P28, DOI 10.1016/j.jclepro.2018.05.022
   de Koeijer B, 2017, PACKAG TECHNOL SCI, V30, P443, DOI 10.1002/pts.2219
   ETH Sustainability Summer School, 2011, FOOD PACKAGING
   Flanigan L., 2013, ANAL LIFE CYCLE ASSE
   Palmer PFI, 2011, J IND ECOL, V15, P458, DOI 10.1111/j.1530-9290.2011.00338.x
   Fullana P., 1997, ANALISIS CICLO VIDA
   Future Market Insight, 2017, PLAST TUB MARK GLOB
   Gaustad G, 2018, RESOUR CONSERV RECY, V135, P24, DOI 10.1016/j.resconrec.2017.08.002
   Geissdoerfer M, 2018, J CLEAN PROD, V190, P712, DOI 10.1016/j.jclepro.2018.04.159
   Glew D, 2014, J CLEAN PROD, V68, P73, DOI 10.1016/j.jclepro.2013.12.085
   Golsteijn L, 2018, INTEGR ENVIRON ASSES, V14, P649, DOI 10.1002/ieam.4064
   Gonzalez-Garcia S, 2016, ENV FOOTPRINTS ECODE, P23, DOI 10.1007/978-981-287-913-4_2
   Group G.C.R., 2018, SUST PLAST SOL
   Herbes C, 2018, J CLEAN PROD, V194, P203, DOI 10.1016/j.jclepro.2018.05.106
   Humbert S, 2009, INT J LIFE CYCLE ASS, V14, P95, DOI 10.1007/s11367-008-0052-6
   Laso J, 2018, RESOUR CONSERV RECY, V133, P428, DOI 10.1016/j.resconrec.2018.02.004
   Lewis H, 2010, PACKAG TECHNOL SCI, V23, P145, DOI 10.1002/pts.886
   Linhardt, 2019, HOM LINH PACK LIF
   Martinez S, 2017, J CLEAN PROD, V145, P348, DOI 10.1016/j.jclepro.2017.01.042
   Molander S, 2004, INT J LIFE CYCLE ASS, V9, P282, DOI 10.1007/BF02979417
   Munoz I, 2009, INT J LIFE CYCLE ASS, V14, P64, DOI 10.1007/s11367-008-0044-6
   Navajas A, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101724
   Navarro A, 2018, ENVIRON MANAGE, V62, P277, DOI 10.1007/s00267-018-1021-x
   Nicholson AL, 2009, IEEE I SYMP SUST SYS, P93
   Raugei M, 2009, PACKAG TECHNOL SCI, V22, P443, DOI 10.1002/pts.865
   Rieckhof R, 2015, J CLEAN PROD, V108, P1262, DOI 10.1016/j.jclepro.2014.10.040
   Roy P, 2009, J FOOD ENG, V90, P1, DOI 10.1016/j.jfoodeng.2008.06.016
   Sandin G, 2014, INT J LIFE CYCLE ASS, V19, P723, DOI 10.1007/s11367-013-0686-x
   Secchi M, 2016, J CLEAN PROD, V129, P269, DOI 10.1016/j.jclepro.2016.04.073
   Simon B, 2019, RESOUR CONSERV RECY, V141, P299, DOI 10.1016/j.resconrec.2018.10.044
   Thinkstep, 2017, PROF EXT DAT SP33
   Valles M., 2001, 1 ANN M SETAC EUR, P6
   Varun, 2016, ENV FOOTPRINTS ECODE, P115, DOI 10.1007/978-981-287-913-4_5
   Xanthos M., 2010, FUNCTIONAL FILLERS P
NR 50
TC 0
Z9 0
U1 27
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104475
DI 10.1016/j.resconrec.2019.104475
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700012
DA 2020-05-12
ER

PT J
AU Corona, B
   Shen, L
   Reike, D
   Carreon, JR
   Worrell, E
AF Corona, Blanca
   Shen, Li
   Reike, Denise
   Carreon, Jesus Rosales
   Worrell, Ernst
TI Towards sustainable development through the circular economy-A review
   and critical assessment on current circularity metrics
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Sustainability; Circularity metrics; Life Cycle Assessment; LCA;
   Validity; Products; MFA; Recycling
ID LIFE-CYCLE ASSESSMENT; INDUSTRIAL SYMBIOSIS; SOLID-WASTE; RESOURCE
   EFFICIENCY; ECO-EFFICIENCY; LCA; INDICATORS; MANAGEMENT; LOOP;
   TRANSITION
AB The circular economy (CE) is perceived as a sustainable economic system where the economic growth is decoupled from the resources use, through the reduction and recirculation of natural resources. In the shift towards the CE, quantifying the circularity of products and services (or their contribution to the CE) is crucial in designing policies and business strategies, and prioritizing sustainable solutions based on evidence. New circularity metrics are being developed for that purpose, but they often present contradiction in both form and content, which contributes to confusion and misunderstanding of the CE concept. This review aims to map methodological developments regarding circularity metrics for products and services, in order to: (1) identify the foundations of circularity metrics used so far and their applications, (2) evaluate the validity of current circularity metrics, based on predefined requirements and a CE definition anchored in the sustainability concept, and (3) provide recommendations on how to measure circularity. The literature search provided a wide variety of CE metrics being developed and applied (seven measurement indices, nine assessment indicators and three assessment frameworks). However, none of them are addressing the CE concept in full, potentially leading to undesirable burden shifting from reduced material consumption to increased environmental, economic or social impacts. Additionally, new metrics under-represent the complexities of multiple cycles and the consequences of material downcycling. Circularity metrics intended to sustainable decision making should be comprehensive enough to avoid burden shifting, and clearly indicate how the benefits of recycling are allocated between the primary and secondary products.
C1 [Corona, Blanca; Shen, Li; Reike, Denise; Carreon, Jesus Rosales; Worrell, Ernst] Univ Utrecht, Copernicus Inst Sustainable Dev, Vening Meinesz Bldg A,Princetonlaan 8a, NL-3584 CB Utrecht, Netherlands.
RP Corona, B (reprint author), Univ Utrecht, Copernicus Inst Sustainable Dev, Vening Meinesz Bldg A,Princetonlaan 8a, NL-3584 CB Utrecht, Netherlands.
EM b.c.coronabellostas@uu.nl
RI Shen, Li/N-3127-2013; Worrell, Ernst/L-5455-2013
OI Shen, Li/0000-0001-9378-7372; Worrell, Ernst/0000-0002-0199-9755
CR Adibi N, 2017, J CLEAN PROD, V165, P1517, DOI 10.1016/j.jclepro.2017.07.226
   Akerman E., 2016, DEV CIRCULAR EC CORE
   Allacker K, 2014, RESOUR CONSERV RECY, V88, P1, DOI 10.1016/j.resconrec.2014.03.016
   Allacker K, 2017, INT J LIFE CYCLE ASS, V22, P1441, DOI 10.1007/s11367-016-1244-0
   [Anonymous], 2006, 14040 ISO
   [Anonymous], 2018, COM201828
   [Anonymous], 2006, 14044 ISO
   Azevedo SG, 2017, RESOURCES-BASEL, V6, DOI 10.3390/resources6040063
   Banaite D., 2016, SOC TRANSFORM CONT S, P142
   Bannigan K, 2009, J CLIN NURS, V18, P3237, DOI 10.1111/j.1365-2702.2009.02939.x
   Broadbent C, 2016, INT J LIFE CYCLE ASS, V21, P1658, DOI 10.1007/s11367-016-1081-1
   Brunner P.H., 2016, HDB MAT FLOW ANAL EN
   Busch J, 2017, J CLEAN PROD, V149, P751, DOI 10.1016/j.jclepro.2017.02.166
   Castellani V, 2015, INTEGR ENVIRON ASSES, V11, P373, DOI 10.1002/ieam.1614
   Cayzer S, 2017, INT J SUSTAIN ENG, V10, P289, DOI 10.1080/19397038.2017.1333543
   Chan A. P. C., 2001, CONSTR MANAGE EC, V19, P699, DOI [10.1080/01446190110066128, DOI 10.1080/01446190110066128]
   Cobo S, 2018, ACS SUSTAIN CHEM ENG, V6, P3493, DOI 10.1021/acssuschemeng.7b03767
   Cooper DR, 2017, J IND ECOL, V21, P38, DOI 10.1111/jiec.12388
   Cooper SJG, 2017, J CLEAN PROD, V162, P1356, DOI 10.1016/j.jclepro.2017.06.169
   Corona B, 2016, SOL ENERG MAT SOL C, V156, P112, DOI 10.1016/j.solmat.2016.03.014
   Cristobal J, 2018, WASTE MANAGE, V72, P3, DOI 10.1016/j.wasman.2017.11.007
   Cullen J.M., 2017, CIRCULAR EC THEORETI
   Daddi T, 2017, J CLEAN PROD, V147, P157, DOI 10.1016/j.jclepro.2017.01.090
   de Almeida ST, 2017, J CLEAN PROD, V168, P876, DOI 10.1016/j.jclepro.2017.09.034
   De Wit M., 2018, CIRCULARITY GAP REPO
   Delgado-Aguilar M, 2015, ENVIRON SCI TECHNOL, V49, P12206, DOI 10.1021/acs.est.5b02676
   Deschamps J, 2018, J CLEAN PROD, V185, P14, DOI 10.1016/j.jclepro.2018.03.021
   Di Maio F., 2015, J ENV PROT, V06, P1095, DOI DOI 10.4236/JEP.2015.610096
   Di Maio F, 2017, RESOUR CONSERV RECY, V122, P163, DOI 10.1016/j.resconrec.2017.02.009
   Dominguez S, 2018, SCI TOTAL ENVIRON, V621, P1047, DOI 10.1016/j.scitotenv.2017.10.122
   EC-JRC, 2011, ILCD HDB REC LIF CYC
   EEA, 2016, CIRC EC EUR DEV KNOW
   Elia V, 2017, J CLEAN PROD, V142, P2741, DOI 10.1016/j.jclepro.2016.10.196
   EMF, 2016, CIRC IND PROJ INTR
   EMF (Ellen MacArthur Foundation), 2015, CIRC IND APPR MEAS C
   European Academies' Science Advisory Council (EASAC), 2016, IND CIRC EC
   European Commission, 2013, OFF J EUR UNION, V56, P1
   European Commission, 2018, COM201829
   European Commission, 2015, COM20156142
   Fang K, 2017, ECOL MODEL, V365, P30, DOI 10.1016/j.ecolmodel.2017.09.024
   Fogarassy C, 2017, ACTA POLYTECH HUNG, V14, P161
   Franklin-Johnson E, 2016, J CLEAN PROD, V133, P589, DOI 10.1016/j.jclepro.2016.05.023
   Geng Y, 2014, ENVIRON SCI POLLUT R, V21, P13572, DOI 10.1007/s11356-014-3287-8
   Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005
   Genovese A, 2017, OMEGA-INT J MANAGE S, V66, P344, DOI 10.1016/j.omega.2015.05.015
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Giljum S, 2011, RESOUR CONSERV RECY, V55, P300, DOI 10.1016/j.resconrec.2010.09.009
   Goedkoop M., 2008, SIMAPRO DATABASE MAN, P22
   Goedkoop M, 2009, REPORT 1 CHARACTERIS, V2008, P1, DOI DOI 10.029/2003JD004283
   Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x
   Haas W, 2015, J IND ECOL, V19, P765, DOI 10.1111/jiec.12244
   Hatfield-Dodds S, 2017, J CLEAN PROD, V144, P403, DOI 10.1016/j.jclepro.2016.12.170
   Haupt M, 2017, J IND ECOL, V21, P615, DOI 10.1111/jiec.12506
   Hu XH, 2009, INT CONF SPEECH DATA, P56, DOI 10.1109/ICSDA.2009.5278375
   Hunkeler D., 2008, ENV LIFE CYCLE COSTI
   Huysman S, 2017, RESOUR CONSERV RECY, V120, P46, DOI 10.1016/j.resconrec.2017.01.013
   Iacovidou E, 2017, J CLEAN PROD, V168, P1279, DOI 10.1016/j.jclepro.2017.09.002
   Iacovidou E, 2017, J CLEAN PROD, V166, P910, DOI 10.1016/j.jclepro.2017.07.100
   Ilic DD, 2018, J CLEAN PROD, V182, P352, DOI 10.1016/j.jclepro.2018.02.031
   Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Korhonen J, 2018, ECOL ECON, V143, P37, DOI 10.1016/j.ecolecon.2017.06.041
   Laso J, 2018, RESOUR CONSERV RECY, V133, P428, DOI 10.1016/j.resconrec.2018.02.004
   Laurent A, 2014, WASTE MANAGE, V34, P573, DOI 10.1016/j.wasman.2013.10.045
   Lausselet C, 2017, RESOUR CONSERV RECY, V126, P50, DOI 10.1016/j.resconrec.2017.07.025
   Leiden University, 2015, CML IA CHAR FACT 201
   LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294
   Lieder M, 2017, INT J ADV MANUF TECH, V93, P1953, DOI 10.1007/s00170-017-0610-9
   Linder M, 2017, J IND ECOL, V21, P545, DOI 10.1111/jiec.12552
   Lonca G, 2018, J CLEAN PROD, V183, P424, DOI 10.1016/j.jclepro.2018.02.108
   Millward-Hopkins J, 2018, SCI TOTAL ENVIRON, V612, P613, DOI 10.1016/j.scitotenv.2017.08.211
   Moraga G, 2019, RESOUR CONSERV RECY, V146, P452, DOI 10.1016/j.resconrec.2019.03.045
   Nakamura S, 2017, ENVIRON SCI TECHNOL, V51, P9469, DOI 10.1021/acs.est.7b01683
   Nasir MHA, 2017, INT J PROD ECON, V183, P443, DOI 10.1016/j.ijpe.2016.06.008
   Niero M, 2017, J IND ECOL, V21, P742, DOI 10.1111/jiec.12554
   Niero M, 2016, RESOUR CONSERV RECY, V114, P18, DOI 10.1016/j.resconrec.2016.06.023
   Noya I, 2017, SCI TOTAL ENVIRON, V589, P122, DOI 10.1016/j.scitotenv.2017.02.186
   Oldfield TL, 2018, J CLEAN PROD, V170, P1554, DOI 10.1016/j.jclepro.2017.09.239
   Park JY, 2014, J ENVIRON MANAGE, V137, P45, DOI 10.1016/j.jenvman.2013.11.053
   Pauliuk S, 2018, RESOUR CONSERV RECY, V129, P81, DOI 10.1016/j.resconrec.2017.10.019
   Pauliuk S, 2017, RESOUR CONSERV RECY, V116, P84, DOI 10.1016/j.resconrec.2016.09.029
   Potting J., 2018, FRAMEWORK BASELINE A
   Reichel A., 2016, CIRCULAR EC EUROPE D
   Rigamonti L, 2017, INT J LIFE CYCLE ASS, V22, P1278, DOI 10.1007/s11367-016-1231-5
   Saidani M, 2017, RECYCLING, V2, P6, DOI [10.3390/recycling2010006, DOI 10.3390/RECYCLING2010006]
   SAIDANI M, 2018, J CLEAN PROD, V207, P542, DOI DOI 10.1016/J.JCLEPR0.2018.10.014
   Scheepens AE, 2016, J CLEAN PROD, V114, P257, DOI 10.1016/j.jclepro.2015.05.075
   Schrijvers DL, 2016, INT J LIFE CYCLE ASS, V21, P994, DOI 10.1007/s11367-016-1069-x
   Tisserant A, 2017, J IND ECOL, V21, P628, DOI 10.1111/jiec.12562
   Tomic T, 2017, J ENVIRON MANAGE, V203, P973, DOI 10.1016/j.jenvman.2017.06.070
   UNEP-SETAC Life Cycle Initiative, 2009, GUID SOC LIF CYCL AS, P978
   Veleva V, 2017, J CLEAN PROD, V154, P517, DOI 10.1016/j.jclepro.2017.03.177
   Villanueva A, 2007, WASTE MANAGE, V27, pS29, DOI 10.1016/j.wasman.2007.02.019
   WALKER S, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10030666
   Wang P, 2018, J CLEAN PROD, V174, P1492, DOI 10.1016/j.jclepro.2017.11.032
   Wen ZG, 2015, J CLEAN PROD, V90, P211, DOI 10.1016/j.jclepro.2014.03.041
   Wen ZG, 2010, J IND ECOL, V14, P641, DOI 10.1111/j.1530-9290.2010.00263.x
   Wolf M-A, 2010, ILCD HDB GEN GUID LI
   Zamagni A, 2013, INT J LIFE CYCLE ASS, V18, P1637, DOI 10.1007/s11367-013-0648-3
   Zampori L., 2019, JRC TECHNICAL REPORT
   Zhou P, 2006, ECOL ECON, V59, P305, DOI 10.1016/j.ecolecon.2005.10.018
NR 101
TC 3
Z9 3
U1 37
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104498
DI 10.1016/j.resconrec.2019.104498
PG 15
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700031
OA Other Gold
DA 2020-05-12
ER

PT J
AU Dilkes-Hoffman, L
   Ashworth, P
   Laycock, B
   Pratt, S
   Lant, P
AF Dilkes-Hoffman, Leela
   Ashworth, Peta
   Laycock, Bronwyn
   Pratt, Steven
   Lant, Paul
TI Public attitudes towards bioplastics - knowledge, perception and
   end-of-life management
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Biobased plastic; Biodegradable plastic; Biodegradable packaging;
   Survey; Consumer attitude; Environmental issues
ID WILLINGNESS-TO-PAY; CONSUMER; SUSTAINABILITY; CHOICES
AB The aim of this research was to understand current knowledge and perceptions regarding bioplastics. Results were gathered through an online survey of 2518 nationally representative Australians. The results indicate that the Australian public's knowledge of bioplastics is low, but perception, particularly of biodegradable plastics, is positive. Biodegradable plastics were perceived as better for the environment than 'normal plastics' and even 'easily recyclable' plastics. The majority of respondents (58%) said they were unsure whether biodegradable plastics can have negative environmental impacts. Sixty-eight percent of people say they would like to see more of the plastic items they use be biodegradable. If this becomes the case, there will be an increased stream of bioplastics entering the recycling system with 62% of people saying they would dispose of bioplastic items in the recycling bin. In light of the results presented in this work, potential issues relating to the introduction of bioplastics are raised and the role that governments and local councils can play in driving the development of the standards, labelling and waste management options that will need to be introduced alongside the introduction of wider bioplastic materials use are discussed.
C1 [Dilkes-Hoffman, Leela; Ashworth, Peta; Laycock, Bronwyn; Pratt, Steven; Lant, Paul] Univ Queensland, Fac Engn Architecture & Informat Technol, Sch Chem Engn, St Lucia, Qld 4072, Australia.
RP Dilkes-Hoffman, L (reprint author), Univ Queensland, Fac Engn Architecture & Informat Technol, Sch Chem Engn, St Lucia, Qld 4072, Australia.
EM l.dilkeshoffman@uq.net.au
FU Australian GovernmentAustralian Government; Westpac Bicentennial
   Foundation; Australian Research CouncilAustralian Research Council
   [DP15010306]
FX LSDH thanks the Australian Government for the Research Training Program
   Scholarship stipend and tuition fee off set and the Westpac Bicentennial
   Foundation for the Future Leaders Scholarship held during this study.
   The authors would also like to extend thanks to Assoc./Prof. Maureen
   Hassall for initial discussions that helped to frame the work,
   Assoc./Prof. Kelly Fielding for reviewing the survey, and Michele
   Ferguson for advice on statistical analysis of the results. This
   research was supported by the Australian Research Council Discovery
   grant scheme (DP15010306).
CR Australian Bureau of Statistics, 2018, AUSTR DEM STAT
   Australian Bureau of Statistics, 2016, 2016 CENS QUICK STAT
   Barbarossa C, 2015, J ENVIRON PSYCHOL, V42, P149, DOI 10.1016/j.jenvp.2015.04.001
   Boesen S, 2019, J CLEAN PROD, V210, P1193, DOI 10.1016/j.jclepro.2018.11.055
   Cornell DD, 2007, J POLYM ENVIRON, V15, P295, DOI 10.1007/s10924-007-0077-0
   de Andrade MFC, 2016, J POLYM ENVIRON, V24, P372, DOI 10.1007/s10924-016-0787-2
   Dilkes-Hoffman LS, 2019, PDL HANDB SER, P469, DOI 10.1016/B978-0-12-813140-4.00019-4
   Dilkes-Hoffman LS, 2018, J CLEAN PROD, V180, P325, DOI 10.1016/j.jclepro.2018.01.169
   Dilkes-Hoffman LS, 2019, MAR POLLUT BULL, V142, P15, DOI 10.1016/j.marpolbul.2019.03.020
   Dilkes-Hoffman LS, 2019, RESOUR CONSERV RECY, V147, P227, DOI 10.1016/j.resconrec.2019.05.005
   European Bioplastics, 2018, BIOPL MARK DAT 2018
   Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782
   Gorrasi G, 2018, ADV POLYM SCI, V279, P119, DOI 10.1007/12_2016_12
   Haider TP, 2019, ANGEW CHEM INT EDIT, V58, P50, DOI 10.1002/anie.201805766
   Hao Y, 2019, RESOUR CONSERV RECY, V141, P21, DOI 10.1016/j.resconrec.2018.10.001
   Harrison JP, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171792
   Herbes C, 2018, J CLEAN PROD, V194, P203, DOI 10.1016/j.jclepro.2018.05.106
   Hoornweg D., 2012, WHAT WASTE GLOBAL RE
   Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352
   Kale G, 2007, PACKAG TECHNOL SCI, V20, P49, DOI 10.1002/pts.742
   Martinho G, 2015, RESOUR CONSERV RECY, V103, P58, DOI 10.1016/j.resconrec.2015.07.012
   Meeks D, 2015, RESOUR CONSERV RECY, V105, P134, DOI 10.1016/j.resconrec.2015.10.022
   Niaounakis M, 2013, PDL HANDB SER, P151, DOI 10.1016/B978-1-4557-3145-9.00005-1
   Orset C, 2017, WASTE MANAGE, V61, P13, DOI 10.1016/j.wasman.2016.12.034
   Piemonte V, 2011, J POLYM ENVIRON, V19, P988, DOI 10.1007/s10924-011-0343-z
   PlasticsEurope: Brussels Belgium, 2016, PLAST THE FACTS 2016
   Rokka J, 2008, INT J CONSUM STUD, V32, P516, DOI 10.1111/j.1470-6431.2008.00710.x
   Scott L, 2014, INT J CONSUM STUD, V38, P642, DOI 10.1111/ijcs.12136
   Shen L., 2009, PRODUCT OVERVIEW MAR
   Sijtsema SJ, 2016, NJAS-WAGEN J LIFE SC, V77, P61, DOI 10.1016/j.njas.2016.03.007
   Singh G, 2018, AUSTRALAS MARK J, V26, P221, DOI 10.1016/j.ausmj.2018.06.001
   Steenis ND, 2017, J CLEAN PROD, V162, P286, DOI 10.1016/j.jclepro.2017.06.036
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   VanDam YK, 1996, ENVIRON MANAGE, V20, P607, DOI 10.1007/BF01204134
   World Economic Forum; Ellen MacArthur Foundation; McKinsey & Company, 2016, NEW PLAST EC RETH FU, DOI [10.1088/0953-8984/19/21/213202, DOI 10.1088/0953-8984/19/21/213202]
   WRAP, 2007, CONS ATT BIOP
NR 36
TC 2
Z9 2
U1 30
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104479
DI 10.1016/j.resconrec.2019.104479
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700019
DA 2020-05-12
ER

PT J
AU Fan, YC
   Xia, M
   Zhang, YG
   Chen, YT
AF Fan, Yancheng
   Xia, Min
   Zhang, Yaguang
   Chen, Yantai
TI The influence of social embeddedness on organizational legitimacy and
   the sustainability of the globalization of the sharing economic
   platform: Evidence from Uber China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Globalization; Organizational legitimacy; Sharing economy platform;
   Social embeddedness; Sustainability
ID VENTURE INTERNATIONALIZATION; COLLABORATIVE CONSUMPTION; INSTITUTIONAL
   DISTANCE; NETWORKS; INTEGRATION; TRANSITION; STRATEGIES; EVOLUTION;
   SURVIVAL; IMPACTS
AB Sharing vehicles and the transportation sharing economy (SE) more generally can help to provide a solution to the sustainable development challenges that arise in societies with a high population density, such as China. The transportation SE alleviates ecological problems as it makes use of idle vehicles and reduces the consumption of consumer resources. The globalization of the SE platform helps to illustrate how the ecosystem can obtain organizational legitimacy and be maintained through social embeddedness. Our case study focuses on a multinational vehicle sharing company on an economic platform, Uber China. The data for this study were obtained from second-hand sources as well as semi-structured interviews with the stakeholders engaged in Uber China's ecosystem. Our findings demonstrate that Uber China's social embeddedness process exerts an impact on its sustainable development in China. Uber China's ecosystem was organized on the basis of its dual home-country advantage and international image, which helped to maintain a balance between different social ties during the early stages of its development. However, its failed attempt to achieve local embeddedness hampered the success of its sustainable business model during the development period. This study reveals the importance of social embeddedness (cognitive, cultural, historical, and structural) to the acquisition of organizational legitimacy and the sustainability of a platform's globalization.
C1 [Fan, Yancheng; Chen, Yantai] Zhejiang Univ Technol, Sch Management, Hangzhou, Zhejiang, Peoples R China.
   [Xia, Min] Zhejiang Univ Technol, Sch Polit & Publ Adm, Hangzhou, Zhejiang, Peoples R China.
   [Zhang, Yaguang] Peking Univ, Sch Econ, Beijing, Peoples R China.
RP Chen, YT (reprint author), Zhejiang Univ Technol, Sch Management, Hangzhou, Zhejiang, Peoples R China.
EM chenyt@zjut.edu.cn
OI fan, yan cheng/0000-0003-4036-8603
FU Major Research Projects in Philosophy and Social Sciences from the
   Ministry of Education in China [17JZD018]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [71772165]; National High-Level Talents Special Support Plan for Youth
   Talent [W03070173]
FX This work was supported by Major Research Projects in Philosophy and
   Social Sciences from the Ministry of Education in China (17JZD018);
   National Natural Science Foundation of China (71772165); National
   High-Level Talents Special Support Plan for Youth Talent (W03070173),
   for providing funding for this research; and the Cultivation Fund of
   Zhejiang University of Technology for an Excellent Doctoral
   Dissertation. We sincerely acknowledge the anonymous reviewers and
   editor's constructive suggestions, which helped us to enhance this
   paper. Gratitude is also extended to all of the individuals who
   participated in the interviews conducted for this research, as well as
   colleagues from Zhejiang Provincial New Key Professional Think Tank
   -China Institute for SMEs, Zhejiang University of Technology -for the
   valuable discussions.
CR Ahuja G, 2000, ADMIN SCI QUART, V45, P425, DOI 10.2307/2667105
   Akbar YH, 2018, INT J HOSP MANAG, V71, P91, DOI 10.1016/j.ijhm.2017.12.004
   Al-Laham A, 2008, J BUS VENTURING, V23, P567, DOI 10.1016/j.jbusvent.2007.09.001
   Aldrich H. E., 2006, ORG EVOLVING
   Andersen KV, 2013, RES POLICY, V42, P139, DOI 10.1016/j.respol.2012.05.005
   ARROW KJ, 1994, AM ECON REV, V84, P1
   Ashton WS, 2012, J IND ECOL, V16, P70, DOI 10.1111/j.1530-9290.2011.00453.x
   Banerjee S, 2018, MANAGE INT REV, V58, P813, DOI 10.1007/s11575-017-0324-0
   Bangara A, 2012, J WORLD BUS, V47, P623, DOI 10.1016/j.jwb.2011.09.002
   Basole RC, 2011, BUS INFORM SYST ENG+, V3, P313, DOI [10.1007/s12599-011-0174-4, 10.1007/s11576-011-0286-y]
   Belk R, 2014, J BUS RES, V67, P1595, DOI 10.1016/j.jbusres.2013.10.001
   Bocker L, 2017, ENVIRON INNOV SOC TR, V23, P28, DOI 10.1016/j.eist,2016.09,004
   Boons F, 2009, SOCIAL EMBEDDEDNESS OF INDUSTRIAL ECOLOGY, P1
   Boons F, 2012, J IND ECOL, V16, P61, DOI 10.1111/j.1530-9290.2011.00432.x
   Burt R.S., 2009, STRUCTURAL HOLES SOC
   Chandler J. D., 2010, J BUSINESS MARKET MA, V4, P199, DOI DOI 10.1007/S12087-010-0041-5
   Chen L, 2019, J INT BUS STUD, V50, P172, DOI 10.1057/s41267-018-0176-2
   Chen YT, 2013, INT J TECHNOL MANAGE, V63, P185, DOI 10.1504/IJTM.2013.056898
   Chertow MR, 2009, SOCIAL EMBEDDEDNESS OF INDUSTRIAL ECOLOGY, P128
   Conroy KM, 2016, J WORLD BUS, V51, P612, DOI 10.1016/j.jwb.2016.03.002
   Creswell JW, 2017, DESIGNING CONDUCTING
   Crilly D, 2012, ACAD MANAGE J, V55, P1429, DOI 10.5465/amj.2010.0697
   Cruz-Suarez A, 2014, RAE-REV ADMIN EMPRES, V54, P575, DOI 10.1590/S0034-759020140510
   Desai VM, 2018, ACAD MANAGE J, V61, P220, DOI 10.5465/amj.2016.0315
   Efthymiou D, 2013, TRANSPORT POLICY, V29, P64, DOI 10.1016/j.tranpol.2013.04.009
   Ehrenfeld J.R., 1997, J IND ECOL, V1, P67, DOI DOI 10.1162/JIEC.1997.1.1.67
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Fraccascia L, 2018, RESOUR CONSERV RECY, V136, P473, DOI 10.1016/j.resconrec.2018.03.009
   Gansky L., 2010, MESH WHY FUTURE BUSI
   Gaur A, 2019, J INT BUS STUD, V50, P1
   Gaur AS, 2007, J MANAGE, V33, P84, DOI 10.1177/0149206306295203
   Gawer A, 2014, RES POLICY, V43, P1239, DOI 10.1016/j.respol.2014.03.006
   George A.L., 2005, CASE STUDIES THEORY
   Gnyawali DR, 2001, ACAD MANAGE REV, V26, P431, DOI 10.2307/259186
   GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311
   Granovetter M.S., 1977, SOC NETWORKS, P347, DOI DOI 10.1016/B978-0-12-442450-0.50025-0
   Hamari J, 2016, J ASSOC INF SCI TECH, V67, P2047, DOI 10.1002/asi.23552
   Hanke T, 2009, J BUS ETHICS, V85, P507, DOI 10.1007/s10551-009-0215-9
   Hewes AK, 2008, REG STUD, V42, P1329, DOI 10.1080/00343400701654079
   Hitt MA, 2004, ORGAN SCI, V15, P173, DOI 10.1287/orsc.1030.0045
   Hu JY, 2019, RESOUR CONSERV RECY, V149, P177, DOI 10.1016/j.resconrec.2019.05.042
   Iansiti M, 2004, HARVARD BUS REV, V82, P68
   Kiss AN, 2010, J INT ENTREP, V8, P273, DOI 10.1007/s10843-010-0051-0
   Kostova T, 1999, ACAD MANAGE REV, V24, P64, DOI 10.5465/amr.1999.1580441
   Lamin A, 2012, ORGAN SCI, V23, P47, DOI 10.1287/orsc.1100.0631
   Laud G, 2015, MARKETING THEOR, V15, P509, DOI 10.1177/1470593115572671
   Leismann K, 2013, RESOURCES-BASEL, V2, P184, DOI 10.3390/resources2030184
   Mainela T, 2008, SCAND J MANAG, V24, P17, DOI 10.1016/j.scaman.2007.10.002
   Martin CJ, 2016, ECOL ECON, V121, P149, DOI 10.1016/j.ecolecon.2015.11.027
   McKeever E, 2014, ENTREP REGION DEV, V26, P453, DOI 10.1080/08985626.2014.939536
   Mohlmann M., 2015, J CONSUM BEHAV, V14, P193, DOI [DOI 10.1002/cb.1512, DOI 10.1002/CB.1512]
   Nadvi K, 1999, DEV CHANGE, V30, P141, DOI 10.1111/1467-7660.00110
   Nikayin F, 2013, INT J MED INFORM, V82, P922, DOI 10.1016/j.ijmedinf.2013.06.013
   Ozalp H, 2018, J MANAGE STUD, V55, P1203, DOI 10.1111/joms.12351
   Parente RC, 2018, J INT MANAG, V24, P52, DOI 10.1016/j.intman.2017.10.001
   Polanyi Karl, 2001, GREAT TRANSFORMATION
   Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988
   Rahman SMM, 2015, RESOUR CONSERV RECY, V104, P254, DOI 10.1016/j.resconrec.2015.07.022
   Rong K, 2018, RESOUR CONSERV RECY, V130, P188, DOI 10.1016/j.resconrec.2017.12.001
   Rong K, 2015, J INT MANAG, V21, P293, DOI 10.1016/j.intman.2015.07.004
   Rottig D., 2008, I DISTANCE SOCIAL CA
   de Abreu MCS, 2018, RESOUR CONSERV RECY, V138, P99, DOI 10.1016/j.resconrec.2018.07.001
   Scott W. R., 2008, I ORG IDEAS INTEREST
   Shaheen SA, 2013, INT J SUSTAIN TRANSP, V7, P5, DOI 10.1080/15568318.2012.660103
   Stallkamp M., 2019, GLOB STRATEG J
   SUCHMAN MC, 1995, ACAD MANAGE REV, V20, P571, DOI 10.2307/258788
   Tussyadiah I.P., 2016, STRATEGIC SELF PRESE, P695
   Umair S, 2015, RESOUR CONSERV RECY, V95, P46, DOI 10.1016/j.resconrec.2014.11.008
   Uzzi B, 1997, ADMIN SCI QUART, V42, P35, DOI 10.2307/2393808
   Vaara E, 2002, ORGANIZATION, V9, P275, DOI 10.1177/1350508402009002912
   Xu D, 2002, ACAD MANAGE REV, V27, P608, DOI 10.2307/4134406
   Yamakawa Y, 2008, ENTREP THEORY PRACT, V32, P59, DOI 10.1111/j.1540-6520.2007.00216.x
   Yin R.K., 2008, CASE STUDY RES APPL
   Zhang D, 2017, RESOUR CONSERV RECY, V125, P115, DOI 10.1016/j.resconrec.2017.06.003
   Zimmerman MA, 2002, ACAD MANAGE REV, V27, P414, DOI 10.2307/4134387
   Zukin S., 1990, STRUCTURES CAPITAL S
NR 77
TC 2
Z9 2
U1 31
U2 31
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104490
DI 10.1016/j.resconrec.2019.104490
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700022
DA 2020-05-12
ER

PT J
AU Hanumante, NC
   Shastri, Y
   Hoadley, A
AF Hanumante, Neeraj C.
   Shastri, Yogendra
   Hoadley, Andrew
TI Assessment of circular economy for global sustainability using an
   integrated model
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Integrated model; Unsustainable resource consumption;
   Agriculture; Policy
AB The circular economy is increasingly gaining importance as one of the ways of transitioning towards a sustainable future. Assessment of the systemic effects of the circular economy on a global scale from a holistic perspective is the need of the hour. This work addresses this challenge and models the circular economy in a planetary model with integrated human, ecological and industrial components.
   The circular economy is modelled as an industry which processes the used industrial goods. These are used along with the goods produced using virgin raw materials. Different time delays and circulation rates parameterize 90 different routes of implementation of the circular economy. These are implemented for nine levels of resource consumption increase by humans complemented by population growth. System collapse due to the scarcity of ecosystem based resources occurs sooner as the consumption level increases.
   Model simulation results indicate substantial benefits of adopting the circular economy. Incorporation of circular economy delays the system collapse by at least a few decades and aggressive implementation of the circular economy, in several cases, avoided this collapse entirely. Based on these results, the time horizon of the next 70 90 years is identified as critical, before which a large scale implementation of the circular economy is essential. However, very aggressive implementation of circular economy leads to system collapse because of the depletion of common access ecosystem services caused by continued high consumption. Thus, this work establishes benefits of the circular economy and recommends a balanced approach for the adoption of the circular economy.
C1 [Hanumante, Neeraj C.] Indian Inst Technol, IITB Monash Res Acad, Mumbai, Maharashtra, India.
   [Hanumante, Neeraj C.; Shastri, Yogendra] Indian Inst Technol, Mumbai, Maharashtra, India.
   [Hanumante, Neeraj C.; Hoadley, Andrew] Monash Univ, Melbourne, Vic, Australia.
RP Shastri, Y (reprint author), Indian Inst Technol, Mumbai, Maharashtra, India.
EM yshastri@iitb.ac.in
FU Tata Chemicals Ltd.; Science & Engineering Research Board (SERB),
   Department of Science & Technology, Government of India; Confederation
   of Indian Industry (CII)
FX This research has been aided by Prime Minister's Fellowship Scheme for
   Doctoral Research, a public-private partnership between Science &
   Engineering Research Board (SERB), Department of Science & Technology,
   Government of India and Confederation of Indian Industry (CII). We
   gratefully acknowledge the support of our industry partner: Tata
   Chemicals Ltd. We thank in particular Ms Alka Talwar, Chief CSR &
   Sustainability Officer, Tata Chemicals Ltd., for her support to the
   project.
CR [Anonymous], 2011, DEC NAT RES US ENV I
   Asif FMA, 2016, J CLEAN PROD, V139, P1261, DOI 10.1016/j.jclepro.2016.08.122
   Asif FMA, 2015, RESOUR CONSERV RECY, V101, P20, DOI 10.1016/j.resconrec.2015.05.002
   Bonciu F, 2014, ROM J EUR AFF, V14, P78
   Ellen MacArthur Foundation, 2015, TECH REP, DOI [10.1038/531435a, DOI 10.1038/531435A]
   Ellen MacArthur Foundation, 2015, TECH REP
   Europeon Union Commission, 2014, CIRC EC ZER WAST PRO
   FAO, 2016, TECH REP
   Fellner J, 2017, J IND ECOL, V21, P494, DOI 10.1111/jiec.12582
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Gregson N, 2015, ECON SOC, V44, P218, DOI 10.1080/03085147.2015.1013353
   Hennicke P., 2013, DECOUPLING RESOURCE, DOI [10.4337/9781783471270.00037, DOI 10.4337/9781783471270.00037]
   Herrera A., 1976, CATASTROPHE NEW SOC, V5, DOI [10.1016/0304-3878(78)90044-5, DOI 10.1016/0304-3878(78)90044-5]
   Hong M, 2017, GREEN CHEM, V19, P3692, DOI 10.1039/c7gc01496a
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Kaya Y., 1977, FUGI FUTURE GLOBAL I
   Khajuria A, 2010, J ENVIRON BIOL, V31, P649
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Kotecha P, 2013, CLEAN TECHNOL ENVIR, V15, P21, DOI 10.1007/s10098-012-0491-4
   Krausmann F, 2017, P NATL ACAD SCI USA, V114, P1880, DOI 10.1073/pnas.1613773114
   Leontief W., 1977, CHALLENGE, V20, P61
   Lineman H., 1979, MOIRA MODEL INT RELA
   Ma SH, 2014, J CLEAN PROD, V64, P505, DOI 10.1016/j.jclepro.2013.10.008
   Ma SJ, 2015, J CLEAN PROD, V87, P839, DOI 10.1016/j.jclepro.2014.10.059
   Meadows D., 1972, TECH REP, DOI [10.1080/07293682.2004.9982332, DOI 10.1080/07293682.2004.9982332]
   Merli R, 2018, J CLEAN PROD, V178, P703, DOI 10.1016/j.jclepro.2017.12.112
   Mesarovic M.D., 1975, C ROME MANKIND TURNI
   Murray A, 2017, J BUS ETHICS, V140, P369, DOI 10.1007/s10551-015-2693-2
   Parker K.T., 1978, SARUM GLOBAL MODEL I
   Pawlowski C.W., 2006, INTEGRATION EC IMPER
   Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8
   Prieto-Sandoval V, 2018, J CLEAN PROD, V179, P605, DOI 10.1016/j.jclepro.2017.12.224
   Reike D, 2018, RESOUR CONSERV RECY, V135, P246, DOI 10.1016/j.resconrec.2017.08.027
   Reuter MA, 2015, J SUSTAIN METALL, V1, P4, DOI 10.1007/s40831-014-0006-0
   Reuter M. A., 2018, WORLD METALL ERZMETA, V71, P68
   Reuter MA, 2015, INT J LIFE CYCLE ASS, V20, P671, DOI 10.1007/s11367-015-0860-4
   Richardson J.M., 1978, GLOBAL MODELLING FUT, P476
   Shastri Y, 2008, ENVIRON SCI TECHNOL, V42, P6710, DOI 10.1021/es800661x
   Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855
   Sutherland JW, 2008, CIRP ANN-MANUF TECHN, V57, P5, DOI 10.1016/j.cirp.2008.03.004
   United Nations, 2004, WORLD POP 2300
   United Nations General Assembly, 2015, TRANSF OUR WORLD 203
   van Schaik A., 2014, MAT CENTRIC ALUMINUM, DOI [10.1016/B978-0-12-396459-5.00022-2, DOI 10.1016/B978-0-12-396459-5.00022-2]
   World Bank, 2010, URBAN DEV SERIES KNO, V3, P8
   Wu XF, 2015, ECOL INFORM, V26, P78, DOI 10.1016/j.ecoinf.2014.06.006
   Zink T, 2017, J IND ECOL, V21, P593, DOI 10.1111/jiec.12545
NR 46
TC 2
Z9 2
U1 12
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104460
DI 10.1016/j.resconrec.2019.104460
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700018
DA 2020-05-12
ER

PT J
AU Hilton, B
   Bawden, K
   Winnebeck, K
   Chandrasiri, C
   Ariyachandra, E
   Peethamparan, S
AF Hilton, Brian
   Bawden, Kimberly
   Winnebeck, Kathryn
   Chandrasiri, Chathurani
   Ariyachandra, Erandi
   Peethamparan, Sulapha
TI The functional and environmental performance of mixed cathode ray tubes
   and recycled glass as partial replacement for cement in concrete
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Pozzolan; Concrete; Life cycle assessment (LCA); Cathode ray tube (CRT);
   Recycle; Glass
ID WASTE GLASS; FINE AGGREGATE; POWDER; MORTAR
AB Concrete is one of the most abundantly produced and commonly used construction materials in the world. The production of cement - the main binder in concrete - is energy-intensive, using roughly ten times the national average ratio for energy to gross output of goods and services. Given the high demand for concrete globally and the amount of energy used to produce cement, it is worthwhile to find lower embodied-energy materials to partially replace cement to improve the environmental impacts of concrete without decreasing the concrete performance. One such potential cement replacement is the panel glass found in discarded cathode-ray tubes (CRTs). It is against this backdrop that this study aimed to investigate the technical feasibility and the environmental impacts of using a novel blend of recycled glass and CRT panel glass as pozzolanic material for replacing a portion of ordinary portland cement (OPC) in concrete, Additionally, this study simultaneously looked at the concrete functional performance and environmental impact, and the study was performed at an industrial scale using existing production infrastructure, production volumes, standardized testing, and a life-cycle assessment (LCA) to support the functional testing and environmental impact quantification. Results show that the novel blend of glass met the required performance standards, and when it was blended with cement, the mixture produced concrete with similar or improved functional performance and significantly reduced environmental impacts across all examined impact categories. Future work is needed to examine the additional benefits of diverting CRTs from their current end-of-life pathways and de-risking CRT storage.
C1 [Hilton, Brian] Rochester Inst Technol, Golisano Inst Sustainabil, Rochester, NY 14623 USA.
   [Bawden, Kimberly; Winnebeck, Kathryn] Rochester Inst Technol, NYS Pollut Prevent Inst, Rochester, NY 14623 USA.
   [Chandrasiri, Chathurani; Ariyachandra, Erandi; Peethamparan, Sulapha] Clarkson Univ, Potsdam, NY USA.
RP Hilton, B (reprint author), Rochester Inst Technol, Golisano Inst Sustainabil, Rochester, NY 14623 USA.
EM bshasp@rit.edu; krbp2i@rit.edu; kmhasp@rit.edu; chandrc@clarkson.edu;
   ariyacm@clarkson.edu; speetham@clarkson.edu
FU RIT through New York State; RIT's Staples Sustainable Innovation
   Laboratory; Electronic Recyclers International
FX Our research was performed consistent with the terms and purposes of the
   New York State Pollution Prevention Institute (NYSP2I) agreement between
   Urban Mining Northeast LLC (UMNE) and Rochester Institute of Technology
   (RIT). It is funded in part by RIT through a grant from New York State.
   Additional funding was provided by RIT's Staples Sustainable Innovation
   Laboratory and the Electronic Recyclers International specifically to
   understand the impacts of replacing a portion of the ordinary portland
   cement (OPC) in concrete with cathode-ray tube (CRT) panel glass. Any
   opinions, findings, and/or interpretations of data contained herein are
   the responsibility of RIT and its NSYP2I and do not necessarily
   represent the opinions, interpretations or policy of New York State.; We
   thank Louis Grasso Jr. and Dale Hauke from UMNE for supporting this
   project, providing the MRF glass pozzolan Pozzotive, crushing and
   providing production quantity and quality CRT glass powder, and for
   allowing access to the manufacturing process and equipment for the LCA
   data. We also thank Aaron Blum, Andrew Nunan, and the technical staff at
   Electronic Recyclers International for providing access to their
   manufacturing process and equipment. This work would not have been
   possible without the full support of the manufacturers involved. We also
   thank Christopher Whitebell for his assistance in preparing the
   manuscript.
CR Aliabdo AA, 2016, CONSTR BUILD MATER, V124, P866, DOI 10.1016/j.conbuildmat.2016.08.016
   Association of State and Territorial Solid Waste Management Officials, 2017, ASTSWMO POS PAP CATH
   ASTM C1202-17a, 2017, C120217A ASTM INT
   ASTM International, 2018, C1012C1012M18A ASTM
   ASTM International, 2017, C61812A ASTM INT
   ASTM International, 2014, PROD CAT RUL PREP EN
   Bare J.C., 2012, TOOL REDUCTION ASSES
   Carsana M, 2014, CEMENT CONCRETE COMP, V45, P39, DOI 10.1016/j.cemconcomp.2013.09.005
   Clarkson University, 2016, STRUCT MAT ENG LAB
   Du HJ, 2017, CEMENT CONCRETE COMP, V75, P22, DOI 10.1016/j.cemconcomp.2016.10.010
   Ellen MacArthur Foundation, 2015, DEL CIRC EC TOOLK PO
   Federico LM, 2011, J THERM ANAL CALORIM, V104, P849, DOI 10.1007/s10973-011-1288-0
   Grasso Jr L.P., 2018, PROCESSING WASTE CAT
   Hossain MU, 2017, RESOUR CONSERV RECY, V120, P199, DOI 10.1016/j.resconrec.2016.12.012
   Iniaghe P., 2015, WASTE MANAG RES
   International Organisation for Standardization, 2006, 140402006 ISO
   ISO, 2006, 140442006 ISO
   Jani Y, 2014, J ENVIRON CHEM ENG, V2, P1767, DOI 10.1016/j.jece.2014.03.016
   Koebler J., 2017, CO ABANDONED 56000 T
   Koebler J., 2017, AM TELEVISION GRAVEY
   Kuusakoski Recycling, 2016, CRT GLASS PROC CAP L
   Ling TC, 2011, J HAZARD MATER, V192, P451, DOI 10.1016/j.jhazmat.2011.05.019
   Liu TJ, 2018, CONSTR BUILD MATER, V163, P634, DOI 10.1016/j.conbuildmat.2017.12.135
   Liu TJ, 2018, J CLEAN PROD, V174, P1436, DOI 10.1016/j.jclepro.2017.11.057
   Lothenbach B, 2011, CEMENT CONCRETE RES, V41, P1244, DOI 10.1016/j.cemconres.2010.12.001
   Mear F, 2006, WASTE MANAGE, V26, P1468, DOI 10.1016/j.wasman.2005.11.017
   Mirzahosseini M, 2015, CEMENT CONCRETE COMP, V56, P95, DOI 10.1016/j.cemconcomp.2014.10.004
   National Agricultural Library, 2012, LIF CYCL INV DAT
   National Precast Concrete Association, 2017, FLY ASH TRENDS DOWNW
   NSF International, 2017, CRMCA MEMB IND WID E
   OECD/International Energy Agency, 2009, CEM TECHN ROADM 2009
   OECD/International Energy Agency, 2018, TECHN ROADM LOW CARB
   Petter Patrícia Melo Halmenschlager, 2015, Rem: Rev. Esc. Minas, V68, P61, DOI 10.1590/0370-44672015680152
   Portland Cement Association, 2018, SUPPLEMENTARY CEMENT
   Portland Cement Association, 2016, PORTL CEM ENV PROD D
   Powell J., 2013, E SCRAP NEWS
   Rashad AM, 2014, CONSTR BUILD MATER, V72, P340, DOI 10.1016/j.conbuildmat.2014.08.092
   Romero D, 2013, WASTE MANAGE, V33, P1659, DOI 10.1016/j.wasman.2013.03.018
   Sadiqul Islam G. M., 2017, International Journal of Sustainable Built Environment, V6, P37, DOI 10.1016/j.ijsbe.2016.10.005
   Schwarz N, 2008, CEMENT CONCRETE COMP, V30, P486, DOI 10.1016/j.cemconcomp.2008.02.001
   Scientific Applications International Corporation, 2006, LIF CYCL ASS PRINC P
   U.S. Energy Information Administration, 2018, NEW YORK STAT PROF E
   U.S. Environmental Protection Agency, 2018, STON CASTL REC PAR F
   U.S. Environmental Protection Agency, 2017, HAZ WAST CATH RAY TU
   U.S. Environmental Protection Agency, 2014, DIAGR CURR CRT LANDS
   U.S. Environmental Protection Agency, 2016, SW846 US EPA
   UN Climate Change Newsroom, 2017, BIGG CLIM ACT EM CEM
   Urban Mining Northeast, 2018, PROD SERV POZZ OV
   Van Oss H., 2017, 2014 MINERALS YB CEM
   Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8
   Yao ZT, 2018, RENEW SUST ENERG REV, V81, P595, DOI 10.1016/j.rser.2017.08.027
   Zhao H, 2017, CONSTR BUILD MATER, V148, P900, DOI 10.1016/j.conbuildmat.2017.05.019
   Zinke R., 2018, MINERAL COMMODITY SU
NR 53
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104451
DI 10.1016/j.resconrec.2019.104451
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700009
DA 2020-05-12
ER

PT J
AU Hsien, C
   Low, JSC
   Fuchen, SC
   Han, TW
AF Hsien, Cadence
   Low, Jonathan Sze Choong
   Fuchen, Shannon Chan
   Han, Tan Wee
TI Life cycle assessment of water supply in Singapore - A water-scarce
   urban city with multiple water sources
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Urban water system; Environmental impact; Water depletion; Carbon
   footprint; Wastewater treatment; Water recycling
ID WASTE-WATER; RECLAMATION PLANT; EFFICIENCY; SYSTEMS; CARBON; MODEL;
   REUSE
AB Water scarcity in Singapore has resulted in a complex urban water system with multiple water sources, advanced treatment processes, and recycling for potable and non-potable reuse. While industries are encouraged to reuse and recycle water, the environmental impact of doing so as compared to using public water supply should be considered. However, there is a lack of studies quantifying the environmental impact of water from a complex urban water system like Singapore's. In this study, Life Cycle Assessment (LCA) was adopted to study the environmental impact of Singapore's public water supply, which consists of NEWater (highly purified recycled water) and tap water, to inform industries and policy makers of the environmental impact of these water supplies. Individual components in Singapore's urban water system were studied and their results combined to develop the LCA of NEWater and tap water. The results show that 1 m(3) of "NEWater at consumer" and 1 m(3) of "tap water at consumer" contributes 2.19 kg CO2-Eq and 1.30 kg CO2-Eq to climate change potential, and 0.00344 m(3) and 0.882 m(3) to water depletion potential respectively. The results indicate the importance of including CH4 , N2O, and NOx emissions in wastewater and urban water system-related LCA studies.
C1 [Hsien, Cadence; Low, Jonathan Sze Choong; Fuchen, Shannon Chan; Han, Tan Wee] Singapore Inst Mfg Technol, 2 Fusionopolis Way,08-04, Singapore 138634, Singapore.
RP Hsien, C (reprint author), Singapore Inst Mfg Technol, 2 Fusionopolis Way,08-04, Singapore 138634, Singapore.
EM cadence_hsien@SIMTech.a-star.edu.sg
CR Al-Sarkal T, 2013, DESALINATION, V317, P55, DOI 10.1016/j.desal.2013.02.019
   Alamdari N, 2018, RESOUR CONSERV RECY, V132, P178, DOI 10.1016/j.resconrec.2017.12.013
   Alkaya E, 2015, RESOUR CONSERV RECY, V104, P172, DOI 10.1016/j.resconrec.2015.08.011
   [Anonymous], 2019, CHANNEL NEWS ASIA
   Barjoveanu G, 2014, INT J LIFE CYCLE ASS, V19, P449, DOI 10.1007/s11367-013-0635-8
   Bhari B., 2016, CHESTNUT AVENUE WATE, P1
   Biswas W., 2009, WORLD ACAD SCI ENG T, V56, P369
   Bonton A, 2012, DESALINATION, V284, P42, DOI 10.1016/j.desal.2011.08.035
   Briao VB, 2019, RESOUR CONSERV RECY, V140, P313, DOI 10.1016/j.resconrec.2018.10.007
   Cao Y, 2017, WATER SCI TECHNOL, V75, P741, DOI 10.2166/wst.2016.565
   Chaosakul T, 2014, J ENVIRON SCI HEAL A, V49, P1316, DOI 10.1080/10934529.2014.910071
   Chaudhary R., 2016, COMP NORMAL AIR CO2, V6, P99, DOI [10.5923/J.aJee.20160603.03, DOI 10.5923/J.AJEE.20160603.03]
   Chen Z, 2018, BIORESOURCE TECHNOL, V269, P246, DOI 10.1016/j.biortech.2018.08.107
   Chen Z, 2017, RESOUR CONSERV RECY, V117, P125, DOI 10.1016/j.resconrec.2016.11.008
   Chhipi-Shrestha G, 2017, SCI TOTAL ENVIRON, V607, P600, DOI 10.1016/j.scitotenv.2017.06.269
   Daigger G.T., 2007, J ENV ENG MANAG, V17, P1
   Department of Statistics Singapore, 2018, YB STAT SING 2018
   Friedrich E, 2009, WATER SA, V35, P73
   Goedkoop M, 2013, RECIPE 2008
   Griffith DR, 2009, ENVIRON SCI TECHNOL, V43, P5647, DOI 10.1021/es9004043
   Hameeteman E, 2013, FUTURE WATER SECURIT
   IPCC, 2006, WAST TREATM DISCH
   ISO, 2007, 14040 ISO
   Jing XE, 2017, RESOUR CONSERV RECY, V126, P74, DOI 10.1016/j.resconrec.2017.07.027
   Koh T., 2006, SINGAPORE ENCY
   Lane JL, 2015, WATER RES, V81, P398, DOI 10.1016/j.watres.2015.03.005
   Lassaux S, 2007, INT J LIFE CYCLE ASS, V12, P118, DOI 10.1065/lca2005.12.243
   Law Y, 2013, WATER RES, V47, P5270, DOI 10.1016/j.watres.2013.06.002
   Lemos D, 2013, J CLEAN PROD, V54, P157, DOI 10.1016/j.jclepro.2013.04.029
   Liu YW, 2015, SCI TOTAL ENVIRON, V524, P40, DOI 10.1016/j.scitotenv.2015.04.029
   Loubet P, 2014, WATER RES, V67, P187, DOI 10.1016/j.watres.2014.08.048
   Ma L, 2018, RESOUR CONSERV RECY, V139, P228, DOI 10.1016/j.resconrec.2018.07.013
   Metcalf E, 2003, WASTEWATER ENG TREAT, DOI [10.1016/0309-1708(80)90067-6, DOI 10.1016/0309-1708(80)90067-6]
   Ng B.J.H., 2014, J ENVIRON MANAGE, DOI [10.1063/1, DOI 10.1063/1]
   PUB, 2019, PUB NEWATER
   PUB, 2016, OUR WAT OUR FUT, P1, DOI [10.1007/978-3-319-01457-9_1, DOI 10.1007/978-3-319-01457-9_1]
   PUB, 2019, PUB NEWATER QUAL
   PUB, 2017, OUR DRINK WAT QUAL S
   PUB, 2018, PUB PUSH FRONT WAT T
   PUB, 2017, SING EXP WAT LOSS RE
   PUB, 2016, PUB WAT LOC CATCHM
   PUB, 2016, APPL WAT EFF FUND
   PUB, 2019, PUB WAT TREATM
   PUB, 2019, PUB DOM NOND
   PUB, 2019, PUB DES WAT
   Qin JJ, 2006, SEP PURIF TECHNOL, V50, P380, DOI 10.1016/j.seppur.2005.12.013
   Raj CBC, 2008, J ENVIRON SCI-CHINA, V20, P1300, DOI 10.1016/S1001-0742(08)62225-1
   Reiss C.R., 2008, PRETREATMENT DESIGN
   Rygaard M, 2011, J ENVIRON MANAGE, V92, P185, DOI 10.1016/j.jenvman.2010.09.009
   Smith K, 2017, ENERG BUILDINGS, V135, P119, DOI 10.1016/j.enbuild.2016.11.033
   Solar Energy Research Institute of Singapore, 2013, SOLAR PHOTOVOLTAIC P
   Solar Yingli, 2015, 1MW PUB PUBLIC UTILI
   Tay C., 2019, STRAITS TIMES
   The International Standards Organisation, 2006, 14044 ISO, V2006, P652, DOI [10.1007/s11367-011-0297-3, DOI 10.1007/S11367-011-0297-3]
   Thompson M., 2003, IMSTEC 03
   UN, 2011, WORLD POP PROSP 2010, P1
   United Nation Department of Economic and Social Affairs, 2014, INT DEC ACT WAT LIF
   Wang M., 2015, ONLINE MONITORING NI
   Yeshi C, 2013, J WATER REUSE DESAL, V3, P402, DOI 10.2166/wrd.2013.012
NR 59
TC 2
Z9 2
U1 22
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104476
DI 10.1016/j.resconrec.2019.104476
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700014
DA 2020-05-12
ER

PT J
AU Hsien, C
   Low, JSC
   Chung, SY
   Tan, DZL
AF Hsien, Cadence
   Low, Jonathan Sze Choong
   Chung, Si Ying
   Tan, Daren Zong Loong
TI Quality-based water and wastewater classification for waste-to-resource
   matching
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Water quality; Water resource; Water categorization; Resource recovery;
   Industrial symbiosis
AB The recycling and recovery of water and resources from wastewater is necessary to maintain sustainable use of our limited global freshwater resources. To do so, we need to be able to distinguish and reference different water and wastewater types. In this paper, we present a method to classify and assign unique numerical identification codes to different water and wastewater types based on their water quality. A limited set of water quality parameters were identified based on national and international standards. Using the parameters identified, we devised a classification method to translate the water quality into unique identification codes based on several water quality ranges. Lastly, the water quality ranges for each parameter was determined based on country regulations and water treatment processes. The result is a ten-digit identification code system that is able to classify different water and wastewater based on their quality. The unique identification code assigned to different water types enables easy identification of water and wastewater resources. This acts as a common basis to reference water and wastewater resources and reduces ambiguity in the communication of water types. We showcased the utility of the classification through a waste-to-resource matching database which recommends possible pathways for waste-to-resource conversions.
C1 [Hsien, Cadence; Low, Jonathan Sze Choong; Chung, Si Ying; Tan, Daren Zong Loong] Singapore Inst Mfg Technol, 2 Fusionopolis Way,08-04, Singapore 138634, Singapore.
RP Hsien, C (reprint author), Singapore Inst Mfg Technol, 2 Fusionopolis Way,08-04, Singapore 138634, Singapore.
EM cadence_hsien@SIMTech.a-star.edu.sg
CR Ammary B. Y., 2004, African Journal of Biotechnology, V3, P236
   [Anonymous], 2018, SING TRAD CLASS CUST
   Boulay AM, 2011, INT J LIFE CYCLE ASS, V16, P639, DOI 10.1007/s11367-011-0300-z
   de Mes T. Z. D., 2003, BIOMETHANE BIOHYDROG, P58, DOI DOI 10.1016/J.BIORTECH.2010.08.032
   Food and Agriculture Organization of the United Nations, 2014, WAT MOST BAS RES AL
   Garcia X, 2015, RESOUR CONSERV RECY, V101, P154, DOI 10.1016/j.resconrec.2015.05.015
   Godsey B.W.E., FRESH BRACKISH SALIN
   Government of Newfoundland and Labrador, 2018, DRINK WAT QUAL IND
   HENZE M, 1983, WATER SCI TECHNOL, V15, P1
   Horton RK, 1965, J WATER POLLUTION CO, V37, P300
   Kerstens SM, 2016, RESOUR CONSERV RECY, V110, P16, DOI 10.1016/j.resconrec.2016.03.002
   Low J.S.C., 2018, COLLABORATION PLATFO
   Mang H., INTRO TECHNICAL DESI
   Metcalf E, 2003, WASTEWATER ENG TREAT, DOI [10.1016/0309-1708(80)90067-6, DOI 10.1016/0309-1708(80)90067-6]
   National Environmental Agency, 2018, ALL LIM TRAD EFFL DI
   Pereira LS, 2002, AGR WATER MANAGE, V57, P175, DOI 10.1016/S0378-3774(02)00075-6
   PUB, 2014, J CHEM INF MODEL, V53, P1689, DOI [10.1017/CB09781107415324.004, DOI 10.1017/CB09781107415324.004]
   PUB, 2013, REQ DISCH TRAD EFFL
   Raut S., 2017, EUR J ADV ENG TECHNO
   Tiu BTC, 2017, RESOUR CONSERV RECY, V119, P89, DOI 10.1016/j.resconrec.2016.06.005
   Tyagi S, 2013, J AM WATER RESOUR AS, V1, P34, DOI DOI 10.12691/AJWR-1-3-3
   United States Geological Survey, 2016, MUCH WAT IS THER EAR
   US EPA, 2012, GUID WAT REUS 2012, P643
   van der Hoek JP, 2016, RESOUR CONSERV RECY, V113, P53, DOI 10.1016/j.resconrec.2016.05.012
   Vijayan G., 2016, INT J ENV ENG MANAG, V7, P69
   VonSperling M., 2008, CHOICE REV, DOI [10.5860/CHOICE.45-2633, DOI 10.5860/CHOICE.45-2633]
   WHO, 2017, WHO GUIDELINES DRINK
   WHO, 2006, EXCR GREY WAT US AGR, VII, P204, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]
   World Economic Forum, 2018, EV YOU NEED KNOW WAT
   Yu HQ, 2002, INT J HYDROGEN ENERG, V27, P1359, DOI 10.1016/S0360-3199(02)00073-3
NR 30
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104477
DI 10.1016/j.resconrec.2019.104477
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700015
DA 2020-05-12
ER

PT J
AU Jiang, Y
   Li, R
   Yang, YN
   Yu, MD
   Xi, BD
   Li, MX
   Xu, Z
   Gao, SB
   Yang, C
AF Jiang, Yu
   Li, Rui
   Yang, Yuning
   Yu, Minda
   Xi, Beidou
   Li, Mingxiao
   Xu, Zheng
   Gao, Shaobo
   Yang, Chao
TI Migration and evolution of dissolved organic matter in landfill
   leachate-contaminated groundwater plume
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Landfill leachate; Groundwater; Dissolved organic matter; Migration;
   Evolution; Hydrochemistry
ID WASTE; SPECTROSCOPY; CARBON; IDENTIFICATION; POLLUTION; SEDIMENT;
   DYNAMICS; REMOVAL; AQUIFER; FENTON
AB Groundwater pollution around landfill sites is becoming a global environmental problem. The hydrochemistry of dissolved organic matter (DOM) in landfill leachate-contaminated groundwater plume has been investigated extensively. The spatial migration and evolution of DOM, the relationship between hydrochemistry and DOM dynamics, and the role of microorganisms in DOM transformation are still largely unclear. In this study, UV-vis, 3D-EEM PARAFAC and principal components analyses were combined to investigate the migration and evolution of DOM. The results show that when the contamination plume gradually diffuses, the molecular weight of DOM in downstream groundwater tends to be high, while the humification degree is low and DOM is mostly derived from microbial metabolism. Compared with humic-like and fulvic-like substances, protein-like substances have a higher migration capability, making them suitable indicators of groundwater pollution. Under low-permeability aquifer medium (K < 10(-7) cm/s), the DOM pollution was easy to rebound. An evident positive correlation exists between electrical conductivity and the maximum fluorescence intensity of humic-like and fulvic-like substances. Venn diagram shows that 15.31% (117 of 764) of the species were unique in the upstream and could not be detected in downstream groundwater. In comparison, 43.05% (489 of 1136) of the species were unique in the downstream and 382 were not detected in upstream groundwater. The main microorganisms (such as Polynucleobacter, Comamonadaceae, Desulfobulbus, and Magnetovibrio) play a pivotal role in DOM transformation in the aquifer. This study provides a novel insight into the monitoring, early warning and remediation of groundwater pollution in landfills.
C1 [Jiang, Yu; Xi, Beidou] Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.
   [Jiang, Yu; Li, Rui; Yang, Yuning; Yu, Minda; Xi, Beidou; Li, Mingxiao; Xu, Zheng; Gao, Shaobo; Yang, Chao] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Simulat & Control, Beijing 100012, Peoples R China.
   [Yang, Yuning; Xu, Zheng] Jilin Jianzhu Univ, Municipal & Environm Engn Coll, Changchun 130118, Jilin, Peoples R China.
   [Gao, Shaobo] China Univ Geosci Beijing, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
RP Li, R; Xi, BD (reprint author), Chinese Res Inst Environm Sci, State Environm Protect Key Lab Simulat & Control, Beijing 100012, Peoples R China.
EM 518lirui@163.com; xibeidou@263.net
FU Natural Science Foundation of China (NSFC)National Natural Science
   Foundation of China [21606214]; China National Critical Project for
   Science and Technology on Water Pollution Prevention and Control
   [2018ZX07109-003]
FX This study work was subsidized by the Natural Science Foundation of
   China (NSFC) (Grant No. 21606214) and China National Critical Project
   for Science and Technology on Water Pollution Prevention and Control
   (2018ZX07109-003). We want to express our sincere thanks to the
   reviewers and the associate editor.
CR Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P1824, DOI 10.1099/ijs.0.044453-0
   Chen M, 2015, WATER RES, V79, P10, DOI 10.1016/j.watres.2015.04.018
   Chen ML, 2010, APPL GEOCHEM, V25, P872, DOI 10.1016/j.apgeochem.2010.03.005
   Chen Z, 2016, J HAZARD MATER, V311, P20, DOI 10.1016/j.jhazmat.2016.02.069
   Claret F, 2003, SCI TOTAL ENVIRON, V317, P189, DOI 10.1016/S0048-9697(03)00337-1
   Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962
   Dvorski SEM, 2016, ENVIRON SCI TECHNOL, V50, P5536, DOI 10.1021/acs.est.6b00849
   Fan MC, 2016, WATER RES, V96, P198, DOI 10.1016/j.watres.2016.03.061
   Gu WL, 2017, WATER SCI TECH-W SUP, V17, P188, DOI 10.2166/ws.2016.122
   Han ZY, 2016, SCI TOTAL ENVIRON, V569, P1255, DOI 10.1016/j.scitotenv.2016.06.201
   Hao TW, 2015, WATER RES, V71, P74, DOI 10.1016/j.watres.2014.12.051
   He XS, 2016, ENVIRON SCI POLLUT R, V23, P21229, DOI 10.1007/s11356-016-7308-7
   He XS, 2015, ENVIRON SCI POLLUT R, V22, P8499, DOI 10.1007/s11356-014-4029-7
   He XS, 2014, ENVIRON SCI POLLUT R, V21, P7522, DOI 10.1007/s11356-014-2674-5
   Huang SB, 2015, SCI TOTAL ENVIRON, V529, P131, DOI 10.1016/j.scitotenv.2015.05.051
   Hudson N, 2007, RIVER RES APPL, V23, P631, DOI 10.1002/rra.1005
   Huguet A, 2009, ORG GEOCHEM, V40, P706, DOI 10.1016/j.orggeochem.2009.03.002
   Huo SL, 2008, J ENVIRON SCI-CHINA, V20, P492, DOI 10.1016/S1001-0742(08)62085-9
   Jalali M, 2011, ENVIRON EARTH SCI, V62, P907, DOI 10.1007/s12665-010-0576-5
   Kamjunke N, 2015, SCI TOTAL ENVIRON, V506, P353, DOI 10.1016/j.scitotenv.2014.11.043
   Kretzschmar R, 1997, ENVIRON SCI TECHNOL, V31, P3497, DOI 10.1021/es970244s
   Labrenz M, 2013, INT J SYST EVOL MICR, V63, P4141, DOI 10.1099/ijs.0.048827-0
   Lapworth DJ, 2008, APPL GEOCHEM, V23, P3384, DOI 10.1016/j.apgeochem.2008.07.011
   Lesaulnier CC, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0344-9
   Li JY, 2016, CHEMOSPHERE, V146, P442, DOI 10.1016/j.chemosphere.2015.12.069
   Li PH, 2017, CRIT REV ENV SCI TEC, V47, P131, DOI 10.1080/10643389.2017.1309186
   Li Y, 2014, ENVIRON POLLUT, V184, P94, DOI 10.1016/j.envpol.2013.08.027
   Ling CP, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5832-7
   Liu ZP, 2015, WASTE MANAGE, V41, P111, DOI 10.1016/j.wasman.2015.03.044
   Ma ZF, 2016, SCI TOTAL ENVIRON, V563, P593, DOI 10.1016/j.scitotenv.2016.04.117
   Minor EC, 2014, ENVIRON SCI-PROC IMP, V16, P2064, DOI 10.1039/c4em00062e
   Moeckel C, 2014, ENVIRON SCI TECHNOL, V48, P130, DOI 10.1021/es403707q
   Moreau JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01389
   Peng Li, 2018, Huanjing Kexue, V39, P4556, DOI 10.13227/j.hjkx.201802136
   Peuravuori J, 1997, ANAL CHIM ACTA, V337, P133, DOI 10.1016/S0003-2670(96)00412-6
   Postma D, 2012, NAT GEOSCI, V5, P656, DOI [10.1038/ngeo1540, 10.1038/NGEO1540]
   Renou S, 2008, J HAZARD MATER, V150, P468, DOI 10.1016/j.jhazmat.2007.09.077
   Rochelle-Newall EJ, 2002, MAR CHEM, V77, P23, DOI 10.1016/S0304-4203(01)00073-1
   Roling WFM, 2001, APPL ENVIRON MICROB, V67, P4619, DOI 10.1128/AEM.67.10.4619-4629.2001
   Samadder SR, 2017, SCI TOTAL ENVIRON, V580, P593, DOI 10.1016/j.scitotenv.2016.12.003
   SHI XQ, 2016, CHINA ENV EARTH SCI, V75, DOI DOI 10.1007/S12665-015-5019-X
   Spigolon LMG, 2018, WASTE MANAGE RES, V36, P606, DOI 10.1177/0734242X18773538
   Stahlschmidt M, 2016, J WATER REUSE DESAL, V6, P249, DOI 10.2166/wrd.2015.220
   Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0
   Tareq SM, 2013, PHYS CHEM EARTH, V58-60, P77, DOI 10.1016/j.pce.2013.04.014
   Tas N, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy156
   Wang JJ, 2018, ENVIRON SCI TECHNOL, V52, P1062, DOI 10.1021/acs.est.7b05506
   Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x
   Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391
   Zhang BL, 2019, WATER RES, V157, P472, DOI 10.1016/j.watres.2019.04.002
   Zhang S, 2017, WATER RES, V119, P114, DOI 10.1016/j.watres.2017.01.029
   Zhu WZ, 2018, J MARINE SYST, V180, P9, DOI 10.1016/j.jmarsys.2017.12.003
NR 52
TC 0
Z9 0
U1 20
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104463
DI 10.1016/j.resconrec.2019.104463
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700008
DA 2020-05-12
ER

PT J
AU Kerdlap, P
   Low, JSC
   Ramakrishna, S
AF Kerdlap, Piya
   Low, Jonathan Sze Choong
   Ramakrishna, Seeram
TI Zero waste manufacturing: A framework and review of technology,
   research, and implementation barriers for enabling a circular economy
   transition in Singapore
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Industrial ecology; Industrial symbiosis; Waste management; Sustainable
   manufacturing; Industry 4.0
ID LIFE-CYCLE ANALYSIS; INDUSTRIAL SYMBIOSIS APPLICATION; COLLABORATION
   PLATFORM; MODULAR BUILDINGS; ANALYSIS PSILA; PERFORMANCE; METHODOLOGY;
   CHALLENGES; INTERNET; DESIGN
AB Zero waste manufacturing (ZWM) is a concept to support countries transition to a circular economy by developing manufacturing technologies and systems that eliminate waste across entire waste value chains to the fullest extent possible through reuse and recycling. Implementation of ZWM, particularly in dense urban settings such as Singapore, presents challenges for stakeholders, which stem from issues related to land scarcity, productivity, and labor shortage. A framework to address these challenges is proposed comprising six themes of design for zero waste, smart waste audit and reduction planning, smart waste collection, high-value mixed waste processing, collaborative platform for industrial symbiosis, and waste to resource conversion and recycling. A systematic literature review is used to examine industry technologies and research across the six themes to determine how the technologies can support ZWM. The research reveals that a variety of mature waste measurement, collection, and conversion technologies can be integrated through Internet-of-things applications and a collaborative platform for industrial symbiosis to support Singapore and other countries in developing a ZWM ecosystem. This research examines the technical limitations of implementing ZWM technologies in dense urban settings using Singapore as a case study. Future areas of research are then proposed to overcome the implementation barriers so that ZWM can be enabled.
C1 [Kerdlap, Piya; Ramakrishna, Seeram] Natl Univ Singapore, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore.
   [Low, Jonathan Sze Choong] Singapore Inst Mfg Technol, 2 Fusionopolis Way, Singapore 138634, Singapore.
RP Kerdlap, P (reprint author), Natl Univ Singapore, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore.
EM piyakerdlap@u.nus.edu
CR ABB, 2018, IMPR PROC EFF PROD Q
   Advanced Remanufacturing Technology Centre, 2019, ADV REM TECHN CTR HO
   Agri-Food and Veterinary Authority of Singapore, 2019, FOOD WE EAT
   Alvarez R, 2017, WASTE BIOMASS VALORI, V8, P1521, DOI 10.1007/s12649-016-9748-1
   [Anonymous], 2018, CHANNEL NEWSASIA
   [Anonymous], 2019, CHANNEL NEWSASIA
   [Anonymous], 2017, CHANNEL NEWSASIA
   Balde C.P., 2017, GLOBAL E WASTE MONIT
   Berge ND, 2011, ENVIRON SCI TECHNOL, V45, P5696, DOI 10.1021/es2004528
   Bigbelly, 2017, SMART CIT SOL
   BigBelly Solar, 2018, JTC PUTS MOR SMART W
   Bin S, 2015, PROC CIRP, V29, P450, DOI 10.1016/j.procir.2015.01.066
   Boston Consulting Group, 2017, BCG LAUNCH IND 4 0 A
   BRE, 2017, SMARTWASTE BROCH
   Cheng GH, 2017, ENVIRON SCI POLLUT R, V24, P8711, DOI 10.1007/s11356-017-8574-8
   Cheng GH, 2017, ENVIRON SCI POLLUT R, V24, P7236, DOI 10.1007/s11356-016-8284-7
   Chertow M., 2015, SCHOLARSHIP PRACTICE, DOI [10.1007/978-3-319-20571-15, DOI 10.1007/978-3-319-20571-15]
   CleanRobotics, 2016, INT TRASHB
   CNN, 2017, CNN
   Denyer D, 2009, SAGE HDB ORG RES MET, P671, DOI DOI 10.1080/03634528709378635
   Eco-Business, 2011, FOOD WAST REC FOLDS
   Economic Development Board of Singapore, 2018, ADV MANUFACTURING
   Ecube Labs, 2017, CAS STUD
   Ecube Labs, 2017, CLEANCAP ULTR FILL L
   Ellen MacArthur Foundation, 2013, ENG CIRC EC FIELD MA
   Ernst and Young, 2015, PERFORMANCE, V7, P56
   Fraccascia L., 2018, ROLE ONLINE INFORM S, DOI [10.1016/j.resconrec.2018.03.009, DOI 10.1016/J.RESCONREC.2018.03.009]
   Gershman Brickner and Bratton Inc, 2017, IMPL SMARTENGINE ONL
   Gershman Brickner and Bratton Inc, 2015, EV MIX WAST PROC FAC
   Gershman Brickner and Bratton Inc, 2016, SUPPL REP EV MIX WAS
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   GreenBiz, 2017, IOT SMART CITY TREND
   Gutierrez JM, 2015, PROCEDIA COMPUT SCI, V61, P120, DOI 10.1016/j.procs.2015.09.170
   Housing Development Board, 2017, NEW IN BOOST CONSTR
   Jose R, 2018, APPL MATER TODAY, V10, P127, DOI 10.1016/j.apmt.2017.12.015
   Kamali M, 2018, BUILD ENVIRON, V138, P21, DOI 10.1016/j.buildenv.2018.04.019
   Kamali M, 2017, J CLEAN PROD, V142, P3592, DOI 10.1016/j.jclepro.2016.10.108
   Kamali M, 2016, RENEW SUST ENERG REV, V62, P1171, DOI 10.1016/j.rser.2016.05.031
   Kellens K, 2017, J IND ECOL, V21, pS49, DOI 10.1111/jiec.12629
   Khoo HH, 2019, RESOUR CONSERV RECY, V145, P67, DOI 10.1016/j.resconrec.2019.02.010
   Kreiger MA, 2014, J CLEAN PROD, V70, P90, DOI 10.1016/j.jclepro.2014.02.009
   Lee Jay, 2015, Manufacturing Letters, V3, P18, DOI 10.1016/j.mfglet.2014.12.001
   Lou XF, 2012, ENERGY SUSTAIN DEV, V16, P509, DOI 10.1016/j.esd.2012.06.004
   Low J.S.C., 2012, ELECT GOES GREEN 201, P1
   Low JSC, 2018, PROC CIRP, V69, P849, DOI 10.1016/j.procir.2017.11.075
   Low JSC, 2016, J CLEAN PROD, V120, P105, DOI 10.1016/j.jclepro.2015.09.095
   Low JSC, 2014, J CLEAN PROD, V70, P105, DOI 10.1016/j.jclepro.2014.02.037
   Massachusetts Institute of Technology, 2013, ADD MAN GE WORLDS LA
   Ministry of the Environment and Water Resources G. of S, 2019, PUBL CONS ZERO WAST
   Ministry of the Environment and Water Resources G. of S, 2019, RUBB CHUT CURS CONV
   Ministry of the Environment and Water Resources Government of Singapore, 2015, SUST SING BLUEPR
   Ministry of Trade and Industry of Singapore, 2017, COMMUNICATION
   Misman M., 2008, INT C SCI TECHN ICST, P11
   Murakami J, 2018, LAND USE POLICY, V75, P292, DOI 10.1016/j.landusepol.2018.03.050
   National Environment Agency of Singapore, 2019, WAST STAT OV REC
   National Environment Agency of Singapore, 2018, INT WAST MAN FAC
   National Environment Agency of Singapore, 2018, NEA IMPL WAST MAN SY
   National Environment Agency of Singapore, 2019, NAT VOL PARTN E WAST
   National Geographic, 2017, WHOPP 91 PLAST ISNT
   National Research Foundation of Singapore, 2018, RIE 2020 PLAN ADV MA
   National Research Foundation of Singapore, 2016, RES INN ENT 2020 PLA
   Navigant Research, 2016, SMART WAST COLL
   Ng YT, 2017, PROC CIRP, V61, P382, DOI 10.1016/j.procir.2016.11.243
   Niaki MK, 2019, J CLEAN PROD, V222, P381, DOI 10.1016/j.jclepro.2019.03.019
   Omar MF, 2016, IOP C SER EARTH ENV, V37, DOI 10.1088/1755-1315/37/1/012059
   Pathway 21, 2019, MAT MARK
   PengjiaWang, 2014, PROC CIRP, V15, P443, DOI 10.1016/j.procir.2014.06.085
   Raabe B, 2017, PROC CIRP, V61, P263, DOI 10.1016/j.procir.2016.11.225
   Ramakrishna S, 2019, J INTELL MANUF, V30, P2307, DOI 10.1007/s10845-018-1392-0
   Rios FC, 2015, PROCEDIA ENGINEER, V118, P1296, DOI 10.1016/j.proeng.2015.08.485
   Sabaghi M., 2016, EVALUATION PRODUCTS, DOI [10.1016/j.jclepro.2016.01, DOI 10.1016/J.JCLEPRO.2016.01]
   Shukla S., 2017, INT J COMPUT APPL, V162, P975
   Singapore Department of Statistics, 2012, SING SUPPL US INP OU
   Singh N., 2016, COMPOSITES B, V115, P409, DOI DOI 10.1016/J.C0MP0SITESB.2016.09.013
   Singh S, 2017, J CLEAN PROD, V168, P1230, DOI 10.1016/j.jclepro.2017.09.108
   Soh SL, 2014, PROC CIRP, V15, P407, DOI 10.1016/j.procir.2014.06.053
   Srikantha Nalavadi, 2017, INT J ENG COMPUTER S, V6, P21507, DOI [10.18535/ijecs/v6i5.53, DOI 10.18535/IJECS/V6I5.53]
   Stock T, 2016, PROC CIRP, V40, P536, DOI 10.1016/j.procir.2016.01.129
   Stojkoska BLR, 2017, J CLEAN PROD, V140, P1454, DOI 10.1016/j.jclepro.2016.10.006
   Pham TPT, 2015, WASTE MANAGE, V38, P399, DOI 10.1016/j.wasman.2014.12.004
   Today, 2018, SING PLAST WAST REC
   Tseng M.L., 2018, RESOUR CONSERV RECY, DOI [10.1016/resconrec.2017.12.028, DOI 10.1016/RESCONREC.2017.12.028]
   United Nations, 2018, WORD URB PROSP 2018
   World Bank, 2018, WHAT WAST 2 0
   World Bank, 2017, WORLD BANK OP DAT PO
   World Economic Forum, 2016, SO WHY DONT WE
   Yeo ZQ, 2019, J IND ECOL, V23, P1087, DOI 10.1111/jiec.12846
   Young CY, 2010, WASTE MANAGE RES, V28, P236, DOI 10.1177/0734242X09337659
   Zaman AU, 2015, J CLEAN PROD, V91, P12, DOI 10.1016/j.jclepro.2014.12.013
   Zhang LG, 2016, J CLEAN PROD, V127, P19, DOI 10.1016/j.jclepro.2016.04.004
   Zheng P, 2018, FRONT MECH ENG-PRC, V13, P137, DOI 10.1007/s11465-018-0499-5
   Zhou YX, 2016, TUNN UNDERGR SP TECH, V55, P249, DOI 10.1016/j.tust.2015.12.018
NR 92
TC 0
Z9 0
U1 40
U2 40
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104438
DI 10.1016/j.resconrec.2019.104438
PG 19
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700028
DA 2020-05-12
ER

PT J
AU Konar, M
   Qiu, SY
   Tougher, B
   Vause, J
   Tlusty, M
   Fitzsimmons, K
   Barrows, R
   Cao, L
AF Konar, Manaswita
   Qiu, Siya
   Tougher, Brendan
   Vause, James
   Tlusty, Michael
   Fitzsimmons, Kevin
   Barrows, Rick
   Cao, Ling
TI Illustrating the hidden economic, social and ecological values of global
   forage fish resources
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Forage fish; Ecosystem services; Social values; Economic benefits;
   Biodiversity
ID ECOSYSTEM SERVICES; MARINE; IMPACTS; FISHERIES; PATTERNS; SEABIRDS;
   TRENDS; MEAL; GULF
AB People benefit from the existence of forage fish through a wide range of uses, both direct and indirect. However, due to lack of data and gaps in existing research, the commercial importance of these species tends to get prioritized over the wider benefits they provide to society and the environment. This paper aims to identify all the multiple beneficiaries of forage fish and present their global value that encompasses different categories of benefits using both quantitative and qualitative methods. By adopting the Millennium Ecosystem Assessment framework, we estimated the global economic benefit provided by forage fish to be $18.7 billion per annum, over three times of their direct catch value. This is a partial estimate due to data limitation. We demonstrated the importance of forage fish to the livelihoods of coastal communities by providing direct employment to 5.6 million fishermen globally. The analysis also explored the important role forage fish plays by addressing the nutritional needs of indigenous and coastal communities, and their role in shaping the culture and customs - the significance of all of which cannot be captured by money values alone. We concluded that attempts to capture the economic values of forage fish are likely to be underestimates of the true value that forage fish hold for humans and other interlinked ecosystems. Understanding the true value of forage fish is important to avoid inadvertently making undesirable tradeoffs or management decisions that are environmentally and economically unsustainable.
C1 [Konar, Manaswita; Qiu, Siya; Cao, Ling] Shanghai Jiao Tong Univ, Sch Oceanog, 1954 Huashan Rd, Shanghai, Peoples R China.
   [Konar, Manaswita; Tougher, Brendan; Barrows, Rick] Anthropocene Inst, 68 Willow Rd, Menlo Pk, CA USA.
   [Vause, James] UN Environm World Conservat Monitoring Ctr, 219 Huntingdon Rd, Cambridge, England.
   [Tlusty, Michael] Univ Massachusetts, Sch Environm, 100 William T Morrissey Blvd, Boston, MA 02125 USA.
   [Fitzsimmons, Kevin] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA.
RP Cao, L (reprint author), Shanghai Jiao Tong Univ, Sch Oceanog, 1954 Huashan Rd, Shanghai, Peoples R China.
EM caoling@sjtu.edu.cn
FU David and Lucile Packard FoundationThe David & Lucile Packard
   Foundation; Anthropocene Institute
FX We thank the Anthropocene Institute and the David and Lucile Packard
   Foundation for financial support leading to this manuscript. We also
   thank Dr. Barbara Page and Alex Driedger for substantive input on the
   manuscript and Dr. Konstantine Rountos for sharing data information.
CR AgroChart, 2017, PER FISHM PROD IS GR
   Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204
   Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512
   [Anonymous], 2013, 3 WORLD BANK GROUP
   Asche F, 2013, J AGR ECON, V64, P97, DOI 10.1111/j.1477-9552.2012.00357.x
   Bassett E., 2014, CULTURAL IMPORTANCE
   Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x
   Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x
   Berman M., 2006, MARINE RESOURCE EC, V21, P211
   Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149
   Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946
   Cooke SJ, 2015, FISHERIES MANAG ECOL, V22, P1, DOI 10.1111/fme.12005
   Crawford R.J., 2007, FINAL REPORT BCLME B, P181
   Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928
   Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720
   Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826
   Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112
   FAO, 2018, STAT WORLD FISH AQ 2
   Fischer M., 2018, SUMMARY POLICYMAKERS, DOI [10.5281/zenodo.3237428, DOI 10.5281/ZENODO.3237428]
   Fish Sea, 2018, FISHM FISH OIL FACTS
   FishStatJ, 2018, SOFTW FISH STAT TIM
   Frederiksen M, 2005, MAR ECOL PROG SER, V300, P201, DOI 10.3354/meps300201
   Froehlich HE, 2018, NAT SUSTAIN, V1, P298, DOI 10.1038/s41893-018-0077-1
   Gannon DP, 1998, FISH B-NOAA, V96, P428
   Gauvreau A., 2017, 81 ANN M SOC AM ARCH
   Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257
   Hilborn R, 2017, FISH RES, V191, P211, DOI 10.1016/j.fishres.2017.01.008
   Horn MH, 2015, J MARINE SYST, V146, P89, DOI 10.1016/j.jmarsys.2014.08.012
   IFFO, 2012, WOULD 17 MILL TONN W
   IndexMundi, 2018, FISHM MONTHL PRIC US
   Jahncke J, 2004, FISH OCEANOGR, V13, P208, DOI 10.1111/j.1365-2419.2004.00283.x
   Jones R, 2017, MAR POLICY, V80, P154, DOI 10.1016/j.marpol.2016.09.031
   Koehn LE, 2017, ICES J MAR SCI, V74, P2448, DOI 10.1093/icesjms/fsx072
   Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, P456
   Lam ME, 2019, MAR ECOL PROG SER, V617, P341, DOI 10.3354/meps12972
   Lam ME, 2016, J AGR ENVIRON ETHIC, V29, P35, DOI 10.1007/s10806-015-9587-2
   LAVERY TJ, 2012, BIOGEOSCI DISCUSS, V9, P8387
   Lewis SEF, 2012, AFR J MAR SCI, V34, P497, DOI 10.2989/1814232X.2012.716008
   Lutz SJ, 2014, FISH CARBON EXPLORIN
   Melnychuk MC, 2017, ICES J MAR SCI, V74, P121, DOI 10.1093/icesjms/fsw169
   MILLENIUM ECOSYSTEM ASSESSMENT, 2005, EC HUM WELL BEING SY
   Mullon C, 2005, FISH FISH, V6, P111, DOI 10.1111/j.1467-2979.2005.00181.x
   O'Connor S, 2009, WHALE WATCHING WORLD
   OECD-FAO, 2017, OECD FAO AGR OUTL 20, DOI [10.1787/agr_outlook-2017-en, DOI 10.1787/AGR_OUTLOOK-2017-EN]
   Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009
   Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444
   Pikitch E., 2012, LITTLE FISH BIG IMPA, P108
   Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004
   Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108
   Pitcher CR, 2017, METHODS ECOL EVOL, V8, P472, DOI 10.1111/2041-210X.12705
   Raman RK, 2018, WETL ECOL MANAG, V26, P677, DOI 10.1007/s11273-018-9600-4
   Rea AW, 2017, INTEGR ENVIRON ASSES, V13, P953, DOI 10.1002/ieam.1924
   Robinson WML, 2015, ICES J MAR SCI, V72, P1822, DOI 10.1093/icesjms/fsv035
   RSPB, 2010, LOC VAL SEAB EST SPE
   Satz D, 2013, AMBIO, V42, P675, DOI 10.1007/s13280-013-0386-6
   SEDDON N., 2016, P ROYAL SOC BIOL SCI, V283, P1844, DOI DOI 10.1098/RSPB.2016.2094
   Selck H, 2016, ENVIRON TOXICOL CHEM, V35, P1055, DOI 10.1002/etc.3385
   Small N, 2017, GLOBAL ENVIRON CHANG, V44, P57, DOI 10.1016/j.gloenvcha.2017.03.005
   Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395
   Sobrevila C., 2008, ROLE INDIGENOUS PEOP
   Stokes S., 2013, WILDLIFE TOURISM GUL
   Tacon AGJ, 2009, AMBIO, V38, P294
   Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015
   Tai TC, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00363
   Thornton RJ, 2015, MON LABOR REV, P1
   Uu-a-thluk, 2018, UU A THLUK STRAT PLA
   von der Porten S, 2016, MAR POLICY, V74, P68, DOI 10.1016/j.marpol.2016.09.007
   Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972
NR 68
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104456
DI 10.1016/j.resconrec.2019.104456
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700002
DA 2020-05-12
ER

PT J
AU Leissner, S
   Ryan-Fogarty, Y
AF Leissner, Sonja
   Ryan-Fogarty, Yvonne
TI Challenges and opportunities for reduction of single use plastics in
   healthcare: A case study of single use infant formula bottles in two
   Irish maternity hospitals
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Single-use plastics; Food packaging; Sustainable healthcare; Waste
   management; Environmental management; Infant feeding
ID PACKAGING WASTE
AB The issue of plastic pollution is now recognised as a catastrophic global crisis. Single-use plastics have attracted much attention in terms of elimination and mitigation measures. The concept of circular economy aims to attain a state where waste no longer exists. Pathways to eliminate or adapt stages of the life cycle, long before the end-of-life phase, are necessary to address single-use plastics.
   This paper examines single-use food packaging plastic waste in Irish maternity hospital settings through a case study of ready-to-use infant formula bottles. A quantitative and qualitative assessment of single-use plastics arising from infant feeding bottles is presented. Quantitative examination reveals a high variability in materials used for bottles, teats and associated packaging, thus creating difficulties in standardising labelling and identifying appropriate waste treatment options. Quantitative calculations reveal the extent of plastic waste generated by this single use product.
   Possible mitigation options include: demand reduction for single-use bottles in the first place, alternative solutions to eliminate single-use bottles, opportunities for manufacturers to address product design, impetus for policy makers to act on coherent labelling systems for materials and improved overall waste management. Considering the level of confusion at hospital and household levels as to best practice in recycling, this research highlights the need for targeted collaborative research utilising sectoral best practice, waste hierarchy and circular economy principles.
C1 [Leissner, Sonja; Ryan-Fogarty, Yvonne] Univ Limerick, Fac Sci & Engn, Limerick V94 T9PX, Ireland.
RP Ryan-Fogarty, Y (reprint author), Univ Limerick, Fac Sci & Engn, Limerick V94 T9PX, Ireland.
EM yvonne.ryan@ul.ie
CR Aarnio T, 2008, RESOUR CONSERV RECY, V52, P612, DOI 10.1016/j.resconrec.2007.08.002
   American Chemistry Council, 2017, PLAST PACK RES
   [Anonymous], 2018, LANCET PLANET HEALTH, V2, pE274, DOI 10.1016/S2542-5196(18)30142-6
   Buleon C, 2013, EUR J ANAESTH, V30, P163, DOI 10.1097/EJA.0b013e32835c1cdb
   Cadogan S., 2017, IRISH EXAMINER
   Campion N, 2015, J CLEAN PROD, V94, P46, DOI 10.1016/j.jclepro.2015.01.076
   Cattaneo A, 2015, ARCH DIS CHILD, V100, P323, DOI 10.1136/archdischild-2014-306996
   Chauhan M.N., 2019, GEN SURG LAPAROSC NE, V2, P6
   Circle Economy, 2015, HEALTHC PLAST WAST A
   D'Ambrieres W., 2019, FIELD ACTIONS SCI RE, V19, P12
   Donnelly E., 2018, IRISH INDEPENDENT
   DuPont, 2017, STER PACK DUPONG TYV
   Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913
   European Aluminium Association, 2008, COLL SORT REC AL PAC
   European Commission, 2014, DEV GUID EXT PROD RE
   European Commission, 2018, SINGL US PLAST NEW E
   European Commission (DG Environment), 2011, PLAST WAST ENV
   FIBL and IFOAM, 2017, WORLD ORG AGR STAT E
   Flynn V., 2017, SUNDAY TIMES
   Government of Ireland, 2019, CAN I DISP WAST
   Health Service Executive, 2016, BREASTF HLTH IR HLTH
   Hopewell J, 2009, PHILOS T R SOC B, V364, P2115, DOI 10.1098/rstb.2008.0311
   Hunt EJ, 2015, RESOUR CONSERV RECY, V97, P24, DOI 10.1016/j.resconrec.2015.02.004
   Ireland Health Service Executive, 2012, NAT INF FEED POL MAT
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0
   Lazarevic D, 2010, RESOUR CONSERV RECY, V55, P246, DOI 10.1016/j.resconrec.2010.09.014
   Lee BK, 2002, WASTE MANAGE, V22, P461, DOI 10.1016/S0956-053X(02)00006-5
   Richard GM, 2011, RESOUR CONSERV RECY, V55, P472, DOI 10.1016/j.resconrec.2010.12.010
   Marcinkowski A, 2012, RESOUR CONSERV RECY, V69, P10, DOI 10.1016/j.resconrec.2012.09.004
   Marfin AG, 2003, ANAESTHESIA, V58, P511, DOI 10.1046/j.1365-2044.2003.03144_9.x
   Marine Litter Solutions, 2018, DECL GLOB PLAST ASS
   McGain F, 2009, ANAESTH INTENS CARE, V37, P820, DOI 10.1177/0310057X0903700521
   McGain F, 2012, ANESTH ANALG, V114, P1073, DOI 10.1213/ANE.0b013e31824e9b69
   Mehrweg GbR A.K., 2019, PFAND
   Minnesota Pollution Control Agency, 2013, CURBS REC SURV
   PlasticsEurope, 2016, PLAST FACTS 2016 AN
   Purdy J, 2017, BREASTFEEDING ISLAND
   Rawlings B., 2009, MANAGING SOLID WASTE
   Repak,, 2019, FAQS TOP TIPS
   Ring E., 2017, IRISH EXAMINER
   Ryan-Fogarty Y, 2017, WASTE MANAGE, V61, P405, DOI 10.1016/j.wasman.2016.12.029
   Sookne K., 2018, HOSP TAKES AIM PLAST
   Stringer R., 2018, PLASTICS HEALTHCARE
   Wearden G, 2016, GUARDIAN
NR 45
TC 1
Z9 1
U1 22
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104462
DI 10.1016/j.resconrec.2019.104462
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700010
DA 2020-05-12
ER

PT J
AU Lin, L
   Chen, YD
   Hua, D
   Liu, Y
   Yan, MY
AF Lin, Lu
   Chen, Yongqin David
   Hua, Dong
   Liu, Yi
   Yan, Mengyao
TI Provincial virtual energy-water use and its flows within China: A
   multiregional input-output approach
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Virtual energy-water use; Virtual water flow; Multiregional input-output
   analysis; Production-Based; Consumption-Based
ID ELECTRIC-POWER SYSTEM; SCARCE WATER; FOOTPRINT; TRANSFERS; TRADE; NEXUS;
   GENERATION; CARBON
AB The energy industry in China is responsible for the largest water withdrawal and consumption in the secondary industry. In addition to the large quantities, another important feature of energy-water use in China is a critical spatial mismatch between water consumption and water availability. We used a multiregional input-output model to investigate virtual water of the energy industry in the Chinese provinces, and to determine virtual water flows embedded in energy-related trade among the provinces. The domestic interprovincial trade of energy in China has caused virtual water being used outside of the energy production province, including 8.6% of the virtual water withdrawal and 15.6% of the virtual water consumption. The results demonstrate there are a general north-to-south flow and a west-to-east flow of virtual energy-water within China. This flowing pattern indicates the energy consumption in the more-developed provinces, such as Beijing, Tianjin, Shanghai, Jiangsu, Zhejiang, and Guangdong, are supported by water use from the less-developed provinces where water scarcity is severe. Particularly, Shanxi and Inner Mongolia are two major exporters of virtual energy-water because more than half of the water resources in these two provinces outflow mainly to the north region, imposing huge pressure on the scarce domestic water resources in these two provinces. This study has proved the great importance of and also provided an approach to integrating water-energy nexus into energy industry planning and management in China.
C1 [Lin, Lu; Yan, Mengyao] China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.
   [Lin, Lu] China Univ Petr, Acad Chinese Energy Strategy, Beijing, Peoples R China.
   [Chen, Yongqin David] Chinese Univ Hong Kong, Sch Humanities & Social Sci, Shenzhen, Peoples R China.
   [Chen, Yongqin David] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Peoples R China.
   [Hua, Dong] Minist Water Resources, Informat Ctr, Beijing, Peoples R China.
   [Liu, Yi] Tsinghua Univ, Sch Environm, Beijing, Peoples R China.
RP Lin, L (reprint author), China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.; Lin, L (reprint author), China Univ Petr, Acad Chinese Energy Strategy, Beijing, Peoples R China.
EM linlu@cup.edu.cn; ydavidchen@cuhk.edu.hk; huadong@mwr.gov.cn;
   yi.liu@thu.edu.cn; iyao7751@163.com
OI Lin, Lu/0000-0002-2702-3427
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71904203]; Humanities and Social Science Foundation
   of Ministry of Education in China [17YJCZH104]; Science Foundation of
   China University of Petroleum, Beijing [2462015YJRC018]
FX This work was supported by the National Natural Science Foundation of
   China (71904203), the Humanities and Social Science Foundation of
   Ministry of Education in China (17YJCZH104) and Science Foundation of
   China University of Petroleum, Beijing (2462015YJRC018).
CR ALLAN JA, 1994, WATER IN THE ARAB WORLD, P65
   Bian Z, 2010, MIN SCI TECHNOL CHIN, V20, P215, DOI DOI 10.1016/S1674-5264(09)60187-3
   Byers EA, 2014, GLOBAL ENVIRON CHANG, V25, P16, DOI 10.1016/j.gloenvcha.2014.01.005
   China National Bureau of Statiatics China National Energy Administration, 2016, CHINA ENERGY STAT YB, DOI [10.1016/j.jclepro.2017.10.273, DOI 10.1016/J.JCLEPRO.2017.10.273]
   Ding N, 2018, J CLEAN PROD, V174, P1021, DOI 10.1016/j.jclepro.2017.10.273
   Feng KS, 2014, ENVIRON SCI TECHNOL, V48, P7704, DOI 10.1021/es500502q
   Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110
   Guan D, 2007, ECOL ECON, V61, P159, DOI 10.1016/j.ecolecon.2006.02.022
   Guo RP, 2016, APPL ENERG, V168, P110, DOI 10.1016/j.apenergy.2016.01.063
   Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109
   International Energy Agency, 2018, WORD EN BAL 2018
   Lenzen M, 2011, ECON SYST RES, V23, P73, DOI 10.1080/09535314.2010.548793
   Li X, 2019, APPL ENERG, V235, P827, DOI 10.1016/j.apenergy.2018.10.097
   Liao XW, 2019, ECOL MODEL, V391, P9, DOI 10.1016/j.ecolmodel.2018.10.009
   Liao XW, 2018, APPL ENERG, V226, P252, DOI 10.1016/j.apenergy.2018.05.132
   Lin L., 2018, SUSTAIN BASEL, V10, DOI [10.3390/sul0010030, DOI 10.3390/SUL0010030]
   Lingying Pan, 2011, 2011 International Conference on Materials for Renewable Energy & Environment, P1578, DOI 10.1109/ICMREE.2011.5930635
   Liu JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11446
   Liu QL, 2017, J CLEAN PROD, V161, P735, DOI 10.1016/j.jclepro.2017.05.003
   Ma J, 2006, PHILOS T R SOC B, V361, P835, DOI 10.1098/rstb.2005.1644
   Macknick J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045803
   Meng FX, 2019, ENERGY, V171, P403, DOI 10.1016/j.energy.2019.01.013
   Mi ZF, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.155
   Mielke E, 2010, WATER CONSUMPTION EN
   Ministry of Environmental Protection China, 2011, DAT 1 NAT POLL SOURC
   Ministry of Water Resource China, 2017, WAT RES B 2016
   Olsson G., 2012, WAT EN THREATS OPP, P190
   State Grid Corporation of China, 2016, STAT GRID CORP CHIN
   Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t
   Su B, 2010, ENERG ECON, V32, P166, DOI 10.1016/j.eneco.2009.07.010
   Tidwell V, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094008
   Wan LY, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074017
   Wang YD, 2015, RESOUR CONSERV RECY, V98, P76, DOI 10.1016/j.resconrec.2015.01.005
   Wang ZW, 2018, J INNOV OPT HEAL SCI, V11, DOI 10.1142/S179354581830001X
   White D.J., 2017, APPL ENERGY, V210
   Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003
   Wiedmann T, 2018, NAT GEOSCI, V11, P314, DOI 10.1038/s41561-018-0113-9
   Wiedmann T, 2011, ECOL ECON, V70, P1937, DOI 10.1016/j.ecolecon.2011.06.014
   World Bank, 2017, DATABANK WORLD BANK
   Zha N, 2018, RESOUR CONSERV RECY, V134, P329, DOI 10.1016/j.resconrec.2017.09.009
   Zhang C, 2017, APPL ENERG, V187, P438, DOI 10.1016/j.apenergy.2016.11.052
   Zhang C, 2014, ECOL ECON, V100, P159, DOI 10.1016/j.ecolecon.2014.02.006
   Zhang C, 2013, ENVIRON SCI TECHNOL, V47, P14459, DOI 10.1021/es402556x
   Zhang W, 2018, ENVIRON SCI TECHNOL, V52, P3888, DOI 10.1021/acs.est.7b05651
   Zhao X, 2015, P NATL ACAD SCI USA, V112, P1031, DOI 10.1073/pnas.1404130112
   Zhu XJ, 2015, APPL ENERG, V151, P345, DOI 10.1016/j.apenergy.2015.04.082
NR 46
TC 0
Z9 0
U1 27
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104486
DI 10.1016/j.resconrec.2019.104486
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700021
DA 2020-05-12
ER

PT J
AU Lin, YC
   Lin, CC
   Lee, M
   Chiueh, PT
   Lo, SL
   Liou, ML
AF Lin, Ying-Chen
   Lin, Chia-Chun
   Lee, Mengshan
   Chiueh, Pei-Te
   Lo, Shang-Lien
   Liou, Ming-Lone
TI Comprehensive assessment of regional food-energy-water nexus with
   GIS-based tool
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Food-Energy-Water; GIS; Life cycle assessment; Land use; Nexus tool
ID LIFE-CYCLE ASSESSMENT; ENVIRONMENTAL IMPACTS; SYSTEMS;
   INTERDEPENDENCIES; SUSTAINABILITY; MANAGEMENT
AB Integration of the food, energy, and water (FEW) nexus thinking is expected to enhance cross-sectoral discussion during the process of policy development. This process can be improved with comprehensive assessment tools to provide quantitative information regarding the interdependence of the FEW nexus. A comprehensive framework of the regional FEW nexus quantitative assessment was proposed in this study. Life cycle assessment (LCA) was the core method used to evaluate the FEW inter-linkages. Land use data which can further imply the resources consumption or requirement was introduced to estimate potential changes in the nexus in future time periods. In order to display the practicality of the FEW nexus approach, a user-friendly nexus platform, a GIS-based Regional Environmental Assessment Tool for Food-Energy-Water nexus (GREAT for FEW) (http://greatforfew.enve.ntu.edu.tw/FEW/), was developed with a solid conceptual model, a database, and calculation methods. The usability of the tool was demonstrated using a Taiwanese case study. The results of the Taiwanese case showed that Scenario 1 (non-nuclear homeland policy) caused the lowest environmental impacts as compared to both Scenario 0 (baseline) and Scenario 2 (non-nuclear homeland policy with National Spatial Plan) due to better energy structures and maintenance of agricultural lands. These outcomes indicate that the selection of indicators does affect the results. Therefore, it is suggested that additional indicators should be designed based on the characteristics of the case study area and concerns of stakeholders.
C1 [Lin, Ying-Chen; Lin, Chia-Chun; Lee, Mengshan; Chiueh, Pei-Te; Lo, Shang-Lien] Natl Taiwan Univ, Grad Inst Environm Engn, 71 Chou Shan Rd, Taipei 106, Taiwan.
   [Lin, Ying-Chen] Feng Chia Univ, Dept Urban Planning & Spatial Informat, 100 Wenhwa Rd, Taichung 407, Taiwan.
   [Lee, Mengshan] Natl Kaohsiung Univ Sci & Technol, Dept Safety Hlth & Environm Engn, 1 Univ Rd, Kaohsiung 824, Taiwan.
   [Liou, Ming-Lone] Taipei City Govt, Dept Environm Protect, 1 City Hall Rd, Taipei 110, Taiwan.
RP Chiueh, PT (reprint author), Natl Taiwan Univ, Grad Inst Environm Engn, 71 Chou Shan Rd, Taipei 106, Taiwan.
EM ptchueh@ntu.edu.tw
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [MOST 107-2627-M-002-015]; Belmont Forum
FX This work was supported by the Ministry of Science and Technology of
   Taiwan (Grant No. MOST 107-2627-M-002-015). As a project partner, the
   authors thank for the collaboration with the other members of the
   CRUNCH: Climate Resilient Urban Nexus Choices -Operationalising the
   Food-Water-Energy Nexus, the Belmont Forum funded project. The technical
   support (including model coding and programming support) from the
   Chain-E Technologies Co., Ltd is also highly appreciated.
CR Al-Ansari T, 2015, SUSTAIN PROD CONSUMP, V2, P52, DOI 10.1016/j.spc.2015.07.005
   Al-Saidi M, 2017, SCI TOTAL ENVIRON, V574, P1131, DOI 10.1016/j.scitotenv.2016.09.046
   [Anonymous], 2006, IS014044
   Bazilian M, 2011, ENERG POLICY, V39, P7896, DOI 10.1016/j.enpol.2011.09.039
   Bieber N, 2018, ENERG POLICY, V113, P584, DOI 10.1016/j.enpol.2017.11.037
   Boulay AM, 2013, ENVIRON SCI TECHNOL, V47, P11926, DOI 10.1021/es403928f
   Chang Y, 2016, ENERGIES, V9, DOI 10.3390/en9020065
   Council of Agriculture, 2018, 2017 FOOD SUPPL UT Y
   Daher B, 2019, SCI TOTAL ENVIRON, V651, P2913, DOI 10.1016/j.scitotenv.2018.09.395
   Daher B, 2019, SCI TOTAL ENVIRON, V647, P449, DOI 10.1016/j.scitotenv.2018.07.398
   Dargin J, 2019, SCI TOTAL ENVIRON, V650, P1566, DOI 10.1016/j.scitotenv.2018.09.080
   Del Borghi A, 2018, SUSTAIN PROD CONSUMP, V13, P24, DOI 10.1016/j.spc.2017.11.001
   Del Borghi A, 2013, INT J LIFE CYCLE ASS, V18, P1158, DOI 10.1007/s11367-013-0549-5
   Hiloidhari M, 2017, BIORESOURCE TECHNOL, V242, P218, DOI 10.1016/j.biortech.2017.03.079
   Hoff H, 2011, BONN2011 C WAT EN FO
   ISO, 2006, IS014040
   Karabulut AA, 2018, J CLEAN PROD, V172, P3874, DOI 10.1016/j.jclepro.2017.05.092
   Klein SJW, 2013, ENERG POLICY, V63, P935, DOI 10.1016/j.enpol.2013.08.057
   Laso J, 2018, WASTE MANAGE, V80, P186, DOI 10.1016/j.wasman.2018.09.009
   Lee M, 2017, APPL ENERG, V205, P589, DOI 10.1016/j.apenergy.2017.08.002
   Lin K.C., 2015, TAIWAN AGR EC REV, V20, P1
   Mannan M, 2018, J CLEAN PROD, V193, P300, DOI 10.1016/j.jclepro.2018.05.050
   Miralles-Wilhelm F., 2016, J ENV STUD SCI, V6, P3, DOI [10.1007/s13412-016-0361-1, DOI 10.1007/S13412-016-0361-1]
   Motoshita M., 2014, INT J LIFE CYCLE ASS, P1
   Motoshita M, 2011, INT J LIFE CYCLE ASS, V16, P65, DOI 10.1007/s11367-010-0236-8
   Namany S, 2019, J CLEAN PROD, V225, P610, DOI 10.1016/j.jclepro.2019.03.304
   Nie YL, 2019, SCI TOTAL ENVIRON, V659, P7, DOI 10.1016/j.scitotenv.2018.12.242
   Payen S, 2015, J CLEAN PROD, V87, P139, DOI 10.1016/j.jclepro.2014.10.007
   Pfister S, 2011, ENVIRON SCI TECHNOL, V45, P5761, DOI 10.1021/es1041755
   Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e
   Ramaswami A., 2017, ENVIRON RES LETT, V12, P1
   Ren DD, 2018, SCI TOTAL ENVIRON, V626, P11, DOI 10.1016/j.scitotenv.2018.01.071
   Schlor H, 2018, J SUSTAIN DEV ENERGY, V6, P1, DOI 10.13044/j.sdewes.d5.0182
   Silalertruksa T, 2018, J CLEAN PROD, V182, P521, DOI 10.1016/j.jclepro.2018.02.085
   Venghaus S, 2018, ENVIRON SCI POLICY, V90, P183, DOI 10.1016/j.envsci.2017.12.014
   Welsch M, 2014, APPL ENERG, V113, P1434, DOI 10.1016/j.apenergy.2013.08.083
   Woldesellasse H., 2018, COMPUT AIDED CHEM EN, V44, P997, DOI [10.1016/B978-0-444-64241-7.50161-0, DOI 10.1016/B978-0-444-64241-7.50161-0]
   Yang XC, 2018, APPL ENERG, V228, P2298, DOI 10.1016/j.apenergy.2018.07.090
   Yuan KY, 2018, ENERG POLICY, V119, P502, DOI 10.1016/j.enpol.2018.05.009
   Zhang C, 2018, J CLEAN PROD, V195, P625, DOI 10.1016/j.jclepro.2018.05.194
   Zhang PP, 2019, RESOUR CONSERV RECY, V142, P215, DOI 10.1016/j.resconrec.2018.11.018
   Zisopoulou K, 2018, ENERG POLICY, V119, P123, DOI 10.1016/j.enpol.2018.04.030
NR 42
TC 0
Z9 0
U1 41
U2 41
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104457
DI 10.1016/j.resconrec.2019.104457
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700027
DA 2020-05-12
ER

PT J
AU Lu, JQ
   Kumagai, S
   Ohno, H
   Kameda, T
   Saito, Y
   Yoshioka, T
   Fukushima, Y
AF Lu, Jiaqi
   Kumagai, Shogo
   Ohno, Hajime
   Kameda, Tomohito
   Saito, Yuko
   Yoshioka, Toshiaki
   Fukushima, Yasuhiro
TI Deducing targets of emerging technologies based on ex ante life cycle
   thinking: Case study on a chlorine recovery process for polyvinyl
   chloride wastes
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Cl recovery; Ex ante assessment; Energy consumption; Greenhouse gas
   emissions; Life cycle assessment; Polyvinyl chloride recycling
ID INDUSTRIAL METABOLISM; ENERGY-CONSUMPTION; SOLID-WASTE; PART 1; PVC;
   DECHLORINATION; INCINERATION; PERSPECTIVE; EMISSION; JAPAN
AB A novel chlorine (Cl) recovery process for polyvinyl chloride (PVC) wastes can potentially avoid the formation of undesirable Cl-containing compounds during thermal treatments, improve hydrocarbon usability, and create a Cl circulation system. Here, using a case study in Japan, we applied an approach based on ex ante life cycle thinking to guide the future development of the Cl recovery process in terms of the potential energy efficiency and greenhouse gas (GHG) emission. First, energy consumption and GHG emissions associated with current PVC waste treatments were investigated to benchmark the evaluated process. Next, a life cycle inventory (LCI) model containing two variables, dechlorination degree X and P/K (a variable decided by operating conditions), was developed based on chemical stoichiometry using previous experimental and material flow analysis studies. Using the LCI, the potential net energy consumption and GHG emission of the Cl recovery process based on the investigated variables were obtained. Subsequently, the target thresholds of variable values were deduced by comparing the impacts against the benchmarks. Based on a contribution analysis, although the dechlorination process would be a hotspot for energy consumption, the energy credit could be generated from the reduced Cl treatment for tail gas during thermal processing of PVC wastes and recovered salt. The acceptable variable thresholds can be used to suggest the development target setting for the Cl recovery process at an industrial scale.
C1 [Lu, Jiaqi; Kumagai, Shogo; Kameda, Tomohito; Saito, Yuko; Yoshioka, Toshiaki] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.
   [Ohno, Hajime; Fukushima, Yasuhiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.
RP Kumagai, S (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.; Fukushima, Y (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.
EM kumagai@tohoku.ac.jp; fuku@sis.che.tohoku.ac.jp
RI Lu, Jiaqi/AAC-6442-2019; Kameda, Tomohito/P-7350-2017
OI Kameda, Tomohito/0000-0002-8929-3772; Lu, Jiaqi/0000-0001-7864-1981;
   Kumagai, Shogo/0000-0002-5046-372X
FU Japan Society for the Promotion of Science KAKENHI grantMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [17H007951]; Japan Science and Technology AgencyJapan
   Science & Technology Agency (JST) [J170002403]; Chinese Scholarship
   CouncilChina Scholarship Council
FX This work was partially supported by a Japan Society for the Promotion
   of Science KAKENHI grant [grant number 17H007951 and Japan Science and
   Technology Agency [grant numberJ170002403]. Jiaqi Lu was supported by
   the Chinese Scholarship Council.
CR Al-Karaghouli A, 2013, RENEW SUST ENERG REV, V24, P343, DOI 10.1016/j.rser.2012.12.064
   AYRES R, 1997, J IND ECOL, V1, P65
   BORN JGP, 1993, ENVIRON SCI TECHNOL, V27, P1849, DOI 10.1021/es00046a013
   Cherubini F, 2009, ENERGY, V34, P2116, DOI 10.1016/j.energy.2008.08.023
   Ciacci L, 2017, RESOUR CONSERV RECY, V123, P108, DOI 10.1016/j.resconrec.2016.08.008
   Dewulf JP, 2002, ENVIRON SCI TECHNOL, V36, P1130, DOI 10.1021/es010140o
   Diaz R, 2006, WASTE MANAGE, V26, P886, DOI 10.1016/j.wasman.2005.05.007
   European Comission, 2000, INFL PVC QUANT HAZ F
   Finnveden G, 2005, J CLEAN PROD, V13, P213, DOI 10.1016/j.jclepro.2004.02.023
   Frischknecht R, 2005, INT J LIFE CYCLE ASS, V10, P3, DOI 10.1065/lca2004.10.181.1
   Hesser F, 2015, COMPOS PART B-ENG, V79, P197, DOI 10.1016/j.compositesb.2015.04.038
   Isobe T., 2016, J LIFE CYCLE ASSESS, V12, P196
   JSIA (Japan Soda Industry Association), 2017, YEARL STAT IND SALT
   Kadirova Z, 2006, J HAZARD MATER, V137, P352, DOI 10.1016/j.jhazmat.2006.02.008
   Kameda T, 2008, IND ENG CHEM RES, V47, P8619, DOI 10.1021/ie8006819
   Kameda T, 2013, J MATER CYCLES WASTE, V15, P111, DOI 10.1007/s10163-012-0098-1
   Kumagai S, 2018, RESOUR CONSERV RECY, V133, P354, DOI 10.1016/j.resconrec.2017.07.007
   Kumagai S, 2016, J JPN PETROL INST, V59, P243, DOI 10.1627/jpi.59.243
   Lazarevic D, 2010, RESOUR CONSERV RECY, V55, P246, DOI 10.1016/j.resconrec.2010.09.014
   Lei JX, 2018, J MATER CYCLES WASTE, V20, P137, DOI 10.1007/s10163-016-0555-3
   METI (Ministry of Economy Trade and Industry of Japan), 2016, FUT DEM TRENDS GLOB
   Nakamura S, 2009, J IND ECOL, V13, P706, DOI 10.1111/j.1530-9290.2009.00153.x
   Nakatani J, 2010, INT J LIFE CYCLE ASS, V15, P590, DOI 10.1007/s11367-010-0189-y
   Perugini F, 2005, ENVIRON PROG, V24, P137, DOI 10.1002/ep.10078
   PWMI, 2016, INTR PLAST REC
   PWMI (Plastic Waste Management Institute), 2017, PLAST PROD PLAST WAS
   PWMI (Plastic Waste Management Institute), 2014, REP ACC IMPR PLAST M
   Sadat-Shojai M, 2011, POLYM DEGRAD STABIL, V96, P404, DOI 10.1016/j.polymdegradstab.2010.12.001
   Schrijvers DL, 2014, GREEN CHEM, V16, P4969, DOI [10.1039/C4GC00830H, 10.1039/c4gc00830h]
   Seike T, 2018, RESOUR CONSERV RECY, V131, P41, DOI 10.1016/j.resconrec.2017.12.003
   Seki S, 2018, J MATER CYCLES WASTE, V20, P2068, DOI 10.1007/s10163-018-0761-2
   Seki S, 2017, J MATER CYCLES WASTE, V19, P21, DOI 10.1007/s10163-015-0421-8
   Sekine Y, 2009, INT J LIFE CYCLE ASS, V14, P122, DOI 10.1007/s11367-008-0055-3
   Shen L, 2011, INT J LIFE CYCLE ASS, V16, P522, DOI 10.1007/s11367-011-0296-4
   Sinnott M, 2006, MINER ENG, V19, P1537, DOI 10.1016/j.mineng.2006.08.012
   Song HS, 1999, KOREAN J CHEM ENG, V16, P202, DOI 10.1007/BF02706837
   Stocker T.F., 2013, IPCC 2013 CLIMATE CH
   Suzuta Y., 2007, J SOC POWDER TECHNOL, V44, pp180
   Tahara K., 2010, P 9 INT C EC TOK
   The Japan Containers and Packaging Recycling Association, 2007, REP METH CALC ENV BU
   U.S. Environmental Protection Agency, 2018, ADV SUST MAT MAN 201
   VEC (Vinyl Environmental Council), 2016, STAT PVC PROD
   Villares M, 2017, INT J LIFE CYCLE ASS, V22, P1618, DOI 10.1007/s11367-017-1270-6
   Villares M, 2016, J CLEAN PROD, V129, P315, DOI 10.1016/j.jclepro.2016.04.066
   Wang LC, 2003, SCI TOTAL ENVIRON, V302, P185, DOI 10.1016/S0048-9697(02)00306-6
   Wey MY, 2008, WASTE MANAGE, V28, P406, DOI 10.1016/j.wasman.2006.12.008
   Zhou CB, 2015, WASTE MANAGE, V35, P191, DOI 10.1016/j.wasman.2014.09.029
   Zhou YC, 2013, RESOUR CONSERV RECY, V73, P33, DOI 10.1016/j.resconrec.2012.12.016
NR 48
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104500
DI 10.1016/j.resconrec.2019.104500
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700030
DA 2020-05-12
ER

PT J
AU Naumanen, M
   Uusitalo, T
   Huttunen-Saarivirta, E
   van der Have, R
AF Naumanen, M.
   Uusitalo, T.
   Huttunen-Saarivirta, E.
   van der Have, R.
TI Development strategies for heavy duty electric battery vehicles:
   Comparison between China, EU, Japan and USA
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Heavy duty vehicle; Electric vehicle; Battery; Literature analysis;
   Statistical methods; Raw material
ID EARTH-ELEMENTS DEMAND; FUEL-CELL TECHNOLOGY; PATENT INFORMATION; POLICY;
   ELECTRIFICATION; BOTTLENECKS; COMPETITION; INDICATORS; PROPULSION;
   INNOVATION
AB This paper investigates the development of heavy duty electric battery vehicles through analysing research papers and patents and identifies emerging technology areas by using a generative probabilistic model, Latent Dirichlet Allocation (LDA). The focus of the analysis is on literature and patents published since 2010 up to date, summing up altogether more than 25 000 references. We divide the references into eight topics: operating an electric vehicle, its control, motor operations, thermal management, battery module, battery technologies, electric vehicle (EV) infrastructure and charging EV. Because battery technologies are of strategic importance in technological competition for companies and relate to the areal raw material base, we take a more detailed look at this field. The results from publication analysis are presented for China, Europe, Japan and USA. The distribution of raw materials required for heavy duty vehicles shows interesting correlations with the national development strategies. China holds reserves and/or mine production for all key raw materials categories (battery, magnet and electric cabling) needed in heavy duty electric vehicles. In addition to having an extensive raw materials base, China has protected intellectual property rights in many areas thus defending the raw materials also by controlling the access to the technologies. USA has some raw material reserves and/or production among all three raw material categories also, but their global contribution is significantly lower. Japan, with very narrow natural resource base, has very limited patenting or scientific publishing in any of the studied sub-areas of heavy duty electric vehicle development.
C1 [Naumanen, M.; Uusitalo, T.; Huttunen-Saarivirta, E.; van der Have, R.] VTT Tech Res Ctr Finland Ltd, POB 1000, FI-02044 Espoo, Finland.
   [Naumanen, M.] Stat Finland, FI-00022 Helsinki, Finland.
RP Naumanen, M (reprint author), VTT Tech Res Ctr Finland Ltd, POB 1000, FI-02044 Espoo, Finland.
EM mika.naumanen@vtt.fi
FU Academy of Finland through the Strategic Research Council project
   CloseLoop [303453]
FX The financial support by the Academy of Finland through the Strategic
   Research Council project CloseLoop (funding decision #303453) is
   gratefully acknowledged.
CR ABERNATHY WJ, 1978, TECHNOL REV, V80, P40
   Alonso Omar, 2009, P 18 ACM C INF KNOWL, DOI [10.1145/1645953.1645968, DOI 10.1145/1645953.1645968]
   [Anonymous], 2017, STUD REV LIST CRIT R
   Azagra-Caro JM, 2011, J AM SOC INF SCI TEC, V62, P1727, DOI 10.1002/asi.21574
   Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Bobba S, 2019, RESOUR CONSERV RECY, V145, P279, DOI 10.1016/j.resconrec.2019.02.022
   Brown T.J., 2018, WORLD MINERAL PRODUC, DOI [10.1136/JCP.54.5.356, DOI 10.1136/JCP.54.5.356]
   Cabukoglu E, 2019, TRANSPORT RES D-TR E, V70, P35, DOI 10.1016/j.trd.2019.03.004
   Cabukoglu E, 2018, TRANSPORT RES C-EMER, V88, P107, DOI 10.1016/j.trc.2018.01.013
   Chen SH, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050425
   Copper Development Association, 2017, COPP DRIV EL VEH
   Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004
   DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9
   Dijk M, 2016, TECHNOL FORECAST SOC, V105, P77, DOI 10.1016/j.techfore.2016.01.013
   Ernst H, 1997, SMALL BUS ECON, V9, P361, DOI 10.1023/A:1007921808138
   European Comission, 2014, QUEST ANSW COMM STRA, P1
   European Commission, 2018, COM2018293
   European Commission, 2017, BATTERIES MAJ OPP SU, DOI [10.2777/864893, DOI 10.2777/864893]
   European Commission, 2017, COM2017490
   Frenken K, 2004, TECHNOL FORECAST SOC, V71, P485, DOI [10.1016/S0040-1625(03)00010-6, 10.1016/s0040-1625(03)00010-6]
   Garfield E., 2003, INT J CLIN HLTH PSYC, V3, P363, DOI DOI 10.1080/09515080020007599
   Golembiewski B, 2015, J CLEAN PROD, V87, P800, DOI 10.1016/j.jclepro.2014.10.034
   Goodenough KM, 2018, NAT RESOUR RES, V27, P201, DOI 10.1007/s11053-017-9336-5
   GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301
   Han EJ, 2015, J TECHNOL TRANSFER, V40, P821, DOI 10.1007/s10961-014-9367-6
   Harhoff D, 2003, RES POLICY, V32, P1343, DOI 10.1016/S0048-7333(02)00124-5
   Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265
   Harrison G, 2017, TECHNOL FORECAST SOC, V114, P165, DOI 10.1016/j.techfore.2016.08.007
   Helbig C, 2018, J CLEAN PROD, V172, P274, DOI 10.1016/j.jclepro.2017.10.122
   Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649
   Huang AH, 2018, MANAGE SCI, V64, P2833, DOI 10.1287/mnsc.2017.2751
   International Energy Agency, 2017, GLOB EV OUTL 2017 2, DOI [10.1787/9789264278882-en, DOI 10.1787/9789264278882-EN]
   Jeon J, 2011, J INTELLECT PROP RIG, V16, P385
   Kast J, 2017, INT J HYDROGEN ENERG, V42, P4508, DOI 10.1016/j.ijhydene.2016.12.129
   Lebedeva Natalia, 2017, LITHIUM ION BATTERY, DOI [10.2760/6060, DOI 10.2760/6060]
   Li R, 2014, J ASSOC INF SCI TECH, V65, P1007, DOI 10.1002/asi.23054
   Li XY, 2019, RESOUR CONSERV RECY, V145, P322, DOI 10.1016/j.resconrec.2019.02.003
   Liebesny Felix, 1974, J AM SOC INFORM SCI, V25, P339, DOI [10.1002/asi.4630250512, DOI 10.1002/ASI.4630250512]
   Liu SJ, 1997, INT J TECHNOL MANAGE, V13, P661, DOI 10.1504/IJTM.1997.001689
   Ma J, 2015, SCIENTOMETRICS, V102, P811, DOI 10.1007/s11192-014-1392-6
   Manzetti S, 2015, RENEW SUST ENERG REV, V51, P1004, DOI 10.1016/j.rser.2015.07.010
   Mayyas Ahmad, 2019, Procedia Manufacturing, V33, P508, DOI 10.1016/j.promfg.2019.04.063
   NARIN F, 1987, RES POLICY, V16, P143, DOI 10.1016/0048-7333(87)90028-X
   Olivetti EA, 2017, JOULE, V1, P229, DOI 10.1016/j.joule.2017.08.019
   Pilkington A., 2002, World Patent Information, V24, P5, DOI 10.1016/S0172-2190(01)00065-5
   Richa K, 2014, RESOUR CONSERV RECY, V83, P63, DOI 10.1016/j.resconrec.2013.11.008
   Romejko K, 2017, J CLEAN PROD, V142, P39, DOI 10.1016/j.jclepro.2016.09.029
   Saidani M, 2018, RESOUR CONSERV RECY, V135, P108, DOI 10.1016/j.resconrec.2017.06.017
   Schipper BW, 2018, RESOUR CONSERV RECY, V132, P28, DOI 10.1016/j.resconrec.2018.01.004
   Sen B, 2017, J CLEAN PROD, V141, P110, DOI 10.1016/j.jclepro.2016.09.046
   Seol H, 2011, EXPERT SYST APPL, V38, P2933, DOI 10.1016/j.eswa.2010.06.083
   Sievert C., 2014, P WORKSH INT LANG LE, P63, DOI DOI 10.13140/2.1.1394.3043
   Spangher Alexander, 2015, NY TIMES
   Steyvers Mark, 2006, LATENT SEMANTIC ANAL, DOI [10.1016/s0364-0213(01)00040-4, DOI 10.1016/S0364-0213(01)00040-4]
   Talebian H, 2018, ENERG POLICY, V115, P109, DOI 10.1016/j.enpol.2018.01.004
   U.S. Geological Survey, 2018, MINERAL COMMODITY SU, DOI [10.3133/70194932, DOI 10.3133/70194932]
   UNEP, 2011, NEDERLANDS TIJDSCHRI
   Valero A, 2018, RENEW SUST ENERG REV, V93, P178, DOI 10.1016/j.rser.2018.05.041
   van den Hoed R, 2005, J POWER SOURCES, V141, P265, DOI 10.1016/j.jpowsour.2004.09.017
   van den Hoed R, 2007, J CLEAN PROD, V15, P1014, DOI 10.1016/j.jclepro.2006.05.032
   Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25, DOI 10.1016/S0040-1625(97)00050-4
   Wesseling JH, 2014, TECHNOL FORECAST SOC, V81, P154, DOI 10.1016/j.techfore.2013.02.005
   Wolinetz M, 2017, TECHNOL FORECAST SOC, V117, P238, DOI 10.1016/j.techfore.2016.11.022
   Yan ZL, 2015, INFORM PROCESS MANAG, V51, P163, DOI 10.1016/j.ipm.2014.07.009
   Yang LF, 2013, WORLD PAT INF, V35, P305, DOI 10.1016/j.wpi.2013.06.002
   Yau CK, 2014, SCIENTOMETRICS, V100, P767, DOI 10.1007/s11192-014-1321-8
   Yoon B., 2004, J HIGH TECHNOLOGY MA, V15, P37, DOI DOI 10.1016/J.HITECH.2003.09.003
   Zeng XL, 2015, RESOUR CONSERV RECY, V104, P12, DOI 10.1016/j.resconrec.2015.09.014
NR 70
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104413
DI 10.1016/j.resconrec.2019.104413
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700007
OA Other Gold
DA 2020-05-12
ER

PT J
AU Pu, Y
   Wu, G
   Tang, BY
   Xu, L
   Wang, B
AF Pu, Yue
   Wu, Gang
   Tang, Biyan
   Xu, Lin
   Wang, Bo
TI Structural features of global recycling trade networks and dynamic
   evolution patterns
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Global recycling trade; Complex network; Top network; Community;
   Centrality degree
ID INTERNATIONAL OIL TRADE; HAZARDOUS-WASTE; FLOW; GOVERNANCE
AB Recycling trade transfers recyclable resources and relevant environmental pressures on a global scale to solve resources limitation problem for some economies and alleviate urgent environment protection pressure for other countries/regions. Correspondingly, recycling trade relationships among economies are changing profoundly with the constant adjustment of economic and environmental policies. Based on complex network approach and top network analysis, this paper aims to comprehensively explore the structural features and their evolutionary patterns of global recycling trade networks from the macro, medium and micro levels by using global multiregion input-output data. The results are: At the macro level, the depth of global recycling import and export markets has strengthened continuously. The breadth of recycling exports showed a "pre-concentration, postdiversification" trend, and the import market breath demonstrated an opposite trend. At the medium level, the community structure of the global recycling export market increased rapidly in the early stage and became stable in the medium and late stages, while that of import market rapidly declined in the late stage, which means the import market was more sensitive to relevant policies and economic events. At the individual level, developed economics have been trying to transfer recycling products to developing economies, causing the former dominate global recycling export markets and the latter dominate the import markets. Recycling policies of economies, especially the developing economies have a serious impact on the global recycling trade pattern. Therefore, China's new announcement in 2018 for prohibiting import "foreign waste" will inevitably have a huge impact on the global recycling market.
C1 [Pu, Yue; Wu, Gang; Xu, Lin; Wang, Bo] Southwestern Univ Finance & Econ, Sch Int Business, Chengdu 611130, Sichuan, Peoples R China.
   [Tang, Biyan] Univ Massachusetts Dartmouth, Dept Econ, Dartmouth, MA 02747 USA.
RP Wu, G (reprint author), Southwestern Univ Finance & Econ, Sch Int Business, Chengdu 611130, Sichuan, Peoples R China.
EM puyue0820@126.com; wugang@swufe.edu.cn; btang@umassd.edu;
   18382425491@163.com; bwang@swufe.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71503213, 71832012]; National Social Science
   Foundation of China [18ZDA039]; Fundamental Research Funds for Central
   UniversitiesFundamental Research Funds for the Central Universities
   [JBK1901022]
FX This study is sponsored by the National Natural Science Foundation of
   China (71503213; 71832012), the National Social Science Foundation of
   China (18ZDA039) and the Fundamental Research Funds for Central
   Universities (JBK1901022).
CR An HZ, 2014, ENERGY, V74, P254, DOI 10.1016/j.energy.2014.06.095
   Baggs J, 2009, REV INT ECON, V17, P1, DOI 10.1111/j.1467-9396.2008.00778.x
   Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004
   Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101
   Basile R, 2018, REV INT ECON, V26, P578, DOI 10.1111/roie.12314
   Bisschop L, 2012, CRIME LAW SOCIAL CH, V58, P221, DOI 10.1007/s10611-012-9383-0
   Brooks A, 2013, GEOFORUM, V44, P10, DOI 10.1016/j.geoforum.2012.06.004
   Brooks A, 2012, GEOGR J, V178, P80, DOI 10.1111/j.1475-4959.2011.00410.x
   Chen XJ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041009
   Christen K, 2000, ENVIRON SCI TECHNOL, V34, p300A, DOI 10.1021/es0033234
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Crang M, 2013, T I BRIT GEOGR, V38, P12, DOI 10.1111/j.1475-5661.2012.00515.x
   Dixon I, 1998, MAR POLLUT BULL, V36, P177
   Du RJ, 2017, APPL ENERG, V196, P142, DOI 10.1016/j.apenergy.2016.12.042
   Efthymiou L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080789
   Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810
   Fagiolo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097331
   Fagiolo G, 2010, J ECON INTERACT COOR, V5, P1, DOI 10.1007/s11403-010-0061-y
   Fan Y, 2014, ECON MODEL, V39, P71, DOI 10.1016/j.econmod.2014.02.027
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075
   Goyal S., 2007, CONNECTIONS INTRO EC
   Gregson N, 2015, ANNU REV ENV RESOUR, V40, P151, DOI 10.1146/annurev-environ-102014-021105
   Gregson N, 2012, ECON GEOGR, V88, P37, DOI 10.1111/j.1944-8287.2011.01138.x
   Hao XQ, 2018, RESOUR POLICY, V57, P45, DOI 10.1016/j.resourpol.2018.01.005
   Hou WY, 2018, RESOUR POLICY, V55, P133, DOI 10.1016/j.resourpol.2017.11.008
   Ichinose D, 2013, ENVIRON DEV ECON, V18, P773, DOI 10.1017/S1355770X13000302
   Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1
   Kellenberg D, 2015, ANNU REV RESOUR ECON, V7, P109, DOI 10.1146/annurev-resource-100913-012639
   Kellenberg D, 2012, J ENVIRON ECON MANAG, V64, P68, DOI 10.1016/j.jeem.2012.02.003
   Keramitsoglou KM, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041240
   Klenovsek A, 2011, REV KRIMINALISTIKO K, V62, P50
   Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938
   Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x
   Liu D, 2019, RESOUR CONSERV RECY, V142, P122, DOI 10.1016/j.resconrec.2018.11.025
   Lovric M, 2018, FOREST POLICY ECON, V86, P45, DOI 10.1016/j.forpol.2017.10.006
   Lozano S, 2018, INT J TOUR RES, V20, P588, DOI 10.1002/jtr.2208
   Lucier CA, 2015, J WORLD SYST RES, V21, P495, DOI 10.5195/jwsr.2015.11
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113
   Oke A, 2015, SUSTAINABILITY-BASEL, V7, P7175, DOI 10.3390/su7067175
   Peres M, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0148615, 10.1371/journal.pone.0162426]
   Pittiglio R, 2017, ECON BULL, V37, P2625
   Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101
   Shinkuma T, 2009, ENVIRON IMPACT ASSES, V29, P25, DOI 10.1016/j.eiar.2008.04.004
   Vidmer A, 2015, PHYSICA A, V436, P188, DOI 10.1016/j.physa.2015.05.057
   Wang XB, 2017, RESOUR CONSERV RECY, V125, P363, DOI 10.1016/j.resconrec.2017.07.006
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342
   West D.B., 1996, INTRO GRAPH THEORY
   Xu HL, 2016, PHYSICA A, V448, P91, DOI 10.1016/j.physa.2015.12.094
   Zhong WQ, 2018, RESOUR CONSERV RECY, V136, P345, DOI 10.1016/j.resconrec.2018.05.006
   Zhong WQ, 2016, APPL ENERG, V165, P868, DOI 10.1016/j.apenergy.2015.12.083
   Zhong WQ, 2014, PHYSICA A, V413, P42, DOI 10.1016/j.physa.2014.06.055
   Zhou M, 2016, SOC NETWORKS, V44, P9, DOI 10.1016/j.socnet.2015.07.006
   Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105496
NR 55
TC 1
Z9 1
U1 28
U2 28
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104445
DI 10.1016/j.resconrec.2019.104445
PG 15
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700003
DA 2020-05-12
ER

PT J
AU Romeiko, XX
AF Romeiko, Xiaobo Xue
TI Comprehensive water footprint assessment of conventional and four
   alternative resource recovery based wastewater service options
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Water footprint; Resource recovery; Water and wastewater treatment; Life
   cycle assessment; Environmental impacts
ID TREATMENT PLANTS; IMPACT ASSESSMENT; TECHNOLOGIES; ENERGY; URBAN;
   SUSTAINABILITY; MANAGEMENT; REDUCTION; GREYWATER; FRAMEWORK
AB Resource recovery based wastewater services, capable of converting wastewater into clean water, energy, and fertilizer, begun to gain global attention. However, Water Footprints (WFs) of resource recovery based wastewater systems remain unknown. This study provided the first assessment on WFs of resource recovery based wastewater systems. A process-based approach was used to estimate WFs of five representative wastewater systems were including a conventional once-through system (BAU) and four resource recovery based systems. The analyses found that BAU presented the highest total WF, with a median value of 15.9 m(3)/household/day. In contrast, composting toilet and septic system (CT-SS) showed the lowest total WF, with a median value of 3.4 m(3)/household/day. The indirect WF and direct grey WFs each contributed to approximately half of total WF for BAU. For four resource recovery based systems, indirect WFs ranked as a dominating contributor, resulting in more than 75% of their total WFs. The WFs of all five systems presented significant variability, mainly because of the embedded variations in electricity's water intensities, electricity consumption during various treatment stages, and effluent quality. The sensitivity analyses indicated that water intensity of electricity was the most influential parameter for total WFs for all five systems. In addition, the comparison across life cycle energy consumption, greenhouse gas emissions, eutrophication and WF indicators suggested environmental tradeoffs existed among resource recovery based systems.
C1 [Romeiko, Xiaobo Xue] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Albany, NY 12222 USA.
RP Romeiko, XX (reprint author), SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Albany, NY 12222 USA.
EM xxue@albany.edu
CR [Anonymous], 2012, OPTIMIZATION COLLECT
   Badruzzaman M, 2017, J AM WATER WORKS ASS, V109, pE393, DOI 10.5942/jawwa.2017.109.0100
   Brown V, 2010, WATER SCI TECHNOL, V62, P510, DOI 10.2166/wst.2010.296
   Chen R, 2009, WATER SCI TECHNOL, V59, P1515, DOI 10.2166/wst.2009.156
   Chen ZM, 2013, ECOL INDIC, V28, P142, DOI 10.1016/j.ecolind.2012.07.024
   Cooper DC, 2012, ENVIRON SCI TECHNOL, V46, P3509, DOI 10.1021/es201901p
   Delgadillo-Mirquez Liliana, 2016, Biotechnol Rep (Amst), V11, P18, DOI 10.1016/j.btre.2016.04.003
   Electric Power Research Institute, 2002, ENV RENEW ENERGY
   Ercin AE, 2011, WATER RESOUR MANAG, V25, P721, DOI 10.1007/s11269-010-9723-8
   Falmouth Department of Water, 2013, WAT TREATM DISTR
   Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276
   GIKAS P, 2012, J ENVIRON MANAGE, V2009, P144
   Gomez-Llanos E, 2018, J CLEAN PROD, V198, P463, DOI 10.1016/j.jclepro.2018.07.062
   Gu YF, 2016, ECOL INDIC, V60, P402, DOI 10.1016/j.ecolind.2015.07.012
   Gu YF, 2015, J CLEAN PROD, V92, P274, DOI 10.1016/j.jclepro.2014.12.094
   Hallmann M, 2003, LIFE CYCLE ASSESSMEN
   Hoekstra A.Y., 2014, WATER FOOTPRINT ASSE
   Ishii SKL, 2015, WATER RES, V79, P88, DOI 10.1016/j.watres.2015.04.010
   Loubet P, 2014, WATER RES, V67, P187, DOI 10.1016/j.watres.2014.08.048
   Malisie AF, 2007, WATER SCI TECHNOL, V56, P141, DOI 10.2166/wst.2007.566
   Martinez-Alcala I, 2018, WATER RES, V135, P278, DOI 10.1016/j.watres.2018.02.033
   Massachusetts Department of Environmental Protection, 2002, ID CHAR MAPP FOOD WA
   McJannet DL, 2012, ENVIRON MODELL SOFTW, V31, P76, DOI 10.1016/j.envsoft.2011.11.017
   Mekonnen M.M., 2015, ENV SCI WATER RES TE, V3
   Memon FA, 2007, ENVIRON MONIT ASSESS, V129, P27, DOI 10.1007/s10661-006-9422-3
   Mo WW, 2013, J ENVIRON MANAGE, V127, P255, DOI 10.1016/j.jenvman.2013.05.007
   Morera S, 2016, J CLEAN PROD, V112, P4741, DOI 10.1016/j.jclepro.2015.05.102
   Moriarty K, 2013, FEASIBILITY STUDY AN
   NIST, 2010, BUILD ENV EC SUST BE
   Otterpohl R, 2003, WATER SCI TECHNOL, V48, P23
   Peter-Froehlich A, 2007, WATER SCI TECHNOL, V56, P239, DOI 10.2166/wst.2007.577
   Risch E, 2014, WATER RES, V57, P20, DOI 10.1016/j.watres.2014.03.023
   Schoen M.E., 2014, ENVRION SCI TECHNOL, V44, P6450
   Schoen ME, 2017, WATER RES, V109, P186, DOI 10.1016/j.watres.2016.11.044
   Schulz M, 2012, INTEGR ENVIRON ASSES, V8, P183, DOI 10.1002/ieam.247
   Scown CD, 2011, ENVIRON SCI TECHNOL, V45, P2541, DOI 10.1021/es102633h
   Shao L, 2013, ENVIRON SCI TECHNOL, V47, P7787, DOI 10.1021/es402013t
   Sharma AK, 2010, WATER SCI TECHNOL, V62, P570, DOI 10.2166/wst.2010.205
   Simcox A.C, 1992, 904144 US GEOL SURV
   Tchobanoglous G., 2003, WASTEWATER ENG TREAT
   Tervahauta T, 2014, WATER RES, V48, P632, DOI 10.1016/j.watres.2013.10.012
   The Aquionics UV Product, 2013, AQ UV LAMP EN CONS
   Trojan UV products, 2013, TROJ UV AMP EN CONS
   U.S. EPA, 2010, EV EN CONS MEAS WAST
   United States Goverment Accountability Office, 2011, GAO 01 801, P10
   US Census Bureau, 2019, POPULATION
   US EIA, 2013, ELECTRICITY
   US Energy Information Administration, 2018, MASS STAT PROF EN ES
   US Energy Information Administration, 2017, WHAT IS US EL GEN EN
   US EPA, 2013, ORG COD EC AN TOOL C
   US EPA, 2011, OPP COMB HEAT POW WA
   US Geological Survey, 2011, 20115137 US GEOL SUR
   US Government Accountability Office, 2014, FRESHWATER SUPPL CON
   USDA, 2011, FOOD AV DAT SYST
   Walker RV, 2014, J ENVIRON MANAGE, V141, P104, DOI 10.1016/j.jenvman.2014.01.054
   Wang X, 2015, P NATL ACAD SCI USA, V112, P1630, DOI 10.1073/pnas.1410715112
   Wood A, 2015, J ENVIRON MANAGE, V150, P344, DOI 10.1016/j.jenvman.2014.10.002
   Xue XB, 2019, WATER RES X, V2, DOI 10.1016/j.wroa.2018.100015
   Xue XB, 2016, WATER-SUI, V8, DOI 10.3390/w8040154
   Xue XB, 2015, WATER RES, V77, P155, DOI 10.1016/j.watres.2015.03.017
   Yamashita T, 2014, INT J ENV RES PUB HE, V11, P9835, DOI 10.3390/ijerph110909835
   Zhao X, 2009, ECOL MODEL, V220, P245, DOI 10.1016/j.ecolmodel.2008.09.016
NR 62
TC 1
Z9 1
U1 25
U2 25
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104458
DI 10.1016/j.resconrec.2019.104458
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700024
DA 2020-05-12
ER

PT J
AU Rong, K
   Xiao, F
   Wang, Y
AF Rong, Ke
   Xiao, Fei
   Wang, Yong
TI Redundancy in the sharing economy
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Accessing service; B2C sharing; Public cost; Redundancy; Sharing economy
ID INDUSTRY LIFE-CYCLE; 2-SIDED MARKETS; DIFFERENTIATION STRATEGY;
   MONOPOLY; TRAGEDY; ENTRY
AB The success of the sharing economy in China has attracted worldwide attention. Alongside the standard model of the customer-to-customer sharing of idle/superfluous resources, the new model of business-to-customer sharing of new resources has been gradually thriving. However, beside the advantages, there are some drawbacks, such as system redundancy, which have so far been ignored. This paper addresses the problem of redundancy in the sharing economy. To do so, we have built a theoretical model indicating the determinants of redundancy, which are mainly affected by the market structure, multi-homing, competitive strategy, public cost, and externality. Furthermore, we support these results by analyzing two of the biggest companies in the sharing-bike sector in China: Mobike and OfO. This paper helps practitioners and the government to better understand the inherent economic logic of redundancy, so that they can harness and regulate the sharing economy more effectively.
C1 [Rong, Ke; Xiao, Fei; Wang, Yong] Tsinghua Univ, Sch Social Sci, Inst Econ, Beijing, Peoples R China.
RP Xiao, F (reprint author), Tsinghua Univ, Sch Social Sci, Inst Econ, Beijing, Peoples R China.
EM feixiao2019@gmail.com
RI Rong, ke/A-4525-2018
OI Rong, ke/0000-0002-4651-5902
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71872098, 71834006, 71772165]; Major Program of
   National Social Science Foundation of ChinaNational Natural Science
   Foundation of China [18ZDA149]; Major Research Projects of Philosophy
   and Social Sciences of the Ministry of Education of China [17JZD018];
   Tsinghua University Initiative Scientific Research Program; research
   project of the institute for state-owned enterprises Tsinghua
   University; Beijing Excellent Talent training Program; Tang Young
   Scholar Awards
FX This research is supported by the National Natural Science Foundation of
   China (Grant no. 71872098; 71834006; 71772165), Major Program of
   National Social Science Foundation of China, (Grant No.18ZDA149), Major
   Research Projects of Philosophy and Social Sciences of the Ministry of
   Education of China (No. 17JZD018), Tsinghua University Initiative
   Scientific Research Program, the research project of the institute for
   state-owned enterprises Tsinghua University, Beijing Excellent Talent
   training Program and 'Tang Young Scholar Awards'.
CR ADAMS WJ, 1976, Q J ECON, V90, P475, DOI 10.2307/1886045
   Argyres N, 2007, MANAGE SCI, V53, P1332, DOI 10.1287/mnsc.1070.0706
   Armstrong M, 2007, ECON THEOR, V32, P353, DOI 10.1007/s00199-006-0114-6
   Avnimelech G, 2006, RES POLICY, V35, P1477, DOI 10.1016/j.respol.2006.09.017
   Baker D., 2014, GUARDIAN, V27
   Baumol W.J., 2001, J ECON PERSPECT, V13, P195
   Belk R, 2014, J BUS RES, V67, P1595, DOI 10.1016/j.jbusres.2013.10.001
   Bimpikis K., 2019, MANAG SCI
   BRAINARD WC, 1967, J POLIT ECON, V75, P86, DOI 10.1086/259241
   BRESNAHAN TF, 1990, REV ECON STUD, V57, P531, DOI 10.2307/2298085
   Bruno B, 2017, INT J EC FINANC, V9, P174
   Cai BF, 2018, RESOUR CONSERV RECY, V129, P232, DOI 10.1016/j.resconrec.2017.10.036
   Carlton DW, 2010, J LAW ECON ORGAN, V26, P54, DOI 10.1093/jleo/ewp006
   Coase RH, 1937, ECONOMICA-NEW SER, V4, P386, DOI 10.1111/j.1468-0335.1937.tb00002.x
   de Reuver M, 2018, J INF TECHNOL-UK, V33, P124, DOI 10.1057/s41265016-0033-3
   DICKSON PR, 1987, J MARKETING, V51, P1, DOI 10.2307/1251125
   Dolbear T, 1967, AM ECON REV, V57, P90
   ECKHARDT GM, 2015, HARVARD BUS REV, V28, P2015
   Einav L, 2016, ANNU REV ECON, V8, P615, DOI 10.1146/annurev-economics-080315-015334
   Elzinga KG, 2011, AM ECON REV, V101, P558, DOI 10.1257/aer.101.3.558
   Ferella F, 2016, RESOUR CONSERV RECY, V108, P10, DOI 10.1016/j.resconrec.2016.01.010
   Greenstein S, 2006, J IND ECON, V54, P323, DOI 10.1111/j.1467-6451.2006.00291.x
   Hamilton J. H., 1990, Games and Economic Behavior, V2, P29, DOI 10.1016/0899-8256(90)90012-J
   HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243
   Heinrichs H, 2013, GAIA, V22, P228, DOI 10.14512/gaia.22.4.5
   Ittner CD, 1997, ACCOUNT ORG SOC, V22, P293, DOI 10.1016/S0361-3682(96)00035-9
   Jaffe AB, 2005, ECOL ECON, V54, P164, DOI 10.1016/j.ecolecon.2004.12.027
   JOVANOVIC B, 1994, J POLIT ECON, V102, P322, DOI 10.1086/261934
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Karniouchina EV, 2013, STRATEGIC MANAGE J, V34, P1010, DOI 10.1002/smj.2042
   Klepper S., 1997, IND CORP CHANGE, V6, P145, DOI DOI 10.1093/ICC/6.1.145
   Koopman C., 2014, SOC SCI ELECT PUBL
   Krystofik M, 2018, RESOUR CONSERV RECY, V135, P14, DOI 10.1016/j.resconrec.2017.07.028
   Landsman V, 2011, J MARKETING, V75, P39, DOI 10.1509/jm.09.0199
   Levitan R, 1972, INT ECON REV, V13, P111, DOI 10.2307/2525908
   Li Y., 2019, RES CONSERV RECYC, V150, P104
   Locke K, 1997, ACAD MANAGE J, V40, P1023, DOI 10.2307/256926
   Maksimovic V, 2008, J FINANC, V63, P673, DOI 10.1111/j.1540-6261.2008.01328.x
   Mayhew BW, 2003, AUDITING-J PRACT TH, V22, P33, DOI 10.2308/aud.2003.22.2.33
   Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a
   Moh Y, 2017, RESOUR CONSERV RECY, V116, P1, DOI 10.1016/j.resconrec.2016.09.012
   MUSSA M, 1978, J ECON THEORY, V18, P301, DOI 10.1016/0022-0531(78)90085-6
   Neisser H, 1934, J POLIT ECON, V42, P433, DOI 10.1086/254636
   OSTROM E, 2002, DRAMA COMMONS
   Parente R, 2019, J INT BUS STUD, V50, P275, DOI 10.1057/s41267-018-0179-z
   Parente RC, 2018, J INT MANAG, V24, P52, DOI 10.1016/j.intman.2017.10.001
   Porter SD, 2016, REG ENVIRON CHANGE, V16, P2279, DOI 10.1007/s10113-015-0783-4
   Rhoades S.A., 1993, FEDERAL RESERVE B, P188
   ROBINSON B, 1975, MANAGE SCI B-APPL, V21, P1113, DOI 10.1287/mnsc.21.10.1113
   Rochet J.C., 2011, J EUR ECON ASSOC, V1, P990
   ROCHET JC, 2006, REV NETW ECON, V5, P1, DOI DOI 10.2202/1446-9022.1085
   Rochet JC, 2006, RAND J ECON, V37, P645, DOI 10.1111/j.1756-2171.2006.tb00036.x
   Rochet JC, 2003, J EUR ECON ASSOC, V1, DOI 10.1162/154247603322493212
   Rong K, 2015, J INT MANAG, V21, P293, DOI 10.1016/j.intman.2015.07.004
   Saijo T, 2010, REV ECON DES, V14, P51, DOI 10.1007/s10058-009-0100-0
   SHAPLEY L, 1969, KYKLOS, V22, P30, DOI 10.1111/j.1467-6435.1969.tb02520.x
   Smith A., 1869, INQUIRY NATURE CAUSE, V2
   Spence M., 1975, MONOPOLY QUALITY REG
   Tomi L, 2019, ACAD MANAG DISCOV
   Tseng ML, 2018, RESOUR CONSERV RECY, V131, P146, DOI 10.1016/j.resconrec.2017.12.028
   VIVES X, 1984, J ECON THEORY, V34, P71, DOI 10.1016/0022-0531(84)90162-5
   Wang HD, 2018, RESOUR CONSERV RECY, V134, P44, DOI 10.1016/j.resconrec.2018.03.006
   Wang Y., 2017, HARVARD BUS REV CHIN, V9, P122
   Wosskow D., 2014, UNLOCKING SHARING EC
   Yang SQ, 2012, COMPUT HUM BEHAV, V28, P129, DOI 10.1016/j.chb.2011.08.019
   Yuan JH, 2018, RESOUR CONSERV RECY, V129, P443, DOI 10.1016/j.resconrec.2016.03.021
   Zervas G., 2013, J MARKETING RES, V54, P687
   Zhao SL, 2018, RESOUR CONSERV RECY, V128, P176, DOI 10.1016/j.resconrec.2016.07.005
   Zhu F., 2009, SOC SCI ELECT PUBL, V33, P88
NR 69
TC 0
Z9 0
U1 26
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104455
DI 10.1016/j.resconrec.2019.104455
PG 15
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700029
DA 2020-05-12
ER

PT J
AU Ryberg, MW
   Hauschild, MZ
   Wang, F
   Averous-Monnery, S
   Laurent, A
AF Ryberg, Morten W.
   Hauschild, Michael Z.
   Wang, Feng
   Averous-Monnery, Sandra
   Laurent, Alexis
TI Global environmental losses of plastics across their value chains
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Marine plastics; Microplastic; Macroplastics; Waste management;
   Plastics; Pollution
ID SOLID-WASTE MANAGEMENT; FRESH-WATER; MICROPLASTICS; DEBRIS; FATE
AB With the increasing focus on marine plastic pollution, quantification of the environmental losses of plastics in the world, with differentiation into geographic regions, polymers and loss occurrences along the plastics value chains, is required. In this study, we make a global estimation of the losses of plastics to the environment across the entire plastic value chain, using existing literature and databases coupled with improved and additional methodological modelling of the losses. The resulting loss estimates are unprecedented in their detailed differentiations between polymers (23), plastic applications (13), geographical regions (11), and plastic value chain stages. Comprehensive sensitivity and uncertainty analyses were also conducted to identify key drivers in terms of plastic losses. We overall found that approximately 6.2 Mt (95% confidence interval, CI: 2.0-20.4 Mt) of macroplastics and 3.0 Mt (CI: 1.5-5.2 Mt) of microplastics were lost to the environment in 2015. The major macroplastic loss source was identified as the mismanaged municipal solid waste (MSW) management in low-income and lower-middle income countries (4.1 Mt). For microplastics, the major sources were abrasion of tyre rubbers, abrasion of road markings and plastics contributing to city dust generation. To curb marine plastic pollution, such quantified mapping as ours are needed to evaluate the magnitude of the plastics losses to environment from different sources and locations, and enable a further assessment of their environmental damage. Through our uncertainty and sensitivity analyses, we highlight plastics sources that should be prioritized in further research works to obtain a more comprehensive and accurate representation of global plastics losses.
C1 [Ryberg, Morten W.; Hauschild, Michael Z.; Laurent, Alexis] Tech Univ Denmark, DTU Management, Sustainabil Div, Quantitat Sustainabil Assessment Grp,Prod Storvet, Bldg 424, DK-2800 Lyngby, Denmark.
   [Wang, Feng; Averous-Monnery, Sandra] UN Environm, 1 Rue Miollis,Bldg 7, F-75015 Paris, France.
RP Ryberg, MW (reprint author), Tech Univ Denmark, DTU Management, Sustainabil Div, Quantitat Sustainabil Assessment Grp,Prod Storvet, Bldg 424, DK-2800 Lyngby, Denmark.
EM moryb@dtu.dk
RI Ryberg, Morten W/N-4958-2015; Laurent, Alexis/E-4747-2010; Hauschild,
   Michael Zwicky/L-6059-2015
OI Ryberg, Morten W/0000-0003-2589-8729; Laurent,
   Alexis/0000-0003-0445-7983; Hauschild, Michael
   Zwicky/0000-0002-8331-7390
FU Global Environment Facility through the project "Addressing Marine
   Plastics - A Systemic Approach" (GEF Project) [9681]
FX The authors acknowledge the support from the Global Environment Facility
   through the project "Addressing Marine Plastics - A Systemic Approach"
   (GEF Project ID 9681). We thank J. Sohn for reviewing and proofreading
   the manuscript. We thank R. Hauschild for design and production of
   figures.
CR Arthur C., 2009, P INT RES WORKSH OCC, P2509
   Auta HS, 2017, ENVIRON INT, V102, P165, DOI 10.1016/j.envint.2017.02.013
   Besseling E, 2017, ENVIRON POLLUT, V220, P540, DOI 10.1016/j.envpol.2016.10.001
   Bonanno G, 2018, ENVIRON SCI POLICY, V85, P146, DOI 10.1016/j.envsci.2018.04.005
   Borrelle SB, 2017, P NATL ACAD SCI USA, V114, P9994, DOI 10.1073/pnas.1714450114
   Boucher J., 2017, PRIMARY MICROPLASTIC
   Brooks AL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0131
   Browne MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2929
   CARPENTE.EJ, 1972, SCIENCE, V178, P749, DOI 10.1126/science.178.4062.749
   CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240
   Christensen T., 1989, SANITARY LANDFILLING
   Cole G, 2016, STUDY QUANTIFY PELLE
   Credence Research, 2016, MON GLYC MEG MARK AP
   Crippa M., 2019, CIRCULAR EC PLASTICS
   Essel R., 2015, SOURCES MICROPLASTIC
   ETRMA, 2011, EUR TYR RUBB IND STA
   ETRMA, 2017, STATISTICS
   Eunomia, 2016, PLASTICS MARINE ENV
   European bioplastics, 2017, BIOPL MARK DAT
   European Commision, 2019, EUR COMM WELC ECHAS
   Everaert G, 2018, ENVIRON POLLUT, V242, P1930, DOI 10.1016/j.envpol.2018.07.069
   GESAMP, 2015, REP STUD GESAMP
   GESAMP, 2016, REP STUD GESAMP
   Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782
   Gouin T., 2015, SOFW-J, V141, P40
   Grand View Research, 2015, ADH SEAL MARK AN TEC
   Haward M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03104-3
   Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361
   Hoornweg D., 2005, WASTE MANAGEMENT CHI
   Hoornweg D., 2012, WORLD BANK URBAN DEV
   Horton AA, 2017, SCI TOTAL ENVIRON, V586, P127, DOI 10.1016/j.scitotenv.2017.01.190
   Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352
   Jerven M., 2014, J AFR TRADE, V1, P45, DOI DOI 10.1016/j.joat.2014.08.001
   Kawecki D, 2018, ENVIRON SCI TECHNOL, V52, P9874, DOI 10.1021/acs.est.8b01513
   Koelmans AA, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9500
   Koelmans AA, 2017, ENVIRON SCI TECHNOL, V51, P11513, DOI 10.1021/acs.est.7b02219
   Kumar S, 2009, WASTE MANAGE, V29, P883, DOI 10.1016/j.wasman.2008.04.011
   Lassen C., 2015, MICROPLASTICS OCCURR
   Laurent A, 2017, CURR OPIN ENV SUST, V25, P20, DOI 10.1016/j.cosust.2017.04.003
   Lebreton LCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15611
   MacArthur E., 2017, SCIENCE, V358
   Maddah H.A., 2016, AM J POLYM SCI, V6, P1, DOI DOI 10.5923/J.AJPS.20160601.01
   Magnusson K., 2016, SWEDISH SOURCES PATH
   Mehlhart G., 2012, STUDY LAND SOURCED L
   Mian MM, 2017, J MATER CYCLES WASTE, V19, P1127, DOI 10.1007/s10163-016-0509-9
   NEMA, 2017, BAN PLAST CARR BAGS
   Noren F., 2007, MIKROSKOPISKA PLASTP
   Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839
   plastemart, 2010, POL GROWTH SLOW 3 20
   PlasticsEurope, 2017, PLASTICSEUROPE OP CL
   PlasticsEurope, 2016, PLAST FACTS 2016
   prnewswire, 2015, GLOB THERM PLAST MAR
   Rochman CM, 2016, ECOLOGY, V97, P302, DOI 10.1890/14-2070.1
   Ryberg M.W., 2015, ENERGY ENV SCI, V2435-2447
   Schmidt C, 2017, ENVIRON SCI TECHNOL, V51, P12246, DOI 10.1021/acs.est.7b02368
   Sherrington C., 2016, STUDY SUPPORT DEV ME
   Sinograce chemical, 2017, GLOB COAT EM POL 202
   Sundt P., 2014, SOURCES MICROPLASTIC
   UN Environment, 2018, MAPP GLOB PLAST VAL
   UNEP, 2016, MAR PLAST DEBR MICR
   United Nations, 2018, GLOB IND FRAM SUST D, P1
   Vince J, 2017, RESTOR ECOL, V25, P123, DOI 10.1111/rec.12388
   Wik A, 2009, ENVIRON POLLUT, V157, P1, DOI 10.1016/j.envpol.2008.09.028
   YEH WWG, 1986, WATER RESOUR RES, V22, P95, DOI 10.1029/WR022i002p00095
NR 64
TC 5
Z9 5
U1 69
U2 69
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104459
DI 10.1016/j.resconrec.2019.104459
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700004
DA 2020-05-12
ER

PT J
AU Singh, A
AF Singh, Ajay
TI Solid waste management through the applications of mathematical models
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Environmental problems; Municipal waste management; Mathematical models;
   Optimization modeling; Multi-objective approach; Multi-criteria decision
   analysis
ID MULTICRITERIA DECISION-ANALYSIS; LIQUID TRANSPORTATION FUELS; ARTIFICIAL
   NEURAL-NETWORK; LANDFILL SITE SELECTION; MULTIOBJECTIVE OPTIMIZATION;
   LOAD ALLOCATION; ENVIRONMENTAL ASSESSMENT; PROGRAMMING APPROACH;
   INFORMATION-SYSTEM; SUPPORT-SYSTEM
AB Growing world population along with fast economic growth and increased living standards have increased the municipal waste generation making its management be a foremost global issue. The problem is even more serious in urban areas as its improper management prompts tainting of soil, water, and environment which create public health risks. These problems of waste disposal and management were usually assessed by traditional methods which require loads of data. The recent development in the new software technologies and Internet along with the introduction of gradually more compact and dependable hardware products have presented the ability to accurately deal with these procedures more easily than costly and tedious field experiments. This paper presents an outline of the utilization of different scientific models in solving the environmental problems of municipal waste disposal. The examination of past literature uncovered that usually optimization models were used to find the answer of 'what is the best' under an explicit arrangement of conditions, while, simulation models were usually helpful to get an answer to 'what if? ' due to their predictive capability. An indication of the municipal waste disposal problems and its management alongside the ramifications of the investigation is provided. The rationale and backdrop of the waste disposal issues are described. The applications of optimization modeling, multi-objective approach, multi-criteria decision analysis, and artificial neural networks in waste management are presented and applications of these modeling techniques in diverse case studies worldwide are described. And finally, the conclusions of the analysis are summarized.
C1 [Singh, Ajay] Indian Inst Technol Kharagpur, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
RP Singh, A (reprint author), Indian Inst Technol Kharagpur, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
EM ajay@agfe.iitkgp.ac.in
RI Singh, Ajay/AAF-4414-2020
OI Singh, Ajay/0000-0002-6700-030X
CR Abushammala M., 2014, INT J ENVIRON SCI TE, P1
   Achillas C, 2013, WASTE MANAGE RES, V31, P115, DOI 10.1177/0734242X12470203
   Ahmed SA, 2006, HABITAT INT, V30, P781, DOI 10.1016/j.habitatint.2005.09.004
   Ameyaw EE, 2015, EXPERT SYST APPL, V42, P5102, DOI 10.1016/j.eswa.2015.02.041
   Anshassi M, 2019, RESOUR CONSERV RECY, V148, P55, DOI 10.1016/j.resconrec.2019.04.011
   Antanasijevic D, 2013, SUSTAIN SCI, V8, P37, DOI 10.1007/s11625-012-0161-9
   Arebey M, 2011, ENVIRON MONIT ASSESS, V177, P399, DOI 10.1007/s10661-010-1642-x
   Aremu AS, 2012, J ENVIRON ENG, V138, P645, DOI 10.1061/(ASCE)EE.1943-7870.0000513
   Ayodele TR, 2018, RESOUR CONSERV RECY, V134, P165, DOI 10.1016/j.resconrec.2018.03.017
   Batool SA, 2009, WASTE MANAGE, V29, P1971, DOI 10.1016/j.wasman.2008.12.016
   Bayar S, 2009, ECOTOX ENVIRON SAFE, V72, P843, DOI 10.1016/j.ecoenv.2007.10.019
   Belien J, 2014, TRANSPORT SCI, V48, P78, DOI 10.1287/trsc.1120.0448
   Bilsel RU, 2011, TRANSPORT RES B-METH, V45, P1284, DOI 10.1016/j.trb.2011.02.007
   Broitman D, 2018, WASTE MANAGE, V75, P37, DOI 10.1016/j.wasman.2018.01.041
   Bunsan S, 2013, CHEMOSPHERE, V92, P258, DOI 10.1016/j.chemosphere.2013.01.083
   Capon-Garcia E, 2013, COMPUT-AIDED CHEM EN, V32, P949
   Chambal S, 2003, ENVIRON MODEL ASSESS, V8, P25, DOI 10.1023/A:1022404016435
   Chang NB, 1997, J ENVIRON ENG-ASCE, V123, P901, DOI 10.1061/(ASCE)0733-9372(1997)123:9(901)
   Chang NB, 1996, J ENVIRON MANAGE, V48, P17, DOI 10.1006/jema.1996.0064
   Chang NB, 1997, FUZZY SET SYST, V89, P35, DOI 10.1016/S0165-0114(96)00086-3
   Chang NB, 1997, EUR J OPER RES, V99, P303, DOI 10.1016/S0377-2217(96)00024-0
   Chang NB, 2012, J CLEAN PROD, V20, P1, DOI 10.1016/j.jclepro.2011.08.017
   Chang YC, 2001, ENVIRON MODEL ASSESS, V6, P237, DOI 10.1023/A:1013369514320
   Chang YH, 1998, RESOUR CONSERV RECY, V24, P7, DOI 10.1016/S0921-3449(98)00036-6
   CHARNES A, 1959, MANAGE SCI, V6, P73, DOI 10.1287/mnsc.6.1.73
   Chen JS, 2007, BIOMED ENVIRON SCI, V20, P78
   Chen WL, 2015, CHEM ENG J, V260, P492, DOI 10.1016/j.cej.2014.08.087
   Chin-Huang Huang, 2008, WSEAS Transactions on Business and Economics, V5, P524
   Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005
   Dai C, 2011, J ENVIRON MANAGE, V92, P3023, DOI 10.1016/j.jenvman.2011.06.038
   Deviney FA, 2012, J ENVIRON INFORM, V19, P70, DOI 10.3808/jei.201200210
   Dewi O., 2010, INT SOL WAST ASS WOR
   Du P, 2013, J ENVIRON ENG, V139, P1178, DOI 10.1061/(ASCE)EE.1943-7870.0000724
   Dyson B, 2005, WASTE MANAGE, V25, P669, DOI 10.1016/j.wasman.2004.10.005
   Economopoulou MA, 2013, WASTE MANAGE, V33, P2177, DOI 10.1016/j.wasman.2013.06.016
   Erkut E, 2008, EUR J OPER RES, V187, P1402, DOI 10.1016/j.ejor.2006.09.021
   Santibanez-Aguilar JE, 2015, AICHE J, V61, P1881, DOI 10.1002/aic.14785
   Santibanez-Aguilar JE, 2013, WASTE MANAGE, V33, P2607, DOI 10.1016/j.wasman.2013.08.010
   Filipiak K.A., 2009, PRACTICE PERIODICAL, V13, P210, DOI DOI 10.1061/(ASCE)1090-025X(2009)13:3(210)
   Galante G, 2010, WASTE MANAGE, V30, P1720, DOI 10.1016/j.wasman.2010.01.039
   Gallardo A, 2015, WASTE MANAGE, V36, P1, DOI 10.1016/j.wasman.2014.11.008
   Garfi M, 2009, WASTE MANAGE, V29, P2729, DOI 10.1016/j.wasman.2009.05.019
   Geldermann J, 2000, FUZZY SET SYST, V115, P45, DOI 10.1016/S0165-0114(99)00021-4
   Gemitzi A, 2006, ENVIRON GEOL, V49, P653, DOI 10.1007/s00254-005-0104-1
   Coelho LMG, 2018, RESOUR CONSERV RECY, V128, P438, DOI 10.1016/j.resconrec.2016.09.026
   Gu BX, 2015, RESOUR CONSERV RECY, V98, P67, DOI 10.1016/j.resconrec.2015.03.001
   Guo P, 2009, J ENVIRON MANAGE, V91, P461, DOI 10.1016/j.jenvman.2009.09.014
   Hering JG, 2012, SCIENCE, V337, P623, DOI 10.1126/science.1227092
   Hokkanen J, 1997, EUR J OPER RES, V98, P19, DOI 10.1016/0377-2217(95)00325-8
   Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022
   Hung ML, 2007, WASTE MANAGE, V27, P209, DOI 10.1016/j.wasman.2006.01.008
   HUTCHESON MR, 1992, WATER RESOUR RES, V28, P215, DOI 10.1029/91WR02480
   Jaligot R, 2018, RESOUR CONSERV RECY, V130, P260, DOI 10.1016/j.resconrec.2017.12.014
   Jalili GZM, 2008, INT J ENVIRON RES, V2, P13
   Joseph K, 2012, J MATER CYCLES WASTE, V14, P75, DOI 10.1007/s10163-012-0046-0
   Juul N, 2013, WASTE MANAGE, V33, P1918, DOI 10.1016/j.wasman.2013.04.015
   Karaca F, 2006, ENVIRON MODELL SOFTW, V21, P1190, DOI 10.1016/j.envsoft.2005.06.006
   Karmperis AC, 2013, WASTE MANAGE, V33, P1290, DOI 10.1016/j.wasman.2013.01.017
   Karmperis AC, 2012, WASTE MANAGE, V32, P194, DOI 10.1016/j.wasman.2011.09.001
   Kataria M, 2010, ENVIRON MODEL ASSESS, V15, P273, DOI 10.1007/s10666-009-9205-7
   Kaushal R.K., 2012, J ENV ENG, P241
   Kirnbauer MC, 2012, J ENVIRON INFORM, V20, P1, DOI 10.3808/jei.201200215
   Kollikkathara N, 2010, WASTE MANAGE, V30, P2194, DOI 10.1016/j.wasman.2010.05.012
   Kou G, 2011, J MULTI-CRITERIA DEC, V18, P1, DOI 10.1002/mcda.476
   Kuo YL, 2010, ENVIRON RESOUR ECON, V47, P423, DOI 10.1007/s10640-010-9386-1
   Laureri F, 2016, WASTE MANAGE, V48, P56, DOI 10.1016/j.wasman.2015.09.020
   Li P, 2011, J ENVIRON MANAGE, V92, P1198, DOI 10.1016/j.jenvman.2010.12.013
   Li XM, 2003, J ENVIRON SCI-CHINA, V15, P43
   Li YP, 2009, ENVIRON ENG SCI, V26, P219, DOI 10.1089/ees.2007.0241.ptB
   Lin CH, 2010, WASTE MANAGE, V30, P863, DOI 10.1016/j.wasman.2009.11.012
   Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013
   Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004
   Liu GS, 2007, WASTE MANAGE, V27, P345, DOI 10.1016/j.wasman.2006.03.010
   Liu YL, 2017, RESOUR CONSERV RECY, V125, P98, DOI 10.1016/j.resconrec.2017.06.005
   Liu Y, 2008, J WATER RES PL-ASCE, V134, P347, DOI 10.1061/(ASCE)0733-9496(2008)134:4(347)
   Lu HD, 2012, PROCEDIA ENGINEER, V29, P4, DOI [10.1016/j.proeng.2011.12.658, 10.1109/RSETE.2012.6260807]
   Lukasheh AF, 2001, WASTE MANAGE RES, V19, P177, DOI 10.1177/0734242X0101900209
   Maalouf A, 2018, RESOUR CONSERV RECY, V133, P263, DOI 10.1016/j.resconrec.2018.02.021
   MacDonald ML, 1996, COMPUT ENVIRON URBAN, V20, P1, DOI 10.1016/S0198-9715(96)00006-3
   Madadian E, 2013, ENVIRON PROG SUSTAIN, V32, P810, DOI 10.1002/ep.11695
   Mahpour A, 2018, RESOUR CONSERV RECY, V134, P216, DOI 10.1016/j.resconrec.2018.01.026
   Makarichi L, 2018, RESOUR CONSERV RECY, V139, P351, DOI 10.1016/j.resconrec.2018.07.024
   Malczewski J, 2006, INT J GEOGR INF SCI, V20, P703, DOI 10.1080/13658810600661508
   Meng XY, 2018, RESOUR CONSERV RECY, V128, P535, DOI 10.1016/j.resconrec.2016.09.033
   Meyers GD, 2006, WASTE MANAGE RES, V24, P505, DOI 10.1177/0734242X06069474
   Minciardi R, 2008, WASTE MANAGE, V28, P2202, DOI 10.1016/j.wasman.2007.10.003
   Mishra B.K., 2017, SUSTAINABILITY WATER, V9-10, P67, DOI DOI 10.1016/j.swaqe.2017.06.001
   Mishra D, 2015, ATMOS ENVIRON, V102, P239, DOI 10.1016/j.atmosenv.2014.11.050
   Morrissey AJ, 2004, WASTE MANAGE, V24, P297, DOI 10.1016/j.wasman.2003.09.005
   Moutavtchi V, 2010, J MATER CYCLES WASTE, V12, P169, DOI 10.1007/s10163-009-0285-x
   Mummolo Giovanni, 1995, Journal of Environmental Systems, V24, P445
   Munster M, 2011, ENERGY, V36, P1612, DOI 10.1016/j.energy.2010.12.070
   Murty YSR, 2006, WATER RESOUR MANAG, V20, P509, DOI 10.1007/s11269-006-3084-3
   Ng W.P.Q., 2004, ENERG CONVERS MANAGE, V85, P866
   Ng WPQ, 2013, CHEM ENGINEER TRANS, V35, P889, DOI 10.3303/CET1335148
   Niziolek AM, 2015, COMPUT CHEM ENG, V74, P184, DOI 10.1016/j.compchemeng.2014.10.007
   Noori R, 2009, ENVIRON PROG SUSTAIN, V28, P249, DOI 10.1002/ep.10317
   Noori R, 2009, IRAN J PUBLIC HEALTH, V38, P74
   Noori R, 2010, J ENVIRON MANAGE, V91, P767, DOI 10.1016/j.jenvman.2009.10.007
   Noori R, 2009, EXPERT SYST APPL, V36, P9991, DOI 10.1016/j.eswa.2008.12.035
   Oenema O, 2005, NUTR CYCL AGROECOSYS, V72, P51, DOI 10.1007/s10705-004-7354-2
   Onel O, 2014, COMPUT CHEM ENG, V71, P636, DOI 10.1016/j.compchemeng.2014.03.008
   Papadopoulou MP, 2007, ENVIRON MODEL ASSESS, V12, P43, DOI 10.1007/s10666-006-9050-x
   Pardo G, 2017, SCI TOTAL ENVIRON, V574, P806, DOI 10.1016/j.scitotenv.2016.09.096
   Philippe F, 2009, RESOUR CONSERV RECY, V54, P73, DOI 10.1016/j.resconrec.2009.06.009
   Phonphoton N, 2019, RESOUR CONSERV RECY, V146, P106, DOI 10.1016/j.resconrec.2019.03.044
   Qu XY, 2009, WASTE MANAGE, V29, P2618, DOI 10.1016/j.wasman.2009.05.014
   Rada EC, 2013, WASTE MANAGE, V33, P785, DOI 10.1016/j.wasman.2013.01.002
   Rathi S, 2007, ENVIRON DEV ECON, V12, P105, DOI 10.1017/S1355770X0600341X
   Raviv O, 2018, WASTE MANAGE, V73, P546, DOI 10.1016/j.wasman.2017.10.011
   Rimaityte I, 2012, WASTE MANAGE RES, V30, P89, DOI 10.1177/0734242X10396754
   Salvia M, 2002, RESOUR CONSERV RECY, V34, P91, DOI 10.1016/S0921-3449(01)00095-7
   Schubeler P., 1996, 19 WORLD BANK
   Sener B, 2006, ENVIRON GEOL, V49, P376, DOI 10.1007/s00254-005-0075-2
   Sener S, 2010, WASTE MANAGE, V30, P2037, DOI 10.1016/j.wasman.2010.05.024
   Shadiya OO, 2012, J CLEAN PROD, V31, P137, DOI 10.1016/j.jclepro.2012.03.008
   SHAHABI H, 2012, WORLD APPL SCI J, V20, P336, DOI DOI 10.5829/idosi.wasj.2012.20.02.3769
   Sharholy M, 2008, WASTE MANAGE, V28, P459, DOI 10.1016/j.wasman.2007.02.008
   Shih LH, 1999, J ENVIRON ENG-ASCE, V125, P479, DOI 10.1061/(ASCE)0733-9372(1999)125:5(479)
   Shu HY, 2006, J AIR WASTE MANAGE, V56, P852, DOI 10.1080/10473289.2006.10464497
   Simsek C., 2005, ENVIRON GEOL, V49, P620
   Singh A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0140
   Singh A, 2019, J ENVIRON MANAGE, V243, P22, DOI 10.1016/j.jenvman.2019.05.017
   Singh A, 2019, J ENVIRON MANAGE, V240, P259, DOI 10.1016/j.jenvman.2019.03.025
   Singh A, 2018, ECOL INDIC, V89, P584, DOI 10.1016/j.ecolind.2018.02.041
   Singh A, 2016, AGR WATER MANAGE, V174, P2, DOI 10.1016/j.agwat.2016.04.021
   Singh A, 2015, LAND USE POLICY, V43, P259, DOI 10.1016/j.landusepol.2014.11.015
   Singh A, 2014, J HYDROL, V508, P43, DOI 10.1016/j.jhydrol.2013.10.042
   Singh A, 2012, AGR WATER MANAGE, V115, P194, DOI 10.1016/j.agwat.2012.09.007
   Singh A, 2014, J MATER CHEM B, V2, P8069, DOI 10.1039/c4tb01083c
   Sokka L, 2007, RESOUR CONSERV RECY, V50, P475, DOI 10.1016/j.resconrec.2007.01.011
   Solano E, 2002, J ENVIRON ENG-ASCE, V128, P981, DOI 10.1061/(ASCE)0733-9372(2002)128:10(981)
   Su JP, 2007, RESOUR CONSERV RECY, V51, P418, DOI 10.1016/j.resconrec.2006.10.007
   Sudhir V, 1996, SOCIO ECON PLAN SCI, V30, P163, DOI 10.1016/0038-0121(96)00012-2
   Sun W, 2010, J ENVIRON INFORM, V16, P80, DOI 10.3808/jei.201000180
   Sung K, 2000, EUR J OPER RES, V121, P32, DOI 10.1016/S0377-2217(99)00035-1
   Tan ST, 2014, J CLEAN PROD, V71, P48, DOI 10.1016/j.jclepro.2013.12.005
   Tanskanen JH, 2000, RESOUR CONSERV RECY, V30, P111, DOI 10.1016/S0921-3449(00)00056-2
   Tatarakis A, 2009, EUR J OPER RES, V197, P557, DOI 10.1016/j.ejor.2008.07.006
   Thanh NP, 2010, J ENVIRON MANAGE, V91, P2307, DOI 10.1016/j.jenvman.2010.06.016
   Tralhao L, 2010, WASTE MANAGE, V30, P2418, DOI 10.1016/j.wasman.2010.06.017
   UN, 2017, WORLD POP PROSP 2017
   Vadenbo C, 2014, RESOUR CONSERV RECY, V89, P41, DOI 10.1016/j.resconrec.2014.05.009
   Vince F, 2008, DESALINATION, V222, P96, DOI 10.1016/j.desal.2007.02.064
   Wei YS, 2000, RESOUR CONSERV RECY, V30, P277, DOI 10.1016/S0921-3449(00)00066-5
   Wise WR, 2011, J ENVIRON ENG-ASCE, V137, P514, DOI 10.1061/(ASCE)EE.1943-7870.0000342
   World Bank, 2012, URB DEV SER KNOWL PA
   Xie YL, 2011, SCI TOTAL ENVIRON, V409, P1757, DOI 10.1016/j.scitotenv.2011.01.036
   Xu LL, 2013, WASTE MANAGE, V33, P1324, DOI 10.1016/j.wasman.2013.02.012
   Xu Y, 2009, J ENVIRON INFORM, V14, P74, DOI 10.3808/jei.200900155
   Yang T, 2017, J CLEAN PROD, V142, P1065, DOI 10.1016/j.jclepro.2016.04.152
   Yeh CH, 2013, J CLEAN PROD, V52, P194, DOI 10.1016/j.jclepro.2013.03.003
   Yesilnacar M. I., 2007, ENVIRON GEOL, V55, P1659
   Younes MK, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4977-5
   Yu L, 2010, INT J NUMER ANAL MET, V34, P1169, DOI 10.1002/nag.856
   Zhou CB, 2015, ECOL MODEL, V318, P150, DOI 10.1016/j.ecolmodel.2014.11.027
   Zhou WB, 2017, J ENVIRON ENG, V143, DOI 10.1061/(ASCE)EE.1943-7870.0001223
NR 157
TC 3
Z9 3
U1 19
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104503
DI 10.1016/j.resconrec.2019.104503
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700032
DA 2020-05-12
ER

PT J
AU Soderman, ML
   Andre, H
AF Soderman, Maria Ljunggren
   Andre, Hampus
TI Effects of circular measures on scarce metals in complex products - Case
   studies of electrical and electronic equipment
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Scarce metals; Critical raw materials; Circular economy; Use extension;
   Recycling; Electrical and electronic equipment (EEE)
ID DISSIPATIVE LOSSES; MATERIAL RECOVERY; MOBILE PHONES; FLOW-ANALYSIS;
   ECONOMY; RESOURCE; SUSTAINABILITY; EXTRACTION; INNOVATION; TRACKING
AB Circular measures such as long-life designs, reuse, repair and recycling have been suggested for prolonging scarce metal life cycles and reducing the dependence on primary resources. This paper explores to what extent circular measures could mitigate metals scarcity when adopted to complex products. Based on three real cases, the effect of extending the use of laptops, smartphones and LED systems before recycling are assessed for between 7 and 15 scarce metals using material flow analysis. As expected, benefits can be gained from such extensions, but, importantly, differ substantially between metals since they occur in various components with various service lifetimes and functional recycling rates vary. Notably, risks of flipping the ranking in favor of short use before recycling are identified: if service lifetimes are short, designs are metal-intensive or if metal contents differ between products. Furthermore, regardless of measure, sizable and varying losses of each metal from functional use occur since all products are not collected for recycling and all metals are not functionally recycled. Thus, neither use extension measures nor recycling can alone nor in combination radically mitigate metals scarcity and criticality currently. Overall, it is a challenge to target the multitude of scarce and critical metals applied in complex products through circular measures. Careful analysis beyond simplified guidelines such as OR frameworks" are recommended. As the importance of scarce metals availability and the attention to the circular economy are expected to continue, these insights may be used for avoiding efforts with unclear or minor benefits or even drawbacks.
C1 [Soderman, Maria Ljunggren; Andre, Hampus] Chalmers Univ Technol, Dept Technol Management & Econ, Div Environm Syst Anal, Gothenburg, Sweden.
RP Soderman, ML (reprint author), Chalmers Univ Technol, Dept Technol Management & Econ, Div Environm Syst Anal, Gothenburg, Sweden.
EM Maria.ljunggren@chalmers.se; Hampus.andre@chalmers.se
RI Ljunggren Soderman, Maria/Q-7016-2016
OI Ljunggren Soderman, Maria/0000-0001-6418-8557; Andre,
   Hampus/0000-0003-2713-9582
FU Mistra REES (Resource-Efficient and Effective Solutions) programme -
   Mistra (The Swedish Foundation for Strategic Environmental Research);
   Chalmers Area of Advance Production
FX This research was supported by the Mistra REES (Resource-Efficient and
   Effective Solutions) programme, funded by Mistra (The Swedish Foundation
   for Strategic Environmental Research) and Chalmers Area of Advance
   Production. The authors wish to thank the Mistra REES partners, other
   industrial and governmental actors and the anonymous reviewers for
   valuable contributions.
CR Andersson M, 2017, WASTE MANAGE, V60, P407, DOI 10.1016/j.wasman.2016.06.031
   Andrae ASG, 2010, INT J LIFE CYCLE ASS, V15, P827, DOI 10.1007/s11367-010-0206-1
   Andre H., 2016, ELECT GOES GREEN 201
   Andre H, 2019, WASTE MANAGE, V88, P268, DOI 10.1016/j.wasman.2019.03.050
   [Anonymous], 2006, 14040 ISO
   [Anonymous], 2006, 14044 ISO
   Ashby M.F., 2016, MAT SUSTAINABLE DEV
   Ayres RU, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0563
   Bakker C, 2014, J CLEAN PROD, V69, P10, DOI 10.1016/j.jclepro.2014.01.028
   Bangs C., 2016, ELECT GOES GREEN 201
   Bellmann K, 2000, TECHNOVATION, V20, P677, DOI 10.1016/S0166-4972(00)00012-2
   Bengtsson T., 2016, COMMUNICATION
   Blickin D., 2018, RESOURCE ENV IMPACTS
   Blomsma F, 2017, J IND ECOL, V21, P603, DOI 10.1111/jiec.12603
   Broman GI, 2017, J CLEAN PROD, V140, P17, DOI 10.1016/j.jclepro.2015.10.121
   Brunner PH, 2004, PRACTICAL HDB MAT FL
   Buchert M, 2012, RECYCLING CRITICAL R
   Casamayor J, 2015, ARCHIT ENG DES MANAG, V11, P105, DOI 10.1080/17452007.2013.834813
   Chancerel P, 2013, WASTE MANAGE RES, V31, P3, DOI 10.1177/0734242X13499814
   Ciacci L, 2015, ENVIRON SCI TECHNOL, V49, P9443, DOI 10.1021/es505515z
   Commission E., 2016, COM2016773
   Cooper Tim, 2010, LONGER LASTING PRODU
   Cucchiella F, 2015, RENEW SUST ENERG REV, V51, P263, DOI 10.1016/j.rser.2015.06.010
   cycLED, 2015, INS INSP EC LED LI 2
   Dahmus JB, 2007, ENVIRON SCI TECHNOL, V41, P7543, DOI 10.1021/es062254b
   Deubzer O., 2012, CYCLING RESOURCES EM
   Drielsma JA, 2016, INT J LIFE CYCLE ASS, V21, P133, DOI 10.1007/s11367-015-1006-4
   EC, 2018, EUR COMM STAT EUR LE
   EC, 2014, AD HOC WORK GROUP DE
   EC [European Commission], 2018, COMM STAFF WORK DOC
   EMF, 2013, CIRC EC, V1
   Franca CL, 2017, J CLEAN PROD, V140, P155, DOI 10.1016/j.jclepro.2016.06.124
   Friege H, 2012, WASTE MANAGE RES, V30, P3, DOI 10.1177/0734242X12448521
   GASG, 2016, GLOB AUT DECL SUBST
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Gotze R., 2012, 2012 ELECT GOES GREE
   Graedel TE, 2015, P NATL ACAD SCI USA, V112, P6295, DOI 10.1073/pnas.1312752110
   Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x
   Greenfield A, 2013, RESOUR CONSERV RECY, V74, P1, DOI 10.1016/j.resconrec.2013.02.010
   Grubler A., 2003, TECHNOLOGY GLOBAL CH
   Guinee JB, 1999, ECOL ECON, V30, P47, DOI 10.1016/S0921-8009(98)00069-X
   Hageluken C., 2009, COMPLEX LIFE CYCLES, P163, DOI DOI 10.7551/MITPRESS/9780262013581.003.0010
   Hageluken C., 2016, RECYCLING, V1
   Harper EM, 2012, ENVIRON SCI TECHNOL, V46, P1079, DOI 10.1021/es201874e
   Hatayama H, 2015, MATER TRANS, V56, P229, DOI 10.2320/matertrans.M2014380
   Hennies L, 2016, RESOUR CONSERV RECY, V112, P73, DOI 10.1016/j.resconrec.2016.04.013
   Hobday M, 1998, RES POLICY, V26, P689, DOI 10.1016/S0048-7333(97)00044-9
   Huisman J., 2016, 2016 ELECT GOES GREE
   Jarbin M., 2016, COMMUNICATION
   Johnson J, 2005, ENVIRON SCI TECHNOL, V39, P4655, DOI 10.1021/es048319x
   Kasulaitis BV, 2015, RESOUR CONSERV RECY, V100, P1, DOI 10.1016/j.resconrec.2015.03.014
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Kissling R, 2013, RESOUR CONSERV RECY, V80, P21, DOI 10.1016/j.resconrec.2013.07.009
   Korhonen J, 2018, ECOL ECON, V143, P37, DOI 10.1016/j.ecolecon.2017.06.041
   Lanzano T, 2006, RESOUR CONSERV RECY, V46, P27, DOI 10.1016/j.resconrec.2005.06.003
   Lazarevic D, 2017, ENERGY RES SOC SCI, V31, P60, DOI 10.1016/j.erss.2017.05.006
   Licht C, 2015, J IND ECOL, V19, P890, DOI 10.1111/jiec.12287
   Liu ZY, 2009, FRONT OPTOELECTRON, V2, P119, DOI 10.1007/s12200-009-0011-2
   Ljunggren Soderman M., 2014, ANVANDNING ATERVINNI
   Machacek E, 2015, RESOUR CONSERV RECY, V104, P76, DOI 10.1016/j.resconrec.2015.09.005
   Marwede M., 2012, MASS FLOWS SELECTED
   OECD, 2013, OECD DUE DIL GUID RE
   Peeters JR, 2017, J CLEAN PROD, V140, P1182, DOI 10.1016/j.jclepro.2016.10.043
   Pettersson E., 2016, COMMUNICATION
   Philips, 2010, US LIF TECHN BRIEF U
   Philips-Electronics, 2012, CAS STUD RAU ARCH
   Proske M, 2016, LIFE CYCLE ASSESSMEN
   Proske M., 2016, ELECT GOES GREEN 201
   Reike D, 2018, RESOUR CONSERV RECY, V135, P246, DOI 10.1016/j.resconrec.2017.08.027
   Reuter M.A., 2013, WORK GROUP GLOB MET
   Reuter MA, 2015, INT J LIFE CYCLE ASS, V20, P671, DOI 10.1007/s11367-015-0860-4
   Rogalski A, 2011, INFRARED PHYS TECHN, V54, P136, DOI 10.1016/j.infrared.2010.12.003
   Roisin B, 2008, ENERG BUILDINGS, V40, P514, DOI 10.1016/j.enbuild.2007.04.006
   Sabbaghi M, 2018, RESOUR CONSERV RECY, V133, P101, DOI 10.1016/j.resconrec.2018.01.015
   Santamaria C., 2016, COMMUNICATION
   Saurat M, 2008, J IND ECOL, V12, P754, DOI 10.1111/j.1530-9290.2008.00087.x
   Schulz K.J., 2017, CRITICAL MINERAL RES
   SGU, 2014, RED REG UPPDR UTF KA
   Sibley S.F., FLOW STUDIES RECYCLI
   Silfvenius C., 2016, COMMUNICATION
   SKINNER BJ, 1979, P NATL ACAD SCI USA, V76, P4212, DOI 10.1073/pnas.76.9.4212
   Sverdrup HU, 2017, J CLEAN PROD, V140, P359, DOI 10.1016/j.jclepro.2015.06.085
   Talens Peiro L, 2013, ENVIRON SCI TECHNOL, V47, P2939, DOI 10.1021/es301519c
   Tecchio P., 2018, ANAL MAT EFFICIENCY
   Thiebaud E, 2018, J IND ECOL, V22, P196, DOI 10.1111/jiec.12551
   Tilton JE, 2003, ON BORROWED TIME?: ASSESSING THE THREAT OF MINERAL DEPLETION, P1
   Tukker A, 2015, J CLEAN PROD, V97, P76, DOI 10.1016/j.jclepro.2013.11.049
   U.S. Department of Energy, 2011, CRITICAL MAT STRATEG
   Ueberschaar M, 2017, WASTE MANAGE, V60, P534, DOI 10.1016/j.wasman.2016.12.035
   UNEP, 2013, WORK GROUP GLOB MET
   US-DOE, 2013, LIF REL BUILD TECHN
   Navazo JMV, 2014, INT J LIFE CYCLE ASS, V19, P721, DOI 10.1007/s11367-013-0663-4
   Villalba G., 2012, TECHNOLOGY FORECAST
   Whalen KA, 2018, RESOUR CONSERV RECY, V135, P123, DOI 10.1016/j.resconrec.2017.07.029
   Wieser H, 2018, J CLEAN PROD, V172, P3042, DOI 10.1016/j.jclepro.2017.11.106
   Zimmermann T, 2017, J IND ECOL, V21, P1198, DOI 10.1111/jiec.12492
NR 96
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104464
DI 10.1016/j.resconrec.2019.104464
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700011
OA Other Gold
DA 2020-05-12
ER

PT J
AU Wang, Q
   Jiang, XT
   Ge, ST
   Jiang, R
AF Wang, Qiang
   Jiang, Xue-ting
   Ge, Shuting
   Jiang, Rui
TI Is economic growth compatible with a reduction in CO2 emissions?
   Empirical analysis of the United States
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Decoupling; Decomposition techniques; Economic growth; CO2 emission; The
   United States
ID CARBON-DIOXIDE EMISSIONS; GREENHOUSE-GAS EMISSIONS; MEAN DIVISIA INDEX;
   DECOMPOSITION ANALYSIS; ENERGY-CONSUMPTION; DECOUPLING ANALYSIS;
   STRUCTURE ADJUSTMENT; INDUSTRIAL-GROWTH; CITY LEVEL; CHINA
AB Energy-related carbon dioxide (CO2) emissions dropped 12% between 2007 and 2016 in the United States (U.S.), while the gross domestic product (GDP) increased by 19%. empirical data related to the decoupling of carbon emissions from economic growth in the U.S. provides a useful study pilot opportunity and serves as a good example for other countries to learn about CO(2 )emission mitigation. This study identified the relationship between CO2 emissions and economic growth in the U.S. The goal was to determine if the rigid link between the two can be changed, and identify the potential drivers of this trend. We combined the Cobb-Douglas (C-D) production function and the extended Kaya equation to develop decomposition and decoupling techniques to quantify six potential effects. The results show that the investment effect and economy structure effect played the most important roles in increasing carbon dioxide emissions. In contrast, the energy intensity effect cut carbon emissions in most of the years studied. Strong decoupling and weak decoupling are the main states; the energy intensity effect accelerated the decoupling process. In contrast, the investment effect and labor effect decelerated the decoupling process in recent decades. The study concludes that emission mitigation and decoupling policies should emphasize energy efficiency, investment patterns, and improvements in labor force quality.
C1 [Wang, Qiang; Jiang, Xue-ting; Ge, Shuting; Jiang, Rui] China Univ Petr East China, Sch Econ & Management, Qingdao 266580, Shandong, Peoples R China.
   [Wang, Qiang; Jiang, Xue-ting; Ge, Shuting; Jiang, Rui] China Univ Petr East China, Inst Energy Econ & Policy, Qingdao 266580, Shandong, Peoples R China.
   [Jiang, Xue-ting] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi 830011, Peoples R China.
   [Jiang, Xue-ting] Chinese Acad Sci, CAS Res Ctr Ecol & Environm Cent Asia, Urumqi 830011, Peoples R China.
   [Jiang, Xue-ting] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
RP Wang, Q (reprint author), China Univ Petr East China, Sch Econ & Management, Qingdao 266580, Shandong, Peoples R China.
EM wangqiang7@upc.edu.cn
RI WANG, Qiang/F-4618-2011
OI WANG, Qiang/0000-0002-8751-8093
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71874203]; Humanities and Social Science Fund of
   Ministry of Education of ChinaMinistry of Education, China
   [18YJA790081]; Natural Science Foundation of Shandong Province,
   ChinaNatural Science Foundation of Shandong Province [ZR2018MG016]
FX The authors would like to thank the editor and these anonymous reviewers
   for their thoughtful comments and constructive suggestions, which
   greatly helped us to improve the manuscript. This work is supported by
   National Natural Science Foundation of China (Grant No. 71874203),
   Humanities and Social Science Fund of Ministry of Education of China
   (Grant No. 18YJA790081), and Natural Science Foundation of Shandong
   Province, China (Grant No. ZR2018MG016).
CR Achour H, 2016, TRANSPORT POLICY, V52, P64, DOI 10.1016/j.tranpol.2016.07.008
   Acs S, 2010, LAND USE POLICY, V27, P550, DOI 10.1016/j.landusepol.2009.07.009
   Alises A, 2015, TRANSPORT RES A-POL, V82, P141, DOI 10.1016/j.tra.2015.09.013
   Andreoni V, 2012, ENERGY, V44, P682, DOI 10.1016/j.energy.2012.05.024
   Ang BW, 2015, ENERG POLICY, V86, P233, DOI 10.1016/j.enpol.2015.07.007
   ANG BW, 1994, ENERG ECON, V16, P83, DOI 10.1016/0140-9883(94)90001-9
   Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010
   Ang BW, 1997, ENERGY J, V18, P59
   Ang BW, 2004, ENERG POLICY, V32, P1131, DOI 10.1016/S0301-4215(03)00076-4
   Ang BW, 2000, ENERGY, V25, P1149, DOI 10.1016/S0360-5442(00)00039-6
   Cansino JM, 2015, RENEW SUST ENERG REV, V48, P749, DOI 10.1016/j.rser.2015.04.011
   Chang N, 2017, J CLEAN PROD, V154, P94, DOI 10.1016/j.jclepro.2017.03.128
   Chang XY, 2019, INT J HYDROGEN ENERG, V44, P16015, DOI 10.1016/j.ijhydene.2018.09.099
   Chen JD, 2019, ENERG ECON, V78, P589, DOI 10.1016/j.eneco.2018.12.011
   Chen JD, 2018, APPL ENERG, V231, P937, DOI 10.1016/j.apenergy.2018.09.179
   Cui LB, 2019, COMPUT IND ENG, V128, P1040, DOI 10.1016/j.cie.2018.04.029
   Cui LB, 2018, WORLD DEV, V101, P173, DOI 10.1016/j.worlddev.2017.08.009
   Dalton M, 2008, ENERG ECON, V30, P642, DOI 10.1016/j.eneco.2006.07.002
   Darby H, 2016, INTELL BUILD INT, V8, P157, DOI 10.1080/17508975.2016.1139535
   Dean A., 1992, COSTS REDUCING CO2 E
   Diakoulaki D, 2007, ENERG ECON, V29, P636, DOI 10.1016/j.eneco.2007.01.005
   Dong B, 2016, ENERG POLICY, V97, P414, DOI 10.1016/j.enpol.2016.07.054
   EIA, 2017, MONTHL EN REV
   Feng KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8714
   Hassan K, 2015, J ECON STUD, V42, P54, DOI 10.1108/JES-04-2013-0046
   Hatzigeorgiou E, 2008, ENERGY, V33, P492, DOI 10.1016/j.energy.2007.09.014
   HOLTZEAKIN D, 1995, J PUBLIC ECON, V57, P85, DOI 10.1016/0047-2727(94)01449-X
   Jeong K, 2013, ENERG POLICY, V62, P1245, DOI 10.1016/j.enpol.2013.06.077
   Jiang XT, 2018, J CLEAN PROD, V199, P85, DOI 10.1016/j.jclepro.2018.07.160
   Jiang XT, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090857
   Klein-Banai C, 2013, J CLEAN PROD, V48, P29, DOI 10.1016/j.jclepro.2011.06.004
   Li L, 2019, STRUCT CHANGE ECON D, V49, P83, DOI 10.1016/j.strueco.2018.09.010
   Lopez NSA, 2018, J CLEAN PROD, V195, P532, DOI 10.1016/j.jclepro.2018.05.231
   Ma MD, 2018, SCI TOTAL ENVIRON, V634, P884, DOI 10.1016/j.scitotenv.2018.04.043
   McDonald J. F., 1987, ENERGY J, V8, P77, DOI DOI 10.5547/ISSN0195-6574-EJ-V0L8-N02-6
   Moutinho V, 2018, RENEW SUST ENERG REV, V90, P605, DOI 10.1016/j.rser.2018.02.009
   Panayotou T., 2016, ENV ANTHR, P140, DOI DOI 10.1016/J.RSER.2015.08.002
   Ren SG, 2014, ENVIRON DEV, V9, P61, DOI 10.1016/j.envdev.2013.11.003
   Romer D., 2001, ADV MACROECONOMICS
   ROSE A, 1991, RESOUR ENERG, V13, P1, DOI 10.1016/0165-0572(91)90017-W
   Rose A., 1996, ECON SYST RES, V8, P33, DOI DOI 10.1080/09535319600000003
   Shahbaz M., 2019, INT EC
   Shahiduzzaman M, 2017, RENEW SUST ENERG REV, V67, P372, DOI 10.1016/j.rser.2016.08.042
   Shahiduzzaman M, 2015, APPL ENERG, V150, P25, DOI 10.1016/j.apenergy.2015.04.007
   Soytas U, 2009, ECOL ECON, V68, P1667, DOI 10.1016/j.ecolecon.2007.06.014
   Stern N., 2007, EC CLIMATE CHANGE ST
   Su B, 2016, ECOL INDIC, V67, P78, DOI 10.1016/j.ecolind.2016.02.020
   Tapio P, 2005, TRANSP POLICY, V12, P137, DOI 10.1016/j.tranpol.2005.01.001
   Wang C, 2005, ENERGY, V30, P73, DOI 10.1016/j.energy.2004.04.002
   Wang M, 2017, APPL ENERG, V190, P772, DOI 10.1016/j.apenergy.2017.01.007
   Wang Q, 2019, J CLEAN PROD, V209, P126, DOI 10.1016/j.jclepro.2018.10.188
   Wang Q, 2019, J CLEAN PROD, V234, P702, DOI 10.1016/j.jclepro.2019.06.174
   Wang Q, 2018, J CLEAN PROD, V205, P499, DOI 10.1016/j.jclepro.2018.09.034
   Wang Q, 2018, J CLEAN PROD, V197, P178, DOI 10.1016/j.jclepro.2018.05.285
   Wang Q, 2017, ENERGY, V127, P78, DOI 10.1016/j.energy.2017.03.111
   Wang Q, 2016, RENEW SUST ENERG REV, V58, P341, DOI 10.1016/j.rser.2015.12.104
   Wei TY, 2018, ECOL ECON, V147, P197, DOI 10.1016/j.ecolecon.2018.01.017
   Wu LY, 2013, PROCEDIA COMPUT SCI, V17, P744, DOI 10.1016/j.procs.2013.05.096
   Xu SC, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101742
   Yu YD, 2017, ECOL INDIC, V75, P27, DOI 10.1016/j.ecolind.2016.12.027
   Zhao X, 2017, J CLEAN PROD, V142, P3500, DOI 10.1016/j.jclepro.2016.10.117
   Zhao XR, 2016, ENERG ECON, V60, P275, DOI 10.1016/j.eneco.2016.10.008
   Zhao YH, 2017, J CLEAN PROD, V144, P287, DOI 10.1016/j.jclepro.2017.01.031
   Zheng J., 2019, ENERGY EC
   Zhu ZS, 2014, APPL ENERG, V113, P808, DOI 10.1016/j.apenergy.2013.07.062
NR 65
TC 0
Z9 0
U1 27
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104443
DI 10.1016/j.resconrec.2019.104443
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700023
DA 2020-05-12
ER

PT J
AU Wang, YC
   Song, JN
   Yang, W
   Dong, L
   Duan, HY
AF Wang, Yichen
   Song, Junnian
   Yang, Wei
   Dong, Liang
   Duan, Haiyan
TI Unveiling the driving mechanism of air pollutant emissions from thermal
   power generation in China: A provincial-level spatiotemporal analysis
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Thermal power generation; Air pollutants; Spatial analysis;
   Socioeconomic drivers; LMDI; Principal component analysis
ID GREENHOUSE-GAS EMISSIONS; CARBON-DIOXIDE EMISSIONS; DECOMPOSITION
   ANALYSIS; CO2 EMISSIONS; ENERGY-CONSUMPTION; LMDI DECOMPOSITION;
   ECONOMIC-GROWTH; SO2 EMISSIONS; GHG EMISSIONS; IMPACTS
AB With largest proportion in power supply structure and intensive air pollutant emissions, thermal power generation (TPG) is critical to China's national actions on energy conservation and pollutant mitigation. Regional disparities of socioeconomic conditions intensify the complexity of region-oriented policy making. With this circumstance, this paper explores the spatiotemporal features and driving mechanisms of SO2, NOx and PM2.5 emissions from TPG during 2005-2015 in 30 provincial regions of China by applying a holistic approach. Firstly, the temporal variations of the emissions are analyzed followed by the identification of spatial aggregation characteristics through spatial autocorrelation analysis. Secondly, the contributions of the drivers of temporal changes in emissions are quantified by LMDI method. Finally, principal component analysis and clustering analysis are combined to further investigate the classification features of regions in terms of the drivers. The results indicate that there is spatial aggregation effect of pollutant emissions and the regions pertain to high-high type mainly gather in the Yangtze River delta and the North China. Treatment technology, power generation technology and power structure are the main inhibitory drivers, while power demand and population are the promotive ones. Emissions in less developed and power-abundant regions are mainly driven by energy structure, power generation technology and power transmission. In developed regions, GDP, population and industrialization rate present greater impacts on emissions. The approach and the analytical results are expected to offer better decision support to targeted national and local emission reduction policies for TPG.
C1 [Song, Junnian; Yang, Wei; Duan, Haiyan] Jilin Univ, Key Lab Groundwater Resources & Environm, Chinas Minist Educ, Changchun 130021, Jilin, Peoples R China.
   [Wang, Yichen; Song, Junnian; Yang, Wei; Duan, Haiyan] Jilin Univ, Coll New Energy & Environm, Changchun 130012, Jilin, Peoples R China.
   [Dong, Liang] City Univ Hong Kong, Dept Publ Policy, Kowloon, 83 Tat Chee Ave, Hong Kong, Peoples R China.
RP Song, JN (reprint author), Jilin Univ, 2699 Qianjin St, Changchun 130012, Jilin, Peoples R China.
EM songjunnian@jlu.edu.cn
RI ; Yang, Wei/E-1882-2017
OI Song, Junnian/0000-0002-9301-8001; Dong, Liang/0000-0001-9747-5851;
   Yang, Wei/0000-0001-8097-9009
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [41801199, 41701628]; 111 Project of Jilin
   University [B16020]; Jilin Province Science Foundation for Outstanding
   Youths [20190103012JH]
FX This work is supported by National Natural Science Foundation of China
   (NO. 41801199, NO. 41701628), 111 Project of Jilin University (NO.
   B16020) and Jilin Province Science Foundation for Outstanding Youths
   (20190103012JH).
CR Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010
   Ang BW, 2004, ENERG POLICY, V32, P1131, DOI 10.1016/S0301-4215(03)00076-4
   Arbolino R, 2017, ECOL INDIC, V81, P115, DOI 10.1016/j.ecolind.2017.05.053
   Chang M, 2018, J CLEAN PROD, V189, P240, DOI 10.1016/j.jclepro.2018.02.111
   Dong KY, 2019, SCI TOTAL ENVIRON, V649, P335, DOI 10.1016/j.scitotenv.2018.08.326
   Dong L, 2014, ATMOS ENVIRON, V92, P280, DOI 10.1016/j.atmosenv.2014.04.032
   Dong XC, 2015, SUSTAINABILITY-BASEL, V7, P6102, DOI 10.3390/su7056102
   Gao CK, 2019, RESOUR CONSERV RECY, V143, P184, DOI 10.1016/j.resconrec.2018.12.032
   Ghaffari HR, 2017, ENVIRON SCI POLLUT R, V24, P27402, DOI 10.1007/s11356-017-0226-5
   Hu JL, 2017, RESOUR CONSERV RECY, V121, P115, DOI 10.1016/j.resconrec.2016.04.011
   Hu Y, 2017, APPL ENERG, V196, P162, DOI 10.1016/j.apenergy.2016.12.085
   Huang L, 2017, RESOUR CONSERV RECY, V121, P103, DOI 10.1016/j.resconrec.2016.04.010
   IEA, 2015, CO2 EM FUEL COMB 201
   Jia JS, 2018, ENVIRON SCI POLLUT R, V25, P9600, DOI 10.1007/s11356-018-1306-x
   Jiang JJ, 2017, J CLEAN PROD, V169, P178, DOI 10.1016/j.jclepro.2017.03.189
   Jiao JL, 2017, J CLEAN PROD, V164, P1455, DOI 10.1016/j.jclepro.2017.07.060
   Kang JD, 2014, ENERGY, V68, P562, DOI 10.1016/j.energy.2014.01.023
   Li H, 2017, ENERG ECON, V68, P522, DOI 10.1016/j.eneco.2017.10.024
   Li Q, 2014, STOCH ENV RES RISK A, V28, P429, DOI 10.1007/s00477-013-0762-6
   Li XZ, 2018, ENVIRON SCI POLLUT R, V25, P6814, DOI 10.1007/s11356-017-1013-z
   Liang HW, 2016, J CLEAN PROD, V126, P223, DOI 10.1016/j.jclepro.2016.02.145
   Long RY, 2016, APPL ENERG, V166, P210, DOI 10.1016/j.apenergy.2015.09.100
   Lu XC, 2019, SCI TOTAL ENVIRON, V652, P683, DOI 10.1016/j.scitotenv.2018.10.140
   Lyu W, 2016, J CLEAN PROD, V133, P136, DOI 10.1016/j.jclepro.2016.04.093
   Ma MD, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101744
   Mavromatidis G, 2016, ENERG POLICY, V88, P343, DOI 10.1016/j.enpol.2015.10.037
   Meng L, 2018, ENERG EFFIC, V11, P203, DOI 10.1007/s12053-017-9559-7
   Miri M, 2018, ECOTOX ENVIRON SAFE, V165, P307, DOI 10.1016/j.ecoenv.2018.09.012
   MORAN PAP, 1948, J ROY STAT SOC B, V10, P243
   Muangthai I, 2014, AEROSOL AIR QUAL RES, V14, P1929, DOI 10.4209/aaqr.2014.03.0066
   National Bureau of Statistics of China, 2018, CHINA ENERGY STAT YB
   National Bureau of Statistics of China, 2018, CHIN EL POW YB
   Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720
   Pejhan A, 2019, CHEMOSPHERE, V226, P447, DOI 10.1016/j.chemosphere.2019.03.185
   Peng JY, 2018, J CLEAN PROD, V203, P197, DOI 10.1016/j.jclepro.2018.08.219
   Pu Y, 2019, J CLEAN PROD, V211, P749, DOI 10.1016/j.jclepro.2018.11.213
   State Council, 2016, INT WORK PROGR 13 5
   Valverde V, 2016, SCI TOTAL ENVIRON, V541, P701, DOI 10.1016/j.scitotenv.2015.09.111
   Wang CJ, 2017, RENEW SUST ENERG REV, V67, P51, DOI 10.1016/j.rser.2016.09.006
   Wang DG, 2015, ADV SCI, V2, DOI 10.1002/advs.201500005
   Wang JF, 2018, J CLEAN PROD, V184, P836, DOI 10.1016/j.jclepro.2018.02.305
   Wang QW, 2017, APPL ENERG, V194, P679, DOI 10.1016/j.apenergy.2016.05.073
   Wang Y, 2017, J CLEAN PROD, V165, P1436, DOI 10.1016/j.jclepro.2017.07.210
   Xu B, 2016, J CLEAN PROD, V112, P1454, DOI 10.1016/j.jclepro.2015.03.067
   Xu SC, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101742
   Xu XS, 2014, APPL ENERG, V132, P298, DOI 10.1016/j.apenergy.2014.07.025
   Yan QY, 2018, ENERGIES, V11, DOI 10.3390/en11051096
   Yang X, 2016, APPL ENERG, V184, P714, DOI 10.1016/j.apenergy.2016.11.013
   Yearbook, 2016, CHIN STAT YB
   Zhang YX, 2015, ENERGY, V81, P294, DOI 10.1016/j.energy.2014.12.041
   Zhang YJ, 2016, APPL ENERG, V174, P213, DOI 10.1016/j.apenergy.2016.04.109
   Zhou CS, 2018, RESOUR CONSERV RECY, V130, P1, DOI 10.1016/j.resconrec.2017.11.007
NR 52
TC 1
Z9 1
U1 23
U2 23
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104447
DI 10.1016/j.resconrec.2019.104447
PG 16
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700005
DA 2020-05-12
ER

PT J
AU Wen, X
   Deng, XZ
   Zhang, F
AF Wen, Xin
   Deng, Xiangzheng
   Zhang, Fan
TI Scale effects of vegetation restoration on soil and water conservation
   in a semi-arid region in China: Resources conservation and sustainable
   for management
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Soil erosion; Water yield; Vegetation; Restoration; Trade-offs; Scale
   effects
ID LOESS HILLY AREA; LAND-USE; ECOSYSTEM SERVICES; SEDIMENT YIELDS;
   PLATEAU; EROSION; RUNOFF; PATTERNS; RIVER; LIMITATIONS
AB The scale effect of vegetation restoration on soil and water conservation has received little attention, despite numerous studies on the assessments of vegetation restoration at different spatial scales. This study investigated the scale effect of vegetation restoration on soil erosion and water yield at Yanhe watershed, Chinese Loess Plateau. It provides the site-based temporal and spatial varying relationships among vegetation restoration, soil erosion, and water yield. Spatial modeling and mapping methods were used to analyze the scale effect at regional and sub-watershed scales. Our results indicated vegetation restoration has generated positive impacts on soil erosion reduction and negative impacts on water provision in the whole watershed. Croplands, sparse grasslands, and moderate grasslands were the land types which contributed the most to soil erosion. The decrease of cropland was the major contribution to soil erosion reduction. Moreover, the trade-off relationship between soil erosion and water yield existed in the whole watershed, but the degree of trade-off varied from one sub-watershed to another. High-risk soil erosion regions were concentrated in the central watershed. But in this region, the impacts of vegetation restoration on soil erosion control varied with different sub-watersheds. A simple increase of vegetation might not help reduce soil erosion in sub-watersheds where are characterized by low vegetation coverage and scattered vegetation restoration. Vegetation restoration should be based on past spatial LULC patterns. Soil erosion control should focus on the current level of cropland management and areas of vegetation maintenance than new afforestation in the high-risk soil erosion regions.
C1 [Wen, Xin; Deng, Xiangzheng; Zhang, Fan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.
   [Wen, Xin; Deng, Xiangzheng; Zhang, Fan] Chinese Acad Sci, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China.
   [Deng, Xiangzheng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Deng, XZ (reprint author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.
EM dengxz@igsnrr.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71225005, 91325302]; Strategic Priority Research
   Program of Chinese Academy of Sciences [XDA20100104]
FX This study was funded by projects of the National Natural Science
   Foundation of China (Grant No. < GN1 > 71225005; Grant No. </GN1 >
   91325302) and the Strategic Priority Research Program of Chinese Academy
   of Sciences (Grant No. XDA20100104). Professor J. Theau, Professor H.B.
   Granberg, Professor Y. Bouroubi, and Professor F. Girard, and P.M.
   Renard are thanked for the helpful advice. The authors would like to
   thank the anonymous reviewers for their helpful and constructive
   comments and suggestions which have substantially improved the quality
   of this manuscript.
CR Ai N, 2017, J ARID LAND, V9, P76, DOI 10.1007/s40333-016-0088-6
   Alewell C, 2019, INT SOIL WATER CONSE, V7, P203, DOI 10.1016/j.iswcr.2019.05.004
   Allen R. G., 1998, FAO Irrigation and Drainage Paper
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x
   Chen H, 2018, CATENA, V170, P141, DOI 10.1016/j.catena.2018.06.006
   Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290
   [程琳 CHENG Lin], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P61
   Correa SW, 2016, CATENA, V147, P110, DOI 10.1016/j.catena.2016.07.003
   Deng XZ, 2016, J GEOGR SCI, V26, P953, DOI 10.1007/s11442-016-1309-9
   Feng TJ, 2019, SCI TOTAL ENVIRON, V657, P535, DOI 10.1016/j.scitotenv.2018.11.476
   Feng TJ, 2018, EARTH SURF PROC LAND, V43, P1860, DOI 10.1002/esp.4361
   Feng XM, 2016, NAT CLIM CHANGE, V6, P1019, DOI [10.1038/nclimate3092, 10.1038/NCLIMATE3092]
   Fu BJ, 2017, ANNU REV EARTH PL SC, V45, P223, DOI 10.1146/annurev-earth-063016-020552
   Fu BJ, 2011, ECOL COMPLEX, V8, P284, DOI 10.1016/j.ecocom.2011.07.003
   Gao JB, 2011, APPL GEOGR, V31, P292, DOI 10.1016/j.apgeog.2010.06.003
   Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109
   Hu J, 2017, PROG PHYS GEOG, V41, P753, DOI 10.1177/0309133317738710
   Hu MM, 2019, RESOUR CONSERV RECY, V149, P106, DOI 10.1016/j.resconrec.2019.05.032
   Huang ZG, 2010, J ENVIRON SCI, V22, P1765, DOI 10.1016/S1001-0742(09)60317-X
   Jia XQ, 2014, ECOL INDIC, V43, P103, DOI 10.1016/j.ecolind.2014.02.028
   Jia XX, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1851
   Jiang C, 2019, ECOL ENG, V127, P135, DOI 10.1016/j.ecoleng.2018.11.018
   Li CJ, 2018, J HYDROL, V558, P90, DOI 10.1016/j.jhydrol.2018.01.007
   Li PF, 2017, EARTH-SCI REV, V170, P17, DOI 10.1016/j.earscirev.2017.05.005
   [李天宏 Li Tianhong], 2012, [自然资源学报, Journal of Natural Resources], V27, P1164
   [李婷 Li Ting], 2016, [自然资源学报, Journal of Natural Resources], V31, P583
   Liang W, 2019, ECOL INDIC, V101, P192, DOI 10.1016/j.ecolind.2019.01.020
   Liu B.Y., 2002, P 12 ISCO
   Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6
   Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012
   Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782
   Ministry of Water Resources of the People's Republic of China, 1997, 1901996 SL MIN WAT R, P3
   Panagos P, 2019, ENVIRON RES, V172, P470, DOI 10.1016/j.envres.2019.02.043
   [邱临静 QIU Linjing], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P49
   Rao EM, 2014, GEOMORPHOLOGY, V207, P64, DOI 10.1016/j.geomorph.2013.10.027
   Sharp R., 2018, INVEST 3 7 0 POST3 U
   Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014
   Wang SA, 2016, NAT GEOSCI, V9, P38, DOI [10.1038/ngeo2602, 10.1038/NGEO2602]
   Wang ZK, 2015, AGR WATER MANAGE, V161, P77, DOI 10.1016/j.agwat.2015.07.012
   Wei W, 2007, J HYDROL, V335, P247, DOI 10.1016/j.jhydrol.2006.11.016
   Wei W, 2014, J HYDROL, V513, P115, DOI 10.1016/j.jhydrol.2014.03.022
   Wei W, 2012, CHINESE GEOGR SCI, V22, P127, DOI 10.1007/s11769-012-0524-2
   Wen X., 2018, THESIS
   Wen X, 2019, AUTOPHAGY, DOI 10.1080/15548627.2019.1659573
   Wischmeier W. H., 1978, USDA AGR HDB
   Wu XT, 2018, LAND USE POLICY, V72, P303, DOI 10.1016/j.landusepol.2018.01.003
   [吴元芝 WU Yuan-zhi], 2008, [自然资源学报, Journal of Natural Resources], V23, P849
   Xie H., 2009, SCI AGR SINICA, V42, P568, DOI [10.3864/j.issn.0578-1752.2009.02.023, DOI 10.3864/J.ISSN.0578-1752.2009.02.023]
   Yan R, 2018, INT SOIL WATER CONSE, V6, P13, DOI 10.1016/j.iswcr.2017.12.002
   Yu Y, 2019, SCI TOTAL ENVIRON, V652, P755, DOI 10.1016/j.scitotenv.2018.10.255
   Zhang SL, 2018, J GEOPHYS RES-BIOGEO, V123, P923, DOI 10.1002/2017JG004038
   Zhang WC, 2019, SOIL TILL RES, V191, P162, DOI 10.1016/j.still.2019.04.004
   [章文波 Zhang Wenbo], 2002, [地理科学, Scientia Geographica Sinica], V22, P705
   Zhao XN, 2014, CATENA, V119, P1, DOI 10.1016/j.catena.2014.03.001
   Zhou ZX, 2015, J HYDROL, V524, P417, DOI 10.1016/j.jhydrol.2015.02.028
   Zuo DP, 2016, SCI TOTAL ENVIRON, V544, P238, DOI 10.1016/j.scitotenv.2015.11.060
NR 57
TC 2
Z9 2
U1 47
U2 47
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104474
DI 10.1016/j.resconrec.2019.104474
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700020
DA 2020-05-12
ER

PT J
AU Xu, CQ
   Tang, T
   Jia, HF
   Xu, M
   Xu, T
   Liu, ZJ
   Long, Y
   Zhang, RR
AF Xu, Changqing
   Tang, Tang
   Jia, Haifeng
   Xu, Ming
   Xu, Te
   Liu, Zijing
   Long, Ying
   Zhang, Rongrong
TI Benefits of coupled green and grey infrastructure systems: Evidence
   based on analytic hierarchy process and life cycle costing
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Analytic hierarchy process; Life cycle costing; Urban flood; Green
   infrastructure; Grey infrastructure
ID PETROCHEMICAL INDUSTRIES; PREDICTION
AB Green infrastructure complements grey infrastructure to provide effective urban stormwater management. Design of coupled green and grey infrastructure systems need a systems-based analysis considering multiple criterion. This study used analytic hierarchy process (AHP) and life cycle costing (LCC) to evaluate environmental and economic benefits of various types of coupled green and grey infrastructure systems. AHP results showed that, based on the local conditions and characteristics, the coupled green and grey scenario with green space, permeable pavement, green roof, and stormwater detention cell performed better than other scenarios in urban residential drainage and flood control. Also for the coupled green and grey scenario, the simulation results showed that no flooding was occurred during the ten-year return period rainfall. Coupled green and grey infrastructure scenarios can save the life cycle cost up to 94% compared to the traditional grey infrastructure scenario considering the design, construction, operation, and maintenance stages. Approximately 13% of commercial loan interest (1.03 million USD) can be saved for homebuyers. In future, urban designers and developers should consider the optimization of coupled green and gray infrastructures system under multiple criterion for the environment, economy, and safety benefits.
C1 [Xu, Changqing; Tang, Tang; Jia, Haifeng; Xu, Te; Liu, Zijing; Zhang, Rongrong] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.
   [Tang, Tang] Southeast Univ, Sch Civil Engn, Dept Municipal Engn, Nanjing 210096, Jiangsu, Peoples R China.
   [Xu, Ming] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA.
   [Xu, Ming] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA.
   [Long, Ying] Tsinghua Univ, Sch Architecture, Beijing 100084, Peoples R China.
RP Jia, HF (reprint author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.
EM jhf@tsinghua.edu.cn
RI Xu, Ming/F-3653-2010
OI Xu, Ming/0000-0002-7106-8390; Long, Ying/0000-0002-8657-6988
FU National Water Pollution Control and Treatment Science and Technology
   Major Project of China [2017ZX07103-002, 2017ZX07205]; Beijing Nature
   Science Foundation Project [8161003]; National Nature Science Foundation
   of ChinaNational Natural Science Foundation of China [51778319,
   41890823]; Tsinghua University (School of Architecture) CIFI Group Joint
   Research Center for Sustainable Community [R201]; Jiangsu Collaborative
   Innovation Center of Technology and Material of Water Treatment (Suzhou,
   China)
FX This work was supported by the National Water Pollution Control and
   Treatment Science and Technology Major Project of China (Grant No.
   2017ZX07103-002 and 2017ZX07205), Beijing Nature Science Foundation
   Project (Grant No. 8161003), the National Nature Science Foundation of
   China (Grant No. 51778319 and 41890823), and Tsinghua University (School
   of Architecture) CIFI Group Joint Research Center for Sustainable
   Community (Grant No. R201). The research is also supported by Jiangsu
   Collaborative Innovation Center of Technology and Material of Water
   Treatment (Suzhou 215009, China).
CR Allen W., 2013, CONSERVATION FUND
   [Anonymous], SPONG CIT SPONG CIT
   [Anonymous], 503782014 GBT MOHURD
   [Anonymous], SPONG CIT CONSTR PER
   [Anonymous], LOW IMP DEV INT DES
   [Anonymous], GB505552010 MOHURD
   [Anonymous], NANJ CIT HOUS PROV F
   [Anonymous], NOT IMPL CENTR FIN S
   Baek SS, 2015, WATER RES, V86, P122, DOI 10.1016/j.watres.2015.08.038
   Braglia M., 2000, J SUPPLY CHAIN MANAG, V36, P63, DOI DOI 10.1111/J.1745-493X.2000.TB00078.X
   Cai Y.T., 2017, MOD SURV MAPP, V2, P46
   Casal-Campos A, 2015, ENVIRON SCI TECHNOL, V49, P8307, DOI 10.1021/es506144f
   Cheng E. W. L., 2001, Information Management & Computer Security, V9, P61, DOI 10.1108/09685220110388827
   Clar M.L., 2004, STORMWATER BEST MANA, V2
   Code for Design of Outdoor Wastewater Engineering, GB500142006 MOHURD
   De Sousa MRC, 2012, J IND ECOL, V16, P901, DOI 10.1111/j.1530-9290.2012.00534.x
   Dong X, 2017, WATER RES, V124, P280, DOI 10.1016/j.watres.2017.07.038
   Geng ZQ, 2018, ENERGY, V160, P898, DOI 10.1016/j.energy.2018.07.077
   Geng ZJ, 2017, IEEE T SYST MAN CY-S, V47, P1763, DOI 10.1109/TSMC.2016.2523936
   Geng ZQ, 2017, ENERGY, V122, P350, DOI 10.1016/j.energy.2017.01.091
   Han YM, 2017, J INTELL FUZZY SYST, V32, P4183, DOI 10.3233/JIFS-16109
   Han YM, 2014, CHINESE J CHEM ENG, V22, P1279, DOI 10.1016/j.cjche.2014.09.032
   Haq AN, 2006, INT J ADV MANUF TECH, V29, P826, DOI 10.1007/s00170-005-2562-8
   Hill R., 1992, INT J PURCHASING MAT, V28, P31, DOI DOI 10.1111/j.1745-493X.1992.tb00561.x
   Jia HF, 2012, SEP PURIF TECHNOL, V84, P112, DOI 10.1016/j.seppur.2011.04.026
   Jiangsu Provincial Department of Housing and Urban Rural Construction, 2014, JIANGS MUN ENG VAL Q, P21
   Martin P., 2001, CR086A CIRIA
   Martin P., 2000, C521 CIRIA, V521
   O'Sullivan AD, 2015, J ENVIRON MANAGE, V149, P236, DOI 10.1016/j.jenvman.2014.10.025
   Prince George's County (Md.). Department of Environmental Resources, 1999, LOW IMP DEV HYDR AN
   Rossman LA, 2010, STORM WATER MANAGEME, P276
   SAATY RW, 1987, MATH MODELLING, V9, P161, DOI 10.1016/0270-0255(87)90473-8
   Saaty T., 2008, INT J SERV SCI, V1, P83, DOI DOI 10.1504/IJSSCI.2008.017590
   Saaty T.L., 2000, FUNDAMENTALS DECISIO
   Saaty TL, 2013, GROUP DECISION MAKIN
   SCHUELER TR, 1987, CONTROLLING URBAN RU
   Whelans C, 1994, PLANNING MANAGEMENT
   Wong THF, 2006, AUSTRALAS J WAT RESO, V10, P213, DOI 10.1080/13241583.2006.11465296
   Xu CQ, 2019, J CLEAN PROD, V213, P1103, DOI 10.1016/j.jclepro.2018.12.272
   Xu CQ, 2017, J CLEAN PROD, V149, P227, DOI 10.1016/j.jclepro.2017.02.086
   Xue S.Q., 2014, J WATER RESOURCES WA, V5, P169
NR 41
TC 2
Z9 2
U1 42
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD DEC
PY 2019
VL 151
AR UNSP 104478
DI 10.1016/j.resconrec.2019.104478
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JF8ZX
UT WOS:000491673700013
DA 2020-05-12
ER

PT J
AU Gangopadhyay, A
   Chakraborty, HJ
   Datta, A
AF Gangopadhyay, Aditi
   Chakraborty, Hirak Jyoti
   Datta, Abhijit
TI Employing virtual screening and molecular dynamics simulations for
   identifying hits against the active cholera toxin
SO TOXICON
LA English
DT Article
DE Cholera toxin; Alkaloids; ADMET; Virtual screening; Docking; Molecular
   dynamics simulation
ID PROTEIN-PROTEIN INTERACTIONS; EL-TOR STRAINS; ACCURATE DOCKING;
   INHIBITORS; OUTBREAK; DESIGN; GLIDE; ARF; O1
AB Cholera is a major global threat, affecting millions each year. The ADP ribosyltransferase activity of the active cholera toxin catalyses the massive loss of water and electrolytes during cholera infections. The active toxin heterodimer comprises the A1 subunit from Vibrio cholerae and ARF (ADP Ribosylation Factor) from the human host. Although the active toxin is a potential target for drug discovery against cholera, it has been scarcely targeted to date. The A1-ARF interface contains a potential druggable site for small molecule inhibitors. By combining a sequential docking and scoring strategy with molecular dynamics (MD) simulations, this study identified hits against the protein-protein interface (PPI) of the active cholera toxin from an in-house library of 9,175 ADMET-screened alkaloids. The docking algorithms and scoring functions of Glide SP, Glide XP, and AutoDock were employed for initial library screening. Three alkaloids were initially selected by docking-based virtual screening. The stability of the hit-toxin complexes was validated by MD simulations. Two of the three hits, namely, A6225 (7-formyldehydrothalicsimidine) and A16503 (1,2,7,8-tetrahydroxy dibenz[cd,f]indol-4(5H)-one), formed stable complexes with the toxin. Analyses of the hydrogen bond occupancies revealed that the hits formed stable hydrogen bonds with the toxin PPI. The hits identified herein can serve as reference compounds for drug discovery against cholera in the future.
C1 [Gangopadhyay, Aditi] Univ Calcutta, Dept Chem Technol, 92 APC Rd, Kolkata 700009, W Bengal, India.
   [Gangopadhyay, Aditi; Chakraborty, Hirak Jyoti; Datta, Abhijit] Presidency Univ, DBT Ctr Bioinformat, Kolkata 700073, W Bengal, India.
   [Chakraborty, Hirak Jyoti] Cent Inland Fisheries Res Inst, Kolkata 700120, W Bengal, India.
   [Datta, Abhijit] Jhargram Raj Coll, Dept Bot, Jhargram 721507, Paschim Medinip, India.
RP Gangopadhyay, A (reprint author), Univ Calcutta, Dept Chem Technol, 92 APC Rd, Kolkata 700009, W Bengal, India.
EM aig.bioinfo@gmail.com
OI Chakraborty, Hirak Jyoti/0000-0003-4294-6091
FU Council of Scientific and Industrial Research, New Delhi, IndiaCouncil
   of Scientific & Industrial Research (CSIR) - India
   [08/155(0042)/2011-EMR-I]
FX This work was supported by the Council of Scientific and Industrial
   Research, New Delhi, India, vide grant number 08/155(0042)/2011-EMR-I,
   provided to AG.
CR Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001
   Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Brahmachari G., 2009, NATURAL PRODUCTS CHE
   Chaudhuri K, 2009, CHOLERA TOXINS
   Cherubin P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166477
   Chowdhury G, 2016, J MED MICROBIOL, V65, P1130, DOI 10.1099/jmm.0.000344
   Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X
   D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Fan EK, 2004, INT J MED MICROBIOL, V294, P217, DOI 10.1016/j.ijmm.2004.07.002
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Gangopadhyay A, 2017, J MOL GRAPH MODEL, V73, P129, DOI 10.1016/j.jmgm.2017.02.018
   Gangopadhyay A, 2015, COMPUT BIOL CHEM, V55, P37, DOI 10.1016/j.compbiolchem.2015.02.011
   Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z
   Ghosh R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01250
   Giorgetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092677
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jameel S.K., 2016, ADV MICROBIOL, V06, P699, DOI [10.4236/aim.2016.69069, DOI 10.4236/AIM.2016.69069]
   Kumar V, 2018, BEILSTEIN J ORG CHEM, V14, P484, DOI 10.3762/bjoc.14.34
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06
   Newman D.J., 2016, NATURAL PRODUCTS AS
   Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1
   O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398
   Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129
   Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723
   Shen R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004368
   Sheng CQ, 2015, CHEM SOC REV, V44, P8238, DOI 10.1039/c5cs00252d
   Vanommeslaeghe K., 2009, J COMPUT CHEM, V31, P971
   Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963
   Zhang B, 2015, FUTURE MED CHEM, V7, P631, DOI 10.4155/fmc.15.13
NR 39
TC 0
Z9 0
U1 6
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 1
EP 9
DI 10.1016/j.toxicon.2019.09.005
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000001
PM 31494206
DA 2020-05-12
ER

PT J
AU Yap, WY
   Tan, KJSX
   Hwang, JS
AF Yap, Wei Yuen
   Tan, Katrina Joan Shu Xian
   Hwang, Jung Shan
TI Expansion of Hydra actinoporin-like toxin (HALT) gene family: Expression
   divergence and functional convergence evolved through gene duplication
SO TOXICON
LA English
DT Article
DE Hydra actinoporin-like toxin; Pore-forming toxin; Sulfatide;
   Protein-lipid interaction; Gene duplication
ID PORE-FORMING TOXIN; STICHOLYSIN-II; EQUINATOXIN-II; SPHINGOSINE
   1-PHOSPHATE; PROTEIN; MECHANISM; BINDING; VENOM; SPHINGOMYELIN; RESIDUES
AB Hydra actinoporin-like toxin 1 (HALT-1) was previously shown to cause cytolysis and haemolysis in a number of human cells and has similar functional properties to the actinoporins equinatoxin and sticholysin. In addition to HALT-1, five other HALTs (HALTs 2, 3, 4, 6 and 7) were also isolated from Hydra magnipapillata and expressed as recombinant proteins in this study. We demonstrated that recombinant HALTs have cytolytic activity on HeLa cells but each exhibited a different range of toxicity. All six recombinant HALTs bound to sulfatide, while rHALT-1 and rHALT-3 bound to two additional sphingolipids, lysophosphatidic acid and sphingosine-1-phosphate as indicated by the protein-lipid overlay assay. When either tryptophan(133) or tyrosine(129) of HALT-1 was mutated, the mutant protein lost binding to sulfatide, lysophosphatidic acid and sphingosine-1-phosphate. As further verification of HALTs' binding to sulfatide, we performed ELISA for each HALT. To determine the cell-type specific gene expression of seven HALTs in Hydra, we searched for individual HALT expression in the single-cell RNA-seq data set of Single Cell Portal. The results showed that HALT-1, 4 and 7 were expressed in differentiating stenoteles. HALT-1 and HALT-6 were expressed in the female germline during oogenesis. HALT-2 was strongly expressed in the gland and mucous cells in the endoderm. Information on HALT-3 and HALT-5 could not be found in the single-cell data set. Our findings show that subfunctionalisation of gene expression following duplication enabled HALTs to become specialized in various cell types of the interstitial cell lineage.
C1 [Yap, Wei Yuen; Tan, Katrina Joan Shu Xian] UCSI Univ, Fac Appl Sci, 1 Jalan Menara Gading, Kuala Lumpur 56000, Malaysia.
   [Hwang, Jung Shan] Sunway Univ, Sch Healthcare & Med Sci, Dept Med Sci, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.
   [Yap, Wei Yuen] Sunway Univ, Sch Sci & Technol, Dept Biol Sci, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.
RP Hwang, JS (reprint author), Sunway Univ, Sch Healthcare & Med Sci, Dept Med Sci, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.
EM hwangjs@sunway.edu.my
RI Hwang, Jung Shan/AAJ-3014-2020
FU UCSI University [Proj-In-FAS-0331]
FX We would like to express our sincere thanks to Dr. Charles N. David for
   his critical reading and constructive comments of the manuscript. This
   work is financially supported by UCSI University under PSIF grant
   [Pioneer Scientist Incentive Fund, grant no. Proj-In-FAS-0331.
CR Alajlouni R, 2011, BBA-BIOMEMBRANES, V1808, P2734, DOI 10.1016/j.bbamem.2011.07.029
   Alegre-Cebollada J, 2007, BIOPHYS J, V93, P3191, DOI 10.1529/biophysj.106.102566
   Alm I, 2015, BBA-BIOMEMBRANES, V1848, P925, DOI 10.1016/j.bbamem.2014.12.017
   Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022
   Ameirika, 2017, TOXICON, V133, P153, DOI 10.1016/j.toxicon.2017.05.007
   Anderluh G, 2003, STRUCTURE, V11, P1312, DOI 10.1016/j.str.2003.10.007
   Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5
   Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200
   BODE HR, 1987, DEV BIOL, V122, P577, DOI 10.1016/0012-1606(87)90321-6
   Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830
   Columbus-Shenkar YY, 2018, ELIFE, V7, DOI [10.7554/e.Life.35014.001, 10.7554/eLife.35014]
   Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Gacesa R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1976-4
   Garcia PS, 2012, TOXICON, V60, P724, DOI 10.1016/j.toxicon.2012.05.018
   Garcia-Linares S, 2016, BIOCHEMISTRY-US, V55, P6406, DOI 10.1021/acs.biochem.6b00935
   Garcia-Linares S, 2015, MAR DRUGS, V13, P1647, DOI 10.3390/md13041647
   Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012
   Glasser E, 2014, TOXICON, V91, P103, DOI 10.1016/j.toxicon.2014.04.004
   Goetzl EJ, 2007, ACTA PAEDIATR, V96, P49, DOI 10.1111/j.1651-2227.2007.00208.x
   Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601
   Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104
   Hwang JS, 2010, P NATL ACAD SCI USA, V107, P18539, DOI 10.1073/pnas.1003256107
   Juliano CE, 2014, P NATL ACAD SCI USA, V111, P337, DOI 10.1073/pnas.1320965111
   Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20
   Koch AW, 1998, J CELL SCI, V111, P1545
   Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Labrie V, 2001, MICROBIOL-SGM, V147, P3141, DOI 10.1099/00221287-147-11-3141
   Leychenko E, 2018, MAR DRUGS, V16, DOI 10.3390/md16060183
   Liew YJM, 2015, TOXINS, V7, P407, DOI 10.3390/toxins7020407
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Macrander J, 2016, TOXINS, V8, DOI 10.3390/toxins8120368
   Macrander J, 2016, GENOME BIOL EVOL, V8, P2358, DOI 10.1093/gbe/evw155
   Madio B, 2018, CELL MOL LIFE SCI, V75, P4511, DOI 10.1007/s00018-018-2897-6
   Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200
   Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019
   Mattson MP, 2008, HUM EXP TOXICOL, V27, P155, DOI 10.1177/0960327107083417
   Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018
   Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013
   Moran Y, 2012, P ROY SOC B-BIOL SCI, V279, P1351, DOI 10.1098/rspb.2011.1731
   Morante K, 2016, J BIOL CHEM, V291, P19210, DOI 10.1074/jbc.M116.734053
   Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785
   Nakayama T, 2008, INT J HEMATOL, V87, P363, DOI 10.1007/s12185-008-0065-8
   Penel S, 2007, RES J MICROBIOL, V2, P209, DOI 10.3923/jm.2007.209.215
   Petersen HO, 2015, MOL BIOL EVOL, V32, P1928, DOI 10.1093/molbev/msv079
   Podobnik M, 2017, SEMIN CELL DEV BIOL, V72, P133, DOI 10.1016/j.semcdb.2017.07.026
   Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007
   Ros U, 2015, BIOCHIMIE, V116, P70, DOI 10.1016/j.biochi.2015.06.024
   Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733
   Sachkova MY, 2019, MOL BIOL EVOL, V36, P2001, DOI 10.1093/molbev/msz132
   Sheng XY, 2015, DEVELOPMENT, V142, P1390, DOI 10.1242/dev.121723
   Siebert S, 2019, SCIENCE, V365, P341, DOI 10.1126/science.aav9314
   Smith HL, 2018, GENOME BIOL EVOL, V10, P1892, DOI 10.1093/gbe/evy128
   Surm JM, 2019, MOL ECOL, V28, P2272, DOI 10.1111/mec.15084
   Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337
   Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014
   Wacklin HP, 2016, BBA-BIOMEMBRANES, V1858, P640, DOI 10.1016/j.bbamem.2015.12.019
   Wang C, 2005, J BIOL CHEM, V281, P656, DOI [10.1074/jbc.M507880200, DOI 10.1074/JBC.M507880200]
   Xiao S, 2013, 2013 5TH IEEE INTERNATIONAL SYMPOSIUM ON MICROWAVE, ANTENNA, PROPAGATION AND EMC TECHNOLOGIES FOR WIRELESS COMMUNICATIONS (MAPE), P279, DOI 10.1109/MAPE.2013.6689885
   Xiao SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385609
NR 61
TC 0
Z9 0
U1 8
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 10
EP 20
DI 10.1016/j.toxicon.2019.09.007
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000002
PM 31513812
DA 2020-05-12
ER

PT J
AU Rathnayaka, RMMKN
   Ranathunga, PEAN
   Kularatne, SAM
AF Rathnayaka, R. M. M. K. Namal
   Ranathunga, P. E. A. Nishanthi
   Kularatne, S. A. M.
TI Systemic bleeding including pulmonary haemorrhage following hump-nosed
   pit viper (Hypnale hypnale) envenoming: A case report from Sri Lanka
SO TOXICON
LA English
DT Review
DE Snakebites; Hump-nosed viper; Hypnale hypnale; Systemic bleeding; Sri
   Lanka; Pulmonary haemorrhage; Thrombotic microangiopathy
ID RUSSELLS VIPER; THROMBOTIC MICROANGIOPATHY; DABOIA-RUSSELII; VENOM;
   DEATH
AB Out of seven venomous land snake species of Sri Lanka, hump-nosed pit viper (Hypnale spp.) causes the commonest venomous snakebites. It is widely distributed all over the country except in the peninsula of Jaffna. The genus has three species naming H. hypnale, H. zara and H. nepa. They frequently cause local envenoming and rarely cause coagulopathy and acute kidney injury. Systemic bleeding is the most trivial complication associated with coagulopathy caused by these snakes and pulmonary haemorrhages are one of them which are rarely reported. Antivenoms are currently not available for genus Hypnale bites in Sri Lanka. We describe a fatal case of pulmonary haemorrhage caused by a proven hump-nosed viper (Hypnale hypnale) bite associated with other systemic bleeding manifestations and thrombotic microangiopathy. This is the first known case of pulmonary and intracranial haemorrhages caused by hump-nosed viper bite.
C1 [Rathnayaka, R. M. M. K. Namal] Teaching Hosp, Intens Care Unit, Ratnapura, Sri Lanka.
   [Rathnayaka, R. M. M. K. Namal] Univ Peradeniya, Fac Vet Med & Anim Sci, Dept Vet Pathobiol, Peradeniya, Sri Lanka.
   [Rathnayaka, R. M. M. K. Namal] Univ Colombo, Postgrad Inst Med Clin Pharmacol & Therapeut, Colombo, Sri Lanka.
   [Ranathunga, P. E. A. Nishanthi] Teaching Hosp, Med Unit, Ratnapura, Sri Lanka.
   [Kularatne, S. A. M.] Univ Peradeniya, Fac Med, Dept Med, Peradeniya, Sri Lanka.
RP Rathnayaka, RMMKN (reprint author), Teaching Hosp, Intens Care Unit, Ratnapura, Sri Lanka.
EM namalrath10@yahoo.com
RI Rathnayaka, R.M.M.K.Namal/AAL-2371-2020
CR [Anonymous], GUID MAN SNAK HOSP E
   Ariaratnam CA, 2008, T ROY SOC TROP MED H, V102, P1120, DOI 10.1016/j.trstmh.2008.03.023
   Benvenuti LA, 2003, TOXICON, V42, P331, DOI 10.1016/S0041-0101(03)00167-3
   Datta K, 1999, CURR SCI INDIA, V77, P1673
   de Silva A., 1983, Ceylon Medical Journal, V28, P144
   de Silva Umesh, 2018, J Med Case Rep, V12, P213, DOI 10.1186/s13256-018-1756-2
   Escalante T, 2003, TOXICOL APPL PHARM, V193, P17, DOI 10.1016/S0041-008X(03)00337-5
   Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185
   Gnanathasan A, 2014, CHEST, V146, P1403, DOI 10.1378/chest.13-2674
   Isbister GK, 2007, INTERN MED J, V37, P523, DOI 10.1111/j.1445-5994.2007.01407.x
   Jeevagan V, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-21
   JEYARAJAH R, 1984, AM J TROP MED HYG, V33, P506, DOI 10.4269/ajtmh.1984.33.506
   Joseph JK, 2007, T ROY SOC TROP MED H, V101, P85, DOI 10.1016/j.trstmh.2006.03.008
   Kularatne S A M, 2003, Southeast Asian J Trop Med Public Health, V34, P855
   Kularatne SAM, 2014, CEYLON MED J, V59, P29, DOI 10.4038/cmj.v59i1.6738
   Kularatne SAM, 2002, POSTGRAD MED J, V78, P276, DOI 10.1136/pmj.78.919.276
   Kularatne SAM, 1999, CEYLON MED J, V144, P169
   Kumara H, 2019, TOXICON, V163, P19, DOI 10.1016/j.toxicon.2019.03.015
   Leong OS, 2018, TOXICON, V150, P188, DOI 10.1016/j.toxicon.2018.05.020
   Maduwage K, 2013, TOXICON, V61, P11, DOI 10.1016/j.toxicon.2012.10.013
   Maduwage K, 2011, TOXICON, V58, P641, DOI 10.1016/j.toxicon.2011.09.014
   Maduwage K, 2009, ZOOTAXA, P1
   Mukheriee AK, 2008, TOXICON, V51, P923, DOI 10.1016/j.toxicon.2007.12.008
   Namal Rathnayaka R.M.M.K, 2019, P SRI LANK MED ASS 1, P96
   Namal Rathnayaka R.M.M.K., 2017, CEYLON MED J S1, V62, P97
   Namal Rathnayaka R.M.M.K., 2018, T R SOC TROP MED HYG, P1
   Namal Rathnayaka R.M.M.K, 2018, WILDERNESS ENV MED, P1
   Palangasinghe DR, 2015, SAUDI MED J, V36, P634, DOI 10.15537/smj.2015.5.10691
   Premawardena AP, 1998, AM J TROP MED HYG, V58, P821, DOI 10.4269/ajtmh.1998.58.821
   Rathnayaka RMMKN, 2018, TOXICON, V148, P33, DOI 10.1016/j.toxicon.2018.03.014
   Tan NH, 2015, J PROTEOMICS, V128, P403, DOI 10.1016/j.jprot.2015.08.017
   Uma B, 2000, TOXICON, V38, P1129, DOI 10.1016/S0041-0101(99)00228-7
   WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8
   2010, SCREEN DON BLOOD, P1
NR 34
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 21
EP 28
DI 10.1016/j.toxicon.2019.09.009
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000003
PM 31513811
DA 2020-05-12
ER

PT J
AU Grabowsky, ER
   Mackessy, SP
AF Grabowsky, Emily R.
   Mackessy, Stephen P.
TI Predator-prey interactions and venom composition in a high elevation
   lizard specialist, Crotalus pricei (Twin-spotted Rattlesnake)
SO TOXICON
LA English
DT Article
DE Adaptation; Evolution; Native prey; Proteomics; Sky islands; Toxicity
ID SPERMOPHILUS-BEECHEYI; EVOLUTIONARY RESPONSE; 3-FINGER TOXIN; GARTER
   SNAKES; VIRIDIS; MEXICO; COEVOLUTION; RESISTANCE; TOXICITY;
   IDENTIFICATION
AB The Twin-spotted Rattlesnake (Crotalus pricei) is a small lizard specialist restricted to higher montane habitat in the Sky Islands of Arizona and Mexico. Though this species is restricted to high elevations and dispersal between mountaintops is impossible, few studies have investigated venom composition or the predator-prey relationship between C. p. pricei and its primary prey source, Yarrow's Spiny Lizard (Sceloporus jarrovii). Because of current isolation of populations in disjunct mountain ranges, it is possible that populations show local adaptation to prey and/or environmental conditions, as reflected by distinct venom phenotypes. Here we characterize venom composition of C. pricei from several different Sky Island mountain ranges and its relationship with S. jarrovii by using various analytical techniques and comparative toxicity tests. Results of venom analyses indicate that there is limited geographic variation in venom composition, occurring primarily in venoms of C. pricei from Durango, Mexico, which had unusual PLA(2) isoforms that are lacking from venoms of U.S. populations. Toxicity assays reveal that S. jarrovii has not developed resistance specific to C. p. pricei venom but does display a general tolerance to venom of several snakes in the genus Crotalus. These results provide insight into the evolutionary relationship between a lizard specialist and its natural prey, in addition to novel information on the venom composition of a little-studied species with a narrow range in the United States.
C1 [Grabowsky, Emily R.; Mackessy, Stephen P.] Univ Northern Colorado, Sch Biol Sci, 501 20th St,CB 92, Greeley, CO 80639 USA.
RP Mackessy, SP (reprint author), Univ Northern Colorado, Sch Biol Sci, 501 20th St,CB 92, Greeley, CO 80639 USA.
EM stephen.mackessy@unco.edu
OI Mackessy, Stephen/0000-0003-4515-2545
FU Charlie W. Painter Grant in Herpetology (2018)
FX This research was partially funded by a Charlie W. Painter Grant in
   Herpetology (2018, to ERG). The authors thank the Chiricahua Desert
   Museum (Bob Ashley) and the Sternberg Museum of Natural History (Curtis
   Schmidt, Brent Schulze) for access to several Crotalus pricei venom
   samples. We thank Dr. Anthony J. Saviola (Scripps Research Institute)
   for LC-MS/MS analysis of two C. p. miquihuanus venom fraction samples.
CR Arbuckle K, 2017, TOXICON, V140, P118, DOI 10.1016/j.toxicon.2017.10.026
   Armstrong B.L., 1979, NATURAL HIST MEXICAN
   Arriaga L., 2005, USDA FOREST SERVICE, P171
   Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048
   Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2
   Biardi JE, 2006, J CHEM ECOL, V32, P137, DOI 10.1007/s10886-006-9357-8
   Blair C, 2016, MOL PHYLOGENET EVOL, V97, P145, DOI 10.1016/j.ympev.2015.12.020
   Brodie ED, 2002, EVOLUTION, V56, P2067
   BRODIE ED, 1990, EVOLUTION, V44, P651, DOI 10.1111/j.1558-5646.1990.tb05945.x
   Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x
   Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x
   Campbell JA, 2004, VENOMOUS REPTILES W, V2
   Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014
   Coblentz D., 2005, USDA FOREST SERVICE, P171
   Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067
   Fave MJ, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0448-4
   Gibbs HL, 2009, TOXICON, V53, P672, DOI 10.1016/j.toxicon.2009.01.034
   Gottfried G.J., 2005, CHANGING BASIS CITIZ, piii
   Heyborne WH, 2013, BIOCHIMIE, V95, P1923, DOI 10.1016/j.biochi.2013.06.025
   Holycross AT, 2002, J HERPETOL, V36, P454, DOI 10.2307/1566190
   Jones BK, 2019, J PROTEOME RES, V18, P2206, DOI 10.1021/acs.jproteome.9b00077
   Jones LLC, 2009, LIZARDS AM SW PHOTOG
   Kishimoto M, 2001, ANAL BIOCHEM, V298, P136, DOI 10.1006/abio.2001.5381
   LOMOLINO MV, 1989, ECOLOGY, V70, P180, DOI 10.2307/1938425
   Mackessy S.P., 2010, HDB VENOMS TOXINS RE, P1
   Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007
   MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927
   MACKESSY SP, 2008, BIOL RATTLESNAKES, P495
   Mackessy SP, 2010, TOXICON, V55, P1463, DOI 10.1016/j.toxicon.2010.02.028
   Mastretta-Yanes A, 2015, J BIOGEOGR, V42, P1586, DOI 10.1111/jbi.12546
   McDonald J. A., 1993, Biological diversity of Mexico: origins and distribution., P681
   Metcalfe SE, 2000, QUATERNARY SCI REV, V19, P699, DOI 10.1016/S0277-3791(99)00022-0
   MINTON SA, 1984, TOXICON, V22, P828, DOI 10.1016/0041-0101(84)90169-7
   Modahl CM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1003
   Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200
   Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555
   Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x
   PORAN NS, 1987, TOXICON, V25, P767, DOI 10.1016/0041-0101(87)90127-9
   Prival D.B., 2016, RATTLESNAKES ARIZONA, V1, P508
   Prival DB, 2012, HERPETOL MONOGR, V26, P1
   Rex CJ, 2019, TOXICON, V164, P51, DOI 10.1016/j.toxicon.2019.03.027
   Saviola AJ, 2017, TOXICON, V138, P119, DOI 10.1016/j.toxicon.2017.08.016
   Saviola AJ, 2015, J PROTEOMICS, V121, P28, DOI 10.1016/j.jprot.2015.03.015
   Smiley-Walters SA, 2018, TOXICON, V144, P42, DOI 10.1016/j.toxicon.2018.01.022
   Smith CF, 2016, TOXICON, V120, P110, DOI 10.1016/j.toxicon.2016.08.001
   Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x
   Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0
NR 47
TC 0
Z9 0
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 29
EP 40
DI 10.1016/j.toxicon.2019.09.011
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000004
PM 31513813
DA 2020-05-12
ER

PT J
AU Machado, M
   Wilson, TM
   de Sousa, DER
   Camara, ACL
   Furlan, FH
   Macedo, JTSAE
   Pupin, RC
   de Lemos, RAA
   Armien, AG
   Barros, SS
   Riet-Correa, F
   de Castro, MB
AF Machado, Mizael
   Wilson, Tais Meziara
   Ribeiro de Sousa, Davi Emanuel
   Lopes Camara, Antonio Carlos
   Furlan, Fernando Henrique
   Silva Almeida e Macedo, Juliana Targino
   Pupin, Rayane Chitolina
   Amaral de Lemos, Ricardo Antonio
   Armien, Anibal G.
   Barros, Severo Sales
   Riet-Correa, Franklin
   de Castro, Marcio Botelho
TI Fatal lancehead pit viper (Bothrops spp.) envenomation in horses
SO TOXICON
LA English
DT Article
DE Snakebite; Snake; Bothrops; Coagulopathy; Acute kidney injury;
   Endothelial injury; Horses
ID SNAKE-VENOM; PATHOLOGICAL ASPECTS; DEATH
AB Snake bite envenomations in farm animals are generally overestimated as the cause of mortality in rural areas in Latin America. However, most cases are based only on anecdotal information and assumptions, and lack diagnostic evidence. There are few proven reports of envenomation and death in horses caused by snakebites from members of the Bothrops genus (lancehead pit vipers). This study presents epidemiological and clinical-pathological findings of fatal bothropic envenomation in horses from Central Western Brazil in order to contribute to the correct diagnosis of this condition. A survey of the records of equine necropsies from the Veterinary Pathology Laboratories of the University of Brasilia, Federal University of Mato Grosso and Federal University of Mato Grosso do Sul, from January 2010 to February 2018, was performed. Five fatal cases of bothropic snakebite were identified in 755 necropsies of horses, corresponding to 0.66% of these cases, ranging annually from 0.33% to 0.89%. The main necropsy findings were marked swelling and diffuse subcutaneous hemorrhage, and identification of the fang marks in 2 out of five horses. Hemorrhage in most organs and tissues was the pathological hallmark of systemic envenomation. Myonecrosis, dermonecrosis, and moderate to severe kidney degeneration and necrosis were also observed. Fatal Bothrops snakebites in horses have a low occurrence in Central Western Brazil and most cases occur in the rainy season. The diagnosis of this condition may be substantiated by clinical signs and pathological findings. Local hemorrhage and necrosis, systemic hemorrhagic disorders and injuries related to acute kidney injury are the predominant clinical signs. These findings should be considered in the diagnosis and therapeutic management of these envenomations.
C1 [Machado, Mizael; Wilson, Tais Meziara; Ribeiro de Sousa, Davi Emanuel; Silva Almeida e Macedo, Juliana Targino; de Castro, Marcio Botelho] Univ Brasilia UnB, Vet Teaching Hosp, Vet Pathol Lab, Via L4 Norte Sn,Campus Univ Darcy Ribeiro, BR-70636200 Brasilia, DF, Brazil.
   [Lopes Camara, Antonio Carlos] Univ Brasilia UnB, Large Anim Vet Teaching Hosp, SIT PqEAT, BR-70297400 Brasilia, DF, Brazil.
   [Furlan, Fernando Henrique] Univ Fed Mato Grosso, Vet Pathol Lab, Vet Teaching Hosp, Av Fernando Correa Costa 2367, BR-78060900 Cuiaba, MG, Brazil.
   [Pupin, Rayane Chitolina; Amaral de Lemos, Ricardo Antonio] Univ Fed Mato Grosso do Sul UFMS, Coll Vet Med & Anim Sci, Av Senador Filinto Muller 2443, BR-79074460 Campo Grande, MS, Brazil.
   [Armien, Anibal G.] Univ Minnesota, Ultrastruct Pathol Unit, Vet Diagnost Lab, 1333 Gortner Ave, St Paul, MN 55108 USA.
   [Barros, Severo Sales] Univ Fed Pelotas, Vet Fac, Dept Pathol, Campus Capao Leao, BR-96010900 Pelotas, RS, Brazil.
   [Riet-Correa, Franklin] INIA, Estn Expt INIA Estanzuela, Ruta 50 Km 11, Colonia, Uruguay.
RP de Castro, MB (reprint author), Univ Brasilia UnB, Vet Teaching Hosp, Vet Pathol Lab, Via L4 Norte Sn,Campus Univ Darcy Ribeiro, BR-70636200 Brasilia, DF, Brazil.
EM mbcastro2005@yahoo.com.br
RI de Castro, Marcio Botelho/AAB-9986-2020
OI de Castro, Marcio Botelho/0000-0002-3996-0856; Wilson,
   Tais/0000-0002-0404-9499; Machado, Mizael/0000-0002-2029-884X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX Special thanks to Dr. Claudio Severo Lombardo de Barros (Federal
   University of Mato Grosso do Sul) for the technical assistance in the
   pathological diagnosis and to Anderson Saravia (National Institute of
   Agricultural Research of Uruguay -Inia, La Estanzuela) for the aid in
   the making of the map. Thanks are due to Dr. Jose Maria Gutierrez for
   the critical reading of the manuscript and suggestions. This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Aragao AP, 2010, PESQUISA VET BRASIL, V30, P717, DOI 10.1590/S0100-736X2010000900003
   Barbosa JD, 2011, PESQUISA VET BRASIL, V31, P967, DOI 10.1590/S0100-736X2011001100005
   Barbosa PSF, 2006, TOXICON, V47, P831, DOI 10.1016/j.toxicon.2006.01.012
   Barraviera B., 1999, CLIN THERAPEUTIC ASP, P261
   Boer-Lima PA, 2002, AM J TROP MED HYG, V67, P217, DOI 10.4269/ajtmh.2002.67.217
   Caldas SA, 2008, PESQUI VET BRASIL, V28, P303, DOI 10.1590/S0100-736X2008000600008
   Cheng Allen C, 2004, J Intensive Care Med, V19, P259, DOI 10.1177/0885066604265799
   Chiacchio SB, 2011, J VENOM ANIM TOXINS, V17, P111, DOI 10.1590/S1678-91992011000100016
   Cruz LS, 2009, ETHNIC DIS, V19, P42
   De Rijk EPCT, 2003, TOXICOL PATHOL, V31, P462, DOI 10.1080/01926230390213775
   Leal MLD, 2013, ACTA SCI VET, V41
   Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026
   Fernandes DS, 2004, HERPETOLOGICA, V60, P245, DOI 10.1655/02-85
   Ferreira Júnior R.S., 2004, J. Venom. Anim. Toxins incl. Trop. Dis, V10, P112, DOI 10.1590/S1678-91992004000200002
   Fielding CL, 2011, JAVMA-J AM VET MED A, V238, P631, DOI 10.2460/javma.238.5.631
   Franco R. L., 2001, Journal of Venomous Animals and Toxins, V7, P56, DOI 10.1590/S0104-79302001000100005
   Gay CC, 2009, TOXICON, V53, P53, DOI 10.1016/j.toxicon.2008.10.010
   Graca FAS, 2008, PESQUISA VET BRASIL, V28, P261, DOI 10.1590/S0100-736X2008000600001
   Grondin TM, 2010, SCHALMS VET HEMATOLO, P821
   Grunert E., 1967, TIERDRZTL WOCHENSCHR, V20, P531
   Grunert E., 1969, VET MED NACHRICHTEN, V3, P217
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150
   Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]
   Herrera C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003731
   Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1
   Lopes CTA, 2012, PESQUI VET BRASIL, V32, P843, DOI 10.1590/S0100-736X2012000900005
   Machado M, 2019, J SMALL ANIM PRACT, V60, P131, DOI 10.1111/jsap.12922
   Malaque C.M.S., 2015, CRIT CARE TOXICOL, V1, DOI [10.1007/978-3-319-20790-2_146-1, DOI 10.1007/978-3-319-20790-2_146-1]
   Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038
   Mello SM, 2010, TOXICON, V55, P470, DOI 10.1016/j.toxicon.2009.09.018
   MENDEZ MD, 1995, VET HUM TOXICOL, V37, P62
   MOREIRA L, 1994, TOXICON, V32, P977, DOI 10.1016/0041-0101(94)90376-X
   Nascimento JM, 2007, BIOCHEM CELL BIOL, V85, P591, DOI 10.1139/O07-067
   Radostits O.M., 2007, VET MED, P1851
   Raposo J.B., 2001, REV FZVA, V8, P51
   Sanchez MJ, 2003, ACTA HORTIC, P33, DOI 10.17660/ActaHortic.2003.605.3
   Sazima I., 1998, MEM I BUTANTAN, V3, P83
   Silva NS, 2011, J VENOM ANIM TOXINS, V17, P496, DOI 10.1590/S1678-91992011000400018
   Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442
   Sousa Melina Garcia de, 2011, Pesq. Vet. Bras., V31, P773, DOI 10.1590/S0100-736X2011000900009
   Tokarnia CH, 2008, PESQUISA VET BRASIL, V28, P643, DOI 10.1590/S0100-736X2008001200014
   Tokarnia CH, 2006, PESQUISA VET BRASIL, V26, P55, DOI 10.1590/S0100-736X2006000200001
   Varanda E.A., 1999, CLIN THERAPEUTIC ASP, P205
   White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030
NR 45
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 41
EP 50
DI 10.1016/j.toxicon.2019.09.002
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000005
PM 31499078
DA 2020-05-12
ER

PT J
AU Ao, D
   Lei, Z
   Dzakpasu, M
   Chen, R
AF Ao, Dong
   Lei, Zhen
   Dzakpasu, Mawuli
   Chen, Rong
TI Role of divalent metals Cu2+ and Zn2+ in Microcystis aeruginosa
   proliferation and production of toxic microcystins
SO TOXICON
LA English
DT Article
DE Cell proliferation; Divalent metal; M. aeruginosa; Microcystins
ID HARMFUL CYANOBACTERIUM; GROWTH; NITROGEN; ZINC; STRAINS; COPPER; RATES
AB Cu2+ and Zn2+, two ubiquitous metals in water environments, can widely trigger algae blooms at favourable environmental conditions. This paper elucidates the roles of Cu2+ and Zn2+ in the proliferation of Microcystis aeruginosa (M. aeruginosa) and synthesis of Microcystins (MCs). Findings indicate significant influences of increasing Cu2+ and Zn2+ concentrations on cell proliferation at limited available phosphorus concentrations of less than 0.1 mg/L. By contrast, Cu2+ and Zn2+ notably affected MCs production at all the inoculated phosphorus concentrations. The critical concentrations of 1 mu g/L and 5 mu g/L for Cu2+ and Zn2+, respectively, are determined to trigger rapid cell proliferation and MCs production. Furthermore, the impacts of Cu2+ and Zn2+ on nitrogen absorption and, subsequently, on amino acids (AAs) formation in cells, is likely key in MCs synthesis. The two AAs Alanine (Ala) and glutamic acid (Glu) demonstrate the most notable variations with the concentrations of Cu2+ & Zn2+.
C1 [Ao, Dong] Xian Polytech Univ, Sch Environm & Chem Engn, Xian 710048, Shaanxi, Peoples R China.
   [Ao, Dong; Lei, Zhen; Dzakpasu, Mawuli; Chen, Rong] Int S&T Cooperat Ctr Urban Alternat Water Resourc, 13 Yanta Rd, Xian 710055, Shaanxi, Peoples R China.
   [Ao, Dong; Lei, Zhen; Dzakpasu, Mawuli; Chen, Rong] Xian Univ Architecture & Technol, Key Lab Environm Engn, 13 Yanta Rd, Xian 710055, Shaanxi, Peoples R China.
RP Ao, D (reprint author), Xian Polytech Univ, Sch Environm & Chem Engn, Xian 710048, Shaanxi, Peoples R China.; Ao, D (reprint author), Int S&T Cooperat Ctr Urban Alternat Water Resourc, 13 Yanta Rd, Xian 710055, Shaanxi, Peoples R China.; Ao, D (reprint author), Xian Univ Architecture & Technol, Key Lab Environm Engn, 13 Yanta Rd, Xian 710055, Shaanxi, Peoples R China.
EM aodong@xpu.edu.cn
RI Dzakpasu, Mawuli/O-1592-2013
OI Dzakpasu, Mawuli/0000-0001-6425-1034
FU National Key Research and Development Program of China
   [SQ2017YFGH001891]; Shaanxi Program for Overseas Returnees [2018012];
   Xi'an Polytechnic University Ph.D. Research Startup Fund [BS201921]
FX This work was supported by the National Key Research and Development
   Program of China (SQ2017YFGH001891), Shaanxi Program for Overseas
   Returnees (No. 2018012) and Xi'an Polytechnic University Ph.D. Research
   Startup Fund (No. BS201921).
CR Baek SH, 2015, ESTUAR COAST SHELF S, V163, P265, DOI 10.1016/j.ecss.2014.12.035
   Bertrand M, 2005, PHOTOSYNTHETICA, V43, P345, DOI 10.1007/s11099-005-0058-2
   Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500
   Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437
   BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182
   Chaloub RM, 2005, J PHYCOL, V41, P1162, DOI 10.1111/j.1529-8817.2005.00143.x
   Chen L, 2016, J HAZARD MATER, V301, P381, DOI 10.1016/j.jhazmat.2015.08.041
   Coale K, 2001, NAT C CARB SEQ
   Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106
   Ellwood MJ, 2004, MAR CHEM, V87, P37, DOI 10.1016/j.marchem.2004.01.005
   Horst GP, 2014, WATER RES, V54, P188, DOI 10.1016/j.watres.2014.01.063
   KASHYAP AK, 1982, Z PFLANZENPHYSIOL, V107, P289, DOI 10.1016/S0044-328X(82)80194-3
   Kovacik J, 2010, PLANT SCI, V178, P307, DOI 10.1016/j.plantsci.2010.01.009
   Li JH, 2015, MAR POLLUT BULL, V92, P52, DOI 10.1016/j.marpolbul.2015.01.001
   Lone Y, 2016, J TOXICOL, DOI 10.1155/2016/8048125
   Long BM, 2010, HARMFUL ALGAE, V9, P74, DOI 10.1016/j.hal.2009.08.003
   LUKAC M, 1993, TOXICON, V31, P293, DOI 10.1016/0041-0101(93)90147-B
   Lurling M, 2012, WATER RES, V46, P1447, DOI 10.1016/j.watres.2011.11.008
   Lyck S, 2004, J PLANKTON RES, V26, P727, DOI 10.1093/plankt/fbh071
   McLellan NL, 2017, TOXICOL RES-UK, V6, P391, DOI [10.1039/c7tx00043j, 10.1039/C7TX00043J]
   Moisander PH, 2009, HARMFUL ALGAE, V8, P889, DOI 10.1016/j.hal.2009.04.005
   Nakamura N, 2003, J BIOSCI BIOENG, V95, P179, DOI 10.1263/jbb.95.179
   Qian HF, 2010, AQUAT TOXICOL, V99, P405, DOI 10.1016/j.aquatox.2010.05.018
   REDFIELD AC, 1958, AM SCI, V46, P205
   Sayyed J.A., 2010, DER CHEM SINICA J P, V1, P104
   Singh S, 2012, TOXICON, V60, P878, DOI 10.1016/j.toxicon.2012.06.005
   Svircev Z, 2017, ARCH TOXICOL, V91, P621, DOI 10.1007/s00204-016-1921-6
   Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1
   Wang YW, 2014, BIOCHEM SYST ECOL, V55, P112, DOI 10.1016/j.bse.2014.02.019
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x
   Wiedner C, 2003, APPL ENVIRON MICROB, V69, P1475, DOI 10.1128/AEM.69.3.1475-1481.2003
   Wu ZX, 2007, J INTEGR PLANT BIOL, V49, P262, DOI 10.1111/j.1744-7909.2007.00368.x
   Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420
   Xu LZ, 2012, MUTAT RES-GEN TOX EN, V743, P75, DOI 10.1016/j.mrgentox.2011.12.024
NR 35
TC 0
Z9 0
U1 16
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 51
EP 59
DI 10.1016/j.toxicon.2019.09.012
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000006
PM 31526809
DA 2020-05-12
ER

PT J
AU Dhanamjayulu, P
   Boga, RB
   Mehta, A
AF Dhanamjayulu, P.
   Boga, Ramesh Babu
   Mehta, Alka
TI Inhibition of aflatoxin B1 biosynthesis and down regulation of aflR and
   of aflB genes in presence of benzimidazole derivatives without impairing
   the growth of Aspergillus flavus
SO TOXICON
LA English
DT Article
DE Mycotoxins; Fermentation process; Antifungal; Aspergillus flavus;
   Anti-Aflatoxigenic
ID WORLDWIDE OCCURRENCE; B-1 PRODUCTION; MYCOTOXINS; ANTIFUNGAL;
   CONTAMINATION; PROLIFERATION; EXPRESSION; TOXICITY; EFFICACY; SYSTEM
AB Aflatoxins are mutagenic secondary metabolites produced by certain ubiquitous saprophytic fungi. These contaminate agricultural crops and pose a serious health threat to humans and livestock all over the world. Benzimidazole and its derivatives are biologically active heterocyclic compounds known for their fungicidal activity. In the present study, second and sixth position substituted benzimidazole derivatives are tested for their antifungal and anti-aflatoxigenic activity. Aflatoxigenic strain of Aspergillus fiavus cultured in Yeast extract sucrose (YES) medium as well as in rice in the presence and absence of test compounds. 2-(2-Furyl) benzimidazole (FBD) showed complete inhibition of fungal growth at 50 mu g/mL. However, the polar derivatives of FBD viz. 6-NFBD, 6-AFBD, 6-CAFBD, and 6-CFBD did not impair the fungal growth but effectively inhibited aflatoxin B-1 biosynthesis. Significant down-regulation of aflR gene involved in regulation and aflB structural gene for aflatoxin B-1 biosynthesis was observed in presence of 6-NFBD. These benzimidazole derivatives also showed good anti-aflatoxigenic activity in rice, though the IC50 concentrations in rice were comparatively higher than those in YES medium. This study summarizes the most notable structure-activity relationship (SAR) of 2-(2-Furyl) benzimidazoles for anti-aflatoxigenic and anti-fungal activities. These molecules can be further studied for their applications in industrial fermentation processes vulnerable to mold growth and subsequent aflatoxin B-1 synthesis like koji fermentation, cheese production, etc.
C1 [Dhanamjayulu, P.; Mehta, Alka] Vellore Inst Technol, Sch Bio Sci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India.
   [Boga, Ramesh Babu] BogaR Labs, Peddapuram 533437, Andhra Pradesh, India.
RP Mehta, A (reprint author), Vellore Inst Technol, Sch Bio Sci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India.
EM alkamehta@vit.ac.in
OI Mehta, Alka/0000-0002-4417-8041
FU VIT
FX The authors wish to thank the management of the VIT University for
   providing the VIT SEED GRANT and facilities for carrying out the work.
   The financial support to one of the authors (Dhanamjayulu P) from the
   VIT is also gratefully acknowledged. The thanks are due to Dr
   Vijayalakshmi S, Associate professor and Dr Ajanta Sircar, Professor,
   School of Social Science and Languages, VIT, Vellore, India, for their
   help in the editing of the manuscript.
CR Aiko V, 2013, WORLD MYCOTOXIN J, V6, P43, DOI 10.3920/WMJ2012.1437
   Aiko V, 2013, J FOOD SAFETY, V33, P440, DOI 10.1111/jfs.12074
   Al-Saad LA, 2016, INT J FOOD MICROBIOL, V217, P123, DOI 10.1016/j.ijfoodmicro.2015.10.016
   Zanon MSA, 2013, INT J FOOD MICROBIOL, V162, P220, DOI 10.1016/j.ijfoodmicro.2013.01.017
   Alasmary FAS, 2015, MOLECULES, V20, P15206, DOI 10.3390/molecules200815206
   Bahrami K, 2007, SYNTHESIS-STUTTGART, P547, DOI 10.1055/s-2007-965878
   BENTRIVEDI A, 1990, AGR BIOL CHEM TOKYO, V54, P2961
   Binder EM, 2007, ANIM FEED SCI TECH, V137, P265, DOI 10.1016/j.anifeedsci.2007.06.005
   Can NO, 2017, J CHEM-NY, DOI 10.1155/2017/9387102
   Chandrika NT, 2018, ACS INFECT DIS, V4, P196, DOI 10.1021/acsinfecdis.7b00254
   Chandrika NT, 2016, BIOORGAN MED CHEM, V24, P3680, DOI 10.1016/j.bmc.2016.06.010
   Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004
   Ciegler A., 1987, CRC HDB MICROBIOLOGY
   Del Poeta M, 1998, ANTIMICROB AGENTS CH, V42, P2503, DOI 10.1128/AAC.42.10.2503
   Divakara Shetty Thimmappa, 2014, Archives of Phytopathology and Plant Protection, V47, P2141, DOI 10.1080/03235408.2013.869892
   Erdogan A, 2004, CHEMOSPHERE, V56, P321, DOI 10.1016/j.chemosphere.2004.02.020
   Gibbons JG, 2012, CURR BIOL, V22, P1403, DOI 10.1016/j.cub.2012.05.033
   Guerra F.Q.S., 2015, ALTERN MED, V2015, DOI [10.1155/2015/925096, DOI 10.1155/2015/925096]
   HEIN DW, 1957, J AM CHEM SOC, V79, P427, DOI 10.1021/ja01559a053
   Herrman TJ, 2002, MYCOTOXINS FEED GRAI
   Hua SST, 2015, WORLD J MICROB BIOT, V31, P729, DOI 10.1007/s11274-015-1824-3
   Hymery N, 2014, COMPR REV FOOD SCI F, V13, P437, DOI 10.1111/1541-4337.12069
   Janeczko M, 2016, POL J MICROBIOL, V65, P359, DOI 10.5604/17331331.1215615
   Alvarez-Figueroa MJ, 2011, AAPS PHARMSCITECH, V12, P573, DOI 10.1208/s12249-011-9622-1
   Karlovsky P, 2016, MYCOTOXIN RES, V32, P179, DOI 10.1007/s12550-016-0257-7
   Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045
   Kedia A, 2014, INT J FOOD MICROBIOL, V168, P1, DOI 10.1016/j.ijfoodmicro.2013.10.008
   KINOSITA R, 1968, CANCER RES, V28, P2296
   Lee HJ, 2017, J AGR FOOD CHEM, V65, P7034, DOI 10.1021/acs.jafc.6b04847
   Liu BH, 1998, APPL ENVIRON MICROB, V64, P3718
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Magan N, 2007, INT J FOOD MICROBIOL, V119, P131, DOI 10.1016/j.ijfoodmicro.2007.07.034
   Mitchell NJ, 2016, FOOD ADDIT CONTAM A, V33, P540, DOI 10.1080/19440049.2016.1138545
   Mohana D. C., 2010, Journal of Mycology and Plant Pathology, V40, P197
   Moon YS, 2016, TOXINS, V8, DOI 10.3390/toxins8080240
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nasser Laila A, 2001, PAKISTAN J BIOL SCI, V4, P733
   Neme K, 2017, FOOD CONTROL, V78, P412, DOI 10.1016/j.foodcont.2017.03.012
   Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559
   Panda P, 2013, J FOOD SAFETY, V33, P265, DOI 10.1111/jfs.12048
   Pandey AK, 2016, J FOOD SCI, V81, pM928, DOI 10.1111/1750-3841.13254
   Pildain MB, 2004, INT J FOOD MICROBIOL, V93, P31, DOI 10.1016/j.ijfoodmicro.2003.10.007
   Scott P. M., 1989, Mycotoxins in dairy products., P193
   Ferre FS, 2016, FOOD CONTROL, V62, P291, DOI 10.1016/j.foodcont.2015.10.051
   Sweeney MJ, 1998, INT J FOOD MICROBIOL, V43, P141, DOI 10.1016/S0168-1605(98)00112-3
   Tarin A, 2004, J CHROMATOGR A, V1047, P235, DOI 10.1016/j.chroma.2004.06.094
   Toteja GS, 2006, FOOD ADDIT CONTAM A, V23, P411, DOI 10.1080/02652030500442490
   Wright MS, 2000, TOXICON, V38, P1215, DOI 10.1016/S0041-0101(99)00221-4
   Yin ZN, 2018, INT J FOOD SCI TECH, V53, P1120, DOI 10.1111/ijfs.13675
   Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004
   Zoghi A, 2014, MINI-REV MED CHEM, V14, P84, DOI 10.2174/1389557513666131211105554
NR 51
TC 1
Z9 1
U1 9
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 60
EP 67
DI 10.1016/j.toxicon.2019.09.018
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000007
PM 31541640
DA 2020-05-12
ER

PT J
AU Lopes-de-Souza, L
   Costal-Oliveira, F
   Stransky, S
   de Freitas, CF
   Guerra-Duarte, C
   Braga, VMM
   Chavez-Olortegui, C
AF Lopes-de-Souza, Leticia
   Costal-Oliveira, Fernanda
   Stransky, Stephanie
   de Freitas, Claudio Fonseca
   Guerra-Duarte, Clara
   Braga, Vania M. M.
   Chavez-Olortegui, Carlos
TI Development of a cell-based in vitro assay as a possible alternative for
   determining bothropic antivenom potency
SO TOXICON
LA English
DT Article
DE Bothrops snake venom; Antivenoms; In vitro assay; Cell viability;
   Neutralizing potency
ID AMINO-ACID OXIDASE; SNAKE-VENOM METALLOPROTEINASE; NEUTRALIZING POTENCY;
   JARARHAGIN; TOXINS; CYTOTOXICITY; MECHANISM; EFFICACY; ADHESION; ELISA
AB Accidents with venomous snakes are a major health hazard in tropical countries. Bothrops genus is responsible for almost 80% of snakebites in Brazil. Immunotherapy is the only approved specific treatment against snake toxins and the production of therapeutic antivenoms requires quality control tests to determine their neutralizing potency. Currently, these controls are performed by in vivo lethality neutralization, however, the inhibition of particular events produced by bothropic venoms such as coagulopathy, hemorrhage, edema or cytotoxic effects are also required. The aim of this work is to develop an in vitro alternative assay for antivenom pre-clinical evaluation. In this sense, we designed a cell viability assay using different amounts (0.2-10 mu L/well) of low and high potency anti-bothropic sera, previously classified by the traditional in vivo test, for assessing the antivenom capacity to protect the cells against B. jararaca venom cytotoxicity (5xEC(50) = 58.95 mu g/mL). We found that high potency sera are more effective in neutralizing B. jararaca venom cytotoxicity when compared to low potency sera, which is in accordance to their pre-determined in vivo potency. Considering sera in vitro inhibitory concentration able to prevent 50% cell death (IC50) and their known in vivo potency, a cut-off point was determined to discriminate low and high potency sera. Our data provide insights for the development of an in vitro method which can determine the anti-bothropic antivenom potency during its production.
C1 [Lopes-de-Souza, Leticia; Costal-Oliveira, Fernanda; Stransky, Stephanie; Chavez-Olortegui, Carlos] Univ Fed Minas Gerais, Dept Bioquim & Imunol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Freitas, Claudio Fonseca; Guerra-Duarte, Clara] Fundacao Ezequiel Dias, Diretoria Pesquisa & Desenvolvimento, BR-30510010 Belo Horizonte, MG, Brazil.
   [Braga, Vania M. M.] Imperial Coll London, Fac Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.
RP Chavez-Olortegui, C (reprint author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, ICB, BR-31270901 Belo Horizonte, MG, Brazil.; Chavez-Olortegui, C (reprint author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM olortegi@icb.ufmg.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [406163/2018-9]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior, Brazil - CAPESCAPES [88881.191812/2018-01]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), BrazilCAPES
   [TOXINOLOGIA - 23038000825/2011-63]; Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), BrazilMinas Gerais State Research
   Foundation (FAPEMIG) [PPM: 00270-16]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), BrazilNational Council
   for Scientific and Technological Development (CNPq) [490269/2013-3,
   17/2013]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brazil (CNPq) (Process: 406163/2018-9);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil -
   CAPES (Program COFECUB Process: 88881.191812/2018-01); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil
   (TOXINOLOGIA - 23038000825/2011-63); Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), Brazil (PPM: 00270-16) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil
   (17/2013, Process: 490269/2013-3).
CR Abdelkafi-Koubaa Z, 2016, INT J BIOL MACROMOL, V82, P757, DOI 10.1016/j.ijbiomac.2015.09.065
   AlapeGiron A, 1997, TOXICON, V35, P573, DOI 10.1016/S0041-0101(96)00150-X
   Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007
   Araujo H.P, 2008, THESIS
   Araya C, 2007, CELL BIOL INT, V31, P263, DOI 10.1016/j.cellbi.2006.11.007
   Baldo C, 2015, TOXICON, V108, P240, DOI 10.1016/j.toxicon.2015.10.016
   BARBOSA CF, 1995, BRAZ J MED BIOL RES, V28, P1077
   Bernardes-Oliveira E., 2016, ALTERN MED, V9, DOI [10.1155/2016/1574971, DOI 10.1155/2016/1574971]
   Jorge RJB, 2017, TOXICON, V125, P84, DOI 10.1016/j.toxicon.2016.11.249
   BOCHE RD, 1968, TOXICON, V6, P125, DOI 10.1016/0041-0101(68)90031-7
   Bonfim VL, 2009, CELL BIOL TOXICOL, V25, P523, DOI 10.1007/s10565-008-9106-6
   Calderon LA, 2014, BIOMED RES INT, DOI 10.1155/2014/203639
   Camey KU, 2002, TOXICON, V40, P501, DOI 10.1016/S0041-0101(01)00245-8
   Cedro RCA, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0170-y
   Chippaux JP, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0127-6
   Chippaux Jean-Philippe, 2010, Biologie Aujourd hui, V204, P87, DOI 10.1051/jbio/2009043
   Costal-Oliveira F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37435-4
   Damico DCS, 2007, TOXICON, V49, P678, DOI 10.1016/j.toxicon.2006.11.014
   de Souza LL, 2015, TOXICOL SCI, V147, P458, DOI 10.1093/toxsci/kfv140
   Estevao-Costa MI, 2016, TOXICON, V122, P67, DOI 10.1016/j.toxicon.2016.09.010
   Fung SY, 2015, TOXICON, V96, P38, DOI 10.1016/j.toxicon.2015.01.012
   Guerra-Duarte C, 2015, TOXICON, V108, P84, DOI 10.1016/j.toxicon.2015.09.007
   GUTIERREZ JM, 1988, TOXICON, V26, P411, DOI 10.1016/0041-0101(88)90010-4
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]
   Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4
   Instituto Clodomiro Picado, 2007, DET ACT TOX VEN SERP
   Jorge Roberta J B, 2011, J Exp Ther Oncol, V9, P249
   Kalam Y, 2011, J PHARMACOL TOX MET, V63, P137, DOI 10.1016/j.vascn.2010.09.001
   Kandarova Helena, 2011, Interdiscip Toxicol, V4, P107, DOI 10.2478/v10102-011-0018-6
   Kim TW, 2019, REGUL TOXICOL PHARM, V105, P15, DOI 10.1016/j.yrtph.2019.03.016
   Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5
   Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Macedo JKA, 2016, TOXINOLOGY, P211, DOI 10.1007/978-94-007-6416-3_21
   Malaque C.M.S., 2016, CRITICAL CARE TOXICO, P1, DOI 10.1007/978-3-319-20790-2
   Gutierrez JM, 2017, TOXINS, V9, DOI 10.3390/toxins9050163
   Gutierrez JM, 2013, TOXICON, V69, P168, DOI 10.1016/j.toxicon.2012.11.016
   Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006
   Gutierrez JM, 2011, BIOLOGICALS, V39, P129, DOI 10.1016/j.biologicals.2011.02.005
   Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020
   Maria WS, 1998, TOXICON, V36, P1433, DOI 10.1016/S0041-0101(98)00077-4
   Maria WS, 2005, TOXICON, V46, P210, DOI 10.1016/j.toxicon.2005.03.024
   MARKLAND FS, 1986, SEMIN THROMB HEMOST, V12, P284, DOI 10.1055/s-2007-1003568
   MEIER J, 1989, TOXICON, V27, P91, DOI 10.1016/0041-0101(89)90409-1
   Mendez I, 2011, TOXICON, V58, P558, DOI 10.1016/j.toxicon.2011.08.018
   Moura-da-Silva AM, 2012, TOXICON, V60, P280, DOI 10.1016/j.toxicon.2012.03.026
   Mushtaq S., 2018, J MED SCI, V38, P161
   Nalbantsoy A, 2017, TOXICON, V135, P71, DOI 10.1016/j.toxicon.2017.06.008
   Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003
   Oliveira JCR, 2002, TOXICON, V40, P321, DOI 10.1016/S0041-0101(01)00229-X
   Paludo KS, 2006, TOXICON, V47, P844, DOI 10.1016/j.toxicon.2006.02.006
   Petras D, 2011, J PROTEOME RES, V10, P1266, DOI 10.1021/pr101040f
   Pontes AS, 2014, TOXICON, V80, P27, DOI 10.1016/j.toxicon.2013.12.013
   Ratanabanangkoon K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08962-3
   Ribeiro PH, 2016, INT J BIOL MACROMOL, V92, P329, DOI 10.1016/j.ijbiomac.2016.07.022
   RUNGSIWONGSE J, 1991, J IMMUNOL METHODS, V136, P37, DOI 10.1016/0022-1759(91)90247-D
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Salama WH, 2018, TOXICON, V150, P270, DOI 10.1016/j.toxicon.2018.06.064
   Samel M, 2006, BBA-PROTEINS PROTEOM, V1764, P707, DOI 10.1016/j.bbapap.2006.01.021
   Sells PG, 2003, TOXICON, V42, P115, DOI 10.1016/S0041-0101(03)00125-9
   SINAN, 2015, AC AN PEC NOT REG BR
   Stransky S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006427
   Tanjoni I, 2005, APOPTOSIS, V10, P851, DOI 10.1007/s10495-005-2945-1
   Taylor IJ, 2009, COMPUT COMMUN NETW S, P3
   Teixeira-Araujo R, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0118-7
   THEAKSTON RDG, 1979, TOXICON, V17, P511, DOI 10.1016/0041-0101(79)90284-8
   Venkatesan C, 2014, BIOLOGICALS, V42, P8, DOI 10.1016/j.biologicals.2013.09.002
   Xiong SW, 2018, TOXICOL LETT, V287, P142, DOI 10.1016/j.toxlet.2018.02.004
   Zamuner SR, 2005, TOXICON, V46, P806, DOI 10.1016/j.toxicon.2005.08.011
   Zigrino P, 2002, J BIOL CHEM, V277, P40528, DOI 10.1074/jbc.M202049200
NR 71
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 68
EP 76
DI 10.1016/j.toxicon.2019.09.010
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000008
PM 31494208
DA 2020-05-12
ER

PT J
AU Geffeney, SL
   Williams, BL
   Rosenthal, JJC
   Birk, MA
   Felkins, J
   Wisell, CM
   Curry, ER
   Hanifin, CT
AF Geffeney, Shana L.
   Williams, Becky L.
   Rosenthal, Joshua J. C.
   Birk, Matthew A.
   Felkins, Justin
   Wisell, Christine M.
   Curry, Eveningstar R.
   Hanifin, Charles T.
TI Convergent and parallel evolution in a voltage-gated sodium channel
   underlies TTX-resistance in the Greater Blue-ringed Octopus:
   Hapalochlaena lunulata
SO TOXICON
LA English
DT Article
DE Tetrodotoxin; TTX; Sodium channel; Hapalochlaena; Convergent evolution;
   Auto resistance
ID ROUGH-SKINNED NEWTS; FIRE-BELLIED NEWT; ADAPTIVE EVOLUTION;
   TARICHA-GRANULOSA; TETRODOTOXIN CONTENT; STRUCTURAL BASIS;
   NERVOUS-SYSTEM; ION CHANNELS; NA+; SELECTIVITY
AB The natural history and pharmacology of tetrodotoxin (TTX) has long intrigued biologists. This toxin has a remarkable distribution that spans two domains of life (Bacteria and Eukarya). Within Eukaryotes, TTX has only been identified in animals but is known to be present in over five-dozen species of phylogenetically distant Metazoans. Despite decades of work, the origin and biosynthetic pathways of TTX remain unresolved. Investigations in puffer fishes and salamanders have provided insights into the acquisition of auto-resistance to TTX through the evolution of voltage-gated sodium ion channels (VGSCs) that have reduced binding affinity for TTX. To date there have been no studies of these proteins in tetrodotoxic Blue-Ringed Octopuses. Here we report data demonstrating that the Greater Blue-ringed Octopus (Hapalochlaena lunulata) expresses a VGSC (HINa(v)1) gene with mutations that reduce the channel's TTX-binding affinity and likely render the organism TTX resistant. We identified three amino-acid substitutions in the TTX-binding site of HINa(v)1 that likely confer TTX-resistance to both the channel and the organism. These substitutions are associated with organismal TTX-resistance in other TTX-bearing taxa and are convergent with substitutions that have evolved in fish, salamanders, and some TTX-resistant invertebrates.
C1 [Geffeney, Shana L.; Williams, Becky L.; Wisell, Christine M.; Curry, Eveningstar R.; Hanifin, Charles T.] Utah State Univ, 320 N Aggie Blvd, Vernal, UT 84078 USA.
   [Rosenthal, Joshua J. C.; Birk, Matthew A.] Bell Ctr, Marine Biol Lab, Woods Hole, MA USA.
   [Felkins, Justin] Utah Valley Univ, Orem, UT USA.
RP Hanifin, CT (reprint author), Utah State Univ, 320 N Aggie Blvd, Vernal, UT 84078 USA.
EM charles.hanifin@usu.edu
OI Birk, Matthew/0000-0003-0407-4077
FU Utah State University; Uintah Impact Mitigation Service District; Uintah
   Basin Research Internship program; NSFNational Science Foundation (NSF)
   [IOS 1528863]; United States-Israel Binational Science
   FoundationUS-Israel Binational Science Foundation [2017262]; National
   Science Foundation postdoctoral fellowshipNational Science Foundation
   (NSF) [DBI-1907197]
FX This project was funded by internal Utah State University start-up
   funding to CTH, SLG, and BLW. Funding from the Uintah Impact Mitigation
   Service District provided support for USU undergraduate workers for the
   project under the supervision of SLG, BLW, and CTH. Additional support
   was provided through the Uintah Basin Research Internship program to
   JLF, CMW, and ERC. Support for JJCR was provided by NSF IOS 1528863 and
   United States-Israel Binational Science Foundation 2017262. MAB was
   supported by a National Science Foundation postdoctoral fellowship
   (DBI-1907197). The authors wish to thank the USU-Uintah Basin campus for
   its support of undergraduate researchers and programs. No funding source
   had any role in the design, analysis, writing, or dissemination of
   results presented in this work. The authors thank R. Caldwell for
   photos. The manuscript was improved by comments from five anonymous
   reviewers.
CR ANDERSON PAV, 1987, J EXP BIOL, V133, P231
   Asakawa M, 2019, TOXINS, V11, DOI 10.3390/toxins11050245
   Barzilai MG, 2012, CELL REP, V2, P242, DOI 10.1016/j.celrep.2012.06.016
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bornancin L, 2017, NAT PROD REP, V34, P644, DOI 10.1039/c6np00097e
   BRODIE ED, 1968, COPEIA, P307
   BRODIE ED, 1974, COPEIA, P506
   BROWN MS, 1963, SCIENCE, V140, P295, DOI 10.1126/science.140.3564.295
   BUCHWALD HD, 1964, SCIENCE, V143, P474, DOI 10.1126/science.143.3605.474
   Calhoun DM, 2017, TOXICON, V137, P120, DOI 10.1016/j.toxicon.2017.07.021
   Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109
   Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204
   Cervenka R, 2010, MAR DRUGS, V8, P1373, DOI 10.3390/md8041373
   Chau R, 2011, AQUAT TOXICOL, V104, P61, DOI 10.1016/j.aquatox.2011.04.001
   Choudhary G, 2003, BIOPHYS J, V84, P287, DOI 10.1016/S0006-3495(03)74849-8
   Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2009, J BIOL CHEM, V284, P33869, DOI 10.1074/jbc.M109.045690
   Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X
   Feldman CR, 2016, HEREDITY, V116, P84, DOI 10.1038/hdy.2015.73
   Feldman CR, 2012, P NATL ACAD SCI USA, V109, P4556, DOI 10.1073/pnas.1113468109
   Forbey JS, 2009, INTEGR COMP BIOL, V49, P314, DOI 10.1093/icb/icp046
   FURUKAWA TARO, 1959, JAPANESE JOUR PHYSIOL, V9, P143
   Gall BG, 2012, J CHEM ECOL, V38, P1351, DOI 10.1007/s10886-012-0213-8
   Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444
   GOTO T, 1965, TETRAHEDRON, V21, P2059, DOI 10.1016/S0040-4020(01)98344-9
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060
   Hanifin CT, 2015, EVOLUTION, V69, P232, DOI 10.1111/evo.12552
   Hanifin CT, 2010, MAR DRUGS, V8, P577, DOI 10.3390/md8030577
   Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823
   Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203
   HILLE B, 1975, BIOPHYS J, V15, P615, DOI 10.1016/S0006-3495(75)85842-5
   HILLE B, 2001, ION CHANNELS EXCITAB
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718
   Huang CJ, 2000, J GEN PHYSIOL, V115, P435, DOI 10.1085/jgp.115.4.435
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   HWANG DF, 1989, MAR BIOL, V100, P327, DOI 10.1007/BF00391147
   Itoi S, 2016, TOXICON, V114, P53, DOI 10.1016/j.toxicon.2016.02.020
   Itoi S, 2014, TOXICON, V78, P35, DOI 10.1016/j.toxicon.2013.11.003
   Johnson PTJ, 2018, J ANIM ECOL, V87, P1192, DOI 10.1111/1365-2656.12816
   Jost MC, 2008, MOL BIOL EVOL, V25, P1016, DOI 10.1093/molbev/msn025
   Kudo Y, 2017, TOXICON, V137, P78, DOI 10.1016/j.toxicon.2017.07.016
   Kudo Y, 2015, TOXICON, V101, P101, DOI 10.1016/j.toxicon.2015.05.008
   Kudo Y, 2014, ANGEW CHEM INT EDIT, V53, P14546, DOI 10.1002/anie.201408913
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108
   Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025
   Liu TI, 1995, RECEPTOR CHANNEL, V3, P243
   McGlothlin JW, 2016, CURR BIOL, V26, P1616, DOI 10.1016/j.cub.2016.04.056
   Mebs D, 2019, SALAMANDRA, V55, P82
   Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   MOORE JW, 1967, J GEN PHYSIOL, V50, P1401, DOI 10.1085/jgp.50.5.1401
   Moran Y, 2015, J EXP BIOL, V218, P515, DOI 10.1242/jeb.110270
   Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918
   NARAHASHI T, 1974, PHYSIOL REV, V54, P813
   NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965
   Nishida R, 2014, BIOSCI BIOTECH BIOCH, V78, P1, DOI 10.1080/09168451.2014.877836
   NODA M, 1987, J RECEPTOR RES, V7, P467, DOI 10.3109/10799898709054998
   Noguchi T, 2008, MAR DRUGS, V6, P220, DOI 10.3390/md20080011
   Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003
   Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca
   Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024
   Ritson-Williams R, 2006, P NATL ACAD SCI USA, V103, P3176, DOI 10.1073/pnas.0506093103
   Rosenthal JJC, 2003, NEUROSIGNALS, V12, P126, DOI 10.1159/000072160
   Sakakura Y, 2017, FISHERIES SCI, V83, P191, DOI 10.1007/s12562-016-1046-0
   Salvitti LR, 2015, MAR DRUGS, V13, P756, DOI 10.3390/md13020756
   Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408
   Santarelli VP, 2007, J BIOL CHEM, V282, P8044, DOI 10.1074/jbc.M611334200
   Savitzky AH, 2012, CHEMOECOLOGY, V22, P141, DOI 10.1007/s00049-012-0112-z
   Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493
   Shen HZ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2596
   SHEUMACK DD, 1978, SCIENCE, V199, P188, DOI 10.1126/science.619451
   SHEUMACK DD, 1984, TOXICON, V22, P811, DOI 10.1016/0041-0101(84)90164-8
   Spafford JD, 1996, J EXP BIOL, V199, P941
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Stokes AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100718
   Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693
   TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6
   Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6
   Toledo G, 2016, CURR TOP MEMBR, V78, P87, DOI 10.1016/bs.ctm.2016.07.006
   TSUDA K, 1964, CHEM PHARM BULL, V12, P642
   Ueyama N, 2018, CHEM-EUR J, V24, P7250, DOI 10.1002/chem.201801006
   Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4
   Whitelaw BL, 2019, AQUAT TOXICOL, V206, P114, DOI 10.1016/j.aquatox.2018.10.012
   Williams BL, 2012, TOXICON, V60, P1307, DOI 10.1016/j.toxicon.2012.08.015
   Williams BL, 2011, CHEMOECOLOGY, V21, P131, DOI 10.1007/s00049-011-0075-5
   Williams BL, 2011, J CHEM ECOL, V37, P10, DOI 10.1007/s10886-010-9901-4
   Williams BL, 2010, CHEMOECOLOGY, V20, P285, DOI 10.1007/s00049-010-0057-z
   Williams BL, 2009, TOXICON, V54, P345, DOI 10.1016/j.toxicon.2009.05.019
   Woodward R.B., 1964, PURE APPL CHEM, V9, P49, DOI 10.1021/ja01076a076.
   Yotsu-Yamashita M, 2007, TOXICON, V49, P410, DOI 10.1016/j.toxicon.2006.10.008
   Yotsu-Yamashita M, 2012, TOXICON, V59, P257, DOI 10.1016/j.toxicon.2011.12.004
   Yotsui-Yamashita M, 2010, TOXICON, V55, P153, DOI 10.1016/j.toxicon.2009.07.003
   Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109
   Zhang TX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003327
   Zhang TX, 2011, INSECT BIOCHEM MOLEC, V41, P451, DOI 10.1016/j.ibmb.2011.04.010
   Zhou W, 2004, NEURON, V42, P101, DOI 10.1016/S0896-6273(04)00148-5
NR 98
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 77
EP 84
DI 10.1016/j.toxicon.2019.09.013
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000009
PM 31550451
DA 2020-05-12
ER

PT J
AU Rey-Suarez, P
   Saldarriaga-Cordoba, M
   Torres, U
   Marin-Villa, M
   Lomonte, B
   Nunez, V
AF Rey-Suarez, Paola
   Saldarriaga-Cordoba, Monica
   Torres, Uday
   Marin-Villa, Marcel
   Lomonte, Bruno
   Nunez, Vitelbina
TI Novel three-finger toxins from Micrurus dumerilii and Micrurus
   mipartitus coral snake venoms: Phylogenetic relationships and
   characterization of Clarkitoxin-I-Mdum
SO TOXICON
LA English
DT Article
DE alpha-neurotoxin; Coral snake; Micrurus dumerilii; Micrurus mipartitus;
   Three-finger toxins; Snake venom
ID MYOTOXIC PHOSPHOLIPASES A(2); ALPHA-NEUROTOXIN; COMPOSITIONAL PATTERNS;
   EVOLUTION; PROTEINS; CLONING; NIGROCINCTUS; EXPRESSION; ELAPIDAE;
   TOXICITY
AB Micrurus mipartitus and M. dumerilii are the most medically important coral snakes in Colombia. Proteomic characterization of their venoms has previously shown that proteins of the three-finger toxin (3FTx) family are abundant components, especially in M. mipartitus (61%) and to a lesser extent in M. dumerilii (28%). In order to increase knowledge on these toxins, in this work a major 3FTx of M. dumerilii venom (8% of the venom proteins), named Clarkitoxin-I-Mdum, was isolated and characterized. Its amino acid sequence comprises 66 residues, with an isotope-averaged molecular mass of 7537 +/- 2 Da and a theoretical pl of 9.36, presenting the conserved pattern of eight cysteines that classifies it as a short-chain (type I) 3FTx. Clarkitoxin-I-Mdum was not lethal to mice by intravenous or intracerebroventricular route and was not cytolytic to myogenic cells in vitro. On the other hand, five coding sequences for 3FTxs were obtained from the venom gland of M. mipartitus. These novel toxin sequences were named Mm3FTx-01 to Mm3FTx-05, all of them also presenting the eight conserved cysteines of short-chain 3FTxs. Phylogenetic analysis revealed high variability of 3FTxs from Micrurus, and ELISA using antibodies raised to the major 3FTxs from M. mipartitus and M. dumerilii confirmed their immunochemical divergence. These results highlight the relevance of performing further studies aiming at a deeper understanding of the functional and antigenic relationships among specific Micrurus toxins, with important implications for the production of antivenoms.
C1 [Rey-Suarez, Paola; Torres, Uday; Nunez, Vitelbina] Univ Antioquia, Programa Ofidismo & Escorpionismo, Calle 62 52-59, Medellin, Colombia.
   [Saldarriaga-Cordoba, Monica] Univ Bernardo OHiggins, Ctr Invest Recursos Nat & Sustentabilidad CIRENYS, Santiago, Chile.
   [Marin-Villa, Marcel] Univ Antioquia, Dept Microbiol & Parasitol, Fac Med, Calle 70 52-21, Medellin, Colombia.
   [Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   [Nunez, Vitelbina] Univ Antioquia, Escuela Microbiol, Calle 70 52-21, Medellin, Colombia.
RP Saldarriaga-Cordoba, M (reprint author), Univ Bernardo OHiggins, Ctr Invest Recursos Nat & Sustentabilidad CIRENYS, Santiago, Chile.
EM monica.saldarriaga@ubo.cl
RI Lomonte, Bruno/B-8862-2019
OI Lomonte, Bruno/0000-0003-2419-6469; Marin Villa,
   Marcel/0000-0001-5116-4935
FU ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [111577757474]; University of Antioquia UdeA;
   Vicerrectoria de Investigacion, University of Costa Rica [VI-741-B7608];
   Colombian Ministry of Environment [151 RGE: 0205, RGE:0156-9]
FX The authors thank Colciencias (111577757474), University of Antioquia
   UdeA, and Vicerrectoria de Investigacion, University of Costa Rica
   (VI-741-B7608) for partial financial support of this study. The
   Colombian Ministry of Environment is also acknowledged for granting
   access to genetic resources (151 RGE: 0205 and RGE:0156-9).
CR Aird SD, 2017, TOXINS, V9, DOI 10.3390/toxins9060187
   AlapeGiron A, 1996, FEBS LETT, V380, P29, DOI 10.1016/0014-5793(95)01543-4
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Carbajal-Saucedo A, 2013, TOXICON, V66, P64, DOI 10.1016/j.toxicon.2013.02.006
   Dokmetjian JC, 2009, TOXICON, V53, P375, DOI 10.1016/j.toxicon.2008.12.015
   Correa-Netto C, 2011, J PROTEOMICS, V74, P1795, DOI 10.1016/j.jprot.2011.04.003
   da Silva DC, 2011, LIFE SCI, V89, P931, DOI 10.1016/j.lfs.2011.09.024
   Das D, 2016, J BIOCHEM MOL TOXIC, V30, P59, DOI 10.1002/jbt.21734
   Dashevsky D, 2018, J MOL EVOL, V86, P58, DOI 10.1007/s00239-017-9825-5
   de la Rosa G, 2018, AMINO ACIDS, V50, P885, DOI 10.1007/s00726-018-2556-0
   de Oliveira JS, 2000, BIOCHEM BIOPH RES CO, V267, P887, DOI 10.1006/bbrc.1999.2033
   Doley R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-196
   Fernandez J, 2015, TOXICON, V107, P217, DOI 10.1016/j.toxicon.2015.08.016
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200
   Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x
   Grindrod P, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160243
   Guerrero-Garzon JF, 2018, BIOCHIMIE, V147, P114, DOI 10.1016/j.biochi.2018.01.006
   Heyborne WH, 2013, BIOCHIMIE, V95, P1923, DOI 10.1016/j.biochi.2013.06.025
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kessler P, 2017, J NEUROCHEM, V142, P7, DOI 10.1111/jnc.13975
   Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308
   King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020
   Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leao LI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-112
   Lippa E, 2019, J PROTEOM
   Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8
   Lomonte B, 2019, TOXICON, V167, P144, DOI 10.1016/j.toxicon.2019.06.023
   Lomonte B, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0117-8
   Lomonte B, 2016, TOXICON, V122, P7, DOI 10.1016/j.toxicon.2016.09.008
   Lomonte B, 2016, TOXINS, V8, DOI 10.3390/toxins8050138
   Lumsden NG, 2005, TOXICON, V45, P329, DOI 10.1016/j.toxicon.2004.11.003
   Margres MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-531
   MENEZ A, 1985, PHARMACOL THERAPEUT, V30, P91, DOI 10.1016/0163-7258(85)90049-X
   Moreira KG, 2010, TOXICON, V56, P55, DOI 10.1016/j.toxicon.2010.02.030
   Neath AA, 2012, WIRES COMPUT STAT, V4, P199, DOI 10.1002/wics.199
   Nicholas K.B., 1997, EMBNEW NEWS, V4, P14
   Ohno M, 2003, TOXICON, V42, P841, DOI 10.1016/j.toxicon.2003.11.003
   Olamendi-Portugal T, 2008, PROTEOMICS, V8, P1919, DOI 10.1002/pmic.200700668
   Otero-Patino R, 2014, CLIN TOXINOLOGY
   Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200
   Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555
   Pergolizzi RG, 2005, HUM GENE THER, V16, P292, DOI 10.1089/hum.2005.16.292
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Rambaut A., 2009, FIGTREE GRAPHICAL VI
   Rambaut A., 2013, TRACER V1 6
   Rey-Suarez P, 2016, J PROTEOMICS, V136, P262, DOI 10.1016/j.jprot.2016.02.006
   Rey-Suarez P, 2012, TOXICON, V60, P851, DOI 10.1016/j.toxicon.2012.05.023
   Rey-Suarez P, 2011, J PROTEOMICS, V75, P655, DOI 10.1016/j.jprot.2011.09.003
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rosso JP, 2015, P NATL ACAD SCI USA, V112, pE891, DOI 10.1073/pnas.1415488112
   Rosso JP, 1996, EUR J BIOCHEM, V238, P231, DOI 10.1111/j.1432-1033.1996.0231q.x
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Soto JG, 2006, GENE, V373, P1, DOI 10.1016/j.gene.2005.11.039
   Sunagar K, 2013, TOXINS, V5, P2172, DOI 10.3390/toxins5112172
   Tan CH, 2016, J PROTEOMICS, V132, P1, DOI 10.1016/j.jprot.2015.11.014
   Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x
   Utkin Yuri N, 2019, World J Biol Chem, V10, P17, DOI 10.4331/wjbc.v10.i1.17
   Vergara I, 2014, J PROTEOMICS, V105, P295, DOI 10.1016/j.jprot.2014.02.027
NR 63
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 85
EP 93
DI 10.1016/j.toxicon.2019.09.017
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000010
PM 31557485
DA 2020-05-12
ER

PT J
AU Echeverry, JS
   Salgado, RAC
AF Echeverry P, Juan S.
   Correa Salgado, Ricardo A.
TI A retrospective study of scorpionism in 11 domestic dogs and a cat in
   the urban area of Manizales, Colombia
SO TOXICON
LA English
DT Review
DE Centruroides gracilis; Scorpionism; Toxinology
AB The present study analyzes cases of scorpionism in 11 dogs and a cat that were registered at a veterinary clinic in the city of Manizales, between 2009 and 2018. All eight cases where expert identification of the arthropod was possible, involved Centruroides gracilis (Latreille, 1804). None of the stings were lethal, though two cases were classified as severe envenomation and five moderate. The primary sign was local pain, in addition to lameness in all 10 cases that involved one of the limbs (83,3%, 10 of 12 cases). The other two cases had injuries involving the face. The established treatment was symptomatic with clinical and patient monitoring. Antivenom could not be used due to its high cost and scarcity. However, even the severest cases improved satisfactorily, and all patients were discharged without complication.
C1 [Echeverry P, Juan S.; Correa Salgado, Ricardo A.] Univ Caldas, Manizales, Caldas, Colombia.
   [Echeverry P, Juan S.; Correa Salgado, Ricardo A.] Ctr Especialistas Vet Mascotas, Manizales, Colombia.
RP Salgado, RAC (reprint author), Carrera 35 62-160, Manizales, Caldas, Colombia.
EM juan.1711721436@ucaldas.edu.co; ricardo.correa@ucaldas.edu.co
CR Armentano R., 2015, SMALL ANIMAL CRITICA, P914
   Bahloul M, 2010, AM J TROP MED HYG, V83, P1084, DOI [10.4269/ajtmh.2010.10.0036, 10.4269/ajtmh.2010.10-0036]
   Chowell G, 2005, INT J ENVIRON HEAL R, V15, P425, DOI 10.1080/09603120500392475
   Dabo A, 2011, TOXICON, V58, P154, DOI 10.1016/j.toxicon.2011.05.004
   DEARMAS LF, 2012, [No title captured], P105
   DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2
   Florez E., 2001, BIOTA COLOMB, P25
   Gazarian KG, 2005, VACCINE, V23, P3357, DOI 10.1016/j.vaccine.2004.12.027
   Gomez J., 2010, BIOMEDICA, P126
   Guinand A., 2004, GAC MED CARACAS, P131
   Hovda L., 2016, BLACKWELLS 5 MINUTE
   lsbister G., 2003, TOXICON, P877
   Mohseni A, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.8901
   Otero R., 2005, 7 REUN EXP ENV AN PO
   Saldarriaga Cordoba M., 2000, MEDUNAB
   Santos EA, 2016, 13TH WORKING CONFERENCE ON MINING SOFTWARE REPOSITORIES (MSR 2016), P504, DOI [10.1109/MSR.2016.065, 10.1145/2901739.2903493]
   Ulug M, 2012, TURKISH J PEDIATR, V54, P119
NR 17
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 94
EP 98
DI 10.1016/j.toxicon.2019.09.023
PG 5
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000011
PM 31563524
DA 2020-05-12
ER

PT J
AU Spolaore, B
   Fernandez, J
   Lomonte, B
   Massimino, ML
   Tonello, F
AF Spolaore, Barbara
   Fernandez, Julian
   Lomonte, Bruno
   Massimino, Maria Lina
   Tonello, Fiorella
TI Enzymatic labelling of snake venom phospholipase A(2) toxins
SO TOXICON
LA English
DT Article
DE Secretory phospholipase A(2); Snake venom toxin; Protein labelling;
   Enzymatic conjugation; Transglutarninase
ID LYSINE RESIDUES; TRANSGLUTAMINASE; PURIFICATION; MECHANISM; GLUTAMINE;
   SEQUENCE
AB Almost all animal venoms contain secretory phospholipases A(2) (PLA(2)s), 14 kDa disulfide-rich enzymes that hydrolyze membrane phospholipids at the sn-2 position, releasing lysophospholipids and fatty acids. These proteins, depending on their sequence, show a wide variety of biochemical, toxic and pharmacological effects and deserve to be studied for their numerous possible applications, and to improve antivenom drugs. The cellular localization and activity of a protein can be studied by conjugating it with a tag. In this work, we applied an enzymatic labelling method, using Streptomyces mobaraense transglutaminase, on three snake venom PLA(2)s: a recombinant neuro- and myotoxic group I PLA(2) from Notechis scutatus scutatus, and two myotoxic group II PLA(2) s from Bothrops asper - one of them a natural catalytically inactive variant. We demonstrate that TGase can be used to produce active mono- or bi-derivatives of these three PLA(2)s modified at specific Lys residues, and that all three of these proteins, conjugated with fluorescent peptides, are internalized in primary myotubes.
C1 [Spolaore, Barbara] Univ Padua, Dipartimento Sci Farmaco, Via F Marzolo 5, I-35131 Padua, Italy.
   [Fernandez, Julian; Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose 11501, Costa Rica.
   [Massimino, Maria Lina; Tonello, Fiorella] CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.
RP Spolaore, B (reprint author), Univ Padua, Dipartimento Sci Farmaco, Via F Marzolo 5, I-35131 Padua, Italy.; Tonello, F (reprint author), CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.
EM barbara.spolaore@unipd.it; fiorella.tonello@cnr.it
RI Lomonte, Bruno/B-8862-2019; Tonello, Fiorella/G-8957-2013
OI Lomonte, Bruno/0000-0003-2419-6469; Tonello,
   Fiorella/0000-0001-8935-8938
FU PRID2018 of the Department of Pharmaceutical and Pharmacological
   Sciences of the University of Padua
FX We acknowledge Caterina Marcato for performing some of the experiments
   here reported during her Master Thesis. This work was supported by
   PRID2018 of the Department of Pharmaceutical and Pharmacological
   Sciences of the University of Padua.
CR ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735
   Angulo Y, 2005, TOXICON, V46, P291, DOI 10.1016/j.toxicon.2005.03.025
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Chiou YL, 2008, J PEPT SCI, V14, P890, DOI 10.1002/psc.1020
   Cintra-Francischinelli M, 2010, TOXICON, V55, P590, DOI 10.1016/j.toxicon.2009.10.013
   Deweid L, 2019, BIOL CHEM, V400, P257, DOI 10.1515/hsz-2018-0335
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   DIMARCO S, 1992, J BIOCHEM-TOKYO, V112, P350
   FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5
   Lizano S, 2001, INT J BIOCHEM CELL B, V33, P127, DOI 10.1016/S1357-2725(00)00073-X
   Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007
   Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006
   Mariniello L, 2014, AMINO ACIDS, V46, P767, DOI 10.1007/s00726-013-1561-6
   Massimino ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28846-4
   Mora-Obando D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109846
   Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041
   Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123
   Nardicchi V, 2007, BBA-MOL CELL BIOL L, V1771, P1345, DOI 10.1016/j.bbalip.2007.08.007
   Ohtsuka T, 2000, J AGR FOOD CHEM, V48, P6230, DOI 10.1021/jf000302k
   Piersma SR, 2002, ENZYME MICROB TECH, V30, P266, DOI 10.1016/S0141-0229(01)00500-2
   Rigoni M, 2008, J BIOL CHEM, V283, P34013, DOI 10.1074/jbc.M803243200
   Simonato M, 2014, TOXICON, V88, P11, DOI 10.1016/j.toxicon.2014.06.009
   Spolaore B, 2016, BIOCONJUGATE CHEM, V27, P2695, DOI 10.1021/acs.bioconjchem.6b00468
   Spolaore B, 2014, BIOCONJUGATE CHEM, V25, P470, DOI 10.1021/bc400378h
   Spolaore B, 2012, BIOCHEMISTRY-US, V51, P8679, DOI 10.1021/bi301005z
   Tonello F, 2017, TOXINOLOGY, P49, DOI 10.1007/978-94-007-6410-1_26
   Zhang Y, 2018, CHEM SOC REV, V47, P9106, DOI 10.1039/c8cs00537k
NR 29
TC 1
Z9 1
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC
PY 2019
VL 170
BP 99
EP 107
DI 10.1016/j.toxicon.2019.09.019
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JL4DA
UT WOS:000495480000012
PM 31563525
DA 2020-05-12
ER

PT J
AU Silveira, L
   DeWitt, J
   Thomas, A
   Tranmer, B
AF Silveira, Luke
   DeWitt, John
   Thomas, Alissa
   Tranmer, Bruce
TI Disseminated Rosette-Forming Glioneuronal Tumor with Spinal Drop
   Metastasis, a Uniquely Aggressive Presentation of Rare Tumor
SO WORLD NEUROSURGERY
LA English
DT Article
DE Disseminated; Rosette-forming glioneuronal tumor (RGNT); Spinal drop
   metastasis
ID CLASSIFICATION; MUTATIONS; SYSTEM
AB BACKGROUND: The rosette-forming glioneuronal tumor (RGNT) is a rare World Health Organization grade I tumor, most often originating in the fourth ventricle and characterized by a predominant glial component, as well as a neurocytic component. Despite its benign grading, there are a few documented cases of RGNT displaying more aggressive behavior with malignant characteristics.
   CASE DESCRIPTION: Herein, we describe a uniquely aggressive presentation of RGNT in a 49-year-old man initially presenting with obstructive hydrocephalus with lesions in the right frontal lobe, fourth ventricle, and left lateral ventricle. The patient was found to have 2 distinct intracranial entities: a right frontal meningioma and disseminated intraventricular RGNT. He underwent an anatomically limited resection of the fourth ventricular lesion with fourth ventricle-to-subarachnoid space shunting. His disease progressed thereafter, with diffuse intracranial dissemination and drop metastases in the lumbar spine. He was treated with craniospinal radiation and remains on palliative care 5 months after completion of radiotherapy.
   CONCLUSIONS: This case supplements and complements the handful of published cases available documenting the evolution of a particularly aggressive case of disseminated RGNT.
C1 [Silveira, Luke; Tranmer, Bruce] Univ Vermont, Med Ctr, Dept Neurosurg, Burlington, VT 05405 USA.
   [DeWitt, John] Univ Vermont, Dept Neuropathol, Med Ctr, Burlington, VT USA.
   [Thomas, Alissa] Univ Vermont, Dept Neurol, Med Ctr, Burlington, VT USA.
RP Silveira, L (reprint author), Univ Vermont, Med Ctr, Dept Neurosurg, Burlington, VT 05405 USA.
EM luke.silveira@uvmhealth.org
CR Allinson KSJ, 2015, CLIN NEUROPATHOL, V34, P64, DOI 10.5414/NP300682
   Anan M, 2009, HUM PATHOL, V40, P898, DOI 10.1016/j.humpath.2008.11.010
   Bidinotto LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137690
   Duan L, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.11.109
   Ellezam B, 2012, ACTA NEUROPATHOL, V123, P285, DOI 10.1007/s00401-011-0886-z
   Frydenberg E, 2010, J CLIN NEUROSCI, V17, P1326, DOI 10.1016/j.jocn.2010.03.003
   Garcia E, 2015, INT J INF LEARN TECH, V32, P124, DOI 10.1108/IJILT-01-2015-0001
   Gessi M, 2014, J NEUROPATH EXP NEUR, V73, P580, DOI 10.1097/NEN.0000000000000080
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Medhi G, 2016, EUR RADIOL, V26, P262, DOI 10.1007/s00330-015-3808-y
   Scheithauer BW, 2009, NEUROSURGERY, V64, P771, DOI 10.1227/01.NEU.0000340979.81362.F3
   Schlamann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101211
   Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1
   Wang Y, 2009, ACTA NEUROPATHOL, V118, P813, DOI 10.1007/s00401-009-0569-1
   Xiong J, 2012, NEUROPATHOLOGY, V32, P301, DOI 10.1111/j.1440-1789.2011.01261.x
   Yamamoto T, 2015, BRAIN TUMOR PATHOL, V32, P291, DOI 10.1007/s10014-015-0226-4
   Yang C, 2017, ONCOTARGET, V8
NR 18
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 7
EP 11
DI 10.1016/j.wneu.2019.08.055
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300118
PM 31442659
DA 2020-05-12
ER

PT J
AU Nigro, L
   Tariciotti, L
   Chiarella, V
AF Nigro, Lorenzo
   Tariciotti, Leonardo
   Chiarella, Vito
TI A Case of Spinal Cord Compression Due to Paraspinal Musculature After
   Cervical Laminectomy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical laminectomy; Paraspinal musculature; Spinal cord compression
ID EPIDURAL HEMATOMA; MYELOPATHY; DECOMPRESSION; LAMINOPLASTY; FUSION
AB BACKGROUND: Only a few cases of spinal cord compression after cervical laminectomy have been reported.
   CASE DESCRIPTION: We report a case of tetraparesis after executing a C3-C6 anterior and posterior decompression and fusion. Cervical magnetic resonance imaging demonstrated a spinal cord compression due to the impingement of the paraspinal muscles through the laminectomy. The patient experienced a spontaneous neurological recovery and the follow-up cervical magnetic resonance imaging showed resolution of the spinal cord compression.
   CONCLUSIONS: This rare complication should be considered among the others after executing a cervical laminectomy.
C1 [Nigro, Lorenzo] Ctr Chirurg Toscano, Arezzo, Italy.
   [Tariciotti, Leonardo; Chiarella, Vito] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy.
RP Tariciotti, L (reprint author), Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy.
EM leonardotariciotti@gmail.com
OI Chiarella, Vito/0000-0003-0286-2256; Tariciotti,
   Leonardo/0000-0002-5942-6677
CR Abumi K, 2015, EUR SPINE J, V24, pS186, DOI 10.1007/s00586-015-3838-9
   Jiang LH, 2015, J SPINAL DISORD TECH, V28, P282, DOI 10.1097/BSD.0000000000000317
   Kou J, 2002, SPINE, V27, P1670, DOI 10.1097/00007632-200208010-00016
   Lee JY, 2006, J BONE JOINT SURG AM, V88A, P198, DOI 10.2106/JBJS.E.00313
   Miyamoto H, 2014, EUR SPINE J, V23, P341, DOI 10.1007/s00586-013-2923-1
   Sciubba DM, 2008, J NEUROSURG-SPINE, V8, P413, DOI 10.3171/SPI/2008/8/5/413
   Tu PH, 2018, EUR SPINE J, V27, P1815, DOI 10.1007/s00586-018-5685-y
   Xiao SW, 2015, EUR SPINE J, V24, P31, DOI 10.1007/s00586-014-3607-1
NR 8
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 12
EP 13
DI 10.1016/j.wneu.2019.08.098
PG 2
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300119
PM 31450000
DA 2020-05-12
ER

PT J
AU Naito, K
   Yamagata, T
   Ohata, K
   Takami, T
AF Naito, Kentaro
   Yamagata, Toru
   Ohata, Kenji
   Takami, Toshihiro
TI Safety and Efficacy of Syringoperitoneal Shunting with a Programmable
   Shunt Valve for Syringomyelia Associated with Extensive Spinal Adhesive
   Arachnoiditis: Technical Note
SO WORLD NEUROSURGERY
LA English
DT Article
DE Programmable shunt valve; Spinal adhesive arachnoiditis; Syringomyelia;
   Syringoperitoneal shunt
ID POSTTRAUMATIC SYRINGOMYELIA; SURGICAL-MANAGEMENT; SUBARACHNOID SPACE;
   CRITICAL-APPRAISAL; ANIMAL-MODEL; FLUID-FLOW; SYRINX; PATHOPHYSIOLOGY;
   PATHOGENESIS; TUMORS
AB OBJECTIVE: Although syringomyelia associated with extensive spinal adhesive arachnoiditis (SAA) can be a progressive disease that has potentially devastating clinical consequences, its surgical resolution has remained poorly defined. The aim of the present study was to verify the safety and efficacy of syringoperitoneal shunting for syringomyelia associated with extensive SAA.
   METHODS: The present retrospective study included 15 patients who had undergone syringoperitoneal shunting with a programmable shunt valve for the diagnosis of syringomyelia associated with extensive SAA from October 2012 to June 2018. The shunt pressure was appropriately adjusted according to the postoperative sequential clinical condition and change in syringomyelia evaluated using magnetic resonance imaging. The average postoperative follow-up duration was 32.7 months.
   RESULTS: No surgery-related complications such as shunt dysfunction or infection occurred during the follow-up period, except for 2 patients with minor issues with the shunt tube. The average shunt pressure at the last follow-up examination was 4.5 cm H2O. The findings from the clinical assessment suggested that the average grade on the sensory pain scale was 2.9 before surgery and had improved significantly to 2.5 at the most recent follow-up examination. Radiological analysis suggested that improvement of syringomyelia was noted in 14 of the 15 patients (93.3%), with no cases of radiological aggravation. No recurrence of syringomyelia developed during the follow-up period in the present study.
   CONCLUSION: Syringoperitoneal shunting with a programmable shunt valve was safe and effective for clinical control of syringomyelia associated with extensive SAA. Long-term follow-up is mandatory to monitor for shunt dysfunction and mechanical trouble.
C1 [Naito, Kentaro; Ohata, Kenji; Takami, Toshihiro] Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
   [Yamagata, Toru] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan.
RP Takami, T (reprint author), Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
EM ttakami@med.osaka-cu.ac.jp
CR Abe J, 2014, NEUROL MED-CHIR, V54, P924, DOI 10.2176/nmc.oa.2014-0158
   Anderson TL, 2017, AM J ROENTGENOL, V209, P648, DOI 10.2214/AJR.16.16704
   BARBARO NM, 1984, J NEUROSURG, V61, P531, DOI 10.3171/jns.1984.61.3.0531
   Batzdorf U, 1998, J NEUROSURG, V89, P382, DOI 10.3171/jns.1998.89.3.0382
   Brodbelt AR, 2003, SPINE, V28, pE413, DOI 10.1097/01.BRS.0000092346.83686.B9
   Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9
   Cacciola F, 2009, NEUROSURGERY, V65, P471, DOI 10.1227/01.NEU.0000350871.47574.DE
   CAPLAN LR, 1990, J NEUROL NEUROSUR PS, V53, P106, DOI 10.1136/jnnp.53.2.106
   Chang HS, 2004, J NEUROL NEUROSUR PS, V75, P754, DOI 10.1136/jnnp.2003.018671
   CHO KH, 1994, J NEUROSURG, V80, P133, DOI 10.3171/jns.1994.80.1.0133
   Davidson KA, 2018, WORLD NEUROSURG, V110, pE53, DOI 10.1016/j.wneu.2017.09.205
   EDGAR R, 1994, BRIT J NEUROSURG, V8, P7, DOI 10.3109/02688699409002388
   Hayashi T, 2013, J NEUROSURG-SPINE, V18, P382, DOI 10.3171/2013.1.SPINE12828
   Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233
   Klekamp J, 2002, ACTA NEUROCHIR, V144, P649, DOI 10.1007/s00701-002-0944-3
   Klekamp J, 2013, NEUROSURGERY, V72, P376, DOI 10.1227/NEU.0b013e31827fcc8f
   Klekamp J, 2012, J NEUROSURG-SPINE, V17, P199, DOI 10.3171/2012.5.SPINE11904
   Koyanagi I, 2005, SURG NEUROL, V63, P350, DOI 10.1016/j.surneu.2004.05.038
   Lee JH, 2002, SPINAL CORD, V40, P501, DOI 10.1038/sj.sc.3101322
   MCCORMICK PC, 1990, J NEUROSURG, V72, P523, DOI 10.3171/jns.1990.72.4.0523
   MILHORAT TH, 1995, J NEUROSURG, V82, P802, DOI 10.3171/jns.1995.82.5.0802
   Morikawa T, 2006, NEUROL RES, V28, P802, DOI 10.1179/016164106X110355
   Morisako H, 2010, J CRANIOVERTEBRAL JU, V1, P100, DOI 10.4103/0974-8237.77673
   Ohata K, 2001, J CLIN NEUROSCI, V8, P40, DOI 10.1054/jocn.2000.0731
   Oluigbo CO, 2010, J NEUROSURG-SPINE, V13, P133, DOI 10.3171/2010.3.SPINE0964
   ROSSIER AB, 1985, BRAIN, V108, P439, DOI 10.1093/brain/108.2.439
   SGOUROS S, 1995, J NEUROSURG, V82, P1, DOI 10.3171/jns.1995.82.1.0001
   Suzuki M, 1995, J NEUROL NEUROSUR PS, V48, P620
   Takami T, 2017, WORLD NEUROSURG, V108, P15, DOI 10.1016/j.wneu.2017.08.127
   Tassigny D, 2017, WORLD NEUROSURG, V98, P1, DOI 10.1016/j.wneu.2016.10.067
   TATOR CH, 1982, J NEUROSURG, V56, P517, DOI 10.3171/jns.1982.56.4.0517
   VANDENBERGH R, 1991, ACTA NEUROCHIR, V110, P82, DOI 10.1007/BF01402052
   Williams B, 1987, Br J Neurosurg, V1, P63, DOI 10.3109/02688698709034342
NR 33
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 14
EP 20
DI 10.1016/j.wneu.2019.08.103
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300120
PM 31465850
DA 2020-05-12
ER

PT J
AU Watson, VL
   Cozzens, JW
AF Watson, Victoria L.
   Cozzens, Jeffrey W.
TI Use of 5-Aminolevulinic Acid for Confirmation of Lesional Biopsy Sample
   in Presumed High-Grade Glioma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aminolevulinic acid; Biopsy; Fluorescence; Glioblastoma
ID FRAMELESS STEREOTACTIC BIOPSY; DIAGNOSTIC YIELD; FLUORESCENCE; RESECTION
AB BACKGROUND: 5-amniolevulinic acid (5-ALA) assists neurosurgeons in defining operative margins during resection of high-grade gliomas, leading to improved rates of complete resection of enhancing tumor and progression-free survival. Here, we propose the use of 5-ALA in stereotactic biopsy for confirmation that the sample obtained is from the targeted mass. To the knowledge of the authors, this is the first known record of 5-ALA use for confirmation of pathologic specimen in stereotactic brain biopsy in the United States. This technique could be pivotal for lesions in highly eloquent areas where it is important to take as little tissue as possible in an effort to decrease neurologic deficits while still obtaining a diagnostic biopsy sample.
   CASE DESCRIPTION: The patient is a 67-year-old male who initially presented with computed tomography and magnetic resonance imaging concerning for a high-grade glioma in the right basal ganglia and deep white matter of the frontal lobe. Final pathology concluded that specimens obtained during biopsy were indeed pathologic at the periphery of the lesion, and there was necrotic tissue at the center of the lesion. Fluorescence of biopsy samples was 100% concordant with pathologic analysis.
   CONCLUSIONS: 5-ALA may prove a useful tool for intraoperative confirmation of pathologic tissue, especially in areas of high eloquence, where small biopsy sizes are essential. It may also obviate the need for an intraoperative consultation to a pathologist. However, additional studies with larger study populations are warranted.
C1 [Watson, Victoria L.] Neurosci Inst, Div Neurosurg, Springfield, IL 62702 USA.
   [Cozzens, Jeffrey W.] Southern Illinois Univ, Neurosci Inst, Div Neurosurg, Sch Med, Springfield, IL USA.
RP Watson, VL (reprint author), Neurosci Inst, Div Neurosurg, Springfield, IL 62702 USA.
EM vlwatson7@gmail.com
CR Amraei Razie, 2017, Asian Pac J Cancer Prev, V18, P659
   Castle M, 2014, NEUROCIRUGIA, V25, P56, DOI 10.1016/j.neucir.2013.11.003
   Catapano G, 2018, NEUROSURG REV, V42, P309
   Dammers R, 2010, ACTA NEUROCHIR, V152, P1915, DOI 10.1007/s00701-010-0752-0
   Fritsch MJ, 1998, STEREOT FUNCT NEUROS, V71, P36, DOI 10.1159/000029645
   Hakan T, 2016, TURK NEUROSURG, V26, P890, DOI 10.5137/1019-5149.JTN.13742-14.0
   Hamisch CA, 2017, KLIN PADIATR, V229, P133, DOI 10.1055/s-0043-101908
   Kang M, 2019, J PATHOL TRANSL MED, V53, P104, DOI 10.4132/jptm.2018.11.10
   Khatab S, 2014, ACTA NEUROCHIR, V156, P1441, DOI 10.1007/s00701-014-2145-2
   Lau D, 2016, J NEUROSURG, V124, P1300, DOI 10.3171/2015.5.JNS1577
   Mat Zin Anani Aila, 2019, Asian Pac J Cancer Prev, V20, P321
   Moriuchi S, 2011, J NEUROSURG, V115, P278, DOI 10.3171/2011.4.JNS102137
   Obeidat FN, 2019, TURK NEUROSURG, V29, P242, DOI 10.5137/1019-5149.JTN.23220-18.2
   Paleologos TS, 2001, NEUROSURGERY, V49, P830, DOI 10.1097/00006123-200110000-00009
   Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322
   Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9
   Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003
   Stummer W, 2014, NEUROSURGERY, V74, P310, DOI 10.1227/NEU.0000000000000267
   Tofte Kathrine, 2014, Surg Neurol Int, V5, P170, DOI 10.4103/2152-7806.146153
   Tsermoulas G, 2013, BRIT J NEUROSURG, V27, P207, DOI 10.3109/02688697.2012.722239
   Widhalm G, 2012, NEUROSURG REV, V35, P381, DOI 10.1007/s10143-012-0374-5
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 21
EP 25
DI 10.1016/j.wneu.2019.08.076
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300121
PM 31442649
DA 2020-05-12
ER

PT J
AU Jabre, R
   Bernat, AL
   Peres, R
   Froelich, S
AF Jabre, Roland
   Bernat, Anne-Laure
   Peres, Roxane
   Froelich, Sebastien
TI Brain Abscesses After Endovascular Embolization of a Brain Arteriovenous
   Malformation with Squid
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain abscess; Ethylene-vinyl alcohol copolymer; Intracranial
   arteriovenous malformation
ID CEREBRAL ABSCESS; COMPLICATING EMBOLIZATION; ONYX; EXPERIENCE;
   INFECTION; ANEURYSM
AB BACKGROUND: The use of nonadhesive liquid embolic agents (NALEAs) has gained great popularity in the treatment of brain vascular malformations, with a lower rate of local complications than surgery. However, we describe the formation of brain abscesses after endovascular treatment of a brain arteriovenous malformation (bAVM) and how important removal of the NALEAs was in the treatment of these abscesses.
   CASE DESCRIPTION: A 68-year-old man presented with seizures after being treated for an unruptured bAVM using Squid (Emboflu), an NALEA. Radiologic imaging revealed brain lesions suspicious of abscesses around the previously treated bAVM. A surgical excision of the bAVM and the embolized material was performed as was drainage of the brain abscesses. Bacterial cultures were positive for Enterococcus faecalis, and the patient left the hospital with an appropriate antibiotic regimen without new deficits.
   CONCLUSIONS: This is the first reported case of a bAVM treated with Squid complicated with brain abscesses, a rare but very serious complication. This complication should be treated not only using antibiotherapy but with complete safe removal of the embolic material.
C1 [Jabre, Roland; Bernat, Anne-Laure; Froelich, Sebastien] Hop Lariboisiere, Dept Neurosurg, Paris, Ile De France, France.
   [Peres, Roxane] Hop Lariboisiere, Dept Neurol, Paris, Ile De France, France.
   [Jabre, Roland] Ctr Hosp Univ Montreal, Dept Neurosurg, Montreal, PQ, Canada.
RP Jabre, R (reprint author), Hop Lariboisiere, Dept Neurosurg, Paris, Ile De France, France.
EM roland.jabre@umontreal.ca
OI Bernat, Anne-Laure/0000-0002-3659-6518
CR Al-Okaili R, 2002, AM J NEURORADIOL, V23, P697
   Chagla AS, 2008, J NEUROSURG, V109, P347, DOI 10.3171/JNS/2008/109/8/0347
   Cossu G, 2017, ACTA NEUROCHIR, V159, P583, DOI 10.1007/s00701-016-3069-9
   Diaz-Romero R, 2009, SURG INFECT, V10, P359, DOI 10.1089/sur.2008.031
   Dinesh SK, 2008, J CLIN NEUROSCI, V15, P463, DOI 10.1016/j.jocn.2006.11.022
   Gunawat P, 2016, J CLIN DIAGN RES, V10, pPD15, DOI 10.7860/JCDR/2016/22705.8836
   Jahan R, 2001, NEUROSURGERY, V48, P984, DOI 10.1097/00006123-200105000-00003
   Khoshnevisan A, 2014, IRAN J NEUROL, V13, P181
   Molyneux AJ, 2004, AM J NEURORADIOL, V25, P39
   MOURIER KL, 1993, ACTA NEUROCHIR, V122, P130, DOI 10.1007/BF01447000
   Pendarkar H, 2006, J NEURORADIOLOGY, V33, P133, DOI 10.1016/S0150-9861(06)77246-7
   Pulhorn H, 2014, CHILD NERV SYST, V30, P1577, DOI 10.1007/s00381-014-2447-y
   Sharma A, 2011, NEUROL INDIA, V59, P131, DOI 10.4103/0028-3886.84351
   Xu F, 2011, ACTA NEUROCHIR, V153, P869, DOI 10.1007/s00701-010-0848-6
NR 14
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 29
EP 32
DI 10.1016/j.wneu.2019.08.095
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300123
PM 31450002
DA 2020-05-12
ER

PT J
AU Goshtasbi, K
   Abiri, A
   Sahyouni, R
   Mahboubi, H
   Raefsky, S
   Kuan, EC
   Hsu, FPK
   Cadena, G
AF Goshtasbi, Khodayar
   Abiri, Arash
   Sahyouni, Ronald
   Mahboubi, Hossein
   Raefsky, Sophia
   Kuan, Edward C.
   Hsu, Frank P. K.
   Cadena, Gilbert
TI Visual and Endocrine Recovery Following Conservative and Surgical
   Treatment of Pituitary Apoplexy: A Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Endocrine; Meta-analysis; Pituitary adenoma; Pituitary apoplexy; Vision
ID ENDOSCOPIC ENDONASAL SURGERY; MANAGEMENT; EXPERIENCE; OUTCOMES; SERIES
AB BACKGROUND: Pituitary apoplexy (PA) can manifest with visual and endocrine defects. The literature lacks strong support for either surgical or conservative management with respect to symptomatic improvement of these deficits. This meta-analysis compared visual and endocrine outcomes in conservative and surgical treatment of PA.
   METHODS: A systematic literature search was performed in PubMed, Cochrane, and Ovid MEDLINE for articles published between 1988 and 2018. Recovery outcomes were binarized, such that complete and partial improvements were combined as "improvement." Primary outcome variables evaluated via a binary random-effects model were improvements in endocrine dysfunction, visual field and acuity deficits, and ophthalmoplegia or ocular nerve palsy.
   RESULTS: Of 483 published articles, 14 studies comprising 457 cases (259 surgical treatments and 198 conservative treatments) were included. On initial examination, 58% of patients had endocrine dysfunction, 37% had visual acuity or field deficit, and 47% had ophthalmoplegia or ocular nerve palsy. Evaluation of outcomes for surgically and conservatively treated patients yielded odds ratios of 0.609 (95% confidence interval [CI], 0.199-1.859; P = 0.383), 0.763 (95% CI, 0.307-2.374; P = 0.763), 1.167 (95% CI, 0.433-3.146; P = 0.760), and 0.801 (95% CI, 0.305-2.105; P = 0.653) for improvements in endocrine dysfunction, visual acuity dysfunction, visual field dysfunction, and ophthalmoplegia or ocular nerve palsy.
   CONCLUSIONS: Both surgical intervention and conservative management of PA can lead to visual and endocrine recovery, although the management decision may heavily rely on severity of initial deficits. Treatment of PA can be multifaceted and tailored to the individual case and clinical judgment. Further investigation into appropriate intervention based on longitudinal outcome data is warranted.
C1 [Goshtasbi, Khodayar; Abiri, Arash; Sahyouni, Ronald; Mahboubi, Hossein; Raefsky, Sophia; Kuan, Edward C.] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA USA.
   [Hsu, Frank P. K.; Cadena, Gilbert] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.
RP Cadena, G (reprint author), Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.
EM gcadena@uci.edu
RI Kuan, Edward C/I-3715-2019
OI Kuan, Edward C/0000-0003-3475-0718; Abiri, Arash/0000-0003-2656-1060
CR Arita K, 2006, J NEUROSURG, V104, P884, DOI 10.3171/jns.2006.104.6.884
   Ayuk J, 2004, CLIN ENDOCRINOL, V61, P747, DOI 10.1111/j.1365-2265.2004.02162.x
   Bi WL, 2015, ENDOCRINE, V48, P69, DOI 10.1007/s12020-014-0359-y
   BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007
   Briet C, 2015, ENDOCR REV, V36, P622, DOI 10.1210/er.2015-1042
   Bujawansa S, 2014, CLIN ENDOCRINOL, V80, P419, DOI 10.1111/cen.12307
   Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794
   Carral San Laureano F, 2001, An Med Interna, V18, P582
   Culpin E, 2018, PITUITARY, V21, P474, DOI 10.1007/s11102-018-0900-8
   Giritharan S, 2016, CLIN ENDOCRINOL, V85, P415, DOI 10.1111/cen.13075
   Gondim JA, 2017, WORLD NEUROSURG, V108, P137, DOI 10.1016/j.wneu.2017.08.131
   Gruber A, 2006, BRIT J NEUROSURG, V20, P379, DOI 10.1080/02688690601046678
   Hage R, 2016, WORLD NEUROSURG, V94, P447, DOI 10.1016/j.wneu.2016.07.026
   Jho DH, 2014, WORLD NEUROSURG, V82, P781, DOI 10.1016/j.wneu.2014.06.005
   Lammert Alexander, 2020, Exp Clin Endocrinol Diabetes, V128, P283, DOI 10.1055/a-0640-2915
   Leyer C, 2011, J ENDOCRINOL INVEST, V34, P502, DOI 10.3275/7241
   Liu ZH, 2010, J CLIN NEUROSCI, V17, P694, DOI 10.1016/j.jocn.2009.11.012
   MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190
   MCFADZEAN RM, 1991, NEUROSURGERY, V29, P669, DOI 10.1227/00006123-199111000-00005
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   MOHR G, 1982, SURG NEUROL, V18, P181, DOI 10.1016/0090-3019(82)90388-3
   Murad-Kejbou S, 2009, CURR OPIN OPHTHALMOL, V20, P456, DOI 10.1097/ICU.0b013e3283319061
   Muthukumar N, 2008, J CLIN NEUROSCI, V15, P873, DOI 10.1016/j.jocn.2007.08.010
   Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x
   Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x
   Reddy NL, 2011, CLIN ENDOCRINOL, V75, P723, DOI 10.1111/j.1365-2265.2011.04081.x
   ROVIT RL, 1972, J NEUROSURG, V37, P280, DOI 10.3171/jns.1972.37.3.0280
   Rutkowski MJ, 2018, J NEUROSURG, V129, P417, DOI 10.3171/2017.2.JNS1784
   Semple PL, 2005, NEUROSURGERY, V56, P65, DOI 10.1227/01.NEU.0000144840.55247.38
   Seo Y, 2018, WORLD NEUROSURG, V115, pE703, DOI 10.1016/j.wneu.2018.04.139
   Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3
   Simon S, 2004, SIGNS, V8
   Singh TD, 2015, J NEUROSURG, V122, P1450, DOI 10.3171/2014.10.JNS141204
   Teixeira JC, 2018, WORLD NEUROSURG, V111, pE495, DOI 10.1016/j.wneu.2017.12.103
   Tu M, 2016, J NEUROL SCI, V370, P258, DOI 10.1016/j.jns.2016.09.047
   Turgut M, 2010, ACTA NEUROCHIR, V152, P749, DOI 10.1007/s00701-009-0595-8
   WAKAI S, 1981, J NEUROSURG, V55, P187, DOI 10.3171/jns.1981.55.2.0187
   Zayour DH, 2004, J CLIN ENDOCR METAB, V89, P5649, DOI 10.1210/jc.2004-0884
   Zoli M, 2017, WORLD NEUROSURG, V106, P331, DOI [10.1016/J.WNEU.2017.06.117, 10.1016/j.wneu.2017.06.117]
NR 39
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 33
EP 40
DI 10.1016/j.wneu.2019.08.115
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300124
PM 31470146
DA 2020-05-12
ER

PT J
AU Gao, MQ
   Li, PF
   Tan, CY
   Liu, JW
   Tie, XX
   Pang, C
   Guo, ZZ
   Lin, Y
AF Gao, Mengqi
   Li, Pengfei
   Tan, Chunyu
   Liu, Jiawei
   Tie, Xinxin
   Pang, Chao
   Guo, Zongze
   Lin, Yi
TI Primary Central Nervous System Angiosarcoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Angiosarcoma; Primary central nervous system tumor; Surgery
ID PRIMARY CEREBRAL ANGIOSARCOMA; SARCOMAS; HEMORRHAGE; BRAIN
AB BACKGROUND: Primary angiosarcoma of the brain is an extremely rare malignant tumor that that arises from vascular endothelial cells of the brain or meninges. The presentation, characteristics, and prognosis of this disease are not well understood. Here we report such a case.
   CASE DESCRIPTION: A 68-year-old Chinese man presented with confusion and progressive impairment of right limb movement. Magnetic resonance imaging (MRI) revealed a hemorrhagic lesion in the left frontal lobe. Exploratory surgery revealed a hematoma-like lesion and extensive superficial hemosiderin deposition. The postoperative pathological diagnosis was angiosarcoma. The tumor recurred at 1 month after the operation, with extensive tumor regrowth in the left hemisphere. The patient died after 4 weeks.
   CONCLUSIONS: Although accurate preoperative diagnosis of angiosarcoma of the brain is difficult, radiologists and neurosurgeons need to be aware of this rare entity. The prognosis of intracranial angiosarcoma is heterogenous. Intra-operatively, the presence of extensive superficial hemosiderosis may aid in its diagnosis.
C1 [Gao, Mengqi; Li, Pengfei; Tan, Chunyu; Liu, Jiawei; Tie, Xinxin; Pang, Chao; Guo, Zongze; Lin, Yi] China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China.
RP Lin, Y (reprint author), China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China.
EM linyi@cmu.edu.cn
FU Liaoning Science and Technology Plan Project [2014021068]
FX This work was supported by the Liaoning Science and Technology Plan
   Project (Grant 2014021068).
CR Antoniadis C, 1996, NEUROSURGERY, V38, P583, DOI 10.1097/00006123-199603000-00033
   Balamurali G, 2009, NEUROSURGERY, V65, P210, DOI 10.1227/01.NEU.0000348294.05571.D9
   Baldovini C, 2013, CASE REP PATHOL, DOI 10.1155/2013/603671
   Bosetti C, 2003, EUR J CANCER PREV, V12, P427, DOI 10.1097/00008469-200310000-00012
   CHARMAN HP, 1988, J NEUROSURG, V68, P806, DOI 10.3171/jns.1988.68.5.0806
   COOKSTON M, 1991, SOUTHERN MED J, V84, P517, DOI 10.1097/00007611-199104000-00031
   Daniel L, 1998, ANN PATHOL, V18, P48
   Fuse Takahisa, 1995, Neurologia Medico-Chirurgica, V35, P364, DOI 10.2176/nmc.35.364
   Gaballah AH, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170039
   Gallo P, 2001, ARQ NEURO-PSIQUIAT, V59, P793, DOI 10.1590/S0004-282X2001000500026
   Hackney James R, 2012, J Med Case Rep, V6, P251
   Hoshiai S, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150374
   Jerjir N, 2016, J BELG SOC RADIOL, V100, DOI 10.5334/jbr-btr.1087
   Kurian KM, 2006, NEUROPATH APPL NEURO, V32, P557, DOI 10.1111/j.1365-2990.2006.00762.x
   La Corte E, 2015, NEUROPATHOLOGY, V35, P184, DOI 10.1111/neup.12178
   Lach B, 2000, ULTRASTRUCT PATHOL, V24, P339
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   MENA H, 1978, CANCER, V42, P1298, DOI 10.1002/1097-0142(197809)42:3<1298::AID-CNCR2820420340>3.0.CO;2-K
   MENA H, 1991, J NEUROSURG, V75, P73, DOI 10.3171/jns.1991.75.1.0073
   Merimsky O, 2000, ONCOLOGY-BASEL, V58, P210, DOI 10.1159/000012102
   O'Hara CD, 2003, ADV ANAT PATHOL, V10, P69, DOI 10.1097/00125480-200303000-00002
   PAULUS W, 1991, HISTOPATHOLOGY, V18, P395, DOI 10.1111/j.1365-2559.1991.tb00869.x
   Ray-Coquard IL, 2015, J CLIN ONCOL, V33, P2797, DOI 10.1200/JCO.2015.60.8505
   Shweikeh Faris, 2014, Sarcoma, V2014, P475175, DOI 10.1155/2014/475175
   Stacchiotti S, 2012, ANN ONCOL, V23, P501, DOI 10.1093/annonc/mdr066
   Suzuki Y, 2000, J NEUROSURG, V92, P466, DOI 10.3171/jns.2000.92.3.0466
   Young RJ, 2017, MEMO-MAG EUR MED ONC, V10, P190, DOI 10.1007/s12254-017-0365-x
   Zhai GD, 2008, J CLIN NEUROSCI, V15, P942, DOI 10.1016/j.jocn.2006.11.018
   Ziegler J W, 1975, J Am Osteopath Assoc, V74, P957
NR 29
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 41
EP 46
DI 10.1016/j.wneu.2019.08.128
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300125
PM 31470162
DA 2020-05-12
ER

PT J
AU Qiao, Y
   Liao, WB
   Du, Q
   Ao, J
   Cai, YQ
   Kong, WJ
   Qin, JP
AF Qiao, Yang
   Liao, Wen-Bo
   Du, Qian
   Ao, Jun
   Cai, Yu-qiang
   Kong, Wei-jun
   Qin, Jianpu
TI Percutaneous Full-Endoscopic Anterior Transcorporeal Diskectomy for
   Massive Migrated Cervical Disk Herniation Treatment: Case Report and
   Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Anterior transcorporeal cervical diskectomy; Full-endoscopic operation;
   Migrated cervical disk herniation; Transcorporeal approach
ID TITANIUM MESH CAGES; TRANSVERTEBRAL HERNIOTOMY; EPIDURAL MIGRATION;
   RECONSTRUCTION; CORPECTOMY; MICROFORAMINOTOMY; RADICULOPATHY; SUBSIDENCE
AB BACKGROUND: With the continuous advancement of the spinal endoscopic technique in recent years, full-endoscopic operations provide a new approach for the treatment of migrated cervical disk herniation.
   CASE DESCRIPTION: A 42-year-old man presented with nuchal pain and limb numbness for 2 months, with recently developed symptoms of unstable walking. Physical examination revealed a diminished skin sensitivity to pain and temperature, beginning at the C4 dermatome. The muscle strength of both upper limbs decreased to grade 4, and the muscle strength was grade 4 on both sides of the lower limbs. Hoffmann sign and ankle clonus were positive. Magnetic resonance imaging (MRI) and computed tomography (CT) scan demonstrated that a large piece of a segmental disk had migrated to the rear area of the C4 vertebral body and seriously compressed the spinal cord. A percutaneous full-endoscopic anterior transcorporeal cervical diskectomy was performed on the patient.
   CONCLUSIONS: The postoperative Japanese Orthopaedic Association (JOA) score increased from 8 to 11 points. At 2-year follow-up, the JOA score was 16 points, the improvement rate was 88.9%, and cervical vertebrae MRI, cervical CT scan, and 3-dimensional reconstruction showed that the cervical vertebrae channel healed without vertebral fractures, bony channel collapse, adjacent segment degeneration, or intervertebral space height.
C1 [Qiao, Yang; Liao, Wen-Bo; Du, Qian; Ao, Jun; Cai, Yu-qiang; Kong, Wei-jun; Qin, Jianpu] Zunyi Med Univ, Dept Spine Surg, Affiliated Hosp, Zunyi, Guizhou, Peoples R China.
RP Liao, WB (reprint author), Zunyi Med Univ, Dept Spine Surg, Affiliated Hosp, Zunyi, Guizhou, Peoples R China.
EM liaowb190211@sina.com
CR Bucknall V, 2018, J ORTHOP SURG-HONG K, V26, DOI 10.1177/2309499018758520
   Choi G, 2010, MINIM INVAS NEUROSUR, V53, P127, DOI 10.1055/s-0030-1249681
   Choi G, 2007, EUR SPINE J, V16, P1387, DOI 10.1007/s00586-006-0286-6
   Choi Kyung-Chul, 2011, Korean J Spine, V8, P292, DOI 10.14245/kjs.2011.8.4.292
   Daubs MD, 2005, SPINE, V30, P1402, DOI 10.1097/01.brs.0000166526.78058.3c
   Deng ZL, 2016, SPINE J, V16, P659, DOI 10.1016/j.spinee.2016.01.187
   Dorai Z, 2003, J NEUROSURG, V99, P3, DOI 10.3171/spi.2003.99.1.0003
   Du Q, 2018, WORLD NEUROSURG, V112, pE23, DOI 10.1016/j.wneu.2017.12.001
   Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e
   Jang JW, 2014, J CLIN NEUROSCI, V21, P1779, DOI 10.1016/j.jocn.2014.02.016
   Jia ZQ, 2018, WORLD NEUROSURG, V118, P385, DOI 10.1016/j.wneu.2018.05.157
   Kim JS, 2011, EUR SPINE J, V20, pS147, DOI 10.1007/s00586-010-1454-2
   Kwak HY, 2008, J KOREAN SOC APPL BI, V51, P142
   Lowry DW, 2015, INT J SPINE SURG, V9, DOI 10.14444/2010
   MANABE S, 1986, SPINE, V11, P873, DOI 10.1097/00007632-198611000-00005
   Nakai S, 2000, J SPINAL DISORD, V13, P16, DOI 10.1097/00002517-200002000-00003
   Qiu H, 2015, ORTHOPAEDICS, V3
   Sakai T, 2009, J SPINAL DISORD TECH, V22, P408, DOI 10.1097/BSD.0b013e31818cd428
   Shim CS, 2009, J SPINAL DISORD TECH, V22, P459, DOI 10.1097/BSD.0b013e31818d5fcb
   Srinivasan US, 2011, ASIAN SPINE J, V5, P220, DOI 10.4184/asj.2011.5.4.220
   Weber MH, 2017, CLIN SPINE SURG, V30, pE1239
   Wu WK, 2018, WORLD NEUROSURG, V114, pE199, DOI 10.1016/j.wneu.2018.02.140
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 47
EP 52
DI 10.1016/j.wneu.2019.08.054
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300126
PM 31442650
DA 2020-05-12
ER

PT J
AU Cox, M
   Ramchand, P
   Sedora-Roman, NI
   Frank, DM
   Kung, D
   Pukenas, BA
AF Cox, Mougnyan
   Ramchand, Preethi
   Sedora-Roman, Neda, I
   Frank, Dale M.
   Kung, David
   Pukenas, Bryan A.
TI Lymphoma Metastasis to Vertebral Body Hemangioma: Collision Tumor
   Causing Cord Compression
SO WORLD NEUROSURGERY
LA English
DT Article
DE Collison tumor; Cord compression; Hemangioma; Lymphoma; Tumor-to-tumor
   metastasis
AB BACKGROUND: Collision tumors of the spine are extremely uncommon. Prior reports have detailed intracranial collision tumors comprising meningiomas and astrocytomas, as well as metastases to meningiomas. Spinal collision tumors are even rarer, with only 5 cases in the literature, none involving the osseous spine. In this report, we highlight the salient features of a case of lymphoma metastasis to a preexisting benign osseous hemangioma, resulting in cord compression.
   CASE DESCRIPTION: An 81-year-old woman with a known typical T8 vertebral body hemangioma stable for over 6 years was evaluated for increasing back pain, new gait instability, and urinary retention. Magnetic resonance imaging showed a change in the appearance of the T8 hemangioma, with marrow replacement and new associated epidural soft tissue causing cord compression. A biopsy was performed, which showed diffuse large B-cell lymphoma within blood elements, consistent with lymphoma metastasis to a vertebral body hemangioma. The patient was treated with intravenous steroids and radiation therapy.
   CONCLUSIONS: Collision tumors of the spine are extremely rare. New or increasingly aggressive appearance of a previously benign spinal osseous lesion should prompt consideration for a collision tumor or malignant transformation of the benign tumor. Biopsy of the lesion should be strongly pursued whenever feasible, as the treatment strategy may vary depending on the histology of the tumor.
C1 [Cox, Mougnyan; Ramchand, Preethi; Sedora-Roman, Neda, I; Pukenas, Bryan A.] Hosp Univ Penn, Sect Neurointervent Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.
   [Frank, Dale M.] Hosp Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA.
   [Kung, David] Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.
RP Cox, M (reprint author), Hosp Univ Penn, Sect Neurointervent Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.
EM Mougnyan.cox@gmail.com
CR Acosta FL, 2006, NEUROSURGERY, V58, P287, DOI 10.1227/01.NEU.0000194846.55984.C8
   Alexander J, 2010, SPINE, V35, pE917, DOI 10.1097/BRS.0b013e3181ddfb24
   Jarrell ST, 2006, J NEUROSURG, V105, P256, DOI 10.3171/jns.2006.105.2.256
   Johnson Mahlon D, 2016, Surg Neurol Int, V7, pS1049, DOI 10.4103/2152-7806.196367
   Moody P, 2012, INT J CLIN EXP PATHO, V5, P367
   STRONG AJ, 1976, J NEUROSURG, V45, P455, DOI 10.3171/jns.1976.45.4.0455
   Syed S, 2018, WORLD NEUROSURG, V116, P454, DOI 10.1016/j.wneu.2018.04.109
   Templin Cary R, 2004, Spine J, V4, P595, DOI 10.1016/j.spinee.2003.08.034
   Zhang Z, 2018, WORLD NEUROSURG, V117, P137, DOI 10.1016/j.wneu.2018.05.246
NR 9
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 53
EP 56
DI 10.1016/j.wneu.2019.08.075
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300127
PM 31470151
DA 2020-05-12
ER

PT J
AU Rubio, RR
   Chae, R
   Khare, A
   Dubnicoff, T
   Winkler, E
   Sloan, E
   Bollen, AW
   Berger, MS
   Abla, AA
AF Rubio, Roberto Rodriguez
   Chae, Ricky
   Khare, Ashna
   Dubnicoff, Todd
   Winkler, Ethan
   Sloan, Emily
   Bollen, Andrew W.
   Berger, Mitchel S.
   Abla, Adib A.
TI Supracerebellar Approach to Radiation-Induced Giant Capillary
   Telangiectasia Within Juvenile Pilocytic Astrocytoma of Upper Brainstem
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3-Dimensional video; Brainstem; Pilocytic astrocytoma; Radiation-induced
   telangiectasia; Supracerebellar approach
ID CAVERNOUS MALFORMATIONS
C1 [Rubio, Roberto Rodriguez; Chae, Ricky; Khare, Ashna; Berger, Mitchel S.; Abla, Adib A.] Univ Calif San Francisco, Skull Base & Cerebrovasc Lab, San Francisco, CA 94143 USA.
   [Rubio, Roberto Rodriguez; Chae, Ricky; Khare, Ashna; Dubnicoff, Todd; Winkler, Ethan; Berger, Mitchel S.; Abla, Adib A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
   [Rubio, Roberto Rodriguez] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.
   [Sloan, Emily; Bollen, Andrew W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
RP Abla, AA (reprint author), Univ Calif San Francisco, Skull Base & Cerebrovasc Lab, San Francisco, CA 94143 USA.; Abla, AA (reprint author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
EM adib.abla@ucsf.edu
OI Rodriguez-Rubio, Roberto/0000-0002-7206-309X; Chae,
   Ricky/0000-0001-5014-9303
CR Awad AJ, 2016, OPER NEUROSURG, V12, P317, DOI 10.1227/NEU.0000000000001327
   GAENSLER EHL, 1994, RADIOLOGY, V193, P629, DOI 10.1148/radiology.193.3.7972799
   Jain R, 2005, AM J NEURORADIOL, V26, P1158
   Koike S, 2004, RADIOLOGY, V230, P93, DOI 10.1148/radiol.2301021143
   Larson JJ, 1998, J NEUROSURG, V88, P51, DOI 10.3171/jns.1998.88.1.0051
   RIGAMONTI D, 1987, J NEUROSURG, V67, P518, DOI 10.3171/jns.1987.67.4.0518
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 57
EP 57
DI 10.1016/j.wneu.2019.08.172
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300128
PM 31479784
DA 2020-05-12
ER

PT J
AU Berry, CA
AF Berry, Chirag A.
TI Oblique Lumbar Interbody Fusion in Patient with Persistent Left-Sided
   Inferior Vena Cava: Case Report and Review of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Anterior to psoas; Inferior vena cava variants; Lumbar interbody fusion;
   Oblique prepsoas retroperitoneal approach; OLIF; Vascular anomalies
ID ANOMALIES; SPECTRUM
AB BACKGROUND: Oblique lumbar interbody fusion takes advantage of the wide interval between the aorta and left-sided psoas muscle to access the lumbar spine, allowing a minimally invasive approach for interbody fusion with lower associated morbidity. As this approach is gaining popularity among spine surgeons, it is important to understand the potential pitfalls that may arise in patients with congenital anomalies of the vascular anatomy.
   CASE DESCRIPTION: We present a case of a persistent left-sided inferior vena cava (IVC) affecting the side of approach in a patient undergoing lumbar interbody fusion through an oblique prepsoas retroperitoneal approach. Preoperative imaging of our patient revealed a persistent left-sided inferior vena cava with a wide interval between the aorta and the right-sided psoas, allowing us a right-sided oblique approach.
   CONCLUSIONS: Thorough preoperative imaging evaluation is essential to identify vascular anomalies that may hinder oblique prepsoas retroperitoneal approach to the lumbar spine. Although rare, double IVC or isolated left IVC may complicate the oblique approach.
C1 [Berry, Chirag A.] Cincinnati VA Med Ctr, Cincinnati, OH 45220 USA.
   [Berry, Chirag A.] Univ Cincinnati, Orthopaed, Cincinnati, OH 45221 USA.
RP Berry, CA (reprint author), Cincinnati VA Med Ctr, Cincinnati, OH 45220 USA.; Berry, CA (reprint author), Univ Cincinnati, Orthopaed, Cincinnati, OH 45221 USA.
EM berrycg@ucmail.uc.edu
RI Berry, Chirag A/H-9840-2019
OI Berry, Chirag A/0000-0002-5102-1237
CR Bass YE, 2000, RADIOGRAPHICS, V20, P639, DOI 10.1148/radiographics.20.3.g00ma09639
   Davis TT, 2014, J NEUROSURG-SPINE, V21, P785, DOI 10.3171/2014.7.SPINE13564
   HIRSCH DM, 1963, JAMA-J AM MED ASSOC, V185, P729, DOI 10.1001/jama.1963.03060090061024
   MAYO J, 1983, AM J ROENTGENOL, V140, P339, DOI 10.2214/ajr.140.2.339
   Silvestre C, 2012, ASIAN SPINE J, V6, P89, DOI 10.4184/asj.2012.6.2.89
   Tannoury T, 2019, SPINE, V44, pE1122, DOI 10.1097/BRS.0000000000003071
   Woods KRM, 2017, SPINE J, V17, P545, DOI 10.1016/j.spinee.2016.10.026
   Zhang LJ, 2007, ABDOM IMAGING, V32, P495, DOI 10.1007/s00261-006-9137-5
NR 8
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 58
EP 62
DI 10.1016/j.wneu.2019.08.176
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300129
PM 31479791
DA 2020-05-12
ER

PT J
AU Miyakoshi, N
   Hongo, M
   Kasukawa, Y
   Ishikawa, Y
   Kudo, D
   Shimada, Y
AF Miyakoshi, Naohisa
   Hongo, Michio
   Kasukawa, Yuji
   Ishikawa, Yoshinori
   Kudo, Daisuke
   Shimada, Yoichi
TI Rapidly Progressing Symptomatic Calcification of Ligamentum Flavum in
   Thoracic Spine After Osteoporotic Vertebral Fractures
SO WORLD NEUROSURGERY
LA English
DT Article
DE Calcification of ligamentum flavum; Osteoporotic vertebral fracture;
   Spine surgery; Thoracic spine
ID DIHYDRATE DEPOSITION DISEASE; CERVICAL MYELOPATHY
AB BACKGROUND: Symptomatic calcification of the ligamentum flavum (CLF) is common in the cervical spine but rare in the thoracic spine. Rapidly progressing CLF in the thoracic spine has not been reported in the literature.
   CASE DESCRIPTION: A 76-year-old Asian male experienced back pain after a fall and was diagnosed with osteoporotic vertebral fractures at T11 and L1. He was treated conservatively because of the lack of neurologic deficits. Nine months after the initial visit, he complained of progressive incomplete paraplegia. Magnetic resonance imaging and computed tomography of the thoracic spine showed CLF at T11-T12 severely compressing the spinal cord. This finding had not been seen on imaging studies at the initial visit. The patient underwent surgical resection of CLF and posterior instrumented spine fusion. Symptoms of muscle weakness recovered postoperatively.
   CONCLUSIONS: In this case, sequential imaging studies with a 9-month interval showed evidence of rapidly progressing thoracic CLF. The preceding osteoporotic vertebral fracture may have triggered the development of CLF.
C1 [Miyakoshi, Naohisa; Hongo, Michio; Kasukawa, Yuji; Ishikawa, Yoshinori; Kudo, Daisuke; Shimada, Yoichi] Akita Univ, Dept Orthoped Surg, Grad Sch Med, Akita, Japan.
RP Miyakoshi, N (reprint author), Akita Univ, Dept Orthoped Surg, Grad Sch Med, Akita, Japan.
EM miyakosh@doc.med.akita-u.ac.jp
OI Kasukawa, Yuji/0000-0001-7008-675X
CR Fye KH, 1999, ARCH INTERN MED, V159, P189, DOI 10.1001/archinte.159.2.189
   Glulioni M, 2007, JOINT BONE SPINE, V74, P504, DOI 10.1016/j.jbspin.2007.01.029
   HIJIOKA A, 1994, SPINE, V19, P2626, DOI 10.1097/00007632-199412000-00005
   Khan MH, 2005, SPINE, V30, pE687, DOI 10.1097/01.brs.0000186472.88141.38
   Muthukumar N, 2003, NEUROSURGERY, V53, P103, DOI 10.1227/01.NEU.0000068861.47199.A8
   Muthukumar N, 2000, NEUROSURGERY, V46, P222
   Mwaka ES, 2009, CLIN EXP RHEUMATOL, V27, P430
   Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913
   Shiguematsu FY, 2012, REV BRAS REUMATOL, V52, P438
   Takahashi T, 2018, NEUROSURG CLIN N AM, V29, P47, DOI 10.1016/j.nec.2017.09.016
   Yamagami T, 2000, NEUROL MED-CHIR, V40, P234, DOI 10.2176/nmc.40.234
   Ziade M, 2007, Skeletal Radiol, V36 Suppl 1, pS116
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 63
EP 66
DI 10.1016/j.wneu.2019.08.177
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300130
PM 31479787
DA 2020-05-12
ER

PT J
AU Kuroda, N
   Inenaga, C
   Arai, Y
   Otsuki, Y
   Tanaka, T
AF Kuroda, Naoto
   Inenaga, Chikanori
   Arai, Yoshifumi
   Otsuki, Yoshiro
   Tanaka, Tokutaro
TI Intracranial Multiple Pseudotumor Due to Immunoglobulin G4-Related
   Disease without Other Lesions: Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE IgG4-related disease; Intracranial; Intradural; Operation; Pathology;
   Pseudotumor; Surgery
ID IGG4-RELATED DISEASE; INFLAMMATORY PSEUDOTUMOR; FEATURES; NECK; HEAD
AB BACKGROUND: Immunoglobulin (Ig)G4-related disease (IgG4-RD) was defined only recently and can be found in many organs. As intracranial lesions, hypophysitis and pachymeningitis are well known, whereas intracranial pseudotumor is unusual. This case involved multiple intracranial pseudotumors without extracranial lesions, mimicking multiple meningioma.
   CASE DESCRIPTION: A 72-year-old woman was referred to our hospital with an incidental mass lesion at the craniocervical junction on magnetic resonance imaging (MRI). MRI showed diffuse enhanced extra-axial nodules around the medulla and middle cranial fossa. Surgery was performed for the gradually enlarging tumor. Intraoperative findings showed hard nodules around the vertebral artery. We performed subtotal resection. Neuropathological findings showed diffuse lymphoplasmacytic infiltration with lymphoid follicles. Immunohistochemical studies for IgG4 and IgG showed the histological criteria for IgG4-RD were met. Given the high IgG4 serum level, we diagnosed IgG4-RD. Steroid was administered initially but was then tapered, and nodules have since remained small.
   CONCLUSIONS: This case demonstrates IgG4-RD mimicking meningioma with multiple masses but without extracranial lesions. This case and previous descriptions suggest the possibility of pseudotumor due to IgG4-RD in the presence of multiple extra-axial lesions at the dura and supplying artery, hard nodules with thickening of the artery, and frozen section findings of lymphoplasmacytes surrounded by rich collagen fibers. In such cases, the pseudotumor due to IgG4-RD should be resected, and total resection might not be warranted.
C1 [Kuroda, Naoto; Inenaga, Chikanori; Tanaka, Tokutaro] Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Hamamatsu, Shizuoka, Japan.
   [Arai, Yoshifumi; Otsuki, Yoshiro] Seirei Hamamatsu Gen Hosp, Dept Pathol, Hamamatsu, Shizuoka, Japan.
RP Kuroda, N (reprint author), Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Hamamatsu, Shizuoka, Japan.
EM h20ms-kuroda@jikei.ac.jp
OI Kuroda, Naoto/0000-0003-1977-4893
CR Brito-Zeron P, 2014, AUTOIMMUN REV, V13, P1203, DOI 10.1016/j.autrev.2014.08.013
   Della-Torre E, 2015, CLIN EXP IMMUNOL, V181, P191, DOI 10.1111/cei.12641
   Deshpande V, 2013, DIAGN HISTOPATHOL, V19, P119
   Goulam-Houssein S, 2019, NEURORADIOL J, V32, P29, DOI 10.1177/1971400918806323
   Guma M, 2012, BEST PRACT RES CL RH, V26, P425, DOI 10.1016/j.berh.2012.07.001
   Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0
   Kasashima F, 2018, ANN VASC DIS, V11, P72, DOI 10.3400/avd.ra.18-00012
   Katsura M, 2011, AJNR Am J Neuroradiol, V32, pE150, DOI 10.3174/ajnr.A2256
   Katsura M, 2012, NEURORADIOLOGY, V54, P873, DOI 10.1007/s00234-012-1012-1
   Kim EH, 2011, J NEUROSURG, V115, P1242, DOI 10.3171/2011.7.JNS1166
   Kuma S, 2017, J VASC SURG CASES IN, V3, P243, DOI 10.1016/j.jvscit.2017.10.005
   Lindstrom KM, 2010, ACTA NEUROPATHOL, V120, P765, DOI 10.1007/s00401-010-0746-2
   Lui PCW, 2009, HUM PATHOL, V40, P1611, DOI 10.1016/j.humpath.2009.04.016
   Moss HE, 2012, J NEUROL SCI, V318, P31, DOI 10.1016/j.jns.2012.04.010
   Nishino T, 2013, JPN J RADIOL, V31, P405, DOI 10.1007/s11604-013-0191-y
   Noshiro S, 2015, BRAIN TUMOR PATHOL, V32, P286, DOI 10.1007/s10014-015-0223-7
   Okano A, 2015, WORLD NEUROSURG, V83, DOI 10.1016/j.wneu.2015.02.011
   Rice C M, 2016, Pract Neurol, V16, P240, DOI 10.1136/practneurol-2015-001315
   Stone JH, 2015, MAYO CLIN PROC, V90, P927, DOI 10.1016/j.mayocp.2015.03.020
   Sturiale CL, 2016, NEUROSURG REV, V39, P565, DOI 10.1007/s10143-015-0691-6
   Toyoda K, 2012, AM J NEURORADIOL, V33, P2136, DOI 10.3174/ajnr.A3147
   Toyoshima Y, 2012, NEUROPATHOLOGY, V32, P100, DOI 10.1111/j.1440-1789.2011.01227.x
   Wong S, 2007, HUM PATHOL, V38, P1720, DOI 10.1016/j.humpath.2007.06.011
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 69
EP 74
DI 10.1016/j.wneu.2019.08.127
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300132
PM 31470167
DA 2020-05-12
ER

PT J
AU Mobbs, RJ
   Choy, WJ
   Singh, T
   Cassar, L
   Davidoff, C
   Harris, L
   Phan, K
   Fiechter, M
AF Mobbs, Ralph J.
   Choy, Wen Jie
   Singh, Telvinderjit
   Cassar, Lachlan
   Davidoff, Chris
   Harris, Leigh
   Phan, Kevin
   Fiechter, Meinrad
TI Three-Dimensional Planning and Patient-Specific Drill Guides for Repair
   of Spondylolysis/L5 Pars Defect
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bucks technique; 3D printing; Pars defect; Pars repair; Patient-specific
   drill guides; Spondylolysis
ID LUMBAR SPONDYLOLYSIS; DIRECT STABILIZATION; SCREW CONSTRUCT; PEDICLE
   SCREW; SPONDYLOLISTHESIS; FIXATION; FUSION
AB BACKGROUND: Incomplete ossification of the pars interarticularis will result in a pars defect, a common cause of low back pain in youth and strongly associated with participation in high-impact sports. If left untreated, it can result in spondylolisthesis, causing dynamic canal stenosis, low back pain, and radiculopathy. The treatment of pars defect was first described by Bucks in 1970, who used screws in the lamina placed through an upward and outward direction. However, because of the multiple inclusion and exclusion criteria and narrow margin of error, the Bucks pars repair technique is not commonly performed.
   METHODS: A 28-year-old woman had with low back pain that she had been experiencing since mid-adolescence. Computed tomography revealed a bilateral L5 pars defect without spondylolisthesis. Her L5 vertebra was reconstructed virtually. The screw trajectories, a 3-dimensional (3D) model of the vertebra, and a patient-specific drill guide (PSDG) were designed and printed using positioning guide software (MySpine MC Guides [Medacta International SA, Castel San Petro, Switzerland]). A modified Bucks procedure using cannulated compression screws and the PSDG was performed.
   RESULTS: Follow-up computed tomography revealed accurate placement of the compression screws, mirroring the planned trajectory. The patient was pain free at 3 months postoperatively, and early union across the defect was visualized on the 5-month radiographic imaging study.
   CONCLUSION: Using 3D planning software, complex surgical procedures can be planned using the patient's anatomy and computed tomography. With the aid of 3D-printed PSDGs, screw placement in narrow corridors, such as was shown in our case, is safe, efficient, and achievable.
C1 [Mobbs, Ralph J.; Choy, Wen Jie; Singh, Telvinderjit; Cassar, Lachlan; Davidoff, Chris; Phan, Kevin] Univ New South Wales, Sydney, NSW, Australia.
   [Mobbs, Ralph J.; Choy, Wen Jie; Singh, Telvinderjit; Cassar, Lachlan; Davidoff, Chris; Phan, Kevin] NeuroSpine Surg Res Grp, Sydney, NSW, Australia.
   [Mobbs, Ralph J.; Davidoff, Chris; Phan, Kevin] Prince Wales Private Hosp, Randwick, NSW, Australia.
   [Mobbs, Ralph J.; Choy, Wen Jie; Singh, Telvinderjit; Cassar, Lachlan] Prince Wales Private Hosp, NeuroSpine Clin, Randwick, NSW, Australia.
   [Harris, Leigh; Fiechter, Meinrad] Medacta Int SA, Castel San Petro, Switzerland.
RP Mobbs, RJ (reprint author), Univ New South Wales, Sydney, NSW, Australia.; Mobbs, RJ (reprint author), NeuroSpine Surg Res Grp, Sydney, NSW, Australia.; Mobbs, RJ (reprint author), Prince Wales Private Hosp, Randwick, NSW, Australia.; Mobbs, RJ (reprint author), Prince Wales Private Hosp, NeuroSpine Clin, Randwick, NSW, Australia.
EM r.mobbs@unsw.edu.au
OI Choy, Wen Jie/0000-0001-8929-8170
CR Brennan RP, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E13
   Buck J E, 1970, J Bone Joint Surg Br, V52, P432
   Chin BZJ, 2019, WORLD NEUROSURG, V129, P531, DOI 10.1016/j.wneu.2019.06.056
   Choy WJ, 2017, WORLD NEUROSURG, V105, DOI 10.1016/j.wneu.2017.05.133
   Deguchi M, 1999, SPINE, V24, P328, DOI 10.1097/00007632-199902150-00004
   Drazin D, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11180
   Garg B, 2019, SPINE J, V19, P56, DOI 10.1016/j.spinee.2018.05.001
   Ghobrial GM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17153
   Gillet P, 1999, SPINE, V24, P1252, DOI 10.1097/00007632-199906150-00014
   HARDCASTLE PH, 1993, J BONE JOINT SURG BR, V75, P398
   Hu SS, 2008, J BONE JOINT SURG AM, V90A, P656
   Ivanic GM, 2003, SPINE, V28, P255, DOI 10.1097/00007632-200302010-00010
   Jia Fangzhi, 2015, J Spine Surg, V1, P103, DOI 10.3978/j.issn.2414-469X.2015.07.02
   Kim J, 2019, WORLD NEUROSURG, V122, P674, DOI 10.1016/j.wneu.2018.11.159
   Kimura M, 1968, Seikei Geka, V19, P285
   Lu T, 2017, MED SCI MONITOR, V23, P3105, DOI 10.12659/MSM.901993
   Mobbs Ralph J, 2015, J Spine Surg, V1, P2, DOI 10.3978/j.issn.2414-469X.2015.10.05
   MORSCHER E, 1984, ARCH ORTHOP TRAUM SU, V103, P175, DOI 10.1007/BF00435550
   NICOL RO, 1986, SPINE, V11, P1027, DOI 10.1097/00007632-198612000-00011
   PEDERSEN AK, 1988, J BONE JOINT SURG AM, V70A, P15, DOI 10.2106/00004623-198870010-00004
   Peersman G, 2006, HSS J, V2, P70, DOI 10.1007/s11420-005-0130-2
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Phan Kevin, 2016, J Spine Surg, V2, P314, DOI 10.21037/jss.2016.12.06
   Rajasekaran S, 2011, INDIAN J ORTHOP, V45, P136, DOI 10.4103/0019-5413.77133
   Rao PJ, 2015, J CLIN NEUROSCI, V22, P1619, DOI 10.1016/j.jocn.2015.03.034
   Sakai T, 2010, J ORTHOP SCI, V15, P281, DOI 10.1007/s00776-010-1454-4
   Shin MH, 2012, J KOREAN NEUROSURG S, V51, P14, DOI 10.3340/jkns.2012.51.1.14
   Snyder LA, 2014, J NEUROSURG-SPINE, V21, P329, DOI 10.3171/2014.5.SPINE13772
   Songer MN, 1998, SPINE, V23, P263, DOI 10.1097/00007632-199801150-00023
   Sugawara T, 2013, J NEUROSURG-SPINE, V19, P185, DOI 10.3171/2013.4.SPINE121059
   Tokuhashi Y, 1996, SPINE, V21, P2041, DOI 10.1097/00007632-199609010-00023
   Wilcox Ben, 2017, J Spine Surg, V3, P433, DOI 10.21037/jss.2017.09.01
NR 32
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 75
EP 80
DI 10.1016/j.wneu.2019.08.112
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300133
PM 31470159
DA 2020-05-12
ER

PT J
AU Verbraeken, B
   Achahbar, SE
   Kamerling, N
   Yperzeele, L
   Voormolen, M
   Van Havenbergh, T
   Menovsky, T
AF Verbraeken, Barbara
   Achahbar, Salah-Eddine
   Kamerling, Niels
   Yperzeele, Laetitia
   Voormolen, Maurits
   Van Havenbergh, Tony
   Menovsky, Tomas
TI Complete Transection of Optic Nerve After Endovascular Coiling of a
   Large Ophthalmic Artery Aneurysm
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysm surgery; Blindness; Complications; Endovascular coiling;
   Ophthalmic artery; Optic nerve
ID INTRACRANIAL ANEURYSMS; PERIANEURYSMAL EDEMA; VERTEBRAL ARTERY; WALL
   ENHANCEMENT; GIANT ANEURYSM; CAROTID-ARTERY; VASA VASORUM; PENETRATION;
   DETERIORATION; EMBOLIZATION
AB BACKGROUND: We describe a patient who developed delayed blindness of the left eye at 5 weeks after endovascular coiling of a large ophthalmic aneurysm.
   CASE DESCRIPTION: A 44-year-old male was admitted with visual decline due to compression of the optic nerve by a large ophthalmic aneurysm. The aneurysm was treated by endovascular coiling, but visual function was unchanged. One month and 7 days later, the patient developed sudden blindness of the affected eye, despite complete angiographical occlusion of the aneurysm. Surgical exploration in an attempt to restore vision showed a fully thrombosed aneurysm but, surprisingly, complete transection of the optic nerve just proximal to its entry into the optic canal.
   CONCLUSIONS: This report describes a rare complication of a sudden increase in size of a large ophthalmic aneurysm despite successful endovascular occlusion.
C1 [Verbraeken, Barbara; Achahbar, Salah-Eddine; Kamerling, Niels; Van Havenbergh, Tony; Menovsky, Tomas] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium.
   [Yperzeele, Laetitia; Voormolen, Maurits; Van Havenbergh, Tony; Menovsky, Tomas] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium.
   [Yperzeele, Laetitia] Antwerp Univ Hosp, Dept Neurol, Edegem, Belgium.
   [Voormolen, Maurits] Antwerp Univ Hosp, Dept Radiol, Edegem, Belgium.
   [Van Havenbergh, Tony] St Augustinus Hosp, Dept Neurosurg, Antwerp, Belgium.
RP Menovsky, T (reprint author), Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium.; Menovsky, T (reprint author), Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium.
EM tomas.menovsky@uza.be
CR Ashour R, 2013, NEUROSURG REV, V36, P661, DOI 10.1007/s10143-013-0472-z
   Bae Dong-Hyun, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P225, DOI 10.7461/jcen.2014.16.3.225
   Boecher-Schwarz HG, 2000, AM J NEURORADIOL, V21, P1532
   Brinjikji W, 2015, AM J NEURORADIOL, V36, P1216, DOI 10.3174/ajnr.A4175
   Darsaut TE, 2014, J NEUROSURG, V120, P618, DOI 10.3171/2013.11.JNS131366
   Date I, 1997, J NEUROSURG, V87, P324, DOI 10.3171/jns.1997.87.2.0324
   Date I, 2010, NEUROL MED-CHIR, V50, P788, DOI 10.2176/nmc.50.788
   Dehdashti AR, 2009, ACTA NEUROCHIR, V151, P1153, DOI 10.1007/s00701-009-0270-0
   Delgado AF, 2017, BRIT J NEUROSURG, V31, P345, DOI 10.1080/02688697.2017.1297371
   Ferns SP, 2010, AM J NEURORADIOL, V31, P464, DOI 10.3174/ajnr.A1841
   Fujita A, 2002, SURG NEUROL, V57, P130, DOI 10.1016/S0090-3019(01)00695-4
   Fulkerson DH, 2009, NEUROSURGERY, V64, P218, DOI 10.1227/01.NEU.0000337127.73667.80
   Hammoud D, 2003, AM J NEURORADIOL, V24, P1237
   House PA, 2005, J NEUROSURG, V102, P390, DOI 10.3171/jns.2005.102.2.0390
   Iihara K, 2003, J NEUROSURG, V98, P407, DOI 10.3171/jns.2003.98.2.0407
   Jawid M, 2014, NEURORADIOLOGY, V56, P1129, DOI 10.1007/s00234-014-1420-5
   Kanamaru K, 2001, J NEUROL NEUROSUR PS, V71, P525, DOI 10.1136/jnnp.71.4.525
   Kawabata S, 2017, J NEUROL SURG REP, V78, pE20, DOI 10.1055/s-0037-1598116
   Konig M, 2011, NEUROSURGERY, V68, pE1468, DOI 10.1227/NEU.0b013e318210c7c0
   La Pira B, 2017, J NEURO-OPHTHALMOL, V37, P154, DOI 10.1097/WNO.0000000000000412
   Naggara O, 2014, LANCET NEUROL, V13, P537, DOI 10.1016/S1474-4422(14)70091-2
   Nakayama Y, 1998, NEUROL MED-CHIR, V38, P274, DOI 10.2176/nmc.38.274
   Oh SW, 2017, J NEUROINTERV SURG, V9, P1243, DOI 10.1136/neurintsurg-2016-012833
   OU SC, 2014, [No title captured], V141
   Pickett GE, 2007, NEUROSURGERY, V61, P873, DOI 10.1227/01.NEU.0000298918.55119.7C
   Russell SM, 2002, J NEUROSURG, V97, P705, DOI 10.3171/jns.2002.97.3.0705
   Schmidt GW, 2007, AM J NEURORADIOL, V28, P1882, DOI 10.3174/ajnr.A0690
   Silva MA, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS1718
   Stracke CP, 2007, AM J NEURORADIOL, V28, P1401, DOI 10.3174/ajnr.A0550
   Su IC, 2014, NEURORADIOLOGY, V56, P487, DOI 10.1007/s00234-014-1355-x
   Tomokiyo M, 2007, Interv Neuroradiol, V13 Suppl 1, P145
   Turner RD, 2008, NEUROSURGERY, V63, P469, DOI 10.1227/01.NEU.0000324730.37144.4B
   Yamada K, 1998, Radiat Med, V16, P305
   Yasui T, 1998, NEUROL MED-CHIR, V38, P860, DOI 10.2176/nmc.38.860
   YASUI T, 1993, SURG NEUROL, V40, P51, DOI 10.1016/0090-3019(93)90171-V
   염유경, 2015, [Journal of The Korean Radiological Society, 대한영상의학회지], V72, P300, DOI 10.3348/jksr.2015.72.4.300
NR 36
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 81
EP 86
DI 10.1016/j.wneu.2019.08.154
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300134
PM 31476463
DA 2020-05-12
ER

PT J
AU Uda, H
   Uda, T
   Nakajo, K
   Tanoue, Y
   Okuno, T
   Koh, S
   Onishi, Y
   Ohata, H
   Watanabe, Y
   Umaba, R
   Kawashima, T
   Ohata, K
AF Uda, Hiroshi
   Uda, Takehiro
   Nakajo, Kosuke
   Tanoue, Yuta
   Okuno, Takahiro
   Koh, Saya
   Onishi, Yohei
   Ohata, Hiroki
   Watanabe, Yusuke
   Umaba, Ryoko
   Kawashima, Toshiyuki
   Ohata, Kenji
TI Adult-Onset Mixed Germ Cell Tumor Composed Mainly of Yolk Sac Tumor
   Around the Pineal Gland: A Case Report and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Adult onset; Mixed germ cell tumor; Pineal region; Yolk sac tumor
AB BACKGROUND: Mixed germ cell tumors (MGCTs) usually occur in children. In the present report, we discuss an extremely rare case of adult-onset MGCT composed mainly of yolk sac tumor (YST) around the pineal gland.
   CASE DESCRIPTION: A 54-year-old Japanese man presented with disturbance of consciousness, Parinaud's syndrome, and gait disturbance. Magnetic resonance imaging revealed a pineal mass lesion, and subtotal resection of the tumor was achieved. The histologic diagnosis was MGCT, consisting mainly of YST. Although he underwent 5 courses of chemotherapy and craniospinal irradiation after surgery, tumor dissemination could not be controlled, and he died 10 months postoperatively.
   CONCLUSION: The present case highlights the need for clinicians to include YST in the differential diagnosis of acute progressive lesions around the pineal region, even in adult patients.
C1 [Uda, Hiroshi; Uda, Takehiro; Nakajo, Kosuke; Tanoue, Yuta; Koh, Saya; Onishi, Yohei; Ohata, Hiroki; Watanabe, Yusuke; Umaba, Ryoko; Kawashima, Toshiyuki; Ohata, Kenji] Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
   [Okuno, Takahiro] Osaka City Univ, Dept Mol Pathol, Grad Sch Med, Osaka, Japan.
RP Uda, T (reprint author), Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
EM uda@med.osaka-cu.ac.jp
OI Uda, Takehiro/0000-0001-6422-4140; Uda, Hiroshi/0000-0002-7814-697X
CR Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037
   KIRIKAE M, 1994, SURG NEUROL, V42, P253, DOI 10.1016/0090-3019(94)90273-9
   Macvanski M, 2012, VOJNOSANIT PREGL, V69, P277, DOI 10.2298/VSP1203277M
   Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446
   Nakamura H, 2011, J NEUROSURG-PEDIATR, V7, P431, DOI 10.3171/2011.1.PEDS10433
   Shibui S, 2014, NEUROL MED-CHIR, V54, P1
   Takahashi T, 2012, CASE REP SURG, DOI 10.1155/2012/473790
   Ushio Y, 1999, J NEUROSURG, V90, P133, DOI 10.3171/jns.1999.90.1.0133
   Zhao SH, 2014, EXP THER MED, V8, P1471, DOI 10.3892/etm.2014.1945
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 87
EP 92
DI 10.1016/j.wneu.2019.08.079
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300135
PM 31470154
DA 2020-05-12
ER

PT J
AU Farhat, S
   Darwish, H
   Nasreddine, W
   Salame, J
   Beydoun, A
AF Farhat, Sahar
   Darwish, Houssein
   Nasreddine, Wassim
   Salame, Joseph
   Beydoun, Ahmad
TI A Surgical Case of Complete Resection of the Focal Cortical and
   Subcortical Dysplasia in the Motor Cortex
SO WORLD NEUROSURGERY
LA English
DT Article
DE Complete resection; Focal cortical dysplasia; Functional MRI; Mapping;
   Motor cortex
ID EPILEPSY SURGERY; CONSENSUS CLASSIFICATION; SPECTRUM; SUBTYPES
AB BACKGROUND: Focal cortical dysplasias (FCDs) are highly epileptogenic and frequently associated with medically refractory focal epilepsy. FCDs are frequently located in the frontal lobe, making its complete resection highly challenging when in proximity to the motor cortex.
   CASE DESCRIPTION: We report a case of a 25-year-old woman with medically refractory epilepsy secondary to a focal cortical dysplasia in the motor cortex and extending deeply into the subcortical white matter. A detailed pre-surgical evaluation and invasive electroencephalographic monitoring performed at our epilepsy monitoring unit, along with the use of motor mapping, functional magnetic resonance imaging, diffusion tensor imaging, and the Stealth navigation system resulted in the complete resection of the lesion without a permanent postoperative motor deficit. The patient remained seizure-free at a 63-month follow-up while being maintained on a single antiepileptic drug.
   CONCLUSION: A detailed presurgical evaluation, accurate mapping of the functional and dysplastic cortex, and a well-planned tailored and complete surgical resection of the cortical dysplasia can result in a favorable outcome with relatively little risk of postoperative neurologic deficit.
C1 [Farhat, Sahar; Nasreddine, Wassim; Beydoun, Ahmad] Amer Univ Beirut, Dept Neurol, Comprehens Epilepsy Program, Med Ctr, Beirut, Lebanon.
   [Darwish, Houssein; Salame, Joseph] Amer Univ Beirut, Dept Neurosurg, Med Ctr, Beirut, Lebanon.
RP Beydoun, A (reprint author), Amer Univ Beirut, Dept Neurol, Comprehens Epilepsy Program, Med Ctr, Beirut, Lebanon.
EM ab29@aub.edu.lb
CR Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   Becker AJ, 2006, J NEUROPATH EXP NEUR, V65, P99, DOI 10.1097/01.jnen.0000199570.19344.33
   Behdad A, 2009, EPILEPSIA, V50, P1450, DOI 10.1111/j.1528-1167.2008.01868.x
   Berntsen EM, 2010, NEUROSURGERY, V67, P251, DOI 10.1227/01.NEU.0000371731.20246.AC
   Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224
   Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x
   Chassoux F, 2000, BRAIN, V123, P1733, DOI 10.1093/brain/123.8.1733
   Oliveira RS, 2011, CHILD NERV SYST, V27, P779, DOI 10.1007/s00381-010-1355-z
   Duffau H, 2002, BRAIN, V125, P199, DOI 10.1093/brain/awf016
   Duffau H, 2003, J NEUROSURG, V98, P764, DOI 10.3171/jns.2003.98.4.0764
   Frater JL, 2000, ARCH PATHOL LAB MED, V124, P545
   Gopinath S, 2016, INT J SURG, V36, P466, DOI 10.1016/j.ijsu.2015.10.036
   Harvey S, 2008, EPILEPSIA, V49, P146, DOI 10.1111/j.1528-1167.2007.01421.x
   Hauptman JS, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03619.x
   Krsek P, 2009, NEUROLOGY, V72, P217, DOI 10.1212/01.wnl.0000334365.22854.d3
   KUZNIECKY RI, 1994, EPILEPSIA, V35, pS44, DOI 10.1111/j.1528-1157.1994.tb05988.x
   Lawson JA, 2005, NEUROLOGY, V64, P55, DOI 10.1212/01.WNL.0000148647.55705.A3
   Marusic P, 2002, EPILEPSIA, V43, P27, DOI 10.1046/j.1528-1157.2002.00801.x
   Najm IM, 2018, NEUROPATH APPL NEURO, V44, P18, DOI 10.1111/nan.12462
   Olivier A, 2012, TECHNIQUES IN EPILEPSY SURGERY: THE MNI APPROACH, P1, DOI 10.1017/CBO9781139021951
   Pondal-Sordo M, 2006, BRAIN, V129, P3307, DOI 10.1093/brain/awl305
   Rowland NC, 2012, J NEUROSURG, V116, P1035, DOI 10.3171/2012.1.JNS111105
   Sisodiya SM, 2004, BRAIN, V127, P2383, DOI 10.1093/brain/awh312
   Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175
   Varotto G, 2012, NEUROIMAGE, V61, P591, DOI 10.1016/j.neuroimage.2012.03.090
   Wagner J, 2011, EPILEPSIA, V52, P1418, DOI 10.1111/j.1528-1167.2011.03158.x
   Widdess-Walsh P, 2005, EPILEPSY RES, V67, P25, DOI 10.1016/j.eplepsyres.2005.07.013
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 93
EP 98
DI 10.1016/j.wneu.2019.08.181
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300136
PM 31491580
DA 2020-05-12
ER

PT J
AU Ohshima, T
   Nagano, Y
   Tadauchi, H
   Mase, T
   Miyachi, S
AF Ohshima, Tomotaka
   Nagano, Yoshitaka
   Tadauchi, Hiroki
   Mase, Tsuyoshi
   Miyachi, Shigeru
TI Novel Concept and Device for Holding the Rotational Hemostasis Valve
   During Neuroendovascular Procedures
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3-Dimensional printer; Catheter; Endovascular treatment; Hemostasis
   valve; Neurointervention
AB BACKGROUND: Hemostasis valves are commonly used in neurointerventions. We propose a novel concept for fixing hemostasis valves to the operating table during procedures. Moreover, we report our preliminary in vitro experience using these new devices created using a 3-dimensional printer.
   METHODS: The hemostasis valve holder (HVH) comprises 2 components: an inner fixer and an outer socket. It was designed to be suitable for use with all rotational hemostasis valves commercially available. HVH contains magnets at the bottom that facilitate its attachment to a thin steel board beneath a sterilized drape on the working table. We evaluated the HVH's efficacy via in vitro experiments involving stent placement by a single operator.
   RESULTS: HVH allowed easy attachment to and detachment from the rotational hemostasis valve. Moreover, the use of multiple HVHs facilitated operators to concentrate on the procedure because they continuously prevented the unexpected movement of devices at several points. Use of HVHs enables stent placement to be performed even by a single operator. We observed that forming a loop of the stent delivery catheter between 2 HVHs enhanced the device control.
   CONCLUSIONS: HVHs should be more useful than conventional methods, particularly in cases requiring fine complementary control of both a microcatheter and microguidewire.
C1 [Ohshima, Tomotaka; Miyachi, Shigeru] Aichi Med Univ, Neuroendovasc Therapy Ctr, Nagakute, Aichi, Japan.
   [Nagano, Yoshitaka; Tadauchi, Hiroki; Mase, Tsuyoshi] Aichi Univ Technol, Dept Elect Control & Robot Engn, Nishihasama Cho, Gamagori, Aichi, Japan.
RP Ohshima, T (reprint author), Aichi Med Univ, Neuroendovasc Therapy Ctr, Nagakute, Aichi, Japan.
EM tmtkoh@gmail.com
CR Lasjaunias P, 1992, SURG NEUROANGIOGRAPH, P205
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 99
EP 102
DI 10.1016/j.wneu.2019.08.171
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300137
PM 31479785
DA 2020-05-12
ER

PT J
AU Oppong, MD
   Jabbarli, R
   Radbruch, A
   Sure, U
   Dammann, P
AF Oppong, Marvin Darkwah
   Jabbarli, Ramazan
   Radbruch, Alexander
   Sure, Ulrich
   Dammann, Philipp
TI Blind Date with an Aneurysm: Acute M1 Middle Cerebral Artery Thrombus
   with Native Computed Tomography Scan Suggesting Aneurysm Rupture
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intracerebral hemorrhage; Intracranial aneurysm; Ischemic stroke;
   Subarachnoid hemorrhage
ID INTERNAL CAROTID-ARTERY; OCCLUSION
AB BACKGROUND: We present a case of a concurrent rupture of a middle cerebral artery (MCA) aneurysm and thrombosis of the associated vessel.
   CASE DESCRIPTION: A male patient presented with acute onset of hemiparesis and nuchal pain. A computed tomography scan revealed a right sided frontotemporal intracerebral hemorrhage and a basal subarachnoid hemorrhage. Owing to obliteration of the M1 segment of the MCA, no aneurysm was visible on digital subtraction angiography. Because of otherwise typical imaging for a subarachnoid hemorrhage, surgical exploration of the MCA was performed. During surgery, a thrombosed MCA bifurcation aneurysm was identified, clipped, and subsequently, endovascular (partly) recanalization of the MCA was performed.
   CONCLUSIONS: In extremely rare cases of aneurysm rupture and subsequent thrombosis of the associated vessel, a 2-stage approach seems to be feasible. In the present case, initial surgical securing of the aneurysm followed by endovascular recanalization of the occluded vessel provided good results.
C1 [Oppong, Marvin Darkwah; Jabbarli, Ramazan; Sure, Ulrich; Dammann, Philipp] Univ Duisburg Essen, Univ Hosp, Dept Neurosurg, Essen, Germany.
   [Radbruch, Alexander] Univ Duisburg Essen, Univ Hosp, Inst Diagnost & Intervent Radiol, Essen, Germany.
RP Oppong, MD (reprint author), Univ Duisburg Essen, Univ Hosp, Dept Neurosurg, Essen, Germany.
EM marvin.darkwahoppong@uk-essen.de
OI Jabbarli, Ramazan/0000-0002-8356-6629
CR BIDZINSKI J, 1989, ACTA NEUROCHIR, V100, P43, DOI 10.1007/BF01405272
   Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6
   Dhandapani S, 2013, ACTA NEUROCHIR, V155, P237, DOI 10.1007/s00701-012-1571-2
   Endo H, 2005, NEUROL MED-CHIR, V45, P400, DOI 10.2176/nmc.45.400
   Oppong MD, 2018, CLIN NEUROL NEUROSUR, V173, P1, DOI 10.1016/j.clineuro.2018.07.014
   Porter RW, 1997, SURG NEUROL, V47, P532, DOI 10.1016/S0090-3019(96)00392-8
   Prickett JT, 2018, WORLD NEUROSURG, V110, P359, DOI 10.1016/j.wneu.2017.11.129
   SATO K, 1990, STROKE, V21, P1506, DOI 10.1161/01.STR.21.10.1506
   WHITTLE IR, 1982, J NEUROSURG, V56, P287, DOI 10.3171/jns.1982.56.2.0287
   Zhang YG, 2013, ACTA NEUROCHIR, V155, P569, DOI 10.1007/s00701-013-1628-x
NR 10
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 103
EP 105
DI 10.1016/j.wneu.2019.08.206
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300138
PM 31493595
DA 2020-05-12
ER

PT J
AU Shields, LBE
   Shields, CB
   Ghiassi, M
   Dashti, SR
   Yao, TL
   Zhang, YP
   Ghiassi, M
AF Shields, Lisa B. E.
   Shields, Christopher B.
   Ghiassi, Mayshan
   Dashti, Shervin R.
   Yao, Tom L.
   Zhang, Yi Ping
   Ghiassi, Mahan
TI Pipeline Embolization Device for Treatment of Craniocervical Internal
   Carotid Artery Dissections: Report of 3 Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysm; Carotid artery; Dissection; Endovascular; Neurosurgery;
   Pipeline Embolization Device
ID VERTEBRAL ARTERY; ANEURYSMS; RECONSTRUCTION; COMMUNITY; STROKE; STENT
AB BACKGROUND: Dissecting pseudoaneurysms of the craniocervical circulation are uncommon, accounting for only 3% of all cerebral aneurysms. These aneurysms pose a challenge due to their location and anatomic configuration. The Pipeline Embolization Device (PED) is a flow diversion technique that successfully treats aneurysms by diverting blood flow away from the aneurysm and reconstructing the diseased parent artery by altering its hemodynamics.
   CASE DESCRIPTION: We report 3 cases in which the PED was used to treat craniocervical carotid artery dissection with associated pseudoaneurysms. A single PED was used in the first case, 4 PEDs were used in the second case, and 3 PEDs and a PRECISE PRO RX carotid stent were placed in the third case. All 3 patients achieved full neurologic recovery postoperatively. Cerebral angiography performed postoperatively demonstrated revascularization, good laminar flow, and no in-stent or adjacent stenosis.
   CONCLUSIONS: PED placement offers a safe and effective method of treating spontaneous or traumatic craniocervical carotid artery dissections with excellent neurologic outcomes postoperatively and complete long-term aneurysmal occlusion.
C1 [Shields, Lisa B. E.; Shields, Christopher B.; Ghiassi, Mayshan; Dashti, Shervin R.; Yao, Tom L.; Zhang, Yi Ping; Ghiassi, Mahan] Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA.
   [Shields, Christopher B.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA.
RP Ghiassi, M (reprint author), Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA.
EM Mahan.Ghiassi@nortonhealthcare.org
CR Brouillard AM, 2016, CUREUS, V8, DOI 10.7759/cureus.472
   Brzezicki G, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011653
   Chan RSK, 2014, INTERV NEURORADIOL, V20, P436, DOI 10.15274/NRJ-2014-10042
   Fiorella D, 2009, J NEUROINTERV SURG, V1, P56, DOI 10.1136/jnis.2009.000083
   Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043
   GIROUD M, 1994, J NEUROL NEUROSUR PS, V57, P1443, DOI 10.1136/jnnp.57.11.1443
   Golitz P, 2016, INTERV NEURORADIOL, V22, P76, DOI 10.1177/1591019915609166
   Golub D, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.11.FOCUS18443
   Guerrero WR, 2018, WORLD NEUROSURG, V109, pE164, DOI 10.1016/j.wneu.2017.09.125
   Kuhn AL, 2016, J NEUROINTERV SURG, V8, P1048, DOI 10.1136/neurintsurg-2015-012028
   Morris NA, 2017, STROKE, V48, P551, DOI 10.1161/STROKEAHA.116.015185
   Narata AP, 2012, NEUROSURGERY, V70, P982, DOI 10.1227/NEU.0b013e318236715e
   Perry BC, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00133
   Rahal JP, 2014, J CLIN NEUROSCI, V21, P1024, DOI 10.1016/j.jocn.2013.10.017
   Rao AS, 2011, J VASC SURG, V54, P370, DOI 10.1016/j.jvs.2011.02.059
   SCHIEVINK WI, 1993, STROKE, V24, P1678, DOI 10.1161/01.STR.24.11.1678
   Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206
   Shah VA, 2015, BMJ CASE REP, V2015
   Wang Arthur, 2017, Surg Neurol Int, V8, P3, DOI 10.4103/2152-7806.198730
   Winkler EA, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.11.FOCUS18530
   Yeung TW, 2012, J NEUROSURG, V116, P882, DOI 10.3171/2011.12.JNS111514
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 106
EP 112
DI 10.1016/j.wneu.2019.08.183
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300139
PM 31491581
DA 2020-05-12
ER

PT J
AU Clifton, W
   Vlasak, A
   Damon, A
   Dove, C
   Pichelmann, M
AF Clifton, William
   Vlasak, Alexander
   Damon, Aaron
   Dove, Conrad
   Pichelmann, Mark
TI Freehand C2 Pedicle Screw Placement: Surgical Anatomy and Operative
   Technique
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3D simulation; Anatomy; Cervical spine; C2 pedicle screw; Freehand;
   Spinal instrumentation
AB We present a surgical video demonstrating the anatomy and technique of freehand C2 pedicle screw placement using a cadaveric specimen and 3-dimensional simulation software. C2 pedicle screws have been shown to augment cervical constructs and provide increased biomechanical stability compared with pars screws due to the increased length and bony purchase of pedicle screws within the pedicle and vertebral body.(1) The presence of vertebral artery variations within the transverse foramen may preclude pedicle screw placement, and these should be identified on preoperative imaging. The C2 pedicle can be directly palpated at the time of screw placement, which aids screw placement in cases of deformity or trauma. A freehand technique without the use of computed tomography scan guidance or intraoperative fluoroscopy decreases radiation exposure for the operator and patient and has been shown to be safe for patient-related outcomes.(2-5) Complete exposure of the C2 posterior elements is key to identifying the pedicle. The trajectory is based on direct visualization of the medial and superior pedicle borders to avoid lateral or inferior breaches into the transverse foramen. A curved probe is used for access into the vertebral body, respecting the outer cortical walls of the pedicle. The intraosseous position is confirmed with a ball-tipped probe. Fluoroscopy should be performed after screw placement to confirm proper position. By accomplishing proper exposure and understanding the anatomy of the C2 pedicle, the placement of C2 pedicle screws using a freehand technique is a safe and efficient technique for high cervical fixation.
C1 [Clifton, William; Vlasak, Alexander; Pichelmann, Mark] Mayo Clin Florida, Dept Neurol Surg, Jacksonville, FL 32224 USA.
   [Damon, Aaron; Dove, Conrad] Mayo Clin Florida, Dept Educ, Jacksonville, FL USA.
RP Clifton, W (reprint author), Mayo Clin Florida, Dept Neurol Surg, Jacksonville, FL 32224 USA.
EM clifton.william@mayo.edu
OI Clifton, William/0000-0003-3533-8776
CR Bydon M, 2014, CLIN NEUROL NEUROSUR, V125, P24, DOI 10.1016/j.clineuro.2014.07.017
   Pham MH, 2018, J NEUROSURG-SPINE, V29, P235, DOI 10.3171/2018.1.SPINE17875
   Punyarat P, 2018, SPINE J, V18, P1197, DOI 10.1016/j.spinee.2017.11.010
   Walker CT, 2015, WORLD NEUROSURG, V83, P282, DOI 10.1016/j.wneu.2015.01.004
   Xu Risheng, 2014, Surg Neurol Int, V5, pS343, DOI 10.4103/2152-7806.139664
NR 5
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 113
EP 113
DI 10.1016/j.wneu.2019.08.198
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300140
PM 31493597
DA 2020-05-12
ER

PT J
AU Cenzato, M
   Fratianni, A
   Stefini, R
AF Cenzato, Marco
   Fratianni, Alessia
   Stefini, Roberto
TI Using a Smartphone as an Exoscope Where an Operating Microscope is not
   Available
SO WORLD NEUROSURGERY
LA English
DT Article
DE Exoscope; Operating microscope; Smartphone
AB OBJECTIVE: Neurosurgical operating rooms are equipped with microscopes in order to provide a good standard of care. Nevertheless, in developing countries, microscopes are not always available. During a short period in a western Africa hospital, we adapted our smartphones as a valid alternative to the microscope.
   METHODS: Using a shaped tin can, a smartphone cover, and a rod fixed to the bed, we could make a support for a smartphone creating a simple "homemade" exoscope, which allowed us to have magnification and light in the surgical field.
   RESULTS: Among others, we performed 5 surgical interventions of both spinal and brain surgery using our smartphone as a magnifier. This allowed us to overcome the absence of a better magnification system.
   CONCLUSIONS: This simple "smartphone-based exoscope" allows surgeons to get an adequate magnification during surgery when microscopes or magnification goggles are not available. It can be a useful solution in developing countries where often nothing better is available.
C1 [Cenzato, Marco; Fratianni, Alessia] Osped Ca Granda Milano, Dept Neurosurg, Milan, Italy.
   [Stefini, Roberto] Osped Civile Legnano, Milan, Italy.
RP Stefini, R (reprint author), Osped Civile Legnano, Milan, Italy.
EM roberto.stefini@asst-ovestmi.it
CR Bedi MS, 2019, WORLD NEUROSURG, V19, P30241
   Choque-Velasquez J, 2018, WORLD NEUROSURG, V112, P126, DOI 10.1016/j.wneu.2018.01.067
   Dogan I, 2019, WORLD NEUROSURG, V125, P240, DOI 10.1016/j.wneu.2019.01.237
   Hou Y, 2016, PLOS ONE, V11, P159
   Huotarinen A, 2017, WORLD NEUROSURG, V107, P358, DOI 10.1016/j.wneu.2017.08.024
   Joshi SS, 2018, BRIT J NEUROSURG, V32, P553, DOI 10.1080/02688697.2018.1490944
   Kameda-Smith MM, 2018, WORLD NEUROSURG, V111, pE465, DOI 10.1016/j.wneu.2017.12.089
   Mandel M, 2019, J NEUROSURG, V130, P90, DOI 10.3171/2017.6.JNS1712
   Ozerov S, 2018, CHILD NERV SYST, V34, P853, DOI 10.1007/s00381-017-3713-6
   Perin A, 2018, OPER NEUROSURG, V14, P572, DOI 10.1093/ons/opx144
NR 10
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 114
EP 117
DI 10.1016/j.wneu.2019.08.137
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300141
PM 31476467
DA 2020-05-12
ER

PT J
AU Sankey, EW
   Park, C
   Howell, EP
   Pennington, Z
   Abd-El-Barr, M
   Karikari, IO
   Shaffrey, CI
   Gokaslan, ZL
   Sciubba, D
   Goodwin, CR
AF Sankey, Eric W.
   Park, Christine
   Howell, Elizabeth P.
   Pennington, Zach
   Abd-El-Barr, Muhammad
   Karikari, Isaac O.
   Shaffrey, Christopher, I
   Gokaslan, Ziya L.
   Sciubba, Daniel
   Goodwin, C. Rory
TI Importance of Spinal Alignment in Primary and Metastatic Spine Tumors
SO WORLD NEUROSURGERY
LA English
DT Review
DE Alignment; Deformity; Patient outcomes; Spine oncology; Spinopelvic
   parameters; Tumor
ID STEREOTACTIC BODY RADIOTHERAPY; VERTEBRAL COMPRESSION FRACTURE; CERVICAL
   SAGITTAL ALIGNMENT; EN-BLOC SPONDYLECTOMY; T1 PELVIC ANGLE;
   QUALITY-OF-LIFE; RADIOGRAPHIC PARAMETERS; RADIATION-THERAPY; SURGICAL
   OUTCOMES; PLANE DEFORMITY
AB Spinal alignment, particularly with respect to spinopelvic parameters, is highly correlated with morbidity and health-related quality-of-life outcomes. Although the importance of spinal alignment has been emphasized in the deformity literature, spinopelvic parameters have not been considered in the context of spine oncology. Because the aim of oncologic spine surgery is mostly palliative, consideration of spinopelvic parameters could improve postoperative outcomes in both the primary and metastatic tumor population by taking overall vertebral stability into account. This review highlights the relevance of focal and global spinal alignment, particularly related to spinopelvic parameters, in the treatment of spine tumors.
C1 [Sankey, Eric W.; Park, Christine; Howell, Elizabeth P.; Abd-El-Barr, Muhammad; Karikari, Isaac O.; Shaffrey, Christopher, I; Goodwin, C. Rory] Duke Univ, Med Ctr, Dept Neurosurg, Spine Div, Durham, NC 27710 USA.
   [Pennington, Zach; Sciubba, Daniel] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Gokaslan, Ziya L.] Brown Univ, Dept Neurosurg, Providence, RI 02912 USA.
RP Goodwin, CR (reprint author), Duke Univ, Med Ctr, Dept Neurosurg, Spine Div, Durham, NC 27710 USA.
EM 1221spineresearch@dm.duke.edu
OI Goodwin, C. Rory/0000-0002-6540-2751; Pennington,
   Zachary/0000-0001-8012-860X
CR Ahmed AK, 2018, SPINE J, V18, P1804, DOI 10.1016/j.spinee.2018.03.011
   Alamanda VK, 2018, J ONCOL, DOI 10.1155/2018/6140381
   Ames CP, 2013, SPINE, V38, pS149, DOI 10.1097/BRS.0b013e3182a7f449
   Ames CP, 2012, J NEUROSURG-SPINE, V16, P547, DOI 10.3171/2012.2.SPINE11320
   Asai Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178697
   ASDOURIAN PL, 1990, J SPINAL DISORD, V3, P119
   Bodin A, 2015, EUR SPINE J, V24, pS72, DOI 10.1007/s00586-014-3651-x
   Boehling NS, 2012, J NEUROSURG-SPINE, V16, P379, DOI 10.3171/2011.11.SPINE116
   Boriani S, 1997, SPINE, V22, P1036, DOI 10.1097/00007632-199705010-00020
   Boriani S, 1996, SPINE, V21, P1927, DOI 10.1097/00007632-199608150-00020
   Bridwell KH, 2006, SPINE, V31, P170, DOI 10.1097/01.brs.0000195226.26646.21
   Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x
   Carl HM, 2018, J NEUROSURG-SPINE, V28, P663, DOI 10.3171/2017.10.SPINE1765
   Chang SY, 2018, ASIAN SPINE J, V12, P919, DOI 10.31616/asj.2018.12.5.919
   Ciftdemir M, 2016, WORLD J ORTHOP, V7, P109, DOI 10.5312/wjo.v7.i2.109
   de Jonge T, 2005, EUR SPINE J, V14, P765, DOI 10.1007/s00586-004-0778-1
   Deinlein Donald, 2013, Spine Deform, V1, P458, DOI 10.1016/j.jspd.2013.08.005
   Dimar JR, 1998, SPINE, V23, P1209, DOI 10.1097/00007632-199806010-00006
   Drake MT, 2013, CURR OSTEOPOROS REP, V11, P163, DOI 10.1007/s11914-013-0154-3
   Dubousset Jean, 1994, P479
   Elder BD, 2016, GLOB SPINE J, V6, P21, DOI 10.1055/s-0035-1555657
   Fisher CG, 2014, AM J ROENTGENOL, V203, P869, DOI 10.2214/AJR.13.12269
   Fisher CG, 2010, SPINE, V35, pE1221, DOI 10.1097/BRS.0b013e3181e16ae2
   FRASER RD, 1977, J BONE JOINT SURG BR, V59, P143
   Gasbarrini A, 2004, Eur Rev Med Pharmacol Sci, V8, P265
   Georgiou KR, 2012, J CELL PHYSIOL, V227, P909, DOI 10.1002/jcp.22807
   Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025
   Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96
   Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7
   Goodwin CR, 2016, WORLD NEUROSURG, V91, P510, DOI [10.1016/J.WNEU.2016.04.026, 10.1016/j.wneu.2016.04.026]
   Goodwin CR, 2015, GLOB SPINE J, V5, P417, DOI 10.1055/s-0035-1554778
   Goodwin CR, 2015, GLOB SPINE J, V5, pE39, DOI 10.1055/s-0034-1398488
   HAMMERBERG KW, 1992, SPINE, V17, P1148, DOI 10.1097/00007632-199210000-00004
   Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20
   Hsieh PC, 2007, J NEUROSURG-SPINE, V6, P368, DOI 10.3171/spi.2007.6.4.15
   Hsieh PC, 2009, NEUROSURGERY, V65, P173, DOI 10.1227/01.NEU.0000345630.47344.17
   Hussain I, 2018, SPINE J, V18, P261, DOI 10.1016/j.spinee.2017.07.008
   Hyun SJ, 2016, SPINE, V41, pE396, DOI 10.1097/BRS.0000000000001264
   Iwata Akira, 2017, Eur J Orthop Surg Traumatol, V27, P87, DOI 10.1007/s00590-016-1844-1
   JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010
   Joseph SA, 2009, J AM ACAD ORTHOP SUR, V17, P378, DOI 10.5435/00124635-200906000-00006
   Kaner T, 2014, TURK NEUROSURG, V24, P75
   Kim DH, 2015, ASIAN SPINE J, V9, P162, DOI 10.4184/asj.2015.9.2.162
   Kim TK, 2016, J KOREAN NEUROSURG S, V59, P597, DOI 10.3340/jkns.2016.59.6.597
   Klimo P, 2004, ONCOLOGIST, V9, P188, DOI 10.1634/theoncologist.9-2-188
   KOSTUIK JP, 1988, SPINE, V13, P250, DOI 10.1097/00007632-198803000-00006
   Lafage V, 2011, SPINE, V36, P1037, DOI 10.1097/BRS.0b013e3181eb9469
   Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219
   Lee JS, 2015, EUR SPINE J, V24, P1199, DOI 10.1007/s00586-014-3491-8
   Marmor E, 2002, PRIMARY SPINAL CORD, P149
   McGirt MJ, 2008, CHILD NERV SYST, V24, P735, DOI 10.1007/s00381-007-0513-4
   McGirt MJ, 2010, NEUROSURGERY, V66, P1005, DOI 10.1227/01.NEU.0000367721.73220.C9
   McPhee IB, 1998, SPINE, V23, P726, DOI 10.1097/00007632-199803150-00015
   Mesfin A, 2016, SPINE, V41, pS262, DOI 10.1097/BRS.0000000000001817
   MIRELS H, 1989, CLIN ORTHOP RELAT R, P256
   Moustafa IM, 2017, EUR J PHYS REHAB MED, V53, P57, DOI 10.23736/S1973-9087.16.04179-4
   Nisson PL, 2018, WORLD NEUROSURG, V119, pE32, DOI 10.1016/j.wneu.2018.06.189
   Paulino AC, 2005, INT J RADIAT ONCOL, V61, P865, DOI 10.1016/j.ijrobp.2004.07.719
   Pellise F, 2015, EUR SPINE J, V24, P3, DOI 10.1007/s00586-014-3542-1
   Protopsaltis T, 2014, J BONE JOINT SURG AM, V96A, P1631, DOI 10.2106/JBJS.M.01459
   Rose PS, 2009, J CLIN ONCOL, V27, P5075, DOI 10.1200/JCO.2008.19.3508
   Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9
   Ryan DJ, 2014, SPINE, V39, P1203, DOI 10.1097/BRS.0000000000000382
   Sahgal A, 2013, J CLIN ONCOL, V31, P3426, DOI 10.1200/JCO.2013.50.1411
   Schuster J M, 2001, Neurosurg Focus, V11, pe3
   Schwab FJ, 2002, SPINE, V27, P387, DOI 10.1097/00007632-200202150-00012
   Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4
   Schwab F, 2009, SPINE, V34, P1828, DOI 10.1097/BRS.0b013e3181a13c08
   Sciubba DM, 2008, J NEUROSURG-SPINE, V8, P413, DOI 10.3171/SPI/2008/8/5/413
   Shi DD, 2018, PRACT RADIAT ONCOL, V8, pE285, DOI 10.1016/j.prro.2018.02.001
   Singla Anuj, 2018, Spine (Phila Pa 1976), DOI 10.1097/BRS.0000000000002864
   Smith JS, 2013, SPINE, V38, P1663, DOI 10.1097/BRS.0b013e31829ec563
   Sohn S, 2012, J KOREAN NEUROSURG S, V51, P1, DOI 10.3340/jkns.2012.51.1.1
   STENER B, 1989, CLIN ORTHOP RELAT R, P72
   SUGIMOTO M, 1991, J BONE JOINT SURG BR, V73, P492
   Sundaresan N, 2002, SPINE, V27, P1802, DOI 10.1097/00007632-200208150-00021
   Sundaresan N, 2009, ORTHOP CLIN N AM, V40, P21, DOI 10.1016/j.ocl.2008.10.004
   Tang JA, 2012, NEUROSURGERY, V71, P662, DOI 10.1227/NEU.0b013e31826100c9
   Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018
   Tschirhart CE, 2007, J BIOMECH, V40, P46, DOI 10.1016/j.jbiomech.2005.11.014
   Uei H, 2017, SPINE, V42, pE1446, DOI 10.1097/BRS.0000000000002382
   van der Velden JM, 2017, ONCOLOGIST, V22, P972, DOI 10.1634/theoncologist.2016-0356
   Versteeg AL, 2016, SPINE, V41, pS231, DOI 10.1097/BRS.0000000000001822
   Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043
   Wang K, 2017, J HEALTHC ENG, DOI 10.1155/2017/2941048
   Windhagen H, 2000, SPINE, V25, P1775, DOI 10.1097/00007632-200007150-00007
   Windhagen HJ, 1997, CLIN ORTHOP RELAT R, P313
NR 87
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 118
EP 128
DI 10.1016/j.wneu.2019.08.161
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300142
PM 31476476
DA 2020-05-12
ER

PT J
AU Manjubashini, D
   Kiran, M
   Akshaya, S
   Nagarajan, K
AF Manjubashini, Duraipandi
   Kiran, Maddaiah
   Akshaya, Saravanan
   Nagarajan, Krishnan
TI Intrasphenoidal Encephalocele with Spontaneous Cerebrospinal Fluid
   Rhinorrhea in Idiopathic Intracranial Hypertension: Need for Clarity in
   Terminology and Imaging Delineation
SO WORLD NEUROSURGERY
LA English
DT Article
DE CSF rhinorrhea; Intrasphenoidal encephalocele (ISE);
   Meningoencephalocele; MR cisternography
ID LEAKS; MENINGOENCEPHALOCELES; DEFECTS; SINUS
AB BACKGROUND: Magnetic resonance imaging plays an important role in identification of any underlying structural cause in spontaneous cerebrospinal fluid (CSF) leaks-either rhinorrhea or otorrhea. Sphenoid bone defects have been reported in those presenting as idiopathic intracranial hypertension with or without CSF rhinorrhea. Sphenoid lateral recess defect with intrasphenoidal encephalocele is one of the uncommon causes of spontaneous CSF leakage. Many classifications of basal encephaloceles have been used along with associated predisposing anatomic factors for the CSF leak.
   CASE DESCRIPTION: We report 2 cases of spontaneous CSF rhinorrhea in 2 middle-aged females and had intrasphenoidal encephalocele on imaging using 3-dimensional magnetic resonance cisternography and computed tomography.
   CONCLUSIONS: We discuss the various classification systems of sphenoidal encephaloceles and review the terminology and comprehensive imaging details to be included in reporting such cases for appropriate treatment planning.
C1 [Manjubashini, Duraipandi; Kiran, Maddaiah; Akshaya, Saravanan; Nagarajan, Krishnan] Jawaharlal Inst Postgrad Med Educ & Res, Dept Radiodiag, Pondicherry, India.
RP Nagarajan, K (reprint author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Radiodiag, Pondicherry, India.
EM lknagarajan1@gmail.com
RI Nagarajan, Krishnan/AAF-6163-2020
CR AlMontasheri A, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.92363
   Baranano CF, 2009, AM J RHINOL ALLERGY, V23, P167, DOI 10.2500/ajra.2009.23.3290
   Byrne RW, 2010, WORLD NEUROSURG, V73, P541, DOI 10.1016/j.wneu.2010.01.018
   Alonso RC, 2013, RADIOGRAPHICS, V33, P553, DOI 10.1148/rg.332125028
   Connor SEJ, 2010, CLIN RADIOL, V65, P832, DOI 10.1016/j.crad.2010.05.002
   HOOPER AC, 1971, J NEUROL NEUROSUR PS, V34, P739, DOI 10.1136/jnnp.34.6.739
   Illing E, 2014, INT FORUM ALLERGY RH, V4, P246, DOI 10.1002/alr.21262
   Kahyaoglu O, 2007, TURK NEUROSURG, V17, P264
   KAUFMAN B, 1977, RADIOLOGY, V122, P379, DOI 10.1148/122.2.379
   Kenning TJ, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.4.FOCUS1265
   Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362
   Quint DJ, 1996, AM J ROENTGENOL, V166, P952, DOI 10.2214/ajr.166.4.8610580
   ROSENBAUM TJ, 1985, NEUROLOGY, V35, P287, DOI 10.1212/WNL.35.2.287-a
   Schick B, 2000, EUR ARCH OTO-RHINO-L, V257, P430, DOI 10.1007/s004050000235
   Schuknecht B, 2008, AM J NEURORADIOL, V29, P542, DOI 10.3174/ajnr.A0840
   Settecase F, 2014, AM J NEURORADIOL, V35, P784, DOI 10.3174/ajnr.A3744
   Spacca B, 2009, NEUROSURGERY, V65, P1140, DOI 10.1227/01.NEU.0000351780.23357.F5
   Tomaszewska M, 2015, VIDEOSURGERY MINIINV, V10, P347, DOI 10.5114/wiitm.2014.47097
   Tomazic PV, 2009, RHINOLOGY, V47, P369, DOI 10.4193/Rhin08.236
   WILKINS RH, 1993, J NEUROSURG, V78, P492, DOI 10.3171/jns.1993.78.3.0492
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 129
EP 133
DI 10.1016/j.wneu.2019.08.186
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300143
PM 31491574
DA 2020-05-12
ER

PT J
AU Jha, RT
   Kumar, J
   Pressman, E
   Agazzi, S
AF Jha, R. Tushar
   Kumar, Jay
   Pressman, Elliot
   Agazzi, Siviero
TI Arterial Sling Decompression for Hemifacial Spasm
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hemifacial spasm; Microvascular decompression; MVD; Sling
AB Hemifacial spasm is a cranial nerve compression syndrome caused by impingement on the facial nerve most frequently by the anterior inferior cerebellar artery or the posterior inferior cerebellar artery. It can be treated with microvascular decompression (MVD) to separate the nerve from the offending artery. Rarely, a large-caliber vessel such as a dolichoectatic vertebrobasilar system may be implicated, requiring more than an MVD. One technique involves placing a sling around the offending vessel to decompress the facial nerve. We find our "neck-tie" technique to be unique and present it in this detailed video. A 36-year-old-woman presented with a 3-month history of severe left hemifacial spasm refractory to medical management. Imaging demonstrated compression of the left facial nerve and its root entry zone by a dolichoectatic vertebrobasilar complex and anterior inferior cerebellar artery. A left retrosigmoid craniotomy was performed. A Dacron sling was placed around the offending vertebral artery in a "neck-tie" fashion. This sling was used to displace the vertebral artery off of the facial nerve and the sling was then sutured in its final position to the petrous dura. In addition, MVD was performed around the facial nerve's root entry zone. Following sling placement and MVD, neuromonitoring demonstrated absence of abnormal motor responses. Postoperative course was uneventful, she remained neurologically intact, and she remained free of symptoms at 6 months' follow-up. This video highlights the decision making for selecting the appropriate case of hemifacial spasm for sling decompression, the key technical nuances, and complication avoidance in these challenging cases.
C1 [Jha, R. Tushar; Kumar, Jay; Agazzi, Siviero] Univ S Florida, Dept Neurosurg, Tampa, FL 33620 USA.
   [Pressman, Elliot] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA.
RP Jha, RT (reprint author), Univ S Florida, Dept Neurosurg, Tampa, FL 33620 USA.
EM rtjha11286@gmail.com
OI Agazzi, Siviero/0000-0001-5760-0187
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 134
EP 134
DI 10.1016/j.wneu.2019.08.109
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300144
PM 31470160
DA 2020-05-12
ER

PT J
AU Jorge, A
   Taylor, T
   Agarwal, N
   Hamilton, DK
AF Jorge, Ahmed
   Taylor, Tavis
   Agarwal, Nitin
   Hamilton, D. Kojo
TI Current Agents and Related Therapeutic Targets for Inflammation After
   Acute Traumatic Spinal Cord Injury
SO WORLD NEUROSURGERY
LA English
DT Review
DE Acute traumatic spinal cord injury; aTSCI; Cyclooxygenases; Fas ligand;
   IL-1 receptor; iNOS; TNF-alpha
ID TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; NUCLEAR FACTOR-KB;
   NF-KAPPA-B; FACTOR-ALPHA; FUNCTIONAL RECOVERY; TNF-ALPHA;
   DOCOSAHEXAENOIC ACID; NEUROPATHIC PAIN; MEDIATED APOPTOSIS
AB BACKGROUND: The infliction of a traumatic spinal cord injury (SCI) propagates damage that occurs in 2 stages. The first phase of trauma develops from the initial mechanical insult. The second phase involves the degradation of nervous tissue but is likely not affected by the initial insult. Thus, therapeutic targets with a high specificity for these secondary injury processes have been of increasing interest. We reviewed the pathophysiologic cascades of inflammation after SCI and potential therapeutic targets. -
   METHODS: The PubMed and EMBASE databases were queried using appropriate medical subject headings for studies involving tumor necrosis factor (TNF)-alpha), nuclear factor (NF)-kappa B, inducible nitric oxide synthase (iNOS), interleukin (IL)-1 beta, and/or Fas ligand (FasL) targets. The relevant studies found were graded into 3 levels (i.e., A, B, C) according to the quality of evidence.
   RESULTS: We have summarized the basis of the neurological damage for TNF-alpha, NF-kappa B, iNOS, IL-1 beta, and FasL after SCI. A total of 17 studies were rated, each of which had reported histological, biochemical, physiological, and behavioral outcomes according to the treatment that had focused on TNF-alpha, NF-kappa B, iNOS, IL-1 beta, and FasL.
   CONCLUSION: The TNF-alpha, iNOS, NF-kappa B, IL-1 beta, and FasL will become active within minutes after SCI. The adverse effects from the activity of these receptors include inflammation and other important neurological damage. Each of these targets can be modulated by specific agents with differing degrees of efficacy according to the reported data.
C1 [Jorge, Ahmed; Taylor, Tavis; Agarwal, Nitin; Hamilton, D. Kojo] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA.
RP Agarwal, N (reprint author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA.
EM agarwaln@upmc.edu
RI /AAA-4616-2020
OI Agarwal, Nitin/0000-0003-0256-3897; Jorge, Ahmed/0000-0003-3484-6197
CR Andrade P, 2014, J NEUROSCI RES, V92, P1490, DOI 10.1002/jnr.23432
   Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906
   Bastien D, 2014, EXP NEUROL, V258, P62, DOI 10.1016/j.expneurol.2014.04.006
   Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006
   Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28
   Biglari B, 2013, SPINAL CORD, V51, P183, DOI 10.1038/sc.2012.139
   Borcek AO, 2015, J KOREAN NEUROSURG S, V57, P73, DOI 10.3340/jkns.2015.57.2.73
   Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038
   Cakir O, 2003, CARDIOVASC SURG, V11, P375, DOI 10.1016/S0967-2109(03)00077-2
   Celik H, 2016, TURK NEUROSURG, V26, P622, DOI 10.5137/1019-5149.JTN.13210-14.1
   Chang X, 2014, BRAIN RES, V1562, P87, DOI 10.1016/j.brainres.2014.03.024
   Chengke Luo, 2013, Spine (Phila Pa 1976), V38, pE861, DOI 10.1097/BRS.0b013e318294892c
   Chi LY, 2008, NEUROSCI LETT, V438, P174, DOI 10.1016/j.neulet.2008.04.043
   Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8
   Dery MA, 2009, NEUROSCI LETT, V453, P73, DOI 10.1016/j.neulet.2009.01.062
   Dhimolea E, 2010, MABS-AUSTIN, V2, P3, DOI 10.4161/mabs.2.1.10328
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Donovan WH, 2007, J SPINAL CORD MED, V30, P85, DOI 10.1080/10790268.2007.11753918
   DUH MS, 1994, NEUROSURGERY, V35, P240, DOI 10.1227/00006123-199408000-00009
   Emmez H, 2010, WORLD NEUROSURG, V73, P729, DOI 10.1016/j.wneu.2010.04.008
   Fan ZK, 2013, J MOL NEUROSCI, V51, P986, DOI 10.1007/s12031-013-0083-8
   Farooq F, 2013, HUM MOL GENET, V22, P3415, DOI 10.1093/hmg/ddt191
   Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008
   Figueroa JD, 2013, J NEUROTRAUM, V30, P853, DOI 10.1089/neu.2012.2718
   Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141
   Gandelman M, 2013, J NEUROCHEM, V126, P382, DOI 10.1111/jnc.12286
   Garcia E, 2012, J NEUROSCI RES, V90, P656, DOI 10.1002/jnr.22771
   Garraway SM, 2014, PAIN, V155, P2344, DOI 10.1016/j.pain.2014.08.034
   Gaudio A, 2013, INT J IMMUNOPATH PH, V26, P229, DOI 10.1177/039463201302600123
   Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188
   Grant RA, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0334-1
   Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013
   Guven C, 2010, J CLIN NEUROSCI, V17, P1563, DOI 10.1016/j.jocn.2010.04.027
   Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x
   Hou XL, 2015, NEURAL REGEN RES, V10, P1836, DOI 10.4103/1673-5374.170314
   Huang H, 2013, INT J CLIN EXP PATHO, V6, P1337
   Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6
   Impellizzeri D, 2012, J PHARMACOL EXP THER, V343, P21, DOI 10.1124/jpet.111.191239
   Jia L, 2011, NEUROCHEM RES, V36, P419, DOI 10.1007/s11064-010-0357-2
   Jiang Y, 2014, INT J MOL SCI, V15, P12270, DOI 10.3390/ijms150712270
   Karppinen J, 2003, SPINE, V28, P750, DOI 10.1097/00007632-200304150-00004
   Kim BS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-217
   Ko WK, 2019, MOL NEUROBIOL, V56, P267, DOI 10.1007/s12035-018-0994-z
   Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038
   La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311
   Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133
   Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015
   Liu D, 2015, CLIN EXP PHARMACOL P, V42, P202, DOI 10.1111/1440-1681.12345
   Liu JB, 2015, BIOCHEM BIOPH RES CO, V467, P197, DOI 10.1016/j.bbrc.2015.10.007
   Maggio DM, 2012, J NEUROTRAUM, V29, P2244, DOI 10.1089/neu.2012.2371
   Maixent JM, 2014, CELL MOL BIOL, V60, P22
   Nacar OA, 2014, TURK NEUROSURG, V24, P337, DOI 10.5137/1019-5149.JTN.8131-13.1
   Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857
   Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0
   Pahan K, 2000, NEUROSCI LETT, V287, P17, DOI 10.1016/S0304-3940(00)01167-8
   Pajoohesh-Ganji A, 2011, NEUROTHERAPEUTICS, V8, P195, DOI 10.1007/s13311-011-0036-2
   Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x
   Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010
   Paterniti I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-6
   Peng XM, 2006, ANN NEUROL, V59, P843, DOI 10.1002/ana.20855
   Pilat D, 2015, EUR J PHARMACOL, V764, P240, DOI 10.1016/j.ejphar.2015.05.058
   Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007
   Prochazkova M, 2006, BASIC CLIN PHARMACOL, V99, P173, DOI 10.1111/j.1742-7843.2006.pto_457.x
   Robins-Steele S, 2012, J NEUROTRAUM, V29, P1586, DOI 10.1089/neu.2011.2005
   Sabour H, 2015, J SPINAL CORD MED, V38, P599, DOI 10.1179/2045772314Y.0000000251
   Sahinkaya FR, 2014, EXP NEUROL, V255, P113, DOI 10.1016/j.expneurol.2014.02.025
   Satkunendrarajah K, 2013, EXP NEUROL, V249, P104, DOI 10.1016/j.expneurol.2013.08.008
   Sobrido-Camean D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00101
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Stillman MD, 2016, SPINAL CORD, V54, P298, DOI 10.1038/sc.2015.180
   Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519
   Wang Cuicui, 2015, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V33, P771
   Wei HY, 2014, NEUROL SCI, V35, P1763, DOI 10.1007/s10072-014-1828-z
   Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9
   Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3
   Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004
   Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3
   Yu WR, 2011, BRAIN, V134, P1277, DOI 10.1093/brain/awr054
   Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116
   Zhou W, 2017, J NEUROPHYSIOL, V117, P2282, DOI 10.1152/jn.00936.2016
NR 80
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 138
EP 147
DI 10.1016/j.wneu.2019.08.108
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300146
PM 31470153
DA 2020-05-12
ER

PT J
AU Durand, WM
   Anderson, M
   Baker, A
   Daniels, AH
   Rogg, JM
   Klinge, PM
AF Durand, Wesley M.
   Anderson, Matthew
   Baker, Amanda
   Daniels, Alan H.
   Rogg, Jeffrey M.
   Klinge, Petra M.
TI Meningocele Manque Discovered During Filum Terminale Resection in Occult
   Tethered Cord Syndrome
SO WORLD NEUROSURGERY
LA English
DT Article
DE Filum terminale release; Meningocele manque; Occult tethered cord
   syndrome; Spinal dysraphism
ID SPINAL DERMAL-SINUS; TRACTS
AB BACKGROUND: Meningocele manque (MM) is characterized by tethering of the spinal cord, nerve roots, or filum terminale by fibrous attachments formed by atrophic or incomplete meningoceles. Patients with MM can present with symptoms of tethered cord syndrome (TCS).
   CASE DESCRIPTION: We present the case of an MM discovered incidentally during microsurgical resection of filum terminale for occult TCS. The MM was not visible on the preoperative magnetic resonance imaging (MRI) studies. After L2-L3 laminotomy, an extradural mass was appreciated adherent to the spinal dura, which was found to be an MM. The nerve roots of the cauda equina were found to protrude through the dura, consistent with tethered cauda equina. After microsurgical resection of the filum terminale, the tethered cauda nerve roots were stimulated, and redundant electromyographic signals were detected at both the left- and the right-sided muscles of the lower extremities. Microsurgical repair of the MM was performed, assuming that the patient's symptoms of TCS would also be explained by the MM and that her symptoms would likely have been incompletely addressed by filum terminale release alone. A review of the preoperative 3-dimensional constructive interference in steady state MRI sequence revealed pathological features at the L2-L3 level suspicious for our intraoperative findings of an MM.
   CONCLUSIONS: Surgeons planning filum terminale release for occult TCS should always be aware of the possibility of associated pathological features of tethering that might be overlooked. In retrospect, the detection of MM was enabled by the high-resolution 3-dimensional constructive interference in steady state MRI sequence. This finding advocates for the use of high-resolution MRI for patients undergoing evaluation for occult TCS to detect pathological features that might otherwise be undetected.
C1 [Durand, Wesley M.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Anderson, Matthew; Klinge, Petra M.] Brown Univ, Dept Neurosurg, Alpert Med Sch, Providence, RI 02912 USA.
   [Baker, Amanda] Brown Univ, Dept Neuroradiol, Alpert Med Sch, Providence, RI 02912 USA.
   [Daniels, Alan H.] Brown Univ, Dept Orthoped Surg, Div Spine Surg, Alpert Med Sch, Providence, RI 02912 USA.
   [Rogg, Jeffrey M.] Rhode Isl Hosp, Dept Neuroradiol, Providence, RI USA.
RP Klinge, PM (reprint author), Brown Univ, Dept Neurosurg, Alpert Med Sch, Providence, RI 02912 USA.
EM pklinge@lifespan.org
CR Aquilina A, 2017, BMJ CASE REP, V2017
   Eid S, 2019, CHILD NERV SYST, V35, P389, DOI 10.1007/s00381-018-3993-5
   James CCM, 1972, SPINAL DYSRAPHISM SP
   KAFFENBERGER DA, 1992, AM J NEURORADIOL, V13, P1083
   Kriss VM, 1996, AM J ROENTGENOL, V167, P1293, DOI 10.2214/ajr.167.5.8911198
   LASSMAN LP, 1977, CHILD BRAIN, V3, P1
   Martinez-Lage JF, 2011, CHILD NERV SYST, V27, P609, DOI 10.1007/s00381-010-1308-6
   Metcalfe PD, 2006, J UROLOGY, V176, P1826, DOI 10.1016/j.juro.2006.04.090
   Nair RP, 2018, CHILD NERV SYST, V34, P2347, DOI 10.1007/s00381-018-3978-4
   Ostling LR, 2012, WORLD NEUROSURG, V77, P187, DOI 10.1016/j.wneu.2011.05.017
   Rajpal S, 2007, J NEUROSURG-SPINE, V7, P315, DOI 10.3171/SPI-07/09/315
   Schmidt C, 2017, CHILD NERV SYST, V33, P1065, DOI 10.1007/s00381-017-3472-4
   Tu A, 2013, CHILD NERV SYST, V29, P1635, DOI 10.1007/s00381-013-2129-1
   Tubbs RS, 2003, BRIT J NEUROSURG, V17, P230, DOI 10.1080/0268869031000153107
   van Aalst J, 2009, CHILD NERV SYST, V25, P191, DOI 10.1007/s00381-008-0669-6
   Yamada S, 2007, CHILD NERV SYST, V23, P371, DOI 10.1007/s00381-006-0276-3
NR 16
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 148
EP 153
DI 10.1016/j.wneu.2019.08.016
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300147
PM 31430540
DA 2020-05-12
ER

PT J
AU Nonaka, Y
   Atsumi, H
   Sorimachi, T
   Matsumae, M
AF Nonaka, Yoichi
   Atsumi, Hideki
   Sorimachi, Takatoshi
   Matsumae, Mitsunori
TI Recurrent Trigeminal Neuralgia Caused by a Subsequently Developed
   Offending Artery Within a Short Period
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior inferior cerebellar artery; Microvascular decompression;
   Recurrent trigeminal neuralgia; Root exit zone; Superior cerebellar
   artery
ID MICROVASCULAR DECOMPRESSION; COMPRESSION; NERVE
AB BACKGROUND: Recurrent trigeminal neuralgia after successful microvascular decompression is not rare.
   CASE DESCRIPTION: A 72-year-old woman who presented with typical right trigeminal neuralgia had been successfully treated by microvascular decompression with transposition of the superior cerebellar artery. However, she complained of trigeminal neuralgia on the ipsilateral side 14 months after the microvascular decompression. Redo microvascular decompression showed that the anterior inferior cerebellar artery, which had not been detected at the initial surgery, compressed the right trigeminal nerve.
   CONCLUSIONS: This case is an unusual type of recurrent trigeminal neuralgia because of a subsequently developed offending vessel within a short period.
C1 [Nonaka, Yoichi; Atsumi, Hideki; Sorimachi, Takatoshi; Matsumae, Mitsunori] Tokai Univ, Dept Neurosurg, Sch Med, Hiratsuka, Kanagawa, Japan.
RP Nonaka, Y (reprint author), Tokai Univ, Dept Neurosurg, Sch Med, Hiratsuka, Kanagawa, Japan.
EM ynonaka1971@yahoo.co.jp
OI NONAKA, YOICHI/0000-0001-5509-6175
CR Bakker NA, 2014, J NEUROSURG, V121, P936, DOI 10.3171/2014.7.JNS132667
   Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701
   CHO DY, 1994, NEUROSURGERY, V35, P665, DOI 10.1227/00006123-199410000-00012
   Gu WT, 2014, J CLIN NEUROSCI, V21, P1549, DOI 10.1016/j.jocn.2013.11.042
   Inoue H, 2016, NEUROL MED-CHIR, V56, P77, DOI 10.2176/nmc.cr.2015-0227
   Inoue H, 2013, NEUROL MED-CHIR, V53, P37, DOI 10.2176/nmc.53.37
   Ishibashi H, 1997, JPN J NEUROSURG, V6, P498
   JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159
   Kondo A, 1997, NEUROSURGERY, V40, P46, DOI 10.1097/00006123-199701000-00009
   Kureshi SA, 1998, NEUROSURGERY, V43, P1111, DOI 10.1097/00006123-199811000-00061
   Tatli M, 2008, ACTA NEUROCHIR, V150, P243, DOI 10.1007/s00701-007-1488-3
   Ugwuanyi UCPC, 2010, BRIT J NEUROSURG, V24, P26, DOI 10.3109/02688690903507489
NR 12
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 154
EP 160
DI 10.1016/j.wneu.2019.08.200
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300148
PM 31493610
DA 2020-05-12
ER

PT J
AU Collazo-Gutierrez, N
   de Jesus, O
   Villamil-Jarauta, M
   Alvarado, M
   Gonzalez, L
   Ramirez, M
   Carlo-Chevere, VJ
AF Collazo-Gutierrez, Naomi
   de Jesus, Orlando
   Villamil-Jarauta, Maria
   Alvarado, Milliette
   Gonzalez, Loida
   Ramirez, Margarita
   Carlo-Chevere, Victor J.
TI Double Pituitary Adenomas with Synchronous Somatotroph and Corticotroph
   Clinical Presentation of Acromegaly and Cushing's Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acromegaly; Cushing's disease; Double; Multiple; Pituitary adenoma;
   Synchronous
ID ADRENOCORTICOTROPIC HORMONE; GROWTH-HORMONE; PATHOGENESIS; PATIENT;
   PIT-1; GH
AB BACKGROUND: Double pituitary adenomas are a rare occurrence. Synchronous clinical manifestation is extremely rare.
   CASE DESCRIPTION: We report a case of a 51-year-old female with symptoms of both hypercortisolism and acromegaly during the past 2 years. Endocrine evaluation confirmed active acromegaly and revealed adrenocorticotropin hormone-dependent hypercortisolemia. Preoperative magnetic resonance imaging of the pituitary demonstrated separated double microadenomas with different intensity. Immunohistochemical analysis of each separate adenoma confirmed an exact diagnosis. The diagnosis of acromegaly and adrenocorticotropin hormone-dependent Cushing's disease was confirmed.
   CONCLUSIONS: This is the third reported case in the literature of synchronous clinical manifestation of acromegaly and Cushing's disease. Extensive surgical exploration of the sella must be performed to avoid surgical failures from residual tumor. Immunohistochemical analysis is required to confirm an exact diagnosis for each of the double pituitary adenomas.
C1 [Collazo-Gutierrez, Naomi; Villamil-Jarauta, Maria; Alvarado, Milliette; Gonzalez, Loida; Ramirez, Margarita] Univ Puerto Rico, Sect Endocrinol, San Juan, PR 00936 USA.
   [de Jesus, Orlando] Univ Puerto Rico, Sect Neurosurg, San Juan, PR 00936 USA.
   [Carlo-Chevere, Victor J.] Puerto Rico Pathol Associates, San Juan, PR USA.
RP de Jesus, O (reprint author), Univ Puerto Rico, Sect Neurosurg, San Juan, PR 00936 USA.
EM drodejesus@aol.com
CR Andrioli M, 2010, ENDOCR J, V57, P833, DOI 10.1507/endocrj.K10E-140
   APEL RL, 1994, ENDOCR PATHOL, V5, P240, DOI 10.1007/BF02921493
   ARITA K, 1991, ENDOCRINOL JAPON, V38, P271
   BLEVINS LS, 1992, AM J MED SCI, V304, P294, DOI 10.1097/00000441-199211000-00005
   Budan RM, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00001
   Jastania RA, 2005, ENDOCR PATHOL, V16, P187, DOI 10.1385/EP:16:3:187
   Jiang XB, 2013, ENDOCRINOL METAB, V28, P245, DOI 10.3803/EnM.2013.28.4.245
   Kageyama K, 2002, AM J MED SCI, V324, P326, DOI 10.1097/00000441-200212000-00007
   Kim K, 2004, CLIN ENDOCRINOL, V61, P26, DOI 10.1111/j.1365-2265.2004.02055.x
   Kobayashi Y, 2014, ENDOCR J, V61, P589, DOI 10.1507/endocrj.EJ14-0093
   KONTOGEORGOS G, 1992, NEUROSURGERY, V31, P840, DOI 10.1227/00006123-199211000-00003
   KONTOGEORGOS G, 1991, J NEUROSURG, V74, P243, DOI 10.3171/jns.1991.74.2.0243
   Kovacs K, 1998, J NEUROSURG, V88, P1111, DOI 10.3171/jns.1998.88.6.1111
   Mazarakis N, 2001, Pituitary, V4, P215, DOI 10.1023/A:1020764013137
   Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40
   Mendola M, 2014, HORM-INT J ENDOCRINO, V13, P574, DOI 10.14310/horm.2002.1503
   Mete O, 2018, ENDOCR PATHOL, V29, P332, DOI 10.1007/s12022-018-9545-4
   Ogando-Rivas E, 2017, PITUITARY, V20, P702, DOI 10.1007/s11102-017-0826-6
   Oki K, 2009, J NEUROSURG, V110, P369, DOI 10.3171/2008.8.JNS08154
   Pu JJ, 2016, ONCOL LETT, V12, P585, DOI 10.3892/ol.2016.4673
   Ratliff JK, 2000, J NEUROSURG, V93, P753, DOI 10.3171/jns.2000.93.5.0753
   Roberts S, 2016, PITUITARY, V19, P472, DOI 10.1007/s11102-016-0727-0
   Tahara S, 2002, MODERN PATHOL, V15, P1102, DOI 10.1097/01.MP.0000030451.28828.00
   Takiguchi T, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0203-5
   Tsuchiya K, 2006, ENDOCR J, V53, P679, DOI 10.1507/endocrj.K06-031
   Zielinski G, 2013, ENDOCR PATHOL, V24, P92, DOI 10.1007/s12022-013-9237-z
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 161
EP 164
DI 10.1016/j.wneu.2019.08.224
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300149
PM 31505284
DA 2020-05-12
ER

PT J
AU Storey, C
   Lebovitz, J
   Sweid, A
   Tjoumakaris, S
   Gooch, R
   Rosenwasser, RH
   Jabbour, P
AF Storey, Christopher
   Lebovitz, Jonathon
   Sweid, Ahmad
   Tjoumakaris, Stavropoula
   Gooch, Reid
   Rosenwasser, Robert H.
   Jabbour, Pascal
TI Bilateral Mechanical Thrombectomies for Simultaneous MCA Occlusions
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bilateral MCA Stroke; Endovascular treatment; Ischemic Stroke;
   Mechanical Thrombectomy
ID CATHETER ABLATION; BLEEDING COMPLICATIONS; PERIPROCEDURAL STROKE;
   ATRIAL-FIBRILLATION; SAFETY; ARTERY; THROMBOEMBOLISM; ANTICOAGULATION;
   MANAGEMENT
AB BACKGROUND: Bilateral hemispheric dysfunction is devastating to consciousness. We present a unique case of a patient who developed bilateral middle cerebral artery infarcts with significant neurological improvement post bilateral thrombolysis in cerebral infarction (TICI) 3 thrombectomies.
   CASE DESCRIPTION: The patient is a 64-year-old woman who presented 3 hours after her husband was awakened and found her with left hemiplegia. She had a history of atrial fibrillation and had her apixaban held for 5 days before the coronary angiogram that she received the day before arrival. Upon presentation, she was antigravity on the right side and withdrawing on the left side. Computed tomography angiogram showed a right M1 occlusion and an left M2 occlusion. Computed tomography perfusion revealed a mismatch with large penumbra, and she was taken for mechanical thrombectomy. Mechanical thrombectomy was performed using a combination of stent retriever and aspiration catheter with a TICI 3 revascularization. By the following morning, the patient was full strength on the right and antigravity on the left with a left facial droop. The patient recovered her speech and was fully oriented before leaving for rehabilitation on postoperative day 3.
   CONCLUSIONS: The transient hypercoagulable state that was created with the withdrawal of apixaban likely increased our patient's risk of stroke. The literature supports continuing oral anticoagulants for endovascular procedures. The devastating consequences of thromboembolic events, whether stroke or pulmonary embolism, can be catastrophic, but luckily, mechanical thrombectomy provides the means to minimize the morbidity and mortality from bilateral infarctions.
C1 [Jabbour, Pascal] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA.
   Jefferson Hosp Neurosci, Philadelphia, PA USA.
RP Jabbour, P (reprint author), Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA.
EM pascal.jabbour@jefferson.edu
OI Sweid, Ahmad/0000-0002-2652-2451
CR Ando M, 2019, HEART VESSELS, V34, P1533, DOI 10.1007/s00380-019-01370-9
   CASTROVIEJO IP, 1971, DEV MED CHILD NEUROL, V13, P613
   Di Biase L, 2015, HEART RHYTHM, V12, P1162, DOI 10.1016/j.hrthm.2015.02.028
   Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426
   Di Biase L, 2010, CIRCULATION, V121, P2550, DOI 10.1161/CIRCULATIONAHA.109.921320
   Gallego-Sanchez G, 2017, J CARDIOL, V69, P561, DOI 10.1016/j.jjcc.2016.04.015
   Genewein U, 1996, BRIT J HAEMATOL, V92, P479, DOI 10.1046/j.1365-2141.1996.d01-1499.x
   GRIP L, 1991, EUR HEART J, V12, P1225, DOI 10.1093/eurheartj/12.11.1225
   Hermans C, 2006, CURR MED RES OPIN, V22, P471, DOI 10.1185/030079906X89801
   Inoue Satoshi, 2016, No Shinkei Geka, V44, P501, DOI 10.11477/mf.1436203318
   JACQUES S, 1975, J NEUROSURG, V42, P217, DOI 10.3171/jns.1975.42.2.0217
   Jamula E, 2010, CHEST, V138, P840, DOI 10.1378/chest.09-2603
   Kirchhof P, 2018, EUR HEART J, V39, P2942, DOI 10.1093/eurheartj/ehy176
   Larrew Thomas, 2020, Oper Neurosurg (Hagerstown), V18, pE143, DOI 10.1093/ons/opz230
   TERPENNING B, 1992, STROKE, V23, P280, DOI 10.1161/01.STR.23.2.280
NR 15
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 165
EP 168
DI 10.1016/j.wneu.2019.08.236
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300150
PM 31505295
DA 2020-05-12
ER

PT J
AU Basaran, AE
   Kiesel, B
   Frischer, JM
   Furtner, J
   Wohrer, A
   Dieckmann, K
   Dorfer, C
AF Basaran, Alim Emre
   Kiesel, Barbara
   Frischer, Josa M.
   Furtner, Julia
   Woehrer, Adelheid
   Dieckmann, Karin
   Dorfer, Christian
TI Intrameningioma Metastasis: A Wolf in Sheep's Clothing? Experience from
   a Series of 7 Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intrameningioma metastasis; Meningioma; Tumor-to-tumor metastasis
ID TO-TUMOR METASTASIS; BREAST-CARCINOMA; INTRACRANIAL MENINGIOMA; CANCER
AB BACKGROUND: Intrameningioma metastasis is a rare differential diagnosis. The clinical implications of these lesions are poorly understood. We screened our database to identify all patients who had been undergone surgery between January 2000 and December 2018 and had been diagnosed with intrameningioma metastasis. Medical charts and radiographic images were reviewed. Brain edema was related to tumor size on preoperative T2-weighted magnetic resonance imaging and classified as little (i.e., less than the tumor size), moderate (i.e., less than triple the size of the tumor), and extensive (i.e., more than triple the size of the tumor).
   CASE DESCRIPTIONS: We identified 7 patients (3 men and 4 women) with a median age of 61 years (range, 33e63 years). A systemic cancer had been diagnosed preoperatively in all patients (lung adenocarcinoma, n = 5; breast adenocarcinoma, n = 1; pancreas adenocarcinoma, n = 1). Mean time interval between diagnosis of the systemic cancer and the intracranial dural mass was 32 months (SD 23.05). The preoperative working diagnosis was meningioma in 5 patients, and metastasis in 2 patients. All patients were symptomatic at the time of diagnosis with a short history of headache (n = 2), nausea (n = 1), and dizziness (n = 1), and 5 patients harbored neurologic deficits, including hemiparesis (n = 2), hemihypesthesia (n = 2), and paresthesia (n = 1). Preoperative images showed brain edema in all patients (extensive, n = 4; moderate, n = 3).
   CONCLUSIONS: Intrameningioma metastases show an aggressive clinical behavior prompting early surgical intervention. Clinicians should be aware of this rare entity when counseling patients.
C1 [Basaran, Alim Emre; Kiesel, Barbara; Frischer, Josa M.; Dorfer, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria.
   [Furtner, Julia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.
   [Woehrer, Adelheid] Med Univ Vienna, Inst Neurol, Vienna, Austria.
   [Dieckmann, Karin] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria.
RP Dorfer, C (reprint author), Med Univ Vienna, Dept Neurosurg, Vienna, Austria.
EM christian.dorfer@meduniwien.ac.at
OI Dorfer, Christian/0000-0002-1843-7732
CR Baratelli G M, 2004, J Neurosurg Sci, V48, P71
   CAMPBELL LV, 1968, CANCER, V22, P635, DOI 10.1002/1097-0142(196809)22:3<635::AID-CNCR2820220320>3.0.CO;2-O
   Caroli E, 2006, NEUROSURG REV, V29, P49, DOI 10.1007/s10143-005-0395-4
   CERVONI L, 1994, NEUROSURG REV, V17, P233, DOI 10.1007/BF00418442
   Doyle S, 2009, CLIN RADIOL, V64, P857, DOI 10.1016/j.crad.2008.08.020
   Elmaci I, 2001, TUMORI, V87, P423
   Fried BM, 1930, AM J PATHOL, V6, P0047
   KOZBOR D, 1984, CANCER RES, V44, P438
   Lanotte M, 2009, CLIN NEUROL NEUROSUR, V111, P87, DOI 10.1016/j.clineuro.2008.07.011
   Lee A, 1998, AM J NEURORADIOL, V19, P1120
   Maillo A, 2007, NEURO-ONCOLOGY, V9, P438, DOI 10.1215/15228517-2007-026
   Moody P, 2012, INT J CLIN EXP PATHO, V5, P367
   Petraki C, 2003, INT J SURG PATHOL, V11, P127, DOI 10.1177/106689690301100214
   ROHRINGER M, 1989, J NEUROSURG, V71, P665, DOI 10.3171/jns.1989.71.5.0665
   Sayegh ET, 2014, RARE TUMORS, V6, P49, DOI 10.4081/rt.2014.5313
   Shimada S, 2005, PATHOL INT, V55, P1, DOI 10.1111/j.1440-1827.2005.01786.x
   SMITH TW, 1981, CANCER, V47, P1872, DOI 10.1002/1097-0142(19810401)47:7<1872::AID-CNCR2820470726>3.0.CO;2-2
   Takei H, 2009, NEUROPATHOLOGY, V29, P303, DOI 10.1111/j.1440-1789.2008.00952.x
   Watanabe T, 2002, AM J CLIN ONCOL-CANC, V25, P414, DOI 10.1097/00000421-200208000-00019
   Widdel L, 2010, WORLD NEUROSURG, V74, P165, DOI 10.1016/j.wneu.2010.01.021
NR 20
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 169
EP 172
DI 10.1016/j.wneu.2019.08.097
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300151
PM 31491578
DA 2020-05-12
ER

PT J
AU Fernandez-de Thomas, RJ
   Vicenty-Padilla, JC
   Sanchez-Jimenez, JG
   Labat, EJ
   Carballo-Cuello, CM
   De Jesus, O
   Vigo-Prieto, JA
AF Fernandez-de Thomas, Ricardo J.
   Vicenty-Padilla, Juan C.
   Sanchez-Jimenez, Jose G.
   Labat, Eduardo J.
   Carballo-Cuello, Cesar M.
   De Jesus, Orlando
   Vigo-Prieto, Juan A.
TI Obstructive Hydrocephalus and Chemical Meningitis Secondary to a
   Ruptured Spinal Epidermoid Cyst
SO WORLD NEUROSURGERY
LA English
DT Article
DE Meningitis; Obstructive hydrocephalus; Ruptured cyst; Spinal epidermoid
   cyst
ID DERMOID TUMORS; FATTY DROPLETS; SPREAD
AB BACKGROUND: Epidermoid cysts of the spinal cord may rupture, resulting in keratin dissemination in the subarachnoid space, in the ventricles, and along the central canal of the spinal cord causing meningitis, myelopathic changes, or hydrocephalus.
   CASE DESCRIPTION: A 53-year-old woman with no past medical history presented with a 2-week history of headache located in the occipital region associated with neck pain. Brain magnetic resonance imaging demonstrated multiple fat droplets scattered throughout the subarachnoid and intraventricular spaces with significant edema of the right posterior temporoparietal lobes with trapping of the right temporal horn of the lateral ventricle and atrium. An intracranial lesion could not be observed in the study. The spinal region was suspected as the possible culprit, and spinal imaging showed a large cystic lesion at the level of the conus medullaris. The patient underwent neuronavigation endoscopic exploration of the right lateral ventricle with flushing of the keratin particles followed by a posterior lumbar decompression with resection of the epidermoid cyst. Pathology was consistent with an epidermoid cyst. Successful recovery with improvement in symptoms was quickly observed.
   CONCLUSIONS: When an epidermoid cyst is suspected but no intracranial lesion is found, the intraspinal area should be studied. Rupture of a spinal epidermoid cyst may cause meningitis and inflammation producing obstructive hydrocephalus. We present this rare entity and describe the diagnostic and surgical techniques used.
C1 [Fernandez-de Thomas, Ricardo J.; Vicenty-Padilla, Juan C.; Sanchez-Jimenez, Jose G.; Carballo-Cuello, Cesar M.; De Jesus, Orlando; Vigo-Prieto, Juan A.] Univ Puerto Rico, Sch Med, Dept Surg, Sect Neurosurg, San Juan, PR 00936 USA.
   [Labat, Eduardo J.] Univ Puerto Rico, Sch Med, Dept Radiol Sci & Diagnost Radiol, San Juan, PR 00936 USA.
RP Fernandez-de Thomas, RJ (reprint author), Univ Puerto Rico, Sch Med, Dept Surg, Sect Neurosurg, San Juan, PR 00936 USA.
EM ricardo.fernandez3@upr.edu
CR Calabro F, 2000, NEURORADIOLOGY, V42, P572, DOI 10.1007/s002340000345
   DONOGHUE V, 1984, J COMPUT ASSIST TOMO, V8, P143, DOI 10.1097/00004728-198402000-00031
   Khanna S, 2015, J NEUROSCI RURAL PRA, V6, P286, DOI 10.4103/0976-3147.150314
   Kim YB, 1999, J KOREAN NEUROSURG S, V28, P368
   Mongia S, 2002, NEUROL INDIA, V50, P529
   SCOTT RM, 1986, J NEUROSURG, V65, P779, DOI 10.3171/jns.1986.65.6.0779
   Teksam M, 2001, NEURORADIOLOGY, V43, P572, DOI 10.1007/s002340000526
   Zhang Y, 2013, J NEUROIMAGING, V23, P71, DOI 10.1111/j.1552-6569.2012.00750.x
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 173
EP 176
DI 10.1016/j.wneu.2019.08.187
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300152
PM 31491571
DA 2020-05-12
ER

PT J
AU Imahori, T
   Shose, H
   Okamura, Y
   Kohmura, E
AF Imahori, Taichiro
   Shose, Hiroyasu
   Okamura, Yusuke
   Kohmura, Eiji
TI Deploying 5 Overlapping Enterprise Stents and Coiling for Treating
   Hemorrhagic Vertebral Artery Dissecting Aneurysm
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endovascular treatment; Overlapping stent; Subarachnoid hemorrhage;
   Vertebral artery dissecting aneurysm
ID ENDOVASCULAR TREATMENT
AB BACKGROUND: Reconstructive endovascular treatment is a method that can ameliorate vertebral artery dissecting aneurysm (VADA) and preserve the parent artery. Recently, 2 or 3 overlapping stents have been used to treat VADAs through the flow-diversion effect. However, little is known about the use of >3 overlapping stents for acute treatment of hemorrhagic VADA.
   CASE DESCRIPTION: A 69-year-old woman was admitted to our institute with the sudden onset of a headache. Brain computed tomography revealed a subarachnoid hemorrhage. Cerebral angiography revealed a VADA in the right intracranial vertebral artery. The contralateral vertebral artery was hypoplastic; thus we performed a reconstructive endovascular procedure using multiple overlapping stents combined with coiling. We used 5 overlapping stents with the aim of preventing coil herniation, fixing the jailed microcatheter, and reinforcing flow diversion and achieved immediate occlusion of the aneurysmal component. Postoperative imaging showed no apparent infarction in the brainstem. Six months after the treatment, angiography revealed complete occlusion of the aneurysm. Therefore in this case, hemorrhagic VADA was successfully treated in the acute setting by 5 overlapping Enterprise stents and coiling, which also preserved the parent artery.
   CONCLUSIONS: Reconstructive endovascular treatment using multiple overlapping stents and coiling may be a beneficial therapy for hemorrhagic VADA, especially when the contralateral vertebral artery is aplastic or hypoplastic. Using >3 overlapping stents may represent a promising, feasible technique for achieving immediate occlusion by increasing flow diversion.
C1 [Imahori, Taichiro; Shose, Hiroyasu; Okamura, Yusuke] Kobe Univ, Toyooka Hosp, Dept Neurosurg, Grad Sch Med, Toyooka, Hyogo, Japan.
   [Kohmura, Eiji] Kobe Univ, Dept Neurosurg, Grad Sch Med, Kobe, Hyogo, Japan.
RP Imahori, T (reprint author), Kobe Univ, Toyooka Hosp, Dept Neurosurg, Grad Sch Med, Toyooka, Hyogo, Japan.
EM taichiro.imahori@gmail.com
OI Imahori, Taichiro/0000-0002-8744-3044
CR Chung Y, 2017, WORLD NEUROSURG, V99, P79, DOI 10.1016/j.wneu.2016.11.118
   Guerrero WR, 2018, WORLD NEUROSURG, V109, pE164, DOI 10.1016/j.wneu.2017.09.125
   Jeon P, 2012, AM J NEURORADIOL, V33, P965, DOI 10.3174/ajnr.A2857
   Kim BM, 2011, STROKE, V42, P2425, DOI 10.1161/STROKEAHA.111.617381
   Kim M, 2007, NEUROSURGERY, V61, P1305, DOI 10.1227/01.NEU.0000280168.25968.49
   Lieber BB, 1997, ANN BIOMED ENG, V25, P460, DOI 10.1007/BF02684187
   Maus V, 2018, WORLD NEUROSURG, V111, pE424, DOI 10.1016/j.wneu.2017.12.095
   MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003
   Sonmez O, 2015, AM J NEURORADIOL, V36, P1293, DOI 10.3174/ajnr.A4360
   Song J, 2016, ACTA NEUROCHIR, V158, P803, DOI 10.1007/s00701-016-2721-8
   Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067169
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 177
EP 181
DI 10.1016/j.wneu.2019.08.226
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300153
PM 31505281
DA 2020-05-12
ER

PT J
AU Rozman, PA
   Benjamin, CG
   Kondziolka, D
   Sen, C
   Roland, JT
   Zagzag, D
   Snuderl, M
   Gordon, D
AF Rozman, Peter A.
   Benjamin, Carolina G.
   Kondziolka, Douglas
   Sen, Chandranath
   Roland, J. Thomas, Jr.
   Zagzag, David
   Snuderl, Matija
   Gordon, David
TI Intraosseous Petrous Apex Schwannoma: Case Report and Review of
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Intraosseous schwannoma; Petrous apex schwannoma; Radiosurgery;
   Transtemporal approach
ID NEURILEMOMA; DIAGNOSIS
AB BACKGROUND: Intraosseous petrous apex schwannomas are an exceedingly rare entity; little is known about their epidemiology, natural history, and postoperative outcomes.
   CASE DESCRIPTION: Here, we present the fourth known case of a primary intraosseous schwannoma of the petrous apex: a 68-year-old woman presenting with diplopia, facial numbness, progressive intermittent vertigo, tinnitus, diminished hearing, and ataxia. She underwent a transtemporal approach for subtotal resection of the tumor with subsequent stereotactic radiosurgery.
   CONCLUSIONS: Our 2-year follow-up demonstrates slow growth and success of multimodal management in the treatment of these tumors. We review the 3 prior reports of petrous apex schwannomas and identify unifying radiographic and clinical characteristics to aid future diagnostic considerations of lesions of the petrous apex.
C1 [Rozman, Peter A.; Benjamin, Carolina G.; Kondziolka, Douglas; Sen, Chandranath; Roland, J. Thomas, Jr.; Zagzag, David; Gordon, David] NYU Langone Hlth, Dept Neurosurg, New York, NY 10016 USA.
   [Kondziolka, Douglas] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA.
   [Roland, J. Thomas, Jr.] NYU Langone Hlth, Dept Otolaryngol, New York, NY USA.
   [Zagzag, David; Snuderl, Matija] NYU Langone Hlth, Dept Pathol, New York, NY USA.
RP Rozman, PA (reprint author), NYU Langone Hlth, Dept Neurosurg, New York, NY 10016 USA.
EM Peter.Rozman@nyulangone.org
OI Gordon, David/0000-0003-1752-4946; Roland, Jr., J.
   Thomas/0000-0003-1181-4651; Kondziolka, Douglas/0000-0001-8925-7344;
   Snuderl, Matija/0000-0003-0752-0917; Sen,
   Chandranath/0000-0003-1603-2958
CR FAWCETT KJ, 1967, AM J CLIN PATHOL, V47, P759
   Goiney C, 2011, J RADIOL CASE REP, V5, P8, DOI 10.3941/jrcr.v5i11.859
   HORN KL, 1995, SKULL BASE SURG, V5, P261, DOI 10.1055/s-2008-1058924
   Isaacson B, 2007, OTOLARYNG CLIN N AM, V40, P479, DOI 10.1016/j.otc.2007.03.003
   JACKLER RK, 1992, AM J OTOL, V13, P561
   KOEPPEN AH, 1968, ARCH NEUROL-CHICAGO, V18, P567, DOI 10.1001/archneur.1968.00470350125012
   MASON TH, 1968, J NEUROSURG, V29, P414, DOI 10.3171/jns.1968.29.4.0414
   Mizutani A, 2010, BRIT J NEUROSURG, V24, P604, DOI 10.3109/02688697.2010.495168
   Muckle RP, 1998, AM J OTOL, V19, P219
   Pekmezci M, 2015, MODERN PATHOL, V28, P187, DOI 10.1038/modpathol.2014.109
   SOLODNIK P, 1986, J COMPUT ASSIST TOMO, V10, P1027, DOI 10.1097/00004728-198611000-00025
   Tamura R, 2015, J NEUROL SURG REP, V76, P135, DOI 10.1055/s-0035-1549312
   WOOD WG, 1975, J NEUROSURG, V42, P465, DOI 10.3171/jns.1975.42.4.0465
NR 13
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 182
EP 187
DI 10.1016/j.wneu.2019.08.157
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300154
PM 31476472
DA 2020-05-12
ER

PT J
AU Campero, A
   Baldoncini, M
   Villalonga, JF
   Abarca-Olivas, J
AF Campero, Alvaro
   Baldoncini, Matias
   Villalonga, Juan F.
   Abarca-Olivas, Javier
TI Three-Dimensional Microscopic Surgical Videos: A Novel and Low-cost
   System
SO WORLD NEUROSURGERY
LA English
DT Article
DE Microsurgery; Neurosurgical teaching; Surgical anatomy;
   Three-dimensional videos
ID NEUROSURGICAL EDUCATION; 3D; TOOL; NEUROANATOMY
AB INTRODUCTION: Three-dimensional (3D) imaging and videos are a very useful tool in the neurosurgical training, although unfortunately the 3D systems available have a very high cost. The objective of this study is to describe a novel and low-cost 3D microsurgical video system.
   METHODS: To obtain the 3D videos we use a surgical microscope, 2 video adapters, 2 cameras, and an HDMI cable. A video editor program is used for processing the videos. For the projection we use a computer with PowerPoint (Microsoft, Inc, Redmond, WA) software, a video splitter, DVI cables, 2 projectors, 2 polarization filters, and a "silver screen" with polarized glasses.
   RESULTS: By using 2 equal cameras and video adaptors in each beam splitter port it was possible for us to obtain 2 videos that were equivalent to the images received by both surgeon's eyes. Using the video signal of both cameras during processing resulted in a 3D stereoscopic recording with Final Cut (Apple, Inc, Cupertino, CA) software. The polarized 3D format provided the best projection conditions. It does not alter the original colors of the videos and its prolonged visualization was more comfortable. The main advantage of this method is the ability to show in a realistic way the spatial relationships and the depth of the structures captured with the microscope.
   CONCLUSIONS: This paper presents in a clear and detailed way how to create and use a low-cost 3D surgical video system.
C1 [Campero, Alvaro; Villalonga, Juan F.] Univ Nacl Tucuman, Fac Med, LINT, San Miguel De Tucuman, Argentina.
   [Campero, Alvaro] Hosp Padilla, Dept Neurol Surg, San Miguel De Tucuman, Argentina.
   [Baldoncini, Matias] Hosp San Fernando, Dept Neurol Surg, Buenos Aires, DF, Argentina.
   [Abarca-Olivas, Javier] Hosp Gen Alicante, Dept Neurosurg, Alicante, Spain.
RP Campero, A (reprint author), Univ Nacl Tucuman, Fac Med, LINT, San Miguel De Tucuman, Argentina.; Campero, A (reprint author), Hosp Padilla, Dept Neurol Surg, San Miguel De Tucuman, Argentina.
EM alvarocampero@yahoo.com.ar
OI Baldoncini, Matias/0000-0001-9323-8306
CR Barone DG, 2014, BRIT J NEUROSURG, V28, P819, DOI 10.3109/02688697.2014.931348
   Bassett DL, 1961, STEREOSCOPIC ATLAS H
   Brewer Danielle N, 2012, Stud Health Technol Inform, V173, P85
   Brewster David, 1856, STEREOSCOPE ITS HIST
   Brown PM, 2012, CLIN TEACH, V9, P50, DOI 10.1111/j.1743-498X.2011.00488.x
   Campero A, 2020, OPER NEUROSURG, V18, pE81, DOI 10.1093/ons/opz138
   Chase RA, 1994, STEREOSCOPIC ATLAS H
   Drapkin ZA, 2015, ANAT SCI EDUC, V8, P502, DOI 10.1002/ase.1509
   Ferwerda JG, 1990, WORLD 3 D PRACTICAL
   Henn JS, 2002, J NEUROSURG, V96, P144, DOI 10.3171/jns.2002.96.1.0144
   Howard BJR., 1995, BINOCULAR VISION STE
   Martins C, 2015, J NEUROSURG, V123, P1077, DOI 10.3171/2014.10.JNS13542
   McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475
   Meneses MS, 2002, ARQ NEURO-PSIQUIAT, V60, P769
   Nowinski WL, 2011, NEUROIMAGE, V55, P986, DOI 10.1016/j.neuroimage.2010.12.079
   Nowinski WL, 2013, J NEUROSCI METH, V215, P12, DOI 10.1016/j.jneumeth.2013.02.005
   Petersson H, 2009, ANAT SCI EDUC, V2, P61, DOI 10.1002/ase.76
   Ribas GC, 2001, J NEUROSURG, V95, P1057, DOI 10.3171/jns.2001.95.6.1057
   Satava RM, 1998, SCIENCES, V38, P34, DOI 10.1002/j.2326-1951.1998.tb03676.x
   Spottiswoode Raymond, 1953, THEORY STEREOSCOPIC
   Trelease RB, 1998, CLIN ANAT, V11, P89, DOI 10.1002/(SICI)1098-2353(1998)11:2<89::AID-CA4>3.0.CO;2-N
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 188
EP 196
DI 10.1016/j.wneu.2019.08.139
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300155
PM 31476454
DA 2020-05-12
ER

PT J
AU Womack, R
   Luther, E
   Perez-Roman, RJ
   Manzano, GR
AF Womack, Rachel
   Luther, Evan
   Perez-Roman, Roberto J.
   Manzano, Glen R.
TI Heterotopic Bone Formation 20 Years After Gunshot Wound to the Cervical
   Spine: A Rare Cause of Progressive Cervical Myelopathy in a Previously
   Asymptomatic Patient
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical spine injury; Gunshot wound; Heterotopic ossification;
   Myelopathy; Radiculopathy; Retained bullet fragments
ID CORD-INJURY; PENETRATING INJURIES; BULLET; OSSIFICATION; MANAGEMENT
AB BACKGROUND: Gunshot wounds are the most common etiology of penetrating spine injuries and have been increasing in incidence in civilian populations. Although these injuries typically result in severe neurologic deficits, operative intervention remains is controversial and is usually reserved for patients with neurologic deterioration, a persistent externalized cerebrospinal fluid fistula, mechanical instability, metallic toxicity, or a bullet location at high risk of migration.
   CASE DESCRIPTION: A previously asymptomatic patient who had sustained a gunshot wound to the cervical spine 20 years previously presented with new-onset progressive myelopathy and radiculopathy secondary to heterotopic ossification (HO) surrounding the retained bullet fragments near the left lateral masses of C5-T1. Computed tomography myelography demonstrated no cranial migration of contrast material past this region of the spine, suggesting severe spinal canal stenosis. Intraoperatively, bullet shrapnel and heterotopic bone fragments were found within the central canal causing compression of the spinal cord. Following decompression and stabilization, the patient had complete resolution of his symptoms and returned to his neurologic baseline. Although HO has been reported as a complication following through and through gunshot wounds, there is a paucity of literature discussing HO formation around retained bullet fragments in the spine.
   CONCLUSIONS: HO surrounding retained bullet fragments in the spine is a rare cause of progressive neurologic deterioration following gunshot wounds. Surgical excision of the shrapnel and heterotopic bone can lead to symptomatic relief, and therefore surgery should be considered as a treatment option in carefully selected patients.
C1 [Womack, Rachel; Luther, Evan; Perez-Roman, Roberto J.; Manzano, Glen R.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
RP Womack, R (reprint author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
EM rachel.womack@med.miami.edu
OI Luther, Evan/0000-0001-9164-4984
CR Azevedo HRC, 2001, NEUROSURG QUART, V11, P199, DOI 10.1097/00013414-200109000-00003
   Chittiboina P, 2011, J CLIN NEUROSCI, V18, P1630, DOI 10.1016/j.jocn.2011.02.047
   Cristante AF, 2010, SPINE, V35, pE140, DOI 10.1097/BRS.0b013e3181ba023e
   de Barros TEP, 2014, SPINAL CORD, V52, P504, DOI 10.1038/sc.2014.56
   Farmer JC, 1998, J SPINAL DISORD, V11, P400
   Federico Massimo D, 2009, J Trauma, V67, pE29, DOI 10.1097/TA.0b013e31804a7ff0
   FETTERMAN BL, 1995, LARYNGOSCOPE, V105, P8, DOI 10.1288/00005537-199501000-00005
   Finitsis SN, 1999, AM J NEURORADIOL, V20, P354
   HAMMOUD MA, 1995, SURG NEUROL, V43, P432, DOI 10.1016/0090-3019(95)80086-V
   Heary RF, 1996, ORTHOP CLIN N AM, V27, P69
   Jaiswal M, 2013, ASIAN SPINE J, V7, P359, DOI 10.4184/asj.2013.7.4.359
   Kafadar AM, 2006, SPINAL CORD, V44, P326, DOI 10.1038/sj.sc.3101808
   Klimo P, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1036
   Le Roux JC, 2005, S AFR J SURG, V43, P165
   Patil R, 2015, J CRANIOVERTEBRAL JU, V6, P149, DOI 10.4103/0974-8237.167855
   PEACOCK WJ, 1977, S AFR MED J, V51, P961
   RAO PM, 1993, SURGERY, V114, P527
   Rentfrow B, 2013, EUR SPINE J, V22, P2353, DOI 10.1007/s00586-013-2805-6
   ROBERTSON DP, 1992, NEUROSURGERY, V31, P265, DOI 10.1227/00006123-199208000-00011
   Sidhu GS, 2013, CLIN ORTHOP RELAT R, V471, P3945, DOI 10.1007/s11999-013-2901-2
   van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309
   Waters RL, 2003, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.0000052067.43194.dc
   WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 197
EP 201
DI 10.1016/j.wneu.2019.08.093
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300156
PM 31450001
DA 2020-05-12
ER

PT J
AU Schlaff, CD
   Sack, KD
   Elliott, RJ
   Rosner, MK
AF Schlaff, Cody D.
   Sack, Kenneth D.
   Elliott, Ross-Jordon
   Rosner, Michael K.
TI Early Experience with Electric Scooter Injuries Requiring Neurosurgical
   Evaluation in District of Columbia: A Case Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Head; Scooters; Spine; Trauma
AB BACKGROUND: To decrease vehicular traffic in major metropolitan cities throughout the United States, multiple ridesharing companies have launched dockless electric scooters and bicycles throughout cities. From September 2017 through November 2018, Washington, DC, launched a 15-month dockless vehicle pilot program to allow for the rapid entry and growth of electric scooters within the metropolitan area. This rapid growth resulted in a number of minor and significant injuries.
   CASE DESCRIPTION: We reviewed the electronic medical record of The George Washington University Hospital to investigate and characterize the types of electric scootererelated injuries resulting in neurosurgical consultation in the 15-month period of the Washington, DC, scooter pilot program. Thirteen patients sustained injuries serious enough to merit neurosurgical consultation, including 1 patient whose symptoms required procedural intervention by a neurointerventional radiologist and another patient who was pronounced dead soon after arrival to the hospital.
   CONCLUSIONS: In this case series, we highlight more severe injuries that resulted in hospitalization or intervention, including skull fracture, central cord syndrome, and vertebral compression fracture. This case series aims to illustrate the potential severity of injuries related to electric scooters, raise awareness on the issues of safety and public health, and call for further investigation into injuries relating to electric scooters.
C1 [Schlaff, Cody D.; Sack, Kenneth D.; Elliott, Ross-Jordon; Rosner, Michael K.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Schlaff, Cody D.; Sack, Kenneth D.; Elliott, Ross-Jordon; Rosner, Michael K.] George Washington Univ Hosp, Dept Neurol Surg, Washington, DC 20037 USA.
RP Schlaff, CD (reprint author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.; Schlaff, CD (reprint author), George Washington Univ Hosp, Dept Neurol Surg, Washington, DC 20037 USA.
EM cody_schlaff90@gwu.edu
CR Anderson B, 2018, THE SACRAMENTO BEE
   BBC News, 2018, BBC NEWS
   Clabaugh J., 2018, BUSINESS FINANCE
   Clewlow R, 2018, DC IS GROWING ITS DO
   Felton R., 2019, CONSUMER REPORTS
   Hamilton I.A., 2019, BUSINESS INSIDER
   Holley P., 2018, WASHINGTON POST
   Lazo L., DC ALLOWS DOCKLESS B
   Lou M., 2019, CNN
   Papoutsi S, 2014, EMERG MED INT, DOI 10.1155/2014/850236
   Siman-Tov M, 2017, TRAFFIC INJ PREV, V18, P318, DOI 10.1080/15389588.2016.1246723
   Social Bicycles Inc, 2017, PR NEWSWIRE
   Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381
   Widner C., 2019, CURBED AUSTIN
   Zhou SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007395
   Zimmerman H., 2019, ELECT SCOOTERS PROLI
NR 16
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 202
EP 207
DI 10.1016/j.wneu.2019.08.237
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300157
PM 31505288
DA 2020-05-12
ER

PT J
AU Terrier, LM
   Leveque, M
   Amelot, A
AF Terrier, Louis-Marie
   Leveque, Marc
   Amelot, Aymeric
TI Brain Lobotomy: A Historical and Moral Dilemma with No Alternative?
SO WORLD NEUROSURGERY
LA English
DT Article
DE Egas Moniz; Lobotomy; Psychosurgery
AB BACKGROUND: Pioneered in 1936 by Portuguese neurologist and politician Egas Moniz, lobotomy was a definitive lesional surgery on the brain, which consisted of splitting the white fibers in the frontal lobes. Sixteen years later, the first antipsychotic medication appeared at Sainte-Anne Mental Hospital in Paris, drastically reducing the number of surgical lobotomies in France and worldwide. Lobotomy has been one of the most criticized medical procedures in history, with thousands of patients lobotomized around the world and causing serious consequences to their personalities and intellectual function. -
   METHODS: In the 1940s, the French language was widely used as an alternative language in medical studies, the reason we decided to focus a francophone review on this subject. We conducted the first francophone review of the reported data for the period from 1935 to 1985. Moreover, for a clearer understanding of the background of the time, we also studied the social historical environment. -
   RESULTS: A total of 1340 cases of lobotomized patients were identified through a review of 29 studies. The indications had varied and were not limited to mental illness. Lobotomy was also performed in some rare cases on patients with peptic ulcers or ulcerative colitis to stop gastrointestinal hemorrhage. The lobotomy techniques were numerous, varying from classic lobotomy to the transorbital injection of radioactive iridium 194.
   CONCLUSION: We have discussed the psychiatric, societal, and media contexts that led to the emergence of lobotomy. Our aim was to highlight this period in the history of medicine and place the medical practice into perspective.
C1 [Terrier, Louis-Marie] Univ Tours, UMR Inserm U1253, Univ Hosp Tours, Neurosurg Dept,iBrain, Tours, France.
   [Terrier, Louis-Marie] Med Univ Tours, Lab Anat, Tours, France.
   [Leveque, Marc] Parc Hosp, Marseille, France.
   [Amelot, Aymeric] La Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France.
   [Amelot, Aymeric] Sorbonne Univ, Pierre & Marie Curie Sch Med, Paris, France.
RP Amelot, A (reprint author), La Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France.; Amelot, A (reprint author), Sorbonne Univ, Pierre & Marie Curie Sch Med, Paris, France.
EM aymmed@hotmail.fr
CR AMBROSELLI C, 1984, HASTINGS CENT REP, V14, P20, DOI 10.2307/3561741
   ANGLADE L, 1955, Ann Med Psychol (Paris), V113 1, P420
   Babe J, 1992, THESIS
   Baruk H, 1951, MED MOSAIQUE LOBOTOM
   Braslow J, 1999, WESTERN J MED, V170, P293
   Brejot A., 1951, THESIS
   BUCAILLE M, 1957, Concours Med, V79, P2013
   CATOIRE J, 1959, Scalpel (Brux), V112, P1063
   CATTAN R, 1957, Acta Gastroenterol Belg, V20, P515
   Collins BM, 2014, J HIST NEUROSCI, V23, P335, DOI 10.1080/0964704X.2013.862123
   COQUET P, 1958, Pediatrie, V13, P167
   COSYNS-DURET S, 1954, Acta Neurol Psychiatr Belg, V54, P378
   DAUMEZON G, 1953, Tech Hosp Med Soc Sanit, V8, P21
   DESCUNS P, 1958, Ann Med Psychol (Paris), V116, P855
   FEUILLET C, 1959, Rev Med Nancy, V84, P628
   Fiamberti AM., 1937, RASS STUD PSICHIAT, V26, P797
   Fiamberti AM, 1939, GIOR PSICHIAT NEUROP, V67, P291
   Freeman W., 1942, BULL NEW YORK ACAD MED, V18, P794
   FROMENTY L, 1956, Rev Otoneuroophtalmol, V28, P157
   Fulton JF, 1935, 2 INT NEUR C LOND, P70
   GACHES MJ, 1966, NEUROCHIRURGIE, V12, P547
   HOFFMANN G R, 1954, Acta Neurol Psychiatr Belg, V54, P388
   Jareczek FJ, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.6.FOCUS17227
   KNIGHT GC, 1955, LANCET, V1, P981
   Lazorthes G, 1967, Ann Chir, V21, P1003
   LAZORTHES G, 1963, NEURO-CHIR, V9, P97
   LEY J, 1954, Acta Neurol Psychiatr Belg, V54, P317
   Lima A, 1974, J Neurol, V207, P167, DOI 10.1007/BF00312557
   MASSION-VERNIORY L, 1954, Acta Neurol Psychiatr Belg, V54, P331
   MASSOT, 1955, J Med Lyon, V36, P745
   MESLE F, 1981, POPULATION, V36, P1035, DOI 10.2307/1532324
   MESSIMY R, 1952, Arq Neuropsiquiatr, V10, P305
   MONDAIN P, 1956, Toulouse Med, V57, P375
   Ogren Kenneth, 2005, J Hist Neurosci, V14, P353, DOI 10.1080/096470490897692
   PERRET, 1955, Toulouse Med, V56, P283
   Plaze Marion, 2013, Soins Psychiatr, P30
   Terrier LM, 2017, NATURE, V548, P523, DOI 10.1038/548523e
   Tooth JC, 1961, LEUCOTOMY ENGLAND WA
   TRILLOT J, 1964, Toulouse Med, V65, P117
   VERSPREEUWEN R, 1954, Acta Neurol Psychiatr Belg, V54, P351
   WERTHEIMER P, 1957, Lyon Chir, V53, P614
   Zanello M, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.6.FOCUS17250
NR 42
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 211
EP 218
DI 10.1016/j.wneu.2019.08.254
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300159
PM 31518743
DA 2020-05-12
ER

PT J
AU Voisin, MR
   Almeida, JP
   Perez-Ordonez, B
   Zadeh, G
AF Voisin, Mathew Ryan
   Almeida, Joao Paulo
   Perez-Ordonez, Bayardo
   Zadeh, Gelareh
TI Recurrent Undifferentiated Carcinoma of the Sella in a Patient with
   Lynch Syndrome
SO WORLD NEUROSURGERY
LA English
DT Article
DE Lynch syndrome; MMR; MSI; p63; Sellar mass; Undifferentiated carcinoma
ID MSH6
AB BACKGROUND: Lynch syndrome (LS) is a cancer-predisposing condition resulting from germline mutations in deoxyribonucleic acid mismatch repair genes. Patients are at high risk for a multitude of tumors, but no reports of undifferentiated sellar carcinomas have previously been described.
   CASE DESCRIPTION: A 56-year-old female with LS due to MSH2 and MSH6 mutations presented with panhypopituitarism and a sellar mass. She was initially diagnosed with pituitary apoplexy and treated nonoperatively. The mass self-resolved. The mass recurred 2 years later, and she underwent endoscopic endonasal biopsy demonstrating an undifferentiated carcinoma of the sella with MSH2 and MSH6 loss. The tumor was negative for pituitary markers and weakly positive for p63. The patient further developed lung and bone metastases and was treated with radiation and chemotherapy.
   CONCLUSIONS: This is the first report of an undifferentiated carcinoma of the sella. Our patient harbored a diagnosis of LS and demonstrated local tumor recurrence and aggressive systemic progression. Patients with LS should undergo close follow-up and active surveillance to detect and treat these aggressive lesions in a timely manner.
C1 [Voisin, Mathew Ryan; Almeida, Joao Paulo; Zadeh, Gelareh] Univ Toronto, Toronto Western Hosp, Dept Neurosurg, Toronto, ON, Canada.
   [Perez-Ordonez, Bayardo] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
RP Voisin, MR (reprint author), Univ Toronto, Toronto Western Hosp, Dept Neurosurg, Toronto, ON, Canada.
EM mvoisin@qmed.ca
CR Bengtsson D, 2017, J CLIN ENDOCR METAB, V102, P3928, DOI 10.1210/jc.2017-01401
   Cahill DP, 2007, NEUROSURGERY, V61, P216, DOI 10.1227/01.neu.0000279946.20527.cd
   Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083
   GOWN AM, 1985, AM J CLIN PATHOL, V84, P413, DOI 10.1093/ajcp/84.4.413
   Gylling AHS, 2008, CARCINOGENESIS, V29, P1351, DOI 10.1093/carcin/bgn133
   Horvat M, 2011, RADIOL ONCOL, V45, P75, DOI 10.2478/v10019-011-0005-8
   Kaufmann O, 2001, AM J CLIN PATHOL, V116, P823
   Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0
   Tafe LJ, 2010, MODERN PATHOL, V23, P781, DOI 10.1038/modpathol.2010.41
   Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 219
EP 222
DI 10.1016/j.wneu.2019.08.180
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300160
PM 31491579
DA 2020-05-12
ER

PT J
AU Muscas, G
   Battista, F
   Lastrucci, G
   Della Puppa, A
AF Muscas, Giovanni
   Battista, Francesca
   Lastrucci, Giancarlo
   Della Puppa, Alessandro
TI An Alternative Route to the Posterior Half of the Third Ventricle: The
   Transoccipital Horn Approach. Technical Note
SO WORLD NEUROSURGERY
LA English
DT Article
DE Surgical approach; Third ventricle; Transcortical; Tumor
ID INTRAVENTRICULAR MENINGIOMAS; SURGICAL CONSIDERATIONS;
   SINGLE-INSTITUTION; 3RD VENTRICLES; TUMORS; ANTERIOR; LESIONS; SERIES
AB BACKGROUND: Lesions arising or abutting in the posterior half of the third ventricle are approached through established routes to avoid damage of essential brain structures. Occasionally, the features of the lesion require rethinking these traditional routes and tailoring the surgical approach to cause fewer debilitating sequelae to the patient. We introduce a modification of previously described transcortical approaches to lesions of the posterior third ventricle. The technique and possible indications are discussed.
   METHODS: Two cases of posterior third ventricle tumors are presented. In both patients, a small posterior fossa and large tentorial veins located along the surgical route, as well as the position of the lesion underneath the internal cerebral veins, encouraged the concept of a novel transoccipital horn approach that was developed to access the tumor with less postoperative deficits.
   RESULTS: Both lesions were removed with transitory postoperative visual deficits.
   CONCLUSIONS: The transoccipital horn approach is a feasible alternative to other surgical routes to the posterior part of the third ventricle in cases of particularly challenging anatomy and tumor characteristics. It allows reaching the lesion along its major axis, fully exploiting the natural space created by the tumor in its growth and avoiding the internal cerebral veins.
C1 [Muscas, Giovanni] Univ Florence, Dept Neurosurg, Florence, Italy.
   Univ Florence, Dept Neurosci, Florence, Italy.
   Univ Florence, Dept Psychol, Florence, Italy.
   Univ Florence, Dept Pharmacol, Florence, Italy.
   Univ Florence, Dept Child Hlth, Florence, Italy.
RP Muscas, G (reprint author), Univ Florence, Dept Neurosurg, Florence, Italy.
EM muscas.giovanni@gmail.com
OI Lastrucci, Giancarlo/0000-0002-1680-026X
CR Agarwal V, 2017, CUREUS, V9, DOI 10.7759/cureus.1722
   Apuzzo MLJ, 1998, SURG 3 VENTRICLE
   Cikla U, 2016, J NEURO-ONCOL, V130, P331, DOI 10.1007/s11060-016-2126-9
   Fusco DJ, 2015, WORLD NEUROSURG, V83, P460, DOI 10.1016/j.wneu.2014.08.042
   Grujicic D, 2017, WORLD NEUROSURG, V97, P178, DOI 10.1016/j.wneu.2016.09.068
   HERRMANN HD, 1992, ACTA NEUROCHIR, V116, P137, DOI 10.1007/BF01540866
   Iacoangeli M, 2017, ACTA NEUROCHIR, V159, P645, DOI 10.1007/s00701-017-3117-0
   JAMIESON KG, 1971, J NEUROSURG, V35, P550, DOI 10.3171/jns.1971.35.5.0550
   Juretschke FR, 2010, NEUROSURG REV, V33, P457, DOI 10.1007/s10143-010-0271-8
   Kim SM, 2013, J KOREAN MED SCI, V28, P1261, DOI 10.3346/jkms.2013.28.9.1261
   Luo YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120525
   Metwali H, 2018, WORLD NEUROSURG, V110, P217, DOI 10.1016/j.wneu.2017.11.039
   Milligan BD, 2010, NEUROSURGERY, V67, P1483, DOI 10.1227/NEU.0b013e3181f7eb68
   Odegaard KM, 2013, NEUROSURG REV, V36, P57, DOI 10.1007/s10143-012-0410-5
   Onoda K, 2001, J NEUROSURG, V94, P315, DOI 10.3171/jns.2001.94.2.0315
   POPPEN JL, 1966, J NEUROSURG, V25, P706, DOI 10.3171/jns.1966.25.6.0706
   Rhoton AL, 2002, NEUROSURGERY, V51, pS273, DOI 10.1227/01.NEU.0000028087.76279.41
   VANWAGENEN WP, 1931, SURG GYNECOL OBSTET, V53, P216
   Wen HT, 1998, NEUROSURGERY, V42, P1205, DOI 10.1097/00006123-199806000-00001
   Yasargil MG, 2008, NEUROSURGERY, V62, P1029, DOI [10.1227/01.NEU.0000316427.57165.01, 10.1227/01.neu.0000333768.12951.9a]
   Yasargil MG, 1996, MICRONEUROSURGERY
   Yasargil MG, 2008, NEUROSURGERY S3, V62, P40
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 223
EP 229
DI 10.1016/j.wneu.2019.08.255
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300161
PM 31518749
DA 2020-05-12
ER

PT J
AU Agarwal, N
   Satyarthee, GD
AF Agarwal, Nitish
   Satyarthee, Guru Dutta
TI Symptomatic Diffuse Vasospasm After Resection of Temporal Ganglioglioma:
   Review of the Literature with Case Illustration
SO WORLD NEUROSURGERY
LA English
DT Review
DE Diffuse vasospasm; Ganglioglioma; Surgery; Symptomatic vasospasm;
   Temporal lobectomy
ID CEREBRAL VASOSPASM; HYPONATREMIA
AB BACKGROUND: Symptomatic cerebral vasospasm may occur in the setting of aneurysmal subarachnoid hemorrhage, traumatic brain injury, or after anterior skull base surgery, but its occurrence is extremely rare in the background of glioma surgical resection.
   CASE DESCRIPTION: We present a rare case of symptomatic diffuse vasospasm, which is the fourth reported case of symptomatic vasospasm after temporal lobectomy and the third in the setting of a glial tumor. This patient, a 10-year-old boy, developed bilateral, progressive cerebral infarcts because of diffuse vasospasm after anteromesial temporal lobectomy for a left temporal ganglioglioma leading to significant morbidity.
   CONCLUSIONS: The risk factors, likely pathogenesis and the importance of early diagnosis and timely institution of treatment, in such cases are discussed in the background of relevant literature. The current case represents the first report of symptomatic diffuse vasospasm occuring after surgical resection of intracranial ganglioglioma in the Western literature.
C1 [Agarwal, Nitish; Satyarthee, Guru Dutta] All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
RP Satyarthee, GD (reprint author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
EM drguruduttaaiims@gmail.com
CR Al-Mufti F, 2018, J NEUROL SCI, V390, P44, DOI 10.1016/j.jns.2018.02.039
   Alotaibi NM, 2013, J NEUROINTERV SURG, V5, P413, DOI 10.1136/neurintsurg-2012-010477
   Chandy D, 2006, NEUROL INDIA, V54, P273, DOI 10.4103/0028-3886.27151
   Chang SD, 1999, SURG NEUROL, V51, P521, DOI 10.1016/S0090-3019(97)00313-3
   Dickerson JC, 2018, ACTA NEUROCHIR, V160, P1883, DOI 10.1007/s00701-018-3606-9
   Goodman RR, 2013, EPILEPSY CURR, V13, P69, DOI 10.5698/1535-7597-13.2.69
   Jabbarli R, 2016, CEREBROVASC DIS, V41, P265, DOI 10.1159/000443744
   Lackner P, 2012, NEUROLOGY, V78, P1215, DOI 10.1212/WNL.0b013e318250d7d6
   Mandonnet E, 2009, ACTA NEUROCHIR, V151, P1723, DOI 10.1007/s00701-009-0314-5
   Morinaga K, 1992, No To Shinkei, V44, P629
   Muzii VF, 2018, INTERDISCIP NEUROSUR, V14, P24, DOI 10.1016/j.inat.2018.05.016
   Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219
   Rao S, 2017, NEUROLOGY, V88, pE230, DOI 10.1212/WNL.0000000000004011
   Schaller C, 1998, SURG NEUROL, V49, P170, DOI 10.1016/S0090-3019(97)00283-8
   Uozumi Y, 2017, J CLIN NEUROSCI, V46, P118, DOI 10.1016/j.jocn.2017.08.037
   WIJDICKS EFM, 1985, ANN NEUROL, V17, P137, DOI 10.1002/ana.410170206
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 230
EP 235
DI 10.1016/j.wneu.2019.08.239
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300162
PM 31505290
DA 2020-05-12
ER

PT J
AU Satis, S
   Tuna, M
   Alparslan, N
   Dere, O
AF Satis, Serap
   Tuna, Mustafa
   Alparslan, Nur
   Dere, Osman
TI Jarcho-Levin Syndrome and Concomitant Carotid Glomus Tumor: First
   Reported Case
SO WORLD NEUROSURGERY
LA English
DT Article
DE Congenital disorder; Glomus tumor; Jarcho-Levin syndrome
AB BACKGROUND: Jarcho-Levin syndrome (JLS) is a rare congenital disorder characterized by different clinical and radiologic findings. The disease was first reported by Jarcho and Levin in 1938, and it was described as the presence of various malformations or abnormal fusion in the thoracic vertebrae and ribs, short trunk, and respiratory distress.
   CASE DESCRIPTION: In our case, fusion at the thoracic and cervical vertebrae, butterfly vertebrae, and a crablike-shaped thorax was present. The patient had a short trunk, short stature, and long extremities. Moreover, he had a syndromic face and restrictive-type respiratory distress. There was a glomus tumor in the carotid space. In our literature review, we found that neural tube defects are frequently present in this syndrome. However, we could not identify any cases with affected neural crest cells.
   CONCLUSIONS: JLS may affect cells derived from the neural crest located between the neural tube and surface ectoderm. Therefore patients with JLS should be screened for other tumors located in this area.
C1 [Satis, Serap; Tuna, Mustafa; Alparslan, Nur] Harran Univ, Fac Med, Dept Phys Med & Rehabil, Sanliurfa, Turkey.
   [Dere, Osman] Harran Univ, Fac Med, Dept Radiol, Sanliurfa, Turkey.
RP Satis, S (reprint author), Harran Univ, Fac Med, Dept Phys Med & Rehabil, Sanliurfa, Turkey.
EM mdseraps@gmail.com
CR Aslan Y, 1997, GENET COUNSEL, V8, P241
   Berdon WE, 2011, PEDIATR RADIOL, V41, P384, DOI 10.1007/s00247-010-1928-8
   Cornier AS, 2003, CURR OPIN PEDIATR, V15, P614, DOI 10.1097/00008480-200312000-00012
   Devita VT, 2003, CANC PRINCIPLES PRAC, P841
   Galguera M A, 1997, Bol Asoc Med P R, V89, P134
   Inan N, 2009, PEDIATR HEMAT ONCOL, V26, P496, DOI 10.1080/08880010902773263
   Kulkarni M. L., 2006, Indian Journal of Pediatrics, V73, P245, DOI 10.1007/BF02825493
   Mortier GR, 1996, AM J MED GENET, V61, P310, DOI 10.1002/(SICI)1096-8628(19960202)61:4<310::AID-AJMG3>3.0.CO;2-Y
   PEREZCOMAS A, 1974, J PEDIATR-US, V85, P388, DOI 10.1016/S0022-3476(74)80126-5
   POOR MA, 1983, J PEDIATR-US, V103, P270, DOI 10.1016/S0022-3476(83)80365-5
   ROBERTS AP, 1988, J BONE JOINT SURG BR, V70, P123
   Torbus Onufry, 2002, Wiad Lek, V55, P778
NR 12
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 236
EP 238
DI 10.1016/j.wneu.2019.08.179
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300163
PM 31479788
DA 2020-05-12
ER

PT J
AU Riedy, LN
   Kim, M
   Yun, JJ
   Borys, E
   Prabhu, VC
AF Riedy, Loren N.
   Kim, Miri
   Yun, Jonathan J.
   Borys, Ewa
   Prabhu, Vikram C.
TI Caudal Homeobox Gene-2 Staining Defines Intracranial Mature Teratoma
   with Differentiation to Colonic Adenocarcinoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intracranial mature teratoma; Malignant transformation
ID GERM-CELL TUMORS; CYSTIC TERATOMA; CHEMOTHERAPY; MANAGEMENT; CISPLATIN;
   DIAGNOSIS; CDX2
AB BACKGROUND: Malignant transformation of a mature intracranial teratoma into an adenocarcinoma is an extremely rare event and portends a poor prognosis. The clinical progression, radiographic changes, histopathological findings, and immunohistochemistry findings from these unique cases might provide clues regarding this transformation. Caudal homeobox gene-2 (CDX-2) is a specific and robust marker for colonic adenocarcinomas and can also be used to identify differentiation of mature intracranial teratoma into colonic-type adenocarcinoma. To the best of our knowledge, this is the first case report of the use of this specific marker for an intracranial malignancy.
   CASE DESCRIPTION: We present the case of a 55-year-old right-handed Hispanic-American woman with progressive headaches who was found to have a left posterior parietotemporal tumor with intraventricular extension. Surgical debulking was performed, and the pathologic examination revealed a mature teratoma. Despite surgical resection and radiotherapy, the teratoma progressed to a malignant mature intracranial teratoma both radiographically and histologically. Histological analysis of the third specimen revealed a moderately differentiated adenocarcinoma. The tumor cells were positive for CDX-2 and cytokeratin 20 and negative for cytokeratin 7 and thyroid transcription factor-1, consistent with an enteric/colonic-type adenocarcinoma, demonstrating progressive atypia and malignancy.
   CONCLUSIONS: Malignant transformation of a mature intracranial teratoma portends a poor prognosis. The exact histopathological diagnosis can facilitate treatment of these patients. CDX-2 is a specific robust marker for identifying differentiation of a mature intracranial teratoma into a colonic adenocarcinoma. This positive staining can also be observed in primary colonic and other adenocarcinomas. To the best of our knowledge, this is the first report of the use of CDX-2 in the diagnosis of an intracranial malignancy. The triangulation of clinical progression, radiographic findings, and histopathological and immunohistochemistry findings provided clues regarding this unique transformation.
C1 [Riedy, Loren N.; Kim, Miri; Yun, Jonathan J.; Prabhu, Vikram C.] Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
   [Borys, Ewa] Loyola Univ Med Ctr, Dept Pathol, Maywood, IL 60153 USA.
RP Prabhu, VC (reprint author), Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
EM vprabhu@lumc.edu
CR Ak H, 2006, ACTA NEUROCHIR, V148, P663, DOI 10.1007/s00701-006-0755-z
   ALLEN JC, 1985, J NEURO-ONCOL, V3, P147, DOI 10.1007/BF02228891
   ALLEN JC, 1987, J NEUROSURG, V67, P65, DOI 10.3171/jns.1987.67.1.0065
   ALLEN JC, 1991, NEUROL CLIN, V9, P441
   ALLEN JC, 1979, J NEUROSURG, V51, P368, DOI 10.3171/jns.1979.51.3.0368
   Atalay FO, 2016, J INT MED RES, V44, P1323, DOI 10.1177/0300060516665472
   Balmaceda C, 1996, J CLIN ONCOL, V14, P2908, DOI 10.1200/JCO.1996.14.11.2908
   CHANG TK, 1995, MED PEDIATR ONCOL, V24, P368, DOI 10.1002/mpo.2950240606
   Chhieng DC, 2001, CANCER CYTOPATHOL, V93, P330, DOI 10.1002/cncr.9048
   COMERCI JT, 1994, OBSTET GYNECOL, V84, P22
   Dunne RF, 2014, RARE TUMORS, V6, P18, DOI 10.4081/rt.2014.5268
   Georgiu C, 2016, ROM J MORPHOL EMBRYO, V57, P1389
   GRIFFITHS D, 1995, GYNECOL ONCOL, V59, P427, DOI 10.1006/gyno.1995.9948
   Hanna N, 2003, HOLLAND FRIE CANC ME
   Huang X, 2009, PEDIATR NEUROSURG, V45, P354, DOI 10.1159/000257524
   JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155
   Keller DL, 2012, J VET DIAGN INVEST, V24, P621, DOI 10.1177/1040638712442882
   Kim ES, 2015, NEUROPATHOLOGY, V35, P44, DOI 10.1111/neup.12140
   Li Y, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0085-3
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Mandal Gautam Kumar, 2016, Asian J Neurosurg, V11, P458
   Mandal S, 2012, CASE REP PATHOL, DOI 10.1155/2012/568062
   Mohammadi A, 2017, WORLD NEUROSURG, V106, DOI 10.1016/j.wneu.2017.06.175
   Mufti Shagufta Tahir, 2012, Asian J Neurosurg, V7, P197, DOI 10.4103/1793-5482.106652
   Nakagawa K, 1992, Radiat Med, V10, P55
   Packer R J, 2000, Oncologist, V5, P312
   PACKER RJ, 1984, PEDIATRICS, V74, P97
   Park SC, 2010, NEUROSURGERY, V67, pE1818, DOI 10.1227/NEU.0b013e3181f846ca
   Sawamura Y, 1997, J NEUROSURG, V87, P262, DOI 10.3171/jns.1997.87.2.0262
   Schild SE, 1996, INT J RADIAT ONCOL, V36, P557, DOI 10.1016/S0360-3016(96)00354-9
   Wang J, 2011, PALGR MAC SER GLOB, P1
   Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003
   Yang WP, 2017, ONCOL LETT, V14, P1129, DOI 10.3892/ol.2017.6213
   YOSHIDA J, 1993, ACTA NEUROCHIR, V120, P111, DOI 10.1007/BF02112027
NR 34
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 239
EP 244
DI 10.1016/j.wneu.2019.08.216
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300164
PM 31520753
DA 2020-05-12
ER

PT J
AU Li, H
   Liu, JF
   Li, CH
   Wang, JW
   Tian, YY
AF Li, Hui
   Liu, Jian-Feng
   Li, Cong-Hui
   Wang, Ji-Wei
   Tian, Yang-Yang
TI Successful Thrombectomy Using Sofia (6F) PLUS Catheter in Acute Stroke
   Patient with Coincident Proximal Unruptured Aneurysm
SO WORLD NEUROSURGERY
LA English
DT Article
DE ADAPT; Aneurysm; Ischemic stroke; Sofia (6F) PLUS
AB BACKGROUND: Little literature is available on mechanical thrombus aspiration in acute ischemic stroke with coincident ipsilateral unruptured aneurysm, especially with aneurysm proximal to the occlusion site. In this report, we describe a case of ischemic stroke in a patient with acute occlusion of M1 segment of the middle cerebral artery with coincident ipsilateral internal carotid arteryLposterior communicating artery aneurysm who was successfully treated by mechanical clot retrieval using the Sofia (6F) PLUS technique (MicroVention Terumo, Tustin, California, USA).
   CASE DESCRIPTION: A 52-year-old woman presented at our hospital 6 hours after sudden onset of dysarthria and right limb hemiplegia on waking up in the morning. She was managed using a direct aspiration first pass technique for distal middle cerebral artery mechanical aspiration using the Sofia (6F) PLUS catheter. The thrombus was manually aspirated in 2 minutes, and Thrombolysis in Cerebral Infarction scale 3 flow was restored. Next, LVIS (MicroVention Terumo, Tustin, California, USA) stent-assisted coiling of the aneurysm of the posterior communicating segment of the left internal carotid artery was immediately undertaken. The National Institutes of Health Stroke Scale score was 4 at day 1 and 0 at day 7 postoperatively. No device-related or catheter-related complications occurred.
   CONCLUSIONS: Ischemic stroke patients with coincident aneurysm are at increased risk of aneurysmal rupture and should be managed with tailored endovascular strategies. Our case shows that a direct aspiration first pass technique using the Sofia (6F) PLUS catheter provides a safe, effective approach for thrombus aspiration in stroke patients.
C1 [Li, Hui; Liu, Jian-Feng; Li, Cong-Hui; Wang, Ji-Wei] Hebei Med Univ, Dept Neurosurg, Hosp 1, Shijiazhuang, Hebei, Peoples R China.
   [Tian, Yang-Yang] Hebei Med Univ, Sch Med, Shijiazhuang, Hebei, Peoples R China.
RP Li, H (reprint author), Hebei Med Univ, Dept Neurosurg, Hosp 1, Shijiazhuang, Hebei, Peoples R China.
EM 10398937@qq.com
CR Can A, 2018, STROKE, V49, P2046, DOI 10.1161/STROKEAHA.118.022412
   Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Jovin TG, 2017, INT J STROKE, V12, P641, DOI 10.1177/1747493017710341
   Kim YW, 2019, ACTA NEUROCHIR, V161, P1197, DOI 10.1007/s00701-019-03914-4
   Onofrio A, 2016, J NEUROINTERV SURG, V8, P67
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   Shallwani H, 2018, NEUROSURGERY, V82, P312, DOI 10.1093/neuros/nyx169
   Zhou TF, 2018, CARDIOVASC INTER RAD, V41, P1399, DOI 10.1007/s00270-018-1945-9
   Zibold F, 2016, J NEUROINTERV SURG, V8, P1016, DOI 10.1136/neurintsurg-2015-012079
NR 10
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 245
EP 250
DI 10.1016/j.wneu.2019.08.143
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300165
PM 31476466
DA 2020-05-12
ER

PT J
AU Wu, C
   Lee, CY
   Huang, TJ
   Wu, MH
AF Wu, Christopher
   Lee, Ching-Yu
   Huang, Tsung-Jen
   Wu, Meng-Huang
TI Full-Endoscopic Lumbar Foraminoplasty for Symptomatic Cement Leakage
   with Exiting Nerve Root Impingement
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cement leakage; Foraminal stenosis; Full-endoscopic lumbar
   foraminoplasty; Local analgesia
ID SURGICAL-TREATMENT; DISC HERNIATIONS; STENOSIS; DECOMPRESSION;
   FORAMINOTOMY; INTERLAMINAR; DISKECTOMY; SURGERY
AB BACKGROUND: Foraminal stenosis, a common disorder occurring in elderly patients, is often caused by narrowing of the foramen, resulting in the confinement of neural structures by the tissue and vertebrae. Full-endoscopic lumbar foraminoplasty (FELF) is an effective treatment option for patients with foraminal stenosis. However, to the best of our knowledge, no previous study has reported the treatment of symptomatic cement leakage. We report a case of symptomatic cement leakage treated with FELF with the patient under local anesthesia.
   CASE DESCRIPTION: An 85-year-old woman was admitted to our spine unit because of lower back pain. The patient had presented with lower back pain and new-onset left thigh pain after vertebroplasty performed 3 months previously. The patient was not able to walk and was bedridden. To overcome this problem, T12 percutaneous vertebroplasty and left transforaminal L3-L4 foraminoplasty was performed with the patient under local anesthesia. After surgery, the patient was able to walk and was discharged 4 days postoperatively.
   CONCLUSION: The present report has shown that FELF can successfully remove symptomatic cement leakage, resulting in pain relief.
C1 [Wu, Christopher] Taipei Med Univ, Coll Med, Taipei, Taiwan.
   [Lee, Ching-Yu; Huang, Tsung-Jen; Wu, Meng-Huang] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan.
   [Lee, Ching-Yu; Huang, Tsung-Jen; Wu, Meng-Huang] Taipei Med Univ, Coll Med, Sch Med, Dept Orthopaed, Taipei, Taiwan.
RP Wu, MH (reprint author), Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan.; Wu, MH (reprint author), Taipei Med Univ, Coll Med, Sch Med, Dept Orthopaed, Taipei, Taiwan.
EM 141036@h.tmu.edu.tw
RI Wu, Meng-huang/AAH-2195-2020
OI Wu, Meng-huang/0000-0003-1606-2444
CR Ahn Y, 2014, NEUROSURGERY, V75, P124, DOI 10.1227/NEU.0000000000000361
   Ao SX, 2018, WORLD NEUROSURG, V115, pE263, DOI 10.1016/j.wneu.2018.04.032
   Bae JS, 2016, J KOREAN NEUROSURG S, V59, P143, DOI 10.3340/jkns.2016.59.2.143
   Becker S, 2007, J Orthop Surg (Hong Kong), V15, P222
   Chen JK, 2007, SPINE, V32, pE358, DOI 10.1097/BRS.0b013e31805c0b25
   Cho SI, 2016, J KOREAN NEUROSURG S, V59, P610, DOI 10.3340/jkns.2016.59.6.610
   Choi DJ, 2019, CLIN ORTHOP SURG, V11, P82, DOI 10.4055/cios.2019.11.1.82
   Choi G, 2008, SPINE, V33, pE508, DOI 10.1097/BRS.0b013e31817bfa1a
   Choi KC, 2017, WORLD NEUROSURG, V106, P484, DOI 10.1016/j.wneu.2017.07.035
   Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018
   DONALDSON WF, 1993, SPINE, V18, P1263, DOI 10.1097/00007632-199308000-00003
   Epstein NE, 2002, SPINAL CORD, V40, P491, DOI 10.1038/sj.sc.3101319
   Eum JH, 2016, J NEUROSURG-SPINE, V24, P602, DOI 10.3171/2015.7.SPINE15304
   Gadjradj PS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2015.10.FOCUS15484
   Hadjipavlou AG, 2005, J BONE JOINT SURG BR, V87B, P1595, DOI 10.1302/0301-620X.87B12.16074
   HIJIKATA S, 1989, CLIN ORTHOP RELAT R, P9
   Hodges SD, 1999, SPINE, V24, P1243, DOI 10.1097/00007632-199906150-00012
   Hu QF, 2018, EUR SPINE J, V27, pS393, DOI 10.1007/s00586-017-5365-3
   Jenis L G, 2001, Am J Orthop (Belle Mead NJ), V30, P205
   Kambin P, 1996, J NEUROSURG, V84, P462, DOI 10.3171/jns.1996.84.3.0462
   Kim DE, 2015, J KOREAN NEUROSURG S, V57, P32, DOI 10.3340/jkns.2015.57.1.32
   Kim Doo Soo, 2014, Korean J Neurotrauma, V10, P155, DOI 10.13004/kjnt.2014.10.2.155
   Kim HS, 2009, J KOREAN NEUROSURG S, V45, P67, DOI 10.3340/jkns.2009.45.2.67
   Kim JS, 2011, SPINE, V36, pE1173, DOI 10.1097/BRS.0b013e3182264458
   Komp M, 2015, PAIN PHYSICIAN, V18, P61
   Krzok G, 2016, WORLD NEUROSURG, V95, P299, DOI 10.1016/j.wneu.2016.08.018
   KUNOGI J, 1991, SPINE, V16, P1312, DOI 10.1097/00007632-199111000-00012
   Ruetten S, 2009, J NEUROSURG-SPINE, V10, P476, DOI 10.3171/2008.7.17634
   Shin SH, 2018, WORLD NEUROSURG, V114, pE873, DOI 10.1016/j.wneu.2018.03.107
   Shin SH, 2015, SPINE, V40, pE859, DOI 10.1097/BRS.0000000000000990
   Wu XB, 2016, PAIN PHYSICIAN, V19, pE675
   Yeom KS, 2011, J ORTHOP SCI, V16, P263, DOI 10.1007/s00776-011-0048-0
NR 32
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 253
EP 257
DI 10.1016/j.wneu.2019.09.007
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300167
PM 31520762
DA 2020-05-12
ER

PT J
AU Delavari, N
   Geh, N
   Hervey-Jumper, SL
   McKean, EL
   Sullivan, SE
AF Delavari, Nader
   Geh, Ndi
   Hervey-Jumper, Shawn L.
   McKean, Erin L.
   Sullivan, Stephen E.
TI Transnasal and Transoral Approaches to Atlantoaxial Synovial Cysts:
   Report of 3 Cases and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Atlantoaxial; Cervical spine; Endoscopic surgery; Odontoid process;
   Synovial cyst; Transnasal approach; Transoral approach
ID RETROODONTOID PSEUDOTUMORS; C1-2 ARTICULATION; ODONTOID PROCESS;
   CERVICAL-SPINE; GANGLION CYST; JUNCTION; FUSION; DETERIORATION;
   RESOLUTION; DIAGNOSIS
AB BACKGROUND: Synovial cysts are cystic masses lined with pseudostratified columnar cells and containing clear or xanthochromic fluid. Although they are commonly encountered in the lumbar spine, synovial cysts infrequently occur in the cervical spine and rarely involve the odontoid process. The causes of synovial cysts of the odontoid process are unknown, but growth of synovial rests, proliferation of multipotent mesenchymal cells, atlantoaxial instability, and trauma are thought to play a role.
   CASE DESCRIPTION: We present 3 cases of atlantoaxial cysts with the associated radiographic features, surgical management, and clinical outcomes. No patient had rheumatoid arthritis. In all cases, preoperative differential diagnosis included neoplastic pathologic changes. Two patients underwent odontoidectomy through either an endonasal or a transoral approach, followed by posterior occipitocervical fusion. The third patient underwent an endoscopic transsphenoidal approach for cyst decompression.
   CONCLUSIONS: Tissue diagnosis is important in confirming pathologic analysis because synovial cysts have radiographic characteristics similar to those of a wide variety of neoplasms of the craniovertebral junction.
C1 [Delavari, Nader; Geh, Ndi; Hervey-Jumper, Shawn L.; McKean, Erin L.; Sullivan, Stephen E.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
   [McKean, Erin L.] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA.
   [Delavari, Nader] NYU, Dept Neurosurg, 550 1St Ave, New York, NY 10016 USA.
RP Delavari, N (reprint author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.; Delavari, N (reprint author), NYU, Dept Neurosurg, 550 1St Ave, New York, NY 10016 USA.
EM nader.delavari@nyumc.org
CR Akiyama H, 1999, NEUROL MED-CHIR, V39, P539, DOI 10.2176/nmc.39.539
   Barbagallo GMV, 2013, EUR SPINE J, V22, pS879, DOI 10.1007/s00586-013-3004-1
   Birch BD, 1996, J NEUROSURG, V85, P810, DOI 10.3171/jns.1996.85.5.0810
   Bydon M, 2014, J NEUROSURG-SPINE, V21, P919, DOI 10.3171/2014.8.SPINE13897
   Cecchi PC, 2008, SPINE J, V8, P687, DOI 10.1016/j.spinee.2007.01.006
   Chikuda H, 2009, SPINE, V34, pE110, DOI 10.1097/BRS.0b013e31818acd27
   CHOE W, 1993, PARAPLEGIA, V31, P803, DOI 10.1038/sc.1993.124
   Colasanti Roberto, 2014, Surg Neurol Int, V5, pS567, DOI 10.4103/2152-7806.148048
   Colen CB, 2006, J NEUROSURG-SPINE, V4, P186, DOI 10.3171/spi.2006.4.2.186
   CROCKARD HA, 1991, J NEUROL NEUROSUR PS, V54, P817, DOI 10.1136/jnnp.54.9.817
   Eustacchio S, 2003, ZBL NEUROCHIR, V64, P86
   Fransen P, 1997, J NEUROSURG, V86, P1027, DOI 10.3171/jns.1997.86.6.1027
   GOFFIN J, 1992, NEUROSURGERY, V30, P914, DOI 10.1227/00006123-199206000-00016
   KAO CC, 1974, J NEUROSURG, V41, P372, DOI 10.3171/jns.1974.41.3.0372
   Kassam AB, 2005, NEUROSURGERY, V57, P213, DOI 10.1227/01.NEU.0000163687.64774.E4
   Kaufmann AM, 1996, CAN J NEUROL SCI, V23, P227, DOI 10.1017/S0317167100038579
   Kirk HJ, 2009, J CLIN NEUROSCI, V16, P822, DOI 10.1016/j.jocn.2008.06.027
   Lyons MK, 2011, TURK NEUROSURG, V21, P483, DOI [10.5137/1019-5149.JTN.4288-11.1, 10.5137/1019-5149.JTN .4288-11.1]
   MILLER JD, 1989, SURG NEUROL, V31, P239, DOI 10.1016/0090-3019(89)90125-0
   Ohnishi Y, 2015, EUR SPINE J, V24, pS508, DOI 10.1007/s00586-014-3578-2
   Okamoto K, 2004, J SPINAL DISORD TECH, V17, P535, DOI 10.1097/01.bsd.0000117546.88865.62
   ONOFRIO BM, 1988, NEUROSURGERY, V22, P642, DOI 10.1227/00006123-198804000-00004
   PENDLETON B, 1983, NEUROSURGERY, V13, P322, DOI 10.1227/00006123-198309000-00021
   Puffer RC, 2013, WORLD NEUROSURG, V79, P773, DOI 10.1016/j.wneu.2012.03.035
   Sameshima T, 2013, NEUROL MED-CHIR, V53, P125, DOI 10.2176/nmc.53.125
   Sonntag VKH, 2013, WORLD NEUROSURG, V79, P660, DOI 10.1016/j.wneu.2012.11.021
   Suetsuna F, 2006, J NEUROSURG-SPINE, V5, P455, DOI 10.3171/spi.2006.5.5.455
   SZE G, 1986, RADIOLOGY, V161, P391, DOI 10.1148/radiology.161.2.3763907
   Tabaddor K, 1996, SPINE, V21, P2019, DOI 10.1097/00007632-199609010-00019
   Theodotou CB, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.04.036
   Van Gompel JJ, 2011, J NEUROSURG-SPINE, V14, P437, DOI 10.3171/2010.12.SPINE10302
   Velan O, 2008, CARDIOVASC INTER RAD, V31, P1219, DOI 10.1007/s00270-008-9347-z
   Werle S, 2013, J NEUROSURG-SPINE, V18, P50, DOI 10.3171/2012.10.SPINE12710
   WEYMANN CA, 1993, NEUROLOGY, V43, P2151, DOI 10.1212/WNL.43.10.2151-a
   Yamaguchi I, 2006, J NEUROSURG-SPINE, V5, P156, DOI 10.3171/spi.2006.5.2.156
   Yu E, 2005, NEURORADIOLOGY, V47, P328, DOI 10.1007/s00234-005-1355-y
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 258
EP 264
DI 10.1016/j.wneu.2019.08.248
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300168
PM 31518745
DA 2020-05-12
ER

PT J
AU Elder, T
   Raghavan, A
   Smith, A
   Wright, CH
   Wright, J
   Burant, C
   Sajatovic, M
   Hoffer, A
AF Elder, Theresa
   Raghavan, Alankrita
   Smith, Arvin
   Wright, Christina Huang
   Wright, James
   Burant, Christopher
   Sajatovic, Martha
   Hoffer, Alan
TI Outcomes After Intracranial Hemorrhage in Patients with Left Ventricular
   Assist Devices: A Systematic Review of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Hemorrhagic stroke; ICH; Intracranial hemorrhage; LVAD; Ventricular
   assist device
ID MECHANICAL CIRCULATORY SUPPORT; VON-WILLEBRAND SYNDROME; STROKE; HEART;
   THERAPY; RISK; TRANSPLANTATION
AB BACKGROUND: Intracranial hemorrhage (ICH) is a common complication in patients with left ventricular assist devices (LVADs) and carries a dismal prognosis. Limited data are available on the management and outcomes in this population, which are essential to determine an optimal treatment strategy. We conducted a systematic literature review to determine the clinical characteristics and survival of this population.
   METHODS: PubMed, Ovid, Embase. Scopus, Cochrane, CENTRAL, and Web of Science articles were selected using the following terms: ("Heart-Assist Devices" or "left ventricular assist device" or "LVAD") AND ("intracranial hemorrhage" OR "cerebral hemorrhage" OR "brain hemorrhage" OR "intracerebral hemorrhage" OR "intraparenchymal hemorrhage" OR "hemorrhagic stroke"). Abstracts and articles were screened according to inclusion and exclusion criteria that were determined a priori. Potential studies were reviewed by 4 authors, who reached a consensus on the final studies to be included.
   RESULTS: The literature review yielded 609 abstracts, which were screened according to predetermined inclusion criteria. A total of 143 full-text articles were reviewed, and 8 articles were included in the final qualitative analysis. These studies reviewed data for 597 patients with LVADs who had ICH. The mortality for ICH was widely variable across studies and ranged from 16% to 100%.
   CONCLUSIONS: There is minimal existing literature on patients with LVAD with ICH that report patient outcomes in a nonstandardized fashion. The studies included in this analysis report mortality consistent with previous reports, indicating a need for further investigation to identify risk factors and improve outcomes in these patients.
C1 [Elder, Theresa; Wright, Christina Huang; Wright, James; Hoffer, Alan] Univ Hosp Cleveland, Med Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA.
   [Sajatovic, Martha] Univ Hosp Cleveland, Dept Neurol & Psychiat, Med Ctr, Cleveland, OH 44106 USA.
   [Sajatovic, Martha] Univ Hosp Cleveland, Neurol & Behav Outcomes Res Ctr, Med Ctr, Cleveland, OH 44106 USA.
   [Raghavan, Alankrita; Smith, Arvin; Wright, Christina Huang; Wright, James; Hoffer, Alan] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Burant, Christopher] Case Western Reserve Univ, Mandel Sch Appl Social Sci, Cleveland, OH 44106 USA.
   [Burant, Christopher] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA.
RP Wright, J (reprint author), Univ Hosp Cleveland, Med Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA.; Wright, J (reprint author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
EM James.Wright@uhhospitals.org
OI Wright, James/0000-0002-4482-7582
CR Acharya D, 2017, JACC-HEART FAIL, V5, P703, DOI 10.1016/j.jchf.2017.06.014
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Birks EJ, 2011, TEX HEART I J, V38, P552
   Briasoulis A, 2018, AM J CARDIOL, V121, P1214, DOI 10.1016/j.amjcard.2018.01.041
   Cho SM, 2017, NEUROCRIT CARE, V27, P17, DOI 10.1007/s12028-017-0386-7
   Chou J, 2017, ASAIO J, V63, pE13, DOI 10.1097/MAT.0000000000000398
   Cushing K, 2016, DIGEST DIS SCI, V61, P1440, DOI 10.1007/s10620-016-4123-4
   Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013
   Flaherty ML, 2006, NEUROCRIT CARE, V5, P197, DOI 10.1385/NCC:5:3:197
   Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417
   Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1
   Klovaite J, 2009, J AM COLL CARDIOL, V53, P2162, DOI 10.1016/j.jacc.2009.02.048
   Lip GYH, 2002, BRIT MED J, V325, P1022, DOI 10.1136/bmj.325.7371.1022
   Meyer AL, 2010, CIRC-HEART FAIL, V3, P675, DOI 10.1161/CIRCHEARTFAILURE.109.877597
   Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758
   Muthiah K, 2016, J HEART LUNG TRANSPL, V35, P743, DOI 10.1016/j.healun.2015.12.024
   Nassif ME, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002680
   Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055
   Paganini-Hill A, 2001, MATURITAS, V38, P243, DOI 10.1016/S0378-5122(01)00167-0
   Patel N, 2018, JACC-HEART FAIL, V6, P424, DOI 10.1016/j.jchf.2018.03.005
   Persky Rebecca W, 2010, Curr Cardiol Rep, V12, P6, DOI 10.1007/s11886-009-0080-2
   Poli D, 2009, THROMB HAEMOSTASIS, V101, P938, DOI 10.1160/TH08-10-0635
   Ramey WL, 2017, WORLD NEUROSURG, V108, P826, DOI 10.1016/j.wneu.2017.09.083
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209
   Slaughter MS, 2010, J CARDIAC SURG, V25, P490, DOI 10.1111/j.1540-8191.2010.01075.x
   Suarez J, 2011, CIRC-HEART FAIL, V4, P779, DOI 10.1161/CIRCHEARTFAILURE.111.962613
   Tahir RA, 2018, WORLD NEUROSURG, V113, pE714, DOI 10.1016/j.wneu.2018.02.135
   Tsiouris A, 2015, WORLD J CARDIOL, V7, P792, DOI 10.4330/wjc.v7.i11.792
   Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016
   Wilson TJ, 2013, J NEUROSURG, V118, P1063, DOI 10.3171/2013.1.JNS121849
   Wong JK, 2016, ASAIO J, V62, P552, DOI 10.1097/MAT.0000000000000404
   Yavar Z, 2018, ASAIO J, V64, P748, DOI 10.1097/MAT.0000000000000734
NR 35
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 265
EP 272
DI 10.1016/j.wneu.2019.08.211
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300169
PM 31493616
DA 2020-05-12
ER

PT J
AU Liu, KY
   Chang, HR
   Wang, LF
   Wang, CL
   Chen, T
   Meng, XZ
AF Liu, Kaiyu
   Chang, Hengrui
   Wang, Lifei
   Wang, Chunlei
   Chen, Tao
   Meng, Xianzhong
TI Risk Factors for Cage Retropulsion After Lumbar Interbody Fusion:
   Systematic Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cage posterior migration; Cage retropulsion; Lumbar interbody fusion;
   Meta-analysis; Risk factors
ID PEDICLE SCREW FIXATION; POSTERIOR MIGRATION; CLINICAL-OUTCOMES;
   SPONDYLOLISTHESIS; COMPLICATIONS; DISEASE
AB OBJECTIVE: Although many risk factors for cage retropulsion (CR) after lumbar interbody fusion (LIF) have been described in the literature, they still remain controversial. The purpose of this study is to investigate the risk factors for CR after LIF.
   METHODS: The literature was searched in PubMed, Cochrane library, and Embase from October 2000 to October 2018. The key words and combinations used in the search included LIF, cage, retropulsion, posterior migration, and risk factors. Only studies with sufficient data to calculate odds ratio for CR were included. Odds ratio and 95% confidence interval were calculated for outcomes via RevMan5.3 and SPSS 22.0.
   RESULTS: A total of 10 studies were included in this study. Twelve risk factors were assessed by analyzing 4467 patients. The pooled results indicated that a pear-shaped disk and straight cage were significant risk factors for CR. However, factors that had no significant relation with CR were preoperative diagnosis (disk herniation, spinal stenosis, and spondylolisthesis); gender; surgical segments (from L2 to S1); multilevel fusion; and unilateral pedicle screws fixation.
   CONCLUSIONS: According to current evidence, a pear-shaped disk and straight cage are significant risk factors for CR. However, preoperative diagnosis, gender, multilevel fusion, surgical segments, and unilateral pedicle screws fixation are not the risk factors associated with CR. A revision surgery is needed when neurologic symptoms happen after CR. The conclusion should be consulted cautiously due to the limited number of included studies. Therefore larger-scale studies are still needed to investigate the risk factors for CR.
C1 [Liu, Kaiyu; Chang, Hengrui; Wang, Lifei; Wang, Chunlei; Meng, Xianzhong] Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China.
   [Chen, Tao] Hebei Med Univ, Dept Neurosurg, Hosp 3, Shijiazhuang, Hebei, Peoples R China.
RP Meng, XZ (reprint author), Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China.
EM drmengxz2018@sina.com
CR Aoki Y, 2010, J NEUROSURG-SPINE, V13, P381, DOI 10.3171/2010.3.SPINE09590
   Aoki Y, 2009, SPINE, V34, pE54, DOI 10.1097/BRS.0b013e3181918aae
   Arnold Paul M, 2009, Am J Orthop (Belle Mead NJ), V38, pE115
   Baeesa SS, 2016, ASIAN SPINE J, V10, P1100, DOI 10.4184/asj.2016.10.6.1100
   Chen DJ, 2018, WORLD NEUROSURG, V115, pE516, DOI 10.1016/j.wneu.2018.04.085
   Chen L, 2005, SPINE, V30, P2171, DOI 10.1097/01.brs.0000180402.50500.5b
   Cho W, 2008, CLIN BIOMECHAN, V23
   Deng QX, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5712-7
   Duncan JW, 2013, EUR SPINE J, V22, P439, DOI 10.1007/s00586-012-2458-x
   Eichholz Kurt M, 2003, Neurosurg Focus, V15, pE1
   Goz V, 2014, SPINE J, V14, P2019, DOI 10.1016/j.spinee.2013.11.050
   Hayashi K, 2016, GLOB SPINE J, V6, P665, DOI 10.1055/s-0036-1578806
   Houten John K, 2006, Neurosurg Focus, V20, pE8
   Huang WQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003857
   Kimura H, 2012, SPINE, V37, P1164, DOI 10.1097/BRS.0b013e318257f12a
   Lee DY, 2018, ASIAN SPINE J, V12, P59, DOI 10.4184/asj.2018.12.1.59
   Li H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007804
   Liang Y, 2015, EUR SPINE J, V24, P2560, DOI 10.1007/s00586-015-3933-y
   Liu FB, 2017, CLIN SPINE SURG, V30, pE776, DOI 10.1097/BSD.0000000000000416
   Madera M, 2016, SPINE J, V16, pS278
   McAfee PC, 2005, SPINE, V30, pS60, DOI 10.1097/01.brs.0000155578.62680.dd
   Moisi M, 2015, CUREUS, V7, DOI 10.7759/cureus.268
   Nagamoto Y, 2019, WORLD NEUROSURG, V121, pE808, DOI 10.1016/j.wneu.2018.09.227
   Pan FM, 2016, INT J SURG, V30, P56, DOI 10.1016/j.ijsu.2016.04.025
   Park MK, 2019, SPINE J, V19, P437, DOI 10.1016/j.spinee.2018.08.007
   Proubasta Ignacio R, 2002, Spine (Phila Pa 1976), V27, pE399, DOI 10.1097/00007632-200209010-00029
   Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004
   Salvi GE, 2018, CLIN ORAL IMPLAN RES, V29, P294, DOI 10.1111/clr.13123
   Selznick LA, 2009, J SPINAL DISORD TECH, V22, P207, DOI 10.1097/BSD.0b013e318169026f
   Sethi A, 2011, AM J ROENTGENOL, V197, pW128, DOI 10.2214/AJR.10.5484
   Shi-Bao LU, 2016, J SPINAL SURG, V14, P16
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Takahashi T, 2011, NEUROL MED-CHIR, V51, P829, DOI 10.2176/nmc.51.829
   Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897
   Watanabe K, 2011, J SPINAL DISORD TECH, V24, P137, DOI 10.1097/BSD.0b013e3181e1cd99
   Zhao Feng-dong, 2012, Orthop Surg, V4, P227, DOI 10.1111/os.12004
NR 36
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 273
EP 281
DI 10.1016/j.wneu.2019.09.019
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300170
PM 31521758
DA 2020-05-12
ER

PT J
AU Coggins, WS
   Pham, NK
   Nguyen, AV
   Branch, DW
   Guillet, JY
   Korst, G
   Lall, RR
AF Coggins, William S.
   Pham, Nguyen K.
   Nguyen, Anthony, V
   Branch, Daniel W.
   Guillet, June Y.
   Korst, Genevieve
   Lall, Rishi R.
TI A Systematic Review of Ion Radiotherapy in Maintaining Local Control
   Regarding Atypical and Anaplastic Meningiomas
SO WORLD NEUROSURGERY
LA English
DT Review
DE Anaplastic meningioma; Atypical meningioma; Carbon ion therapy; Ion
   radiotherapy; Meningioma; Proton beam therapy
ID PROTON RADIATION-THERAPY; INTRACRANIAL MENINGIOMA; PARTICLE THERAPY;
   PHOTON; RECURRENT; SURVIVAL; OUTCOMES; SURGERY; BENIGN
AB OBJECTIVE: Atypical and anaplastic meningiomas, unlike their benign counterparts, are highly aggressive, locally destructive, and likely to recur after treatment. These diseases are difficult to definitively treat with traditional radiotherapy without injuring adjacent brain parenchyma. The physical properties of ion radiotherapy allows for treatment plans that avoid damaging critical neural structures. The objectives of this systematic review were to evaluate the use and efficacy of ion radiotherapy in the treatment of atypical and anaplastic meningiomas.
   METHODS: We performed a systematic review of the literature by querying the PubMed and Ovid databases to identify and examine literature addressing the efficacy of ion radiotherapy in maintaining long-term local tumor control for patients with atypical or anaplastic meningiomas. The outcome of interest was rate of local tumor control at 5 years after ion radiotherapy.
   RESULTS: Across the included studies, proton therapy delivered a mean local control rate of 59.62% after 5 years. Carbon ion radiotherapy studies showed local control rates of 95% and 63% at 2 years for grade II and III meningiomas, respectively. In contrast, carbon ion radiotherapy studies that failed to differentiate between atypical and anaplastic meningiomas produced a local control rate of 33% at 2 years.
   CONCLUSIONS: Proton and carbon ion radiotherapy maintain comparable rates of local control to conventional photon therapy and allow for more targeted treatment plans that may limit excess radiation damage. Although additional prospective trials are needed, ion therapy represents a burgeoning field in the treatment of atypical and anaplastic meningiomas.
C1 [Coggins, William S.; Pham, Nguyen K.; Nguyen, Anthony, V; Korst, Genevieve] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA.
   [Branch, Daniel W.; Guillet, June Y.; Lall, Rishi R.] Univ Texas Med Branch, Div Neurosurg, Galveston, TX 77555 USA.
RP Coggins, WS (reprint author), Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA.
EM wscoggin@utmb.edu
CR Adeberg S, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0924-7
   Adeberg S, 2012, INT J RADIAT ONCOL, V83, P859, DOI 10.1016/j.ijrobp.2011.08.010
   Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63
   [Anonymous], 2018, EXT BEAM RAD
   [Anonymous], 2009, COMM TERM CRIT ADV E, V4
   Arvold ND, 2009, INT J RADIAT ONCOL, V75, P1166, DOI 10.1016/j.ijrobp.2008.12.056
   Boskos C, 2009, INT J RADIAT ONCOL, V75, P399, DOI 10.1016/j.ijrobp.2008.10.053
   Buttrick S, 2016, NEUROSURG CLIN N AM, V27, P239, DOI 10.1016/j.nec.2015.11.003
   Chan AW, 2012, TECHNOL CANCER RES T, V11, P607, DOI 10.7785/tcrt.2012.500267
   Combs SE, 2013, RADIOTHER ONCOL, V106, P186, DOI 10.1016/j.radonc.2012.07.008
   Combs SE, 2013, ACTA ONCOL, V52, P514, DOI 10.3109/0284186X.2013.762996
   Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882
   Combs SE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-615
   Combs SE, 2010, RADIOTHER ONCOL, V95, P54, DOI 10.1016/j.radonc.2009.12.029
   Cozzi L, 2001, RADIOTHER ONCOL, V61, P287, DOI 10.1016/S0167-8140(01)00403-0
   Dijkstra M, 2009, J NEUROL NEUROSUR PS, V80, P910, DOI 10.1136/jnnp.2007.138925
   El Shafie RA, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1026-x
   El Shafie RA, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1002-5
   Goyal LK, 2000, INT J RADIAT ONCOL, V46, P57, DOI 10.1016/S0360-3016(99)00349-1
   Grosu A, 2006, DEFINITION TARGET VO
   Halperin EC, 2006, LANCET ONCOL, V7, P676, DOI 10.1016/S1470-2045(06)70795-1
   Hanft S, 2010, J NEURO-ONCOL, V99, P433, DOI 10.1007/s11060-010-0348-9
   Hansen TM, 2015, INT J RADIAT ONCOL, V93, pE61, DOI 10.1016/j.ijrobp.2015.07.698
   Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7
   Karger CP, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa9102
   Lesueur P, 2019, CANCER TREAT REV, V72, P56, DOI 10.1016/j.ctrv.2018.11.004
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Liu Hui, 2011, Chin J Cancer, V30, P315
   Lomax AJ, 2003, INT J RADIAT ONCOL, V55, P785, DOI 10.1016/S0360-3016(02)04210-4
   Madani I, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0384-x
   Miralbell R, 2000, INT J RADIAT ONCOL, V47, P1111, DOI 10.1016/S0360-3016(00)00494-6
   Mock U, 2014, RADIOTHER ONCOL, V111, P451, DOI 10.1016/j.radonc.2014.05.018
   Mozes P, 2017, ACTA ONCOL, V56, P431, DOI 10.1080/0284186X.2016.1259659
   Murray FR, 2017, INT J RADIAT ONCOL, V99, P1190, DOI 10.1016/j.ijrobp.2017.08.005
   Ohno T, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-9
   Peeters A, 2010, RADIOTHER ONCOL, V95, P45, DOI 10.1016/j.radonc.2009.12.002
   Pompos A, 2016, JAMA ONCOL, V2, P1539, DOI 10.1001/jamaoncol.2016.2646
   Rieken S, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-41
   Rogers L, 2010, J NEURO-ONCOL, V99, P393, DOI 10.1007/s11060-010-0343-1
   Saeed P, 2010, BRIT J OPHTHALMOL, V94, P564, DOI 10.1136/bjo.2009.166793
   Slater JD, 2012, INT J RADIAT ONCOL, V83, pE633, DOI 10.1016/j.ijrobp.2012.01.079
   Sughrue ME, 2010, J NEUROSURG, V113, P202, DOI 10.3171/2010.1.JNS091114
   van Nieuwenhuizen D, 2007, J NEURO-ONCOL, V84, P271, DOI 10.1007/s11060-007-9366-7
   Verma V, 2016, CANCER-AM CANCER SOC, V122, P1483, DOI 10.1002/cncr.29882
   Weber DC, 2012, INT J RADIAT ONCOL, V83, P865, DOI 10.1016/j.ijrobp.2011.08.027
   Weber DC, 2004, RADIOTHER ONCOL, V71, P251, DOI 10.1016/j.radonc.2004.02.011
   Wells G, 2011, NEWCASTLE OTTAWA SCA
NR 47
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 282
EP 291
DI 10.1016/j.wneu.2019.08.149
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300171
PM 31476452
DA 2020-05-12
ER

PT J
AU McGuire, LS
   Keldahl, M
   Tsimpas, A
AF McGuire, Laura Stone
   Keldahl, Mark
   Tsimpas, Asterios
TI Mechanical Embolectomy of Distally Migrated Onyx After Surgical
   Resection of Glomus Vagale Tumor: Technical Report and Review of
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Complication of endovascular treatment; Mechanical embolectomy; Onyx
   reflux
ID SOLITAIRE AB STENT; EMBOLIZATION; REMOVAL; PIECE; NECK; HEAD
AB BACKGROUND: Endovascular embolization is an important tool in the management of multiple pathologies as a preoperative adjunct in the care of arteriovenous malformations or vascular tumors.
   CASE DESCRIPTION: We report a case of delayed distal Onyx migration after surgical resection of a glomus vagale tumor, which had been preoperatively embolized. In this report, the patient underwent successful embolectomy of the migrated Onyx fragment using manual aspiration.
   CONCLUSIONS: This case represents the first in the literature to describe this potential delayed complication, as well as its management strategy.
C1 [McGuire, Laura Stone; Tsimpas, Asterios] Univ Illinois, Dept Neurol Surg, Chicago, IL 60607 USA.
   [Keldahl, Mark; Tsimpas, Asterios] Advocate Illinois Masonic Med Ctr, Dept Surg, Sect Neurosurg, Chicago, IL USA.
RP McGuire, LS (reprint author), Univ Illinois, Dept Neurol Surg, Chicago, IL 60607 USA.
EM lmcguir1@uic.edu
OI Tsimpas, Asterios/0000-0002-3867-9229
CR Cayli E, 2017, EURASIAN J MED, V49, P224, DOI 10.5152/eurasianjmed.2017.17260
   Elhammady MS, 2012, WORLD NEUROSURG, V77, P725, DOI 10.1016/j.wneu.2011.02.033
   Fahed R, 2016, J NEUROSURG, V125, P173, DOI 10.3171/2015.5.JNS15145
   Gungor D, 2017, INTERV NEURORADIOL, V23, P293, DOI 10.1177/1591019917694022
   Hopf-Jensen S, 2013, J CLIN NEUROSCI, V20, P884, DOI 10.1016/j.jocn.2012.06.012
   Kabbani MR, 2014, BMJ CASE REP
   Li MW, 2015, J VASC INTERV RADIOL, V26, P927, DOI 10.1016/j.jvir.2015.01.024
   Liu KC, 2014, J CLIN NEUROSCI, V21, P503, DOI 10.1016/j.jocn.2013.10.012
   Michael SG, 2010, NEUROCRIT CARE, V12, P269, DOI 10.1007/s12028-009-9272-2
   Nas OF, 2016, DIAGN INTERV IMAG, V97, P379, DOI 10.1016/j.diii.2015.09.004
   Rangel-Castilla L, 2014, J NEUROINTERV SURG, V6, P51, DOI 10.1136/neurintsurg-2012-010542
   Senturk C, 2015, CARDIOVASC INTER RAD, V38, P1654, DOI 10.1007/s00270-015-1095-2
   Singh Devendra Pal, 2016, J Cerebrovasc Endovasc Neurosurg, V18, P48, DOI 10.7461/jcen.2016.18.1.48
NR 13
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 292
EP 294
DI 10.1016/j.wneu.2019.08.153
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300172
PM 31476459
DA 2020-05-12
ER

PT J
AU Kang, SS
   Lee, SC
   Kim, SK
AF Kang, Sang-Soo
   Lee, Su-Chan
   Kim, Seung-Kook
TI Endoscopy-Assisted Diagnosis and Revision of a Malpositioned Screw
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic spine surgery; Minimally invasive spine surgery; Misplaced
   screw; Pedicle screw revision
ID PLACEMENT; ACCURACY; COMPLICATIONS; FIXATION; GUIDANCE; OUTCOMES;
   SURGERY; FUSION
AB BACKGROUND: Pedicle screw insertion is a common procedure in spine surgery, and freehand, fluoroscopic, and robotic-assisted techniques all are used. These are indirect methods that use fluoroscopy, and direct visualization of canal involvement has not been possible. However, owing to the development of high-definition imaging modalities, delicate procedures that use endoscopy are possible.
   CASE DESCRIPTION: A 47-year-old man presented with severe radiating pain in his leg after undergoing L5-S1 level endoscopic transforaminal lumbar interbody fusion and percutaneous pedicular screw fixation. The patient then underwent an endoscopy-assisted technique for violated spinal canal and screw revision in which the misplaced screw was directly visualized using endoscopy and the trajectory of the misplaced screw was changed. With 30 degrees endoscopy, we directly visualized the screw thread and root compression. Then with 0 degrees endoscopy, we changed the screw trajectory inside the pedicle with an anatomic landmark. The patient's radiating pain was completely relieved after revision of the malpositioned screw. Postoperative imaging showed the revised screw trajectory inside the pedicle.
   CONCLUSIONS: Endoscopy-assisted pedicle screw insertion does not require an additional incision, and early recovery after the procedure is possible. Accurate diagnosis of canal pathology and treatment are possible with direct visualization using endoscopy.
C1 [Kang, Sang-Soo] Leaders Hosp, Dept Orthoped Surg, Seoul, South Korea.
   [Lee, Su-Chan; Kim, Seung-Kook] Himchan Hosp, Orthoped Surg, Joint & Arthrit Res, Seoul, South Korea.
   [Kim, Seung-Kook] Univ Hosp Sharjah, Himchan UHS Spine & Joint Inst, Neurosurg, Sharjah, U Arab Emirates.
   [Kim, Seung-Kook] Yonsei Univ, Coll Med & Pharm, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea.
RP Kim, SK (reprint author), Himchan Hosp, Orthoped Surg, Joint & Arthrit Res, Seoul, South Korea.; Kim, SK (reprint author), Univ Hosp Sharjah, Himchan UHS Spine & Joint Inst, Neurosurg, Sharjah, U Arab Emirates.; Kim, SK (reprint author), Yonsei Univ, Coll Med & Pharm, Dept Pharmaceut Med & Regulatory Sci, Incheon, South Korea.
EM hyunipapa@yonsei.ac.kr
OI Kang, Sang Soo/0000-0003-1581-3744
CR Amato V, 2010, J NEUROSURG-SPINE, V12, P306, DOI 10.3171/2009.9.SPINE09261
   Chang PY, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.2.FocusVid.1694
   France JC, 1999, SPINE, V24, P553, DOI 10.1097/00007632-199903150-00010
   Fujishiro T, 2015, SPINE, V40, P1882, DOI 10.1097/BRS.0000000000001099
   Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3
   Heo DH, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17146
   Kang SS, 2019, WORLD NEUROSURG, V129, P49, DOI 10.1016/j.wneu.2019.05.214
   Kim JE, 2018, CLIN ORTHOP SURG, V10, P508, DOI 10.4055/cios.2018.10.4.508
   Kosmopoulos V, 2007, INT ORTHOP, V31, P531, DOI 10.1007/s00264-006-0230-8
   Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003
   Masferrer R, 1998, J NEUROSURG, V89, P371, DOI 10.3171/jns.1998.89.3.0371
   Nevzati E, 2014, WORLD NEUROSURG, V82, P866, DOI 10.1016/j.wneu.2014.06.023
   Okuda S, 2006, J NEUROSURG-SPINE, V4, P304, DOI 10.3171/spi.2006.4.4.304
   Park SM, 2019, WORLD NEUROSURG, V128, pE709, DOI 10.1016/j.wneu.2019.04.240
   Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32
   Rivet DJ, 2004, J NEUROSURG-SPINE, V1, P261, DOI 10.3171/spi.2004.1.3.0261
   Tai CL, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-197
   West JL III, 1976, SPINE, V16, P576
   Woo EJ, 2018, SPINE J, V18, P1166, DOI 10.1016/j.spinee.2017.11.006
NR 19
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 295
EP 299
DI 10.1016/j.wneu.2019.09.045
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300173
PM 31526881
DA 2020-05-12
ER

PT J
AU Kuwano, A
   Kubota, Y
   Nonaka, T
   Miyao, S
   Nakamoto, H
   Kawamata, T
AF Kuwano, Atsushi
   Kubota, Yuichi
   Nonaka, Taku
   Miyao, Satoru
   Nakamoto, Hidetoshi
   Kawamata, Takakazu
TI Mechanical Thrombectomy for Middle Cerebral Artery Occlusion Suspected
   of Ovarian Hyperstimulation Syndrome: Case Report and Review of the
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cerebral infarction; Ovarian hyperstimulation syndrome; Thrombectomy
AB BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic disorder associated with infertility treatment. The main pathology of OHSS is intravascular dehydration and hyperestrogenemia. In mild cases, abdominal symptoms are the main symptoms, but in severe cases, thrombosis such as cerebral infarction may occur.
   CASE DESCRIPTION: A 36-year-old woman was undergoing infertility treatment in obstetrics and gynecology for infertility. She received HMG-HCG therapy and artificial insemination 1 week before onset, and on the day of onset she had mild abdominal distension and was suspected of having OHSS. She was prescribed aspirin for prevention of thrombosis. She presented with right upper hemiparesis and aphasia. Magnetic resonance imaging showed left middle cerebral artery occlusion. We performed mechanical thrombectomy and finally achieved Thrombolysis in Cerebral Infarction 3 recanalization. We suspected embolism as the etiology of cerebral infarction and started anticoagulation therapy. Various examinations were conducted to investigate the embolism source, but no anatomic abnormality or thrombophilia factors were observed. Because the patient had OHSS since admission, we concluded that OHSS was suspected as the cause of the stroke.
   CONCLUSIONS: We experienced the first case of mechanical thrombectomy for middle cerebral artery occlusion suspected to be caused by OHSS. It is necessary to suspect OHSS involvement if young women, especially those on infertility treatment, show neurologic deficits.
C1 [Kuwano, Atsushi; Kubota, Yuichi; Nonaka, Taku; Miyao, Satoru; Nakamoto, Hidetoshi] TMG Asaka Med Ctr, Stroke & Epilepsy Ctr, Dept Neurosurg, Saitama, Japan.
   [Kuwano, Atsushi; Kubota, Yuichi; Nonaka, Taku; Miyao, Satoru; Nakamoto, Hidetoshi; Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan.
RP Kubota, Y (reprint author), TMG Asaka Med Ctr, Stroke & Epilepsy Ctr, Dept Neurosurg, Saitama, Japan.; Kubota, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan.
EM kubota.yuichi@twmu.ac.jp
CR Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS188, DOI 10.1016/j.fertnstert.2008.08.034
   Jahromi BN, 2018, IRAN J MED SCI, V43, P248
   Mor YS, 2014, AM J REPROD IMMUNOL, V72, P541, DOI 10.1111/aji.12310
   Naredi Nikita, 2014, Med J Armed Forces India, V70, P58, DOI 10.1016/j.mjafi.2012.03.005
   Pellicer A, 1999, FERTIL STERIL, V71, P482, DOI 10.1016/S0015-0282(98)00484-1
   Qazi Amna, 2008, J Pak Med Assoc, V58, P411
   Stewart JA, 1997, HUM REPROD, V12, P2174, DOI 10.1093/humrep/12.10.2174
   Takahashi M, 2009, HISTOL HISTOPATHOL, V24, P1391, DOI 10.14670/HH-24.1391
   Watanabe TT, 2019, J STROKE CEREBROVASC, V28, P70, DOI 10.1016/j.jstrokecerebrovasdis.2018.09.002
   Whelan JG, 2000, FERTIL STERIL, V73, P883, DOI 10.1016/S0015-0282(00)00491-X
NR 10
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 300
EP 302
DI 10.1016/j.wneu.2019.09.023
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300174
PM 31525479
DA 2020-05-12
ER

PT J
AU Zaldivar-Jolissaint, JF
   Bobinski, L
   Duff, JM
AF Zaldivar-Jolissaint, Julien Francisco
   Bobinski, Lukas
   Duff, John Michael
TI Multilevel Pedicular Osteotomies for En Bloc Resection of a Primary
   Ewing Sarcoma of the Subaxial Cervical Spine with Pedicle Screw
   Reconstruction
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical pedicle screw stabilization; Cervical spine; En bloc excision;
   Ewing sarcoma; Multilevel cervical pedicular osteotomies
ID BIOMECHANICAL ANALYSIS; PRIMARY TUMORS; LAMINECTOMY; DEFORMITY;
   CHILDREN; FIXATION
AB BACKGROUND: Primary Ewing sarcoma of the mobile spine is a rare disease. Its management requires careful surgical planning, because radical, margin-free excision is directly correlated with prognosis. Extensive bone removal in the cervical spine can lead to instability and cause postoperative iatrogenic cervical deformity. Thus, spinal instrumentation plays an important role in restoring post-resection spinal stability and improving quality of life.
   METHODS: We present a novel technique that allows successful removal of a large Ewing sarcoma of the subaxial cervical spine, infiltrating and traversing the posterior bone elements, and extending into the paraspinal muscles. This technique involves radical en bloc resection of posteriorly located cervical tumors via multilevel pediculotomy, with terminal vertebrae pedicle screw reconstruction.
   RESULTS: Terminal vertebrae cervical pedicle screw reconstruction allowed wide surgical excision with satisfactory oncologic and mechanical results.
   CONCLUSIONS: This technique enables 1-stage total tumor resection and stabilization and may be a viable alternative to radical en bloc resection of posteriorly located epidural malignant lesions of the cervical spine in selected cases.
C1 [Zaldivar-Jolissaint, Julien Francisco] Ctr Hosp Univ Grenoble Alpes, Neurosurg Serv, La Tronche, France.
   [Bobinski, Lukas] Univ Hosp Umea, Dept Orthoped Surg, Spine Unit, Umea, Sweden.
   [Duff, John Michael] Clin Genolier, Neurosurg Dept, Genolier, Switzerland.
RP Zaldivar-Jolissaint, JF (reprint author), Ctr Hosp Univ Grenoble Alpes, Neurosurg Serv, La Tronche, France.
EM julienzaldivar@gmail.com
OI Zaldivar-Jolissaint, Julien Francisco/0000-0001-7415-6903
CR Ames CP, 2013, J NEUROSURG-SPINE, V19, P269, DOI 10.3171/2013.5.SPINE121067
   Boriani S, 2011, EUR REV MED PHARMACO, V15, P831
   de Jonge T, 2005, EUR SPINE J, V14, P765, DOI 10.1007/s00586-004-0778-1
   Dunlap BJ, 2010, EUR SPINE J, V19, P803, DOI 10.1007/s00586-010-1278-0
   Fisher CG, 2011, SPINE, V36, P830, DOI 10.1097/BRS.0b013e3181e502e5
   Ilaslan H, 2004, SKELETAL RADIOL, V33, P506, DOI 10.1007/s00256-004-0810-x
   Johnston Todd L, 2006, Spine J, V6, P667
   Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009
   KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007
   Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b
   Liljenqvist U, 2008, EUR SPINE J, V17, P600, DOI 10.1007/s00586-008-0599-8
   Marco RAW, 2005, SPINE, V30, P769, DOI 10.1097/01.brs.0000157755.17502.d6
   Mukherjee D, 2011, J NEUROSURG-SPINE, V14, P143, DOI 10.3171/2010.10.SPINE10189
   Oda I, 2006, SPINE, V31, P1439, DOI 10.1097/01.brs.0000219952.40906.1f
   Papagelopoulos PJ, 1997, SPINE, V22, P442, DOI 10.1097/00007632-199702150-00019
   Placantonakis DG, 2008, J NEUROSURG-SPINE, V9, P111, DOI 10.3171/SPI/2008/9/8/111
   Sciubba DM, 2009, SPINE PHILA PA 197 S, V34, pS58
   SIM FH, 1974, J BONE JOINT SURG AM, VA 56, P564, DOI 10.2106/00004623-197456030-00014
   Talac R, 2002, CLIN ORTHOP RELAT R, P127
   WEINSTEIN JN, 1987, SPINE, V12, P843, DOI 10.1097/00007632-198711000-00004
   Yamazaki T, 2009, SPINE, V34, pS31, DOI 10.1097/BRS.0b013e3181b8b796
   Yao KC, 2007, J NEUROSURG, V107, P463, DOI 10.3171/PED-07/12/463
   Zileli M, 2007, SPINE J, V7, P165, DOI 10.1016/j.spinee.2006.04.027
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 303
EP 308
DI 10.1016/j.wneu.2019.07.208
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300175
PM 31394361
DA 2020-05-12
ER

PT J
AU Lin, CK
   Tsai, YD
AF Lin, Cheng-Kai
   Tsai, Yu-Duan
TI Nonresectable Thoracic Rosai-Dorfman Disease: A Case Report and Review
   of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Adjuvant therapy; Recurrent; Rosai-Dorfman disease
ID SPINAL-CORD COMPRESSION; CENTRAL-NERVOUS-SYSTEM; LESIONS
AB INTRODUCTION: Rosai-Dorfman disease (RDD) is a rare disease that can be triggered by either viral or bacterial infection. Several parts of the body can be involved, from the central nervous system to the pelvic regions had been reported. At present, there is a serious lack of guidelines as to how to treat cases of RDD involving the spine. Current trends show that surgery remains the first method of choice to cure this disease, but in refractory or recurrent RDD, repeat surgery cannot guarantee total resection. Under such circumstances, adjuvant therapy can be very useful. Here, we share our experience of treating recurrent spinal RDD.
   CASE DESCRIPTION: Our patient was a 32-year-old male patient with hepatitis B virus infection. He suffered from lower back pain with lower limb weakness after being hit by a metal pipe. Laminectomy of T11-12 was performed to decompress the spinal cord. The final pathological results demonstrated chronic inflammation. After surgery, the lower limbs improved and the patient recovered quite well. However, he returned 3 years later with the same complaints and was diagnosed with RDD. Durectomy was performed and repaired with an artificial dura. Thalidomide therapy was initiated. Currently, 9 years later, the patient has not experienced recurrence or any form of neurological deficit.
   CONCLUSIONS: RDD is a rare disease and can be misdiagnosed easily. Although it may resolve spontaneously, recurrence is possible. Hence, extensive follow-up is necessary. Surgery remained the first choice of surgery, however, when encountered recurrent or nonresectable RDD, adjuvant therapy such as corticosteroids, thalidomide, and radiotherapy could help. In this article, we shared our experience using thalidomide in treating nonresectable RDD.
C1 [Lin, Cheng-Kai; Tsai, Yu-Duan] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan.
RP Tsai, YD (reprint author), I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan.
EM windos101@hotmail.com
CR Abla O, 2018, BLOOD, V131, P2877, DOI 10.1182/blood-2018-03-839753
   Abou-Zeid AH, 2010, NEUROSURGERY, V67, pE514, DOI 10.1227/01.NEU.0000372203.38326.CF
   Al-Saad K, 2005, PEDIATR DEVEL PATHOL, V8, P593, DOI 10.1007/s10024-005-8102-6
   Bhandari A, 2006, SURG NEUROL, V65, P308, DOI 10.1016/j.surneu.2005.05.022
   Lima GLD, 2016, SPINE J, V16, pE521, DOI 10.1016/j.spinee.2016.01.209
   El Molla M, 2014, WORLD NEUROSURG, V81, DOI 10.1016/j.wneu.2013.01.002
   Huang BY, 2016, WORLD NEUROSURG, V85, DOI 10.1016/j.wneu.2015.09.097
   Huang YC, 2007, SPINAL CORD, V45, P641, DOI 10.1038/sj.sc.3102006
   Igrutinovic Z, 2016, TURKISH J PEDIATR, V58, P566, DOI 10.24953/turkjped.2016.05.020
   Kim Do Young, 2014, Korean J Spine, V11, P198, DOI 10.14245/kjs.2014.11.3.198
   Kozak B, 2015, J RADIOL CASE REP, V9, P6, DOI 10.3941/jrcr.v9i11.2629
   Li YN, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012722
   Ma JM, 2008, J NEUROSURG-SPINE, V9, P55, DOI 10.3171/SPI/2008/9/7/055
   Parmar V, 2013, CLIN NEUROL NEUROSUR, V115, P808, DOI 10.1016/j.clineuro.2012.07.024
   Qin Guowen, 2019, Br J Neurosurg, P1, DOI 10.1080/02688697.2019.1567681
   Robert EG, 2006, J NEUROSURG-SPINE, V4, P425, DOI 10.3171/spi.2006.4.5.425
   Tan S, 2018, INT J NEUROSCI, V128, P192, DOI 10.1080/00207454.2017.1377709
   Tu J, 2017, J INT MED RES, V45, P875, DOI 10.1177/0300060516687228
   Tubbs RS, 2005, CHILD NERV SYST, V21, P951, DOI 10.1007/s00381-004-1121-1
   Wang Y, 2010, NEUROPATHOLOGY, V30, P154, DOI 10.1111/j.1440-1789.2009.01045.x
   Wu L, 2014, SPINE J, V14, P3058, DOI 10.1016/j.spinee.2014.07.016
   Xu HC, 2017, EUR SPINE J, V26, pS117, DOI 10.1007/s00586-017-4975-0
NR 22
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 309
EP 313
DI 10.1016/j.wneu.2019.09.034
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300176
PM 31525482
DA 2020-05-12
ER

PT J
AU Boutet, A
   Jain, M
   Elias, GJB
   Gramer, R
   Germann, J
   Davidson, B
   Coblentz, A
   Giacobbe, P
   Kucharczyk, W
   Wennberg, RA
   Ibrahim, GM
   Lozano, AM
AF Boutet, Alexandre
   Jain, Mehr
   Elias, Gavin J. B.
   Gramer, Robert
   Germann, Juergen
   Davidson, Benjamin
   Coblentz, Ailish
   Giacobbe, Peter
   Kucharczyk, Walter
   Wennberg, Richard A.
   Ibrahim, George M.
   Lozano, Andres M.
TI Network Basis of Seizures Induced by Deep Brain Stimulation: Literature
   Review and Connectivity Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Deep brain stimulation; Epilepsy; Functional connectivity; Functional
   neurosurgery; Magnetic resonance imaging
ID TREATMENT-RESISTANT DEPRESSION; REFRACTORY ANOREXIA-NERVOSA;
   TEMPORAL-LOBE EPILEPSY; FOLLOW-UP; ELECTRICAL-STIMULATION; SUBCALLOSAL
   CINGULATE; MOVEMENT-DISORDERS; ANTERIOR NUCLEUS
AB BACKGROUND: Whereas transient, self-limiting seizures are an infrequent but known complication of deep brain stimulation (DBS) implantation surgery, stimulation itself has occasionally been reported to result in seizure activity at delayed time points. The neural circuitry implicated in stimulation-induced seizures is unknown.
   CASE DESCRIPTION: A 47-year-old woman underwent chronic subcallosal cingulate DBS for treatment of refractory anorexia nervosa and experienced seizure with stimulation onset. Supratherapeutic voltage caused a generalized seizure. The patient subsequently experienced a full recovery. We reviewed the literature for other cases of delayed postoperative DBS seizures associated with stimulation. We also investigated whether the higher voltage may have recruited networks implicated in epilepsy. The supratherapeutic voltage stimulated a larger area and engaged vulnerable networks, including bilateral hippocampi, cingulate gyrus, and temporal lobes. Literature review identified 20 studies reporting delayed seizure after DBS surgery, 13 of which demonstrated a robust association with mostly nonmotor DBS stimulation.
   CONCLUSIONS: Nonmotor DBS targets, particularly in patients with epilepsy, may be more vulnerable to stimulation-induced seizures; as such, extra caution should be used when programming stimulation parameters at these DBS targets.
C1 [Wennberg, Richard A.] Krembil Brain Inst, Div Neurol, Toronto, ON, Canada.
   [Boutet, Alexandre; Jain, Mehr; Elias, Gavin J. B.; Gramer, Robert; Germann, Juergen; Davidson, Benjamin; Kucharczyk, Walter; Lozano, Andres M.] Univ Hlth Network, Toronto, ON, Canada.
   [Boutet, Alexandre; Kucharczyk, Walter] Joint Dept Med Imaging, Toronto, ON, Canada.
   [Ibrahim, George M.] Dept Surg, Toronto, ON, Canada.
   [Ibrahim, George M.] Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Giacobbe, Peter] Univ Toronto, Toronto, ON, Canada.
   [Coblentz, Ailish] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada.
   [Ibrahim, George M.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada.
   [Giacobbe, Peter] Sunnybrook Hlth Sci Ctr, Harquail Ctr Neuromodulat, Toronto, ON, Canada.
RP Lozano, AM (reprint author), Univ Hlth Network, Toronto, ON, Canada.
EM lozano@uhnresearch.ca
OI Lozano, Andres/0000-0001-8257-3694; Elias, Gavin/0000-0002-7495-550X;
   Boutet, Alexandre/0000-0001-6942-5195
FU RR Tasker Chair in Functional Neurosurgery at University Health Network;
   Tier 1 Canada Research Chair in Neuroscience
FX This study was supported by the RR Tasker Chair in Functional
   Neurosurgery at University Health Network and a Tier 1 Canada Research
   Chair in Neuroscience. The corresponding author (A.M.L.) confirms that
   he had full access to all the data in the study and had final
   responsibility for the decision to submit for publication. A. M. Lozano
   is the cofounder of Functional
CR Alkawadri R, 2013, JAMA NEUROL, V70, P995, DOI 10.1001/jamaneurol.2013.2940
   Andrade DM, 2006, NEUROLOGY, V66, P1571, DOI 10.1212/01.wnl.0000206364.19772.39
   Boex C, 2011, SEIZURE-EUR J EPILEP, V20, P485, DOI 10.1016/j.seizure.2011.03.001
   Boutet A, 2019, RADIOLOGY, V293, P174, DOI 10.1148/radiol.2019190546
   Boutet A, 2020, J NEUROSURG, V132, P586, DOI 10.3171/2018.11.JNS181338
   Coley E, 2009, BRIT J NEUROSURG, V23, P179, DOI 10.1080/02688690802673197
   Cukiert A, 2014, SEIZURE-EUR J EPILEP, V23, P6, DOI 10.1016/j.seizure.2013.08.005
   Dandekar MP, 2018, MOL PSYCHIATR, V23, P1094, DOI 10.1038/mp.2018.2
   Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410
   Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225
   Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x
   FISHER RS, 1992, EPILEPSIA, V33, P841, DOI 10.1111/j.1528-1157.1992.tb02192.x
   GLOOR P, 1990, BRAIN, V113, P1673, DOI 10.1093/brain/113.6.1673
   Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034
   Hancu I, 2019, J MAGN RESON IMAGING, V49, P1736, DOI 10.1002/jmri.26321
   Herrman H, 2019, ACTA NEUROL SCAND, V139, P294, DOI 10.1111/ane.13047
   Hooper J, 2002, BRIT J NEUROSURG, V16, P102, DOI 10.1080/02688690220131769
   Horn A, 2019, NEUROIMAGE, V184, P293, DOI 10.1016/j.neuroimage.2018.08.068
   Horn A, 2017, ANN NEUROL, V82, P67, DOI 10.1002/ana.24974
   Joutsa J, 2018, ANN NEUROL, V84, P153, DOI 10.1002/ana.25285
   Joutsa J, 2018, BRAIN, V141, P2445, DOI 10.1093/brain/awy161
   Kim HY, 2017, J NEUROSURG, V126, P2028, DOI 10.3171/2016.6.JNS152958
   Kim SH, 2017, NEUROPSYCH DIS TREAT, V13, P2607, DOI 10.2147/NDT.S148617
   Krishna V, 2016, NEUROSURGERY, V78, P802, DOI 10.1227/NEU.0000000000001197
   Lee KJ, 2012, STEREOT FUNCT NEUROS, V90, P379, DOI 10.1159/000339991
   Lipsman N, 2017, LANCET PSYCHIAT, V4, P285, DOI 10.1016/S2215-0366(17)30076-7
   Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6
   Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020
   Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014
   Medtronic, 2015, MRI GUIDELINES MEDTR, P44
   Nora T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00066
   Pouratian N, 2011, J NEUROSURG, V115, P310, DOI 10.3171/2011.4.JNS102075
   Richieri R, 2016, BRAIN STIMUL, V9, P636, DOI 10.1016/j.brs.2016.05.001
   Riva-Posse P, 2018, MOL PSYCHIATR, V23, P843, DOI 10.1038/mp.2017.59
   Tellez-Zenteno JF, 2006, NEUROLOGY, V66, P1490, DOI 10.1212/01.wnl.0000209300.49308.8f
   Testini P, 2016, MAYO CLIN PROC, V91, P218, DOI 10.1016/j.mayocp.2015.11.016
   Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0
   Vonck K, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065712500347
   Wennberg R, 2018, CAN J NEUROL SCI, V45, P255, DOI 10.1017/cjn.2018.5
   Wille C, 2011, EPILEPSIA, V52, P489, DOI 10.1111/j.1528-1167.2010.02884.x
   Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011
NR 41
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 314
EP 320
DI 10.1016/j.wneu.2019.08.094
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300177
PM 31449994
DA 2020-05-12
ER

PT J
AU Xiang, G
   Wu, ZX
   Zhao, X
   Zhao, XL
   Feng, YF
AF Xiang, Geng
   Wu, Zixiang
   Zhao, Xiong
   Zhao, Xiaolei
   Feng, Yafei
TI Nail Gun Injury of the Spine: Case Report and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Injury; Nail gun; Spine; Vertebral artery
ID HELICAL CT ANGIOGRAPHY; MAXILLOFACIAL REGION; NECK; TRAUMA
AB BACKGROUND: Since the first report about nail gun injuries in 1959, there has been an average of approximately 37,000 patients hurt by nail guns and treated in emergency departments. Carotid arterial injury by nail gun has been reported, but vertebral artery damage is extremely rare.
   CASE DESCRIPTION: A 42-year-old man was transported to the emergency department after suffering an accidental self-inflicted nail gun injury to the left lateral aspect of his neck. Radiographic imaging of the cervical spine revealed a 3.1-cm metallic nail in the C5 region. A computed tomography (CT) angiogram revealed the nail passing through the left C5 transverse foramen and compressing the left vertebral artery. He was immediately brought to the operating room for removal of the nail. At 1-month follow-up, the patient did not have any neck complaints and postoperative CT angiogram indicated the patient was asymptomatic with no signs of complication or infection.
   CONCLUSIONS: Based on our experience and a review of the literature, in terms of treating a nail gun injury to the cervical spine, we would like emphasize that preoperative CT scan or CT angiogram is necessary to assess the location and shape of the nail, especially nails with barbers or washers. Improving awareness of the risk from accidental nail gun trauma may lead to better prevention of this rare but potentially life-threatening injury.
C1 [Xiang, Geng; Wu, Zixiang; Zhao, Xiong; Zhao, Xiaolei; Feng, Yafei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
RP Feng, YF (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
EM fengyafei2005@163.com
CR Adamo MA, 2010, J TRAUMA, V68, pE99, DOI 10.1097/TA.0b013e318169cd5f
   BARBER F A, 1989, Arthroscopy, V5, P172, DOI 10.1016/0749-8063(89)90166-7
   Bigder M, 2015, CAN J NEUROL SCI, V42, P203, DOI 10.1017/cjn.2015.17
   Boya H, 2015, ACTA ORTHOP TRAUMATO, V49, P334, DOI 10.3944/AOTT.2015.3263
   Bruno JR, 1998, J TRAUMA, V45, P410, DOI 10.1097/00005373-199808000-00041
   Buchalter Gregory M, 2002, Ear Nose Throat J, V81, P779
   Choi KJ, 2017, CRANIOMAX TRAUM REC, V10, P159, DOI 10.1055/s-0036-1584405
   DelsolLiebel MA, 1996, J ORAL MAXIL SURG, V54, P632, DOI 10.1016/S0278-2391(96)90649-7
   Demetriades D, 2001, WORLD J SURG, V25, P1044, DOI 10.1007/s00268-001-0057-9
   Erkutlu I, 2011, ULUS TRAVMA ACIL CER, V17, P79, DOI 10.5505/tjtes.2011.49092
   Galano E., 2009, Annals of Physical and Rehabilitation Medicine, V52, P687, DOI 10.1016/j.rehab.2009.10.001
   Gulsen S, 2007, NEUROL MED-CHIR, V47, P415, DOI 10.2176/nmc.47.415
   Harris EB, 2008, J ORTHOP TRAUMA, V22, P501, DOI 10.1097/BOT.0b013e318180def1
   Hoffman DR, 1997, AM FAM PHYSICIAN, V56, P1643
   Horne BR, 2008, INJURY, V39, P357, DOI 10.1016/j.injury.2007.07.011
   Kryl J, 2006, Acta Chir Orthop Traumatol Cech, V73, P353
   Kulaylat AN, 2016, PEDIATR EMERG CARE, V32, P536, DOI 10.1097/PEC.0000000000000449
   LeBlang SD, 2000, AM J ROENTGENOL, V174, P1269, DOI 10.2214/ajr.174.5.1741269
   Lee AD, 2007, LARYNGOSCOPE, V117, P977, DOI 10.1097/MLG.0b013e31804714c1
   Lipscomb H. J., 2007, Morbidity and Mortality Weekly Report, V56, P329
   Munera F, 2002, RADIOLOGY, V224, P366, DOI 10.1148/radiol.2242010973
   Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356
   Nathoo N, 2011, J NEUROSURG-SPINE, V15, P60, DOI 10.3171/2011.3.SPINE10718
   Naysan J, 2016, OPHTHAL PLAST RECONS, V32, pE98, DOI 10.1097/IOP.0000000000000579
   Nunez DB, 2004, RADIOGRAPHICS, V24, P1087, DOI 10.1148/rg.244035035
   Pazardzhikliev DD, 2014, BALK MED J, V31, P254, DOI 10.5152/balkanmedj.2014.13139
   Sasaoka Y, 1995, NEUROL SURG TOKYO, V23, P1099
   Selvanathan S, 2007, J CLIN NEUROSCI, V14, P678, DOI 10.1016/j.jocn.2006.02.017
   Stephens GC, 2015, J SURG CASE REP, V2, P1
   Stern LC, 2011, SPINE, V36, pE1778, DOI 10.1097/BRS.0b013e318226771f
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 321
EP 325
DI 10.1016/j.wneu.2019.08.125
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300178
PM 31470149
DA 2020-05-12
ER

PT J
AU Tompkins, A
   Chandran, A
   Lind, C
   Simonin, A
AF Tompkins, Andrew
   Chandran, Arjun
   Lind, Christopher
   Simonin, Alexandre
TI Sudden Onset of Paraparesis Caused by a Hemorrhagic Thoracic Synovial
   Cyst
SO WORLD NEUROSURGERY
LA English
DT Article
DE Paraparesis; Spine; Synovial cyst
AB BACKGROUND: Hemorrhage is a rare presentation of spinal synovial cysts, which are usually located in the lumbar spine. They may cause an epidural hematoma and compression of the cauda equina. Infrequently, they may be located in the thoracic spine.
   CASE DESCRIPTION: We present a case of sudden onset paraparesis caused by hemorrhage in a synovial cyst at a midthoracic level. Clinical, radiologic, and histologic findings are described.
   CONCLUSIONS: This report describes a unique case of hemorrhagic synovial cyst at the mid-thoracic spine. These lesions are rarely located in the cervicothoracic spine but should be included in the differential diagnosis of myelopathy.
C1 [Tompkins, Andrew; Chandran, Arjun; Lind, Christopher; Simonin, Alexandre] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.
   [Lind, Christopher] Univ Western Australia, Sch Med, Perth, WA, Australia.
RP Simonin, A (reprint author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.
EM alexandresimonin21@gmail.com
OI Simonin, Alexandre/0000-0001-7679-671X
CR Bisson EF, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.3.FOCUS1385
   Cohen-Gadol AA, 2004, J NEUROSURG-SPINE, V1, P52, DOI 10.3171/spi.2004.1.1.0052
   Dahuja Anshul, 2015, Korean J Spine, V12, P193, DOI 10.14245/kjs.2015.12.3.193
   Giovannini SJM, 2019, NEUROCHIRURGIE, V65, P89, DOI 10.1016/j.neuchi.2019.03.002
   Janjua M Burhan, 2017, J Spine Surg, V3, P294, DOI 10.21037/jss.2017.06.12
   Lyons MK, 2011, SPINE, V36, pE1285, DOI 10.1097/BRS.0b013e31820709a8
   Merkle M, 2009, SPINE, V34, pE199, DOI 10.1097/BRS.0b013e318198c64d
   Pratesi A, 2009, BMJ CASE REP
   Shtaya A, 2017, WORLD NEUROSURG, V106, DOI 10.1016/j.wneu.2017.07.068
   Sobowale O, 2012, BRIT J NEUROSURG, V26, P120, DOI 10.3109/02688697.2011.591853
   Stoodley MA, 2000, SPINE, V25, P970, DOI 10.1097/00007632-200004150-00012
   Sundskard MM, 2017, CASE REP NEUROL MED, DOI 10.1155/2017/6257294
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 326
EP 328
DI 10.1016/j.wneu.2019.08.096
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300179
PM 31449995
DA 2020-05-12
ER

PT J
AU Sato, H
   Haraguchi, K
   Takahashi, Y
   Ohtaki, S
   Shimizu, T
   Matsuura, N
   Ogane, K
   Ito, T
AF Sato, Hirotaka
   Haraguchi, Koichi
   Takahashi, Yashuhiro
   Ohtaki, Shunya
   Shimizu, Tadakazu
   Matsuura, Nobuyuki
   Ogane, Kazumi
   Ito, Takeo
TI Flow-Diverter Stent for an Unruptured Aneurysm at the Junction of the
   Internal Carotid Artery and Persistent Primitive Trigeminal Artery: Case
   Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Flow-diverter stent; Internal carotid artery; Persistent primitive
   trigeminal artery aneurysm; Selective coil embolization
AB BACKGROUND: Persistent primitive trigeminal artery (PPTA), which is a fetal carotid-basilar anastomosis, is the most common embryologic vascular remnant persisting in adults. Aneurysms can arise between the internal carotid artery (ICA) and PPTA. Here we present a case of ICA-PPTA aneurysm treated with a flow-diverter stent.
   CASE DESCRIPTION: A 52-year-old woman had left abducens nerve palsy. Imaging detected a large left ICA-PPTA aneurysm, which we chose to treat with a flow-diverter stent after embolizing the PPTA with a coil. Although the abducens nerve palsy did not change, there were no signs of cerebral infarction, and no new symptoms appeared postoperatively. Blood flow in the aneurysm had disappeared on digital subtraction angiography after 6 months. -
   CONCLUSIONS: This is the first case report of ICA-PPTA aneurysm successfully treated with a flow-diverter stent. We could stop blood flow from the posterior circulation by embolizing the PPTA with a coil, allowing the use of a flow-diverter stent. This report can be used as a reference for the procedure in future work.
C1 [Sato, Hirotaka; Haraguchi, Koichi; Takahashi, Yashuhiro; Ohtaki, Shunya; Shimizu, Tadakazu; Matsuura, Nobuyuki; Ogane, Kazumi; Ito, Takeo] Hakodate Shintoshi Hosp, Dept Neurosurg, Hakodate, Hokkaido, Japan.
RP Sato, H (reprint author), Hakodate Shintoshi Hosp, Dept Neurosurg, Hakodate, Hokkaido, Japan.
EM kyokui080021@gmail.com
CR Chen WH, 2015, CLIN NEURORADIOL, V25, P207, DOI 10.1007/s00062-014-0314-6
   Ishikawa T, 2017, WORLD NEUROSURG, V108, DOI 10.1016/j.wneu.2017.09.033
   Kim MJ, 2015, SURG RADIOL ANAT, V37, P69, DOI 10.1007/s00276-014-1318-2
   Li MH, 2004, ACTA RADIOL, V45, P664, DOI 10.1080/02841850410001196
   Salas E, 1998, NEUROSURGERY, V43, P563, DOI 10.1097/00006123-199809000-00089
   Salas E, 1998, NEUROSURGERY, V43, P557, DOI 10.1097/00006123-199809000-00082
   Weon YC, 2011, ACTA RADIOL, V52, P1043, DOI 10.1258/ar.2011.110191
   Zhang CW, 2009, KOREAN J RADIOL, V10, P519, DOI 10.3348/kjr.2009.10.5.519
NR 8
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 329
EP 332
DI 10.1016/j.wneu.2019.08.199
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300180
PM 31493612
DA 2020-05-12
ER

PT J
AU ReFaey, K
   Grewal, SS
   Segura-Duran, I
   Thomas, M
   Wharen, RE
AF ReFaey, Karim
   Grewal, Sanjeet S.
   Segura-Duran, Ivan
   Thomas, Mathew
   Wharen, Robert E., Jr.
TI Video-Assisted Bilateral Thoracoscopic Sympathotomy for Palmar
   Hyperhidrosis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hyperhidrosis; Operative video; Surgical video; Sympathectomy;
   Sympathotomy
C1 [ReFaey, Karim; Grewal, Sanjeet S.; Segura-Duran, Ivan; Wharen, Robert E., Jr.] Mayo Clin, Dept Neurol Surg, Jacksonville, FL 32224 USA.
   [Thomas, Mathew] Mayo Clin, Dept Thorac Surg, Jacksonville, FL 32224 USA.
RP Wharen, RE (reprint author), Mayo Clin, Dept Neurol Surg, Jacksonville, FL 32224 USA.
EM Wharen.Robert@mayo.edu
OI ReFaey, Karim/0000-0001-7227-1529
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 333
EP 333
DI 10.1016/j.wneu.2019.09.036
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300181
PM 31525484
DA 2020-05-12
ER

PT J
AU Brotis, AG
   Tasiou, A
   Paterakis, K
   Tzerefos, C
   Fountas, KN
AF Brotis, Alexandros G.
   Tasiou, Anastasia
   Paterakis, Kostantinos
   Tzerefos, Christos
   Fountas, Kostas N.
TI Complications Associated with Surgery for Thoracic Disc Herniation: A
   Systematic Review and Network Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cerebrospinal fluid; Complications; Medical; Morbidity; Mortality;
   Neurological deterioration; Surgery; Surgical site; Thoracic disc
   herniation
ID SURGICAL-MANAGEMENT; SPINAL-CORD; ANTERIOR; DIAGNOSIS
AB BACKGROUND: A systematic review and network meta-analysis (Prospero ID CRD42018106936) were performed.
   OBJECTIVE: The selection of the appropriate surgical approach for the management of thoracic disc herniation (TDH) is often challenging because of the frequency and variability of the associated complications. We evaluated the safety of the surgical approaches for TDH by estimating the mortality (Q1) and morbidity (Q2), and frequency of the most common complications (Q3).
   METHODS: We searched the medical literature for randomized controlled trials and observational studies reporting on the management of TDH. Postoperative complications were the outcome of interest. The absolute and relative risk estimates, along with the rank probability scores, were estimated for each approach, through a network meta-analysis. The results were read in the light of the quality of the available evidence.
   RESULTS: Fifteen studies with a total of 1036 patients fulfilled our eligibility criteria. Three deaths were reported. The overall morbidity was as high as 29%, largely attributed to medical (21%; 95% confidence interval [CI], 10%-38%), surgical site (11%; 95% CI, 5%-22%), cerebrospinal fluid-related (8%; 95% CI, 3%-8%), and neurologic complications (5%; 95% CI, 1%-24%). The anterior and lateral approaches were associated with a higher risk for medical and surgical complications compared with the posterolateral approach.
   CONCLUSIONS: Surgery for TDH is associated with minimal mortality but significant morbidity, with large variations among the available approaches. An understanding of the perioperative complications rates is important to develop complication avoidance strategies and to aid accurate patient-to-doctor communication.
C1 [Brotis, Alexandros G.; Tasiou, Anastasia; Paterakis, Kostantinos; Tzerefos, Christos; Fountas, Kostas N.] Univ Hosp Larissa, Dept Neurosurg, Larisa, Thessaly, Greece.
   [Paterakis, Kostantinos; Fountas, Kostas N.] Univ Thessaly, Med Sch, Larisa, Thessaly, Greece.
RP Brotis, AG (reprint author), Univ Hosp Larissa, Dept Neurosurg, Larisa, Thessaly, Greece.
EM amprotis@med.uth.gr
RI Paterakis, Konstantinos/AAH-4554-2019
OI Tasiou, Anastasia/0000-0002-8853-540X
CR ABBOTT KH, 1956, NEUROLOGY, V6, P1
   Al-Mahfoudh R, 2016, GLOB SPINE J, V6, P584, DOI 10.1055/s-0035-1570087
   ARCE CA, 1985, SURG NEUROL, V23, P356, DOI 10.1016/0090-3019(85)90206-X
   ARSENI C, 1960, J NEUROSURG, V17, P418, DOI 10.3171/jns.1960.17.3.0418
   Arts MP, 2014, SPINE J, V14, P1654, DOI 10.1016/j.spinee.2013.09.053
   AWWAD EE, 1991, NEUROSURGERY, V28, P180, DOI 10.1227/00006123-199102000-00002
   Barbanera A, 2009, J NEUROSURG SCI, V53, P19
   Bransford Richard J, 2010, Evid Based Spine Care J, V1, P21, DOI 10.1055/s-0028-1100889
   BROWN CW, 1992, [No title captured], V17, pS9
   Cornips E, 2017, WORLD NEUROSURG, V105, P441, DOI 10.1016/j.wneu.2017.05.173
   Cornips EMJ, 2018, WORLD NEUROSURG, V109, pE691, DOI 10.1016/j.wneu.2017.10.056
   Cornips EMJ, 2011, J NEUROSURG-SPINE, V14, P520, DOI 10.3171/2010.12.SPINE10273
   Court C, 2018, ORTHOP TRAUMATOL-SUR, V104, pS31, DOI 10.1016/j.otsr.2017.04.022
   DAHER MURILO TAVARES, 2016, Coluna/Columna, V15, P213, DOI 10.1590/S1808-185120161503157849
   DOMMISSE GF, 1974, J BONE JOINT SURG BR, VB 56, P225
   ELKALLINY M, 1991, ACTA NEUROCHIR, V111, P22, DOI 10.1007/BF01402509
   EPSTEIN JA, 1954, J NEUROSURG, V11, P525, DOI 10.3171/jns.1954.11.6.0525
   Gong M, 2018, WORLD NEUROSURG, V118, P109, DOI 10.1016/j.wneu.2018.06.232
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Hott JS, 2005, J NEUROSURG-SPINE, V3, P191, DOI 10.3171/spi.2005.3.3.0191
   Hurley ET, 2017, SPINE, V42, pE1437, DOI 10.1097/BRS.0000000000002202
   Johnson J P, 2000, Neurosurg Focus, V9, pe11
   Kapoor S, 2018, EUR SPINE J, V27, P1555, DOI 10.1007/s00586-017-5192-6
   Kerezoudis P, 2018, CLIN NEUROL NEUROSUR, V167, P17, DOI 10.1016/j.clineuro.2018.02.009
   Khoo LT, 2011, J NEUROSURG-SPINE, V14, P250, DOI 10.3171/2010.10.SPINE09456
   Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960
   LARSON SJ, 1976, J NEUROSURG, V45, P628, DOI 10.3171/jns.1976.45.6.0628
   Lin LF, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i05
   LOVE JG, 1950, J NEUROSURG, V7, P62, DOI 10.3171/jns.1950.7.1.0062
   Menard V., 1894, REV ORTHOP, V5, P47
   Moher D, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-1
   Nayak NR, 2017, CLIN SPINE SURG, V30, pE901, DOI 10.1097/BSD.0000000000000375
   Oppenlander ME, 2013, J NEUROSURG-SPINE, V19, P774, DOI 10.3171/2013.8.SPINE121041
   Quraishi N A, 2014, Eur Spine J, V23 Suppl 1, pS76, DOI 10.1007/s00586-014-3210-5
   RIDENOUR TR, 1993, J SPINAL DISORD, V6, P218, DOI 10.1097/00002517-199306030-00006
   Rosenthal D, 2000, EUR SPINE J, V9, pS8, DOI 10.1007/PL00010017
   SINGOUNAS EG, 1992, ACTA NEUROCHIR, V116, P49, DOI 10.1007/BF01541253
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Stillerman CB, 1998, J NEUROSURG, V88, P623, DOI 10.3171/jns.1998.88.4.0623
   Wait SD, 2012, SPINE, V37, P35, DOI 10.1097/BRS.0b013e3182147b68
   WILLIAMS MP, 1988, RADIOLOGY, V167, P874, DOI 10.1148/radiology.167.3.3363161
   WILLIAMS MP, 1989, J COMPUT ASSIST TOMO, V13, P211, DOI 10.1097/00004728-198903000-00004
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 334
EP 342
DI 10.1016/j.wneu.2019.08.202
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300182
PM 31493617
DA 2020-05-12
ER

PT J
AU Tran, DK
   Tretiakov, P
   Brock, J
   Chen, J
   Vadera, S
AF Tran, Diem Kieu
   Tretiakov, Peter
   Brock, Julia
   Chen, Jefferson
   Vadera, Sumeet
TI Novel Use of Dual-Lumen Catheter for Irrigation and Drainage After
   Evacuation of Chronic Subdural Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic; Drain; Evacuation; Hematoma; Subdural
ID BURR-HOLE; MANAGEMENT
AB BACKGROUND: Chronic subdural hematoma (cSDH) is an intracranial pathology most commonly affecting elderly patients. Patients may present with worsening headache, seizures, weakness, balance and gait problems, and memory deficits. Even in patients undergoing hematoma evacuation, there is a substantial risk for recurrence. The authors present the first use of an irrigating external ventricular drain in the United States in the perioperative management of a patient with cSDH treated with craniotomy (IRRAS, Stockholm, Sweden).
   CASE DESCRIPTION: An 82-year-old male presented with right-sided weakness, confusion, and right-sided neglect with expressive aphasia. He was found to have a large 2.5-cm cSDH with a 9-mm left-to-right midline shift. The patient was treated with a minicraniotomy to evacuate the hematoma and placement of an irrigating drain in the subdural space. The patient was discharged home on postoperative day 3 without complication. He was at neurologic baseline 2 weeks later on follow-up.
   CONCLUSIONS: The use of an irrigating drain for perioperative management of cSDH is a novel means to prevent recurrence and warrants further exploration.
C1 [Tran, Diem Kieu; Tretiakov, Peter; Chen, Jefferson; Vadera, Sumeet] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.
   [Brock, Julia] Univ Calif Los Angeles, Dept Neurol Surg, Los Angeles, CA USA.
RP Tran, DK (reprint author), Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.
EM diemkt@uci.edu
CR Carlsen JG, 2011, BRIT J NEUROSURG, V25, P388, DOI 10.3109/02688697.2011.558945
   Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510
   FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457
   Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8
   Ishfaq A, 2017, JCPSP-J COLL PHYSICI, V27, P419, DOI 2656
   Ishibashi Akira, 2011, Kurume Medical Journal, V58, P35
   Kiymaz N, 2007, MED SCI MONITOR, V13, pCR240
   KOMOTAR RJ, 2010, NEUROSURGERY, V66
   Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026
   Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825
   Ou YW, 2019, WORLD NEUROSURG, V126, pE1412, DOI 10.1016/j.wneu.2019.03.111
   Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381
   Santarius T, 2010, WORLD NEUROSURG, V73, P747, DOI 10.1016/j.wneu.2010.03.031
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53
   Sjavik K, 2017, J NEUROSURG, V23, P1, DOI DOI 10.3171/2016.12.JNS161713
   Soleman J, 2019, NEUROSURGERY, V85, pE825, DOI 10.1093/neuros/nyz095
   Sousa EB, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-5
   SVIEN HJ, 1964, J NEUROSURG, V21, P172, DOI 10.3171/jns.1964.21.3.0172
   Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937
   Williams GR, 2001, J CLIN NEUROSCI, V8, P551, DOI 10.1054/jocn.2000.0926
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 343
EP 346
DI 10.1016/j.wneu.2019.08.225
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300183
PM 31505285
DA 2020-05-12
ER

PT J
AU Gupta, VR
   Giller, C
   Kolhe, R
   Forseen, SE
   Sharma, S
AF Gupta, V. Rohan
   Giller, Cole
   Kolhe, Ravindra
   Forseen, Scott E.
   Sharma, Suash
TI Polymorphous Low-Grade Neuroepithelial Tumor of the Young: A Case Report
   with Genomic Findings
SO WORLD NEUROSURGERY
LA English
DT Article
DE BRAF V600E; Dysembryoplastic neuroepithelial tumor; Epilepsy; FGFR1;
   Ganglioglioma; Low-grade neuroepithelial tumors; Polymorphous low-grade
   neuroepithelial tumor of the young
ID GENETIC ALTERATIONS; EPILEPSY; EXPRESSION; CD34; BRAF; MUTATIONS;
   CLASSIFICATION; FREQUENCY; SPECTRUM; FEATURES
AB BACKGROUND: Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently recognized epileptogenic neuroepithelial tumor. Despite its distinctiveness, its polymorphous histology and the nature of its oligodendrocyte-like cells remain unclear.
   CASE DESCRIPTION: A 30-year-old, right-handed man was diagnosed with intractable epilepsy since 22 years of age. Magnetic resonance imaging revealed T2 signal hyperintensity and corresponding T1 signal hypointensity within the subcortical white matter of the right middle temporal gyrus. Positron emission tomography scan demonstrated hypometabolism in the right anterior temporal region. Electroencephalography and stereo-electroencephalography monitoring localized seizures to the right temporal lobe, allowing the patient to undergo right temporal lobectomy. Histologic sections demonstrated cortical dysplasia, white matter heterotopia, and hippocampal reactive gliosis without neuronal loss. Interestingly, an approximately 6-mm subcortical neoplasm was identified in the temporal lobectomy. It was composed of well-differentiated oligodendroglial-like cells but exhibited mild-to-moderate nuclear variability and pleomorphism, and mild infiltration into the overlying cortex without peri-neuronal satellitosis. No mitotic activity, microvascular proliferation, or necrosis was identified, and Ki-67 labeling index was less than 1%. The tumor was diffusely CD34 positive with moderate glial fibrillary acidic protein and retained ATRX staining, and demonstrated the presence of the BRAF V600E mutation. The tumor was negative for reticulin condensation, synaptophysin, SMI31, neuronal nuclei immunostains, and both the IDH1 mutation and 1p19q codeletion. Overall histologic findings were most consistent with PLNTY.
   CONCLUSIONS: The correct diagnosis of PLNTY and its distinction from closely resembling low-grade neuroepithelial tumors is important. We hope our proposed diagnostic features will aid in its proper diagnosis and management.
C1 [Kolhe, Ravindra; Sharma, Suash] Georgia Augusta Univ, Med Coll, Dept Pathol, Augusta, GA 30912 USA.
   [Gupta, V. Rohan; Giller, Cole] Georgia Augusta Univ, Med Coll, Dept Neurosurg, Augusta, GA USA.
   [Forseen, Scott E.] Georgia Augusta Univ, Med Coll, Dept Radiol & Imaging, Augusta, GA USA.
RP Sharma, S (reprint author), Georgia Augusta Univ, Med Coll, Dept Pathol, Augusta, GA 30912 USA.
EM susharma@augusta.edu
OI KOLHE, RAVINDRA/0000-0002-8283-2403
CR Aronica E, 2014, NEUROTHERAPEUTICS, V11, P251, DOI 10.1007/s13311-013-0251-0
   Behling F, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0506-2
   Bitar M, 2018, CLIN NEUROPATHOL, V37, P178, DOI 10.5414/NP301081
   Blumcke I, 2016, NAT REV NEUROL, V12, P732, DOI 10.1038/nrneurol.2016.173
   Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x
   Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784
   Blumcke I, 2002, J NEUROPATH EXP NEUR, V61, P575
   Blumcke I, 2014, ACTA NEUROPATHOL, V128, P39, DOI 10.1007/s00401-014-1288-9
   Boer K, 2010, BRAIN PATHOL, V20, P234, DOI 10.1111/j.1750-3639.2009.00268.x
   Bongaarts Anika, 2018, Oncotarget, V9, P28103, DOI 10.18632/oncotarget.25563
   Dahiya S, 2013, ACTA NEUROPATHOL, V125, P901, DOI 10.1007/s00401-013-1120-y
   Deb P, 2006, NEUROPATH APPL NEURO, V32, P461, DOI 10.1111/j.1365-2990.2006.00734.x
   Dougherty MJ, 2010, NEURO-ONCOLOGY, V12, P621, DOI 10.1093/neuonc/noq007
   Giulioni M, 2019, WORLD NEUROSURG, V121, pE761, DOI 10.1016/j.wneu.2018.09.212
   Ho CY, 2015, ACTA NEUROPATHOL, V130, P575, DOI 10.1007/s00401-015-1467-3
   Huse JT, 2017, ACTA NEUROPATHOL, V133, P417, DOI 10.1007/s00401-016-1639-9
   Kasper BS, 2017, EPILEPSY BEHAV, V67, P91, DOI 10.1016/j.yebeh.2016.12.020
   Koh HY, 2018, NAT MED, V24, P1662, DOI 10.1038/s41591-018-0172-x
   Phi JH, 2019, J KOREAN NEUROSURG S, V62, P313, DOI 10.3340/jkns.2019.0033
   Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z
   Ramkissoon LA, 2013, P NATL ACAD SCI USA, V110, P8188, DOI 10.1073/pnas.1300252110
   Reifenberger G, 2003, ACTA NEUROPATHOL, V105, P358, DOI 10.1007/s00401-002-0652-3
   Riva G, 2018, NEUROPATHOLOGY, V38, P557, DOI 10.1111/neup.12504
   Rivera B, 2016, ACTA NEUROPATHOL, V131, P847, DOI 10.1007/s00401-016-1549-x
   Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6
   Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661
   Stone TJ, 2018, ACTA NEUROPATHOL, V135, P115, DOI 10.1007/s00401-017-1773-z
   Sumdani H, 2019, WORLD NEUROSURG, V127, P47, DOI 10.1016/j.wneu.2019.03.181
   Tan C, 2018, GLIOMA, V1, P89, DOI [10.4103/glioma.glioma_24_18, DOI 10.4103/GLIOMA.GLIOMA_24_18]
   Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x
   Vogt VL, 2018, EPILEPSY BEHAV, V88, P25, DOI 10.1016/j.yebeh.2018.08.028
   Vornetti G, 2017, J CLIN NEUROSCI, V44, P158, DOI 10.1016/j.jocn.2017.06.022
   Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611
NR 33
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 347
EP 355
DI 10.1016/j.wneu.2019.08.221
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300184
PM 31520766
DA 2020-05-12
ER

PT J
AU Krivoshapkin, A
   Gaytan, A
   Salim, N
   Abdullaev, O
   Sergeev, G
   Marmazeev, I
   Cesnulis, E
   Killeen, T
AF Krivoshapkin, Alexey
   Gaytan, Alexey
   Salim, Nidal
   Abdullaev, Orkhan
   Sergeev, Gleb
   Marmazeev, Ilya
   Cesnulis, Evaldas
   Killeen, Tim
TI Repeat Resection and Intraoperative Radiotherapy for Malignant Gliomas
   of the Brain: A History and Review of Current Techniques
SO WORLD NEUROSURGERY
LA English
DT Review
DE Anaplastic astrocytoma; Anaplastic oligodendroglioma; Brachytherapy;
   Glioblastoma; Intraoperative radiotherapy; Radiotherapy
ID RECURRENT GLIOBLASTOMA-MULTIFORME; RADIATION-THERAPY; EUROPEAN
   ASSOCIATION; REOPERATION; GUIDELINES; DIAGNOSIS; BRACHYTHERAPY;
   RADIOSURGERY; MULTICENTER; IRRADIATION
AB The degree of primary resection of malignant brain gliomas (MBGs) has correlated positively with progression-free and overall survival. The indications for surgery and reoperation in MBG relapse remain controversial. Surgery will not be curative and should be followed by adjuvant treatment. We reviewed the reported studies with respect to repeat resection and the various methods of intraoperative radiotherapy for MBGs from the initial experience with high-energy linear accelerators in Japan to modern, integrated brachytherapy solutions using solid and balloon applicators. Because of the findings from our review, we have begun to research into the use of intraoperative balloon brachytherapy for recurrent MBGs.
C1 [Krivoshapkin, Alexey; Abdullaev, Orkhan] Novosibirsk State Med Univ, Novosibirsk, Russia.
   [Krivoshapkin, Alexey; Gaytan, Alexey; Salim, Nidal; Abdullaev, Orkhan; Sergeev, Gleb; Marmazeev, Ilya] European Med Ctr, Moscow, Russia.
   [Cesnulis, Evaldas; Killeen, Tim] Klin Hirslanden, Dept Neurosurg, Zurich, Switzerland.
RP Krivoshapkin, A (reprint author), Novosibirsk State Med Univ, Novosibirsk, Russia.; Krivoshapkin, A (reprint author), European Med Ctr, Moscow, Russia.
EM alkr01@yandex.ru
CR ABE M, 1971, ACTA RADIOL THER PHY, V10, P408, DOI 10.3109/02841867109130786
   AMMIRATI M, 1987, NEUROSURGERY, V21, P607, DOI 10.1227/00006123-198711000-00001
   Bensaleh S, 2009, ACTA ONCOL, V48, P487, DOI 10.1080/02841860802537916
   Bloch O, 2012, J NEUROSURG, V117, P1032, DOI 10.3171/2012.9.JNS12504
   Chan TA, 2005, INT J RADIAT ONCOL, V62, P1133, DOI 10.1016/j.ijrobp.2004.12.032
   CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654
   Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8
   DEURBINA DO, 1995, NEUROL RES, V17, P289, DOI 10.1080/01616412.1995.11740329
   Ellingson BM, 2017, NEUROTHERAPEUTICS, V14, P307, DOI 10.1007/s13311-016-0507-6
   FUJIWARA T, 1995, J NEURO-ONCOL, V23, P81, DOI 10.1007/BF01058463
   GASPAR LE, 1992, INT J RADIAT ONCOL, V24, P55, DOI 10.1016/0360-3016(92)91021-E
   Giordano FA, 2019, NEUROSURGERY, V84, P41, DOI 10.1093/neuros/nyy018
   Goryaynov S A, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P5, DOI 10.17116/neiro20178135-16
   Haj A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010005
   Hardesty Douglas A, 2012, Front Neurol, V3, P140, DOI 10.3389/fneur.2012.00140
   HARSH GR, 1987, NEUROSURGERY, V21, P615, DOI 10.1227/00006123-198711000-00002
   Hauser SB, 2016, NEUROSURGERY, V78, P475, DOI 10.1227/NEU.0000000000001035
   Herskind C, 2014, TRANSL CANCER RES, V3, P3, DOI 10.3978/j.issn.2218-676X.2014.01.06
   Krivoshapkin A, 2016, B NEUROL PSYCHIAT NE, V6, P59
   Krivoshapkin A L, 2014, Zh Vopr Neirokhir Im N N Burdenko, V78, P33
   LANDY HJ, 1994, SOUTH MED J, V87, P211, DOI 10.1097/00007611-199402000-00013
   Lederman G, 2000, AM J CLIN ONCOL-CANC, V23, P155, DOI 10.1097/00000421-200004000-00010
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lozares-Cordero S, 2019, J RADIOTHER PRACT, V18, P16, DOI 10.1017/S1460396918000353
   Mallick S, 2016, J EGYPT NATL CANCER, V28, P199, DOI 10.1016/j.jnci.2016.07.001
   Martinez-Garcia M, 2018, CLIN TRANSL ONCOL, V20, P22, DOI 10.1007/s12094-017-1763-6
   MASCIOPINTO JE, 1994, STEREOT FUNCT NEUROS, V63, P233, DOI 10.1159/000100319
   MATSUTANI M, 1994, ACTA NEUROCHIR, V131, P80, DOI 10.1007/BF01401457
   Miyatake SI, 2015, NEUROL MED-CHIR, V55, P50, DOI 10.2176/nmc.ra.2014-0188
   Nemoto K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-1
   Nguyen D, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0239-x
   Pace A, 2017, LANCET ONCOL, V18, pE330, DOI 10.1016/S1470-2045(17)30345-5
   Park CK, 2013, NEURO-ONCOLOGY, V15, P1096, DOI 10.1093/neuonc/not069
   Patel R, 2017, J CONTEMP BRACHYTHER, V9, P338, DOI 10.5114/jcb.2017.68480
   Ramachandran P, 2017, WORLD J RADIOL, V9, P148, DOI 10.4329/wjr.v9.i4.148
   Ringel F, 2016, NEURO-ONCOLOGY, V18, P96, DOI 10.1093/neuonc/nov145
   Ruben JD, 2006, INT J RADIAT ONCOL, V65, P499, DOI 10.1016/j.ijrobp.2005.12.002
   SAKAI N, 1991, Neurologia Medico-Chirurgica, V31, P702, DOI 10.2176/nmc.31.702
   Scanderbeg DJ, 2011, MED DOSIM, V36, P344, DOI 10.1016/j.meddos.2010.08.001
   Schueller P, 2005, STRAHLENTHER ONKOL, V181, P500, DOI 10.1007/s00066-005-1354-2
   Schwartzberg BS, 2018, AM J SURG, V216, P689, DOI 10.1016/j.amjsurg.2018.07.022
   Seddighi A, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp-3795
   Silverstein MJ, 2018, ANN SURG ONCOL, V25, P2987, DOI 10.1245/s10434-018-6614-3
   Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Takakura K, 2000, Gan To Kagaku Ryoho, V27 Suppl 2, P449
   van Linde ME, 2017, J NEURO-ONCOL, V135, P183, DOI 10.1007/s11060-017-2564-z
   Veldwijk MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084991
   WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3
   Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8
   YOUNG B, 1981, J NEUROSURG, V55, P917, DOI 10.3171/jns.1981.55.6.0917
   Zamzuri I, 2012, Med J Malaysia, V67, P121
NR 52
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 356
EP 362
DI 10.1016/j.wneu.2019.09.037
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300185
PM 31536810
DA 2020-05-12
ER

PT J
AU Ferreira, JA
   Botelho, RV
AF Ferreira, Janio Alves
   Botelho, Ricardo Vieira
TI Determination of Normal Values of the Basal Angle in the Era of Magnetic
   Resonance Imaging
SO WORLD NEUROSURGERY
LA English
DT Review
DE Arnold-Chiari malformation type 1; Basilar impression; Pathophysiology;
   Platybasia
ID CRANIAL BASE; CRANIOVERTEBRAL JUNCTION; MALFORMATION; PLATYBASIA;
   STATISTICS
AB BACKGROUND: The flexion of the skull base (basal angle [BA]) is the inclination between the anterior fossae and the basilar ramp of the occipital and sphenoid bones. An increased BA, termed platybasia, is usually associated with basilar invagination. BA reference values in the magnetic resonance imaging (MRI) era and the diagnosis of platybasia are of clinical importance. The transnasal approach has been the surgical technique of choice to remove the odontoid process in cases of ventral brainstem compression in patients with platybasia. The knowledge of normal BA values has been influenced by technological image acquisitions. The aim of this study was to determine the normal BA values in normal subjects in the MRI era.
   METHODS: For the determination of normal BA values, the literature reporting these values in normal individuals was reviewed and a meta-analysis of pertinent studies was performed.
   RESULTS: A total of 8 articles were included in this study, evaluating a total of 667 individuals. A summary measure of the results was obtained. The data obtained in this analysis provided a final basal angle value of 116.5 degrees (95% confidence interval, 104.39-128.7). The normal basal angle ranges between 104 and 129 degrees.
   CONCLUSION: Platybasia can be defined as a value >129 from the basal angle.
C1 [Ferreira, Janio Alves; Botelho, Ricardo Vieira] Hosp Servidor Publ Estado Sao Paulo, Dept Neurosurg, Sao Paulo, SP, Brazil.
RP Botelho, RV (reprint author), Hosp Servidor Publ Estado Sao Paulo, Dept Neurosurg, Sao Paulo, SP, Brazil.
EM bitbot@uol.com.br
CR Alkoc OA, 2015, J KOREAN NEUROSURG S, V58, P454, DOI 10.3340/jkns.2015.58.5.454
   Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903
   Antar V, 2018, J KOREAN NEUROSURG S, V61, P277, DOI 10.3340/jkns.2017.0197
   Batista UC, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14642
   Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004
   Botelho RV, 2018, WORLD NEUROSURG, V117, pE180, DOI 10.1016/j.wneu.2018.05.233
   Burke K, 2014, LARYNGOSCOPE, V124, P1760, DOI 10.1002/lary.24639
   Carlin JB, 2000, J PAEDIATR CHILD H, V36, P502, DOI 10.1046/j.1440-1754.2000.00588.x
   Dash C, 2018, NEUROL INDIA, V66, P797, DOI 10.4103/0028-3886.232288
   Ferreira Janio A, 2015, Surg Neurol Int, V6, P118, DOI 10.4103/2152-7806.160322
   Garcia-Casal MN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196576
   Goel A, 2004, J NEUROSURG-SPINE, V1, P281, DOI 10.3171/spi.2004.1.3.0281
   Henderson FC, 2018, NEUROSURG REV, V41, P149, DOI 10.1007/s10143-017-0830-3
   Hirunpat S, 2017, J ORAL HLTH CRANIOFA, V2
   Horowitz Gary L, 2008, EJIFCC, V19, P95
   Karagoz F, 2002, ACTA NEUROCHIR, V144, P165, DOI 10.1007/s007010200020
   Kimbel WH, 2010, PHILOS T R SOC B, V365, P3365, DOI 10.1098/rstb.2010.0070
   Koenigsberg RA, 2005, AM J NEURORADIOL, V26, P89
   Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x
   Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117
   MCGREGOR M, 1948, BRIT J RADIOL, V21, P171, DOI 10.1259/0007-1285-21-244-171
   Meschan I., 1985, ROENTGEN SIGNS DIAGN, P265
   ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306
   SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952
   Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008
NR 25
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 363
EP 367
DI 10.1016/j.wneu.2019.09.056
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300186
PM 31541760
DA 2020-05-12
ER

PT J
AU Ganapa, SV
   Ramani, MD
   Ebunlomo, OO
   Rahman, RK
   Herschman, Y
   Mammis, A
AF Ganapa, Somnath, V
   Ramani, Margish D.
   Ebunlomo, Oladotun O.
   Rahman, Raphia K.
   Herschman, Yehuda
   Mammis, Antonios
TI Treatment of Persistent Hemiballism with Deep Brain Stimulation of the
   Globus Pallidus Internus: Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Case report; DBS; Deep brain stimulation; DBS-GPi; Globus pallidus
   internus; GPi; Persistent hemiballism
ID HEMICHOREA-HEMIBALLISMUS
AB BACKGROUND: Hemiballism is a rare hyperkinetic movement disorder characterized by involuntary, high-amplitude, unilateral flailing of upper or lower extremities or both. In the case of hemiballism refractory to pharmaceutical interventions, deep brain stimulation (DBS) is an effective primary neurosurgical treatment. DBS targets for hemiballism include the thalamus, subthalamic nucleus, and globus pallidus internus (GPi).
   CASE DESCRIPTION: We present a case of a patient who sustained a posterior cerebral artery ischemic stroke that eventually led to uncontrolled hemiballism, which was then successfully treated by unilateral GPi stimulation. We include a video depicting the patient preoperatively, intraoperatively with stimulation off, and intraoperatively with stimulation on. We also review published cases of hemiballism treated by GPi-DBS, which support the claim that GPi-DBS is an effective method for treating hemiballism.
   CONCLUSIONS: Evidence gathered from the literature indicates that GPi-DBS is an effective treatment for hemiballism, especially after neuroleptics have failed. Results from various case studies of GPi-DBS used to treat hemiballism reveal improved motor ability and decreased dyskinesia, although degree of improvement may vary. More studies are required to establish which DBS target requires the least amount of stimulation to treat hemiballism.
C1 [Ganapa, Somnath, V; Ramani, Margish D.; Ebunlomo, Oladotun O.; Rahman, Raphia K.; Herschman, Yehuda; Mammis, Antonios] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA.
RP Ganapa, SV (reprint author), Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA.
EM somnath.ganapa@gmail.com
CR Capelle HH, 2011, J NEUROSURG, V115, P966, DOI 10.3171/2011.6.JNS101388
   Chiken S, 2016, NEUROSCIENTIST, V22, P313, DOI 10.1177/1073858415581986
   Driver-Dunckley E, 2005, CLIN NEUROPHARMACOL, V28, P142, DOI 10.1097/01.wnf.0000164160.71206.a3
   Francisco GE, 2006, AM J PHYS MED REHAB, V85, P779, DOI 10.1097/01.phm.0000233173.32432.6f
   Franzini A, 2014, J NEURAL TRANSM, V121, P391, DOI 10.1007/s00702-013-1122-x
   Goto T, 2010, MOVEMENT DISORD, V25, P1295, DOI 10.1002/mds.23058
   Hasegawa H, 2009, MOVEMENT DISORD, V24, P1697, DOI 10.1002/mds.22598
   Hawley JS, 2012, PARKINSONISM RELAT D, V18, P125, DOI 10.1016/j.parkreldis.2011.08.015
   Mukand JA, 2005, ARCH PHYS MED REHAB, V86, P587, DOI 10.1016/j.apmr.2004.05.012
   Oyama G, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8542KQ5
   Pabaney A, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.06.070
   Postuma RB, 2003, LANCET NEUROL, V2, P661, DOI 10.1016/S1474-4422(03)00554-4
   Ramirez-Zamora A, 2018, ANN CLIN TRANSL NEUR, V5, P865, DOI 10.1002/acn3.573
   Shannon Kathleen M, 2005, Curr Treat Options Neurol, V7, P203, DOI 10.1007/s11940-005-0013-3
   Sitburana O, 2006, MOVEMENT DISORD, V21, P2023, DOI 10.1002/mds.21100
   Son BC, 2017, CASE REP NEUROL MED, DOI 10.1155/2017/2165905
NR 16
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 368
EP 370
DI 10.1016/j.wneu.2019.08.247
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300187
PM 31541757
DA 2020-05-12
ER

PT J
AU Uchino, H
   Hamada, S
   Kashiwazaki, D
   Tomita, T
   Akioka, N
   Akai, T
   Kuroda, S
AF Uchino, Haruto
   Hamada, Saori
   Kashiwazaki, Daina
   Tomita, Takahiro
   Akioka, Naoki
   Akai, Takuya
   Kuroda, Satoshi
TI Repeated Deterioration of Consciousness Resulting from Spontaneous
   Intracranial Hypotension Associated with Deep Cerebral Vein Stagnation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain sagging; Coma; Spontaneous intracranial hypotension; Venous
   stagnation
ID REVERSIBLE COMA
AB BACKGROUND: Although the clinical course of spontaneous intracranial hypotension (SIH) is generally benign, in unusual cases it can result in deterioration of consciousness. The exact mechanisms involved have not always been described in previously reported cases.
   CASE DESCRIPTION: Herein we describe the case of a 36-year-old man who presented complaining of orthostatic headache. Brain magnetic resonance imaging depicted typical findings associated with SIH. He initially underwent conservative treatments, but he subsequently began to exhibit deterioration of consciousness. Magnetic resonance imaging revealed progressive brain sagging, swelling of the brainstem, and focal hyperintensity in the left side of the thalamus on diffusion-weighted imaging. The vein of Galen was stretched downwards, creating a narrow angle between it and the straight sinus. We concluded that deep venous hypertension had occurred due to functional venous stenosis. He underwent epidural blood patch twice and ultimately recovered without any neurologic deficits.
   CONCLUSIONS: SIH should be recognized as a possible cause of coma as a result of deep cerebral vein stagnation due to severe brain sagging. A change in the vein of Galen/straight sinus angle may be an anatomic marker associated with functional venous stenosis.
C1 [Uchino, Haruto; Hamada, Saori; Kashiwazaki, Daina; Tomita, Takahiro; Akioka, Naoki; Akai, Takuya; Kuroda, Satoshi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Neurosurg, Toyama, Japan.
   [Uchino, Haruto] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
RP Uchino, H (reprint author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Neurosurg, Toyama, Japan.; Uchino, H (reprint author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
EM uchino-hok@umin.ac.jp
RI Uchino, Haruto/L-6627-2019
OI Uchino, Haruto/0000-0001-6567-8136
CR Ajlan Abdulrazag M, 2014, J Neurointerv Surg, V6, pe38, DOI 10.1136/neurintsurg-2013-010823.rep
   Kashmere JL, 2004, CAN J NEUROL SCI, V31, P565, DOI 10.1017/S0317167100003826
   Kranz PG, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0639-3
   Loya JJ, 2012, J NEUROSURG, V117, P615, DOI 10.3171/2012.4.JNS112030
   Sade B, 2007, J NEUROSURG, V107, P932, DOI 10.3171/JNS-07/11/0932
   Savoiardo M, 2007, BRAIN, V130, P1884, DOI 10.1093/brain/awm101
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 371
EP 374
DI 10.1016/j.wneu.2019.09.062
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300188
PM 31542442
DA 2020-05-12
ER

PT J
AU Gandhoke, GS
   Belykh, E
   Zhao, XC
   Leblanc, R
   Preul, MC
AF Gandhoke, Gurpreet S.
   Belykh, Evgenii
   Zhao, Xiaochun
   Leblanc, Richard
   Preul, Mark C.
TI Edwin Boldrey and Wilder Penfield's Homunculus: A Life Given by Mrs.
   Cantlie (In and Out of Realism)
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain mapping; Cerebral functional localization; Cortical stimulation;
   Edwin Boldrey; Homunculus; Montreal Neurological Institute; Wilder
   Penfield
AB For nearly 90 years, notions of the brain have been inextricably associated with a homunculus that has become embedded within medical education as the precise representation of rolandic cortical function. We sought to define the history, evolution, accuracy, and impact of this pictorial means of showing cortical representation. We mathematically defined the evolutionary accuracy of appropriate homunculi using image analysis techniques for all points defined by Penfield, Boldrey, Rasmussen, Jasper, and Erickson, calculating perpendicular distances and defining areas and distributions of rolandic and sylvian regions labeled for sensory and motor activity with comparison with all homunculi. Prerolandic sensory representation composed 13%-47% of total sensory area (mean, 29%); postrolandic motor representation composed 15%-65% of total motor area (mean, 31%). Discrepancy between cortical perpendicular length attributed to a particular function on 1937 diagrams was greater than that attributed on the 1950 homunculus (motor: mean, 74%; range, 63%-96%; sensory: mean, 66%; range, 17%-92%) (P < 0.05). The homunculus, if truly drawn according to cortical mapping evidence, could never have been recognized as near humanoid, yet it has attained epic educational and practical longevity.
C1 [Gandhoke, Gurpreet S.] Univ Missouri Kansas City, Dept Surg, Mar Bloch Neurosci Inst, St Lukes Hosp Kansas City, Kansas City, MO USA.
   [Belykh, Evgenii; Zhao, Xiaochun; Preul, Mark C.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Loyal & Edith Davis Neurosurg Res Lab, Phoenix, AZ 85013 USA.
   [Leblanc, Richard] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
RP Preul, MC (reprint author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Loyal & Edith Davis Neurosurg Res Lab, Phoenix, AZ 85013 USA.
EM Neuropub@barrowneuro.org
RI Belykh, Evgenii/O-8279-2017
OI Belykh, Evgenii/0000-0003-2060-5739
FU Newsome Chair in Neurosurgery Research, Barrow Neurological Institute;
   Barrow Neurological Foundation
FX The authors are grateful for funds from the Newsome Chair in
   Neurosurgery Research, Barrow Neurological Institute, held by Dr. Preul
   and from Barrow Neurological Foundation that supported this project.
CR Boldrey EB, 1936, ARCHITECTONIC SUBDIV
   Feindel W, 1977, Neurosurgery, V1, P93
   Feindel W, 2007, BRAIN, V130, P2758, DOI 10.1093/brain/awm098
   Feinsod M, 2005, NEUROLOGY, V64, P524, DOI 10.1212/01.WNL.0000150893.86066.29
   Krause F, 1908, CHIRURG GEHIRNS RUCK, VII
   Krause F, 1908, CHIRURG GEHIMS RUCKE, VI
   Krause F, 1912, SURG BRAIN SPINAL CO
   Leblanc R, 2019, J NEUROSURG, V130, P76, DOI 10.3171/2017.7.JNS171256
   PENFIELD W, 1957, BRAIN, V80, P402, DOI 10.1093/brain/80.3.402
   Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389
   PENFIELD W, 1947, ANN SURG, V126, P740, DOI 10.1097/00000658-194711000-00008
   Penfield W, 1939, AM J PSYCHIAT, V96, P255, DOI 10.1176/ajp.96.2.255
   Penfield W, 1954, EPILEPSY FUNCTIONAL
   PENFIELD W, 1950, CEREBRAL CORTEX MAN
   Penfield W., 1946, COMMUNICATION   0820
   PENFIELD W, 1958, EXCITABLE CORTEX CON
   Penfield W, 1941, EPILEPSY CEREBRAL LO
   Penfield W, 1959, COMMUNICATION   0116
   Penfield W., 1959, SPEECH BRAIN MECH
   Penfield W, 1959, COMMUNICATION   0203
   Penfield W, 1952, NATURE, V169, P690
   Penfield W, 1951, EPILEPTIC SEIZURE PA
   Walshe FM, 1958, COMMUNICATION   1001
   Walshe FM, 1943, COMMUNICATION   0425
   Walshe FM., 1959, COMMUNICATION   0120
   Walshe FM, 1959, COMMUNICATION   0205
   Walshe FM, 1946, COMMUNICATION   0806
NR 27
TC 5
Z9 5
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 377
EP 388
DI 10.1016/j.wneu.2019.08.116
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300190
PM 31470165
DA 2020-05-12
ER

PT J
AU Song, JP
   Liu, PX
   Pan, ZG
   Quan, K
   Zhao, XC
   Zhu, W
AF Song, Jianping
   Liu, Peixi
   Pan, Zhiguang
   Quan, Kai
   Zhao, Xiaochun
   Zhu, Wei
TI Thalamus Cavernous Malformation Resection of via Contralateral Anterior
   Interhemispheric Transcallosal Approach: Two-Dimensional Operative Video
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior interhemispheric transcallosal; Cavernous malformation;
   Surgery; Thalamus
C1 [Song, Jianping; Liu, Peixi; Pan, Zhiguang; Quan, Kai; Zhu, Wei] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Collage, Shanghai, Peoples R China.
   [Zhao, Xiaochun] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA.
RP Zhu, W (reprint author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Collage, Shanghai, Peoples R China.
EM drzhuwei@fudan.edu.cn
FU outstanding academic leaders program of Shanghai Municipal Commission of
   Health and Family Planning [2017BR006]; Shanghai Rising-Star Program,
   China [18QA1400900]
FX This study was sponsored by the outstanding academic leaders program of
   Shanghai Municipal Commission of Health and Family Planning (No.
   2017BR006 to W.Z.), the Shanghai Rising-Star Program, China
   (No.18QA1400900 to J.P.S.)
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 389
EP 389
DI 10.1016/j.wneu.2019.09.010
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300191
PM 31520761
DA 2020-05-12
ER

PT J
AU Aciduman, A
AF Aciduman, Ahmet
TI Wounds in the Head from Kitab al-Dhakhira fi 'Ilm al-Tibb by Thabit b.
   Qurra in the Ninth Century
SO WORLD NEUROSURGERY
LA English
DT Article
DE History of medicine; History of neurosurgery; Kitab al-Dhakhira fi Ilm
   al-Tibb; Thabit b. Qurra; Wounds in the head
AB OBJECTIVE: Kitab al-Dhakhira fi Ilm al-Tibb is one of Thabit b. Qurra's most noteworthy books on medicine in Arabic in the ninth century. This study aims to present and discuss the section subtitled "wounds in the head" in the 24th chapter of Kitab al-Dhakhira considering the information in the literature.
   MATERIALS AND METHODS: This study is primarily based on a copy of Kitab al-Dhakhira edited by Dr. G. Sobhy and printed in al-Matba'at al-Amiriyya, Cairo in 1928. It is compared with the manuscript, which is in the Sehit Ali Pasa Collection, nr. 2028, in the Suleymaniye Manuscript Library in Istanbul, Turkey. The 24th chapter was first translated into English and then examined. The acquired knowledge from the chapter is discussed in this study by comparing it with that on this subject from the literature regarding the history of medicine.
   RESULTS: The 24th chapter, entitled "On Wounds and Wounds in the Head and Hemorrhage from Them and from Other Wounds and on Gently Drawing Arrowhead/Spearhead and Thorn," includes a section subtitled "wounds in the head." This section provides information regarding steps to be taken if the head is simply wounded or if there is an accompanying swelling, how to control hemorrhage, which medicines should be used for treatment, and how to bandage wounds in the head, but unfortunately, it specifies no details regarding surgical interventions for such wounds. -
   CONCLUSIONS: Kitab al-Dhakhira presents interesting knowledge regarding wounds in the head, reflecting the medical paradigm of that era.
C1 [Aciduman, Ahmet] Ankara Univ, Fac Med, Dept Hist Med & Eth, Ankara, Turkey.
RP Aciduman, A (reprint author), Ankara Univ, Fac Med, Dept Hist Med & Eth, Ankara, Turkey.
EM aciduman@medicine.ankara.edu.tr
FU Turkish Neurosurgical Society
FX The author thanks Assoc. Prof. Cagatay Askit from Department of Ancient
   Languages and Cultures, Sub-Department of Latin Language and Literature,
   Faculty of Languages, History and Geography, Ankara University, Ankara,
   Turkey, for the transcriptions of Latin texts in tables. Preparation for
   publication of this article is partly supported by Turkish Neurosurgical
   Society.
CR Aciduman A, 2017, WORLD NEUROSURG, V107, P834, DOI 10.1016/j.wneu.2017.08.037
   Agirakca A, 2010, HIST ISLAMIC MED BEG
   [Anonymous], 1900, CHAH MAQ
   Byzantine A, 1959, GREEK HERBAL DIOSCOR
   ELGOOD CA, 1951, MED HIST PERSIA E CA
   Faiboglu I., 2008, TDV ISLAM ANSIKLOPED, V35, P353
   Ibn Qurra Thabir, 1928, BOOK AL DAKHIRA
   Ibn Sina Abu Ali, 1593, KITAB AL QANIN FI AL
   Johnston Ian, 2011, METHODS MED, V5-9
   MEYERHOF M, 1930, ISIS, V14, P55
   Meyerhof M., 1931, LEGACY ISLAM, P311
   Muhammad Muhammad Ismail D, 1341, AL HAWI FI AL TIBB, V4
   Nizami Masse H, 1995, ENCY ISLAM, VVIII
   Qurra Thabit B., KITAB AL DHAKHIRA
   Rhasis M, 1486, LIBER ELHAVI SEU ARS
   Sezgin F, 1997, ISLAMIC MED, V78
   Sezgin Fuat, 1970, GESCH ARABISCHEN SCH, VIII
   Siddiqi MZ, 1928, SUBSIDESED EGW GIBB, P137
   ULLMANN Manfred, 1978, ISLAMIC MED
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 390
EP 396
DI 10.1016/j.wneu.2019.07.214
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300192
PM 31394356
DA 2020-05-12
ER

PT J
AU Graffeo, CS
   Perry, A
   Mikula, AL
   Brinjikji, W
   Castilla, LR
AF Graffeo, Christopher S.
   Perry, Avital
   Mikula, Anthony L.
   Brinjikji, Waleed
   Castilla, Leonardo Rangel
TI Ruptured Posterior Inferior Cerebellar Artery Dural Fistula After
   Vestibular Schwannoma Resection
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebrovascular; Embolization; Endovascular; Intracranial dural
   arteriovenous fistula; Subarachnoid hemorrhage; Vestibular schwannoma
C1 [Graffeo, Christopher S.; Perry, Avital; Mikula, Anthony L.; Brinjikji, Waleed; Castilla, Leonardo Rangel] Mayo Clin, Dept Neurol Surg & Radiol, Rochester, MN 55905 USA.
RP Castilla, LR (reprint author), Mayo Clin, Dept Neurol Surg & Radiol, Rochester, MN 55905 USA.
EM RangelCastilla.Leonardo@mayo.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 397
EP 397
DI 10.1016/j.wneu.2019.09.057
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300193
PM 31541758
DA 2020-05-12
ER

PT J
AU Cecchini, G
   Sorenson, TJ
   Graffeo, CS
   Vitale, G
   Di Biase, F
AF Cecchini, Giulio
   Sorenson, Thomas J.
   Graffeo, Christopher S.
   Vitale, Giovanni
   Di Biase, Francesco
TI Two-Operator Endoscopic Resection of Left Cerebellopontine Angle
   Epidermoid
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebellopontine angle; Endoscopic; Epidermoid; Retrosigmoid; Surgery
C1 [Cecchini, Giulio; Vitale, Giovanni; Di Biase, Francesco] San Carlo Hosp, Dept Neurol Surg, Potenza, Italy.
   [Sorenson, Thomas J.; Graffeo, Christopher S.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA.
   [Sorenson, Thomas J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.
RP Di Biase, F (reprint author), San Carlo Hosp, Dept Neurol Surg, Potenza, Italy.
EM franc.dibiase@gmail.com
OI Cecchini, Giulio/0000-0002-8963-7811
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 398
EP 398
DI 10.1016/j.wneu.2019.09.008
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300194
PM 31520755
DA 2020-05-12
ER

PT J
AU Narducci, A
   Ronchetti, G
   Nannucci, F
   Vaudano, GP
   Griva, F
AF Narducci, Alessandro
   Ronchetti, Gabriele
   Nannucci, Federico
   Vaudano, Giacomo Paolo
   Griva, Federico
TI Infundibulum of Accessory Anterior Cerebral Artery: Rare, Likely Benign
   Malformation of Anterior Communicating Artery Complex to Keep in Mind
SO WORLD NEUROSURGERY
LA English
DT Article
DE Accessory anterior cerebral artery; Aneurysms; Anterior communicating
   artery; Cerebrovascular diseases; Infundibular dilations
ID DIFFERENTIAL-DIAGNOSIS; ANEURYSM FORMATION; JUNCTIONAL DILATATION;
   MICROSURGICAL ANATOMY; RUPTURE; DILATION; ORIGIN; RISK
AB BACKGROUND: Infundibular dilations (IDs) are funnel-shaped enlargements located at the origin of cerebral arteries. Neuroradiologists and neurosurgeons are familiar with IDs of the posterior communicating artery, which are relatively common. Other locations, being unexpected sites of IDs, can pose diagnostic and therapeutic challenges.
   CASE DESCRIPTION: In this paper, we describe a case of infundibulum of the accessory anterior cerebral artery, diagnosed with 3-dimensional reconstructions of computed tomography angiography, which is to our knowledge the first report of an ID of this anatomic variant.
   CONCLUSIONS: Anterior communicating artery represents a rare location for infundibular dilations. Differential diagnosis between them and true aneurysms can be sometimes challenging, especially when associated with anatomic variants; thus neurosurgeons and radiologists must be aware of these pathologic entities.
C1 [Narducci, Alessandro; Ronchetti, Gabriele; Nannucci, Federico; Griva, Federico] San Giovanni Bosco Hosp, Dept Neurosurg, Turin, Italy.
   [Vaudano, Giacomo Paolo] San Giovanni Bosco Hosp, Dept Radiol, Turin, Italy.
RP Narducci, A (reprint author), San Giovanni Bosco Hosp, Dept Neurosurg, Turin, Italy.
EM alessandro.narducci@gmail.com
CR Aydin IH, 1997, MINIM INVAS NEUROSUR, V40, P17, DOI 10.1055/s-2008-1053407
   BAPTISTA AG, 1963, NEUROLOGY, V13, P825, DOI 10.1212/WNL.13.10.825
   Bijlenga P, 2013, STROKE, V44, P3018, DOI 10.1161/STROKEAHA.113.001667
   Brinjikji W, 2010, STROKE, V41, P116, DOI 10.1161/STROKEAHA.109.566356
   Chen CJ, 2016, J NEUROINTERV SURG, V8, P791, DOI 10.1136/neurintsurg-2015-011827
   Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317
   EBINA K, 1986, NEURORADIOLOGY, V28, P23, DOI 10.1007/BF00341761
   EPSTEIN F, 1970, J NEUROSURG, V33, P529, DOI 10.3171/jns.1970.33.5.0529
   Fischer S, 2011, CLIN NEURORADIOL, V21, P87, DOI 10.1007/s00062-010-0038-1
   HASSLER OVE, 1959, ACTA PATHOL ET MICROBIOL SCAND, V46, P305
   ITAKURA T, 1983, J NEUROSURG, V58, P117, DOI 10.3171/jns.1983.58.1.0117
   Kangasniemi M, 2004, NEUROSURGERY, V54, P336, DOI 10.1227/01.NEU.0000103448.07132.E1
   Kubota T, 2000, NEUROL SURG TOKYO, V28, P31
   Marshman LAG, 1998, NEUROSURGERY, V43, P1445, DOI 10.1097/00006123-199812000-00107
   Min KJ, 2014, NEURORADIOLOGY, V56, P917, DOI 10.1007/s00234-014-1400-9
   NATHAL E, 1992, J NEUROSURG, V76, P629, DOI 10.3171/jns.1992.76.4.0629
   OGAWA A, 1990, J NEUROSURG, V72, P706, DOI 10.3171/jns.1990.72.5.0706
   Park J, 2013, J NEUROSURG, V119, P243, DOI 10.3171/2013.3.JNS122058
   Pereira BJ, 2013, BMJ CASE REP, V2013
   PERLMUTTER D, 1976, J NEUROSURG, V45, P259, DOI 10.3171/jns.1976.45.3.0259
   PERLMUTTER D, 1978, J NEUROSURG, V49, P204, DOI 10.3171/jns.1978.49.2.0204
   Rinaldo L, 2017, WORLD NEUROSURG, V108, P662, DOI 10.1016/j.wneu.2017.09.092
   SALTZMAN GF, 1959, ACTA RADIOL, V51, P415, DOI 10.3109/00016925909171114
   Satoh T, 2006, AM J NEURORADIOL, V27, P306
   Shi WY, 2011, SURG RADIOL ANAT, V33, P75, DOI 10.1007/s00276-010-0728-z
   STUNTZ JT, 1970, J NEUROSURG, V33, P591, DOI 10.3171/jns.1970.33.5.0591
   Sun ZK, 2011, J CLIN NEUROSCI, V18, P504, DOI 10.1016/j.jocn.2010.07.128
   Xu T, 2017, J NEUROINTERV SURG, V9, P278, DOI 10.1136/neurintsurg-2016-012294
   Yu JL, 2015, INT J CLIN EXP MED, V8, P17080
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 399
EP 402
DI 10.1016/j.wneu.2019.08.238
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300195
PM 31505294
DA 2020-05-12
ER

PT J
AU Chen, T
   Mastorakos, GM
   Swanson, KI
   Eschbacher, JM
   Smith, KA
AF Chen, Tsinsue
   Mastorakos, George M.
   Swanson, Kyle, I
   Eschbacher, Jennifer M.
   Smith, Kris A.
TI Temporal Horn Choroid Plexus Papilloma Presenting with Seizures in
   Adulthood: Clinical Case Report and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Adult; Choroid plexus papilloma; Epilepsy; Seizures; Temporal horn;
   Ventricle
ID GROSS TOTAL RESECTION; LOBE EPILEPSY; TUMORS
AB BACKGROUND: Choroid plexus papillomas (CPPs) are benign World Health Organization grade I tumors that comprise 2%-4% of all brain tumors among children and less than 1% of brain tumors in adults. Most adult cases occur in the fourth ventricle, with only 1 previous report describing an adult patient with a temporal horn CPP.
   CASE DESCRIPTION: We report a rare case of a temporal horn CPP presenting in an adult with seizures. We performed a minimally invasive subtemporal approach for gross total resection of the lesion.
   CONCLUSIONS: CPP presenting in the temporal horn is rare among adults. We discuss the surgical nuances of the subtemporal approach for resection and review the literature regarding adult presentation of CPP and the treatment strategies for adult CPP.
C1 [Chen, Tsinsue; Swanson, Kyle, I; Smith, Kris A.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.
   [Eschbacher, Jennifer M.] St Josephs Hosp, Barrow Neurol Inst, Dept Neuropathol, Phoenix, AZ USA.
   [Chen, Tsinsue] Chandler Reg Med Ctr, Barrow Neurol Inst, Dept Neurosurg, Chandler, AZ 85224 USA.
   [Mastorakos, George M.] Mayo Clin, Sch Med, Scottsdale, AZ USA.
RP Chen, T (reprint author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.; Chen, T (reprint author), Chandler Reg Med Ctr, Barrow Neurol Inst, Dept Neurosurg, Chandler, AZ 85224 USA.
EM Neuropub@barrowneuro.org
OI Swanson, Kyle/0000-0003-2639-7010
CR Erman T, 2003, ACTA NEUROCHIR, V145, P139, DOI 10.1007/s00701-002-1047-x
   Jeibmann A, 2006, J NEUROPATH EXP NEUR, V65, P1069, DOI 10.1097/01.jnen.0000240464.26005.90
   Kim IY, 2008, J NEURO-ONCOL, V90, P105, DOI 10.1007/s11060-008-9639-9
   Lannelli A, 2008, J CHILD NEUROL, V23, P315, DOI 10.1177/0883073807308713
   Little AS, 2009, J NEUROSURG, V111, P1263, DOI 10.3171/2008.10.17673
   Lozier AP, 2009, NEUROSURGERY, V65, P816, DOI 10.1227/01.NEU.0000348291.48810.C2
   Mohanty Sureswar, 2016, World J Oncol, V7, P51, DOI 10.14740/wjon967w
   Ogiwara H, 2012, BRIT J NEUROSURG, V26, P32, DOI 10.3109/02688697.2011.601820
   Pandey S, 2016, J PEDIATR NEUROSCI, V11, P61, DOI 10.4103/1817-1745.181254
   PAULUS W, 1990, ACTA NEUROPATHOL, V80, P635, DOI 10.1007/BF00307632
   Pencalet P, 1998, J NEUROSURG, V88, P521, DOI 10.3171/jns.1998.88.3.0521
   Phi JH, 2004, CLIN NEUROPATHOL, V23, P95
   Safaee M, 2013, J CLIN NEUROSCI, V20, P808, DOI 10.1016/j.jocn.2012.08.003
   Safaee M, 2013, NEURO-ONCOLOGY, V15, P255, DOI 10.1093/neuonc/nos289
   Schmeiser B, 2017, NEUROSURGERY, V81, P992, DOI 10.1093/neuros/nyx138
   Sener RN, 1998, COMPUT MED IMAG GRAP, V22, P263
   Seol HJ, 2003, J NEURO-ONCOL, V62, P315, DOI 10.1023/A:1023357810796
   Sun MZ, 2014, NEUROSURG REV, V37, P179, DOI 10.1007/s10143-013-0499-1
   Sun MZ, 2014, J NEURO-ONCOL, V116, P179, DOI 10.1007/s11060-013-1281-5
   Talacchi A, 1999, SURG NEUROL, V51, P621, DOI 10.1016/S0090-3019(99)00024-5
NR 20
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 403
EP 407
DI 10.1016/j.wneu.2019.08.201
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300196
PM 31493601
DA 2020-05-12
ER

PT J
AU Keorochana, G
   Arirachakaran, A
   Setrkraising, K
   Kongtharvonskul, J
AF Keorochana, Gun
   Arirachakaran, Alisara
   Setrkraising, Kittipong
   Kongtharvonskul, Jatupon
TI Comparison of Complications and Revisions After Sacral 2 Alar Iliac
   Screw and Iliac Screw Fixation for Sacropelvic Fixation in Pediatric and
   Adult Populations: Systematic Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Complication; Iliac screw fixation; Meta-analysis; S2AI fixation;
   Sacropelvic; Systematic review
ID PROXIMAL JUNCTIONAL KYPHOSIS; POSTERIOR SPINAL-FUSION; PELVIC FIXATION;
   RISK-FACTOR; S2-ALAR-ILIAC SCREWS; PUBLICATION BIAS; FUNNEL PLOTS;
   SURGERY; INSTRUMENTATION; REOPERATION
AB OBJECTIVE: This systematic review and meta-analysis aims to assess and compare the postoperative outcomes of iliac screw (IS) fixation versus sacral 2 alar iliac (S2AI) screw fixation in the adult and pediatric populations.
   METHODS: We searched all comparative studies that compared postoperative outcomes of IS and S2AI fixation techniques for pelvic fixation from the PubMed and Scopus databases up to June 23, 2019.
   RESULTS: Eleven of 951 studies (N = 632 patients) were eligible; 8, 10, 5, 6, 3, 7, 2, and 2 studies were included in pooling of postoperative complications, revisions, implant failure, screw breakage, screw prominence, wound dehiscence, wound infection, visual analog scale (VAS), and ambulatory status (AS), respectively. The IS technique had a statistically significant higher chance of postoperative complications, revisions, implant failure, screw breakage, screw prominent, wound dehiscence, and wound infection by 1.89 (95% confidence interval [CI], 1.48-2.40), 1.91 (95% CI, 1.29-2.82), 2.28 (95% CI, 1.55-3.35), 3.96 (95% CI, 1.46-10.75), 6.83 (95% CI, 2.54-18.37), 4.62 (95% CI, 1.32-16.25), and 3.03 (95% CI, 1.62-5.66), respectively compared with the S2AI fixation technique. In subgroup analysis, the IS technique had a statistically significant higher chance of postoperative complications and revisions of 1.65 (95% CI, 1.25-2.16) and 1.71 (95% CI, 1.03-2.84) in pediatric populations and 2.32 (95% CI, 1.60-3.38) and 1.94 (95% CI, 1.00-3.73) in the adult populations compared with the S2AI fixation technique. IS screw fixation had a lower AS of -0.40 (95% CI, -0.76 to -0.15) than did S2AI fixation in the adult and pediatric populations. However, there was no difference in pain VAS between both groups.
   CONCLUSIONS: Sacropelvic fixation with IS screw fixation had more postoperative complications and revisions and lower AS than did S2AI fixation.
C1 [Keorochana, Gun] Mahidol Univ, Ramathibodi Hosp, Orthoped Dept, Fac Med, Bangkok, Thailand.
   [Arirachakaran, Alisara] Bumrungrad Int Hosp, Orthoped Dept, Bangkok, Thailand.
   [Setrkraising, Kittipong] Police Gen Hosp, Orthoped Dept, Bangkok, Thailand.
   [Kongtharvonskul, Jatupon] Samitivej Hosp, Sport & Orthoped Ctr, Bangkok, Thailand.
   [Kongtharvonskul, Jatupon] Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Bangkok, Thailand.
RP Kongtharvonskul, J (reprint author), Samitivej Hosp, Sport & Orthoped Ctr, Bangkok, Thailand.; Kongtharvonskul, J (reprint author), Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Bangkok, Thailand.
EM Jatupon_kong@hotmail.com
CR Abousamra Oussama, 2016, Spine Deform, V4, P217, DOI 10.1016/j.jspd.2015.11.001
   Bachy M, 2012, INT ORTHOP, V36, P465, DOI 10.1007/s00264-011-1439-8
   Chang TL, 2009, SPINE, V34, P436, DOI 10.1097/BRS.0b013e318194128c
   Chechik O, 2011, J CHILD ORTHOP, V5, P41, DOI 10.1007/s11832-010-0318-y
   Cottrill E, 2019, SPINE DEFORM, V7, P364
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edwards CC, 2004, SPINE, V29, P1996, DOI 10.1097/01.brs.0000138272.54896.33
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elder BD, 2017, SPINE, V42, pE142, DOI 10.1097/BRS.0000000000001722
   Even JL, 2012, SPINE, V37, pE46, DOI 10.1097/BRS.0b013e31821fd21f
   Finger T, 2014, EUR SPINE J, V23, P1013, DOI 10.1007/s00586-014-3165-6
   Fu KMG, 2014, WORLD NEUROSURG, V82, pE547, DOI 10.1016/j.wneu.2013.02.059
   Glattes RC, 2005, SPINE, V30, P1643, DOI 10.1097/01.brs.0000169451.76359.49
   Guler UO, 2015, EUR SPINE J, V24, P1085, DOI 10.1007/s00586-014-3615-1
   Hamilton DK, 2013, J NEUROSURG-SPINE, V19, P95, DOI 10.3171/2013.4.SPINE121078
   Ilyas H, 2015, J SPINAL DISORD TECH, V28, pE199, DOI 10.1097/BSD.0000000000000222
   Ishida W, 2019, CLIN SPINE SURG, V32, pE200, DOI 10.1097/BSD.0000000000000806
   Ishida W, 2017, GLOB SPINE J, V7, P672, DOI 10.1177/2192568217700111
   Ishida W, 2016, WORLD NEUROSURG, V93, P253, DOI 10.1016/j.wneu.2016.06.042
   Jain A, 2016, JBJS ESSENT SURG TEC, V6, DOI 10.2106/JBJS.ST.15.00074
   Jain A, 2015, J BONE JOINT SURG AM, V97A, P1521, DOI 10.2106/JBJS.O.00576
   Kebaish KM, 2010, SPINE, V35, P2245, DOI 10.1097/BRS.0b013e3181f5cfae
   Kim HJ, 2012, CLIN ORTHOP RELAT R, V470, P1633, DOI 10.1007/s11999-011-2179-1
   Kim YJ, 2006, SPINE, V31, P2329, DOI 10.1097/01.brs.0000238968.82799.d9
   Kuklo TR, 2001, SPINE, V26, P1976, DOI 10.1097/00007632-200109150-00007
   Lee MC, 2018, SPINE J, V18, P648, DOI 10.1016/j.spinee.2017.08.253
   Mazur MD, 2015, J NEUROSURG-SPINE, V23, P67, DOI 10.3171/2014.10.SPINE14541
   Moshirfar A, 2005, J BONE JOINT SURG AM, V87A, P89, DOI 10.2106/JBJS.E.00453
   Nazemi Alireza K, 2018, Surg Neurol Int, V9, P75, DOI 10.4103/sni.sni_460_17
   O'Brien JR, 2013, SPINE, V38, pE1250, DOI 10.1097/BRS.0b013e31829e17ff
   O'Brien JR, 2009, SPINE, V34, pE439, DOI 10.1097/BRS.0b013e3181a4e3e4
   O'Shaughnessy BA, 2012, SPINE, V37, P1175, DOI 10.1097/BRS.0b013e3182426970
   Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206
   Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010
   Ramo BA, 2014, J BONE JOINT SURG AM, V96A, P2038, DOI 10.2106/JBJS.N.00277
   Ramos RD, 2019, J NEUROSURG-SPINE, V30, P253, DOI 10.3171/2018.7.SPINE18710
   Shabtai L, 2017, J PEDIATR ORTHOPED, V37, pE470, DOI 10.1097/BPO.0000000000000720
   Shen FH, 2013, EUR SPINE J, V22, pS265, DOI 10.1007/s00586-012-2525-3
   Sponseller PD, 2010, CLIN ORTHOP RELAT R, V468, P711, DOI 10.1007/s11999-009-0933-4
   StataCorp, 2017, STAT STAT SOFTW REL
   Tsuchiya K, 2006, SPINE, V31, P303, DOI 10.1097/01.brs.0000197193.81296.f1
   Wang MY, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15180
   Wells GA, NEWCASTLE OTTAWA SCA
NR 43
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 408
EP +
DI 10.1016/j.wneu.2019.08.104
PG 14
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300197
PM 31465853
DA 2020-05-12
ER

PT J
AU Ho, AL
   Varshneya, K
   Medress, ZA
   Pendharkar, AV
   Sussman, ES
   Cheng, I
   Veeravagu, A
AF Ho, Allen L.
   Varshneya, Kunal
   Medress, Zachary A.
   Pendharkar, Arjun, V
   Sussman, Eric S.
   Cheng, Ivan
   Veeravagu, Anand
TI Grade II Spondylolisthesis: Reverse Bohlman Procedure with Transdiscal
   S1-L5 and S2 Alar Iliac Screws Placed with Robotic Guidance
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior lumbar interbody fusion; Bohlman procedure; Grade II
   spondylolisthesis; Spondylolisthesis; Transdiscal screw
ID ISTHMIC SPONDYLOLISTHESIS; S2-ALAR-ILIAC SCREWS; INSTRUMENTED REDUCTION;
   INTERBODY FUSION; PELVIC FIXATION; DECOMPRESSION; MANAGEMENT;
   COMPLICATIONS; PARAMETERS; KYPHOSIS
AB BACKGROUND: Grade II spondylolisthesis remains a complex surgical pathology for which there is no consensus regarding optimal surgical strategies. Surgical strategies vary regarding extent of reduction, use of instrumentation/interbody support, and anterior versus posterior approaches with or without decompression. Here we provide the first report on the efficacy of robotic spinal surgery systems in support of the treatment of grade II spondylolisthesis.
   METHODS: Using 2 illustrative cases, we provide a technical report describing how robotic spinal surgery platform can be used to treatment grade II spondylolisthesis with a novel instrumentation strategy.
   RESULTS: We describe how the "reverse Bohlman" technique to achieve a large anterior fusion construct spanning the pathological level and buttressed by the adjacent level above, coupled with a novel, high-fidelity posterior fixation scheme with transdiscal S1-L5 and S2 alar iliac (S2AI) screws placed in a minimally invasive fashion with robot guidance allows for the best chance of fusion in situ.
   CONCLUSIONS: The reverse Bohlman technique coupled with transdiscal S1-L5 and S2AI screw fixation accomplishes the surgical goals of creating a solid fusion construct, avoiding neurologic injury with aggressive reduction, and halting the progression of anterolisthesis. The use of robot guidance allows for efficient placement of these difficult screw trajectories in a minimally invasive fashion.
C1 [Ho, Allen L.; Varshneya, Kunal; Medress, Zachary A.; Pendharkar, Arjun, V; Sussman, Eric S.; Veeravagu, Anand] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
   [Cheng, Ivan] Stanford Univ, Dept Orthoped Surg, Sch Med, Stanford, CA 94305 USA.
RP Veeravagu, A (reprint author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
EM Anandv2@stanford.edu
CR ABDU WA, 1994, SPINE, V19, P710, DOI 10.1097/00007632-199403001-00011
   Acosta FL, 2007, NEUROSURG CLIN N AM, V18, P249, DOI 10.1016/j.nec.2007.01.001
   Bederman SS, 2017, CLIN SPINE SURG, V30, pE49, DOI 10.1097/BSD.0b013e3182a3572b
   Boachie-Adjei O, 2002, SPINE, V27, pE161, DOI 10.1097/00007632-200203150-00019
   BOHLMAN HH, 1982, J BONE JOINT SURG AM, V64, P415, DOI 10.2106/00004623-198264030-00012
   Boos N, 1997, Eur Spine J, V6, P2, DOI 10.1007/BF01676569
   Burns Camden B, 2016, Spine Deform, V4, P10, DOI 10.1016/j.jspd.2015.07.008
   Chang TL, 2009, SPINE, V34, P436, DOI 10.1097/BRS.0b013e318194128c
   Collados-Maestre I, 2016, EUR SPINE J, V25, P1806, DOI 10.1007/s00586-016-4550-0
   Delgado-Fernandez J, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.10.FOCUS17557
   Elder BD, 2017, SPINE, V42, pE142, DOI 10.1097/BRS.0000000000001722
   Gao ST, 2018, EUR SPINE J, V27, P921, DOI 10.1007/s00586-017-5333-y
   Goyal N, 2009, J SPINAL DISORD TECH, V22, P321, DOI 10.1097/BSD.0b013e318182cdab
   Hasegawa K, 2016, EUR SPINE J, V25, P3675, DOI 10.1007/s00586-016-4702-2
   Hu XB, 2017, EUR SPINE J, V26, P720, DOI 10.1007/s00586-016-4639-5
   Hu XB, 2013, EUR SPINE J, V22, P661, DOI 10.1007/s00586-012-2499-1
   Hyun SJ, 2017, SPINE, V42, P353, DOI 10.1097/BRS.0000000000001778
   Ishida W, 2016, WORLD NEUROSURG, V93, P253, DOI 10.1016/j.wneu.2016.06.042
   Januszewski J, 2017, J CLIN NEUROSCI, V45, P218, DOI 10.1016/j.jocn.2017.07.007
   Johnson RD, 2013, J CLIN NEUROSCI, V20, P191, DOI 10.1016/j.jocn.2012.05.023
   Jouve JL, 2014, EUR SPINE J, V23, P457, DOI 10.1007/s00586-014-3343-6
   Kantelhardt S, 2011, EUR SPINE J, V20, P860, DOI 10.1007/s00586-011-1729-2
   Kasliwal MK, 2013, NEUROSURG CLIN N AM, V24, P275, DOI 10.1016/j.nec.2012.12.002
   Kasliwal MK, 2012, NEUROSURGERY, V71, P109, DOI 10.1227/NEU.0b013e3182535881
   Kuklo TR, 2001, SPINE, V26, P61, DOI 10.1097/00007632-200101010-00012
   Laratta JL, 2018, SPINE DEFORM, V6, P130, DOI DOI 10.1016/J.JSPD.2017.08.009]
   LEHMER SM, 1994, SPINE, V19, P2060, DOI 10.1097/00007632-199409150-00009
   Longo UG, 2014, J BONE JOINT SURG AM, V96A, P53, DOI 10.2106/JBJS.L.01012
   Macagno AE, 2016, J ORTHOP, V13, P1, DOI 10.1016/j.jor.2015.12.004
   Minamide T, 2003, J SPINAL DISORD TECH, V16, P144, DOI 10.1097/00024720-200304000-00005
   O'Brien JR, 2009, SPINE, V34, pE439, DOI 10.1097/BRS.0b013e3181a4e3e4
   Park YS, 2017, CLIN SPINE SURG, V30, pE877, DOI 10.1097/BSD.0000000000000520
   Rodriguez-Olaverri JC, 2008, SPINE, V33, P1977, DOI 10.1097/BRS.0b013e31817ecc01
   Rosner MK, 2004, SEMIN SPINE SURG, V16, P107
   Sailhan F, 2006, SPINE, V31, P161, DOI 10.1097/01.brs.0000194780.17528.6b
   Sarwahi V, 2016, SPINE, V41, pE548, DOI 10.1097/BRS.0000000000001318
   Shillingford JN, 2018, J BONE JOINT SURG AM, V100, P334, DOI 10.2106/JBJS.17.00052
   Smith BW, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17200
   STEVENS DB, 1989, CLIN ORTHOP RELAT R, P164
   Tian NF, 2011, EUR SPINE J, V20, P846, DOI 10.1007/s00586-010-1577-5
   TRANSFELDT EE, 1989, SPINE, V14, P884, DOI 10.1097/00007632-198908000-00021
   WILTSE LL, 1976, CLIN ORTHOP RELAT R, P23
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 421
EP +
DI 10.1016/j.wneu.2019.07.229
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300198
PM 31398524
DA 2020-05-12
ER

PT J
AU Liu, H
   Zhang, JX
   Chen, WK
   Chen, AC
   Ji, W
   Meng, B
   Yang, HL
   Liu, T
AF Liu, Hao
   Zhang, Junxin
   Chen, Weikai
   Chen, Angela Carley
   Ji, Wei
   Meng, Bin
   Yang, Huilin
   Liu, Tao
TI Reperfusion Revision Surgery for Augmented Vertebral Nonunion with
   Movable Cement
SO WORLD NEUROSURGERY
LA English
DT Article
DE Kyphoplasty; Minimally invasive; Nonunion; Reperfusion; Revision surgery
ID PERCUTANEOUS KYPHOPLASTY; COMPRESSION FRACTURES; VERTEBROPLASTY
AB BACKGROUND: Osteoporotic vertebral nonunion is a special type of osteoporotic vertebral fracture and can gain satisfactory clinical outcomes using vertebral augmentation. In the rare occurrence that augmented vertebral nonunion occurs postoperatively, pedicle screw fixation is the primary strategy. However, is a different method like the second shot of cement reliable? The purpose of this study is to introduce the reperfusion revision surgery strategy for treatment of osteoporotic vertebral nonunion.
   CASE DESCRIPTION: An 80-year-old female patient experienced vertebral re-nonunion in situ after receiving kyphoplasty at the T11 vertebrae. During revision surgery, we tried a new, minimally invasive surgical method in which we inserted cement into the intravertebral cleft around the movable cement without obvious leakage. Special bone cement perfusion techniques (incremental temperature cement delivery and secondary cement preparation based-perfusion and blocking) were used. The cement tail was performed to increase the anchor and fastness between the cement and vertebral body.
   CONCLUSIONS: The patient gained immediate pain relief and vertebral stability after the revision surgery. A 2-year postoperative radiograph and follow-up showed sufficient vertebral height and clinical outcomes. Using special puncture and bone cement perfusion techniques, reperfusion revision surgery in situ is an effective strategy for the treatment of vertebral re-nonunion.
C1 [Liu, Hao; Zhang, Junxin; Chen, Weikai; Ji, Wei; Meng, Bin; Yang, Huilin; Liu, Tao] Soochow Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China.
   [Chen, Angela Carley] Univ Waterloo, Hlth Study, Waterloo, ON, Canada.
RP Liu, T (reprint author), Soochow Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China.
EM sudalt@126.com
CR Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007
   Chen LH, 2011, ARCH ORTHOP TRAUM SU, V131, P927, DOI 10.1007/s00402-010-1236-7
   Czerwinski Edward, 2007, Ortop Traumatol Rehabil, V9, P337
   Edidin AA, 2015, SPINE, V40, P1228, DOI 10.1097/BRS.0000000000000992
   Harrop JS, 2004, SPINE, V29, P2120, DOI 10.1097/01.brs.0000141176.63158.8e
   Kim YY, 2010, EUR SPINE J, V19, P1907, DOI 10.1007/s00586-010-1479-6
   Kummel H, 1895, DTSCH MED, V21, P180
   Li XG, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008961
   Lin WC, 2008, EUR SPINE J, V17, P592, DOI 10.1007/s00586-007-0564-y
   Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320
   Shuler Franklin D, 2016, W V Med J, V112, P84
   Si L, 2015, OSTEOPOROSIS INT, V26, P1929, DOI 10.1007/s00198-015-3093-2
   Song DW, 2015, ACTA RADIOL, V56, P970, DOI 10.1177/0284185114544240
   Wilson DR, 2000, SPINE, V25, P158, DOI 10.1097/00007632-200001150-00004
   Yang HL, 2017, J ORTHOP TRANSL, V11, P73, DOI 10.1016/j.jot.2017.04.003
   Yang HL, 2016, SPINE, V41, pB52, DOI 10.1097/BRS.0000000000001804
   Yang HL, 2014, SPINE, V39, pB4, DOI 10.1097/BRS.0000000000000538
NR 17
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP 429
EP +
DI 10.1016/j.wneu.2019.07.212
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300199
PM 31394357
DA 2020-05-12
ER

PT J
AU Akar, E
   Emon, ST
   Uslu, S
   Orakdogen, M
   Somay, H
AF Akar, Ezgi
   Emon, Selin Tural
   Uslu, Serap
   Orakdogen, Metin
   Somay, Hakan
TI Effect of L-Arginine Therapy on Vasospasm: Experimental Study in Rats
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral vasospasm; L-arginine; Nitric oxide; Subarachnoid hemorrhage;
   Vasospasm
ID NITRIC-OXIDE SYNTHASE; SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM;
   OXIDATIVE STRESS; ARTERY
AB OBJECTIVE: Cerebral vasospasm occurring after subarachnoid hemorrhage is a serious cause of morbidity. Cerebral vasospasm-related studies aim to prevent complications after subarachnoid hemorrhage. Nitric oxide affects brain blood flow and local vascular hemodynamics. L-arginine is used in the synthesis of nitric oxide, and hence we have investigated the efficacy of L-arginine treatment by using femoral artery vasospasm model.
   METHODS: Twenty-four male Sprague-Dawley rats have been divided into 3 groups as vasospasm, vasospasm + L-arginine, and control. In this study, we have preferred the "Rat Femoral Artery Vasospasm Model" described by Okada et al. Rats in the vasospasm + L-arginine group were given 300 mg/kg L-arginine for 7 days. At the end of the study, all samples of rat femoral arteries have been dissected and examined microscopically for histopathologic analysis. Statistical analysis was performed using Kruskal-Wallis and Mann-Whitney U tests, and P < 0.05 value was considered statistically significant.
   RESULTS: L-arginine treatment reduced the morphometric changes such as irregularity of the elastic lamina, disruption of the endothelial cells, vacuolization, and hemorrhages that are caused by vasospasm. When the wall thickness and lumen diameter measurements were evaluated statistically, significant improvement was observed in the vasospasm + L-arginine group compared with the vasospasm group (P < 0.01).
   CONCLUSIONS: In our study, the use of L-arginine, as a nitric oxide substrate, improved the experimental vasospasm in rats. Therefore we think that L-arginine therapy can be used in the prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage.
C1 [Akar, Ezgi; Emon, Selin Tural] Haydarpasa Numune Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey.
   [Uslu, Serap] Istanbul Medeniyet Univ, Dept Histol & Embryol, Istanbul, Turkey.
   [Orakdogen, Metin; Somay, Hakan] Medicana Kadikoy Hosp, Dept Neurosurg, Istanbul, Turkey.
RP Akar, E (reprint author), Haydarpasa Numune Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey.
EM ezgiaycicek@gmail.com
OI AKAR, ezgi/0000-0002-8582-2948
CR Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33
   Baggott CD, 2014, NEUROSURG CLIN N AM, V25, P497, DOI 10.1016/j.nec.2014.04.008
   CHEHRAZI BB, 1989, STROKE, V20, P217, DOI 10.1161/01.STR.20.2.217
   EDVINSSON L, 2002, CEREBRAL BLOOD FLOW
   Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532
   Hakan T, 2008, J CLIN NEUROSCI, V15, P55, DOI 10.1016/j.jocn.2006.10.010
   KAJITA Y, 1994, J NEUROSURG, V80, P476, DOI 10.3171/jns.1994.80.3.0476
   Karaoglan A, 2008, SURG NEUROL, V70, P337, DOI 10.1016/j.surneu.2007.07.031
   Kilic T, 2005, TEMEL NOROSITURJI, P191
   Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035
   Munakata A, 2009, NEUROSURGERY, V64, P423, DOI 10.1227/01.NEU.0000338067.83059.EB
   NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6
   OKADA T, 1990, NEUROSURGERY, V27, P349, DOI 10.1227/00006123-199009000-00002
   Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002
   Pyne-Geithman GJ, 2009, NEUROL RES, V31, P195, DOI 10.1179/174313209X393906
   SUZUKI S, 1995, J NEUROSURG, V83, P862, DOI 10.3171/jns.1995.83.5.0862
   Tierney TS, 2006, NEUROSURGERY, V58, P952, DOI 10.1227/01.NEU.0000210182.48546.8F
   Wolf EW, 1998, J NEUROSURG, V89, P279, DOI 10.3171/jns.1998.89.2.0279
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E443
EP E446
DI 10.1016/j.wneu.2019.08.119
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300052
PM 31494312
DA 2020-05-12
ER

PT J
AU Alexopoulos, G
   Cikla, U
   El Tecle, N
   Kulkarni, N
   Pierson, M
   Mercier, P
   Kemp, J
   Coppens, J
   Mahmoud, S
   Sehi, M
   Bucholz, R
   Abdulrauf, S
AF Alexopoulos, Georgios
   Cikla, Ulas
   El Tecle, Najib
   Kulkarni, Neha
   Pierson, Matthew
   Mercier, Philippe
   Kemp, Joanna
   Coppens, Jeroen
   Mahmoud, Shamseldeen
   Sehi, Mehrdad
   Bucholz, Richard
   Abdulrauf, Saleem
TI The Value of White Matter Tractography by Diffusion Tensor Imaging in
   Altering a Neurosurgeon's Operative Plan
SO WORLD NEUROSURGERY
LA English
DT Article
DE DTI; Neurosurgery; Planning; Presurgical; Supratentorial; Tractography;
   Tumors
ID FIBER TRACTOGRAPHY; GRADE GLIOMA; BRAIN; RESECTION; TRACKING; TRACTS;
   TUMOR; DTI; VISUALIZATION; SURGERY
AB OBJECTIVE: To investigate if the implementation of white matter (WM) fiber tractography by diffusion tensor imaging in presurgical planning for supratentorial tumors proximal to eloquent WM tracts can alter a neurosurgeon's operative strategy.
   METHODS: A retrospective review was conducted of patients with supratentorial brain tumors within eloquent WM tracts who underwent diffusion tensor imaging (DTI) tractography as part of their preoperative assessment. These patients were classified into 3 different DTI groups per the radiology reports: group 1, intact WM tracts; group 2, deviated and/or displaced WM bundles; and group 3, patients with an established WM injury (interrupted and/or destroyed tracts). A blinded prospective behavioral study followed, in which 4 neurosurgeons reviewed the preoperative images at 2 different times (magnetic resonance imaging without DTI, followed by a review of the DTI). They provided estimations about the DTI group of each individual eloquent WM category in every patient, and their planned surgical approach.
   RESULTS: Fifteen patients (mean age, 58.3 years) were included in the study. The neurosurgeons provided a correct DTI group estimation in 53%, 60%, and 57% of the cases that involved motor/sensory pathway tracts, optic tracts, and language tracts, respectively. The neurosurgeons underestimated DTI group 3 in the motor category and in the optic category 75% of the time. DTI did not alter the planned surgical approach.
   CONCLUSIONS: DTI WM tractography helped neurosurgeons to correctly identify patients with interrupted motor and optic pathway tracts so they could be more aggressive with the extent of tumor resection, despite its inability to alter the operative approach.
C1 [Alexopoulos, Georgios; El Tecle, Najib; Pierson, Matthew; Mercier, Philippe; Kemp, Joanna; Coppens, Jeroen; Bucholz, Richard; Abdulrauf, Saleem] St Louis Univ Hosp, Dept Neurosurg, St Louis, MO 63110 USA.
   [Mahmoud, Shamseldeen; Sehi, Mehrdad] St Louis Univ Hosp, Dept Radiol, St Louis, MO USA.
   [Alexopoulos, Georgios; El Tecle, Najib; Kulkarni, Neha; Pierson, Matthew; Mercier, Philippe; Kemp, Joanna; Coppens, Jeroen; Mahmoud, Shamseldeen; Sehi, Mehrdad; Bucholz, Richard; Abdulrauf, Saleem] St Louis Univ Hosp, Sch Med, St Louis, MO 63110 USA.
   [Cikla, Ulas] Yale New Haven Med Ctr, Dept Neurosurg, 20 York St, New Haven, CT 06504 USA.
RP Alexopoulos, G (reprint author), St Louis Univ Hosp, Dept Neurosurg, St Louis, MO 63110 USA.; Alexopoulos, G (reprint author), St Louis Univ Hosp, Sch Med, St Louis, MO 63110 USA.
EM alexopoulos_george@hotmail.com
OI el Tecle, Najib/0000-0002-5242-1646; Alexopoulos,
   Georgios/0000-0002-6225-3033
CR Abdullah KG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.1.FOCUS12412
   Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113
   Bailey PD, 2015, J NEUROIMAGING, V25, P776, DOI 10.1111/jon.12273
   Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031
   Berman J, 2009, MAGN RESON IMAGING C, V17, P205, DOI 10.1016/j.mric.2009.02.002
   Castellano A, 2012, NEURO-ONCOLOGY, V14, P192, DOI 10.1093/neuonc/nor188
   Caverzasi E, 2016, J NEUROSURG, V125, P33, DOI 10.3171/2015.6.JNS142203
   Coenen VA, 2001, NEUROSURGERY, V49, P86, DOI 10.1097/00006123-200107000-00013
   D'Andrea G, 2016, WORLD NEUROSURG, V87, P627, DOI 10.1016/j.wneu.2015.10.076
   Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X
   Essayed WI, 2017, NEUROIMAGE-CLIN, V15, P659, DOI 10.1016/j.nicl.2017.06.011
   Farshidfar Z, 2014, NEURORADIOL J, V27, P75, DOI 10.15274/NRJ-2014-10008
   Feigl GC, 2014, WORLD NEUROSURG, V81, P144, DOI 10.1016/j.wneu.2013.01.004
   Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb
   Jellison BJ, 2004, AM J NEURORADIOL, V25, P356
   Kamali A, 2014, BRAIN STRUCT FUNCT, V219, P269, DOI 10.1007/s00429-012-0498-y
   Klein AP, 2014, FUNCTIONAL BRAIN TUM, P95
   Leclercq D, 2011, NEUROSURG CLIN N AM, V22, P253, DOI 10.1016/j.nec.2010.11.004
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   Nimsky C, 2016, ADV TECH STAND NEURO, V43, P37, DOI 10.1007/978-3-319-21359-0_2
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A
   Panigrahi M, 2017, WORLD NEUROSURG, V98, P587, DOI 10.1016/j.wneu.2016.11.001
   Romano A, 2009, EUR RADIOL, V19, P2798, DOI 10.1007/s00330-009-1483-6
   Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998
   Sarubbo S, 2015, J ANAT, V226, P47, DOI 10.1111/joa.12254
   Soni N, 2017, CUREUS, V9, DOI 10.7759/cureus.1739
   Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568
   Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027
   Yen PS, 2009, SURG NEUROL, V72, P464, DOI 10.1016/j.surneu.2009.05.008
   Yu CS, 2005, EUR J RADIOL, V56, P197, DOI 10.1016/j.ejrad.2005.04.010
NR 30
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E305
EP E313
DI 10.1016/j.wneu.2019.08.168
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300037
PM 31494311
DA 2020-05-12
ER

PT J
AU Alwani, MM
   Monaco, GN
   Harmon, SM
   Nwosu, OI
   Vortmeyer, AO
   Payner, TD
   Ting, J
AF Alwani, Mohamedkazim M.
   Monaco, Gina N.
   Harmon, Sydney M.
   Nwosu, Obi, I
   Vortmeyer, Alexander O.
   Payner, Troy D.
   Ting, Jonathan
TI A Systematic Review of Sellar and Parasellar Brown Tumors: An Analysis
   of Clinical, Diagnostic, and Management Profiles
SO WORLD NEUROSURGERY
LA English
DT Review
DE Brown tumor; Hyperparathyroidism; Parasellar tumor; Sellar tumor;
   Sphenoid sinus tumor
ID SECONDARY HYPERPARATHYROIDISM; HYPERCALCEMIA
AB OBJECTIVE: To systematically review and analyze clinical, diagnostic, and management trends in sellar and parasellar brown tumors reported in existing literature.
   METHODS: In this systematic review, PubMed, Ovid MEDLINE, Scopus, and Google Scholar databases were searched for reported cases of sellar/parasellar brown tumors. Relevant titles and abstracts were screened in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. Articles meeting inclusion criteria were subjected to data extraction, summarization, and analysis. A rare case of parasellar brown tumor was also presented.
   RESULTS: Eight reports (including the current report) were eligible for inclusion. Mean patient age was 42.75 years. Reported symptoms included visual disturbances (n = 6), headache (n = 5), fatigue ( n = 3), nausea/vomiting (n = 2), chest pain ( n = 1), neck pain (n = 1), and dysphagia (n = 1). In cases where computed tomography findings were provided (n = 6), lesions were noted to be expansile and lytic. Lesions were hyperintense on T2-weighted magnetic resonance imaging (66.7%) and demonstrated contrast enhancement (83.3%). Histology unanimously showed multinucleated giant cells in a fibrovascular connective tissue stroma. Dramatic symptom resolution was noted in all patients who underwent resection of the sellar/parasellar brown tumor (n = 4; 50%).
   CONCLUSIONS: Sellar/parasellar brown tumors are a rare, tertiary manifestation of hyperparathyroidism and can be elusive to diagnose. Diagnosis requires a high index of clinical suspicion in addition to comprehensive biochemical testing, imaging, and histopathologic analysis. Surgical extirpation is favored in cases where the lesion is causing compressive symptoms, or if it is unresponsive to management of hyperparathyroidism.
C1 [Alwani, Mohamedkazim M.; Ting, Jonathan] Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46201 USA.
   [Monaco, Gina N.; Payner, Troy D.; Ting, Jonathan] Dept Neurol Surg, Indianapolis, IN USA.
   [Vortmeyer, Alexander O.] Dept Pathol & Lab Med, Indianapolis, IN USA.
   [Harmon, Sydney M.; Nwosu, Obi, I] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
RP Alwani, MM (reprint author), Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46201 USA.
EM malwani@iupui.edu
CR Benmoussa L, 2015, J ORAL MAXIL SURG, V73, P2142, DOI 10.1016/j.joms.2015.05.029
   DeMonte F, 2000, NEUROSURGERY, V46, P1084, DOI 10.1097/00006123-200005000-00012
   Erem C, 2004, J ENDOCRINOL INVEST, V27, P366, DOI 10.1007/BF03351064
   Kanaan I, 1998, NEUROSURGERY, V42, P1374, DOI 10.1097/00006123-199806000-00113
   Lando H M, 2012, Endocr Regul, V46, P31
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Loya-Solis A, 2014, CASE REP ENDOCRINOL, V2014, P1
   Misiorowski W, 2017, ENDOCRINE, V58, P380, DOI 10.1007/s12020-017-1414-2
   National Institute of Diabetes and Digestive and Kidney Disease, KIDN DIS STAT US
   Queiroz IV, 2016, ORAL MAXILLOFAC SURG, V20, P435, DOI 10.1007/s10006-016-0575-0
   SCHWEITZER VG, 1986, HEAD NECK-J SCI SPEC, V8, P379, DOI 10.1002/hed.2890080509
   Selvi F, 2009, DENTOMAXILLOFAC RAD, V38, P53, DOI 10.1259/dmfr/81694583
   Takeshita Tohru, 2004, Radiat Med, V22, P265
   Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022
   Yilmazlar S, 2004, SKULL BASE-INTERD AP, V14, P163, DOI 10.1055/s-2004-832261
   Zhang HL, 2010, ENDOCRINOLOGIST, V20, P152, DOI 10.1097/TEN.0b013e3181e94743
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E423
EP E429
DI 10.1016/j.wneu.2019.08.126
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300049
PM 31470158
DA 2020-05-12
ER

PT J
AU Ares, WJ
   Maroon, JC
   Jankowitz, BT
AF Ares, William J.
   Maroon, Joseph C.
   Jankowitz, Brian T.
TI In Pursuit of Balance: The UPMC Neurosurgery Wellness Initiative
SO WORLD NEUROSURGERY
LA English
DT Article
DE Balance; Burnout; Wellness
ID MEDICAL-STUDENTS; BURNOUT; SATISFACTION; PHYSICIANS
AB BACKGROUND: Burnout among physicians has been a topic of growing interest in both the scientific and the lay press. It has been well established that burnout and perceived inequity in work-life balance can contribute to poor physician work satisfaction and poorer patient outcomes. To better understand burnout among neurosurgery residents at our institution, we systematically surveyed residents for symptoms of burnout and enacted responsive protocols to try to combat its deleterious effects.
   METHODS: Before and after the institution of a series of initiatives aimed at combating burnout, residents were surveyed to assess for symptoms of burnout, strength of relationships, and status of physical and mental health. Initiatives included gym access and group gym visits, a mentoring program, and a lecture series targeting multiple facets of health and well-being.
   RESULTS: Nearly two thirds of neurosurgery residents demonstrated >= 1 signs of burnout at a moderate to severe level before and after the first year of our wellness initiative. Residents reported that work schedule and time availability were obstacles in focusing on their own personal health and wellness (utilization preventive health care visits, participation in group gym activities). Less than half of residents were content with their work-life balance.
   CONCLUSIONS: Making a significant change in burnout rates in neurosurgery will require a number of key factors, including targeted initiatives that focus on specific local needs, honest buy-in by departmental leaders, and recognition by the physicians themselves that a problem exists.
C1 [Ares, William J.] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA.
   [Maroon, Joseph C.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA.
   [Jankowitz, Brian T.] Cooper Univ Hosp, Dept Neurosurg, Camden, NJ 08103 USA.
RP Jankowitz, BT (reprint author), Cooper Univ Hosp, Dept Neurosurg, Camden, NJ 08103 USA.
EM jankowitz-brian@cooperhealth.edu
CR Agarwal N, 2019, J NEUROSURG, V131, P1668, DOI 10.3171/2018.5.JNS18519
   Attenello FJ, 2018, J NEUROSURG, V129, P1349, DOI 10.3171/2017.9.JNS17996
   Balch CM, 2011, THORAC SURG CLIN, V21, P417, DOI 10.1016/j.thorsurg.2011.05.004
   Brown AJ, 2007, NEUROSURGERY, V61, P1314, DOI 10.1227/01.neu.0000306111.62797.08
   Buchholz AL, 2018, WORLD NEUROSURG, V119, pE947, DOI 10.1016/j.wneu.2018.08.009
   Danforth W, 2006, I DARE YOU
   DECKARD G, 1994, MED CARE, V32, P745, DOI 10.1097/00005650-199407000-00007
   Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008
   Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134
   Elmore LC, 2016, J AM COLL SURGEONS, V223, P440, DOI 10.1016/j.jamcollsurg.2016.05.014
   Maroon JC, 2017, SQUARE ONE SIMPLE GU
   McAbee JH, 2015, J NEUROSURG, V123, P161, DOI 10.3171/2014.12.JNS141348
   Oreskovich MR, 2012, ARCH SURG-CHICAGO, V147, P168, DOI 10.1001/archsurg.2011.1481
   Renfrow JJ, 2016, J NEUROSURG, V124, P834, DOI 10.3171/2015.3.JNS142313
   Shakir HJ, 2018, NEUROSURGERY, V83, P582, DOI 10.1093/neuros/nyx494
   Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023
   Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3
   Spiotta AM, 2019, NEUROSURGERY, V84, P339, DOI 10.1093/neuros/nyy113
   Spiotta AM, 2018, NEUROSURGERY, V83, pE71, DOI 10.1093/neuros/nyy228
   Spiotta AM, 2016, NEUROSURGERY, V79, P613, DOI 10.1227/NEU.0000000000001358
   Wolfe SQ, 2019, NEUROSURGERY, V84, P1149, DOI 10.1093/neuros/nyy418
   ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2
   Zuckerman SL, 2016, WORLD NEUROSURG, V86, P120, DOI 10.1016/j.wneu.2015.08.081
NR 23
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E704
EP E709
DI 10.1016/j.wneu.2019.08.034
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300085
PM 31421293
DA 2020-05-12
ER

PT J
AU Atsumi, H
   Sorimachi, T
   Nonaka, Y
   Matsumae, M
AF Atsumi, Hideki
   Sorimachi, Takatoshi
   Nonaka, Yoichi
   Matsumae, Mitsunori
TI Basal Cistern Effacement and Pseudo-Subarachnoid Hemorrhage on Computed
   Tomography Images of Chronic Subdural Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Computed tomography; Prognosis; Subarachnoid
   hemorrhage; Surgical complication
ID SPONTANEOUS INTRACRANIAL HYPOTENSION; PSEUDOSUBARACHNOID HEMORRHAGE;
   PREDICTORS
AB OBJECTIVE: Computed tomography images of patients with chronic subdural hematoma (CSDH) sometimes show obliteration of the basal cistern with high density in an obliterated Sylvian cistern, termed pseudo-subarachnoid hemorrhage (SAH). The present study aimed to clarify the characteristics and outcomes of these conditions.
   METHODS: We retrospectively investigated 669 consecutive patients who were surgically treated for CSDH between January 2006 and May 2019.
   RESULTS: Basal cistern effacement and pseudo-SAH were found in 24 (3.6%) and 11 (1.6%) patients, respectively. Predictors of basal cistern effacement in patients with CSDH were younger age, cerebrospinal fluid leak, and bilateral CSDH (P < 0.05). In patients with basal and Sylvian cistern effacement, the significantly different main features to differentiate patients with and without pseudo-SAH were younger age, cerebrospinal fluid leak, and thick small hematomas on computed tomography slices of the Sylvian cistern (P < 0.05). Magnetic resonance imaging showed that high-density areas in the Sylvian cistern of pseudo-SAH on precontrast computed tomography images corresponded to the M1 segment of the middle cerebral artery. The outcomes of patients with basal cistern effacement and of patients with pseudo-SAH did not differ from other patients with CSDH, although rates of surgical complications were significantly higher among patients with basal cistern effacement.
   CONCLUSIONS: Although the outcomes of patients with basal cistern effacement and pseudo-SAH were similar to outcomes of other patients with CSDH, problematic postsurgical complications and cerebrospinal fluid leaks were more likely to arise in such patients.
C1 [Atsumi, Hideki; Sorimachi, Takatoshi; Nonaka, Yoichi; Matsumae, Mitsunori] Tokai Univ, Dept Neurosurg, Isehara, Kanagawa, Japan.
RP Sorimachi, T (reprint author), Tokai Univ, Dept Neurosurg, Isehara, Kanagawa, Japan.
EM sorimachi@tokai-u.jp
OI NONAKA, YOICHI/0000-0001-5509-6175
CR Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869
   Cucchiara B, 2004, NEUROCRIT CARE, V1, P371, DOI 10.1385/NCC:1:3:371
   Ferrante E, 2013, CLIN NEUROL NEUROSUR, V115, P2324, DOI 10.1016/j.clineuro.2013.08.028
   Given CA, 2003, AM J NEURORADIOL, V24, P254
   Hasan TF, 2018, J STROKE CEREBROVASC, V27, P2319, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.016
   Ho AL, 2018, NEUROCRIT CARE, V29, P113, DOI 10.1007/s12028-018-0547-3
   Honda Y, 2015, NEUROL RES, V37, P985, DOI 10.1179/1743132815Y.0000000083
   Huang D, 1999, Radiat Med, V17, P439
   Koh E, 2011, J CLIN NEUROSCI, V18, P1264, DOI 10.1016/j.jocn.2011.01.015
   Lee BK, 2017, J CRIT CARE, V40, P36, DOI 10.1016/j.jcrc.2017.02.021
   Ohno Shingo, 2004, No To Shinkei, V56, P701
   Rabinstein AA, 2003, J NEUROL NEUROSUR PS, V74, P1131, DOI 10.1136/jnnp.74.8.1131
   Schievink WI, 2005, NEUROLOGY, V65, P135, DOI 10.1212/01.wnl.0000167192.86419.15
   Serra C, 2019, OPER NEUROSURG, V17, P311, DOI 10.1093/ons/opy345
   Shima Hiroshi, 2019, Asian J Neurosurg, V14, P510, DOI 10.4103/ajns.AJNS_11_19
   Shimizu S, 2001, NEUROL MED-CHIR, V41, P536, DOI 10.2176/nmc.41.536
   Son Dookyung, 2019, Korean J Neurotrauma, V15, P28, DOI 10.13004/kjnt.2019.15.e11
   Tokuno T, 1996, NEUROL SURG TOKYO, V24, P573
   TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691
   Yokota H, 2016, ACTA NEUROL BELG, V116, P643, DOI 10.1007/s13760-016-0623-4
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E109
EP E115
DI 10.1016/j.wneu.2019.08.249
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300015
PM 31518737
DA 2020-05-12
ER

PT J
AU Bass, DI
   Buckley, R
   Meyer, RM
   Lawrence, B
   Paschall, C
   Ojemann, J
   Ko, AL
AF Bass, David, I
   Buckley, Robert
   Meyer, R. Michael
   Lawrence, Brady
   Paschall, Courtnie
   Ojemann, Jeffrey
   Ko, Andrew L.
TI Standard Free Versus Osteoplastic Craniotomy: Assessment of Complication
   Rates During Intracranial Electroencephalogram Electrode Placement for
   Seizure Localization
SO WORLD NEUROSURGERY
LA English
DT Article
DE Complication; Epilepsy; Electrocorticography; Osteoplasty
ID NEUROSURGICAL SITE INFECTIONS; EPILEPSY SURGERY; RISK-FACTORS
AB OBJECTIVE: Patients with medically intractable epilepsy often undergo sequential surgeries and are therefore exposed to an elevated risk for infection, resulting in unanticipated returns to the operating room. The goal of our study was to determine whether use of an osteoplastic bone flap technique would reduce the infection rate in these patients.
   METHODS: A single-institution, retrospective chart review of patients with medically intractable epilepsy for grid placement was performed. Univariate analyses and linear regression were used to assess primary outcomes, including infection and hematomas requiring surgical evacuation. Secondary outcomes included duration of treatment and other, unanticipated surgeries.
   RESULTS: A total of 199 patients were identified, 56 (28%) with osteoplastic flaps. Standard free flaps were associated with an increased rate of infection at the craniotomy site (n = 24, 17%, vs. 0, 0%, P = 0.003), whereas osteoplastic flaps were associated with more returns to operating room for hematoma evacuation (n = 5, 9% vs. 3.2%, P = 0.024). Overall, the rate of return to operating room for unanticipated surgeries was similar, but infectious complications prolonged the duration of treatment (median: 17 days vs. 2 days, chi(2) = 13.97, P < 0.001).
   CONCLUSIONS: Osteoplastic bone flaps markedly decreased the risk of craniotomy infections compared with free flaps in patients undergoing sequential surgeries. This decrease is offset, however, by an increase in intracranial hematoma requiring return to the operating room. Infection appeared to be a more significant complication as it was associated with increased duration of treatment. The osteoplastic technique is especially appealing in those patients likely to undergo multiple surgeries in short succession.
C1 [Bass, David, I; Buckley, Robert; Meyer, R. Michael; Lawrence, Brady; Paschall, Courtnie; Ojemann, Jeffrey; Ko, Andrew L.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA.
RP Bass, DI (reprint author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA.
EM respub@uw.edu
OI Ko, Andrew/0000-0002-6253-9891; Lawrence, Braden/0000-0002-1936-3122
CR Arya R, 2013, EPILEPSIA, V54, P828, DOI 10.1111/epi.12073
   Balasingam V, 2005, J NEUROSURG, V102, P940, DOI 10.3171/jns.2005.102.5.0940
   Behrens E, 1997, NEUROSURGERY, V41, P1, DOI 10.1097/00006123-199707000-00004
   Burneo JG, 2006, CAN J NEUROL SCI, V33, P223, DOI 10.1017/S0317167100005023
   Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220
   Hamer HM, 2002, NEUROLOGY, V58, P97, DOI 10.1212/WNL.58.1.97
   Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639
   Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010
   Nagahama Y, 2019, J NEUROSURG, V130, P1180, DOI 10.3171/2018.1.JNS171808
   RASMUSSEN S, 1990, British Journal of Neurosurgery, V4, P493, DOI 10.3109/02688699008993798
   Schipmann S, 2016, WORLD NEUROSURG, V95, P178, DOI 10.1016/j.wneu.2016.07.093
   Schmidt RF, 2016, EPILEPSIA, V57, P1697, DOI 10.1111/epi.13503
   Shelef I, 2016, J CLIN NEUROSCI, V31, P63, DOI 10.1016/j.jocn.2015.11.031
   Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1
   Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x
   Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501
   Yasargil M., 1996, MICRONEUROSURGERY CO, V1-4B
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E599
EP E603
DI 10.1016/j.wneu.2019.08.066
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300071
PM 31442661
DA 2020-05-12
ER

PT J
AU Behbahani, M
   Rosenberg, DM
   Rosinski, CL
   Chaudhry, NS
   Nikas, D
AF Behbahani, Mandana
   Rosenberg, David M.
   Rosinski, Clayton L.
   Chaudhry, Nauman S.
   Nikas, Demitrios
TI Cranioplasty in Infants Less Than 24 Months of Age: A Retrospective Case
   Review of Pitfalls, Outcomes, and Complications
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cranioplasty; Decompressive hemicraniectomy; Pediatrics
ID TRAUMATIC BRAIN-INJURY; BONE FLAP RESORPTION; DECOMPRESSIVE CRANIECTOMY;
   CALVARIAL DEFECTS; CHILDREN; DURA; HYDROXYAPATITE; IMMATURE; IMPLANTS;
   REPAIR
AB BACKGROUND: Management of pediatric skull defects after decompressive craniectomy (DC) poses unique problems, particularly in children younger than 24 months. These problems include complications such as resorption and infection as well as difficulties with plagiocephaly and reconstruction. The goal of this study was to evaluate bone resorption complications after cranioplasty in patients <24 months.
   METHODS: A single-center retrospective case study was performed of all patients younger than 24 months who underwent cranioplasty after DC between 2011 and 2018. The following variables were assessed: injury cause, age at craniotomy, time to cranioplasty, craniectomy size, mode of fixation, drain use, shunt use, subdural fluid collection, resorption, need for synthetic graft revision, and plagiocephaly.
   RESULTS: A total of 10 patients were identified who met inclusion criteria; 3 patients were excluded for insufficient follow-up. Ages ranged from <1 day to 19 months, with a mean of 10.7 months. Overall rate of cranioplasty resorption was 85.7%, 57.1% of which required revision with synthetic graft. There were univariate trends toward more frequent implant resorption with subdural fluid collection (P = 0.1071) and without shunt placement (P = 0.1429). These effects persisted through multivariable analysis and even reached statistical significance in the case of subdural collection when controlling for operative and demographic characteristics (P = 0.01138, P = 0.0694). In addition, univariate analysis showed a trend toward more frequent neurologic complications with greater craniotomy-to-cranioplasty intervals (P = 0.1043), which reached significance on multivariable analysis (P = 0.00518).
   CONCLUSIONS: In patients younger than 24 months undergoing cranioplasty subdural collection, a lack of shunt placement and increased time to cranioplasty were associated with increased rates of resorption.
C1 [Behbahani, Mandana; Chaudhry, Nauman S.; Nikas, Demitrios] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.
   [Rosenberg, David M.; Rosinski, Clayton L.] Univ Illinois, Coll Med, Chicago, IL USA.
RP Behbahani, M (reprint author), Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.
EM moni@uic.edu
OI behbahani, mandana/0000-0003-3882-8658
CR Bowers CA, 2015, J NEUROSURG-PEDIATR, V16, P439, DOI 10.3171/2015.2.PEDS14536
   Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483
   Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6
   Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029
   Ernst G, 2018, J NEUROSURG, V129, P1604, DOI 10.3171/2017.6.JNS17943
   Frassanito P, 2018, CHILD NERV SYST, V34, P2283, DOI 10.1007/s00381-018-3905-8
   Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8
   Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y
   Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312
   Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5
   Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962
   Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Graziano F, 2019, Br J Neurosurg, P1, DOI 10.1080/02688697.2019.1584267
   Greenwald JA, 2000, PLAST RECONSTR SURG, V105, P1382, DOI 10.1097/00006534-200004040-00018
   Greenwald JA, 2000, PLAST RECONSTR SURG, V106, P630, DOI 10.1097/00006534-200009030-00016
   Jin SW, 2016, J KOREAN NEUROSURG S, V59, P192, DOI 10.3340/jkns.2016.59.3.192
   Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2
   Lam S, 2015, CRANIOMAX TRAUM REC, V8, P159, DOI 10.1055/s-0034-1395880
   Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0
   Nakajima T, 1975, No Shinkei Geka, V3, P925
   Ozcelik Derya, 2003, Arch Facial Plast Surg, V5, P301, DOI 10.1001/archfaci.5.4.301
   Pang DL, 2005, J NEUROSURG, V102, P36, DOI 10.3171/ped.2005.102.1.0036
   Phillips BZ, 2014, CLEFT PALATE-CRAN J, V51, P361, DOI 10.1597/13-083
   Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268
   Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234
   Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605
   Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86
   Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290
   Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E479
EP E486
DI 10.1016/j.wneu.2019.08.106
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300057
PM 31465852
DA 2020-05-12
ER

PT J
AU Bhimani, AD
   Rosinski, CL
   Patel, S
   Chaudhry, NS
   Denyer, S
   Behbahani, M
   Mehta, AI
AF Bhimani, Abhiraj D.
   Rosinski, Clayton L.
   Patel, Saavan
   Chaudhry, Nauman S.
   Denyer, Steven
   Behbahani, Mandana
   Mehta, Ankit, I
TI Adult Spinal Arteriovenous Malformations: Natural History and a
   Multicenter Study of Short-Term Surgical Outcomes
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformations; AVM; CNS; Outcomes; Spinal cord
ID RISK-FACTORS; SITE INFECTION; STEREOTACTIC RADIOSURGERY; MICROSURGICAL
   TREATMENT; VASCULAR MALFORMATIONS; MANAGEMENT; CLASSIFICATION;
   RESECTION; AVMS
AB OBJECTIVE: Spinal arteriovenous malformations (SAVMs) are a very rare and complex spinal cord pathology that require high clinical acumen to diagnose and treat. Management includes both nonoperative and operative paradigms. A review of the literature yields a paucity of data regarding the surgical outcomes of SAVMs, with the majority of data limited to single-center outcomes and/or small sample sizes. The purpose of this study was to use a multi-institutional international database to study the natural history of SAVMs.
   METHODS: We used the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to select patients that underwent laminectomy for surgical excision of a SAVM between 2008 and 2017.
   RESULTS: The data from 196 patients were studied (65.8% male, 34.2% female). A majority of cases were in the thoracic region (53.6%), followed by thoracolumbar (31.6%) and cervical (14.8%) regions. The mean age was 57.4 years and 52.5% patients were graded ASA class 3-5 before the operation. The mean operation time was 215 minutes, with a significantly lower operative time for thoracic arteriovenous malformations (195.6 minutes) when compared with cervical (266.6 minutes) and thoracolumbar (223.7 minutes). The mean length of hospital stay was 6.4 days. Patients had a 6.6% readmission rate and a 4.6% reoperation rate within 30 days.
   CONCLUSIONS: This study presents the largest analysis of patients undergoing surgery for SAVMs and 30-day postoperative outcomes. Operative time differed based on SAVM location. The three most frequent complications (deep vein thrombosis, wound infection, and UTI) occurred at rates of 3.6% or less.
C1 [Bhimani, Abhiraj D.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.
   [Bhimani, Abhiraj D.; Rosinski, Clayton L.; Patel, Saavan; Chaudhry, Nauman S.; Denyer, Steven; Behbahani, Mandana; Mehta, Ankit, I] Univ Illinois, Dept Neurosurg, Chicago, IL 60680 USA.
RP Mehta, AI (reprint author), Univ Illinois, Dept Neurosurg, Chicago, IL 60680 USA.
EM ankitm@uic.edu
RI Mehta, Ankit/AAL-3851-2020
OI behbahani, mandana/0000-0003-3882-8658; Denyer,
   Steven/0000-0001-5631-8788
CR AMINOFF MJ, 1974, BRAIN, V97, P197, DOI 10.1093/brain/97.1.197
   AMINOFF MJ, 1974, BRAIN, V97, P211, DOI 10.1093/brain/97.1.211
   Bao YH, 1997, NEUROSURGERY, V40, P75, DOI 10.1097/00006123-199701000-00017
   Bostrom A, 2009, J NEUROSURG-SPINE, V10, P423, DOI 10.3171/2009.1.SPINE08355
   Burneikis D, 2018, WORLD J SURG, V42, P3125, DOI 10.1007/s00268-018-4599-5
   Chaloupka JC, 2002, SEMIN CEREBROVASC DI, V2, P245
   Cizik AM, 2012, J BONE JOINT SURG AM, V94A, P335, DOI 10.2106/JBJS.J.01084
   COGEN P, 1983, J NEUROSURG, V59, P471, DOI 10.3171/jns.1983.59.3.0471
   Cohen DB, 2019, EUR SPINE J, V19, P982
   Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f
   Flores BC, 2017, NEUROSURG REV, V40, P15, DOI 10.1007/s10143-016-0713-z
   Friedman ND, 2007, INFECT CONT HOSP EP, V28, P1060, DOI 10.1086/519864
   Gross BA, 2013, NEUROSURGERY, V72, P25, DOI 10.1227/NEU.0b013e318276b5d3
   Jing LK, 2017, J CLIN NEUROSCI, V46, P141, DOI 10.1016/j.jocn.2017.09.003
   Kalani MA, 2016, J CLIN NEUROSCI, V29, P162, DOI 10.1016/j.jocn.2015.12.005
   Kim Louis J, 2006, Neurosurgery, V59, pS195
   Koutsoumbelis S, 2011, J BONE JOINT SURG AM, V93A, P1627, DOI 10.2106/JBJS.J.00039
   Maragakis LL, 2009, ANESTHESIOLOGY, V110, P556, DOI 10.1097/ALN.0b013e3181974be7
   MORGAN MK, 1989, J NEUROSURG, V70, P832, DOI 10.3171/jns.1989.70.6.0832
   Olsen MA, 2003, J NEUROSURG, V98, P149, DOI 10.3171/spi.2003.98.2.0149
   Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515
   Potharaju M, 2014, SPINE J, V14, P2582, DOI 10.1016/j.spinee.2014.02.025
   Rangel-Castilla L, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14236
   Rodesch G, 2003, EUR J RADIOL, V46, P221, DOI 10.1016/S0720-048X(03)00093-7
   ROSENBLUM B, 1987, J NEUROSURG, V67, P795, DOI 10.3171/jns.1987.67.6.0795
   Schimmel JJP, 2010, EUR SPINE J, V19, P1711, DOI 10.1007/s00586-010-1421-y
   Spetzler RF, 2002, J NEUROSURG, V96, P145, DOI 10.3171/spi.2002.96.2.0145
   SPETZLER RF, 1989, J NEUROSURG, V70, P628, DOI 10.3171/jns.1989.70.4.0628
   ter Gunne AFP, 2009, SPINE, V34, P1422, DOI 10.1097/BRS.0b013e3181a03013
   Veeravagu A, 2009, SPINE, V34, P1869, DOI 10.1097/BRS.0b013e3181adc989
   Velat GJ, 2012, J NEUROSURG-SPINE, V16, P523, DOI 10.3171/2012.3.SPINE11982
   Wang T, 2018, WORLD NEUROSURG, V110, pE438, DOI 10.1016/j.wneu.2017.11.010
   Wilson DA, 2012, NEUROSURGERY, V71, P100, DOI 10.1227/NEU.0b013e318256c042
   Xing D, 2013, EUR SPINE J, V22, P605, DOI 10.1007/s00586-012-2514-6
   Ye ZP, 2016, WORLD NEUROSURG, V96, P362, DOI 10.1016/j.wneu.2016.09.022
NR 35
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E290
EP E296
DI 10.1016/j.wneu.2019.08.173
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300035
PM 31479792
DA 2020-05-12
ER

PT J
AU Cabuk, B
   Selek, A
   Emengen, A
   Anik, I
   Canturk, Z
   Ceylan, S
AF Cabuk, Burak
   Selek, Alev
   Emengen, Atakan
   Anik, Ihsan
   Canturk, Zeynep
   Ceylan, Savas
TI Clinicopathologic Characteristics and Endoscopic Surgical Outcomes of
   Symptomatic Rathke's Cleft Cysts
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopy; Rathke's cleft cyst; Transsphenoidal
ID TRANSSPHENOIDAL MANAGEMENT; SURGERY; RECURRENCE; LESIONS; RESECTION;
   HEADACHE; FEATURES; LIGHT
AB BACKGROUND: The purpose of this study was to evaluate the preoperative clinical data and postoperative endocrinologic improvement, recurrence, and complications of Rathke's cleft cysts (RCCs) in a large series of endoscopic transsphenoidal surgery patients, operated in a single center.
   METHODS: Between 1997 and April 2018, 84 patients underwent endoscopic transsphenoidal surgery for RCCs. The presentation symptoms, endocrinologic results by localization and content of the cysts, surgical resections, postoperative complications, and recurrences were evaluated retrospectively.
   RESULTS: Chronic headache was reported in 66.6% (56/84), visual field defects were present in 20.2% (17/84), and 23.8% (20/84) of the cases had pituitary dysfunction. Among the endocrinopathies, 17 of 17 patients had hyperprolactinemia, 2 of 7 patients had cortisol deficiency, and 2 of 13 had hypogonadism, which resolved after surgery. Preoperative pituitary hormone deficiency was associated with gelatinous tumor content (P = 0.044). However, there was no significant relationship between tumor localization and preoperative hormone insufficiency. Postoperative hypocortisolemia was seen more frequently in intrasellar RCCs (P = 0.048). Three new pituitary hormonal deficiencies were identified in postoperative patients (1 hypocortisolism, 1 diabetes insipidus, 1 hypogonadism). Gross total resection was achieved in 20 cases (23.8%), 9 of which were performed using an extended approach. Postoperative complications included 3 cerebrospinal fluid leakages and 1 epistaxis. Two patients presented with cyst recurrence at follow-up at 12 and 26 months.
   CONCLUSIONS: Preoperative hormone deficiency was found to be associated with tumor content, independent of size or localization. The surgical aim for symptomatic RCCs should be decompression and this is effective for endocrinologic improvement. An extended endoscopic approach was adequate for total cyst wall removal in suprasellar cysts. Endoscopic transsphenoidal surgery was successful, with low complication rates, for decompression of intrasellar and suprasellar cysts in both complete cyst wall resection and cyst fenestration.
C1 [Cabuk, Burak; Emengen, Atakan; Anik, Ihsan; Ceylan, Savas] Kocaeli Univ, Sch Med, Dept Neurosurg, Kocaeli, Turkey.
   [Selek, Alev; Canturk, Zeynep] Kocaeli Univ, Sch Med, Dept Endocrinol, Kocaeli, Turkey.
   [Cabuk, Burak; Emengen, Atakan; Anik, Ihsan; Ceylan, Savas] Kocaeli Univ, Pituitary Res Ctr, Kocaeli, Turkey.
RP Ceylan, S (reprint author), Kocaeli Univ, Sch Med, Dept Neurosurg, Kocaeli, Turkey.; Ceylan, S (reprint author), Kocaeli Univ, Pituitary Res Ctr, Kocaeli, Turkey.
EM ssceylan@yahoo.com
RI Ceylan, Savas/H-1308-2018; Cabuk, Burak/G-9285-2018
OI Cabuk, Burak/0000-0003-1198-3869
CR Aho CJ, 2005, J NEUROSURG, V102, P189, DOI 10.3171/jns.2005.102.2.0189
   Benveniste RJ, 2004, J NEUROSURG, V101, P577, DOI 10.3171/jns.2004.101.4.0577
   Cappabianca P, 2003, ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL SURGERY, P176
   Cavallo LM, 2008, NEUROSURG REV, V31, P55, DOI 10.1007/s10143-007-0098-0
   Cavallo Luigi M, 2005, Neurosurg Focus, V19, pE2
   Ceylan S, 2009, NEUROSURG REV, V32, P309, DOI 10.1007/s10143-009-0201-9
   Chotai S, 2015, J NEUROSURG, V122, P1380, DOI 10.3171/2014.12.JNS14596
   Cote DJ, 2016, PITUITARY, V19, P57, DOI 10.1007/s11102-015-0686-x
   Couldwell WT, 1999, PITUITARY DISORDERS
   El-Mahdy W, 1998, NEUROSURGERY, V42, P7, DOI 10.1097/00006123-199801000-00003
   Fan J, 2013, J NEUROSURG, V119, P1437, DOI 10.3171/2013.8.JNS13777
   Frank G, 2005, NEUROSURGERY, V56, P124, DOI 10.1227/01.NEU.0000144824.80046.1F
   Higgins DM, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1175
   HIRANO A, 1988, CHILD NERV SYST, V4, P325, DOI 10.1007/BF00270605
   HIRANO A, 1971, ACTA NEUROPATHOL, V18, P214, DOI 10.1007/BF00685067
   Iannelli A, 2012, CHILD NERV SYST, V28, P297, DOI 10.1007/s00381-011-1626-3
   Kanter AS, 2006, FRONT HORM RES, V34, P127, DOI 10.1159/000091579
   Kim JE, 2004, J NEUROSURG, V100, P33, DOI 10.3171/jns.2004.100.1.0033
   Kinoshita Y, 2016, J NEUROSURG, V125, P1002, DOI 10.3171/2015.8.JNS151282
   Koutourousiou M, 2009, J CLIN NEUROSCI, V16, P900, DOI 10.1016/j.jocn.2008.10.007
   Langlois F, 2019, ENDOCRINE, V63, P463, DOI 10.1007/s12020-018-1784-0
   Laws ER, 2008, NAT CLIN PRACT ENDOC, V4, P662, DOI 10.1038/ncpendmet0975
   Lillehei KO, 2011, J NEUROSURG, V114, P310, DOI 10.3171/2010.7.JNS091793
   Lin M, 2019, J NEUROSURG, V130, P831, DOI 10.3171/2017.11.JNS171498
   Madhok R, 2010, J NEUROSURG, V112, P1333, DOI 10.3171/2009.10.JNS09348
   MATSUSHIMA T, 1988, SURG NEUROL, V30, P197, DOI 10.1016/0090-3019(88)90272-8
   Mendelson ZS, 2014, J CLIN NEUROSCI, V21, P378, DOI 10.1016/j.jocn.2013.07.008
   MIDHA R, 1991, SURG NEUROL, V35, P446, DOI 10.1016/0090-3019(91)90178-C
   Oyama N, 2013, ENDOCR J, V60, P207, DOI 10.1507/endocrj.EJ12-0039
   Park JK, 2012, NEUROSURGERY, V70, P250, DOI 10.1227/NEU.0b013e3182418034
   Potts MB, 2011, NEUROSURGERY, V69, P1058, DOI 10.1227/NEU.0b013e318228bcea
   Sala E, 2018, CLIN ENDOCRINOL, V89, P178, DOI 10.1111/cen.13744
   SHUANGSHOTI S, 1970, ARCH PATHOL, V90, P444
   Solari D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139609
   Soto-Rivera CL, 2017, PITUITARY, 4TH EDITION, P47, DOI 10.1016/B978-0-12-804169-7.00003-9
   Tate MC, 2010, NEUROSURGERY, V67, P762, DOI 10.1227/01.NEU.0000377017.53294.B5
   TERAMOTO A, 1994, RADIOLOGY, V193, P161, DOI 10.1148/radiology.193.1.8090885
   VOELKER JL, 1991, J NEUROSURG, V74, P535, DOI 10.3171/jns.1991.74.4.0535
   Wait SD, 2010, NEUROSURGERY, V67, P837, DOI 10.1227/01.NEU.0000374768.16291.03
   Wen L, 2010, CLIN RADIOL, V65, P47, DOI 10.1016/j.crad.2009.09.010
   Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318
   Zhong WY, 2012, J CLIN NEUROSCI, V19, P501, DOI 10.1016/j.jocn.2011.07.022
NR 42
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E208
EP E216
DI 10.1016/j.wneu.2019.08.196
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300026
PM 31493602
DA 2020-05-12
ER

PT J
AU Cetin, A
   Biltekin, B
   Degirmencioglu, S
AF Cetin, Abdurrahman
   Biltekin, Burcu
   Degirmencioglu, Sevgin
TI Ellagic Acid Enhances the Antitumor Efficacy of Bevacizumab in an In
   Vitro Glioblastoma Model
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cancer therapy; Ellagic acid; Glioblastoma; Temozolomide
ID MULTIDRUG-RESISTANCE; APOPTOSIS; INHIBITION; PROLIFERATION
AB BACKGROUND: The anticarcinogenic effect of ellagic acid (EA), a natural phenol of fruits and vegetables, has been investigated in several types of tumors. The combined effect of EA with bevacizumab (BEV), a common drug used in treatment of recurrent glioma, on glioblastoma has not been reported. This study observed the combined effect of EA with BEV on the expression profile of the C6 glioma cell line.
   METHODS: Rat C6 glioma cells were treated with EA at 100 mu mol/L concentration in combination with BEV at 100 ng/mL concentration for 24, 48, and 72 hours. Cell proliferation was detected by 5-bromo-2'-deoxyuridine immunohistochemistry, and p53 and caspase-3 protein levels were determined by immunohistochemistry and assessed by the H-Score. Expression profiles for P-glycoprotein (MDR1), O-6-methylguanine DNA methyltransferase (MGMT), caspase-3, and p53 related proteins were detected by reverse transcriptase polymerase chain reaction after EA treatment with or without BEV.
   RESULTS: EA combined with BEV conspicuously reduced the cell viability of C6 glioma cells for all incubation times. EA significantly downregulated expression of MGMT regardless of combination with BEV even in the early hours after treatment. Combined EA and BEV reduced MDR1 expression only at 72 hours. EA affected the apoptotic proteins of p53 and caspase-3 at protein level in a time-dependent manner, but not at gene level.
   CONCLUSIONS: This study suggests successful antiproliferative efficacy of EA combined with BEV, probably through inhibition of MGMT expression and time-dependent inhibition of MDR1. EA combined with BEV may be an alternative treatment for drug-resistant gliomas.
C1 [Cetin, Abdurrahman] Hlth Sci Univ, Dept Neurosurg, Gazi Yasargil Educ & Res Hosp, Diyarbakir, Turkey.
   [Biltekin, Burcu] Istanbul Atlas Univ, Med Fac, Dept Histol & Embryol, Istanbul, Turkey.
   [Degirmencioglu, Sevgin] Demiroglu Bilim Univ, Vocat Sch Hlth Serv, Istanbul, Turkey.
RP Cetin, A (reprint author), Hlth Sci Univ, Dept Neurosurg, Gazi Yasargil Educ & Res Hosp, Diyarbakir, Turkey.
EM acetin2147@gmail.com
OI Cetin, Abdurrahman/0000-0002-5246-7652
CR Avgeropoulos N G, 1999, Oncologist, V4, P209
   Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163
   Cetin A, 2019, ANAL QUANT CYTOPATHO, V41, P75
   Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345
   Edderkaoui M, 2008, WORLD J GASTROENTERO, V14, P3672, DOI 10.3748/wjg.14.3672
   Fack F, 2015, ACTA NEUROPATHOL, V129, P115, DOI 10.1007/s00401-014-1352-5
   Hanif Farina, 2017, Asian Pac J Cancer Prev, V18, P3
   Hermann DM, 2006, ANN NEUROL, V60, P489, DOI 10.1002/ana.21012
   Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c
   Iacob Gabriel, 2009, J Med Life, V2, P386
   Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243
   Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024
   Leweke F, 1998, PATHOL RES PRACT, V194, P149, DOI 10.1016/S0344-0338(98)80015-0
   Mertens-Talcott SU, 2003, J NUTR, V133, P2669
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1
   NIJHOFF WA, 1994, CARCINOGENESIS, V15, P1769, DOI 10.1093/carcin/15.9.1769
   Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351
   Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719
   Simon T, 2014, NEUROMOL MED, V16, P752, DOI 10.1007/s12017-014-8324-8
   Soydas T, 2018, J PHYSIOL BIOCHEM, V74, P273, DOI 10.1007/s13105-018-0613-5
   Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965
   Thomas Hilary, 2003, Cancer Control, V10, P159
   Thresiamma K. C., 1996, Indian Journal of Physiology and Pharmacology, V40, P363
   Umesalma S, 2011, EUR J PHARMACOL, V660, P249, DOI 10.1016/j.ejphar.2011.03.036
   van den Bent MJ, 2018, LANCET ONCOL, V19, P1170, DOI 10.1016/S1470-2045(18)30362-0
   Wang DL, 2017, ONCOL REP, V37, P1084, DOI 10.3892/or.2016.5331
   Wang DL, 2016, ACTA CIR BRAS, V31, P143, DOI 10.1590/S0102-865020160020000010
   Zhang H, 2014, EUR J RADIOL, V83, P2181, DOI 10.1016/j.ejrad.2014.09.018
   Zhao J, 2017, ONCOTARGETS THER, V10, P5471, DOI 10.2147/OTT.S149708
NR 30
TC 1
Z9 1
U1 9
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E59
EP E65
DI 10.1016/j.wneu.2019.08.257
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300010
PM 31518741
DA 2020-05-12
ER

PT J
AU Cetin, A
   Biltekin, B
AF Cetin, Abdurrahman
   Biltekin, Burcu
TI Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch
   and Angiogenesis in a Glioblastoma Model
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cancer therapy; Ellagic acid; Glioblastoma; Temozolomide
ID IN-VITRO; KAPPA-B; APOPTOSIS; GLIOMA; INHIBITION; RESISTANCE;
   PROLIFERATION; THERAPY; CELLS
AB OBJECTIVE: We aimed to evaluate the combined effect of ellagic acid (EA) and temozolomide (TEM) on the cadherin switch and angiogenesis in the C6 glioma cell line.
   METHODS: A total of 100 mu M EA and 100 mu M TEM were applied to rat C6 glioma cells for 24, 48, and 72 hours. Cell proliferation was detected by 5-bromo-2'-deoxyuridine immunohistochemistry. The messenger RNA and protein levels of E-cadherin, N-cadherin, and vascular endothelial growth factor (VEGF) were determined by real-time polymerase chain reaction and their immunohistochemistry, respectively, subsequent to EA treatment combined with TEM.
   RESULTS: EA in combination with TEM conspicuously reduced the viability of C6 glioma cells at all incubation times (P < 0.001). EA upregulated the expression of E-cadherin at the gene and protein levels in a time-independent manner (P < 0.05 and P < 0.001, respectively). By the presence of TEM, the increase was exaggerated at 24-hour incubation (P < 0.01). Conversely, EA reduced N-cadherin expression and immunoreactivity in a time-independent manner (P < 0.05 and P < 0.001, respectively), and combination with TEM enhanced this effect at the 24th hour (P < 0.001). Combination also downregulated the gene expression (P < 0.001) and immunoreactivity of VEGF only at 72 hours (P < 0.001).
   CONCLUSIONS: A successful therapeutic efficacy of EA combined with TEM is suggested probably by inhibiting the cadherin switch and angiogenesis.
C1 [Cetin, Abdurrahman] Gazi Yasargil Educ & Rcsearch Hosp Hlth Sci Univ, Dept Neurosurg, Diyarbakir, Turkey.
   [Biltekin, Burcu] Istanbul Atlas Univ, Med Fac, Dept Histol & Embryol, Istanbul, Turkey.
RP Cetin, A (reprint author), Gazi Yasargil Educ & Rcsearch Hosp Hlth Sci Univ, Dept Neurosurg, Diyarbakir, Turkey.
EM acetin2147@gmail.com
OI Cetin, Abdurrahman/0000-0002-5246-7652
CR Avgeropoulos N G, 1999, Oncologist, V4, P209
   Baysan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094045
   Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001
   Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345
   Chung YC, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/306705
   Edderkaoui M, 2008, WORLD J GASTROENTERO, V14, P3672, DOI 10.3748/wjg.14.3672
   Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213
   Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010
   Kahlert UD, 2012, CANCER LETT, V325, P42, DOI 10.1016/j.canlet.2012.05.024
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kast RE, 2017, ONCOTARGET, V8, P60727, DOI 10.18632/oncotarget.18337
   Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502
   Lee DH, 2014, TOXICOL APPL PHARM, V279, P253, DOI 10.1016/j.taap.2014.06.030
   Lee J, 2016, J NEURO-ONCOL, V128, P29, DOI 10.1007/s11060-016-2091-3
   Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37
   Mertens-Talcott SU, 2003, J NUTR, V133, P2669
   Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1
   Navone SE, 2018, WORLD NEUROSURG, V120, pE380, DOI 10.1016/j.wneu.2018.08.080
   Noh MG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3591-z
   Rajesh Y, 2017, ACTA PHARMACOL SIN, V38, P591, DOI 10.1038/aps.2016.167
   Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719
   Seeram NP, 2005, J NUTR BIOCHEM, V16, P360, DOI 10.1016/j.jnutbio.2005.01.006
   Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x
   Soydas T, 2018, J PHYSIOL BIOCHEM, V74, P273, DOI 10.1007/s13105-018-0613-5
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Tobias A, 2013, J NEUROL NEUROSUR PS, V84, P213, DOI 10.1136/jnnp-2012-302946
   Umesalma S, 2011, EUR J PHARMACOL, V660, P249, DOI 10.1016/j.ejphar.2011.03.036
   Urdiciain A, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2010005
   Wang DL, 2017, ONCOL REP, V37, P1084, DOI 10.3892/or.2016.5331
   Yang JA, 2015, INT J CLIN EXP MED, V8, P10132
   Yang L, 2012, TUMOR BIOL, V33, P1477, DOI 10.1007/s13277-012-0398-z
   Zarkoob H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064169
   Zhang R, 2016, J NEURO-ONCOL, V126, P235, DOI 10.1007/s11060-015-1968-x
   Zhang X, 2013, CURR MED CHEM, V20, P1974, DOI 10.2174/0929867311320150004
   Zhao J, 2017, ONCOTARGETS THER, V10, P5471, DOI 10.2147/OTT.S149708
   Zhao MJ, 2017, ONCOL REP, V37, P601, DOI 10.3892/or.2016.5231
NR 38
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E178
EP E184
DI 10.1016/j.wneu.2019.08.228
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300022
PM 31505280
DA 2020-05-12
ER

PT J
AU Chang, DG
   Suk, SI
   Song, KS
   Kim, YH
   Oh, IS
   Kim, SI
   Park, HY
   Kim, GU
   Lee, JW
   Park, JB
   Ha, KY
AF Chang, Dong-Gune
   Suk, Se-Il
   Song, Kwang-Sup
   Kim, Young-Hoon
   Oh, In-Soo
   Kim, Sang-Il
   Park, Hyung-Youl
   Kim, Gang-Un
   Lee, Joong-Won
   Park, Jong-Beom
   Ha, Kee-Yong
TI How to Avoid Distal Adding-on Phenomenon for Rigid Curves in Major
   Thoracolumbar and Lumbar Adolescent Idiopathic Scoliosis? Identifying
   the Incidence of Distal Adding-on by Selection of Lowest Instrumented
   Vertebra
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adding on; Adolescent idiopathic scoliosis; Fusion level; Pedicle screw
   instrumentation; Rigid curve; Thoracolumbar scoliosis
ID PEDICLE SCREW FIXATION; FUSION LEVEL; MOTION; RISK
AB OBJECTIVE: We sought to compare the radiologic outcomes for different distal fusion levels in a rigid curve with major thoracolumbar and lumbar (TL/L) adolescent idiopathic scoliosis (AIS) using rod derotation (RD) with direct vertebral rotation (DVR) after pedicle screw instrumentation (PSI).
   METHODS: This study finally enrolled 28 patients who were diagnosed with AIS in rigid curve with major TL/L curves, treated by PSI with RD and DVR and with a minimum 2-year follow-up. Patients were divided into 2 groups, L3 and L4, on the basis of the distal fusion level at the lowest instrumented vertebra (LIV) of L3 or L4.
   RESULTS: There was no significant difference in TL/L curve, thoracic (minor), and compensatory (caudal) curves between the L3 and L4 groups either postoperatively (P = 0.162, 0.426, and 0.762, respectively) or at the last follow-up (P = 0.952, 0.620, and 0.562, respectively). The overall prevalence of unsatisfactory results was 42.9% (12/28 patients). The prevalence of unsatisfactory results was 61.1% (11/18) in the L3 group and 10% (1/10) in the L4 group, which was significantly different (P < 0.05).
   CONCLUSIONS: Unsatisfactory results occurred more often in the L3 group than in the L4 group, and unsatisfactory results had significant influence on progression of TL/L and distal compensatory curves. Such progression was closely correlated with deteriorating LIV disk angle in the L3 group. Therefore if the curve is rigid, LIV should be extended to L4 to avoid the adding-on phenomenon in the treatment of major TL/L AIS using RD with DVR after PSI.
C1 [Chang, Dong-Gune; Suk, Se-Il; Kim, Gang-Un; Lee, Joong-Won] Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Song, Kwang-Sup] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Kim, Young-Hoon; Kim, Sang-Il; Park, Hyung-Youl; Ha, Kee-Yong] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Oh, In-Soo] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Orthoped Surg, Incheon, South Korea.
   [Park, Jong-Beom] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Orthoped Surg, Incheon, South Korea.
RP Ha, KY (reprint author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
EM kyh@catholic.ac.kr
RI Song, Kwang-Sup/AAC-3891-2020
OI Chang, Dong-Gune/0000-0001-6731-1063; Kim,
   Young-Hoon/0000-0003-1237-4600; Park, Hyung-Youl/0000-0002-0084-8867
FU SAMJIN PHARM
FX This study was supported by a grant of SAMJIN PHARM.
CR Chang DG, 2017, SPINE, V42, pE890, DOI 10.1097/BRS.0000000000001998
   Chang DG, 2014, SPINE, V39, pE1359, DOI 10.1097/BRS.0000000000000578
   Cho RH, 2012, SPINE, V37, P1384, DOI 10.1097/BRS.0b013e31824bac7a
   Ding R, 2014, J SPINAL DISORD TECH, V27, pE155, DOI 10.1097/BSD.0000000000000073
   GOLDSTEI.LA, 1969, J BONE JOINT SURG AM, VA 51, P209, DOI 10.2106/00004623-196951020-00001
   Hamzaoglu A, 2013, SPINE J, V13, P845, DOI 10.1016/j.spinee.2013.03.043
   HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001
   Huang ZF, 2016, CLIN SPINE SURG, V29, pE157, DOI 10.1097/BSD.0000000000000123
   Kim SS, 2014, ASIAN SPINE J, V8, P804, DOI 10.4184/asj.2014.8.6.804
   Lakhal W, 2014, ORTHOP TRAUMATOL-SUR, V100, pS249, DOI 10.1016/j.otsr.2014.03.012
   Lee CS, 2016, EUR SPINE J, V25, P3256, DOI 10.1007/s00586-015-4373-4
   Lee MC, 2013, SPINE, V38, pE1405, DOI 10.1097/BRS.0b013e3182a4038b
   Lee SM, 2004, SPINE, V29, P343, DOI 10.1097/01.BRS.0000109991.88149.19
   Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006
   Li JF, 2011, SPINE, V36, P1673, DOI 10.1097/BRS.0b013e3182091fba
   Margulies J Y, 1998, Eur Spine J, V7, P88, DOI 10.1007/s005860050036
   Marks M, 2012, SPINE, V37, P826, DOI 10.1097/BRS.0b013e31823b4eab
   Matsumoto M, 2013, SPINE, V38, P737, DOI 10.1097/BRS.0b013e318279b666
   Okada E, 2015, SPINE, V40, P25, DOI 10.1097/BRS.0000000000000652
   Suk SI, 2012, EUR SPINE J, V21, P13, DOI 10.1007/s00586-011-1986-0
   Suk SI, 2011, CLIN ORTHOP SURG, V3, P89, DOI 10.4055/cios.2011.3.2.89
   SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012
   Suk SI, 2005, SPINE, V30, P1602, DOI 10.1097/01.brs.0000169452.50705.61
   Suk SI, 2003, SPINE, V28, P484, DOI 10.1097/00007632-200303010-00014
   Sun ZJ, 2014, EUR SPINE J, V23, P1251, DOI 10.1007/s00586-014-3276-0
   Upasani VV, 2015, J CHILD ORTHOP, V9, P29, DOI 10.1007/s11832-015-0632-5
   Wang Y, 2013, SPINE, V38, pE894, DOI 10.1097/BRS.0b013e31829537be
   Wang Y, 2011, SPINE, V36, P1113, DOI 10.1097/BRS.0b013e3181f51e95
NR 28
TC 0
Z9 0
U1 4
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E472
EP E478
DI 10.1016/j.wneu.2019.08.110
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300056
PM 31470145
DA 2020-05-12
ER

PT J
AU Chen, JW
   Hou, CX
   Wang, P
   Yang, Y
   Zhou, D
AF Chen, Jiawei
   Hou, Chongxian
   Wang, Peng
   Yang, Yong
   Zhou, Dong
TI Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit
SO WORLD NEUROSURGERY
LA English
DT Article
DE CGGA; ESTIMATE algorithm; Grade II/III glioma; TCGA; Tumor
   microenvironment
ID TUMOR-ASSOCIATED MACROPHAGES; INFLAMMATION; EXPRESSION; CELLS; IMMUNITY;
   IL-10; PROGRESSION; MICROGLIA; SYSTEM; NICHE
AB OBJECTIVE: The tumor microenvironment greatly influences tumor formation, invasion, and progression. The ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues) algorithm quantifies stromal and immune components in a tumor, reflecting the tumor microenvironment. This study aimed to explore key prognostic genes in a grade II/III glioma microenvironment.
   METHODS: We obtained stromal/immune scores for the Cancer Genome Atlas (TCGA) grade II/III glioma cohort from the online ESTIMATE portal. The associations of stromal/immune scores with clinicopathologic characteristics and overall survival of patients with grade II/III glioma were assessed by the Mann-Whitney U test and the Kaplan-Meier method, respectively. Functional enrichment analysis and protein-protein interaction network assessments were employed to analyze differentially expressed genes (DEGs). The top 7 genes with 5 or more edges in the protein-protein interaction network were selected. For validation, CGGA grade II/III glioma data were analyzed.
   RESULTS: The results showed that elevated stromal/immune/ESTIMATE score was significantly associated with poor survival of patients with TCGA grade II/III glioma. Functional enrichment analysis showed that DEGs were associated with immune cell regulation, extracellular matrix, cytokine activation, and receptor binding. The selected DEGs (interleukin-10, beta-2 microglobulin, C-C motif chemokine ligand 5, cluster of differentiation 74, human leukocyte antigen-DRA, lymphocyte cytosolic protein 2, and myxovirus resistance protein 1) showed prognostic values in patients with grade II/III glioma of the TCGA and CGGA database.
   CONCLUSIONS: Stromal/immune/ESTIMATE scores have prognostic values in patients with grade II/III glioma. The selected DEGs, including interleukin-10, beta-2 microglobulin, C-C motif chemokine ligand 5, cluster of differentiation 74, human leukocyte antigen-DRA, lymphocyte cytosolic protein 2, and myxovirus resistance protein 1, associated with tumor immunity and microenvironment, have prognostic values in grade II/III glioma. Further investigation of these genes could provide novel insights into the tumor microenvironment of glioma.
C1 [Chen, Jiawei; Wang, Peng; Yang, Yong; Zhou, Dong] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.
   [Chen, Jiawei] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China.
   [Hou, Chongxian] Hokkaido Univ, Fac Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Zhou, D (reprint author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.
EM zhoudong5413@163.com
OI Chen, Jiawei/0000-0001-5383-1359
FU Natural Science Foundation of Guangdong Province of China, China
   [2018A0303130236]; National Natural Science Foundation of China,
   ChinaNational Natural Science Foundation of China [81901250]; High-level
   Hospital Construction Project
FX This study was financially supported by the Natural Science Foundation
   of Guangdong Province of China, China (No.2018A0303130236), the National
   Natural Science Foundation of China, China (No.81901250), and the
   High-level Hospital Construction Project (No.DFJH201924).
CR Batchu RB, 2018, SURGERY, V163, P627, DOI 10.1016/j.surg.2017.10.056
   Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121
   Burkholder B, 2014, BBA-REV CANCER, V1845, P182, DOI 10.1016/j.bbcan.2014.01.004
   Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028
   Chang JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005541
   Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148
   Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254
   Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025
   Da Ros M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102879
   Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562
   Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010
   Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912
   Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185
   Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022
   Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266
   Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808
   Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108
   Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173
   Lakins MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03347-0
   Lau EYT, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3714190
   Lee SJ, 2017, CANCER RES TREAT, V49, P313, DOI 10.4143/crt.2016.098
   Li BS, 2019, ONCOL LETT, V18, P713, DOI 10.3892/ol.2019.10338
   Li GJ, 2017, OPEN MED-WARSAW, V12, P247, DOI 10.1515/med-2017-0035
   Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116
   Li YN, 2016, INT J MOL MED, V38, P1170, DOI 10.3892/ijmm.2016.2717
   Lin CY, 2018, CANCER EPIDEM BIOMAR, V27, P1176, DOI [10.1158/1055-9965.EPI-18-0408, 10.1158/1055-9965.epi-18-0408]
   Liu C, 2015, CANCER BIOMARK, V15, P735, DOI 10.3233/CBM-150515
   Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058
   Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217
   Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501
   Miroshnikova YA, 2016, NAT CELL BIOL, V18, P1336, DOI 10.1038/ncb3429
   Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956
   Muller E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02520
   Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001
   Oelkrug C, 2014, CLIN EXP IMMUNOL, V178, P1, DOI 10.1111/cei.12382
   Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139
   Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131
   Pang MF, 2016, CANCER RES, V76, P5277, DOI 10.1158/0008-5472.CAN-16-0579
   Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001
   Pizzi M, 2016, LEUKEMIA, V30, P1805, DOI 10.1038/leu.2016.161
   Rangel LBA, 2004, CANCER BIOL THER, V3, P1021, DOI 10.4161/cbt.3.10.1142
   Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Seano G, 2018, CURR OPIN ONCOL, V30, P54, DOI 10.1097/CCO.0000000000000417
   Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z
   Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302
   Sharma I, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0464-y
   Siggs OM, 2015, J IMMUNOL, V194, P2587, DOI 10.4049/jimmunol.1400326
   Sonnenschein C, 2008, SEMIN CANCER BIOL, V18, P372, DOI 10.1016/j.semcancer.2008.03.012
   Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644
   Takeuchi Y, 2016, INT IMMUNOL, V28, P401, DOI 10.1093/intimm/dxw025
   Wang HY, 2019, J CELL BIOCHEM, V120, P18762, DOI 10.1002/jcb.29189
   Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003
   Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320
   Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274
   Yang S, 2020, J CELL PHYSIOL, V235, P1025, DOI 10.1002/jcp.29018
   Yeung JT, 2013, CLIN CANCER RES, V19, P1816, DOI 10.1158/1078-0432.CCR-12-2861
   Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612
   Zeiner PS, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0521-5
   Zhang LX, 2019, ONCOL LETT, V17, P2365, DOI 10.3892/ol.2018.9842
   Zhao LF, 2015, ACTA BIOCH BIOPH SIN, V47, P890, DOI 10.1093/abbs/gmv095
NR 65
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E76
EP E88
DI 10.1016/j.wneu.2019.08.253
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300012
PM 31518750
DA 2020-05-12
ER

PT J
AU Chong, AJ
   Lim, SW
   Lee, YL
   Chio, CC
   Chang, CH
   Kuo, JR
   Wang, CC
AF Chong, Arng Jack
   Lim, Sher-Wei
   Lee, Yao-lin
   Chio, Chung-Ching
   Chang, Chin-Hung
   Kuo, Jinn-Rung
   Wang, Che-Chuan
TI The Neuroprotective Effects of Simvastatin on High Cholesterol Following
   Traumatic Brain Injury in Rats
SO WORLD NEUROSURGERY
LA English
DT Article
DE Apoptosis, tumor necrosis factor-alpha; Cholesterol; Fluid percussion
   injury; Simvastatin; Tumor necrosis factor-alpha receptor
ID STATINS; CNS; NEUROINFLAMMATION; DEGENERATION; DEPRESSION; PROTEIN
AB BACKGROUND: High cholesterol has been correlated with a greater risk of cerebrovascular diseases. Whether pre-existing high cholesterol exacerbates traumatic brain injury (TBI), and whether treatment with the cholesterol-lowering agent simvastatin has neuroprotective effects, especially anti-neuroinflammatory effects, after TBI are not well investigated.
   METHODS: Five-week-old male Sprague-Dawley rats were fed a high-fat diet for 8 weeks to induce hypercholesterolemia. Anesthetized male Sprague-Dawley rats were divided into 5 groups, including the sham-operated control, TBI control, and TBI with simvastatin treatment (4 mg/kg, 10 mg/kg, or 20 mg/kg) groups. Simvastatin was intraperitoneally injected at 0, 24, and 48 hours after TBI. Motor function was measured using an inclined plane. Neuronal apoptosis (maker Neu-N, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling), tumor necrosis factor-alpha expression in microglia (marker OX42) and astrocytes (marker glial fibrillary acidic protein), and Tumor necrosis factor-alpha receptor (TNFR) 1 and TNFR2 expression in neurons in the ischemic cortex were investigated using an immunofluorescence assay. All of the parameters were measured on the third day after TBI.
   RESULTS: TBI significantly increased the serum levels of cholesterol. The TBI-induced motor deficit was significantly attenuated by 4, 10, and 20 mg/kg simvastatin therapy on the third day after TBI. TBI-induced neuronal TNFR1 activation and apoptosis, as well as tumor necrosis factor-alpha expression in astrocytes in the ischemic cortex, were significantly attenuated by simvastatin, particularly when 20 mg/kg was administered. Simultaneously, the serum cholesterol remained high despite simvastatin treatment.
   CONCLUSIONS: The neuroprotection effects of simvastatin on the pre-existing hypercholesterolemia during TBI in rats may be related to its anti-neuroinflammatory effects but not to its cholesterol-lowing effects.
C1 [Chong, Arng Jack; Lim, Sher-Wei; Lee, Yao-lin; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.
   [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan.
   [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Gen Educ, Tainan, Taiwan.
   [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.
RP Kuo, JR (reprint author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (reprint author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.
EM kuojinnrung@gmail.com
CR Adekunle A.S., 2013, ASIAN J NAT APPL SCI, V2, P82
   Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b
   Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019
   Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128
   Cucchiara B, 2001, J NEUROL SCI, V187, P81, DOI 10.1016/S0022-510X(01)00529-9
   DEMEDIUK P, 1988, Journal of Neurotrauma, V5, P105, DOI 10.1089/neu.1988.5.105
   Diaz-Castro L, 2011, ACTAS ESP PSIQUIATRI, V39, P115
   Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113
   Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254
   Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011
   Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006
   Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865
   Herz J, 2014, NEUROBIOL DIS, V62, P456, DOI 10.1016/j.nbd.2013.10.022
   Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953
   Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185
   Krisanova N, 2012, BBA-MOL BASIS DIS, V1822, P1553, DOI 10.1016/j.bbadis.2012.06.005
   Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6
   Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070
   MAURO VF, 1993, CLIN PHARMACOKINET, V24, P195, DOI 10.2165/00003088-199324030-00002
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008
   Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038
   Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23
   Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x
   Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x
   Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031
   Wang KW, 2014, ANN CLIN LAB SCI, V44, P145
   Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749
   Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3
NR 29
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E99
EP E108
DI 10.1016/j.wneu.2019.08.250
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300014
PM 31518751
DA 2020-05-12
ER

PT J
AU Dhandapani, S
   Sahoo, SK
AF Dhandapani, Sivashanmugam
   Sahoo, Sushant K.
TI Developmental Retrocerebellar Cysts: A New Classification for
   Neuroendoscopic Management and Systematic Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cisternostomy; Dandy-Walker; ETV; Hydrocephalus; Neuroendoscopy;
   Posterior fossa cyst; Retrocerebellar cyst; Ventriculocystostomy
ID ENDOSCOPIC 3RD VENTRICULOSTOMY; CHOROID-PLEXUS CAUTERIZATION;
   POSTERIOR-FOSSA; ARACHNOID CYSTS; INFANT HYDROCEPHALUS; CHILDREN;
   MALFORMATIONS; PLACEMENT; YOUNGER; FENESTRATION
AB OBJECTIVE: Posterior fossa cystic malformations are diversely classified with considerable overlap without therapeutic relevance. These cysts posterior to the cerebellum, presenting in children younger than 5 years, are labeled developmental retrocerebellar cysts (DRCCs) under a new classification in relation to neuroendoscopy.
   METHODS: DRCC was categorized as type 0 for asymptomatic enlarged cistern magna and was not treated. Among symptomatic cases, cysts with a compressed fourth ventricle were labeled type 1, whereas cysts in continuity with the fourth ventricle were termed type 2. They were further categorized as subtype B if hydrocephalus was greater relative to the cyst, or otherwise as subtype A. The literature was reviewed according to PRISMA guidelines.
   RESULTS: There were 13 children aged 3-48 months. Type 1A DRCC was noted in 5 patients, with onset before 6 months, 4 of whom (80%) had intracranial hypertension. All underwent suboccipital endoscopic deroofing and cis-ternostomy (SEDC), a new technique. Type 1B DRCC was seen in 2 patients, with onset at 8-9 months, who underwent endoscopic third ventriculostomy (ETV) + endoscopic ventriculocystostomy (EVC). Type 2A DRCC was observed in 4 patients, with onset at 5-47 months, who underwent SEDC. Type 2B DRCC was noted in 2 patients, with onset 6-8 months, who underwent ETV. With a mean follow-up of 32 months, all showed clinicoradiologic improvement. The application of our classification to other studies showed ETV/EVC to be successful in only 67% of type 1A DRCC and 72% of type 2A DRCC, compared with 100% efficacy of SEDC in our series.
   CONCLUSIONS: This is probably the first ever endoscopic classification of pediatric posterior fossa cyts, elucidating pathophysiology, presentation, and treatment. Patients with type 1 DRCC present early because of extraneous compression. Among patients with type 2 DRCC, posterior fossa compliance determines the degree of hydrocephalus. The newly described SEDC seems more appropriate for types 1A and 2A DRCC. ETV is adequate in type 2B DRCC and effective with EVC in type 1B.
C1 [Dhandapani, Sivashanmugam; Sahoo, Sushant K.] PGIMER, Dept Neurosurg, Chandigarh, India.
RP Dhandapani, S (reprint author), PGIMER, Dept Neurosurg, Chandigarh, India.
EM ssdhandapani.neurosurg@gmail.com
RI Dhandapani, Sivashanmugam/I-2395-2013
OI Dhandapani, Sivashanmugam/0000-0002-3497-4255
CR BARKOVICH AJ, 1989, AM J ROENTGENOL, V153, P1289, DOI 10.2214/ajr.153.6.1289
   BENDA CE, 1954, J NEUROPATH EXP NEUR, V13, P14, DOI 10.1093/jnen/13.1.14
   Blake JA, 1900, J COMP NEUROL, V10, P79, DOI 10.1002/cne.910100104
   Brusius CV, 2013, ARQ NEURO-PSIQUIAT, V71, P545, DOI 10.1590/0004-282X20130086
   Choi JU, 1999, CHILD NERV SYST, V15, P285, DOI 10.1007/s003810050396
   Cornips EMJ, 2010, CHILD NERV SYST, V26, P1057, DOI 10.1007/s00381-010-1085-2
   Correa Gustavo Gumz, 2011, Top Magn Reson Imaging, V22, P303, DOI 10.1097/RMR.0b013e3182a2ca77
   Val JAC, 2012, CHILD NERV SYST, V28, P1233, DOI 10.1007/s00381-012-1740-x
   Dandy WE, 1922, B JOHNS HOPKINS HOSP, V33, P189
   Dandy WE, 1914, AM J DIS CHILD, V8, P406
   Dhandapani S, 2018, SPINE J, V18, P1592, DOI 10.1016/j.spinee.2018.02.002
   Dhandapani S, 2017, CHILD NERV SYST, V33, P385, DOI 10.1007/s00381-016-3266-0
   Dhandapani S, 2016, J NEUROSURG-PEDIATR, V17, P103, DOI 10.3171/2015.6.PEDS15179
   Domingo Z, 1996, PEDIATR NEUROSURG, V24, P111, DOI 10.1159/000121026
   Eiras Ajuria J, 1991, Neurochirurgie, V37, P278
   Faggin R, 2009, EUR J PEDIATR SURG, V19, P216, DOI 10.1055/s-0029-1202282
   Feletti A, 2016, ACTA NEUROCHIR, V158, P655, DOI 10.1007/s00701-016-2734-3
   GILLES FH, 1971, J PEDIATR-US, V79, P436, DOI 10.1016/S0022-3476(71)80153-1
   Gonsette R, 1968, Acta Neurol Psychiatr Belg, V68, P559
   Harwood-Nash D, 1976, NEURORADIOLOGY INFAN, V3
   Hu CF, 2011, PEDIATR NEONATOL, V52, P42, DOI 10.1016/j.pedneo.2010.12.005
   Idowu O, 2008, CHILD NERV SYST, V24, P253, DOI 10.1007/s00381-007-0491-6
   Idris Z, 2017, J NEUROL SURG PART A, V78, P210, DOI 10.1055/s-0035-1571161
   Jiang L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012139
   KAPLAN A, 1948, J NERV MENT DIS, V108, P435
   King JAJ, 2010, J NEUROSURG-PEDIATR, V5, P403, DOI 10.3171/2009.10.PEDS09208
   KOLLIAS SS, 1993, RADIOGRAPHICS, V13, P1211, DOI 10.1148/radiographics.13.6.8031352
   MATSON DD, 1956, AMER J ROENTGENOL RA, V76, P499
   MIXTER WJ, 1923, BOSTON MED SURG J, V188, P277
   Mohanty A, 2003, NEUROSURGERY, V53, P1223, DOI 10.1227/01.NEU.0000088810.75724.0E
   Mohanty A, 2006, J NEUROSURG, V105, P348, DOI 10.3171/ped.2006.105.5.348
   Nelson MD, 2004, PEDIATR RADIOL, V34, P720, DOI 10.1007/s00247-004-1253-1
   OBERBAUER RW, 1992, CHILD NERV SYST, V8, P281, DOI 10.1007/BF00300797
   Ogiwara H, 2010, CHILD NERV SYST, V26, P343, DOI 10.1007/s00381-009-1019-z
   Prakash P, 2018, J PEDIATR NEUROSCI, V13, P189, DOI 10.4103/jpn.JPN_118_17
   RAIMONDI AJ, 1969, J NEUROSURG, V31, P202, DOI 10.3171/jns.1969.31.2.0202
   Spennato P, 2011, CHILD NERV SYST, V27, P1665, DOI 10.1007/s00381-011-1544-4
   Sridhar S, 2013, NEUROL INDIA, V61, P87, DOI 10.4103/0028-3886.108030
   Stone SSD, 2014, J NEUROSURG-PEDIATR, V14, P439, DOI 10.3171/2014.7.PEDS14152
   Sufianov AA, 2010, J NEUROSURG-PEDIATR, V5, P392, DOI 10.3171/2009.11.PEDS09197
   Taggart JK, 1942, ARCH NEURO PSYCHIATR, V48, P583, DOI 10.1001/archneurpsyc.1942.02290100083008
   TortoriDonati P, 1996, CHILD NERV SYST, V12, P303, DOI 10.1007/BF00301017
   Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P377, DOI 10.3171/2011.7.PEDS1198
   Zhang B, 2012, J NEUROSURG-PEDIATR, V10, P302, DOI 10.3171/2012.7.PEDS11540
NR 44
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E654
EP E664
DI 10.1016/j.wneu.2019.08.052
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300079
PM 31442641
DA 2020-05-12
ER

PT J
AU Duan, WR
   Du, YQ
   Qi, TF
   Jiang, BW
   Wang, K
   Liu, ZL
   Guan, J
   Wang, XW
   Wu, H
   Chen, Z
   Jian, FZ
AF Duan, Wanru
   Du, Yueqi
   Qi, Tengfei
   Jiang, Bowen
   Wang, Kai
   Liu, Zhenlei
   Guan, Jian
   Wang, Xingwen
   Wu, Hao
   Chen, Zan
   Jian, Fengzeng
TI The Value and Limitation of Cervical Traction in the Evaluation of the
   Reducibility of Atlantoaxial Dislocation and Basilar Invagination Using
   the Intraoperative O-Arm
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atlantoaxial dislocation; Basilar invagination; Cervical traction;
   O-arm; Posterior approach
ID DIRECT POSTERIOR REDUCTION; TRANSNASAL ODONTOIDECTOMY; CLASSIFICATION;
   COMPLICATIONS; ANTERIOR; FUSION; STABILIZATION; DISTRACTION; FIXATION;
   RELEASE
AB OBJECTIVE: To assess the value and limitation of cervical traction in the evaluation of the reducibility of atlantoaxial dislocation (AAD) and basilar invagination (BI) using the intraoperative O-arm.
   METHODS: A total of 22 patients with hyperextensive, irreducible AAD were included. The cervical traction test under general anesthesia was performed, and the degree of reduction was evaluated using the O-arm before the operation started. The traction effects both vertically and horizontally were evaluated. All cases then underwent modified direct posterior reduction and fixation. Clinical outcomes were evaluated using the Japanese Orthopaedic Association (JOA) scale. Radiologic measurements included the anterior atlantodental interval, the distance of odontoid tip above Chamberlain line, and the clivus-canal angle. Magnetic resonance imaging signal changes, size of syringomyelia, and the space ventral to medulla also were used to evaluate the postoperative reduction result.
   RESULTS: After the cervical traction test, 7 patients achieved incomplete reduction, 5 achieved only vertical reduction, 6 achieved only horizontal reduction, and 4 achieved complete reduction in both horizontal and vertical orientations as assessed by the O-arm. All patients underwent a direct reduction technique. The mean JOA score increased from 11.1 to 14.5. Complete reduction of AAD and BI were achieved in 19 patients (86.4%), with partial reduction achieved in 3 (13.6%). Sufficient cerebrospinal fluid space anterior to the medulla with improved JOA score was achieved in the 3 partially reduced patients.
   CONCLUSIONS: With the innovations of direct posterior reduction techniques, cervical traction under anesthesia may not sufficiently predict the reducibility of BI and AAD. Cervical traction still plays an important role during the direct posterior reduction procedure.
C1 [Duan, Wanru; Du, Yueqi; Qi, Tengfei; Wang, Kai; Liu, Zhenlei; Guan, Jian; Wang, Xingwen; Wu, Hao; Chen, Zan; Jian, Fengzeng] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Jiang, Bowen] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
RP Jian, FZ (reprint author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.
EM fengzengjian@hotmail.com
CR Bo XF, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0246-2
   Chandra PS, 2015, NEUROSURGERY, V77, P67, DOI 10.1227/NEU.0000000000000737
   Dai LY, 2000, EUR SPINE J, V9, P118, DOI 10.1007/s005860050221
   Deepak AN, 2017, J NEUROSURG-SPINE, V26, P331, DOI 10.3171/2016.8.SPINE16408
   Goel A, 2004, J NEUROSURG-SPINE, V1, P281, DOI 10.3171/spi.2004.1.3.0281
   GREENBERG AD, 1968, BRAIN, V91, P655, DOI 10.1093/brain/91.4.655
   Hao DJ, 2016, CLIN SPINE SURG, V29, pE240, DOI 10.1097/BSD.0b013e31826be885
   Hedequist D, 2010, SPINE, V35, pE128, DOI 10.1097/BRS.0b013e3181bad0c2
   Jian FZ, 2010, NEUROSURGERY, V66, P678, DOI 10.1227/01.NEU.0000367632.45384.5A
   Kumar R, 2002, PEDIATR NEUROSURG, V36, P197, DOI 10.1159/000056057
   MENEZES AH, 1980, J NEUROSURG, V53, P444, DOI 10.3171/jns.1980.53.4.0444
   Menezes AH, 2008, CHILD NERV SYST, V24, P1101, DOI 10.1007/s00381-008-0605-9
   Salunke P, 2006, J NEUROSURG, V104, P115, DOI 10.3171/ped.2006.104.2.115
   Salunke P, 2016, WORLD NEUROSURG, V95, P156, DOI 10.1016/j.wneu.2016.07.097
   Salunke P, 2016, CLIN NEUROL NEUROSUR, V145, P19, DOI 10.1016/j.clineuro.2016.04.001
   Salunke P, 2016, EUR SPINE J, V25, P1098, DOI 10.1007/s00586-015-4370-7
   Salunke P, 2015, J NEUROSURG-SPINE, V23, P294, DOI 10.3171/2014.12.SPINE14310
   Salunke P, 2015, CLIN NEUROL NEUROSUR, V131, P47, DOI 10.1016/j.clineuro.2015.01.025
   Shriver MF, 2016, CLIN NEUROL NEUROSUR, V148, P121, DOI 10.1016/j.clineuro.2016.07.019
   Srivastava SK, 2016, SPINE J, V16, P1, DOI 10.1016/j.spinee.2015.09.037
   Steinberger J, 2016, SPINE, V41, pE535, DOI 10.1097/BRS.0000000000001320
   Tubbs RS, 2016, CHILD NERV SYST, V32, P55, DOI 10.1007/s00381-015-2864-6
   Wang C, 2006, SPINE, V31, pE306, DOI 10.1097/01.brs.0000217686.80327.e4
   Wang C, 2017, NEUROSURGERY, V80, pE227, DOI 10.1093/neuros/nyw114
   Wang SL, 2013, SPINE, V38, pE1348, DOI 10.1097/BRS.0b013e3182a1e5e4
   Wang XW, 2018, WORLD NEUROSURG, V116, pE595, DOI 10.1016/j.wneu.2018.05.047
   Wang ZW, 2017, EUR SPINE J, V26, P1019, DOI 10.1007/s00586-016-4740-9
   Xia ZY, 2018, WORLD NEUROSURG, V114, pE501, DOI 10.1016/j.wneu.2018.03.016
   Xu JJ, 2013, ORTHOPEDICS, V36, pE95, DOI 10.3928/01477447-20121217-25
   Yin YH, 2014, SPINE, V39, P2013, DOI 10.1097/BRS.0000000000000611
   Zileli M, 2002, J SPINAL DISORD TECH, V15, P284, DOI 10.1097/00024720-200208000-00004
NR 31
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E324
EP E332
DI 10.1016/j.wneu.2019.08.160
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300039
PM 31476460
DA 2020-05-12
ER

PT J
AU Durand, WM
   Daniels, AH
   Hamilton, DK
   Passias, PG
   Kim, HJ
   Protopsaltis, T
   Lafage, V
   Smith, JS
   Shaffrey, C
   Gupta, M
   Kelly, MP
   Klineberg, E
   Schwab, F
   Burton, D
   Bess, S
   Ames, C
   Hart, R
AF Durand, Wesley M.
   Daniels, Alan H.
   Hamilton, David K.
   Passias, Peter G.
   Kim, Han Jo
   Protopsaltis, Themistocles
   Lafage, Virginie
   Smith, Justin S.
   Shaffrey, Christopher
   Gupta, Munish
   Kelly, Michael P.
   Klineberg, Eric
   Schwab, Frank
   Burton, Doug
   Bess, Shay
   Ames, Christopher
   Hart, Robert
CA Int Spine Study Grp
TI Younger Patients Are Differentially Affected by Stiffness-Related
   Disability Following Adult Spinal Deformity Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adult spinal deformity; HRQOL; Lumbar spine stiffness
ID QUALITY-OF-LIFE; LUMBAR STIFFNESS; FUNCTIONAL LIMITATIONS; SATISFACTION;
   ARTHRODESIS; IMPACT; REPLACEMENT; PREDICTORS; OUTCOMES; FUSION
AB OBJECTIVE: The Lumbar Stiffness Disability Index (LSDI) assesses impact of lumbar stiffness on activities of daily living. We hypothesized that patients <60 years old would perceive greater lumbar stiffness-related functional limitation following fusion for adult spinal deformity.
   METHODS: Patients completed the LSDI and Scoliosis Research Society 22 Questionnaire, Revised (SRS-22r) preoperatively and at 2 years postoperatively. The primary independent variable was patient age <60 versus >= 60. Multivariable regression analyses were used.
   RESULTS: Analysis included 267 patients. Patients <60 years old (51.3%) and >= 60 years old (48.7%) were evenly represented. In bivariable analysis, patients age <60 exhibited lower LSDI at baseline versus patients age >= 60 (25.7 vs. 35.5, beta -9.8, P < 0.0001), but a directionally smaller difference at 2 years (26.4 vs. 32.3, beta -5.8, P = 0.0147). LSDI was associated with lower SRS-22r total score among both age groups at baseline and 2 years (all P < 0.0001); the association was stronger among patients age <60 versus >= 60 at 2 years. LSDI was associated with SRS-22r satisfaction scores at 2 years among patients age <60 (P < 0.0001), but not patients age >= 60 (P = 0.2250). The difference in SRS-22r satisfaction per unit LSDI between patients <60 years old and >= 60 years old was significant (P = 0.0021).
   CONCLUSIONS: Among patients with adult spinal deformity managed operatively, higher LSDI was associated with inferior SRS-22r total score and satisfaction at 2 years postoperatively. The association between increased LSDI and worse patient-reported outcome measures was greater among patients age <60 versus >= 60. Preoperative counseling is needed for patients age <60 undergoing adult spinal deformity surgery regarding effects that lumbar stiffness may have on postoperative function and satisfaction.
C1 [Durand, Wesley M.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA.
   [Daniels, Alan H.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Hamilton, David K.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA.
   [Passias, Peter G.; Protopsaltis, Themistocles] NYU Langone Orthoped Hosp, Dept Orthoped, New York, NY USA.
   [Kim, Han Jo; Lafage, Virginie; Schwab, Frank] Hosp Special Surg, Dept Orthoped Surg, 535 E 70th St, New York, NY 10021 USA.
   [Smith, Justin S.] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA.
   [Shaffrey, Christopher] Duke Univ, Spine Div, Durham, NC USA.
   [Gupta, Munish; Kelly, Michael P.] Washington Univ, Dept Orthoped Surg, St Louis, MO 63110 USA.
   [Klineberg, Eric] Univ Calif Davis, Dept Orthoped Surg, Sacramento, CA 95817 USA.
   [Burton, Doug] Univ Kansas Hosp, Dept Orthoped Surg, Kansas City, KS USA.
   [Bess, Shay] Denver Int Spine Ctr, Dept Orthoped Surg, Denver, CO USA.
   [Ames, Christopher] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.
   [Hart, Robert] Swedish Neurosci Inst, Dept Orthoped Surg, Seattle, WA USA.
RP Daniels, AH (reprint author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
EM alandanielsmd@gmail.com
RI /AAA-4616-2020; Lafage, Virginie/E-7747-2010
OI bess, shay/0000-0002-9697-8999; Lafage, Virginie/0000-0002-0119-7111
FU DePuy Synthes Spine; K2M; NuVasive; Biomet; Orthofix; Allosource
FX The International Spine Study Group is funded through research grants
   from DePuy Synthes Spine, K2M, NuVasive, Biomet, Orthofix, and
   Allosource. The authors declare that the article content was composed in
   the absence of any commercial or financial relationships that could be
   construed as a potential conflict of interest.
CR Alderman AK, 2000, PLAST RECONSTR SURG, V106, P769, DOI 10.1097/00006534-200009040-00003
   Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9
   Cameron A. C., 2009, MICROECONOMETRICS ST
   Daniels AH, 2017, EUR SPINE J, V26, P1645, DOI 10.1007/s00586-016-4790-z
   Daniels AH, 2015, SPINE, V40, P1599, DOI 10.1097/BRS.0000000000001090
   Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a
   Fu KM, 2012, SPINE J, V12, pS2, DOI DOI 10.1016/j.spinee.2012.08.028
   de Tejada MGS, 2010, VALUE HEALTH, V13, P447, DOI 10.1111/j.1524-4733.2009.00685.x
   Hamilton DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002525
   Hart RA, 2017, SPINE, V42, P1151, DOI 10.1097/BRS.0000000000002006
   Hart RA, 2014, SPINE, V39, pE1468, DOI 10.1097/BRS.0000000000000595
   Hart RA, 2013, SPINE J, V13, P157, DOI 10.1016/j.spinee.2012.12.001
   Hart RA, 2013, SPINE J, V13, P150, DOI 10.1016/j.spinee.2012.10.014
   Husted H, 2008, ACTA ORTHOP, V79, P168, DOI 10.1080/17453670710014941
   Jansson KA, 2005, J BONE JOINT SURG BR, V87B, P959, DOI 10.1302/0301-620X.87B7.16240
   Jansson KA, 2011, ACTA ORTHOP, V82, P82, DOI 10.3109/17453674.2010.548026
   Mira JJ, 2009, SURGERY, V145, P536, DOI 10.1016/j.surg.2009.01.012
   Jones CA, 2001, ARCH INTERN MED, V161, P454, DOI 10.1001/archinte.161.3.454
   Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656
   McCarthy IM, 2014, SPINE J, V14, P2326, DOI 10.1016/j.spinee.2014.01.032
   McCarthy IM, 2013, SPINE J, V13, P1843, DOI 10.1016/j.spinee.2013.06.048
   Morris BJ, 2013, AAOS NOW, V7, P29
   Myles PS, 2000, BRIT J ANAESTH, V84, P6
   Pellise F, 2015, EUR SPINE J, V24, P3, DOI 10.1007/s00586-014-3542-1
   Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb
   Sciubba DM, 2015, SPINE, V40, P1338, DOI 10.1097/BRS.0000000000000968
   Wilson TR, 2008, BRIT J SURG, V95, P1408, DOI 10.1002/bjs.6376
   Younger ASE, 2015, FOOT ANKLE INT, V36, P123, DOI 10.1177/1071100714565902
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E297
EP E304
DI 10.1016/j.wneu.2019.08.169
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300036
PM 31479783
DA 2020-05-12
ER

PT J
AU Eichberg, DG
   Di, L
   Shah, AH
   Luther, E
   Richardson, AM
   Sarkiss, CA
   Ivan, ME
   Komotar, RJ
AF Eichberg, Daniel G.
   Di, Long
   Shah, Ashish H.
   Luther, Evan
   Richardson, Angela M.
   Sarkiss, Christopher A.
   Ivan, Michael E.
   Komotar, Ricardo J.
TI Brain Tumor Surgery is Safe in Octogenarians and Nonagenarians: A
   Single-Surgeon 741 Patient Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aging; Brain tumor; Brain tumor surgery; Geriatrics; Surgical risk
ID ELDERLY-PATIENTS; RISK-FACTORS; GLIOBLASTOMA-MULTIFORME; OLDER PATIENTS;
   OUTCOMES; CRANIOTOMY; COMPLICATIONS; MORTALITY; CANCER; MENINGIOMA
AB OBJECTIVES: Elderly patients with surgically accessible brain tumors are often not offered clinically indicated brain tumor surgery (BTS) because of to assumptions of greater risk for perioperative morbidity and mortality. Because brain tumor incidence is highest in the geriatric population, and because the global population is aging, accurate understanding of BTS risk in elderly patients is critical. We aimed to compare safety of BTS in elderly patients with younger counterparts to better understand the risk-benefit profile of BTS for elderly patients.
   METHODS: Retrospective cohort study of young (20-29 years), senior (60-79 years), and elderly (80+ years) patients who underwent BTS with a single neurosurgeon. Differences between pre- and postoperative modified Rankin score (Delta mRS), length of hospitalization (LOH), complication rate, and 30-day readmission rates (30DRR) were recorded.
   RESULTS: A total of 741 patients (83 elderly, 570 senior, and 88 young) were identified. No significant difference in preoperative mRS between different age groups, chi(2) = 0.269, P = 0.874. Elderly complication rate was 6.0%, not significantly different from young (4.5%, P = 0.667) or senior (7.2%, P = 0.696) complication rate. Elderly LOH was 1.93 +/- SD 0.176 days; not significantly different from young (3.01 +/- 0.384 days, P = 0.081) or senior (2.47 +/- 0.144 days, P = 0.881). Statistical equivalence testing showed with 95% confidence that there was equivalence in Delta mRS among age groups.
   CONCLUSIONS: Elderly patients did not have significantly different Delta mRS, LOH, 30DRR, or complication rates after BTS compared with younger counterparts. Therefore, in healthy patients, advanced age alone should not prevent patients from being offered BTS.
C1 [Eichberg, Daniel G.; Di, Long; Shah, Ashish H.; Luther, Evan; Richardson, Angela M.; Sarkiss, Christopher A.; Ivan, Michael E.; Komotar, Ricardo J.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
RP Eichberg, DG (reprint author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
EM deichberg35@gmail.com
OI Luther, Evan/0000-0001-9164-4984
CR Anthofer J, 2016, WORLD NEUROSURG, V91, P58, DOI [10.1016/j.wneu.2016.03.087, 10.1016/J.WNEU.2016.03.087]
   Barker FG, 2004, CANCER-AM CANCER SOC, V100, P999, DOI 10.1002/cncr.20058
   Barnholtz-Sloan JS, 2008, J NEUROSURG, V108, P642, DOI 10.3171/JNS/2008/108/4/0642
   BINDAL RK, 1993, J NEUROSURG, V79, P210, DOI 10.3171/jns.1993.79.2.0210
   Black P, 1998, ACTA NEUROCHIR, V140, P1013, DOI 10.1007/s007010050209
   Brandes AA, 2003, SEMIN ONCOL, V30, P58, DOI 10.1053/j.seminoncol.2003.11.025
   Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088
   Broderick JP, 2017, STROKE, V48, P2007, DOI 10.1161/STROKEAHA.117.017866
   Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081
   Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175
   Chiang HY, 2014, J NEUROSURG, V120, P509, DOI 10.3171/2013.9.JNS13843
   CROOKS V, 1991, J GERONTOL, V46, pM139, DOI 10.1093/geronj/46.4.M139
   Curry WT, 2005, J NEUROSURG, V102, P977, DOI 10.3171/jns.2005.102.6.0977
   D'Amico RS, 2015, WORLD NEUROSURG, V84, P913, DOI 10.1016/j.wneu.2015.05.072
   Drewes C, 2018, WORLD NEUROSURG, V117, pE465, DOI 10.1016/j.wneu.2018.06.052
   Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002
   Gelman A, 2019, ANN SURG, V269, pE9, DOI 10.1097/SLA.0000000000002908
   Goel NJ, 2018, WORLD NEUROSURG, V118, pE195, DOI 10.1016/j.wneu.2018.06.153
   Grossman R, 2013, ANN SURG ONCOL, V20, P1722, DOI 10.1245/s10434-012-2748-x
   Grossman R, 2011, ANN SURG ONCOL, V18, P521, DOI 10.1245/s10434-010-1299-2
   Hardesty DA, 2011, J NEUROSURG-PEDIATR, V7, P609, DOI 10.3171/2011.3.PEDS1120
   Harrison JK, 2013, CLIN INTERV AGING, V8, P201, DOI 10.2147/CIA.S32405
   Helminen O, 2019, ANN SURG, V269, pE10, DOI 10.1097/SLA.0000000000002907
   Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897
   Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706
   Iwamoto FM, 2009, CANCER-AM CANCER SOC, V115, P5534, DOI 10.1002/cncr.24612
   James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Johans SJ, 2017, WORLD NEUROSURG, V107, P216, DOI [10.1016/j.wneu.2017.07.177, 10.1016/J.WNEU.2017.07.177]
   Lara-Velazquez M, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120166
   Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010
   Lobatto DJ, 2018, PITUITARY, V21, P84, DOI 10.1007/s11102-017-0839-1
   Long DM, 2003, NEUROSURGERY, V52, P1056, DOI 10.1227/01.NEU.0000057745.48813.93
   Martinez R, 2007, ZBL NEUROCHIR, V68, P176, DOI 10.1055/s-2007-985851
   Mohan DS, 1998, INT J RADIAT ONCOL, V42, P981, DOI 10.1016/S0360-3016(98)00296-X
   Moiyadi AV, 2012, J NEUROSCI RURAL PRA, V3, P28, DOI 10.4103/0976-3147.91927
   Nayak L, 2010, CURR NEUROL NEUROSCI, V10, P252, DOI 10.1007/s11910-010-0110-x
   Patil CG, 2010, J NEUROL NEUROSUR PS, V81, P502, DOI 10.1136/jnnp.2009.185074
   Reponen E, 2015, J NEUROSURG, V123, P594, DOI 10.3171/2014.11.JNS141970
   SALCMAN M, 1982, J AM GERIATR SOC, V30, P501, DOI 10.1111/j.1532-5415.1982.tb01687.x
   Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054
   SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419
   Seicean A, 2013, CANCER-AM CANCER SOC, V119, P1058, DOI 10.1002/cncr.27851
   Steinberger J, 2018, WORLD NEUROSURG, V109, pE16, DOI 10.1016/j.wneu.2017.09.021
   Tanaka S, 2013, J NEUROSURG, V118, P786, DOI 10.3171/2012.10.JNS112268
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141
   Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   Warren KE, 2001, J NATL CANCER I, V93, P1401, DOI 10.1093/jnci/93.18.1401
   Wellek S, 2010, TESTING STAT HYPOTHE
   Williams M, 2016, BRIT J CANCER, V115, P1379, DOI 10.1038/bjc.2016.317
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E185
EP E192
DI 10.1016/j.wneu.2019.08.219
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300023
PM 31505286
DA 2020-05-12
ER

PT J
AU Eksi, MS
   Canbolat, C
   Akbas, A
   Ozmen, BB
   Akpinar, E
   Usseli, MI
   Gungor, A
   Guduk, M
   Hacihanefioglu, M
   Danyeli, AE
   Ozduman, K
   Pamir, MN
AF Eksi, Murat Sakir
   Canbolat, Cagri
   Akbas, Ahmet
   Ozmen, Berk Baris
   Akpinar, Ebubekir
   Usseli, Murat Imre
   Gungor, Abuzer
   Guduk, Mustafa
   Hacihanefioglu, Mehmet
   Danyeli, Ayca Ersen
   Ozduman, Koray
   Pamir, M. Necmettin
TI Elderly Patients with Intracranial Meningioma: Surgical Considerations
   in 228 Patients with a Comprehensive Analysis of the Literature
SO WORLD NEUROSURGERY
LA English
DT Article
DE Elderly; Meningioma; Morbidity; Mortality; Surgery
ID NERVOUS-SYSTEM TUMORS; PRIMARY BRAIN-TUMORS; 70 YEARS OLD;
   NATURAL-HISTORY; UNITED-STATES; GROWTH-RATE; ASYMPTOMATIC MENINGIOMAS;
   9TH DECADE; SURGERY; AGE
AB BACKGROUND: Improved life expectancy and advanced diagnostic tools including computed tomography and magnetic resonance imaging have increased the awareness and diagnosis of intracranial meningiomas in the elderly population. The risk/benefit ratio of surgery in elderly patients with intracranial meningioma has not been clearly defined because of the lack of objective measurement tools. We aimed to understand the risk factors associated with postsurgical outcomes and how these risk factors affected postsurgical outcomes in elderly patients with intracranial meningioma.
   METHODS: We retrospectively evaluated 1372 patients, who were operated on for intracranial meningioma, using our prospectively collected database. The same senior author operated on all patients at 2 different tertiary clinics. Patients' clinical charts, presurgical postcontrast T1-weighted magnetic resonance images, operative reports, and pathology reports were reviewed. The relevant literature was also reviewed.
   RESULTS: Higher age, higher American Society of Anesthesiologists class, presence of comorbidities, tumor location, larger initial tumor size, and presence of peritumoral edema were all associated with postsurgical complications in elderly patients with intracranial meningioma. Age >= 50 years was the strongest predictor of postsurgical systemic complications, whereas higher American Society of Anesthesiologists class was the strongest predictor of postsurgical neurologic complications. A literature review showed higher morbidity and mortality of elderly patients with intracranial meningioma. Initial tumor size and postsurgical MIB-1 labeling index were higher in the elderly patients, both of which were predictors of tumor growth.
   CONCLUSIONS: Even though elderly patients operated on for intracranial meningioma had higher morbidity and mortality compared with younger patients, surgery is still much more beneficial than wait-and-see strategy in elderly patients.
C1 [Eksi, Murat Sakir; Usseli, Murat Imre; Gungor, Abuzer; Guduk, Mustafa; Ozduman, Koray; Pamir, M. Necmettin] Acibadem Mehmet Ali Aydinlar Univ, Dept Neurosurg, Istanbul, Turkey.
   [Danyeli, Ayca Ersen] Acibadem Mehmet Ali Aydinlar Univ, Dept Pathol, Istanbul, Turkey.
   [Ozmen, Berk Baris] Acibadem Mehmet Ali Aydinlar Univ, Istanbul, Turkey.
   [Canbolat, Cagri] Vezirkopru State Hosp, Neurosurg Clin, Samsun, Turkey.
   [Akbas, Ahmet; Akpinar, Ebubekir] Hlth Sci Univ, Bakirkoy Psychiat Hosp, Dept Neurosurg, Istanbul, Turkey.
   [Hacihanefioglu, Mehmet] Acibadem Altunizade Hosp, Neurosurg Clin, Acibadem Healthcare Grp, Istanbul, Turkey.
RP Eksi, MS (reprint author), Acibadem Mehmet Ali Aydinlar Univ, Dept Neurosurg, Istanbul, Turkey.
EM muratsakireksi@gmail.com
CR Amano T, 2018, J CLIN NEUROSCI, V56, P63, DOI 10.1016/j.jocn.2018.07.009
   ARIENTA C, 1990, ACTA NEUROCHIR, V107, P47, DOI 10.1007/BF01402612
   Arienta C, 1992, Aging (Milano), V4, P29
   AWAD IA, 1989, NEUROSURGERY, V24, P557, DOI 10.1227/00006123-198904000-00011
   Baldi I, 2018, NEUROCHIRURGIE, V64, P5, DOI 10.1016/j.neuchi.2014.05.006
   Bartek J, 2015, WORLD NEUROSURG, V83, P673, DOI 10.1016/j.wneu.2015.01.022
   Bateman BT, 2005, NEUROSURGERY, V57, P866, DOI 10.1227/01.NEU.0000179923.66729.87
   Bir SC, 2016, WORLD NEUROSURG, V90, P251, DOI 10.1016/j.wneu.2016.02.066
   Black P, 1998, ACTA NEUROCHIR, V140, P1013, DOI 10.1007/s007010050209
   Boviatsis EJ, 2007, SURG NEUROL, V68, P407, DOI 10.1016/j.surneu.2006.11.071
   Brokinkel B, 2017, J NEUROSURG, V126, P1201, DOI 10.3171/2016.2.JNS152611
   Buhl R, 2000, NEUROSURG REV, V23, P25, DOI 10.1007/s101430050027
   BURCHANOT JH, 1949, CLIN EVALUATION CHEM
   Caroli M, 2005, J NEUROSURG, V102, P290, DOI 10.3171/jns.2005.102.2.0290
   Chen ZY, 2015, ACTA NEUROCHIR, V157, P1549, DOI 10.1007/s00701-015-2502-9
   Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9
   Cohen-Inbar O, 2011, ACTA NEUROCHIR, V153, P1501, DOI 10.1007/s00701-011-1034-1
   Cohen-Inbar O, 2010, ACTA NEUROCHIR, V152, P87, DOI 10.1007/s00701-009-0552-6
   CORNU P, 1990, ACTA NEUROCHIR, V102, P98, DOI 10.1007/BF01405421
   D'Andrea G, 2005, NEUROSURGERY, V56, P956, DOI 10.1227/01.NEU.0000158303.28823.E9
   da Silva CE, 2018, WORLD NEUROSURG, V120, pE1149, DOI 10.1016/j.wneu.2018.09.024
   Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152
   Delgado-Fernandez J, 2018, WORLD NEUROSURG, V114, pE1057, DOI 10.1016/j.wneu.2018.03.146
   Di Cristofori A, 2018, J NEURO-ONCOL, V137, P611, DOI 10.1007/s11060-018-2754-3
   Diaz J, 2016, NEUROCIRUGIA, V27, P2, DOI 10.1016/j.neucir.2015.04.003
   DJINDJIAN M, 1988, ACTA NEUROCHIR, V90, P121, DOI 10.1007/BF01560565
   Dobran M, 2018, CLIN NEUROL NEUROSUR, V167, P173, DOI 10.1016/j.clineuro.2018.02.024
   Duong LM, 2012, CANCER-AM CANCER SOC, V118, P4220, DOI 10.1002/cncr.27390
   Elia-Pasquet S, 2004, NEUROEPIDEMIOLOGY, V23, P110, DOI 10.1159/000075953
   FIRSCHING RP, 1990, J NEUROSURG, V73, P545, DOI 10.3171/jns.1990.73.4.0545
   GIJTENBEEK JMM, 1993, CLIN NEUROL NEUROSUR, V95, P291, DOI 10.1016/0303-8467(93)90104-O
   Grossman R, 2011, WORLD NEUROSURG, V75, P279, DOI 10.1016/j.wneu.2010.09.003
   Hashiba T, 2009, J NEUROSURG, V110, P675, DOI 10.3171/2008.8.JNS08481
   Herscovici Z, 2004, NEUROLOGY, V63, P1133, DOI 10.1212/01.WNL.0000138569.45818.50
   Ikawa F, 2017, NEUROL MED-CHIR, V57, P521, DOI 10.2176/nmc.ra.2017-0011
   Isobe N, 2018, WORLD NEUROSURG, V119, pE167, DOI 10.1016/j.wneu.2018.07.080
   JAN M, 1986, NEUROCHIRURGIE, V32, P129
   Kasuya H, 2012, J MED INVESTIG, V59, P241, DOI 10.2152/jmi.59.241
   Kolakshyapati M, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17730
   Konglund A, 2013, ACTA NEUROL SCAND, V127, P161, DOI 10.1111/j.1600-0404.2012.01692.x
   Konglund A, 2013, ACTA NEUROCHIR, V155, P2263, DOI 10.1007/s00701-013-1872-0
   Krampla W, 2004, CANCER, V100, P1208, DOI 10.1002/cncr.20088
   Kuratsu J, 2000, J NEUROSURG, V92, P766, DOI 10.3171/jns.2000.92.5.0766
   Lee CH, 2010, J KOREAN NEUROSURG S, V48, P145, DOI 10.3340/jkns.2010.48.2.145
   Lieu Ann-Shung, 1998, Kaohsiung Journal of Medical Sciences, V14, P498
   Louis DN, 2000, WHO CLASSIFICATION T, P175
   MASTRONARDI L, 1995, NEUROSURGERY, V36, P270, DOI 10.1227/00006123-199502000-00005
   MAURICEWILLIAMS RS, 1992, BRIT J NEUROSURG, V6, P131, DOI 10.3109/02688699209002915
   MCGRAIL KM, 1994, SURG NEUROL, V42, P2, DOI 10.1016/0090-3019(94)90241-0
   Meling TR, 2019, NEUROSURG REV, V42, P961, DOI 10.1007/s10143-018-1005-6
   Nakamura M, 2005, ACTA NEUROCHIR, V147, P603, DOI 10.1007/s00701-005-0517-3
   Nakamura M, 2003, NEUROSURGERY, V53, P62, DOI 10.1227/01.NEU.0000068730.76856.58
   Nayeri A, 2016, J CLIN NEUROSCI, V26, P101, DOI 10.1016/j.jocn.2015.11.002
   Niiro M, 2000, J NEUROL NEUROSUR PS, V68, P25, DOI 10.1136/jnnp.68.1.25
   NISHIZAKI T, 1994, ACTA NEUROCHIR, V126, P59, DOI 10.1007/BF01476411
   OLIVERO WC, 1995, J NEUROSURG, V83, P222, DOI 10.3171/jns.1995.83.2.0222
   Oya S, 2011, J NEUROSURG, V114, P1250, DOI 10.3171/2010.12.JNS101623
   PAPO I, 1983, ACTA NEUROCHIR, V67, P195, DOI 10.1007/BF01401421
   Patil CG, 2010, J NEUROL NEUROSUR PS, V81, P502, DOI 10.1136/jnnp.2009.185074
   Pirracchio R, 2010, J NEUROSURG ANESTH, V22, P342, DOI 10.1097/ANA.0b013e3181e6daa2
   Pompili A, 1998, LANCET, V351, P337, DOI 10.1016/S0140-6736(98)24005-0
   Poon MTC, 2013, J NEURO-ONCOL, V114, P219, DOI 10.1007/s11060-013-1173-8
   Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066
   Proust F, 1997, NEUROCHIRURGIE, V43, P15
   Riffaud L, 2007, PRESSE MED, V36, P197, DOI 10.1016/j.lpm.2006.11.009
   Rogne SG, 2009, ACTA NEUROL SCAND, V120, P288, DOI 10.1111/j.1600-0404.2009.01157.x
   Roser F, 2007, J CLIN NEUROSCI, V14, P224, DOI 10.1016/j.jocn.2005.12.004
   Sacko O, 2007, NEUROSURGERY, V61, P950, DOI 10.1227/01.neu.0000303190.80049.7d
   Schul DB, 2012, NEUROSURGERY, V70, P555, DOI 10.1227/NEU.0b013e318233a99a
   SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22
   Slot K, 2018, EUR GERIATR MED, V9, P95, DOI 10.1007/s41999-017-0015-1
   Sonoda Y, 2005, ACTA NEUROCHIR, V147, P131, DOI 10.1007/s00701-004-0391-4
   Timmer M, 2019, WORLD NEUROSURG, V125, pE697, DOI 10.1016/j.wneu.2019.01.158
   Troya Castilla Marta, 2016, Rev Esp Geriatr Gerontol, V51, P82, DOI 10.1016/j.regg.2015.06.004
   Tucha O, 2001, BRIT J NEUROSURG, V15, P184
   UMANSKY F, 1992, J NEUROL NEUROSUR PS, V55, P481, DOI 10.1136/jnnp.55.6.481
   Yamamoto J, 2017, ONCOL LETT, V14, P909, DOI 10.3892/ol.2017.6174
   Yano S, 2006, J NEUROSURG, V105, P538, DOI 10.3171/jns.2006.105.4.538
   Yasargil MG, 1996, MICRONEUROSURGERY, P134
   Yoneoka Y, 2000, ACTA NEUROCHIR, V142, P507, DOI 10.1007/s007010050463
   Zeidman LA, 2008, J NEUROL, V255, P891, DOI 10.1007/s00415-008-0801-2
   Zhang B, 2015, MOL CLIN ONCOL, V3, P501, DOI 10.3892/mco.2015.493
   Zhao XC, 2018, J CLIN NEUROSCI, V56, P143, DOI 10.1016/j.jocn.2018.06.011
   Zoia Cesare, 2018, J Neurosurg Sci, DOI 10.23736/S0390-5616.18.04333-3
NR 84
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E350
EP E365
DI 10.1016/j.wneu.2019.08.150
PG 16
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300042
PM 31476477
DA 2020-05-12
ER

PT J
AU El-Menyar, A
   Asim, M
   Ramzee, AF
   Nabir, S
   Ahmed, MN
   Al-Thani, A
   Al-Abdulmalek, A
   Al-Thani, H
AF El-Menyar, Ayman
   Asim, Mohammad
   Ramzee, Ahmed Faidh
   Nabir, Syed
   Ahmed, Mohamed Nadeem
   Al-Thani, Abdulaziz
   Al-Abdulmalek, Abdulrahman
   Al-Thani, Hassan
TI Bio-Shock Index: Proposal and Rationale for a New Predictive Tool for
   In-Hospital Mortality in Patients with Traumatic Brain Injury
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bio-SI; HsTnT; Shock index; Traumatic brain injury
ID CLASSIFICATION; OUTCOMES; UTILITY
AB BACKGROUND: We proposed a novel prognostic tool for the prediction of in-hospital mortality based on a combination of hemodynamic parameters and biomarkers in patients with traumatic brain injury (TBI). We hypothesized that a combination of shock index (SI) with high sensitive troponin T (HsTnT), the Bio-Shock Index (Bio-SI), has better prognostic power than its individual components.
   METHODS: A retrospective chart review was conducted (2011-2018) for patients with TBI. Patients were categorized into 2 groups (low and high Bio-SI) based on the receiver operating characteristic curve.
   RESULTS: A total of 2619 patients were admitted with TBI, and 1471 fulfilled the inclusion criteria and 73% had high Bio-SI (>= 10). High Bio-SI values were associated with more intraventricular hemorrhage (P = 0.001), brain edema (P = 0.001), and had lower mean arterial pressure (P = 0.001), admission Glasgow Coma Scale score (P = 0.001), and higher SI (P = 0.001), serum lactate (P= 0.001), HsTnT values (P = 0.001), and Rotterdam score (P = 0.03). Patients with high Bio-SI had a prolonged hospital (P = 0.003) and intensive care unit stay (P = 0.001); longer ventilatory days (P = 0.001) and had higher rates of pneumonia (P = 0.001), sepsis (P = 0.001), and in-hospital mortality (P = 0.001). The Bio-SI showed high sensitivity and negative predictive value (91.4% and 94.4%, respectively) as compared with elevated SI (50.2% and 87.6%, respectively) and positive troponin (79.7% and 93.7%, respectively).
   CONCLUSIONS: The Bio-SI is potentially a better tool than its individual components to predict in-hospital mortality among patients with TBI; however, HsTnT alone outperforms SI. Prospective studies and multicenter trials studying troponin levels and SI in all patients with TBI with the inclusion of outcome scores will prove or disprove the predictability of the new index.
C1 [Ramzee, Ahmed Faidh] Hamad Gen Hosp, Dept Surg, Doha, Qatar.
   [Nabir, Syed; Ahmed, Mohamed Nadeem] Hamad Gen Hosp, Dept Radiol, Doha, Qatar.
   [Al-Thani, Abdulaziz; Al-Abdulmalek, Abdulrahman] Hamad Gen Hosp, Dept Med, Doha, Qatar.
   [Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg Sect, Doha, Qatar.
   [El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar.
   [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Clin Res Trauma & Vasc Surg Sect, Doha, Qatar.
RP El-Menyar, A (reprint author), Weill Cornell Med Coll, Clin Med, Doha, Qatar.; El-Menyar, A (reprint author), Hamad Gen Hosp, Clin Res Trauma & Vasc Surg Sect, Doha, Qatar.
EM aymanco65@yahoo.com
RI El-Menyar, Ayman/F-6734-2015
OI El-Menyar, Ayman/0000-0003-2584-953X
CR Acker SN, 2015, PEDIATR SURG INT, V31, P1041, DOI 10.1007/s00383-015-3789-6
   Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016
   Boyd C R, 1987, Am J Surg, V153, P514, DOI 10.1016/0002-9610(87)90790-2
   Boyd CR, 1987, AM J SURG, V153, P514
   Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916
   Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728
   Crewdson Kate, 2019, J Intensive Care Soc, V20, P132, DOI 10.1177/1751143718767782
   Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019
   El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675
   El-Menyar A, 2019, AM J EMERG MED, V37, P133, DOI 10.1016/j.ajem.2018.10.002
   El-Menyar A, 2018, J TRAUMA ACUTE CARE, V85, P646, DOI 10.1097/TA.0000000000001865
   El-Menyar A, 2018, J SURG RES, V227, P52, DOI 10.1016/j.jss.2018.02.013
   Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0340-2
   Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584
   Gerdin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144886
   Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12
   Huang JF, 2019, INT J SURG, V61, P48, DOI 10.1016/j.ijsu.2018.11.030
   Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668
   Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017
   McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889
   Montoya KF, 2015, J ACUTE DIS, V4, P202, DOI 10.1016/j.joad.2015.04.006
   Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003
   Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a
   Zarzaur BL, 2008, J SURG RES, V147, P229, DOI 10.1016/j.jss.2008.03.025
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E169
EP E177
DI 10.1016/j.wneu.2019.08.229
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300021
PM 31505291
DA 2020-05-12
ER

PT J
AU El-Shehaby, AMN
   Reda, WA
   Karim, KMA
   Eldin, RME
   Nabeel, AM
   Tawadros, SR
AF El-Shehaby, Amr M. N.
   Reda, Wael A.
   Karim, Khaled M. Abdel
   Eldin, Reem M. Emad
   Nabeel, Ahmed M.
   Tawadros, Sameh R.
TI Volume-Staged Gamma Knife Radiosurgery for Large Brain Arteriovenous
   Malformation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Gamma Knife; Single-session; Staged
ID STEREOTACTIC RADIOSURGERY; TREATMENT MODALITY; OBLITERATION RATE;
   SEIZURE OUTCOMES; NATURAL-HISTORY; SINGLE-SESSION; EMBOLIZATION;
   SURGERY; HEMORRHAGE; RISK
AB OBJECTIVE: Large brain arteriovenous malformations (AVMs) pose a management dilemma because of the limited success of any single treatment modality by itself. Surgery alone is associated with significant morbidity and mortality. Similarly, embolization alone has limited efficacy. Volume-staged Gamma Knife radiosurgery (VSGR) has been developed for the treatment of large AVMs to increase the efficacy and improve safety of treatment of these lesions. The aim of this study was to assess the efficacy and safety of VSGR technique for the treatment of large brain AVMs.
   METHODS: The study included patients treated by VSGR between May 2009 and July 2015. All patients had large AVMs (>10 mL). There were 29 patients.
   RESULTS: Twenty-four patients completed radiographic follow-up, with 15 obliteration cases (62.5%). A total of 56 sessions were performed. The mean AVM volume was 16 mL (range, 10.1-29.3 mL). The mean prescription dose was 18 Gy (range, 14-22 Gy). The mean follow-up duration was 43 months (range, 21-73 months). One patient died during follow-up of an unrelated cause. Two patients had hemorrhage during follow-up. Symptomatic edema developed in 5 patients (17%). The factors affecting obliteration were smaller total volume, higher dose/stage, nondeep location, compact AVM, AVM score <3, >18 Gy dose, and <15 mL total volume. The factors affecting symptomatic edema were smaller total volume and shorter time between first and last sessions (P = 0.012). T2 image changes were affected by Spetzler-Martin grade >= 3 (P = 0.013) and AVM score >= 3 (P = 0.014).
   CONCLUSIONS: VSGR provides an effective and safe treatment option for large brain AVMs. Smaller AVM volume is associated with higher obliteration rate.
C1 [El-Shehaby, Amr M. N.; Reda, Wael A.; Karim, Khaled M. Abdel; Eldin, Reem M. Emad; Nabeel, Ahmed M.; Tawadros, Sameh R.] Gamma Knife Ctr Cairo, Cairo, Egypt.
   [El-Shehaby, Amr M. N.; Reda, Wael A.; Tawadros, Sameh R.] Ain Shams Univ, Fac Med, Dept Neurosurg, Cairo, Egypt.
   [Karim, Khaled M. Abdel] Shams Univ, Fac Med, Dept Clin Oncol, Cairo, Egypt.
   [Eldin, Reem M. Emad] Cairo Univ, Natl Canc Inst, Dept Radiat Oncol, Cairo, Egypt.
   [Nabeel, Ahmed M.] Benha Univ, Fac Med, Neurosurg Dept, Cairo, Egypt.
RP El-Shehaby, AMN (reprint author), Gamma Knife Ctr Cairo, Cairo, Egypt.; El-Shehaby, AMN (reprint author), Ain Shams Univ, Fac Med, Dept Neurosurg, Cairo, Egypt.
EM amrelshehaby@yahoo.com
RI Karim, Khaled Abdel/C-8895-2015
OI nabeel, ahmed/0000-0002-9217-8142
CR Abla AA, 2015, J NEUROSURG, V122, P419, DOI 10.3171/2014.10.JNS1424
   Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9
   AlKhalili K, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS14217
   Amponsah K, 2011, STEREOT FUNCT NEUROS, V89, P365, DOI 10.1159/000329363
   Andrade-Souza YM, 2007, NEUROSURGERY, V60, P443, DOI 10.1227/01.NEU.0000255347.25959.D0
   Back AG, 2008, J NEUROSURG, V109, P57, DOI 10.3171/JNS/2008/109/12/S10
   Baranoski JF, 2014, J NEUROINTERV SURG, V6, P684, DOI 10.1136/neurintsurg-2013-010945
   Blackburn SL, 2011, J NEUROSURG, V114, P1758, DOI 10.3171/2011.1.JNS10571
   Chung WY, 2008, J NEUROSURG, V109, P65, DOI 10.3171/JNS/2008/109/12/S11
   Chytka T, 2015, STEREOT FUNCT NEUROS, V93, P342, DOI 10.1159/000439116
   Dalyai R, 2014, BIOMED RES INT, DOI 10.1155/2014/306518
   Ding DL, 2014, BRIT J NEUROSURG, V28, P666, DOI 10.3109/02688697.2013.872227
   Ditty BJ, 2017, J NEUROSURG, V126, P845, DOI 10.3171/2015.12.JNS152461
   Ellis Jason A, 2014, Methodist Debakey Cardiovasc J, V10, P234, DOI 10.14797/mdcj-10-4-234
   Fiehler J, 2008, NEURORADIOLOGY, V50, P465, DOI 10.1007/s00234-008-0380-z
   Flickinger JC, 1997, INT J RADIAT ONCOL, V38, P485, DOI 10.1016/S0360-3016(97)89481-3
   Franzin A, 2016, J NEUROSURG, V125, P104, DOI 10.3171/2016.7.GKS161549
   Gobin YP, 1996, J NEUROSURG, V85, P19, DOI 10.3171/jns.1996.85.1.0019
   Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29
   Han JH, 2008, J NEUROSURG, V109, P191, DOI 10.3171/JNS/2008/109/8/0191
   Han PP, 2003, J NEUROSURG, V98, P3, DOI 10.3171/jns.2003.98.1.0003
   Hanakita S, 2016, WORLD NEUROSURG, V87, P242, DOI 10.1016/j.wneu.2015.12.020
   HEROS RC, 1990, NEUROSURGERY, V26, P570, DOI 10.1227/00006123-199004000-00003
   Huang PP, 2012, NEUROSURGERY, V71, P632, DOI 10.1227/NEU.0b013e31825fd247
   Jayaraman M, 2009, AM J NEURORADIOL, V30, P107, DOI 10.3174/ajnr.A1394
   Jones Jesse, 2007, Neurosurg Focus, V23, pE7
   Kano H, 2012, J NEUROSURG, V117, P265, DOI 10.3171/2012.4.JNS111935
   Kano H, 2012, J NEUROSURG, V116, P54, DOI 10.3171/2011.9.JNS11177
   Karlsson B, 2007, J NEUROSURG, V107, P740, DOI 10.3171/JNS-07/10/0740
   Kemeny AA, 2004, ACT NEUR S, V91, P55
   Kim HY, 2010, J NEUROSURG, V113, P2, DOI 10.3171/2010.7.GKS101043
   MATHIS JA, 1995, AM J NEURORADIOL, V16, P299
   Mizoi K, 1998, NEUROL MED-CHIR, V38, P186, DOI 10.2176/nmc.38.suppl_186
   Moosa S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS14205
   Nagy G, 2017, NEUROSURGERY, V80, P180, DOI 10.1227/NEU.0000000000001212
   Nagy G, 2012, NEUROSURGERY, V70, P1458, DOI 10.1227/NEU.0b013e318246a4d0
   Nagy G, 2012, ACTA NEUROCHIR, V154, P383, DOI 10.1007/s00701-011-1245-5
   Pan DHC, 2000, J NEUROSURG, V93, P113, DOI 10.3171/jns.2000.93.supplement_3.0113
   Paul L, 2014, NEUROSURGERY, V75, P568, DOI 10.1227/NEU.0000000000000506
   Pollock BE, 2000, INT J RADIAT ONCOL, V48, P817, DOI 10.1016/S0360-3016(00)00696-9
   Pollock BE, 2002, J NEUROSURG, V96, P79, DOI 10.3171/jns.2002.96.1.0079
   Schauble B, 2004, NEUROLOGY, V63, P683, DOI 10.1212/01.WNL.0000134659.95217.6E
   Schuster L, 2011, EUR RADIOL, V21, P1267, DOI 10.1007/s00330-010-2031-0
   Seymour ZA, 2016, J NEUROSURG, V124, P163, DOI 10.3171/2014.12.JNS141308
   Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87
   Taeshineetanakul P, 2012, NEUROSURGERY, V71, P1071, DOI 10.1227/NEU.0b013e31826f79ec
   Yang SY, 2009, ACTA NEUROCHIR, V151, P113, DOI 10.1007/s00701-008-0173-5
   Zipfel GJ, 2004, J NEUROSURG, V101, P393, DOI 10.3171/jns.2004.101.3.0393
NR 48
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E604
EP E612
DI 10.1016/j.wneu.2019.08.065
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300072
PM 31442655
DA 2020-05-12
ER

PT J
AU Fanous, AA
   Kolcun, JPG
   Brusko, GD
   Paci, M
   Ghobrial, GM
   Nakhla, J
   Eleswarapu, A
   Lebwohl, NH
   Green, BA
   Gjolaj, JP
AF Fanous, Andrew A.
   Kolcun, John Paul G.
   Brusko, G. Damian
   Paci, Michael
   Ghobrial, George M.
   Nakhla, Jonathan
   Eleswarapu, Ananth
   Lebwohl, Nathan H.
   Green, Barth A.
   Gjolaj, Joseph P.
TI Surgical Site Infection as a Risk Factor for Long-Term Instrumentation
   Failure in Patients with Spinal Deformity: A Retrospective Cohort Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Instrumentation failure; Scoliosis; Spinal deformity; Surgical site
   infection
ID LUMBAR INTERBODY FUSION; DEEP WOUND-INFECTION; POSTOPERATIVE INFECTIONS;
   FOLLOW-UP; SURGERY; DISEASE; MANAGEMENT; ARTHRODESIS; DEBRIDEMENT;
   FIXATION
AB BACKGROUND: Surgical site infection (SSI) remains a complication of spine deformity surgery. Although fusion/instrumentation failure in the setting of SSI has been reported, few studies have investigated the relationship between these entities. We examine the relationship between early SSI and fusion/instrumentation failure after instrumented fusion in patients with thoracolumbar scoliosis.
   METHODS: A retrospective review of a prospectively maintained case series for patients undergoing spine surgery between January 1, 2006, and October 3, 2017. Inclusion criteria included age >= 18 years and surgery performed for correction of thoracolumbar scoliosis. Data collected included various demographic, clinical, and operative variables.
   RESULTS: 532 patients met inclusion criteria, with 20 (4%) experiencing SSI. Diabetes mellitus was the only demographic risk factor for increased SSI (P = 0.026). Number of fused levels, blood volume loss, and operative time were similar between groups. Fusion/instrumentation failure occurred in 68 (13%) patients, 10 of whom (15%) had SSI, whereas of the 464 patients with no fusion/instrumentation failure, only 10 (2%) had SSI (P < 0.001). Of the 20 patients with SSI, 10 (50%) had fusion/instrumentation failure, whereas in the 512 patients with no infection, only 58 (11%) had fusion/instrumentation failure (P < 0.001). Patients with infection also experienced significantly shorter time to fusion/instrumentation failure (P = 0.025), higher need for revision surgery (P < 0.001), and shorter time to revision surgery (P = 0.012).
   CONCLUSIONS: Early SSI significantly increases the risk of fusion/instrumentation failure in patients with thoracolumbar scoliotic deformity, and it significantly shortens the time to failure. Patients with early SSI have a significantly higher likelihood of requiring revision surgery and after a significantly shorter time interval.
C1 [Fanous, Andrew A.; Kolcun, John Paul G.; Brusko, G. Damian; Paci, Michael; Ghobrial, George M.; Green, Barth A.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
   [Eleswarapu, Ananth; Lebwohl, Nathan H.; Gjolaj, Joseph P.] Univ Miami, Miller Sch Med, Dept Orthoped Surg, Miami, FL 33136 USA.
   [Nakhla, Jonathan] Brown Univ, Rhode Isl Hosp, Dept Neurol Surg, Warren Alpert Med Sch, Providence, RI 02903 USA.
RP Brusko, GD (reprint author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
EM g.brusko@med.miami.edu
OI Eleswarapu, Ananth/0000-0002-8946-3647
CR ABBEY DM, 1995, J SPINAL DISORD, V8, P278, DOI 10.1097/00002517-199508040-00003
   Agha RA, 2017, INT J SURG, V46, P198, DOI 10.1016/j.ijsu.2017.08.586
   Ahn DK, 2012, J SPINAL DISORD TECH, V25, pE230, DOI 10.1097/BSD.0b013e31825c6f7b
   Alpert HW, 2014, J PEDIATR ORTHOPED, V34, P613, DOI 10.1097/BPO.0000000000000145
   BRANCH CL, 1987, SURG NEUROL, V27, P449, DOI 10.1016/0090-3019(87)90252-7
   Caputo Adam M, 2013, J Surg Orthop Adv, V22, P295
   Carragee E, 2008, SPINE, V33, P2089, DOI 10.1097/BRS.0b013e3181839b9c
   Chaichana KL, 2014, J NEUROSURG-SPINE, V20, P45, DOI 10.3171/2013.10.SPINE1364
   CLOWARD RB, 1985, CLIN ORTHOP RELAT R, P16
   COLLIS JS, 1985, CLIN ORTHOP RELAT R, P64
   De la Garza-Ramos R, 2017, J NEUROSURG SCI, V61, P64
   Falavigna A, 2011, J NEUROSURG-SPINE, V15, P399, DOI 10.3171/2011.5.SPINE10825
   Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f
   Faraj A A, 2000, Acta Orthop Belg, V66, P242
   Glaser J, 2003, SPINE, V28, P1390, DOI 10.1097/00007632-200307010-00008
   Glassman SD, 1996, SPINE, V21, P2163, DOI 10.1097/00007632-199609150-00021
   Hagg O, 2003, EUR SPINE J, V12, P22, DOI 10.1007/s00586-002-0465-z
   HEGGENESS MH, 1993, SPINE, V18, P492
   HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606
   HUTTER CG, 1985, CLIN ORTHOP RELAT R, P103
   Kanayama M, 2007, J NEUROSURG-SPINE, V6, P327, DOI 10.3171/spi.2007.6.4.7
   Kanayama M, 2017, CLIN SPINE SURG, V30, pE99, DOI 10.1097/BSD.0b013e3182aa4c72
   Kasliwal Manish K, 2013, Surg Neurol Int, V4, pS392, DOI 10.4103/2152-7806.120783
   Kuklo TR, 2006, J SPINAL DISORD TECH, V19, P376, DOI 10.1097/01.bsd.0000203945.03922.f6
   Lall RR, 2015, J CLIN NEUROSCI, V22, P238, DOI 10.1016/j.jocn.2014.07.010
   Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975
   Malhotra A, 2015, INSIGHTS IMAGING, V6, P579, DOI 10.1007/s13244-015-0435-8
   MASSIE JB, 1992, CLIN ORTHOP RELAT R, P99
   McPhee IB, 1998, SPINE, V23, P726, DOI 10.1097/00007632-199803150-00015
   Mirovsky Y, 2007, J SPINAL DISORD TECH, V20, P127, DOI 10.1097/01.bsd.0000211266.66615.e5
   Perry JW, 1997, CLIN INFECT DIS, V24, P558, DOI 10.1093/clind/24.4.558
   Piazza M, 2017, J CLIN NEUROSCI, V45, P33, DOI 10.1016/j.jocn.2017.07.038
   Rayes M, 2010, J NEUROSURG-SPINE, V12, P647, DOI 10.3171/2009.12.SPINE09428
   RICHARDS BS, 1995, J BONE JOINT SURG AM, V77A, P524, DOI 10.2106/00004623-199504000-00004
   ROYCAMILLE R, 1986, CLIN ORTHOP RELAT R, P7
   SCHOFFERMAN L, 1991, SPINE, V16, P356, DOI 10.1097/00007632-199103000-00017
   Shapiro SA, 1997, SURG NEUROL, V48, P566, DOI 10.1016/S0090-3019(97)00296-6
   Smith JS, 2011, SPINE, V36, P556, DOI 10.1097/BRS.0b013e3181eadd41
   Soultanis K, 2003, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000068357.47147.10
   Talia AJ, 2015, J CLIN NEUROSCI, V22, P1111, DOI 10.1016/j.jocn.2014.12.028
   THALGOTT JS, 1991, SPINE, V16, P981, DOI 10.1097/00007632-199108000-00020
   Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967
   Venu V, 2011, SEMIN MUSCULOSKEL R, V15, P151, DOI 10.1055/s-0031-1275598
   Viola RW, 1997, SPINE, V22, P2444, DOI 10.1097/00007632-199710150-00023
   Wang TY, 2017, J CLIN NEUROSCI, V39, P164, DOI 10.1016/j.jocn.2017.01.020
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
NR 46
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E514
EP E519
DI 10.1016/j.wneu.2019.08.088
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300061
PM 31449998
DA 2020-05-12
ER

PT J
AU Field, NC
   Raviv, N
   Adamo, MA
AF Field, Nicholas C.
   Raviv, Nataly
   Adamo, Matthew A.
TI Utility of Postoperative Fever Workup After Craniosynostosis Repair
SO WORLD NEUROSURGERY
LA English
DT Article
DE Craniosynostosis; Fever; Pediatrics
ID SURGICAL-TREATMENT; TRANSFUSION; COMPLICATIONS; CHILDREN; COST
AB BACKGROUND: Craniosynostosis is the premature fusion of >= 1 cranial sutures. Surgical management involves early cranial vault reconstruction. Postoperative management of these patients is often complicated by fever of unknown origin and results in additional laboratory studies, extended hospital intensive care unit stays, and increased cost to the patient.
   METHODS: A retrospective analysis of 70 consecutive patients who underwent cranial vault reconstruction were included. Postoperative fever (Tmax), length of stay, transfusions, estimated blood loss, and white blood cell counts were obtained, as well as blood, urine, and other culture data.
   RESULTS: Mean age at surgery was 1.1 years. Sixty (86%) patients had idiopathic postoperative fevers >38 degrees C. Of those, 20% underwent fever workups, none of which returned a positive culture or concern for pneumonia. Length of stay was significantly increased in patients who had fever workups (6.1 days vs. 4.7, P < 0.001). There was no significant difference in age, estimated blood loss, Tmax, white blood cell count, and day of postoperative fever between groups. The average estimated cost of a fever workup at our institution is $1288 (U.S. dollars).
   CONCLUSIONS: Fever of unknown origin is a common finding after craniosynostosis repair. Workup for fever of unknown did not result in the identification of an infection and added significantly to the cost and patient's length of stay.
C1 [Field, Nicholas C.; Raviv, Nataly; Adamo, Matthew A.] Albany Med Coll, Dept Neurosurg, Albany, NY 12208 USA.
RP Field, NC (reprint author), Albany Med Coll, Dept Neurosurg, Albany, NY 12208 USA.
EM fieldn@amc.edu
CR Abbott MM, 2012, J CRANIOFAC SURG, V23, P88, DOI 10.1097/SCS.0b013e318240f965
   Chan JWH, 2013, J CRANIOFAC SURG, V24, P170, DOI 10.1097/SCS.0b013e3182646ab8
   Cornelissen M, 2016, J CRANIO MAXILL SURG, V44, P1273, DOI 10.1016/j.jcms.2016.07.007
   Dadure C, 2011, ANESTHESIOLOGY, V114, P856, DOI 10.1097/ALN.0b013e318210f9e3
   Deva AY, 2002, PLAST RECONSTR SURG, V109, P58, DOI 10.1097/00006534-200201000-00010
   Di Rocco F, 2009, J NEUROSURG-PEDIATR, V4, P21, DOI 10.3171/2009.3.PEDS08355
   Esparza J, 2008, NEUROCIRUGIA, V19, P509
   Esparza J, 2008, CHILD NERV SYST, V24, P1421, DOI 10.1007/s00381-008-0691-8
   Fearon JA, 2002, PLAST RECONSTR SURG, V109, P2190, DOI 10.1097/00006534-200206000-00002
   KEARNEY RA, 1989, CAN J ANAESTH, V36, P473, DOI 10.1007/BF03005352
   Markiewicz MR, 2017, J ORAL MAXIL SURG, V75, P1732, DOI 10.1016/j.joms.2017.01.029
   Takagi S, 2006, J CRANIOFAC SURG, V17, P202, DOI 10.1097/01.scs.0000194173.99044.c8
   Vega RA, 2014, J NEUROSURG-PEDIATR, V14, P190, DOI 10.3171/2014.4.PEDS13449
   Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647
   Wolfswinkel EM, 2017, PLAST RECONSTR SURG, V140, P1235, DOI 10.1097/PRS.0000000000003848
NR 15
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E430
EP E433
DI 10.1016/j.wneu.2019.08.122
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300050
PM 31470155
DA 2020-05-12
ER

PT J
AU Flores-Justa, A
   Baldoncini, M
   Cruz, JCP
   Gonzalez, FS
   Martinez, OA
   Gonzalez-Lopez, P
   Campero, A
AF Flores-Justa, Ana
   Baldoncini, Matias
   Perez Cruz, Julio C.
   Sanchez Gonzalez, Federico
   Martinez, Oscar A.
   Gonzalez-Lopez, Pablo
   Campero, Alvaro
TI White Matter Topographic Anatomy Applied to Temporal Lobe Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Epilepsy surgery; Fiber dissection; Fiber tracts; Fiber tracts
   topography; Tractography
ID MICROSURGICAL ANATOMY; SURGICAL-TREATMENT; EPILEPSY; NETWORKS
AB BACKGROUND: The temporal lobe is an important and complex anatomic region of the brain. Accurate knowledge of anatomic relationships becomes extremely relevant when deciding surgical strategy, such as epilepsy or oncologic surgery, involving this lobe. To our knowledge, there is no strong literature highlighting the relationship between white matter tracts and craniometric landmarks applied to temporal lobe surgery. We aim to describe the topographic relationship between the craniometric points and white matter tracts of the temporal lobe through dissection of cadaveric specimens and describe the potential preoperative usefulness of diffusion tensor imaging in relation to the anatomic features found during the dissections.
   METHODS: Fifteen formalin-fixed whole cadaveric heads were dissected by the Klingler technique in a stepwise manner across the temporal and sphenoid bone windows. The white matter pathways were identified in their different planes and their position was described in relation to craniometric landmarks. Diffusion tensor studies were performed in 2 healthy volunteers to analyze the temporal fasciculi in vivo.
   RESULTS: We identified the topographic relationships between craniometric points and relevant association tracts that lie within the cranial corridors (superior and inferior frontal, parietal, occipital, sphenoidal, and temporal). Important landmarks were defined in correspondence to these different fasciculi.
   CONCLUSIONS: Through this kind of microsurgical anatomic study, a better understanding of the different anatomic layers of the temporal region might be achieved. This factor is essential in planning adequate surgery and strategies to operate in the temporal lobe, improving surgical results and minimizing functional deficits.
C1 [Flores-Justa, Ana] Univ Clin Hosp Santiago de Compostela, Dept Neurol Surg, Santiago De Compostela, Spain.
   [Flores-Justa, Ana; Baldoncini, Matias] Univ Buenos Aires, Med Sch, Lab Neuroanat Microsurg LaNeMic, Div Anat 2, Buenos Aires, DF, Argentina.
   [Baldoncini, Matias] San Fernando Hosp, Dept Neurol Surg, Buenos Aires, DF, Argentina.
   [Perez Cruz, Julio C.] IPN, Fac Med, Higher Sch Med, Anat Acad, Mexico City, DF, Mexico.
   [Perez Cruz, Julio C.] Univ Nacl Autonoma Mexico, Fac Med, Lic Neurosci, Mexico City, DF, Mexico.
   [Sanchez Gonzalez, Federico] Univ Buenos Aires, Clin Hosp, Neurosurg Div, Epilepsy Surg Sect, Buenos Aires, DF, Argentina.
   [Sanchez Gonzalez, Federico] Clin Cuyo, Neurosurg Div, Mendoza, Argentina.
   [Martinez, Oscar A.] Univ Buenos Aires, Clin Hosp, Neurol Div, Epilepsy Sect, Buenos Aires, DF, Argentina.
   [Gonzalez-Lopez, Pablo] Hosp Gen Alicante, Dept Neurosurg, Alicante, Spain.
   [Campero, Alvaro] Padilla Hosp, Dept Neurol Surg, San Miguel De Tucuman, Argentina.
RP Flores-Justa, A (reprint author), Univ Clin Hosp Santiago de Compostela, Dept Neurol Surg, Santiago De Compostela, Spain.; Flores-Justa, A (reprint author), Univ Buenos Aires, Med Sch, Lab Neuroanat Microsurg LaNeMic, Div Anat 2, Buenos Aires, DF, Argentina.
EM annaflores36@gmail.com
OI Gonzalez-Lopez, Pablo/0000-0001-8614-0992; Baldoncini,
   Matias/0000-0001-9323-8306
CR Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x
   Cataldi M, 2013, EPILEPSIA, V54, P2048, DOI 10.1111/epi.12400
   EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373
   Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D
   FALCONER MA, 1968, ARCH NEUROL-CHICAGO, V19, P353, DOI 10.1001/archneur.1968.00480040019001
   Gusmao S, 2003, ARQ NEURO-PSIQUIAT, V61, P305, DOI 10.1590/S0004-282X2003000200030
   Kendir S, 2009, J NEUROSURG, V111, P365, DOI 10.3171/2008.10.JNS08159
   Klingler J, 1956, ATLAS CEREBRI HUMANI
   Liu M, 2016, BRAIN, V139, P2431, DOI 10.1093/brain/aww167
   Martino J, 2013, NEUROSURGERY, V72, P87, DOI 10.1227/NEU.0b013e318274294b
   Niewenhuys R, 2008, HUMAN CENTRAL NERVOU
   Parraga RG, 2012, NEUROSURGERY, V71, P160, DOI 10.1227/NEU.0b013e3182556fde
   PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001
   Rhoton AL, 2002, NEUROSURGERY, V51, pS375, DOI 10.1227/01.NEU.0000028833.01529.E7
   Ribas EC, 2015, J NEUROSURG, V122, P1263, DOI 10.3171/2014.10.JNS141194
   Ribas GC, 2006, NEUROSURGERY, V59, P177, DOI 10.1227/01.NEU.0000240682.28616.b2
   Ribas GC, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09245
   SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005
   SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x
   Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x
   Testut L, 1988, TRATADO ANATOMIA HUM
   Ture U, 2000, NEUROSURGERY, V47, P417, DOI 10.1097/00006123-200008000-00028
   Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501
   Yagmurlu K, 2015, OPER NEUROSURG, V11, P274, DOI 10.1227/NEU.0000000000000704
NR 24
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E670
EP E679
DI 10.1016/j.wneu.2019.08.050
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300081
PM 31442654
DA 2020-05-12
ER

PT J
AU Giordano, M
   Bianconi, A
   Gallieni, M
   Metwali, H
   Samii, M
   Samii, A
AF Giordano, Mario
   Bianconi, Andrea
   Gallieni, Massimo
   Metwali, Hussam
   Samii, Madjid
   Samii, Amir
TI Prognostic Significance of Preoperative Geometric Changes in the
   Internal Acoustic Canal for Hearing Preservation in Vestibular
   Schwannoma Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hearing preservation; Internal acoustic canal; Vestibular schwannoma
ID MIDDLE FOSSA; FACIAL-NERVE; TUMOR SIZE; NEUROMA; RESECTION; REMOVAL
AB OBJECTIVE: This study focused on the changes in the internal acoustic canal (IAC) caused by vestibular schwannomas (VSs) and their prognostic significance for postoperative hearing outcome.
   METHODS: A total of 125 consecutive cases of VS were included. We used a neuronavigation software to perform the following measurements on both the tumor side and healthy side: volume of the IAC (VIAC), maximal diameter of the IAC (DIAC), and length of the IAC (LIAC). A statistical analysis was realized using Spearman correlation to test the correlation of the morphometric measure of the IAC and postoperative hearing. Multivariate analysis was performed to test the impact of measurements of the IAC and preoperative hearing on postoperative hearing.
   RESULTS: The mean VIAC on the tumor side and on the healthy side was 0.271 and 0.169 cm(3), respectively. The mean DIAC was 9.438 mm on the tumor side and 7.034 mm contralateral. The correlations tests showed significant correlations of both postoperative hearing deficit and degree of hearing loss with 1) VIAC on the tumor side, 2) difference between VIAC on the tumor side and healthy side, 3) DIAC on the tumor side, and 4) difference between the DIAC on the tumor side and healthy side. The multivariate analysis showed significant impact of the DIAC (P = 0.01) and preoperative hearing status (P = 0.02) on postoperative hearing.
   CONCLUSIONS: Enlargement of the VIAC and DIAC are negative prognostic factors for hearing preservation. Reasons may be long-standing compression of the auditory nerve and an increased vulnerability of the inner ear structures during the drilling of the IAC.
C1 [Giordano, Mario; Gallieni, Massimo; Metwali, Hussam; Samii, Madjid; Samii, Amir] Int Neurosci Inst, Dept Neurosurg, Hannover, Germany.
   [Bianconi, Andrea] Univ Turin, Dept Neurosci, Turin, Italy.
   [Samii, Amir] Leibniz Inst Neurobiol, Magdeburg, Germany.
RP Gallieni, M (reprint author), Int Neurosci Inst, Dept Neurosurg, Hannover, Germany.
EM drgallieni@gmail.com
OI Gallieni, Massimo/0000-0002-5314-8581
CR Ahsan SF, 2017, OTOL NEUROTOL, V38, P1505, DOI 10.1097/MAO.0000000000001560
   BRACKMANN DE, 1994, AM J OTOL, V15, P614
   BROOKES GB, 1994, CLIN OTOLARYNGOL, V19, P204, DOI 10.1111/j.1365-2273.1994.tb01216.x
   Colletti V, 1997, OTOLARYNG HEAD NECK, V117, P596, DOI 10.1016/S0194-5998(97)70039-1
   Colletti V, 2003, OTOL NEUROTOL, V24, P927, DOI 10.1097/00129492-200311000-00018
   DORNHOFFER JL, 1995, LARYNGOSCOPE, V105, P184, DOI 10.1288/00005537-199502000-00014
   Gerganov V, 2009, J CLIN NEUROSCI, V16, P1009, DOI 10.1016/j.jocn.2008.08.029
   Gerganov VM, 2012, J NEUROSURG, V116, P713, DOI 10.3171/2011.12.JNS111682
   Gerganov VM, 2011, J NEUROSURG, V115, P1087, DOI 10.3171/2011.7.JNS11495
   Gjuric M, 2008, SKULL BASE-INTERD AP, V18, P317, DOI 10.1055/s-0028-1086056
   GLASSCOC.ME, 1968, ARCH OTOLARYNGOL, V88, P578
   HAINES SJ, 1993, J NEUROSURG, V79, P515, DOI 10.3171/jns.1993.79.4.0515
   Hecht CS, 1997, LARYNGOSCOPE, V107, P1122, DOI 10.1097/00005537-199708000-00021
   Irving RM, 1998, J NEUROSURG, V88, P840, DOI 10.3171/jns.1998.88.5.0840
   Jacob A, 2007, LARYNGOSCOPE, V117, P2087, DOI 10.1097/MLG.0b013e3181453a07
   Miller ME, 2014, OTOL NEUROTOL, V35, P348, DOI 10.1097/MAO.0000000000000191
   Mohr G, 2005, J NEUROSURG, V102, P1, DOI 10.3171/jns.2005.102.1.0001
   Nguyen QT, 2012, OTOL NEUROTOL, V33, P455, DOI 10.1097/MAO.0b013e318245cf01
   Roosli C, 2012, OTOL NEUROTOL, V33, P473, DOI 10.1097/MAO.0b013e318248ee02
   Samii M, 2008, Prog Neurol Surg, V21, P136, DOI 10.1159/000156900
   Samii M, 1997, NEUROSURGERY, V40, P248, DOI 10.1097/00006123-199702000-00005
   SAMII M, 1997, NEUROSURGERY, V40, P260, DOI DOI 10.1227/01.NEU.0000023603.90705.6B
   Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527
   Samii M, 2010, J NEUROSURG, V112, P860, DOI 10.3171/2009.7.JNS0989
   SHELTON C, 1991, LARYNGOSCOPE, V101, P925
   Somers T, 2001, OTOL NEUROTOL, V22, P87, DOI 10.1097/00129492-200101000-00017
   Staecker H, 2000, AM J OTOL, V21, P399, DOI 10.1016/S0196-0709(00)80051-4
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E223
EP E227
DI 10.1016/j.wneu.2019.08.194
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300028
PM 31493598
DA 2020-05-12
ER

PT J
AU Giordano, M
   Gallieni, M
   Metwali, H
   Fahlbusch, R
   Samii, M
   Samii, A
AF Giordano, Mario
   Gallieni, Massimo
   Metwali, Hussam
   Fahlbusch, Rudolf
   Samii, Madjid
   Samii, Amir
TI Can Intraoperative Magnetic Resonance Imaging Be Helpful in the Surgical
   Resection of Parasellar Meningiomas? A Case Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Imaging; Intraoperative; MRI; Parasellar meningiomas
ID TUMOR RESECTION; GLIOMA SURGERY; RESECTABILITY; FEASIBILITY; EXTENT
AB OBJECTIVE: The surgery of parasellar meningiomas is crucial. There are only a few reports of the use of intraoperative magnetic resonance imaging (iMRI) for resection of these lesions. We discuss the safety and usefulness of this technique in achieving the planned surgical goal and analyze patients' outcomes.
   METHODS: Nineteen cases of parasellar meningioma were treated in our institution using iMRI. We classified the tumors according to their primary location: tuberculum sellae, clinoidal, and cavernous sinus meningiomas. We evaluated the history of previous surgery, outcome, residual (if present) tumor volume, degree of resection, achievement of the surgical goal, and number of iMRI scans.
   RESULTS: The preoperative surgical goal was achieved in all patients. In 7 of 19 patients, (37%) further tumor resection was performed after the first iMRI scan. Regarding the cavernous sinus group, the surgical resection was continued after the first iMRI in 56% of patients, obtaining substantial additional volume reduction. No complications were found related to the use of iMRI scan.
   CONCLUSIONS: iMRI has been effective in safely increasing the extent of parasellar meningioma resection mainly for recurrent and invasive tumors. Its usefulness has been seen mostly in cavernous sinus lesions, in which it allowed the further safe resection in 56% of cases. Moreover, this tool was particularly useful in recurrent or residual meningiomas with extension in extracranial compartments.
C1 [Giordano, Mario; Gallieni, Massimo; Metwali, Hussam; Fahlbusch, Rudolf; Samii, Madjid; Samii, Amir] Int Neurosci Inst, Dept Neurosurg, Hannover, Germany.
   [Samii, Amir] Leibniz Inst Neurobiol, Magdeburg, Germany.
RP Giordano, M (reprint author), Int Neurosci Inst, Dept Neurosurg, Hannover, Germany.
EM giordano.nch@gmail.com
OI Gallieni, Massimo/0000-0002-5314-8581
CR Adeolu A A, 2006, West Afr J Med, V25, P174
   Akutsu H, 2009, NEUROSURGERY, V65, P54, DOI 10.1227/01.NEU.0000348016.69726.A6
   Ashour R, 2016, WORLD NEUROSURG, V93, P183, DOI 10.1016/j.wneu.2016.06.045
   Attia M, 2013, WORLD NEUROSURG, V80, pE367, DOI 10.1016/j.wneu.2012.10.016
   Coburger J, 2016, NEUROSURGERY, V78, P775, DOI 10.1227/NEU.0000000000001081
   Dort JC, 2001, LARYNGOSCOPE, V111, P1570, DOI 10.1097/00005537-200109000-00014
   Frisius J, 2015, CLIN NEUROL NEUROSUR, V133, P46, DOI 10.1016/j.clineuro.2015.03.005
   Gerganov VM, 2012, TUMOR CENT NERV SYST, V4, P167, DOI 10.1007/978-94-007-1706-0_18
   Gerlach R, 2008, NEUROSURGERY, V63, P272, DOI 10.1227/01.NEU.0000312362.63693.78
   Giordano M, 2017, J NEUROSURG-PEDIATR, V19, P77, DOI 10.3171/2016.8.PEDS15708
   Giordano M, 2016, CHILD NERV SYST, V32, P1915, DOI 10.1007/s00381-016-3177-0
   Giordano M, 2014, NEUROSURG REV, V37, P139, DOI 10.1007/s10143-013-0510-x
   GOLDSMITH BJ, 1994, J NEUROSURG, V80, P195, DOI 10.3171/jns.1994.80.2.0195
   Knauth M, 1999, AM J NEURORADIOL, V20, P1642
   LARSON JJ, 1995, J NEUROSURG, V83, P596, DOI 10.3171/jns.1995.83.4.0596
   Li D, 2015, NEUROSURG REV, V38, P71, DOI 10.1007/s10143-014-0575-1
   Matsuda Masahide, 2017, Surg Neurol Int, V8, P185, DOI 10.4103/sni.sni_86_17
   Nakamura M, 2006, NEUROSURGERY, V59, P1019, DOI 10.1227/01.NEU.0000245600.92322.06
   Nanda A, 2016, J NEUROSURG, V125, P378, DOI 10.3171/2015.3.JNS142494
   Nimsky C, 2006, NEUROSURGERY, V59, P105, DOI 10.1227/01.NEU.0000219198.38423.1E
   OSullivan MG, 1997, NEUROSURGERY, V40, P238, DOI 10.1097/00006123-199702000-00003
   Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6
   Shrivastava RK, 2005, J NEUROSURG, V103, P491, DOI 10.3171/jns.2005.103.3.0491
   Sughrue ME, 2010, J NEUROSURG, V113, P1087, DOI 10.3171/2010.3.JNS091807
   Terpolilli NA, 2016, J NEUROSURG, V124, P1319, DOI 10.3171/2015.5.JNS15330
   Vaughan TB, 2012, SCHMIDEK SWEET OPERA, P192
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E577
EP E584
DI 10.1016/j.wneu.2019.08.070
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300068
PM 31442639
DA 2020-05-12
ER

PT J
AU Gjerde, PB
   Litleskare, S
   Lura, NG
   Tangen, T
   Helland, CA
   Wester, K
AF Gjerde, Priyanthi B.
   Litleskare, Sverre
   Lura, Njal Gjaerde
   Tangen, Tone
   Helland, Christian A.
   Wester, Knut
TI Anxiety and Depression in Patients with Intracranial Arachnoid Cysts-A
   Prospective Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anxiety; Arachnoid cyst; Cognition; Depression; Frontal lobe; Temporal
   lobe
ID QUALITY-OF-LIFE; INCIDENTAL FINDINGS; HOSPITAL ANXIETY; NATURAL-HISTORY;
   FOSSA; DECOMPRESSION; PSYCHOSIS; PREVALENCE; LATERALITY; ASYMMETRY
AB BACKGROUND: Arachnoid cysts yield cognitive deficits that are normalized after surgical cyst decompression.
   OBJECTIVE: The present study aimed to investigate whether arachnoid cysts also affect symptoms of anxiety and depression, and if surgical cyst decompression leads to reduction of these symptoms.
   METHODS: Twenty-two adult patients (13 men and 9 women) with symptomatic temporal or frontal cysts were included in this questionnaire (Hospital Anxiety and Depression Scale [HADS])-based prospective study. The mean time between answering the preoperative questionnaire and surgery was 37 days. The patients answered the same HADS questionnaire 3-6 months postoperatively.
   RESULTS: Preoperatively, both patients with frontal (N = 4) and patients with temporal (N = 18) cyst had higher mean HADS anxiety scores than those found in the general population. For patients with temporal cyst, there was a significant or near-significant difference in anxiety and depression scores and the combined scores between those with right-sided cysts and those with left-sided cysts. Postoperatively, the HADS scores normalized and were no longer different from those of the general population. The difference in scores between patients with right and left temporal cyst also disappeared.
   CONCLUSIONS: Patients with arachnoid cyst have higher levels of anxiety and depression than do the general population and these scores were normalized after decompressive cyst surgery. We further found a hemispheric asymmetry: patients with a right temporal cyst showed higher anxiety, depression, and combined scores than did patients with a left temporal cyst. Also, this disparity normalized after cyst decompression. Thus, arachnoid cysts seem to affect not only cognition but also the level of affective symptoms.
C1 [Gjerde, Priyanthi B.; Litleskare, Sverre; Lura, Njal Gjaerde; Tangen, Tone; Helland, Christian A.; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
   [Gjerde, Priyanthi B.] Univ Bergen, Norwegian Ctr Mental Disorders Res NORMENT, Dept Clin Med K2, Bergen, Norway.
   [Gjerde, Priyanthi B.] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Med K2, Bergen, Norway.
   [Litleskare, Sverre] Uni Res Hlth, Res Unit Gen Practice, Bergen, Norway.
   [Lura, Njal Gjaerde] Haukeland Hosp, Dept Radiol, Bergen, Norway.
   [Helland, Christian A.; Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway.
   [Tangen, Tone] Haukeland Hosp, Sect Psychiat, Bergen, Norway.
RP Wester, K (reprint author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.; Wester, K (reprint author), Haukeland Hosp, Dept Neurosurg, Bergen, Norway.
EM kgwe@helse-bergen.no
CR Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548
   Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464
   Bahk WM, 2002, PSYCHIAT CLIN NEUROS, V56, P203, DOI 10.1046/j.1440-1819.2002.00945.x
   Baquero G A, 2014, Open Neuroimag J, V8, P1, DOI 10.2174/1874440001408010001
   Bechter K, 2010, PSYCHIAT RES-NEUROIM, V184, P196, DOI 10.1016/j.pscychresns.2010.03.009
   Berle M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-8
   Berle M, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-17
   Berle M, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-19
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Cummings JL, 1997, BRAIN LANG, V57, P22, DOI 10.1006/brln.1997.1832
   da Silva Joaquim Alves, 2007, Ann Gen Psychiatry, V6, P16, DOI 10.1186/1744-859X-6-16
   Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008
   DEVOLDER AG, 1994, J NEUROL NEUROSUR PS, V57, P296, DOI 10.1136/jnnp.57.3.296
   Eskandary H, 2005, SURG NEUROL, V63, P550, DOI 10.1016/j.surneu.2004.07.049
   GALASSI E, 1982, SURG NEUROL, V17, P363, DOI 10.1016/0090-3019(82)90315-9
   Ganguli Mary, 2009, Indian J Psychiatry, V51 Suppl 1, pS29
   Gjerde PB, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-21
   Gundersen H, 2007, J NEUROL, V254, P60, DOI 10.1007/s00415-006-0280-2
   Helland CA, 2007, J NEUROL NEUROSUR PS, V78, P1129, DOI 10.1136/jnnp.2006.107995
   Helland CA, 2007, J NEUROL NEUROSUR PS, V78, P620, DOI 10.1136/jnnp.2006.101865
   Helland CA, 2006, J NEUROSURG, V105, P385, DOI 10.3171/ped.2006.105.5.385
   Helland CA, 2018, ARACHNOID CYSTS: CLINICAL AND SURGICAL MANAGEMENT, P45, DOI 10.1016/B978-0-12-814378-0.00005-4
   Helland CA, 2010, J NEUROSURG, V113, P934, DOI 10.3171/2009.11.JNS081663
   Horiguchi T, 2000, World J Biol Psychiatry, V1, P159, DOI 10.3109/15622970009150585
   Isaksen E, 2013, ACTA NEUROCHIR, V155, P841, DOI 10.1007/s00701-013-1641-0
   Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36
   Kohn R, 1989, J Neuropsychiatry Clin Neurosci, V1, P60
   KUHNLEY EJ, 1981, J CLIN PSYCHIAT, V42, P167
   Kuloglu M, 2008, PROG NEURO-PSYCHOPH, V32, P1353, DOI 10.1016/j.pnpbp.2008.04.014
   Laporte N, 2012, PEDIATR NEUROL, V46, P44, DOI 10.1016/j.pediatrneurol.2011.10.001
   Lebowitz BK, 2006, NEUROCASE, V12, P339, DOI 10.1080/13554790601087165
   Levy ML, 2003, NEUROSURGERY, V53, P1138, DOI 10.1227/01.NEU.0000089060.65702.03
   Mainio A, 2005, J NEUROSURG, V103, P841, DOI 10.3171/jns.2005.103.5.0841
   Mainio A, 2003, J NEUROL NEUROSUR PS, V74, P1278, DOI 10.1136/jnnp.74.9.1278
   Morkve SH, 2016, NEUROSURGERY, V78, P613, DOI 10.1227/NEU.0000000000001100
   Morris Zoe, 2009, BMJ, V339, pb3016, DOI 10.1136/bmj.b3016
   Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540
   Park YS, 2009, CHILD NERV SYST, V25, P1071, DOI 10.1007/s00381-009-0872-0
   Pringle AM, 1999, BRIT J NEUROSURG, V13, P46, DOI 10.1080/02688699944177
   Raeder MB, 2005, NEUROLOGY, V64, P160, DOI 10.1212/01.WNL.0000148724.61966.A4
   RICHARDS A, 1995, NEUROPSYCHOLOGIA, V33, P835, DOI 10.1016/0028-3932(95)00022-U
   Richter A, 2015, WORLD NEUROSURG, V84, P927, DOI 10.1016/j.wneu.2015.05.031
   Soukup VM, 1998, BRAIN DEV-JPN, V20, P589, DOI 10.1016/S0387-7604(98)00049-7
   Spansdahl T, 2007, ACTA NEUROCHIR, V149, P1025, DOI 10.1007/s00701-007-1272-4
   Stowe LA, 2000, BRAIN LANG, V75, P347, DOI 10.1006/brln.2000.2358
   Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8
   Torgersen J, 2010, J NEUROL, V257, P1909, DOI 10.1007/s00415-010-5634-0
   Tsurushima H, 2000, NEUROL MED-CHIR, V40, P339, DOI 10.2176/nmc.40.339
   Vakis AF, 2006, BRIT J NEUROSURG, V20, P156, DOI 10.1080/02688690600776986
   Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972
   Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008
   WESTER K, 1995, J NEUROL NEUROSUR PS, V59, P293, DOI 10.1136/jnnp.59.3.293
   WESTER K, 1992, NEUROSURGERY, V31, P940, DOI 10.1227/00006123-199211000-00018
   Wester K, 2003, J NEUROL, V250, P36, DOI 10.1007/s00415-003-0941-3
   Wester K, 2008, J NEUROL, V255, P1113, DOI 10.1007/s00415-008-0011-y
   Wester K, 2018, ARACHNOID CYSTS: CLINICAL AND SURGICAL MANAGEMENT, P55, DOI 10.1016/B978-0-12-814378-0.00006-6
   Wiedemann G, 1999, ARCH GEN PSYCHIAT, V56, P78, DOI 10.1001/archpsyc.56.1.78
   Zaatreh MM, 2002, PEDIATR NEUROL, V26, P134, DOI 10.1016/S0887-8994(01)00379-4
NR 59
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E645
EP E653
DI 10.1016/j.wneu.2019.08.058
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300078
PM 31442638
DA 2020-05-12
ER

PT J
AU Gmeiner, M
   Wagner, H
   Schlogl, C
   van Ouwerkerk, WJR
   Senker, W
   Sardi, G
   Rauch, P
   Holl, K
   Gruber, A
AF Gmeiner, Matthias
   Wagner, Helga
   Schloegl, Claudia
   van Ouwerkerk, Willem J. R.
   Senker, Wolfgang
   Sardi, Gracija
   Rauch, Philip
   Holl, Kurt
   Gruber, Andreas
TI Adult Outcome in Shunted Pediatric Hydrocephalus: Long-Term Functional,
   Social, and Neurocognitive Results
SO WORLD NEUROSURGERY
LA English
DT Article
DE Epilepsy; Hydrocephalus; Long-term functional, social, and cognitive
   outcome; Shunt infection; Shunt revision; Ventriculoperitoneal shunt
ID QUALITY-OF-LIFE; YOUNG-ADULTS; SPINA-BIFIDA; FOLLOW-UP; CONGENITAL
   HYDROCEPHALUS; WORK PARTICIPATION; CHILDREN; CHILDHOOD; MEMORY; DEATH
AB OBJECTIVE: Very long-term outcomes are rarely reported for patients with shunted pediatric hydrocephalus. This study aimed to determine the functional, social, and neurocognitive outcomes of such patients after transition to adulthood.
   METHODS: Adult patients with pediatric hydrocephalus who underwent their first shunt operation between 1982 and 1992 were included. Functional, social, educational, working aspects, and verbal intelligence were evaluated. In patients with average or above average verbal intelligence, detailed neuropsychological testing was performed and memory, executive functioning, selective attention, and concentration were assessed.
   RESULTS: Overall, 137 patients underwent primary surgery because of pediatric hydrocephalus, 53 (38.7%) of whom died during the follow-up period. Of the 84 long-term survivors, 65 (77.4%) agreed to participate and were included for further analysis. Forty-five patients (69.2%) had completed secondary school, but only 34 (52.3%) were integrated in the open labor market. Although the verbal intelligence of 31 patients (47.7%) was within the normal range, 19 (29.2%) had a severe mental handicap. Shunt infections (P = 0.0025), epilepsy (P < 0.0001), and the number of shunt operations (P = 0.0082) were associated with reduced verbal intelligence. Most patients with average or above average verbal intelligence had deficits in detailed neuropsychological testing. In 23 patients, detailed neuropsychological testing was performed.
   CONCLUSIONS: The overall long-term outcome of patients with shunted pediatric hydrocephalus is poor. These results highlight the importance of lifelong routine controls to avoid later complications. Further, repeated neuropsychological examinations might be important to understand the patient's special needs to optimize professional support.
C1 [Gmeiner, Matthias; Senker, Wolfgang; Sardi, Gracija; Rauch, Philip; Holl, Kurt; Gruber, Andreas] Kepler Univ Hosp, Dept Neurosurg, Neuromed Campus, Linz, Austria.
   [Gmeiner, Matthias; Gruber, Andreas] Johannes Kepler Univ JKU Linz, Linz, Austria.
   [Wagner, Helga] Johannes Kepler Univ Linz, Dept Appl Stat, Linz, Austria.
   [Schloegl, Claudia] Kepler Univ Hosp, Dept Clin Psychol, Linz, Austria.
   [van Ouwerkerk, Willem J. R.] Vrije Univ, Dept Neurosurg, Univ Med Ctr Amsterdam, Amsterdam, Netherlands.
RP Gmeiner, M (reprint author), Kepler Univ Hosp, Dept Neurosurg, Neuromed Campus, Linz, Austria.; Gmeiner, M (reprint author), Johannes Kepler Univ JKU Linz, Linz, Austria.
EM matthias.gmeiner@kepleruniklinikum.at
CR Acakpo-Satchivi L, 2008, CHILD NERV SYST, V24, P197, DOI 10.1007/s00381-007-0408-4
   Anger H, 1980, VERBALER KURZINTELLI
   Arrington CN, 2016, NEUROPSYCHOL REV, V26, P329, DOI 10.1007/s11065-016-9335-z
   Aschoff A, 1999, NEUROSURG REV, V22, P67, DOI 10.1007/s101430050035
   Barnes M, 2004, J INT NEUROPSYCH SOC, V10, P655, DOI 10.1017/S1355617704105055
   Bourgeois M, 1999, J NEUROSURG, V90, P274, DOI 10.3171/jns.1999.90.2.0274
   Casey ATH, 1997, PEDIATR NEUROSURG, V27, P63, DOI 10.1159/000121229
   Cope H, 2013, DISABIL HEALTH J, V6, P236, DOI 10.1016/j.dhjo.2012.12.003
   Dennis M, 2010, CHILD NERV SYST, V26, P1749, DOI 10.1007/s00381-010-1140-z
   Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750
   Gmeiner M, 2018, WORLD NEUROSURG, V111, pE912, DOI 10.1016/j.wneu.2018.01.032
   Gmeiner M, 2017, CHILD NERV SYST, V33, P101, DOI 10.1007/s00381-016-3268-y
   Gnambs T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134033
   Gupta N, 2007, J NEUROSURG, V106, P334, DOI 10.3171/ped.2007.106.5.334
   H_arting C., 2000, WECHSLER MEMORY SCAL
   Hampton LE, 2011, J NEUROSURG-PEDIATR, V8, P289, DOI 10.3171/2011.6.PEDS10584
   Hanak BW, 2017, PEDIATR NEUROSURG, V52, P381, DOI 10.1159/000452840
   Heinsbergen Ina, 2002, Eur J Paediatr Neurol, V6, P99, DOI 10.1053/ejpn.2001.0555
   Hommet C, 1999, J CHILD NEUROL, V14, P144, DOI 10.1177/088307389901400302
   Iddon JL, 2003, EUR J PEDIATR SURG, V13, pS32
   Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058
   Iglesias S, 2018, J NEUROSURG-PEDIATR, V21, P224, DOI 10.3171/2017.8.PEDS16700
   Iskandar BJ, 1998, PEDIATR NEUROSURG, V28, P173, DOI 10.1159/000028644
   Keene DL, 1999, CHILD NERV SYST, V15, P158, DOI 10.1007/s003810050359
   Kim YK, 2008, PSYCHIAT INVEST, V5, P106, DOI 10.4306/pi.2008.5.2.106
   KOKKONEN J, 1994, CHILD NERV SYST, V10, P384, DOI 10.1007/BF00335127
   Kulkarni AV, 2007, J NEUROSURG, V107, P358, DOI 10.3171/PED-07/11/358
   Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P334, DOI 10.3171/2013.7.PEDS12637
   Kutscher A, 2015, J NEUROSURG-PEDIATR, V16, P621, DOI 10.3171/2015.4.PEDS15106
   Lee HJ, 2003, PSYCHIAT CLIN NEUROS, V57, P490, DOI 10.1046/j.1440-1819.2003.01153.x
   Lindquist B, 2005, ACTA PAEDIATR, V94, P878, DOI 10.1080/08035250510027345
   Lindquist B, 2008, ACTA PAEDIATR, V97, P596, DOI 10.1111/j.1651-2227.2008.00747.x
   Lindquist B, 2014, CHILD NERV SYST, V30, P1413, DOI 10.1007/s00381-014-2425-4
   Lindquist B, 2011, CHILD NERV SYST, V27, P597, DOI 10.1007/s00381-010-1311-y
   Lindsay S, 2015, DISABIL REHABIL, V37, P701, DOI 10.3109/09638288.2014.939775
   Pastotter B, 2013, NEUROPSYCHOLOGY, V27, P280, DOI 10.1037/a0031797
   Paulsen AH, 2010, J NEUROSURG-PEDIATR, V6, P527, DOI 10.3171/2010.9.PEDS09548
   Paulsen AH, 2015, J NEUROSURG-PEDIATR, V16, P633, DOI 10.3171/2015.5.PEDS14532
   Persson EK, 2007, CHILD NERV SYST, V23, P1111, DOI 10.1007/s00381-007-0324-7
   Platenkamp M, 2007, J NEUROSURG, V107, P26, DOI 10.3171/PED-07/07/026
   Preuss M, 2015, CHILD NERV SYST, V31, P49, DOI 10.1007/s00381-014-2571-8
   Rekate HL, 2016, HAND CLINIC, V136, P1261, DOI 10.1016/B978-0-444-53486-6.00064-8
   Rijken M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-803
   Schuhfried G., 2012, VIENNA TEST SYSTEM C
   Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298
   Team RC, 2019, LANG ENV STAT COMP
   Tuli S, 2004, J NEUROSURG, V100, P442, DOI 10.3171/ped.2004.100.5.0442
   Vachha Behroze, 2005, Cerebrospinal Fluid Res, V2, P10
   Vinchon M, 2008, NEUROCHIRURGIE, V54, P587, DOI 10.1016/j.neuchi.2008.07.002
   Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8
   Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18
   Vinchon M, 2012, CHILD NERV SYST, V28, P847, DOI 10.1007/s00381-012-1723-y
NR 52
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E314
EP E323
DI 10.1016/j.wneu.2019.08.167
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300038
PM 31479789
DA 2020-05-12
ER

PT J
AU Goel, A
   Prasad, A
   Shah, A
   Patil, A
   Vutha, R
   Ranjan, S
AF Goel, Atul
   Prasad, Apurva
   Shah, Abhidha
   Patil, Abhinandan
   Vutha, Ravikiran
   Ranjan, Shashi
TI Transcranial Insertion of Atlas Facetal Screw for Atlantoaxial Fixation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Assimilation of atlas; Atlantoaxial fixation; Basilar invagination;
   Platybasia; Short neck
ID BASILAR INVAGINATION; JOINT DISTRACTION; PLATE; C1-C2
AB OBJECTIVE: We evaluated the technical feasibility and potential advantages of transcranial insertion of an atlas screw for atlantoaxial fixation.
   METHODS: From January 2016 to August 2018, the transcranial technique for atlas screw insertion was used in 6 patients. Conventional lateral mass atlantoaxial fixation was not possible because of the presence of a complex craniovertebral junctional abnormality and difficulty in direct exposure of the facet of the atlas. In all cases, severe basilar invagination and assimilation of the atlas was present. Of the 6 patients, 3 were male and 3 were female. The age range was 12-41 years (average, 23 years). The surgical technique involved a small suboccipital craniotomy in line with the facet of the axis. Extradural elevation of the cerebellum exposed the region of the occipital condyle and fused atlas. The screw was directed medially and inferiorly into the facet of the atlas.
   RESULTS: In all 6 patients, strong and successful atlantoaxial fixation was achieved. All patients showed clinical improvement after surgery. At an average follow-up period of 21 months, successful arthrodesis of atlantoaxial joint had been achieved in all 6 patients, with no complications.
   CONCLUSIONS: Transcranial insertion of atlas screw can be used as a salvage procedure when the conventional method of screw insertion is not possible because of technical difficulties.
C1 [Goel, Atul; Shah, Abhidha; Patil, Abhinandan; Vutha, Ravikiran; Ranjan, Shashi] King Edward Mem Hosp, Dept Neurosurg, Mumbai, Maharashtra, India.
   [Goel, Atul; Shah, Abhidha; Patil, Abhinandan; Vutha, Ravikiran; Ranjan, Shashi] Seth Gordhandas Sunderdas Med Coll, Mumbai, Maharashtra, India.
   [Goel, Atul; Prasad, Apurva] Lilavati Hosp & Res Ctr, Dept Neurosurg, Mumbai, Maharashtra, India.
RP Goel, A (reprint author), King Edward Mem Hosp, Dept Neurosurg, Mumbai, Maharashtra, India.; Goel, A (reprint author), Seth Gordhandas Sunderdas Med Coll, Mumbai, Maharashtra, India.; Goel, A (reprint author), Lilavati Hosp & Res Ctr, Dept Neurosurg, Mumbai, Maharashtra, India.
EM atulgoel62@hotmail.com
CR Ashafai Nabeel S, 2019, Acta Neurochir Suppl, V125, P247, DOI 10.1007/978-3-319-62515-7_35
   Chytas D, 2018, Eur J Orthop Surg Traumatol, V28, P343, DOI 10.1007/s00590-017-2072-z
   Duan WR, 2019, J NEUROSURG-SPINE, V31, P525, DOI 10.3171/2019.4.SPINE1921
   Goel A, 2004, J NEUROSURG-SPINE, V1, P281, DOI 10.3171/spi.2004.1.3.0281
   GOEL A, 1994, ACTA NEUROCHIR, V129, P47, DOI 10.1007/BF01400872
   Goel A, 1998, J NEUROSURG, V88, P962, DOI 10.3171/jns.1998.88.6.0962
   Goel A, 2002, NEUROSURGERY, V51, P1351, DOI 10.1097/00006123-200212000-00004
   Goel A, 2019, WORLD NEUROSURG, V127, pE856, DOI 10.1016/j.wneu.2019.03.286
   Goel A, 2018, WORLD NEUROSURG, V116, P476, DOI 10.1016/j.wneu.2018.02.058
   Goel A, 2018, WORLD NEUROSURG, V110, P533, DOI 10.1016/j.wneu.2017.07.007
   Goel A, 2017, WORLD NEUROSURG, V100, P236, DOI 10.1016/j.wneu.2017.01.015
   Goel A, 2017, WORLD NEUROSURG, V99, P164, DOI 10.1016/j.wneu.2016.11.093
   Goel A, 2016, J NEUROSURG-SPINE, V25, P740, DOI 10.3171/2016.4.SPINE151268
   Goel A, 2010, J NEUROSURG-SPINE, V13, P1, DOI 10.3171/2009.10.SPINE09761
   Lan SB, 2018, WORLD NEUROSURG, V111, pE135, DOI 10.1016/j.wneu.2017.12.013
   Martinez-del-Campo E, 2016, NEUROSURGERY, V79, P549, DOI 10.1227/NEU.0000000000001340
   Menendez JA, 2007, NEUROSURGERY, V60, P103, DOI 10.1227/01.NEU.0000249220.50085.E4
NR 17
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E333
EP E340
DI 10.1016/j.wneu.2019.08.152
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300040
PM 31476458
DA 2020-05-12
ER

PT J
AU Goertz, L
   Speier, J
   Schulte, AP
   Stavrinou, P
   Krischek, B
   Goldbrunner, R
   Timmer, M
AF Goertz, Lukas
   Speier, Joerg
   Schulte, Andre Pascal
   Stavrinou, Pantelis
   Krischek, Boris
   Goldbrunner, Roland
   Timmer, Marco
TI Independent Risk Factors for Postoperative Seizures in Chronic Subdural
   Hematoma Identified by Multiple Logistic Regression Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Burr hole craniotomy; Chronic subdural hematoma; Membranectomy; Midline
   shift; Seizures
ID ANTIEPILEPTIC DRUGS; EPILEPSY; MEMBRANECTOMY; EVACUATION; INJECTION;
   BLOOD
AB BACKGROUND: Postoperative seizures are potential complications of chronic subdural hematoma (cSDH). Knowledge of risk factors may help to identify patients that may benefit from antiepileptic prophylaxis.
   METHODS: A total of 101 patients (mean age, 70.1 +/- 32.1 years) with surgical evacuation of cSDH were enrolled. We retrospectively collected patient characteristics, hematoma specifics, and procedural aspects and evaluated their impact on postoperative seizures within a 14-day follow-up period by means of bivariate logistic regression analysis.
   RESULTS: Postoperative seizures occurred in 14 patients (13.9%). At discharge, the mean Markwalder grading scale score was 1.1 +/- 1.1 and 0.5 +/- 0.8 in patients with and without seizures, respectively (P = 0.04). In the univariate analysis, preoperative midline shift (8.3 vs. 4.5 mm, P = 0.045), open craniotomy (85.7% vs. 55.2%, P = 0.031), and membranectomy (57.1% vs. 20.7%, P = 0.004) were significantly associated with postoperative seizures, respectively. In the multivariate analysis, preoperative midline shift (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.01-1.26; P = 0.029) and membranectomy (OR, 3.9; 95% CI, 1.0-15.0; P = 0.048) remained as independent risk factors for seizures.
   CONCLUSIONS: Perioperative antiepileptic prophylaxis may be recommended in patients with preoperative midline shift. Membranectomy may not be routinely applied during surgery.
C1 [Goertz, Lukas; Speier, Joerg; Stavrinou, Pantelis; Krischek, Boris; Goldbrunner, Roland; Timmer, Marco] Univ Cologne, Fac Med, Ctr Neurosurg, Dept Gen Neurosurg, Cologne, Germany.
   [Goertz, Lukas; Speier, Joerg; Stavrinou, Pantelis; Krischek, Boris; Goldbrunner, Roland; Timmer, Marco] Univ Cologne, Univ Hosp, Cologne, Germany.
   [Schulte, Andre Pascal] Krankenhaus Augustinerinnen, Orthoped Spine Surg, Cologne, Germany.
RP Timmer, M (reprint author), Univ Cologne, Fac Med, Ctr Neurosurg, Dept Gen Neurosurg, Cologne, Germany.; Timmer, M (reprint author), Univ Cologne, Univ Hosp, Cologne, Germany.
EM marco.timmer@uk-koeln.de
CR Arzimanoglou A, 2010, EPILEPTIC DISORD, V12, P3, DOI 10.1684/epd.2010.0303
   Branco PM, 2017, CURR PHARM DESIGN, V23, P6442, DOI 10.2174/1381612823666171024144318
   BRODERSEN P, 1975, ACTA NEUROL SCAND, V51, P233, DOI 10.1111/j.1600-0404.1975.tb07604.x
   Chen CW, 2004, J CLIN NEUROSCI, V11, P706, DOI 10.1016/j.jocn.2004.03.019
   Cramer JA, 2010, EXPERT REV NEUROTHER, V10, P885, DOI 10.1586/ERN.10.71
   Dudek H, 1999, Rocz Akad Med Bialymst, V44, P119
   Flores G, 2017, ACTA NEUROCHIR, V159, P2033, DOI 10.1007/s00701-017-3298-6
   Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x
   GRISOLI F, 1988, NEUROSURGERY, V23, P616, DOI 10.1227/00006123-198811000-00012
   Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928
   HAMMOND EJ, 1980, EPILEPSIA, V21, P3, DOI 10.1111/j.1528-1157.1980.tb04039.x
   Hirakawa K, 1972, Neurol Med Chir (Tokyo), V12, P71, DOI 10.2176/nmc.12.71
   Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8
   Katsigiannis Sotirios, 2020, J Neurosurg Sci, V64, P133, DOI 10.23736/S0390-5616.17.04056-5
   Kim JH, 2011, J KOREAN NEUROSURG S, V50, P103, DOI 10.3340/jkns.2011.50.2.103
   Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163
   KOTWICA Z, 1991, ACTA NEUROCHIR, V113, P118, DOI 10.1007/BF01403195
   Lavergne P, 2020, J NEUROSURG, V132, P284, DOI 10.3171/2018.9.JNS182092
   Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026
   MARKWALDER TM, 1986, ACTA NEUROCHIR, V79, P100, DOI 10.1007/BF01407452
   OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231
   Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392
   Ratilal BO, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004893.pub3
   Rocchi G, 2007, SURG NEUROL, V67, P374, DOI 10.1016/j.surneu.2006.08.066
   SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7
   Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Stavrinou P, 2017, WORLD NEUROSURG, V99, P465, DOI 10.1016/j.wneu.2016.12.058
   van Nieuwenhuizen D, 2018, J NEURO-ONCOL, V140, P605, DOI 10.1007/s11060-018-2987-1
   Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017
NR 30
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E716
EP E721
DI 10.1016/j.wneu.2019.08.032
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300087
PM 31421304
DA 2020-05-12
ER

PT J
AU Guo, SM
   Wang, L
   Xie, YJ
   Luo, X
   Zhang, SJ
   Xiong, LB
   Ai, HB
   Yuan, ZH
   Wang, JX
AF Guo, Shengmin
   Wang, Li
   Xie, Yujie
   Luo, Xi
   Zhang, Shaojun
   Xiong, Linbo
   Ai, Haibo
   Yuan, Zhihao
   Wang, Jianxiong
TI Bibliometric and Visualized Analysis of Stem Cells Therapy for Spinal
   Cord Injury Based on Web of Science and CiteSpace in the Last 20 Years
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bibliometric analysis; CiteSpace; Co-citation; Co-occurrence; Spinal
   cord injury; Stem cells
ID MESENCHYMAL STROMAL CELLS; AXONAL GROWTH; RECOVERY; TRANSPLANTATION;
   DIFFERENTIATE; RELIABILITY; GRAFTS
AB OBJECTIVE: To provide an analysis of Web of Science (WoS) indexed literature related to stem cells therapy in spinal cord injury published between 1999 and 2018.
   METHODS: Data were obtained from the WoS Core Collection on March 30, 2019. Qualitative and quantitative analysis was conducted based on WoS. Co-citation analysis, collaboration analysis, and co-words analysis of keywords was conducted by using CiteSpace.
   RESULTS: A total of 4188 references were obtained. The number of publications continually increased over the investigated period. Articles were the most frequently document type. Cell Transplantation (127) was the most productive journal. Experimental Neurology (2180) was the most frequently co-cited journal. H. Okano was the most productive and influential author, with 98 publications and 4860 cited counts. The most productive country and institution were the United States and University of Toronto, respectively. Researchers and institutions from Canada, the United States, Japan, and China were the core research forces. There was a broad and close cooperation worldwide. The Lu et al.'s (2012) article (co-citation counts, 177) was the most representative and symbolic reference. Transplantation, functional recovery, marrow-derived mesenchymal stem cell treatment, and progenitor cells were the hot spots. Inflammation, glial scar, nerve regeneration, neurite outgrowth, and bone marrow stromal cell were research frontiers.
   CONCLUSIONS: Research on stem cells for spinal cord injury is a well-developed and promising research field. There is broad global scientific research cooperation. More cooperation among top authors, institutions, and countries is needed. Our results may be helpful for researchers in identifying further potential perspectives on collaborators, research frontiers, and hot topics.
C1 [Guo, Shengmin; Wang, Li; Xie, Yujie; Luo, Xi; Yuan, Zhihao; Wang, Jianxiong] Southwest Med Univ, Affiliated Hosp, Rehabil Med Dept, Luzhou, Sichuan, Peoples R China.
   [Wang, Li; Xie, Yujie; Luo, Xi; Yuan, Zhihao; Wang, Jianxiong] Southwest Med Univ, Dept Rehabil Med, Luzhou, Sichuan, Peoples R China.
   [Zhang, Shaojun] Hosp Mianzhu City, Rehabil Dept, Mianzhu, Sichuan, Peoples R China.
   [Xiong, Linbo] Mianyang Cent Hosp, Dept Rehabil Med, Mianyang, Sichuan, Peoples R China.
   [Ai, Haibo] Third Hosp Mianyang, Dept Rehabil Med, Mianyang, Sichuan, Peoples R China.
RP Wang, JX (reprint author), Southwest Med Univ, Affiliated Hosp, Rehabil Med Dept, Luzhou, Sichuan, Peoples R China.; Wang, JX (reprint author), Southwest Med Univ, Dept Rehabil Med, Luzhou, Sichuan, Peoples R China.
EM jianxiongwang_swmu@126.com
FU Department of Education Research Project of Sichuan Province [17ZB0488]
FX This work was supported by the Department of Education Research Project
   of Sichuan Province in 2017 (grant number 17ZB0488).
CR Basso DM, 2015, ARCH PHYS MED REHAB, V96, P1397, DOI 10.1016/j.apmr.2014.11.026
   Behrman AL, 2015, ARCH PHYS MED REHAB, V96, P1375, DOI 10.1016/j.apmr.2015.03.022
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Chen CM, 2012, EXPERT OPIN BIOL TH, V12, P593, DOI 10.1517/14712598.2012.674507
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405
   Huang JH, 2017, J NEUROTRAUM, V34, P3388, DOI 10.1089/neu.2017.5063
   Itakura G, 2017, STEM CELL REP, V8, P673, DOI 10.1016/j.stemcr.2017.02.003
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Karova K, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1394-7
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Larocca TF, 2017, CYTOTHERAPY, V19, P1189, DOI 10.1016/j.jcyt.2017.06.006
   Lenehan B, 2012, SPINE, V37, P321, DOI 10.1097/BRS.0b013e31822e5ff8
   Leng ZK, 2013, NEURAL REGEN RES, V8, P1286, DOI 10.3969/j.issn.1673-5374.2013.14.005
   Li J., 2017, CITESPACE TEXT MININ
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Okubo T, 2018, STEM CELL REP, V11, P1416, DOI 10.1016/j.stemcr.2018.10.022
   Ramotowski C, 2019, STEM CELL TRANSL MED, V8, P681, DOI 10.1002/sctm.18-0225
   Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thompson RE, 2018, BIOMATERIALS, V162, P208, DOI 10.1016/j.biomaterials.2018.02.013
   Tsuji O, 2019, STEM CELLS, V37, P6, DOI 10.1002/stem.2926
   Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107
   Vaquero J, 2017, CYTOTHERAPY, V19, P349, DOI 10.1016/j.jcyt.2016.12.002
   Venable GT, 2016, J NEUROSURG, V124, P569, DOI 10.3171/2015.3.JNS15149
   Veneruso V, 2019, J CONTROL RELEASE, V300, P141, DOI 10.1016/j.jconrel.2019.02.038
   Zhang X, 2012, NEURAL REGEN RES, V7, P2818, DOI 10.3969/j.issn.1673-5374.2012.35.010
NR 34
TC 1
Z9 1
U1 60
U2 69
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E246
EP E258
DI 10.1016/j.wneu.2019.08.191
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300031
PM 31493613
DA 2020-05-12
ER

PT J
AU Hajianfar, G
   Shiri, I
   Maleki, H
   Oveisi, N
   Haghparast, A
   Abdollahi, H
   Oveisi, M
AF Hajianfar, Ghasem
   Shiri, Isaac
   Maleki, Hassan
   Oveisi, Niki
   Haghparast, Abbas
   Abdollahi, Hamid
   Oveisi, Mehrdad
TI Noninvasive O-6 Methylguanine-DNA Methyltransferase Status Prediction in
   Glioblastoma Multiforme Cancer Using Magnetic Resonance Imaging
   Radiomics Features: Univariate and Multivariate Radiogenomics Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE GBM; MGMT; MRI; Radiomics; Radiogenomics
AB BACKGROUND: This study aimed to predict methylation status of the O-6 methylguanine-DNA methyltransferase (MGMT) gene promoter status by using magnetic resonance imaging radiomics features, as well as univariate and multivariate analysis.
   METHODS: Eighty-two patients who had an MGMT methylation status were included in this study. Tumors were manually segmented in the 4 regions of magnetic resonance images, 1) whole tumor, 2) active/enhanced region, 3) necrotic regions, and 4) edema regions. About 7000 radiomics features were extracted for each patient. Feature selection and classifier were used to predict MGMT status through different machine learning algorithms. The area under the curve (AUC) of the receiver operating characteristic curve was used for model evaluations.
   RESULTS: Regarding univariate analysis, the Inverse Variance feature From Gray Level Co-occurrence Matrix in whole tumor segment with 4.5 mm Sigma of Laplacian of Gaussian filter with AUC of 0.71 (P value = 0.002) was found to be the best predictor. For multivariate analysis, the Decision Tree classifier with Select from Model feature selector and LOG (Laplacian of Gaussian) filter in edema region had the highest performance (AUC, 0.78), followed by Ada-Boost classifier with Select from Model feature selector and LOG filter in edema region (AUC, 0.74).
   CONCLUSIONS: This study showed that radiomics using machine learning algorithms is a feasible noninvasive approach to predict MGMT methylation status in patients with glioblastoma multiforme cancer.
C1 [Hajianfar, Ghasem; Haghparast, Abbas] Kermanshah Univ Med Sci, Fac Med, Dept Med Phys, Kermanshah, Iran.
   [Hajianfar, Ghasem; Maleki, Hassan; Oveisi, Mehrdad] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
   [Shiri, Isaac] Geneva Univ Hosp, Dept Med Imaging, Div Nucl Med & Mol Imaging, Geneva, Switzerland.
   [Oveisi, Niki] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Oveisi, Mehrdad] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada.
   [Abdollahi, Hamid] Kerman Univ Med Sci, Fac Allied Med, Dept Radiol Sci & Med Phys, Kerman, Iran.
RP Hajianfar, G (reprint author), Kermanshah Univ Med Sci, Fac Med, Dept Med Phys, Kermanshah, Iran.; Hajianfar, G (reprint author), Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
OI shiri, isaac/0000-0002-5735-0736; Oveisi, Mehrdad/0000-0002-8100-5609
FU Rajaie Cardiovascular Medical and Research Center, Iran University of
   Medical Science and Kermanshah University of Medical Sciences, Iran
   [980002]
FX This study was funded by Rajaie Cardiovascular Medical and Research
   Center, Iran University of Medical Science and Kermanshah University of
   Medical Sciences, Iran (grant number 980002).
CR Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Fan RE, 2008, J MACH LEARN RES, V9, P1871
   Haykin S., 2009, NEURAL NETWORKS LEAR
   Lakshmi Devasena C., 2011, MULTIPLE CLASSIFIER, V1, P5, DOI DOI 10.1016/S0031-3203(00)00099-6
   Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251
   Rish I., 2001, IJCAI 2001 WORKSH EM
   Srivastava S, 2007, J MACH LEARN RES, V8, P1277
   Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742
   Tsuruoka Y, 2009, P JOINT C 47 ANN M A, V1
   Zhang H., 2004, P FLAIRS C, V1, P3
   Zhu J, 2009, STAT INTERFACE, V2, P349
NR 11
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E140
EP E161
DI 10.1016/j.wneu.2019.08.232
PG 22
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300019
PM 31505292
DA 2020-05-12
ER

PT J
AU Hamamoto , PT
   Fogaroli, MO
   Oliveira, MAC
   Oliveira, CC
   Batah, SS
   Fabro, AT
   Vulcano, LC
   Bazan, R
   Zanini, MA
AF Hamamoto Filho, Pedro Tadao
   Fogaroli, Marcelo Ortolani
   Chiantelli Oliveira, Marcelo Augusto
   Oliveira, Cristiano Claudino
   Batah, Sabrina Setembre
   Fabro, Alexandre Todorovic
   Vulcano, Luiz Carlos
   Bazan, Rodrigo
   Zanini, Marco Antonio
TI A Rat Model of Neurocysticercosis-Induced Hydrocephalus: Chronic
   Progressive Hydrocephalus with Mild Clinical Impairment
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hydrocephalus; Kaolin; Neurocysticercosis; Taenia crassiceps;
   Ventricular dilatation
ID KAOLIN; INJECTION; BEHAVIOR; MICE
AB BACKGROUND: Hydrocephalus is the most common complication of extraparenchymal neurocysticercosis, combining obstructive and inflammatory mechanisms that impair cerebrospinal fluid circulation.
   METHODS: We studied the long-term progression of neurocysticercosis-induced hydrocephalus in a rat model. We generated an experimental rat model of neurocysticercosis-induced hydrocephalus by cisternal inoculation of cysts or antigens of Taenia crassiceps and compared it with the classic model of kaolin-induced hydrocephalus. We used 52 animals divided into 4 groups: 1) control, 2) neurocysticercosis-induced hydrocephalus by cysts or 3) by antigens, and 4) kaolin-induced hydrocephalus. We studied behavioral, radiologic, and morphologic alterations at 1 and 6 months after inoculation by open field test, magnetic resonance imaging, and immunohistochemical localization of aquaporin-4 (AQP-4).
   RESULTS: Behavioral changes were observed later in neurocysticercosis-induced than in kaolin-induced hydrocephalic rats (P = 0.023). The ventricular volume of hydrocephalus induced by experimental neurocysticercosis progressively evolved, with the magnetic resonance imaging changes being similar to those observed in humans. Periventricular inflammatory and astrocytic reactions were also observed. AQP-4 expression was higher in the sixth than in the first month after inoculation (P = 0.016) and also occurred in animals that received antigen inoculation but did not develop hydrocephalus, suggesting that AQP-4 may constitute an alternative route of cerebrospinal fluid absorption under inflammatory conditions.
   CONCLUSIONS: Our neurocysticercosis-induced hydrocephalus model allows for the long-term maintenance of hydrocephalic animals, involving mild clinical performance impairments, including body weight and behavioral changes.
C1 [Hamamoto Filho, Pedro Tadao; Fogaroli, Marcelo Ortolani; Chiantelli Oliveira, Marcelo Augusto; Bazan, Rodrigo; Zanini, Marco Antonio] Botucatu Med Sch, Dept Neurol Psychol & Psychiat, Sao Paulo, SP, Brazil.
   [Oliveira, Cristiano Claudino] Botucatu Med Sch, Dept Pathol, Sao Paulo, SP, Brazil.
   [Batah, Sabrina Setembre; Fabro, Alexandre Todorovic] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Sao Paulo, SP, Brazil.
   [Vulcano, Luiz Carlos] Univ Estadual Paulista, UNESP, Sch Vet Med & Anim Sci, Dept Anim Reprod & Vet Radiol, Sao Paulo, SP, Brazil.
RP Hamamoto , PT (reprint author), Botucatu Med Sch, Dept Neurol Psychol & Psychiat, Sao Paulo, SP, Brazil.
EM pedro.hamamoto@unesp.br
RI Filho, Pedro Tadao Hamamoto/D-2800-2012
OI Filho, Pedro Tadao Hamamoto/0000-0001-6436-9307
CR Agapejev S, 2007, ARQ NEURO-PSIQUIAT, V65, P674, DOI 10.1590/S0004-282X2007000400025
   Alvarez JI, 2010, PARASITOLOGY, V137, P359, DOI 10.1017/S0031182009991971
   Arora N, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12439
   Garcia CAB, 2017, CHILD NERV SYST, V33, P419, DOI 10.1007/s00381-016-3313-x
   Colli Benedicto O, 2002, Neurosurg Focus, V12, pe3
   Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453
   DelBigio MR, 1997, EXP NEUROL, V148, P256, DOI 10.1006/exnr.1997.6644
   DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666
   Escobar A, 1983, CYSTICERCOSIS CENTRA, P27
   Figueroa JJ, 2011, J NEUROIMAGING, V21, P38, DOI 10.1111/j.1552-6569.2009.00452.x
   Filippidis AS, 2011, CHILD NERV SYST, V27, P27, DOI 10.1007/s00381-010-1227-6
   Fleury A, 2011, EXPERT REV ANTI-INFE, V9, P123, DOI [10.1586/eri.10.150, 10.1586/ERI.10.150]
   Garcia HH, 2003, ACTA TROP, V87, P71, DOI 10.1016/S0001-706X(03)00057-3
   GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637
   Hamamoto PT, 2019, WORLD NEUROSURG, V126, P264, DOI 10.1016/j.wneu.2019.03.071
   Hamamoto PT, 2017, CHILD NERV SYST, V33, P119, DOI 10.1007/s00381-016-3239-3
   HARRIS NG, 1992, EXP NEUROL, V118, P1, DOI 10.1016/0014-4886(92)90016-J
   Hwang YS, 2011, J NEUROSURG-PEDIATR, V7, P401, DOI 10.3171/2011.1.PEDS10182
   Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6
   Jusue-Torres I, 2016, NEUROSURGERY, V79, P746, DOI 10.1227/NEU.0000000000001405
   Li J, 2008, EXP NEUROL, V211, P351, DOI 10.1016/j.expneurol.2007.12.030
   Li ZY, 2017, WORLD NEUROSURG, V107, P853, DOI 10.1016/j.wneu.2017.08.059
   Lopes LD, 2009, EXP NEUROL, V219, P187, DOI 10.1016/j.expneurol.2009.05.015
   Matos-Silva H, 2012, ARQ NEURO-PSIQUIAT, V70, P287, DOI 10.1590/S0004-282X2012005000010
   Moura VBL, 2016, PARASITOLOGY, V143, P334, DOI 10.1017/S0031182015001572
   Nagra G, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-4
   Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a
   Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19
   Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018
   Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191
   Silverberg GD, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-2
   Sotelo J, 2011, CURR NEUROL NEUROSCI, V11, P529, DOI 10.1007/s11910-011-0226-7
   Torres-Corzo JG, 2010, CLIN NEUROL NEUROSUR, V112, P11, DOI 10.1016/j.clineuro.2009.08.022
   Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070
   Wang DW, 2011, MOL CELL NEUROSCI, V46, P318, DOI 10.1016/j.mcn.2010.10.003
   WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23
   Willms K, 2010, PARASITOLOGY, V137, P335, DOI 10.1017/S0031182009991442
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zhang SL, 2015, FOLIA NEUROPATHOL, V53, P60, DOI 10.5114/fn.2015.49975
NR 39
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E535
EP E544
DI 10.1016/j.wneu.2019.08.085
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300064
PM 31470163
DA 2020-05-12
ER

PT J
AU Hogan, WB
   Kuris, EO
   Durand, WM
   Eltorai, AEM
   Daniels, AH
AF Hogan, William B.
   Kuris, Eren O.
   Durand, Wesley M.
   Eltorai, Adam E. M.
   Daniels, Alan H.
TI Timing of Surgical Decompression for Cauda Equina Syndrome
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cauda equina syndrome; Lumbar decompression; Operative timing
ID INTERVENTION; OUTCOMES; SURGERY
AB OBJECTIVE: Cauda equina syndrome (CES) is a potentially devastating spinal condition requiring prompt diagnosis and intervention. This study examines the relationship between timing of surgery and patient outcomes such as mortality and total complications, and longitudinal trends in timing of operative treatment over the years 2000-2014.
   METHODS: This study considered patients in the Healthcare Cost and Utilization Project National Inpatient Sample Database between 2000 and 2014 who had both an International Classification of Disease, Ninth Edition, Clinical Modification code for CES (344.61) and an International Classification of Disease, Ninth Edition, Clinical Modification procedure code for either disc excision (8051) or spinal canal exploration and decompression (0309) in their inpatient record. Patients were separated into an early surgical intervention cohort versus a delayed intervention cohort, and associated outcomes were analyzed using linear regression. Trends in timing of surgery were examined for the years 2000-2014, and linear regression was used to assess degree of change over time.
   RESULTS: In total, 20,924 patients with CES met inclusion criteria. Following adjustment for demographic variables, the delayed-intervention group was associated with statistically significant increased inpatient mortality (odds ratio [OR] 9.60, P = 0.002), total complications (OR 1.41, P = 0.018), and non-routine discharge (OR 2.37, P < 0.0001). The proportion of patients receiving early intervention within 48 hours remained unchanged from 2000 to 2014 ranging from 80.2% (2000-2002) to 76.2% (2012-2014) (P = 0.190).
   CONCLUSIONS: This study represents the largest investigation to date examining CES and reveals the timing of surgical management for CES has not changed appreciably from 2000 to 2014 despite mounting evidence for early decompression. Patients receiving decompression within 0 or 1 day after admission are associated with improved inpatient outcomes, including lower complication and mortality rates.
C1 [Hogan, William B.; Kuris, Eren O.; Durand, Wesley M.; Eltorai, Adam E. M.; Daniels, Alan H.] Brown Univ, Dept Orthoped, Warren Alpert Med Sch, Providence, RI 02912 USA.
RP Daniels, AH (reprint author), Brown Univ, Dept Orthoped, Warren Alpert Med Sch, Providence, RI 02912 USA.
EM alandanielsmd@gmail.com
CR Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010
   Chau AMT, 2014, WORLD NEUROSURG, V81, P640, DOI 10.1016/j.wneu.2013.11.007
   Heyes G, 2018, J ORTHOP, V15, P210, DOI 10.1016/j.jor.2018.01.020
   Kaiser R, 2018, NEUROSURGERY, V83, P1193, DOI 10.1093/neuros/nyx607
   McCarthy MJH, 2007, SPINE, V32, P207, DOI 10.1097/01.brs.0000251750.20508.84
   Nater A, 2015, WORLD NEUROSURG, V83, P19, DOI 10.1016/j.wneu.2014.03.017
   Olivero WC, 2009, J SPINAL DISORD TECH, V22, P202, DOI 10.1097/BSD.0b013e31817baad8
   Qureshi A, 2007, EUR SPINE J, V16, P2143, DOI 10.1007/s00586-007-0491-y
   Sonntag VKH, 2014, WORLD NEUROSURG, V82, P70, DOI 10.1016/j.wneu.2014.03.016
   Srikandarajah N, 2015, SPINE, V40, P580, DOI 10.1097/BRS.0000000000000813
   Thakur JD, 2017, SPINE J, V17, P1435, DOI 10.1016/j.spinee.2017.04.023
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E732
EP E738
DI 10.1016/j.wneu.2019.08.030
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300089
PM 31415897
DA 2020-05-12
ER

PT J
AU Horie, N
   Shobayashi, K
   Morofuji, Y
   Sadakata, E
   Iki, Y
   Matsunaga, Y
   Kanamoto, T
   Tateishi, Y
   Izumo, T
   Anda, T
   Morikawa, M
   Tsujino, A
   Matsuo, T
AF Horie, Nobutaka
   Shobayashi, Kazuya
   Morofuji, Yoichi
   Sadakata, Eisaku
   Iki, Yusuke
   Matsunaga, Yuki
   Kanamoto, Tadashi
   Tateishi, Yohei
   Izumo, Tsuyoshi
   Anda, Takeo
   Morikawa, Minoru
   Tsujino, Akira
   Matsuo, Takayuki
TI Impact of Mechanical Thrombectomy Device on Thrombus Histology in Acute
   Embolic Stroke
SO WORLD NEUROSURGERY
LA English
DT Article
DE Device; Stroke; Thrombectomy
ID ACUTE ISCHEMIC-STROKE
AB BACKGROUND: Although many studies have evaluated the retrieved thrombus to assess the cause of stroke after mechanical thrombectomy for acute large vessel occlusion, the results remain controversial. We investigated the hypothesis that histology of the retrieved thrombus is enhanced by mechanical thrombectomy devices.
   METHODS: Thrombi were collected from consecutive patients who had undergone endovascular mechanical recanalization for large intracranial vessel occlusion. The mechanical thrombectomy device used was either an aspiration catheter or a stent retriever. The hematoxylin and eosin-stained specimens were quantitatively analyzed with respect to the relative fractions of the main constituents (erythrocytes and fibrin). Clinical and radiologic findings were also evaluated.
   RESULTS: Of 65 patients, an aspiration catheter was used in 27, and a stent retriever was used in 38. The presence of a preoperative susceptibility vessel sign on magnetic resonance imaging was not correlated with the percentage of erythrocytes. Thrombus cross-sectional area was larger in the aspiration group than in the stent group (P < 0.01). Conversely, the percentage of the fibrin component was higher in the stent group (P < 0.001). Preoperative intravenous administration of recombinant tissue plasminogen activator reduced thrombus cross-sectional area with a trend of increased percentage of fibrin and reduced percentage of erythrocyte in the stent group.
   CONCLUSIONS: Histologic differences in retrieved thrombi are enhanced by mechanical thrombectomy devices. Stent retrievers may crush the thrombus, which may have a synergistic effect with recombinant tissue plasminogen activator. Histology of the retrieved thrombi might be different from histology of the original thrombi.
C1 [Horie, Nobutaka; Morofuji, Yoichi; Sadakata, Eisaku; Iki, Yusuke; Matsunaga, Yuki; Izumo, Tsuyoshi; Anda, Takeo; Matsuo, Takayuki] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki, Japan.
   [Kanamoto, Tadashi; Tateishi, Yohei; Tsujino, Akira] Nagasaki Univ, Sch Med, Dept Neurol, Nagasaki, Japan.
   [Morikawa, Minoru] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki, Japan.
   [Shobayashi, Kazuya] Biomed Solut, Tokyo, Japan.
RP Horie, N (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki, Japan.
EM nobstanford@gmail.com
OI Morofuji, Yoichi/0000-0001-7135-2220; Iki, Yusuke/0000-0001-5326-7815
CR Boeckh-Behrens T, 2016, STROKE, V47, P1864, DOI 10.1161/STROKEAHA.116.013105
   Chaves CJ, 2000, J NEUROL SCI, V173, P3, DOI 10.1016/S0022-510X(99)00299-3
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524
   Hashimoto T, 2016, STROKE, V47, P3035, DOI 10.1161/STROKEAHA.116.015228
   Jerjes-Sanchez C, 2005, EUR HEART J, V26, P3, DOI 10.1093/eurheartj/ehi041
   Kim SK, 2015, AM J NEURORADIOL, V36, P1756, DOI 10.3174/ajnr.A4402
   Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94
   Niesten JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088882
   Sato Y, 2012, THROMB RES, V130, P278, DOI 10.1016/j.thromres.2012.04.008
   Simons N, 2015, J NEURORADIOLOGY, V42, P86, DOI 10.1016/j.neurad.2014.01.124
   Sporns PB, 2017, STROKE, V48, P2206, DOI 10.1161/STROKEAHA.117.016590
   Turk AS, 2019, LANCET, V393, P998, DOI 10.1016/S0140-6736(19)30297-1
NR 13
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E418
EP E422
DI 10.1016/j.wneu.2019.08.130
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300048
PM 31470156
DA 2020-05-12
ER

PT J
AU Houten, JK
   Pasternack, J
   Norton, RP
AF Houten, John K.
   Pasternack, Jordan
   Norton, Robert P.
TI Cervical Myelopathy without Symptoms in the Upper Extremities: Incidence
   and Presenting Characteristics
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical myelopathy; Cervical spine surgery; False localizing sign;
   Neurologic examination; Presenting symptoms; Sensory level; Spinal cord
ID SPINAL-CORD; SPONDYLOTIC MYELOPATHY; PRIMARY COMPLAINT; COMPRESSION;
   HERNIATION; LAMINECTOMY; LIGAMENT; HANDS; DISC
AB BACKGROUND: Common signs and symptoms of cervical myelopathy (CM) predominantly manifest in the upper extremities and include hand numbness, hand clumsiness, and distal upper extremity weakness. CM manifesting without symptoms in the upper extremities is rare. This study aimed to better understand the incidence and character of such cases.
   METHODS: A retrospective review of surgeries for CM from disc herniation, spondylosis, or ossification of posterior longitudinal ligament over a 12-year period was performed to identify patients presenting without symptoms in the upper extremities.
   RESULTS: Of 982 surgically treated patients with CM, 12 (1.2%) had no upper extremity symptoms. All had difficulty ambulating, and 7 of 12 (58%) patients had objective lower extremity weakness. Ten (83%) patients had a history of lumbar degenerative disease. On sensory examination, 4 (33%) patients had a discernible midthoracic pin level, 3 (25%) had loss of sensation from the upper leg and genital area down, and 2 (17%) had only genital/upper thigh area sensory loss. All patients demonstrated neurologic improvement after decompressive surgery.
   CONCLUSIONS: Patients with CM may rarely present without symptoms in the upper extremities, presenting with numbness perceived from the upper trunk, waist area, or perineum and legs in addition to leg weakness and gait difficulty. All patients had cervical cord compression at either C5-6 or C6-7 level, accounting for 1% of all patients undergoing cervical surgery. Awareness of this atypical pattern of presentation may aid in clinical assessment of a subset of patients with cervical cord compression.
C1 [Houten, John K.; Pasternack, Jordan] Maimonides Hosp, Dept Orthoped Surg, Brooklyn, NY 11219 USA.
   [Houten, John K.] Maimonides Hosp, Dept Neurosurg, Brooklyn, NY 11219 USA.
   [Houten, John K.] Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY 11030 USA.
   [Norton, Robert P.] Florida Atlantic Univ, Dept Surg, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.
RP Houten, JK (reprint author), Maimonides Hosp, Dept Orthoped Surg, Brooklyn, NY 11219 USA.; Houten, JK (reprint author), Maimonides Hosp, Dept Neurosurg, Brooklyn, NY 11219 USA.; Houten, JK (reprint author), Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY 11030 USA.
EM jkhmd@yahoo.com
OI Pasternack, Jordan/0000-0001-6651-1944
CR Akhavan-Sigari R, 2013, J NEUROL SURG REP, V74, P101, DOI 10.1055/s-0033-1349202
   BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005
   BUCY PC, 1949, SURG CLIN N AM, V29, P163
   Chan CK, 2011, EUR SPINE J, V20, pS217, DOI 10.1007/s00586-010-1585-5
   Chiles BW, 1999, NEUROSURGERY, V44, P762, DOI 10.1097/00006123-199904000-00041
   Choi Byung-Wan, 2017, Eur J Orthop Surg Traumatol, V27, P889, DOI 10.1007/s00590-017-1972-2
   Elsberg CA, 1931, B NEUROL I NY, V1, P350
   Funaba M, 2016, SPINAL CORD, V54, P798, DOI 10.1038/sc.2015.203
   GOOD DC, 1984, SURG NEUROL, V22, P285, DOI 10.1016/0090-3019(84)90016-8
   Hellmann MA, 2013, CLIN NEUROL NEUROSUR, V115, P54, DOI 10.1016/j.clineuro.2012.04.011
   Houten J, 2005, CERVICAL SPINE, P985
   Houten JK, 2003, NEUROSURGERY, V52, P1081, DOI 10.1227/01.NEU.0000057746.74779.55
   Houten John K, 2018, J Neurosurg Sci, DOI 10.23736/S0390-5616.18.04563-0
   Houten JK, 2016, J CLIN NEUROSCI, V27, P99, DOI 10.1016/j.jocn.2015.07.025
   Kondo A, 2019, BRAIN DEV-JPN, V41, P392, DOI 10.1016/j.braindev.2018.11.004
   Mixter WJ, 1935, NEW ENGL J MED, V213, P385, DOI 10.1056/NEJM193508292130901
   Ross MD, 2010, J SPINAL CORD MED, V33, P431, DOI 10.1080/10790268.2010.11689724
   Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004
   Sasai Kunihiko, 2006, Spine J, V6, P464, DOI 10.1016/j.spinee.2005.10.018
   SPILLANE JD, 1952, BRAIN, V75, P177, DOI 10.1093/brain/75.2.177
   Stookey B, 1940, ARCH SURG-CHICAGO, V40, P417, DOI 10.1001/archsurg.1940.04080020046004
   VOSKUHL RR, 1990, ARCH NEUROL-CHICAGO, V47, P309, DOI 10.1001/archneur.1990.00530030085020
NR 22
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E162
EP E168
DI 10.1016/j.wneu.2019.08.231
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300020
PM 31513953
DA 2020-05-12
ER

PT J
AU Huang, Q
   Lin, SW
   Hu, WP
   Li, HY
   Yao, PS
   Sun, Y
   Zeng, YL
   Huang, QY
   Kang, DZ
   Wu, SY
AF Huang, Qing
   Lin, Shao-wei
   Hu, Wei-Peng
   Li, Huang-Yuan
   Yao, Pei-Sen
   Sun, Yi
   Zeng, Yi-Le
   Huang, Qiu-Yu
   Kang, De-Zhi
   Wu, Si-Ying
TI Meteorological Variation Is a Predisposing Factor for Aneurismal
   Subarachnoid Hemorrhage: A 5-Year Multicenter Study in Fuzhou, China
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atmospheric pressure; Intracranial aneurysm; Meteorological variation;
   Subarachnoid hemorrhage; Temperature
ID BAROMETRIC-PRESSURE; RISK-FACTORS; AMBIENT-TEMPERATURE; BLOOD-PRESSURE;
   WEATHER; SEASON; ASSOCIATION; CLIMATE; ONSET; AGE
AB OBJECTIVE: The climatic characteristics of aneurysmal subarachnoid hemorrhage (aSAH) have been reported, but consensus has not yet been reached. It is of great significance to elucidate the relationships between meteorological variation and aSAH in regions with specific climate patterns. We analyzed the occurrence of aSAH in the capital city of Fujian Province, China, through a multicenter, 5-year study, and aimed to reveal the meteorological influences on aSAH in the coastal city of eastern Fujian under the subtropical marine monsoon condition.
   METHODS: A total of 2555 consecutive patients with aSAH in Fuzhou were collected using specialized stroke admission database from January 2013 to December 2017. Meteorological parameters including temperature, atmospheric pressure, and humidity were obtained from China Surface Meteorological Station during the same period. Poisson regression was used to explore the association between meteorological parameters and aSAH to calculate the incidence rate ratios (IRRs) with corresponding 95% confidence intervals (CIs). Generalized additive model analysis further revealed the nonlinear relationships between weather and aSAH.
   RESULTS: Daily minimum temperature (IRR 0.976, 95% CI 0.958-0.996) and maximum pressure (IRR 1.022, 95% CI 1.001-1.042) were independently correlated with the onset of aSAH. Low temperature (below 16 degrees C) and excessive atmospheric pressure (above 1008 hPa) increased the risk of aSAH. In addition, March in spring and December in winter were the 2 ictus peaks in Fuzhou throughout the year.
   CONCLUSIONS: Cold and excessive atmospheric pressure are triggers for the occurrence of aSAH; March in spring and December in winter are the predominant onset periods in Fuzhou.
C1 [Huang, Qing; Hu, Wei-Peng; Zeng, Yi-Le; Huang, Qiu-Yu] Fujian Med Univ, Affiliated Hosp 2, Quanzhou, Fujian, Peoples R China.
   [Huang, Qing; Lin, Shao-wei; Li, Huang-Yuan; Sun, Yi; Wu, Si-Ying] Fujian Med Univ, Sch Publ Hlth, Fuzhou, Fujian, Peoples R China.
   [Yao, Pei-Sen; Kang, De-Zhi] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.
RP Wu, SY (reprint author), Fujian Med Univ, Sch Publ Hlth, Fuzhou, Fujian, Peoples R China.
EM fmuwsy@163.com
FU Natural Science Foundation of Fujian ProvinceNatural Science Foundation
   of Fujian Province [2019J01315]
FX This study was supported by the Natural Science Foundation of Fujian
   Province (grant no. 2019J01315).
CR Abe T, 2008, J CLIN NEUROSCI, V15, P1005, DOI 10.1016/j.jocn.2007.07.081
   Andreasen TH, 2013, STROKE, V44, P3607, DOI 10.1161/STROKEAHA.113.001575
   Backes D, 2016, J NEUROSURG, V125, P737, DOI 10.3171/2015.8.JNS151473
   Becker WJ, 2001, AM J PHYSIOL-REG I, V280, pR1897
   Beseoglu K, 2008, NEUROSURGERY, V62, P1033, DOI 10.1227/01.neu.0000325864.91584.c7
   BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919
   BRUCE N, 1991, J HYPERTENS, V9, P851, DOI 10.1097/00004872-199109000-00013
   Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391
   Chakraborty U, 2013, INT J BIOMETEOROL, V57, P769, DOI 10.1007/s00484-012-0605-z
   Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390
   Chen RJ, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4306
   Cowperthwaite MC, 2011, NEUROSURGERY, V68, P132, DOI 10.1227/NEU.0b013e3181fe23a1
   Feigin VL, 2001, STROKE, V32, P613, DOI 10.1161/01.STR.32.3.613
   Gill RS, 2013, WORLD NEUROSURG, V79, P136, DOI 10.1016/j.wneu.2012.06.020
   Goggins WB, 2012, INT J BIOMETEOROL, V56, P865, DOI 10.1007/s00484-011-0491-9
   Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165
   Han J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014741
   Jehn M, 2002, AM J HYPERTENS, V15, P941, DOI 10.1016/S0895-7061(02)02999-0
   Kawai K, 2001, NEUROL MED-CHIR, V41, P229, DOI 10.2176/nmc.41.229
   Kent ST, 2013, ANN NEUROL, V73, P32, DOI 10.1002/ana.23737
   Lee SML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107567
   Lee S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040449
   LEJEUNE JP, 1994, STROKE, V25, P338, DOI 10.1161/01.STR.25.2.338
   McDonald RJ, 2012, AM J NEURORADIOL, V33, P1663, DOI 10.3174/ajnr.A3059
   Nieuwkamp DJ, 2013, INT J STROKE, V8, P90, DOI 10.1111/ijs.12006
   Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7
   Overton JM, 2001, AM J PHYSIOL-REG I, V280, pR1007
   Piters WAAD, 2013, J NEUROL, V260, P614, DOI 10.1007/s00415-012-6687-z
   Qureshi AI, 2001, NEUROSURGERY, V49, P607, DOI 10.1097/00006123-200109000-00014
   Ronning P, 2013, WORLD NEUROSURG, V79, P62, DOI 10.1016/j.wneu.2012.07.018
   Rothwell PM, 1996, LANCET, V347, P934, DOI 10.1016/S0140-6736(96)91415-4
   Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544
   Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060
   Stienen MN, 2015, WORLD NEUROSURG, V83, P588, DOI 10.1016/j.wneu.2014.12.021
   Swerdel JN, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001354
   Vulekovic P, 2011, ACTA NEUROCHIR, V153, P1313, DOI 10.1007/s00701-011-1017-2
NR 36
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E687
EP E695
DI 10.1016/j.wneu.2019.08.048
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300083
PM 31442657
DA 2020-05-12
ER

PT J
AU Ikawa, F
   Michihata, N
   Akiyama, Y
   Iihara, K
   Matano, F
   Morita, A
   Kato, Y
   Iida, K
   Kurisu, K
   Fushimi, K
   Yasunaga, H
AF Ikawa, Fusao
   Michihata, Nobuaki
   Akiyama, Yasuhiko
   Iihara, Koji
   Matano, Fumihiro
   Morita, Akio
   Kato, Yoko
   Iida, Koji
   Kurisu, Kaoru
   Fushimi, Kiyohide
   Yasunaga, Hideo
TI Treatment Risk for Elderly Patients with Unruptured Cerebral Aneurysm
   from a Nationwide Database in Japan
SO WORLD NEUROSURGERY
LA English
DT Article
DE Elderly patient; Endovascular coiling; Functional outcome; Nationwide
   database; Surgical clipping; Unruptured cerebral aneurysm
ID INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; MEDICARE BENEFICIARIES;
   UNITED-STATES; COILING; OUTCOMES; PREDICTION; MANAGEMENT; RUPTURE; SCORE
AB BACKGROUND: This study aimed to clarify the risk factors of treatment for unruptured cerebral aneurysms (UCAs) in elderly patients by comparing the morbidity at discharge between surgical clipping and endovascular coiling in nonelderly (<65 years) and elderly (>= 65 years) patients based on a national database in Japan.
   METHODS: A total of 36,017, including 15,671 patients with UCA after exclusion of unknown location, were registered in the Diagnosis Procedure Combination, the nationwide database, from 2010 to 2015 in Japan. Outcome of Barthel Index at discharge was investigated and multi-variate logistic regression analysis identified risk factors for morbidity of Barthel Index <90 at discharge in non-elderly and elderly patient groups.
   RESULTS: Risk factors for morbidity at discharge were basilar artery aneurysm compared with internal carotid artery (ICA), diabetes mellitus (odds ratio [OR], 2.0-2.5; 95% confidence interval [CI], 1.6-3.7), antiplatelet drug, and anticoagulation drug; however, highest hospital volume compared with lowest was an inverse risk factor in both age groups. Endovascular coiling (OR, 0.4; 95% CI, 0.3-0.5) was a significantly inverse risk in the elderly group. Anterior communicating artery aneurysm compared with ICA was a significant risk (OR, 1.6; 95% CI, 1.0-2.6) in the nonelderly group; on the other hand, anterior communicating artery aneurysm (OR, 0.7; 95% CI, 0.5-0.95) and middle cerebral artery aneurysm (OR, 0.6; 95% CI, 0.5-0.8) compared with ICA were significantly inverse risks in the elderly group.
   CONCLUSIONS: Endovascular coiling after control of diabetes mellitus was recommended for the treatment of UCA in elderly patients. The ICA location of aneurysm in the elderly should be paid attention as the treatment risk.
C1 [Ikawa, Fusao; Iida, Koji; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan.
   [Michihata, Nobuaki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.
   [Akiyama, Yasuhiko] Shimane Univ, Fac Med, Dept Neurol Surg, Izumo, Shimane, Japan.
   [Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Fukuoka, Japan.
   [Matano, Fumihiro; Morita, Akio] Nippon Med Coll Hosp, Dept Neurol Surg, Tokyo, Japan.
   [Kato, Yoko] Fujita Hlth Univ, Bantae Hosp, Dept Neurosurg, Nagoya, Aichi, Japan.
   [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan.
RP Ikawa, F (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan.
EM fikawa-nsu@umin.ac.jp
OI Ikawa, Fusao/0000-0003-4205-1490; Yasunaga, Hideo/0000-0002-6017-469X
FU Pfizer Health Research Foundation Japan, Japan; Japan Society for the
   Promotion of Science, JapanMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT)Japan Society for the Promotion of
   Science [17K10829]
FX This work was supported by the Pfizer Health Research Foundation Japan,
   Japan 2016 and the Japan Society for the Promotion of Science, Japan,
   Grant-in-Aid for Scientific Research (C) 17K10829.
CR Aishima K, 2016, WORLD NEUROSURG, V95, P434, DOI 10.1016/j.wneu.2016.08.060
   Algra AM, 2019, JAMA NEUROL, V76, P282, DOI 10.1001/jamaneurol.2018.4165
   Alshekhlee A, 2010, STROKE, V41, P1471, DOI 10.1161/STROKEAHA.110.580647
   Backes D, 2017, NEUROLOGY, V88, P1600, DOI 10.1212/WNL.0000000000003865
   Backes D, 2015, STROKE, V46, P1607, DOI 10.1161/STROKEAHA.115.008795
   Barker FG, 2004, NEUROSURGERY, V54, P18, DOI 10.1227/01.NEU.0000097195.48840.C4
   Bekelis K, 2017, J NEUROSURG, V126, P811, DOI 10.3171/2016.1.JNS152028
   Brinjikji W, 2013, AM J NEURORADIOL, V34, P1022, DOI 10.3174/ajnr.A3321
   Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453
   Brinjikji W, 2012, STROKE, V43, P3200, DOI 10.1161/STROKEAHA.112.671214
   Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986
   Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1
   Higashida RT, 2007, AM J NEURORADIOL, V28, P146
   Hishikawa T, 2015, NEUROLOGY, V85, P1879, DOI 10.1212/WNL.0000000000002149
   Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269
   Ikawa Fusao, 2020, Neurosurg Rev, V43, P655, DOI 10.1007/s10143-019-01096-2
   Jalbert JJ, 2015, STROKE, V46, P2452, DOI 10.1161/STROKEAHA.115.009777
   Kestle JRW, 2015, J NEUROSURG, V122, P441, DOI 10.3171/2014.4.JNS14689
   Malhotra A, 2018, JAMA NEUROL, V75, P27, DOI 10.1001/jamaneurol.2017.3232
   Matsukawa H, 2018, J CLIN NEUROSCI, V58, P160, DOI 10.1016/j.jocn.2018.08.006
   McDonald JS, 2013, STROKE, V44, P988, DOI 10.1161/STROKEAHA.111.000196
   Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260
   O'Donnell JM, 2019, J NEUROSURG, V130, P278, DOI 10.3171/2017.8.JNS171576
   Ogilvy CS, 2003, NEUROSURGERY, V52, P82, DOI 10.1097/00006123-200301000-00010
   Oravec CS, 2018, NEUROSURGERY, V82, P728, DOI 10.1093/neuros/nyx328
   Park JC, 2016, J NEUROSURG, V124, P777, DOI 10.3171/2015.3.JNS142835
   Park YK, 2018, WORLD NEUROSURG, V114, pE605, DOI 10.1016/j.wneu.2018.03.040
   Qureshi AI, 2014, NEUROSURGERY, V75, P380, DOI 10.1227/NEU.0000000000000450
   Rinaldo L, 2017, J NEUROSURG, V127, P1297, DOI 10.3171/2016.9.JNS161875
   Sekhar LN, 2007, NEUROSURGERY, V61, P273, DOI 10.1227/01.neu.0000303980.96504.d9
   Silva NA, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17714
   Sim SY, 2016, WORLD NEUROSURG, V95, P335, DOI 10.1016/j.wneu.2016.08.057
   Song Jihye, 2016, Surg Neurol Int, V7, pS391, DOI 10.4103/2152-7806.183497
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   Tominari S, 2015, ANN NEUROL, V77, P1050, DOI 10.1002/ana.24400
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   Yamashiro S, 2007, J NEUROSURG, V107, P1086, DOI 10.3171/JNS-07/12/1086
   Yasunaga H, 2013, ASIAN PAC J DIS MANA, V7, P19, DOI DOI 10.7223/APJDM.7.19
   Zhang XX, 2018, WORLD NEUROSURG, V115, P393, DOI 10.1016/j.wneu.2018.04.028
NR 39
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E89
EP E98
DI 10.1016/j.wneu.2019.08.252
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300013
PM 31518740
DA 2020-05-12
ER

PT J
AU Jankowitz, BT
   Gross, BA
   Mintz, E
   Jalgaonkar, U
   Marchesiello, D
   Girdhar, G
   Jadhav, AP
   Jovin, TG
AF Jankowitz, Brian T.
   Gross, Bradley A.
   Mintz, Eric
   Jalgaonkar, Ujwal
   Marchesiello, David
   Girdhar, Gaurav
   Jadhav, Ashutosh P.
   Jovin, Tudor G.
TI Safety and Efficacy Evaluation of Aspiration Thrombectomy With Large
   Bore Catheters in a Porcine Model
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aspiration; Catheter; Recanalization; Stroke; Thrombectomy
ID ACUTE ISCHEMIC-STROKE; LARGE VESSEL OCCLUSION; STENT RETRIEVER; SWINE
   MODEL; ADAPT; DEVICES
AB OBJECTIVE: Thrombectomy with aspiration catheters has shown to be effective for treatment of intracranial large vessel occlusion (LVO). We present preclinical evaluation of the safety and efficacy of React68 and React71 (Medtronic PLC, Irvine, CA) catheters in animal models of LVO.
   METHODS: In vivo evaluation of catheter safety was performed in superficial cervical, internal maxillary, and renal arteries in a porcine model with or without clot (LVO). Animals were survived for 3 days and 30 days. Angio-graphic outcomes, usability, and histological parameters were compared for treatment with React68, React71, and ACE68 (Penumbra, Alameda, CA) catheters.
   RESULTS: The in vivo angiographic analysis in a porcine thrombectomy LVO model demonstrated that there was no statistically significant difference in the rate of Thrombolysis in Cerebral Infarction scale 2b/3 recanalization between React68, React71, and ACE68 catheters. There were no physical or neurologic deficits in any of the treated animals throughout the survival period. Histologic analysis showed statistically non-inferior safety profile of React68 and React71 catheters relative to ACE68 catheters, with minimal but similar mild internal elastic lamina disruption and smooth muscle loss, but a lack of inflammation, fibrin deposits, and changes in the adventitia at both time points examined.
   CONCLUSIONS: React68 and React71 aspiration catheters have an excellent safety, efficacy, and usability profile in animal models of LVO.
C1 [Jankowitz, Brian T.; Gross, Bradley A.; Jadhav, Ashutosh P.] Stroke Inst, Pittsburgh, PA 15213 USA.
   [Jankowitz, Brian T.; Gross, Bradley A.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA.
   [Jadhav, Ashutosh P.] Univ Pittsburgh, Dept Neurol, Med Ctr, Pittsburgh, PA 15260 USA.
   [Mintz, Eric; Jalgaonkar, Ujwal; Marchesiello, David; Girdhar, Gaurav] Medtron PLC, Irvine, CA USA.
   [Jovin, Tudor G.] Cooper Neurol Inst, Dept Neurol, Camden, NJ USA.
RP Gross, BA (reprint author), Stroke Inst, Pittsburgh, PA 15213 USA.; Gross, BA (reprint author), Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA.
EM Grossb2@upmc.edu
FU MedtronicMedtronic
FX This research was funded by Medtronic. B. T. Jankowitz is a consultant
   for Medtronic. B. A. Gross is a consultant for Microvention. T. G. Jovin
   is a consultant for Stryker Neurovascular (PI DAWN-unpaid) and Blockade
   Medical; has ownership interest (Advisory Board/Investor) in Anaconda,
   FreeOx Biotech, and Route92; and has received honoraria from Cerenovus.
CR Arslanian RA, 2019, J NEUROINTERV SURG, V11, P931, DOI 10.1136/neurintsurg-2018-014625
   Chapot R, 2002, AM J NEURORADIOL, V23, P282
   Chueh JY, 2011, AM J NEURORADIOL, V32, P1237, DOI 10.3174/ajnr.A2485
   Delgado F, 2019, J NEUROINTERV SURG, V11, P147, DOI 10.1136/neurintsurg-2018-014163
   Gory B, 2013, AM J NEURORADIOL, V34, P2192, DOI 10.3174/ajnr.A3531
   Gory B, 2013, INTERV NEURORADIOL, V19, P147, DOI 10.1177/159101991301900201
   Herrmann AM, 2019, J CEREBR BLOOD F MET, V39, P375, DOI 10.1177/0271678X19827446
   Jankowitz B, 2012, STROKE, V43, P1408, DOI 10.1161/STROKEAHA.111.646117
   Lapergue B, 2017, JAMA-J AM MED ASSOC, V318, P443, DOI 10.1001/jama.2017.9644
   Massari F, 2016, INTERV NEURORADIOL, V22, P325, DOI 10.1177/1591019916632369
   Maus V, 2019, CLIN NEURORADIOL, V29, P669, DOI 10.1007/s00062-018-0702-4
   McTaggart RA, 2017, J NEUROINTERV SURG, V9, P1154, DOI 10.1136/neurintsurg-2016-012838
   Menon BK, 2019, LANCET, V393, P962, DOI 10.1016/S0140-6736(19)30476-3
   Nogueira RG, 2012, J NEUROINTERV SURG, V4, P295, DOI 10.1136/neurintsurg-2011-010053
   Peschillo S, 2017, J NEUROINTERV SURG, V9, P743, DOI 10.1136/neurintsurg-2016-012533
   Peschillo S, 2018, INTERV NEUROL, V7, P501, DOI 10.1159/000491028
   Smith Mickey, 2019, J Neuroradiol, DOI 10.1016/j.neurad.2019.03.013
   Srinivasan VM, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.1.FOCUS16501
   Turk AS, 2014, J NEUROINTERV SURG, V6, P231, DOI 10.1136/neurintsurg-2013-010713
   Turk AS, 2019, LANCET, V393, P998, DOI 10.1016/S0140-6736(19)30297-1
   Wainwright JM, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011856
   Yuki I, 2013, AM J NEURORADIOL, V34, pE87, DOI 10.3174/ajnr.A3221
NR 22
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E409
EP E417
DI 10.1016/j.wneu.2019.08.131
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300047
PM 31470150
DA 2020-05-12
ER

PT J
AU Jean, WC
   Huynh, T
   Tai, AX
   Felbaum, DR
   Syed, HR
   Ngo, HM
AF Jean, Walter C.
   Huynh, Trong
   Tai, Alexander X.
   Felbaum, Daniel R.
   Syed, Hasan R.
   Ngo, Hung M.
TI Outcome of Microsurgery for Arteriovenous Malformations in a
   Resource-Restricted Environment: Single-Surgeon Series from Vietnam
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Intracerebral hemorrhage; Modified Rankin
   Scale; Vietnam
ID CONSECUTIVE SERIES; BRAIN; MANAGEMENT; ARUBA
AB BACKGROUND: The health care expenditure in Vietnam is equivalent to 1% of that in the United States. For most patients with brain arteriovenous malformations (AVM), surgery is the only available treatment modality. This study reports on the outcomes on AVM microsurgery in this resource-restricted environment.
   METHODS: This is a prospectively collected, retrospectively analyzed case series of consecutive patients who underwent surgical resection of AVM by a single surgeon in Vietnam. All surgeries were performed in a 3-year period in Hanoi. The primary endpoints were obliteration of the AVM and surgical morbidity (modified Rankin Scale [mRS] > 1).
   RESULTS: There were 86 patients and 62% presented with hemorrhage. Only 2 patients had preoperative embolization, and 47 patients (54%) had preoperative digital subtraction angiography. All patients underwent microsurgical resection of their AVM. Excluding the 4 patients who died, the AVM obliteration rate was 98%. The mean follow-up was 20.1 months. Before surgery, 36% of patients had at least some disability (mRS > 1). Postoperatively, this was reduced to 10% (McNemar P=0.007). For the overall cohort, neurologic status was improved from initial encounter to final assessment (P=0.001). Because of resource restrictions, some patients with hemorrhage experienced delays in treatment. There was no difference in outcome between patients who were admitted before or after 24 hours post ictus (P=0.6). The days spent waiting for surgery did not correlate with final mRS in univariate regression (R-2=0.01).
   CONCLUSIONS: Notwithstanding the limitation in health care resources in Vietnam, surgery for AVMs was successful in eliminating the malformation, with obliteration rates and morbidity comparable with international standards.
C1 [Jean, Walter C.] George Washington Univ, Dept Neurosurg, Washington, DC 20052 USA.
   [Tai, Alexander X.; Felbaum, Daniel R.] Georgetown Univ Hosp, Dept Neurosurg, Washington, DC 20007 USA.
   [Jean, Walter C.; Felbaum, Daniel R.; Syed, Hasan R.] Global Brainsurg Initiat, Washington, DC 20024 USA.
   [Huynh, Trong] Rutgers New Jersey Med Sch, Dept Neurosurg, Newark, NJ USA.
   [Syed, Hasan R.] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA.
   [Huynh, Trong; Ngo, Hung M.] Viet Duc Hosp, Dept Neurosurg, Hanoi, Vietnam.
RP Jean, WC (reprint author), George Washington Univ, Dept Neurosurg, Washington, DC 20052 USA.; Jean, WC (reprint author), Global Brainsurg Initiat, Washington, DC 20024 USA.
EM wjean@mfa.gwu.edu
RI Jean, Walter/L-2780-2019
OI Jean, Walter/0000-0001-6774-2066; NGO, Hung M/0000-0002-4132-5528; Tai,
   Alexander/0000-0003-3800-6101
CR Berman MF, 1999, AM J NEURORADIOL, V20, P2004
   Bervini D, 2014, J NEUROSURG, V121, P878, DOI 10.3171/2014.7.JNS132691
   Bradac O, 2013, ACTA NEUROCHIR, V155, P199, DOI 10.1007/s00701-012-1572-1
   Cenzato M, 2018, WORLD NEUROSURG, V110, pE374, DOI 10.1016/j.wneu.2017.11.003
   Davidson AS, 2010, NEUROSURGERY, V66, P498, DOI 10.1227/01.NEU.0000365518.47684.98
   Javadpour M, 2016, BRIT J NEUROSURG, V30, P619, DOI 10.1080/02688697.2016.1181153
   Lawton MT, 2005, NEUROSURGERY, V56, P485, DOI 10.1227/01.NEU.0000153924.67360.EA
   Luksik AS, 2017, WORLD NEUROSURG, V104, P430, DOI 10.1016/j.wneu.2017.05.026
   Miller CE, 2009, STROKE, V40, P1973, DOI 10.1161/STROKEAHA.108.539528
   Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8
   Patel NJ, 2019, NEUROSURGERY, V84, P655, DOI 10.1093/neuros/nyy088
   Potts MB, 2015, J NEUROSURG, V122, P912, DOI 10.3171/2014.12.JNS14938
   Rutledge WC, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14242
   Schramm J, 2017, J NEUROSURG, V126, P1056, DOI 10.3171/2016.4.JNS153017
   Spears J, 2006, STROKE, V37, P1457, DOI 10.1161/01.STR.0000222937.30216.13
   Tong XZ, 2017, WORLD NEUROSURG, V99, P644, DOI 10.1016/j.wneu.2016.12.088
   Wellis G, 2003, ACTA NEUROCHIR, V145, P249, DOI 10.1007/s00701-003-0007-4
   Wong J, 2017, STROKE, V48, P136, DOI 10.1161/STROKEAHA.116.014660
   Zygourakis CC, 2017, J NEUROSURG, V126, P620, DOI 10.3171/2016.2.JNS152442
NR 19
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E66
EP E75
DI 10.1016/j.wneu.2019.08.256
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300011
PM 31518746
DA 2020-05-12
ER

PT J
AU Jeon, C
   Park, KA
   Hong, SD
   Choi, JW
   Seol, HJ
   Nam, DH
   Lee, JI
   Shin, HJ
   Kong, DS
AF Jeon, Chiman
   Park, Kyung-Ah
   Hong, Sang Duk
   Choi, Jung Won
   Seol, Ho Jun
   Nam, Do-Hyun
   Lee, Jung-Il
   Shin, Hyung Jin
   Kong, Doo-Sik
TI Clinical Efficacy of Optical Coherence Tomography to Predict the Visual
   Outcome After Endoscopic Endonasal Surgery for Suprasellar Tumors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic endonasal surgery; Optic coherence tomography; Visual outcome
ID NERVE-FIBER LAYER; PITUITARY-ADENOMA RESECTION; FIELD RECOVERY;
   PROGNOSTIC VALUE; BAND ATROPHY; TIME-COURSE; THICKNESS; ANATOMY; CHIASM
AB BACKGROUND: Prediction of visual outcome after endoscopic endonasal tumor resection still remains a challenge. We investigated the prognostic value of the preoperative peripapillary retinal nerve fiber layer (pRNFL) using optical coherence tomography for visual outcome after endoscopic endonasal surgery (EES) for suprasellar tumors.
   METHODS: We retrospectively analyzed 122 patients who underwent EES for sellar and suprasellar tumors between January 2016 and January 2018. We retrospectively analyzed the pre- and postoperative relationship between pRNFL thickness and visual outcome based on visual acuity (visual acuity score) and visual field (mean deviation [MD]).
   RESULTS: Preoperatively, 216 eyes (mean global pRNFL thickness, 94.3 +/- 12.4 mu m; 88.5%) were included in the normal pRNFL group (>= 70 mu m) and 28 eyes (mean global pRNFL thickness, 54.3 +/- 11.0 mu m; 11.5%) were included in the thin pRNFL group (<70 mu m). There was a very strong correlation between pre- and postoperative pRNFL thickness (r = 0.930). The thin pRNFL group showed a stronger correlation between pre- and postoperative MDs than the normal pRNFL group (r = 0.619 and r = 0.420, respectively; P < 0.01). Multivariate analyses identified pRNFL thickness as the only significant predictor of postoperative visual acuity (odds ratio [OR], 25.02; 95% confidence interval [CI], 7.68-81.50; P < 0.01) and visual field (OR, 39.46; 95% CI, 10.39-149.83; P < 0.01).
   CONCLUSIONS: Preoperative pRNFL thickness plays a prognostic value in postoperative visual outcome after EES for sellar and suprasellar tumors. Patients with pRNFL thickness >= 70 mu m before surgery are more likely to improve visual outcome than those with thickness <70 mu m.
C1 [Jeon, Chiman; Hong, Sang Duk; Choi, Jung Won; Seol, Ho Jun; Nam, Do-Hyun; Lee, Jung-Il; Shin, Hyung Jin; Kong, Doo-Sik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg,Endoscop Skull Base Surg Clin,Brai, Seoul, South Korea.
   [Park, Kyung-Ah] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.
   [Hong, Sang Duk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
RP Kong, DS (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg,Endoscop Skull Base Surg Clin,Brai, Seoul, South Korea.
EM neurokong@gmail.com
CR Anraku A, 2014, GRAEF ARCH CLIN EXP, V252, P109, DOI 10.1007/s00417-013-2527-9
   Banc A, 2018, NEUROSURG REV, V41, P415, DOI 10.1007/s10143-016-0772-1
   Beltrame Sofia, 2018, Surg Neurol Int, V9, pS57, DOI 10.4103/sni.sni_463_17
   Blanch RJ, 2018, PITUITARY, V21, P515, DOI 10.1007/s11102-018-0906-2
   Bussat A, 2018, J NEUROSURG-PEDIATR, V21, P516, DOI 10.3171/2017.11.PEDS17526
   Chan CKM, 2007, J NEURO-OPHTHALMOL, V27, P176, DOI 10.1097/WNO.0b013e31814b1ac4
   COHEN AR, 1985, NEUROSURGERY, V17, P446, DOI 10.1227/00006123-198509000-00008
   Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127
   Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327
   Danesh-Meyer HV, 2015, J CLIN NEUROSCI, V22, P1098, DOI 10.1016/j.jocn.2015.02.001
   Epstein AE, 2014, J NEURO-OPHTHALMOL, V34, P103, DOI 10.1097/WNO.0000000000000092
   Esquenazi Y, 2017, WORLD NEUROSURG, V101, P186, DOI 10.1016/j.wneu.2017.01.110
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Garcia T, 2014, J NEUROSURG, V121, P165, DOI 10.3171/2014.2.JNS131767
   Gnanalingham KK, 2005, J NEUROL NEUROSUR PS, V76, P415, DOI 10.1136/jnnp.2004.035576
   Gospe SM, 2017, SEMIN PEDIATR NEUROL, V24, P135, DOI 10.1016/j.spen.2017.04.008
   Higashiyama T, 2016, OSLI RETINA, V47, P724, DOI 10.3928/23258160-20160808-05
   Hong SD, 2016, WORLD NEUROSURG, V87, P162, DOI 10.1016/j.wneu.2015.12.050
   Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016
   Johansson C, 2009, ACTA OPHTHALMOL, V87, P776, DOI 10.1111/j.1755-3768.2008.01344.x
   Kanamori A, 2004, OPHTHALMOLOGY, V111, P2278, DOI 10.1016/j.ophtha.2004.05.035
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P813, DOI 10.1016/S0002-9394(00)00539-0
   Kim KH, 2018, WORLD NEUROSURG, V114, pE306, DOI 10.1016/j.wneu.2018.02.178
   Kim TW, 2008, BRIT J NEUROSURG, V22, P231, DOI 10.1080/02688690701772405
   Komotar RJ, 2012, PITUITARY, V15, P150, DOI 10.1007/s11102-011-0359-3
   Kong DS, 2019, J NEUROSURG, V130, P838, DOI 10.3171/2017.11.JNS171337
   KRAVITZ D, 1948, AM J OPHTHALMOL, V31, P415, DOI 10.1016/0002-9394(48)92163-1
   KRISHT AF, 1994, NEUROSURGERY, V35, P899, DOI 10.1227/00006123-199411000-00014
   LAWS ER, 1977, J NEUROSURG, V46, P717, DOI 10.3171/jns.1977.46.6.0717
   Lee Dong Kyu, 2018, Korean J Ophthalmol, V32, P488, DOI 10.3341/kjo.2017.0094
   Lee J, 2016, J NEURO-ONCOL, V130, P155, DOI 10.1007/s11060-016-2227-5
   Loo JL, 2013, BRIT J OPHTHALMOL, V97, P1455, DOI 10.1136/bjophthalmol-2013-303449
   Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118
   Monteiro MLR, 2010, CAN J OPHTHALMOL, V45, P404, DOI 10.3129/i09-276
   Monteiro MLR, 2004, BRIT J OPHTHALMOL, V88, P896, DOI 10.1136/bjo.2003.038489
   Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P8527, DOI 10.1167/iovs.11-8034
   Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P7966, DOI 10.1167/iovs.11-7450
   Muskens IS, 2017, PITUITARY, V20, P539, DOI 10.1007/s11102-017-0815-9
   Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480
   Ostri C, 2012, ACTA OPHTHALMOL, V90, P792, DOI 10.1111/j.1755-3768.2011.02128.x
   Park HH, 2015, J NEUROSURG, V123, P1489, DOI 10.3171/2014.12.JNS141549
   Sherwood PR, 2019, J NEUROSURG, V130, P2032, DOI 10.3171/2018.1.JNS171915
   Sun M, 2017, INT J OPHTHALMOL-CHI, V10, P1742, DOI 10.18240/ijo.2017.11.17
   Sun M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179532
   Sung KR, 2011, BRIT J OPHTHALMOL, V95, P909, DOI 10.1136/bjo.2010.186924
   Truong HQ, 2019, J NEUROSURG, V131, P154, DOI 10.3171/2018.2.JNS172959
   Valdes PA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2015.12.FOCUS15550
   Wannemuehler TJ, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16314
NR 48
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E722
EP E731
DI 10.1016/j.wneu.2019.08.031
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300088
PM 31421301
DA 2020-05-12
ER

PT J
AU Kamada, K
   Guger, C
   Takeuchi, F
AF Kamada, Kyousuke
   Guger, Christoph
   Takeuchi, Fumiya
TI Multispectrum Indocyanine Green Videography for Visualizing Brain
   Vascular Pathology
SO WORLD NEUROSURGERY
LA English
DT Article
DE Fluorescence; Indocyanine green; Regional blood flow; Vascular surgical
   procedures
ID DUAL-IMAGE VIDEOANGIOGRAPHY
AB OBJECTIVE: Currently, neurosurgical vascular surgery frequently uses indocyanine green (ICG)-videography (VG) to evaluate the blood flow in brain vessels. Although ICG-VG delineates intravascular ICG fluorescence as a high-intensity signal in gray-scale with dark background, it is hard to identify anatomical structures, including vasculature or surgical devices simultaneously. This report developed combination of a near-infrared (NIR) camera with particular sensitivity and an optical filter to observe the blood-flow conditions and anatomical structures.
   METHODS: To overcome the specific issues of ICG-VG, we applied a high-sensitivity camera with a 980-nm NIR component to delineate anatomical and fluorescence images, detecting signals between 830 and 1000 nm simultaneously during operation. We used a diluted ICG phantom to evaluate fluorescence signal changes by changing wavelength of the emission light. For clinical use, we used a high-sensitivity NIR camera with a high-pass filter on a surgical microscope. The new NIR system detected signals between 770 and 1000 nm, and the lighting system illuminated objects mainly at 980-nm wavelength. Both images with the blood flow and anatomical structures were projected to the smart glasses in real time.
   RESULTS: In the phantom experiment, we found that the emission light with wide band widths (575-800 nm) evoked various intensities of ICG fluorescence. This new NIR system allowed us to observe ICG fluorescence and anatomical structures without image fusion or time-delay. The both information of anatomy and fluorescence was projected on wearable smart glasses. Furthermore, the new NIR system detected ICG-fluorescence signals for a longer duration than the original camera, which allowed us to achieve careful and detailed observation of more vasculature and fine vessels.
   CONCLUSIONS: This study proposes a new NIR system and emphasizes simultaneous observation of anatomy and fluorescence signals during operation. It paves the way for further possibilities in the development of optical systems. To understand the natural phenomena and combination of different scientific and clinical fields, it might be important to understand and combine not only fluorescence, but also natural science, optics, and background pathology. This simple system would be available for neuroendoscope and robotic surgery.
C1 [Kamada, Kyousuke] Megumino Hosp, Dept Neurosurg, Eniwa, Japan.
   [Kamada, Kyousuke] Adv Telecommun Res Inst Int, Computat Imaging Lab, Kyoto, Japan.
   [Takeuchi, Fumiya] Asahikawa Med Univ, Ctr Adv Res & Educ, Sch Med, Asahikawa, Hokkaido, Japan.
   [Guger, Christoph] Gtac Geger Technol AG, Dev Sect, Graz, Austria.
RP Kamada, K (reprint author), Megumino Hosp, Dept Neurosurg, Eniwa, Japan.; Kamada, K (reprint author), Adv Telecommun Res Inst Int, Computat Imaging Lab, Kyoto, Japan.
EM kamady-k@umin.ac.jp
OI Ogawa, Hiroshi/0000-0002-5887-4021
FU Japanese government [16H05434, 17H05900, JP 17K19708]
FX This work was supported by the Japanese government (Grant-in-Aid for
   Scientific Research [B] No. 16H05434, Grant-in-Aid for Exploratory
   Research No. 17H05900, and Grant-in-Aid for Scientific Research on
   Innovative Areas [Shintaisei System] No. JP 17K19708).
CR BRUCKER AJ, 1993, RETINA-J RET VIT DIS, V13, P169, DOI 10.1097/00006982-199313020-00016
   Feletti A, 2017, WORLD NEUROSURG, V99, P572, DOI 10.1016/j.wneu.2016.12.070
   Horie N, 2014, ACTA NEUROCHIR, V156, P919, DOI 10.1007/s00701-014-2054-4
   Kamada K, 2014, NEUROL MED-CHIR, V54, P775, DOI 10.2176/nmc.st.2014-0176
   Lane B, 2015, J NEUROSURG, V122, P618, DOI 10.3171/2014.10.JNS132766
   Raabe A, 2003, NEUROSURGERY, V52, P132, DOI 10.1097/00006123-200301000-00017
   Riva M, 2018, NEUROSURGERY, V83, P166, DOI 10.1093/neuros/nyx387
   Saito M, 2018, WORLD NEUROSURG, V116, pE187, DOI 10.1016/j.wneu.2018.04.148
   Sato T, 2015, ACTA NEUROCHIR, V157, P1295, DOI 10.1007/s00701-015-2481-x
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E545
EP E553
DI 10.1016/j.wneu.2019.08.078
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300065
PM 31442653
DA 2020-05-12
ER

PT J
AU Karhade, AV
   Ogink, PT
   Thio, QCBS
   Cha, TD
   Hershman, SH
   Schoenfeld, AJ
   Bono, CM
   Schwab, JH
AF Karhade, Aditya, V
   Ogink, Paul T.
   Thio, Quirina C. B. S.
   Cha, Thomas D.
   Hershman, Stuart H.
   Schoenfeld, Andrew J.
   Bono, Christopher M.
   Schwab, Joseph H.
TI Discharge Disposition After Anterior Cervical Discectomy and Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior cervical discectomy and fusion; Discharge disposition;
   Prediction; Spine surgery
ID SPINE SURGERY; RESOURCE UTILIZATION; UNITED-STATES; TRENDS; PREDICTORS;
   COMPLICATIONS; EPIDEMIOLOGY; MYELOPATHY; CHARLSON; OUTCOMES
AB OBJECTIVE: Age and comorbidity burden of patients going anterior cervical discectomy and fusion (ACDF) have increased significantly over the past 2 decades, resulting in increased expenditures. Non-home discharge after ACDF contributes to increased direct and indirect costs of postoperative care. The purpose of this study was to identify independent prognostic factors for discharge disposition in patients undergoing ACDF.
   METHODS: A retrospective review was conducted at 5 medical centers to identify patients undergoing ACDF for degenerative conditions. The primary outcome was non-home discharge. Additional outcomes considered included discharge to rehabilitation and home discharge with services. Bivariate and multivariable analyses were used to identify independent prognostic factors for non-home discharge.
   RESULTS: Of 2070 patients undergoing ACDF, 114 (5.5%) had non-home discharge and 63 (3.0%) had discharge to inpatient rehabilitation. Factors independently associated with non-home discharge included older age, marital status, Medicare insurance, Medicaid insurance, previous spine surgery, myelopathy, preoperative comorbidities (hemiplegia/paraplegia, congestive heart failure, cerebrovascular accident), anemia, and leukocytosis. C-statistic for the overall model was 0.85. Results were relatively similar for patients younger than the age of 65 years as well as for discharge to inpatient rehabilitation and discharge home with services.
   CONCLUSIONS: Numerous sociodemographic and clinical characteristics influence the risk of non-home discharge and discharge to inpatient rehabilitation in patients undergoing ACDF. Policy makers and payers should consider these factors when determining appropriate preoperative adjustment for risk-based reimbursements.
C1 [Karhade, Aditya, V; Ogink, Paul T.; Thio, Quirina C. B. S.; Cha, Thomas D.; Hershman, Stuart H.; Bono, Christopher M.; Schwab, Joseph H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
   [Schoenfeld, Andrew J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
RP Schwab, JH (reprint author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
EM jhschwab@mgh.harvard.edu
CR Alosh H, 2015, J SPINAL DISORD TECH, V28, P5, DOI 10.1097/BSD.0000000000000001
   Barsoum WK, 2010, J ARTHROPLASTY, V25, P885, DOI 10.1016/j.arth.2009.06.022
   Boakye M, 2008, NEUROSURGERY, V62, P455, DOI 10.1227/01.neu.0000316013.97926.4c
   Collins GS, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0241-z
   Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75
   Di Capua J, 2018, GLOB SPINE J, V8, P266, DOI 10.1177/2192568217717971
   Di Capua J, 2017, SPINE, V42, P1538, DOI 10.1097/BRS.0000000000002140
   Elsamadicy AA, 2018, WORLD NEUROSURG, V112, pE348, DOI 10.1016/j.wneu.2018.01.046
   Kalakoti P, 2019, SPINE, V44, P334, DOI 10.1097/BRS.0000000000002825
   King JT, 2009, NEUROSURGERY, V65, P1011, DOI 10.1227/01.NEU.0000360347.10596.BD
   Leu S, 2016, WORLD NEUROSURG, V92, P323, DOI 10.1016/j.wneu.2016.05.011
   Lu CY, 2011, J CLIN EPIDEMIOL, V64, P223, DOI 10.1016/j.jclinepi.2010.02.015
   Marawar S, 2010, SPINE, V35, P1454, DOI 10.1097/BRS.0b013e3181bef3cb
   Marquez-Lara A, 2014, SPINE, V39, P476, DOI 10.1097/BRS.0000000000000165
   Martin BI, 2014, SPINE, V39, P769, DOI 10.1097/BRS.0000000000000275
   McGirt MJ, 2017, J NEUROSURG-SPINE, V27, P382, DOI 10.3171/2016.12.SPINE16928
   Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783
   Murphy ME, 2017, NEUROSURGERY, V81, P638, DOI 10.1093/neuros/nyx057
   Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913
   Oglesby M, 2013, SPINE, V38, P1226, DOI 10.1097/BRS.0b013e31828be75d
   Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433
   Saifi C, 2018, SPINE J, V18, P1022, DOI 10.1016/j.spinee.2017.10.072
   Sanoufa M, 2015, J Perioper Pract, V25, P267
   Shamji MF, 2009, SPINE J, V9, P31, DOI 10.1016/j.spinee.2008.07.005
   Shepperd S, 2016, COCHRANE DB SYST REV
   Smith AL, 2017, J STROKE CEREBROVASC, V26, P711, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.037
   Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597
   Ugiliweneza B, 2014, SPINE, V39, P1235, DOI 10.1097/BRS.0000000000000378
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E14
EP E20
DI 10.1016/j.wneu.2019.09.026
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300004
PM 31521753
DA 2020-05-12
ER

PT J
AU Kawabata, T
   Takeuchi, K
   Nagata, Y
   Ishikawa, T
   Choo, J
   Sato, Y
   Tambara, M
   Teranishi, M
   Wakabayashi, T
AF Kawabata, Teppei
   Takeuchi, Kazuhito
   Nagata, Yuichi
   Ishikawa, Takayuki
   Choo, Jungsu
   Sato, Yusuke
   Tambara, Masao
   Teranishi, Masaaki
   Wakabayashi, Toshihiko
TI Preservation of Olfactory Function Following Endoscopic Single-Nostril
   Transseptal Transsphenoidal Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Olfactory function; Single nostril; T&T olfactometer; Transsphenoidal
   surgery; Venous olfaction test
ID QUALITY-OF-LIFE; PITUITARY SURGERY; OUTCOMES
AB OBJECTIVE: Olfactory dysfunction is a significant postoperative complication related to endoscopic transsphenoidal surgery (TSS). This study aimed to determine the impact of endoscopic TSS on olfactory function.
   METHODS: We conducted a prospective study of 32 patients with sellar or parasellar tumors who were treated with endoscopic TSS between December 2013 and October 2016. TSS was performed via a right transseptal approach. We performed the Toyota and Takagi olfactometer test and the venous olfaction test for the evaluation of olfactory function preoperatively and at 1 and 3 months postoperatively.
   RESULTS: The results of the Toyota and Takagi test showed that olfactory function deteriorated in 4 of 32 (12.5%) patients 1 month postoperatively and improved to preoperative baseline levels in all patients 3 months after the procedure. Olfactory function deteriorated in 1 of 31 (3.2%) patients 3 months after the procedure. The venous olfaction test revealed no response in 1 of 31 (3.2%) patients 1 month postoperatively, with no improvement 3 months after the procedure.
   CONCLUSIONS: Endoscopic single-nostril transseptal TSS for sellar or parasellar tumor resection has minimal impact on olfactory function.
C1 [Kawabata, Teppei; Takeuchi, Kazuhito; Nagata, Yuichi; Ishikawa, Takayuki; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi, Japan.
   [Teranishi, Masaaki] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi, Japan.
   [Choo, Jungsu] Chukyo Hosp, Dept Neurosurg, Nagoya, Aichi, Japan.
   [Sato, Yusuke] Fukushima Med Univ, Dept Neurosurg, Fukushima, Japan.
   [Tambara, Masao] Okazaki City Hosp, Dept Neurosurg, Okazaki, Aichi, Japan.
RP Kawabata, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi, Japan.
EM kawabata.teppei@b.mbox.nagoya-u.ac.jp
OI Nagata, Yuichi/0000-0003-4130-5380
CR Actor B, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10162
   Hong SD, 2016, WORLD NEUROSURG, V87, P162, DOI 10.1016/j.wneu.2015.12.050
   Ikeda K, 1999, AM J RHINOL, V13, P45, DOI 10.2500/105065899781389957
   Ishikawa T, 2019, J NEUROSURG, V131, P1625, DOI 10.3171/2018.4.JNS18366
   Jho HD, 1997, J NEUROSURG, V87, P44, DOI 10.3171/jns.1997.87.1.0044
   Kahilogullari G, 2013, LARYNGOSCOPE, V123, P2112, DOI 10.1002/lary.24037
   Kassam A, 2005, NEUROSURG FOCUS, V19, P1, DOI DOI 10.3171/foc.2005.19.1.4
   Kobayashi M, 2007, NEUROL MED, V66, P332
   Little AS, 2015, J NEUROSURG, V122, P1458, DOI 10.3171/2014.10.JNS141624
   Nagata Y, 2018, WORLD NEUROSURG, V114, pE1225, DOI 10.1016/j.wneu.2018.03.180
   Nagata Y, 2018, PITUITARY, V21, P1, DOI 10.1007/s11102-017-0836-4
   Reisch R, 2017, ACTA NEUROCHIR, V159, P453, DOI 10.1007/s00701-017-3075-6
   Rotenberg BW, 2011, LARYNGOSCOPE, V121, P1611, DOI 10.1002/lary.21890
   Shibuya Enatsu, 2002, Nihon Jibiinkoka Gakkai Kaiho, V105, P783
   Takeuchi K, 2015, ACTA NEUROCHIR, V157, P2089, DOI 10.1007/s00701-015-2612-4
   Tam S, 2013, INT FORUM ALLERGY RH, V3, P62, DOI 10.1002/alr.21069
   Upadhyay S, 2017, LARYNGOSCOPE, V127, P1970, DOI 10.1002/lary.26546
   Wang SS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000465
NR 18
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E665
EP E669
DI 10.1016/j.wneu.2019.08.051
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300080
PM 31442636
DA 2020-05-12
ER

PT J
AU Kikkawa, Y
   Kayahara, T
   Teranishi, A
   Shibata, A
   Suzuki, K
   Kamide, T
   Ikeda, T
   Kurita, H
AF Kikkawa, Yuichiro
   Kayahara, Tomomichi
   Teranishi, Akio
   Shibata, Aoto
   Suzuki, Kaima
   Kamide, Tomoya
   Ikeda, Toshiki
   Kurita, Hiroki
TI Predictors of the Resolution of Cavernous Sinus Syndrome Caused by
   Large/Giant Cavernous Carotid Aneurysms After Parent Artery Occlusion
   with High-Flow Bypass
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cavernous carotid aneurysm; High-flow bypass; Ophthalmoplegia;
   Trigeminal pain
ID ENDOVASCULAR TREATMENT; GIANT ANEURYSMS; DIVERSION; EMBOLIZATION;
   PORTION; COILING
AB OBJECTIVE: To evaluate the clinical results and factors related to the resolution of preoperative cranial neuropathy after internal carotid artery ligation with high-flow bypass in patients with symptomatic large or giant cavernous carotid aneurysms.
   METHODS: This study included 18 consecutive patients (15 women) with cranial neuropathy. All patients underwent therapeutic internal carotid artery ligation with high-flow bypass using a radial artery graft. Patient demographics, duration of symptoms, clinical outcomes, complications, and radiographic findings were retrospectively analyzed. The mean follow-up period was 31.0 months (range: 3-74 months).
   RESULTS: Patients' mean age was 66.6 years, and the mean aneurysm size was 23.7 mm. Six patients (33%) had partially thrombosed aneurysms. Preoperatively, 16 (89%) and 8 (44%) patients presented with ophthalmoplegia and facial pain, respectively. Bypass patency was confirmed in 15 patients (83%), and obliteration of the aneurysm was confirmed in all patients at the final follow-up. Preoperative ophthalmoplegia resolved in 10 patients (63%), and trigeminal pain resolved in all patients. Postoperative resolution of patients' ophthalmoplegia was significantly associated with age (P = 0.044), symptom duration before treatment (P = 0.042), and the degree of ophthalmoplegia (P = 0.046). The degree of postoperative residual ophthalmoplegia was positively correlated with the duration of ophthalmoplegia from onset to surgery (r = 0.619; P = 0.011). Preoperative trigeminal pain resolved regardless of the preoperative duration of this symptom in all patients.
   CONCLUSIONS: Early treatment is recommended when treating large or giant cavernous carotid aneurysms with cranial neuropathy. Complete resolution is possible in younger patients with partial neuropathy.
C1 [Kikkawa, Yuichiro; Kayahara, Tomomichi; Teranishi, Akio; Shibata, Aoto; Suzuki, Kaima; Kamide, Tomoya; Ikeda, Toshiki; Kurita, Hiroki] Saitama Med Univ, Int Med Ctr, Dept Cerebrovasc Surg, Saitama, Japan.
   [Kikkawa, Yuichiro; Shibata, Aoto] Saitama Prefecture Cardiovasc & Resp Ctr, Dept Neurosurg, Saitama, Japan.
RP Kikkawa, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Cerebrovasc Surg, Saitama, Japan.; Kikkawa, Y (reprint author), Saitama Prefecture Cardiovasc & Resp Ctr, Dept Neurosurg, Saitama, Japan.
EM ykikkawa@saitama-med.ac.jp
CR Ahn JY, 2006, NEUROLOGY, V66, P121, DOI 10.1212/01.wnl.0000191398.76450.c4
   Ambekar S, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.03.042
   Brown BL, 2016, J NEUROSURG, V124, P1107, DOI 10.3171/2015.4.JNS142790
   Chalouhi N, 2013, AM J NEURORADIOL, V34, P828, DOI 10.3174/ajnr.A3294
   Chibbaro S, 2006, J CLIN NEUROSCI, V13, P1001, DOI 10.1016/j.jocn.2005.07.027
   Choulakian A, 2010, J NEUROINTERV SURG, V2, P359, DOI 10.1136/jnis.2010.003137
   Date I, 1998, NEUROL MED-CHIR, V38, P62, DOI 10.2176/nmc.38.suppl_62
   Field M, 2003, AM J NEURORADIOL, V24, P1200
   Fukutome K, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.11.033
   Guan N, 2016, J STROKE CEREBROVASC, V25, P1929, DOI 10.1016/j.jstrokecerebrovasdis.2016.04.012
   Kai Y, 2007, SURG NEUROL, V67, P148, DOI 10.1016/j.surneu.2006.03.037
   Kikkawa Y, 2017, WORLD NEUROSURG, V105, P470, DOI 10.1016/j.wneu.2017.06.033
   Matano F, 2017, WORLD NEUROSURG, V98, P182, DOI 10.1016/j.wneu.2016.10.082
   Miyachi Shigeru, 2017, Neurointervention, V12, P83, DOI 10.5469/neuroint.2017.12.2.83
   Morita K, 2011, NEUROL MED-CHIR, V51, P762
   O'Kelly CJ, 2013, AM J NEURORADIOL, V34, P381, DOI 10.3174/ajnr.A3224
   Oishi H, 2018, NEUROL MED-CHIR, V58, P461, DOI 10.2176/nmc.oa.2018-0148
   Ono H, 2018, NEUROSURG REV, V41, P655, DOI 10.1007/s10143-017-0911-3
   Puffer RC, 2014, AM J NEURORADIOL, V35, P948, DOI 10.3174/ajnr.A3826
   Pedro JRD, 2017, CLIN NEUROL NEUROSUR, V160, P59, DOI 10.1016/j.clineuro.2017.06.008
   Stiebel-Kalish H, 2003, NEUROSURGERY, V53, P1268, DOI 10.1227/01.NEU.0000093495.70639.AE
   Tanweer O, 2014, AM J NEURORADIOL, V35, P2334, DOI 10.3174/ajnr.A4081
   van Rooij WJ, 2012, AM J NEURORADIOL, V33, P323, DOI 10.3174/ajnr.A2759
   Zanaty M, 2014, STROKE, V45, P2656, DOI 10.1161/STROKEAHA.114.006247
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E637
EP E644
DI 10.1016/j.wneu.2019.08.059
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300077
PM 31442640
DA 2020-05-12
ER

PT J
AU Kim, J
   Yi, HJ
   Lee, DH
   Sung, JH
AF Kim, Jeeyong
   Yi, Ho Jun
   Lee, Dong Hoon
   Sung, Jae Hoon
TI Safety and Feasibility of Using Argatroban Immediately After Mechanical
   Thrombectomy for Large Artery Occlusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anticoagulation; Ischemic stroke; Thrombectomy; Thrombin inhibitor;
   Thrombolysis
ID TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC-STROKE; RANDOMIZED-TRIAL;
   REOCCLUSION; MULTICENTER; ALTEPLASE; THERAPY; UPDATE; DEVICE; ONSET
AB BACKGROUND: This study aims to evaluate the safety and effects of using argatroban, immediately after mechanical thrombectomy (MT) with large artery occlusion.
   METHODS: A total of 302 patients were divided into 2 groups: the MT with post argatroban (MT+ARG) group and the MT without post argatroban (MT-ARG) group. Baseline characteristics, time interval categories, and results of MT were reviewed. Outcome assessment with the National Institutes of Health Stroke Scale, modified Rankin Scale, TICI, reocclusion, and various complications were evaluated and compared between the 2 groups. Subgroup analysis was also performed for patients using tissue plasminogen activator or tirofiban.
   RESULTS: Baseline characteristics and time intervals were similar for the 2 groups. The MT+ARG group showed significantly less occurrence of reocclusion at 24 hours and 7 days compared with the MT-ARG group (2.5% vs. 6.0%, P = 0.018; 4.2% vs. 8.2%, P = 0.020). However, there were no significant differences in incidence of complications such as brain hemorrhage between the 2 groups. In subgroup analysis with tissue plasminogen activator, the MTDARG group showed less occurrence of reocclusion at 24 hours and 7 days compared with the MT-ARG group (P = 0.008 and P = 0.018, respectively). In subgroup analysis with tirofiban, reocclusion at 7 days occurred less in the MT+ARG group (P = 0.040).
   CONCLUSIONS: This study showed the safety and use-fulness of argatroban immediately after MT, indicating that using argatroban after MT could prevent reocclusion of target artery without increasing bleeding complications.
C1 [Kim, Jeeyong; Yi, Ho Jun; Lee, Dong Hoon; Sung, Jae Hoon] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
   [Yi, Ho Jun] Hallym Univ, Hangang Sacred Heart Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
RP Yi, HJ (reprint author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.; Yi, HJ (reprint author), Hallym Univ, Hangang Sacred Heart Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
EM 431anarchy@naver.com
OI Yi, Ho Jun/0000-0003-3061-0689
CR Asada Y, 2018, J ATHEROSCLER THROMB, V25, P653, DOI 10.5551/jat.RV17022
   Barreto AD, 2017, STROKE, V48, P1608, DOI 10.1161/STROKEAHA.117.016720
   Barreto AD, 2012, STROKE, V43, P770, DOI 10.1161/STROKEAHA.111.625574
   Bath PMW, 2012, STROKE, V43, P623, DOI 10.1161/STROKEAHA.111.640557
   Berekashvili K, 2018, J STROKE CEREBROVASC, V27, P3647, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.036
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Enomoto Y, 2014, J STROKE CEREBROVASC, V23, P2834, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.011
   Fareed J, 2006, FUTUR CARDIOL, V2, P403, DOI 10.2217/14796678.2.4.403
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656
   Hursting MJ, 1997, SEMIN THROMB HEMOST, V23, P503, DOI 10.1055/s-2007-996128
   Hwang YH, 2016, STROKE, V47, P1850, DOI 10.1161/STROKEAHA.116.013046
   Jang IK, 1999, J AM COLL CARDIOL, V33, P1879, DOI 10.1016/S0735-1097(99)00107-2
   Johnson S, 2017, ANN BIOMED ENG, V45, P2494, DOI 10.1007/s10439-017-1906-5
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Kang DH, 2014, CEREBROVASC DIS, V37, P350, DOI 10.1159/000362435
   Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500
   Millan M, 2017, STROKE, V48, P983, DOI 10.1161/STROKEAHA.116.015455
   Mistry EA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006167
   Moledina M, 2001, J THROMB THROMBOLYS, V12, P141, DOI 10.1023/A:1012919404290
   Mosimann PJ, 2018, STROKE, V49, P2643, DOI 10.1161/STROKEAHA.118.021685
   Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517
   Qureshi AI, 2009, NEUROCRIT CARE, V10, P195, DOI 10.1007/s12028-008-9161-0
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Swan SK, 2000, PHARMACOTHERAPY, V20, P318, DOI 10.1592/phco.20.4.318.34881
   Tanaka KA, 2004, ANESTH ANALG, V99, P1283, DOI 10.1213/01.ANE.0000134685.75813.EB
   Turan TN, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0422-y
   Vitt JR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00138
   Walenga JM, 2002, PATHOPHYSIOL HAEMO T, V32, P9, DOI 10.1159/000069103
   Wykrzykowska JJ, 2003, J THROMB THROMBOLYS, V15, P47, DOI 10.1023/A:1026144518686
   Yeh RW, 2006, AM HEART J, V151, P1131, DOI 10.1016/j.ahj.2005.09.002
NR 34
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E341
EP E349
DI 10.1016/j.wneu.2019.08.151
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300041
PM 31476456
DA 2020-05-12
ER

PT J
AU Kochanski, RB
   Bus, S
   Brahimaj, B
   Borghei, A
   Kraimer, KL
   Keppetipola, KM
   Beehler, B
   Pal, G
   Metman, LV
   Sani, S
AF Kochanski, Ryan B.
   Bus, Sander
   Brahimaj, Bledi
   Borghei, Alireza
   Kraimer, Kristen L.
   Keppetipola, Kavantissa M.
   Beehler, Blake
   Pal, Gian
   Metman, Leo Verhagen
   Sani, Sepehr
TI The Impact of Microelectrode Recording on Lead Location in Deep Brain
   Stimulation for the Treatment of Movement Disorders
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deep brain stimulation; Discordance; Error; Microelectrode recording;
   Targeting
ID SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; INTERVENTIONAL MRI;
   CLINICAL-OUTCOMES; IMAGE FUSION; STN DBS; SURGERY; ACCURACY; SHIFT;
   DYSTONIA
AB OBJECTIVE: During deep brain stimulation (DBS) surgery, microelectrode recording (MER) leads to target refinement from the initial plan in 30% to 47% of hemispheres; however, it is unclear whether the DBS lead ultimately resides within the MER-optimized target in relation to initial radiographic target coordinates in these hemispheres. This study aimed to determine the frequency of discordance between radiographic and neurophysiologic nucleus and whether target optimization with MER leads to a significant change in DBS lead location away from initial target.
   METHODS: Consecutive cases of DBS surgery with MER using intraoperative computed tomography were included. Coordinates of initial anatomic target (AT), MER-optimized target (MER-O) and DBS lead were obtained. Hemispheres were categorized as "discordant" (D) if there was a suboptimal neurophysiologic signal despite accurate targeting of AT. Hemispheres where the first MER pass was satisfactory were deemed "concordant" (C). Coordinates and radial distances between 1) AT/MER-O; 2) MER-O/DBS; and 3) AT/DBS were calculated and compared.
   RESULTS: Of the 273 hemispheres analyzed, 143 (52%) were D, and 130 (48%) were C. In C hemispheres, DBS lead placement error (mean +/- standard error of the mean) was 0.88 +/- 0.07 mm. In D hemispheres, MER resulted in significant migration of DBS lead (mean AT-DBS error 2.11 +/- 0.07 mm), and this distance was significantly greater than the distance between MER-O and DBS (2.11 vs. 1.09 mm, P < 0.05). Directional assessment revealed that the DBS lead migrated in the intended direction as determined by MER-O in D hemispheres, except when the intended direction was anterolateral.
   CONCLUSIONS: Discordance between radiographic and neurophysiologic target was seen in 52% of hemispheres, and MER resulted in appropriate deviation of the DBS lead toward the appropriate target. The actual value of the deviation, when compared with DBS lead placement error in C hemispheres, was, on average, small.
C1 [Kochanski, Ryan B.; Brahimaj, Bledi; Borghei, Alireza; Kraimer, Kristen L.; Keppetipola, Kavantissa M.; Beehler, Blake; Sani, Sepehr] Rush Univ, Dept Neurosurg, Med Ctr, Chicago, IL 60612 USA.
   [Bus, Sander; Pal, Gian; Metman, Leo Verhagen] Rush Univ, Dept Neurol, Med Ctr, Sect Movement Disorders, Chicago, IL 60612 USA.
RP Sani, S (reprint author), Rush Univ, Dept Neurosurg, Med Ctr, Chicago, IL 60612 USA.
EM Sepehr_Sani@rush.edu
OI Sani, Sepehr/0000-0002-1737-5269
CR Bakay RAE, 1999, NEUROSURGERY, V45, P1382
   Barnaure I, 2015, NEURORADIOLOGY, V57, P903, DOI 10.1007/s00234-015-1547-z
   BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T
   Bot M, 2017, STEREOT FUNCT NEUROS, V95, P183, DOI 10.1159/000475672
   Brahimaj B, 2018, J CLIN NEUROSCI, V50, P58, DOI 10.1016/j.jocn.2018.01.020
   Burchiel KJ, 2013, J NEUROSURG, V119, P301, DOI 10.3171/2013.4.JNS122324
   Burchiel KJ, 1999, NEUROSURGERY, V45, P1375, DOI 10.1097/00006123-199912000-00024
   Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034
   Calabrese E, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00045
   Carl B, 2019, WORLD NEUROSURG, V124, pE252, DOI 10.1016/j.wneu.2018.12.079
   Chandran AS, 2016, J NEUROSURG, V124, P96, DOI 10.3171/2015.1.JNS142066
   Chen T, 2017, WORLD NEUROSURG, V105, P191, DOI 10.1016/j.wneu.2017.05.042
   Coenen VA, 2016, AM J NEURORADIOL, V37, P1470, DOI 10.3174/ajnr.A4753
   Coenen VA, 2011, CENT EUR NEUROSURG, V72, P181, DOI 10.1055/s-0031-1279748
   Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281
   Elias WJ, 2007, J NEUROSURG, V107, P983, DOI 10.3171/JNS-07/11/0983
   Fried I, 2014, SINGLE NEURON STUDIES OF THE HUMAN BRAIN: PROBING COGNITION, P1
   Ho AL, 2018, J NEUROL NEUROSUR PS, V89, P687, DOI 10.1136/jnnp-2016-314500
   Holl EM, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7422a
   Holloway K, 2013, NEUROSURGERY, V72, P47, DOI 10.1227/NEU.0b013e318273a090
   Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456
   Ivan ME, 2014, J NEUROSURG, V121, P149, DOI 10.3171/2014.3.JNS121312
   Kochanski RB, 2017, WORLD NEUROSURG, V103, P168, DOI 10.1016/j.wneu.2017.04.003
   Kochanski RB, 2017, J CLIN NEUROSCI, V40, P130, DOI 10.1016/j.jocn.2017.02.037
   Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618
   Lanotte MM, 2002, J NEUROL NEUROSUR PS, V72, P53, DOI 10.1136/jnnp.72.1.53
   Mirzadeh Z, 2016, J NEUROSURG, V124, P902, DOI 10.3171/2015.4.JNS1550
   Montgomery EB, 2012, MOVEMENT DISORD, V27, P1387, DOI 10.1002/mds.25000
   Nakajima T, 2011, STEREOT FUNCT NEUROS, V89, P318, DOI 10.1159/000330379
   O'Gorman RL, 2009, STEREOT FUNCT NEUROS, V87, P205, DOI 10.1159/000225973
   Ostrem JL, 2016, J NEUROSURG, V124, P908, DOI 10.3171/2015.4.JNS15173
   Ostrem JL, 2013, CLIN NEUROL NEUROSUR, V115, P708, DOI 10.1016/j.clineuro.2012.08.019
   Pallavaram S, 2010, INT J COMPUT ASS RAD, V5, P221, DOI 10.1007/s11548-009-0391-1
   Papavassiliou E, 2004, NEUROSURGERY, V54, P1120, DOI 10.1227/01.NEU.0000119329.66931.9E
   Saleh S, 2015, STEREOT FUNCT NEUROS, V93, P419, DOI 10.1159/000442425
   Schlaier JR, 2011, ACTA NEUROCHIR, V153, P2307, DOI 10.1007/s00701-011-1081-7
   Shah Dhwani B, 2008, Psychiatry (Edgmont), V5, P24
   Smith AP, 2011, J NEUROSURG, V115, P301, DOI 10.3171/2011.3.JNS101642
   Starr PA, 2006, J NEUROSURG, V104, P488, DOI 10.3171/jns.2006.104.4.488
   Starr PA, 2014, J NEUROSURG-PEDIATR, V14, P400, DOI 10.3171/2014.6.PEDS13605
   Sterio D, 2002, NEUROSURGERY, V50, P58, DOI 10.1097/00006123-200201000-00012
   van den Munckhof P, 2010, NEUROSURGERY, V67, P49, DOI 10.1227/01.NEU.0000370597.44524.6D
NR 42
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E487
EP E495
DI 10.1016/j.wneu.2019.08.092
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300058
PM 31449992
DA 2020-05-12
ER

PT J
AU Laukamp, KR
   Shakirin, G
   Baessler, B
   Thiele, F
   Zopfs, D
   Hokamp, NG
   Timmer, M
   Kabbasch, C
   Perkuhn, M
   Borggrefe, J
AF Laukamp, Kai Roman
   Shakirin, Georgy
   Baessler, Bettina
   Thiele, Frank
   Zopfs, David
   Hokamp, Nils Grosse
   Timmer, Marco
   Kabbasch, Christoph
   Perkuhn, Michael
   Borggrefe, Jan
TI Accuracy of Radiomics-Based Feature Analysis on Multiparametric Magnetic
   Resonance Images for Noninvasive Meningioma Grading
SO WORLD NEUROSURGERY
LA English
DT Article
DE Logistic models; Magnetic resonance imaging; Meningioma; Multivariate
   analysis; ROC curve
ID HISTOGRAM ANALYSIS; PREOPERATIVE MRI; TEXTURE ANALYSIS; SEGMENTATION;
   BENIGN; SYSTEM
AB OBJECTIVE: Meningioma grading is relevant to therapy decisions in complete or partial resection, observation, and radiotherapy because higher grades are associated with tumor growth and recurrence. The differentiation of low and intermediate grades is particularly challenging. This study attempts to apply radiomics-based shape and texture analysis on routine multiparametric magnetic resonance imaging (MRI) from different scanners and institutions for grading.
   METHODS: We used MRI data (T1-weighted/T2-weighted, T1-weighted-contrast-enhanced [T1CE], fluid-attenuated inversion recovery [FLAIR], diffusion-weighted imaging [DWI], apparent diffusion coefficient [ADC]) of grade I (n = 46) and grade II (n = 25) nontreated meningiomas with histologic workup. Two experienced radiologists performed manual tumor segmentations on FLAIR, T1CE, and ADC images in consensus. The MRI data were preprocessed through T1CE and T1-subtraction, coregistration, resampling, and normalization. A PyRadiomics package was used to generate 990 shape/texture features. Stepwise dimension reduction and robust radiomics feature selection were performed. Biopsy results were used as standard of reference.
   RESULTS: Four statistically independent radiomics features were identified as showing the strongest predictive values for higher tumor grades: roundness-of-FLAIR-shape (area under curve [AUC], 0.80), cluster-shades-of-FLAIR/T1CE-gray-level (AUC, 0.80), DWI/ADC-gray-level-variability (AUC, 0.72), and FLAIR/T1CE-gray-level-energy (AUC, 0.76). In a multivariate logistic regression model, the combination of the features led to an AUC of 0.91 for the differentiation of grade I and grade II meningiomas.
   CONCLUSIONS: Our results indicate that radiomics-based feature analysis applied on routine MRI is viable for meningioma grading, and a multivariate logistic regression model yielded strong classification performances. More advanced tumor stages are identifiable through certain shape parameters of the lesion, textural patterns in morphologic MRI sequences, and DWI/ADC variability.
C1 [Laukamp, Kai Roman; Shakirin, Georgy; Baessler, Bettina; Thiele, Frank; Zopfs, David; Hokamp, Nils Grosse; Kabbasch, Christoph; Perkuhn, Michael; Borggrefe, Jan] Univ Hosp Cologne, Inst Diagnost & Intervent Radiol, Cologne, Germany.
   [Timmer, Marco] Univ Hosp Cologne, Dept Neurosurg, Cologne, Germany.
   [Laukamp, Kai Roman; Hokamp, Nils Grosse] Univ Hosp Cleveland Med Ctr, Dept Radiol, Cleveland, OH USA.
   [Laukamp, Kai Roman; Hokamp, Nils Grosse] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
   [Shakirin, Georgy; Thiele, Frank; Perkuhn, Michael] Philips Res Europe, Aachen, Germany.
RP Borggrefe, J (reprint author), Univ Hosp Cologne, Inst Diagnost & Intervent Radiol, Cologne, Germany.
EM jan.borggrefe@uk-koeln.de
RI Laukamp, Kai/AAH-7230-2020; Baessler, Bettina/AAE-9137-2020; Borggrefe,
   Jan/N-6549-2018
OI Baessler, Bettina/0000-0002-3244-3864; Borggrefe,
   Jan/0000-0003-2908-7560; Zopfs, David/0000-0001-9978-7453; Kabbasch,
   Christoph/0000-0003-3712-2258
CR Akkus Z, 2017, J DIGIT IMAGING, V30, P449, DOI 10.1007/s10278-017-9983-4
   Avanzo M, 2017, PHYS MEDICA, V38, P122, DOI 10.1016/j.ejmp.2017.05.071
   Baessler B, 2019, INVEST RADIOL, V54, P221, DOI 10.1097/RLI.0000000000000530
   Baessler B, 2018, EUR J RADIOL, V102, P61, DOI 10.1016/j.ejrad.2018.03.013
   Baessler B, 2018, RADIOLOGY, V286, P103, DOI 10.1148/radiol.2017170213
   Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001
   Coroller TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187908
   Fountain DM, 2017, ACTA NEUROCHIR, V159, P435, DOI 10.1007/s00701-016-3071-2
   Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
   Hsu CC, 2010, J CLIN NEUROSCI, V17, P584, DOI 10.1016/j.jocn.2009.09.018
   Joo B, 2018, EUR RADIOL, V28, P331, DOI 10.1007/s00330-017-4962-1
   Kanazawa T, 2018, WORLD NEUROSURG, V120, pE1208, DOI 10.1016/j.wneu.2018.09.044
   Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686
   Kollova A, 2007, J NEUROSURG, V107, P325, DOI 10.3171/JNS-07/08/0325
   Kunimatsu A, 2016, JPN J RADIOL, V34, P459, DOI 10.1007/s11604-016-0550-6
   Kursa MB, 2011, DECEIVING CHARM FEAT, P145
   Laukamp KR, 2017, MOL IMAGING, V16, DOI 10.1177/1536012116687651
   Laukamp KR, 2019, EUR RADIOL, V29, P124, DOI 10.1007/s00330-018-5595-8
   Lin BJ, 2014, J NEUROSURG, V121, P1201, DOI 10.3171/2014.7.JNS132359
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lu YP, 2019, EUR RADIOL, V29, P1318, DOI 10.1007/s00330-018-5632-7
   Nagar VA, 2008, AM J NEURORADIOL, V29, P1147, DOI 10.3174/ajnr.A0996
   Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455
   Niu L, 2019, WORLD NEUROSURG, V126, pE646, DOI 10.1016/j.wneu.2019.02.109
   Park YW, 2019, EUR RADIOL, V29, P4068, DOI 10.1007/s00330-018-5830-3
   R Core Team, 2017, R LANG ENV STAT COMP
   RStudio Team, 2016, RSTUDIO INT DEV R
   Sanverdi SE, 2012, EUR J RADIOL, V81, P2389, DOI 10.1016/j.ejrad.2011.06.031
   Schob S, 2016, TRANSL ONCOL, V9, P274, DOI 10.1016/j.tranon.2016.05.003
   Tamrazi B, 2016, NEUROSURG CLIN N AM, V27, P137, DOI 10.1016/j.nec.2015.11.004
   van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339
   Wang SM, 2012, RADIOLOGY, V262, P584, DOI 10.1148/radiol.11110576
   Yan PF, 2017, TRANSL ONCOL, V10, P570, DOI 10.1016/j.tranon.2017.04.006
   Yao A, 2018, NEUROSURG REV, V41, P745, DOI 10.1007/s10143-016-0801-0
   Zhang X, 2017, ONCOTARGET, V8, P47816, DOI 10.18632/oncotarget.18001
   Zhou M, 2018, AM J NEURORADIOL, V39, P208, DOI 10.3174/ajnr.A5391
   Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095
NR 37
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E366
EP E390
DI 10.1016/j.wneu.2019.08.148
PG 25
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300043
PM 31476455
DA 2020-05-12
ER

PT J
AU Lee, JH
   Choi, KC
   Lee, JH
AF Lee, Jung Hwan
   Choi, Kyung-Chul
   Lee, Jun Ho
TI Could the Splitting of the Annulus During Percutaneous Endoscopic Lumbar
   Diskectomy (PELD) Be a Culprit for Recurrent Disk Herniation?: An
   Analysis of the Reherniation Pattern After PELD
SO WORLD NEUROSURGERY
LA English
DT Article
DE Annular tear; Location; Lumbosacral disk herniation; Percutaneous
   endoscopic lumbar diskectomy; Posterior longitudinal ligament; Severity
ID POSTERIOR LONGITUDINAL LIGAMENT; RISK-FACTORS; MICRODISCECTOMY;
   REOPERATION
AB OBJECTIVE: To explore which preoperative radiologic variables have propensity for reherniation and to evaluate whether the inherent annulus splitting procedure during percutaneous endoscopic lumbar diskectomy (PELD) could prompt reherniation, we assessed the correlation between the anatomic location of annular penetration and reherniation.
   METHODS: Three hundred and fifty patients who underwent PELD for central or subarticular disk herniation through a transforaminal approach were followed-up for at least 24 months. Fifty-four subjects that were reoperated for recurrent herniation were allocated as the reherniation group and the other 296 subjects were allocated as the non-reherniation group. The numerical rating scale score, another lumbosacral disk herniation (LDH) lesion in addition to the PELD level (another LDH), location (central or subarticular) and severity of LDH (protrusion or extrusion), and tear of the posterior longitudinal ligament (PLL) were compared between the 2 groups to identify which variables could be predictive factors for reherniation. To assess the influences of PELD on reherniation, location and severity of reherniation were compared with those of initial herniation.
   RESULTS: The location at the subarticular region and the existence of a concomitant PLL tear during initial LDH were significantly related to subsequent reherniation. The location and severity of these reherniations were significantly retained when compared with those of primary herniation.
   CONCLUSIONS: PLL tear and subarticular herniation were significantly related to recurrent disk herniation. Reherniation patterns after PELD generally matched those of primary herniation. The annulus penetrating step during PELD did not increase the risk of reherniation.
C1 [Lee, Jung Hwan] Namdarun Rehabil Clin, Dept Rehabil Med, Yong In City, Gyeonggi Do, South Korea.
   [Choi, Kyung-Chul] Leon Wiltse Mem Hosp, Dept Neurosurg, Anyang, Gyeonggi Do, South Korea.
   [Lee, Jun Ho] Kyung Hee Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.
RP Lee, JH (reprint author), Kyung Hee Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.
EM moo9924@khu.ac.kr
OI LEE, JUN HO/0000-0001-6246-8053
CR Abdu RW, 2017, SPINE, V42, P1106, DOI 10.1097/BRS.0000000000002088
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Choi KC, 2016, PAIN PHYSICIAN, V19, pE291
   Cong L, 2016, EUR SPINE J, V25, P134, DOI 10.1007/s00586-015-3776-6
   EBELING U, 1992, ACTA NEUROCHIR, V117, P143, DOI 10.1007/BF01400611
   GROEN GJ, 1990, AM J ANAT, V188, P282, DOI 10.1002/aja.1001880307
   Kim CH, 2015, SPINE, V40, pE1063, DOI 10.1097/BRS.0000000000001053
   Kim CH, 2013, SPINE, V38, P581, DOI 10.1097/BRS.0b013e318274f9a7
   Kim JM, 2007, MINIM INVAS NEUROSUR, V50, P82, DOI 10.1055/s-2007-982504
   Kim KT, 2015, J SPINAL DISORD TECH, V28, pE571, DOI 10.1097/BSD.0000000000000041
   Kim M, 2018, BIOMED RES INT, DOI 10.1155/2018/9073460
   Lee SB, 2018, J KOREAN NEUROSURG S, V61, P89, DOI 10.3340/jkns.2017.0257
   Loughenbury PR, 2006, CLIN ANAT, V19, P487, DOI 10.1002/ca.20200
   Miller LE, 2018, SPINE, V43, pE308, DOI 10.1097/BRS.0000000000002501
   Rasouli MR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010328.pub2
   Ruan WF, 2016, INT J SURG, V31, P86, DOI 10.1016/j.ijsu.2016.05.061
   Salaud C, 2018, SURG RADIOL ANAT, V40, P563, DOI 10.1007/s00276-017-1964-2
   van Heeswijk VM, 2018, SPINE, V43, P467, DOI 10.1097/BRS.0000000000002336
   Wang YP, 2018, PAIN PHYSICIAN, V21, pE113
   Yao Y, 2017, WORLD NEUROSURG, V100, P1, DOI 10.1016/j.wneu.2016.12.089
   Yin S, 2018, PAIN PHYSICIAN, V21, P337
NR 21
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E623
EP E629
DI 10.1016/j.wneu.2019.08.061
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300075
PM 31442646
DA 2020-05-12
ER

PT J
AU Lee, JJ
   Kim, HY
   Dhong, HJ
   Chung, SK
   Kong, DS
   Nam, DH
   So, YK
   Hong, SD
AF Lee, Jung Joo
   Kim, Hyo Yeol
   Dhong, Hun-Jong
   Chung, Seung-Kyu
   Kong, Doo-Sik
   Nam, Do-Hyun
   So, Yoon Kyoung
   Hong, Sang Duk
TI Delayed Cerebrospinal Fluid Leakage After Treatment of Skull Base
   Tumors: Case Series of 9 Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebrospinal fluid; Delayed; Endoscopic repair; Reconstruction
ID TRANSSPHENOIDAL SURGERY; RHINORRHEA; EXPERIENCE; BROMOCRIPTINE; REPAIR
AB INTRODUCTION: Cerebrospinal fluid (CSF) leaks usually happen in the early postoperative period. However, delayed CSF leak can happen several years after treatment. The purpose of this study was to review the characteristics and clinical course of delayed CSF leak after treating skull base tumors.
   METHODS: We treated 9 patients with delayed CSF leak (occurring at least 3 months after treatment) between December 2015 and February 2018. Clinical data including initial treatment modality for skull base tumor, time between treatment and CSF rhinorrhea, and the result of endoscopic CSF repair were evaluated by retrospective chart review.
   RESULTS: Nine patients with delayed CSF leak were evaluated. The mean age was 42.3 +/- 5.2 (mean +/- SD) years. Six patients with pituitary adenomas, 1 with a Rathke cleft cyst, 1 with a meningioma, and 1 with an osteosarcoma were enrolled. Seven patients (78%) received radiation, and the mean radiation dose was 55.7 +/- 2.6 Gy. The median time between the end of treatment for the skull base tumor and CSF rhinorrhea was 137.0 (interquartile range 24-145) months. Seven patients (78%) had meningitis at the time of operation. CSF rhinorrhea was treated with endoscopic reconstruction using a multilayer technique. Meningitis was improved without neurologic sequelae after reconstruction and antibiotic therapy. One patient had recurrence of CSF leak.
   CONCLUSION: Patients with delayed CSF leak are more likely to have a history of radiation and to present with meningitis at diagnosis. Therefore, CSF rhinorrhea should always be suspected, even several years after treatment, if early symptoms of CSF leak develop in patients with a history of skull base tumor.
C1 [Lee, Jung Joo; Kim, Hyo Yeol; Dhong, Hun-Jong; Chung, Seung-Kyu; Hong, Sang Duk] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.
   [Kong, Doo-Sik; Nam, Do-Hyun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea.
   [So, Yoon Kyoung] Inje Univ, Ilsan Paik Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Goyang Si, South Korea.
RP Hong, SD (reprint author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.
EM kkam97@gmail.com
CR AFSHAR F, 1982, SURG NEUROL, V18, P61, DOI 10.1016/0090-3019(82)90020-9
   BEVAN JS, 1992, ENDOCR REV, V13, P220, DOI 10.1210/er.13.2.220
   Cappabianca P, 2004, SURG NEUROL, V62, P227, DOI 10.1016/j.surneu.2004.01.016
   Cesak T, 2018, PITUITARY, V21, P561, DOI 10.1007/s11102-018-0907-1
   Couldwell William T, 2006, Neurosurg Focus, V20, pE11, DOI 10.3171/foc.2006.20.3.12
   de Lacy P, 2009, SURG NEUROL, V72, P461, DOI 10.1016/j.surneu.2009.06.005
   Han ZL, 2008, CLIN NEUROL NEUROSUR, V110, P570, DOI 10.1016/j.clineuro.2008.02.017
   Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019
   KOK JG, 1985, NEUROLOGY, V35, P1193, DOI 10.1212/WNL.35.8.1193
   Kudo H, 2000, NEUROL MED-CHIR, V40, P160, DOI 10.2176/nmc.40.160
   Lam G, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.4.FOCUS1268
   LANDOLT AM, 1982, NEUROSURGERY, V11, P395, DOI 10.1227/00006123-198209000-00010
   LAWS ER, 1995, BAILLIERE CLIN ENDOC, V9, P391, DOI 10.1016/S0950-351X(95)80418-8
   Machicado JD, 2012, J CLIN ENDOCR METAB, V97, P3412, DOI 10.1210/jc.2012-2245
   Nishioka H, 2005, ACTA NEUROCHIR, V147, P1163, DOI 10.1007/s00701-005-0586-3
   Ogawa Y, 2007, NEUROL MED-CHIR, V47, P483, DOI 10.2176/nmc.47.483
   Perry A, 2017, WORLD NEUROSURG, V100, P201, DOI 10.1016/j.wneu.2017.01.001
   Rabadan AT, 2009, J NEURO-ONCOL, V93, P127, DOI 10.1007/s11060-009-9858-8
   Seiler RW, 2000, J NEUROSURG, V93, P762, DOI 10.3171/jns.2000.93.5.0762
   Suliman SGI, 2007, J CLIN ENDOCR METAB, V92, P3829, DOI 10.1210/jc.2007-0373
   Yan HM, 2012, J CLIN NEUROSCI, V19, P900, DOI 10.1016/j.jocn.2011.09.016
   Zada G, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10155
NR 22
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E591
EP E598
DI 10.1016/j.wneu.2019.08.067
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300070
PM 31442635
DA 2020-05-12
ER

PT J
AU Lee, Y
   Kim, M
   Park, J
   Kim, BJ
   Son, W
   Jung, S
AF Lee, Youngseop
   Kim, Myungsoo
   Park, Jaechan
   Kim, Byoung-Joon
   Son, Wonsoo
   Jung, Sungmoon
TI Mirroring with Indocyanine Green Angiography in Aneurysm Surgery:
   Technical Note and Case Presentations
SO WORLD NEUROSURGERY
LA English
DT Article
DE Craniotomy; Indocyanine green angiography; Intracranial aneurysm;
   Micromirror
ID POSTERIOR COMMUNICATING ARTERY; ANTERIOR CHOROIDAL ARTERY;
   VIDEO-ANGIOGRAPHY; INTRAOPERATIVE ASSESSMENT; MICROSURGICAL ANATOMY;
   RIGID ENDOSCOPE; MANAGEMENT
AB OBJECTIVE: The authors used a micromirror under a microscope with an indocyanine green (ICG) imaging system to assess clipped aneurysms and the blood flow in hidden regions during aneurysm surgery. This study then investigated the usefulness of such mirroring with ICG angiography (MICGA).
   METHODS: A micromirror was used during aneurysm surgery on 25 patients, and MICGA was performed on 10 of these 25 patients to inspect the hidden region after clipping. The mirrored aneurysms were located at the posterior communicating artery (n = 4), anterior choroidal artery (n = 4), proximal A1 segment (n = 1), and middle cerebral artery (n = 1).
   RESULTS: In all 10 cases, MICGA was successful in assessing the state of the clipped aneurysm and blood flow of the vessels in the hidden region after clipping. This led to clip repositioning in 3 patients (30.0%) because of incomplete clipping of a hidden aneurysm or occlusion of a hidden perforator. Complete occlusion of the aneurysm was achieved in 8 patients, and the other 2 patients showed near complete occlusion because of an intentional residual aneurysm to avoid a small vessel adherent to the posterior wall of the aneurysm base.
   CONCLUSIONS: MICGA can provide useful and reliable information on the state of a clipped aneurysm and the blood flow of associated vessels and perforators in a hidden region after aneurysm clipping.
C1 [Lee, Youngseop; Kim, Myungsoo; Park, Jaechan; Kim, Byoung-Joon; Son, Wonsoo] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Daegu, South Korea.
   [Jung, Sungmoon] Kyungpook Natl Univ, Sch Med, Biomed Res Inst, Daegu, South Korea.
   [Park, Jaechan; Jung, Sungmoon] Kyungpook Natl Univ Hosp, Res Ctr Artificial Intelligence Med, Daegu, South Korea.
RP Park, J (reprint author), Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Daegu, South Korea.; Park, J (reprint author), Kyungpook Natl Univ Hosp, Res Ctr Artificial Intelligence Med, Daegu, South Korea.
EM jparkneurosurgery@gmail.com
CR Cho WS, 2017, WORLD NEUROSURG, V100, P316, DOI 10.1016/j.wneu.2017.01.042
   Dashti R, 2010, ACTA NEUROCHIR SUPPL, V107, P107, DOI 10.1007/978-3-211-99373-6_17
   de Oliveira JG, 2008, NEUROSURGERY, V62, P1300, DOI [10.1227/01.NEU.0000279982.48426.A1, 10.1227/01.neu.0000333795.21468.d4]
   Fischer G, 2012, NEUROSURGERY, V70, P184, DOI 10.1227/NEU.0b013e3182376a36
   He WZ, 2011, WORLD NEUROSURG, V75, P64, DOI 10.1016/j.wneu.2010.09.012
   He WZ, 2010, J NEUROSURG, V112, P611, DOI 10.3171/2009.8.JNS08731
   Hino A, 2002, ACTA NEUROCHIR, V144, P1291, DOI 10.1007/s00701-002-1014-6
   HUSSEIN S, 1988, ACTA NEUROCHIR, V92, P19, DOI 10.1007/BF01401968
   Kalavakonda C, 2002, NEUROSURGERY, V51, P1119, DOI 10.1097/00006123-200211000-00004
   Kuzmik GA, 2012, ACTA NEUROCHIR, V154, P1707, DOI 10.1007/s00701-012-1435-9
   Lee YS, 2013, J KOREAN NEUROSURG S, V54, P86, DOI 10.3340/jkns.2013.54.2.86
   Maiti TK, 2016, WORLD NEUROSURG, V85, P85, DOI 10.1016/j.wneu.2015.07.022
   Marinkovic S, 1999, SURG NEUROL, V52, P30, DOI 10.1016/S0090-3019(99)00043-9
   Mielke D, 2014, OPER NEUROSURG, V10, P418, DOI 10.1227/NEU.0000000000000345
   Nishiyama Y, 2012, J NEUROSURG, V117, P302, DOI 10.3171/2012.5.JNS112300
   Park Hyun-Seok, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P13, DOI 10.7461/jcen.2013.15.1.13
   Profeta G, 2004, CHILD NERV SYST, V20, P811, DOI 10.1007/s00381-004-0935-1
   Raabe A, 2003, NEUROSURGERY, V52, P132, DOI 10.1097/00006123-200301000-00017
   Roessler K, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13475
   Taniguchi R, 1999, J NEUROSURG, V91, P231, DOI 10.3171/jns.1999.91.2.0231
   Tanriover N, 2014, J NEUROSURG, V120, P1217, DOI 10.3171/2014.1.JNS131325
   Wanibuchi M, 2001, SURG NEUROL, V55, P148, DOI 10.1016/S0090-3019(01)00396-2
   Wilson J, 2012, NEUROSURGERY, V71, pE195, DOI 10.1227/NEU.0b013e318257d0c6
   YASARGIL MG, 1996, MICRONEUROSURGERY B, V4
   Yazici I, 2009, J CRANIOFAC SURG, V20, P201, DOI 10.1097/SCS.0b013e318191cfe3
   Zhao C, 2018, J CRANIOFAC SURG, V29, pE287, DOI 10.1097/SCS.0000000000004318
NR 26
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E696
EP E703
DI 10.1016/j.wneu.2019.08.042
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300084
PM 31421297
DA 2020-05-12
ER

PT J
AU Liang, TY
   Wang, XX
   Wang, F
   Feng, ES
   You, G
AF Liang, Tingyu
   Wang, Xiaoxuan
   Wang, Fang
   Feng, Enshan
   You, Gan
TI Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response
   in Glioma Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE GAL-9; Glioma; Immune response; Prognosis
ID LIGAND GALECTIN-9; TIM-3; EXPRESSION; APOPTOSIS
AB BACKGROUND: Glioma is the most frequent primary brain tumor. Immunotherapy is one of the most promising therapeutic approaches for gliomas. T cell immunoglobulin domain and mucin domain-3 can induce the malignancy of gliomas. The function of galectin-9 (GAL-9), as one of the ligands of T cell immunoglobulin domain and mucin domain-3, in glioma has remained elusive. The aim of this study was to characterize the expression of GAL-9 in patients with glioma.
   METHODS: This study enrolled 1292 patients with glioma from the GSE 16011 array set, the Chinese Glioma Genome Atlas, and The Cancer Genome Atlas datasets. Kaplan-Meier analysis was undertaken to explore the prognostic value of GAL-9. Graphpad software and R language were used for statistical analysis.
   RESULTS: Expression of GAL-9 was highly correlated with major clinical and molecular features. Patients with high expression of GAL-9 were more susceptible to development of malignant tumors. Gene Ontology analysis revealed that expression of GAL-9 was closely associated with function of immune response in glioma. Clinically, the results of Kaplan-Meier analysis showed that expression of GAL-9 was negatively associated with overall survival in all grades of glioma including high-grade gliomas. High expression of GAL-9 was an independent indicator of poor prognosis.
   CONCLUSIONS: Our results highlight the pivotal role of GAL-9 in regulation of immune suppressive features of gliomas and indicate that GAL-9 is a promising target for cancer immunotherapy and may lead to development of further therapies.
C1 [Liang, Tingyu; Wang, Fang; Feng, Enshan] Capital Med Univ, Beijing Ditan Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Wang, Xiaoxuan] Capital Med Univ, Dept Pathol, Beijing, Peoples R China.
   [You, Gan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.
RP You, G (reprint author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.
EM Ganyou2016@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81871013]; Beijing Medical Management Bureau
   Cultivation Plan [PX2018079]; National Key Sci-Tech Special Project of
   China [2018ZX10302207]; Beijing Tiantan Hospital Young Scientist Program
   [YSP 201705]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81871013), the Beijing Medical Management Bureau Cultivation
   Plan (No. PX2018079), National Key Sci-Tech Special Project of China
   (No.2018ZX10302207), and Beijing Tiantan Hospital Young Scientist
   Program (Grant No. YSP 201705).
CR Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001
   Cheng W, 2017, MOL NEUROBIOL, V54, P5996, DOI 10.1007/s12035-016-0150-6
   Dehcordi SR, 2017, WORLD NEUROSURG, V105, P895, DOI 10.1016/j.wneu.2017.05.099
   Feng ES, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1418-3
   Gieryng A, 2017, LAB INVEST, V97, P498, DOI 10.1038/labinvest.2017.19
   He YY, 2018, ONCOTARGETS THER, V11, P7005, DOI 10.2147/OTT.S170385
   Hu HM, 2018, CELL, V175, P1665, DOI 10.1016/j.cell.2018.09.038
   Hu HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11962-y
   Hung AL, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1466769
   Jiang JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055729
   Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398
   Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436
   Li GZ, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1328339
   Li G, 2018, ACS APPL MATER INTER, V10, P40189, DOI 10.1021/acsami.8b16094
   Liu ZJ, 2016, ONCOL LETT, V11, P1829, DOI 10.3892/ol.2016.4142
   Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043
   McGranahan T, 2017, THER ADV MED ONCOL, V9, P347, DOI 10.1177/1758834017693750
   Okada H, 2009, CRIT REV IMMUNOL, V29, P1
   Okura R, 2018, ONCOL LETT, V15, P407, DOI 10.3892/ol.2017.7316
   Palumbo P, 2018, INT J MOL SCI, P19
   Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009
   Romani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00464
   Wang K, 2018, CELL PHYSIOL BIOCHEM, V45, P993, DOI 10.1159/000487294
   Wang Z, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1196310
   Wdowiak K, 2019, ONCOL LETT, V17, P1019, DOI 10.3892/ol.2018.9656
   Yang RY, 2017, SCI CHINA LIFE SCI, V60, P1058, DOI 10.1007/s11427-017-9176-7
   Zhang CB, 2017, CLIN CANCER RES, V23, P6279, DOI 10.1158/1078-0432.CCR-16-2598
   Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271
   Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072
NR 29
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E455
EP E462
DI 10.1016/j.wneu.2019.08.117
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300054
PM 31470166
DA 2020-05-12
ER

PT J
AU Lim, SH
   Park, CK
   Park, BJ
   Lim, YJ
AF Lim, Seung Hoon
   Park, Chang Kyu
   Park, Bong Jin
   Lim, Young Jin
TI Long-Term Outcomes of Gamma Knife Radiosurgery for Cystic Vestibular
   Schwannomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cysts; Gamma knife radiosurgery; Postoperative complications; Vestibular
   schwannoma
ID STEREOTACTIC RADIOSURGERY; ACOUSTIC NEURINOMAS; SURGERY; TUMORS
AB OBJECTIVE: Vestibular schwannomas (VSs) can either be solid or contain variable amounts of cystic components. It has been established that gamma knife radiosurgery (GKRS) is an effective treatment modality for solid VSs. However, in the case of cystic VS, given the somewhat unpredictable growth of the cystic portion of these tumors, microsurgery has often been preferred to GKRS in the management of cystic VS. However, to date, a relative paucity of data evaluating the outcomes after GKRS for cystic VS has been available. In the present study, we reviewed our experience treating cystic VSs with GKRS and evaluated the results.
   METHODS: The data from patients with a diagnosis of cystic VS who had undergone GKRS from 1999 to 2018 were analyzed. Only those patients who had undergone GKRS as the initial treatment of cystic VSs were included in the present study. Patients who had undergone previous surgical treatment were excluded. The cystic VSs were divided into intratumoral and peritumoral cysts.
   RESULTS: A total of 24 patients were enrolled in the present study. The mean age was 60.8 +/- 2.4 years (range, 38-82 years). The mean follow-up period was 55.8 +/- 8.1 months (range, 8-145 months). Of the 24 patients, 11 were men. The control rate after GKRS for cystic VSs was 75%. The 5-year progression-free rate was 70%. Six patients had presented with an increasing lesion size after GKS. Of these 6 patients, 2 underwent surgical treatment and 1 underwent repeat GKRS. No statistically significant differences were found between the control rate and cystic type (P = 0.093).
   CONCLUSION: The results from the present study have demonstrated that GKRS is an effective treatment modality for cystic VSs.
C1 [Lim, Seung Hoon; Park, Chang Kyu; Park, Bong Jin; Lim, Young Jin] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea.
   [Park, Chang Kyu; Park, Bong Jin; Lim, Young Jin] Kyung Hee Univ, Dept Neurosurg, Coll Med, Seoul, South Korea.
RP Park, CK (reprint author), Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea.; Park, CK (reprint author), Kyung Hee Univ, Dept Neurosurg, Coll Med, Seoul, South Korea.
EM changchaz@naver.com
OI Park, Chang Kyu/0000-0002-5935-8264
FU Kyung Hee University [KHU-20182176]
FX The present study was supported by Kyung Hee University (grant
   KHU-20182176, awarded in 2018).
CR Battista RA, 2009, OTOLARYNG CLIN N AM, V42, P635, DOI 10.1016/j.otc.2009.04.009
   Bowden G, 2017, NEUROSURGERY, V81, P490, DOI 10.1093/neuros/nyx027
   Charabi S, 2000, ACTA OTO-LARYNGOL, P11
   Delsanti C, 2004, NEUROCHIRURGIE, V50, P401
   FLICKINGER JC, 1993, RADIOTHER ONCOL, V27, P91, DOI 10.1016/0167-8140(93)90127-T
   Frisch CD, 2017, NEUROSURGERY, V80, P112, DOI 10.1227/NEU.0000000000001376
   Ganslandt O, 2008, ZBL NEUROCHIR, V69, P204, DOI 10.1055/s-2008-1077074
   Hasegawa T, 2013, J NEUROSURG, V118, P557, DOI 10.3171/2012.10.JNS12523
   Hirato M, 1996, STEREOT FUNCT NEUROS, V66, P134, DOI 10.1159/000099803
   Hirato Masafumi, 1995, Neurologia Medico-Chirurgica, V35, P737, DOI 10.2176/nmc.35.737
   Jeyakumar A, 2007, ACTA OTO-LARYNGOL, V127, P1051, DOI 10.1080/00016480701200210
   Lunsford LD, 2017, NEUROSURGERY, V80, P119, DOI 10.1093/neuros/nyw011
   Morcos JJ, 2013, J NEUROSURG, V118, P550, DOI 10.3171/2012.6.JNS12866
   Myrseth E, 2009, NEUROSURGERY, V64, P654, DOI 10.1227/01.NEU.0000340684.60443.55
   Pendl G, 1996, STEREOT FUNCT NEUROS, V66, P103, DOI 10.1159/000099775
   Prabhuraj AR, 2019, WORLD NEUROSURG, V127, pE114, DOI 10.1016/j.wneu.2019.02.169
   Seo Y, 1996, STEREOT FUNCT NEUROS, V66, P93, DOI 10.1159/000099774
   Shirato H, 2000, INT J RADIAT ONCOL, V48, P1395, DOI 10.1016/S0360-3016(00)00731-8
   Shuto T, 2016, J CLIN NEUROSCI, V33, P239, DOI 10.1016/j.jocn.2016.05.022
   Teo M, 2010, NEUROSURGERY, V67, pE878, DOI 10.1227/NEU.0B013E3181EE3C0D
   THOMPSON BG, 1990, SURG NEUROL, V33, P96
   Timmer FCA, 2011, LARYNGOSCOPE, V121, P1359, DOI 10.1002/lary.21763
   Yang SY, 2008, J NEUROL NEUROSUR PS, V79, P431, DOI 10.1136/jnnp.2007.119602
NR 23
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E34
EP E39
DI 10.1016/j.wneu.2019.09.009
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300007
PM 31520763
DA 2020-05-12
ER

PT J
AU Liu, LX
   Cao, XD
   Ren, YM
   Zhou, LX
   Yang, CH
AF Liu, Lun-Xin
   Cao, Xu-Dong
   Ren, Yan-Ming
   Zhou, Liang-Xue
   Yang, Chao-Hua
TI Risk Factors for Recurrence of Chronic Subdural Hematoma: A Single
   Center Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE Burr hole; Chronic subdural hematoma; Membrane; Mixed density hematoma;
   Recurrence
ID POSTOPERATIVE-PATIENT POSTURE; BURR-HOLE CRANIOSTOMY; INDEPENDENT
   PREDICTORS; DRAINAGE; MEMBRANECTOMY; EPIDEMIOLOGY; CRANIOTOMY;
   EVACUATION; MANAGEMENT; RATES
AB OBJECTIVE: Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage with a substantial recurrence rate. We aimed to investigate the predictive factors for the postsurgical recurrence of CSDH.
   METHODS: We retrospectively reviewed the medical records of patients with CSDH who underwent surgery in West China Hospital between January 2012 and June 2018. Univariate and multivariate analyses were performed to identify the relationships between recurrence of CSDH and factors such as age, sex, history of injury, Markwalder grading, computed tomography findings, surgical methods, and outcomes.
   RESULTS: A total of 328 patients (281 men and 47 women) aged 22-93 years (mean age, 65.14 +/- 13.76 years) were included. Computed tomography findings at admission showed mixed density hematoma in 136 patients, isodensity hematoma in 140, high-density hematoma in 34, and low-density hematoma in 18. The mortality and recurrence rate were 0.30% (1 of 328) and 2.44% (8 of 328), respectively. Six months postoperatively, 327 patients had Markwalder grade 0. Hematoma recurred in 8 patients of which 7 were mixed density hematoma and 1 was isodensity hematoma. Six patients who underwent craniotomy had thickened inner neomembrane that was resected. Univariate and multivariate analyses found mixed density hematoma to be an independent risk factor for the recurrence of CSDH.
   CONCLUSIONS: Burr hole craniostomy with irrigation and closed-system drainage is effective for the surgical treatment of CSDH. Mixed density hematoma is an independent predictor for the recurrence of CSDH. Presence of thick inner neomembrane might be the primary cause of CSDH recurrence.
C1 [Liu, Lun-Xin; Ren, Yan-Ming; Zhou, Liang-Xue; Yang, Chao-Hua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
   [Cao, Xu-Dong] Peoples Hosp Tibet Autonomous Reg, Dept Neurosurg, Lhasa, Tibet, Peoples R China.
RP Yang, CH (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM yangchaohua999@126.com
CR Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67
   Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71
   Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232
   Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290
   Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550
   Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9
   Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6
   FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457
   Fukuhara T, 1996, SURG NEUROL, V45, P570, DOI 10.1016/0090-3019(95)00471-8
   HAMILTON MG, 1993, NEUROSURGERY, V33, P67
   Ishibashi Akira, 2011, Kurume Medical Journal, V58, P35
   Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030
   Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149
   Kim Dong Hwan, 2014, Korean J Neurotrauma, V10, P101, DOI 10.13004/kjnt.2014.10.2.101
   Kim JH, 2011, J KOREAN NEUROSURG S, V50, P103, DOI 10.3340/jkns.2011.50.2.103
   Kim SU, 2017, J KOREAN NEUROSURG S, V60, P701, DOI 10.3340/jkns.2016.1010.003
   KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207
   Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026
   Lind CRP, 2003, J NEUROSURG, V99, P44, DOI 10.3171/jns.2003.99.1.0044
   MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390
   Maurice-Williams RS., 2009, BRIT J NEUROSURG, V13, P547
   Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298
   Nagatani K, 2011, ACTA NEUROCHIR, V153, P1713, DOI 10.1007/s00701-011-0971-z
   Nakaguchi H, 2000, J NEUROSURG, V93, P791, DOI 10.3171/jns.2000.93.5.0791
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Nakajima H, 2002, SURG NEUROL, V58, P385, DOI 10.1016/S0090-3019(02)00921-7
   Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z
   Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382
   Park HR, 2013, J KOREAN NEUROSURG S, V54, P38, DOI 10.3340/jkns.2013.54.1.38
   Pont LMEB, 2012, EUR J NEUROL, V19, P1397, DOI 10.1111/j.1468-1331.2012.03768.x
   Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022
   Ro HW, 2016, ACTA NEUROCHIR, V158, P135, DOI 10.1007/s00701-015-2625-z
   Sahyouni R, 2017, WORLD NEUROSURG, V104, P418, DOI 10.1016/j.wneu.2017.05.030
   Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   SARTI C, 1991, STROKE, V22, P848, DOI 10.1161/01.STR.22.7.848
   SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311
   Tanaka Yoji, 2013, J Med Dent Sci, V60, P55
   Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17
   Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937
   Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217
   Yu GJ, 2009, BRIT J NEUROSURG, V23, P606, DOI 10.3109/02688690903386983
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E506
EP E513
DI 10.1016/j.wneu.2019.08.089
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300060
PM 31450003
DA 2020-05-12
ER

PT J
AU Lorente, L
   Martin, MM
   Perez-Cejas, A
   Gonzalez-Rivero, AF
   Argueso, M
   Ramos, L
   Sole-Violan, J
   Caceres, JJ
   Jimenez, A
   Garcia-Marin, V
AF Lorente, Leonardo
   Martin, Maria M.
   Perez-Cejas, Antonia
   Gonzalez-Rivero, Agustin F.
   Argueso, Monica
   Ramos, Luis
   Sole-Violan, Jordi
   Caceres, Juan J.
   Jimenez, Alejandro
   Garcia-Marin, Victor
TI Persistently High Serum Substance P Levels and Early Mortality in
   Patients with Severe Traumatic Brain Injury
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain trauma; Injury; Mortality; Patients; Substance P
ID FUNCTIONAL DEFICITS; TACHYKININS; NEUROPEPTIDES; INTERLEUKIN-6;
   INFLAMMATION; ANTAGONISTS; ASTROCYTES; RECEPTORS; CYTOKINES; ALPHA
AB BACKGROUND: Substance P is a neuropeptide belonging to the tachykinin family and is involved in neuroinflammation. In a previous study by our team, we found higher serum substance P levels on day 1 of traumatic brain injury (TBI) in nonsurviving than in surviving patients. Thus, the objective of this study was to determine whether serum substance P levels during the first week of TBI could predict early mortality.
   METHODS: This was a multicenter, observational, and prospective study. We included patients with an isolated severe TBI, defining isolated as <9 points in non-cranial aspects of Injury Severity Score and severe as <9 points of Glasgow Coma Scale. We determined serum substance P concentrations at days 1, 4, and 8 of TBI. We performed receiver operating characteristic analyses to determine the capacity of serum substance P levels at day 1, 4, and 8 of TBI to predict 30-day mortality.
   RESULTS: Nonsurviving (n = 34) compared with surviving patients (n = 90) had greater serum substance P levels on day 1 (P < 0.001), 4 (P < 0.001), and 8 (P < 0.001) of TBI. The areas under curve of serum substance P concentrations at days 1, 4, and 8 of TBI to predict 30-day mortality were 76% (P < 0.001), 87% (P < 0.001), and 89% (P < 0.001), respectively.
   CONCLUSIONS: The new finding of our study is that the presence of elevated serum substance P levels during the first week of TBI is associated with increased mortality.
C1 [Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain.
   [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.] Hosp Univ Canarias, Lab Dept, Santa Cruz De Tenerife, Spain.
   [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Santa Cruz De Tenerife, Spain.
   [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Santa Cruz De Tenerife, Spain.
   [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain.
   [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain.
   [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, La Palma, Spain.
   [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain.
   [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain.
RP Lorente, L (reprint author), Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain.
EM lorentemartin@msn.com
OI Argueso, Monica/0000-0001-5917-1056
FU Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife,
   Spain) [OA18/011]
FX This study was supported by a grant (OA18/011) from Fundacion DISA a la
   Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748
   Ameliorate JL, 2017, MAGNESIUM RES, V30, P88, DOI 10.1684/mrh.2017.0427
   ANSEL JC, 1993, J IMMUNOL, V150, P4478
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998
   Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028
   Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z
   Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155
   Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9
   Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8
   Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632
   Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63
   Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37
   Graham GJ, 2004, BLOOD, V104, P1058, DOI 10.1182/blood-2003-11-3979
   Jones S, 2008, BLOOD, V111, P605, DOI 10.1182/blood-2007-07-103424
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P529, DOI 10.1111/j.1365-3083.1990.tb02801.x
   Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018
   Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142
   Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165
   Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z
   LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950
   Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
   MARRIOTT DR, 1991, J NEUROCHEM, V56, P259, DOI 10.1111/j.1471-4159.1991.tb02590.x
   Marriott I, 2004, FRONT BIOSCI, V9, P2153, DOI 10.2741/1377
   MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287
   Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003
   Palma C, 1997, GLIA, V21, P183, DOI 10.1002/(SICI)1098-1136(199710)21:2<183::AID-GLIA2>3.0.CO;2-8
   PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B
   Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273
   Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788
   TEASDALE G, 1974, LANCET, V2, P81
   Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598
   Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018
   Walsh DA, 2006, CURR DRUG TARGETS, V7, P1031, DOI 10.2174/138945006778019291
   Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z
   Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E613
EP E617
DI 10.1016/j.wneu.2019.08.064
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300073
PM 31442647
DA 2020-05-12
ER

PT J
AU Lorente, L
   Martin, MM
   Gonzalez-Rivero, AF
   Sabatel, R
   Ramos, L
   Argueso, M
   Caceres, JJ
   Sole-Violan, J
   Alvarez-Castillo, A
   Jimenez, A
   Borreguero-Leon, JM
   Garcia-Marin, V
AF Lorente, Leonardo
   Martin, Maria M.
   Gonzalez-Rivero, Agustin F.
   Sabatel, Rafael
   Ramos, Luis
   Argueso, Monica
   Caceres, Juan J.
   Sole-Violan, Jordi
   Alvarez-Castillo, Andrea
   Jimenez, Alejandro
   Borreguero-Leon, Juan M.
   Garcia-Marin, Victor
TI High Serum sCD40L Levels During the First Week of Malignant Middle
   Cerebral Artery Infarction and Mortality
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral infarction; Mortality; Patientss; CD40L
ID SOLUBLE CD40 LIGAND; CAROTID PLAQUE VULNERABILITY; DIFFERENTIATION 40
   LIGAND; C-REACTIVE PROTEIN; TISSUE FACTOR; PLATELET ACTIVATION;
   ENDOTHELIAL-CELLS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; INFLAMMATION
AB BACKGROUND: Higher circulating soluble cluster of differentiation 40 ligand (sCD40L) levels at admission of an ischemic stroke have been found in nonsurvivor than in survivor patients. The objectives of this study were to determine whether serum sCD40L levels during the first week of a severe malignant middle cerebral artery infarction (MMCAI) are higher in nonsurvivor than in survivor patients and whether they could be used as biomarker of mortality prediction.
   METHODS: This multicenter study included patients with severe MMCAI (defined as Glasgow Coma Scale score <9). We determined serum sCD40L concentrations at days 1, 4, and 8 and performed receiver operating characteristic analyses to determine their capacity for 30-day mortality prediction.
   RESULTS: Nonsurvivors (n = 34) showed higher sCD40L levels on days 1 (P < 0.001), 4 (P = 0.004), and 8 (P < 0.001) than did survivor patients (n = 34). Areas under the curve of serum sCD40L concentrations at days 1, 4, and 8 of severe MMCAI for 30-day mortality prediction were 83% (P < 0.001), 89% (P < 0.001), and 87% (P < 0.001), respectively.
   CONCLUSIONS: The findings that nonsurvivors showed higher serum sCD40L levels during the first week of MMCAI than did survivors and that serum sCD40L levels during the first week of MMCAI could be used as a mortality predictor biomarker are 2 novel findings.
C1 [Lorente, Leonardo; Alvarez-Castillo, Andrea] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.
   [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Dept, San Cristobal la Laguna, Santa Cruz De T, Spain.
   [Sabatel, Rafael] Hosp Univ Canarias, Dept Radiol, San Cristobal la Laguna, Santa Cruz De T, Spain.
   [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, San Cristobal la Laguna, Santa Cruz De T, Spain.
   [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.
   [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Tenerife, Santa Cruz De T, Spain.
   [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, Santa Cruz De T, Spain.
   [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain.
   [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain.
   [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Spain.
RP Lorente, L (reprint author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.
EM lorentemartin@msn.com
OI Argueso, Monica/0000-0001-5917-1056; Borreguero Leon, Juan
   Maria/0000-0001-7414-5278
FU Fundacion DISA a la Investigacion Medica
FX This study was supported by a grant from Fundacion DISA a la
   Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain). Funding did
   not influence the study design, the collection, analysis, and
   interpretation of data, the manuscript writing, or the decision to
   submit it for publication.
CR Aloui C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24715
   Anand SX, 2003, THROMB HAEMOSTASIS, V90, P377, DOI 10.1160/TH03-05-0268
   Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247
   Antoniades C, 2006, J AM COLL CARDIOL, V47, P1959, DOI 10.1016/j.jacc.2005.12.057
   Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076
   Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023
   BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864
   Chandler AB, 2010, THROMB RES, V125, P44, DOI 10.1016/j.thromres.2009.04.017
   Chen KQ, 2006, CELL MOL IMMUNOL, V3, P163
   Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277
   Davi G, 2009, J ATHEROSCLER THROMB, V16, P707
   Ding SF, 2008, AM J MED SCI, V336, P27, DOI 10.1097/MAJ.0b013e31815b60a1
   Ferroni P, 2007, CURR MED CHEM, V14, P2170
   Gremmel T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134599
   Hamdan Righab, 2011, J Med Liban, V59, P65
   Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021
   Han YP, 2017, WORLD NEUROSURG, V105, P709, DOI 10.1016/j.wneu.2017.06.074
   Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Lewis KM, 2013, INT J INFLAMM, DOI 10.1155/2013/578480
   Li J, 2004, CLIN CHEM, V50, P1696, DOI 10.1373/clinchem.2003.030940
   Li JJ, 2015, STROKE, V46, P1990, DOI 10.1161/STROKEAHA.115.008685
   Lin R, 2006, CURR NEUROVASC RES, V3, P41, DOI 10.2174/156720206775541796
   Liu ZL, 2018, BIOMED RES INT, DOI 10.1155/2018/7497314
   Lorente L, 2018, J CRIT CARE, V43, P316, DOI 10.1016/j.jcrc.2017.09.032
   Lorente L, 2015, INT J MOL SCI, V16, P12147, DOI 10.3390/ijms160612147
   Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034
   Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104
   Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
   Lukasik M, 2012, PLATELETS, V23, P132, DOI 10.3109/09537104.2011.597528
   Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931
   Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36
   Mao De-Jun, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P177
   Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373
   Nannizzi-Alaimo L, 2003, CIRCULATION, V107, P1123, DOI 10.1161/01.CIR.0000053559.46158.AD
   NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550
   Novo S, 2005, STROKE, V36, P673, DOI 10.1161/01.STR.0000154878.58398.14
   Obradovic S, 2015, J ATHEROSCLER THROMB, V22, P284, DOI 10.5551/jat.26765
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100
   Pusch G, 2015, J STROKE CEREBROVASC, V24, P1938, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.005
   Rosiak M, 2013, CARDIOL J, V20, P545, DOI 10.5603/CJ.2013.0045
   Serena J, 2005, STROKE, V36, P1921, DOI 10.1161/01.STR.0000177870.14967.94
   Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008
   TEASDALE G, 1974, LANCET, V2, P81
   Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032
   Undas A, 2009, KARDIOL POL, V67, P591
   Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4
   Vavuranakis M, 2006, CLIN THER, V28, P860, DOI 10.1016/j.clinthera.2006.06.010
   Wang JH, 2013, NEUROL RES, V35, P693, DOI 10.1179/1743132813Y.0000000190
   Wang M, 2011, DNA CELL BIOL, V30, P173, DOI 10.1089/dna.2010.1129
   Wang YJ, 2015, GENET MOL RES, V14, P8091, DOI 10.4238/2015.July.17.18
   Weber M, 2006, CLIN CHEM, V52, P888, DOI 10.1373/clinchem.2005.062083
   Zhang BK, 2014, NEUROSCI LETT, V567, P6, DOI 10.1016/j.neulet.2014.03.003
   Zhang BK, 2013, IMMUNOL LETT, V153, P58, DOI 10.1016/j.imlet.2013.07.005
   Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025
NR 56
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E630
EP E636
DI 10.1016/j.wneu.2019.08.060
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300076
PM 31442656
DA 2020-05-12
ER

PT J
AU Lucattelli, E
   Menichini, G
   Brogi, M
   Roselli, G
   Innocenti, M
AF Lucattelli, Elena
   Menichini, Giulio
   Brogi, Mattia
   Roselli, Giuliana
   Innocenti, Marco
TI Long-Term Functional Outcome After Surgical Treatment of Peroneal
   Intraneural Ganglion Cyst
SO WORLD NEUROSURGERY
LA English
DT Article
DE Foot drop; Ganglion cyst; Peroneal ganglia; Peroneal palsy
ID SUPERIOR TIBIOFIBULAR JOINT; ARTICULAR BRANCH; CONSISTENT COMMUNICATION;
   ARTHROGRAPHY
AB BACKGROUND: Intraneural ganglia are benign mucinous cystic formations that originate within the epineurium of peripheral nerves. Different treatments have been recommended, with an overall satisfactory outcome. In this paper, we aim to evaluate the long-term outcomes of surgical treatment of peroneal intraneural ganglia by reviewing our local institutional experience.
   METHODS: We performed a case series review of peroneal intraneural ganglia surgical treatment performed by the senior author. Demographic and surgical details were abstracted from the medical record for each patient. Electrodiagnostic studies and magnetic resonance imaging (MRI) were performed in all patients pre- and postoperatively.
   RESULTS: Eight men were enrolled, with an average age at time of surgery of 47.5 years (range 28-68 years). Motor testing revealed a preoperative deficit of dorsiflexion, eversion, and toe extension in 7 patients, with a median preoperative Medical Research Council (MRC) score of 0/5. Sensory loss in the distribution of the common peroneal nerve was present in 7 patients. Mean clinical follow-up time was 113 months (range 32-189 months). Significant pain relief was achieved in all patients. Overall neurologic function was improved, more so for motor function. The median postoperative dorsiflexion, eversion, and toe extension at last follow-up were MRC score of 5/5. No complications occurred postoperatively. There was no clinical evidence of intraneural recurrence, as confirmed in postoperative MRI. In 2 patients, an extraneural cystic formation was visible in the anterior muscular compartment.
   CONCLUSIONS: The data from our series support excellent long-term postoperative motor outcomes with a low recurrence rate. To avoid extraneural recurrence, resection of the superior tibiofibular joint is necessary.
C1 [Lucattelli, Elena; Menichini, Giulio; Brogi, Mattia; Innocenti, Marco] Careggi Univ Hosp, Plast & Reconstruct Microsurg, Florence, Italy.
   [Roselli, Giuliana] Careggi Univ Hosp, Radiol Dept, Florence, Italy.
RP Lucattelli, E (reprint author), Careggi Univ Hosp, Plast & Reconstruct Microsurg, Florence, Italy.
EM elena.lucattelli@gmail.com
OI Lucattelli, Elena/0000-0002-1501-8022
CR Blitz NM, 2009, J FOOT ANKLE SURG, V48, P80, DOI 10.1053/j.jfas.2008.09.002
   Cesmebasi A, 2014, CLIN ANAT, V27, P1130, DOI 10.1002/ca.22464
   Compston A., 1942, AIDS INVESTIGATION P, P48
   Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274
   Consales A, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.10.023
   Desy NM, 2016, J NEUROSURG, V125, P615, DOI 10.3171/2015.9.JNS141368
   Lipinski LJ, 2015, ACTA NEUROCHIR, V157, P837, DOI 10.1007/s00701-014-2323-2
   Puffer RC, 2014, CLIN ANAT, V27, P1128, DOI 10.1002/ca.22455
   Puffer RC, 2013, CLIN ANAT, V26, P253, DOI 10.1002/ca.22087
   Spinner RJ, 2006, SKELETAL RADIOL, V35, P172, DOI 10.1007/s00256-005-0036-6
   Spinner RJ, 2003, J NEUROSURG, V99, P330, DOI 10.3171/jns.2003.99.2.0330
   Spinner RJ, 2003, J NEUROSURG, V99, P319, DOI 10.3171/jns.2003.99.2.0319
   Spinner Robert J, 2007, Neurosurg Focus, V22, pE27
   Spinner RJ, 2008, SKELETAL RADIOL, V37, P1091, DOI 10.1007/s00256-008-0545-1
   Spinner RJ, 2008, CLIN ANAT, V21, P611, DOI 10.1002/ca.20709
   Spinner Robert J, 2007, Neurosurg Focus, V22, pE16
   Spinner RJ, 2008, SKELETAL RADIOL, V37, P79, DOI 10.1007/s00256-007-0400-9
   Spinner Robert J, 2007, Neurosurg Focus, V22, pE17
   Spinner RJ, 2007, J NEUROSURG, V107, P296, DOI 10.3171/JNS-07/08/0296
   Spinner RJ, 2007, SKELETAL RADIOL, V36, P281, DOI 10.1007/s00256-006-0213-2
   Spinner RJ, 2006, NEUROSURGERY, V59, P157, DOI 10.1227/01.NEU.0000219820.31012.22
   Spinner RJ, 2016, J HAND SURG-AM, V41, pE223, DOI 10.1016/j.jhsa.2016.04.004
   Spinner RJ, 2013, CLIN ANAT, V26, P267, DOI 10.1002/ca.22152
   Spinner RJ, 2012, CLIN ANAT, V25, P683, DOI 10.1002/ca.22050
   Spinner RJ, 2012, CLIN ANAT, V25, P641, DOI 10.1002/ca.21290
   Spinner RJ, 2011, CLIN ANAT, V24, P268, DOI 10.1002/ca.21109
   Spinner RJ, 2011, J NEUROSURG, V114, P217, DOI 10.3171/2010.4.JNS091969
   Spinner Robert J, 2010, J Surg Orthop Adv, V19, P143
   Spinner RJ, 2010, J FOOT ANKLE SURG, V49, P575, DOI 10.1053/j.jfas.2010.08.010
   Spinner R, 2009, ACTA NEUROCHIR, V151, P89, DOI 10.1007/s00701-008-0182-4
   Wilson TJ, 2018, MUSCLE NERVE, V57, P989, DOI 10.1002/mus.26062
   Wilson TJ, 2018, OPER NEUROSURG, V14, P208, DOI 10.1093/ons/opx114
   Wilson TJ, 2017, ACTA NEUROCHIR, V159, P925, DOI 10.1007/s00701-017-3130-3
   Wilson TJ, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16439
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E217
EP E222
DI 10.1016/j.wneu.2019.08.195
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300027
PM 31493600
DA 2020-05-12
ER

PT J
AU Lutz, K
   Kamenova, M
   Schaedelin, S
   Guzman, R
   Mariani, L
   Fandino, J
   Soleman, J
AF Lutz, Katharina
   Kamenova, Maria
   Schaedelin, Sabine
   Guzman, Raphael
   Mariani, Luigi
   Fandino, Javier
   Soleman, Jehuda
TI Time to and Possible Risk Factors for Recurrence after Burr-hole
   Drainage of Chronic Subdural Hematoma: A Subanalysis of the cSDH-Drain
   Randomized Controlled Trial
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Subperiosteal drain; Subdural drain; Risk
   factors; Recurrence; Time to recurrence; Traumatic brain injury
ID PREDICTORS; EVACUATION; MANAGEMENT; RESUMPTION
AB OBJECTIVE: The randomized controlled Chronic Subdural Hematoma (cSDH)-Drain-Trial showed comparable recurrence rates after placing a subperiosteal drain (SPD) or a subdural drain (SDD) for surgically drained cSDH, although SDD was associated with higher rates of infection and iatrogenic brain injury. This subanalysis examines the time to recurrence and possible risk factors for recurrence after burr-hole drainage of cSDH and placement of a SPD compared with a SDD.
   METHODS: We included 220 patients from the preceding cSDH-Drain-Trial. Time to recurrence was compared within the 2 groups using a univariate Cox proportional hazards model. Apart from intraoperative brain expansion (iBE), defined by residual hematoma-cavity on computer tomography 24 hours after surgery, other possible pre-, intra- and postoperative risk factors for recurrence were assessed through univariate and multivariate analysis.
   RESULTS: Median time to recurrence was 22.5 days (interquartile range: 9.25-52 days, range: 0-81) showing no difference between the 2 groups. Less iBE (P = 0.019), lower Glasgow Outcome Scale score at discharge (P = 0.007), and lower Glasgow Coma Scale score at 24 hours (P = 0.037) were strongly associated with recurrence on univariate analysis. After multivariate logistic analysis, less iBE (odds ratio: 1.10, 95% CI: 1.01; 1.21; P = 0.03) remained the only significant risk factor associated with recurrence. When comparing the risk factors within the 2 groups, less iBE and lower Glasgow Outcome Scale score at release were associated with recurrence only in the SDD group.
   CONCLUSIONS: The inserted drain type after burr-hole drainage of cSDH does not seem to influence time to recurrence. SPD may be warranted in routine clinical practice, independent of individual patient, surgical, or hematoma characteristics.
C1 [Lutz, Katharina; Guzman, Raphael; Mariani, Luigi; Soleman, Jehuda] Univ Basel, Fac Med, Basel, Switzerland.
   [Kamenova, Maria; Guzman, Raphael; Mariani, Luigi; Soleman, Jehuda] Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland.
   [Lutz, Katharina] Inselspital Bern, Dept Neurosurg, Bern, Switzerland.
   [Schaedelin, Sabine] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland.
   [Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland.
RP Soleman, J (reprint author), Univ Basel, Fac Med, Basel, Switzerland.; Soleman, J (reprint author), Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland.
EM jehuda.soleman@gmail.com
OI Guzman, Raphael/0000-0001-9620-0581; Lutz, Katharina/0000-0002-4938-6974
FU Research Foundation Kantonsspital Aarau
FX The cSDH-Drain-Trial and the present subanalysis were funded by the
   Research Foundation Kantonsspital Aarau.
CR Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255
   Altaf I, 2018, PAK J MED SCI, V34, P194, DOI 10.12669/pjms.341.13735
   Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232
   Bartek J, 2017, WORLD NEUROSURG, V106, P609, DOI 10.1016/j.wneu.2017.07.044
   Brennan PM, 2017, J NEUROSURG, V127, P732, DOI 10.3171/2016.8.JNS16134
   Guha D, 2016, J NEUROSURG, V124, P750, DOI 10.3171/2015.2.JNS141889
   Hammer A, 2017, TURK NEUROSURG, V27, P756, DOI 10.5137/1019-5149.JTN.17347-16.1
   Kamenova M, 2017, WORLD NEUROSURG, V100, P594, DOI 10.1016/j.wneu.2017.01.065
   Kamenova M, 2016, NEUROSURGERY, V79, P715, DOI 10.1227/NEU.0000000000001393
   Kawabata S, 2018, NEUROL MED-CHIR, V58, P247, DOI 10.2176/nmc.oa.2018-0019
   Kim SU, 2017, J KOREAN NEUROSURG S, V60, P701, DOI 10.3340/jkns.2016.1010.003
   Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163
   Miki K, 2019, J NEUROSURG, V4, P1
   Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918
   Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z
   Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382
   Poon MTC, 2018, NEUROSURG REV, V41, P439, DOI 10.1007/s10143-017-0860-x
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002
   Soleman J, 2019, NEUROSURGERY
   Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398
   Soleman J, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5339
   Stanisic M, 2013, ACTA NEUROCHIR, V155, P323, DOI 10.1007/s00701-012-1565-0
   Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17
NR 24
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E283
EP E289
DI 10.1016/j.wneu.2019.08.175
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300034
PM 31479790
DA 2020-05-12
ER

PT J
AU Luzzi, S
   Lucifero, AG
   Del Maestro, M
   Marfia, G
   Navone, SE
   Baldoncini, M
   Nunez, M
   Campero, A
   Elbabaa, SK
   Galzio, R
AF Luzzi, Sabino
   Lucifero, Alice Giotta
   Del Maestro, Mattia
   Marfia, Giovanni
   Navone, Stefania Elena
   Baldoncini, Matias
   Nunez, Maximiliano
   Campero, Alvaro
   Elbabaa, Samer K.
   Galzio, Renato
TI Anterolateral Approach for Retrostyloid Superior Parapharyngeal Space
   Schwannomas Involving the Jugular Foramen Area: A 20-Year Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterolateral approach; Glossopharyngeal nerve diseases; Jugular foramen
   tumors; Lower cranial nerves; Parapharyngeal space; Schwannoma; Skull
   base neoplasms
ID UPPER CERVICAL-SPINE; SURGICAL-MANAGEMENT; INFRATEMPORAL FOSSA;
   MICROSURGICAL ANATOMY; VERTEBRAL ARTERY; TUMORS; ANEURYSMS;
   TRANSCONDYLAR; NEURINOMAS; DIAGNOSIS
AB BACKGROUND: Schwannomas encompassing the superior parapharyngeal space are challenging lesions because of the anatomical complexity of this region and the frequent involvement of the neurovascular structures of the jugular foramen. The purpose of this study is to report the technical aspects and the advantages of the anterolateral approach, here proposed for schwannomas of this complex area.
   METHODS: The main steps of the anterolateral approach are described in detail, along with the results of a consecutive series of 38 patients with a retrostyloid superior parapharyngeal schwannoma involving the jugular foramen operated on by means of this route between 1999 and 2019.
   RESULTS: The supine position is generally preferred. The medial border of the sternocleidomastoid muscle, mastoid tip, and superior nuchal line are the landmarks for the hockey-stick skin incision. The accessory nerve is retrieved and mobilized cranially. Detachment of the sternocleidomastoid, digastric, and nuchal muscles allows for a 180 degrees exposure of the extracranial side of the jugular foramen. Three working corridors, namely the pre-carotid, pre-jugular, and retro-jugular, allow access to the deeper part of the jugular foramen area and the superior parapharyngeal space. In the present series, a gross total resection was achieved in 89.4% of the patients. Three recurrences occurred after an average follow-up of 80.5 +/- 51 months.
   CONCLUSIONS: The anterolateral approach is highly effective in the treatment of retrostyloid superior parapharyngeal space schwannomas involving the jugular foramen. Its simplicity of execution, versatility, and very low morbidity are among its main strengths.
C1 [Luzzi, Sabino; Lucifero, Alice Giotta; Galzio, Renato] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, Pavia, Italy.
   [Luzzi, Sabino; Del Maestro, Mattia; Galzio, Renato] Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, Pavia, Italy.
   [Del Maestro, Mattia] Univ Pavia, PhD Sch Expt Med, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Marfia, Giovanni; Navone, Stefania Elena] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Neurosurg Unit, Expt Neurosurg & Cell Therapy Lab, Milan, Italy.
   [Marfia, Giovanni] Italian Air Force, Inst Aerosp Med, Milan, Italy.
   [Baldoncini, Matias] Univ Buenos Aires, Med Sch, Microsurg Neuroanat Lab LaNeMic, Div Anat 2, Buenos Aires, DF, Argentina.
   [Baldoncini, Matias] San Fernando Hosp, Dept Neurol Surg, Buenos Aires, DF, Argentina.
   [Nunez, Maximiliano] Hosp El Cruce, Dept Neurosurg, Buenos Aires, DF, Argentina.
   [Campero, Alvaro] Univ Nacl Tucuman, Serv Neurocirugia, San Miguel De Tucuman, Tucuman, Argentina.
   [Campero, Alvaro] Hosp Padilla, Dept Neurosurg, San Miguel De Tucuman, Tucuman, Argentina.
   [Elbabaa, Samer K.] Arnold Palmer Hosp Children, Pediat Neurosci Ctr Excellence, Pediat Neurosurg, Orlando, FL USA.
RP Luzzi, S (reprint author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, Pavia, Italy.; Luzzi, S (reprint author), Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, Pavia, Italy.
EM sabino.luzzi@unipv.it
RI Marfia, Giovanni/AAB-8702-2020
OI Marfia, Giovanni/0000-0002-5849-7000; Luzzi, Sabino/0000-0002-1381-8528
CR Abd el-Bary TH, 1995, SURG NEUROL, V44, P400
   AlMefty O, 1996, J NEUROSURG, V84, P1, DOI 10.3171/jns.1996.84.1.0001
   Bejjani GK, 1998, NEUROSURGERY, V43, P842, DOI 10.1097/00006123-199810000-00072
   Bellantoni G, 2019, eNeurologicalSci, V14, P31, DOI 10.1016/j.ensci.2018.11.021
   BILLER HF, 1981, ANN OTO RHINOL LARYN, V90, P3
   Bongetta D, 2019, CLIN NEUROL NEUROSUR, V176, P34, DOI 10.1016/j.clineuro.2018.11.009
   Bruneau M, 2008, NEUROSURG REV, V31, P19, DOI 10.1007/s10143-007-0097-1
   CARRAU RL, 1990, LARYNGOSCOPE, V100, P583
   Chang SS, 2012, ANN OTO RHINOL LARYN, V121, P620, DOI 10.1177/000348941212100910
   Cheng CY, 2018, OPER NEUROSURG, V15, pE92, DOI 10.1093/ons/opy068
   Chung HJ, 2019, J CRANIOFAC SURG, V30, P589, DOI 10.1097/SCS.0000000000005108
   Ciappetta P, 2009, J NEUROSURG SCI, V53, P147
   Ciappetta P, 2009, NEUROSURGERY, V64, P429, DOI 10.1227/01.NEU.0000337573.17073.9F
   Ciappetta P, 2008, J NEUROSURG-SPINE, V8, P92, DOI 10.3171/SPI-08/01/092
   Cohen SM, 2005, HEAD NECK-J SCI SPEC, V27, P669, DOI 10.1002/hed.20199
   DASGUPTA TK, 1969, CANCER-AM CANCER SOC, V24, P355
   De Tommasi A, 2008, NEUROSURGERY, V63, P976, DOI 10.1227/01.NEU.0000327699.93146.CD
   De Tommasi Antonio, 2007, World J Surg Oncol, V5, P72, DOI 10.1186/1477-7819-5-72
   Dehcordi SR, 2017, WORLD NEUROSURG, V105, P895, DOI 10.1016/j.wneu.2017.05.099
   Del Maestro M, 2018, ACTA NEUROCHIR SUPPL, V129, P109, DOI 10.1007/978-3-319-73739-3_16
   Dimitrijevic MV, 2010, INT J ORAL MAX SURG, V39, P983, DOI 10.1016/j.ijom.2010.06.005
   Ding YH, 2019, WORLD NEUROSURG, V123, P318, DOI 10.1016/j.wneu.2018.11.254
   Ding YH, 2018, WORLD NEUROSURG, V119, P335, DOI 10.1016/j.wneu.2018.08.087
   Eisele DE, 1999, HEAD NECK-J SCI SPEC, V21, P154, DOI 10.1002/(SICI)1097-0347(199903)21:2<154::AID-HED9>3.0.CO;2-W
   ElBary THA, 1995, SURG NEUROL, V44, P392, DOI 10.1016/0090-3019(95)00033-X
   Gallieni M, 2018, ACTA NEUROCHIR SUPPL, V129, P19, DOI 10.1007/978-3-319-73739-3_3
   GEORGE B, 1985, NEUROSURGERY, V16, P591, DOI 10.1227/00006123-198505000-00001
   GEORGE B, 1995, J NEUROSURG, V82, P917, DOI 10.3171/jns.1995.82.6.0917
   GEORGE B, 1980, ACTA NEUROCHIR, V51, P259, DOI 10.1007/BF01406753
   Guinto G, 1999, NEUROSURGERY, V45, P1385, DOI 10.1097/00006123-199912000-00025
   Hamza A, 1997, ARCH OTOLARYNGOL, V123, P622
   He HY, 2018, WORLD NEUROSURG, V118, P172, DOI 10.1016/j.wneu.2018.07.087
   Khafif A, 2005, OTOLARYNG HEAD NECK, V132, P401, DOI 10.1016/j.otohns.2004.09.062
   Kim SM, 2019, MAX PLAST RECONSTR S, V41, DOI 10.1186/s40902-018-0185-x
   Lang J, 2001, SKULL BASE RELATED S
   LESOIN F, 1987, SURG NEUROL, V27, P228, DOI 10.1016/0090-3019(87)90034-6
   LESOIN F, 1986, J CHIR-PARIS, V123, P343
   LESOIN F, 1985, NEUROCHIRURGIE, V31, P65
   LESOIN F, 1986, ACTA NEUROCHIR, V80, P100, DOI 10.1007/BF01812282
   Liao Hua, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P276
   Lot G, 1997, NEUROSURGERY, V41, P813, DOI 10.1097/00006123-199710000-00010
   Luzzi S, 2019, TURK NEUROSURG, V29, P875, DOI 10.5137/1019-5149.JTN.26052-19.2
   Luzzi S, 2019, WORLD NEUROSURG, V131, P10, DOI 10.1016/j.wneu.2019.07.152
   Luzzi S, 2019, WORLD NEUROSURG, V127, P255, DOI 10.1016/j.wneu.2019.04.056
   Luzzi Sabino, 2019, Asian J Neurosurg, V14, P193, DOI 10.4103/ajns.AJNS_279_17
   Luzzi S, 2019, WORLD NEUROSURG, V124, pE769, DOI 10.1016/j.wneu.2019.01.016
   Luzzi S, 2018, ACTA NEUROCHIR SUPPL, V129, P25, DOI 10.1007/978-3-319-73739-3_4
   Luzzi S, 2018, WORLD NEUROSURG, V116, pE340, DOI 10.1016/j.wneu.2018.04.203
   Luzzi Sabino, 2018, Surg Neurol Int, V9, P19, DOI 10.4103/sni.sni_369_17
   Malone JP, 2001, ANN OTO RHINOL LARYN, V110, P1093, DOI 10.1177/000348940111001202
   O'Malley BW, 2010, ORL-J OTO-RHIN-LARYN, V72, P332, DOI 10.1159/000320596
   Palumbo P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123010
   Palumbo P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092801
   Prasad SC, 2015, AURIS NASUS LARYNX, V42, P189, DOI 10.1016/j.anl.2014.09.002
   Ricci Alessandro, 2017, Surg Neurol Int, V8, P117, DOI 10.4103/sni.sni_50_17
   Salas E, 1999, J NEUROSURG, V90, P206, DOI 10.3171/spi.1999.90.2.0206
   SHAHINIAN H, 1995, SKULL BASE SURG, V5, P73, DOI 10.1055/s-2008-1058937
   STELL PM, 1985, AM J OTOLARYNG, V6, P92, DOI 10.1016/S0196-0709(85)80045-4
   Toms J, 2016, J NEUROSURG-SPINE, V24, P160, DOI 10.3171/2015.4.SPINE15192
   Wen HT, 1997, J NEUROSURG, V87, P555, DOI 10.3171/jns.1997.87.4.0555
   Zheng XK, 2017, HEAD NECK-J SCI SPEC, V39, P42, DOI 10.1002/hed.24523
   Zoia Cesare, 2019, Surg Neurol Int, V10, P76, DOI 10.25259/SNI-132-2019
   Zoia Cesare, 2018, J Neurosurg Sci, DOI 10.23736/S0390-5616.18.04333-3
NR 63
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E40
EP E52
DI 10.1016/j.wneu.2019.09.006
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300008
PM 31520759
DA 2020-05-12
ER

PT J
AU Maingard, J
   Phan, K
   Lamanna, A
   Kok, HK
   Barras, CD
   Russell, J
   Hirsch, JA
   Chandra, RV
   Thijs, V
   Brooks, M
   Asadi, H
AF Maingard, Julian
   Phan, Kevin
   Lamanna, Anthony
   Kok, Hong Kuan
   Barras, Christen D.
   Russell, Jeremy
   Hirsch, Joshua A.
   Chandra, Ronil, V
   Thijs, Vincent
   Brooks, Mark
   Asadi, Hamed
TI Rescue Intracranial Stenting After Failed Mechanical Thrombectomy for
   Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Acute ischemic stroke; Angioplasty; Intracranial atherosclerosis;
   Stenting; Thrombectomy
ID ENDOVASCULAR TREATMENT; STENOSIS; THERAPY; TIROFIBAN; FAILURE
AB BACKGROUND: Up to 20% of patients fail to achieve reperfusion with modified Thrombolysis in Cerebral Infarction (mTICI) scores of 0-1 after mechanical thrombectomy (MT). Furthermore, underlying intracranial atherosclerotic disease, particularly when associated with >70% residual or flow limiting stenosis, is associated with higher rates of failed MT and high failure risk MT. The aim of this study was to systematically review the procedural and clinical outcomes in patients with failed MT and high failure risk MT. We also explored differences between patients receiving acute rescue stenting compared with medical management alone.
   METHODS: A systematic literature search was conducted in Ovid MEDLINE, PubMed, Embase, and Cochrane online scientific publication databases for English language publications from their date of inception until October 2018. Studies including adult patients with acute ischemic stroke because of emergent large vessel occlusion with failed (mTICI score 0-1) or high failure risk MT within the anterior circulation who underwent rescue stenting were included. A systematic review and meta-analysis of proportions was performed.
   RESULTS: Rescue intracranial stenting after failed MT or high failure risk MT results in improved clinical outcomes compared with patients without stenting (48.5% vs. 19.7%, respectively; P < 0.001), without an increase in the rate of symptomatic intracranial hemorrhage, despite additional use of antiplatelet agents (9.7% vs. 14.1%, respectively; P = 0.04).
   CONCLUSIONS: In patients who fail initial attempts at MT or are high risk for acute reocclusion, rescue intracranial stenting could be considered with the aim to improve functional outcomes. Antiplatelet agents do not increase the risk of hemorrhage in these patients.
C1 [Maingard, Julian; Chandra, Ronil, V; Asadi, Hamed] Monash Hlth, Intervent Neuroradiol Unit, Monash Imaging, Melbourne, Vic, Australia.
   [Maingard, Julian; Kok, Hong Kuan; Brooks, Mark; Asadi, Hamed] Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia.
   [Phan, Kevin] Prince Wales Private Hosp, NeuroSpine Surg Res Grp, Sydney, NSW, Australia.
   [Lamanna, Anthony; Brooks, Mark; Asadi, Hamed] Austin Hosp, Radiol Dept, Intervent Neuroradiol Serv, Melbourne, Vic, Australia.
   [Russell, Jeremy] Austin Hosp, Dept Neurosurg, Melbourne, Vic, Australia.
   [Kok, Hong Kuan] Northern Hosp, Dept Radiol, Intervent Radiol Serv, Melbourne, Vic, Australia.
   [Barras, Christen D.] South Australian Inst Hlth & Med Res, Adelaide, SA, Australia.
   [Barras, Christen D.] Univ Adelaide, Sch Med, Adelaide, SA, Australia.
   [Hirsch, Joshua A.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.
   [Chandra, Ronil, V] Monash Univ, Dept Imaging, Melbourne, Vic, Australia.
   [Thijs, Vincent; Brooks, Mark; Asadi, Hamed] Univ Melbourne, Stroke Div, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.
   [Thijs, Vincent; Brooks, Mark; Asadi, Hamed] Univ Melbourne, Sch Med, Melbourne, Vic, Australia.
   [Thijs, Vincent] Austin Hlth, Dept Neurol, Melbourne, Vic, Australia.
RP Maingard, J (reprint author), Monash Hlth, Intervent Neuroradiol Unit, Monash Imaging, Melbourne, Vic, Australia.; Maingard, J (reprint author), Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia.
EM julian.maingard@gmail.com
OI Chandra, Ronil/0000-0001-7555-2297; Russell, Jeremy/0000-0003-3692-120X;
   Lamanna, Anthony/0000-0003-0705-2252
CR Achit H, 2017, STROKE, V48, P2843, DOI 10.1161/STROKEAHA.117.017856
   Acosta FD, 2017, RADIOLOGIA-MADRID, V59, P218, DOI 10.1016/j.rx.2017.01.003
   Al Kasab S, 2017, J NEUROINTERV SURG, V9, P948, DOI 10.1136/neurintsurg-2016-012529
   Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973
   Baek JH, 2016, STROKE, V47, P2360, DOI 10.1161/STROKEAHA.116.014073
   Baracchini C, 2017, WORLD NEUROSURG, V103, P57, DOI 10.1016/j.wneu.2017.03.070
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Blackham KA, 2012, J NEUROINTERV SURG, V4, P87, DOI 10.1136/neurintsurg-2011-010243
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Chang Y, 2018, STROKE, V49, P958, DOI 10.1161/STROKEAHA.117.020072
   Cornelissen SA, 2019, CLIN NEURORADIOL, V29, P677, DOI 10.1007/s00062-018-0697-x
   Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3
   Fiehler J, 2018, STROKE, V49, P811, DOI 10.1161/STROKEAHA.118.020541
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Kim GE, 2016, AM J NEURORADIOL, V37, P1690, DOI 10.3174/ajnr.A4770
   Leslie-Mazwi T, 2018, J NEUROINTERV SURG, V10, P507, DOI 10.1136/neurintsurg-2018-013792
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Muir KW, 2017, J NEUROL NEUROSUR PS, V88, P38, DOI 10.1136/jnnp-2016-314117
   Nappini S, 2019, J NEURORADIOLOGY, V46, P141, DOI 10.1016/j.neurad.2018.05.004
   Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Seo WK, 2016, J STROKE CEREBROVASC, V25, P1411, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.054
   Siebler M, 2011, STROKE, V42, P2388, DOI 10.1161/STROKEAHA.110.599662
   Wareham J, 2019, J NEUROINTERV SURG, V11, P675, DOI 10.1136/neurintsurg-2018-014459
   Woo HG, 2018, AM J NEURORADIOL, V39, P331, DOI 10.3174/ajnr.A5477
   Yang D, 2018, INTERV NEURORADIOL, V24, DOI 10.1177/1591019918763380
   Yoon W, 2015, NEUROSURGERY, V76, P680, DOI 10.1227/NEU.0000000000000694
   Yu WG, 2018, STROKE VASC NEUROL, V3, P140, DOI 10.1136/svn-2018-000158
   Zaidat OO, 2015, JAMA-J AM MED ASSOC, V313, P1240, DOI 10.1001/jama.2015.1693
   Zhao WB, 2017, STROKE, V48, P3289, DOI 10.1161/STROKEAHA.117.019193
   Zhou TF, 2018, WORLD NEUROSURG, V120, pE181, DOI 10.1016/j.wneu.2018.08.002
NR 35
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E235
EP E245
DI 10.1016/j.wneu.2019.08.192
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300030
PM 31493593
DA 2020-05-12
ER

PT J
AU Mandonnet, E
AF Mandonnet, Emmanuel
TI Transopercular Resection of IDH-Mutated Insular Glioma: A Critical
   Appraisal of an Initial Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE Extent of resection; Insular glioma; Learning curve; Neuropsychological
   outcomes; Surgery
ID SURGICAL RESECTION; CONSECUTIVE SERIES; AWAKE CRANIOTOMY; SURGERY;
   LIMITATIONS; OUTCOMES; EXTENT; TUMORS; BRAIN
AB BACKGROUND: Recent data suggest a favorable benefit/risk ratio for insular glioma surgery. However, it remains unknown if this is also applicable in the learning period of this expertise. Moreover, little is known about the neuropsychological outcomes after resection of insular glioma.
   OBJECTIVE: To report an initial experience of isocitrate dehydrogenase (IDH)-mutated insular glioma resection and to contribute to our knowledge of neuropsychological outcomes after insular glioma resection.
   METHODS: A consecutive series of 12 patients operated on for an IDH-mutated insular glioma was retrospectively reviewed. Surgery was performed through a transopercular approach. In 10 of the 12 patients, brain mapping with electric stimulation in an awake patient guided the resection. The extent of resection was assessed by volumetric measures of postoperative fluid-attenuated inversion recovery magnetic resonance imaging. Areas of postoperative ischemia were detected by diffusion imaging. Neurologic, neuropsychological, and professional outcomes were retrieved from medical files.
   RESULTS: The median extent of resection was 94% (range, 80%-100%). None of the patients had permanent speech or motor deficits. Areas of ischemia were observed in 75% of patients. Neuropsychological evaluations showed slight deterioration regarding lexical abilities and verbal memory in patients with left-sided tumors. Patients' performances in cognitive flexibility also commonly declined, regardless of the tumor side. Eight of the 9 patients working at the time of the surgery were able to resume their professional activity.
   CONCLUSIONS: Resecting insular glioma under brain mapping techniques is a safe option, even during the learning period. Patients should be informed about the risk of mild deterioration of lexical abilities and cognitive flexibility.
C1 [Mandonnet, Emmanuel] Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France.
   [Mandonnet, Emmanuel] Univ Paris 07, Paris, France.
   [Mandonnet, Emmanuel] ICM, Frontlab, Paris, France.
RP Mandonnet, E (reprint author), Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France.; Mandonnet, E (reprint author), Univ Paris 07, Paris, France.; Mandonnet, E (reprint author), ICM, Frontlab, Paris, France.
EM mandonnet@mac.com
CR Alimohamadi M, 2016, WORLD NEUROSURG, V92, P151, DOI 10.1016/j.wneu.2016.04.079
   Amelot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130596
   BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D
   BRICKENKAMP R, 1981, TEST D2 AUFMERKSAMKE
   Corrivetti F, 2019, BRAIN STRUCT FUNCT, V224, P1151, DOI 10.1007/s00429-019-01827-7
   Corrivetti F, 2018, OPER NEUROSURG, V14, P441, DOI 10.1093/ons/opx128
   Di Carlo Davide Tiziano, 2019, Neurosurg Rev, DOI 10.1007/s10143-019-01113-4
   Duffau H, 2000, NEUROSURGERY, V47, P801, DOI 10.1097/00006123-200010000-00001
   Duffau H, 2009, J NEUROSURG, V110, P696, DOI 10.3171/2008.8.JNS08741
   Ekman P., 1976, PICTURES FACIAL AFFE
   Eseonu CI, 2017, WORLD NEUROSURG, V103, P265, DOI 10.1016/j.wneu.2017.04.002
   Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110
   Fontaine D, 2018, BRAIN, V141, P1040, DOI 10.1093/brain/awy005
   Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117
   Gravesteijn BY, 2018, NEUROL RES, V40, P87, DOI 10.1080/01616412.2017.1402147
   GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900
   Hameed NUF, 2019, J NEUROSURG, V131, P706, DOI 10.3171/2018.4.JNS18424
   Hamer PCD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073353
   Hentschel SJ, 2005, NEUROSURGERY, V57, P176, DOI 10.1227/01.NEU.0000163603.70972.AB
   Hervey-Jumper SL, 2016, J NEUROSURG, V124, P482, DOI 10.3171/2015.4.JNS1521
   Howard H, 1992, PYRAMIDAL PALM TREE
   Ius T, 2014, J NEUROSURG, V120, P12, DOI 10.3171/2013.9.JNS13728
   Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022
   Lang FF, 2001, J NEUROSURG, V95, P638, DOI 10.3171/jns.2001.95.4.0638
   Loit MP, 2019, ACTA NEUROCHIR, V161, P91, DOI 10.1007/s00701-018-3717-3
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lu VM, 2019, CLIN NEUROL NEUROSUR, V177, P20, DOI 10.1016/j.clineuro.2018.12.013
   Mandonnet E, 2017, WORLD NEUROSURG, V98, P239, DOI 10.1016/j.wneu.2016.10.020
   Mandonnet E, 2015, NEUROSURGERY, V76, P382, DOI 10.1227/NEU.0000000000000644
   Metz-Lutz M. N., 1991, REV NEUROPSYCHOL, V1, P73
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Przybylowski Colin J, 2019, J Neurosurg, P1, DOI 10.3171/2018.12.JNS183075
   Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286
   Sanai N, 2010, J NEUROSURG, V112, P1, DOI 10.3171/2009.6.JNS0952
   Simon M, 2009, J NEUROSURG, V110, P685, DOI 10.3171/2008.7.JNS17639
   Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15
   Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251
   Wu AS, 2011, J NEUROSURG, V115, P1115, DOI 10.3171/2011.8.JNS11488
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E563
EP E576
DI 10.1016/j.wneu.2019.08.071
PG 14
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300067
PM 31442644
DA 2020-05-12
ER

PT J
AU Ferrete-Araujo, AM
   Rodriguez-Rodriguez, A
   Egea-Guerrero, JJ
   Vilches-Arenas, A
   Godoy, DA
   Murillo-Cabezas, F
AF Maria Ferrete-Araujo, Ana
   Rodriguez-Rodriguez, Ana
   Jose Egea-Guerrero, Juan
   Vilches-Arenas, Angel
   Agustin Godoy, Daniel
   Murillo-Cabezas, Francisco
TI Brain Injury Biomarker Behavior in Spontaneous Intracerebral Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Biomarkers; Functional results; Intracerebral hemorrhage; Mortality;
   Outcome; Prognosis
ID NEURON-SPECIFIC ENOLASE; PLASMA S100B LEVEL; BLOOD; STROKE; PROTEIN;
   S-100; CONSCIOUSNESS; PREDICTION; MANAGEMENT; S100-BETA
AB BACKGROUND: S100B and neuron-specific enolase (NSE) have been widely studied in diverse neurocritical pathologies, being recognized as the most promising bio-markers for brain injury assessment. However, their role in intracerebral hemorrhage (ICH) has not been widely analyzed.
   METHODS: This was an observational prospective cohort study of patients with ICH admitted to a neurocritical care unit. Blood samples were collected on admission and at 24 hours, 48 hours, and 72 hours. Patient outcomes were assessed at 6 months after the event.
   RESULTS: Thirty-six patients with ICH were included in the study. The mortality rate was 36%. Nonsurvivors had higher S100B values than survivors at admission, 24 hours, and 48 hours (P < 0.05). Likewise, S100B levels were higher in patients with poor outcomes (modified Rankin Scale [mRS] score >4) compared with those with good outcome (mRS score <= 3) in the 24-hour, 48-hour, and 72-hour samples. Receiver operating characteristic (ROC) curve analysis showed that S100B at admission, 24 hours, and 48 hours can discriminate between patients who survive and those who die as a consequence of ICH. The 48-hour sample (area under the ROC curve, 0.817; P = 0.003) reached the best values for sensitivity (75%) and specificity (80%); cutoff, 0.250 mu g/L. For 6-month functional outcome, S100B protein could differentiate between groups at 24, 48, and 72 hours. The S100B 24-hour sample had the best values for sensitivity (82.6%) and specificity (72.7%), with a cutoff of 0.202 mu g/L. We found no clear relationship between NSE values and clinical characteristics.
   CONCLUSIONS: S100B protein acts as early predictor of mortality and functional outcome in patients with ICH. This biomarker measurement can provide additional information beyond clinical and radiologic findings to guide physicians in the management of these patients.
C1 [Maria Ferrete-Araujo, Ana; Rodriguez-Rodriguez, Ana; Jose Egea-Guerrero, Juan; Murillo-Cabezas, Francisco] Univ Seville, Virgen Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Seville, Spain.
   [Vilches-Arenas, Angel] Univ Seville, Virgen Macarena Univ Hosp, Dept Prevent Med & Publ Hlth, Seville, Spain.
   [Agustin Godoy, Daniel] San Juan Bautista Hosp, NeuroCrit Care Unit, Catamarca, Argentina.
RP Ferrete-Araujo, AM (reprint author), Univ Seville, Virgen Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Seville, Spain.
EM rodriguezana13m@gmail.com
RI Egea-Guerrero, Juan Jose/P-5080-2014
OI Egea-Guerrero, Juan Jose/0000-0002-4166-313X
CR Alatas OD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002007
   Arboix A, 2002, ACTA NEUROL SCAND, V105, P282, DOI 10.1034/j.1600-0404.2002.1o170.x
   Brea D, 2009, CLIN CHEM LAB MED, V47, P1513, DOI 10.1515/CCLM.2009.337
   Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008
   Cho DY, 2008, CRIT CARE MED, V36, P2151, DOI 10.1097/CCM.0b013e318173fc99
   Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z
   Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad
   Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009
   Ferrete-Araujo AM, 2015, MED INTENSIVA, V39, P422, DOI 10.1016/j.medin.2014.10.008
   GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795
   Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069
   Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88
   Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870
   James ML, 2009, BIOMARKERS, V14, P388, DOI 10.1080/13547500903015784
   Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409
   Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kumar A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0384-3
   Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272
   Maas MB, 2009, BIOMARK MED, V3, P363, DOI 10.2217/BMM.09.30
   MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x
   Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109
   Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363
   Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956
   Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841
   Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823
   Ng SES, 2009, J MAGN RESON IMAGING, V30, P708, DOI 10.1002/jmri.21865
   Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030
   Pfeifer R, 2005, RESUSCITATION, V65, P49, DOI 10.1016/j.resuscitation.2004.10.011
   Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907
   RANKIN J, 1957, Scott Med J, V2, P200
   Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410
   Ronning P, 2008, ACTA NEUROL SCAND, V118, P347, DOI 10.1111/j.1600-0404.2008.01023.x
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Senn R, 2014, CEREBROVASC DIS, V38, P395, DOI 10.1159/000366470
   Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041
   Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7
   Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284
   TEASDALE G, 1974, LANCET, V2, P81
   Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD
   Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
NR 42
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E496
EP E505
DI 10.1016/j.wneu.2019.08.090
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300059
PM 31449996
DA 2020-05-12
ER

PT J
AU Miller, WK
   Caras, A
   Mansour, TR
   Mierzwa, A
   Mugge, L
   Qu, WK
   Schroeder, J
AF Miller, William Kyle
   Caras, Andrew
   Mansour, Tarek R.
   Mierzwa, Adam
   Mugge, Luke
   Qu, Weikai
   Schroeder, Jason
TI Patients with Parkinson Disease Experience Increased Perioperative
   Complications Following Cervical Decompression and Fusion: A
   Retrospective Review of the National Inpatient Sample
SO WORLD NEUROSURGERY
LA English
DT Article; Proceedings Paper
CT Annual Scientific Meeting of the
   American-Association-of-Neurological-Surgeons (AANS)
CY APR 13-17, 2019
CL San Diego, CA
SP Amer Assoc Neurol Surg
DE Anterior cervical diskectomy and fusion; Parkinson disease; Posterior
   cervical diskectomy and Fusion
ID IN-HOSPITAL COMPLICATIONS; LUMBAR SPINE SURGERY; QUALITY-OF-LIFE; LENGTH
AB BACKGROUND: Despite improved medical management, the incidence of spinal pathology remains high in patients with Parkinson disease (PD). Several studies have investigated lumbar spine surgery in this population, but data regarding costs and perioperative complications for patients undergoing cervical decompression/fusion on a nationwide scale are lacking.
   METHODS: Cases of cervical spinal decompression, fusion, or exploration in years 2008-2014 were collected via the Healthcare Cost and Utilization Project National Inpatient Sample. Demographics, complications, outcome, and total charges were compared in patients with and without PD (NPD). Confounding variables were identified for multivariate analysis.
   RESULTS: Data were available for 195,341 cervical spine cases, of which PD was prevalent in 779 cases (0.4%). Cases with PD experienced greater overall complication rates (12.5 vs. 7.6%; P < 0.001). Multivariate analysis revealed longer lengths of stay for the PD cohort (mean =1.21 days longer; P < 0.001) and decreased routine discharge (odds ratio = 0.308; P < 0.001). There was no significant difference in mean total charges between PD and NPD (-$1532; P = 0.337). Mortality rates did not significantly differ for either group.
   CONCLUSIONS: Although patients with PD experience greater complication rates and non-home discharges following cervical spine surgery compared with NPD patients, the overall clinical impact of these results may be minimal relative to surgery at other spinal levels in this population.
C1 [Miller, William Kyle; Caras, Andrew; Mierzwa, Adam; Mugge, Luke; Schroeder, Jason] Univ Toledo, Med Ctr, Div Neurosurg, 2801 W Bancroft St, Toledo, OH 43606 USA.
   [Miller, William Kyle; Caras, Andrew; Mierzwa, Adam; Mugge, Luke; Qu, Weikai; Schroeder, Jason] Univ Toledo, Med Ctr, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA.
   [Mansour, Tarek R.] Henry Ford Hlth Syst, Dept Neurol Surg, Detroit, MI USA.
RP Miller, WK (reprint author), Univ Toledo, Med Ctr, Div Neurosurg, 2801 W Bancroft St, Toledo, OH 43606 USA.; Miller, WK (reprint author), Univ Toledo, Med Ctr, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA.
EM william.miller9@rockets.utoleda.edu
OI Miller, William/0000-0003-4533-6993; Caras, Andrew/0000-0001-6379-8089
CR Babat LB, 2004, SPINE, V29, P2006, DOI 10.1097/01.brs.0000138306.02425.21
   Baker JF, 2017, WORLD NEUROSURG, V106, P470, DOI 10.1016/j.wneu.2017.07.006
   Bartolo M, 2010, MOVEMENT DISORD, V25, P325, DOI 10.1002/mds.23007
   De la Garza Ramos Rafael, 2017, J Spine Surg, V3, P601, DOI 10.21037/jss.2017.11.09
   Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9
   Gerlach OHH, 2011, MOVEMENT DISORD, V26, P197, DOI 10.1002/mds.23449
   Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x
   Iijima Mutsumi, 2015, eNeurologicalSci, V1, P21, DOI 10.1016/j.ensci.2015.09.001
   Kleiner JE, 2018, GLOB SPINE J, V8, P842, DOI 10.1177/2192568218776653
   Koller H, 2010, EUR SPINE J, V19, P1785, DOI 10.1007/s00586-010-1405-y
   Martini ML, 2020, NEUROSURGERY, V86, P298, DOI 10.1093/neuros/nyz087
   McClelland S, 2017, J CLIN NEUROSCI, V43, P220, DOI 10.1016/j.jocn.2017.05.006
   McClelland S, 2017, J CLIN NEUROSCI, V35, P88, DOI 10.1016/j.jocn.2016.10.008
   Menon N, 2016, J SPINAL CORD MED, V39, P620, DOI 10.1179/2045772314Y.0000000284
   Muslimovic D, 2008, NEUROLOGY, V70, P2241, DOI 10.1212/01.wnl.0000313835.33830.80
   Oeda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073547
   Rocca WA, 2018, LANCET NEUROL, V17, P928, DOI 10.1016/S1474-4422(18)30355-7
   Sarkiss CA, 2015, CLIN NEUROL NEUROSUR, V134, P122, DOI 10.1016/j.clineuro.2015.04.022
   Sato Y, 2003, J NEUROL SCI, V212, P55, DOI 10.1016/S0022-510X(03)00101-1
   Scemama C, 2018, ORTHOP TRAUMATOL-SUR, V104, P417, DOI 10.1016/j.otsr.2017.12.019
   Schroeder JE, 2015, J BONE JOINT SURG AM, V97A, P1661, DOI 10.2106/JBJS.N.01049
   Sheu H, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2481-8
   Uzawa A, 2009, MOVEMENT DISORD, V24, P2408, DOI 10.1002/mds.22779
   Westermann L, 2017, WORLD NEUROSURG, V108, P513, DOI 10.1016/j.wneu.2017.09.028
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E463
EP E471
DI 10.1016/j.wneu.2019.08.114
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300055
PM 31470148
DA 2020-05-12
ER

PT J
AU Opoku-Darko, M
   Eagles, ME
   Cadieux, M
   Isaacs, AM
   Kelly, JJP
AF Opoku-Darko, Michael
   Eagles, Matthew E.
   Cadieux, Magalie
   Isaacs, Albert M.
   Kelly, John J. P.
TI Natural History and Growth Patterns of Incidentally Discovered Diffusely
   Infiltrating Low-Grade Gliomas: A Volumetric Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Asymptomatic; Growth rate; Incidental; Low-grade glioma; Natural history
ID PROGNOSTIC-FACTORS; ADULT PATIENTS; II GLIOMAS; CLASSIFICATION;
   MANAGEMENT; TUMORS; SURGERY
AB BACKGROUND: Incidentally discovered diffusely infiltrating low-grade gliomas (iDLGGs) are rare findings on neuroimaging that pose a challenge to neurosurgeons. There is a paucity of data regarding the natural history of these lesions, and thus management is controversial. We characterize the growth rates and patterns of iDLGGs in a cohort of patients who underwent serial magnetic resonance imaging before surgical treatment.
   METHODS: We performed a retrospective review of all adult patients (>= 18 years old) with diffuse low-grade glioma diagnosed at our institution between April 2004 and April 2016. iDLGG was defined as any lesion discovered on computed tomography or magnetic resonance imaging performed for reasons and/or symptoms not attributable to the lesion and confirmed on histopathology as low-grade glioma. Tumor growth rates and patterns of growth were analyzed in patients who had serial imaging available.
   RESULTS: Inclusion criteria were met by 15 patients. Mean velocity of diametric expansion was 2.93 mm/year. Of 15 patients, 11 (73.3%) had tumors with an exponential growth pattern, and 4 (26.7%) had a linear growth pattern. Initial tumor volume was positively correlated (r = 0.78) with velocity of diametric expansion.
   CONCLUSIONS: iDLGGs grow over time, and most exhibit an exponential pattern of growth. Tumor volume at the time of diagnosis is predictive of a faster growth rate, but not the pattern of growth.
C1 [Opoku-Darko, Michael; Eagles, Matthew E.; Cadieux, Magalie; Isaacs, Albert M.; Kelly, John J. P.] Univ Calgary, Div Neurosurg, Calgary, AB, Canada.
   [Kelly, John J. P.] Univ Calgary, Arne Charbonneau Canc Inst, Calgary, AB, Canada.
RP Kelly, JJP (reprint author), Univ Calgary, Div Neurosurg, Calgary, AB, Canada.; Kelly, JJP (reprint author), Univ Calgary, Arne Charbonneau Canc Inst, Calgary, AB, Canada.
EM jjkelly@ucalgary.ca
CR Aghi MK, 2015, J NEURO-ONCOL, V125, P503, DOI 10.1007/s11060-015-1867-1
   Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121
   Claus EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.10.FOCUS12367
   Delgado-Lopez PD, 2017, CLIN TRANSL ONCOL, V19, P931, DOI 10.1007/s12094-017-1631-4
   Duffau H, 2015, NEURO-ONCOLOGY, V17, P332, DOI 10.1093/neuonc/nou153
   Gorlia T, 2013, NEURO-ONCOLOGY, V15, P1568, DOI 10.1093/neuonc/not117
   Gui C, 2018, J NEURO-ONCOL, V139, P167, DOI 10.1007/s11060-018-2857-x
   Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Mandonnet E, 2008, NEUROSURG REV, V31, P263, DOI 10.1007/s10143-008-0128-6
   Morris Zoe, 2009, BMJ, V339, pb3016, DOI 10.1136/bmj.b3016
   Nakamura M, 2003, NEUROSURGERY, V53, P62, DOI 10.1227/01.NEU.0000068730.76856.58
   Pallud J, 2006, ANN NEUROL, V60, P380, DOI 10.1002/ana.20946
   Pallud J, 2013, NEURO-ONCOLOGY, V15, P595, DOI 10.1093/neuonc/nos331
   Pallud J, 2010, ANN NEUROL, V68, P727, DOI 10.1002/ana.22106
   Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121
   Potts MB, 2012, J NEUROSURG, V116, P365, DOI 10.3171/2011.9.JNS111068
   Shah AH, 2013, WORLD NEUROSURG, V80, pE75, DOI 10.1016/j.wneu.2012.06.021
   Shah AH, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11219
   Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001
   Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5
   Teixidor P, 2007, J NEURO-ONCOL, V81, P305, DOI 10.1007/s11060-006-9233-y
   Woodward DE, 1996, CELL PROLIFERAT, V29, P269, DOI 10.1111/j.1365-2184.1996.tb01580.x
   Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E133
EP E139
DI 10.1016/j.wneu.2019.08.235
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300018
PM 31505287
DA 2020-05-12
ER

PT J
AU Park, CK
   Jung, NY
   Chang, WS
   Jung, HH
   Chang, JW
AF Park, Chang Kyu
   Jung, Na Young
   Chang, Won Seok
   Jung, Hyun Ho
   Chang, Jin Woo
TI Gamma Knife Radiosurgery for Postoperative Remnant Meningioma: Analysis
   of Recurrence Factors According to World Health Organization Grade
SO WORLD NEUROSURGERY
LA English
DT Article
DE Gamma Knife radiosurgery; Malignant meningioma; Meningioma; Recurrence
ID STEREOTACTIC RADIOSURGERY; ANAPLASTIC MENINGIOMAS; ADJUVANT
   RADIOTHERAPY; PATTERNS; SURGERY; TUMOR
AB OBJECTIVE: The effectiveness of tumor control after Gamma Knife radiosurgery (GKS) for intracranial meningioma is well established. Moreover, GKS is an alternative to reduce surgical-remnant meningioma recurrence. Nevertheless, the tumor can recur even after GKS and is associated with its histologic malignancy. We here investigated the risk factors associated with recurrence from remnant lesions after GKS, assessing recurrence patterns according to histological grades.
   METHODS: From January 2007 to January 2017, 218 patients underwent GKS for surgical-remnant lesions. To evaluate post-GKS lesion recurrence, pre-GKS magnetic resonance images were compared with those at follow-up. We retrospectively analyzed the histologic classification of meningioma and patients' clinical characteristics (sex, age, tumor location, target volume, and prescription dose).
   RESULTS: Of the 218 patients, 13 (5.9%) developed post-GKS recurrence within a mean follow-up period of 37.4 months. The recurrence patterns were as follows: adjacent to the 50% marginal-dose field (9 patients); within the 50% marginal-dose field (2 patients); and outside the field (2 patients). Six of 196 World Health Organization grade I meningioma cases, 6 of 20 grade II cases, and 1 of 2 grade III cases developed recurrence. Thus 32% of high-grade meningioma cases (grades II and III) developed recurrence during the follow-up period. Histologic grade was significantly associated (P < 0.001) with recurrence.
   CONCLUSIONS: The study findings indicate that the post-GKS meningioma recurrence likelihood is high when the meningioma has malignant histologic features. In addition, considering the recurrence patterns, it is important to define a precise target for GKS.
C1 [Park, Chang Kyu] Kyung Hee Univ, Coll Med, Dept Neurosurg, Seoul, South Korea.
   [Chang, Won Seok; Jung, Hyun Ho; Chang, Jin Woo] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurosurg, Seoul, South Korea.
   [Jung, Na Young] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Neurosurg, Ulsan, South Korea.
RP Jung, HH (reprint author), Yonsei Univ, Coll Med, Severance Hosp, Dept Neurosurg, Seoul, South Korea.
EM JUNGHH@yuhs.ac
OI Jung, Hyun Ho/0000-0002-8289-564X; Chang, Won Seok/0000-0003-3145-4016;
   Park, Chang Kyu/0000-0002-5935-8264
CR Attia A, 2012, J NEURO-ONCOL, V108, P179, DOI 10.1007/s11060-012-0828-1
   Bagshaw HP, 2017, J NEUROSURG, V126, P1822, DOI 10.3171/2016.5.JNS152809
   Cohen-Inbar O, 2016, NEUROSURGERY, V79, P58, DOI 10.1227/NEU.0000000000001045
   Couldwell WT, 2007, J NEUROSURG, V106, P30, DOI 10.3171/jns.2007.106.1.30
   D'Ambrosio Anthony L, 2003, Curr Neurol Neurosci Rep, V3, P206, DOI 10.1007/s11910-003-0080-3
   El-Khatib M, 2011, ACTA NEUROCHIR, V153, P1761, DOI 10.1007/s00701-011-1073-7
   Ferraro DJ, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-38
   Frostell A, 2016, WORLD NEUROSURG, V88, P475, DOI 10.1016/j.wneu.2015.10.062
   GANZ JC, 1993, STEREOT FUNCT NEUROS, V61, P23, DOI 10.1159/000100656
   Goto T, 2016, NEUROL MED-CHIR, V56, P372, DOI 10.2176/nmc.ra.2015-0354
   Hardesty DA, 2013, J NEUROSURG, V119, P475, DOI 10.3171/2012.12.JNS12414
   Kano H, 2007, J NEURO-ONCOL, V84, P41, DOI 10.1007/s11060-007-9338-y
   Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025
   Kuhn EN, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13283
   Piscevic I, 2015, WORLD NEUROSURG, V83, P987, DOI 10.1016/j.wneu.2015.02.021
   Pollock BE, 2012, CANCER-AM CANCER SOC, V118, P1048, DOI 10.1002/cncr.26362
   Refaat T, 2017, J NEUROL SURG PART B, V78, P288, DOI 10.1055/s-0036-1597834
   Reinert M, 2006, ACTA NEUROCHIR, V148, P1257, DOI 10.1007/s00701-006-0909-z
   Shakir SI, 2018, J NEUROSURG, V129, P1240, DOI 10.3171/2017.6.JNS17120
   Stafford SL, 2001, NEUROSURGERY, V49, P1029, DOI 10.1097/00006123-200111000-00001
   Starke RM, 2012, J NEUROSURG, V116, P588, DOI 10.3171/2011.11.JNS11530
   Takeuchi H, 1997, SURG NEUROL, V48, P501, DOI 10.1016/S0090-3019(97)00235-8
   Wang WH, 2016, WORLD NEUROSURG, V87, P557, DOI 10.1016/j.wneu.2015.10.021
   Williams BJ, 2013, J RADIOSURGERY SBRT, V2, P183
   Yang SY, 2008, J NEUROL NEUROSUR PS, V79, P574, DOI 10.1136/jnnp.2007.121582
   Zhang M, 2016, WORLD NEUROSURG, V91, P574, DOI 10.1016/j.wneu.2016.04.019
NR 26
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E399
EP E402
DI 10.1016/j.wneu.2019.08.136
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300045
PM 31476462
DA 2020-05-12
ER

PT J
AU Ran, G
   Chen, KZ
   Huang, YZ
   Hu, CB
   Shen, X
AF Ran, Guo
   Chen, Kaizheng
   Huang, Yanzhe
   Hu, Chunbo
   Shen, Xia
TI Electromyographic Response of Facial Nerve Stimulation Under Partial
   Neuromuscular Blockade During Resection of Vestibular Schwannoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anesthesia technique; Facial nerve monitoring; Train-of-four; Vestibular
   schwannoma surgery
ID INTRAOPERATIVE ELECTROMYOGRAPHY; RETROSIGMOID APPROACH; HEARING
   PRESERVATION; SURGERY
AB OBJECTIVE: To evaluate whether use of partial nondepolarizing neuromuscular blocking agents, at a train-of-four level 1, compromise facial nerve monitoring during vestibular schwannoma (VS) resection.
   METHODS: Sixty consecutive patients undergoing VS resection were enrolled into a partial peripheral neuromuscular blockade group or free of neuromuscular blockade group. Stimulation threshold to elicit an electromyographic response amplitude of at least 100 mu V was recorded at the proximal and distal facial nerve after VS removal. The proximal-to-distal ratio of amplitude of the orbicularis oculi and oris muscles was calculated.
   RESULTS: All patients successfully passed the electromyography monitoring test. Mean electrical stimulation thresholds were higher in the peripheral neuromuscular blockade group than in the free of neuromuscular blockade group (0.12 mA vs. 0.06 mA at proximal site, P = 0.001; 0.08 mA vs. 0.03 mA at distal site, P = 0.0002). The differences in median proximal-to-distal amplitude ratios were not statistically significant in both groups. There was a trend toward more patients needing phenylephrine. Recovery profiles were comparable in the 2 groups.
   CONCLUSIONS: Although mean stimulation threshold to elicit a response amplitude was higher in the peripheral neuromuscular blockade group than in the free of neuromuscular blockade group at the proximal site, the stimulation thresholds in both groups were sufficient for facial nerve monitoring in VS surgery, indicating no clinical difference in both groups.
C1 [Ran, Guo; Chen, Kaizheng; Huang, Yanzhe; Hu, Chunbo; Shen, Xia] Fudan Univ, Shanghai Med Coll, Dept Anesthesiol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China.
RP Shen, X (reprint author), Fudan Univ, Shanghai Med Coll, Dept Anesthesiol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China.
EM zlsx@yahoo.com
CR Antognini JF, 2000, CAN J ANAESTH, V47, P273, DOI 10.1007/BF03018926
   BLAIR EA, 1994, AM J OTOL, V15, P161
   Brauer M, 1996, EUR J ANAESTH, V13, P612, DOI 10.1046/j.1365-2346.1996.00010.x
   Choe WJ, 2013, J INT MED RES, V41, P762, DOI 10.1177/0300060513484435
   Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30
   Goldbrunner RH, 2000, NEUROSURGERY, V46, P1140, DOI 10.1097/00006123-200005000-00023
   Grayeli AB, 2005, OTOL NEUROTOL, V26, P114, DOI 10.1097/00129492-200501000-00021
   HAMMERSCHLAG PE, 1990, OTOLARYNG HEAD NECK, V103, P681, DOI 10.1177/019459989010300502
   HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202
   LALWANI AK, 1995, AM J OTOL, V16, P758
   LENNON RL, 1992, ANESTH ANALG, V75, P729
   Lin VYW, 2006, OTOL NEUROTOL, V27, P1017, DOI 10.1097/01.mao.0000235308.87689.35
   Magnan J, 2002, OTOL NEUROTOL, V23, P141, DOI 10.1097/00129492-200203000-00006
   Mastronardi P, 1997, Minerva Anestesiol, V63, P305
   Newfield P, 2012, HDB NEUROANESTHESIA, P136
   Noudel R, 2009, ACTA NEUROCHIR, V151, P935, DOI 10.1007/s00701-009-0344-z
   OWEN JH, 1994, SPINE, V19, P1704, DOI 10.1097/00007632-199408000-00009
   Rowed DW, 1997, J NEUROSURG, V86, P456, DOI 10.3171/jns.1997.86.3.0456
   Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527
   Selesnick SH, 1996, LARYNGOSCOPE, V106, P633, DOI 10.1097/00005537-199605000-00022
   SILVERSTEIN H, 1994, LARYNGOSCOPE, V104, P539, DOI 10.1002/lary.5541040506
   SILVERSTEIN H, 1993, AM J OTOL, V14, P524
   van Dongen EP, 1999, ANESTH ANALG, V88, P22, DOI 10.1097/00000539-199901000-00005
   Yokoyama T, 1999, BRIT J NEUROSURG, V13, P570, DOI 10.1080/02688699943079
NR 24
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E28
EP E33
DI 10.1016/j.wneu.2019.09.020
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300006
PM 31521756
DA 2020-05-12
ER

PT J
AU Ravina, K
   Kim, PE
   Rennert, RC
   Wolfswinkel, EM
   Strickland, B
   Carey, JN
   Russin, JJ
AF Ravina, Kristine
   Kim, Paul E.
   Rennert, Robert C.
   Wolfswinkel, Erik M.
   Strickland, Ben A.
   Carey, Joseph N.
   Russin, Jonathan J.
TI Lessons Learned from the Initial Experience with Pedicled
   Temporoparietal Fascial Flap for Combined Revascularization In Moyamoya
   Angiopathy: A Case Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral revascularization; Combined bypass; Moyamoya angiopathy;
   Temporoparietal pedicled flap
ID INDIRECT BYPASS; SURGICAL-TREATMENT; CLINICAL-FEATURES; DISEASE;
   COMPLICATIONS; ADULTS
AB BACKGROUND: The pedicled temporoparietal fascial flap (TPFF) with a direct superficial temporal (STA) artery to middle cerebral artery (MCA) bypass is a novel combined revascularization approach for moyamoya angiopathy (MMA). With this case series, we aim to report the initial experience with pedicled TPFF combined revascularization for MMA treatment.
   METHODS: Data from 14 consecutive patients undergoing pedicled TPFF combined revascularization for MMA between May 2016 and December 2018 were retrospectively reviewed. Patients admitted with acute ischemia or a modified Rankin Scale (mRS) score >3 were considered high risk.
   RESULTS: Mean +/- standard deviation age on surgery was 41.9 +/- 15.4 years. Three of 14 patients (21.4%) presented with an mRS score >3. Nine of 14 patients (64.3%) presented with ischemic stroke, 4 of whom (44.4%) had acute ischemia. Direct anastomosis patency was confirmed in all cases postoperatively. Mean hospitalization time was 13 +/- 9.3 days and mean follow-up time was 14.1 +/- 9.3 months. From admission to follow-up, neurologic status improved in 8 patients (57.1%) and stabilized in 6 patients (42.9%). Overall, 11/14 patients (78.6%) achieved good functional outcome (mRS score <= 2). All patients achieved some radiographic collateral development, with 5 (71.5%) graded as Matsushima A and B. Three patients developed new radiographic ischemia and 3 experienced wound complications, all in the high-risk group.
   CONCLUSIONS: The TPFF combined approach is a viable strategy for revascularization in MMA. This technique may be suboptimal in patients presenting with acute ischemia and/or mRS score >3.
C1 [Ravina, Kristine; Russin, Jonathan J.] Univ Southern Calif, Keck Sch Med, Neurorestorat Ctr, Los Angeles, CA 90007 USA.
   [Kim, Paul E.] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90007 USA.
   [Strickland, Ben A.; Russin, Jonathan J.] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA.
   [Wolfswinkel, Erik M.; Carey, Joseph N.] Univ Southern Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90007 USA.
   [Rennert, Robert C.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA.
RP Russin, JJ (reprint author), Univ Southern Calif, Keck Sch Med, Neurorestorat Ctr, Los Angeles, CA 90007 USA.; Russin, JJ (reprint author), Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA.
EM jonathan.russin@med.usc.edu
OI Ravina, Kristine/0000-0002-0927-5719
CR Acker G, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.11.FOCUS18512
   Acker G, 2018, STROKE, V49, P476, DOI 10.1161/STROKEAHA.117.018563
   Amin-Hanjani S, 2013, NEUROSURGERY, V73, P962, DOI 10.1227/NEU.0000000000000139
   Bang JS, 2012, NEUROSURGERY, V70, P625, DOI 10.1227/NEU.0b013e3182333c47
   Bao XY, 2015, CEREBROVASC DIS, V39, P75, DOI 10.1159/000369524
   Choi In Jae, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P216, DOI 10.7461/jcen.2012.14.3.216
   Chou SC, 2018, WORLD NEUROSURG, V119, pE180, DOI 10.1016/j.wneu.2018.07.088
   Chung Y, 2017, WORLD NEUROSURG, V97, P304, DOI 10.1016/j.wneu.2016.10.002
   DAVID SK, 1995, ARCH OTOLARYNGOL, V121, P1153
   Demirdover C, 2011, INT J MED SCI, V8, P362, DOI 10.7150/ijms.8.362
   Deng XF, 2018, J NEUROSURG, V128, P1785, DOI 10.3171/2017.2.JNS162405
   Guey S, 2015, APPL CLIN GENET, V8, P49, DOI 10.2147/TACG.S42772
   Houkin K, 1997, CLIN NEUROL NEUROSUR, V99, pS142
   Hyun SJ, 2010, ACTA NEUROCHIR, V152, P1181, DOI 10.1007/s00701-010-0638-1
   Katsuta T, 2001, NEUROSURGERY, V49, P879, DOI 10.1097/00006123-200110000-00019
   Kawaguchi S, 2000, J NEUROSURG, V93, P397, DOI 10.3171/jns.2000.93.3.0397
   Kim DS, 2012, NEUROL MED-CHIR, V52, P333, DOI 10.2176/nmc.52.333
   Kim H, 2016, WORLD NEUROSURG, V94, P273, DOI 10.1016/j.wneu.2016.07.009
   Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99
   Lee SB, 2012, ACTA NEUROCHIR, V154, P1179, DOI 10.1007/s00701-012-1325-1
   Lee SU, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0511-8
   Matsushima T, 1998, Neurosurg Focus, V5, pe4
   Mokal Nitin J, 2013, Indian J Plast Surg, V46, P493, DOI 10.4103/0970-0358.121988
   Ravina K, 2019, J NEUROSURG, V131, P1501, DOI 10.3171/2018.5.JNS18938
   Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622
   Sun H, 2016, WORLD NEUROSURG, V92, P179, DOI 10.1016/j.wneu.2016.04.083
   SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012
   Takanari K, 2015, J NEUROSURG, V123, P1145, DOI 10.3171/2014.12.JNS132602
   Uchino H, 2017, NEUROSURGERY, V80, P201, DOI 10.1227/NEU.0000000000001201
   WORMALD PJ, 1991, J LARYNGOL OTOL, V105, P522, DOI 10.1017/S0022215100116500
   Yokoyama R, 2018, WORLD NEUROSURG, V115, P247, DOI 10.1016/j.wneu.2018.04.167
   Zhao JB, 2018, EXP THER MED, V15, P3570, DOI 10.3892/etm.2018.5850
   Zhao M, 2019, J NEUROSURG, V130, P531, DOI 10.3171/2017.10.JNS171749
   Zhao YH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01121
NR 34
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E259
EP E273
DI 10.1016/j.wneu.2019.08.182
PG 15
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300032
PM 31491577
DA 2020-05-12
ER

PT J
AU Rutkowski, M
   Song, I
   Mack, W
   Zada, G
AF Rutkowski, Martin
   Song, Ivy
   Mack, William
   Zada, Gabriel
TI Outcomes After Minimally Invasive Parafascicular Surgery for
   Intracerebral Hemorrhage: A Single-Center Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE BrainPath; Hematoma; ICH; Minimally invasive; MIPS
ID EVALUATING ACCELERATED RESOLUTION; INITIAL CONSERVATIVE TREATMENT;
   PLASMINOGEN-ACTIVATOR; PHASE-III; EVACUATION; HEMATOMAS; THROMBECTOMY;
   SAFETY; STICH
AB BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) comprises 10%-15% of strokes with a high mortality (40%) and low rates of functional independence within 6 months (25%). Minimally invasive parafascicular surgery has emerged as a potentially safer option for ICH management.
   METHODS: Data from 25 patients who underwent channel-based ICH evacuation were retrospectively collected regarding demographics, clinical presentation, neuroimaging characteristics, follow-up modified Rankin Scale (mRS) score, Glasgow Coma Scale (GCS) score, and disposition.
   RESULTS: Sixteen patients were male (64%) and 9 were female (36%), with a mean age of 52 years. There were 4 frontal, 1 occipital, and 20 basal ganglia hemorrhages; 15 (60%) showed intraventricular extension. Seventeen ICHs (68%) and 6 of 7 patient deaths (86%) were left sided. The mean volume was 46 cm(3) (range, 13.1-101.2 cm(3)), and the mean clot reduction was 92%. Left-sided ICH (P = 0.014) and the presence of intraventricular hemorrhage (P = 0.038) were associated with worsened postoperative GCS score. Larger hemorrhages were associated with mortality (66 cm(3) vs. 38 cm(3); P < 0.005). With a mean follow-up time of 5 months, the median follow-up mRS score was 3.5 (vs. 4 preoperatively), and median follow-up GCS was 15 (vs. 10 preoperatively). Patients with higher postoperative mRS scores and lower postoperative GCS were more likely to die.
   CONCLUSIONS: BrainPath-mediated transsulcal approaches are associated with improved mRS and GCS scores, with low rates of residual hematoma, although further data are needed via controlled studies to determine the importance of hemorrhage location and size, timing of surgical intervention, and long-term patient outcomes.
C1 [Rutkowski, Martin; Song, Ivy; Mack, William; Zada, Gabriel] Univ Southern Calif, Dept Neurosurg, Keck Sch Med, Los Angeles, CA 90007 USA.
RP Song, I (reprint author), Univ Southern Calif, Dept Neurosurg, Keck Sch Med, Los Angeles, CA 90007 USA.
EM ivysong@usc.edu
CR Abdu E, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11362
   Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718
   AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530
   BACKLUND EO, 1978, SURG NEUROL, V9, P99
   Bauer AM, 2017, OPER NEUROSURG, V13, P69, DOI 10.1227/NEU.0000000000001258
   Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624
   Fiorella D, 2016, STROKE, V47, P1399, DOI 10.1161/STROKEAHA.115.011415
   Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933
   Gregson BA, 2012, STROKE, V43, P1496, DOI 10.1161/STROKEAHA.111.640284
   Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4
   Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891
   Hersh EH, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0836-4
   HONDO H, 1990, STEREOT FUNCT NEUROS, V54-5, P432, DOI 10.1159/000100248
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   KANDEL EI, 1985, J NEUROSURG, V62, P206, DOI 10.3171/jns.1985.62.2.0206
   Labib MA, 2017, NEUROSURGERY, V80, P515, DOI 10.1227/NEU.0000000000001316
   Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1
   Mendelow AD, 2005, LANCET, V365, P387
   Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P217
   Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017
   Mould WA, 2013, STROKE, V44, P627, DOI 10.1161/STROKEAHA.111.000411
   Naff N, 2011, STROKE, V42, P3009, DOI 10.1161/STROKEAHA.110.610949
   Newell DW, 2011, J NEUROSURG, V115, P592, DOI 10.3171/2011.5.JNS10505
   Norton SP, 2017, CLINICOECONOMIC OUTC, V9, P519, DOI 10.2147/CEOR.S133623
   Preti MG, 2017, NEUROIMAGE, V160, P41, DOI 10.1016/j.neuroimage.2016.12.061
   Przybylowski CJ, 2015, J CLIN NEUROSCI, V22, P1727, DOI 10.1016/j.jocn.2015.05.015
   Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8
   Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Southwell DG, 2016, J NEUROSURG, V124, P1460, DOI 10.3171/2015.5.JNS142833
   Webb AJS, 2012, STROKE, V43, P1666, DOI 10.1161/STROKEAHA.112.650523
   Ziai WC, 2014, INT J STROKE, V9, P536, DOI 10.1111/ijs.12097
   Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833
NR 33
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E520
EP E528
DI 10.1016/j.wneu.2019.08.087
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300062
PM 31449997
DA 2020-05-12
ER

PT J
AU Sethi, A
   Cavalcante, D
   Ormond, DR
AF Sethi, Akal
   Cavalcante, Daniel
   Ormond, D. Ryan
TI Endoscopic Versus Microscopic Transcallosal Excision of Colloid Cysts: A
   Systematic Review in the Era of Complete Endoscopic Excision
SO WORLD NEUROSURGERY
LA English
DT Review
DE Colloid cyst; Endoscopic; Microscopic; Transcallosal
ID MICROSURGICAL TREATMENT; TOTAL RESECTION; MANAGEMENT; EXPERIENCE;
   3RD-VENTRICLE; SERIES
AB OBJECTIVE: Transcallosal microscopic and endoscopic excisions are both well established approaches to colloid cyst resection; however, there has been no clear consensus regarding the favored approach. We performed a systematic review comparing the transcallosal microscopic and endoscopic transcortical approaches for colloid cyst excision.
   METHODS: We performed a systematic review from 2000-2018 of patients undergoing colloid cyst excision via a microscopic transcallosal or endoscopic transcortical approach where the surgical intent was gross total resection. Studies that included multiple approaches were included if the reported results were stratified by approach.
   RESULTS: The microsurgical transcallosal approach had a higher rate of gross total resection when compared with endoscopic excision (96% for transcallosal vs. 78.5% endoscopic; P < 0.0001). There was also a lower recurrence rate with the transcallosal approach (0.98% vs. 2.16%; P = 0.0036); however, there was no difference in reoperation rates with similar length of follow-up (0.33% transcallosal, 0.61% endoscopic; P = 1.000). Endoscopy had lower overall morbidity when compared with transcallosal approaches (8.7% vs. 18.6%; P = 0.0001), including statistically significant lower rates of infection, infarct, and seizures in the endoscopic cohort. Rates of permanent memory deficit were similar (6.55% transcallosal vs. 4.5% endoscopic; P = 0.52). Shunt dependency was 9.8% after transcallosal excision versus 3.5% after endoscopic excision (P = 0.0002).
   CONCLUSIONS: Modern series of colloid cyst excision continue to favor transcallosal approaches in achieving gross total resection. Nevertheless, endoscopic techniques have significantly reduced morbidity compared to transcallosal approaches, including lower rates of infection, infarct, and seizure. Endoscopic approaches also have a statistically significant decreased rate of shunt dependency-arguably the most important primary endpoint of surgery. With improving endoscopic technology and mastery of the technique, endoscopic excision is maturing into a standard first-line approach for colloid cyst excision.
C1 [Sethi, Akal; Cavalcante, Daniel; Ormond, D. Ryan] Univ Colorado, Dept Neurosurg, Sch Med, Aurora, CO 80045 USA.
RP Sethi, A (reprint author), Univ Colorado, Dept Neurosurg, Sch Med, Aurora, CO 80045 USA.
EM akal.sethi@ucdenver.edu
RI Ormond, David Ryan/R-4847-2017
OI Ormond, David Ryan/0000-0001-7027-2915
CR Bergsneider M, 2007, NEUROSURGERY, V60, P33, DOI 10.1227/01.NEU.0000249227.82365.36
   Birski M, 2016, WORLD NEUROSURG, V85, P205, DOI 10.1016/j.wneu.2015.08.080
   Boogaarts HD, 2011, NEUROSURGERY, V68, P179, DOI 10.1227/NEU.0b013e3181ffae71
   Chibbaro S, 2014, NEUROSURG REV, V37, P235, DOI 10.1007/s10143-013-0508-4
   Desai KI, 2002, SURG NEUROL, V57, P295, DOI 10.1016/S0090-3019(02)00701-2
   Engh JA, 2010, NEUROSURGERY, V67, P198, DOI 10.1227/01.NEU.0000382974.81828.F9
   Greenlee JDW, 2008, NEUROSURGERY, V63, P51, DOI [10.1227/01.NEU.0000297004.20222.ED, 10.1227/01.neu.0000317373.00018.6f]
   Hernesniemi J, 2008, SURG NEUROL, V69, P447, DOI 10.1016/j.surneu.2007.11.005
   Hernesniemi J, 2008, SURG NEUROL, V69, P455, DOI 10.1016/j.surneu.2007.12.004
   Hoffman CE, 2013, NEUROSURGERY, V73, P233, DOI 10.1227/01.neu.0000430300.10338.71
   Horn EM, 2008, NEUROSURGERY, V62, P1076, DOI [10.1227/01.NEU.0000255409.61398.EA, 10.1227/01.neu.0000333773.43445.7b]
   Ibanez-Botella G, 2014, NEUROSURG REV, V37, P227, DOI 10.1007/s10143-014-0529-7
   Kwiek S, 2012, NEUROL NEUROCHIR POL, V46, P216, DOI 10.5114/ninp.2012.29129
   Levine NB, 2007, MINIM INVAS NEUROSUR, V50, P313, DOI 10.1055/s-2007-993215
   Margetis K, 2014, J NEUROSURG, V120, P1259, DOI 10.3171/2014.3.JNS131289
   Mishra S, 2010, NEUROL INDIA, V58, P412, DOI 10.4103/0028-3886.66222
   Pollock BE, 2000, NEUROSURGERY, V46, P1077, DOI 10.1097/00006123-200005000-00010
   Sabanci PA, 2017, TURK NEUROSURG, V27, P546, DOI 10.5137/1019-5149.JTN.17142-16.2
   Sampath R, 2010, NEUROSURGERY, V66, P368, DOI 10.1227/01.NEU.0000363858.17782.82
   Shapiro S, 2009, J NEUROSURG, V110, P112, DOI 10.3171/2008.4.17495
   Sharifi G, 2015, WORLD NEUROSURG, V84, P398, DOI 10.1016/j.wneu.2015.03.033
   Sheikh AB, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.06.024
   Sribnick EA, 2014, WORLD NEUROSURG, V81, P584, DOI 10.1016/j.wneu.2013.12.006
   Stachura K, 2009, NEUROL NEUROCHIR POL, V43, P251
   Symss NP, 2011, NEUROL INDIA, V59, P53, DOI 10.4103/0028-3886.84334
   Wait SD, 2013, NEUROSURGERY, V73, P39, DOI 10.1227/NEU.0b013e3182870980
   Wilson DA, 2013, WORLD NEUROSURG, V80, P576, DOI 10.1016/j.wneu.2012.07.014
   Yadav YR, 2014, J NEUROL SURG PART A, V75, P376, DOI 10.1055/s-0033-1343984
NR 28
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E53
EP E58
DI 10.1016/j.wneu.2019.08.259
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300009
PM 31518748
DA 2020-05-12
ER

PT J
AU Shao, J
   Gao, YZ
   Gao, K
   Yu, ZH
AF Shao, Jia
   Gao, Yan Zheng
   Gao, Kun
   Yu, Zheng Hong
TI Posterior Screw-Rod Fixation and Selective Axial Loosening for the
   Treatment of Atlantoaxial Instability or Dislocation Caused by Os
   Odontoideum: A Case Series for a Single Posterior Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atlantoaxial dislocation; Axial loosening; Irreducible atlantoaxial
   dislocation; Os odontoideum; Posterior fixation
ID BASILAR INVAGINATION; ETIOLOGY; FUSION; SIGN
AB OBJECTIVE: To evaluate the effect of screw-rod fixation and selective axial loosening in the treatment of atlantoaxial instability or dislocation (including reducible and irreducible) caused by os odontoideum (OO) via a single posterior approach.
   METHODS: A consecutive series of patients with OO surgically treated in our hospital were retrospectively analyzed. For atlantoaxial instability and reducible atlantoaxial dislocation, C1-C2 screw-rod fixation and fusion were performed. OO combined with irreducible atlantoaxial dislocation was reduced after posterior axial loosening, followed by screw-rod fixation and fusion. The general information, clinical data, and radiographic data were compared between the 2 different procedures.
   RESULTS: There were 41 patients with an average age of 40.6 +/- 21.7 years. All the patients underwent posterior reduction and C1-2 screw rod fixation, 6 with axial loosening and 35 without axial loosening. The clinical manifestations and radiographic data significantly improved after the operation with a low rate of complications. Except for clivus-canal angle and visual analogue score of cervical pain, there were no differences in clinical and radiographic data between the 2 procedures.
   CONCLUSIONS: Posterior screws-rod fixation and selective axial loosening is appropriate for treating OO complicated with atlantoaxial instability or dislocation (including reducible and irreducible) without the need for anterior decompression.
C1 [Shao, Jia; Gao, Yan Zheng; Gao, Kun; Yu, Zheng Hong] Henan Prov Peoples Hosp, Dept Spinal Surg, Zhengzhou, Henan, Peoples R China.
RP Gao, YZ (reprint author), Henan Prov Peoples Hosp, Dept Spinal Surg, Zhengzhou, Henan, Peoples R China.
EM doctorgao63@126.com
FU Overseas Research Project for Health Care and Family Planning Talents of
   Henan Province [2018090]
FX This work is supported by Overseas Research Project for Health Care and
   Family Planning Talents of Henan Province (grant number 2018090).
CR Arvin B, 2010, NEUROSURGERY, V66, pA22, DOI 10.1227/01.NEU.0000366113.15248.07
   Bach CM, 2013, EUR SPINE J, V22, P29, DOI 10.1007/s00586-012-2329-5
   Dyck P, 1978, Neurosurgery, V2, P93
   Fagan AB, 2004, EUR SPINE J, V13, P295, DOI 10.1007/s00586-004-0732-2
   FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P187, DOI 10.2106/00004623-197456010-00023
   FLEMMING C, 1955, J BONE JOINT SURG BR, V37, P622
   Goel A, 2004, J NEUROSURG-SPINE, V1, P281, DOI 10.3171/spi.2004.1.3.0281
   Hadley MN, 2002, NEUROSURGERY, V50, pS148
   Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014
   HAWKINS RJ, 1976, J BONE JOINT SURG AM, V58, P413, DOI 10.2106/00004623-197658030-00023
   HOLT RG, 1989, RADIOLOGY, V173, P207, DOI 10.1148/radiology.173.1.2781009
   Huang DG, 2017, CLIN NEUROL NEUROSUR, V163, P71, DOI 10.1016/j.clineuro.2017.10.016
   Jian FZ, 2010, NEUROSURGERY, V66, P678, DOI 10.1227/01.NEU.0000367632.45384.5A
   Jumah F, 2017, CUREUS, V9, DOI 10.7759/cureus.1551
   Kikuchi Kenji, 1993, Neurologia Medico-Chirurgica, V33, P769, DOI 10.2176/nmc.33.769
   Kim IS, 2011, J CLIN NEUROSCI, V18, P481, DOI 10.1016/j.jocn.2010.07.114
   KIRLEW KA, 1993, SKELETAL RADIOL, V22, P525
   Klimo P, 2008, J NEUROSURG-SPINE, V9, P332, DOI 10.3171/SPI.2008.9.10.332
   Klimo P, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11227
   Matsui H, 1997, SPINE, V22, P1706, DOI 10.1097/00007632-199708010-00004
   McHugh BJ, 2012, J NEUROSURG-SPINE, V17, P594, DOI 10.3171/2012.9.SPINE12824
   Menezes A H, 1999, Neurosurg Focus, V6, pe2
   Ni B, 2011, WORLD NEUROSURG, V75, P540, DOI 10.1016/j.wneu.2010.07.021
   RICCIARDI JE, 1976, J BONE JOINT SURG AM, V58, P410, DOI 10.2106/00004623-197658030-00022
   ROWLAND LP, 1958, ARCH NEURO PSYCHIATR, V80, P286, DOI 10.1001/archneurpsyc.1958.02340090022002
   Rozzelle CJ, 2013, NEUROSURGERY, V72, P159, DOI 10.1227/NEU.0b013e318276ee69
   SCHULER TC, 1991, J PEDIATR ORTHOPED, V11, P222, DOI 10.1097/01241398-199103000-00017
   SHIASAKI N, 1991, SPINE, V16, P706, DOI 10.1097/00007632-199107000-00003
   SPIERINGS ELH, 1982, J BONE JOINT SURG BR, V64, P422
   Srivastava SK, 2016, SPINE J, V16, P1, DOI 10.1016/j.spinee.2015.09.037
   Straus David, 2014, Surg Neurol Int, V5, P37, DOI 10.4103/2152-7806.129259
   Verska JM, 1997, SPINE, V22, P706, DOI 10.1097/00007632-199703150-00026
   Visocchi M, 2009, ACTA NEUROCHIR, V151, P1265, DOI 10.1007/s00701-009-0277-6
   Wada E, 2009, J BONE JOINT SURG AM, V91A, P1750, DOI 10.2106/JBJS.H.01182
   Wang SL, 2013, SPINE, V38, pE1348, DOI 10.1097/BRS.0b013e3182a1e5e4
   Wang X, 2010, EUR SPINE J, V19, pS91, DOI 10.1007/s00586-009-1088-4
   Wilson Jefferson R, 2010, Evid Based Spine Care J, V1, P67, DOI 10.1055/s-0028-1100896
   Zhao D, 2015, NEUROSURGERY, V76, P514, DOI 10.1227/NEU.0000000000000668
   Zygourakis CC, 2011, J NEUROSURG-PEDIATR, V7, P201, DOI 10.3171/2010.11.PEDS10289
NR 39
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E193
EP E201
DI 10.1016/j.wneu.2019.08.208
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300024
PM 31493594
DA 2020-05-12
ER

PT J
AU Shen, J
   Shao, XF
   Wang, QF
   Ge, RX
   Zhang, JN
AF Shen, Jun
   Shao, Xuefei
   Wang, Qifu
   Ge, Ruixiang
   Zhang, Jianning
TI Comparison of Clinical and Radiologic Characteristics and Prognosis of
   Patients with Chronic Subdural Hematoma with and without a History of
   Head Trauma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Glasgow Coma Scale; Glasgow Outcome Scale;
   Mortality; Recurrence rate
ID RECURRENCE; MANAGEMENT
AB OBJECTIVE: To compare clinical and radiologic characteristics and prognosis of patients with chronic subdural hematoma (CSDH) with and without a history of head trauma.
   METHODS: Clinical and radiologic characteristics and prognosis of patients with CSDH with a history of head trauma (HT group) and without a history of head trauma (WHT group) were comparatively analyzed.
   RESULTS: Mean age in the WHT group was 70.23 +/- 11.53 years, which was significantly older than mean age 67.56 +/- 11.18 years in the HT group (P = 0.008). Stroke, uremia, anticoagulant therapy, and antiplatelet therapy were encountered more often in the WHT group than the HT group. Motor weakness was more prevalent in the WHT group (P = 0.011). Modified Rankin Scale score of 2-3 was more common in the WHT group (P = 0.03), whereas a score of 4-5 was more common in the HT group (P = 0.014). Hematoma density on CT was mainly homogeneous in the 2 groups, with significantly more homogeneous density in the HT group compared with the WHT group (P = 0.014). There was significantly more mixed density in the WHT group (P = 0.001). Patients with CSDH in the WHT group had higher mortality (P = 0.026) and lower Glasgow Outcome Scale score (P = 0.033).
   CONCLUSIONS: Patients with CSDH with or without a history of head trauma presented with different clinical and radiologic characteristics. Patients with CSDH without a history of head trauma had a higher mortality and lower GOS score, which indicates these patients warrant more attention.
C1 [Shen, Jun; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.
   [Shen, Jun; Shao, Xuefei; Wang, Qifu; Ge, Ruixiang] Yijishan Hosp, Wannan Med Coll, Dept Neurosurg, Wuhu, Peoples R China.
RP Zhang, JN (reprint author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.
EM jianningzhang@hotmail.com
FU Collegiate Major Natural Science Research Projects, Anhui Province,
   China [KJ2017A267, KJ2018ZD027]
FX This study was supported by Collegiate Major Natural Science Research
   Projects, Anhui Province, China (Grant Nos. KJ2017A267 and KJ2018ZD027).
CR Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71
   Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255
   Christopher E, 2019, NEUROSURG REV, V42, P427, DOI 10.1007/s10143-018-0979-4
   Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y
   Gelabert-Gonzalez M, 2015, MED CLIN-BARCELONA, V144, P514, DOI 10.1016/j.medcli.2015.01.006
   Heringer LC, 2017, ARQ NEURO-PSIQUIAT, V75, P809, DOI [10.1590/0004-282X20170136, 10.1590/0004-282x20170136]
   Hsieh CT, 2016, J CLIN NEUROSCI, V34, P252, DOI 10.1016/j.jocn.2016.09.015
   KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207
   LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947
   Lee Kyeong-Seok, 1996, Journal of Korean Medical Science, V11, P55
   Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001
   Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715
   MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637
   Mehta V, 2018, J CLIN NEUROSCI, V50, P7, DOI 10.1016/j.jocn.2018.01.050
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918
   Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z
   Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382
   Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013
   Shen J, 2019, WORLD NEUROSURG, V130, pE133, DOI 10.1016/j.wneu.2019.06.016
   Shen J, 2019, WORLD NEUROSURG, V126, pE773, DOI 10.1016/j.wneu.2019.02.148
   Sood P, 2007, CLIN J AM SOC NEPHRO, V2, P956, DOI 10.2215/CJN.03781106
   Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090
   Tsai TH, 2010, J TRAUMA, V68, P571, DOI 10.1097/TA.0b013e3181a5f31c
   Wada M, 2014, CLIN NEUROL NEUROSUR, V120, P49, DOI 10.1016/j.clineuro.2014.02.007
   Yamada SM, 2018, NEUROSURG REV, V41, P549, DOI 10.1007/s10143-017-0889-x
   You WD, 2018, ACTA NEUROCHIR, V160, P893, DOI 10.1007/s00701-018-3513-0
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E391
EP E398
DI 10.1016/j.wneu.2019.08.142
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300044
PM 31476468
DA 2020-05-12
ER

PT J
AU Song, SJ
   Shin, MH
   Kim, JT
AF Song, Se-Jin
   Shin, Myung-Hoon
   Kim, Jong-Tae
TI Anatomical Feasibility of Right Oblique Approach for L5-S1 Oblique
   Lumbar Interbody Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE L5-S1; Magnetic resonance imaging; Oblique approach; Oblique lumbar
   interbody fusion; Perivascular adipose tissue
ID PERIVASCULAR ADIPOSE-TISSUE; ILIAC VEIN; ANTERIOR; COMPLICATIONS
AB BACKGROUND: We compared left and right vascular anatomy at the L5-S1 disc space and validated the anatomical feasibility of the right oblique approach for L5-S1 oblique lumbar interbody fusion.
   METHODS: Axial T2-weighted magnetic resonance imaging studies at the L5-S1 disc level were used to study 274 subjects (164 women and 110 men; average age, 62.97 years). The distance from the center of the L5-S1 disc to the medial wall of the left or right vessel was measured. Using the vessel position, 3 groups were established: medial, middle, and lateral. To describe the morphological configuration, the vessel type and the presence of perivascular adipose tissue (PVAT) around the vessels were identified on both sides.
   RESULTS: The vessels on the left L5-S1 disc space were located 12.47 mm from the midline and most subjects (209 subjects; 76.3%) were included in the medial or middle group. On the right side, the vessels were located more laterally (16.93 mm; P = 0.000) and most subjects (248 subjects; 90.5%) were in the middle or lateral group. On the left side, vessels were mostly veins (260 subjects; 94.9%) and 139 subjects (50.7%) had PVAT. On the right side, the vessels were mostly arteries (213 subjects; 77.7%) and 242 (88.3%) had PVAT.
   CONCLUSIONS: The vessels on the right side of the L5-S1 disc were located more laterally, and most vessels on the right side were arteries accompanying PVAT, which might minimize vessel manipulation. These results indicate that the right side of the L5-S1 disc could provide feasible access for oblique lumbar interbody fusion at L5-S1.
C1 [Song, Se-Jin; Shin, Myung-Hoon; Kim, Jong-Tae] Catholic Univ, Incheon St Marys Hosp, Coll Med, Dept Neurosurg, Incheon, South Korea.
RP Shin, MH (reprint author), Catholic Univ, Incheon St Marys Hosp, Coll Med, Dept Neurosurg, Incheon, South Korea.
EM novice97@naver.com
CR Brau Salvador A, 2004, Spine J, V4, P409, DOI 10.1016/j.spinee.2003.12.003
   Brown NK, 2014, ARTERIOSCL THROM VAS, V34, P1621, DOI 10.1161/ATVBAHA.114.303029
   Capellades J, 2000, SPINE, V25, P1695, DOI 10.1097/00007632-200007010-00013
   Chung NS, 2017, EUR SPINE J, V26, P2797, DOI 10.1007/s00586-017-5176-6
   Datta JC, 2007, SPINE, V32, P113, DOI 10.1097/01.brs.0000250991.02387.84
   Deukmedjian AR, 2012, J NEUROSURG-SPINE, V16, P615, DOI 10.3171/2012.3.SPINE1210
   Fantini GA, 2007, SPINE, V32, P2751, DOI 10.1097/BRS.0b013e31815a996e
   Fantini GA, 2013, WORLD J ORTHOP, V4, P19, DOI 10.5312/wjo.v4.i1.19
   Moore KL, 2013, CLIN ORIENTED ANATOM
   Paraskevas G, 2008, SURG RADIOL ANAT, V30, P481, DOI 10.1007/s00276-008-0352-3
   Phan K, 2015, BRIT J NEUROSURG, V29, P705, DOI 10.3109/02688697.2015.1036838
   Silvestre C, 2012, ASIAN SPINE J, V6, P89, DOI 10.4184/asj.2012.6.2.89
   Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151
   Tribus CB, 2001, SPINE, V26, P1205, DOI 10.1097/00007632-200106010-00007
   Villacorta L, 2015, HORM MOL BIOL CLIN I, V21, P137, DOI 10.1515/hmbci-2014-0048
   Woods KRM, 2017, SPINE J, V17, P545, DOI 10.1016/j.spinee.2016.10.026
NR 16
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E403
EP E408
DI 10.1016/j.wneu.2019.08.135
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300046
PM 31476457
DA 2020-05-12
ER

PT J
AU Speckter, H
   Santana, J
   Bido, J
   Hernandez, G
   Rivera, D
   Suazo, L
   Valenzuela, S
   Oviedo, J
   Gonzalez, CF
   Stoeter, P
AF Speckter, Herwin
   Santana, Jairo
   Bido, Jose
   Hernandez, Giancarlo
   Rivera, Diones
   Suazo, Luis
   Valenzuela, Santiago
   Oviedo, Jairo
   Gonzalez, Cesar F.
   Stoeter, Peter
TI Texture Analysis of Standard Magnetic Resonance Images to Predict
   Response to Gamma Knife Radiosurgery in Vestibular Schwannomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Magnetic resonance imaging; Radiosurgery; Texture analysis; Vestibular
   schwannoma
ID FRACTIONATED STEREOTACTIC RADIOTHERAPY; ACOUSTIC NEUROMAS; SURGERY
AB PURPOSE: To search for texture features of routine magnetic resonance imaging to predict tumor volume reduction and transient versus permanent tumor progression of vestibular schwannomas treated by Gamma Knife stereotactic radiosurgery.
   MATERIALS AND METHODS: Included were 23 patients with vestibular schwannomas treated in our center and followed over a period of 23.7-80.3 months (mean 42.7). Magnetic resonance imaging was performed on a 3-Tesla scanner and included T1-weighted images with and without contrast enhancement, T2-weighted, and fluid-attenuated inversion recovery images. Volumetric results were followed longitudinally over time and correlated to texture features as mean, minimum, maximum, standard deviation, skewness, and kurtosis of normalized signals taken from regions of interest covering the total tumor volume.
   RESULTS: In total, 14 tumors showed early progression during the first 5-18 months (2 cases permanent, 12 cases transient), whereas 9 tumors regressed immediately after SRS. Kurtosis of T2-weighted image intensity values turned out to predict progression best with a sensitivity and specificity of 71% and 78%. From all texture feature parameters, only the minimum of the normalized T2-weighted image intensity values correlated significantly to the final reduction of tumor volume per month (correlation coefficient = -0.634, P < 0.05, corrected for false discovery rate).
   CONCLUSIONS: Texture feature analysis helps to predict permanent versus transient enlargement and final volume reduction of schwannomas after SRS. Thus, alternative treatment strategies might be considered, mainly in large tumors, where further clinical deterioration cannot be excluded. To confirm these results, a prospective study including more cases and a longer follow-up period is necessary.
C1 [Speckter, Herwin; Santana, Jairo; Bido, Jose; Hernandez, Giancarlo; Rivera, Diones; Suazo, Luis; Valenzuela, Santiago; Oviedo, Jairo; Stoeter, Peter] CEDIMAT, Ctr Gamma Knife Dominicano, Plaza Salud, Santo Domingo, Dominican Rep.
   [Speckter, Herwin; Oviedo, Jairo; Gonzalez, Cesar F.; Stoeter, Peter] CEDIMAT, Dept Radiol, Plaza Salud, Santo Domingo, Dominican Rep.
RP Speckter, H (reprint author), CEDIMAT, Ctr Gamma Knife Dominicano, Plaza Salud, Santo Domingo, Dominican Rep.; Speckter, H (reprint author), CEDIMAT, Dept Radiol, Plaza Salud, Santo Domingo, Dominican Rep.
EM hspeckter@cedimat.net
RI Speckter, Herwin/AAF-1806-2020; Oviedo Abreu, Jairo/E-6640-2017
OI Oviedo Abreu, Jairo/0000-0002-9304-7857
CR Battaglia A, 2006, OTOL NEUROTOL, V27, P705, DOI 10.1097/01.mao.0000226302.59198.87
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bowden G, 2017, NEUROSURGERY, V81, P490, DOI 10.1093/neuros/nyx027
   Breshears JD, 2019, NEUROSURGERY, V84, P123, DOI 10.1093/neuros/nyy019
   Chuang CC, 2012, J NEUROSURG, V117, P63, DOI 10.3171/2012.7.GKS121003
   de Ipolyi Amy R, 2008, Neurosurgery, V62, pE1164, DOI 10.1227/01.neu.0000325880.13494.f2
   DEIPOLYI AR, 2008, NEUROSURGERY, V62, pE1165
   Delsanti Christine, 2008, Prog Neurol Surg, V21, P93, DOI 10.1159/000156712
   Frisch CD, 2017, NEUROSURGERY, V80, P112, DOI 10.1227/NEU.0000000000001376
   Hasegawa T, 2013, J NEUROSURG, V118, P557, DOI 10.3171/2012.10.JNS12523
   Hayhurst C, 2012, NEURO-ONCOLOGY, V14, P87, DOI 10.1093/neuonc/nor171
   Iwai Y, 2007, NEUROSURGERY, V60, P75, DOI 10.1227/01.NEU.0000249251.78794.45
   Kim JH, 2017, WORLD NEUROSURG, V107, P175, DOI [10.1016/J.WNEU.2017.07.139, 10.1016/j.wneu.2017.07.139]
   Meijer OWM, 2008, AM J NEURORADIOL, V29, P906, DOI 10.3174/ajnr.A0969
   Nagano O, 2010, J NEUROSURG, V113, P122, DOI 10.3171/2010.8.GKS10960
   Nakamura H, 2000, AM J NEURORADIOL, V21, P1540
   Pendl G, 1996, STEREOT FUNCT NEUROS, V66, P103, DOI 10.1159/000099775
   Pollock BE, 2006, NEUROSURGERY, V58, P241, DOI 10.1227/01.NEU.0000194833.66593.8B
   Regis J, 2017, J NEUROSURG, V127, P374, DOI 10.3171/2016.7.JNS161236
   Regis J, 2013, NEUROSURG CLIN N AM, V24, P521, DOI 10.1016/j.nec.2013.06.002
   Regis Jean, 2007, Prog Neurol Surg, V20, P129, DOI 10.1159/000100100
   Schneider T, 2016, EUR RADIOL, V26, P849, DOI 10.1007/s00330-015-3895-9
   Shirato H, 2000, INT J RADIAT ONCOL, V48, P1395, DOI 10.1016/S0360-3016(00)00731-8
   Speckter H, 2018, J NEUROSURG, V129, P31, DOI 10.3171/2018.7.GKS181327
   Speckter H, 2016, J NEUROSURG, V125, P83, DOI 10.3171/2016.7.GKS161455
   Vernimmen FJAI, 2010, INT J RADIAT BIOL, V86, P486, DOI 10.3109/09553001003667982
   Watanabe S, 2016, J NEUROSURG, V125, P64, DOI 10.3171/2016.7.GKS161494
   Wippold FJ, 2007, AM J NEURORADIOL, V28, P1633, DOI 10.3174/ajnr.A0682
   Wu CC, 2017, J NEUROSURG, V127, P1384, DOI 10.3171/2016.9.JNS161510
   Yang HC, 2011, J NEUROSURG, V114, P801, DOI 10.3171/2010.8.JNS10674
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E228
EP E234
DI 10.1016/j.wneu.2019.08.193
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300029
PM 31493607
DA 2020-05-12
ER

PT J
AU Spina, A
   Gagliardi, F
   Abarca-Olivas, J
   Bailo, M
   Boari, N
   Gonzalez-Lopez, P
   Gragnaniello, C
   Caputy, AJ
   Mortini, P
AF Spina, Alfio
   Gagliardi, Filippo
   Abarca-Olivas, Javier
   Bailo, Michele
   Boari, Nicola
   Gonzalez-Lopez, Pablo
   Gragnaniello, Cristian
   Caputy, Anthony J.
   Mortini, Pietro
TI Endonasal Endoscopic and Transoral Approaches to the Craniovertebral
   Junction and the Clival Region: A Comparative Anatomical Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clivus; Craniovertebral junction; Endoscopic endonasal approach;
   Operability score; Transoral approach
ID SKULL-BASE TUMORS; SURGICAL FREEDOM; LESIONS; ODONTOIDECTOMY;
   COMPLICATIONS; OPERABILITY; TRANSNASAL; MANAGEMENT; CHORDOMAS; RESECTION
AB OBJECTIVE: Anterior craniovertebral junction (CVJ) surgery has continued to be one of the most debated neurosurgical topics. The transoral approach (TOA) has been considered the choice for this region. However, it has some limitations and a not negligible degree of surgery-related morbidity. With the advent of endoscopy, the endoscopic endonasal approach (EEA) was developed, which minimized morbidity and improved exposure. To the best of our knowledge, despite the extensive reported data, a comparative anatomical study has not been performed and no definitive consensus has been reached on the indications for both approaches.
   METHODS: We compared the TOA and EEA to the CVJ using the previously described operability score (OS), calculated at 4 different targets: the C1 tubercle (C1), the lowest exposed point of the odontoid process (C2), the basion (BS) and the middle clivus (MC). The higher the OS for the selected targets, the more favorable the approach.
   RESULTS: The TOA had higher OSs at the MC, C1, and C2 targets, and the EEA showed greater OSs at MC and C1. The TOA and EEA had similar OSs at the BS. These results have shown that the OS is more favorable at C1-C2 using the TOA and the OSs at the MC and BS were similar.
   CONCLUSIONS: The OS is an effective method to compare surgical approaches. The present study demonstrated the maximal exposure capability of the 2 approaches. The TOA seemed to be superior for lower targets and the EEA for upper targets. Because of the strong variability in the CVJ anatomy and pathological features, we suggest considering the OS as a further tool to better define the best surgical approach.
C1 [Spina, Alfio; Gagliardi, Filippo; Bailo, Michele; Boari, Nicola; Mortini, Pietro] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy.
   [Abarca-Olivas, Javier; Gonzalez-Lopez, Pablo] Miguel Hernandez Univ, Hosp Gen Univ Alicante, Dept Neurosurg, Alicante, Spain.
   [Gragnaniello, Cristian; Caputy, Anthony J.] George Washington Univ, Dept Neurol Surg, Washington, DC USA.
RP Spina, A (reprint author), Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy.
EM spina.alfio@hsr.it
RI ; Bailo, Michele/M-3599-2016
OI Gonzalez-Lopez, Pablo/0000-0001-8614-0992; Bailo,
   Michele/0000-0003-4151-2873
CR Abarca-Olivas J, 2014, NEUROCIRUGIA, V25, P1, DOI 10.1016/j.neucir.2013.02.009
   Abuzayed B, 2009, J NEUROSURG SCI, V53, P37
   Abuzayed B, 2009, TURK NEUROSURG, V19, P249
   Aldana PR, 2012, NEUROSURGERY, V71, P308, DOI 10.1227/NEU.0b013e318266e488
   Ponce-Gomez JA, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14301
   Balasingam V, 2006, J NEUROSURG, V105, P301, DOI 10.3171/jns.2006.105.2.301
   Banu MA, 2014, J NEUROSURG-PEDIATR, V13, P155, DOI 10.3171/2013.10.PEDS13303
   Benke Michael, 2011, Am J Orthop (Belle Mead NJ), V40, pE205
   Boari N, 2010, J NEUROSURG, V113, P1011, DOI 10.3171/2010.4.JNS091887
   Choi D, 2013, NEUROSURGERY, V73, P296, DOI 10.1227/01.neu.0000430324.24623.10
   CROCKARD HA, 1985, ANN ROY COLL SURG, V67, P321
   DAVIES RJO, 1990, EUR RESPIR J, V3, P509
   de Almeida JR, 2009, LARYNGOSCOPE, V119, P239, DOI 10.1002/lary.20108
   de Divitiis O, 2004, NEUROSURGERY, V54, P125, DOI 10.1227/01.NEU.0000097271.55741.60
   Dlouhy BJ, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14837
   DONALD P, 1998, SURG SKULL BASE
   El-Sayed IH, 2010, J CRANIOVERTEBRAL JU, V1, P44, DOI 10.4103/0974-8237.65481
   Elhadi AM, 2015, OPER NEUROSURG, V11, P69, DOI 10.1227/NEU.0000000000000601
   ERBENGI A, 1991, NEUROSURG REV, V14, P23
   Frempong-Boadu AK, 2002, NEUROSURGERY, V51, pS60, DOI 10.1227/01.NEU.0000031002.35411.D4
   Gagliardi F, 2016, WORLD NEUROSURG, V95, P246, DOI 10.1016/j.wneu.2016.08.034
   Gagliardi F, 2015, ACTA NEUROCHIR, V157, P597, DOI 10.1007/s00701-014-2340-1
   Gagliardi F, 2014, J CRANIO MAXILL SURG, V42, P1000, DOI 10.1016/j.jcms.2014.01.024
   Gilsbach J, 1983, Neurosurg Rev, V6, P199, DOI 10.1007/BF01743101
   Hussain A, 2014, EUR ARCH OTO-RHINO-L, V271, P575, DOI 10.1007/s00405-013-2550-9
   Jain VK, 1999, NEUROL INDIA, V47, P188
   Kassam AB, 2005, NEUROSURGERY, V57, P213, DOI 10.1227/01.NEU.0000163687.64774.E4
   Kassam Amin, 2005, Neurosurg Focus, V19, pE4
   Kwong Y, 2011, AM J ROENTGENOL, V196, pW421, DOI 10.2214/AJR.10.5339
   La Corte E, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14777
   LITVAK J, 1981, J NEUROSURG, V55, P491, DOI 10.3171/jns.1981.55.3.0491
   Liu JK, 2008, SKULL BASE-INTERD AP, V18, P151, DOI 10.1055/s-2007-994288
   Mallory GW, 2016, J NEUROSURG-SPINE, V24, P521, DOI 10.3171/2015.6.SPINE141250
   Mazzatenta D, 2014, SPINE, V39, P846, DOI 10.1097/BRS.0000000000000271
   Menezes AH, 2005, OPER TECH NEUROSURG, V8, P150
   Menezes AH, 2005, OPER TECH NEUROSURG, V8, P158
   Menezes AH, 2005, OPER TECH NEUROSURG, V8, P164
   Menezes AH, 2008, CHILD NERV SYST, V24, P1187, DOI 10.1007/s00381-008-0599-3
   Messina A, 2007, NEUROSURG REV, V30, P189, DOI 10.1007/s10143-007-0084-6
   Mouchaty H, 2009, EUR SPINE J, V18, pS13, DOI 10.1007/s00586-009-0988-7
   Perrini P, 2014, ACTA NEUROCHIR, V156, P1231, DOI 10.1007/s00701-014-2057-1
   Perrini P, 2009, NEUROSURGERY, V64, P331, DOI 10.1227/01.NEU.0000334430.25626.DC
   Pillai P, 2009, NEUROSURGERY, V64, P437, DOI 10.1227/01.NEU.0000334050.45750.C9
   SEIFERT V, 1991, ACTA NEUROCHIR, V112, P141, DOI 10.1007/BF01405143
   Shidoh S, 2014, NEUROL MED-CHIR, V54, P991, DOI 10.2176/nmc.st.2014-0135
   Shoda N, 2004, SPINE, V29, pE204, DOI 10.1097/00007632-200405150-00022
   SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952
   Spina A, 2016, WORLD NEUROSURG, V95, P457, DOI 10.1016/j.wneu.2016.08.073
   Spina A, 2016, ACTA NEUROCHIR, V158, P1637, DOI 10.1007/s00701-016-2880-7
   UTTLEY D, 1989, J NEUROSURG, V71, P705, DOI 10.3171/jns.1989.71.5.0705
   Vaid N, 2001, Indian J Otolaryngol Head Neck Surg, V53, P307, DOI 10.1007/BF02991556
   Visocchi M., 2015, J NEUROSURG SCI
   Williams WG, 1998, PLAST RECONSTR SURG, V102, P2310, DOI 10.1097/00006534-199812000-00006
   Youssef AS, 2008, NEUROSURGERY, V63, P145, DOI [10.1227/01.NEU.0000297065.37186.84, 10.1227/01.neu.0000317386.99055.3f]
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E116
EP E123
DI 10.1016/j.wneu.2019.08.243
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300016
PM 31518738
DA 2020-05-12
ER

PT J
AU Sugimoto, T
   Matsuda, R
   Tamamoto, T
   Hontsu, S
   Yamaki, K
   Miura, S
   Park, YS
   Nakase, H
   Hasegawa, M
AF Sugimoto, Tadashi
   Matsuda, Ryosuke
   Tamamoto, Tetsuro
   Hontsu, Shigeto
   Yamaki, Kaori
   Miura, Sachiko
   Park, Young-Su
   Nakase, Hiroyuki
   Hasegawa, Masatoshi
TI Linac-Based Fractionated Stereotactic Radiotherapy with a
   Micro-Multileaf Collimator for Brainstem Metastasis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brainstem metastasis; Fractionated radiotherapy; Novalis; Stereotactic
   radiotherapy
ID GAMMA-KNIFE RADIOSURGERY; PROGNOSTIC-FACTORS; LOCAL-CONTROL; MANAGEMENT;
   SURVIVAL; OUTCOMES; RADIOBIOLOGY; TUMORS
AB BACKGROUND: To assess the neuroimaging and clinical outcomes in patients with brainstem metastasis (BSM) treated with linac-based fractionated stereotactic radiotherapy (fSRT) with a micro-multileaf collimator.
   METHODS: Between May 2007 and January 2017, 24 patients (15 male and 9 female) with BSM (25 lesions: midbrain, 10; pons, 13; and medulla oblongata, 2) were consecutively treated with linac-based fSRT. BSM originated from the lung (n = 18, 75.0%), colon (n = 3, 12.5%), and breast (n = 3, 12.5%). The median patient age was 67.0 (range: 42-80) years. Recursive partition analysis classified 2 patients as class I, 17 as class II, and 5 as class III. Overall survival was calculated using the Kaplan-Meier method.
   RESULTS: Tumor volume ranged from 0.01 to 7.49 cm(3) (median: 0.233 cm(3)), and patients were treated with a dose of 24-40 Gy in 7-13 fractions. The median OS was 9 months after fSRT (95% confidence interval 4.104-13.896). Large tumor volume, presence of brainstem-related symptoms, poor pretreatment Karnofsky performance status, and recursive partition analysis class III were significantly associated with low overall survival. Tumor volume decreased in 18 metastatic lesions, remained stable in 6, and increased in 1. No patient exhibited permanent radiation injury. Grade 2 nausea and vomiting according to the Common Terminology Criteria for Adverse Events 4.0 occurred in 1 patient who received corticosteroids.
   CONCLUSIONS: Linac-based fSRT with a micro-multileaf collimator delivered in the doses of 24-40 Gy in 7-13 fractions is a safe and effective local therapy for patients with BSM.
C1 [Sugimoto, Tadashi] Osaka Gen Med Ctr, Dept Neurosurg, Osaka, Japan.
   [Matsuda, Ryosuke; Park, Young-Su; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Kashihara, Nara, Japan.
   [Tamamoto, Tetsuro; Yamaki, Kaori; Miura, Sachiko; Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara, Japan.
   [Hontsu, Shigeto] Nara Med Univ, Dept Resp Med, Kashihara, Nara, Japan.
RP Matsuda, R (reprint author), Nara Med Univ, Dept Neurosurg, Kashihara, Nara, Japan.
EM cak93500@pop02.odn.ne.jp
CR Bilger A, 2017, CLIN TRANSL RAD ONCO, V7, P55, DOI 10.1016/j.ctro.2017.09.007
   BRENNER DJ, 1991, INT J RADIAT ONCOL, V21, P819, DOI 10.1016/0360-3016(91)90703-7
   CHASON JL, 1963, CANCER, V16, P781, DOI 10.1002/1097-0142(196306)16:6<781::AID-CNCR2820160614>3.0.CO;2-M
   Fuentes S, 2006, NEUROSURGERY, V58, P37, DOI 10.1227/01.NEU.0000190655.95669.5C
   Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0
   Gevaert T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-120
   HALL EJ, 1993, INT J RADIAT ONCOL, V25, P381, DOI 10.1016/0360-3016(93)90367-5
   Hatiboglu MA, 2011, NEUROSURGERY, V69, P796, DOI 10.1227/NEU.0b013e31821d31de
   Huang CF, 1999, J NEUROSURG, V91, P563, DOI 10.3171/jns.1999.91.4.0563
   Hussain A, 2007, INT J RADIAT ONCOL, V67, P521, DOI 10.1016/j.ijrobp.2006.08.081
   Johnson JD, 1996, NEUROSURG CLIN N AM, V7, P337
   Joshi R, 2016, CLIN NEUROL NEUROSUR, V147, P30, DOI 10.1016/j.clineuro.2016.05.001
   Jung EW, 2013, CLIN NEUROL NEUROSUR, V115, P2023, DOI 10.1016/j.clineuro.2013.06.012
   Kased N, 2008, J NEURO-ONCOL, V86, P195, DOI 10.1007/s11060-007-9458-4
   Kawabe T, 2012, J NEUROSURG, V117, P23, DOI 10.3171/2012.7.GKS12977
   Kelly PJ, 2011, J NEURO-ONCOL, V104, P553, DOI 10.1007/s11060-010-0514-0
   Voong KR, 2015, NEURO-ONCOL PRACT, V2, P40, DOI 10.1093/nop/npu032
   Kilburn JM, 2014, J NEURO-ONCOL, V117, P167, DOI 10.1007/s11060-014-1373-x
   Koyfman SA, 2010, INT J RADIAT ONCOL, V78, P409, DOI 10.1016/j.ijrobp.2009.07.1750
   Leeman JE, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-107
   Li YH, 2012, J NEUROSURG, V117, P13, DOI 10.3171/2012.7.GKS121020
   Lin CS, 2012, NEUROSURGERY, V70, P953, DOI 10.1227/NEU.0b013e31823c40fe
   Liu SH, 2016, J CLIN NEUROSCI, V25, P105, DOI 10.1016/j.jocn.2015.10.013
   Lorenzoni JG, 2009, SURG NEUROL, V71, P188, DOI 10.1016/j.surneu.2008.01.029
   Matsumoto K, 1998, J NEUROSURG, V88, P141, DOI 10.3171/jns.1998.88.1.0141
   Mori Y, 2010, J NEURO-ONCOL, V98, P213, DOI 10.1007/s11060-010-0179-8
   Nakamura M, 2017, J RADIAT RES, V58, P834, DOI 10.1093/jrr/rrx042
   Ogura K, 2012, J NEURO-ONCOL, V109, P425, DOI 10.1007/s11060-012-0912-6
   Sengoz M, 2013, J NEURO-ONCOL, V113, P33, DOI 10.1007/s11060-013-1086-6
   Shrieve DC, 2006, NEUROSURG CLIN N AM, V17, P67, DOI 10.1016/j.nec.2006.02.003
   Shrieve Dennis C., 1996, P205
   Shuto T, 2003, ACTA NEUROCHIR, V145, P755, DOI 10.1007/s00701-003-0034-1
   Trifiletti DM, 2016, INT J RADIAT ONCOL, V96, P280, DOI 10.1016/j.ijrobp.2016.06.009
   Valery CA, 2011, INT J RADIAT ONCOL, V80, P362, DOI 10.1016/j.ijrobp.2010.02.028
   Williams BJ, 2009, J NEUROSURG, V111, P439, DOI 10.3171/2008.11.JNS08984
   Yen CP, 2006, J NEUROSURG, V105, P213, DOI 10.3171/jns.2006.105.2.213
   Yoo TW, 2011, J KOREAN NEUROSURG S, V50, P299, DOI 10.3340/jkns.2011.50.4.299
NR 37
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E680
EP E686
DI 10.1016/j.wneu.2019.08.049
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300082
PM 31442651
DA 2020-05-12
ER

PT J
AU Tamura, R
   Toda, M
   Morimoto, Y
   Sato, M
   Akiyama, T
   Yoshida, K
AF Tamura, Ryota
   Toda, Masahiro
   Morimoto, Yukina
   Sato, Mizuto
   Akiyama, Takenori
   Yoshida, Kazunari
TI Analysis of Temporobasal Vein with Short Subdural Segment for Anterior
   Transpetrosal Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior transpetrosal approach; Bridging vein; Dural sinus; Meningeal
   vein; Subtemporal approach; Temporobasal vein
ID MIDDLE CEREBRAL VEIN; UPPER BASILAR ARTERY; BRIDGING VEINS;
   MICROSURGICAL ANATOMY; TRANSTENTORIAL APPROACH; VENOUS DRAINAGE; DURAL
   ENTRANCE; LESIONS; PRESERVATION; ANEURYSMS
AB BACKGROUND: The anterior transpetrosal approach (ATPA) is applied to petroclival and brainstem lesions. Although neurosurgeons need to minimize the risk of neurologic complications, brain retraction is necessary for procedures of ATPA. Bridging veins (BVs) limit mobility of the temporal lobe. In the present study, BVs around the petrous bone were analyzed, focusing on the dural entrance and termination points.
   METHODS: The relationship between subdural and meningeal segments of temporobasal veins (TBVs) was analyzed by preoperative computed tomography venography in 102 patients who underwent ATPA. TBVs were classified by the dural entrance and termination points.
   RESULTS: TBVs mainly entered the transverse sinus and rarely entered transverse-sigmoid sinus (T-S) junction and superior petrosal sinus (SPS). TBVs entered a dural sinus either directly or indirectly through a meningeal vein. The changes in vascular diameter of the lumen, shape, and course were identified between the subdural and meningeal segments. Generally, BVs with long subdural segment do not limit mobility of the temporal lobe. TBVs draining into the T-S junction and SPS tended to be shorter than those draining into the transverse sinus. Furthermore, a few TBVs indirectly entered the dural sinuses through the meningeal vein (early dural entrance). The subdural segment of these TBVs was much shorter.
   CONCLUSIONS: TBVs entering the T-S junction or SPS with short subdural segment may limit the mobility of the temporal lobe. Changes in vascular diameter, shape, and course were detected by computed tomography venography, which was helpful to detect the subdural-meningeal transition.
C1 [Tamura, Ryota; Toda, Masahiro; Morimoto, Yukina; Sato, Mizuto; Akiyama, Takenori; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.
RP Toda, M (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.
EM todam@keio.jp
RI ; Akiyama, Takenori/L-3453-2013
OI Toda, Masahiro/0000-0003-2700-1620; Akiyama,
   Takenori/0000-0003-2795-7411
CR Ammerman JM, 2005, J NEUROSURG, V103, P783, DOI 10.3171/jns.2005.103.5.0783
   Browder J, 1975, Surg Neurol, V3, P37
   Campero A, 2014, J CLIN NEUROSCI, V21, P1803, DOI 10.1016/j.jocn.2014.01.020
   CASS SP, 1994, J NEURO-ONCOL, V20, P337, DOI 10.1007/BF01053048
   DAUTHERIBES M, 1989, SURG RADIOL ANAT, V11, P187, DOI 10.1007/BF02337820
   DAY JD, 1994, J NEUROSURG, V81, P230, DOI 10.3171/jns.1994.81.2.0230
   DOLENC VV, 1994, ACTA NEUROCHIR, V130, P55, DOI 10.1007/BF01405503
   DRAKE CG, 1965, J NEUROSURG, V23, P457, DOI 10.3171/jns.1965.23.5.0457
   FUJITSU K, 1985, J NEUROSURG, V62, P340, DOI 10.3171/jns.1985.62.3.0340
   Gu SX, 2011, CLIN NEUROL NEUROSUR, V113, P889, DOI 10.1016/j.clineuro.2011.06.008
   Guppy KH, 1997, NEUROSURGERY, V41, P615, DOI 10.1097/00006123-199709000-00021
   HAKUBA A, 1986, SURG NEUROL, V26, P271, DOI 10.1016/0090-3019(86)90161-8
   Han H, 2008, NEUROSURGERY, V62, P289, DOI 10.1227/01.NEU.0000310772.04153.58
   Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z
   Han H, 2010, NEUROSURGERY, V67, P9, DOI 10.1227/01.NEU.0000381683.27324.14
   Ikushima I, 2006, EUR J RADIOL, V58, P96, DOI 10.1016/j.ejrad.2005.11.011
   Jeffery N, 2002, J ANAT, V200, P135, DOI 10.1046/j.0021-8782.2001.00017.x
   Kawase T, 1996, ACTA NEUROCHIR, V138, P402, DOI 10.1007/BF01420302
   KAWASE T, 1991, NEUROSURGERY, V28, P869, DOI 10.1227/00006123-199106000-00014
   KAWASE T, 1985, J NEUROSURG, V63, P857, DOI 10.3171/jns.1985.63.6.0857
   MacDonald JD, 1998, NEUROSURGERY, V43, P84, DOI 10.1097/00006123-199807000-00054
   MATSUSHIMA T, 1989, J NEUROSURG, V71, P923, DOI 10.3171/jns.1989.71.6.0923
   Miabi Z, 2004, AM J NEURORADIOL, V25, P1181
   OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003
   PADGET DH, 1956, AM J ANAT, V98, P307, DOI 10.1002/aja.1000980302
   Sakata K, 1996, SURGERY OF THE INTRACRANIAL VENOUS SYSTEM, P163
   Sakata K, 2000, NEUROSURGERY, V47, P153, DOI 10.1097/00006123-200007000-00032
   Sampei T, 1996, NEUROSURGERY, V38, P971, DOI 10.1097/00006123-199605000-00024
   Sano K, 1980, Neurol Res, V2, P361
   Sekhar LN, 2002, J CLIN NEUROSCI, V9, P391, DOI 10.1054/jocn.2001.1008
   Shibao S, 2016, J NEUROSURG, V124, P432, DOI 10.3171/2015.1.JNS141854
   SPETZLER RF, 1992, J NEUROSURG, V76, P588, DOI 10.3171/jns.1992.76.4.0588
   SUGITA K, 1982, J NEUROSURG, V57, P856, DOI 10.3171/jns.1982.57.6.0856
   Suzuki Y, 2000, AM J NEURORADIOL, V21, P932
   Tamura R, 2019, J NEUROSURG, V130, P360, DOI 10.3171/2017.9.JNS171622
   Truwit C L, 1994, Neuroimaging Clin N Am, V4, P663
   Ueyama T, 1998, NEUROSURGERY, V43, P1137, DOI 10.1097/00006123-199811000-00068
   Yoshida K, 1999, J NEUROSURG, V91, P202, DOI 10.3171/jns.1999.91.2.0202
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E554
EP E562
DI 10.1016/j.wneu.2019.08.077
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300066
PM 31442652
DA 2020-05-12
ER

PT J
AU Tan, ZH
   Shen, LF
   Wu, HJ
   Deng, L
   Li, ZZ
   Huang, XQ
AF Tan, Zhaohua
   Shen, Liangfang
   Wu, Haijun
   Deng, Liang
   Li, Zhanzhan
   Huang, Xinqiong
TI Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic
   Biomarker in Patients with Low-Grade Gliomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Glioma; Low-grade; Lymphocyte; Neutrophil; Ratio
ID LYMPHOCYTE RATIO; NEUTROPHIL; SURVIVAL; TUMOR; INFILTRATION;
   INFLAMMATION; PREDICTORS; PLATELET; MUTATION; MARKER
AB BACKGROUND: There are no standardized criteria to predict the prognosis of patients with low-grade gliomas. Therefore, novel prognostic biomarkers that can guide follow-up schedules and therapeutic approaches urgently are required in patients with low-grade gliomas.
   METHODS: One hundred nineteen patients with World Health Organization (WHO) II gliomas were recruited between January 2010 and December 2016 from Xiangya Hospital for this study. We collected neutrophil and lymphocyte values from the full blood counts measured 24 h before surgery. Neutrophil-to-lymphocyte ratios (NLRs) were then calculated. The significance of the NLR was determined based on a nonparametric test. The Kaplan-Meier method was used to estimate survival rates. The influence of the NLR on progression-free survival and overall survival was evaluated using univariate and multivariate Cox proportional hazards models.
   RESULTS: Preoperative NLRs were upregulated in patients with WHO II gliomas who relapsed or died. Preoperative NLRs were also significantly correlated with age, preoperative neutrophil values, and preoperative lymphocyte values. Compared with the low preoperative NLR group, patients with WHO II gliomas in the high preoperative NLR group had significantly higher relapse and lower survival rates. In addition, the preoperative NLR and tumor type were independent prognostic parameters of progression-free survival for WHO II gliomas, whereas only the preoperative NLR was an independent prognostic parameter of overall survival for WHO II gliomas.
   CONCLUSIONS: High preoperative NLRs were significantly associated with greater relapse and poor prognosis in patients with WHO II gliomas.
C1 [Tan, Zhaohua; Shen, Liangfang; Wu, Haijun; Deng, Liang; Li, Zhanzhan; Huang, Xinqiong] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China.
RP Huang, XQ (reprint author), Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China.
EM 18163723537@163.com
FU National Natural Science and Technology Major Foundation of China
   [2017ZX090361]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81602683]
FX This work was supported by grants from the National Natural Science and
   Technology Major Foundation of China (No. 2017ZX090361) and National
   Natural Science Foundation of China (No.81602683).
CR Amaral SR, 2019, ANN ONCOL S1, V30
   Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9
   Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121
   Daniels TB, 2011, INT J RADIAT ONCOL, V81, P218, DOI 10.1016/j.ijrobp.2010.05.003
   Deng L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190544
   Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013
   Duan JW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013340
   Fossati G, 1999, ACTA NEUROPATHOL, V98, P349, DOI 10.1007/s004010051093
   Fukuya Y, 2019, J NEURO-ONCOL, V144, P519, DOI 10.1007/s11060-019-03250-8
   Gan YJ, 2019, WORLD NEUROSURG, V127, pE261, DOI 10.1016/j.wneu.2019.03.085
   Gandhi P, 2018, INT J MOL CELL MED, V7, P111, DOI 10.22088/IJMCM.BUMS.7.2.111
   Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009
   Hewer E, 2017, VIRCHOWS ARCH, V471, P641, DOI 10.1007/s00428-017-2216-x
   Hiramatsu S, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0251-2
   Huo XJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36605-8
   Hwang KT, 2017, J BREAST CANCER, V20, P254, DOI 10.4048/jbc.2017.20.3.254
   Karsy M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0722-5
   Lalosevic MS, 2019, DIS MARKERS, DOI 10.1155/2019/6036979
   Li CL, 2018, DRUG DES DEV THER, V12, P1363, DOI 10.2147/DDDT.S161602
   Liu B, 2019, MED SCI MONITOR, V25, P3624, DOI 10.12659/MSM.916648
   Lohr J, 2011, CLIN CANCER RES, V17, P4296, DOI 10.1158/1078-0432.CCR-10-2557
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Lv YJ, 2019, CLIN NEUROL NEUROSUR, V181, P24, DOI 10.1016/j.clineuro.2019.03.017
   Murphy J, 2000, AM J GASTROENTEROL, V95, P3607
   Prabawa I Putu Yuda, 2019, Asian Pac J Cancer Prev, V20, P863
   Sabha N, 2014, NEURO-ONCOLOGY, V16, P914, DOI 10.1093/neuonc/not299
   Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636
   Wang JL, 2018, EXCLI J, V17, P505, DOI 10.17179/excli2017-978
   Wang PF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00886
   Weng WJ, 2018, NEUROL RES, V40, P917, DOI 10.1080/01616412.2018.1497271
   Wu CW, 2019, CANCER MANAG RES, V11, P3139, DOI 10.2147/CMAR.S199207
   Zadora P, 2015, NEUROL NEUROCHIR POL, V49, P41, DOI 10.1016/j.pjnns.2014.12.006
   Zhao Z, 2018, ARCH GYNECOL OBSTET, V297, P849, DOI 10.1007/s00404-018-4678-8
   Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051
   Zhu T, 2018, CNS NEUROSCI THER, V24, P178, DOI 10.1111/cns.12803
NR 35
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E585
EP E590
DI 10.1016/j.wneu.2019.08.068
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300069
PM 31442642
DA 2020-05-12
ER

PT J
AU Tang, SH
   Fu, WJ
   Zhang, HD
   Zhang, HN
   Liang, BR
AF Tang, Shenghui
   Fu, Wangjun
   Zhang, Hongda
   Zhang, Haonan
   Liang, Biru
TI Efficacy and Safety of High-Viscosity Bone Cement Vertebroplasty in
   Treatment of Osteoporotic Vertebral Compression Fractures with
   Intravertebral Cleft
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cement leakage; High-viscosity cement; Intravertebral cleft;
   Low-viscosity cement; Osteoporotic vertebral compression fractures;
   Percutaneous vertebroplasty
ID PERCUTANEOUS VERTEBROPLASTY; BALLOON KYPHOPLASTY; VACUUM CLEFT;
   OUTCOMES; SIGN
AB OBJECTIVE: To evaluate and compare clinical outcomes and cement leakage of high-viscosity bone cement versus low-viscosity bone cement vertebroplasty in treating osteoporotic vertebral compression fractures with intravertebral cleft.
   METHODS: The study included 72 patients with osteoporotic vertebral compression fractures with intravertebral cleft, who were divided into high-viscosity cement (HVC) (38 cases) and low-viscosity cement (LVC) (34 cases) groups according to the viscosity of bone cement used. Cement leakage, visual analog scale score, Oswestry Disability Index, and kyphotic angle (KA) were evaluated.
   RESULTS: All patients were followed for at least 12 months. Overall cement leakage rate was 18.4% in the HVC group, lower than the rate of 61.8% obtained in the LVC group. A statistically significant difference was found in the overall cement leakage rate between the groups (P < 0.05). Visual analog scale and Oswestry Disability Index scores were significantly improved after percutaneous vertebroplasty without significant differences between the HVC and LVC groups (P > 0.05). The KA of patients from both groups was also significantly corrected immediately after surgery. Although the KA gradually increased in both groups during the follow-up period, there was no statistically significant difference between the HVC and LVC groups in KA during follow-up (P > 0.05).
   CONCLUSIONS: Percutaneous vertebroplasty using HVC to treat osteoporotic vertebral compression fractures with intravertebral cleft significantly reduces cement leakage and improves the safety of the operation. In terms of clinical efficacy and prevention of augmented vertebral recollapse, HVC may not have obvious advantages.
C1 [Tang, Shenghui; Fu, Wangjun; Zhang, Hongda; Zhang, Haonan; Liang, Biru] Southern Med Univ, Affiliated Hosp 5, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China.
RP Liang, BR (reprint author), Southern Med Univ, Affiliated Hosp 5, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China.
EM nywylbr1971@163.com
CR Armingeat T, 2006, JOINT BONE SPINE, V73, P428, DOI 10.1016/j.jbspin.2005.10.011
   Baroud G, 2006, SPINE, V31, P2562, DOI 10.1097/01.brs.0000240695.58651.62
   Chen B, 2014, INDIAN J ORTHOP, V48, P53, DOI 10.4103/0019-5413.125498
   Dupuy DE, 1996, AM J ROENTGENOL, V167, P1535, DOI 10.2214/ajr.167.6.8956592
   Fang XT, 2015, INT J CLIN EXP MED, V8, P16960
   Georgy BA, 2010, AM J NEURORADIOL, V31, P504, DOI 10.3174/ajnr.A1861
   Georgy B, 2013, PAIN PHYSICIAN, V16, pE513
   Guo D, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006549
   Ha KY, 2006, J BONE JOINT SURG BR, V88B, P629, DOI 10.1302/0301-620X.88B5.17345
   Kim DY, 2004, J NEUROSURG, V100, P24, DOI 10.3171/spi.2004.100.1.0024
   Kim YJ, 2010, SKELETAL RADIOL, V39, P757, DOI 10.1007/s00256-009-0866-8
   Kim YC, 2014, SPINE J, V14, P659, DOI 10.1016/j.spinee.2013.06.106
   Li Z, 2019, INT ORTHOP, V43, P359, DOI 10.1007/s00264-018-4007-7
   Libicher M, 2007, EUR RADIOL, V17, P2248, DOI 10.1007/s00330-007-0684-0
   MALDAGUE BE, 1978, RADIOLOGY, V129, P23, DOI 10.1148/129.1.23
   McCarthy J, 2016, AM FAM PHYSICIAN, V94, P44
   Nakamae T, 2017, J ORTHOP SCI, V22, P201, DOI 10.1016/j.jos.2016.12.002
   Nakamae Toshio, 2015, Open Orthop J, V9, P107, DOI 10.2174/1874325001509010107
   Nakamae T, 2013, EUR SPINE J, V22, P1624, DOI 10.1007/s00586-013-2686-8
   NAUL LG, 1989, RADIOLOGY, V172, P219, DOI 10.1148/radiology.172.1.2740507
   Nieuwenhuijse MJ, 2012, SPINE, V37, P974, DOI 10.1097/BRS.0b013e318238bf22
   Peh WCG, 2003, AM J ROENTGENOL, V180, P1411, DOI 10.2214/ajr.180.5.1801411
   Wang CY, 2018, SPINE J, V18, P2297, DOI 10.1016/j.spinee.2018.07.020
   Wu AM, 2014, J SPINAL DISORD TECH, V27, pE88, DOI 10.1097/BSD.0b013e31829142bf
   Wu AM, 2012, ACTA ORTHOP BELG, V78, P790
   Yu WB, 2019, OSTEOPOROSIS INT, V30, P423, DOI 10.1007/s00198-018-4754-8
   Yu WB, 2017, PAIN PHYSICIAN, V20, pE978
   Yu WB, 2017, INT J SURG, V40, P17, DOI 10.1016/j.ijsu.2017.02.019
   Yu WB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005675
   Zeng TH, 2015, INT J CLIN EXP MED, V8, P18855
   Zhang L, 2015, CLIN NEUROL NEUROSUR, V129, P10, DOI 10.1016/j.clineuro.2014.11.018
   Zhang ZF, 2017, INT J SURG, V43, P126, DOI 10.1016/j.ijsu.2017.05.067
NR 32
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E739
EP E745
DI 10.1016/j.wneu.2019.08.029
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300090
PM 31415893
DA 2020-05-12
ER

PT J
AU Thomas, PAW
   Marshman, LAG
   Rudd, D
   Moffat, C
   Mitchell, PS
AF Thomas, Piers A. W.
   Marshman, Laurence A. G.
   Rudd, Donna
   Moffat, Claire
   Mitchell, Paul S.
TI Growth and Resorption of Chronic Subdural Hematomas: Gardner, Weir, and
   the Osmotic Hypothesis Revisited
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Osmosis
ID PRESSURE; PATHOGENESIS; MEMBRANE; SPACE
AB BACKGROUND: To explain why some chronic subdural hematomas (CSDHs) grow and/or resorb, a physically decreasing outer membrane (OM) surface area (SA) to CSDH volume (V) ratio has been reexplored, and a critical CSDH size inferred (OM SA approximate to V). Gardner showed that since CSDH protein exceeded cerebrospinal fluid (CSF) protein, CSF -> CSDH osmosis occurred across a semipermeable inner membrane (n = 1). By contrast, Zollinger and Gross demonstrated that serum -> CSDH osmosis could also occur across the OM (n = 1). Notably, Weir refuted Zollinger and Gross by finding equal CSDH and serum total protein (n = 20); however, Weir did not refute Gardner. Although all extant mechanisms, especially rehemorrhages, explain CSDH growth, only OM SA >= V simultaneously permits resorption. We aimed to reevaluate the osmotic hypothesis.
   METHODS: Paired serum and CSDH samples were measured in a prospective cohort.
   RESULTS: Results were consecutively obtained in 116 patients (87 men; mean age, 73 +/- 13 years). Serum osmolality and CSDH osmolality were similar (285.70 +/- 7.99 vs. 283.85 +/- 7.52 mmol/kg, respectively; P = 0.11) and significantly correlated (r = 0.75, P < 0.0001). Serum total protein significantly exceeded CSDH total protein (66.6 +/- 6.8 vs. 43.68 +/- 20.24 g/L, P < 0.0001) as did serum albumin (35.62 +/- 4.46 vs. 30.85 +/- 8.5 g/L, P < 0.0001) and serum total globulins (31.5 +/- 6 vs. 18.6 +/- 11.4 g/L, P < 0.0001). Serum and CSDH proteins were not correlated (total protein: r = 0.003; albumin: r = 0.08; globulins: r = 0.21).
   CONCLUSIONS: Only crystalloids equilibrated. CSDH colloids were significantly decreased. CSDH dilution or colloidal flocculation is implied. CSDH dilution (by CSF -> CSDH inner membrane [IM] osmosis or OM transudation/exudation) could favor CSDH growth, as would repeated OM hemorrhages. Contrariwise, isolated colloidal flocculation could favor CSDH shrinkage by OM CSDH -> serum osmosis. The latter may result in OM SA >= V favorable for ultimate resolution. Our results refute Weir and Zollinger and Gross, but not Gardner. Osmotic gradients simultaneously exist for both CSDH growth and resorption. Each equilibrium could depend on each gradient relative to each IM/OM semipermeability.
C1 [Thomas, Piers A. W.; Marshman, Laurence A. G.; Mitchell, Paul S.] Townsville Hosp, Dept Neurosurg, Townsville, Qld, Australia.
   [Thomas, Piers A. W.; Marshman, Laurence A. G.] James Cook Univ, Sch Med & Dent, Townsville, Qld, Australia.
   [Rudd, Donna] James Cook Univ, Dept Psychol, Townsville, Qld, Australia.
   [Moffat, Claire] James Cook Univ, Dept Physiol, Townsville, Qld, Australia.
RP Marshman, LAG (reprint author), Townsville Hosp, Dept Neurosurg, Townsville, Qld, Australia.; Marshman, LAG (reprint author), James Cook Univ, Sch Med & Dent, Townsville, Qld, Australia.
EM l.a.g.marshman@btinternet.com
FU Townsville Hospital Research fund [SERTA RG00513]
FX This research received an internal grant from the Townsville Hospital
   Research fund (SERTA RG00513).
CR ALTMAN DG, 1982, STAT PRACTICE
   APFELBAUM RI, 1974, J NEUROSURG, V40, P336, DOI 10.3171/jns.1974.40.3.0336
   BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001
   DUNCAN A, 1982, CLIN CHEM, V28, P141
   FRIEDE RL, 1978, AM J PATHOL, V92, P69
   GARDNER WJ. TRAUMATIC SUBDURAL HEMATOMA, 1932, ARCH NEUROL PSYCHIAT, V27, P847
   GITLIN D, 1955, PEDIATRICS, V16, P345
   HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017
   ITO H, 1976, J NEUROSURG, V45, P26, DOI 10.3171/jns.1976.45.1.0026
   Killeffer JA, 2000, NEUROSURG CLIN N AM, V11, P407, DOI 10.1016/S1042-3680(18)30102-5
   Kristof RA, 2008, J NEUROSURG, V108, P275, DOI 10.3171/JNS/2008/108/2/0275
   Manickam A, 2017, J CLIN NEUROSCI, V40, P39, DOI 10.1016/j.jocn.2016.12.043
   Manickam A, 2017, WORLD NEUROSURG, V100, P256, DOI 10.1016/j.wneu.2017.01.031
   ORLIN JR, 1991, ANAT RECORD, V230, P22, DOI 10.1002/ar.1092300104
   RABE EF, 1962, NEUROLOGY, V12, P79, DOI 10.1212/WNL.12.2.79
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005
   Thomas PAW, 2019, WORLD NEUROSURG, V124, pE489, DOI 10.1016/j.wneu.2018.12.119
   WEIR B, 1980, J NEUROSURG, V53, P512, DOI 10.3171/jns.1980.53.4.0512
   WEIR B, 1971, J NEUROSURG, V34, P528, DOI 10.3171/jns.1971.34.4.0528
   Whitby LG, 1988, LECT NOTES CLIN CHEM, P428
   Yamashima T, 2000, NEUROSURG CLIN N AM, V11, P413, DOI 10.1016/S1042-3680(18)30103-7
   Zollinger R, 1934, J AMER MED ASSOC, V103, P0245, DOI 10.1001/jama.1934.02750300019008
NR 23
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E202
EP E207
DI 10.1016/j.wneu.2019.08.204
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300025
PM 31493614
DA 2020-05-12
ER

PT J
AU Traylor, JI
   Patel, R
   Habib, A
   Muir, M
   Bastos, DCD
   Rao, G
   Prabhu, SS
AF Traylor, Jeffrey, I
   Patel, Rajan
   Habib, Ahmed
   Muir, Matthew
   de Almeida Bastos, Dhiego Chaves
   Rao, Ganesh
   Prabhu, Sujit S.
TI Laser Interstitial Thermal Therapy to the Posterior Fossa: Challenges
   and Nuances
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain metastases; Deep-seated tumor; Laser interstitial thermal therapy;
   Posterior fossa; Radiation necrosis
ID BRAIN METASTASES; STEREOTACTIC RADIOSURGERY; SURGICAL-TREATMENT;
   MANAGEMENT; RESECTION; SURVIVAL; CRITERIA; CHILDREN; TUMORS
AB BACKGROUND: Posterior fossa tumors are rare in adults and pose a challenge to treat due to the bony contour of the posterior fossa, complex anatomical structures including deep venous sinuses, and the proximity of the fourth ventricle and brain stem. We describe our experience with laser interstitial thermal therapy (LITT) for the management of brain metastases and radiation necrosis of the posterior fossa.
   METHODS:We retrospectively analyzed 13 patients with metastases and radiation necrosis of the posterior fossa managed with LITT.
   RESULTS: Thirteen patients with histopathologically confirmed radiation necrosis (n = 5) and metastases (n = 8) of the posterior fossa underwent LITT. The median preoperative tumor was 4.66 cm(3), and median postoperative ablation cavity volume was 6.29 cm(3). The median volume of the ablation cavity was decreased to 2.90 cm(3) at a 9-month follow-up. The median volume of peritumoral edema was 12.25 cm(3), which fell to a median of 5.77 cm(3) at 1-month follow-up. The median progression-free survival was 7 months (range, 3-14 months) and the mean overall survival was 40 months (range, 2-49 months) after LITT. There were no intraoperative complications. One patient experienced palsy of the seventh and eighth cranial nerves on follow-up, attributable to LITT.
   CONCLUSIONS: Lesions of the posterior fossa are challenging to treat given their proximity to the dura and venous sinuses. Our findings demonstrate that LITT ablation may be a safe and feasible option for metastases and radiation necrosis of the posterior fossa. Larger studies are needed to confirm the efficacy of this approach.
C1 [Traylor, Jeffrey, I; Patel, Rajan; Habib, Ahmed; Muir, Matthew; de Almeida Bastos, Dhiego Chaves; Rao, Ganesh; Prabhu, Sujit S.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.
RP Prabhu, SS (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.
EM sprabhu@mdanderson.org
RI Bastos, Dhiego/AAH-9731-2019; Traylor, Jeffrey I./AAC-4274-2020
OI Traylor, Jeffrey I./0000-0003-1749-8143
CR Ahluwalia M, 2019, J NEUROSURG, V130, P804, DOI 10.3171/2017.11.JNS171273
   Badiyan SN, 2016, J ONCOL PRACT, V12, P702, DOI 10.1200/JOP.2016.012922
   Beechar VB, 2018, J NEURO-ONCOL, V137, P57, DOI 10.1007/s11060-017-2694-3
   Borghei-Razavi H, 2018, WORLD NEUROSURG, V117, pE146, DOI 10.1016/j.wneu.2018.05.217
   Chan AY, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.4.FOCUS1622
   Cho KH, 1998, J NEURO-ONCOL, V40, P73, DOI 10.1023/A:1006169109920
   Churilla TM, 2019, JAMA ONCOL, V5, P243, DOI 10.1001/jamaoncol.2018.4610
   Dadey DYA, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16207
   DEPOORTER J, 1995, MAGNET RESON MED, V34, P359
   Dorner L, 2007, CHILD NERV SYST, V23, P887, DOI 10.1007/s00381-007-0323-8
   Dohm A, 2018, NEUROSURGERY, V83, P114, DOI 10.1093/neuros/nyx355
   ELIYAS JK, 2014, [No title captured], V16, DOI DOI 10.1093/NEUONC/NOU265.14
   Ghia A, 2007, INT J RADIAT ONCOL, V68, P971, DOI 10.1016/j.ijrobp.2007.02.016
   Hadanny A, 2016, WORLD NEUROSURG, V89, P193, DOI 10.1016/j.wneu.2016.01.076
   Javalkar V, 2010, NEUROSURGERY, V67, P1515, DOI 10.1227/NEU.0b013e3181fa239e
   Kanner AA, 2003, STEREOT FUNCT NEUROS, V81, P18, DOI 10.1159/000075099
   Lesser GJ, 1996, NEUROSURG CLIN N AM, V7, P527
   Leuthardt EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148613
   Lin NU, 2015, LANCET ONCOL, V16, pE270, DOI 10.1016/S1470-2045(15)70057-4
   Lippitz B, 2014, CANCER TREAT REV, V40, P48, DOI 10.1016/j.ctrv.2013.05.002
   Mahajan A, 2017, LANCET ONCOL, V18, P1040, DOI 10.1016/S1470-2045(17)30414-X
   Mohammadi AM, 2014, CANCER MED-US, V3, P971, DOI 10.1002/cam4.266
   Rao MS, 2014, NEUROSURGERY, V74, P658, DOI 10.1227/NEU.0000000000000332
   Salehi A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00499
   Schoch B, 2006, NEUROPEDIATRICS, V37, P350, DOI 10.1055/s-2007-964904
   Shiau CY, 1997, INT J RADIAT ONCOL, V37, P375, DOI 10.1016/S0360-3016(96)00497-X
   Shih RY, 2016, NEUROIMAG CLIN N AM, V26, P493, DOI 10.1016/j.nic.2016.06.003
   Silva Danilo, 2016, Neurosurgery, V63 Suppl 1, P15, DOI 10.1227/NEU.0000000000001289
   Sunderland GJ, 2016, J NEURO-ONCOL, V130, P535, DOI 10.1007/s11060-016-2254-2
   Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060
   Thomas JG, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16234
   WRONSKI M, 1995, J NEUROSURG, V83, P605, DOI 10.3171/jns.1995.83.4.0605
   Wronski M, 1999, CANCER, V85, P1677, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1677::AID-CNCR6>3.0.CO;2-C
   Wronski M, 2000, J NEUROSURG, V93, P9, DOI 10.3171/jns.2000.93.1.0009
   Zhang Y, 2014, J RADIOSURGERY SBRT, V3, P91, DOI 10.6000/1929-6037.2014.03.02.4
NR 35
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E124
EP E132
DI 10.1016/j.wneu.2019.08.242
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300017
PM 31518744
DA 2020-05-12
ER

PT J
AU Villalonga, JF
   Ries-Centeno, T
   Saenz, A
   Solari, D
   Cervio, A
   Campero, A
AF Villalonga, Juan F.
   Ries-Centeno, Tomas
   Saenz, Amparo
   Solari, Domenico
   Cervio, Andres
   Campero, Alvaro
TI The Mixed Sellar Barrier: A New Subtype of this Novel Concept
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic endonasal approach; Pituitary adenomas; Sellar barrier; Skull
   base; Surgical treatment
ID MICROSURGICAL ANATOMY; CAVERNOUS SINUS; PITUITARY; EXPERIENCE
AB BACKGROUND: The use of the recent concept of sellar barrier revealed that a specific group of patients were difficult to categorize. For this reason, we propose to add a new subtype: the mixed sellar barrier. The aim of this work was to define the new mixed barrier subtype and analyze this in a series of operated patients.
   METHODS: A retrospective study was carried out. From January to December 2018, 72 patients with pituitary adenomas underwent surgery by transsphenoidal approach. Patients with more than 1 surgery were excluded. Each patient's magnetic resonance imaging (MRI) was analyzed and classified using the following criteria: strong barrier (>1 mm), weak barrier (<1 mm), and mixed barrier (<1 mm in one region and >1 mm in another part).
   RESULTS: Mixed sellar barrier is the coexistence of 2 types of sellar barrier (strong and weak). The presence of a mixed sellar barrier on MRI was associated with the presence of a mixed sellar barrier intraoperatively (P < 0.0001). By using the new MRI classification that includes the mixed sellar barrier, we found a stronger statistically significant association regarding the risk of cerebrospinal fluid leak (for the extreme categories; i.e., strong and weak) compared to the original work.
   CONCLUSIONS: The new mixed sellar barrier subtype was precisely defined and illustrated. The correlation between MRI and intraoperative findings for this new subtype has been demonstrated in this study. A prospective study with a larger series of patients is required for validation.
C1 [Villalonga, Juan F.; Ries-Centeno, Tomas; Saenz, Amparo; Campero, Alvaro] Univ Nacl Tucuman, Fac Med, LINT, San Miguel De Tucuman, Tucuman, Argentina.
   [Villalonga, Juan F.; Solari, Domenico] Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.
   [Ries-Centeno, Tomas; Cervio, Andres] FLENI, Dept Neurocirugia, Buenos Aires, DF, Argentina.
   [Campero, Alvaro] Hosp Padilla, Serv Neurocirugia, San Miguel De Tucuman, Tucuman, Argentina.
RP Villalonga, JF (reprint author), Univ Nacl Tucuman, Fac Med, LINT, San Miguel De Tucuman, Tucuman, Argentina.; Villalonga, JF (reprint author), Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.
EM jfvillalonga@gmail.com
OI SOLARI, Domenico/0000-0003-1535-8737
CR BLACK PM, 1987, NEUROSURGERY, V20, P920, DOI 10.1227/00006123-198706000-00017
   Campero A, 2019, WORLD NEUROSURG, V50, P1878
   Campero A, 2019, NEUROANATOMIA QUIRUR, P12
   Campero A, 2008, NEUROSURGERY, V62, P717, DOI 10.1227/01.neu.0000317321.79106.37
   Campero A, 2010, J CLIN NEUROSCI, V17, P746, DOI 10.1016/j.jocn.2009.10.015
   Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D
   Casanueva FF, 2017, PITUITARY, V20, P489, DOI 10.1007/s11102-017-0838-2
   Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668
   Jho HD, 1997, J NEUROSURG, V87, P44, DOI 10.3171/jns.1997.87.1.0044
   Martins C, 2006, NEUROSURGERY, V58, P220, DOI 10.1227/01.NEU.0000204673.55834.BE
   Rhoton AL, 2002, NEUROSURGERY, V51, pS375, DOI 10.1227/01.NEU.0000028833.01529.E7
   Rivera-Serrano CM, 2011, LARYNGOSCOPE, V121, P990, DOI 10.1002/lary.21419
   Solari D, 2019, WORLD NEUROSURG, V123, pE440, DOI 10.1016/j.wneu.2018.11.186
   Strickland BA, 2018, J NEUROSURG, V129, P425, DOI 10.3171/2017.4.JNS162451
   TAPTAS JN, 1982, NEUROSURGERY, V11, P712, DOI 10.1227/00006123-198211000-00019
   Villalonga JF, 2019, WORLD NEUROSURG, V129, P45, DOI 10.1016/j.wneu.2019.05.088
   Yasuda Alexandre, 2005, Neurosurgery, V56, P4
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E5
EP E13
DI 10.1016/j.wneu.2019.09.027
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300003
PM 31521751
DA 2020-05-12
ER

PT J
AU Wang, YF
   Xu, XQ
   Hu, PP
   Jia, N
   Ji, SL
   Yuan, HJ
AF Wang, Yufeng
   Xu, Xiaoqing
   Hu, Peipei
   Jia, Ning
   Ji, Shiliang
   Yuan, Hongjie
TI Effect of Toll-Like Receptor 4/Myeloid Differentiation Factor 88
   Inhibition by Salvianolic Acid B on Neuropathic Pain After Spinal Cord
   Injury in Mice
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hyperalgesia; Neuropathic pain; Salvianolic acid B (SalB); Spinal cord
   injury; TLR4/MyD88
ID LIVER-INJURY; PATHWAY; PROTECTS; STRESS
AB BACKGROUND: Spinal cord injury (SCI) is a common type of injury, and about half of patients affected by SCI will suffer from neuropathic pain within a year after injury. However, the treatment effect of neuropathic pain is far from satisfactory. Our study attempted to reveal whether salvianolic acid B (SalB) could relieve the neuropathic pain caused by SCI in mice by inhibiting the Toll-like receptor 4 (TLR4)/Myeloid differentiation factor 88 (MyD88) pathway.
   METHODS: The mice were randomly divided into a sham group, model group, high-dose treatment group, and low-dose treatment group. The high- and low-dose groups received varying doses of SalB after modeling.
   RESULTS: The increase of pain sensitivity was evaluated by detecting paw withdrawal mechanical threshold and withdrawal thermal latency. Messenger RNA and protein expression levels of TLR4 and myD88 were detected by using quantitative reverse-transcription polymerase chain reaction and western blot, respectively. Compared with the model group, there was a significant reduction in paw withdrawal mechanical threshold and withdrawal thermal latency after SalB treatment.
   CONCLUSIONS: SalB reduced the release of tumor necrosis factor-a and substance P by inhibiting the TLR4/MyD88 pathway in the SCI mouse model. This not only resulted in lower pain, but also contributed to long-term relief of mechanical hyperalgesia.
C1 [Wang, Yufeng] Nantong Hosp Tradit Chinese Med, Dept Radiol, Nantong, Jiangsu, Peoples R China.
   [Xu, Xiaoqing; Hu, Peipei; Yuan, Hongjie] Nantong Hosp Tradit Chinese Med, Dept Pain Med, Nantong, Jiangsu, Peoples R China.
   [Jia, Ning] Qidong Peoples Hosp, Dept Acupuncture, Nantong, Jiangsu, Peoples R China.
   [Ji, Shiliang] Nanjing Med Univ, Affiliated Suzhou Sci & Technol Town Hosp, Dept Pharm, Suzhou, Peoples R China.
RP Yuan, HJ (reprint author), Nantong Hosp Tradit Chinese Med, Dept Pain Med, Nantong, Jiangsu, Peoples R China.
EM hongjieyuan@yandex.com
CR Allison DJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0625-4
   Chaiyana W, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101105
   Chen LJ, 2016, ENVIRON TOXICOL PHAR, V46, P255, DOI 10.1016/j.etap.2016.08.004
   Chen ZY, 2015, EUR J PAIN, V19, P176, DOI 10.1002/ejp.534
   Di Sole F, 2011, AM J PHYSIOL-CELL PH, V301, pC1290, DOI 10.1152/ajpcell.00350.2011
   Ding Y, 2016, INFLAMMATION, V39, P849, DOI 10.1007/s10753-016-0315-5
   Djoric D, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00392-17
   Dong ZH, 2016, NEUROSCI LETT, V619, P92, DOI 10.1016/j.neulet.2016.01.008
   HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7
   Hung SC, 2017, MICROBES INFECT, V6, P3710
   Jiang X, 2018, NEUROSCI LETT, V662, P36, DOI 10.1016/j.neulet.2017.09.064
   Jurga AM, 2016, NEURAL PLAST, V12, P751
   Kameda Takuya, 2017, J Exp Orthop, V4, P31, DOI 10.1186/s40634-017-0105-5
   Lerch JK, 2014, SEMIN IMMUNOL, V26, P409, DOI 10.1016/j.smim.2014.03.004
   Lewis KT, 2018, SEMIN CELL DEV BIOL, V73, P57, DOI 10.1016/j.semcdb.2017.08.003
   Li MZ, 2014, TOXICOL LETT, V228, P67, DOI 10.1016/j.toxlet.2014.04.011
   Liu X, 2016, NEPHRON, V134, P253, DOI 10.1159/000448223
   Ma XW, 2017, CELL PHYSIOL BIOCHEM, V43, P1381, DOI 10.1159/000481849
   Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701
   Moore C, 2018, NEUROSCI BULL, V34, P120, DOI 10.1007/s12264-017-0200-8
   Park J, 2017, PAIN PRACT, V14, P9871
   Peterson SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11410-x
   Souza A, 2017, BRAIN RES, V12, P625
   Trussoni CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125793
   Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011
   Wang J, 2011, CHIN J INTEGR MED, V17, P775, DOI 10.1007/s11655-011-0877-x
   Wang X, 2017, NEUROSCIENCE, V17, P369
   Wang YJ, 2016, INFLAMMATION, V39, P1503, DOI 10.1007/s10753-016-0384-5
   Yan XS, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0005-6
   Yu FJ, 2015, J CELL MOL MED, V19, P2617, DOI 10.1111/jcmm.12655
   Zhang N, 2017, TOXICOL LETT, V267, P1, DOI 10.1016/j.toxlet.2016.12.010
NR 31
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E529
EP E534
DI 10.1016/j.wneu.2019.08.086
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300063
PM 31449993
DA 2020-05-12
ER

PT J
AU Wiesmann, M
   Kalder, J
   Reich, A
   Dekeyzer, S
   Riabikin, A
   Mpotsaris, A
   Nikoubashman, O
AF Wiesmann, Martin
   Kalder, Johannes
   Reich, Arno
   Dekeyzer, Sven
   Riabikin, Alexander
   Mpotsaris, Anastasios
   Nikoubashman, Omid
TI Combined Surgical and Endovascular Carotid Access for Endovascular
   Thrombectomy in Acute Ischemic Stroke
SO WORLD NEUROSURGERY
LA English
DT Article
DE Catheter; Cervical; Complication; Stroke; Thrombectomy
ID METAANALYSIS; ANGIOGRAPHY; VESSEL
AB OBJECTIVE: Conventional carotid catheterization is impossible in 2%-5% of acute stroke cases. Surgical carotid cutdown may be a necessary bailout strategy to allow for carotid access. We assessed the effectiveness and safety of surgical carotid cutdown for vascular access in interventional acute stroke treatment.
   METHODS: We compare imaging and clinical data of 15 consecutive patients, in whom we performed a carotid cutdown for acute stroke treatment with 10 consecutive patients, in whom treatment was discontinued because transfemoral access to the occlusion site was not possible.
   RESULTS: Baseline characteristics of both groups were comparable (P >= 0.065). Cutdown patients had significantly smaller infarctions (P = 0.031), significantly more often favorable clinical outcome (38% vs. 0% modified Rankin score 0-2, P = 0.046), and a lower mortality (31% vs. 60%, P = 0.222) at 3months. Other than a small hematoma at the operation site, there were no procedure-related complications.
   CONCLUSIONS: Carotid cutdown is an effective bailout strategy for acute stroke patients, in whom conventional catheterization is not possible.
C1 [Wiesmann, Martin; Dekeyzer, Sven; Riabikin, Alexander; Mpotsaris, Anastasios; Nikoubashman, Omid] Univ Hosp RWTH, Dept Neuroradiol, Aachen, Germany.
   [Kalder, Johannes] Univ Hosp RWTH, Dept Vasc Surg, Aachen, Germany.
   [Reich, Arno] Univ Hosp RWTH, Dept Neurol, Aachen, Germany.
RP Nikoubashman, O (reprint author), Univ Hosp RWTH, Dept Neuroradiol, Aachen, Germany.
EM onikoubashman@ukaachen.de
CR Arnold M, 2003, J NEUROL NEUROSUR PS, V74, P739, DOI 10.1136/jnnp.74.6.739
   BAUER J, 1980, J NEUROSURG, V52, P525, DOI 10.3171/jns.1980.52.4.0525
   Behme D, 2015, AM J NEURORADIOL, V36, P2340, DOI 10.3174/ajnr.A4459
   Fields JD, 2011, J NEUROINTERV SURG, V3, P151, DOI 10.1136/jnis.2010.002766
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Goyal M, 2014, J NEUROINTERV SURG, V6, P83, DOI 10.1136/neurintsurg-2013-010665
   Haussen DC, 2016, J NEUROINTERV SURG, V8, P247, DOI 10.1136/neurintsurg-2014-011519
   Iwata T, 2013, J NEUROINTERV SURG, V5, P77, DOI 10.1136/neurintsurg-2012-010506
   Jadhav AP, 2014, J NEUROINTERV SURG, V6, P652, DOI 10.1136/neurintsurg-2013-010971
   Kaymaz ZO, 2017, INTERV NEURORADIOL, V23, DOI 10.1177/1591019917729364
   Mokin M, 2015, J NEUROINTERV SURG, V7, P108, DOI 10.1136/neurintsurg-2013-011007
   Nikoubashman O, 2016, EUR J NEUROL, V23, P807, DOI 10.1111/ene.12944
   Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534
   Ribo M, 2013, J NEUROINTERV SURG, V5, P70, DOI 10.1136/neurintsurg-2012-010438
   Ross IB, 2006, SURG NEUROL, V65, P207, DOI 10.1016/j.surneu.2005.06.023
   Wiesmann M, 2016, J NEUROINTERV SURG, V8, P571, DOI 10.1136/neurintsurg-2015-011719
   Wilson MP, 2018, J NEUROINTERV SURG, V10, P721, DOI 10.1136/neurintsurg-2017-013707
NR 17
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E1
EP E4
DI 10.1016/j.wneu.2019.09.031
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300002
PM 31525481
DA 2020-05-12
ER

PT J
AU Wright, AK
   La Selva, D
   Nkrumah, L
   Yanamadala, V
   Leveque, JC
   Sethi, RK
AF Wright, Anna K.
   La Selva, Danielle
   Nkrumah, Louis
   Yanamadala, Vijay
   Leveque, Jean-Christophe
   Sethi, Rajiv K.
TI Postoperative Ileus: Old and New Observations on Prevention and
   Treatment in Adult Spinal Deformity Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adult spinal deformity (ASD) surgery; Length of stay (LOS);
   Postoperative ileus (POI); Surgical complications
ID RISK-FACTORS; MECHANISMS
AB BACKGROUND: The reported incidence of postoperative ileus (POI) after spine surgery depends on the surgical approach and definition used. It is therefore possible that the overall incidence is substantially higher than previously thought. POI has consequences for both the patient and hospital resources, and can significantly increase health care costs.
   METHODS: We retrospectively reviewed all patients aged 18 years or older who underwent elective complex spine surgery at our tertiary referral institution from 2011 through 2017. Preoperative comorbidities, operating time and approach, estimated blood loss, postoperative complications, and length of stay (LOS) were analyzed for patients meeting the inclusion criteria.
   RESULTS: Of 174 patients included in the study, 32 patients (18.4%) developed POI, leading to a significant increase in their median LOS (9 vs. 7 days; P = 0.020). Total estimated blood loss (1649.5 +/- 1266.2 vs. 1124.6 +/- 936.3 mL; P = 0.009) and total surgical time (501.6 +/- 170.5 vs. 388.4 +/- 159.8 minutes; P < 0.001) were significantly higher in the POI cohort. The use of nonselective mu-opioid receptor antagonists in 66% of patients with POI did not significantly impact the median LOS (9 vs. 8 days; P = 0.477) compared with patients with POI who did not receive this intervention. The incidence of postoperative adverse events other than ileus was similar between the 2 patient groups.
   CONCLUSIONS: Despite use of early interventions, the median LOS remains significantly longer in patients who develop POI after complex spine surgery. Knowledge of the associated predictive risk factors could potentially assist with the development of rigorous, evidence-based preventative strategies.
C1 [Wright, Anna K.; Nkrumah, Louis; Leveque, Jean-Christophe; Sethi, Rajiv K.] Virginia Mason Med Ctr, Inst Neurosci, Seattle, WA 98101 USA.
   [La Selva, Danielle] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA.
   [Yanamadala, Vijay] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA.
   [Sethi, Rajiv K.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
RP Sethi, RK (reprint author), Virginia Mason Med Ctr, Inst Neurosci, Seattle, WA 98101 USA.; Sethi, RK (reprint author), Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
EM Rajiv.Sethi@virginiamason.org
RI Leveque, Jean-Christophe/L-6367-2017
OI Leveque, Jean-Christophe/0000-0003-2465-444X
FU Digestive Disease Institute at Virginia Mason Medical Center
FX This research was supported by a grant from the Digestive Disease
   Institute at Virginia Mason Medical Center.
CR Al Maaieh MA, 2014, SPINE, V39, P688, DOI 10.1097/BRS.0000000000000238
   Althausen PL, 2001, J SPINAL DISORD, V14, P541, DOI 10.1097/00002517-200112000-00014
   Artinyan A, 2008, WORLD J SURG, V32, P1495, DOI 10.1007/s00268-008-9491-2
   Baig MK, 2004, DIS COLON RECTUM, V47, P516, DOI 10.1007/s10350-003-0067-9
   Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x
   Berend KR, 2004, J ARTHROPLASTY, V19, P82, DOI 10.1016/j.arth.2004.06.013
   Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250
   Bragg D, 2015, CLIN NUTR, V34, P367, DOI 10.1016/j.clnu.2015.01.016
   Chapman SJ, 2018, BRIT J SURG, V105, P797, DOI 10.1002/bjs.10781
   Durand WM, 2018, WORLD NEUROSURG, V116, pE806, DOI 10.1016/j.wneu.2018.05.099
   Fineberg SJ, 2014, SPINE J, V14, P1680, DOI 10.1016/j.spinee.2013.10.015
   GOLDSTEIN JL, 2007, P & T, V32, P82
   Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209
   Kiely PD, 2016, INT ORTHOP, V40, P1067, DOI 10.1007/s00264-016-3148-9
   Kronberg U, 2011, ANN SURG, V253, P78, DOI 10.1097/SLA.0b013e3181fcb83e
   Li LDT, 2013, J AM GERIATR SOC, V61, P1175, DOI 10.1111/jgs.12307
   LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233
   Luckey A, 2003, ARCH SURG-CHICAGO, V138, P206, DOI 10.1001/archsurg.138.2.206
   Mattei P, 2006, WORLD J SURG, V30, P1382, DOI 10.1007/s00268-005-0613-9
   Shah KN, 2015, ORTHOP REV, V7, P87, DOI 10.4081/or.2015.6087
   Vather R, 2014, CLIN EXP PHARMACOL P, V41, P358, DOI 10.1111/1440-1681.12220
   Vather R, 2013, J GASTROINTEST SURG, V17, P962, DOI 10.1007/s11605-013-2148-y
NR 22
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E618
EP E622
DI 10.1016/j.wneu.2019.08.062
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300074
PM 31442660
DA 2020-05-12
ER

PT J
AU Yamaguchi, S
   Terasaka, S
   Okamoto, M
   Ishi, Y
   Motegi, H
   Kobayashi, H
   Houkin, K
AF Yamaguchi, Shigeru
   Terasaka, Shunsuke
   Okamoto, Michinari
   Ishi, Yukitomo
   Motegi, Hiroaki
   Kobayashi, Hiroyuki
   Houkin, Kiyohiro
TI Simplified Dural Reconstruction Procedure Using Biocompatible
   Polyglycolic Acid Felt with Autologous Abdominal Fat Grafts after a
   Transpetrosal Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebrospinal fluid leakage; Dural reconstruction; Petrosal approach;
   Polyglycolic acid felt; Skull base surgery
ID SKULL BASE DEFECTS; MENINGIOMAS; PERICRANIUM; DURAPLASTY; RESECTION;
   RATES
AB BACKGROUND: Dural reconstruction after transpetrosal approaches is complicated because complete primary closure of presigmoid dura mater is difficult to achieve. To address this problem, we use biocompatible polyglycolic acid (PGA) felt (Durawave) to reconstruct dural defects. To evaluate the use of PGA felt in dural reconstruction, we compared these results with those after conventional duraplasty using autologous fascia grafts.
   METHODS: We retrospectively surveyed all cases involving a transpetrosal approach reported since 2013. In the conventional procedure, autologous fascia was fixed over the dural defect using stay sutures; any remaining dead space was obliterated by placing abdominal fat grafts. Since April 2017, we have used PGA felt instead of fascia.
   RESULTS: Of the 37 cases identified, 27 were reconstructed according to the conventional procedure, and the remaining 10 cases were reconstructed using PGA felt. Among the 27 conventional cases, 8 involved cerebrospinal fluid (CSF)-related complications, including 3 cases of rhinorrhea and 5 cases of subcutaneous fluid collection, and 2 cases (7%) required repair surgery. Of the 10 cases involving PGA felt, 1 case (10%) involved subcutaneous fluid collection and required repair surgery, and whereas the remaining 9 cases had no evidence of CSF leakage. In addition, the median dural reconstruction time using PGA felt was 9 minutes, significantly shorter than that when autologous fascia was used (median, 44 minutes).
   CONCLUSIONS: Using PGA felt for presigmoid dura simplifies dural reconstruction because it obviates the need to suture in a deep field. PGA felt has the potential to prevent CSF-related complications after transpetrosal approaches.
C1 [Yamaguchi, Shigeru; Okamoto, Michinari; Ishi, Yukitomo; Motegi, Hiroaki; Houkin, Kiyohiro] Hokkaido Univ, Fac Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.
   [Terasaka, Shunsuke; Kobayashi, Hiroyuki] Kashiwaba Neurosurg Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Yamaguchi, S (reprint author), Hokkaido Univ, Fac Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.
EM yama-shu@med.hokudai.ac.jp
RI Yamaguchi, Shigeru/G-5419-2012
OI Yamaguchi, Shigeru/0000-0003-3710-5888
CR Bernal-Sprekelsen M, 2014, BIOMED RES INT, DOI 10.1155/2014/346873
   Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19
   Fukaya R, 2011, NEUROSURG REV, V34, P159, DOI 10.1007/s10143-010-0289-y
   Grossi PM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12141
   KAWASE T, 1991, NEUROSURGERY, V28, P869, DOI 10.1227/00006123-199106000-00014
   Klimo P, 2009, J NEUROSURG-PEDIATR, V4, P353, DOI 10.3171/2009.4.PEDS08426
   Kshettry VR, 2016, J KOREAN NEUROSURG S, V59, P52, DOI 10.3340/jkns.2016.59.1.52
   Kusumi M, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182356269
   Lam FC, 2012, NEUROSURGERY, V71, P302, DOI 10.1227/NEU.0b013e31826a8ab0
   Little KM, 2005, NEUROSURGERY, V56, P546, DOI 10.1227/01.NEU.0000153906.12640.62
   Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A
   Martinez-Lage J, 2006, CHILD NERV SYST, V22, P139, DOI 10.1007/s00381-005-1232-3
   Metwali H, 2018, WORLD NEUROSURG, V110, P249, DOI 10.1016/j.wneu.2017.11.084
   Narotam PK, 2009, J NEUROSURG, V111, P380, DOI 10.3171/2008.10.JNS08993
   Nickele CM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12208
   Ray J, 2005, CLIN OTOLARYNGOL, V30, P405, DOI 10.1111/j.1365-2273.2005.01034.x
   Ricaurte JC, 2000, CLIN INFECT DIS, V30, P613, DOI 10.1086/313732
   Rosen CL, 2011, NEUROSURGERY, V69, P1093, DOI 10.1227/NEU.0b013e3182284aca
   Shimizu S, 2007, NEUROL MED-CHIR, V47, P379, DOI 10.2176/nmc.47.379
   Stevens EA, 2009, J NEUROSURG-SPINE, V11, P80, DOI 10.3171/2009.3.SPINE08196
   Tachibana E, 2002, J NEUROSURG, V96, P280, DOI 10.3171/jns.2002.96.2.0280
   Taha ANM, 2011, WORLD NEUROSURG, V75, P692, DOI 10.1016/j.wneu.2011.01.023
   Tamura R, 2019, J NEUROSURG, V130, P360, DOI 10.3171/2017.9.JNS171622
   Terasaka S, 2006, NEUROSURGERY, V58, P134, DOI 10.1227/01.NEU.0000193515.95039.49
   Terasaka S, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5877-8
   Terasaka S, 2011, SKULL BASE-INTERD AP, V21, P123, DOI 10.1055/s-0030-1265826
   Walcott BP, 2012, J CLIN NEUROSCI, V19, P92, DOI 10.1016/j.jocn.2011.08.001
   Zenga F, 2016, J NEUROL SURG REP, V77, pE50, DOI 10.1055/s-0035-1570388
   Zhao Jin-cheng, 2008, Neurosurg Focus, V25, pE5, DOI 10.3171/FOC.2008.25.12.E5
NR 29
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E710
EP E715
DI 10.1016/j.wneu.2019.08.033
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300086
PM 31421296
DA 2020-05-12
ER

PT J
AU Yang, K
   Guo, S
   Xu, JW
   Tao, HR
   Chen, HY
   Feng, CS
   Wang, J
   Li, HP
AF Yang, Kai
   Guo, Shuai
   Xu, Jiawei
   Tao, Huiren
   Chen, Huayou
   Feng, Chaoshuai
   Wang, Jie
   Li, Haopeng
TI Cervical Range of Motion after Anterior Corpectomy and Fusion versus
   Laminoplasty for Multilevel Cervical Spondylotic Myelopathy: A
   Three-Dimensional Comparison Based on the Coda Motion System
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior cervical corpectomy and fusion; Cervical range of motion;
   Cervical spondylotic myelopathy; Coda Motion; Laminoplasty; Surgical
   approach
ID POSTERIOR LONGITUDINAL LIGAMENT; INTRA-RATER; NECK PAIN; RELIABILITY;
   VALIDITY; SPINE; DECOMPRESSION; OSSIFICATION
AB OBJECTIVE: To compare the change in cervical range of motion (CROM) after the 2 most widely used techniques for multilevel cervical spondylotic myelopathy (CSM): anterior cervical corpectomy and fusion (ACCF) and laminoplasty.
   METHODS: Patients with multilevel CSM treated in our hospital between 2014 and 2018 were divided into an ACCF group and a laminoplasty (LAMP) group according to the treatment received. Their demographic data, preoperative and postoperative Japanese Orthopedic Association (JOA) scores, and CROM, measured using the Coda Motion system, were analyzed and compared.
   RESULTS: A total of 53 patients were enrolled, including 29 patients in the ACCF group and 24 patients in the LAMP group. Age, sex, duration of follow-up, and preoperative and postoperative JOA scores were comparable in the 2 groups. Compared with preoperative measurements, ACCF group lost an average of 9.8%, 28.5%, 8.9%, 9.9%, 10.6%, and 7.8% of their CROM in flexion, extension, left and right lateral flexion, and left and right rotation, respectively, at the latest follow-up. For the LAMP group, these average losses were 3.5%, 16.4%, 3.2%, 6.3%, 7.0%, and 5.7%, respectively. Thus, the ACCF group exhibited greater average CROM loss than the LAMP group in all directions at the latest follow-up.
   CONCLUSIONS: Both ACCF and laminoplasty cause significant CROM loss in patients with multilevel CSM. The laminoplasty technique preserved more CROM than ACCF in all 6 directions after at least 1 year of follow-up. These results can be used when counseling patients undergoing surgery.
C1 [Yang, Kai; Guo, Shuai; Xu, Jiawei; Chen, Huayou; Feng, Chaoshuai; Wang, Jie; Li, Haopeng] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
   [Tao, Huiren] Shenzhen Univ, Dept Orthoped, Gen Hosp, Shenzhen, Guangdong, Peoples R China.
RP Li, HP (reprint author), Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.
EM lihaopeng3993@163.com
RI Yang, Kai/AAA-2165-2020
OI Xu, Jiawei/0000-0002-3802-2139
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [10698201736]
FX This study was supported by a grant from the Fundamental Research Funds
   for the Central Universities (10698201736).
CR Antonaci F, 2000, CLIN EXP RHEUMATOL, V18, pS45
   Bernstein IA, 2002, BRIT J SPORT MED, V36, P108, DOI 10.1136/bjsm.36.2.108
   Bishop MD, 2013, J ORTHOP SPORT PHYS, V43, P457, DOI 10.2519/jospt.2013.4492
   Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6
   Charalambous L, 2012, J SPORT SCI, V30, P1, DOI 10.1080/02640414.2011.616948
   Chen H, 2018, WORLD NEUROSURG, V116, pE1007, DOI 10.1016/j.wneu.2018.05.150
   de Koning CHP, 2008, EUR SPINE J, V17, P905, DOI 10.1007/s00586-008-0656-3
   Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007
   Exell TA, 2012, J BIOMECH, V45, P1108, DOI 10.1016/j.jbiomech.2012.01.007
   Gao ZY, 2017, EXP THER MED, V14, P5371, DOI 10.3892/etm.2017.5239
   HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003
   Hirai T, 2011, SPINE, V36, P1940, DOI 10.1097/BRS.0b013e3181feeeb2
   Huang D, 2016, INT J SURG, V35, P21, DOI 10.1016/j.ijsu.2016.09.008
   Langenfeld A, 2018, SPINE, V43, pE1082, DOI 10.1097/BRS.0000000000002627
   Lawrence BD, 2013, SPINE, V38, pS173, DOI 10.1097/BRS.0b013e3182a7eaaf
   Lebl DR, 2015, J AM ACAD ORTHOP SUR, V23, P648, DOI 10.5435/JAAOS-D-14-00250
   Liu XZ, 2014, ORTHOPEDICS, V37, pE117, DOI 10.3928/01477447-20140124-12
   Luo JQ, 2015, EUR SPINE J, V24, P1621, DOI 10.1007/s00586-015-3911-4
   Maynard V, 2003, GAIT POSTURE, V17, P59, DOI 10.1016/S0966-6362(02)00051-6
   Monaghan K, 2007, GAIT POSTURE, V25, P303, DOI 10.1016/j.gaitpost.2006.04.011
   O'Sullivan K, 2010, PHYSIOTHERAPY IRELAN, V31, P16
   Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a
   Qin RQ, 2018, EUR SPINE J, V27, P1375, DOI 10.1007/s00586-017-5451-6
   Seng CS, 2013, SPINE J, V13, P723, DOI 10.1016/j.spinee.2013.02.038
   Sessumpun K, 2018, CLIN SPINE SURG, V31, pE239, DOI 10.1097/BSD.0000000000000605
   Song H, 2018, J ELECTROMYOGR KINES, V38, P56, DOI 10.1016/j.jelekin.2017.11.008
   Sun YF, 2015, CLIN NEUROL NEUROSUR, V134, P28, DOI 10.1016/j.clineuro.2015.04.011
   Tousignant M, 2000, SPINE, V25, P324, DOI 10.1097/00007632-200002010-00011
   Wada E, 2001, SPINE, V26, P1443, DOI 10.1097/00007632-200107010-00011
   Wei LX, 2019, WORLD NEUROSURG, V126, pE842, DOI 10.1016/j.wneu.2019.02.182
   Whitcroft KL, 2010, SPINE, V35, pE976, DOI 10.1097/BRS.0b013e3181cd6176
   Williams MA, 2012, EUR SPINE J, V21, P872, DOI 10.1007/s00586-011-2096-8
   Williams MA, 2010, J MANIP PHYSIOL THER, V33, P138, DOI 10.1016/j.jmpt.2009.12.009
   Yuan W, 2015, CLIN NEUROL NEUROSUR, V134, P17, DOI 10.1016/j.clineuro.2015.04.004
   Zhu B, 2013, EUR SPINE J, V22, P1583, DOI 10.1007/s00586-013-2817-2
   Zhu YR, 2019, ONCOL LETT, V17, P360, DOI 10.3892/ol.2018.9573
NR 36
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E274
EP E282
DI 10.1016/j.wneu.2019.08.178
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300033
PM 31491573
DA 2020-05-12
ER

PT J
AU Yang, KY
   Zhang, S
   Liu, HC
   Wu, WL
AF Yang, Kaiyun
   Zhang, Shuai
   Liu, Haichun
   Wu, Wenliang
TI Transforaminal Lumbar Interbody Fusion with Antibiotics Delivered by
   CaSO4 Drug Carrier System for Pyogenic Spondylodiscitis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Drug delivery system; Methicillin-resistant Staphylococcus aureus
   (MRSA); Spondylodiscitis; Transforaminal lumbar interbody fusion
ID PEDICLE SCREW FIXATION; STAPHYLOCOCCUS-AUREUS; SURGICAL-TREATMENT;
   OSTEOMYELITIS; DEBRIDEMENT; INFECTIONS; DIAGNOSIS
AB BACKGROUND: Spondylodiscitis is a challenging spinal disorder that requires surgical treatment only as a last resort. The use of various procedures and instruments remains controversial. In this retrospective study, we reported the safety and efficacy of a CaSO4 drug carrier system for the transforaminal lumbar interbody fusion (TLIF) procedure for lumbar pyogenic spondylodiscitis.
   METHODS: Thirty-four patients with lumbar spondylodiscitis underwent TLIF. CaSO4 beads carrying vancomycin and gentamycin were implanted in the trajectory of screws and disc spaces. We measured markers of inflammation, scores of neurologic recovery, and quality of life. The fusion status was assessed at final follow-up and the correction of local and total lordotic angle was calculated.
   RESULTS: The patients were followed up for at least 12 months (range, 12-24 months). At 3 months follow-up, C-reactive protein levels and erythrocyte sedimentation rate returned to normal with no relapse. Nineteen patients with American Spinal Injury Association grade D preoperatively returned to American Spinal Injury Association grade E. The improvement on the visual analog scale and Oswestry Disability Index was 66.9% and 84.9%, respectively. At 12 months follow-up, 67.6% of patients achieved definitive union. The corrections of total and local lordotic angle were 10.02 degrees +/- 8.77 degrees and 7.7 degrees +/- 8.75 degrees, respectively. The rate of achievement of satisfactory Kirkaldy-Willis functional criteria was 85.3%.
   CONCLUSIONS: The combined use of single-level TLIF with a CaSO4 drug delivery system was safe and effective for treatment of pyogenic lumbar spondylodiscitis. The system promoted reduction of inflammation with limited fixed segments without a negative impact on fusion status. This procedure may be considered a novel choice for spondylodiscitis, with more efficacy and less invasion.
C1 [Yang, Kaiyun; Zhang, Shuai; Liu, Haichun; Wu, Wenliang] Shandong Univ, Qilu Hosp, Dept Orthopaed, Jinan, Shandong, Peoples R China.
RP Wu, WL (reprint author), Shandong Univ, Qilu Hosp, Dept Orthopaed, Jinan, Shandong, Peoples R China.
EM wuwenliang@sdu.edu.cn
FU Science Foundation of Qilu Hospital of Shandong University [2017QLQN05];
   Development Program of Shandong Medicine and Health Science [2018WS328]
FX This study was supported by Science Foundation of Qilu Hospital of
   Shandong University (number 2017QLQN05) and Development Program of
   Shandong Medicine and Health Science (number 2018WS328).
CR Bernard L, 2015, LANCET, V385, P875, DOI 10.1016/S0140-6736(14)61233-2
   Bue M, 2018, J ORTHOP RES, V36, P1093, DOI 10.1002/jor.23776
   Cheung WY, 2012, INT ORTHOP, V36, P397, DOI 10.1007/s00264-011-1384-6
   Gasbarrini A, 2011, INT J IMMUNOPATH PH, V24, P95, DOI 10.1177/03946320110241S218
   Jensen AG, 1997, J INFECTION, V34, P113, DOI 10.1016/S0163-4453(97)92395-1
   Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008
   Karadimas EJ, 2008, ACTA ORTHOP, V79, P650, DOI 10.1080/17453670810016678
   Kim CJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1897-0
   Lee BH, 2012, CLIN ORTHOP SURG, V4, P200, DOI 10.4055/cios.2012.4.3.200
   LEE CK, 1995, SPINE, V20, P356, DOI 10.1097/00007632-199502000-00018
   Lee JS, 2006, J BONE JOINT SURG BR, V88B, P765, DOI 10.1302/0301-620X.88B6
   Lin TY, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-443
   Lu ML, 2015, EUR SPINE J, V24, P555, DOI 10.1007/s00586-014-3585-3
   Cervan AM, 2012, INT ORTHOP, V36, P421, DOI 10.1007/s00264-011-1433-1
   Nandi SK, 2016, BIOTECHNOL ADV, V34, P1305, DOI 10.1016/j.biotechadv.2016.09.005
   Papagelopoulos PJ, 2006, J INT MED RES, V34, P704, DOI 10.1177/147323000603400618
   Pee YH, 2008, J NEUROSURG-SPINE, V8, P405, DOI 10.3171/SPI/2008/8/5/405
   Pforringer D, 2016, ANTIMICROB AGENTS CH, V60, P3897, DOI 10.1128/AAC.00080-16
   Pintado-Garcia V, 2008, ENFERM INFEC MICR CL, V26, P510, DOI 10.1157/13127458
   Rayes M, 2010, J NEUROSURG-SPINE, V12, P647, DOI 10.3171/2009.12.SPINE09428
   Rutges JPHJ, 2016, EUR SPINE J, V25, P983, DOI 10.1007/s00586-015-4318-y
   Shiban E, 2016, ACTA NEUROCHIR, V158, P349, DOI 10.1007/s00701-015-2630-2
   Sobottke R, 2008, DTSCH ARZTEBL INT, V105, P181, DOI 10.3238/arztebl.2008.0181
   Stoffel M, 2011, ADV TECH STAND NEURO, V37, P213, DOI 10.1007/978-3-7091-0673-0_7
   Tuli SM, 2013, EUR SPINE J, V22, P529, DOI 10.1007/s00586-012-2388-7
   Woertgen C, 2006, J NEUROSURG-SPINE, V4, P441, DOI 10.3171/spi.2006.4.6.441
   Yee DKH, 2010, SPINE, V35, P635, DOI 10.1097/BRS.0b013e3181cff4f6
   Zaveri GR, 2009, J SPINAL DISORD TECH, V22, P257, DOI 10.1097/BSD.0b013e31818859d0
NR 28
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E447
EP E454
DI 10.1016/j.wneu.2019.08.118
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300053
PM 31470157
DA 2020-05-12
ER

PT J
AU Yin, TK
   Zhang, H
   Wang, W
   Zhang, LY
   Wang, SS
AF Yin, Tengkun
   Zhang, Hao
   Wang, Wei
   Zhang, Liyong
   Wang, Shousen
TI Falcine Sinus and Parafalcine Collateral Veins in Meningiomas Invading
   the Superior Sagittal Sinus
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral falx; Collateral venous anastomoses; Contrast-enhanced magnetic
   resonance venography; Parasagittal meningiomas
ID PARASAGITTAL MENINGIOMAS; VENOUS SINUS; OBSTRUCTION; ANATOMY
AB BACKGROUND: Venous collaterals form because of occlusion of the superior sagittal sinus (SSS), thus preserving venous drainage. Previous studies have focused on the evaluation and protection of sinuses and cortical veins and have neglected the collaterals between the SSS and deep venous system, which are important for surgical planning. We aimed to study the venous compensatory patterns inside and on both sides of the cerebral falx (parafalx) in patients with meningioma invading the SSS.
   METHODS: Conventional magnetic resonance imaging, magnetic resonance venography, and a three-dimensional reconstructed venous model of 45 patients were analyzed. The venous collateral pattern of the parafalx was divided into 4 types: A), with cerebral medial cortical vein displacement or hyperplasia; B), collaterals connect the 2 ends of the occluded segment of the SSS; C), collaterals connect the occluded segment of the SSS with the deep cerebral venous system; and D), recanalization or secondary formation of a falcine sinus. The incidence of each type in different occlusion grades and positions of the SSS was analyzed.
   RESULTS: The 4 types of venous collaterals were ranked according to their prevalence: A, 46.7%; C, 15.6%; D, 8.9%; and B, 4.4%. The collaterals of types B, C, and D were found only in patients with severe SSS occlusion, and both types C and D were found only in middle and posterior occlusions of the SSS.
   CONCLUSIONS: In meningiomas invading the SSS, especially with complete posterior SSS occlusion, the parafalcine collateral veins and falcine sinus should be evaluated preoperatively to avoid iatrogenic injury.
C1 [Yin, Tengkun; Zhang, Hao; Wang, Wei; Wang, Shousen] Fujian Med Univ, Hosp Joint Logist Team 900, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.
   [Yin, Tengkun; Zhang, Liyong] Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng, Shandong, Peoples R China.
RP Wang, SS (reprint author), Fujian Med Univ, Hosp Joint Logist Team 900, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.
EM wshsen@126.com
FU Key Project of Science and Technology Plan of Fujian Province, China
   [2014Y0036]
FX This research was supported by Key Project of Science and Technology
   Plan of Fujian Province, China through project number 2014Y0036.
CR Adachi K, 2016, WORLD NEUROSURG, V92, P339, DOI 10.1016/j.wneu.2016.05.019
   Della Puppa A, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.12.FOCUS13385
   DiMeco F, 2008, NEUROSURGERY, V62, P1124, DOI [10.1227/01.NEU.0000143373.74160.F2, 10.1227/01.neu.0000333779.73940.c4]
   Elhammady MS, 2015, WORLD NEUROSURG, V83, P320, DOI 10.1016/j.wneu.2013.06.003
   Kashimura H, 2007, NEUROL MED-CHIR, V47, P83, DOI 10.2176/nmc.47.83
   Kesava PP, 1996, AM J NEURORADIOL, V17, P1646
   Lee I, 2015, NEUROLOGY, V85, pe162, DOI 10.1212/WNL.0000000000002163
   Menovsky T, 2002, MICROSURG, V22, P27, DOI 10.1002/micr.22005
   Nussbaum ES, 2009, SURG NEUROL, V72, P530, DOI 10.1016/j.surneu.2009.03.009
   OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003
   OKA K, 1994, J NEUROSURG, V81, P520, DOI 10.3171/jns.1994.81.4.0520
   Qureshi Adnan I, 2010, J Vasc Interv Neurol, V3, P1
   Rhoton AL, 2002, NEUROSURGERY, V51, pS159, DOI 10.1227/01.NEU.0000028228.51706.2D
   Ryu CW, 2010, AM J NEURORADIOL, V31, P367, DOI 10.3174/ajnr.A1794
   Sindou M, 2005, ACT NEUR S, V94, P167
   Sindou M, 2000, ADV TECH STAND NEUR, V26, P131
   Tanriverdi T, 2009, CAN J NEUROL SCI, V36, P65, DOI 10.1017/S0317167100006338
   Tatarli N, 2013, ACTA NEUROCHIR, V155, P2183, DOI 10.1007/s00701-013-1863-1
   Tomasello F, 2013, J NEUROSURG, V119, P74, DOI 10.3171/2012.11.JNS112011
   Tubbs RS, 2007, J NEUROSURG, V107, P155, DOI 10.3171/JNS-07/07/0155
   Yin TK, 2017, WORLD NEUROSURG, V104, P220, DOI 10.1016/j.wneu.2017.04.145
NR 21
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E434
EP E442
DI 10.1016/j.wneu.2019.08.120
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300051
PM 31470161
DA 2020-05-12
ER

PT J
AU Zhang, LM
   Li, R
   Sun, WB
   Wang, XP
   Qi, MM
   Bai, Y
   Bai, J
   Zheng, WC
AF Zhang, Li-Min
   Li, Rui
   Sun, Wen-Bo
   Wang, Xu-Peng
   Qi, Man-Man
   Bai, Yang
   Bai, Jing
   Zheng, Wei-Chao
TI Low-Dose, Early Fresh Frozen Plasma Transfusion Therapy After Severe
   Trauma Brain Injury: A Clinical, Prospective, Randomized, Controlled
   Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Delayed traumatic intracranial hematoma; Fresh frozen plasma; Glasgow
   Outcome Scale; Traumatic brain injury
ID LARGE ANIMAL-MODEL; CRITICALLY-ILL; NORMAL SALINE; SINGLE-CENTER;
   COAGULOPATHY; RESUSCITATION; PLATELET; CARE
AB BACKGROUND: To investigate role of Low-dose, Early Fresh frozen plasma Transfusion (LEFT) therapy in preventing perioperative coagulopathy and improving long-term outcome after severe traumatic brain injury (TBI).
   METHODS: A prospective, single-center, parallel-group, randomized trial was designed. Patients with severe TBI were eligible. We used a computer-generated randomization list and closed opaque envelops to randomly allocate patients to treatment with fresh frozen plasma (5 mL/kg body weight; LEFT group) or normal saline (5 mL/kg body weight; NO LEFT group) after admission in the operating room.
   RESULTS: Between January 1, 2018, and November 31, 2018, 63 patients were included and randomly allocated to LEFT (n = 28) and NO LEFT (n = 35) groups. The final interim analysis included 20 patients in the LEFT group and 32 patients in the NO LEFT group. The study was terminated early for futility and safety reasons because a high proportion of patients (7 of 20; 35.0%) in the LEFT group developed new delayed traumatic intracranial hematoma after surgery compared with the NO LEFT group (3 of 32; 9.4%) (relative risk, 5.205; 95% confidence interval, 1.159-23.384; P = 0.023). Demographic characteristics and indexes of severity of brain injury were similar at baseline.
   CONCLUSIONS: LEFT therapy was associated with a higher incidence of delayed traumatic intracranial hematoma than normal fresh frozen plasma transfusion in patients with severe TBI. A restricted fresh frozen plasma transfusion protocol, in the right clinical setting, may be more appropriate in patients with TBIs.
C1 [Zhang, Li-Min; Li, Rui; Sun, Wen-Bo; Wang, Xu-Peng; Qi, Man-Man; Bai, Yang; Bai, Jing; Zheng, Wei-Chao] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.
RP Zhang, LM (reprint author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.
EM azai2010@126.com
FU Bureau of Science and Technology of Hebei Province [172777117]
FX This study was supported by the Bureau of Science and Technology of
   Hebei Province (Grant No. 172777117 [to Dr. Li-Min Zhang]).
CR Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x
   Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622
   Bianchi P, 2017, BRIT J ANAESTH, V118, P788, DOI 10.1093/bja/aex069
   Brazinova A, 2016, J NEUROTRAUM, DOI 10.1089/neu.2015.4126
   Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO
   Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001
   Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057
   Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535
   Innerhofer P, 2017, LANCET HAEMATOL, V4, pE258, DOI 10.1016/S2352-3026(17)30077-7
   Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1
   Kor DJ, 2010, CURR OPIN CRIT CARE, V16, P309, DOI 10.1097/MCC.0b013e32833bc4a4
   Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y
   Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X
   Marshall A, 2015, J THROMB, V14, P324
   May AK, 1997, AM SURGEON, V63, P233
   Nilsson CU, 2016, PERIOPER MED, V5, DOI 10.1186/s13741-016-0046-z
   Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x
   Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5
   Sezik S, 2014, J EMERG MED, V47, P596, DOI 10.1016/j.jemermed.2014.04.042
   Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193
   Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129
   Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0
   Vlaar APJ, 2009, TRANSFUSION MED, V19, P207, DOI 10.1111/j.1365-3148.2009.00928.x
   Warner MA, 2017, ANESTH ANALG, V124, P1636, DOI 10.1213/ANE.0000000000001730
   Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140
NR 25
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
BP E21
EP E27
DI 10.1016/j.wneu.2019.09.024
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300005
PM 31521754
DA 2020-05-12
ER

PT J
AU Banno, F
   Zreik, J
   Alvi, MA
   Goyal, A
   Freedman, BA
   Bydon, M
AF Banno, Fady
   Zreik, Jad
   Alvi, Mohammed Ali
   Goyal, Anshit
   Freedman, Brett A.
   Bydon, Mohamad
TI Anterior Cervical Corpectomy and Fusion Versus Anterior Cervical
   Discectomy and Fusion for Treatment of Multilevel Cervical Spondylotic
   Myelopathy: Insights from a National Registry
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical spondylotic myelopathy; Corpectomy; Discectomy; NSQIP;
   Outcomes; Spine; Surgery
AB BACKGROUND: Anterior cervical discectomy and fusion (ACDF) is the most common procedure for single-level cervical spondylotic myelopathy (CSM); however, for multilevel CSM, some patients may also undergo anterior cervical corpectomy and fusion (ACCF). We sought to assess differences in clinical outcomes between patients undergoing ACDF and those undergoing ACCF for multilevel CSM.
   METHODS: The National Surgical Quality Improvement Program (NSQIP) database was queried from 2007 to 2017 to identify patients diagnosed with CSM undergoing 1- or 2-level ACCF and 2- or 3-level ACDF. Three-to-one propensity scoring was used to match patients undergoing 1-level ACCF to those undergoing 2-level ACDF. Multivariable regression was performed to compare 30-day clinical outcomes between ACCF and ACDF recipients.
   RESULTS: A total of 3708 patients undergoing 1-level ACCF (n = 729; 18.7%) or 2-level ACDF (n = 3179; 81.3%) were identified. On multivariable regression, 1-level ACCF was associated with significantly longer length of stay (coefficient, 0.79; 95% confidence interval [CI], 0.46-1.11; P < 0.001), longer operative time (coefficient, 19.01; 95% CI, 11.94-26.08; P < 0.001), decreased odds of readmissions (odds ratio [OR], 0.95; 95% CI, 0.91-0.99; P = 0.018), and increased odds of complications (OR, 1.02; 95% CI, 1.00-1.04; P = 0.028) compared with those undergoing 2-level ACDF. A total of 939 patients undergoing either 2-level ACCF (n = 348; 37.1%) or 3-level ACDF (n = 591; 62.9%) were identified. On multivariable regression, 2-level ACCF was associated with significantly longer length of stay (coefficient, 1.17; 95% CI, 0.55-1.79; P < 0.001) and increased risk of complications (OR, 1.05; 95% CI, 1.01-1.08; P = 0.004) compared with 3-level ACDF. -
   CONCLUSIONS: Our analyses indicate that ACCF may be associated with worse clinical outcomes than ACDF following multilevel treatment for CSM.
C1 [Banno, Fady; Zreik, Jad; Alvi, Mohammed Ali; Goyal, Anshit; Bydon, Mohamad] Mayo Clin, Mayo Clin Neuroinformat Lab, Rochester, MN 55905 USA.
   [Banno, Fady; Zreik, Jad; Alvi, Mohammed Ali; Goyal, Anshit; Bydon, Mohamad] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Freedman, Brett A.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.
RP Bydon, M (reprint author), Mayo Clin, Mayo Clin Neuroinformat Lab, Rochester, MN 55905 USA.
EM bydon.mohamad@mayo.edu
OI Alvi, Mohammed Ali/0000-0002-7131-079X
CR American College of Surgeons, SURG RISK CALC
   [Anonymous], R LANG ENV STAT COMP
   Arvin B, 2013, SPINE, V38, P1170, DOI 10.1097/BRS.0b013e31828e23a8
   Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200
   BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e
   Gore DR, 2001, SPINE, V26, P1259, DOI 10.1097/00007632-200106010-00016
   Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4
   Han YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087191
   Hwang SL, 2007, J SPINAL DISORD TECH, V20, P565, DOI 10.1097/BSD.0b013e318036b463
   Jiang SD, 2012, ARCH ORTHOP TRAUM SU, V132, P155, DOI 10.1007/s00402-011-1402-6
   Kawakami M, 2000, CLIN ORTHOP RELAT R, P129
   Kerezoudis P, 2016, CLIN NEUROL NEUROSUR, V149, P75, DOI 10.1016/j.clineuro.2016.07.027
   Lau D, 2015, J NEUROSURG-SPINE, V23, P280, DOI 10.3171/2014.12.SPINE14545
   Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9
   Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4
   Mummaneni PV, 2009, J NEUROSURG-SPINE, V11, P130, DOI 10.3171/2009.3.SPINE08728
   Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a
   Park Y, 2010, SPINE J, V10, P193, DOI 10.1016/j.spinee.2009.09.006
   Rao RD, 2006, J BONE JOINT SURG AM, V88A, P1619, DOI 10.2106/JBJS.F.00014
   Sebastian A, 2019, WORLD NEUROSURG, V126, pE323, DOI 10.1016/j.wneu.2019.02.049
   Song KJ, 2012, EUR SPINE J, V21, P1551, DOI 10.1007/s00586-012-2296-x
   Toledano M, 2013, NEUROL CLIN, V31, P287, DOI 10.1016/j.ncl.2012.09.003
   Wang JC, 2003, SPINE, V28, P1016, DOI 10.1097/00007632-200305150-00011
   Wang JC, 2003, SPINE, V28, P1021
   Wei LX, 2019, WORLD NEUROSURG, V126, pE842, DOI 10.1016/j.wneu.2019.02.182
   Witwer BP, 2007, NEUROSURGERY, V60, P130, DOI 10.1227/01.NEU.0000215351.32372.CE
   Wu JC, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.4.FOCUS13122
   YONENOBU K, 1985, SPINE, V10, P710, DOI 10.1097/00007632-198510000-00004
   Young WF, 2000, AM FAM PHYSICIAN, V62, P1064
NR 31
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e852
DI 10.1016/j.wneu.2019.07.220
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300103
PM 31394355
DA 2020-05-12
ER

PT J
AU Baydin, S
   Gungor, A
   Holanda, VM
   Tanriover, N
   Danish, SF
AF Baydin, Serhat
   Gungor, Abuzer
   Holanda, Vanessa M.
   Tanriover, Necmettin
   Danish, Shabbar F.
TI Microneuroanatomy of the Anterior Frontal Laser Trajectory to the Insula
SO WORLD NEUROSURGERY
LA English
DT Article
DE Insula; Laser; Microsurgical anatomy; White matter
ID INTERSTITIAL THERMAL THERAPY; SURGERY; EPILEPSY
AB BACKGROUND: Magnetic resonance imaging-guided laser interstitial thermal therapy (LITT) is an emerging minimally invasive procedure for the treatment of deep intracranial lesions. Insular lesions are challenging to treat because of the risk of damaging important surrounding structures. The precise knowledge of the neural structures that are at risk along the trajectory and during the ablation is essential to reduce associated complications. This study aims to describe the relevant anatomy of the anterior frontal LITT trajectory to the insular region by using sectional anatomy and fiber dissection technique. -
   METHODS: Three silicone-injected cadaveric heads were used to implant laser catheters bilaterally to the insular region by using a frameless stereotactic technique from a frontal approach. Sections were cut in both the oblique axial plane parallel to the trajectory and in the coronal plane. White matter fiber dissections were used to establish the tracts related to the laser trajectory from lateral to medial and medial to lateral.
   RESULTS: Supraorbital regions were selected as entry points. After crossing the frontal bone, the track intersected the inferior frontal lobe. The catheter was illustrated reaching the insular region medial to the inferior fronto-occipital fasciculus and insular cortex, and superior to the uncinate fasciculus. The uncinate fasciculus, extreme capsule, claustrum, external capsule, and putamen were traversed, preserving the major vascular structures.
   CONCLUSIONS: Independent of the insular area treated, an understanding of the neuroanatomy related to the anterior frontal laser trajectory is essential to improve the ability to perform LITT of this challenging region.
C1 [Baydin, Serhat] Ondokuz Mayis Univ, Fac Med, Dept Neurosurg, Samsun, Turkey.
   [Gungor, Abuzer] Acibadem Mehmet Ali Aydinlar Univ, Dept Neurosurg, Istanbul, Turkey.
   [Holanda, Vanessa M.] Beneficencia Portuguesa Sao Paulo Hosp, Ctr Neurol & Neurosurg Associates NeuroCENNA, Sao Paulo, SP, Brazil.
   [Tanriover, Necmettin] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey.
   [Danish, Shabbar F.] Rutgers RWJ Med Sch, Dept Neurosurg, New Brunswick, NJ USA.
RP Baydin, S (reprint author), Ondokuz Mayis Univ, Fac Med, Dept Neurosurg, Samsun, Turkey.
EM drsserhatb@gmail.com
RI Tanriover, Necmettin/AAD-3212-2020
OI Tanriover, Necmettin/0000-0001-7628-9443; gungor,
   abuzer/0000-0002-2792-7610
CR Ashraf O, 2018, WORLD NEUROSURG, V112, P166, DOI [10.1016/j.wneu.2018.01.123, 10.1016/J.WNEU.2018.01.123]
   Barnett GH, 2016, STEREOT FUNCT NEUROS, V94, P164, DOI 10.1159/000446247
   Bouthillier A, 2017, NEUROSURGERY, V81, P602, DOI 10.1093/neuros/nyx080
   Bouthillier A, 2012, NEUROSURGERY, V70, P1574, DOI 10.1227/NEU.0b013e318246a3b7
   Gras-Combe G, 2016, NEUROSURGERY, V79, P578, DOI 10.1227/NEU.0000000000001257
   Gungor A, 2017, J NEUROSURG, V126, P945, DOI 10.3171/2016.1.JNS152082
   Hawasli AH, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14471
   Hawasli AH, 2013, NEUROSURGERY, V73, P1007, DOI 10.1227/NEU.0000000000000144
   Hawasli AH, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e318232fc90
   Jethwa PR, 2012, NEUROSURGERY, V71, P133, DOI 10.1227/NEU.0b013e31826101d4
   Kaneko N, 2012, NEUROSURGERY, V70, P290, DOI 10.1227/NEU.0b013e3182315112
   LaRiviere MJ, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00064
   Lee I, 2016, NEUROSURGERY, V79, pS24, DOI 10.1227/NEU.0000000000001443
   Perry MS, 2017, J NEUROSURG-PEDIATR, V20, P575, DOI 10.3171/2017.6.PEDS17158
   Rahmathulla G, 2012, STEREOT FUNCT NEUROS, V90, P192, DOI 10.1159/000338251
   SILFVENIUS H, 1964, EPILEPSIA, V5, P307, DOI 10.1111/j.1528-1157.1964.tb03338.x
   Tanriover N, 2004, J NEUROSURG, V100, P891, DOI 10.3171/jns.2004.100.5.0891
   Ture U, 2000, J NEUROSURG, V92, P676, DOI 10.3171/jns.2000.92.4.0676
   Wright J, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16233
   Wu AS, 2011, J NEUROSURG, V115, P1115, DOI 10.3171/2011.8.JNS11488
NR 20
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e909
DI 10.1016/j.wneu.2019.07.130
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300110
PM 31351206
DA 2020-05-12
ER

PT J
AU Capilla-Guasch, P
   Quilis-Quesada, V
   Regin-Neto, M
   Holanda, VM
   Gonzalez-Darder, JM
   de Oliveira, E
AF Capilla-Guasch, Pau
   Quilis-Quesada, Vicent
   Regin-Neto, Mateus
   Holanda, Vanessa M.
   Gonzalez-Darder, Jose M.
   de Oliveira, Evandro
TI White Matter Relationships Examined by Transillumination Technique Using
   a Lateral Transcortical Parietal Approach to the Atrium:
   Three-Dimensional Images and Surgical Considerations
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atrium; Fiber dissection; Optic radiations; Transillumination;
   Transsulcal surgical approaches
ID SUPRACEREBELLAR-TRANSTENTORIAL APPROACH; TRANSFALCINE TRANSPRECUNEUS
   APPROACH; MEDIOBASAL TEMPORAL REGION; MICROSURGICAL ANATOMY; FIBER
   DISSECTION; OPTIC RADIATIONS; VENTRICLE; MENINGIOMAS; LANGUAGE; TRIGONE
AB BACKGROUND: Numerous lesions are found in the ventricular atrium (VA). Access is gained through many white matter tracts with great relevance and specific neurologic functions. It is important to understand the configuration of the most relevant structures surrounding this zone and, thus, select the safest entry zone on the lateral cerebral surface.
   OBJECTIVE: We studied the white matter layers traversed in the lateral transcortical parietal approach through the intraparietal sulcus (IPS), adding a transillumination technique. With this knowledge, we selected the safest highway to improve this particular approach.
   METHODS: An in-depth study of the white matter tracts was performed on 24 cerebral hemispheres (12 human whole brains). The Klingler technique and microsurgical dissection techniques were used under 36 to 340 magnification. The transillumination technique (torch illuminating the ventricular cavity) was used to expose the layers surrounding the VA and, thus, guide the dissection.
   RESULTS: Taking the IPS on the cerebral surface as a reference, we identified the following white matter layers ordered from the surface to the ependyma: U fibers, superior longitudinal fascicle, arcuate fascicle, vertical occipital fascicle, sagittal stratum with the optic radiations, and tapetum fibers. The transillumination technique allowed for the easier identification of the white matter deep periventricular layers.
   CONCLUSIONS: Knowledge of the main fascicles in the path and neighborhood of the VA allowed us to understand how certain neurologic functions can be affected by lesions at this level and to select the most appropriate way to avoid damaging relevant fascicles.
C1 [Capilla-Guasch, Pau; Quilis-Quesada, Vicent; Gonzalez-Darder, Jose M.] Hosp Clin Univ Valencia, Dept Neurosurg, Valencia, Spain.
   [Capilla-Guasch, Pau; Quilis-Quesada, Vicent; Gonzalez-Darder, Jose M.] Univ Valencia, Dept Anat & Human Embriol, Microneurosurg Lab, Valencia, Spain.
   [Regin-Neto, Mateus; Holanda, Vanessa M.; de Oliveira, Evandro] Inst Neurol Sci ICNE, Sao Paulo, SP, Brazil.
   [Regin-Neto, Mateus; Holanda, Vanessa M.; de Oliveira, Evandro] Hosp Beneficiencia Portuguese, Microneurosurg Lab, Sao Paulo, SP, Brazil.
   [Quilis-Quesada, Vicent] Mayo Clin, Coll Med & Sci, Jacksonville, FL 32224 USA.
RP Capilla-Guasch, P (reprint author), Hosp Clin Univ Valencia, Dept Neurosurg, Valencia, Spain.; Capilla-Guasch, P (reprint author), Univ Valencia, Dept Anat & Human Embriol, Microneurosurg Lab, Valencia, Spain.
EM paucg89@hotmail.com
OI Capilla Guasch, Pau/0000-0002-8068-6852; Reghin Neto,
   Mateus/0000-0003-4448-8231
CR Alves RV, 2012, J NEUROSURG, V116, P1014, DOI 10.3171/2012.1.JNS11978
   Bohnstedt BN, 2015, J NEUROSURG, V123, P1045, DOI 10.3171/2015.3.JNS14847
   Chechlacz M, 2013, CORTEX, V49, P487, DOI 10.1016/j.cortex.2011.11.008
   Choi CY, 2010, J KOREAN NEUROSURG S, V47, P365, DOI 10.3340/jkns.2010.47.5.365
   Davies J, 2012, NEUROSURGERY, V71, P4, DOI 10.1227/NEU.0b013e318246a7f8
   De Benedictis A, 2014, J ANAT, V225, P132, DOI 10.1111/joa.12204
   de Champfleur NM, 2013, EUR J RADIOL, V82, P151, DOI 10.1016/j.ejrad.2012.05.034
   Ellenbogen R G, 2001, Neurosurg Focus, V10, pE2
   Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]
   Fernandez-Miranda J, 2015, BRAIN STRUCT FUNCT, V220, P1665, DOI 10.1007/s00429-014-0751-7
   FORNARI M, 1981, J NEUROSURG, V54, P64, DOI 10.3171/jns.1981.54.1.0064
   Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004
   Gungor A, 2017, J NEUROSURG, V126, P945, DOI 10.3171/2016.1.JNS152082
   Izci Y, 2009, SURG NEUROL, V72, P509, DOI 10.1016/j.surneu.2009.01.025
   Juretschke FR, 2010, NEUROSURG REV, V33, P457, DOI 10.1007/s10143-010-0271-8
   Kawashima M, 2006, SURG NEUROL, V65, P436, DOI 10.1016/j.surneu.2005.09.033
   Keser Z, 2016, J NEUROIMAGING, V26, P188, DOI 10.1111/jon.12268
   Klingler J, 1935, SCHWEIZ ARCH NEUROL, V36, P247
   Ma J, 2014, WORLD NEUROSURG, V82, P757, DOI 10.1016/j.wneu.2014.05.026
   Mahaney KB, 2008, NEUROSURGERY, V63, P195, DOI 10.1227/01.NEU.0000313121.58694.4A
   Maldonado IL, 2011, J NEUROSURG, V115, P770, DOI 10.3171/2011.5.JNS112
   Marcus HJ, 2013, NEUROSURGERY, V73, pE295, DOI 10.1227/01.neu.0000430294.16175.20
   Milligan BD, 2010, NEUROSURGERY, V67, P1483, DOI 10.1227/NEU.0b013e3181f7eb68
   Moftakhar R, 2008, NEUROSURGERY, V63, P1, DOI [10.1227/01.NEU.0000297030.82996.6E, 10.1227/01.neu.0000317367.61899.65]
   Nishizaki T, 2009, ACTA NEUROCHIR, V151, P1717, DOI 10.1007/s00701-009-0310-9
   OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316
   ONO M, 1990, ATLAS CEREBRAL SULCI
   Parraga RG, 2012, NEUROSURGERY, V71, P160, DOI 10.1227/NEU.0b013e3182556fde
   Parraga RG, 2011, WORLD NEUROSURG, V75, P233, DOI 10.1016/j.wneu.2010.10.053
   Peltier J, 2012, J NEUROL, V259, P1860, DOI 10.1007/s00415-012-6421-x
   Rhoton AL, 2002, NEUROSURGERY, V51, pS1, DOI 10.1227/01.NEU.0000028086.48597.4F
   Rhoton AL, 2002, NEUROSURGERY, V51, pS273, DOI 10.1227/01.NEU.0000028087.76279.41
   Ribas GC, 2001, J NEUROSURG, V95, P1057, DOI 10.3171/jns.2001.95.6.1057
   Ribas GC, 2006, REV MED SAO PAULO, V85, P78
   Ribas GC, 2006, NEUROSURGERY, V59, P177, DOI 10.1227/01.NEU.0000240682.28616.b2
   Ribas GC, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09245
   Rubino PA, 2005, NEUROSURGERY, V57, P219, DOI 10.1227/01.NEU.0000176415.83417.16
   Sarubbo S, 2015, J ANAT, V226, P47, DOI 10.1111/joa.12254
   Schramm J, 2015, WORLD NEUROSURG, V83, P486, DOI 10.1016/j.wneu.2014.09.012
   Sincoff EH, 2004, J NEUROSURG, V101, P739, DOI 10.3171/jns.2004.101.5.0739
   Sun CJ, 2014, J CLIN NEUROSCI, V21, P1968, DOI 10.1016/j.jocn.2014.03.030
   Ture U, 2000, NEUROSURGERY, V47, P417, DOI 10.1097/00006123-200008000-00028
   Ture U, 2012, J NEUROSURG, V116, P773, DOI 10.3171/2011.12.JNS11791
   VOIGT K, 1976, NEUROCHIRURGIA, V19, P59
   Wang YB, 2013, CEREB CORTEX, V23, P2347, DOI 10.1093/cercor/bhs225
   Wassermann D, 2013, LECT NOTES COMPUT SC, V8149, P647, DOI 10.1007/978-3-642-40811-3_81
   Whittingstall K, 2014, CORTEX, V56, P85, DOI 10.1016/j.cortex.2013.02.004
   Yagmurlu K, 2015, OPER NEUROSURG, V11, P274, DOI 10.1227/NEU.0000000000000704
   Yasargil M Gazi, 2005, Neurosurg Focus, V18, pE1
   Yasargil MG, 2008, NEUROSURGERY, V62, P1029, DOI [10.1227/01.NEU.0000316427.57165.01, 10.1227/01.neu.0000333768.12951.9a]
   Yasargil MG, 1996, MICRONEUROSURGERY MI, V4
   Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111
   Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010
   Zhu W, 2013, WORLD NEUROSURG, V80, P167, DOI 10.1016/j.wneu.2012.08.010
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e783
DI 10.1016/j.wneu.2019.08.018
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300096
PM 31415888
DA 2020-05-12
ER

PT J
AU Choi, HH
   Lee, SH
   Yeon, EK
   Yoo, DH
   Cho, YD
   Cho, WS
   Kim, JE
   Son, YJ
   Han, MH
   Kang, HS
AF Choi, Hyun Ho
   Lee, Su Hwan
   Yeon, Eung Koo
   Yoo, Dong Hyun
   Cho, Young Dae
   Cho, Won-Sang
   Kim, Jeong Eun
   Son, Young-Je
   Han, Moon Hee
   Kang, Hyun-Seung
TI Determination of Aneurysm Volume Critical for Stability After Coil
   Embolization: A Retrospective Study of 3530 Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysm size; Aneurysm volume; Coil embolization; Recurrence; Stability
ID UNRUPTURED INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL
   ANEURYSMS; FLOW DIVERSION; FOLLOW-UP; RECANALIZATION; RECURRENCES;
   PACKING; GUIDELINES; EXPERIENCE
AB BACKGROUND: Recurrence is one of the concerns even after successful endovascular treatment of intracranial aneurysms. We sought to determine the critical aneurysm volume and risk factors related to aneurysmal stability in patients undergoing coil embolization of intracranial aneurysms.
   METHODS: Aneurysm volume and follow-up imaging data were retrieved in 3042 patients with 3530 aneurysms who were treated with endovascular coil embolization from January 2006 to October 2016. We analyzed the anatomic outcome in relation to aneurysm volume and determined the critical aneurysm volume favoring coil embolization.
   RESULTS: Recanalization rates were 2.8%, 6.3%, 19.4%, and 67.4% in each group with aneurysm volume of <10, 10-100, 100-1000, and >1000 mm(3), respectively. When we investigated the 100-1000 mm(3) group, the recanalization rate remarkably increased at 500 mm(3) (16.4% vs. 57.5%, P < 0.0001; odds ratio [OR], 6.968; 95% confidence interval [CI], 3.562-13.631). In the entire cohort, recanalization rates were significantly different between aneurysm volume of <500 and >500 mm(3) (7.2% vs. 62.9%, respectively; P < 0.0001; OR, 21.848; 95% CI, 13.944-34.235). In aneurysm volumes of >500 mm(3), the location was a significant prognostic factor for long-term stability (posterior circulation vs. anterior circulation; OR, 4.737; 95% CI, 1.275-17.602; P = 0.020).
   CONCLUSIONS: In our series of cerebral aneurysms treated with coil embolization, 500 mm(3) was found to be the critical volume determining stability after coil embolization. Large volume aneurysms in the posterior circulation were especially prone to recanalization after coiling.
C1 [Choi, Hyun Ho] Chung Ang Univ, Chung Ang Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.
   [Lee, Su Hwan; Cho, Won-Sang; Kim, Jeong Eun; Kang, Hyun-Seung] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.
   [Yeon, Eung Koo; Yoo, Dong Hyun; Cho, Young Dae] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea.
   [Son, Young-Je] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Neurosurg, Coll Med,Boramae Med Ctr, Seoul, South Korea.
   [Han, Moon Hee] Korea Vet Hosp, Dept Neurosurg, Med Ctr, Seoul, South Korea.
RP Kang, HS (reprint author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.
EM kanghs@snuh.org
OI YEON, EUNG KOO/0000-0001-7965-0118
CR Adeeb N, 2017, WORLD NEUROSURG, V105, P232, DOI 10.1016/j.wneu.2017.05.128
   Ban Seung Pil, 2017, Oper Neurosurg (Hagerstown), V13, P679, DOI 10.1093/ons/opx039
   Byrne JV, 1999, J NEUROSURG, V90, P656, DOI 10.3171/jns.1999.90.4.0656
   Chalouhi N, 2013, STROKE, V44, P2150, DOI 10.1161/STROKEAHA.113.001785
   Drake CG, 1997, J NEUROSURG, V87, P141, DOI 10.3171/jns.1997.87.2.0141
   El-Chalouhi N, 2014, WORLD NEUROSURG, V82, P696, DOI 10.1016/j.wneu.2013.02.089
   Ferns SP, 2009, STROKE, V40, pE523, DOI 10.1161/STROKEAHA.109.553099
   Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755
   Jeon JP, 2016, AM J NEURORADIOL, V37, P1490, DOI 10.3174/ajnr.A4763
   Jeon JP, 2016, EUR RADIOL, V26, P3319, DOI 10.1007/s00330-015-4176-3
   Lecler A, 2015, RADIOLOGY, V277, P173, DOI 10.1148/radiol.2015142496
   Leng B, 2014, J NEUROINTERV SURG, V6, P595, DOI 10.1136/neurintsurg-2013-010920
   Lv N, 2016, J CLIN NEUROSCI, V33, P173, DOI 10.1016/j.jocn.2016.03.039
   Mortimer AM, 2015, J NEUROINTERV SURG, V7, P373, DOI 10.1136/neurintsurg-2014-011152
   Nakayama H, 2007, INTERV NEURORADIOL, V13, P281, DOI 10.1177/159101990701300308
   Nguyen TN, 2007, SURG NEUROL, V68, P19, DOI 10.1016/j.surneu.2006.10.021
   Niimi Y, 2006, STROKE, V37, P1028, DOI 10.1161/01.STR.0000206459.73897.a3
   Pandey AS, 2007, NEUROSURGERY, V60, P36
   Pandley AS, 2007, NEUROSURGERY, V60, P626, DOI 10.1227/NEU.0000255433.47044.8F
   Piotin M, 2007, RADIOLOGY, V243, P500, DOI 10.1148/radiol.2431060006
   Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9
   Sanai N, 2009, NEUROSURGERY, V65, P670, DOI 10.1227/01.NEU.0000348557.11968.F1
   Sluzewski M, 2004, RADIOLOGY, V231, P653, DOI 10.1148/radiol.2313030460
   Songsaeng D, 2011, J NEUROSURG, V114, P994, DOI 10.3171/2010.8.JNS10241
   Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087
   Suzuki J, 1980, Neurol Res, V2, P305
   Takeshita Tomonori, 2012, No Shinkei Geka, V40, P61
   Tan IYL, 2011, INTERV NEURORADIOL, V17, P27, DOI 10.1177/159101991101700106
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   Wali AR, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS1749
   Zhang QQ, 2018, J NEUROINTERV SURG, V10, P252, DOI 10.1136/neurintsurg-2017-013041
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e766
DI 10.1016/j.wneu.2019.08.020
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300094
PM 31415892
DA 2020-05-12
ER

PT J
AU Dundar, TT
   Aralasmak, A
   Kitis, S
   Yilmaz, FT
   Abdallah, A
AF Dundar, Tolga Turan
   Aralasmak, Ayse
   Kitis, Serkan
   Yilmaz, Fatih Temel
   Abdallah, Anas
TI Comparison of Subtracted Computed Tomography from Computed Tomography
   Perfusion and Digital Subtraction Angiography in Residue Evaluation of
   Treated Intracranial Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clipped aneurysm; CTA; CTP; DSA; Follow-up; Sub-CTA
ID FOLLOW-UP; RISK
AB BACKGROUND: Assessing clipped intracranial aneurysms for residues or incomplete occlusions is critical. Digital subtraction angiography (DSA) has been the gold standard for this. Previously, we presented subtracted computed tomography angiography (sub-CTA) from computed tomography perfusion as a more effective noninvasive technique for clipped aneurysms. The aim of this study was to compare effectiveness of sub-CTA with DSA in residue evaluation.
   METHODS: A retrospective study of 17 patients with aneurysmal subarachnoid hemorrhage operated on at our institution between November 1, 2016, and December 31, 2018, was performed. Residue aneurysms were evaluated with both sub-CTA and DSA. Positive predictive value and negative predictive value were calculated. Correlation between techniques was determined by the McNemar test and k value.
   RESULTS: Sensitivity of sub-CTA in residue evaluation was low in aneurysms 3 pound mm (positive predictive value [ 60%). DSA detected residue aneurysm in 29% (5/17) of patients, whereas sub-CTA detected residue aneurysm in 11% (2/17). Only 40% of aneurysms (2/5) were demonstrated by sub-CTA, all >3 mm; 60% (3/5) were missed, all 3 pound mm.
   CONCLUSIONS: This is the first study comparing the effectiveness of sub-CTA from computed tomography perfusion with DSA in residue aneurysm evaluation. Our results were suggestive, but not conclusive. DSA is still the gold standard in residue evaluation. Sub-CTA from computed tomography perfusion can be a reliable method in evaluation of residual aneurysm >3 mm.
C1 [Dundar, Tolga Turan; Kitis, Serkan; Abdallah, Anas] Bezmi Alem Univ, Fac Med, Dept Neurosurg, Istanbul, Turkey.
   [Aralasmak, Ayse; Yilmaz, Fatih Temel] Bezmi Alem Univ, Fac Med, Dept Radiol, Istanbul, Turkey.
RP Dundar, TT (reprint author), Bezmi Alem Univ, Fac Med, Dept Neurosurg, Istanbul, Turkey.
EM tdundar@bezmialem.edu.tr
OI Abdallah, Anas/0000-0003-3600-089X
CR Akyuz M, 2004, ACTA NEUROCHIR, V146, P245, DOI 10.1007/s00701-003-0206-z
   Aralasmak A, 2015, J COMPUT ASSIST TOMO, V39, P313, DOI 10.1097/RCT.0000000000000211
   Burkhardt JK, 2017, WORLD NEUROSURG, V106, P74, DOI [10.1016/j.WNEU.2017.06.110, 10.1016/j.wneu.2017.06.110]
   Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317
   Dundar TT, 2018, TURK NEUROSURG, V28, P563, DOI 10.5137/1019-5149.JTN.21113-17.2
   Hansel NH, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2017.07.011
   Hattingen E, 2010, NEUROSURG REV, V33, P431, DOI 10.1007/s10143-010-0267-4
   Kang HS, 2004, AM J NEURORADIOL, V25, P1463
   Kim ST, 2019, AM J NEURORADIOL, V40, P116, DOI 10.3174/ajnr.A5909
   Kwee TC, 2007, NEURORADIOLOGY, V49, P703, DOI 10.1007/s00234-007-0266-5
   Manninen AL, 2012, AM J NEURORADIOL, V33, P2038, DOI 10.3174/ajnr.A3123
   Meijer FJA, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0685-y
   Monsivais D, 2019, WORLD NEUROSURG, V124, pE125, DOI 10.1016/j.wneu.2018.12.028
   Pang JW, 2019, CELL TRANSPLANT, V28, P26, DOI 10.1177/0963689718812054
   Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693
   Thornton J, 2000, NEUROSURGERY, V46, P1294, DOI 10.1097/00006123-200006000-00003
   Wachter D, 2010, CENT EUR NEUROSURG, V71, P121, DOI 10.1055/s-0030-1261946
   Wallace RC, 2007, AM J NEURORADIOL, V28, P1207, DOI 10.3174/ajnr.A0664
   Yoon NK, 2016, NEUROVASC IMAGING, V2, P6, DOI DOI 10.1186/S40809-016-0016-3
   Zachenhofer I, 2010, CLIN NEUROL NEUROSUR, V112, P386, DOI 10.1016/j.clineuro.2010.02.001
   Zheng J, 2019, WORLD NEUROSURG, V1, P173
NR 21
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e746
DI 10.1016/j.wneu.2019.08.028
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300091
PM 31415894
DA 2020-05-12
ER

PT J
AU Fallah, N
   Taghvaei, M
   Sadaghiani, S
   Sadrhosseini, SM
   Esfahanian, F
   Zeinalizadeh, M
AF Fallah, Nahid
   Taghvaei, Mohammad
   Sadaghiani, Shokufeh
   Sadrhosseini, Seyed Mousa
   Esfahanian, Fatemeh
   Zeinalizadeh, Mehdi
TI Surgical Outcome of Endoscopic Endonasal Surgery of Large and Giant
   Pituitary Adenomas: An Institutional Experience from the Middle East
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic transsphenoidal surgery; Giant pituitary adenoma; Knosp
   score; Large pituitary adenoma; Pituitary surgery
ID TRANSSPHENOIDAL SURGERY; TRANSCRANIAL SURGERY; CAVERNOUS SINUS; SKULL
   BASE; MANAGEMENT; TUMORS; RESECTION; REMOVAL; COMPLICATIONS; STRATEGIES
AB OBJECTIVE: Surgical treatment of large and giant pituitary adenomas is challenging and associated with higher risk of complications and lower rate of gross total resection. We present our experience with surgical management of large and giant adenomas using the extended endoscopic transsphenoidal approach (EETA).
   METHODS: A total of 80 patients with large (30-39 mm) and giant (>= 40 mm) pituitary adenomas who underwent tumor resection using EETAwere studied. Radiologic data, hormonal and visual status, surgical outcomes, complications, and factors affecting the extent of resection were evaluated.
   RESULTS: Forty-five tumors (56.3%) were classified as large and 35 (43.8%) as giant adenomas. Gross total resection was achieved in 66 patients (82.5%), near-total resection in 10 (12.5%), and subtotal resection in 4 (5%). Preoperative factors including larger tumor size, multilobular shape of tumor, and higher Knosp scores significantly decrease the likelihood of gross total resection. Of patients with preoperative visual acuity impairment and visual field deficit, 76.8% and 74.1%, respectively, experienced improvement after surgery. The most common complications include new pituitary insufficiency (16.4%), permanent diabetes insipidus (7.5%), and cerebrospinal fluid leakage (5%). Two cases of meningitis (2.5%) and 3 deaths (3.8%) occurred in this cohort of patients. Mean follow-up duration was 24.2 months.
   CONCLUSIONS: EETA can be a safe and efficient approach as the first-line treatment of patients with large and giant pituitary adenomas and is associated with high rates of gross total resection or near-total resection, visual function improvement, and a relatively low rate of complications.
C1 [Fallah, Nahid; Taghvaei, Mohammad; Zeinalizadeh, Mehdi] Univ Tehran Med Sci, Brain & Spinal Injury Res Ctr BASIR, Neurosci Inst, Pituitary Clin, Tehran, Iran.
   [Fallah, Nahid; Taghvaei, Mohammad; Zeinalizadeh, Mehdi] Univ Tehran Med Sci, Dept Neurol Surg, Tehran, Iran.
   [Sadrhosseini, Seyed Mousa] Univ Tehran Med Sci, Dept Otolaryngol Head & Neck Surg, Tehran, Iran.
   [Esfahanian, Fatemeh] Univ Tehran Med Sci, Dept Endocrinol & Metab, Imam Khomeini Hosp Complex, Tehran, Iran.
   [Sadaghiani, Shokufeh] Univ Tehran Med Sci, MS Res Ctr, Neurosci Inst, Tehran, Iran.
RP Zeinalizadeh, M (reprint author), Univ Tehran Med Sci, Brain & Spinal Injury Res Ctr BASIR, Neurosci Inst, Pituitary Clin, Tehran, Iran.; Zeinalizadeh, M (reprint author), Univ Tehran Med Sci, Dept Neurol Surg, Tehran, Iran.
EM mzeinalizadeh@tums.ac.ir
RI Taghvaei, Mohammad/AAE-1937-2020
CR Agrawal A, 2007, CLIN NEUROL NEUROSUR, V109, P645, DOI 10.1016/j.clineuro.2007.06.007
   Alleyne CH, 2002, SURG NEUROL, V57, P380, DOI 10.1016/S0090-3019(02)00705-X
   Bedi AD, 2011, SKULL BASE-INTERD AP, V21, P189, DOI 10.1055/s-0031-1275632
   Cappabianca P, 2008, ADV TECH STAND NEURO, V33, P151, DOI 10.1007/978-3-211-72283-1_4
   Cappabianca P, 2015, NEUROSURG CLIN N AM, V26, P323, DOI 10.1016/j.nec.2015.03.007
   Chabot JD, 2015, WORLD NEUROSURG, V84, P978, DOI 10.1016/j.wneu.2015.06.007
   Colao A, 2006, J CLIN ENDOCR METAB, V91, P85, DOI 10.1210/jc.2005-1208
   Constantino ER, 2016, ARQ NEURO-PSIQUIAT, V74, P388, DOI 10.1590/0004-282X20160042
   Couldwell WT, 2004, J NEURO-ONCOL, V69, P237, DOI 10.1023/B:NEON.0000041886.61149.ab
   Cusimano MD, 2012, CAN J NEUROL SCI, V39, P446, DOI 10.1017/S0317167100013950
   de Divitiis E, 2007, NEUROSURGERY, V60, P46, DOI 10.1227/01.NEU.0000249211.89096.25
   Neto MAD, 2010, CLIN ENDOCRINOL, V72, P512, DOI 10.1111/j.1365-2265.2009.03665.x
   Elshazly K, 2018, WORLD NEUROSURG, V114, pE447, DOI 10.1016/j.wneu.2018.03.006
   Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670
   Goel A, 2004, SURG NEUROL, V61, P436, DOI 10.1016/j.surneu.2003.08.036
   Gondim JA, 2014, WORLD NEUROSURG, V82, pE281, DOI 10.1016/j.wneu.2013.08.028
   Greenfield JP, 2008, MINIM INVAS NEUROSUR, V51, P306, DOI 10.1055/s-0028-1082323
   Guvenc G, 2016, J CRANIOFAC SURG, V27, P1015, DOI 10.1097/SCS.0000000000002684
   Juraschka K, 2013, J NEUROL SURG PART B, V74
   Kasuki L, 2013, EUR J ENDOCRINOL, V169, P217, DOI 10.1530/EJE-13-0349
   Komotar RJ, 2012, PITUITARY, V15, P150, DOI 10.1007/s11102-011-0359-3
   Koutourousiou M, 2012, J NEUROL SURG PART B, V73, pA140
   Koutourousiou M, 2013, J NEUROSURG, V118, P621, DOI 10.3171/2012.11.JNS121190
   Kuo CH, 2016, WORLD NEUROSURG, V91, P121, DOI 10.1016/j.wneu.2016.03.092
   Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692
   MOHR G, 1990, CAN J NEUROL SCI, V17, P62, DOI 10.1017/S0317167100030055
   Mortini P, 2007, NEUROSURGERY, V60, P993, DOI 10.1227/01.NEU.0000255459.14764.BA
   Nakao N, 2011, J CLIN NEUROSCI, V18, P71, DOI 10.1016/j.jocn.2010.04.049
   SAITO K, 1995, NEUROSURGERY, V36, P668, DOI 10.1227/00006123-199504000-00005
   SCHEITHAUER BW, 1986, J NEUROSURG, V65, P733, DOI 10.3171/jns.1986.65.6.0733
   Shrivastava RK, 2002, J NEUROSURG, V97, P299, DOI 10.3171/jns.2002.97.2.0299
   Sinha S, 2010, BRIT J NEUROSURG, V24, P31, DOI 10.3109/02688690903370305
   Soneru CP, 2019, ACTA NEUROCHIR WIEN, P1
   Tandon V, 2017, J CLIN NEUROSCI, V37, P96, DOI 10.1016/j.jocn.2016.10.044
   Teramoto A., 1992, NEUROSURGEONS, V11, P163
   Yano S, 2017, WORLD NEUROSURG, V99, P533, DOI 10.1016/j.wneu.2016.12.068
   Yokoyama S, 2001, NEUROSURGERY, V49, P857, DOI 10.1097/00006123-200110000-00014
   Youssef AS, 2005, NEUROSURGERY, V57, P168, DOI 10.1227/01.NEU.0000163602.05663.86
   Zhao B, 2010, J NEUROSURG, V112, P108, DOI 10.3171/2009.3.JNS0929
NR 39
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e802
DI 10.1016/j.wneu.2019.08.004
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300098
PM 31404693
DA 2020-05-12
ER

PT J
AU Frio, F
   Solari, D
   Cavallo, LM
   Cappabianca, P
   Raverot, G
   Jouanneau, E
AF Frio, Federico
   Solari, Domenico
   Cavallo, Luigi Maria
   Cappabianca, Paolo
   Raverot, Gerald
   Jouanneau, Emmanuel
TI Ommaya Reservoir System for the Treatment of Cystic Craniopharyngiomas:
   Surgical Results in a Series of 11 Adult Patients and Review of the
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Continuous drainage; Cystic craniopharyngioma; Cystic drainage;
   Electromagnetic navigation; Neuroendoscopy; Ommaya reservoir
ID SUPRASELLAR CRANIOPHARYNGIOMAS; INTRATUMORAL CHEMOTHERAPY; STEREOTACTIC
   APPROACH; CATHETER PLACEMENT; ENDONASAL APPROACH; MANAGEMENT; RESECTION;
   EXPERIENCE; CHILDREN; NEUROENDOSCOPY
AB OBJECTIVE: Treatment of cystic craniopharyngiomas can be challenging and recurrences are frequent, even after total resection. In selected cases, less-aggressive surgery with the sole drainage of the cyst reliefs symptoms caused by mass effect and represents a valid alternative option, notably in pediatric population. We herein analyze a series of adult cystic craniopharyngiomas, managed with Ommaya Reservoir implant, focusing on local tumor control and eventual complications.
   METHODS: In total, 11 nonconsecutive adult cystic craniopharyngiomas (7 recurrent lesions) were treated with Ommaya Reservoir System (ORS), in 2 neurosurgical centers. ORS was placed in 9 cases using minimally invasive procedures: 6 burr-hole endoscopic insertion and 3 navigated electromagnetic placement; in the remaining 2 patients, the Ommaya reservoir was used as a shunt to prevent cyst recollection during a transcranial approach.
   RESULTS: The main presenting symptoms were visual impairment (75%), cognitive and behavioral disorders (66.7%), hypopituitarism (38%), headache (30.8%), and hypothalamic obesity (8%). The median follow-up period was 41.4 months. In all patients, the visual function and intracranial hypertension improved after decompression. Local tumor control was accomplished in 8 patients (72.7%), without the need of adjuvant treatments. The endoscopic vision carried similar rates of tumor control than stereotaxy (75% vs. 66.7%).
   CONCLUSIONS: In selected patients, tailored procedures are required to achieve long-term tumor control and as well limit surgery-related morbidity. ORS could represent a safe and effective treatment option for cystic craniopharyngiomas, providing also reduced surgical-related morbidity, especially in recurrent lesions and in patients not suitable for radical surgery.
C1 [Frio, Federico; Solari, Domenico; Cavallo, Luigi Maria; Cappabianca, Paolo] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Neurosurg, Naples, Italy.
   [Raverot, Gerald] Univ Lyon, Hosp Civils Lyon, Reference Ctr Rare Pituitary Dis HYPO, Dept Endocrinol, Lyon, France.
   [Jouanneau, Emmanuel] Hosp Civils Lyon, Grp Hosp Est, Serv NeuroChirurg Base Crane & Hypophyse, Lyon, France.
RP Frio, F (reprint author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Neurosurg, Naples, Italy.
EM frio.federico@gmail.com
OI Frio, Federico/0000-0002-0010-2942; SOLARI, Domenico/0000-0003-1535-8737
CR BACKLUND EO, 1994, PEDIATR NEUROSURG, V21, P82, DOI 10.1159/000120867
   Barajas MA, 2002, J NEUROSURG, V97, P607, DOI 10.3171/jns.2002.97.supplement_5.0607
   Caldarelli M, 2005, CHILD NERV SYST, V21, P747, DOI 10.1007/s00381-005-1186-5
   Cavalheiro S, 2005, CHILD NERV SYST, V21, P719, DOI 10.1007/s00381-005-1226-1
   Cavallo LM, 2014, J NEUROSURG, V121, P100, DOI 10.3171/2014.3.JNS131521
   Chung WY, 2000, J NEUROSURG, V93, P47, DOI 10.3171/jns.2000.93.supplement_3.0047
   Dastoli PA, 2011, ARQ NEURO-PSIQUIAT, V69, P50, DOI 10.1590/S0004-282X2011000100011
   Derrey S, 2008, NEUROSURGERY, V63, P1045, DOI 10.1227/01.NEU.0000335786.10968.2F
   Fahlbusch R, 1999, J NEUROSURG, V90, P237, DOI 10.3171/jns.1999.90.2.0237
   Gardner PA, 2008, J NEUROSURG, V109, P6, DOI 10.3171/JNS/2008/109/7/0006
   Greenfield JP, 2008, STEREOT FUNCT NEUROS, V86, P101, DOI 10.1159/000112431
   GUTIN PH, 1980, J NEUROSURG, V52, P36, DOI 10.3171/jns.1980.52.1.0036
   Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P397, DOI 10.1111/j.1365-2265.2005.02231.x
   Karavitaki N, 2014, J ENDOCRINOL INVEST, V37, P219, DOI 10.1007/s40618-013-0050-9
   Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715
   Kilday JP, 2017, NEURO-ONCOLOGY, V19, P1398, DOI 10.1093/neuonc/nox056
   Lauretti L, 2018, WORLD NEUROSURG, V110, pE367, DOI 10.1016/j.wneu.2017.11.004
   Lee M, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/5/E4
   Mead PA, 2014, J INFECTION, V68, P225, DOI 10.1016/j.jinf.2013.11.014
   Morisako H, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16211
   Mortini P, 2017, ENDOCRINE, V57, P191, DOI 10.1007/s12020-016-1192-2
   Mortini P, 2011, J NEUROSURG, V114, P1350, DOI 10.3171/2010.11.JNS10670
   Moussa AH, 2013, BRIT J NEUROSURG, V27, P370, DOI 10.3109/02688697.2012.741732
   Muskens IS, 2017, PITUITARY, V20, P539, DOI 10.1007/s11102-017-0815-9
   Nicolato A, 2004, MINIM INVAS NEUROSUR, V47, P32, DOI 10.1055/s-2003-812467
   Ottenhausen M, 2019, J NEUROSURG SCI, V63, P83, DOI 10.23736/S0390-5616.17.04171-6
   Park YS, 2011, J NEUROSURG, V114, P1360, DOI 10.3171/2009.9.JNS09301
   Pereira AM, 2005, CLIN ENDOCRINOL, V62, P197, DOI 10.1111/j.1365-2265.2004.02196.x
   Peyrl A, 2014, J NEURO-ONCOL, V120, P139, DOI 10.1007/s11060-014-1531-1
   Prieto R, 2018, WORLD NEUROSURG, V110, pE404, DOI 10.1016/j.wneu.2017.11.012
   Prieto R, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16304
   Puget S, 2006, J PEDIATR ENDOCR MET, V19, P367
   Rachinger W, 2017, NEUROSURGERY, V80, P733, DOI 10.1227/NEU.0000000000001408
   Rahmathulla Gazanfar, 2013, Surg Neurol Int, V4, pS411, DOI 10.4103/2152-7806.121612
   Reda WAH, 2002, J NEUROSURG, V97, P610, DOI 10.3171/jns.2002.97.supplement_5.0610
   Saleem M Abid, 2013, Acta Neurochir Suppl, V116, P55, DOI 10.1007/978-3-7091-1376-9_9
   SPAZIANTE R, 1989, ACTA NEUROCHIR, V97, P95, DOI 10.1007/BF01772817
   Srikandarajah N, 2014, BRIT J NEUROSURG, V28, P475, DOI 10.3109/02688697.2013.854314
   Steinbok P, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09315
   Szvalb AD, 2014, J INFECTION, V68, P216, DOI 10.1016/j.jinf.2013.12.002
   Takahashi M, 2007, MINIM INVAS NEUROSUR, V50, P340, DOI 10.1055/s-2007-993162
   Takano S, 2015, WORLD NEUROSURG, V84, P1305, DOI 10.1016/j.wneu.2015.06.022
   Van Effenterre R, 2002, J NEUROSURG, V97, P3, DOI 10.3171/jns.2002.97.1.0003
   Weiner GM, 2015, CLIN NEUROL NEUROSUR, V130, P61, DOI 10.1016/j.clineuro.2014.12.018
   WEINER HL, 1994, NEUROSURGERY, V35, P1001, DOI 10.1227/00006123-199412000-00001
   YASARGIL MG, 1990, J NEUROSURG, V73, P3, DOI 10.3171/jns.1990.73.1.0003
   Zhang C, 2018, AM J CLIN ONCOL-CANC, V41, P807, DOI 10.1097/COC.0000000000000378
NR 47
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e869
DI 10.1016/j.wneu.2019.07.217
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300105
PM 31400528
DA 2020-05-12
ER

PT J
AU Hashimoto, Y
   Matsushige, T
   Shimonaga, K
   Hosogai, M
   Kaneko, M
   Ono, C
   Mizoue, T
AF Hashimoto, Yukishige
   Matsushige, Toshinori
   Shimonaga, Koji
   Hosogai, Masahiro
   Kaneko, Mayumi
   Ono, Chiaki
   Mizoue, Tatsuya
TI Vessel Wall Imaging Predicts the Presence of Atherosclerotic Lesions in
   Unruptured Intracranial Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atherosclerosis; Intraoperative inspection; Unruptured intracranial
   aneurysm; Vessel wall imaging
ID CEREBRAL ANEURYSMS; CLINICOPATHOLOGICAL INSIGHTS; METAANALYSIS; RUPTURE;
   SAFETY
AB BACKGROUND: Recent studies have suggested that magnetic resonance vessel wall imaging (VWI) can visualize thickened intracranial aneurysm wall. We aimed to investigate correlations between VWI findings and intraoperative aneurysm wall features based on the hypothesis that VWI can visualize atherosclerotic changes in unruptured intracranial aneurysm (UIA) walls.
   METHODS: A total of 36 microsurgically treated UIAs were retrospectively reviewed. All aneurysms underwent VWI before microsurgical clipping, and fusion images with time-of-flight magnetic resonance angiography were created to localize aneurysm wall enhancement (AWE) lesions. Intraoperatively, 2 neurosurgeons who were blinded to the VWI findings evaluated the aneurysm wall features, giving each aneurysm an atherosclerosis score on a 5-point scale (5: yellowish, 4: whitish, 3: normal, 2: slightly reddish, 1: reddish). We defined atherosclerotic lesions as those having average scores >= 4. We evaluated the rate of correspondence between AWE lesions and atherosclerotic lesions, and the factors associated with AWE.
   RESULTS: Sixteen of the 36 UIAs (44%) were identified as AWE. The sensitivity, specificity, positive predictive value, and negative predictive value of correspondence between AWE lesions and atherosclerotic lesions were 79%, 94%, 94%, and 80%, respectively. The average atherosclerosis scores (4.2 +/- 0.5 vs. 2.7 +/- 0.9; P < 0.001) were significantly higher in aneurysms with AWE. Twelve of 16 UIAs with wall enhancement had wall thinning adjacent to the part with AWE.
   CONCLUSIONS: AWE lesions corresponded with intraoperatively confirmed atherosclerotic lesions of UIAs. Detecting these lesions would be valuable in exploring UIAs with wall degeneration.
C1 [Hashimoto, Yukishige; Matsushige, Toshinori; Shimonaga, Koji; Hosogai, Masahiro; Mizoue, Tatsuya] Hiroshima City Asa Citizens Hosp, Dept Neurosurg & Intervent Neuroradiol, Hiroshima, Japan.
   [Kaneko, Mayumi] Hiroshima City Asa Citizens Hosp, Dept Pathol, Hiroshima, Japan.
   [Ono, Chiaki] Hiroshima City Asa Citizens Hosp, Dept Radiol, Hiroshima, Japan.
RP Matsushige, T (reprint author), Hiroshima City Asa Citizens Hosp, Dept Neurosurg & Intervent Neuroradiol, Hiroshima, Japan.
EM teruteru728@hiroshima-u.ac.jp
OI Hosogai, Masahiro/0000-0001-7217-4446
CR Bhatia S, 2011, ACTA NEUROCHIR, V153, P905, DOI 10.1007/s00701-010-0846-8
   Carvi y Nievas Mario N., 2000, Journal of Neurosurgery, V92, P478
   Cebral JR, 2019, AM J NEURORADIOL, V40, P510, DOI 10.3174/ajnr.A5970
   Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84
   Chen Peng Roc, 2004, Neurosurg Focus, V17, pE5
   Edjlali M, 2018, RADIOLOGY, V289, P181, DOI 10.1148/radiol.2018172879
   Etminan N, 2017, NAT REV NEUROL, V13, P126, DOI 10.1038/nrneurol.2017.14
   Flamm ES, 2000, ANN SURG, V232, P570, DOI 10.1097/00000658-200010000-00012
   Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da
   Frosen J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-71
   Fu QC, 2018, CLIN NEURORADIOL, V28, P509, DOI 10.1007/s00062-017-0598-4
   Furukawa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191287
   Grigorian AA, 2003, J NEUROSURG, V99, P452, DOI 10.3171/jns.2003.99.3.0452
   Hudson JS, 2019, STROKE, V50, pE18, DOI 10.1161/STROKEAHA.118.023744
   Hudson JS, 2019, STROKE, V50, pE1, DOI 10.1161/STROKEAHA.118.023701
   Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396
   KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837
   Kotowski M, 2013, J NEUROL NEUROSUR PS, V84, P42, DOI 10.1136/jnnp-2011-302068
   Larsen N, 2018, AM J NEURORADIOL, V39, P1617, DOI 10.3174/ajnr.A5731
   Liu A, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0628-2
   Matouk CC, 2013, NEUROSURGERY, V72, P492, DOI 10.1227/NEU.0b013e31827d1012
   Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558
   Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
   Ohno K, 1999, ACTA NEUROCHIR, V141, P699, DOI 10.1007/s007010050364
   Ollikainen E, 2016, J NEUROPATH EXP NEUR, V75, P689, DOI 10.1093/jnen/nlw041
   Park Chang Kyu, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P247, DOI 10.7461/jcen.2014.16.3.247
   Ruan CH, 2015, BRIT J NEUROSURG, V29, P485, DOI 10.3109/02688697.2015.1023771
   Shimonaga K, 2018, STROKE, V49, P2516, DOI 10.1161/STROKEAHA.118.021819
   Shinagawa K, 2017, WORLD NEUROSURG, V108, P418, DOI 10.1016/j.wneu.2017.09.020
   Sugiyama S, 2013, NEUROSURGERY, V73, P767, DOI 10.1227/NEU.0000000000000096
   Suzuki T, 2016, NEUROSURGERY, V79, P589, DOI 10.1227/NEU.0000000000001232
NR 31
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e775
DI 10.1016/j.wneu.2019.08.019
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300095
PM 31415889
DA 2020-05-12
ER

PT J
AU Hernandez-Duran, S
   Mielke, D
   Rohde, V
   Malinova, V
AF Hernandez-Duran, Silvia
   Mielke, Dorothee
   Rohde, Veit
   Malinova, Vesna
TI Does Nimodipine Interruption due to High Catecholamine Doses Lead to a
   Greater Incidence of Delayed Cerebral Ischemia in the Setting of
   Aneurysmal Subarachnoid Hemorrhage?
SO WORLD NEUROSURGERY
LA English
DT Article
DE Delayed cerebral ischemia; Induced hypertension; Nimodipine;
   Subarachnoid hemorrhage; Triple-H; Vasopressors; Vasospasm
ID INDUCED HYPERTENSION; VASOSPASM; MANAGEMENT; PATHOPHYSIOLOGY;
   NEUROTOXICITY; STROKE
AB BACKGROUND: Current guidelines recommend the administration of nimodipine for the prevention of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). However, nimodipine can lead to significant drops in mean arterial pressure and cerebral perfusion pressure. Catecholamines are then used to maintain them while nimodipine is reduced and/or held. There is no evidence that nimodipine retains its neuroprotective effect at lower doses. We aimed to investigate the role of nimodipine interruption in the setting of aSAH and its possible impact on the incidence of DCI.
   METHODS: We performed a retrospective analysis in patients with aSAH admitted to our center from January 2012 to October 2015. Nimodipine prophylaxis duration and dosage and the incidence of DCI were recorded. Bivariate correlation with Spearman's rho (r) and ordinal regression analyses were performed.
   RESULTS: A total of 170 patients were included in the study. Of these, 165 (97.1%) received nimodipine prophylaxis starting on day 0. Nimodipine was interrupted in 85 of 165 (51.5%), whereas dose was reduced in 47 of 165 (28.5%); full dose was received by only 33 of 165 (20%). DCI was observed in 85 of 170 (50%). Nimodipine interruption correlated in a statistically significant way with a greater incidence of DCI (r = 0.431, P < 0.001); receiving full doses of nimodipine showed a statistically significant inverse correlation to DCI (r = -0.273, P < 0.001). Ordinal regression analysis revealed nimodipine interruption as a statistically significant independent predictor of DCI (odds ratio 0.194; 95% confidence interval 0.079-0.474, P < 0.001).
   CONCLUSIONS: Our analysis reveals a greater incidence of DCI in patients with aSAH when nimodipine is interrupted.
C1 [Hernandez-Duran, Silvia; Mielke, Dorothee; Rohde, Veit; Malinova, Vesna] Univ Med Gottingen, Dept Neurol Surg, Gottingen, Germany.
RP Hernandez-Duran, S (reprint author), Univ Med Gottingen, Dept Neurol Surg, Gottingen, Germany.
EM silvia.hernandez@med.uni-goettingen.de
CR Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975
   ALLCOCK JM, 1963, J NEUROSURG, V20, P752, DOI 10.3171/jns.1963.20.9.0752
   Barker FG, 1996, J NEUROSURG, V84, P405, DOI 10.3171/jns.1996.84.3.0405
   Boluijt J, 2015, J CEREBR BLOOD F MET, V35, P724, DOI 10.1038/jcbfm.2015.13
   Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711
   Choi HA, 2012, NEUROCRIT CARE, V16, P363, DOI 10.1007/s12028-012-9670-8
   Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A
   Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839
   Dankbaar JW, 2010, CRIT CARE, V14, DOI 10.1186/cc8886
   Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y
   Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691
   Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9
   Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3
   Duzenli S, 2005, TOXICOL IN VITRO, V19, P589, DOI 10.1016/j.tiv.2005.03.007
   Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7
   Foreman B, 2016, J CLIN NEUROPHYSIOL, V33, P174, DOI 10.1097/WNP.0000000000000273
   Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6
   Frontera JA, 2015, J NEUROL NEUROSUR PS, V86, P71, DOI 10.1136/jnnp-2013-307313
   Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700
   Gathier CS, 2014, INT J STROKE, V9, P375, DOI 10.1111/ijs.12055
   Gathier CS, 2018, STROKE, V49, P76, DOI 10.1161/STROKEAHA.117.017956
   Hashioka S, 2012, NEUROPHARMACOLOGY, V63, P685, DOI 10.1016/j.neuropharm.2012.05.033
   Kronvall E, 2009, J NEUROSURG, V110, P58, DOI 10.3171/2008.7.JNS08178
   Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191
   Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497
   MacKenzie Meghan, 2014, Can J Hosp Pharm, V67, P358
   Malinova V, 2016, J NEUROSURG, V125, P128, DOI 10.3171/2015.6.JNS15720
   MILLIKAN CH, 1975, ARCH NEUROL-CHICAGO, V32, P433, DOI 10.1001/archneur.1975.00490490037003
   Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD
   Muhammad S, 2016, STROKE, V47, P519, DOI 10.1161/STROKEAHA.115.011697
   PORCHET F, 1995, ACTA NEUROCHIR, V137, P62, DOI 10.1007/BF02188783
   Roos YBWEM, 2001, STROKE, V32, P1860, DOI 10.1161/01.STR.32.8.1860
   Sandow N, 2016, NEUROCRIT CARE, V25, P29, DOI 10.1007/s12028-015-0230-x
   Sanelli PC, 2014, AM J NEURORADIOL, V35, P2209, DOI 10.3174/ajnr.A3782
   Soppi V, 2007, EUR J CLIN PHARMACOL, V63, P355, DOI 10.1007/s00228-007-0267-7
   Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e834
DI 10.1016/j.wneu.2019.08.001
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300101
PM 31404696
DA 2020-05-12
ER

PT J
AU Hu, LY
   Wu, TK
   Liu, H
   Wang, BY
   Zhang, JY
   Meng, Y
   Ding, C
   Gao, XL
   Hong, Y
AF Hu, Lingyun
   Wu, Tingkui
   Liu, Hao
   Wang, Beiyu
   Zhang, Jianying
   Meng, Yang
   Ding, Chen
   Gao, Xinlin
   Hong, Ying
TI Influence of Fusion on the Behavior of Adjacent Disc Arthroplasty in
   Contiguous 2-Level Hybrid Surgery In Vivo
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical disc arthroplasty; Complications; Hybrid construct; Multilevel
   cervical degenerative disc disease; Prosthetic behavior; Radiography
ID SINGLE-LEVEL; PRESTIGE LP; PRODISC-C; HETEROTOPIC OSSIFICATION;
   BIOMECHANICAL ANALYSIS; CERVICAL-SPINE; REPLACEMENT; MULTILEVEL; BRYAN;
   CONSTRUCTS
AB OBJECTIVE: To investigate whether the behavior of disc arthroplasty in 2-level hybrid surgery (HS) was affected by adjacent fusion in vivo compared with cervical disc arthroplasty (CDA) alone.
   METHODS: Seventy-nine patients undergoing either a 1-level CDA or contiguous 2-level HS were retrospectively reviewed. Radiologic assessments included segmental lordosis (SL), intervertebral disc height (IDH), changes in SL and IDH, range of motion (ROM) of the disc replacement and its adjacent segments, migration and subsidence of the prosthesis, heterotopic ossification (HO), and adjacent segment degeneration (ASD) adjacent to the arthroplasty level. Clinical features and outcome scores were also recorded.
   RESULTS: Compared with 1-level CDA, the increased SL and IDH immediately after surgery in 2-level HS were more likely to be lost throughout the follow- up period. However, both groups generally maintained the SL and IDH of the arthroplasty segment postoperatively. Two-level HS did not exhibit hypermobility of the disc prosthesis and preserved preoperative ROM of the adjacent segment of the device. The HS group showed adverse effects on the prosthesis stability, but there was no significant difference in the number of cases of obvious migration or subsidence between the groups. The differences in HO, ASD, and clinical outcomes between the groups were not significant at the final follow-up.
   CONCLUSIONS: Although the fusion in 2-level HS partially affected the behavior of adjacent disc arthroplasty compared with CDA alone, it did not cause severe complications and adverse clinical outcomes. However, largescale and long follow-up trials are warranted.
C1 [Hu, Lingyun; Wu, Tingkui; Liu, Hao; Wang, Beiyu; Meng, Yang; Ding, Chen; Gao, Xinlin; Hong, Ying] Sichuan Univ, West China Hosp, Dept Orthoped Surg, Chengdu, Sichuan, Peoples R China.
   [Hu, Lingyun] North Sichuan Med Coll, Clin Med Coll 2, Nanchong Cent Hosp, Dept Orthopaed Surg, Nanchong, Sichuan, Peoples R China.
   [Zhang, Jianying] North Sichuan Med Coll, Clin Med Coll 2, Nanchong Cent Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China.
RP Liu, H (reprint author), Sichuan Univ, West China Hosp, Dept Orthoped Surg, Chengdu, Sichuan, Peoples R China.
EM liuhaohuaxi@126.com
CR Barrey C, 2012, EUR SPINE J, V21, P432, DOI 10.1007/s00586-011-1974-4
   Chen J, 2016, J CLIN NEUROSCI, V27, P59, DOI 10.1016/j.jocn.2015.07.030
   Cho BY, 2010, SPINE, V35, P1769, DOI 10.1097/BRS.0b013e3181c225fa
   Chung TT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002048
   Di Martino A, 2015, EUR SPINE J, V24, pS810, DOI 10.1007/s00586-015-4258-6
   Ding F, 2014, SPINE, V39, P1934, DOI 10.1097/BRS.0000000000000588
   Du W, 2013, EUR SPINE J, V22, P1594, DOI 10.1007/s00586-013-2741-5
   Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003
   Gandhi AA, 2015, SPINE, V40, P1578, DOI 10.1097/BRS.0000000000001044
   Grasso G, 2015, EUR SPINE J, V24, pS842, DOI 10.1007/s00586-015-4281-7
   Jia ZW, 2014, EUR SPINE J, V23, P1619, DOI 10.1007/s00586-014-3389-5
   Kim KS, 2016, CLIN SPINE SURG, V29, pE309, DOI 10.1097/BSD.0000000000000054
   Kowalczyk I, 2011, J NEUROSURG-SPINE, V15, P630, DOI 10.3171/2011.8.SPINE11273
   Lanman TH, 2017, J NEUROSURG-SPINE, V27, P7, DOI 10.3171/2016.11.SPINE16746
   Laratta JL, 2018, GLOB SPINE J, V8, P78, DOI 10.1177/2192568217701095
   Lee SE, 2015, EUR SPINE J, V24, P2899, DOI 10.1007/s00586-015-4132-6
   Liao ZH, 2015, MED SCI MONITOR, V21, P3348, DOI 10.12659/MSM.896085
   Lin CY, 2009, SPINE, V34, P1554, DOI 10.1097/BRS.0b013e3181aa643b
   Liu BG, 2015, MED SCI MONITOR, V21, P1031, DOI 10.12659/MSM.892712
   Martin S, 2011, SPINE, V36, P1359, DOI 10.1097/BRS.0b013e318222d4ad
   McAfee PC, 2003, J SPINAL DISORD TECH, V16, P384, DOI 10.1097/00024720-200308000-00010
   Mo ZJ, 2017, EUR SPINE J, V26, P1181, DOI 10.1007/s00586-016-4777-9
   Park J, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.06.013
   Ren XJ, 2016, CLIN SPINE SURG, V29, P218, DOI 10.1097/BSD.0b013e31826994bb
   Roberts TT, 2018, CLIN SPINE SURG, V31, P6, DOI 10.1097/BSD.0000000000000607
   Shin DA, 2009, SPINE, V34, P1153, DOI [10.1097/BRS.0b013e31819c9d39, 10.1097/BRS.0b013e3181ba2a8d]
   Walraevens J, 2010, NEUROSURGERY, V67, P679, DOI 10.1227/01.NEU.0000377039.89725.F3
   Wang KF, 2018, WORLD NEUROSURG, V113, pE70, DOI 10.1016/j.wneu.2018.01.157
   Wu JC, 2012, SPINE, V37, pE1251, DOI 10.1097/BRS.0b013e318265a126
   Wu TK, 2018, SPINE J, V18, P2171, DOI 10.1016/j.spinee.2018.04.019
   Xu JX, 2009, SPINE, V34, P1012, DOI 10.1097/BRS.0b013e31819c4a5b
NR 31
TC 0
Z9 0
U1 7
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e929
DI 10.1016/j.wneu.2019.07.073
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300112
PM 31323402
DA 2020-05-12
ER

PT J
AU Hu, X
   Jiang, MJ
   Liu, H
   Rong, X
   Hong, Y
   Ding, C
   Wang, BY
AF Hu, Xu
   Jiang, Majiao
   Liu, Hao
   Rong, Xin
   Hong, Ying
   Ding, Chen
   Wang, Beiyu
TI Five-Year Trends in Center of Rotation After Single-Level Cervical
   Arthroplasty with the Prestige-LP Disc
SO WORLD NEUROSURGERY
LA English
DT Article
DE Center of rotation; Cervical disc arthroplasty; Prestige-LP disc; Range
   of motion
ID FLEXION-EXTENSION; FOLLOW-UP; PROSTHESIS; MOTION; SPINE; IMPLANTATION;
   REPLACEMENT; KINEMATICS; OUTCOMES; HEIGHT
AB OBJECTIVES: To assess the in vivo longitudinal kinematic performance of the Prestige-LP Disc and describe the 5-year trends in the center of rotation (COR) at the instrumented level.
   METHODS: Forty-two patients with single-level cervical disc arthroplasty (CDA) were reviewed retrospectively. Lateral static and dynamic cervical radiographs were obtained preoperatively and postoperatively at 1, 3, and 5 years. Kinematic parameters collected included range of motion (ROM), COR, intervertebral disc height (IDH), functional spinal unit (FSU) angle. Japanese Orthopedic Association (JOA), visual analog scale (VAS), and Neck Disability Index (NDI) scores were used to evaluate clinical outcomes.
   RESULTS: The JOA score was increased significantly and VAS and NDI scores were decreased significantly after CDA. The ROM was preserved, stabilizing at 7.8 degrees at the final follow-up. The mean IDH increased significantly from 4.4 +/- 2.6 mm to 7.3 +/- 1.9 mm after surgery, and remained unchanged thereafter. The mean FSU increased by nearly 4 degrees from the preoperative value to 3.6 degrees +/- 4.4 degrees at the 1-year follow-up but failed to maintain lordosis, decreasing to 0.4 degrees +/- 4.7 degrees at the last follow-up. The mean COR-x was calculated as 38.9% preoperatively and remained unchanged throughout the follow-up period. The mean COR- y showed a significant cranial shift after surgery, and an upward trend continued in the subsequent measurements (12.7% at 1 year, 15.4% at 3 years, 19.2% at 5 years); however, there was no significant difference between the 1-year and 5-year measurements.
   CONCLUSIONS: Single-level CDA with the Prestige-LP Disc achieved favorable clinical outcomes and provided a durable solution for spinal motion at the instrumented level. The COR showed a significant cranial shift after surgery and remained relatively stable during the 5-year follow- up period.
C1 [Hu, Xu; Liu, Hao; Rong, Xin; Ding, Chen; Wang, Beiyu] Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China.
   [Jiang, Majiao; Hong, Ying] Sichuan Univ, West China Hosp, Operat Room, Chengdu, Sichuan, Peoples R China.
RP Liu, H (reprint author), Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China.
EM liuhao6304@126.com
FU Sichuan Province Science and Technology Program of China [18ZDYF2182]
FX This study was supported by the Sichuan Province Science and Technology
   Program of China (Grant 18ZDYF2182).
CR Ahn HS, 2008, SPINE, V33, P883, DOI 10.1097/BRS.0b013e31816b1f5c
   AMEVO B, 1992, SPINE, V17, P748, DOI 10.1097/00007632-199207000-00004
   Barrey C, 2012, EUR SPINE J, V21, P1648, DOI 10.1007/s00586-012-2180-8
   Barrey C, 2009, J NEUROSURG-SPINE, V11, P538, DOI 10.3171/2009.6.SPINE0949
   Burkhardt BW, 2016, WORLD NEUROSURG, V92, P371, DOI 10.1016/j.wneu.2016.05.036
   Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513
   DVORAK J, 1991, J ORTHOPAED RES, V9, P828, DOI 10.1002/jor.1100090608
   Galbusera F, 2010, CLIN BIOMECH, V25, P397, DOI 10.1016/j.clinbiomech.2010.01.010
   Gornet MF, 2015, SPINE J, V15, pS127
   Johnson J Patrick, 2004, Neurosurg Focus, V17, pE14
   Kurtz SM, 2008, SPINE, V33, P481, DOI 10.1097/BRS.0b013e318165e3be
   Li HB, 2016, CLIN NEUROL NEUROSUR, V148, P1, DOI 10.1016/j.clineuro.2016.06.010
   Liu BG, 2014, EUR SPINE J, V23, P2307, DOI 10.1007/s00586-014-3431-7
   Liu JY, 2006, SPINE, V31, pE350, DOI 10.1097/01.brs.0000219496.42765.8a
   Nanda A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.09.022
   O'Leary Patrick, 2005, Spine J, V5, P590, DOI 10.1016/j.spinee.2005.06.015
   Peng CWB, 2009, SPINE J, V9, P551, DOI 10.1016/j.spinee.2009.03.008
   Peng CWB, 2011, SPINE, V36, pE105, DOI 10.1097/BRS.0b013e3181d76f99
   Quan GMY, 2011, SPINE, V36, P639, DOI 10.1097/BRS.0b013e3181dc9b51
   Resnick DK, 2013, SPINE J, V13, P635, DOI 10.1016/j.spinee.2013.04.002
   Rong X, 2014, SPINE, V39, pB12, DOI 10.1097/BRS.0000000000000634
   Rousseau MA, 2008, SPINE, V33, pE6, DOI 10.1097/BRS.0b013e31815e5dce
   Rousseau MA, 2008, SPINE, V33, pE10, DOI 10.1097/BRS.0b013e31815e62ea
   Sasso RC, 2011, SPINE, V36, P991, DOI 10.1097/BRS.0b013e3182076d70
   Zeng JF, 2018, CLIN NEUROL NEUROSUR, V164, P97, DOI 10.1016/j.clineuro.2017.12.004
NR 25
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e941
DI 10.1016/j.wneu.2019.07.042
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300113
PM 31302269
DA 2020-05-12
ER

PT J
AU Huang, DZ
   Ju, JH
   Jiang, B
   Wang, YH
   He, W
   Yin, X
   Guo, WQ
   Wang, ZG
AF Huang, Dezhang
   Ju, Jianghua
   Jiang, Bin
   Wang, Yihua
   He, Wei
   Yin, Xin
   Guo, Wenqiang
   Wang, Zhigang
TI Changes of the Expression and Activity of Phosphodiesterase V in the
   Basilar Artery Before and After Cerebral Vasospasm in a Rabbit Model
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral vasospasm; Digital subtraction angiography (DSA);
   Phosphodiesterase V; Subarachnoid hemorrhage; Transcranial Doppler (TCD)
ID SUBARACHNOID HEMORRHAGE; SYMPTOMATIC VASOSPASM; THERAPY; INHIBITION;
   VESSELS; FLOW
AB OBJECTIVE: To examine changes of expression and activity of phosphodiesterase V (PDE V) in the basilar artery following cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) in a rabbit model.
   METHODS: A rabbit model of CVS after SAH was constructed by double blood injection into the cisterna magna. Subjects were divided into 3 groups: blank control group, normal saline group, and SAH group. Transcranial Doppler and selective vertebrobasilar digital subtraction angiography were performed to identify changes of CVS. Changes of PDE V expression and activity were examined.
   RESULTS: Mean basilar arterial blood flow rate measured by transcranial Doppler was significantly increased in the SAH group compared with the blank control group and normal saline group. Mean basilar artery diameter measured by digital subtraction angiography in the SAH group was narrower than in the other 2 groups. Compared with the other 2 groups, the expression of PDE V in the SAH group was significantly upregulated, and the activity was significantly enhanced.
   CONCLUSIONS: The rabbit model of SAH-induced CVS was successfully constructed through double blood injection method. Increased basilar artery blood flow, narrowing of the basilar artery, increased PDE V expression, and enhanced PDE V activity in the basilar artery were detected in the CVS rabbits, suggesting that PDE V has the potential to be used as a target for CVS therapy.
C1 [Huang, Dezhang; Jiang, Bin; Wang, Yihua; He, Wei; Yin, Xin; Guo, Wenqiang; Wang, Zhigang] Shandong Univ Qing Dao, Dept Neurosurg, Qilu Hosp, Qingdao, Shandong, Peoples R China.
   [Ju, Jianghua] Shandong Univ Qing Dao, Dept Endocrinol, Qilu Hosp, Qingdao, Shandong, Peoples R China.
RP Wang, ZG (reprint author), Shandong Univ Qing Dao, Dept Neurosurg, Qilu Hosp, Qingdao, Shandong, Peoples R China.
EM wzg1110@126.com
FU 2018 Annual Medical Research Guidance Program of Qingdao City, China
   [2018-WJZD133]
FX This work was supported by the 2018 Annual Medical Research Guidance
   Program of Qingdao City, China (2018-WJZD133).
CR Bobin P, 2016, ARCH CARDIOVASC DIS, V109, P431, DOI 10.1016/j.acvd.2016.02.004
   Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045
   Friedman JA, 2002, J NEUROSURG, V97, P401, DOI 10.3171/jns.2002.97.2.0401
   Kovacic S, 2006, AUTON NEUROSCI-BASIC, V130, P28, DOI 10.1016/j.autneu.2006.05.002
   Li HL, 2015, J SURG RES, V195, P271, DOI 10.1016/j.jss.2015.01.016
   Loch R, 2006, AM J PHYSIOL-HEART C, V290, pH2329, DOI 10.1152/ajpheart.00911.2005
   Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003
   Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035
   Mergia E, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0646-5
   Miki K, 2015, CARDIOVASC INTERV TH, V30, P227, DOI 10.1007/s12928-014-0307-z
   Movsesian M, 2016, PHARMACOL THERAPEUT, V163, P74, DOI 10.1016/j.pharmthera.2016.03.014
   Mukherjee Kanchan K, 2012, Surg Neurol Int, V3, P3, DOI 10.4103/2152-7806.92164
   Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751
   Oka M, 2001, AM J PHYSIOL-LUNG C, V280, pL432
   Otawara Y, 2002, NEUROSURGERY, V51, P939, DOI 10.1097/00006123-200210000-00015
   OTSUJI T, 1994, STROKE, V25, P657, DOI 10.1161/01.STR.25.3.657
   Pathak A, 2003, BRIT J NEUROSURG, V17, P306, DOI 10.1080/02688690310001601180
   SCHNECK SA, 1964, ARCH NEUROL-CHICAGO, V11, P668, DOI 10.1001/archneur.1964.00460240100013
   Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227
   Singh TP, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.006
   Sobey CG, 1999, AM J PHYSIOL-HEART C, V277, pH1718
   Takeo S, 2003, BRIT J PHARMACOL, V138, P642, DOI 10.1038/sj.bjp.0705096
   Treggiari MM, 2003, J NEUROSURG, V98, P978, DOI 10.3171/jns.2003.98.5.0978
   Vatter H, 2007, NEUROSURGERY, V60, P179, DOI 10.1227/01.NEU.0000249212.96719.95
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e795
DI 10.1016/j.wneu.2019.08.008
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300097
PM 31404697
DA 2020-05-12
ER

PT J
AU Hulsbergen, AFC
   Mirzaei, L
   van der Boog, ATJ
   Smith, TR
   Muskens, IS
   Broekman, MLD
   Mekary, RA
   Moojen, WA
AF Hulsbergen, Alexander F. C.
   Mirzaei, Lida
   van der Boog, Arthur T. J.
   Smith, Timothy R.
   Muskens, Ivo S.
   Broekman, Marike L. D.
   Mekary, Rania A.
   Moojen, Wouter A.
TI Long-Term Durability of Open Surgical versus Endovascular Repair of
   Intracranial Aneurysms: A Systematic Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Article; Proceedings Paper
CT European-Association-of-Neurosurgical-Societies Annual Meeting
CY OCT 21-25, 2018
CL Brussels, BELGIUM
SP European Assoc Neurosurg Soc
DE Clipping; Endovascular aneurysm treatment; Intracranial aneurysms;
   Meta-analysis; Recurrence; Rebleeding; Retreatment
ID CEREBRAL-ARTERY ANEURYSMS; COILING; TRIAL; MANAGEMENT; EXPERIENCE;
   EFFICACY; DEVICES; SAFETY; SERIES; ISAT
AB OBJECTIVE: The long-term durability of different modalities of intracranial aneurysm repair remains unclear. The aim of this study was to conduct a meta-analysis comparing long-term rates of intracranial aneurysm recurrence, retreatment, and rebleeding after surgical clipping or endovascular treatment (EVT).
   METHODS: A systematic review of PubMed and Embase was performed in accordance with the PRISMA guidelines and a meta-analysis was conducted. Cohort studies and randomized controlled trials (RCTs) with a surgical and an endovascular arm of 10 patients each and a median follow-up of 3 years were included. Pooled-effect estimates for reported outcomes were calculated using the random-effects model; sensitivity analysis was performed using the fixed-effects model.
   RESULTS: Of 4876 articles, 11 studies including 3 RCTs comprising 4517 patients were analyzed. Coiling was the modality of EVT in all included studies. In the randomeffects model, coiling was associated with an increased relative risk of 8.1 for recurrence (95% confidence interval [CI], 3.8-17.2), 4.5 for retreatment (95% CI, 3.4-5.9), and 2.1 for rebleeding (95% CI, 1.3-3.5); the fixed-effects model yielded similar results. Meta-regression by study design, length of follow-up, age, aneurysm size, ruptured versus unruptured aneurysms, or posterior versus anterior location did not yield significant results (all P interactions >0.05). No significant publication bias was identified.
   CONCLUSIONS: These results indicate better long-term durability of clipping compared with coiling-based EVT. The relatively high incidence of recurrence and retreatment after coiling should be considered when determining treatment strategy.
C1 [Hulsbergen, Alexander F. C.; Smith, Timothy R.; Muskens, Ivo S.; Broekman, Marike L. D.; Mekary, Rania A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, CNOC, Boston, MA 02115 USA.
   [Hulsbergen, Alexander F. C.; Mirzaei, Lida; van der Boog, Arthur T. J.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.
   [Hulsbergen, Alexander F. C.; Broekman, Marike L. D.; Moojen, Wouter A.] Haaglanden Med Ctr, Dept Neurosurg, The Hague, Zuid Holland, Netherlands.
   [Hulsbergen, Alexander F. C.; Broekman, Marike L. D.; Moojen, Wouter A.] Haga Teaching Hosp, Dept Neurosurg, The Hague, Zuid Holland, Netherlands.
   [Hulsbergen, Alexander F. C.; Broekman, Marike L. D.; Moojen, Wouter A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Zuid Holland, Netherlands.
   [Muskens, Ivo S.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Ctr Genet Epidemiol, Los Angeles, CA 90033 USA.
   [Muskens, Ivo S.; Mekary, Rania A.] Massachusetts Coll Pharm & Hlth Sci, Sch Pharm, Dept Pharmaceut Business & Adm Sci, Boston, MA 02115 USA.
RP Moojen, WA (reprint author), Haaglanden Med Ctr, Dept Neurosurg, The Hague, Zuid Holland, Netherlands.; Moojen, WA (reprint author), Haga Teaching Hosp, Dept Neurosurg, The Hague, Zuid Holland, Netherlands.; Moojen, WA (reprint author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Zuid Holland, Netherlands.
EM w.moojen@haaglandenmc.nl
CR Aboukais R, 2014, NEUROCHIRURGIE, V60, P283, DOI 10.1016/j.neuchi.2014.06.010
   Aboukais R, 2014, CLIN NEUROL NEUROSUR, V125, P155, DOI 10.1016/j.clineuro.2014.08.006
   Bernat AL, 2017, J NEURORADIOLOGY, V44, P298, DOI 10.1016/j.neurad.2017.05.003
   Blackburn SL, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/348147
   Campi A, 2007, STROKE, V38, P1538, DOI 10.1161/STROKEAHA.106.466987
   Caplan JM, 2014, NEUROSURGERY, V75, P437, DOI 10.1227/NEU.0000000000000468
   Caplan JM, 2014, OPER NEUROSURG, V10, P200, DOI 10.1227/NEU.0000000000000348
   Chen M, 2016, J NEUROINTERV SURG, V8, P42, DOI 10.1136/neurintsurg-2014-011492
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Darsaut TE, 2017, J NEUROL NEUROSUR PS, V88, P663, DOI 10.1136/jnnp-2016-315433
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dong QL, 2016, INT J SURG, V32, P129, DOI 10.1016/j.ijsu.2016.07.004
   Fotakopoulos G, 2017, WORLD NEUROSURG, V104, P482, DOI 10.1016/j.wneu.2017.05.040
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hirst A, 2019, ANN SURG, V269, P211, DOI 10.1097/SLA.0000000000002794
   Hwang JS, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-99
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Jia ZY, 2018, J STROKE, V20, P46, DOI 10.5853/jos.2017.02229
   Johnston SC, 2008, STROKE, V39, P120, DOI 10.1161/STROKEAHA.107.495747
   Lawton MT, 2017, NEW ENGL J MED, V377, P257, DOI 10.1056/NEJMcp1605827
   Lecler A, 2015, RADIOLOGY, V277, P173, DOI 10.1148/radiol.2015142496
   Lehecka M, 2007, NEUROSURGERY, V60, P235, DOI 10.1227/01.NEU.0000249261.95826.8F
   Li H, 2013, STROKE, V44, P29, DOI 10.1161/STROKEAHA.112.663559
   Maud A, 2009, J NEUROSURG, V110, P880, DOI 10.3171/2008.8.JNS0858
   McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767
   Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873
   Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6
   Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8
   Muskens IS, 2017, J AM COLL SURGEONS, V225, P558, DOI 10.1016/j.jamcollsurg.2017.07.1068
   Petr O, 2017, WORLD NEUROSURG, V100, P557, DOI 10.1016/j.wneu.2016.11.134
   Piotin M, 2003, NEURORADIOLOGY, V45, P404, DOI 10.1007/s00234-002-0922-8
   Raja PV, 2008, NEUROSURGERY, V62, P1187, DOI 10.1227/01.neu.0000333291.67362.0b
   Raymond J, 2012, NEUROCHIRURGIE, V58, P103, DOI 10.1016/j.neuchi.2012.02.020
   Raymond J, 2017, J NEUROSURG, V127, P454, DOI 10.3171/2016.4.JNS152662
   Ruan CH, 2015, BRIT J NEUROSURG, V29, P485, DOI 10.3109/02688697.2015.1023771
   Schwarzer G., 2007, R NEWS, V7, P40, DOI DOI 10.3389/FPSYG.2014.01521
   Sejkorova A, 2017, ACTA NEUROCHIR, V159, P549, DOI 10.1007/s00701-016-3058-z
   Sekhar LN, 2013, NEUROSURGERY, V72, P284, DOI 10.1227/NEU.0b013e3182797952
   Smith TR, 2015, WORLD NEUROSURG, V84, P942, DOI 10.1016/j.wneu.2015.05.073
   Spetzler RF, 2015, J NEUROSURG, V123, P609, DOI 10.3171/2014.9.JNS141749
   Wells GA, NEWCASTLE OTTAWA SCA
   Xin WQ, 2019, WORLD NEUROSURG, V128, P464, DOI 10.1016/j.wneu.2019.05.149
NR 42
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e820
DI 10.1016/j.wneu.2019.08.002
PG 14
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300100
PM 31419590
DA 2020-05-12
ER

PT J
AU Iida, K
   Kagawa, K
   Katagiri, M
   Seyama, G
   Hashizume, A
   Abiko, M
   Katayama, J
   Suzuki, H
   Kurisu, K
   Otsubo, H
AF Iida, Koji
   Kagawa, Kota
   Katagiri, Masaya
   Seyama, Go
   Hashizume, Akira
   Abiko, Masaru
   Katayama, Junko
   Suzuki, Hiroharu
   Kurisu, Kaoru
   Otsubo, Hiroshi
TI Preservation of Memory Despite Unresected Contralateral Hippocampal
   Volume Loss After Resection of Hippocampal Sclerosis in Seizure-Free
   Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hippocampal volume; Progressive hippocampal volume loss; Small residual
   hippocampus; Smaller dominant hippocampus; Sparing memory functions
ID TEMPORAL-LOBE EPILEPSY; AUTOMATED SEGMENTATION; BRAIN; ATROPHY; SURGERY;
   MRI; AMYGDALA; DAMAGE
AB OBJECTIVE: To determine postoperative long-termchanges of hippocampal volume (HV) correlating with cognitive functions in patients who underwent surgery for hippocampal sclerosis with postoperative freedom from seizures.
   METHODS: We studied 1.5T magnetic resonance imaging before and after surgery in 24 patients (mean +/- SD age, 36.9 +/- 11.0 years) with hippocampal sclerosis. We performed serial magnetic resonance imaging at 6 months to 1 year, 1-2 years, 2-3 years, and 3-5 years postoperatively. We compared HVs of 24 patients with HVs of 14 age-matched control subjects. We analyzed correlations between consecutive HVs and seizure duration and age at surgery. We compared consecutive changes in HVs between dominant and nondominant hemispheres with concurrent cognitive functions.
   RESULTS: Preoperative HVs of unresected contralateral hippocampus were significantly smaller than HVs of control subjects (P < 0.01). Unresected contralateral HV changes compared with preoperative HVs were -3.6% +/- 6.9%, -2.3% +/- 8.5%, -3.6% +/- 10.2% (P < 0.05), and -5.0% +/- 9.5% (P < 0.05) at consecutive postoperative periods. Largest change in HVs at 3-5 years was significantly correlated with older age at surgery (P < 0.05). Unresected contralateral dominant 14 HVs remained consistently smaller than nondominant 10 HVs up to 5 years with statistical significance (P < 0.05). Verbal memory was preserved in 14 patients with unresected contralateral smaller dominant hippocampus.
   CONCLUSIONS: In seizure-free patients after hippocampal sclerosis resection, unresected contralateral HV significantly declined with older age at surgery. Visual memory was preserved regardless of side and volume loss. Despite significantly reduced HVs, verbal memory was preserved with the unresected contralateral dominant hippocampus. Earlier surgical intervention may have lower potential risk for memory decline secondary to postoperative HV loss.
C1 [Iida, Koji; Kagawa, Kota; Katagiri, Masaya; Seyama, Go; Hashizume, Akira; Abiko, Masaru; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan.
   [Iida, Koji; Kagawa, Kota; Katagiri, Masaya; Seyama, Go; Hashizume, Akira] Hiroshima Univ Hosp, Epilepsy Ctr, Hiroshima, Japan.
   [Katayama, Junko] Hiroshima Chuo Kenshin Sho, Div Radiol, Hiroshima, Japan.
   [Suzuki, Hiroharu; Otsubo, Hiroshi] Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON, Canada.
RP Iida, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan.; Iida, K (reprint author), Hiroshima Univ Hosp, Epilepsy Ctr, Hiroshima, Japan.
EM iidak@hiroshima-u.ac.jp
OI Katagiri, Masaya/0000-0002-2207-6642
CR AMARAL DG, 1984, J COMP NEUROL, V224, P307, DOI 10.1002/cne.902240302
   Araujo D, 2006, EPILEPSIA, V47, P1354, DOI 10.1111/j.1528-1167.2006.00605.x
   Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012
   BERKOVIC SF, 1991, ANN NEUROL, V29, P175, DOI 10.1002/ana.410290210
   Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x
   CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719
   Dupont S, 2002, J NEUROL NEUROSUR PS, V73, P478, DOI 10.1136/jnnp.73.5.478
   Elliott CA, 2016, EPILEPSY RES, V125, P62, DOI 10.1016/j.eplepsyres.2016.06.007
   Engel Jr J., 1993, SURG TREATMENT EPILE, P609
   Fernandes DA, 2014, EPILEPSY BEHAV, V36, P108, DOI 10.1016/j.yebeh.2014.04.028
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Gleissner U, 1998, J NEUROL NEUROSUR PS, V65, P665, DOI 10.1136/jnnp.65.5.665
   Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576
   Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692
   JACK CR, 1990, RADIOLOGY, V176, P205, DOI 10.1148/radiology.176.1.2353093
   JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869
   Japanese WAIS-III Publication Committee, 2006, ADM SCOR MAN JAP VER
   Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2
   Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2
   Lovett M, 2014, PEDIATR NEUROL, V51, P284, DOI 10.1016/j.pediatrneurol.2014.04.019
   MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499
   Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033
   Noulhiane A, 2006, J NEUROSCI METH, V156, P293, DOI 10.1016/j.jneumeth.2006.02.021
   Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x
   Powell S, 2008, NEUROIMAGE, V39, P238, DOI 10.1016/j.neuroimage.2007.05.063
   Rausch R, 2003, NEUROLOGY, V60, P951, DOI 10.1212/01.WNL.0000048203.23766.A1
   Sackellares JC, 1996, PSYCHOL DISTURBANCES, P245
   Salmenpera T, 2005, NEUROLOGY, V64, P62, DOI 10.1212/01.WNL.0000148643.36513.2A
   Seeck M, 1999, EPILEPTIC DISORD, V1, P179
   Seidenberg M, 2005, EPILEPSIA, V46, P420, DOI 10.1111/j.0013-9580.2005.27004.x
   Strauss E, 2006, COMPENDIUM NEUROPSYC
   Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353
   Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6
   Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015
   Wechsler D, 2010, JAPANESE VERSION WEC
   Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501
   Wu WC, 2005, AM J NEURORADIOL, V26, P1270
NR 37
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e759
DI 10.1016/j.wneu.2019.08.021
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300093
PM 31415886
DA 2020-05-12
ER

PT J
AU Ju, DG
   Jeon, C
   Kim, KH
   Park, KA
   Hong, SD
   Seoul, HJ
   Shin, HJ
   Nam, DH
   Lee, JI
   Kong, DS
AF Ju, Dong Gyun
   Jeon, Chiman
   Kim, Kyung Hwan
   Park, Kyung-Ah
   Hong, Sang Duk
   Seoul, Ho Jun
   Shin, Hyung Jin
   Nam, Do-Hyun
   Lee, Jung-Il
   Kong, Doo-Sik
TI Clinical Significance of Tumor-Related Edema of Optic Tract Affecting
   Visual Function in Patients with Sellar and Suprasellar Tumors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic surgery; EOT; Optic coherence tomography; Visual outcome
ID DIAGNOSIS
AB OBJECTIVE: Preoperative tumor-related edema of the optic tract (EOT) is often found along the white matter tract of the visual system. However, the relationship of EOT with visual function and outcome remains unclear. Therefore we aimed to elucidate whether the presence of EOT is associated with visual outcome in patients with sellar and suprasellar tumors.
   METHODS: A total of 212 eyes of 106 patients who underwent endoscopic endonasal surgery for sellar and suprasellar tumors at our institution between March 2016 and August 2018 were included in this retrospective study. Data on patient characteristics, preoperative magnetic resonance imaging findings, and ophthalmologic evaluations were collected. Patients were assigned to 2 groups depending on preoperative magnetic resonance imaging findings (EOT group [ 19 [17.9%], non-EOT group [ 87 [82.1%]). Visual acuity, visual field (VF), global visual function score, VF index, VF mean deviation, and retinal nerve fiber layer thickness as determined by optical coherence tomography were compared between the groups before and after treatment.
   RESULTS: In the EOT group, 4 patients had pituitary adenoma, 8 had craniopharyngioma, and 7 had other pathologies. There was no significant difference of pathologies between the groups. Preoperatively, EOT group showed significantly lower values of global visual function score, VF index, mean deviation, and retinal nerve fiber layer thickness than did the non-EOT group (P < 0.001). Postoperatively, the EOT group showed worse visual outcomes than did the non-EOT group.
   CONCLUSIONS: This study reveals that EOT caused by sellar and suprasellar tumors is associated with worse visual function and poor improvement postoperatively.
C1 [Ju, Dong Gyun; Jeon, Chiman; Seoul, Ho Jun; Shin, Hyung Jin; Nam, Do-Hyun; Lee, Jung-Il; Kong, Doo-Sik] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Brain Tumor Ctr,Dept Neurosurg,Endoscop Skull Bas, Seoul, South Korea.
   [Hong, Sang Duk] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Park, Kyung-Ah] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Ophthalmol, Seoul, South Korea.
   [Kim, Kyung Hwan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Neurosurg, Sch Med, Daejeon, South Korea.
RP Kong, DS (reprint author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Brain Tumor Ctr,Dept Neurosurg,Endoscop Skull Bas, Seoul, South Korea.
EM neurokong@gmail.com
OI Kim, Kyung Hwan/0000-0003-1244-6969
FU Ministry of Health & Welfare,Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea; National Research Foundation of
   KoreaNational Research Foundation of Korea; Ministry of Science, ICT and
   Future Planning (MSIP) of Korea [NRF-2015M3A9A7029740,
   NRF-2015M3C9A1044522, NRF-2015M3A9B5053642]; Samsung Medical Center
   grant
FX This study was supported by the Ministry of Health & Welfare,Republic of
   Korea, the National Research Foundation of Korea, the Ministry of
   Science, ICT and Future Planning (MSIP) of Korea, (NRF-2015M3A9A7029740,
   NRF-2015M3C9A1044522, and NRF-2015M3A9B5053642), and a Samsung Medical
   Center grant.
CR Asaeda Masahiro, 2004, No To Shinkei, V56, P243
   Baggenstos M, 2008, J NEUROSURG, V109, P313, DOI 10.3171/JNS/2008/109/8/0313
   Beltrame Sofia, 2018, Surg Neurol Int, V9, pS57, DOI 10.4103/sni.sni_463_17
   Bussat A, 2018, J NEUROSURG-PEDIATR, V21, P516, DOI 10.3171/2017.11.PEDS17526
   Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327
   HIGASHI S, 1990, NEUROSURGERY, V27, P993, DOI 10.1227/00006123-199012000-00023
   Hirunpat S, 2005, ACTA RADIOL, V46, P419, DOI 10.1080/02841850510021599
   Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016
   Kearney D, 1993, Australas Radiol, V37, P370, DOI 10.1111/j.1440-1673.1993.tb00098.x
   Nagahata M, 1998, AM J NEURORADIOL, V19, P1753
   Saeki N, 2004, AM J NEURORADIOL, V25, P1218
   Saeki N, 2003, AM J NEURORADIOL, V24, P336
   Saeki N, 2001, BRIT J NEUROSURG, V15, P523, DOI 10.1080/026886901317195482
   Shizukuishi T, 2014, JPN J RADIOL, V32, P179, DOI 10.1007/s11604-013-0279-4
   Sklar EML, 2000, AM J NEURORADIOL, V21, P1661
   Takahashi M, 2003, NEUROL SURG TOKYO, V31, P775
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e862
DI 10.1016/j.wneu.2019.07.218
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300104
PM 31394363
DA 2020-05-12
ER

PT J
AU Kong, C
   Li, XY
   Sun, XY
   Ding, JZ
   Guo, MC
   Lu, SB
AF Kong, Chao
   Li, Xiangyu
   Sun, Xiangyao
   Ding, Junzhe
   Guo, Machao
   Lu, Shibao
TI Complications in Elderly Patients Undergoing Lumbar Arthrodesis for
   Spinal Stenosis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Elderly; Lumbar arthrodesis; Perioperative complication; Risk factor
ID PERIOPERATIVE COMPLICATIONS; RISK-FACTORS; FUSION SURGERY;
   UNITED-STATES; OUTCOMES; AGE; INFECTION; DECOMPRESSION; MORTALITY; OLDER
AB PURPOSE: To report the perioperative complication rates in elderly patients undergoing lumbar arthrodesis and to analyze the risk factors.
   METHODS: Between September 2015 and June 2018, 215 patients aged >= 70 underwent posterior lumbar arthrodesis with pedicle screw fixation. Demographic data including age, gender, smoking status, body mass index (BMI) and preoperative comorbidities were collected. Operative records as the number of levels fused, estimated blood loss, time of surgery, and the occurrence of perioperative complications were reviewed. Risk factors of perioperative complications were determined by logistic regression analysis.
   RESULTS: The total perioperative complication rate in all patients was 30.2%, of which major complications occurred in 24 patients (11.2%) and minor complications occurred in 41 patients (19.1%). Two risk factors of perioperative complications (major or minor) were chosen: BMI (cutoff value 24.32) and surgical level (>= 3). Lower surgical level (>= 3) and smaller BMI were risk factors for perioperative minor complications, and major complication was affected only by surgical level (>= 3).
   CONCLUSIONS: The risk factor of perioperative complication in elderly patients after lumbar arthrodesis was fusion segment (>= 3), and BMI was a protective factor. Elderly patients with BMI <24.32 are more likely to have perioperative complications after lumbar arthrodesis.
C1 [Kong, Chao; Li, Xiangyu; Sun, Xiangyao; Ding, Junzhe; Guo, Machao; Lu, Shibao] Capital Med Univ, Beijing Xuanwu Hosp, Dept Orthoped, Beijing, Peoples R China.
RP Lu, SB (reprint author), Capital Med Univ, Beijing Xuanwu Hosp, Dept Orthoped, Beijing, Peoples R China.
EM spinelu@163.com
OI Kong, Chao/0000-0001-7611-2648; Sun, Xiangyao/0000-0001-9385-2402
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81672201, 81871794]
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers 81672201 and 81871794).
CR Abdallah DY, 2013, EUR SPINE J, V22, P2800, DOI 10.1007/s00586-013-2890-6
   Benz RJ, 2001, CLIN ORTHOP RELAT R, P116
   Best NM, 2007, SPINE, V32, P1135, DOI 10.1097/01.brs.0000261486.51019.4a
   Buser Z, 2018, GLOB SPINE J, V8, P57, DOI 10.1177/2192568217696688
   Carreon LY, 2003, J BONE JOINT SURG AM, V85A, P2089, DOI 10.2106/00004623-200311000-00004
   Cassinelli EH, 2007, SPINE, V32, P230, DOI 10.1097/01.brs.0000251918.19508.b3
   Choma TJ, 2015, J AM ACAD ORTHOP SUR, V23, pe91, DOI 10.5435/JAAOS-D-15-00245
   Cloyd JM, 2008, J AM GERIATR SOC, V56, P1318, DOI 10.1111/j.1532-5415.2008.01771.x
   Daubs MD, 2007, SPINE, V32, P2238, DOI 10.1097/BRS.0b013e31814cf24a
   DEYO RA, 1992, J BONE JOINT SURG AM, V74A, P536, DOI 10.2106/00004623-199274040-00009
   Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75
   Fehlings MG, 2015, NEUROSURGERY, V77, pS1, DOI 10.1227/NEU.0000000000000953
   Imajo Y, 2017, J ORTHOP SCI, V22, P10, DOI 10.1016/j.jos.2016.08.014
   Kilincer C, 2005, J NEUROSURG-SPINE, V3, P34, DOI 10.3171/spi.2005.3.1.0034
   Kim HJ, 2008, SPINE, V33, P2116, DOI 10.1097/BRS.0b013e31817e1022
   Kim IC, 2013, J KOREAN NEUROSURG S, V54, P323, DOI 10.3340/jkns.2013.54.4.323
   Kobayashi K, 2017, GLOB SPINE J, V7, P636, DOI 10.1177/2192568217716144
   Lagman C, 2017, WORLD NEUROSURG, V103, P780, DOI 10.1016/j.wneu.2017.04.001
   Lieber B, 2016, WORLD NEUROSURG, V89, P517, DOI 10.1016/j.wneu.2015.12.085
   Lingutla KK, 2015, BONE JOINT J, V97B, P1395, DOI 10.1302/0301-620X.97B10.35724
   Lucas F, 2016, WORLD NEUROSURG, V92, P229, DOI 10.1016/j.wneu.2015.12.104
   Mirza SK, 2008, SPINE, V33, P2651, DOI 10.1097/BRS.0b013e31818dad07
   Nasser R, 2010, J NEUROSURG-SPINE, V13, P144, DOI 10.3171/2010.3.SPINE09369
   Okuda S, 2006, J BONE JOINT SURG AM, V88A, P2714, DOI 10.2106/JBJS.F.00186
   Okuda Shinya, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.2, P310, DOI 10.2106/JBJS.G.00307
   OLDRIDGE NB, 1994, AM J PUBLIC HEALTH, V84, P1292, DOI 10.2105/AJPH.84.8.1292
   Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515
   Onyekwelu I, 2017, J NEUROSURG-SPINE, V26, P158, DOI 10.3171/2016.7.SPINE16448
   Patel N, 2007, J NEUROSURG-SPINE, V6, P291, DOI 10.3171/spi.2007.6.4.1
   Peng CWB, 2009, SPINE J, V9, P715, DOI 10.1016/j.spinee.2009.04.023
   Raffo CS, 2006, SPINE, V31, P99, DOI 10.1097/01.brs.0000192678.25586.e5
   Ragab AA, 2003, SPINE, V28, P348, DOI 10.1097/00007632-200302150-00007
   Saleh A, 2017, SPINE J, V17, P1106, DOI 10.1016/j.spinee.2017.03.019
   Shabat S, 2008, EUR SPINE J, V17, P193, DOI 10.1007/s00586-007-0514-8
   Sidhu KS, 1997, CLIN ORTHOP RELAT R, P39
   SILVERS HR, 1993, J NEUROSURG, V78, P695, DOI 10.3171/jns.1993.78.5.0695
   Sobottke R, 2012, EUR SPINE J, V21, P411, DOI 10.1007/s00586-011-2016-y
   Vaidya R, 2009, SPINE, V34, P495, DOI 10.1097/BRS.0b013e318198c5f2
   Vitaz TW, 1999, J NEUROSURG, V91, P181, DOI 10.3171/spi.1999.91.2.0181
   Watanabe M, 2010, J NEUROSURG-SPINE, V12, P540, DOI 10.3171/2009.11.SPINE09308
NR 40
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e949
DI 10.1016/j.wneu.2019.06.147
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300114
PM 31254702
DA 2020-05-12
ER

PT J
AU McGregor, SMK
   Detombe, SA
   Goncalves, S
   Doyle-Pettypiece, P
   Bartha, R
   Duggal, N
AF McGregor, Stuart M. K.
   Detombe, Sarah A.
   Goncalves, Sandy
   Doyle-Pettypiece, Patricia
   Bartha, Robert
   Duggal, Neil
TI Does the Neurological Examination Correlate with Patient-Perceived
   Outcomes in Degenerative Cervical Myelopathy?
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical spine; Degenerative cervical myelopathy; Patient-perceived
   outcomes; Surgery
ID QUALITY-OF-LIFE; SPONDYLOTIC MYELOPATHY; SHORT FORM-36; MOTOR CORTEX;
   RECOVERY; DECOMPRESSION; RELIABILITY; IMPAIRMENT; PREDICTORS; SURGERY
AB BACKGROUND: In patients with neurological disorders, a divergence can exist between patients' perceptions regarding the outcomes and the objective neurological findings. Degenerative cervical myelopathy (DCM), a prevalent condition characterized by progressive compression of the cervical spinal cord, can produce debilitating symptoms and profound neurological findings. The purpose of the present study was to determine whether the physician-derived neurological examination findings, as recorded by American Spine Injury Association (ASIA) summary score, correlated with the patient-derived outcome measures for DCM.
   METHODS: A total of 78 patients underwent surgical management of DCM with completion of preoperative and 6-month follow-up assessments. Surgical management consisted of either anterior or posterior cervical decompression. All patients underwent a neurological evaluation, including an ASIA assessment before surgery and 6 months after surgery, and completed the modified Japanese Orthopaedic Association (mJOA), neck disability index (NDI), and Short-Form 36-item (SF-36) scales pre- and postoperatively to measure both disease-specific and general perceived outcomes.
   RESULTS: The objective physician-derived neurological testing (ASIA) did not correlate with the patient-derived scales (mJOA, NDI, and SF-36) pre- or postoperatively. Patients reported significant improvements (P < 0.001) at 6 months postoperatively in extremity functioning (mJOA), neck pain (NDI), overall physical health (SF-36), and objective strength and sensory functioning (ASIA). All patient-perceived outcome measures correlated with each other pre- and postoperatively (P < 0.01). -
   CONCLUSIONS: Objective scoring of postoperative neurological function did not correlate with patientperceived outcomes before and after surgery for DCM. Traditional testing of motor and sensory function as part of the neurological assessment may not be sensitive enough to assess the scope of neurological changes experienced by patients with DCM.
C1 [McGregor, Stuart M. K.; Duggal, Neil] Western Univ, Dept Clin Neurol Sci, Div Neurosurg, London, ON, Canada.
   [Detombe, Sarah A.; Doyle-Pettypiece, Patricia; Duggal, Neil] London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada.
   [Goncalves, Sandy; Bartha, Robert; Duggal, Neil] Western Univ, Dept Med Biophys, London, ON, Canada.
   [Goncalves, Sandy; Bartha, Robert] Western Univ, Ctr Funct & Metab Mapping, Robarts Res Inst, London, ON, Canada.
RP Duggal, N (reprint author), Western Univ, Dept Clin Neurol Sci, Div Neurosurg, London, ON, Canada.; Duggal, N (reprint author), London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada.; Duggal, N (reprint author), Western Univ, Dept Med Biophys, London, ON, Canada.
EM neil.duggal@lhsc.on.ca
FU Canadian Institute for Health ResearchCanadian Institutes of Health
   Research (CIHR) [231560]; Physicians Services Incorporated Foundation
   [07-37]
FX The present study was supported by the Canadian Institute for Health
   Research (grant 231560) and the Physicians Services Incorporated
   Foundation (grant 07-37).
CR Al-Tamimi YZ, 2013, EUR SPINE J, V22, P2552, DOI 10.1007/s00586-013-2965-4
   Alafifi T, 2007, J NEUROIMAGING, V17, P315, DOI 10.1111/j.1552-6569.2007.00119.x
   Aleksanderek I, 2017, J NEUROSURG-SPINE, V26, P547, DOI 10.3171/2016.9.SPINE151507
   Aleksanderek I, 2017, RADIOLOGY, V282, P817, DOI 10.1148/radiol.2016152083
   Ali ZS, 2018, CLIN NEUROL NEUROSUR, V164, P142, DOI 10.1016/j.clineuro.2017.12.003
   American Spinal Injury Association Scale, 1996, INT STAND NEUR FUNCT
   COLEBATCH JG, 1989, BRAIN, V112, P749, DOI 10.1093/brain/112.3.749
   ElMasry WS, 1996, SPINE, V21, P614, DOI 10.1097/00007632-199603010-00015
   Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988
   Goncalves S, 2016, J NEUROSURG-SPINE, V25, P436, DOI 10.3171/2016.2.SPINE15944
   Gray MJ, 2010, J SPINAL DISORD TECH, V23, P157, DOI 10.1097/BSD.0b013e31819e31a4
   Holly LT, 2009, J NEUROSURG-SPINE, V11, P238, DOI 10.3171/2009.2.SPINE08715
   Holly LT, 2009, J NEUROSURG-SPINE, V11, P112, DOI 10.3171/2009.1.SPINE08718
   Hopman WM, 2000, CAN MED ASSOC J, V163, P265
   Kalsi-Ryan S, 2015, CERV SPIN RES SOC AN
   Kamper DG, 2001, MUSCLE NERVE, V24, P673, DOI 10.1002/mus.1054
   Kamper DG, 2003, MUSCLE NERVE, V28, P309, DOI 10.1002/mus.10443
   Karpova A, 2013, SPINE, V38, P392, DOI 10.1097/BRS.0b013e3182715bc3
   King JT, 2003, NEUROSURGERY, V52, P113, DOI 10.1097/00006123-200301000-00014
   King JT, 2002, J NEUROSURG, V97, P180, DOI 10.3171/spi.2002.97.2.0180
   Lang CE, 2003, J NEUROPHYSIOL, V90, P1160, DOI 10.1152/jn.00130.2003
   Latimer M, 2002, BRIT J NEUROSURG, V16, P545
   Lubelski D, 2016, J NEUROSURG-SPINE, V24, P483, DOI 10.3171/2015.6.SPINE159
   Morishita Y, 2015, SPINAL CORD, V53, P408, DOI 10.1038/sc.2014.137
   Raghavan P, 2006, BRAIN, V129, P1415, DOI 10.1093/brain/awl070
   Rajshekhar V, 2007, SURG NEUROL, V68, P185, DOI 10.1016/j.surneu.2006.10.071
   Rao RD, 2006, J BONE JOINT SURG AM, V88A, P1619, DOI 10.2106/JBJS.F.00014
   Ren H, 2017, CLIN SPINE SURG, V30, pE1104, DOI 10.1097/BSD.0000000000000396
   Revanappa KK, 2011, EUR SPINE J, V20, P1545, DOI 10.1007/s00586-011-1773-y
   Singh A, 2001, J Outcome Meas, V5, P798
   Singh A, 2015, EUR SPINE J, V24, pS209, DOI 10.1007/s00586-013-2935-x
   Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638
   Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996
   Tetreault L, 2015, NEUROSURGERY, V77, pS51, DOI 10.1227/NEU.0000000000000951
   Tetreault LA, 2015, EUR SPINE J, V24, pS236, DOI 10.1007/s00586-013-2658-z
   VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409
   Whitmore RG, 2013, SPINE J, V13, P902, DOI 10.1016/j.spinee.2012.11.058
   Young WF, 2000, AM FAM PHYSICIAN, V62, P1064
   Zhang YL, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0237-1
NR 39
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e885
DI 10.1016/j.wneu.2019.07.195
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300107
PM 31382071
DA 2020-05-12
ER

PT J
AU Rotman, LE
   Alford, EN
   Shank, CD
   Dalgo, C
   Stetler, WR
AF Rotman, Lauren E.
   Alford, Elizabeth N.
   Shank, Christopher D.
   Dalgo, Caitlin
   Stetler, William R.
TI Is There an Association Between Physician Review Websites and Press
   Ganey Survey Results in a Neurosurgical Outpatient Clinic?
SO WORLD NEUROSURGERY
LA English
DT Review
DE Ambulatory care; Neurosurgery; Online physician review websites;
   Patient; Press Ganey; Satisfaction
ID HEALTH-CARE PROVIDERS; PATIENT-SATISFACTION; CONSUMER ASSESSMENT;
   RATINGS; EXPERIENCE; OUTCOMES; TRUST
AB OBJECTIVE: Recent studies suggest a poor association between physician review websites and the validated metrics used by the Centers for Medicare and Medicaid Services. The purpose of this study was to evaluate the association between online and outpatient Press Ganey (PG) measures of patient satisfaction in a neurosurgical department.
   METHODS: We obtained PG survey results from one large academic institution's outpatient neurosurgery clinic. Popular physician review websites were searched for each of the faculty captured in the PG data. Average physician rating and percent Top Box scores were calculated for each physician. PG data were separated into new and established clinic visits for subset analysis. Spearman's rank correlation coefficients were calculated to determine associations.
   RESULTS: Twelve neurosurgeons were included. Established patients demonstrated greater PG scores as compared with new patients, with an average physician rating increase of 0.55 and an average Top Box increase of 12.5%. Online physician ratings were found to demonstrate strong agreement with PG scores for the entire PG population, new patient subset, and established patient subset (r = 0.77-0.79, P < 0.05). Online Top Box scores demonstrated moderate agreement with overall PG Top Box scores (r = 0.59, P = 0.042), moderate agreement with the new patient population Top Box scores (r = 0.56, P = 0.059), and weak agreement with established patient population Top Box scores (r = 0.38, P = 0.217).
   CONCLUSIONS: Our findings demonstrated a strong agreement between PG ratings and online physician ratings and a poorer correlation when comparing PG Top Box scores with online physician Top Box scores, particularly in the established patient population.
C1 [Rotman, Lauren E.; Alford, Elizabeth N.; Shank, Christopher D.; Dalgo, Caitlin; Stetler, William R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA.
RP Rotman, LE (reprint author), Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA.
EM lerotman@uabmc.edu
FU University of Alabama Department of Neurosurgery
FX The authors of this paper acknowledge and thank the University of
   Alabama Department of Neurosurgery for their support in the writing of
   this paper.
CR Abelson Robert P., 1995, ATTITUDE STRENGTH AN, P25
   [Anonymous], 2016, CAHPS ASSESSING HLTH
   Biondi EA, 2016, J HOSP MED, V11, P785, DOI 10.1002/jhm.2621
   Burkle CM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1099-2
   Burn MB, 2018, ORTHOPEDICS, V41, pE445, DOI 10.3928/01477447-20180409-06
   Centers for Medicare and Medicaid Services, TOT PERF SCOR INF
   Centers for Medicare and Medicaid Services, MED CLAIMS PROC MAN
   Centers for Medicare & Medicaid Services ( CMS) HHS, 2018, FED REGISTER, V83
   Chen J, 2018, J SURG RES, V227, P1, DOI 10.1016/j.jss.2018.01.037
   Chughtai M, 2018, J ARTHROPLASTY, V33, P783, DOI 10.1016/j.arth.2017.09.037
   Daskivich T, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9160
   Daskivich TJ, 2018, J AM MED INFORM ASSN, V25, P401, DOI 10.1093/jamia/ocx083
   Donnally CJ, 2018, SPINE, V43, P1725, DOI 10.1097/BRS.0000000000002740
   Dyer N, 2012, MED CARE, V50, pS28, DOI 10.1097/MLR.0b013e31826cbc0d
   Ellimoottil Chandy, 2013, Bull Am Coll Surg, V98, P34
   Emmert M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2360
   Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662
   Fox S, 2013, HLTH ONLINE 2013
   Graham B, 2015, J BONE JOINT SURG AM, V97A, P80, DOI 10.2106/JBJS.N.00811
   Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223
   Haskins IN, 2017, J AM COLL SURGEONS, V225, P582, DOI 10.1016/j.jamcollsurg.2017.08.007
   HealthGrades, REV YOUR DOCT
   Hinkle D, 2003, APPL STAT BEHAV SCI
   Kadry B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1960
   Keating NL, 2004, ARCH INTERN MED, V164, P1015, DOI 10.1001/archinte.164.9.1015
   Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0
   Liu JJ, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.7475
   Long C, 2016, OPHTHALMOLOGY, V123, P242, DOI 10.1016/j.ophtha.2015.09.044
   McGrath RJ, 2018, INTERACT J MED RES, V7, DOI 10.2196/ijmr.9350
   Murray-Garcia JL, 2000, MED CARE, V38, P300, DOI 10.1097/00005650-200003000-00007
   Naggara O, 2011, AM J NEURORADIOL, V32, P437, DOI 10.3174/ajnr.A2425
   Nieman CL, 2014, LARYNGOSCOPE, V124, P290, DOI 10.1002/lary.24307
   O'Donnell J., 2018, US TODAY
   Okike K, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6612
   Oliver RL, 1997, J RETAILING, V73, P311, DOI 10.1016/S0022-4359(97)90021-X
   Presson AP, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0610-3
   RateMDs, 2018, DOCT REV RAT
   Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331
   Ryan T, 2016, OTOLARYNG HEAD NECK, V155, P411, DOI 10.1177/0194599816652386
   Sage Jill, 2013, Bull Am Coll Surg, V98, P53
   Schmocker RK, 2015, SURGERY, V158, P1725, DOI 10.1016/j.surg.2015.06.018
   Schulz KA, 2012, OTOLARYNG HEAD NECK, V147, P671, DOI 10.1177/0194599812452834
   Scotti A, 2018, NEW YORK DAILY NEWS
   Segal J, 2009, J LEGAL MED, V30, P349, DOI 10.1080/01947640903146121
   Shirley Eric D, 2013, J Bone Joint Surg Am, V95, pe69, DOI 10.2106/JBJS.L.01048
   Siddiqui ZK, 2015, J HOSP MED, V10, P165, DOI 10.1002/jhm.2297
   Trehan SK, 2016, J HAND SURG-AM, V41, P316, DOI 10.1016/j.jhsa.2015.04.018
   Tyser AR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1595-z
   Widmer RJ, 2018, MAYO CLIN PROC, V93, P453, DOI 10.1016/j.mayocp.2018.01.021
   Wittink D. R., 1994, MARK RES, V6, P14
   Zusman EE, 2012, NEUROSURGERY, V71, pN21, DOI 10.1227/01.neu.0000417536.07871.ed
NR 51
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e891
DI 10.1016/j.wneu.2019.07.193
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300108
PM 31382063
DA 2020-05-12
ER

PT J
AU Sippl, C
   Teping, F
   Ketter, R
   Braun, L
   Tremmel, L
   Schulz-Schaeffer, W
   Oertel, J
   Urbschat, S
AF Sippl, Christoph
   Teping, Fritz
   Ketter, Ralf
   Braun, Luisa
   Tremmel, Luisa
   Schulz-Schaeffer, Walter
   Oertel, Joachim
   Urbschat, Steffi
TI The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F
   Pathway on the Clinical Progression of Glioblastoma Multiforme
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clinical; Epigenetic; Glioblastoma multiforme; microRNA; Prognosis
ID CENTRAL-NERVOUS-SYSTEM; MICRORNA EXPRESSION; PROMOTER METHYLATION;
   TEMOZOLOMIDE; TUMORS; BRAIN; QUANTIFICATION; DELETION; GENES; PCR
AB OBJECTIVE: The microRNAs (miRNAs) -26a, -24, and -21 have been reported as regulators of the P15/P16/RB1/E2F pathway, which plays a major role in glioblastoma multiforme (GBM) progression. In the present study, their predictive marker for the progression of GBMs is evaluated and described.
   METHODS: The expression of miRNA-21, -24, and -26a was analyzed as fold change (FC) in tumor specimens of 104 patients with GBM and 8 specimen of non-neoplastic brain tissue as control group. The results were referred to the individual clinical data sets and evaluated statistically.
   RESULTS: The FC of miRNA-21, -24, and -26a was 1.51 +/- 1.35, 0.75 +/- 0.67, and 0.39 +/- 0.24 in the tumor samples. Within the control group, FC of miRNA-21, -24, and -26a was 0.31 +/- 0.51, 0.66 +/- 0.33, and 0.18 +/- 0.11, respectively. MiRNA-26a and -21 were significantly overexpressed in GBM samples compared with healthy brain tissue (miRNA-21: P < 0.001; miRNA-26a: P = 0.011). High expression ofmiRNA-24 trended for a prolonged overall survival (P = 0.07). Patients with high miRNA-26a expression showed a significantly prolonged progression-free survival (hazard ratio 0.21; 95% confidence interval 0.09-0.51], P < 0.001) and overall survival (hazard ratio 0.3; 95% confidence interval 0.136-0.682], P = 0.003). The effect of miRNA-26a was mediated via regulation of mRNA of RB1. There was a significant inverse correlation between mRNA-26a and mRNA expression of RB1.
   CONCLUSIONS: The expression levels of miRNA-26a and -24 turned out to be promising predictors of further clinical course in patients with GBM multiforme.
C1 [Sippl, Christoph; Teping, Fritz; Ketter, Ralf; Braun, Luisa; Tremmel, Luisa; Oertel, Joachim; Urbschat, Steffi] Univ Saarland, Fac Med, Dept Neurosurg, Homburg, Germany.
   [Schulz-Schaeffer, Walter] Univ Saarland, Fac Med, Inst Neuropathol, Homburg, Germany.
RP Sippl, C (reprint author), Univ Saarland, Fac Med, Dept Neurosurg, Homburg, Germany.
EM Christoph.sippl@uks.eu
OI Ketter, Ralf/0000-0001-7790-3425
CR Afra D, 2002, LANCET, V359, P1011
   Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Busato Florence, 2018, Methods Mol Biol, V1708, P427, DOI 10.1007/978-1-4939-7481-8_22
   Campomenosi P, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0292-7
   Chen XJ, 2016, OPEN MED-WARSAW, V11, P133, DOI 10.1515/med-2016-0026
   Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731
   Duda J, 2018, METHODS MOL BIOL, V1723, P335, DOI 10.1007/978-1-4939-7558-7_19
   Gao P, 2017, MED SCI MONITOR, V23, P881, DOI 10.12659/MSM.898233
   Giglio S, 2013, J CELL PHYSIOL, V228, P2015, DOI 10.1002/jcp.24368
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Gittleman H, 2018, NEURO-ONCOLOGY, V20, P6, DOI 10.1093/neuonc/noy090
   Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106
   Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331
   Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964
   Henriksen M, 2014, NEUROMOL MED, V16, P565, DOI 10.1007/s12017-014-8309-7
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   JEN J, 1994, CANCER RES, V54, P6353
   Koshkin FA, 2014, B EXP BIOL MED+, V157, P794, DOI 10.1007/s10517-014-2669-8
   Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864
   Lopez-Urrutia E, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695945
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Maachani UB, 2016, ONCOTARGET, V7, P52912, DOI 10.18632/oncotarget.4143
   Mase M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41127
   Nelson PT, 2018, BRAIN RES, V1678, P374, DOI 10.1016/j.brainres.2017.11.009
   Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   Roncon Paolo, 2017, Epilepsia Open, V2, P90, DOI 10.1002/epi4.12023
   Saliminejad K, 2019, J CELL PHYSIOL, V234, P5451, DOI 10.1002/jcp.27486
   Sasmita AO, 2018, ASIA-PAC J CLIN ONCO, V14, P40, DOI 10.1111/ajco.12756
   Sathipati SY, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3321-y
   SCHMIDT EE, 1994, CANCER RES, V54, P6321
   Shen FM, 2014, J CANCER, V5, P804, DOI 10.7150/jca.10456
   Song JN, 2013, ONCOL LETT, V6, P1733, DOI 10.3892/ol.2013.1626
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Wemmert S, 2009, INT J ONCOL, V34, P1743, DOI 10.3892/ijo_00000305
   Wu L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-200
   Yoshioka Masaki, 2018, Oncotarget, V9, P27728, DOI 10.18632/oncotarget.25543
   Yu JC, 2013, NEUROL SCI, V34, P1283, DOI 10.1007/s10072-012-1228-1
   Zhang YF, 2013, MOL BIOL REP, V40, P1711, DOI 10.1007/s11033-012-2222-7
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e900
DI 10.1016/j.wneu.2019.07.134
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300109
PM 31351207
DA 2020-05-12
ER

PT J
AU Sun, T
   Li, XP
   Zhang, QM
   Zhou, YC
   Guan, JW
AF Sun, Tong
   Li, Xuepei
   Zhang, Qiuming
   Zhou, Yicheng
   Guan, Junwen
TI Efficacy and Safety of Lumboperitoneal Shunt in the Treatment of
   All-Cause Communicating Hydrocephalus: Analysis of Risk Factors of Shunt
   Failure
SO WORLD NEUROSURGERY
LA English
DT Article
DE Communicating hydrocephalus; Efficacy; Lumboperitoneal shunt; Risk
   factors; Safety
ID NORMAL-PRESSURE HYDROCEPHALUS; COMPLICATIONS; SURGERY
AB OBJECTIVE: To analyze the outcomes of use of a lumboperitoneal shunt (LPS) to treat all-cause communicating hydrocephalus (ACCH).
   METHODS: We analyzed the outcomes of adult patients with ACCH treated with an LPS between June 2015 and June 2018, using Keifer's hydrocephalus score (KHS), postoperative symptom improvement score (SIS), and the Evans index for 5 days after surgery. All patients were followed up to assess long-term outcomes and quality of life. Based on the followup data in shunt successful (SS) patients and shunt failure (SF) patients, multivariate analysis with binary logistic regression was used to identify risk factors for LPS failure.
   RESULTS: A total of 71 eligible patients were included in this study. The KHS (mean, 8.31 +/- 4.80 vs. 3.65 +/- 3.08; P < 0.001) and Evans index (mean, 0.35 +/- 0.05 vs. 0.28 +/- 0.05; P < 0.001) were significantly improved following LPS. However, the overall incidence of complications was 40.8%. According to follow-up data, 18 patients (25.4%) failed; the most common reason for failure was catheter obstruction. The majority of patients obtain good prognosis with low level of RBCs counts in CSF (P = 0.039) and postoperative Evans index (P = 0.046) were statistically different between SS and SF group. The multivariate analysis identified elevated RBC count in CSF as a dependent risk factor for LPS failure (odds ratio, 24.111; 95% confidence interval, 2.611-222.629; P = 0.005).
   CONCLUSIONS: Our findings indicate that LPS may be a promising option for the treatment of ACCH.
C1 [Sun, Tong; Zhang, Qiuming; Zhou, Yicheng; Guan, Junwen] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
   [Li, Xuepei] Sichuan Univ, Coll Basic Med & Forens Med, Hlth Minist Key Lab Chronobiol, Chengdu, Sichuan, Peoples R China.
RP Guan, JW (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM guanjunwen_scu@outlook.com
FU Sichuan Province Science and Technology Support Program [2015SZ0193]
FX This study is supported by the Sichuan Province Science and Technology
   Support Program (2015SZ0193).
CR AOKI N, 1990, NEUROSURGERY, V26, P998, DOI 10.1227/00006123-199006000-00013
   Aoki N., 1990, NEUROSURGERY, P1003
   Botfield H, 2013, BRAIN, V136, P2842, DOI 10.1093/brain/awt203
   De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425
   Erps A, 2018, PEDIATR INT, V60, P1056, DOI 10.1111/ped.13709
   Farahmand D, 2009, J NEUROL NEUROSUR PS, V80, P1248, DOI 10.1136/jnnp.2007.141416
   Fulkerson DH, 2011, J NEUROSURG-PEDIATR, V7, P147, DOI 10.3171/2010.11.PEDS10244
   HAAN J, 1988, NEUROSURGERY, V22, P388, DOI 10.1227/00006123-198802000-00020
   Hung AL, 2017, CLIN NEUROL NEUROSUR, V157, P1, DOI 10.1016/j.clineuro.2017.03.014
   Jartti P, 2004, ACTA RADIOL, V45, P333, DOI 10.1080/02841850410004274
   Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8
   Karabatsou K, 2004, ACTA NEUROCHIR, V146, P1193, DOI 10.1007/s00701-004-0392-3
   Khan Farid, 2015, Surg Neurol Int, V6, P25, DOI 10.4103/2152-7806.151388
   Lehman RM, 2008, NEUROSURGERY, V63, P376
   McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352
   Miyajima M, 2016, J NEUROSURG, V125, P1483, DOI 10.3171/2015.10.JNS151894
   Nakajima M, 2018, OPER NEUROSURG, V15, P634, DOI 10.1093/ons/opy044
   Nigim F, 2014, J SURG RES, V191, P140, DOI 10.1016/j.jss.2014.03.075
   Pelegrin I, 2017, CLIN INFECT DIS, V64, P989, DOI 10.1093/cid/cix005
   Rinaldo L, 2018, CLIN NEUROL NEUROSUR, V174, P75, DOI 10.1016/j.clineuro.2018.09.009
   Sun T, 2018, ACTA NEUROCHIR, V160, P2031, DOI 10.1007/s00701-018-3654-1
   Sun T, 2018, WORLD NEUROSURG, V117, pE308, DOI 10.1016/j.wneu.2018.06.021
   Tisell M, 2005, ACTA NEUROL SCAND, V112, P72, DOI 10.1111/j.1600-0404.2005.00451.x
   Wang VY, 2007, NEUROSURGERY, V60, P1045, DOI 10.1227/01.NEU.0000255469.68129.81
   Weerakkody RA, 2011, ACTA NEUROL SCAND, V124, P85, DOI 10.1111/j.1600-0404.2010.01467.x
   Woo PYM, 2016, HONG KONG MED J, V22, P410, DOI 10.12809/hkmj154735
NR 26
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e956
DI 10.1016/j.wneu.2019.06.070
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300115
PM 31226460
DA 2020-05-12
ER

PT J
AU Unal, TC
   Dolas, I
   Unal, OF
AF Unal, Tugrul Cem
   Dolas, Ilyas
   Unal, Omer Faruk
TI Unilateral Alar Ligament Injury: Diagnostic, Clinical, and Biomechanical
   Features
SO WORLD NEUROSURGERY
LA English
DT Article
DE Alar ligament injury; Biomechanics; Cervical trauma; Craniovertebral
   junction; Flexioneextension CT; Post-traumatic neck pain
ID WHIPLASH-ASSOCIATED DISORDERS; UPPER CERVICAL-SPINE; RUPTURE; MRI;
   SUBLUXATION; DISLOCATION; INTERVAL; CHILDREN; ANATOMY
AB BACKGROUND: Isolated unilateral alar ligament injury (ALI) is a very rarely diagnosed condition, with only 9 cases reported in the literature. The purpose of this study is to determine clinical, diagnostic, and biomechanical features of unilateral ALI.
   METHODS: A total of 6 patients diagnosed with ALI were included in this series. The hospital records and radiologic imaging of admission and follow-ups were investigated retrospectively.
   RESULTS: Rotation of the neck and/or hyperflexion was always present as a mechanism of injury. The patients were neurologically intact. All patients presented with mild neck pain aggravated by head rotation. On computed tomography (CT) scans, the dens was observed to be displaced to the opposite side. Magnetic resonance imaging (MRI) showed a widened lateral dens-atlas space with high signal intensity. All patients underwent lateral flexioneextension CTs for the confirmation of craniovertebral junction (CVJ) stability. The patients were treated with hard collars. The follow-up MRI of 3 patients obtained at the third month showed normal lateral denseatlas interval and recovered ligaments. All patients were pain free after 6 months.
   CONCLUSIONS: Unilateral ALI appears to be more common but misdiagnosed than previously thought. Trauma mechanism consists of hyperflexion and contralateral rotation. Neck pain aggravated with rotation is the most significant clinical finding. Dens lateralization is the most important finding in CT scans. An MRI focusing on the CVJ is essential for the diagnosis. The stability of CVJ must be checked with a flexioneextension CT scan. Unilateral ALI is a stable condition and responds to conservative treatment.
C1 [Unal, Tugrul Cem] Tunceli State Hosp, Dept Neurosurg, Tunceli, Turkey.
   [Dolas, Ilyas] Acibadem Taksim Hosp, Dept Neurosurg, Istanbul, Turkey.
   [Unal, Omer Faruk] Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, Istanbul, Turkey.
RP Unal, TC (reprint author), Tunceli State Hosp, Dept Neurosurg, Tunceli, Turkey.
EM tugrulcem@gmail.com
RI Dolas, Ilyas/AAD-6885-2020; Unal, Tugrul Cem/AAD-5217-2020
OI Unal, Tugrul Cem/0000-0001-6228-1379
CR Ackland HM, 2011, ANN EMERG MED, V58, P521, DOI 10.1016/j.annemergmed.2011.06.008
   Bloom AI, 1996, PEDIATR RADIOL, V26, P786, DOI 10.1007/BF01396202
   Borders HL, 2011, J COMPUT ASSIST TOMO, V35, P557, DOI 10.1097/RCT.0b013e3182253673
   Briem D, 2002, UNFALLCHIRURG, V105, P555, DOI 10.1007/s00113-001-0367-2
   Caird MS, 2009, J BONE JOINT SURG AM, V91A, P2713, DOI 10.2106/JBJS.H.01405
   Demetrious James, 2007, Chiropr Osteopat, V15, P20, DOI 10.1186/1746-1340-15-20
   DVORAK J, 1988, J ORTHOP RES, V6, P452, DOI 10.1002/jor.1100060317
   DVORAK J, 1987, SPINE, V12, P183, DOI 10.1097/00007632-198703000-00016
   Eran A, 2016, AM J NEURORADIOL, V37, P176, DOI 10.3174/ajnr.A4492
   FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P1683, DOI 10.2106/00004623-197456080-00019
   Karray Maher, 2004, Acta Orthop Belg, V70, P189
   Kaufmann RA, 2015, WORLD J RADIOL, V7, P357, DOI 10.4329/wjr.v7.i10.357
   Krakenes J, 2002, NEURORADIOLOGY, V44, P617, DOI 10.1007/s00234-002-0799-6
   Lummel N, 2012, SPINE, V37, pE1062, DOI 10.1097/BRS.0b013e31825831ca
   Mendenhall SK, 2018, J NEUROSURG-PEDIATR, V22, P195, DOI 10.3171/2018.2.PEDS17694
   Missori P, 2014, WORLD NEUROSURG, V82, pE645, DOI 10.1016/j.wneu.2014.07.020
   Myran R, 2011, SPINE, V36, pE862, DOI 10.1097/BRS.0b013e3181ff1dde
   Niibayashi H, 1998, SPINE, V23, P1494, DOI 10.1097/00007632-199807010-00012
   Pang D, 2007, NEUROSURGERY, V61, P995, DOI 10.1227/01.neu.0000303196.87672.78
   PANJABI M, 1991, J SPINAL DISORD, V4, P157, DOI 10.1097/00002517-199106000-00005
   PANJABI M, 1991, J ORTHOPAED RES, V9, P584, DOI 10.1002/jor.1100090415
   Pfirrmann CWA, 2001, RADIOLOGY, V218, P133, DOI 10.1148/radiology.218.1.r01ja36133
   Santin MDN, 2017, NEUROCHIRURGIE, V63, P478, DOI 10.1016/j.neuchi.2017.07.002
   Tubbs RS, 2000, J NEUROSURG, V92, P197, DOI 10.3171/spi.2000.92.2.0197
   Vetti N, 2009, NEURORADIOLOGY, V51, P227, DOI 10.1007/s00234-008-0482-7
   Wilmink JT, 2001, NEURORADIOLOGY, V43, P859, DOI 10.1007/s002340100600
   Wong ST, 2014, J NEUROSURG-PEDIATR, V13, P541, DOI 10.3171/2014.2.PEDS13527
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e878
DI 10.1016/j.wneu.2019.07.198
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300106
PM 31382064
DA 2020-05-12
ER

PT J
AU Wasinpongwanich, K
   Pongpirul, K
   Lwin, KMM
   Kesornsak, W
   Kuansongtham, V
   Ruetten, S
AF Wasinpongwanich, Kanthika
   Pongpirul, Krit
   Lwin, Khin Myat Myat
   Kesornsak, Withawin
   Kuansongtham, Verapan
   Ruetten, Sebastian
TI Full-Endoscopic Interlaminar Lumbar Discectomy: Retrospective Review of
   Clinical Results and Complications in 545 International Patients
SO WORLD NEUROSURGERY
LA English
DT Review
DE Endoscopic discectomy; Full endoscopic lumbar discectomy; Herniated
   nucleus pulposus; Interlaminar discectomy; Lumbar disc herniation;
   Lumbar discectomy; Percutaneous endoscopic discectomy
ID DISC HERNIATION; SURGICAL TECHNIQUE; LEARNING-CURVE; SINGLE-CENTER;
   OUTCOMES
AB BACKGROUND: Minimally invasive techniques have been developed to provide access to the disc with better visualization while causing less muscle trauma and its consequences. This study was aimed at evaluating the clinical outcomes and complications of the fully endoscopic lumbar discectomy interlaminar approach in a large number of patients.
   METHODS: Patients diagnosed with lumbar herniated nucleus pulposus who underwent fully endoscopic interlaminar lumbar discectomy between 2011 and 2016 were reviewed. Perioperative data, preoperative and postoperative Oswestry Disability Index (ODI) scores, visual analog scale (VAS) back pain scores, VAS leg pain scores, and complications were evaluated and recorded at 1 week and 3 and 6 months postoperatively and each year thereafter.
   RESULTS: The study cohort comprised 545 patients (average age, 46.43 years; 34.31% female). The affected levels were L2-3 in 1.47%, L3-4 in 6.96%, L4-5 in 49.45%, and L5-S1 in 44.69%. Mean preoperative ODI, VAS back pain score, and VAS leg pain score were 43.00%, 5.00, and 5.69, respectively. Postoperative ODI at 1 month was reduced to 15.59% and remained within a range of 14.83%18.32% throughout follow-up. Postoperative VAS back and leg pain score results at 1 week were decreased to 1.66 and 1.79, respectively, and remained at 1.89-3.14 and 1.59-2.66, respectively, throughout follow-up. Sixty-six recurrences (12.11%) were diagnosed. Intraoperative complications were nerve root-related (n = 3) and dural tear (n = 1). Postoperative complications included numbness (n = 18), weakness (n = 5), and residual disc (n = 1). No infections or hematomas were reported.
   CONCLUSIONS: Fully endoscopic interlaminar lumbar discectomy is a safe, effective option for treating lumbar disc herniation, with a long recurrence-free recovery.
C1 [Wasinpongwanich, Kanthika; Lwin, Khin Myat Myat; Kesornsak, Withawin; Kuansongtham, Verapan] Bumrungrad Int Hosp, Spine Inst, Bangkok, Thailand.
   [Wasinpongwanich, Kanthika] Suranaree Univ Technol, Sch Orthoped, Inst Med, Nakhon Ratchasima, Thailand.
   [Pongpirul, Krit] Bumrungrad Int Hosp, Bumrungrad Res Ctr, Bangkok, Thailand.
   [Pongpirul, Krit] Chulalongkorn Univ, Fac Med, Bangkok, Thailand.
   [Pongpirul, Krit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Ruetten, Sebastian] Ruhr Univ Bochum, Ctr Orthoped & Traumatol,Marien Hosp Witten, Ctr Spine Surg & Pain Therapy,Marien Hosp Heme Un, St Elisabeth Grp,Catholic Hosp Rhein Ruhr,St Anna, Herne, Germany.
RP Pongpirul, K (reprint author), Bumrungrad Int Hosp, Bumrungrad Res Ctr, Bangkok, Thailand.; Pongpirul, K (reprint author), Chulalongkorn Univ, Fac Med, Bangkok, Thailand.; Pongpirul, K (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
EM doctorkrit@gmail.com
OI Pongpirul, Krit/0000-0003-3818-9761
CR Ahn Y, 2004, SPINE, V29, pE326, DOI 10.1097/01.BRS.0000134591.32462.98
   Chen Hsien-Te, 2011, Surg Neurol Int, V2, P93, DOI 10.4103/2152-7806.82570
   Choi G, 2006, NEUROSURGERY, V58, P59, DOI 10.1227/01.NEU.0000192713.95921.4A
   Choi KC, 2015, NEUROSURGERY, V76, P372, DOI 10.1227/NEU.0000000000000628
   Choi KC, 2013, PAIN PHYSICIAN, V16, P547
   Eun SS, 2016, PAIN PHYSICIAN, V19, pE1161
   Feng F, 2017, PAIN PHYSICIAN, V20, pE862
   Kamson S, 2017, PAIN PHYSICIAN, V20, pE221
   Kuonsongtum Verapan, 2009, Journal of the Medical Association of Thailand, V92, P776
   Li ZZ, 2015, CLIN NEUROL NEUROSUR, V133, P40, DOI 10.1016/j.clineuro.2015.03.003
   Nakamura J, 2017, PAIN PHYSICIAN, V20, pE507
   Passacantilli E, 2015, ASIAN J ENDOSC SURG, V8, P445, DOI 10.1111/ases.12214
   Ruetten S, 2008, SPINE, V33, P931, DOI 10.1097/BRS.0b013e31816c8af7
   Sencer A, 2014, WORLD NEUROSURG, V82, P884, DOI 10.1016/j.wneu.2014.05.032
   Shi C, 2018, BIOMED RES INT, DOI 10.1155/2018/9157089
   Tonosu Juichi, 2016, J Spine Surg, V2, P281, DOI 10.21037/jss.2016.11.05
   Wang B, 2012, ARCH ORTHOP TRAUM SU, V132, P1531, DOI 10.1007/s00402-012-1581-9
   Wang B, 2011, SPINE J, V11, P122, DOI 10.1016/j.spinee.2010.12.006
   Wu JL, 2016, WORLD NEUROSURG, V92, P142, DOI 10.1016/j.wneu.2016.04.127
   Xie TH, 2017, PAIN PHYSICIAN, V20, pE379
   Yao Y, 2017, WORLD NEUROSURG, V100, P1, DOI 10.1016/j.wneu.2016.12.089
   Yorukoglu AG, 2017, NEUROCIRUGIA, V28, P235, DOI 10.1016/j.neucir.2017.03.003
   Zhou CL, 2018, PAIN PHYSICIAN, V21, pE105
NR 23
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e922
DI 10.1016/j.wneu.2019.07.101
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300111
PM 31326641
DA 2020-05-12
ER

PT J
AU Watanabe, S
   Kato, N
   Sato, M
   Aiyama, H
   Fujiwara, Y
   Goto, M
   Yamazaki, T
   Yasuda, S
   Ishikawa, E
   Matsumura, A
AF Watanabe, Shinya
   Kato, Noriyuki
   Sato, Masayuki
   Aiyama, Hitoshi
   Fujiwara, Yusuke
   Goto, Masayuki
   Yamazaki, Tomosato
   Yasuda, Susumu
   Ishikawa, Eiichi
   Matsumura, Akira
TI Treatment Outcomes of Burr-Hole Surgery for Chronic Subdural Hematoma in
   the Elderly Living Beyond Life Expectancy: A Study Comparing Cure,
   Recurrence, and Complications in Patients Aged >= 80 Years versus <= 79
   Years
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Complications; Cure; Elderly; Life
   expectancy; Recurrence
ID DISEASE
AB BACKGROUND: Few reports have focused on chronic subdural hematoma (CSDH) in the very elderly, who have lived beyond average life expectancy. Our aim is to appraise treatment outcomes of burr-hole craniotomy for CSDH in the elderly, focusing on cure, recurrence, and complications.
   METHODS: Fifty patients <= 79 years of age (group A) and 73 patients 80 years of age (group B) were studied. Recurrence was defined as requiring reoperation for hematoma regrowth or symptomatic failure. A cure was regarded as having been achieved in the absence of hematoma on postoperative computed tomography. Complications were defined as any harmful event related to the treatment procedure for CSDH.
   RESULTS: Cure was documented in 31 patients in group A (63%) and 24 patients in group B (33%) (P = 0.0017). Median intervals to cure were 2.76 and 3.73 months, respectively (P = 0.06). Cumulative cure rates were 51%/ 76% and 36%/59%, respectively, at the sixth/twelfth postoperative months. Recurrence was documented in 2 patients (4%) and 11 patients (15%), respectively (P = 0.07). Median intervals to recurrence were 0.81 and 1.25 months, respectively (P = 0.049). Cumulative recurrence-free rates were 96%/92% and 87%/75%, respectively, at the third/sixth postoperative months. Complications were observed in 2 patients (4%) and 4 patients (5%), respectively (P = 1.00).
   CONCLUSIONS: With advancing age, CSDH might show a greater tendency to recur and a longer time is required to achieve a cure. However, complications developed only in high-risk patients. Thus, surgical treatment for CSDH in elderly patients, even those who have lived beyond life expectancy, might provide acceptably effective results.
C1 [Watanabe, Shinya] Univ Tsukuba, Fac Med, Tsukuba Clin Res & Dev Org, Tsukuba, Ibaraki, Japan.
   [Sato, Masayuki; Aiyama, Hitoshi; Ishikawa, Eiichi; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan.
   [Watanabe, Shinya; Kato, Noriyuki; Yamazaki, Tomosato; Yasuda, Susumu] Mito Med Ctr, Dept Neurosurg, Ibaraki, Japan.
   [Fujiwara, Yusuke] Sapporo Shuyukai Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan.
   [Goto, Masayuki] Ibaraki Seinan Med Ctr Hosp, Dept Neurosurg, Sakai, Osaka, Japan.
RP Ishikawa, E (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan.
EM e-ishikawa@md.tsukuba.ac.jp
OI WATANABE, SHINYA/0000-0002-9953-8665
CR Brennan Paul M, 2017, J Neurosurg, P1, DOI 10.3171/2016.8.JNS16134.test
   Castro-Rodriguez Cristina, 2016, Rev Esp Geriatr Gerontol, V51, P309, DOI 10.1016/j.regg.2016.05.003
   Christopher E, 2019, NEUROSURG REV, V42, P427, DOI 10.1007/s10143-018-0979-4
   de Araujo Silva Danilo Otavio, 2012, Surg Neurol Int, V3, P150, DOI 10.4103/2152-7806.104744
   De Bonis P, 2018, CLIN NEUROL NEUROSUR, V170, P88, DOI 10.1016/j.clineuro.2018.05.002
   Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004
   Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418
   Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736
   Hattori Masumi, 2004, Nihon Hoshasen Gijutsu Gakkai Zasshi, V60, P993
   Ishfaq A, 2009, JCPSP-J COLL PHYSICI, V19, P492, DOI 08.2009/JCPSP.492495
   Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042
   Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kurabe S, 2010, ACTA NEUROCHIR, V152, P1171, DOI 10.1007/s00701-010-0627-4
   Link TW, 2019, NEUROSURGERY, V85, P801, DOI 10.1093/neuros/nyy521
   Mahmood SD, 2017, WORLD NEUROSURG, V106, P676, DOI 10.1016/j.wneu.2017.07.057
   Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298
   Miyagami M, 2009, NEUROL SURG TOKYO, V37, P765
   Muzii V F, 2005, J Neurosurg Sci, V49, P41
   Muzii VF, 2005, J NEUROSURG SCI, V49, P6
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Ohta Hirotsugu, 2005, Journal of UOEH, V27, P377
   Ou YW, 2019, CLIN NEUROL NEUROSUR, V178, P63, DOI 10.1016/j.clineuro.2019.01.018
   Rauhala M, 2020, J NEUROSURG, V132, P1147, DOI 10.3171/2018.12.JNS183035
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Shimizu K, 2018, GERIATR GERONTOL INT, V18, P1173, DOI 10.1111/ggi.13436
   Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f
   Tagle P, 2003, REV MED CHILE, V131, P177, DOI 10.4067/S0034-98872003000200007
   Toi H, 2018, J NEUROSURG, V128, P222, DOI 10.3171/2016.9.JNS16623
   Turgut M, 2018, J NEUROSURG, V129, P267, DOI 10.3171/2017.12.JNS172979
   Uno M, 2017, NEUROL MED-CHIR, V57, P402, DOI 10.2176/nmc.ra.2016-0337
   Waqas M, 2019, WORLD NEUROSURG, V126, P228, DOI 10.1016/j.wneu.2019.02.208
   Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937
   Yao Z, 2017, ACTA NEUROCHIR, V159, P2037, DOI 10.1007/s00701-017-3309-7
   Yasunaga H, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/817616
NR 35
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e812
DI 10.1016/j.wneu.2019.08.003
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300099
PM 31404689
DA 2020-05-12
ER

PT J
AU Xu, ZQ
   Rao, HM
   Zhang, LQ
   Li, GS
   Xu, ZX
   Xu, WH
AF Xu, Zhengquan
   Rao, Hongming
   Zhang, Liqun
   Li, Guishuang
   Xu, Zixing
   Xu, Weihong
TI Anterior Cervical Discectomy and Fusion Versus Hybrid Decompression and
   Fusion for the Treatment of 3-Level Cervical Spondylotic Myelopathy: A
   Comparative Analysis of Cervical Sagittal Balance and Outcomes
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior cervical discectomy and fusion; Cervical spondylotic
   myelopathy; Hybrid decompression and fusion; Outcomes; Sagittal balance
ID RECONSTRUCTIVE TECHNIQUES
AB OBJECTIVE: To compare the cervical sagittal balance and surgical outcomes between anterior cervical discectomy and fusion (ACDF) and hybrid decompression and fusion (HDF; 1-level corpectomy combined with 1-level discectomy) for consecutive 3-level cervical spondylotic myelopathy (CSM).
   METHODS: From January 2013 to June 2016, 82 patients with 3-level CSM who underwent ACDF (n = 40) and HDF (n = 42) were retrospectively reviewed. Perioperative parameters, clinical outcomes, and radiologic sagittal alignment were analyzed and compared.
   RESULTS: Patients were followed up for 35.5 similar to 6.5 months (range, 25-53 months). All patients had achieved significant improvement in Neck Disability Index and Japanese Orthopedic Association scores after operation, with similar clinical outcomes between both groups (P > 0.05). In the ACDF group, 2 patients were found with axial symptoms, and 1 with hoarseness. In the HDF group, 5 patients were found with axial symptoms, 1 with hoarseness, 1 with dysphagia, and 1 with pseudarthrosis. The ACDF group had less operation time and bleeding compared with the HDF group (P < 0.05). The restoration of segmental and C2-7 lordosis were significantly greater in the ACDF group than the HDF group (P < 0.05). The C2-7 sagittal vertical axis and T1 slope minus C2-7 lordosis decreased in the ACDF group at final follow-up (P < 0.05); however, there was no obvious change in those of the HDF group (P > 0.05).
   CONCLUSIONS: Both ACDF and HDF were safe and effective for the treatment of 3-level CSM. ACDF showed superiority to HDF in terms of less blood loss, shorter operation time, and better postoperative sagittal balance.
C1 [Xu, Zhengquan; Rao, Hongming; Zhang, Liqun; Li, Guishuang; Xu, Zixing; Xu, Weihong] Fujian Med Univ, Affiliated Hosp 1, Dept Spine Surg, Fuzhou, Fujian, Peoples R China.
RP Xu, WH (reprint author), Fujian Med Univ, Affiliated Hosp 1, Dept Spine Surg, Fuzhou, Fujian, Peoples R China.
EM xwhfygk@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81802050]
FX This publication was partially funded by the National Natural Science
   Foundation of China (81802050).
CR Du W, 2013, EUR SPINE J, V22, P1594, DOI 10.1007/s00586-013-2741-5
   Fraser JF, 2007, J NEUROSURG-SPINE, V6, P298, DOI 10.3171/spi.2007.6.4.298
   Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4
   Hillard Virany H, 2006, Spine J, V6, p242S, DOI 10.1016/j.spinee.2006.05.005
   Hyun SJ, 2017, SPINE, V42, P1859, DOI 10.1097/BRS.0000000000002250
   Jeon SI, 2018, WORLD NEUROSURG, V113, pE548, DOI 10.1016/j.wneu.2018.02.088
   Khoueir P, 2007, NEUROSURGERY, V61, P963, DOI 10.1227/01.neu.0000303192.64802.c6
   Kim HS, 2018, EUR SPINE J, V27, P2023, DOI 10.1007/s00586-018-5634-9
   Kwon WK, 2017, SPINE, V42, P318, DOI 10.1097/BRS.0000000000001776
   Lee SH, 2012, J SPINAL DISORD TECH, V25, pE41, DOI 10.1097/BSD.0b013e3182396301
   Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9
   Liu T, 2011, EUR SPINE J, V20, P224, DOI 10.1007/s00586-010-1486-7
   Liu Y, 2012, EUR SPINE J, V21, P2428, DOI 10.1007/s00586-012-2323-y
   Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4
   Medow Joshua E, 2006, Spine J, V6, p233S, DOI 10.1016/j.spinee.2006.05.007
   MONTGOMERY DM, 1992, ORTHOP CLIN N AM, V23, P487
   Papadopoulos EC, 2006, SPINE, V31, P897, DOI 10.1097/01.brs.0000209348.17377.be
   Rihn JA, 2011, CLIN ORTHOP RELAT R, V469, P658, DOI 10.1007/s11999-010-1731-8
   Schoenfeld AJ, 2012, J SPINAL DISORD TECH, V25, P17, DOI 10.1097/BSD.0b013e31820d77ea
   Tang Jessica A, 2015, Neurosurgery, V76 Suppl 1, pS14, DOI 10.1227/01.neu.0000462074.66077.2b
NR 20
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e752
DI 10.1016/j.wneu.2019.08.022
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300092
PM 31415890
DA 2020-05-12
ER

PT J
AU Yang, L
   Xie, SH
   Fang, C
   Zeng, EM
   Tang, B
   Hong, T
AF Yang, Le
   Xie, Shen Hao
   Fang, Chao
   Zeng, Er Ming
   Tang, Bin
   Hong, Tao
TI Preservation of Hypothalamic Function with Endoscopic Endonasal
   Resection of Hypothalamus-Invaded Craniopharyngiomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Body mass index; Craniopharyngioma; Endoscopic endonasal approach; Gross
   total resection; Hypothalamic function; Surgical outcome; Transcranial
   approach
ID QUALITY-OF-LIFE; SUPRASELLAR CRANIOPHARYNGIOMAS; TRANSSPHENOIDAL
   SURGERY; OUTCOMES; CHILDREN; MANAGEMENT; SERIES; RISK
AB OBJECTIVE: To analyze the preservation of hypothalamic function using the endoscopic endonasal approach (EEA) in a single-center clinical series of patients with hypothalamus-invaded craniopharyngioma (CP) and compare this series with reported cases by the open transcranial approach (TCA).
   METHODS: A retrospective review of hypothalamusinvaded CP surgical cases treated with EEA was performed. Hypothalamic damage was evaluated in terms of the body mass index (BMI), endocrine status, and quality of life before and after surgery. A review of the available literature reporting the use of EEA and TCA over the last decade was performed for comparison.
   RESULTS: In total, 63 cases amenable to EEA were investigated. The elevation in BMI was substantial and an increase in BMI greater than 9% was observed in 22 patients (34.92%). Most patients exhibited a BMI gain >9% within 3 months postoperatively. A total of 16 of the 19 patients who had normal anterior pituitary function preoperatively worsened after surgery. Of the 27 cases reporting preoperative partial hypopituitarism, 16 cases worsened postoperatively and 11 cases remained unchanged. All 9 cases with preoperative panhypopituitarism remained unchanged postoperatively. A total of 40 new cases developed diabetes insipidus, and 3 of the 10 patients with preoperative diabetes insipidus exhibited resolved at the latest follow-up. The quality of life showed no significant difference.
   CONCLUSIONS: EEA can achieve greater gross total resection than TCA when performed by an experienced surgeon. Combined with the reduced postoperative hypothalamic damage in our patients with only hypothalamusinvaded CP, especially the shortened time horizons of hypothalamic obesity development and reduced percentage of patients with obesity, the EEA technique should be a preferred alternative over TCA.
C1 [Yang, Le; Xie, Shen Hao; Fang, Chao; Zeng, Er Ming; Tang, Bin; Hong, Tao] Nanchang Univ, Dept Neurosurg, Affiliated Hosp 5, Nanchang, Jiangxi, Peoples R China.
RP Hong, T (reprint author), Nanchang Univ, Dept Neurosurg, Affiliated Hosp 5, Nanchang, Jiangxi, Peoples R China.
EM ht2000@vip.sina.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81560207, 81460381]; Gaopo555 engineering
   excellence of Jiangxi Science and Technology Department; Key research
   and invention plan of Jiangxi Science and Technology Department
   [20192BBG10026]; Graduate Innovation Foundation of Nanchang University
   [cx2016313]
FX This work was supported by the National Natural Science Foundation of
   China (grant nos. 81560207 and 81460381), Gaopo555 engineering
   excellence of Jiangxi Science and Technology Department (2013), Key
   research and invention plan of Jiangxi Science and Technology Department
   (20192BBG10026) and the Graduate Innovation Foundation of Nanchang
   University (cx2016313).
CR Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083
   Andereggen Lukas, 2018, Swiss Med Wkly, V148, pw14521, DOI 10.4414/smw.2018.14521
   Bao Y, 2016, J NEUROSURG, V125, P24, DOI 10.3171/2015.6.JNS141883
   Cavallo LM, 2009, J NEUROSURG, V111, P578, DOI 10.3171/2009.2.JNS081026
   Cavel O, 2012, J NEUROL SURG PART B, V73, P112, DOI 10.1055/s-0032-1301392
   Chakrabarti I, 2005, J NEUROSURG, V102, P650, DOI 10.3171/jns.2005.102.4.0650
   Clark AJ, 2012, J NEUROSURG-PEDIATR, V10, P293, DOI 10.3171/2012.7.PEDS11436
   Dekkers OM, 2006, EUR J ENDOCRINOL, V154, P483, DOI 10.1530/eje.1.02114
   Dho YS, 2018, J NEUROSURG, V129, P611, DOI 10.3171/2017.4.JNS162143
   Dusick JR, 2008, SURG NEUROL, V70, P482, DOI 10.1016/j.surneu.2008.03.027
   Elliott RE, 2011, NEUROSURGERY, V69, P630, DOI 10.1227/NEU.0b013e31821a872d
   Elowe-Gruau E, 2013, J CLIN ENDOCR METAB, V98, P2376, DOI 10.1210/jc.2012-3928
   Gardner PA, 2008, J NEUROSURG, V109, P6, DOI 10.3171/JNS/2008/109/7/0006
   Gil Z, 2004, J NEUROSURG, V100, P813, DOI 10.3171/jns.2004.100.5.0813
   Gil Z, 2003, ARCH OTOLARYNGOL, V129, P1303, DOI 10.1001/archotol.129.12.1303
   Guo FY, 2018, CLIN NEUROL NEUROSUR, V167, P162, DOI 10.1016/j.clineuro.2018.02.034
   Hofmann BM, 2012, J NEUROSURG, V116, P373, DOI 10.3171/2011.6.JNS081451
   Jane JA, 2010, J NEUROSURG-PEDIATR, V5, P49, DOI 10.3171/2009.7.PEDS09252
   Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715
   Kenning TJ, 2015, ENDOSCOPIC RESECTION, P155
   Kitano M, 2009, SURG NEUROL, V71, P290, DOI 10.1016/j.surneu.2007.11.014
   Kshettry VR, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16292
   Leng LZ, 2012, NEUROSURGERY, V70, P110, DOI 10.1227/NEU.0b013e31822e8ffc
   Lustig RH, 2013, J CLIN ENDOCR METAB, V88, P611
   McCoul ED, 2015, J NEUROSURG, V123, P813, DOI 10.3171/2014.11.JNS14559
   Moussazadeh N, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16299
   Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300
   Patel KS, 2015, J NEUROSURG, V123, P571, DOI 10.3171/2014.12.JNS141591
   Patel VS, 2017, WORLD NEUROSURG, V108, P6, DOI 10.1016/j.wneu.2017.08.058
   Rath SR, 2013, J PAEDIATR CHILD H, V49, P403, DOI 10.1111/jpc.12190
   Roth CL, 2015, OBESITY, V23, P1226, DOI 10.1002/oby.21067
   Shirane R, 2002, J NEUROSURG, V96, P704, DOI 10.3171/jns.2002.96.4.0704
   Sterkenburg AS, 2015, NEURO-ONCOLOGY, V17, P1029, DOI 10.1093/neuonc/nov044
   Szathmari A, 2013, NEUROPATHOLOGY, V33, P17, DOI 10.1111/j.1440-1789.2012.01321.x
   Tang B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28282-4
   Van Effenterre R, 2002, J NEUROSURG, V97, P3, DOI 10.3171/jns.2002.97.1.0003
   Van Gompel JJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09303
   van Iersel L, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26911
   Xiao GL, 2014, EXP THER MED, V7, P1055, DOI 10.3892/etm.2014.1561
   Yamada S, 2018, J NEUROSURG-PEDIATR, V21, P549, DOI 10.3171/2017.10.PEDS17254
   Yano S, 2016, WORLD NEUROSURG, V85, P153, DOI 10.1016/j.wneu.2015.08.059
   Zada G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076562
   Zoli M, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16317
NR 43
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD DEC
PY 2019
VL 132
AR e841
DI 10.1016/j.wneu.2019.07.225
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA JN5VR
UT WOS:000496966300102
PM 31398519
DA 2020-05-12
ER

PT J
AU Buskova, J
   Kostalova, J
   Miletinova, E
   Busek, P
AF Buskova, Jitka
   Kostalova, Jana
   Miletinova, Eva
   Busek, Petr
TI Comorbid episodes of primary bruxism and bruxism as an epileptic
   activity-related motor event
SO SLEEP MEDICINE
LA English
DT Article
ID SLEEP BRUXISM
C1 [Buskova, Jitka; Kostalova, Jana; Miletinova, Eva] Natl Inst Mental Hlth, Klecany, Czech Republic.
   [Buskova, Jitka; Miletinova, Eva] Charles Univ Prague, Fac Med 3, Prague, Czech Republic.
   [Busek, Petr] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Dept Neurol, Prague, Czech Republic.
   [Busek, Petr] Gen Univ Hosp, Prague, Czech Republic.
RP Buskova, J (reprint author), Natl Inst Mental Hlth, Dept Sleep Med, Topolova 748, Klecany 25067, Czech Republic.
EM vankjit@seznam.cz
FU MEYS under the NPU I program [LO1611];  [PROGRES Q35]
FX This study was supported by project Nr. LO1611 with financial support
   from the MEYS under the NPU I program and by PROGRES Q35.
CR American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   Carra MC, 2015, SLEEP MED CLIN, V10, P375, DOI 10.1016/j.jsmc.2015.05.005
   Gibbs SA, 2016, SLEEP MED REV, V25, P4, DOI 10.1016/j.smrv.2015.05.002
   Guaita M, 2015, SLEEP MED, V16, P1429, DOI 10.1016/j.sleep.2015.05.024
   Lobbezoo F, 2001, J ORAL REHABIL, V28, P1085, DOI 10.1046/j.1365-2842.2001.00839.x
   Macaluso GM, 1998, J DENT RES, V77, P565, DOI 10.1177/00220345980770040901
   Meletti S, 2004, NEUROLOGY, V62, P2306, DOI 10.1212/WNL.62.12.2306
   Ohayon MM, 2001, CHEST, V119, P53, DOI 10.1378/chest.119.1.53
   Parrino L, 2006, SLEEP MED REV, V10, P267, DOI 10.1016/j.smrv.2005.12.004
   World Health Organization, 1992, INT STAT CLASS DIS R
NR 10
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 1
EP 2
DI 10.1016/j.sleep.2019.06.009
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300001
PM 31655318
OA Bronze
DA 2020-05-12
ER

PT J
AU Radovanovic, D
   Rizzi, M
   Airoldi, A
   Mantero, M
   Di Marco, F
   Raccanelli, R
   Santus, P
AF Radovanovic, Dejan
   Rizzi, Maurizio
   Airoldi, Andrea
   Mantero, Marco
   Di Marco, Fabiano
   Raccanelli, Rita
   Santus, Pierachille
TI Effect of continuous positive airway pressure on respiratory drive in
   patients with obstructive sleep apnea
SO SLEEP MEDICINE
LA English
DT Article
DE Sleep apnea; Respiratory drive; CPAP; Thoracic impedance; Inspiratory
   impedance; Ventilatory response
ID TERM CPAP THERAPY; VENTILATORY RESPONSE; PERIPHERAL CHEMOSENSITIVITY;
   INTERMITTENT HYPOXIA; PATHOGENESIS; HYPERCAPNIA; FREQUENCY; MEDICINE;
   PATTERN; NIGHT
AB Objective: Patients with obstructive sleep apnea (OSA) have an altered control of breathing during wakefulness. Thus far, whether and how treatment with continuous positive airway pressure (CPAP) may restore these abnormalities has been poorly understood. The aim of this study was to investigate the long-term effects of CPAP on the breathing pattern, ventilatory drive (VDr), and chemoreceptor sensitivity in OSA patients.
   Patients and methods: This was a prospective, observational study, carried out in an academic sleep outpatient clinic. A total of 62 patients with OSA (mean age [SD], 51 [11] years) underwent polysomnography (PSG), breathing pattern assessment, mouth occlusion pressure, ventilatory response to hypoxemia (V-e/SaO(2)), and hypercapnia (V-e/PETCO2) before and after CPAP titration and during 12-month follow-up. A total of 48 age-matched healthy subjects served as controls. Patients with good (>= 6 h/night) and poor (<6 h/night) compliance with CPAP were also compared.
   Results: At baseline, VDr as well as thoracic and inspiratory impedances were greater in patients with OSA compared with controls and were reduced by CPAP treatment, starting from the night of titration (P < 0.01), especially in patients with good compliance with CPAP. Baseline V-e/SaO(2) was higher in OSA patients (P < 0.05) and was progressively normalized during CPAP treatment (P < 0.001). The pathophysiological changes were mainly due to a reduction in tidal volume. The remaining breathing pattern parameters were unaltered by CPAP treatment and were similar between groups.
   Conclusion: In OSA patients, the mechanics of breathing are inefficient because of an imbalance of the VDr. Regular CPAP treatment improves the efficiency of the respiratory system and normalizes the hypoxemic stimulus. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Radovanovic, Dejan; Rizzi, Maurizio; Airoldi, Andrea; Santus, Pierachille] Univ Milan, Luigi Sacco Univ Hosp, Dept Biomed & Clin Sci DIBIC, Div Resp Dis, Milan, Italy.
   [Mantero, Marco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Mantero, Marco] IRCCS Fdn Ca Granda Osped Policlin, Dept Internal Med, Resp Unit, Milan, Italy.
   [Mantero, Marco] IRCCS Fdn Ca Granda Osped Policlin, Reg Adult Cyst Fibrosis Ctr, Milan, Italy.
   [Di Marco, Fabiano] Univ Milan, ASST Osped Papa Giovanni XXIII, Resp Unit, Dipartimento Sci Salute, Bergamo, Italy.
   [Raccanelli, Rita] IRCCS ICS Maugeri SPA SB, Cardioresp Rehabil Med, Milan, Italy.
RP Santus, P (reprint author), Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci DIBIC, Div Resp Dis, Via GB Grassi 74, I-20157 Milan, Italy.
EM pierachille.santus@unimi.it
RI Radovanovic, Dejan/AAI-1920-2019; SANTUS, PIERACHILLE/T-4688-2017
OI Radovanovic, Dejan/0000-0002-9013-3418; di marco,
   fabiano/0000-0002-1743-0504; SANTUS, PIERACHILLE/0000-0003-3462-8253
CR Argacha JF, 2008, J HYPERTENS, V26, P284, DOI 10.1097/HJH.0b013e3282f2b93c
   Bamberga M, 2015, RESP MED, V109, P540, DOI 10.1016/j.rmed.2015.02.010
   BENLLOCH E, 1995, RESPIRATION, V62, P4
   BERTHONJONES M, 1987, AM REV RESPIR DIS, V135, P144
   Bonsignore MR, 2002, AM J RESP CRIT CARE, V166, P279, DOI 10.1164/rccm.2107117
   Bouloukaki I, 2014, EUR RESPIR J, V44, P1262, DOI 10.1183/09031936.00021314
   Breska B, 1992, J SLEEP RES S1, V1, P247
   BULOW K, 1963, Acta Physiol Scand Suppl, V209, P1
   Butler MP, 2015, SLEEP, V38, P1793, DOI 10.5665/sleep.5166
   Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010
   CHEN HI, 1989, AM REV RESPIR DIS, V140, P907, DOI 10.1164/ajrccm/140.4.907
   Ching-Kai L, 2012, RESPIROLOGY, V17, P402
   Dellaca RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116317
   DERENNE JP, 1977, REV FR MAL RESPIR, V5, P714
   Devouassoux G, 2007, J ALLERGY CLIN IMMUN, V119, P597, DOI 10.1016/j.jaci.2006.11.638
   Doberty LS, 2005, CHEST, V127, P2076
   El-Chami M, 2015, J APPL PHYSIOL, V119, P617, DOI 10.1152/japplphysiol.00346.2015
   GARAY SM, 1981, AM REV RESPIR DIS, V124, P451
   Garcia-Rio F, 2002, EUR RESPIR J, V20, P724, DOI 10.1183/09031936.02.00250102
   GOLD AR, 1993, CHEST, V103, P1325, DOI 10.1378/chest.103.5.1325
   HUDGEL DW, 1990, J APPL PHYSIOL, V69, P443
   Hudgel DW, 1998, AM J RESP CRIT CARE, V158, P1142, DOI 10.1164/ajrccm.158.4.9712105
   Iber C., 2007, AASM MANUAL SCORING
   JACKSON MJ, 1993, BRIT MED BULL, V49, P630, DOI 10.1093/oxfordjournals.bmb.a072636
   JARDIM J, 1981, AM REV RESPIR DIS, V124, P274
   Jaworski J, 2019, J THEOR BIOL, V469, P148, DOI 10.1016/j.jtbi.2019.03.001
   Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408
   Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506
   Krakow B, 2014, J CLIN SLEEP MED, V10, P121, DOI 10.5664/jcsm.3432
   Kushida CA, 2008, J CLIN SLEEP MED, V4, P157
   Lampert E, 1990, SLEEP, V90, P206
   LIN CC, 1994, EUR RESPIR J, V7, P2005
   Lin CK, 2012, RESPIROLOGY, V17, P402, DOI 10.1111/j.1440-1843.2011.02124.x
   LOPATA M, 1982, AM REV RESPIR DIS, V126, P640
   Martinez-Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909, DOI 10.1164/rccm.201203-0448OC
   Masa JF, 2014, EUR RESPIR J, V44, P1119, DOI 10.1183/09031936.00121514
   Millc-Emili J, 1981, REGULATION BREATHING, P675
   Mitchell GS, 2001, J APPL PHYSIOL, V90, P2466
   Mortola JP, 2004, EUR J APPL PHYSIOL, V91, P119, DOI 10.1007/s00421-003-0978-0
   Narkiewicz K, 1999, CIRCULATION, V99, P1183, DOI 10.1161/01.CIR.99.9.1183
   Narkiewicz K, 1999, CIRCULATION, V100, P2332, DOI 10.1161/01.CIR.100.23.2332
   NISHIMURA M, 1991, AM REV RESPIR DIS, V143, P1278, DOI 10.1164/ajrccm/143.6.1278
   Osanai S, 1999, EUR RESPIR J, V13, P418, DOI 10.1183/09031936.99.13241899
   Phillipson EA, 1986, HDB PHYSL 3, P649
   RADWAN L, 1995, EUR RESPIR J, V8, P542
   RAJAGOPAL KR, 1984, CHEST, V85, P174, DOI 10.1378/chest.85.2.174
   Raschke F, 1989, Pneumologie, V43 Suppl 1, P568
   READ DJC, 1967, AUSTRALAS ANN MED, V16, P20
   REMMERS JE, 1978, J APPL PHYSIOL, V44, P931
   Rey S, 2004, J PHYSIOL-LONDON, V560, P577, DOI 10.1113/jphysiol.2004.072033
   Sforza E, 1996, AM J RESP CRIT CARE, V154, P1741, DOI 10.1164/ajrccm.154.6.8970364
   SFORZA E, 1990, AM REV RESPIR DIS, V141, P866, DOI 10.1164/ajrccm/141.4_Pt_1.866
   SOMERS VK, 1989, J APPL PHYSIOL, V67, P2101
   SOMERS VK, 1993, SLEEP, V16, pS30, DOI 10.1093/sleep/16.suppl_8.S30
   Spicuzza L, 2006, CHEST, V130, P774, DOI 10.1378/chest.130.3.774
   Steier J, 2010, RESP PHYSIOL NEUROBI, V171, P54, DOI 10.1016/j.resp.2010.01.012
   SULLIVAN CE, 1983, NEW ENGL J MED, V309, P112
   Terblanche J, 2004, PHYSIOL MEAS, V25, P1189, DOI 10.1088/0967-3334/25/5/009
   TOBIN MJ, 1983, CHEST, V84, P202, DOI 10.1378/chest.84.2.202
   TOBIN MJ, 1988, J APPL PHYSIOL, V65, P309
   Truong KK, 2016, ANN AM THORAC SOC, V13, P1144, DOI 10.1513/AnnalsATS.201602-125FR
   Verbraecken J, 2000, RESP PHYSIOL, V123, P121, DOI 10.1016/S0034-5687(00)00140-7
   Wang D, 2007, SLEEP BREATH, V11, P103, DOI 10.1007/s11325-006-0090-x
   Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005
   Wellman A, 2004, AM J RESP CRIT CARE, V170, P1225, DOI 10.1164/rccm.200404-510OC
   White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO
   WILCOX PG, 1990, AM REV RESPIR DIS, V142, P533, DOI 10.1164/ajrccm/142.3.533
   Younes M, 1989, CURR PULMONOL, V10, P265
NR 68
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 3
EP 11
DI 10.1016/j.sleep.2019.05.019
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300002
PM 31655322
DA 2020-05-12
ER

PT J
AU Ayache, M
   Rosen, CL
   Chiang, A
   Little, JA
   Strohl, KP
AF Ayache, Mirna
   Rosen, Carol L.
   Chiang, Ambrose
   Little, Jane A.
   Strohl, Kingman P.
TI Overnight oxygen desaturation index in sickle cell disease: prediction
   of sleep apnea
SO SLEEP MEDICINE
LA English
DT Article
ID NOCTURNAL OXIMETRY
C1 [Ayache, Mirna] Metrohlth Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH USA.
   [Rosen, Carol L.; Chiang, Ambrose; Little, Jane A.; Strohl, Kingman P.] Univ Hosp Cleveland, Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA.
   [Strohl, Kingman P.] Louis Stokes Vet Affair Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH USA.
   [Rosen, Carol L.] Rainbow Babies & Childrens Hosp, Div Pediat Pulm & Sleep Med, 2101 Adelbert Rd, Cleveland, OH 44106 USA.
RP Ayache, M (reprint author), 2500 MetroHlth Dr, Cleveland, OH 44109 USA.
EM mayache1@metrohealth.org
OI Rosen, Carol/0000-0002-3070-4266
CR BECKLAKE MR, 1955, J CLIN INVEST, V34, P751, DOI 10.1172/JCI103129
   Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172
   Chiner E, 1999, THORAX, V54, P968, DOI 10.1136/thx.54.11.968
   Chung F, 2012, ANESTH ANALG, V114, P993, DOI 10.1213/ANE.0b013e318248f4f5
   Magalang UJ, 2003, CHEST, V124, P1694, DOI 10.1378/chest.124.5.1694
   Needleman JP, 1999, PEDIATR PULM, V28, P418, DOI 10.1002/(SICI)1099-0496(199912)28:6<418::AID-PPUL6>3.3.CO;2-4
   Rotz SJ, 2016, AM J HEMATOL, V91, pE355, DOI 10.1002/ajh.24432
   Sharma S, 2015, J CLIN SLEEP MED, V11, P219, DOI 10.5664/jcsm.4530
   Worsham CM, 2017, AM J HEMATOL, V92, pE649, DOI 10.1002/ajh.24892
   Yawn BP, 2015, AM FAM PHYSICIAN, V92, P1069
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 12
EP 14
DI 10.1016/j.sleep.2019.06.007
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300003
PM 31655319
DA 2020-05-12
ER

PT J
AU Montie, K
   Quaedackers, L
   Perlitius, V
   van der Horst, E
   Vandenbussche, N
   Overeem, S
   Pillen, S
AF Montie, Koen
   Quaedackers, Laury
   Perlitius, Vera
   van der Horst, Els
   Vandenbussche, Nele
   Overeem, Sebastiaan
   Pillen, Sigrid
TI The impact of delayed sleep phase disorder on adolescents and their
   family
SO SLEEP MEDICINE
LA English
DT Article
DE Delayed sleep phase syndrome; Adolescents; Impact; Family; Social
   functioning; School
ID QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; PARENTAL STRESS; YOUNG-ADULTS;
   CHILDREN; INFANT; HEALTH; CONSEQUENCES; ASSOCIATIONS; PERFORMANCE
AB Introduction: We investigated the impact of delayed sleep phase disorder (DSPD) on the daily lives of adolescents and their families.
   Method: In this qualitative study, six adolescents with DSPD, and six parents were given in-depth interviews. Using thematic analysis, we merged open codes into themes that reflected the impact of the disorder.
   Result: We identified five themes: (1) Impact on the adolescents' school and social life: describing the negative influence of DSPD on school performance and friendships. (2) Impact on the parents, feeling guilty and powerless: showing the consequences of many unsuccessful attempts to improve the situation, with a lack of understanding from their social support system. (3) Impact on the family, conflicts, and misunderstanding: describing the negative influence on other family members, family relationships, and home atmosphere. (4) Impact on the parents, being weary of everything: describing the effect on the parents' mood and social life. (5) Factors mediating the severity of impact, of which personal characteristics and school support seemed most important. Themes 2 to 4 were highly interrelated.
   Conclusions: Adolescent DSPD not only affects cognitive functioning and mental health but has a much broader impact, also affecting social life, family life, and parental well-being. This information provides new potential points of engagement for therapy, guidance, and support for these families. Greater awareness and recognition of the impact of DSPD is needed on the part of physicians as well as the general population, to increase support and reduce misunderstanding of these adolescents and their parents. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Montie, Koen; Quaedackers, Laury; Perlitius, Vera; van der Horst, Els; Vandenbussche, Nele; Overeem, Sebastiaan; Pillen, Sigrid] Kempenhaeghe, Sleep Med Ctr, Sterkselseweg 65, NL-5591 VE Heeze, Netherlands.
   [Montie, Koen] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands.
   [Overeem, Sebastiaan; Pillen, Sigrid] Tech Univ Eindhoven, Dept Ind Design, Eindhoven, Netherlands.
   [Overeem, Sebastiaan] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands.
RP Pillen, S (reprint author), Kempenhaeghe, Sleep Med Ctr, Sterkselseweg 65, NL-5591 VE Heeze, Netherlands.
EM PillenS@kempenhaeghe.nl
OI Overeem, Sebastiaan/0000-0002-6445-9836
CR Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443
   American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   Ando K, 2002, ISRAEL J PSYCHIAT, V39, P11
   Bastiaansen D, 2004, J AM ACAD CHILD PSY, V43, P221, DOI 10.1097/00004583-200402000-00019
   Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125
   Bayer JK, 2007, J PAEDIATR CHILD H, V43, P66, DOI 10.1111/j.1440-1754.2007.01005.x
   Brand S, 2009, SLEEP MED, V10, P1124, DOI 10.1016/j.sleep.2008.12.013
   Byars KC, 2011, SLEEP MED, V12, P898, DOI 10.1016/j.sleep.2011.05.002
   Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59
   Danielsson K, 2016, CHRONOBIOL INT, V33, P1331, DOI 10.1080/07420528.2016.1217002
   Doran SM, 2001, ARCH ITAL BIOL, V139, P253
   Eckerberg B, 2004, ACTA PAEDIATR, V93, P126, DOI 10.1080/08035250310007754
   El-Sheikh M, 2014, J FAM PSYCHOL, V28, P887, DOI 10.1037/fam0000031
   El-Sheikh M, 2012, J CHILD PSYCHOL PSYC, V53, P806, DOI 10.1111/j.1469-7610.2012.02530.x
   Gangwisch JE, 2010, SLEEP, V33, P97, DOI 10.1093/sleep/33.1.97
   Gray David E., 1992, Australia and New Zealand Journal of Developmental Disabilities, V18, P83
   Gromov I, 2009, CHILD ADOL PSYCH CL, V18, P929, DOI 10.1016/j.chc.2009.04.004
   Hiscock H, 2001, PEDIATRICS, V107, P1317, DOI 10.1542/peds.107.6.1317
   Hysing M, 2015, BRIT J PSYCHIAT, V207, P306, DOI 10.1192/bjp.bp.114.146514
   Kalak N, 2012, J PSYCHIATR RES, V46, P1374, DOI 10.1016/j.jpsychires.2012.07.006
   Lam P, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e203
   Martin J, 2007, PEDIATRICS, V119, P947, DOI 10.1542/peds.2006-2569
   Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772
   Mindell Jodi A, 2013, BMC Res Notes, V6, P130, DOI 10.1186/1756-0500-6-130
   Mindell JA, 2011, SLEEP MED, V12, P928, DOI 10.1016/j.sleep.2011.07.001
   Moturi Sricharan, 2010, Psychiatry (Edgmont), V7, P24
   Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019
   Quach J, 2009, PEDIATRICS, V123, P1287, DOI 10.1542/peds.2008-1860
   Roberts RE, 2002, J PSYCHOSOM RES, V53, P561, DOI 10.1016/S0022-3999(02)00446-4
   Roberts RE, 2001, J YOUTH ADOLESCENCE, V30, P1, DOI 10.1023/A:1005230820074
   Saloviita T, 2003, J INTELL DISABIL RES, V47, P300, DOI 10.1046/j.1365-2788.2003.00492.x
   Schmidt RE, 2015, SLEEP MED CLIN, V10, P117, DOI 10.1016/j.jsmc.2015.02.007
   Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005
   Sivertsen B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1163
   Sivertsen B, 2015, J SLEEP RES, V24, P11, DOI 10.1111/jsr.12254
   Stores Gregory, 2009, Dialogues Clin Neurosci, V11, P81
   Telman LGE, 2017, CHILD PSYCHIAT HUM D, V48, P891, DOI 10.1007/s10578-017-0712-5
   Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43
   Watson SMR, 2002, MENT RETARD, V40, P304, DOI 10.1352/0047-6765(2002)040<0304:CTQOLO>2.0.CO;2
NR 39
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 15
EP 22
DI 10.1016/j.sleep.2019.05.022
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300004
PM 31655320
OA Bronze
DA 2020-05-12
ER

PT J
AU Giabicani, E
   Boule, M
   Aubertin, G
   Galliani, E
   Brioude, F
   Dubern, B
   Netchine, I
AF Giabicani, Eloise
   Boule, Michele
   Aubertin, Guillaume
   Galliani, Eva
   Brioude, Frederic
   Dubern, Beatrice
   Netchine, Irene
TI Sleep disordered breathing in Silver-Russell syndrome patients: a new
   outcome
SO SLEEP MEDICINE
LA English
DT Article
DE Silver-Russell syndrome; Sleep disordered breathing; Growth hormone;
   Sleep apnea syndrome; Sleep recording
ID PRADER-WILLI-SYNDROME; GROWTH-HORMONE TREATMENT; CHILDREN; MANAGEMENT;
   CHILDHOOD; THERAPY; BORN
AB Objective: Imprinting disorders (ID), such as Prader-Willi syndrome (PWS), are associated with sleep-disordered breathing (SDB). No data are available for Silver-Russell syndrome (SRS), another ID that shares clinical features with PWS, although many patients describe excessive daytime sleepiness, disturbed sleep, and snoring. The aim of this study was to characterize sleep in children with SRS and to evaluate the impact of recombinant growth hormone (rGH) therapy.
   Methods: We performed a retrospective analysis of sleep recordings in 40 patients with molecularly proven SRS (methylation anomaly in 11p15 [n = 32] or maternal uniparental disomy of chromosome 7 [n = 16]). Sleep recordings were either by means of polygraphy or polysomnography (PSG) (n = 16). A total of 34 patients received rGH therapy.
   Results: We collected 61 sleep recordings. The mean apnea-hypopnea index (AHI) was 3.4 events/h (0 - 12.4), with a mean central AHI of 0.5 events/h (0-2.4). SDB was identified in 73.8% (n = 45) of the recordings and was severe in 4.9%. SDB was present in 86.4% of patients before rGH therapy and was severe in 13.6%. AHI worsened for 5 of 12 patients with sleep recordings before and after rGH therapy initiation, reaching mild impairment. The mean rGH dose was 32.3 mg/kg/(12.9-51.4), with a mean insulin-like growth factor 1 plasma level of 1.7 SDS (-1.9 to 6.6).
   Conclusion: Most patients with SRS present with SDB with an obstructive profile, possibly explained by narrowing of the airways and lymphoid organ hypertrophy. We recommend systematic ear-nose-throat evaluation of SRS patients and PSG if there are clinical anomalies, preferably before initiating rGH therapy, to monitor and adapt the management of patients with SDB. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Giabicani, Eloise; Brioude, Frederic; Netchine, Irene] Sorbonne Univ, Hop Armand Trousseau, APHP,INSERM,UMR S 938, Explorat Fonct Endocriniennes,Ctr Rech St Antoine, Paris, France.
   [Boule, Michele] Hop Armand Trousseau, APHP, Explorat Fonct Resp & Sommeil, Paris, France.
   [Aubertin, Guillaume] Hop Armand Trousseau, APHP, Serv Pneumol Pediat, Ctr References Malad Resp Rares Enfant, Paris, France.
   [Aubertin, Guillaume] Ramsay Gen Sante, Clin Chirurg, Ctr Pneumol Enfant, Boulogne, France.
   [Galliani, Eva] Hop Necker Enfants Malad, AP HP, Chirurg Maxillofaciale & Chirurg Plast, Paris, France.
   [Dubern, Beatrice] Hop Armand Trousseau, APHP, Serv Nutr & Gastroenterol Pediat, Paris, France.
   [Dubern, Beatrice] Sorbonne Univ, INSERM, Nutri, Paris, France.
RP Giabicani, E (reprint author), Hop Armand Trousseau, Explorat Fonct Endocriniennes, 26 Ave Dr Arnold Netter, F-75012 Paris, France.
EM eloise.giabicani@aphp.fr
RI Giabicani, Eloise/AAM-8783-2020
OI GIABICANI, Eloise/0000-0001-5360-8616
CR Al-Saleh S, 2013, J PEDIATR-US, V162, P263, DOI 10.1016/j.jpeds.2012.07.042
   Azzi S, 2015, J MED GENET, V52, P446, DOI 10.1136/jmedgenet-2014-102979
   Azzi S, 2014, CURR PHARM DESIGN, V20, P1751, DOI 10.2174/13816128113199990525
   Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172
   Bridges N, 2014, ARCH DIS CHILD, V99, P166, DOI 10.1136/archdischild-2013-303760
   Clayton PE, 2007, J CLIN ENDOCR METAB, V92, P804, DOI 10.1210/jc.2006-2017
   Festen DAM, 2006, J CLIN ENDOCR METAB, V91, P4911, DOI 10.1210/jc.2006-0765
   Geoffron S, 2018, J CLIN ENDOCR METAB, V103, P2436, DOI 10.1210/jc.2017-02152
   Goldstone AP, 2008, J CLIN ENDOCR METAB, V93, P4183, DOI 10.1210/jc.2008-0649
   Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P2206, DOI 10.1210/jc.2002-021536
   Hoyos CM, 2014, SLEEP, V37, P733, DOI 10.5665/sleep.3580
   Iliev DI, 2014, GROWTH HORM IGF RES, V24, P187, DOI 10.1016/j.ghir.2014.06.005
   Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065
   Kisnisci RS, 1999, AM J ORTHOD DENTOFAC, V116, P25, DOI 10.1016/S0889-5406(99)70299-4
   Lindgren AC, 1999, EUR J PEDIATR, V158, P936, DOI 10.1007/s004310051246
   Mackay Deborah J. G., 2015, BioMolecular Concepts, V6, P47, DOI 10.1515/bmc-2014-0037
   Manni R, 2001, CLIN NEUROPHYSIOL, V112, P800, DOI 10.1016/S1388-2457(01)00483-7
   Marsaud C, 2015, ARCH DIS CHILD, V100, P353, DOI 10.1136/archdischild-2013-305864
   Morselli LL, 2013, EUR J ENDOCRINOL, V168, P763, DOI 10.1530/EJE-12-1037
   Nixon GM, 2002, PEDIATR PULM, V34, P209, DOI 10.1002/ppul.10152
   O'Donoghue FJ, 2005, J PEDIATR-US, V147, P823, DOI 10.1016/j.jpeds.2005.07.021
   Padia R, 2017, ANN OTO RHINOL LARYN, V126, P733, DOI 10.1177/0003489417729834
   Pavone M, 2015, PEDIATR PULM, V50, P1354, DOI 10.1002/ppul.23177
   Quang SV, 2019, J STOMATOL ORAL MAXI, V120, P110, DOI 10.1016/j.jormas.2018.10.011
   Salvatoni A, 2012, HORM RES PAEDIAT, V78, P201, DOI 10.1159/000342649
   Scholle S, 2011, SLEEP MED, V12, P988, DOI 10.1016/j.sleep.2011.05.006
   Sedky K, 2012, J CLIN SLEEP MED, V8, P597
   Swaab DF, 1997, ACTA PAEDIATR, V86, P50
   Tauber M, 2007, HORM RES, V68, P48, DOI 10.1159/000110475
   USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6
   Van Cauter E, 2000, GROWTH HORM IGF RES, V10, P57
   Vandeleur M, 2013, J PAEDIATR CHILD H, V49, P238, DOI 10.1111/jpc.12109
   Wakeling EL, 2017, NAT REV ENDOCRINOL, V13, P105, DOI 10.1038/nrendo.2016.138
   Won Christine H J, 2008, Proc Am Thorac Soc, V5, P193, DOI 10.1513/pats.200708-121MG
NR 34
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 23
EP 29
DI 10.1016/j.sleep.2019.05.020
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300005
PM 31655321
DA 2020-05-12
ER

PT J
AU Chamorro, R
   Algarin, C
   Rojas, O
   Garrido, M
   Duran-Aguero, S
   Causa, L
   Held, C
   Lozoff, B
   Ferri, R
   Peirano, P
AF Chamorro, Rodrigo
   Algarin, Cecilia
   Rojas, Oliver
   Garrido, Marcelo
   Duran-Aguero, Samuel
   Causa, Leonardo
   Held, Claudio
   Lozoff, Betsy
   Ferri, Raffaele
   Peirano, Patricio
TI Night-time cardiac autonomic modulation as a function of sleep-wake
   stages is modified in otherwise healthy overweight adolescents
SO SLEEP MEDICINE
LA English
DT Article
DE Autonomic regulation; Heart rate variability; Overweight; Obesity;
   Sleep; Adolescents
ID HEART-RATE-VARIABILITY; IRON-DEFICIENCY ANEMIA; SCHOOL-AGED CHILDREN;
   ATHEROSCLEROSIS RISK; CHILDHOOD OBESITY; STATE; INFLAMMATION;
   ASSOCIATION; DYSFUNCTION; INFANCY
AB Objective: Even though sympathetic dominance during the daytime period is well known, currently, scarce data exist on autonomic nervous system (ANS) regulation during sleep in pediatric obesity. We aimed to evaluate sleep cardiac ANS regulation in normal-weight (NW) and overweight and obese (OW) adolescents.
   Patients/methods: In this study, 60 healthy adolescents (15.7 +/- 0.7 years) belonging to a birth cohort since infancy were classified based on body mass index percentiles criteria as: OW (N = 27) or NW (N = 33). Sleep was evaluated by polysomnography (PSG) during two consecutive in-lab overnight sessions. Non-rapid eye movement (non-REM) sleep stages (stages 1, 2, and slow-wave sleep [SWS]), rapid eye movement (REM) sleep, and wakefulness (Wake) were scored. R-waves were detected automatically in the electrocardiographic (ECG) signal. An all-night heart rate variability analysis was conducted in the ECG signal, with several time- and frequency-domain measures calculated for each sleep-wake stage. Sleep time was divided into thirds (T1, T2, T3). The analysis was performed using a mixed-effects linear regression model.
   Results: Sleep organization was comparable except for reduced REM sleep percentage in the OW group (p < 0.04). Shorter R-R intervals were found for all sleep stages in the OW group; time-domain measured standard deviation of all R-R intervals (RRSD) was lower during stage 2, SWS and REM sleep (all p < 0.05). The square root of the mean of the sum of the squares of differences between adjacent R-R intervals (RMSSD) was also lower only during wake after sleep onset (WASO) in T1 and T3 (p < 0.05). The OW group had increased very low- and low-frequency (LF) power during WASO (in T1 and T2), and LF power during stage 2 and REM sleep (in T2). During WASO in the OW group, high-frequency (HF) power was lower (in T1 and T2), and LF/HF ratio was higher (in T2, p < 0.007).
   Conclusions: Several sleep-stage-dependent changes in cardiac autonomic regulation characterized the OW group. As sleep-related ANS balance was disturbed in the absence of concomitant metabolic alterations in this sample of otherwise healthy OW adolescents, their relevance for pediatric obesity should be further explored throughout development. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Chamorro, Rodrigo; Algarin, Cecilia; Rojas, Oliver; Garrido, Marcelo; Duran-Aguero, Samuel; Peirano, Patricio] Univ Chile, Sleep & Funct Neurobiol Lab, Inst Nutr & Food Technol INTA, Santiago, Chile.
   [Chamorro, Rodrigo] Univ Chile, Dept Nutr, Fac Med, Santiago, Chile.
   [Causa, Leonardo; Held, Claudio] Univ Chile, Dept Elect Engn, Fac Phys & Math Sci, Santiago, Chile.
   [Lozoff, Betsy] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.
   [Lozoff, Betsy] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
   [Ferri, Raffaele] Oasi Res Inst IRCCS, Sleep Res Ctr, Troina, Italy.
RP Peirano, P (reprint author), Univ Chile, Sleep Lab, INTA, Av El Libano 5524,POB 138-11, Santiago, Chile.
EM ppeirano@inta.uchile.cl
RI Ferri, Raffaele/B-5439-2013
OI Ferri, Raffaele/0000-0001-6937-3065
FU FondecytComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [1110513]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   HD33487]; National Commission on Research, Science and Technology,
   CONICYT [21100352]
FX The authors are grateful to the participants and their families who have
   made this study possible and the technicians and personnel for their
   valuable collaboration during the study. Financial support: Fondecyt
   1110513 and NIH R01 HD33487 grants. R.C. was recipient of a Doctoral
   Fellowship (No. 21100352) from the National Commission on Research,
   Science and Technology, CONICYT. Funding sources had no influence in
   study design and collection, analysis, and interpretation of data, in
   the writing of the manuscript, or in the decision to submit the article
   for publication. The content is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Institutes of Health (NIH).
CR Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546
   BERLAD I, 1993, J SLEEP RES, V2, P88, DOI 10.1111/j.1365-2869.1993.tb00067.x
   Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172
   Camm AJ, 1996, CIRCULATION, V93, P1043, DOI 10.1016/0044-8486(94)90048-5
   Carskadon MA, 2005, PRINCIPLES PRACTICE, V4, P13, DOI DOI 10.1016/B0-72-160797-7/50009-4
   Causa L, 2010, IEEE T BIO-MED ENG, V57, P2135, DOI 10.1109/TBME.2010.2052924
   Chamorro R, 2014, INT J OBESITY, V38, P1120, DOI 10.1038/ijo.2013.238
   Chamorro R, 2014, SLEEP, V37, P557, DOI 10.5665/sleep.3496
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Emdin M, 2001, CIRCULATION, V103, P513, DOI 10.1161/01.CIR.103.4.513
   Ferri R, 2002, J SLEEP RES, V11, P153, DOI 10.1046/j.1365-2869.2002.00283.x
   Gozal D, 2012, ANN NY ACAD SCI, V1264, P135, DOI 10.1111/j.1749-6632.2012.06723.x
   Graziano PA, 2011, OBESITY, V19, P1818, DOI 10.1038/oby.2011.98
   Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028
   Hakim Fahed, 2012, Front Neurol, V3, P7, DOI 10.3389/fneur.2012.00007
   Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007
   Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7
   Hilz MJ, 2011, STROKE, V42, P1528, DOI 10.1161/STROKEAHA.110.607721
   Hursh BE, 2016, HORM RES PAEDIAT, V85, P339, DOI 10.1159/000445685
   Jarrin DC, 2013, INT J OBESITY, V37, P552, DOI 10.1038/ijo.2013.4
   Jarrin DC, 2015, J YOUTH ADOLESCENCE, V44, P285, DOI 10.1007/s10964-014-0235-3
   Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1
   Kaufman CL, 2007, OBESITY, V15, P1164, DOI 10.1038/oby.2007.619
   Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326
   KEMP B, 1992, ELECTROEN CLIN NEURO, V82, P391, DOI 10.1016/0013-4694(92)90009-7
   Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213
   Lazarou C, 2011, ADV NUTR, V2, P295, DOI 10.3945/an.110.000166
   Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524
   Liu XC, 2008, ARCH GEN PSYCHIAT, V65, P924, DOI 10.1001/archpsyc.65.8.924
   Lozoff B, 2003, PEDIATRICS, V112, P846
   Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mendelson R, 2007, APPL PHYSIOL NUTR ME, V32, P495, DOI 10.1139/H07-003
   Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6
   Peirano P, 2003, J PEDIATR-US, V143, pS70, DOI 10.1067/S0022-3476(03)00404-9
   Peirano P, 2012, SLEEP MED, V13, P1006, DOI 10.1016/j.sleep.2012.05.011
   Peirano PD, 2007, PEDIATR RES, V62, P715, DOI 10.1203/PDR.0b013e3181586aef
   Rabbia F, 2003, OBES RES, V11, P541, DOI 10.1038/oby.2003.76
   RECHTSCHAFFEN A, 1968, MANUAL STANDARDIZED
   Redon P, 2017, J HYPERTENS, V35
   Riva P, 2001, CLIN EXP HYPERTENS, V23, P57, DOI 10.1081/CEH-100001197
   Rodriguez-Colon SM, 2015, METABOLISM, V64, P626, DOI 10.1016/j.metabol.2015.01.018
   Rodriguez-Colon SM, 2015, SLEEP MED, V16, P67, DOI 10.1016/j.sleep.2014.10.007
   Rodriguez-Colon SM, 2011, INT J PEDIATR OBES, V6, P128, DOI 10.3109/17477166.2010.490265
   Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73
   Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6
   Tarokh L, 2010, SLEEP, V33, P801, DOI 10.1093/sleep/33.6.801
   Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543
   Tobaldini E, 2013, EUR J INTERN MED, V24, P664, DOI 10.1016/j.ejim.2013.03.011
   Trinder J, 2001, J SLEEP RES, V10, P253, DOI 10.1046/j.1365-2869.2001.00263.x
   Trinder J, 2011, PFLUGERS ARCH, P161, DOI [10.1007/s00424-011-1041, DOI 10.1007/S00424-011-1041]
   Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831
   Walter LM, 2009, SLEEP, V32, P1093, DOI 10.1093/sleep/32.8.1093
   Wojnar J, 2010, SLEEP MED, V11, P295, DOI 10.1016/j.sleep.2009.02.012
NR 56
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 30
EP 36
DI 10.1016/j.sleep.2019.06.008
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300006
PM 31655323
OA Bronze
DA 2020-05-12
ER

PT J
AU Lavoie, MR
   Patel, JA
   Camacho, M
AF Lavoie, Matthew R.
   Patel, Jagatkumar A.
   Camacho, Macario
TI Nocturnal dialysis improves sleep apnea more than daytime dialysis: a
   meta-analysis of crossover studies
SO SLEEP MEDICINE
LA English
DT Review
DE Sleep apnea; Nocturnal hemodialysis; Apnea hypopnea index; Fluid shift
ID STAGE RENAL-DISEASE; BODY POSITIVE-PRESSURE; UPPER AIRWAY;
   PERITONEAL-DIALYSIS; HEMODIALYSIS; FAILURE; COMPLICATIONS; RESISTANCE;
   DISORDERS; COMMUNITY
AB Purpose: To systematically review the literature for articles evaluating differences in polysomnography (PSG) data when patients are on primarily daytime hemodialysis (conventional hemodialysis or continuous ambulatory peritoneal dialysis) versus nocturnal hemodialysis (nocturnal hemodialysis or nocturnal peritoneal dialysis). Then to perform a meta-analysis on the available PSG data, specifically evaluating differences in apnea hypopnea index (AHI) and mean saturation of oxygen (SpO(2)) between these two groups.
   Methods: Two authors systematically searched MEDLINE/Pubmed, Scopus, EMBASE, CINAHL, and Cochrane. Searches were performed through December 6, 2018.
   Results: A total of four adult crossover studies (91 patients, age 50.4 +/- 12.4, BMI 25.1 +/- 5.3) reported PSG data. The daytime hemodialysis (DHD) and nocturnal hemodialysis (NHD) AHI decreased from 24.6 +/- 18.2 to 12.6 +/- 11.8 (events/hour) with a mean difference of -11.9 [95% CI -13.47, -10.37], Z score of 15.07 (P < 0.00001). The standardizedmean difference was -1.35 [95% CI -2.70, 0.01]. Two studies reported mean SpO(2) changes during PSG. The DHD and NHD SpO(2) increased from 92.7 +/- 2.4 to 94.7 +/- 2.2 with a mean difference of 2.26 [95% CI -0.18, 4.71], Z score 1.82 (P = 0.07).
   Conclusion: In the current literature, nocturnal hemodialysis improves AHI more than daytime hemodialysis. A trend towards improvement in mean SpO(2) with nocturnal dialysis was noted, but did not reach statistical significance. Consideration can be given for transitioning patients who have end stage renal disease and sleep apnea from daytime to nocturnal hemodialysis as an adjunct to other treatment modalities. Published by Elsevier B.V.
C1 [Lavoie, Matthew R.] Madigan Army Med Ctr, Dept Med, 9040A Jackson Ave, Joint Base Lewis Mcchord, WA 98431 USA.
   [Patel, Jagatkumar A.] Madigan Army Med Ctr, Dept Otolaryngol, 9040A Jackson Ave, Joint Base Lewis Mcchord, WA 98431 USA.
   [Camacho, Macario] Tripler Army Med Ctr, Div Otolaryngol Head & Neck Surg, 1 Jarrett White Rd, Tripler, HI 96859 USA.
RP Lavoie, MR (reprint author), Madigan Army Med Ctr, Dept Med, 9040A Jackson Ave, Joint Base Lewis Mcchord, WA 98431 USA.
EM mattrlavoie@gmail.com; drcamachoent@yahoo.com
OI Camacho, Macario/0000-0001-9200-9085
CR Anastassov GE, 1998, ORAL SURG ORAL MED O, V86, P644, DOI 10.1016/S1079-2104(98)90197-4
   Auckley DH, 1999, AM J KIDNEY DIS, V34, P739, DOI 10.1016/S0272-6386(99)70401-4
   Beecroft J, 2006, EUR RESPIR J, V28, P151, DOI 10.1183/09031936.06.00075405
   Beecroft JM, 2007, EUR RESPIR J, V30, P965, DOI 10.1183/09031936.00161906
   Beecroft JM, 2008, NEPHROL DIAL TRANSPL, V23, P673, DOI 10.1093/ndt/gfm598
   Beecroft JM, 2009, SLEEP MED, V10, P47, DOI 10.1016/j.sleep.2007.11.017
   Blankfield RP, 2004, SLEEP MED, V5, P589, DOI 10.1016/j.sleep.2004.06.008
   Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012
   Bucca CB, 2007, CHEST, V132, P440, DOI 10.1378/chest.07-0311
   Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x
   Chiu KL, 2006, AM J RESP CRIT CARE, V174, P1378, DOI 10.1164/rccm.200607-927OC
   FLEETHAM JA, 1992, CLIN CHEST MED, V13, P399
   Hanly PJ, 2003, AM J KIDNEY DIS, V41, P403, DOI 10.1053/ajkd.2003.50066
   Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HUDGEL DW, 1987, AM REV RESPIR DIS, V135, P899, DOI 10.1164/arrd.1987.135.4.899
   Ip MSM, 2004, CHEST, V125, P127, DOI 10.1378/chest.125.1.127
   Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62
   ISSA FG, 1986, CHEST, V90, P165, DOI 10.1378/chest.90.2.165
   Kaur J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081682
   Khoo MCK, 2000, RESP PHYSIOL, V122, P167, DOI 10.1016/S0034-5687(00)00157-2
   Kraus MA, 1997, ADV PERIT D, V13, P88
   MENDELSON WB, 1990, CLIN NEPHROL, V33, P247
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   ONAL E, 1986, J APPL PHYSIOL, V61, P1438
   Pierratos A, 2004, KIDNEY INT, V65, P1975, DOI 10.1111/j.1523-1755.2004.00603.x
   Pierratos A, 1999, NEPHROL DIAL TRANSPL, V14, P2835, DOI 10.1093/ndt/14.12.2835
   Raj DSC, 2000, NEPHROL DIAL TRANSPL, V15, P58, DOI 10.1093/ndt/15.1.58
   Shiota S, 2007, THORAX, V62, P868, DOI 10.1136/thx.2006.071183
   Solin P, 1999, CIRCULATION, V99, P1574, DOI 10.1161/01.CIR.99.12.1574
   STEPANSKI E, 1995, J AM SOC NEPHROL, V6, P192
   Tang SCW, 2006, J AM SOC NEPHROL, V17, P2607, DOI 10.1681/ASN.2005090936
   Tang SCW, 2009, CLIN J AM SOC NEPHRO, V4, P410, DOI 10.2215/CJN.03520708
   WADHWA NK, 1992, PERITON DIALYSIS INT, V12, P51
   WALKER S, 1995, AM J KIDNEY DIS, V26, P751, DOI 10.1016/0272-6386(95)90438-7
   Welch KC, 2002, SLEEP, V25, P532, DOI 10.1093/sleep/25.5.530
   Wilcox I, 1998, EUR RESPIR J, V11, P7, DOI 10.1183/09031936.98.11010007
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
   Yuen D, 2005, ASAIO J, V51, P236, DOI 10.1097/01.MAT.0000160578.43422.60
   Zoccali C, 2002, J AM SOC NEPHROL, V13
   Zoccali C, 2001, J AM SOC NEPHROL, V12, P2854
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 37
EP 42
DI 10.1016/j.sleep.2019.06.005
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300007
PM 31655324
DA 2020-05-12
ER

PT J
AU Migueis, DP
   Lacerda, GCB
   Lopes, MC
   Azevedo-Soster, LMSF
   Thuler, LCS
   Lemes, LNA
   Araujo-Melo, MH
AF Migueis, D. P.
   Lacerda, G. C. B.
   Lopes, M. C.
   Azevedo-Soster, L. M. S. F.
   Thuler, L. C. S.
   Lemes, L. N. A.
   Araujo-Melo, M. H.
TI Obstructive sleep apnea in patients with chronic rhinosinusitis with
   nasal polyps: a cross-sectional study
SO SLEEP MEDICINE
LA English
DT Article
DE Obstructive sleep apnea; Nasal polyps; Rhinosinusitis; Adults; STOP-Bang
ID PHYSICAL-EXAMINATION; DAYTIME SLEEPINESS; PREVALENCE; OBESITY
AB Introduction: Adults with chronic rhinosinusitis with nasal polyps (CRSwNP) often suffer from sleep disruption and sleep apnea. As the apneic profile of CRSwNP may differ from obstructive sleep apnea (OSA) classic patients without nasal polyps (NP), it may prove useful to define a new profile for OSA screening in these patients. The aim of the current study was to compare baseline characteristics and apneic profile of OSA patients with CRSwNP to OSA patients without NP.
   Materials and methods: Thirty-one apneic patients with CRSwNP and 62 apneic cases without NP were included in our study. Both groups underwent nasal endoscopy, Epworth Sleepiness Scale (ESS) evaluation, and overnight polysomnography (PSG). We additionally accessed anthropometric characteristics such as snoring, tiredness, observed apnea, high blood pressure, body mass index (BMI), age, neck circumference, male gender, and OSA risk via the STOP-Bang questionnaire.
   Results: Although the patients were matched according to age and gender, the median BMI and STOP-Bang score were significantly higher in patients with OSA than in those with OSA and CRSwNP. Notably, the median ESS showed low somnolence and a low median apnea-hypopnea index in patients with CRSwNP, despite the fact that the lowest median oxygen saturation was not significantly different between groups.
   Conclusions: Anthropometric characteristics in individuals with apnea caused by CRSwNP were significantly different from those in individuals with typical. This finding will improve screening and treatment of apneic patients CRSwNP. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Migueis, D. P.; Lacerda, G. C. B.; Araujo-Melo, M. H.] Fed Univ State Rio de Janeiro, Gafree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Lopes, M. C.; Azevedo-Soster, L. M. S. F.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Thuler, L. C. S.] Natl Canc Inst, Brasilia, DF, Brazil.
   [Lemes, L. N. A.] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
RP Migueis, DP (reprint author), LabSono, Rua Mariz e Barros 775 3 Andar, BR-20270901 Rio De Janeiro, RJ, Brazil.
EM debpetrungaro@gmail.com
CR AASM-American Academy of Sleep Medicine, 2012, AM ACAD SLEEP MED
   Alt JA, 2013, INT FORUM ALLERGY RH, V3, P941, DOI 10.1002/alr.21217
   American Academy of Sleep Medicine (AASM), 2014, INT CLASSIFICATION S
   Ayappa I, 2000, SLEEP, V23, P763, DOI 10.1093/sleep/23.6.763
   Bengtsson C, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw021
   Berson SR, 2018, INT FORUM ALLERGY RH, V8, P817, DOI 10.1002/alr.22099
   Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009
   Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064
   Boynton G, 2013, J SLEEP DISORD TREAT, V2, P4, DOI [10.4172/2325-9639.1000121, DOI 10.4172/2325-9639.1000121]
   Chen HJ, 2018, PUBLIC HEALTH, V161, P20, DOI 10.1016/j.puhe.2018.01.013
   Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022
   Collop N, 2014, J CLIN SLEEP MED, V10, P125, DOI 10.5664/jcsm.3434
   de Godoy LBM, 2015, SLEEP SCI, V8, P42, DOI 10.1016/j.slsci.2015.03.001
   Dennis SK, 2016, LARYNSCOPE INVESTIG, V1, P130, DOI 10.1002/lio2.32
   Dokkedal-Silva V, 2018, EUR J INTERN MED, V52, pE17, DOI 10.1016/j.ejim.2018.02.036
   Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065
   Eckert DJ, 2013, AM J RESP CRIT CARE, V188, P996, DOI 10.1164/rccm.201303-0448OC
   Fokkens WJ, 2012, RHINOLOGY, V50, P1
   Friedman M, 2002, OTOLARYNG HEAD NECK, V127, P13, DOI 10.1067/mhn.2002.126477
   GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781
   Hui JW, 2017, ANN ALLERG ASTHMA IM, V118, P685, DOI 10.1016/j.anai.2017.03.009
   Johansson L, 2003, ANN OTO RHINOL LARYN, V112, P625, DOI 10.1177/000348940311200709
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Lal D, 2016, INT FORUM ALLERGY RH, V6, P278, DOI 10.1002/alr.21667
   Nagappa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143697
   Ng SK, 2010, ARCH OTOLARYNGOL, V136, P159, DOI 10.1001/archoto.2009.170
   PALOMBINI L, 2011, [No title captured], V4, P72
   Pedrosa RP, 2018, METAB SYNDR RELAT D, V16, P2, DOI 10.1089/met.2017.0112
   Reis R, 2015, REV PORT PNEUMOL, V21, P61, DOI 10.1016/j.rppnen.2014.04.009
   Romero-Corral A, 2010, CHEST, V137, P711, DOI 10.1378/chest.09-0360
   Saxby AJ, 2013, OTOLARYNG HEAD NECK, V148, P717, DOI 10.1177/0194599813477837
   Uz U, 2017, AURIS NASUS LARYNX, V44, P708, DOI 10.1016/j.anl.2017.01.015
   Varendh M, 2017, RHINOLOGY, V55, P45, DOI [10.4193/Rhin16.065, 10.4193/Rhino16.065]
   VINER S, 1991, ANN INTERN MED, V115, P356, DOI 10.7326/0003-4819-115-5-356
   White David P, 2017, Adv Otorhinolaryngol, V80, P7, DOI 10.1159/000470522
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
   Zonato AI, 2005, LARYNGOSCOPE, V115, P1030, DOI 10.1097/01.MLG.0000163494.19965.DC
NR 37
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 43
EP 47
DI 10.1016/j.sleep.2019.06.006
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300008
PM 31655325
DA 2020-05-12
ER

PT J
AU Kotzian, ST
   Saletu, MT
   Schwarzinger, A
   Haider, S
   Spatt, J
   Kranz, G
   Saletu, B
AF Kotzian, Stefan T.
   Saletu, Michael T.
   Schwarzinger, Angela
   Haider, Sandra
   Spatt, Josef
   Kranz, Gottfried
   Saletu, Bernd
TI Proactive telemedicine monitoring of sleep apnea treatment improves
   adherence in people with stroke- a randomized controlled trial (HOPES
   study)
SO SLEEP MEDICINE
LA English
DT Article
DE Obstructive sleep apnea; Stroke; Rehabilitation; PAP adherence;
   Telemedicine
ID POSITIVE AIRWAY PRESSURE; ACUTE ISCHEMIC-STROKE; CARDIOVASCULAR EVENTS;
   IMPACT; RISK; CLASSIFICATION; THERAPY; ATTACK; CPAP
AB Objective: Obstructive sleep apnea (OSA) impacts stroke recovery and outcome negatively. Although its identification and treatment are part of the current stroke guidelines, standard management with positive airway pressure (PAP) therapy is not routinely performed and adherence rates are very low. The purpose of this study was to determine whether PAP adherence can be improved by a PAP training strategy during in-hospital rehabilitation combined with a telemedicine monitoring system after discharge.
   Methods: In this study, we performed a controlled trial (RCT) on standard PAP treatment (SG) as compared with proactive telemonitored PAP treatment (TG). After three months and one year, PAP adherence (min of use per day) and clinical outcome variables were compared.
   Results: In 33 (47.1%) out of 70 patients diagnosed with therapy-relevant OSA [70% male, 62 (5) years, body mass index (BMI) 30 (4) kg/m(2), Barthel Index 90 (20), NIHSS 3 (3)] in-hospital PAP titration was performed. Subsequently, they were randomized to SG or TG. Drop-out rates after three months and after one year were 12% and 30%, respectively, with no differences between the groups. After three months, telemonitored patients used the PAP device 76 min longer per night (SG: 299 (76), TG: 375 (86) minutes per night; p = 0.017), after one year there was no significant difference.
   Conclusion: People with stroke and therapy-relevant OSA who accept PAP therapy should receive additional telemedicine monitoring at least for three months. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Kotzian, Stefan T.; Saletu, Michael T.; Schwarzinger, Angela; Haider, Sandra; Spatt, Josef; Kranz, Gottfried] Neurol Rehabil Zentrum Rosenhugel, Vienna, Austria.
   [Saletu, Michael T.] LKH Graz II, Dept Sleep Med, Graz, Austria.
   [Haider, Sandra] Med Univ Vienna, Dept Social & Prevent Med, Ctr Publ Hlth, Vienna, Austria.
   [Saletu, Bernd] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria.
RP Saletu, MT (reprint author), LKH Graz II, Neurol, Dept Sleep Med, Wagner Jauregg Pl 17, A-8053 Graz, Austria.
EM michael.saletu@gmail.com
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   Anttalainen U, 2016, SLEEP BREATH, V20, P1209, DOI 10.1007/s11325-016-1337-9
   Ballard RD, 2007, J CLIN SLEEP MED, V3, P706
   BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O
   Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3
   Berry RB, 2014, J CLIN SLEEP MED, V10, P1269, DOI 10.5664/jcsm.4272
   Birkbak J, 2014, J CLIN SLEEP MED, V10, P103, DOI 10.5664/jcsm.3376
   Bravata DM, 2010, STROKE, V41, P1464, DOI 10.1161/STROKEAHA.109.566745
   Brill AK, 2018, NEUROLOGY, V90, pE1222, DOI 10.1212/WNL.0000000000005262
   Bros JS, 2018, TELEMED E-HEALTH, V24, P351, DOI 10.1089/tmj.2017.0134
   Brown DL, 2019, SLEEP MED, V59, P90, DOI 10.1016/j.sleep.2018.09.009
   Cohen J., 1988, STAT POWER ANAL BEHA
   Colelli DR, 2020, SLEEP MED, V66, P243, DOI 10.1016/j.sleep.2018.10.009
   Dale O, 1996, ACTA ANAESTH SCAND, V40, P771, DOI 10.1111/j.1399-6576.1996.tb04530.x
   Fox N, 2012, SLEEP, V35, P477, DOI 10.5665/sleep.1728
   Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060
   Gupta A, 2018, J CLIN SLEEP MED, V14, P511, DOI 10.5664/jcsm.7034
   Haas DC, 2005, CIRCULATION, V111, P614, DOI 10.1161/01.CIR.0000154540.62381.CF
   Hage AV, 2011, NURSE COM NURSING SP, V24, P44
   Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Johnson KG, 2010, J CLIN SLEEP MED, V6, P131
   Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
   Kim Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146317
   Kotzian ST, 2012, TOP STROKE REHABIL, V19, P45, DOI 10.1310/tsr1901-45
   Kotzian ST, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018847
   Kumar R, 2017, SLEEP MED, V34, P50, DOI 10.1016/j.sleep.2017.02.025
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7
   McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599
   McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813
   Mezzich JE, 2011, J EVAL CLIN PRACT, V17, P357, DOI 10.1111/j.1365-2753.2010.01609.x
   Minnerup J, 2012, STROKE, V43, P1137, DOI 10.1161/STROKEAHA.111.637611
   Munafo D, 2016, SLEEP BREATH, V20, P777, DOI 10.1007/s11325-015-1298-4
   Olindo S, 2008, J NEUROL NEUROSUR PS, V79, P965, DOI 10.1136/jnnp.2007.140285
   Parra O, 2015, J SLEEP RES, V24, P47, DOI 10.1111/jsr.12181
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Ryan CM, 2011, STROKE, V42, P1062, DOI 10.1161/STROKEAHA.110.597468
   Saletu MT, 2018, J CLIN SLEEP MED, V14, P1495, DOI 10.5664/jcsm.7322
   Sarfo FS, 2018, J STROKE CEREBROVASC, V27, P2306, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.013
   Schipper MH, 2017, J NEUROL, V264, P1247, DOI 10.1007/s00415-017-8522-z
   Shi YF, 2009, SLEEP MED, V10, P717, DOI 10.1016/j.sleep.2008.08.006
   Tomfohr LM, 2012, STROKE, V43, P3118, DOI 10.1161/STROKEAHA.112.666248
   Tsivgoulis G, 2017, STROKE, V48, P2285, DOI 10.1161/STROKEAHA.117.017661
   Turino C, 2017, EUR RESP J, V49
   Valentin A, 2011, SLEEP, V34, P801, DOI 10.5665/SLEEP.1054
   Woehrle H, 2017, SOMNOLOGIE, V21, P121, DOI 10.1007/s11818-016-0098-9
   Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2
   Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104
NR 50
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 48
EP 55
DI 10.1016/j.sleep.2019.06.004
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300009
PM 31670004
DA 2020-05-12
ER

PT J
AU Abolhassani, N
   Haba-Rubio, J
   Heinzer, R
   Vollenweider, P
   Marques-Vidal, P
AF Abolhassani, Nazanin
   Haba-Rubio, Jose
   Heinzer, Raphael
   Vollenweider, Peter
   Marques-Vidal, Pedro
TI Ten-year trend in sleeping pills use in Switzerland: the CoLaus study
SO SLEEP MEDICINE
LA English
DT Article
DE Epidemiology; Prospective study; Sleeping pills; Change; Trends;
   Population
ID LONG-TERM BENZODIAZEPINE; GENERAL-PRACTICE; OLDER-PEOPLE; PRIMARY-CARE;
   Z-DRUGS; INSOMNIA; PREVALENCE; MEDICATION; POPULATION; ADULTS
AB Objective: The aim of this study was to assess the trends and determinants of sleeping pill consumption in the general population.
   Methods: This was a prospective study that included 4329 participants (2379 women, 51.9 +/- 10.4 years) living in the city of Lausanne, Switzerland, followed up for an average of 10.9 years. Benzodiazepines and benzodiazepine receptor agonists were considered as sleeping pills.
   Results: The prevalence (95% confidence interval [CI]) of sleeping pills use was 8.0% (7.2-8.9) at baseline and 8.4 (7.6-9.3) after 10.9 years. Overall, sleeping pills use was higher among women, elderly individuals, and individuals reporting a history of anxiety and depression. During the 10.9-year follow-up, 85.8% of participants never used sleeping pills, 2.7% used the sleeping pills at all assessments, and 11.5% shifted from using to quitting (and vice versa). On multivariate analysis, the factors associated with "always" sleeping pills use were as follows: female gender (relative risk ratio and [95% CI] = 1.80 [1.14-2.85]); older age (7.05 [3.56-14.0] for 65 thorn vs < 45 years); lower educational level (2.06 [1.06-3.99] for mandatory vs university); anxiety (5.61 [3.61-8.71] for yes/no); and depression (3.75 [2.47-5.69] for yes/no). The same factors were also associated with occasional sleeping pills use (ie, shifters): relative risk ratios and 95% CI = 1.56 (1.26-1.94), 2.37 (1.72-3.26), 1.35 (0.98-1.87), 3.40 (2.59-4.45), and 2.50 (1.99-3.15) for female gender, older age, lower educational level, and anxiety and depression, respectively.
   Conclusion: During a 10.9-year follow-up, one out of seven participants (14.2%) used sleeping pills at least once during the study period. Sleeping pills use is more frequent among individuals with anxiety or depression, elderly individuals, and women. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Abolhassani, Nazanin; Vollenweider, Peter; Marques-Vidal, Pedro] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland.
   [Haba-Rubio, Jose; Heinzer, Raphael] Lausanne Univ Hosp CHUV, CIRS, Lausanne, Switzerland.
RP Marques-Vidal, P (reprint author), Lausanne Univ Hosp, Off BH10 642, Dept Med, Internal Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.
EM Pedro-Manuel.Marques-Vidal@chuv.ch
RI ; Marques-Vidal, Pedro/C-9449-2009
OI Abolhassani, Nazanin/0000-0002-3616-3595; Marques-Vidal,
   Pedro/0000-0002-4548-8500
FU GlaxoSmithKlineGlaxoSmithKline; Faculty of Biology and Medicine of
   Lausanne; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [3200B0-105993, 3200B0-118308, 33CSCO-122661,
   33CS30-139468, 33CS30-148401]
FX The CoLaus vertical bar PsyCoLaus study was supported by research grants
   from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne,
   and the Swiss National Science Foundation (grants 3200B0-105993,
   3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). The
   funding source had no contribution to the study design, analysis and
   interpretation, as well as writing the report and decision to submit the
   article for publication.
CR Achermann R, 2011, CLIN MICROBIOL INFEC, V17, P855, DOI 10.1111/j.1469-0691.2010.03348.x
   Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004
   Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9
   Bartlett G, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-1
   Berman E, 2017, PHARMACOEPIDEM DR S, V26, P1555, DOI 10.1002/pds.4338
   Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410
   Bjorvatn B, 2017, FAM PRACT, V34, P20, DOI 10.1093/fampra/cmw107
   Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700
   Cimolai N, 2007, CAN FAM PHYSICIAN, V53, P2124
   CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202
   Cunningham CM, 2010, HEALTH POLICY, V97, P122, DOI 10.1016/j.healthpol.2010.03.008
   Damen-van Beek Zamire, 2015, Ned Tijdschr Geneeskd, V159, pA8679
   Davies J, 2017, BRIT J GEN PRACT, V67, pE609, DOI 10.3399/bjgp17X691865
   DEMENT WC, 1992, J CLIN PSYCHIAT, V53, P50
   Drieling RL, 2016, AM J EPIDEMIOL, V184, P233, DOI 10.1093/aje/kwv446
   Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972
   Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6
   Foral Pamela, 2011, Consult Pharm, V26, P414, DOI 10.4140/TCP.n.2011.414
   Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914
   Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326
   Fujita M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009490
   Gunja N, 2013, J MED TOXICOL, V9, P163, DOI 10.1007/s13181-013-0294-y
   Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000
   Hogan David B, 2003, Can J Clin Pharmacol, V10, P72
   HOHAGEN F, 1993, EUR ARCH PSY CLIN N, V242, P329, DOI 10.1007/BF02190245
   Huber CA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-44
   Kaufmann CN, 2016, PHARMACOEPIDEM DR S, V25, P637, DOI 10.1002/pds.3951
   Kodaira K, 2015, VALUE HEALTH, V18, pA408, DOI 10.1016/j.jval.2015.09.963
   Kodaira K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016233
   Kurko TAT, 2015, EUR PSYCHIAT, V30, P1037, DOI 10.1016/j.eurpsy.2015.09.003
   Leggett A, 2016, J GERONTOL A-BIOL, V71, P954, DOI 10.1093/gerona/glv227
   Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x
   Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033
   Manthey L, 2011, J CLIN PSYCHOPHARM, V31, P774, DOI 10.1097/JCP.0b013e3182362484
   Moloney ME, 2011, AM J PUBLIC HEALTH, V101, P1429, DOI 10.2105/AJPH.2010.300014
   Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817, DOI 10.4088/JCP.v63n0912
   Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9
   Sakshaug S, 2017, BASIC CLIN PHARMACOL, V120, P292, DOI 10.1111/bcpt.12684
   Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470
   Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487
   Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
   Terzano MG, 2004, SLEEP MED, V5, P67, DOI 10.1016/j.sleep.2003.09.006
   Tinguely G, 2014, THER UMSCH, V71, P637, DOI 10.1024/0040-5930/a000604
   Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307
   Windle A, 2007, AUST NZ J PUBL HEAL, V31, P379, DOI 10.1111/j.1753-6405.2007.00091.x
NR 45
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 56
EP 61
DI 10.1016/j.sleep.2018.06.022
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300010
PM 31670162
DA 2020-05-12
ER

PT J
AU Xu, XM
   Wei, YD
   Liu, Y
   Li, ZX
AF Xu, Xiao-Min
   Wei, You-Dong
   Liu, Yang
   Li, Zuo-Xiao
TI Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated
   systematic review and meta-analysis
SO SLEEP MEDICINE
LA English
DT Review
DE Narcolepsy; Cataplexy; Gamma-hydroxybutyrate (GHB); Sodium oxybate;
   Meta-analysis; Adult
ID QUALITY-OF-LIFE; NOCTURNAL SLEEP DISRUPTION; SODIUM OXYBATE;
   DOUBLE-BLIND; ECONOMIC CONSEQUENCES; PLACEBO; HEALTH; REDUCTION;
   CATAPLEXY; BURDEN
AB Background: Narcolepsy is a chronic and debilitating sleep disorder characterized by cataplexy and excessive daytime sleeping. Gamma-hydroxybutyrate (GHB) has been widely used to treat narcolepsy, and new findings have been published in recent years.
   Objective: A meta-analysis was conducted to assess the efficacy and tolerability of GHB treatment in adults with narcolepsy.
   Methods: A systematic search of PubMed, Cochrane, Embase, Web of Science, and clinical-trials.gov from inception to June 2018 was performed. Change in daily diaries and polysomnographic data of narcoleptic patients were defined as the efficacy outcomes. The tolerability and acceptability outcomes were the rates of adverse events and dropping out for adverse effects or other reasons.
   Results: Fifteen randomized controlled trials involving 2104 participants were identified. GHB was found to improve cataplexy attacks (P = 0.001), subjective daytime sleepiness (P < 0.0001), daytime sleep latency (P < 0.0001), inadvertent naps/sleep attacks (P < 0.00001), effective rates (Clinical Global Impression of change) (P < 0.00001), hypnagogic hallucinations (P = 0.004), sleep paralysis (P = 0.004), stage 1 sleep (P = 0.04), slow wave sleep (P = 0.003), REM sleep (P = 0.0006), sleep shifts (P = 0.005), nocturnal awakenings (P = 0.004), quality of nocturnal sleep (P < 0.00001), chin muscle activity, and quality of life, but had no effect on stage 2 sleep (P = 0.88). GHB was less well tolerated than placebo because of side effects that occurred in a dose-dependent fashion (RR = 6.08; 95% CI = 2.18 to 16.97; P = 0.0006).
   Conclusions: GHB was effective in improving narcolepsy-cataplexy and related symptoms in adults but was less well tolerated than placebo because of dose-dependent side effects. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Xu, Xiao-Min; Li, Zuo-Xiao] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Taiping St, Luzhou 646000, Sichuan, Peoples R China.
   [Wei, You-Dong; Liu, Yang] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.
   [Wei, You-Dong; Liu, Yang] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China.
RP Li, ZX (reprint author), Southwest Med Univ, Affiliated Hosp, Dept Neurol, Taiping St, Luzhou 646000, Sichuan, Peoples R China.
EM lizuoxiao2335@163.com
FU Science and Technology Support Project of Science & Technology
   Department of Sichuan [14ZC0063]
FX This work was supported by the Science and Technology Support Project of
   Science & Technology Department of Sichuan (No. 14ZC0063).
CR Ahmed M, 2005, J CLIN SLEEP MED, V1, P391
   Alshaikh MK, 2012, J CLIN SLEEP MED, V8, P451, DOI 10.5664/jcsm.2048
   American Academy of Sleep Medicine, 2014, INT CLASS CAT SLEEP
   Black J, 2002, SLEEP, V25, P42
   Black J, 2006, SLEEP, V29, P939, DOI 10.1093/sleep/29.7.939
   Black J, 2016, SLEEP MED, V23, P57, DOI 10.1016/j.sleep.2016.07.010
   Black J, 2014, SLEEP MED, V15, P522, DOI 10.1016/j.sleep.2014.02.001
   Black J, 2010, J CLIN SLEEP MED, V6, P596
   Black J, 2009, SLEEP MED, V10, P829, DOI 10.1016/j.sleep.2009.05.004
   Bogan R, 2016, NEUROL THER, V5, P203, DOI 10.1007/s40120-016-0053-5
   Boscolo-Berto R, 2012, SLEEP MED REV, V16, P431, DOI 10.1016/j.smrv.2011.09.001
   Daniels E, 2001, J SLEEP RES, V10, P75, DOI 10.1046/j.1365-2869.2001.00234.x
   Dauvilliers Y, 2003, CLIN NEUROPHYSIOL, V114, P2000, DOI 10.1016/S1388-2457(03)00203-7
   Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2
   Dauvilliers Y, 2017, SLEEP MED, V40, P53, DOI 10.1016/j.sleep.2017.07.030
   Dodel R, 2004, SLEEP, V27, P1123, DOI 10.1093/sleep/27.6.1123
   Dodel R, 2007, SLEEP MED, V8, P733, DOI 10.1016/j.sleep.2006.10.010
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Jennum P, 2012, SLEEP MED, V13, P1086, DOI 10.1016/j.sleep.2012.06.006
   Jennum P, 2009, J CLIN SLEEP MED, V5, P240
   LAMMERS GJ, 1993, SLEEP, V16, P216, DOI 10.1093/sleep/16.3.216
   Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13
   Mayer G, 2017, SLEEP MED, V35, P1, DOI 10.1016/j.sleep.2017.03.023
   Roth T, 2017, J SLEEP RES, V26, P407, DOI 10.1111/jsr.12468
   Scammell TE, 2015, NEW ENGL J MED, V373, P2654, DOI 10.1056/NEJMra1500587
   SCRIMA L, 1990, SLEEP, V13, P479, DOI 10.1093/sleep/13.6.479
   SCRIMA L, 1989, BIOL PSYCHIAT, V26, P331, DOI 10.1016/0006-3223(89)90048-6
   Thorpy MJ, 2017, AM HEALTH DRUG BENEF, V10, P233
   Weaver TE, 2006, SLEEP, V29, P1189, DOI 10.1093/sleep/29.9.1189
   Xyrem Int Study Grp, 2005, SLEEP MED, V6, P415, DOI 10.1016/j.sleep.2005.03.010
NR 30
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 62
EP 70
DI 10.1016/j.sleep.2019.06.017
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300011
PM 31671326
DA 2020-05-12
ER

PT J
AU Cook, JD
   Rumble, ME
   Plante, DT
AF Cook, J. D.
   Rumble, M. E.
   Plante, D. T.
TI Identifying subtypes of Hypersomnolence Disorder: a clustering analysis
SO SLEEP MEDICINE
LA English
DT Article
DE Hypersomnolence; Hypersomnolence disorder; Depression; Clustering
ID DAYTIME SLEEPINESS; IDIOPATHIC HYPERSOMNIA; PSYCHOMOTOR VIGILANCE;
   NARCOLEPSY; WAKEFULNESS
AB Background: Patient heterogeneity is problematic for the accurate assessment and effective treatment of Hypersomnolence Disorder. Clustering analysis is a preferred approach for establishing homogenous subclassifications. Thus, this investigation aimed to identify more homogeneous subclassifications of Hypersomnolence Disorder through clustering analysis.
   Methods: Patients undergoing polysomnography (PSG) and multiple sleep latency test (MSLT) assessment for hypersomnolence were recruited as part of a larger investigation. A sample of patients with Hypersomnolence Disorder was determined based on a post hoc chart review protocol. After removing persons with missing data, 62 participants were included in the analyses. Self-report total sleep time, Epworth Sleepiness Scale (ESS) score, and Sleep Inertia Questionnaire (SIQ) score were chosen as clustering variables to mirror Hypersomnolence Disorder diagnostic traits. A statistically-driven clustering process produced two clusters using Ward's D hierarchical approach. Clusters were compared across characteristics, self-report measures, PSG/MSLT results, and additional objective measures.
   Results: The resulting clusters differed across a variety of hypersomnolence-related subjective metrics and objective measurements. A more severe hypersomnolence phenotype was identified in a cluster that also had elevated depressive symptoms. This cluster endorsed significantly greater daytime sleepiness, sleep inertia, and functional impairment, while displaying longer sleep duration and worse vigilance.
   Conclusions: These results provide growing support for a nosological reformulation of hypersomnolence associated with psychiatric disorders. Future research is necessary to solidify the conceptualization and characterization of unexplained hypersomnolence presenting with-and-without psychiatric illness. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Cook, J. D.; Rumble, M. E.; Plante, D. T.] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53703 USA.
   [Cook, J. D.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.
RP Plante, DT (reprint author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53703 USA.
EM dplante@wisc.edu
FU American Sleep Medicine Foundation Strategic Research Award [138-SR-16]
FX This research was support by a grant from the American Sleep Medicine
   Foundation Strategic Research Award (138-SR-16) to Dr. Plante.
CR American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Barateau L, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0763-0
   Berkowski JA, 2016, SLEEP MED CLIN, V11, P365, DOI 10.1016/j.jsmc.2016.04.005
   Berry RB, 2014, AASM MANUAL SCORING
   Buysse D J, 1989, Psychiatry Res, V28, P193
   Charrad M, 2014, J STAT SOFTW, V61, P1
   Chasens ER, 2009, SLEEP, V32, P915, DOI 10.1093/sleep/32.7.915
   Dauvilliers Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-78
   Evangelista E, 2018, EXPERT OPIN INV DRUG, V27, P187, DOI 10.1080/13543784.2018.1417385
   Fernandez-Mendoza J, 2015, SLEEP, V38, P351, DOI 10.5665/sleep.4488
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x
   Kanady JC, 2015, COGNITIVE THER RES, V39, P601, DOI 10.1007/s10608-015-9686-4
   Kaplan KA, 2015, PSYCHOL MED, V45, P1751, DOI 10.1017/S0033291714002918
   Kaplan KA, 2015, SLEEP S, V38, pA432
   Kassambara A., 2017, PRACTICAL GUIDE CLUS
   Khan Z, 2015, CHEST, V148, P262, DOI 10.1378/chest.14-1304
   Kim H, 2007, SLEEP, V30, P1309, DOI 10.1093/sleep/30.10.1309
   Leu-Semenescu S, 2016, SLEEP MED, V17, P38, DOI 10.1016/j.sleep.2015.10.005
   Lopez R, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx164
   Marquand Andre F, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P433
   McLaren Jay W, 2002, Sleep Med, V3, P347, DOI 10.1016/S1389-9457(02)00017-5
   Mignot EJM, 2012, NEUROTHERAPEUTICS, V9, P739, DOI 10.1007/s13311-012-0150-9
   Mun EY, 2008, DEV PSYCHOL, V44, P481, DOI 10.1037/0012-1649.44.2.481
   Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001
   Paulus Martin P, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P386, DOI 10.1016/j.bpsc.2016.05.001
   Plante DT, 2017, J SLEEP RES, V26, P255, DOI 10.1111/jsr.12498
   Plante DT, 2017, SLEEP MED REV, V31, P48, DOI 10.1016/j.smrv.2016.01.004
   Plante David T, 2015, Curr Sleep Med Rep, V1, P122
   Prasad Bharati, 2011, Front Psychiatry, V2, P35, DOI 10.3389/fpsyt.2011.00035
   Soehner AM, 2014, J AFFECT DISORDERS, V167, P93, DOI 10.1016/j.jad.2014.05.060
   Sonka K, 2015, SLEEP MED, V16, P225, DOI 10.1016/j.sleep.2014.09.016
   Thomann J, 2014, J CLIN SLEEP MED, V10, P1019, DOI 10.5664/jcsm.4042
   Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107
   van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346
NR 36
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 71
EP 76
DI 10.1016/j.sleep.2019.06.015
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300012
PM 31670163
DA 2020-05-12
ER

PT J
AU Ji, XP
   Saylor, J
   Liu, JH
AF Ji, Xiaopeng
   Saylor, Jennifer
   Liu, Jianghong
TI The interactive effect of habitual midday napping and nighttime sleep
   duration on impaired fasting glucose risk in healthy adolescents
SO SLEEP MEDICINE
LA English
DT Article
DE Nighttime sleep; Midday nap; Impaired fasting glucose; Adolescents
ID CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; METABOLIC SYNDROME;
   DIABETES-MELLITUS; CHILDHOOD OBESITY; CIRCADIAN-RHYTHMS; NOCTURNAL
   SLEEP; OLDER-ADULTS; POOR SLEEP; TIME
AB Objectives: To investigate the association between habitual midday napping and impaired fasting glucose (IFG), and the interactive effect of napping and time in bed (TIB) at night on IFG among healthy adolescents.
   Methods: The sample comprised 625 early adolescents (12.26 +/- 0.63 years old) who self-reported good health status from Jintan, China. Midday napping and nighttime sleep were measured using the Youth Self-report Sleep Questionnaire. Fasting plasma glucose was dichotomized into normal (<5.6 mmol/L) and impaired (>= 5.6 mmol/L) levels. The multivariate random-effect logistic regression examined the nap-glucose relationship and the interaction between nap and TIB. Marginal effects of napping were calculated when TIB was held constant at different values.
   Results: Of the participants, 83.20% (n = 520) took naps and 62.28% reported average nap durations >= 31 min in the past month. Moreover, 16% (n = 101) of participants had IFG. After adjusting for covariates, early adolescents who napped 3-4 days/week (OR = 1.72, p < 0.001), 5-7 days/week (OR = 1.34, p = 0.02) or >= 31 min/nap (OR = 1.52, 1.56, p's < 0.05) were associated with increased likelihoods of IFG compared to non-nappers. There was an inverse relationship between TIB and IFG among non-nappers (OR = 0.45, p = 0.03). Interaction analyses also showed significantly increased likelihoods of IFG only among nappers with TIB >= 9 hours.
   Conclusion: The relationship between midday napping and IFG is dependent on TIB. Midday naps may increase the risk for IFG among early adolescents who have sufficient nighttime sleep. However, further research is needed to confirm our preliminary findings. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Ji, Xiaopeng; Saylor, Jennifer] Univ Delaware, Coll Hlth Sci, Sch Nursing, Newark, DE USA.
   [Liu, Jianghong] Univ Penn, Sch Nursing, 418 Curie Blvd,Room 426,Claire M Fagin Hall, Philadelphia, PA 19104 USA.
RP Liu, JH (reprint author), Univ Penn, Sch Nursing, 418 Curie Blvd,Room 426,Claire M Fagin Hall, Philadelphia, PA 19104 USA.; Liu, JH (reprint author), Univ Penn, Sch Med, 418 Curie Blvd,Room 426,Claire M Fagin Hall, Philadelphia, PA 19104 USA.
EM jixiaop@udel.edu; jsaylor@udel.edu; jhliu@nursing.upenn.edu
RI Liu, Jianghong/AAE-8130-2020
OI Liu, Jianghong/0000-0002-8405-6153; Ji, Xiaopeng/0000-0002-6977-3883
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Institute of
   Environment Health Sciences [NIEHS]United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Environmental Health Sciences (NIEHS) [R01-ES018858,
   K02-ES019878, K01-ES015877, P30-ES013508]; Jintan City Government;
   Jintan Hospital, China
FX This study was supported by the National Institutes of Health and
   National Institute of Environment Health Sciences [NIEHS, R01-ES018858,
   K02-ES019878, K01-ES015877, and P30-ES013508]; and by the Jintan City
   Government as well as the Jintan Hospital, China.
CR Amin MM, 2012, ACAD MED, V87, P1428, DOI 10.1097/ACM.0b013e3182676b37
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Arslanian S, 2018, PEDIATR DIABETES, V19, P205, DOI 10.1111/pedi.12562
   Ball GDC, 2006, J PEDIATR-US, V148, P16, DOI 10.1016/j.jpeds.2005.08.059
   Balserak BI, 2013, SLEEP BREATH, V17, P1093, DOI 10.1007/s11325-013-0809-4
   Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041
   Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032
   Cohen-Mansfield J, 2012, SLEEP, V35, P1003, DOI 10.5665/sleep.1970
   DeBoer MD, 2015, J AM COLL CARDIOL, V66, P756, DOI 10.1016/j.jacc.2015.05.061
   Fang WM, 2013, SLEEP MED, V14, P950, DOI 10.1016/j.sleep.2013.04.015
   Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67
   Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008
   Gruber R, 2012, PEDIATRICS, V130, pE1155, DOI 10.1542/peds.2012-0564
   Hagman E, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.34
   Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010
   Huang B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005097
   Jakubowski KP, 2017, BEHAV SLEEP MED, V15, P257, DOI 10.1080/15402002.2015.1126595
   Ji X, 2016, CHILD CARE HLTH DEV, V42, P825, DOI 10.1111/cch.12376
   Ji XP, 2019, BEHAV SLEEP MED, V17, P537, DOI 10.1080/15402002.2018.1425868
   Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455
   Knutson KL, 2009, J PEDIATR-US, V154, P426, DOI 10.1016/j.jpeds.2008.08.035
   Komada Y, 2012, SLEEP MED, V13, P107, DOI 10.1016/j.sleep.2011.10.017
   Kuula L, 2015, SLEEP MED, V16, P1207, DOI 10.1016/j.sleep.2015.06.017
   Lam KBH, 2010, SLEEP, V33, P402
   Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079
   Leng Y, 2016, NUTR METAB CARDIOVAS, V26, P996, DOI 10.1016/j.numecd.2016.06.006
   Leng Y, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006071
   Liang YJ, 2015, ENDOCRINE, V50, P87, DOI 10.1007/s12020-015-0560-7
   Liu JH, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz126
   Liu JH, 2018, SLEEP BIOL RHYTHMS, V16, P283, DOI 10.1007/s41105-018-0152-z
   Liu JH, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv119
   Liu JH, 2010, INT J EPIDEMIOL, V39, P668, DOI 10.1093/ije/dyp205
   Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F
   Llewellyn A, 2016, OBES REV, V17, P56, DOI 10.1111/obr.12316
   Luo Z, 2000, PSYCHIAT CLIN NEUROS, V54, P207, DOI 10.1046/j.1440-1819.2000.00660.x
   Makino S, 2018, SLEEP MED, V44, P4, DOI 10.1016/j.sleep.2017.11.1124
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   Matthews KA, 2016, SLEEP MED, V18, P36, DOI 10.1016/j.sleep.2015.06.004
   Meijer AM, 2010, J CHILD PSYCHOL PSYC, V51, P1278, DOI 10.1111/j.1469-7610.2010.02261.x
   Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920
   National Sleep Foundation, 2011, SLEEP AM POLL
   Ohkuma T, 2014, METABOLISM, V63, P484, DOI 10.1016/j.metabol.2013.12.001
   Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002
   Pamidi S, 2010, BEST PRACT RES CL EN, V24, P703, DOI 10.1016/j.beem.2010.08.009
   Patel SR, 2014, INT J OBESITY, V38, P1159, DOI 10.1038/ijo.2014.13
   Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222
   Reinehr T, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0695-1
   Selby JV, 2004, AM J MANAG CARE, V10, P163
   Shadyab AH, 2015, SLEEP MED, V16, P243, DOI 10.1016/j.sleep.2014.11.010
   Smolensky MH, 2007, SLEEP MED, V8, P668, DOI 10.1016/j.sleep.2006.11.011
   Stang A, 2007, SLEEP, V30, P1111, DOI 10.1093/sleep/30.9.1111
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333
   Woods DL, 2013, BIOL RES NURS, V15, P185, DOI 10.1177/1099800411420861
   Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143
   Yamada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38075
   Yamada T, 2015, SLEEP, V38, P1945, DOI 10.5665/sleep.5246
   Yin X, 2018, J DIABETES, V10, P302, DOI 10.1111/1753-0407.12605
   Zimmet P, 2007, METABOLIC SYNDROME C, V8, P299, DOI DOI 10.1111/J.1399-5448.2007.00271.X
NR 61
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 77
EP 84
DI 10.1016/j.sleep.2019.06.016
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300013
PM 31671327
DA 2020-05-12
ER

PT J
AU Loddo, G
   Zanardi, M
   Caletti, MT
   Mignani, F
   Petroni, ML
   Chiaro, G
   Marchesini, G
   Provini, F
AF Loddo, Giuseppe
   Zanardi, Marilena
   Caletti, Maria Turchese
   Mignani, Francesco
   Petroni, Maria Letizia
   Chiaro, Giacomo
   Marchesini, Giulio
   Provini, Federica
TI Searching food during the night: the role of video-polysomnography in
   the characterization of the night eating syndrome
SO SLEEP MEDICINE
LA English
DT Article
DE Night eating syndrome; Sleep-related eating; Videopolysomnography;
   Diagnostic criteria
ID PREVALENCE; DISORDERS; FEATURES
AB Objectives: To describe the video-polysomnographic (VPSG) features of the night eating syndrome (NES), exploring the existence of potential subtypes.
   Methods: In this study, 20 consecutive patients with NES according to the most recent diagnostic criteria underwent an overnight VPSG. None of them presented with a sleep-related eating disorder (SRED). VPSG recordings were reviewed identifying all eating episodes. For each episode, eating latency (time delay from awakening to food intake), eating duration (time between eating onset to eating offset) and sleep latency after eating offset (time delay from eating offset to sleep) were calculated. Total episode duration was considered as the time between awakening and sleep latency after eating offset.
   Results: Ten patients fulfilled the A1 core criterion for NES (evening hyperphagia with consumption of at least 25% of the daily caloric intake after the evening meal); within this group, eight patients also fulfilled the A2 criterion (at least two episodes of nocturnal eating per week) and were thus included in the evening hyperphagia (EH) subgroup. The remaining 10 patients satisfied only the A2 core criterion for NES, constituting the nocturnal ingestion (NI) subgroup. We recorded 20 eating episodes, seven in the EH group and 13 in the NI group. In the EH subgroup, three eating episodes occurred before sleep onset, one after an awakening from non-rapid eye movement (NREM) stage 1 sleep, two from NREM stage 2 and one from REM sleep. All 13 NI episodes occurred after an awakening from sleep (1 from NREM stage 1 sleep, 8 from NREM stage 2 and four from NREM stage 3). In EH patients, eating latency, total episode duration and sleep latency after eating offset were significantly longer than in NI patients.
   Conclusion: Our VPSG data from a case series of 20 patients referred to our center for nocturnal eating indicate potential different NES subtypes. This distinction may have an impact on patients' treatment and follow-up. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Loddo, Giuseppe; Zanardi, Marilena; Chiaro, Giacomo; Provini, Federica] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy.
   [Caletti, Maria Turchese; Petroni, Maria Letizia; Marchesini, Giulio] Univ Bologna, Unit Metab Dis & Clin Dietet, Bologna, Italy.
   [Mignani, Francesco; Provini, Federica] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Chiaro, Giacomo] Neuroctr Southern Switzerland, Lugano, Switzerland.
RP Provini, F (reprint author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bellaria Hosp, Via Altura 3, I-40139 Bologna, Italy.
EM federica.provini@unibo.it
RI Provini, Federica/AAB-9637-2020; Mignani, Francesco/AAC-2094-2020
OI Mignani, Francesco/0000-0001-9927-4500; Loddo,
   Giuseppe/0000-0001-8748-5984
CR Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693
   American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Auger R., 2006, PSYCHIATRY, V1, P64
   Berry RB, 2014, AASM MANUAL SCORING
   Birketvedt GS, 1999, JAMA-J AM MED ASSOC, V282, P657, DOI 10.1001/jama.282.7.657
   Calugi S, 2009, INT J OBESITY, V33, P899, DOI 10.1038/ijo.2009.105
   de Zwaan M, 2015, EUR EAT DISORD REV, V23, P426, DOI 10.1002/erv.2405
   Garcia-Mayor RV, 2017, DIABETES METAB SYND, V11, P221, DOI 10.1016/j.dsx.2016.08.004
   Gluck ME, 2011, OBESITY, V19, P319, DOI 10.1038/oby.2010.206
   Inoue Y, 2015, PSYCHIAT CLIN NEUROS, V69, P309, DOI 10.1111/pcn.12263
   Lundgren JD, 2006, AM J PSYCHIAT, V163, P156, DOI 10.1176/appi.ajp.163.1.156
   Lundgren Jennifer D, 2008, Eat Behav, V9, P343, DOI 10.1016/j.eatbeh.2007.12.004
   Manni R, 1997, SLEEP, V20, P734, DOI 10.1093/sleep/20.9.734
   Marshall HM, 2004, INT J EAT DISORDER, V35, P217, DOI 10.1002/eat.10241
   Provini F, 2010, SLEEP MED, V11, P218, DOI 10.1016/j.sleep.2009.05.016
   Provini F, 2008, SLEEP MED, V9, P903, DOI 10.1016/j.sleep.2007.10.021
   Rand CSW, 1997, INT J EAT DISORDER, V22, P65, DOI 10.1002/(SICI)1098-108X(199707)22:1&lt;65::AID-EAT8&gt;3.0.CO;2-0
   Saracli O, 2015, COMPR PSYCHIAT, V57, P79, DOI 10.1016/j.comppsych.2014.11.007
   SCHENCK CH, 1993, SLEEP, V16, P457
   SCHENCK CH, 1994, INT J EAT DISORDER, V15, P343, DOI 10.1002/eat.2260150405
   SCHENCK CH, 1991, SLEEP, V14, P419, DOI 10.1093/sleep/14.5.419
   SPAGGIARI MC, 1994, SLEEP, V17, P339, DOI 10.1093/sleep/17.4.339
   Striegel-Moore RH, 2005, INT J EAT DISORDER, V37, P200, DOI 10.1002/eat.20128
   Striegel-Moore RH, 2008, INT J EAT DISORDER, V41, P411, DOI 10.1002/eat.20514
   STUNKARD AJ, 1955, AM J MED, V19, P78, DOI 10.1016/0002-9343(55)90276-X
   Vetrugno R, 2006, SLEEP, V29, P949, DOI 10.1093/sleep/29.7.949
   Vinai P, 2015, SLEEP MED, V16, P746, DOI 10.1016/j.sleep.2014.12.020
   Winkelman JW, 2006, SLEEP, V29, P876, DOI 10.1093/sleep/29.7.876
   Winkelman JW, 1998, J CLIN PSYCHIAT, V59, P14, DOI 10.4088/JCP.v59n0104
NR 30
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 85
EP 91
DI 10.1016/j.sleep.2019.06.018
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300014
PM 31671328
DA 2020-05-12
ER

PT J
AU Kohli, M
   Sharma, SK
   Upadhyay, V
   Varshney, S
   Sengupta, S
   Basak, T
   Sreenivas, V
AF Kohli, Mikashmi
   Sharma, S. K.
   Upadhyay, Vishwanath
   Varshney, Swati
   Sengupta, Shantanu
   Basak, Trayambak
   Sreenivas, V.
TI Urinary EPCR and dermcidin as potential novel biomarkers for severe
   adult OSA patients
SO SLEEP MEDICINE
LA English
DT Article
DE Obstructive sleep apnea; Urinary biomarkers; Non-invasive test;
   Endothelial protein C receptor; Dermcidin
ID OBSTRUCTIVE SLEEP-APNEA; PROTEIN-C RECEPTOR; ENDOTHELIAL DYSFUNCTION;
   MECHANISMS; INFLAMMATION; ASSOCIATION; DISEASE; RISK
AB Background: Due to low predictive values of obstructive sleep apnea (OSA) screening tools, there is a need for biomarker for screening of OSA patients at an early stage. The aim of the study was to evaluate differentially expressed proteins in blood and urine samples of OSA patients.
   Methods: In this study, we used isobaric tagging for relative and absolute quantification (iTRAQ) based proteomics approach to identify differentially expressed proteins, which were subsequently verified and validated using enzyme-linked immunosorbent assay (ELISA) technique in adult OSA patients.
   Results: Seventeen differentially expressed proteins were selected from iTRAQ data for verification, based on their clinical significance and reproducibility among different iTRAQ experiment sets. Five of these proteins (plasma = 2; urine = 3) were further validated in plasma (non-OSA = 42; OSA = 198) and urine samples (non-OSA = 46; OSA = 197). ROC curve analysis for all OSA vs. non-OSA subjects ensured optimal diagnostic utility of two urinary proteins: Endothelial protein c receptor (EPCR) (AUC = 73%, cut-off: 35 pg/ml) and dermcidin (AUC = 74%, cut-off: 4.6 pg/ml). For severe OSA, diagnostic accuracy significantly improved with AUC as 88% and 82% for EPCR (cut-off: 46 pg/ml) and dermcidin (cut-off: 5.2 pg/ml) respectively. Sensitivity and specificity of combined performance of both urinary proteins for severe OSA were 94% and 91% respectively.
   Conclusion: In this study, urinary EPCR and dermcidin emerged as novel biomarkers for screening severe OSA patients. (C) 2019 Published by Elsevier B.V.
C1 [Kohli, Mikashmi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Sharma, S. K.; Upadhyay, Vishwanath] Jamia Hamdard Deemed To Be Univ, Dept Mol Med, Jamia Hamdard Inst Mol Med, New Delhi, India.
   [Varshney, Swati; Sengupta, Shantanu] Inst Genom & Integrat Biol, CSIR, Genom & Mol Med Unit, Mathura Rd, New Delhi, India.
   [Basak, Trayambak] Vanderbilt Univ Sch Med, Div Nephrol & Hypertens, Nashville, TN USA.
   [Sreenivas, V.] AIIMS, Dept Biostat, New Delhi, India.
   [Sharma, S. K.] Jamia Hamdard Deemed To Be Univ, Dept Mol Med, Jamia Hamdard Inst Mol Med, Delhi 110062, India.
RP Sharma, SK (reprint author), All India Inst Med Sci, Dept Internal Med, Ctr Excellence EPTB MoH & FW GoI, WHO Collaborating Ctr Res & Training TB, New Delhi 110029, India.
EM sksharma.aiims2@gmail.com
RI Basak, Trayambak/AAB-8534-2020
FU Department of Biotechnology, Government of IndiaDepartment of
   Biotechnology (DBT) India; Department of Science & Technology, Ministry
   of Science and Technology, Government of India, New Delhi
   [SB/S2/JCB-04/2013]
FX Department of Biotechnology, Government of India and JC Bose National
   Fellowship (SB/S2/JCB-04/2013) of Professor SK Sharma of the Department
   of Science & Technology, Ministry of Science and Technology, Government
   of India, New Delhi.
CR Atkeson A, 2008, VASC HEALTH RISK MAN, V4, P1327, DOI 10.2147/VHRM.S4078
   Basak T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28042
   Farooqui FA, 2017, SLEEP BREATH, V21, P69, DOI 10.1007/s11325-016-1371-7
   Ghosh R, 2012, THROMB THROMB, V2012
   Gozal D, 2009, AM J RESP CRIT CARE, V180, P1253, DOI 10.1164/rccm.200905-0765OC
   Haase VH, 2013, J AM SOC NEPHROL, V24, P537, DOI 10.1681/ASN.2012080855
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Jonas DE, 2017, JAMA-J AM MED ASSOC, V317, P415, DOI 10.1001/jama.2016.19635
   Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200
   Jurado-Gamez B, 2012, J SLEEP RES, V21, P139, DOI 10.1111/j.1365-2869.2011.00955.x
   Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506
   Kim J, 2009, J SLEEP RES, V18, P313, DOI 10.1111/j.1365-2869.2008.00725.x
   Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697
   Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004
   Peled N, 2007, RESP MED, V101, P1696, DOI 10.1016/j.rmed.2007.02.025
   Peppard PE, 2013, AM J EPIDEMIOL
   Saposnik B, 2012, THROMB RES, V129, P152, DOI 10.1016/j.thromres.2011.07.023
   Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732
   Seetho IW, 2014, EUR J CLIN INVEST, V44, P1104, DOI 10.1111/eci.12346
   Sesin CA, 2005, KIDNEY INT, V68, P110, DOI 10.1111/j.1523-1755.2005.00385.x
   Shah ZA, 2006, PEDIATR RES, V59, P466, DOI 10.1203/01.pdr.0000198817.35627.fc
   Sharma SK, 2006, INDIAN J MED RES, V124, P281
   Sharma SK, 2006, CHEST, V130, P149, DOI 10.1378/chest.130.1.149
   Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]
   Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104
   Varshney S, 2015, J PRACT CARDIOVASC S, V1, P45
   Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165
   World Health Organisation, GLOB DAT BOD MASS IN
   Zaghloul A, 2014, DIABETES RES CLIN PR, V106, P597, DOI 10.1016/j.diabres.2014.09.007
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 92
EP 100
DI 10.1016/j.sleep.2019.07.002
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300015
PM 31677485
DA 2020-05-12
ER

PT J
AU Byun, JI
   Shin, YY
   Hwang, KJ
   Jung, YJ
   Shin, WC
AF Byun, Jung-Ick
   Shin, Yu Yong
   Hwang, Kyoung Jin
   Jung, Yujin
   Shin, Won Chul
TI Comparison of cardiac autonomic activity between positional and
   nonpositional obstructive sleep apnea using heart rate variability
SO SLEEP MEDICINE
LA English
DT Article
DE Obstructive sleep apnea; Heart rate variability; Body position;
   Sympathetic nervous system
ID KOREAN VERSION; RISK-FACTORS; MORTALITY; SEVERITY; ASSOCIATION;
   PREVALENCE
AB Objectives: Patients with obstructive sleep apnea (OSA) experience sympathetic hyperactivation during sleep, which is associated with increased cardiovascular risk factors. However, the difference in cardiac autonomic activity in OSA patients according to position dependency has not been evaluated. This study aimed to evaluate the differences between positional OSA (pOSA) and nonpositional OSA (npOSA) using heart rate variability (HRV) analysis.
   Methods: This was a single-center cross-sectional study. Twenty-eight patients with npOSA and 28 age-, sex-, and AHI-matched patients with pOSA underwent standard polysomnography. A five-minute R-R interval from stable waking conditions before bedtime was collected from each subject and analyzed for HRV.
   Results: Patients with pOSA had lower body-mass index (BMI, 25.8 +/- 2.9 vs 28.9 +/- 3.7 kg/m(2), p = 0.001), shorter apnea duration (24.1 +/- 7.1 vs 30.3 +/- 12.7 s, p = 0.028) and higher minimum oxygen saturation (78.2 +/- 7.1 vs 71.5 +/- 11.4%, p = 0.011) than those with npOSA. HRV analysis showed higher parasympathetic activity in pOSA patients than in npOSA patients, including a higher square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD, 31.3 +/- 29.0 vs 18.6 +/- 9.2, p = 0.032), percentage of pairs of adjacent NN intervals that differ by more than 50 ms (pNN50%, 10.7 +/- 17.1 vs 3.3 +/- 6.5, p = 0.024), and high-frequency (HF) power (534.7 +/- 986.8 vs 146.7 +/- 150.5, p = 0.026). The group difference was insignificant after adjusting for age and BMI. The log-transformed supine/nonsupine AHI ratio was the sole independent predictor of HRV parameters.
   Conclusion: The waking HRV was higher in pOSA patients than in npOSA patients due to the lower BMI of pOSA patients. The difference was especially apparent in parasympathetic indices. Higher parasympathetic activity in pOSA may suggest a lower risk for cardiovascular morbidity and mortality. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Byun, Jung-Ick; Shin, Won Chul] Kyunghee Univ Hosp Gangdong, Dept Neurol, 892 Dongnam Ro, Seoul 134727, South Korea.
   [Shin, Yu Yong] Naeun Hosp, Dept Neurol, Incheon, South Korea.
   [Byun, Jung-Ick; Hwang, Kyoung Jin; Shin, Won Chul] Kyung Hee Univ, Sch Med, Dept Neurol, Seoul, South Korea.
   [Jung, Yujin] Catholic Univ, Dept Neurol, Daejeon St Marys Hosp, Coll Med, Daejeon, South Korea.
RP Shin, WC (reprint author), Kyunghee Univ Hosp Gangdong, Dept Neurol, 892 Dongnam Ro, Seoul 134727, South Korea.
EM shin1chul@gmail.com
CR Camm AJ, 1996, CIRCULATION, V93, P1043, DOI 10.1016/0044-8486(94)90048-5
   CARTWRIGHT RD, 1984, SLEEP, V7, P110, DOI 10.1093/sleep/7.2.110
   Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210
   Cho YW, 2011, SLEEP BREATH, V15, P377, DOI 10.1007/s11325-010-0343-6
   Chouchou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086434
   Chung JW, 2010, ORAL SURG ORAL MED O, V110, P605, DOI 10.1016/j.tripleo.2010.06.017
   DeGiorgio CM, 2010, EPILEPSY BEHAV, V19, P78, DOI 10.1016/j.yebeh.2010.06.011
   Ernst G., 2014, HEART RATE VARIABILI
   Flevari A, 2015, SLEEP BREATH, V19, P359, DOI 10.1007/s11325-014-1029-2
   Gong XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156628
   Gopalakrishnan P, 2011, CARDIOL REV, V19, P279, DOI 10.1097/CRD.0b013e318223bd08
   Heinzer R, 2018, SLEEP MED, V48, P157, DOI 10.1016/j.sleep.2018.02.011
   Joosten SA, 2014, SLEEP MED REV, V18, P7, DOI 10.1016/j.smrv.2013.01.005
   Joosten SA, 2012, RESPIROLOGY, V17, P99, DOI 10.1111/j.1440-1843.2011.02037.x
   Kawano Y, 2010, J CARDIOL, V56, P27, DOI 10.1016/j.jjcc.2010.01.007
   Kim KT, 2016, CLIN NEUROPHYSIOL, V127, P565, DOI 10.1016/j.clinph.2015.06.009
   Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x
   Kufoy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033769
   Kulkas A, 2015, SLEEP BREATH, V19, P653, DOI 10.1007/s11325-014-1071-0
   Lee SA, 2017, SLEEP BREATH, V21, P109, DOI 10.1007/s11325-016-1379-z
   Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045
   Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130
   Medicine AAoS, 2012, AASM MANUAL SCORING
   Mo JH, 2011, ARCH OTOLARYNGOL, V137, P786, DOI 10.1001/archoto.2011.122
   Montemurro LT, 2014, J CLIN SLEEP MED, V10, P271, DOI 10.5664/jcsm.3526
   Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510
   Oksenberg A, 2000, CHEST, V118, P1018, DOI 10.1378/chest.118.4.1018
   Oksenberg A, 1997, CHEST, V112, P629, DOI 10.1378/chest.112.3.629
   Oksenberg A, 2012, J SLEEP RES, V21, P402, DOI 10.1111/j.1365-2869.2011.00988.x
   Oulhaj A, 2017, SLEEP BREATH, V21, P877, DOI 10.1007/s11325-017-1499-0
   Palma JA, 2013, SLEEP, V36, P933, DOI 10.5665/sleep.2728
   Park DH, 2008, J KOREAN MED SCI, V23, P226, DOI 10.3346/jkms.2008.23.2.226
   Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9
   Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]
   Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x
   Tarvainen MP, 2009, IEEE ENG MED BIO, P1, DOI 10.1109/IEMBS.2009.5332678
   Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024
   Teerapraipruk B, 2012, SLEEP BREATH, V16, P1167, DOI 10.1007/s11325-011-0627-5
   Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543
   Urbanik D, 2019, SLEEP MED, V54, P8, DOI 10.1016/j.sleep.2018.09.014
   송열매, 2012, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V51, P402
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 101
EP 105
DI 10.1016/j.sleep.2019.06.021
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300016
PM 31677484
DA 2020-05-12
ER

PT J
AU Mascia, G
   Perini, AP
   Cartei, S
   Binazzi, B
   Gigliotti, F
   Solimene, F
   Mascioli, G
   Giaccardi, M
AF Mascia, Giuseppe
   Perini, Alessandro Paoletti
   Cartei, Stella
   Binazzi, Barbara
   Gigliotti, Francesco
   Solimene, Francesco
   Mascioli, Giosue
   Giaccardi, Marzia
TI Sleep-disordered breathing and effectiveness of cardiac
   resynchronization therapy in heart failure patients: gender differences?
SO SLEEP MEDICINE
LA English
DT Article
DE Sleep apnoea; Heart failure; Cardiac resynchronization therapy;
   Pulmonary medicine
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ANTIARRHYTHMIC-DRUG THERAPY;
   BUNDLE-BRANCH BLOCK; EJECTION FRACTION; QRS PROLONGATION;
   RANDOMIZED-TRIAL; ESC GUIDELINES; APNEA; PREVALENCE; IMPACT
AB Objectives: This study evaluated heart failure (HF) patients who underwent cardiac resynchronization therapy (CRT) and who had device-documented sleep-disordered breathing (SDB). We found gender differences in acute changes in SDB due to CRT impact.
   Background: SDB typically occurs in HF patients. However, the role of SDB and its response to CRT in HF patients, as well as the relation with gender are currently not fully researched.
   Methods: Among 63 consecutive patients who received CRT with an SDB algorithm, 23 patients documented SDB at one-month cardiac device interrogation and represented our population. We defined a Sleep apnoea Severity SCore(SSSC), and consequently, patients were categorized to have mild, moderate, and severe sleep apnoea syndrome divided into two groups: Group-1: 18 males (78%); Group-2: 5 females (22%). We evaluated the variation of apnoea burden and CRT response based on gender differences.
   Results: A significantly higher proportion of patients in the male group were non-responders to CRT at 12-months follow-up (p = 0.076) while in the female population 5/5 patients (100%) were responders to CRT at the same follow-up time (p = 0.021). Among Group-2 subjects, we documented a significant linear decrease in SSSC(p > 0,01) while in Group-1 the CRT effect on SSSC was variable. At 12-months follow-up, the difference in SSSC between the two groups was statistically significant (p < 0.001).
   Conclusions: Our study reports a correlation between CRT response and sleep apnoea burden considering gender differences. In particular, HF-women responders to CRT demonstrate a significant linear decrease in sleep apnoea burden determined through a device algorithm, when compared to a similar male population. Further research is needed to confirm these findings. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Mascia, Giuseppe; Perini, Alessandro Paoletti; Cartei, Stella; Giaccardi, Marzia] Azienda USL Toscana Ctr, Cardiol & Electrophysiol Unit, Via Torregalli 3, I-50100 Florence, Italy.
   [Binazzi, Barbara; Gigliotti, Francesco] Rehabil Pneumol IRCCS Fdn Don Gnocchi Hosp, Florence, Italy.
   [Solimene, Francesco] Clin Montevergine, Electrophysiol Unit, Avellino, Italy.
   [Mascioli, Giosue] Clin Gavazzeni, Cardiol & Electrophysiol Unit, Bergamo, Italy.
RP Mascia, G (reprint author), Azienda USL Toscana Ctr, Cardiol & Electrophysiol Unit, Via Torregalli 3, I-50100 Florence, Italy.
EM giuseppe_mascia@virgilio.it
RI Binazzi, Barbara/AAA-6522-2020; Gigliotti, Francesco/AAA-6330-2020
OI Binazzi, Barbara/0000-0002-7871-0243; Gigliotti,
   Francesco/0000-0003-4608-2059
CR Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168
   Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061
   Arzt M, 2016, JACC-HEART FAIL, V4, P116, DOI 10.1016/j.jchf.2015.09.014
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Barra S, 2018, EUROPACE, V20, P897, DOI 10.1093/europace/eux203
   Bradley TD, 2001, CHEST, V119, P1827, DOI 10.1378/chest.119.6.1827
   Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Cappola TP, 2006, J CARD FAIL, V12, P182, DOI 10.1016/j.cardfail.2005.11.003
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297
   D'Onofrio A, 2018, HEART RHYTHM, V15, P211, DOI 10.1016/j.hrthm.2017.09.038
   Defaye P, 2014, HEART RHYTHM, V11, P842, DOI 10.1016/j.hrthm.2014.02.011
   DIMSDALE JE, 1995, SLEEP, V18, P377
   Fox H, 2017, SLEEP MED CLIN, V12, P229, DOI 10.1016/j.jsmc.2017.01.003
   Fox H, 2016, J CARDIOPULM REHABIL, V36, P421, DOI 10.1097/HCR.0000000000000192
   Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489
   Ignaszewski MT, 2019, HEART FAIL CLIN, V15, P109, DOI 10.1016/j.hfc.2018.08.011
   Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506
   Kato M, 2000, CIRCULATION, V102, P2607
   Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029
   Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748
   Kutyifa V, 2013, J AM COLL CARDIOL, V61, P936, DOI 10.1016/j.jacc.2012.11.051
   Lee NS, 2017, J CARDIOL, V70, P1, DOI 10.1016/j.jjcc.2016.12.008
   Lewis EF, 2017, AM HEART J, V189, P59, DOI 10.1016/j.ahj.2017.03.001
   Linde C, 2018, EUR J HEART FAIL, V20, P780, DOI 10.1002/ejhf.1133
   Linde C, 2015, EUROPACE, V17, P424, DOI 10.1093/europace/euu205
   Linde C, 2013, CIRC-HEART FAIL, V6, P1180, DOI 10.1161/CIRCHEARTFAILURE.113.000326
   Linde Cecilia, 2008, Congest Heart Fail, V14, P66, DOI 10.1111/j.1751-7133.2008.07613.x
   Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027
   Linz D, 2018, J AM COLL CARDIOL, V72, P2406, DOI 10.1016/j.jacc.2018.08.2159
   Linz D, 2018, INT J CARDIOL, V271, P281, DOI 10.1016/j.ijcard.2018.04.076
   Linz D, 2018, JAMA CARDIOL, V3, P532, DOI 10.1001/jamacardio.2018.0095
   Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022
   Loring Z, 2013, JACC-HEART FAIL, V1, P237, DOI 10.1016/j.jchf.2013.03.005
   Lund LH, 2013, EUR HEART J, V34, P529, DOI 10.1093/eurheartj/ehs305
   Marijon E, 2015, EUR HEART J, V36, P2767, DOI 10.1093/eurheartj/ehv455
   McAnulty J, 1997, NEW ENGL J MED, V337, P1576
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431
   Moubarak G, 2017, HEART RHYTHM, V14, P359, DOI 10.1016/j.hrthm.2016.11.033
   Oldenburg O, 2007, EUR J HEART FAIL, V9, P820, DOI 10.1016/j.ejheart.2007.03.009
   Omran H, 2018, CLIN RES CARDIOL, V107, P965, DOI 10.1007/s00392-018-1269-4
   Parati G, 2012, J HYPERTENS, V30, P633, DOI 10.1097/HJH.0b013e328350e53b
   Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Rickard J, 2016, INT J CARDIOL, V225, P345, DOI 10.1016/j.ijcard.2016.09.078
   Shantha G, 2018, HEART RHYTHM, V15, P1283, DOI 10.1016/j.hrthm.2018.06.016
   Stanchina ML, 2007, CHEST, V132, P433, DOI 10.1378/chest.06-2509
   Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889
   Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540
   Varma N, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005031
   Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18
   Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685
   Zabarovskaja S, 2012, EUROPACE, V14, P1148, DOI 10.1093/europace/eus039
   Zusterzeel R, 2014, J AM COLL CARDIOL, V64, P887, DOI 10.1016/j.jacc.2014.06.1162
NR 56
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 106
EP 111
DI 10.1016/j.sleep.2019.06.019
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300017
PM 31678699
DA 2020-05-12
ER

PT J
AU Prihodova, I
   Skibova, J
   Nevsimalova, S
AF Prihodova, Iva
   Skibova, Jelena
   Nevsimalova, Sona
TI Sleep-related rhythmic movements and rhythmic movement disorder beyond
   early childhood
SO SLEEP MEDICINE
LA English
DT Article
DE Rhythmic movement disorder; Rhythmic movement type; Clinical
   comorbidities; Childhood and young adulthood; Polysomnography
ID PARASOMNIAS
AB Introduction: Sleep-related rhythmic movements (SRRMs) are common in young children and become less prevalent with increasing age. When SRRMs significantly interfere with sleep and/or affect daytime functioning, potentially resulting in injury, rhythmic movement disorder (SRRMD) is diagnosed.
   Objective: The aim of our study was to assess clinical comorbidities, types of SRRMs, sleep stage/wakefulness distribution during night, and age-dependence of these parameters.
   Material and methods: In sum, 45 patients (age range 1-26 years, mean age 10.56 +/- 6.4 years, 29 men) were clinically examined for SRRMs or SRRMD. Nocturnal polysomnography (PSG) was recorded in 38 patients. To evaluate clinical and sleep comorbidity, the cohort of 38 patients was divided according to age into four groups: (1) younger than 5 years (N = 7), (2) 5-9 years (N = 12), (3) 10-14 years (N = 11), and (4) >= 15 years (N = 8).
   Results: A clear relationship between perinatal risk factors and developmental disorders (attention deficit hyperactivity disorder - ADHD, specific learning disability) was found which extended population prevalence at least five times. A total of 62 recordings were evaluated in 38 patients; SRRMs were found in PSG in 31 of 38 patients (82%). No age-dependent correlation between type of SRRMs and sleep stage/wakefulness distribution during the night was observed. However, when all recordings were correlated together, rolling stereotypes occurred more frequently in REM sleep, and rocking stereotypes in superficial NREM sleep.
   Conclusion: Developmental disorders and perinatal risk factors were connected with SRRMs and SRRMD in children and young adults. Rolling movements were significantly associated with REM stage and rocking stereotypes with superficial NREM sleep, independent of age. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Prihodova, Iva; Nevsimalova, Sona] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic.
   [Prihodova, Iva; Nevsimalova, Sona] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic.
   [Prihodova, Iva; Nevsimalova, Sona] Gen Univ Hosp, Prague, Czech Republic.
   [Skibova, Jelena] Inst Clin & Expt Med, Unit Stat, Prague, Czech Republic.
RP Nevsimalova, S (reprint author), Katerinska 30, Prague 12800 2, Czech Republic.
EM snevsi@lf1.cuni.cz
RI Nevsimalova, Sona/H-3533-2017
OI Nevsimalova, Sona/0000-0003-0083-3742
FU  [Progres Q27/LF1]
FX Supported by Progres Q27/LF1.
CR American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Attarian H, 2009, J CLIN SLEEP MED, V5, P571
   Blunden Sarah, 2010, Clin Child Psychol Psychiatry, V15, P55, DOI 10.1177/1359104509339090
   Chiaro G, 2017, J CLIN SLEEP MED, V13, P1213, DOI 10.5664/jcsm.6778
   Chokroverty S, 2017, SLEEP DISORDERS MED, P713
   Dyken ME, 1977, PEDIATR NEUROL, V16, P37
   Gwyther ARM, 2017, SLEEP MED REV, V35, P62, DOI 10.1016/j.smrv.2016.08.003
   Haywood PM, 2012, PAEDIAT CHILD HLTH, V22, P207, DOI DOI 10.1016/J.PAED.2012.02.010
   Iber C., 2007, AASM MANUAL SCORING
   Kohyama J, 2002, BRAIN DEV-JPN, V24, P33, DOI 10.1016/S0387-7604(01)00393-X
   Laberge L, 2000, PEDIATRICS, V106, P67, DOI 10.1542/peds.106.1.67
   Manni R, 2005, NEUROL SCI, V26, pS181, DOI 10.1007/s10072-005-0484-8
   Manni R, 2007, MOVEMENT DISORD, V22, P1797, DOI 10.1002/mds.21622
   Mayer G, 2007, J SLEEP RES, V16, P110, DOI 10.1111/j.1365-2869.2007.00577.x
   Shah B, 2018, SLEEP MED, V51, P115, DOI 10.1016/j.sleep.2018.07.005
   Silvestri R, 2009, SLEEP MED, V10, P1132, DOI 10.1016/j.sleep.2009.04.003
   Stepanova I, 2005, SLEEP, V28, P851, DOI 10.1093/sleep/28.7.851
   Urrestarazu E, 2016, J SLEEP MED DISORDER, V3, P1049
   Walters AS, 2008, J CLIN SLEEP MED, V4, P591
NR 20
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 112
EP 115
DI 10.1016/j.sleep.2019.05.021
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300018
PM 31683092
DA 2020-05-12
ER

PT J
AU Reyes, S
   Algarin, C
   Lozoff, B
   Peigneux, P
   Peirano, P
AF Reyes, Sussanne
   Algarin, Cecilia
   Lozoff, Betsy
   Peigneux, Philippe
   Peirano, Patricio
TI Sleep and motor sequence learning consolidation in former iron deficient
   anemic adolescents
SO SLEEP MEDICINE
LA English
DT Article
DE Sleep; Motor skill learning; Iron deficiency; Infancy; Adolescence;
   Gender
ID PROACTIVE-INTERFERENCE; SEX-DIFFERENCES; BASAL GANGLIA; SKILL; CHILDREN;
   INFANCY; MEMORY; PERFORMANCE; TRAJECTORIES; METABOLISM
AB Background: Iron deficiency is the most prevalent micronutrient deficiency worldwide. There is evidence that iron deficiency produces alterations in the developing brain, eventually leading to long-lasting effects on various cognitive functions.
   Methods: Here, we investigated motor learning and its consolidation after sleep in adolescents who sustained iron deficiency anemia (IDA) in infancy, compared to healthy controls, in the context of a long-term follow-up Chilean research project. Fifty-three adolescents who formerly had iron deficiency anemia as infants and 40 control adolescents practiced a sequential motor finger tapping task, before and after a night of sleep. Performance was measured at the end of learning, 30 min later (boost effect), and the next morning.
   Results: Revealed slower learning in subjects with infant iron deficiency anemia than control subjects, followed by a proportionally similar performance boost at 30 min. Performance remained stable overnight in healthy controls but further improved in infant IDA adolescents, suggesting a beneficial effect of post-training sleep on the consolidation of incompletely learned motor skills. In particular, overnight gains in performance were observed in female, but not male infant iron deficiency anemic subjects, suggesting a gender effect.
   Conclusions: Our results indicate long-lasting motor learning deficits in infant IDA adolescents and provide support to the hypothesis that post-training sleep might, to some extent, compensate for hampered motor learning during wakefulness. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Reyes, Sussanne; Algarin, Cecilia; Peirano, Patricio] Univ Chile, Sleep & Funct Neurobiol Lab, Inst Nutr & Food Technol INTA, El Libano 5524, Santiago, Chile.
   [Lozoff, Betsy] Univ Michigan, Dept Pediat & Communicable Dis, North Ingalls Bldg,10th Floor,300 N Ingalls St, Ann Arbor, MI 48109 USA.
   [Peigneux, Philippe] Univ Libre Bruxelles, UR2NF Neuropsychol & Funct Neuroimaging Res Grp, CRCN, UNI ULB Neurosci Inst, 50 Ave FD Roosevelt CP191, B-1050 Brussels, Belgium.
RP Peirano, P (reprint author), Univ Chile, Sleep & Funct Neurobiol Lab, Inst Nutr & Food Technol INTA, El Libano 5524, Santiago, Chile.; Peigneux, P (reprint author), Univ Libre Bruxelles, UR2NF Neuropsychol & Funct Neuroimaging Res Grp, CRCN, UNI ULB Neurosci Inst, 50 Ave FD Roosevelt CP191, B-1050 Brussels, Belgium.
EM philippe.peigneux@ulb.ac.be; ppeirano@inta.uchile.cl
FU Chilean National Fund for Scientific and Technological Development
   [1110513]; US National Institutes of Health, (Bethesda, MD)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [HD33487]
FX This study was supported by the Chilean National Fund for Scientific and
   Technological Development grant 1110513, and the US National Institutes
   of Health, (Bethesda, MD) grant HD33487.
CR Adi-Japha E, 2011, RES DEV DISABIL, V32, P1011, DOI 10.1016/j.ridd.2011.01.048
   Algarin C, 2003, PEDIATR RES, V53, P217, DOI 10.1203/01.PDR.0000047657.23156.55
   Algarin C, 2013, DEV MED CHILD NEUROL, V55, P453, DOI 10.1111/dmcn.12118
   Angulo-Barroso RM, 2013, EARLY HUM DEV, V89, P1025, DOI 10.1016/j.earlhumdev.2013.08.014
   Astill RG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00910
   Bastian TW, 2019, J NEUROSCI, V39, P802, DOI 10.1523/JNEUROSCI.1504-18.2018
   Bastian TW, 2016, DEV NEUROSCI-BASEL, V38, P264, DOI 10.1159/000448514
   Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739
   Borragan G, 2015, BRAIN COGNITION, V95, P54, DOI 10.1016/j.bandc.2015.01.011
   Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106
   Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012
   Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048
   Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008
   Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107
   Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033
   Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012
   Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256
   Fox O, 2016, RES DEV DISABIL, V51-52, P135, DOI 10.1016/j.ridd.2016.01.014
   Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632
   Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190
   Garraux G, 2007, J NEUROSCI, V27, P14434, DOI 10.1523/JNEUROSCI.1595-07.2007
   Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006
   Herszage J, 2018, NEUROSCIENCE, V392, P270, DOI 10.1016/j.neuroscience.2018.08.006
   HORNE J A, 1976, International Journal of Chronobiology, V4, P97
   Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406
   Humiston GB, 2018, NEUROBIOL LEARN MEM, V155, P1, DOI 10.1016/j.nlm.2018.06.002
   Iber C., 2007, AASM MANUAL SCORING
   KEMP B, 1992, ELECTROEN CLIN NEURO, V82, P391, DOI 10.1016/0013-4694(92)90009-7
   Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3
   Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304
   Kwik-Uribe CL, 2000, J NUTR, V130, P2821
   Landry S, 2016, NEUROBIOL LEARN MEM, V127, P56, DOI 10.1016/j.nlm.2015.11.009
   Levi M, 2016, EUR J HAEMATOL, V97, P583, DOI 10.1111/ejh.12776
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037
   Lozoff B, 2003, PEDIATRICS, V112, P846
   Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51
   Lozoff B, 2011, J NUTR, V141, p740S, DOI 10.3945/jn.110.131169
   Lustenberger C, 2017, DEV PSYCHOBIOL, V59, P5, DOI 10.1002/dev.21446
   Mary A, 2015, NEUROIMAGE, V104, P59, DOI 10.1016/j.neuroimage.2014.10.010
   McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960
   Ortiz E, 2004, J NEUROSCI RES, V77, P681, DOI 10.1002/jnr.20207
   Pan SC, 2015, PSYCHOL BULL, V141, P812, DOI 10.1037/bul0000009
   Peigneux P, 2014, ARCH ITAL BIOL, V152, P79, DOI 10.12871/000298292014233
   Peigneux P., 2017, PRINCIPLES PRACTICE, P229
   Peirano P, 2012, SLEEP MED, V13, P1006, DOI 10.1016/j.sleep.2012.05.011
   Prehn-Kristensen A, 2011, RES DEV DISABIL, V32, P2480, DOI 10.1016/j.ridd.2011.06.021
   Shafir T, 2006, HUM MOVEMENT SCI, V25, P821, DOI 10.1016/j.humov.2006.06.006
   Sim DEK, 2012, INT J PEDIAT, DOI 10.1155/2012/354060
   Sommer WH, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00087
   Tomas Vila M, 2007, An Pediatr (Barc), V66, P121
   Urbain C, 2014, J SLEEP RES, V23, P44, DOI 10.1111/jsr.12082
   Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8
   Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1389-9457
EI 1878-5506
J9 SLEEP MED
JI Sleep Med.
PD DEC
PY 2019
VL 64
BP 116
EP 122
DI 10.1016/j.sleep.2019.05.023
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA JU6ND
UT WOS:000501790300019
PM 31704427
DA 2020-05-12
ER

PT J
AU Arias-Hernandez, D
   Flores-Perez, FI
   Dominguez-Roldan, R
   Baez-Saldana, A
   Carreon, RA
   Garcia-Jimenez, S
   Hallal-Calleros, C
AF Arias-Hernandez, David
   Ivan Flores-Perez, Fernando
   Dominguez-Roldan, Rosa
   Baez-Saldana, Armida
   Carreon, Ramon A.
   Garcia-Jimenez, Sara
   Hallal-Calleros, Claudia
TI Influence of the interaction between cysticercosis and obesity on rabbit
   behavior and productive parameters
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Animal behavior; Parasitic infection; Taeniasis; Obesity; Parasite load
ID SEXUAL-BEHAVIOR; ADIPOSE-TISSUE; INHIBITION; INFECTION; MARKING;
   QUALITY; HOST
AB Parasites induce behavioral changes in the host and obesity is a health problem affecting different animal species. Cysticercosis caused by Taenia pisiformis affects some behavior of rabbits and reproductive behavior of does. Rabbits do not escape from metabolic disorders, being long-live animals useful in breeding, research and companion animals. Here, we addressed the interaction between parasitosis and obesity, and studied how these conditions or the comorbidity affect behavioral and productive parameters in bucks infected with 3000 T. pisiformis eggs. We found that the chronic infection reduced locomotor activity by 28.5% in obese, 18.5% in infected and 47% in obese-infected group (comorbid). The exploratory activity reduced by 42% in obese, 48% in infected and 68% in comorbid rabbits (P <= 0.001). Chinning was not affected by obesity, while infection decreased it by 25%. Behavioral reproductive parameters like response time, the mount latency and number of ejaculates were affected by infection and obesity. Furthermore, obesity seems to increase the parasite load promoting the formation of liver granulomas (16% granulomas compared with normal weight), with a higher number of cysticerci in obese animals (86% more than normal weight). Infection decreases body weight, body mass index and the zoometric index BW/LV in obese and normal weight rabbits. In conclusion, infection with T. pisiformis altered behavioral and productive parameters, and obesity magnifies the impact caused by the infection. Also, obesity leads to major susceptibility to infection with T. pisiformis.
C1 [Arias-Hernandez, David; Ivan Flores-Perez, Fernando; Dominguez-Roldan, Rosa; Hallal-Calleros, Claudia] Univ Autonoma Estado Morelos, Fac Ciencias Agr, Av Univ 1,001, Cuernavaca 62209, Morelos, Mexico.
   [Baez-Saldana, Armida] Univ Nacl Autonoma Mexico, Inst Invest Biomed, AP 70228, Mexico City 70228, DF, Mexico.
   [Carreon, Ramon A.] IMSS, UMF 06, Constituc & Olas Altas SN, Villa De Ahome 81318, Sinaloa, Mexico.
   [Garcia-Jimenez, Sara] Univ Autonoma Estado Morelos, Fac Farm, Av Univ 1,001, Cuernavaca 62209, Morelos, Mexico.
RP Hallal-Calleros, C (reprint author), Univ Autonoma Estado Morelos, Fac Ciencias Agr, Av Univ 1,001, Cuernavaca 62209, Morelos, Mexico.; Garcia-Jimenez, S (reprint author), Univ Autonoma Estado Morelos, Fac Farm, Av Univ 1,001, Cuernavaca 62209, Morelos, Mexico.
EM dariasher@hotmail.com; ivan.flores@uaem.mx; rosa.dguez88@gmail.com;
   armida@biomedicas.unam.mx; ramon.carreon@imss.gob.mx;
   saragarcia@uaem.mx; challalc@gmail.com
OI Hallal-Calleros, Claudia/0000-0002-9687-8752
FU Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [492304, 273755]; Agreement UAEMUNAM
   [42467-2177-8-IX-15]
FX DAH and RDR acknowledge the PhD fellowships 492304 and 273755 received
   by Consejo Nacional de Ciencia y Tecnologia. Authors acknowledge the
   technical support received from Claudia A. Garay Canales. This study was
   partially supported by the Agreement UAEMUNAM (42467-2177-8-IX-15),
   awarded to FIFP.
CR Antic V, 1999, AM J HYPERTENS, V12, P826, DOI 10.1016/S0895-7061(98)00231-3
   Arteaga L, 2008, PHYSIOL BEHAV, V94, P510, DOI 10.1016/j.physbeh.2008.03.005
   Bate S.T., 2014, DESIGN STAT ANAL ANI
   Betancourt-Alonso MA, 2011, WORLD RABBIT SCI, V19, P21, DOI 10.4995/wrs.2011.801
   Bittar JFF, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0571-x
   Boiti C, 2005, WORLD RABBIT SCI, V13, P71
   CONTRERAS JL, 1979, PHYSIOL BEHAV, V23, P939, DOI 10.1016/0031-9384(79)90204-X
   Dominguez-Roldan R, 2018, PARASITOL RES, V117, P2201, DOI 10.1007/s00436-018-5907-6
   Fausto AM, 2001, REPROD NUTR DEV, V41, P217, DOI 10.1051/rnd:2001125
   FLATT RE, 1975, LAB ANIM SCI, V25, P162
   Fuentes VO, 2004, ANIM REPROD SCI, V80, P157, DOI 10.1016/S0378-4320(03)00007-1
   Guigas B, 2015, TRENDS PARASITOL, V31, P435, DOI 10.1016/j.pt.2015.04.008
   Hallal-Calleros C, 2016, VET PARASITOL, V229, P50, DOI 10.1016/j.vetpar.2016.09.015
   Hallal-Calleros C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-361
   Heath D.D., 1971, INT J PARASITOL, V1, P152
   Hegde V, 2013, CLIN MICROBIOL INFEC, V19, P314, DOI 10.1111/1469-0691.12157
   HUDSON R, 1990, HORM BEHAV, V24, P1, DOI 10.1016/0018-506X(90)90022-P
   Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239
   Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X
   LARRALDE C, 1995, J STEROID BIOCHEM, V52, P575, DOI 10.1016/0960-0760(95)00062-5
   Morales J, 1996, J PARASITOL, V82, P689, DOI 10.2307/3283875
   Mykytowycz R., 1962, NATURE, P193
   Pritt S, 2012, AM COLL LAB, P415, DOI 10.1016/B978-0-12-380920-9.00015-8
   RIKIHISA Y, 1985, EXP PARASITOL, V59, P390, DOI 10.1016/0014-4894(85)90094-3
   Rodriguez-De Lara R, 2015, ANIM REPROD SCI, V152, P90, DOI 10.1016/j.anireprosci.2014.11.005
   Sagae SC, 2012, PHYSIOL BEHAV, V105, P1104, DOI 10.1016/j.physbeh.2011.12.002
   Shea-Donohue T, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12422
   Sweet H, 2013, VET REC, V173, P369, DOI 10.1136/vr.101771
   W. H. O. World health Organization, 2010, LAB MAN EX PROC HUM, P22
   Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297
   Wiria AE, 2012, SEMIN IMMUNOPATHOL, V34, P889, DOI 10.1007/s00281-012-0358-0
   Yahya RS, 2018, ARCH MED SCI, V14, P101, DOI 10.5114/aoms.2016.60707
   Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13
NR 33
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108964
DI 10.1016/j.vetpar.2019.108964
PG 8
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700003
PM 31698093
DA 2020-05-12
ER

PT J
AU Barros, PSC
   Mota, CM
   Miranda, VD
   Ferreira, FB
   Ramos, ELP
   Santana, SS
   Costa, LF
   Pajuaba, ACAM
   Mineo, JR
   Mineo, TWP
AF Cardoso Barros, Patricio Silva
   Mota, Caroline Martins
   Miranda, Vanessa dos Santos
   Ferreira, Flavia Batista
   Pires Ramos, Eliezer Lucas
   Santana, Silas Silva
   Costa, Lourenco Faria
   Arantes Marques Pajuaba, Ana Claudia
   Mineo, Jose Roberto
   Patriarca Mineo, Tiago Wilson
TI Inducible Nitric Oxide Synthase is required for parasite restriction and
   inflammatory modulation during Neospora caninum infection
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Neospora caninum; iNOS; Cytokines; Inflammation; Parasite load
ID TOXOPLASMA-GONDII; INTERFERON-GAMMA; IFN-GAMMA; MURINE MACROPHAGES;
   IMMUNE-RESPONSES; RESISTANCE; TH1; OVERPRODUCTION; INTERLEUKIN-12;
   PROLIFERATION
AB Neospora caninum infection is an important cause of neuromuscular disease in dogs and abortion in cattle, leading to significant economic losses in beef and dairy industries. The protective immunity against apicomplexan parasites, specifically Toxoplasma gondii and N. caninum, is typically achieved by inducing an IL-12-driven Th1 immune response. IL-12 stimulates IFN-gamma production, which activates Inducible Nitric Oxide Synthase (iNOS) and promotes consequent Nitric Oxide (NO) synthesis, classically described as one of the main effector mechanisms for parasite elimination. Here, we aimed to evaluate the role played by iNOS during N. caninum infection. Our results show that N. caninum infection in C57BL/6 wild type (WT) mice induce NO production in vivo and in vitro. In agreement, iNOS deficient mice, as well as WT mice treated with iNOS inhibitor aminoguanidine, succumbed during acute infection with a dose lethal to 50 % of the WT mice, and presented significant increase in parasite load when submitted to sub-lethal infection protocols. Interestingly, the lack of control of parasite proliferation observed in iNOS(-/-) mice was associated with notable CNS inflammation and increased production of the main systemic proinflammatory cytokines (IL-12, IFN-gamma, IL-6, TNF and IL-17A). Taken together, our findings show that iNOS plays an important role in restricting N. caninum replication, while also modulates the inflammatory process induced by the infection.
C1 [Cardoso Barros, Patricio Silva; Mota, Caroline Martins; Miranda, Vanessa dos Santos; Ferreira, Flavia Batista; Pires Ramos, Eliezer Lucas; Santana, Silas Silva; Costa, Lourenco Faria; Arantes Marques Pajuaba, Ana Claudia; Mineo, Jose Roberto; Patriarca Mineo, Tiago Wilson] Univ Fed Uberlandia, Inst Ciencias Biomed, Dept Imunol, Lab Imunoparasitol Dr Mario Endsfeldz Camargo, Av Para 1720,Bloco 4C,Campus Umuarama, BR-38400902 Uberlandia, MG, Brazil.
RP Mineo, TWP (reprint author), Univ Fed Uberlandia, Inst Ciencias Biomed, Dept Imunol, Lab Imunoparasitol Dr Mario Endsfeldz Camargo, Av Para 1720,Bloco 4C,Campus Umuarama, BR-38400902 Uberlandia, MG, Brazil.
EM tiago.mineo@ufu.br
RI Mineo, Tiago W. P./B-4153-2009
OI Mineo, Tiago W. P./0000-0002-2339-2743; Mota,
   Caroline/0000-0002-9183-4443; Mineo, Jose Roberto/0000-0002-9010-7228;
   Ramos, Eliezer LP/0000-0002-9437-5545
FU Brazilian governamental agency: Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [307548/2016-3]; Brazilian
   governamental agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES [AUXPE-PARASITOLOGIA 1348/2011]; Brazilian
   governamental agency: Fundacao de Amparo a Pesquisa de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG) [CVZ-0547-17,
   APQ-01313-14]
FX The authors thank Marley Dantas Barbosa and Zilda Mendonca da Silva
   Rodrigues for their technical assistance. This study was funded by the
   Brazilian governamental agencies: Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq; Project #307548/2016-3), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Project
   #AUXPE-PARASITOLOGIA 1348/2011) and Fundacao de Amparo a Pesquisa de
   Minas Gerais (FAPEMIG; Project #CVZ-0547-17 and APQ-01313-14). The
   funders had no role in study design, data collection and interpretation,
   or the decision to submit the work for publication.
CR Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593
   Bogdan C, 1998, J EXP MED, V187, P1361, DOI 10.1084/jem.187.9.1361
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x
   Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214
   Collantes-Fernandez E, 2002, J CLIN MICROBIOL, V40, P1194, DOI 10.1128/JCM.40.4.1194-1198.2002
   da Silva MV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00245
   Davoli-Ferreira M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29289
   Dubey JP, 2011, VET PARASITOL, V180, P90, DOI 10.1016/j.vetpar.2011.05.031
   Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902
   GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533
   GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115
   Giordano D, 2011, J LEUKOCYTE BIOL, V89, P443, DOI 10.1189/jlb.0610329
   Goodswen SJ, 2013, INFECT GENET EVOL, V13, P133, DOI 10.1016/j.meegid.2012.08.012
   Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006
   Hemphill Andrew, 2013, Front Biosci (Elite Ed), V5, P23
   Innes EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3
   Jesus LB, 2019, VET PARASITOL, V266, P96, DOI 10.1016/j.vetpar.2019.01.003
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812
   Livonesi MC, 2009, MICROBES INFECT, V11, P123, DOI 10.1016/j.micinf.2008.10.015
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Marugan-Hernandez V, 2017, J COMP PATHOL, V157, P193, DOI 10.1016/j.jcpa.2017.08.001
   Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237
   Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006
   Miles AM, 1996, METHOD ENZYMOL, V268, P105
   Mineo TWP, 2010, IMMUNOL CELL BIOL, V88, P825, DOI 10.1038/icb.2010.52
   Mineo TWP, 2010, INT J PARASITOL, V40, P797, DOI 10.1016/j.ijpara.2009.12.003
   Mineo TWP, 2009, VET RES, V40, DOI 10.1051/vetres/2009015
   Miranda VD, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00739-18
   Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574
   Mota CM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01456
   Mueller C, 2016, J CELL SCI, V129, P1031, DOI 10.1242/jcs.177386
   Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108
   Nishikawa Y, 2001, CLIN DIAGN LAB IMMUN, V8, P811, DOI 10.1128/CDLI.8.4.811-817.2001
   Pinheiro AM, 2010, EXP PARASITOL, V124, P442, DOI 10.1016/j.exppara.2009.12.018
   Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022
   SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261
   SchartonKersten TM, 1996, J IMMUNOL, V157, P4045
   Spekker K, 2009, INFECT IMMUN, V77, P4496, DOI 10.1128/IAI.00310-09
   Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339
   Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375
   SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869
   Tanaka T, 2000, PARASITOL RES, V86, P768, DOI 10.1007/s004360000242
   Vonlaufen N, 2002, INT J PARASITOL, V32, P1253, DOI 10.1016/S0020-7519(02)00126-1
   WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0
   Woods S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003535
   Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200
   Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598
NR 50
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108990
DI 10.1016/j.vetpar.2019.108990
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700012
PM 31775103
DA 2020-05-12
ER

PT J
AU Ceriac, S
   Durbant, P
   Godard, X
   Barbier, C
   Feuillet, D
   Felicite, Y
   Archimede, H
   Bambou, JC
AF Ceriac, Steve
   Durbant, Priscilla
   Godard, Xavier
   Barbier, Claude
   Feuillet, Dalila
   Felicite, Yoann
   Archimede, Harry
   Bambou, Jean-Christophe
TI Effect of the nutritional status of Creole goats on the
   density-dependent prolificacy of Haemonchus contortus
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Haemonchus contortus; Goat kids; Nutrition; Prolificacy;
   Density-dependent
ID ANTHELMINTIC RESISTANCE; DIETARY-PROTEIN; GASTROINTESTINAL NEMATODES;
   SHEEP; SUPPLEMENTATION; PARASITISM; KIDS; INFECTIONS; PARAMETERS;
   RESPONSES
AB The objective of this study was to measure the effect of the nutritional status of Creole goat kids on the host responses and the nematode population established after an experimental H. contortus infection. Fifty six kids were fed with 4 diets corresponding to 2 nutritional statuses: the low nutritional status (HAY, hay ad libitum and HB, Hay ad libitum + banana) and the high nutritional status (HS, hay ad libitum + soya meal and HSB, hay ad libitum + banana + soya meal). For each diet, 8 kids were experimentally infected with 10,000 H. contortus infective larvae (L3) and 6 kids were kept as non-infected controls. From the day of infection until 6 weeks post-infection, samples were collected to measure individual intake, total tract digestibility, parasitological and hematological parameters. The dry matter intake (DMI), the average daily gain (ADG), the crude protein (CP) and the digestible CP intake were higher in goats fed the HS and HSB diets, but no statistically significant interaction between the nutritional status and the infection was observed. The packed cell volume (PCV), the red blood cell counts (RBC) and the mean corpuscular volume (MCV) were higher with the HS and the HSB diets. In kids with the high nutritional status the nematode burden and pathophysiological impact of the infection were significantly lower but not the FEC. In conclusion, this reduced establishment rate was associated with an increased production of eggs by the female parasites and suggested a phenomenon of density-dependent prolificacy of H. contortus probably inherent to the fitness of the parasite population.
C1 [Ceriac, Steve; Durbant, Priscilla; Feuillet, Dalila; Felicite, Yoann; Archimede, Harry; Bambou, Jean-Christophe] INRA, URZ, F-97170 Petit Bourg, Guadeloupe, France.
   [Godard, Xavier; Barbier, Claude] INRA, PTEA, F-97170 Petit Bourg, Guadeloupe, France.
RP Bambou, JC (reprint author), INRA, URZ, F-97170 Petit Bourg, Guadeloupe, France.
EM jean-christophe.bambou@inra.fr
FU Project Agroecodiv (La Region Guadeloupe); Project Agroecodiv (Fonds
   Europeens FEDER); INRA metaprogramme GISA (Gestion Integree de la Sante
   Animale) Project Strep (drastic and Sustainable Treatment Reduction
   against Parasitism in livestock); Region Guadeloupe; animal genetics
   division of INRA
FX The authors want to give thanks to the Duclos team for care and handling
   of the animals: P. -J. Dumoulin, F. Periacarpin and C. Deloumeaux. This
   study was funded by the Project Agroecodiv (La Region Guadeloupe and
   Fonds Europeens FEDER) and the INRA metaprogramme GISA (Gestion Integree
   de la Sante Animale) Project Strep (drastic and Sustainable Treatment
   Reduction against Parasitism in livestock). S. Ceriac was supported by a
   doctoral fellowship from la Region Guadeloupe and the animal genetics
   division of INRA.
CR ABBOTT EM, 1988, RES VET SCI, V45, P41, DOI 10.1016/S0034-5288(18)30892-0
   ABBOTT EM, 1986, VET PARASITOL, V20, P291, DOI 10.1016/0304-4017(86)90127-5
   Adler N, 2016, ENVIRON TOXICOL CHEM, V35, P1914, DOI 10.1002/etc.3308
   Alonso-Diaz MA, 2008, VET PARASITOL, V153, P313, DOI 10.1016/j.vetpar.2008.01.042
   AOAC, 2006, OFFICIAL METHODS ANA
   Bambou JC, 2013, BIOMED RES INT, DOI 10.1155/2013/902759
   Bambou JC, 2009, J ANIM SCI, V87, P2367, DOI 10.2527/jas.2008-1702
   Bambou JC, 2008, VET PARASITOL, V158, P311, DOI 10.1016/j.vetpar.2008.09.020
   Beynon SA, 2015, ECOL ENTOMOL, V40, P124, DOI 10.1111/een.12240
   BLACKBURN HD, 1991, VET PARASITOL, V40, P99, DOI 10.1016/0304-4017(91)90086-B
   Bricarello PA, 2005, VET PARASITOL, V134, P99, DOI 10.1016/j.vetpar.2005.05.068
   BUENO L, 1982, PARASITOLOGY, V84, P367, DOI 10.1017/S0031182000044905
   Cei W, 2018, LIVEST SCI, V212, P34, DOI 10.1016/j.livsci.2018.03.015
   Ceriac S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37800-3
   Ceriac S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1248-4
   Churcher TS, 2008, EVOLUTION, V62, P528, DOI 10.1111/j.1558-5646.2007.00290.x
   Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6
   DAWKINS HJS, 1989, INT J PARASITOL, V19, P199, DOI 10.1016/0020-7519(89)90008-8
   Dorny P, 1998, RES VET SCI, V65, P259, DOI 10.1016/S0034-5288(98)90153-9
   Horvat AJM, 2012, TRAC-TREND ANAL CHEM, V31, P61, DOI 10.1016/j.trac.2011.06.023
   Hoste H, 2016, ADV PARASIT, V93, P239, DOI 10.1016/bs.apar.2016.02.025
   Houdijk JGM, 2012, SMALL RUMINANT RES, V103, P41, DOI 10.1016/j.smallrumres.2011.10.017
   Jackson F, 2000, PARASITOLOGY, V120, pS95, DOI 10.1017/S0031182099005740
   Konwar P, 2015, VET WORLD, V8, P1351, DOI 10.14202/vetworld.2015.1351-1355
   Mendez-Ortiz FA, 2019, VET PARASITOL, V265, P1, DOI 10.1016/j.vetpar.2018.11.008
   MICHAEL E, 1989, PARASITOLOGY, V98, P451, DOI 10.1017/S0031182000061540
   Papadopoulos E, 2008, SMALL RUMINANT RES, V76, P99, DOI 10.1016/j.smallrumres.2007.12.012
   Ploeger HW, 2018, VET PARASITOL, V262, P11, DOI 10.1016/j.vetpar.2018.09.007
   SHAW KL, 1995, INT J PARASITOL, V25, P381, DOI 10.1016/0020-7519(94)00098-9
   Strain SAJ, 2001, PARASITE IMMUNOL, V23, P527, DOI 10.1046/j.1365-3024.2001.00410.x
   Sykes Andrew R., 2010, R. Bras. Zootec., V39, P376, DOI 10.1590/S1516-35982010001300041
   van Wyk JA, 2002, VET RES, V33, P509, DOI 10.1051/vetres:2002036
   Wallace DS, 1996, RES VET SCI, V60, P138, DOI 10.1016/S0034-5288(96)90008-9
NR 33
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108973
DI 10.1016/j.vetpar.2019.108973
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700006
PM 31785456
DA 2020-05-12
ER

PT J
AU de Jesus, RF
   Borges-Silva, W
   Bezerra, TL
   Gondim, LQ
   Uzeda, RS
   Gondim, LFP
AF de Jesus, Rogerio F.
   Borges-Silva, Waleria
   Bezerra, Taynar L.
   Gondim, Leane Q.
   Uzeda, Rosangela S.
   Gondim, Luis F. P.
TI Serologic cross-reactivity between Sarcocystis neurona and Sarcocystis
   falcatula-like in experimentally infected Mongolian gerbils
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Sarcocystis sp.; Cross-reaction; Antibody; Serology; Didelphis sp.
ID EQUINE PROTOZOAL MYELOENCEPHALITIS; FLUORESCENT-ANTIBODY TEST;
   NEOSPORA-CANINUM; MOLECULAR CHARACTERIZATION; SERUM ANTIBODIES;
   PREVALENCE; OPOSSUMS; SPP.; DIAGNOSIS; ANTIGEN
AB Sarcocystis neurona is the major cause of the equine protozoal myeloencephalitis (EPM) in the Americas and has opossums of the genus Didelphis as definitive hosts. Most isolates of Sarcocystis sp. shed by opossums in Brazil differ genetically from the known species of Sarcocystis. These Brazilian isolates behave similarly as Sarcocystis falcatula, which causes sarcocystosis in birds, and for this reason, have been classified as Sarcocystis falcatula-like. Genes coding for the immunodominant surface antigens SAG2, SAG3 and SAG4 of S. falcatula-like are similar to those from S. neurona. It is unknown the Sarcocystis species that causes EPM in Brazil, as S. neurona has never been genetically confirmed in Brazilian horses. All cases associated with EPM in Brazil were diagnosed by immunological tests, which are not specific for S. neurona infection. It is possible that S. falcatula-like may infect horses in Brazil. The aims of the current study were to test the susceptibility of gerbils (Meriones unguiculatus) to experimental infections with S. neurona and S. falcatula-like, and to investigate potential serologic cross-reactivity to these parasites by immunofluorescent antibody test (IFAT) and Western blot (WB). A total of 27 gerbils, distributed in five experimental groups (G1-G5), were employed in this work (G1: 4 negative controls; G2: 6 infected with S. neurona merozoites, G3: 6 infected with S. falcatula-like merozoites; G4 and G5 (5 and 6, respectively, infected with different doses of sporocysts). None of the 17 animals that seroconverted for the parasites in IFAT presented any visualized organism or Sarcocystis DNA in the examined tissues. No serologic cross-reactivity was observed using IFAT. However, sera from animals infected with S. falcatula-like and S. neurona presented the same pattern of antigenic recognition when S. neurona merozoites were used as antigen in WB, including reactivity to proteins of 30 and 16 kDa, regarded as specific markers for S. neurona-infected animals. Gerbils did not sustain infection by these parasites, although produced antibodies after inoculation. These results are suggestive that other animal species that are exposed to S. falcatula-like, including horses, may present serologic cross-reactivity to S. neurona in WB. IFAT was demonstrated to be more specific that WB for the detection of antibodies to S. falcatula-like and S. neurona in the experimental conditions of this study.
C1 [de Jesus, Rogerio F.; Borges-Silva, Waleria; Bezerra, Taynar L.; Gondim, Leane Q.; Gondim, Luis F. P.] Univ Fed Bahia, Dept Anat Patol & Clin, Escola Med Vet & Zootecnia, Ave Adhemar de Barros 500, BR-40170110 Salvador, BA, Brazil.
   [Uzeda, Rosangela S.] Univ Fed Bahia, Dept Med Vet Prevent & Prod Anim, Escola Med Vet & Zootecnia, Ave Adhemar de Barros 500, BR-40170110 Salvador, BA, Brazil.
RP Gondim, LFP (reprint author), Univ Fed Bahia, Dept Anat Patol & Clin, Escola Med Vet & Zootecnia, Ave Adhemar de Barros 500, BR-40170110 Salvador, BA, Brazil.
EM pita@ufba.br
OI Gondim, Luis/0000-0003-3741-121X
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
   [APP0053/2016]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Brazil (CNPq)National Council for Scientific and
   Technological Development (CNPq) [308795/2015-6]
FX The authors thank Dr. Wagner Porto (Federal University of Alagoas at
   Vicosa) for kindly donating Mongolian gerbils for the study. This work
   was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia
   (FAPESB) under the grant number APP0053/2016. Luis F.P. Gondim is
   recipient of a scholarship from Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brazil (CNPq) (process number: 308795/2015-6).
CR Cesar MO, 2018, EXP PARASITOL, V188, P42, DOI 10.1016/j.exppara.2018.03.004
   Cutler TJ, 1999, J PARASITOL, V85, P301, DOI 10.2307/3285638
   Duarte PC, 2004, J PARASITOL, V90, P379, DOI 10.1645/GE-3263
   Duarte PC, 2003, J VET DIAGN INVEST, V15, P8, DOI 10.1177/104063870301500103
   Dubey JP, 1999, J AM VET MED ASSOC, V215, P970
   Dubey JP, 2001, VET PARASITOL, V95, P295, DOI 10.1016/S0304-4017(00)00395-2
   Dubey JP, 2001, VET PARASITOL, V95, P155, DOI 10.1016/S0304-4017(00)00387-3
   Ellison SP, 2002, INT J PARASITOL, V32, P217, DOI 10.1016/S0020-7519(01)00324-1
   Fenger CK, 1995, J PARASITOL, V81, P916, DOI 10.2307/3284040
   Foster D.N., 1997, IMMORTALIZED CELL LI
   Gennari SM, 2016, REV BRAS PARASITOL V, V25, P109, DOI 10.1590/S1984-29612016003
   Gondim LFP, 2015, VET PARASITOL, V210, P131, DOI 10.1016/j.vetpar.2015.03.028
   Gondim LSQ, 2017, VET PARASITOL, V243, P192, DOI 10.1016/j.vetpar.2017.07.002
   Gondim LFP, 2019, INT J PARASITOL-PAR, V10, P132, DOI 10.1016/j.ijppaw.2019.08.008
   Gondim LFP, 2016, EXP PARASITOL, V163, P46, DOI 10.1016/j.exppara.2016.01.014
   GRANSTROM DE, 1993, J VET DIAGN INVEST, V5, P88, DOI 10.1177/104063879300500118
   Hoane JS, 2006, VET PARASITOL, V136, P155, DOI 10.1016/j.vetpar.2005.10.023
   Lindsay DS, 2004, J PARASITOL, V90, P461, DOI 10.1645/GE-230R
   Menses I.D., 2014, REV BRAS PARASITOL V, V23, P526
   Reed SM, 2016, J VET INTERN MED, V30, P491, DOI 10.1111/jvim.13834
   Rossano MG, 2000, J VET DIAGN INVEST, V12, P28, DOI 10.1177/104063870001200105
   Sager H, 2006, VET PARASITOL, V139, P84, DOI 10.1016/j.vetpar.2006.02.021
   SMITH JH, 1987, LAB INVEST, V56, P72
   Tanhauser SM, 1999, J PARASITOL, V85, P221, DOI 10.2307/3285623
   Valadas SYOB, 2016, EXP PARASITOL, V164, P71, DOI 10.1016/j.exppara.2016.02.008
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108962
DI 10.1016/j.vetpar.2019.108962
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700002
PM 31704559
DA 2020-05-12
ER

PT J
AU de Oliveira, PC
   de Almeida, GPS
   Cardoso, JD
   Tavares, RB
   Fernandes, JI
   Correia, TR
   Verocai, GG
   Scott, FB
AF de Oliveira, Priscila Cardim
   Salca de Almeida, Gabriela Pereira
   Cardoso, Jaime Dias
   Tavares, Renan Bernardes
   Fernandes, Julio Israel
   Correia, Thais Ribeiro
   Verocai, Guilherme Gomes
   Scott, Fabio Barbour
TI Efficacy of sarolaner on the treatment of myiasis caused by Cochliomyia
   hominivorax (Diptera: Calliphoridae) in dogs
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Larvicidal effect; Larval expulsion; New world screwworm; Primary
   myiasis
ID SIMPARICA(TM); INFESTATIONS; ISOXAZOLINE
AB The aim of this study was to evaluate the larval expulsion, larvicidal effect, retention rate of dead larvae and overall efficacy of sarolaner on the treatment of myiasis caused by New World screwworm Cochliomyia hominivorax in naturally infested dogs. Eight Beagle dogs received a single dose of saroalner 40 mg, with dosage ranging from 2.7 mg/kg to 3.7 mg/kg. Evaluations occurred every 15 min in the first hour, every hour for up to 6 h, and after 24 h of treatment. At 24 h post-treatment, total wound cleaning was performed, including removal and counting of remaining live and dead larvae. The animals received antibiotic, analgesic and wound cleaning support until complete wound healing. The average expulsion of the larvae was 50.9 % occurring mainly after 4 h of treatment. The larvicidal effect was 70.6 % at 6 h after treatment and 100 % at 24 h. The mean retention rate of dead larvae of sarolaner was 33.9 %, The overall efficacy was 100 %, thus making sarolaner an excellent treatment option in myiasis caused by C. hominivorax larvae in dogs.
C1 [de Oliveira, Priscila Cardim; Salca de Almeida, Gabriela Pereira; Cardoso, Jaime Dias; Tavares, Renan Bernardes; Correia, Thais Ribeiro; Scott, Fabio Barbour] Univ Fed Rural Rio de Janeiro, Vet Inst, Dept Anim Parasitol, BR 465,Km 7 Anexo 1 4 UFRRJ, Seropedica, RJ, Brazil.
   [Fernandes, Julio Israel] Univ Fed Rural Rio de Janeiro, Vet Inst, Dept Vet Med & Surg, BR 465,Km 7 Anexo 1 4 UFRRJ, Seropedica, RJ, Brazil.
   [Verocai, Guilherme Gomes] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA.
RP Fernandes, JI (reprint author), Univ Fed Rural Rio de Janeiro, Vet Inst, Dept Vet Med & Surg, BR 465,Km 7 Anexo 1 4 UFRRJ, Seropedica, RJ, Brazil.
EM vetjulio@yahoo.com.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil
   (CAPES)CAPES
FX This work was performed with support of the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES).
CR Cardoso S.V., 2007, R BRAS CI VET, V14, P139, DOI DOI 10.4322/RBCV.2014.250
   Correia TR, 2010, VET PARASITOL, V173, P169, DOI 10.1016/j.vetpar.2010.06.019
   de Souza CP, 2010, J FELINE MED SURG, V12, P166, DOI 10.1016/j.jfms.2009.08.003
   Garcia-Reynaga P, 2013, CHEM RES TOXICOL, V26, P514, DOI 10.1021/tx400055p
   Gassel M, 2014, INSECT BIOCHEM MOLEC, V45, P111, DOI 10.1016/j.ibmb.2013.11.009
   Guimaraes J.H., 1999, MYIASIS MAN ANIMALS, P97
   Han HS, 2018, VET DERMATOL, V29, P442, DOI 10.1111/vde.12672
   Han HS, 2017, VET DERMATOL, V28, P239, DOI 10.1111/vde.12403
   Oliveira PC, 2018, VET PARASITOL, V258, P53, DOI 10.1016/j.vetpar.2018.06.006
   Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131
   Six RH, 2016, VET PARASITOL, V222, P37, DOI 10.1016/j.vetpar.2016.02.014
   Six RH, 2016, VET PARASITOL, V222, P62, DOI 10.1016/j.vetpar.2016.02.027
   Six RH, 2016, VET PARASITOL, V222, P28, DOI 10.1016/j.vetpar.2015.12.023
   Woods D.J., 2018, ECTOPARASITES DRUG D, V8, P295
NR 14
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108966
DI 10.1016/j.vetpar.2019.108966
PG 4
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700014
PM 31759192
DA 2020-05-12
ER

PT J
AU Evans, CC
   Bradner, JL
   Savadelis, MD
   Nelson, CT
   Moorhead, AR
AF Evans, Christopher C.
   Bradner, Jenna L.
   Savadelis, Molly D.
   Nelson, C. Thomas
   Moorhead, Andrew R.
TI Acetic acid as an alternative reagent in the modified Knott test
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Dirofilaria immitis; Knott test; Diagnosis; Microfilaria
AB The suitability of acetic acid as a safer alternative to formalin in the modified Knott test was evaluated for the diagnosis of canine heartworm (Dirofilaria immitis). Microfilaria concentration was measured by both methods and found to agree within reasonable limits ( - 5.84 % bias; - 88.1-76.4 % limits of agreement). The level of agreement was lower when samples were prepared with a 24 h delay, but this was due to the formalin method tending to yield lower counts ( - 20.1 % bias; - 90.5-50.2 % limits of agreement). Clearing the sample of hemoglobin improves readability and is a key feature of the modified Knott test. Hemolysis was significantly lower in the acetic acid method than the formalin method as measured by red blood cell count (6.83 x 10(6) and 8.79 x 10(6) cells/ml, respectively; p = 0.015) and absorbance at 415 nm (33.20 and 34.75, respectively; p < 0.001). Visual assessment, however, revealed little practical difference in readability. Finally, lengths of microfilariae were measured to ensure the validity of species identification by the acetic acid method; mean length was significantly shorter after acetic acid treatment (273 mu m) than formalin treatment (316 mu m; p < 0.001). Length reduction was also observed in acetic acid-treated Acanthocheilonema reconditum (254 mu m versus 262 mu m; p = 0.035), though these samples were stored prior to testing and are not directly comparable. We conclude that, while the readability of samples is similar for both methods, species differentiation must still be accomplished by other means. For most clinical purposes in determining the presence or absence of blood circulating microfilariae, however, acetic acid appears to be a suitable alternative to formalin in the modified Knott test.
C1 [Evans, Christopher C.; Bradner, Jenna L.; Savadelis, Molly D.; Moorhead, Andrew R.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
   [Nelson, C. Thomas] Anim Med Ctr, 719 Quintard Ave, Anniston, AL 36205 USA.
RP Evans, CC (reprint author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
EM ccevans@uga.edu
CR American Heartworm Society, 2018, CURRENT CANINE GUIDE
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Brianti E, 2012, PARASITOLOGY, V139, P530, DOI 10.1017/S0031182011002198
   CHURCH EM, 1976, CORNELL VET, V66, P333
   EBERHARD ML, 1991, CLIN LAB MED, V11, P977, DOI 10.1016/S0272-2712(18)30531-6
   Han V, 2010, VOX SANG, V98, P116, DOI 10.1111/j.1423-0410.2009.01249.x
   KNOTT J., 1939, TRANS ROY SOC TROP MED AND HYG, V33, P191, DOI 10.1016/S0035-9203(39)90101-X
   Leong AY, 1994, LAB HISTOPATHOLOGY, P41
   Magnis J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-48
   Neer T.M., 1989, PROCEEDINGS OF THE A
   NTP, 2011, REP CARCINOG, V12, piii
   Ranjbar-Bahadori S, 2011, IRAN J PARASITOL, V6, P73
   Rhee Jae Ku, 1998, Korean Journal of Parasitology, V36, P235, DOI 10.3347/kjp.1998.36.4.235
   Rodak Bernadette F., 2007, HEMATOLOGY CLIN PRIN
   TILLEY LP, 1974, VET MED SM ANIM CLIN, V69, P288
   Valenciano A.C., 2014, ATLAS OF CANINE FELI, P259
   Velasquez L, 2014, VET PARASITOL, V206, P67, DOI 10.1016/j.vetpar.2014.03.021
NR 17
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108975
DI 10.1016/j.vetpar.2019.108975
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700009
PM 31775102
DA 2020-05-12
ER

PT J
AU Geuthner, AC
   Koethe, M
   Ludewig, M
   Pott, S
   Schares, G
   Maksimov, P
   Daugschies, A
   Bangoura, B
AF Geuthner, Anne-Catrin
   Koethe, Martin
   Ludewig, Martina
   Pott, Susan
   Schares, Gereon
   Maksimov, Pavlo
   Daugschies, Arwid
   Bangoura, Berit
TI Development of an in vivo model for Toxoplasma gondii infections in
   chickens and turkeys simulating natural routes of infection
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Toxoplasma; Chickens; Turkeys; Natural routes of infection; PCR
ID FREE-RANGE CHICKENS; TISSUE CYSTS; MAGNETIC-CAPTURE; ORAL INOCULATION;
   PREGNANT-WOMEN; CATS; SEROPREVALENCE; OOCYSTS; PIGS; SUSCEPTIBILITY
AB Turkeys and chickens were orally infected with tissue cysts (one mouse brain) or oocysts (10(3), 10(5) or 10(6) oocysts) of three T. gondii strains of the clonal types II and III (ME49, CZ-Tiger, NED) to investigate the influence of the applied T. gondii strain and infective doses on the distribution of T. gondii in several organs and tissues and the serologic response of chickens and turkeys. Organ samples from 16 different tissues, including heart, brain, muscles and gizzard were analyzed by PCR. Brain and heart were found most frequently positive for T. gondii DNA in both species, followed by gizzard. Serological analysis with kinetic ELISA for turkey samples and IFAT for chicken samples were performed once a week. In both species a dose-depending serological response was found. Turkeys seroconverted one week after infection with CZ-Tiger strain and medium and high doses of ME49 oocysts. In chickens, infection with medium and high doses of CZ-Tiger led to seroconversion one week p.i. Frequency of T. gondii positive organs showed a trend of a dose-effect in both species after infection with the type II strains. The NED strain showed low virulence in chickens and turkeys, demonstrated by clearly less T. gondii positive organs. Infection with tissue cysts of all three strains revealed T. gondii stages in tissues of turkeys and chickens. In conclusion, our data show a risk for human infection with T. gondii due to consumption of chicken and turkey meat.
C1 [Geuthner, Anne-Catrin; Daugschies, Arwid; Bangoura, Berit] Univ Leipzig, Fac Vet Med, Inst Parasitol, Tierkliniken 35, D-04103 Leipzig, Germany.
   [Koethe, Martin; Ludewig, Martina; Pott, Susan] Univ Leipzig, Fac Vet Med, Inst Food Hyg, Tierkliniken 1, D-04103 Leipzig, Germany.
   [Ludewig, Martina] Univ Vet Med, Inst Milk Hyg Milk Technol & Food Sci, Vet Pl 1, A-1210 Vienna, Austria.
   [Schares, Gereon; Maksimov, Pavlo] Natl Reference Ctr Toxoplasmosis, Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Epidemiol, Suedufer 10, D-17493 Greifswald, Germany.
   [Bangoura, Berit] Univ Wyoming, Dept Vet Sci, Wyoming State Vet Lab, 1174 Snowy Range Rd, Laramie, WY 82072 USA.
   [Geuthner, Anne-Catrin] State Off Consumer Protect Saxony Anhalt, Dept Food Safety 3, Freiimfelder Str 68, D-06112 Halle, Saale, Germany.
RP Bangoura, B (reprint author), Univ Leipzig, Fac Vet Med, Inst Parasitol, Tierkliniken 35, D-04103 Leipzig, Germany.
EM bbangour@uwyo.edu
OI Schares, Gereon R. M./0000-0002-3217-289X
FU German Federal Ministry of Research and Education (BMBF)Federal Ministry
   of Education & Research (BMBF) [01KI1002C]
FX We would like to thank Marion Fritsche and Rene Schuhmacher for
   outstanding animal attendance and the staff of the Institute of
   Parasitology and the State Office for Consumer Protection of
   SaxonyAnhalt for technical support. We thank Andrea Barwald and
   Liselotte Minke for their excellent technical assistance. Furthermore,
   we acknowledge the financial support by the German Federal Ministry of
   Research and Education (BMBF) within the research network ToxoNet (grant
   no. 01KI1002C).
CR Ajzenberg D, 2010, FUTURE MICROBIOL, V5, P841, DOI 10.2217/FMB.10.55
   Algaba IG, 2018, INT J PARASITOL, V48, P555, DOI 10.1016/j.ijpara.2017.12.009
   Aubert D, 2010, VET PARASITOL, V171, P346, DOI 10.1016/j.vetpar.2010.03.033
   Bangoura B, 2013, VET PARASITOL, V196, P272, DOI 10.1016/j.vetpar.2013.03.032
   Bartova E, 2004, AVIAN PATHOL, V33, P153, DOI 10.1080/03079450310001652068
   BIANCIFIORI F, 1986, COMP IMMUNOL MICROB, V9, P337, DOI 10.1016/0147-9571(86)90046-9
   Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142
   DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305
   Darde ML, 1996, CURR TOP MICROBIOL, V219, P27
   de Sousa S, 2006, VET PARASITOL, V135, P133, DOI 10.1016/j.vetpar.2005.08.012
   Dubey JP, 2008, J PARASITOL, V94, P68, DOI 10.1645/GE-1362.1
   Dubey JP, 2015, VET PARASITOL, V214, P55, DOI 10.1016/j.vetpar.2015.09.004
   Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x
   Dubey JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156255
   Dubey JP, 2006, J PARASITOL, V92, P184, DOI 10.1645/GE-652R.1
   DUBEY JP, 1988, AM J VET RES, V49, P910
   Dubey JP, 2005, VET PARASITOL, V133, P299, DOI 10.1016/j.vetpar.2005.06.006
   Dubey JP, 2005, VET PARASITOL, V133, P289, DOI 10.1016/j.vetpar.2005.06.007
   Dubey JP, 2002, J PARASITOL, V88, P713, DOI 10.1645/0022-3395(2002)088[0713:TILCOT]2.0.CO;2
   DUBEY JP, 1993, J PARASITOL, V79, P949, DOI 10.2307/3283736
   DUBEY JP, 1993, AM J VET RES, V54, P1668
   Dubey JP, 1997, J PARASITOL, V83, P946, DOI 10.2307/3284295
   Dubey JP, 2001, J PARASITOL, V87, P215, DOI 10.1645/0022-3395(2001)087[0215:OSBCFI]2.0.CO;2
   Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267
   DUBEY JP, 1990, J PARASITOL, V76, P201, DOI 10.2307/3283016
   Esteban-Redondo I, 1999, VET PARASITOL, V86, P155, DOI 10.1016/S0304-4017(99)00138-7
   Forbes LB, 2012, VET PARASITOL, V190, P362, DOI 10.1016/j.vetpar.2012.06.040
   FRENKEL JK, 1970, SCIENCE, V167, P893, DOI 10.1126/science.167.3919.893
   Geuthner AC, 2014, PARASITOLOGY, V141, P1359, DOI 10.1017/S003118201400078X
   Gotteland C, 2014, VET PARASITOL, V205, P629, DOI 10.1016/j.vetpar.2014.08.003
   Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030
   HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561
   HOWERTH EW, 1985, J WILDLIFE DIS, V21, P446, DOI 10.7589/0090-3558-21.4.446
   Jungersen G, 1999, INT J PARASITOL, V29, P1307, DOI 10.1016/S0020-7519(99)00078-8
   Jurankova J, 2014, FOOD MICROBIOL, V38, P167, DOI 10.1016/j.fm.2013.08.011
   Jurankova J, 2013, VET PARASITOL, V193, P95, DOI 10.1016/j.vetpar.2012.11.016
   Kaneto CN, 1997, VET PARASITOL, V69, P203, DOI 10.1016/S0304-4017(96)01126-0
   Khademi SZ, 2018, J FOOD SAFETY, V38, DOI 10.1111/jfs.12534
   Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005
   Koethe M, 2015, FOOD MICROBIOL, V52, P11, DOI 10.1016/j.fm.2015.06.005
   Koethe M, 2011, VET PARASITOL, V180, P179, DOI 10.1016/j.vetpar.2011.03.036
   LUNDE MN, 1983, J PARASITOL, V69, P806, DOI 10.2307/3281034
   Maksimov P, 2018, INT J PARASITOL, V48, P845, DOI 10.1016/j.ijpara.2018.04.004
   Maksimov P, 2011, VET PARASITOL, V182, P140, DOI 10.1016/j.vetpar.2011.05.049
   Martinez-Carrasco C, 2004, VET PARASITOL, V121, P143, DOI 10.1016/j.vetpar.2004.02.010
   Messaritakis I, 2008, AM J TROP MED HYG, V79, P205, DOI 10.4269/ajtmh.2008.79.205
   Nowakowska D, 2006, J CLIN MICROBIOL, V44, P1382, DOI 10.1128/JCM.44.4.1382-1389.2006
   OECD, 2018, MEAT CONS IND, DOI [10.1787/fa290fd0-en, DOI 10.1787/FA290FD0-EN]
   Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027
   PANDE PG, 1961, SCIENCE, V133, P648, DOI 10.1126/science.133.3453.648
   Pott S, 2013, J FOOD PROTECT, V76, P1056, DOI 10.4315/0362-028X.JFP-12-519
   QUIST CF, 1995, J WILDLIFE DIS, V31, P255, DOI 10.7589/0090-3558-31.2.255
   Saraf P, 2017, EXP PARASITOL, V174, P25, DOI 10.1016/j.exppara.2017.01.009
   Schares G, 2008, VET PARASITOL, V152, P34, DOI 10.1016/j.vetpar.2007.12.004
   Schares G, 2018, INT J PARASITOL, V48, P751, DOI 10.1016/j.ijpara.2018.03.007
   Schares G, 2017, INT J PARASITOL, V47, P765, DOI 10.1016/j.ijpara.2017.07.003
   Sedlak K, 2000, AVIAN PATHOL, V29, P563, DOI 10.1080/03079450020016805
   Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Wilking H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22551
   Zoller B, 2013, PARASITOL RES, V112, P1841, DOI 10.1007/s00436-013-3337-z
NR 61
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108956
DI 10.1016/j.vetpar.2019.108956
PG 10
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700001
PM 31706235
DA 2020-05-12
ER

PT J
AU Huertas-Lopez, A
   Martinez-Carrasco, C
   Ceron, JJ
   Sanchez-Sanchez, R
   Vazquez-Calvo, A
   Alvarez-Garcia, G
   Martinez-Subiela, S
AF Huertas-Lopez, Ana
   Martinez-Carrasco, Carlos
   Joaquin Ceron, Jose
   Sanchez-Sanchez, Roberto
   Vazquez-Calvo, Angela
   Alvarez-Garcia, Gema
   Martinez-Subiela, Silvia
TI A time-resolved fluorescence immunoassay for the detection of
   anti-Neospora caninum antibodies in sheep
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Fluorometry; Neospora caninum; Serodiagnosis; Sheep
ID C-REACTIVE PROTEIN; GONDII RECOMBINANT ANTIGENS; SEROLOGICAL DIAGNOSIS;
   IN-OVINE; INFECTION; ASSAYS; QUANTIFICATION; SERODIAGNOSIS;
   TOXOPLASMOSIS; MARKER
AB Neospora caninum is a protozoan parasite (Phylum Apicomplexa) that has been recently suggested as a relevant cause of reproductive disorders in small ruminants. The aim of the present study is to develop and validate a new serological test based on time resolved fluorescency using N. caninum GRA7 recombinant antigen (GRA7-TRFIA) for the detection of N. caninum antibodies in sheep. A total of 346 serum samples (208 from experimentally infected sheep, 117 from a dairy farm with a previous history of Neospora-associated abortion, and 21 negative sera) were used. The validation of the new assay was performed by the evaluation of assay precision, analytical sensitivity (Se), accuracy and cross reactivity. In the experimentally infected sheep, antibody kinetics was compared between GRA7-TRFIA and an in house N. caninum tachyzoite soluble extract-based ELISA (NcSALUVET ELISA) by Wilcoxon matched-pairs signed rank test. The cut-off and diagnostic Se and specificity (Sp) of GRA7-TRFIA was estimated by ROC analysis with field samples. In addition, concordance and correlation between GRA7-TRFIA and a commercial ELISA and NcSALUVET ELISA were assessed by kappa value and Spearman correlation coefficient, respectively.
   Overall, GRA7-TRFIA showed an adequate precision, analytical Se and accuracy to detect anti-N. caninum antibodies in ovine serum, and no cross reactivity with the closely related protozoan Toxoplasma gondii. In naturally infected sheep, 100% Se and 95.35% Sp were obtained for a cut-off point of 62.68 Units of Fluorometry for N. caninum (UFN). Moreover, GRA7-TRFIA allowed earlier detection of N. caninum infection than NcSALUVET ELISA in experimentally infected sheep.
C1 [Huertas-Lopez, Ana; Joaquin Ceron, Jose; Martinez-Subiela, Silvia] Univ Murcia, Interdisciplinary Lab Clin Anal, Interlab UMU, E-30100 Murcia, Spain.
   [Martinez-Carrasco, Carlos] Univ Murcia, Dept Anim Hlth, E-30100 Murcia, Spain.
   [Sanchez-Sanchez, Roberto; Vazquez-Calvo, Angela] Saluvet Innova SL, Madrid 28040, Spain.
   [Alvarez-Garcia, Gema] Univ Complutense Madrid, Dept Anim Hlth, Ciudad Univ S-N, Madrid 28040, Spain.
RP Martinez-Carrasco, C (reprint author), Univ Murcia, Dept Anim Hlth, E-30100 Murcia, Spain.
EM cmcpleit@um.es
RI GARCIA, GEMA ALVAREZ/E-3577-2016; Martinez-Subiela, Silvia/H-5719-2015;
   Martinez-Carrasco Pleite, Carlos/G-5272-2016
OI GARCIA, GEMA ALVAREZ/0000-0002-6627-7577; Martinez-Subiela,
   Silvia/0000-0002-1524-1558; Martinez-Carrasco Pleite,
   Carlos/0000-0002-8742-0109
FU University of Murcia [R-1207/2017]; Seneca Foundation of Murcia Region,
   SpainFundacion Seneca [19894/GERM/15]
FX Ana Huertas Lopez was supported by a pre-doctoral grant from University
   of Murcia (R-1207/2017). This work was supported by the Seneca
   Foundation of Murcia Region, Spain (project 19894/GERM/15).
CR Abdelbaky HH, 2018, PARASITOL INT, V67, P675, DOI 10.1016/j.parint.2018.06.012
   Aguado-Martinez A, 2008, VET PARASITOL, V157, P182, DOI 10.1016/j.vetpar.2008.08.002
   Alvarez-Garcia G, 2007, PARASITOLOGY, V134, P41, DOI 10.1017/S0031182006001284
   Alvarez-Garcia G, 2003, VET RES, V34, P341, DOI 10.1051/vetres:2003009
   Alvarez-Garcia G, 2013, VET PARASITOL, V198, P85, DOI 10.1016/j.vetpar.2013.07.033
   Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179
   Andreotti R, 2009, REV BRAS PARASITOL V, V18, P19, DOI 10.4322/rbpv.01802004
   [Anonymous], 2013, GUID IND BIOAN METH
   Cantos-Barreda A, 2017, VET IMMUNOL IMMUNOP, V189, P11, DOI 10.1016/j.vetimm.2017.05.007
   Cantos-Barreda A, 2017, VET PARASITOL, V242, P54, DOI 10.1016/j.vetpar.2017.05.017
   Dubey JP, 2006, VET PARASITOL, V140, P1, DOI 10.1016/j.vetpar.2006.03.035
   Dubey J P, 1990, J Vet Diagn Invest, V2, P230
   Dubey JP, 2011, VET PARASITOL, V180, P90, DOI 10.1016/j.vetpar.2011.05.031
   Dubey JP, 2009, VET PARASITOL, V163, P1, DOI 10.1016/j.vetpar.2009.02.026
   Dubey J.P., 2017, NEOSPOROSIS ANIMALS, V2017, DOI [10.1201/9781315152561, DOI 10.1201/9781315152561]
   Fransson BA, 2007, AM J VET RES, V68, P1281, DOI 10.2460/ajvr.68.12.1281
   Garcia-Lunar P, 2015, VET PARASITOL, V214, P49, DOI 10.1016/j.vetpar.2015.09.011
   Gonzalez-Warleta M, 2014, VET RES, V45, DOI 10.1186/s13567-014-0088-5
   Guido S, 2016, TRENDS PARASITOL, V32, P131, DOI 10.1016/j.pt.2015.11.014
   Haddad JPA, 2005, CAN VET J, V46, P230
   Hassig A, 2003, VET PARASITOL, V117, P213, DOI 10.1016/j.vetpar.2003.07.029
   Holec-Gasior L, 2014, VET PARASITOL, V206, P146, DOI 10.1016/j.vetpar.2014.09.018
   Holec-Gasior L, 2013, CLIN VACCINE IMMUNOL, V20, P1343, DOI 10.1128/CVI.00117-13
   Hu ZG, 2015, J CLIN LAB ANAL, V29, P498, DOI 10.1002/jcla.21800
   Huang PL, 2007, CLIN VACCINE IMMUNOL, V14, P1640, DOI 10.1128/CVI.00251-07
   Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119
   LINDSAY DS, 1989, J PARASITOL, V75, P163, DOI 10.2307/3282960
   Martinez-Subiela S, 2011, J VET DIAGN INVEST, V23, P63, DOI 10.1177/104063871102300109
   Moreno B, 2012, VET PARASITOL, V187, P312, DOI 10.1016/j.vetpar.2011.12.034
   Oku Y, 2011, VET J, V190, P244, DOI 10.1016/j.tvjl.2010.10.024
   Parra MD, 2007, ACTA VET HUNG, V55, P295, DOI 10.1556/AVet.55.2007.3.3
   Parra MD, 2005, AM J VET RES, V66, P62, DOI 10.2460/ajvr.2005.66.62
   Pinheiro AF, 2015, REV BRAS PARASITOL V, V24, P148, DOI 10.1590/S1984-29612015015
   Reichel MP, 2008, VET PARASITOL, V151, P323, DOI 10.1016/j.vetpar.2007.11.002
   Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022
   Sanchez-Sanchez R, 2019, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00436
   Sanchez-Sanchez R, 2018, VET RES, V49, DOI 10.1186/s13567-018-0539-5
   Shaapan RM, 2008, VET PARASITOL, V153, P359, DOI 10.1016/j.vetpar.2008.02.016
   West DM, 2006, SMALL RUMINANT RES, V62, P135, DOI 10.1016/j.smallrumres.2005.07.041
   Yin JG, 2012, VET PARASITOL, V187, P28, DOI 10.1016/j.vetpar.2012.01.003
   Zhou M, 2016, J VET MED SCI, V78, P1877, DOI 10.1292/jvms.16-0234
NR 41
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108994
DI 10.1016/j.vetpar.2019.108994
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700013
PM 31778941
DA 2020-05-12
ER

PT J
AU Khadir, F
   Taheri, T
   Habibzadeh, S
   Zahedifard, F
   Gholami, E
   Heidari-Kharaji, M
   Oryan, A
   Rafati, S
AF Khadir, Fatemeh
   Taheri, Tahereh
   Habibzadeh, Sima
   Zahedifard, Farnaz
   Gholami, Elham
   Heidari-Kharaji, Maryam
   Oryan, Ahmad
   Rafati, Sima
TI Antileishmanial effect of rapamycin as an alternative approach to
   control Leishmania tropica infection
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Cutaneous leishmaniosis; L. tropica; Rapamycin; mTOR; Combination
   therapy; BALB/c mouse model
ID LIPOSOMAL AMPHOTERICIN-B; IN-VITRO; DONOVANI; MTOR; PAROMOMYCIN;
   EFFICACY
AB Cutaneous leishmaniosis (CL) is a parasitic disease in animals and human with no satisfactory treatments and vaccination. Rapamycin is a potent inhibitor of mammalian target of rapamycin (mTOR) with various applications. Here, the effect of rapamycin alone or in combination with two other drugs, namely amphotericin B (AmB) and glucantime, was investigated against Leishmania tropica infection. In vitro viability and electron microscopy evaluation of the parasites showed detrimental changes in their appearance and viability. Treatment with clinically relevant dose of rapamycin (10.2 mu g/dose) is able to control the parasite load in BALB/c mice infected with L. tropica. Furthermore, the cytokine profiles showed significant polarization towards Th1 immune response. Surprisingly, combination therapy with either AmB or glucantime was not efficient. Rapamycin is showed an effective alternative therapy against leishmaniosis caused by L. tropica.
C1 [Khadir, Fatemeh; Taheri, Tahereh; Habibzadeh, Sima; Zahedifard, Farnaz; Gholami, Elham; Heidari-Kharaji, Maryam; Rafati, Sima] Pasteur Inst Iran, Dept Immunotherapy & Leishmania Vaccine Res, Tehran, Iran.
   [Khadir, Fatemeh; Oryan, Ahmad] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran.
RP Rafati, S (reprint author), Pasteur Inst Iran, Dept Immunotherapy & Leishmania Vaccine Res, Tehran, Iran.
EM sima-rafatisy@pasteur.ac.ir
FU Pasteur institute of Iran [743]; Shiraz University [9231337]; Iran
   National Science Foundation (INSF)Iran National Science Foundation
   (INSF) [940007, 95824986, 96006039]
FX This study was made possible by grant ID 743 from Pasteur institute of
   Iran, grants ID 9231337 from Shiraz University, grants ID 940007 and
   95824986 to Sima Rafati and < GN2 > 96006039 to Ahmad Oryan. from Iran
   National Science Foundation (INSF).
CR Abdossamadi Z, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006123
   Abdossamadi Z, 2017, IMMUNOTHERAPY-UK, V9, P1089, DOI 10.2217/imt-2017-0076
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155
   Arevalo I, 2007, CLIN INFECT DIS, V44, P1549, DOI 10.1086/518172
   Bamorovat M, 2015, IRAN J PUBLIC HEALTH, V44, P1359
   Baneth G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2050-7
   Bojsen R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21874
   Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0
   Bryceson A, 2001, TROP MED INT HEALTH, V6, P928, DOI 10.1046/j.1365-3156.2001.00795.x
   CHANG KP, 1979, EXP PARASITOL, V48, P175, DOI 10.1016/0014-4894(79)90097-3
   Cheekatla SS, 2012, MED MICROBIOL IMMUN, V201, P37, DOI 10.1007/s00430-011-0202-5
   da Silva LM, 2010, P NATL ACAD SCI USA, V107, P11965, DOI 10.1073/pnas.1004599107
   Dayakar A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00670
   Demicheli C, 2002, BBA-GEN SUBJECTS, V1570, P192, DOI 10.1016/S0304-4165(02)00198-8
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Diaz R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000950
   Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08
   Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310
   Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Gijon-Robles P, 2018, TRANSBOUND EMERG DIS, V65, P1615, DOI 10.1111/tbed.12914
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hatam GR, 2013, PARASITOL RES, V112, P643, DOI 10.1007/s00436-012-3179-0
   Heidari-Kharaji M, 2016, PARASITE IMMUNOL, V38, P599, DOI 10.1111/pim.12340
   Hossein F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185606
   Kassahun A, 2015, ACTA TROP, V145, P39, DOI 10.1016/j.actatropica.2015.02.006
   Khadir F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006701
   Kharaji MH, 2016, AAPS PHARMSCITECH, V17, P1110, DOI 10.1208/s12249-015-0439-1
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Liu YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010020
   MEBRAHTU YB, 1992, AM J TROP MED HYG, V47, P852, DOI 10.4269/ajtmh.1992.47.852
   Meheus F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000818
   Mistro S, 2016, TROP MED INT HEALTH, V21, P692, DOI 10.1111/tmi.12697
   Moreira VR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02360-16, 10.1128/aac.02360-16]
   Moreno MLV, 1998, MEM I OSWALDO CRUZ, V93, P99, DOI 10.1590/S0074-02761998000100017
   Ntais P, 2013, AM J TROP MED HYG, V89, P906, DOI 10.4269/ajtmh.13-0070
   Pagan AJ, 2016, J IMMUNOL, V196
   Pourshafie M, 2004, ANTIMICROB AGENTS CH, V48, P2409, DOI 10.1128/AAC.48.7.2409-2414.2004
   Ramos H, 1996, J MEMBRANE BIOL, V152, P65, DOI 10.1007/s002329900086
   Ribeiro RR, 2018, BIOMED RES INT, DOI 10.1155/2018/3296893
   Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010
   Singh P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00070
   Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9
   Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022
   Souza W.D., 2007, MOD RES ED TIOPICS I, P77
   Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656
   Sundar S, 2006, INDIAN J MED RES, V123, P345
   Vendrame CMV, 2010, T ROY SOC TROP MED H, V104, P566, DOI 10.1016/j.trstmh.2010.03.007
   Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651
   Yardley V, 1997, ANTIMICROB AGENTS CH, V41, P752, DOI 10.1128/AAC.41.4.752
   Zhang WW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004244
   Zhang XX, 2017, INT J INFECT DIS, V59, P110, DOI 10.1016/j.ijid.2017.04.004
NR 53
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108976
DI 10.1016/j.vetpar.2019.108976
PG 8
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700005
PM 31739256
DA 2020-05-12
ER

PT J
AU Kueakhai, P
   Chaithirayanon, K
   Chaiwichien, A
   Samrit, T
   Osotprasit, S
   Suksomboon, P
   Jaikua, W
   Sobhon, P
   Changklungmoa, N
AF Kueakhai, Pornanan
   Chaithirayanon, Kulathida
   Chaiwichien, Athit
   Samrit, Tepparit
   Osotprasit, Supawadee
   Suksomboon, Phawiya
   Jaikua, Wipaphorn
   Sobhon, Prasert
   Changklungmoa, Narin
TI Monoclonal antibody against Fasciola gigantica glutathione peroxidase
   and their immunodiagnosis potential for fasciolosis
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Fasciola gigantica; Liver fluke; Glutathione peroxidase; Monoclonal
   antibody; Diagnosis
ID SAPOSIN-LIKE PROTEIN-2; MOLECULAR-CLONING; HEPATICA; IDENTIFICATION;
   THIOREDOXIN; EXPRESSION; DIAGNOSIS; ANTIGEN
AB Glutathione peroxidases (GPx), major antioxidant enzymes, secreted by Fasciola spp., are important for the parasite evasion and protection against the host's immune responses. In the present study, a monoclonal antibody (MoAb) against recombinant F. gigantica glutathione peroxidase (rFgGPx) was produced by hybridoma technique using spleen cells from BALB/c mice immunized with rFgGPx. This MoAb (named 7B8) is IgG1 with it light chains, and it reacted specifically with rFgGPx at a molecular weight 19 kDa as shown by immunoblotting, and reacted with the native FgGPx in the extracts of whole body (WB), metacercariae, newly excysted juveniles (NEJs), 4 week-old juveniles and adult F. gigantica as shown by indirect ELISA. It did not cross react with antigens in WB fractions from other adult trematodes, including Fischoederius cobboldi, Paramphistomum cervi, Setaria labiato-papillosa, Eurytrema pancreaticum, Gastrothylax crumenifer and Gigantocotyle explanatum. By immunolocalization, MoAb against rFgGPx reacted with the native protein in the tegument, vitelline cells, and eggs of adult F. gigantica. In addition, the sera from mice experimentally infected with F. gigantica were tested positive by this indirect sandwich ELISA. This result indicated that FgGPx is an abundantly expressed parasite protein that is secreted into the tegumental antigens (TA), therefore, FgGPx and its MoAb may be used for immunodiagnosis of both early and late fasciolosis gigantica in animals and humans.
C1 [Kueakhai, Pornanan; Chaiwichien, Athit; Samrit, Tepparit; Osotprasit, Supawadee; Suksomboon, Phawiya; Jaikua, Wipaphorn; Changklungmoa, Narin] Burapha Univ, Fac Allied Hlth Sci, Long Hard Bangsaen Rd, Mueang Dist 20131, Chonburi, Thailand.
   [Kueakhai, Pornanan; Chaiwichien, Athit; Samrit, Tepparit; Osotprasit, Supawadee; Suksomboon, Phawiya; Jaikua, Wipaphorn; Changklungmoa, Narin] Burapha Univ, Res Unit Vaccine & Diag Parasit Dis, Long Hard Bangsaen Rd, Mueang Dist 20131, Chonburi, Thailand.
   [Chaithirayanon, Kulathida; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Rama VI Rd, Bangkok 10400, Thailand.
RP Changklungmoa, N (reprint author), Burapha Univ, Fac Allied Hlth Sci, Long Hard Bangsaen Rd, Mueang Dist 20131, Chonburi, Thailand.
EM narinchang@go.buu.ac.th
FU Burapha University [18/2562]; Mahidol University [MRG5980048]; Thailand
   Research FundThailand Research Fund (TRF)
FX This research was financially supported by a grant from Burapha
   University as approved by the National Research Council of Thailand to
   Assistant Professor Dr. Narin Changklungmoa (Grant no. 18/2562), a grant
   from Mahidol University as approved by the National Research Council of
   Thailand to Associate Professor Dr. Kulathida Chaithirayanon, the
   Thailand Research Fund for New Scholar to Assistant Professor Dr. Narin
   Changklungmoa (Grant no. MRG5980048), and a Senior Research Scholar
   grant from Thailand Research Fund to Professor Dr. Prasert Sobhon.
CR Aguayo V, 2018, ACTA TROP, V186, P41, DOI 10.1016/j.actatropica.2018.07.002
   Anuracpreeda P, 2011, EXP PARASITOL, V127, P340, DOI 10.1016/j.exppara.2010.08.012
   Chaithirayanon K, 2002, ACTA TROP, V84, P1, DOI 10.1016/S0001-706X(02)00138-9
   Chaithirayanon K, 2010, EXP PARASITOL, V125, P106, DOI 10.1016/j.exppara.2010.01.004
   Changklungmoa N, 2018, PARASITOL RES, V117, P3487, DOI 10.1007/s00436-018-6046-9
   Changklungmoa N, 2015, PARASITOL RES, V114, P2119, DOI 10.1007/s00436-015-4400-8
   Changklungmoa N, 2014, PARASITOL RES, V113, P2335, DOI 10.1007/s00436-014-3888-7
   Changklungmoa N, 2012, EXP PARASITOL, V131, P283, DOI 10.1016/j.exppara.2012.04.008
   Chaouadi M, 2019, TROP ANIM HEALTH PRO, V51, P2315, DOI 10.1007/s11250-019-01951-w
   Cordova M, 1999, T ROY SOC TROP MED H, V93, P54, DOI 10.1016/S0035-9203(99)90178-5
   Figueroa-Santiago O, 2011, DIAGN MICR INFEC DIS, V70, P355, DOI 10.1016/j.diagmicrobio.2011.03.016
   Gupta A, 2015, INT J BIOL MACROMOL, V81, P983, DOI 10.1016/j.ijbiomac.2015.09.035
   Jaikua W, 2016, ACTA TROP, V162, P75, DOI 10.1016/j.actatropica.2016.06.020
   Kalita P, 2018, BBA-GEN SUBJECTS, V1862, P1306, DOI 10.1016/j.bbagen.2018.03.007
   Khabisi Samaneh Abdolahi, 2017, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V36, P8, DOI 10.1089/mab.2016.0034
   Krailas D, 1999, ASIAN PAC J ALLERGY, V17, P53
   Kueakhai P, 2015, EXP PARASITOL, V151, P8, DOI 10.1016/j.exppara.2015.01.019
   Kueakhai P, 2013, ACTA TROP, V125, P157, DOI 10.1016/j.actatropica.2012.11.001
   Kueakhai P, 2011, PARASITOL RES, V108, P1493, DOI 10.1007/s00436-010-2201-7
   Maleewong W, 1999, AM J TROP MED HYG, V61, P648, DOI 10.4269/ajtmh.1999.61.648
   Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010
   Mirzadeh A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203490
   O'Neill SM, 1998, AM J TROP MED HYG, V58, P417, DOI 10.4269/ajtmh.1998.58.417
   Ottaviano FG, 2009, MOL CELL BIOCHEM, V327, P111, DOI 10.1007/s11010-009-0049-x
   Preyavichyapugdee N, 2008, EXP PARASITOL, V119, P229, DOI 10.1016/j.exppara.2008.01.014
   Sangpairoj K, 2014, EXP PARASITOL, V140, P24, DOI 10.1016/j.exppara.2014.02.017
   Wongwairot S, 2015, PARASITOL RES, V114, P133, DOI 10.1007/s00436-014-4170-8
   Zhang Y, 2015, MOL BIOCHEM PARASIT, V203, P5, DOI 10.1016/j.molbiopara.2015.10.001
NR 28
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108979
DI 10.1016/j.vetpar.2019.108979
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700008
PM 31778940
DA 2020-05-12
ER

PT J
AU Lawrence, KE
   Gedye, K
   Pomroy, WE
AF Lawrence, K. E.
   Gedye, K.
   Pomroy, W. E.
TI A longitudinal study of the effect of Theileria orientalis Ikeda type
   infection on three New Zealand dairy farms naturally infected at pasture
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Theileriosis; Cattle; Bovine; Theileria orientalis; Ikeda; Anaemia; New
   Zealand
ID HAEMAPHYSALIS-LONGICORNIS; HEMOLYTIC-ANEMIA; BOVINE ANEMIA; CATTLE;
   MILK; TICK; BUPARVAQUONE; EPIDEMIC; OUTBREAK
AB The aims of this study were to monitor the change in Theileria orientalis Ikeda type infection intensity, haematocrit, milk production and reproduction on three New Zealand spring calving dairy herds, over the 2014-2015 milking season.
   Three spring calving dairy farms, A, B and C, from high risk (endemically stable), low risk (endemically unstable), and zero risk (disease-free) tick areas respectively were followed through the 2014-2015 milking season. On Farms, A and B, 100 cows were randomly selected at the first visit, and the same cows blood sampled every month thereafter, whilst on Farm C, the whole herd was blood sampled bimonthly (140 cows). Blood samples were tested for haematocrit, by centrifugation, and Ikeda infection intensity, using qPCR. Animals that were Ikeda type PCR positive at the first sampling were described as prevalence cases and cows that were negative at the first sampling and became PCR positive during the sampling period were described as incidence cases. Production and reproduction data were accessed through LIC MINDA (R) and milk production data was standardised to energy corrected milk (ECM). In addition, the effect of buparvaquone (BPQ) treatment on milk production was estimated on Farm B.
   The prevalence of infection at the first sampling was 100 % on Farm A, 57 % on Farm B and 26 % on Farm C. The incidence risk of infection over the sampling period on Farms B and C was 25 % and 2 % and the incident rate was 0.026 and 0.002 cases per cow-month respectively. The average infection intensity for prevalence cases on all farms was low throughout the milking season, < 7000 Ikeda organisms/mu L however, cases of anaemia still occurred. There was no direct effect of infection intensity on milk production or from being a prevalence case compared to an uninfected cow on milk production, across all farms. However, on Farm B there was a loss of 266 kg (95 % CI 82- 450) ECM (similar to 20 kg milk solids) for incidence cases and a loss of 458 kg (95 % CI 211- 710) of ECM for buparvaquone treated cows, compared to uninfected cows. No significant effect of Ikeda infection on reproduction could be shown for Farms B and C, reproductive data for Farm A was not available.
   The effect of T. orientalis Ikeda type infection on production and reproduction appears to be minimal once animals have passed through the acute phase of infection and reached the chronic, asymptomatic carrier phase of infection.
C1 [Lawrence, K. E.; Gedye, K.; Pomroy, W. E.] Massey Univ, Sch Vet Sci, Palmerston North 4410, New Zealand.
RP Lawrence, KE (reprint author), Massey Univ, Sch Vet Sci, Palmerston North 4410, New Zealand.
EM K.Lawrence@massey.ac.nz
RI Lawrence, Kevin/L-1295-2019
OI Lawrence, Kevin/0000-0002-2453-1485
FU C Alma Baker Trust
FX The authors are thankful to the C Alma Baker Trust for funding this
   research. The authors would also like to gratefully acknowledge the
   assistance of the staff, managers and owners of all three farms, Aaron
   Frazer, Gerard and Kate Lynch, and Sean Galvin without whose
   enthusiastic support this study would not have been possible. Further
   thanks are given to Barbara Adlington and Anne Tunnicliffe for
   performing the haematocrits and storing the samples.
CR Aktas M, 2006, VET PARASITOL, V138, P179, DOI 10.1016/j.vetpar.2006.01.052
   [Anonymous], 2015, TURK RATIONAL DRUG U, V2, P1
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bogema DR, 2015, J CLIN MICROBIOL, V53, P941, DOI 10.1128/JCM.03387-14
   Carter P., 2011, ASSESSMENT EFFICACY
   Cufos N.S.S.S., 2012, GENETIC ANAL THEILER
   Eum SY, 2006, NETWORKS 2006, 12TH INTERNATIONAL TELECOMMUNICATIONS NETWORK STRATEGY AND PLANNING SYMPOSIUM, P27
   FRY M, 1984, BIOCHEM PHARMACOL, V33, P2115, DOI 10.1016/0006-2952(84)90581-1
   FUJISAKI K, 1993, ANN TROP MED PARASIT, V87, P217, DOI 10.1080/00034983.1993.11812757
   Gebrekidan H, 2017, PARASITOLOGY, V144, P738, DOI 10.1017/S0031182016002328
   HADI A, 2012, AL QADISIYA J VET ME, V11, P28
   Hammer JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1323-x
   Hammer JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0839-9
   Heath ACG, 2016, NEW ZEAL VET J, V64, P10, DOI 10.1080/00480169.2015.1035769
   Islam MK, 2011, INFECT GENET EVOL, V11, P2095, DOI 10.1016/j.meegid.2011.08.012
   Izzo MM, 2010, AUST VET J, V88, P45, DOI 10.1111/j.1751-0813.2009.00540.x
   JAMES MP, 1984, NEW ZEAL VET J, V32, P154, DOI 10.1080/00480169.1984.35103
   Jenkins C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1395-7
   Johnson D. L., 1996, Proceedings of the New Zealand Society of Animal Production, V56, P16
   Johnson Gemma, 2013, Methods Mol Biol, V943, P1, DOI 10.1007/978-1-60327-353-4_1
   Khukhuu A, 2011, J VET MED SCI, V73, P701, DOI 10.1292/jvms.10-0472
   L'Hostis M, 2002, VET RES, V33, P599, DOI 10.1051/vetres:2002041
   Lane J., 2015, BAHE0010 MEAT LIV AU, P76
   Lawrence K, 2016, NEW ZEAL VET J, V64, P38, DOI 10.1080/00480169.2015.1090894
   LAWRENCE K, 2013, VETSCRIPT, V26, P12
   Lawrence K E, 2018, Vet Parasitol Reg Stud Reports, V14, P85, DOI 10.1016/j.vprsr.2018.09.004
   Lawrence KE, 2019, NEW ZEAL VET J, V67, P66, DOI 10.1080/00480169.2018.1547227
   Lawrence KE, 2017, VET PARASITOL, V243, P226, DOI 10.1016/j.vetpar.2017.07.001
   Lawrence KE, 2016, VET PARASITOL, V218, P59, DOI 10.1016/j.vetpar.2016.01.003
   Mason WA, 2012, VET PARASITOL, V189, P250, DOI 10.1016/j.vetpar.2012.05.003
   McDougall S, 2016, NEW ZEAL VET J, V64, P318, DOI 10.1080/00480169.2016.1204960
   McDougall S., 2014, P SOC DAIR CATTL VET, P103
   McFadden A., 2013, P SOC DAIR CATTL VET, P207
   McFadden AMJ, 2017, VET PARASITOL, V245, P29, DOI 10.1016/j.vetpar.2017.07.035
   McFadden AMJ, 2011, NEW ZEAL VET J, V59, P79, DOI 10.1080/00480169.2011.552857
   McFadden AM, 2005, NEW ZEAL VET J, V53, P39, DOI 10.1080/00480169.2005.36467
   MCHARDY N, 1985, RES VET SCI, V39, P29, DOI 10.1016/S0034-5288(18)31765-X
   McHardy N., 1992, RECENT DEV RES CONTR
   Mills M., 2010, INTRO SURVIVAL EVENT
   Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969
   Perera PK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-73
   Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368
   Pulford DJ, 2016, NEW ZEAL VET J, V64, P29, DOI 10.1080/00480169.2015.1089798
   Randolph J.J., 2014, PRACTICAL ASSESSMENT, V19
   Rankin D., 2015, VETSCRIPT, V28, P20
   Rawdon T., 2006, P 14 FAVA C FOOD SAF, P107
   Riond B., 2008, Comparative Clinical Pathology, V17, P171, DOI 10.1007/s00580-007-0713-z
   Santschi DE, 2011, J DAIRY SCI, V94, P2302, DOI 10.3168/jds.2010-3594
   SHIMIZU S, 1992, J VET MED SCI, V54, P375, DOI 10.1292/jvms.54.375
   Vink D, 2013, VETSCRIPT, V26, P34
   Vink WD, 2016, NEW ZEAL VET J, V64, P48, DOI 10.1080/00480169.2015.1090893
   Watts JG, 2016, NEW ZEAL VET J, V64, P3, DOI 10.1080/00480169.2015.1064792
NR 52
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108977
DI 10.1016/j.vetpar.2019.108977
PG 13
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700011
PM 31775104
DA 2020-05-12
ER

PT J
AU Pedraza-Diaz, S
   Arranz-Solis, D
   Gomez-Couso, H
   Fuschs, L
   Fort, M
   Rengifo-Herrera, C
   Navarro-Lozano, V
   Ortega-Mora, LM
   Collantes-Fernandez, E
AF Pedraza-Diaz, Susana
   Arranz-Solis, David
   Gomez-Couso, Hipolito
   Fuschs, Lumila
   Fort, Marcelo
   Rengifo-Herrera, Claudia
   Navarro-Lozano, Vanesa
   Ortega-Mora, Luis M.
   Collantes-Fernandez, Esther
TI Multilocus analysis reveals further genetic differences between
   Tritrichomonas foetus from cats and cattle
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Tritrichomonas foetus; Trichomonads; Cats; Cattle; Multilocus sequence;
   Microsatellite genotyping; Molecular markers
ID GENOTYPE; DEHYDROGENASE; RIEDMULLER; INFECTION; DIARRHEA; ENZYME
AB Tritrichomonas foetus isolates from feline and bovine origin has been previously shown to carry a certain degree of genetic heterogeneity. Here, novel candidate molecular markers were developed by means of multilocus sequence typing of the gap2 gene (encoding for T. foetus glyceraldehyde-3-phosphate dehydrogenase), ITS region, the TR7/TR8 variable-length repeat and microsatellite genotyping. These markers were used to characterize T. foetus field isolates from bulls and domestic cats and to compare phylogenetically with the following ATCC isolates: T. foetus isolated from cattle and pig (syn. Tritrichomonas suis), Tritrichomonas mobilensis, Tetratrichomonas gallinarum and Pentatrichomonas hominis. Among them, TEMS10 and TFMS7 were found to be the most polymorphic markers. Moreover, an 809 bp fragment of the gap2 gene was successfully amplified from all the trichomonads included in this study and the sequence analysis revealed differences between T. foetus porcine and feline genotypes and T. mobilensis in comparison to the bovine T. foetus ATCC isolate. The TR7/TR8 repeat pattern was not reproducible, being only consistent the fragments of approximately 110 and 217 bp. Sequence analysis of the latter revealed the existence of 3 SNPs resulting in 98.6 % homology between bovine and feline isolates. A search for similar sequences was carried out to develop a Restriction Length Fragment Polymorphism analysis. A 503 bp region, named TF1, revealed the existence of two BbvI restriction enzyme sites that were able to generate different length fragments for T. foetus feline and bovine isolates. Finally, the neighbour-joining analyses showed that T. foetus porcine genotype clusters together with bovine genotype, whereas T. mobilensis and the feline genotype form a separate cluster.
C1 [Pedraza-Diaz, Susana; Arranz-Solis, David; Gomez-Couso, Hipolito; Rengifo-Herrera, Claudia; Navarro-Lozano, Vanesa; Ortega-Mora, Luis M.; Collantes-Fernandez, Esther] Univ Complutense Madrid, Fac Vet Sci, Anim Hlth Dept, SALUVET, Ciudad Univ S-N, Madrid 28040, Spain.
   [Fuschs, Lumila; Fort, Marcelo] INTA, Anguil, La Pampa, Argentina.
   [Pedraza-Diaz, Susana] Inst Salud Carlos III, Natl Ctr Environm Hlth CNSA, Environm Toxicol, Majadahonda 28220, Spain.
   [Arranz-Solis, David] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA.
   [Gomez-Couso, Hipolito] Univ Santiago de Compostela, Fac Pharm, Dept Microbiol & Parasitol, Lab Parasitol, Campus Vida, Santiago De Compostela 15782, A Coruna, Spain.
   [Rengifo-Herrera, Claudia] Univ Panama, Fac Vet Med, Campus Harmodio Arias Madrid Curundu, Panama City 4, Panama.
RP Collantes-Fernandez, E (reprint author), Univ Complutense Madrid, Fac Vet Sci, Anim Hlth Dept, SALUVET, Ciudad Univ S-N, Madrid 28040, Spain.
EM esthercf@ucm.es
RI Arranz-Solis, D./D-9877-2019; Ortega-Mora, Luis-Miguel/F-1470-2016;
   Collantes-Fernandez, Esther/F-6301-2016
OI Arranz-Solis, D./0000-0002-2647-3194; Ortega-Mora,
   Luis-Miguel/0000-0002-4986-6783; Collantes-Fernandez,
   Esther/0000-0002-1601-6889
FU USC through the Programme Angeles Alvariiio of Xunta de Galicia
   (Government of the Autonomous Region of Galicia); Xunta de GaliciaXunta
   de Galicia; European Social FundEuropean Social Fund (ESF); National
   Research System of the National Secretary of Science, Technology and
   Innovation (SNI-SENACYT), of Republic of Panama;  [RTA2017-00076-0000]; 
   [PLATESA2-CM P2018/BAA-4370]
FX This study was funded by the research projects RTA2017-00076-0000 and
   PLATESA2-CM P2018/BAA-4370. HGC was funded by USC through the Programme
   Angeles Alvariiio of Xunta de Galicia (Government of the Autonomous
   Region of Galicia). For this specific study, HGC was awarded a mobility
   grant by Xunta de Galicia and the European Social Fund. CRH was funded
   by the National Research System of the National Secretary of Science,
   Technology and Innovation (SNI-SENACYT), of Republic of Panama. We thank
   Guadalupe Miro and Diego Esteban for the collection of feline faecal
   samples.
CR Arranz-Solis D, 2016, VET PARASITOL, V221, P118, DOI 10.1016/j.vetpar.2016.03.019
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   BonDurant RH, 1997, VET CLIN N AM-FOOD A, V13, P345, DOI 10.1016/S0749-0720(15)30346-7
   Castelo AT, 2002, BIOINFORMATICS, V18, P634, DOI 10.1093/bioinformatics/18.4.634
   Casteriano A, 2016, PARASITOLOGY, V143, P1954, DOI 10.1017/S003118201600158X
   Collantes-Fernandez E, 2019, THERIOGENOLOGY, V128, P116, DOI 10.1016/j.theriogenology.2019.01.030
   Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006
   Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212
   Felleisen RSJ, 1998, J CLIN MICROBIOL, V36, P513, DOI 10.1128/JCM.36.2.513-519.1998
   Frey CF, 2012, MOL CELL PROBE, V26, P132, DOI 10.1016/j.mcp.2012.02.002
   Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013
   Gookin JL, 1999, J AM VET MED ASSOC, V215, P1450
   Kumar S, 2018, MOL BIOL EVOL, V35, P1, DOI 10.1093/molbev/msx313
   Levy MG, 2003, J PARASITOL, V89, P99, DOI 10.1645/0022-3395(2003)089[0099:TFANPH]2.0.CO;2
   Lun ZR, 2005, TRENDS PARASITOL, V21, P122, DOI 10.1016/j.pt.2004.12.001
   Mendoza-Ibarra JA, 2012, VET J, V193, P146, DOI 10.1016/j.tvjl.2011.09.020
   Morin-Adeline V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-955
   Oyhenart J, 2014, VET PARASITOL, V206, P267, DOI 10.1016/j.vetpar.2014.09.024
   Prokopi M, 2011, T ROY SOC TROP MED H, V105, P479, DOI 10.1016/j.trstmh.2011.05.005
   Reinmann K, 2012, VET PARASITOL, V185, P138, DOI 10.1016/j.vetpar.2011.09.032
   Rogers M.B., 2007, BMC EVOL BIOL, V7
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sager H, 2007, PROTOZOAL ABORTION F, P232
   Slapeta J, 2012, INT J PARASITOL, V42, P1143, DOI 10.1016/j.ijpara.2012.10.004
   Slapeta J, 2010, EXP PARASITOL, V126, P209, DOI 10.1016/j.exppara.2010.04.024
   Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101
   Stroud LJ, 2017, INT J PARASITOL, V47, P203, DOI 10.1016/j.ijpara.2016.11.004
   Sun ZC, 2012, VET PARASITOL, V186, P445, DOI 10.1016/j.vetpar.2011.12.001
   Suzuki J, 2016, J VET MED SCI, V78, P633, DOI 10.1292/jvms.15-0644
   Tachezy J, 2002, J EUKARYOT MICROBIOL, V49, P154, DOI 10.1111/j.1550-7408.2002.tb00360.x
   Viscogliosi E, 1998, J MOL EVOL, V47, P190, DOI 10.1007/PL00006376
   Wu G, 1999, P NATL ACAD SCI USA, V96, P6285, DOI 10.1073/pnas.96.11.6285
   Yao CQ, 2018, T ROY SOC TROP MED H, V112, P64, DOI 10.1093/trstmh/try027
   Yao CQ, 2015, VET RES, V46, DOI 10.1186/s13567-015-0169-0
NR 34
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108965
DI 10.1016/j.vetpar.2019.108965
PG 9
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700004
PM 31726324
DA 2020-05-12
ER

PT J
AU Ucan-Mezquita, A
   Jimenez-Coello, M
   Guzman-Marin, E
   Gutierrez-Blanco, E
   Chan-Perez, JI
   Travi, BL
   Hernandez-Cortazar, I
   Ortega-Pacheco, A
AF Ucan-Mezquita, A.
   Jimenez-Coello, M.
   Guzman-Marin, E.
   Gutierrez-Blanco, E.
   Chan-Perez, J., I
   Travi, B. L.
   Hernandez-Cortazar, I
   Ortega-Pacheco, A.
TI Efficacy of a topical combination of fipronil-permethrin against
   Rhodnius prolixus on dogs
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE American trypanosomiasis; Dogs; Fipronil; Permethrin; Rhodnius prolixus
ID CHAGAS-DISEASE; SPOT-ON; INFESTATION; EFFITIX(R); FELIS
AB A controlled clinical trial was carried out to assess the mortality and repellency of a new topical combination of fipronil-permethrin (Effitix (R) Virbac, Mexico) against Rhodnius prolixus in dogs. Ten medium-size dogs (10 -15 kg) with short hair were used. The dogs were exposed to 8 adult triatomines once weekly for 7 weeks. On the control day (D0), the dogs were exposed to the insects without treatment. On D7, the dogs were immediately treated with a spot-on 2.2 ml pipette containing 134 mg of fipronil and 1200 mg permethrin after exposure to the insects. The dose was repeated after 4 weeks following the manufacturer's instructions. Repellency at D0 was, 0 % and the insects had a high blood content. After 12 h post-contact, repellency was 86.3 % and slowly decrease though D21 and D28. On D7, none of the insects survived after 3 h of feeding on the treated dogs. On D14, D35 and D42, all insects died within 12 h post-feeding, whereas no mortality was observed in the control D0 (P < 0.05). The results of this study indicated that administration of the product following the manufacturer's instructions was efficacious at inducing rapid mortality of R. prolixus and therefore could be useful to prevent the transmission of American trypanosomiasis in dogs.
C1 [Ucan-Mezquita, A.; Gutierrez-Blanco, E.; Hernandez-Cortazar, I; Ortega-Pacheco, A.] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Km 15-5 Carr Merida Xmatkuil,AP 4-116, Merida, Yucatan, Mexico.
   [Jimenez-Coello, M.; Guzman-Marin, E.; Chan-Perez, J., I; Hernandez-Cortazar, I] Ctr Invest Reg Dr Hideyo Noguchi, Av Itzaes Ctr, Merida, Yucatan, Mexico.
   [Travi, B. L.; Hernandez-Cortazar, I] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.
RP Ortega-Pacheco, A (reprint author), Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Km 15-5 Carr Merida Xmatkuil,AP 4-116, Merida, Yucatan, Mexico.
EM opacheco@correo.uady.mx
FU Virbac Mexico SA de CV
FX The authors acknowledge Dr. Christelle Navarro, Virbac S.A., MVZ Luis
   Carlos Lorenzana-Castro and MVZ Francisco Giiemez from Virbac Mexico SA
   de CV for partial financing of the project and the donation of products.
CR Alzogaray RA, 2017, J INSECT PHYSIOL, V97, P93, DOI 10.1016/j.jinsphys.2016.04.004
   Arce-Fonseca M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0333-z
   Beugnet F, 2012, TRENDS PARASITOL, V28, P267, DOI 10.1016/j.pt.2012.04.004
   Cardoso L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0672-1
   Chatzis M., 2017, PARASITE VECTOR, V10, P2016
   Cvejic D, 2017, VET PARASITOL, V243, P52, DOI 10.1016/j.vetpar.2017.06.011
   de Fuentes-Vicente JA, 2018, ACTA TROP, V183, P23, DOI 10.1016/j.actatropica.2018.04.008
   Endris Richard G, 2002, Vet Ther, V3, P64
   Fankhauser B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0691-y
   Fankhauser B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0687-7
   Franc M, 2015, VET PARASITOL, V212, P156, DOI 10.1016/j.vetpar.2015.05.030
   Franc M, 2015, PARASITOL RES, V114, P2093, DOI 10.1007/s00436-015-4397-z
   Gentile Alberto G., 2004, Cad. Saúde Pública, V20, P1240, DOI 10.1590/S0102-311X2004000500018
   Gurtler RE, 2009, T ROY SOC TROP MED H, V103, P298, DOI 10.1016/j.trstmh.2008.09.018
   Gupta RC, 2014, BIOMARKERS IN TOXICOLOGY, P389, DOI 10.1016/B978-0-12-404630-6.00023-3
   GURTLER RE, 1993, T ROY SOC TROP MED H, V87, P12, DOI 10.1016/0035-9203(93)90400-K
   Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000447
   Jimenez-Coello M, 2010, TRANSBOUND EMERG DIS, V57, P33, DOI 10.1111/j.1865-1682.2010.01130.x
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   Laino MA, 2019, VET PARASITOL, V268, P98, DOI 10.1016/j.vetpar.2019.03.005
   Loza A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2278-2
   Montenegro S, 1983, PHYSIS-BUENOS AIRES, V41, P159
   Navarro C, 2016, BIOMED RES INT, DOI 10.1155/2016/9498604
   Palomino M, 2008, PERIL REV PERUANA ME, V25, P9
   Reithinger R, 2005, T ROY SOC TROP MED H, V99, P502, DOI 10.1016/j.trstmh.2004.11.013
   Schofield C., 1987, TRIATOMINE BUGS BIOL, P12
   Schofield C., 2000, POSITION PAPER, P8
   Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7
   Travi BL, 2019, VECTOR-BORNE ZOONOT, V19, P90, DOI 10.1089/vbz.2018.2325
   World Health Organization, 2018, CHAG DIS AM TRIP
   Zhao XL, 2004, J PHARMACOL EXP THER, V310, P192, DOI 10.1124/jpet.104.065516
NR 31
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108978
DI 10.1016/j.vetpar.2019.108978
PG 4
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700007
PM 31765865
DA 2020-05-12
ER

PT J
AU Zhou, BH
   Jia, LS
   Guo, HW
   Ding, HY
   Yang, JY
   Wang, HW
AF Zhou, Bian-hua
   Jia, Liu-shu
   Guo, Hong-wei
   Ding, Hai-yan
   Yang, Jing-yun
   Wang, Hong-wei
TI Eukaryotic elongation factor 2 is involved in the anticoccidial action
   of diclazuril in the second-generation merozoites of Eimeria tenella
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Eimeria tenella; Diclazuril; Eukaryotic elongation factor 2;
   Second-generation merozoites
ID TRANSLATION ELONGATION; PROTEIN LOCALIZATION; OXIDATIVE STRESS;
   SEQUENCE; EEF2; CDNA; EF-2; PHOSPHORYLATION; COCCIDIOSIS; PREDICTION
AB Eimeria tenella, an obligate intracellular parasite, can actively invade the cecal epithelial cells of chickens and cause severe enteric disease. Eukaryotic elongation factor 2 (eEF2) plays a major role in protein synthesis and cell survival. This study aims to explore the exact mechanisms underlying diclazuril inhibition in second-generation merozoites of E. tenella. The eEF2 cDNA of the second-generation merozoites of E. tenella (EtEF2) was cloned by reverse transcriptase polymerase chain reaction and rapid amplification of cDNA ends. Diclazuril-induced expression profiles of EtEF2 were also analyzed. The cloned full-length cDNA (2893 bp) of the EtEF2 nucleotide sequence encompassed a 2499 bp open reading frame (ORF) that encoded a polypeptide of 832 residues with an estimated molecular mass of 93.12 kDa and a theoretical isoelectric point of 5.99. The EtEF2 nucleotide sequence was submitted to the GenBank database with the accession number KF188423. The EtEF2 protein sequence shared 99 % homology with the eEF2 sequence of Toxoplasma gondii (GenBank XP_002367778.1). The GTPase activity domain and ADP-ribosylation domain were conserved signature sequences of the eEF2 gene family. The changes in the transcriptional and translational levels of EtEF2 were detected through quantitative real-time PCR and Western blot analyses. The mRNA expression level of EtEF2 was 2.706 fold increases and the protein level of EtEF2 was increased 67.31 % under diclazuril treatment. In addition, the localization of EtEF2 was investigated through immunofluorescence assay. Experimental results demonstrated that EtEF2 was distributed primarily in the cytoplasm of second-generation merozoites, and its fluorescence intensity was enhanced after diclazuril treatment. These findings indicated that EtEF2 may have an important role in understanding the signaling mechanism underlying the anticoccidial action of diclazuril and could be a promising target for novel drug exploration.
C1 [Zhou, Bian-hua; Jia, Liu-shu; Ding, Hai-yan; Yang, Jing-yun; Wang, Hong-wei] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Kaiyuan Ave 263, Luoyang 471000, Henan, Peoples R China.
   [Guo, Hong-wei] Henan Univ Anim Husb & Econ, Coll Anim Sci & Technol, Longzi Hubei Rd 6, Zhengzhou 450046, Henan, Peoples R China.
RP Wang, HW (reprint author), Henan Univ Sci & Technol, Coll Anim Sci & Technol, Kaiyuan Ave 263, Luoyang 471000, Henan, Peoples R China.
EM zhoubh@haust.edu.cn; jials@stu.haust.edu.cn; guohongwei@hnuahe.edu.cn;
   dinghy@stu.haust.edu.cn; YangJingyun@stu.haust.edu.cn;
   wanghw@haust.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31472238, 31101855]; Henan province science and
   technology planning project [182102110214]; Young Backbone Teachers
   Training Project of Colleges and Universities in Henan Province, China
   [2016GGJS-061]
FX This work is sponsored by the National Natural Science Foundation of
   China (grant nos. 31472238 and 31101855), Henan province science and
   technology planning project (grant no.182102110214) and Young Backbone
   Teachers Training Project of Colleges and Universities in Henan
   Province, China (grant no. 2016GGJS-061).
CR Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105
   Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x
   Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952
   Chen T, 2018, PARASITOL RES, V117, P2053, DOI 10.1007/s00436-018-5875-x
   El-Banna HA, 2005, J VET MED A, V52, P287, DOI 10.1111/j.1439-0442.2005.00727.x
   Gallie DR, 1998, BIOCHEM BIOPH RES CO, V245, P295, DOI 10.1006/bbrc.1998.8427
   Han HY, 2015, EXP PARASITOL, V154, P118, DOI 10.1016/j.exppara.2015.04.002
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259
   Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110
   Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274
   Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041115
   Kim CW, 1993, MOL CELLS, V3, P27
   KOHNO K, 1986, P NATL ACAD SCI USA, V83, P4978, DOI 10.1073/pnas.83.14.4978
   Lim EJ, 2007, GENE, V386, P183, DOI 10.1016/j.gene.2006.09.007
   Liu LL, 2016, VET PARASITOL, V215, P88, DOI 10.1016/j.vetpar.2015.11.011
   Liu R, 2016, ACTA PHARMACOL SIN, V37, P285, DOI 10.1038/aps.2015.123
   Luo L.L., 2014, J ANHUI AGR SCI, V42, P8112
   Malave TM, 2004, GENE, V326, P97, DOI 10.1016/j.gene.2003.10.016
   Marugan-Hernandez V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04049-1
   Marugan-Hernandez V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1756-2
   McCamphill PK, 2017, J NEUROCHEM, V142, P246, DOI 10.1111/jnc.14030
   Nodeh H, 2008, J VET PHARMACOL THER, V31, P265, DOI 10.1111/j.1365-2885.2008.00940.x
   OLEINIKOV AV, 1989, FEBS LETT, V248, P131, DOI 10.1016/0014-5793(89)80447-8
   Qiu LH, 2008, MOL BIOL REP, V35, P431, DOI 10.1007/s11033-007-9103-5
   Ramly NZ, 2013, ACTA CRYSTALLOGR F, V69, P1380, DOI 10.1107/S1744309113029734
   RAPP G, 1989, BIOL CHEM H-S, V370, P1071, DOI 10.1515/bchm3.1989.370.2.1071
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Rennie MJ, 2005, J PHYSIOL-LONDON, V569, P3, DOI 10.1113/jphysiol.2005.099424
   Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809
   Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164
   Satyamoorthy K, 1997, DNA CELL BIOL, V16, P401, DOI 10.1089/dna.1997.16.401
   Shen XJ, 2012, VET PARASITOL, V185, P290, DOI 10.1016/j.vetpar.2011.10.018
   Shi NN, 2018, TISSUE CELL, V53, P53, DOI 10.1016/j.tice.2018.05.014
   Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023
   Susorov D, 2018, J BIOL CHEM, V293, P5220, DOI 10.1074/jbc.RA117.000761
   Taha E, 2013, NEUROBIOL LEARN MEM, V105, P100, DOI 10.1016/j.nlm.2013.04.015
   Tian L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01245
   Vislovukh A, 2013, BRIT J CANCER, V108, P2304, DOI 10.1038/bjc.2013.243
   Wang L, 2011, MOL BIOL REP, V38, P2167, DOI 10.1007/s11033-010-0345-2
   Wang L, 2019, PARASITOL RES, V118, P1919, DOI 10.1007/s00436-019-06321-x
   Wang X., 1998, BIOCH J 1, V334
   Watanabe S, 2003, J CELL SCI, V116, P2647, DOI 10.1242/jcs.00476
   Yan M, 2018, PARASITE, V25, DOI 10.1051/parasite/2018061
   Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018
   Zhou BH, 2013, PARASITOL RES, V112, P1771, DOI 10.1007/s00436-013-3336-0
   Zhou BH, 2010, EXP PARASITOL, V125, P264, DOI 10.1016/j.exppara.2010.01.022
   Zhou BH, 2010, PARASITOL RES, V106, P571, DOI 10.1007/s00436-009-1699-z
   Zhou BH, 2010, VET PARASITOL, V168, P217, DOI 10.1016/j.vetpar.2009.11.007
NR 49
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD DEC
PY 2019
VL 276
AR UNSP 108991
DI 10.1016/j.vetpar.2019.108991
PG 8
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA JW2JT
UT WOS:000502884700010
PM 31770701
DA 2020-05-12
ER

PT J
AU Roberts, NJ
AF Roberts, Norbert J., Jr.
TI Respiratory syncytial virus suppression of the antiviral immune
   response: Implications for evaluation of candidate vaccines
SO VACCINE
LA English
DT Review
DE Respiratory syncytial virus; Anamnestic immune response; Vaccine
   evaluation; Influenza virus; Peripheral blood mononuclear cells;
   Lymphocytes
ID HUMAN MONONUCLEAR LEUKOCYTES; INTERLEUKIN-1 INHIBITOR PRODUCTION;
   INFLUENZA-VIRUS; HUMAN-LYMPHOCYTES; INTERFERON-PRODUCTION; BIRTH COHORT;
   CELL MEMORY; INFECTION; REINFECTION; MACROPHAGES
AB Respiratory syncytial virus infections recur throughout life despite induction of immunity by the first natural infection. Results of an extensive series of studies indicate that the virus adversely affects the human antiviral recall response to challenge, although subsequent infections are less severe than the initial illness. The observations suggest that candidate vaccines for respiratory syncytial virus should not be expected to prevent clinical illness upon subsequent exposure. Candidate vaccines may be considered effective if they render a subsequent natural infection less severe. This is what would be expected from an initial and commonly more severe natural infection and sensitization. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Roberts, Norbert J., Jr.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.
   [Roberts, Norbert J., Jr.] NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA.
RP Roberts, NJ (reprint author), NYU, Sch Med, Div Infect Dis & Immunol, 462 First Ave,Room A619, New York, NY 10016 USA.
EM norbert.roberts@nyulangone.org
OI Roberts Jr, Norbert J/0000-0002-4427-2986
CR Agoti CN, 2012, J INFECT DIS, V206, P1532, DOI 10.1093/infdis/jis570
   [Anonymous], 1986, LANCET, V2, P372
   BELL DM, 1983, NATURE, V305, P319, DOI 10.1038/305319a0
   Bont L, 2002, PEDIATR RES, V52, P363, DOI 10.1203/01.PDR.0000028458.76706.C7
   Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54
   CHONMAITREE T, 1981, INFECT IMMUN, V32, P300, DOI 10.1128/IAI.32.1.300-303.1981
   Cusi Maria Grazia, 2010, Immun Ageing, V7, P14, DOI 10.1186/1742-4933-7-14
   DOMURAT F, 1985, J INFECT DIS, V152, P895, DOI 10.1093/infdis/152.5.895
   Domurat F., 1989, VIRUS INDUCED IMMUNO, P303
   DOMURAT FM, 1989, CELL BIOPHYS, V15, P173, DOI 10.1007/BF02989682
   Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77
   Fleming EH, 2018, J MED VIROL, V90, P26, DOI 10.1002/jmv.24917
   Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC
   HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693
   Karron RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8463
   Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466
   Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5
   MCCARTHY DO, 1989, J LEUKOCYTE BIOL, V46, P189
   Memoli MJ, 2019, CLIN INFECT DIS
   MOCK DJ, 1987, J CLIN INVEST, V79, P620, DOI 10.1172/JCI112856
   Mock DJ, 2018, VIRUSES, V10, P8
   Moscona A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2515
   Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336
   OGRA PL, 1988, PEDIATR INFECT DIS J, V7, P246, DOI 10.1097/00006454-198804000-00002
   Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257
   Openshaw PJM, 2017, ANNU REV IMMUNOL, V35, P501, DOI 10.1146/annurev-immunol-051116-052206
   PRESTON FM, 1992, J INFECT DIS, V165, P819, DOI 10.1093/infdis/165.5.819
   Raiden S, 2017, J INFECT DIS, V215, P1049, DOI 10.1093/infdis/jix070
   ROBERTS NJ, 1992, MICROB PATHOGENESIS, V12, P409, DOI 10.1016/0882-4010(92)90003-7
   ROBERTS NJ, 1978, J IMMUNOL, V121, P1052
   ROBERTS NJ, 1989, J MED VIROL, V27, P179, DOI 10.1002/jmv.1890270302
   ROBERTS NJ, 1979, J IMMUNOL, V123, P365
   ROBERTS NJ, 1985, J INFECT DIS, V151, P308, DOI 10.1093/infdis/151.2.308
   ROBERTS NJ, 1982, INFECT IMMUN, V35, P1142, DOI 10.1128/IAI.35.3.1142-1146.1982
   ROBERTS NJ, 1986, J EXP MED, V163, P511, DOI 10.1084/jem.163.3.511
   SALKIND AR, 1991, J INFECT DIS, V163, P71, DOI 10.1093/infdis/163.1.71
   SALKIND AR, 1991, J CLIN INVEST, V88, P505, DOI 10.1172/JCI115332
   SALKIND AR, 1992, VACCINE, V10, P519, DOI 10.1016/0264-410X(92)90350-S
   Sananez I, 2018, J INFECT DIS, V218, P75, DOI 10.1093/infdis/jiy180
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Vekemans J, 2018, VACCINE
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7451
EP 7454
DI 10.1016/j.vaccine.2019.09.096
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000001
PM 31607601
DA 2020-05-12
ER

PT J
AU Hill, K
   Arsic, N
   Nordstrom, S
   Griebel, PJ
AF Hill, Kevin
   Arsic, Natasa
   Nordstrom, Scott
   Griebel, Philip J.
TI Immune memory induced by intranasal vaccination with a modified-live
   viral vaccine delivered to colostrum fed neonatal calves
SO VACCINE
LA English
DT Article
DE Bovine herpesvirus-1; IgA; Immune memory; Interferon; Mucosal vaccine
ID INFECTIOUS BOVINE-RHINOTRACHEITIS; RESPIRATORY SYNCYTIAL VIRUS;
   DIARRHEA-VIRUS; MATERNAL ANTIBODIES; RAPID ONSET; DISEASE; INTERFERON;
   HERPESVIRUS-1; RESPONSES; PROTECTION
AB Bovine respiratory disease (BRD) remains a major health problem despite extensive use of vaccines during the post-weaning period. Apparent vaccine failure is attributed, in part, to primary vaccination during the period of greatest risk for BRD, providing inadequate time for onset of protective immunity. The current study investigated whether intranasal (IN) vaccination of 3-6 week old calves with a modified-live viral (MLV) vaccine induced sufficient immune memory to prevent respiratory disease and accelerate onset of protective immunity 5 months later. Vaccine groups included naive controls, a single IN vaccination at 3-6 weeks of age, primary IN vaccination at 6 months, and either an IN or subcutaneous (SC) booster vaccination at 6 months (n = 10/group). All calves were challenged with BHV-1 four days after vaccination at 6 months of age. Primary IN vaccination at 6 months did not significantly reduce clinical disease but significantly (P < 0.01) reduced virus shedding. A single IN vaccination at 3-6 weeks of age significantly (P < 0.05) reduced weight loss but did not reduce fever or virus shedding. Both IN and SC booster vaccinations, significantly (P < 0.01) reduced clinical disease but virus shedding was significantly (P < 0.001) reduced only by IN booster vaccination. Reduction in virus shedding was significantly (P < 0.01) greater following booster versus primary IN vaccination at 6 months. All vaccination regimes significantly (P < 0.01) reduced secondary bacterial pneumonia and altered interferon responses relative to naive controls. Only IN booster vaccination significantly (P < 0.05) increased BHV-1 specific IgA in nasal secretions. These results confirm primary MLV IN vaccination at 3 to 6 weeks of age, when virus neutralizing maternal antibody was present, induced immune memory with a 5 month duration. This immune memory supported rapid onset of protective immunity four days after an IN booster vaccination. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Arsic, Natasa; Griebel, Philip J.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK S7N 5E3, Canada.
   [Griebel, Philip J.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK S7N 5E5, Canada.
   [Hill, Kevin; Nordstrom, Scott] Merck Anim Hlth, De Soto, KS USA.
RP Griebel, PJ (reprint author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK S7N 5E3, Canada.
EM philip.griebel@usask.ca
OI Griebel, Philip/0000-0002-2450-9368
FU Alberta Livestock and Meat Agency (ALMA); Saskatchewan Agriculture
   Development Fund (ADF); Merck Animal HealthMerck & Company; Tier I
   Canada Research Chair (CRC) in Neonatal Mucosal Immunology by Canada
   Institutes for Health Research (CIHR)
FX This research was funded by Alberta Livestock and Meat Agency (ALMA),
   Saskatchewan Agriculture Development Fund (ADF) and Merck Animal Health.
   Dr. Philip Griebel is funded by a Tier I Canada Research Chair (CRC) in
   Neonatal Mucosal Immunology provided by Canada Institutes for Health
   Research (CIHR). The authors (KH and SN) declare they have a conflict of
   interest. We also acknowledge the excellent technical assistance of Dr.
   Steward Walker and the VIDO-Intervac Animal Care staff for performing
   vaccinations, viral challenge and collecting clinical data and
   biological samples. We gratefully acknowledge the technical assistance
   provided by Donna Dent for completion of ELISAs and Elaine Van Moorlehem
   for culturing BHV-1 and performing plaque assays.
CR Abrahams A, 1919, LANCET, V1, P1
   BABIUK LA, 1987, ANTIMICROB AGENTS CH, V31, P752, DOI 10.1128/AAC.31.5.752
   BABIUK LA, 1988, [No title captured], V35, P219
   Braun R, 1998, J GEN VIROL, V79, P2965, DOI 10.1099/0022-1317-79-12-2965
   Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821
   Connelley TK, 2014, J IMMUNOL, V192, P3868, DOI 10.4049/jimmunol.1302464
   Demberg T, 2014, CLIN IMMUNOL, V153, P264, DOI 10.1016/j.clim.2014.04.017
   Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501
   Ellis J, 2001, J AM VET MED ASSOC, V219, P351, DOI 10.2460/javma.2001.219.351
   Ellis JA, 2013, JAVMA-J AM VET MED A, V243, P1602, DOI 10.2460/javma.243.11.1602
   Endsley JJ, 2004, VIRAL IMMUNOL, V17, P13, DOI 10.1089/088282404322875421
   Fairbanks KF, 2004, VET THER, V5, P17
   Gaertner FH, 2005, J CONTROL RELEASE, V107, P189, DOI 10.1016/j.jconrel.2005.06.008
   Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x
   Hill KL, 2012, JAVMA-J AM VET MED A, V240, P1231, DOI 10.2460/javma.240.10.1231
   Hodgson PD, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-21
   HOERLEIN ALVIN B., 1957, JOUR AMER VET MED ASSOC, V131, P123
   Lima SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29050
   LITTELVANDENHURK SV, 1990, VACCINE, V8, P358, DOI 10.1016/0264-410X(90)90095-4
   Miles Delbert G., 2009, Animal Health Research Reviews, V10, P101, DOI 10.1017/S1466252309990090
   Okeke EB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00680
   Osman R, 2017, J GEN VIROL, V98, P1831, DOI 10.1099/jgv.0.000825
   Osman RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01393
   Pinto MV, 2017, J INFECTION, V74, pS114, DOI 10.1016/S0163-4453(17)30201-3
   Platt R, 2009, VACCINE, V27, P4508, DOI 10.1016/j.vaccine.2009.05.012
   Prysliak T, 2011, CAN VET J, V52, P1195
   Raggo C, 2000, J GEN VIROL, V81, P2665, DOI 10.1099/0022-1317-81-11-2665
   Ribble CS, 1995, J AM VET MED ASSOC, V207, P2
   Ridpath JF, 2003, AM J VET RES, V64, P65, DOI 10.2460/ajvr.2003.64.65
   SAVAN M, 1979, CAN VET J, V20, P207
   Step DL, 2008, J ANIM SCI, V86, P3146, DOI 10.2527/jas.2008-0883
   Takahashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2358, DOI 10.1271/bbb.70142
   Waldner CL, 2005, AM J VET RES, V66, P825, DOI 10.2460/ajvr.2005.66.825
   Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110
   Woolums AR, 2003, VACCINE, V21, P1158, DOI 10.1016/S0264-410X(02)00560-1
   Xue WZ, 2010, VACCINE, V28, P3784, DOI 10.1016/j.vaccine.2010.03.043
   YATES WDG, 1983, CAN J COMP MED, V47, P257
NR 37
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7455
EP 7462
DI 10.1016/j.vaccine.2019.09.080
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000002
PM 31590936
DA 2020-05-12
ER

PT J
AU Ranamukhaarachchi, SA
   Esposito, TV
   Raeiszadeh, M
   Hafeli, UO
   Stoeber, B
AF Ranamukhaarachchi, Sahan A.
   Esposito, Tullio, V
   Raeiszadeh, Mehrsa
   Hafeli, Urs O.
   Stoeber, Boris
TI Precise measurement of intradermal fluid delivery using a low activity
   technetium-99m pertechnetate tracer
SO VACCINE
LA English
DT Article
DE Hollow microneedles; Intradermal delivery; Fluid delivery efficiency;
   Fluid backflow; Technetium-99m pertechnetate; Radiotracer
ID DOSING ACCURACY; VACCINE
AB A method was developed and validated to determine the intradermal (ID) fluid delivery potential of several ID devices, including hollow microneedles. The novel method used water soluble technetium-99 m pertechnetate ((TcO4-)-Tc-99m) diluted in normal saline to measure the volume of fluid delivered to and remaining in the skin. The fluid that back-flowed to the skin surface and the fluid left on the device surface were also quantified, thus capturing all fluid volumes deposited during intradermal injections. The technique described in this manuscript was used to assess the injection performance of conventional hypodermic needles and hollow microneedles ex vivo using porcine skin and in vivo with a rat model. Since only a small fraction, 1.1%, of the water-soluble tracer remained bound to the skin when applied topically, the technique can be used to differentiate between injected fluid and backflow. Counting of gamma radiation from (TcO4-)-Tc-99m provided sub-nanoliter resolution for volume measurements, making the proposed method powerful, sensitive, and suitable for the assessments of ID injection devices, particularly for vaccine delivery. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ranamukhaarachchi, Sahan A.; Raeiszadeh, Mehrsa; Stoeber, Boris] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada.
   [Ranamukhaarachchi, Sahan A.; Esposito, Tullio, V; Hafeli, Urs O.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada.
   [Stoeber, Boris] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1Z4, Canada.
RP Stoeber, B (reprint author), Univ British Columbia, 2054-6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada.
EM boris.stoeber@ubc.ca
OI Stoeber, Boris/0000-0003-0230-238X; Hafeli, Urs/0000-0003-0671-4509
FU Vanier Canada Graduate Scholarship program, Canada; Canadian Institute
   for Health Research, CanadaCanadian Institutes of Health Research (CIHR)
   [CHRP 446570-13]; Natural Sciences and Engineering Research Council of
   Canada, CanadaNatural Sciences and Engineering Research Council of
   Canada; Canada Research Chairs program, CanadaCanada Research Chairs
   [950-228738]
FX The authors thank the Center for Comparative Medicine at UBC for
   providing the excised porcine skin samples for the ex vivo injection
   assessments; and the Vancouver General Hospital for providing the
   radioisotopes used in this study. The authors also thank the Vanier
   Canada Graduate Scholarship program, Canada and the Collaborative Health
   Research Program (grant ID: CHRP 446570-13) by the Canadian Institute
   for Health Research, Canada and the Natural Sciences and Engineering
   Research Council of Canada, Canada for financial contributions towards
   this research. This research was undertaken, in part, thanks to funding
   from the Canada Research Chairs program, Canada (file number:
   950-228738).
CR Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90
   Alvarez-Roman R, 2004, EUR J PHARM BIOPHARM, V58, P301, DOI 10.1016/j.ejpb.2004.03.027
   Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032
   Asakura T, 2008, CURR MED RES OPIN, V24, P1429, DOI 10.1185/030079908X297394 
   England PH, 2011, IONISING RADIATION D
   Kendall M, 2006, VACCINE, V24, P4651, DOI 10.1016/j.vaccine.2005.08.066
   Krzywon M, 2012, DIABETES TECHNOL THE, V14, P804, DOI 10.1089/dia.2011.0298
   Laurent P E, 2006, Med Device Technol, V17, P16
   Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020
   Luijf YM, 2010, DIABETES TECHNOL THE, V12, pS73, DOI 10.1089/dia.2009.0178
   Mansoor I, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/8/085011
   Mansoor I, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9967-4
   Mantoux C., 1910, PRESSE MED, V18, P10
   Pearson FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067888
   Poppe LB, 2016, J ONCOL PHARM PRACT, V22, P3, DOI 10.1177/1078155214549489
   Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504
   Ranamukhaarachchi S, 2016, SCI REP, V6
   Ranamukhaarachchi SA, 2016, MACROMOL MATER ENG, V301, P306, DOI 10.1002/mame.201500320
   Schwarz M, 2015, IEEE T MED IMAGING, V34, P672, DOI 10.1109/TMI.2014.2365239
   Stabin MG, 2005, J NUCL MED, V46, P1023
   van der Maaden K, 2014, PHARM RES-DORDR, V31, P1846, DOI 10.1007/s11095-013-1288-9
   Weniger BG, 2008, VACCINES, P1357
NR 22
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7463
EP 7469
DI 10.1016/j.vaccine.2019.09.078
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000003
PM 31587894
DA 2020-05-12
ER

PT J
AU Massora, S
   Lessa, FC
   Moiane, B
   Pimenta, FC
   Mucavele, H
   Chauque, A
   Cossa, A
   Verani, JR
   Tembe, N
   Carvalho, MD
   Munoz-Almagro, C
   Sigauque, B
AF Massora, Sergio
   Lessa, Fernanda C.
   Moiane, Benild
   Pimenta, Fabiana C.
   Mucavele, Helio
   Chauque, Alberto
   Cossa, Anelsio
   Verani, Jennifer R.
   Tembe, Nelson
   da Gloria Carvalho, Maria
   Munoz-Almagro, Carmen
   Sigauque, Betuel
TI Invasive disease potential of Streptococcus pneumoniae serotypes before
   and after 10-valent pneumococcal conjugate vaccine introduction in a
   rural area, southern Mozambique
SO VACCINE
LA English
DT Article
DE Invasive disease potential; Nasopharyngeal carriage; Invasive
   pneumococcal disease; Pneumococcal conjugate vaccine
ID NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; CHILDREN; COLONIZATION;
   PREVALENCE; ENGLAND; BURDEN; WALES
AB Background: Invasive pneumococcal disease (IPD) is a significant cause of morbidity and mortality among children worldwide. In April 2013, Mozambique introduced 10-valent PCV (PCV10) into the National Expanded Program on immunization using a three-dose schedule at 2, 3, and 4 months of age. We aimed to evaluate the invasive disease potential of pneumococcal serotypes among children in our region before and after PCV10 introduction.
   Methods: We used data from ongoing population-based surveillance for IPD and cross-sectional pneumococcal carriage surveys among children aged <5 years in Manhica, Mozambique. To determine the invasive disease potential for each serotype pre- and post-PCV10 introduction, odds ratios (OR) and 95% confidence intervals (95% CI) were calculated comparing serotype-specific prevalence in IPD and in carriage. For each serotype, OR and 95% CI > 1 indicated high invasive disease potential and OR and 95% CI < 1 indicated low invasive disease potential.
   Results: In the pre-PCV10 period, 524 pneumococcal isolates were obtained from 411 colonized children and IPD cases were detected in 40 children. In the post-PCV10 period, 540 pneumococcal isolates were obtained from 507 colonized children and IPD cases were detected in 30 children. The most prevalent serotypes causing IPD pre-PCV10 were 6A (17.5%), 6B (15.0%), 14 (12.5%), 23F (10.0%) and 19F (7.5%), and post-PCV10 were 6A (36.7%), 13 (10%), 1 (10.0%), 613 (6.7%) and 19A (6.7%). Serotypes associated with high invasive disease potential pre-PCV10 included 1 (OR:22.3 [95% CI 2.0; 251.2]), 6B (OR:3.1 [95% CI 1.2; 8.1]), 14 (OR: 3.4 [95% CI 1.2; 9.8]) and post-PCV10 included serotype 6A (OR:6.1[95% CI 2.7; 13.5]).
   Conclusion: The number of serotypes with high invasive disease potential decreased after PCV10 introduction. Serotype 6A, which is not included in PCV10, was the most common cause of IPD throughout the study and showed a high invasive potential in the post-PCV10 period. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Massora, Sergio; Moiane, Benild; Mucavele, Helio; Chauque, Alberto; Cossa, Anelsio; Tembe, Nelson; Sigauque, Betuel] Fundacao Manhica, CISM, Maputo, Mozambique.
   [Lessa, Fernanda C.; Pimenta, Fabiana C.; Verani, Jennifer R.; da Gloria Carvalho, Maria] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA.
   [Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Inst Recerca Pediat, Mol Microbiol Dept, Barcelona, Spain.
   [Munoz-Almagro, Carmen] Inst Salud Carlos III, CIBERESP, Ciber Epidemiol & Publ Hlth, Madrid, Spain.
   [Munoz-Almagro, Carmen] Univ Int Catalunya, Med Dept, Barcelona, Spain.
RP Massora, S (reprint author), Fundacao Manhica, CISM, Maputo, Mozambique.
EM sergio.massora@manhica.net; dta3@cdc.gov; benild.moiane@manhica.net;
   gzy7@cdc.gov; mucavele@manhica.net; alberto.chauque@mahica.net;
   anelsio.cossa@manhica.net; qzr7@cdc.gov; nelson.tembe@-manhica.net;
   msc8@cdc.gov; cma@sjdhospi-talbarcelona.org; betuel.sigauque@manhica.net
FU U.S. Agency for International Development in Mozambique Fixed Obligation
   Grant (FOG), Surveillance for Pediatric Pneumonia and Invasive
   Pneumococcal Disease in Mozambique [AID-656-F-12-00001,
   RFA-656-12-000003]; Spanish Agency for International Development
   Cooperation (AECID-Ministry of Foreign Affairs, Spain)
FX The work was supported by the U.S. Agency for International Development
   in Mozambique Fixed Obligation Grant (FOG) No. AID-656-F-12-00001, under
   RFA-656-12-000003, Surveillance for Pediatric Pneumonia and Invasive
   Pneumococcal Disease in Mozambique. The core funding of CISM provided by
   the Spanish Agency for International Development Cooperation
   (AECID-Ministry of Foreign Affairs, Spain), partially contributed to
   support the study. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Balsells E, 2018, J INFECTION, V77, P368, DOI 10.1016/j.jinf.2018.06.004
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820
   Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624
   Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09
   Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06
   del Amo E, 2015, EUR J CLIN MICROBIOL, V34, P705, DOI 10.1007/s10096-014-2280-y
   del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422
   Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849
   Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017
   Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15
   Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x
   Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4
   Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005
   Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339
   Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06
   Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5
   Lindstrand A, 2016, VACCINE, V34, P4565, DOI 10.1016/j.vaccine.2016.07.031
   Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2
   Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1
   Ministerio da Saude. Comite de Peritos de imunizacao (CoPI) Decima Primeira ReuniSo, 2016, REC MUD VAC PCV10 PC
   Navne JE, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1309504
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Pomat WS, 2019, CLIN INFECT DIS, V68, P1472, DOI 10.1093/cid/ciy743
   Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016
   Richter L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210081
   Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x
   Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10
   Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148
   Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6
   Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6
   Sigauque B, 2018, PLOS ONE, V13, P1
   Sigauque B, 2018, PEDIATR INFECT DIS J, V37, P1054, DOI 10.1097/INF.0000000000002134
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/erv.12.53, 10.1586/ERV.12.53]
   Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4
   Varon E, 2015, VACCINE, V33, P6178, DOI 10.1016/j.vaccine.2015.10.015
   Verani JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191113
   von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914
   Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X
   WHO, 2018, SUMM WHO VACC PREV D
   World Health Organization, 2011, CHILD GROWTH STAND
   Yildirim I, 2017, VACCINE, V35, P4002, DOI 10.1016/j.vaccine.2017.05.077
   Zemlickova H, 2010, J MED MICROBIOL, V59, P1079, DOI 10.1099/jmm.0.018390-0
   2009, [No title captured], V958, P1
NR 45
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7470
EP 7477
DI 10.1016/j.vaccine.2019.09.079
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000004
PM 31575493
OA Other Gold
DA 2020-05-12
ER

PT J
AU Luo, J
   Zhang, Y
   He, HL
   Liu, Q
   Huang, SL
   Guo, XF
AF Luo, Jun
   Zhang, Yue
   He, Hongling
   Liu, Qing
   Huang, Shile
   Guo, Xiaofeng
TI Artesunate enhances the immune response of rabies vaccine as an adjuvant
SO VACCINE
LA English
DT Article
DE Rabies; Vaccine; Adjuvant; Artesunate; Dihydroartemisinin
ID VIRUS; ARTEMISININ; STRAIN
AB Rabies is an ancient zoonosis that continues to be an important health problem worldwide. Vaccination with rabies vaccine is the most important strategy to prevent rabies. Adjuvants contribute to the immune response of viral vaccine. The aim of this study was to investigate whether artemisinin derivatives artesunate and dihydroartemisinin could enhance the immunogenicity of inactivated rabies virus in mice. Administration of artesunate or dihydroartemisinin by intramuscular injection at a dose of 5 mg/kg did not cause body weight loss and unusual symptoms in mice. Mice were immunized with inactivated CVS-11 or inactivated rHEP-dG together with either artesunate or dihydroartemisinin through intramuscular injection. Blood samples were collected to investigate the virus-neutralizing antibody (VNA) titers, and challenge assays were then conducted. The results showed that the rabies VNA titers in mice co-treated with artesunate rather than dihydroartemisinin were significantly higher than in the control animals treated with the phosphate buffered saline (PBS). In addition, mice co-treated with artesunate survived from lethal rabies virus challenge compared with those treated with PBS. In contrast, co-treatment with dihydroartemisinin did not improve the survival rate of the challenged mice. The findings indicate that artesunate could be used as a new candidate adjuvant for rabies vaccination. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Luo, Jun; Zhang, Yue; He, Hongling; Liu, Qing; Guo, Xiaofeng] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.
   [Luo, Jun; Huang, Shile] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1501 Kings Highway, Shreveport, LA 71130 USA.
   [Huang, Shile] Louisiana State Univ, Feist Weiller Canc Ctr, Hlth Sci Ctr, Shreveport, LA 71130 USA.
RP Guo, XF (reprint author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.; Huang, SL (reprint author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1501 Kings Highway, Shreveport, LA 71130 USA.
EM shuan1@lsuhsc.edu; xfguo@scau.edu.cn
OI Huang, Shile/0000-0002-3239-1072; Guo, Xiaofeng/0000-0003-2896-3629
FU National Key Research and Development Program of China [2016YFD0500400];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31772742]; Natural Science Foundation of
   GuangdongNational Natural Science Foundation of Guangdong Province
   [2015A03031103]
FX This study was partially supported by the National Key Research and
   Development Program of China (No. 2016YFD0500400), the National Natural
   Science Foundation of China (No. 31772742), and the Natural Science
   Foundation of Guangdong (No. 2015A03031103).
CR Choi WH, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030030
   Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3
   Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002
   Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Hosokawa-Muto J, 2006, MICROBIOL IMMUNOL, V50, P187, DOI 10.1111/j.1348-0421.2006.tb03785.x
   Hou LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032424
   Houh YK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071600
   Jia J G, 2016, Zhonghua Wai Ke Za Zhi, V54, P222, DOI 10.3760/cma.j.issn.0529-5815.2016.03.014
   Khakzad MR, 2017, IMMUNOPHARM IMMUNOT, V39, P348, DOI 10.1080/08923973.2017.1379087
   Koraka P, 2014, VACCINE, V32, P4644, DOI 10.1016/j.vaccine.2014.06.058
   Lalloo DG, 2016, J INFECTION, V72, P635, DOI 10.1016/j.jinf.2016.02.001
   Lee SH, 2015, ARCH PHARM RES, V38, P1195, DOI 10.1007/s12272-014-0491-5
   Li HJ, 2012, PARASITOL RES, V110, P1727, DOI 10.1007/s00436-011-2692-x
   Li HJ, 2011, PARASITOL RES, V109, P515, DOI 10.1007/s00436-011-2474-5
   Li X, 2013, PLOS ONE, V2
   Liu XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087105
   Meng QF, 2018, PHARMAZIE, V73, P526, DOI 10.1691/ph.2018.8516
   Morimoto K, 2011, MICROBIOL IMMUNOL, V55, P558, DOI 10.1111/j.1348-0421.2011.00354.x
   Noori S, 2011, CELL IMMUNOL, V271, P67, DOI 10.1016/j.cellimm.2011.06.008
   Odaka Y, 2014, CARCINOGENESIS, V35, P192, DOI 10.1093/carcin/bgt277
   Patel Arunkumar C., 2015, VirusDisease, V26, P288, DOI 10.1007/s13337-015-0285-5
   Tao LH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-454
   Tasai S, 2017, VET PARASITOL, V233, P97, DOI 10.1016/j.vetpar.2016.12.008
   Tu YY, 1999, CHINESE MED J-PEKING, V112, P976
   Wang L, 2017, ARCH MED RES, V48, P623, DOI 10.1016/j.arcmed.2018.03.004
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   World Health Organization, 2015, GUID TREATM MAL
   YANG SX, 1993, CLIN IMMUNOL IMMUNOP, V69, P143, DOI 10.1006/clin.1993.1162
NR 29
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7478
EP 7481
DI 10.1016/j.vaccine.2019.09.077
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000005
PM 31582270
DA 2020-05-12
ER

PT J
AU Hammitt, LL
   Campbell, JC
   Borys, D
   Weatherholtz, RC
   Reid, R
   Goklish, N
   Moulton, LH
   Traskine, M
   Son, Y
   Swinnen, K
   Santosham, M
   O'Brien, KL
AF Hammitt, Laura L.
   Campbell, James C.
   Borys, Dorota
   Weatherholtz, Robert C.
   Reid, Raymond
   Goklish, Novalene
   Moulton, Lawrence H.
   Traskine, Magali
   Son, Yue
   Swinnen, Kristien
   Santosham, Mathuram
   O'Brien, Katherine L.
TI Efficacy, safety and immunogenicity of a pneumococcal protein-based
   vaccine co-administered with 13-valent pneumococcal conjugate vaccine
   against acute otitis media in young children: A phase IIb randomized
   study
SO VACCINE
LA English
DT Article
DE Streptococcus pneumoniae; Immunogenicity; Reactogenicity; Acute otitis
   media; Vaccines; Native American
ID STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; DETOXIFIED
   PNEUMOLYSIN; DISEASE; ANTIBODIES; REACTOGENICITY; CARRIAGE; IMPACT;
   PHTD; IMMUNIZATION
AB Background: Native American populations experience a substantial burden of pneumococcal disease despite use of highly effective pneumococcal conjugate vaccines (PCVs). Protein-based pneumococcal vaccines may extend protection beyond the serotype-specific protection elicited by PCVs.
   Methods: In this phase IIb, double-blind, controlled trial, 6-12 weeks-old Native American infants randomized 1:1, received either a protein-based pneumococcal vaccine (dPly/PhtD) containing pneumolysin toxoid (dPly, 10 mu g) and pneumococcal histidine triad protein D (PhtD, 10 mu g) or placebo, administered along with 13-valent PCV (PCV13) at ages 2, 4, 6 and 12-15 months. Other pediatric vaccines were given per the routine immunization schedule. We assessed vaccine efficacy (VE) against acute otitis media (AOM) and acute lower respiratory tract infection (ALRI) endpoints. Immunogenicity, reactogenicity and unsolicited adverse events were assessed in a sub-cohort and serious adverse events were assessed in all children.
   Results: 1803 infants were randomized (900 dPly/PhtD; 903 Control). VE against all episodes of American Academy of Pediatrics (AAP)-defined AOM was 3.8% (95% confidence interval: -11.4, 16.9). Point estimates of VE against other AOM outcomes ranged between 2.9% (-9.5, 14.0) and 5.2% (-8.0, 16.8). Point estimates of VE against ALRI outcomes ranged between -4.4% (-39.2, 21.8) and 2.0% (-18.3, 18.8). Point estimates of VE tended to be higher against first than all episodes but the confidence intervals included zero. dPly/PhtD vaccine was immunogenic and had an acceptable reactogenicity and safety profile after primary and booster vaccination in Native American infants.
   Conclusions: The dPly/PhtD vaccine was immunogenic and well tolerated, however, incremental efficacy in preventing AAP-AOM over PCV13 was not demonstrated. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Hammitt, Laura L.; Campbell, James C.; Weatherholtz, Robert C.; Reid, Raymond; Goklish, Novalene; Moulton, Lawrence H.; Santosham, Mathuram; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21231 USA.
   [Borys, Dorota; Traskine, Magali; Swinnen, Kristien] GSK, Wavre, Belgium.
   [Son, Yue] GSK, XPE Pharma & Sci, Wavre, Belgium.
RP Hammitt, LL (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, 415 N Washington St,4th Floor, Baltimore, MD 21231 USA.
EM LHammitt@JHU.edu
FU GlaxoSmithKline Biologicals SAGlaxoSmithKline
FX This study was funded by GlaxoSmithKline Biologicals SA.
CR Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001
   Alderson MR, 2016, VACCINE, V34, P2959, DOI 10.1016/j.vaccine.2016.03.107
   ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994
   Bergenfelz Caroline, 2017, Curr Otorhinolaryngol Rep, V5, P115, DOI 10.1007/s40136-017-0152-6
   Bruce MG, 2015, VACCINE, V33, P4813, DOI 10.1016/j.vaccine.2015.07.080
   Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48
   CORTESE MM, 1992, ARCH INTERN MED, V152, P2277, DOI 10.1001/archinte.152.11.2277
   DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368
   Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051
   Denoel P, 2011, VACCINE, V29, P6451, DOI 10.1016/j.vaccine.2011.01.085
   Edwards KM, 2015, VACCINE, V33, P6469, DOI 10.1016/j.vaccine.2015.07.085
   Eijkelkamp BA, 2016, INFECT IMMUN, V84, P407, DOI 10.1128/IAI.01082-15
   Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602
   Flannery B, 2018, MMWR-MORBID MORTAL W, V67, P180, DOI 10.15585/mmwr.mm6706a2
   Fortanier AC, 2019, COCHRANE DB SYST REV, V5
   Grant LR, 2016, PEDIATR INFECT DIS J, V35, P907, DOI 10.1097/INF.0000000000001207
   Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128
   Hermand P, 2017, HUM VACC IMMUNOTHER, V13, P220, DOI 10.1080/21645515.2016.1234553
   Kaleida PH, 2009, PEDIATRICS, V124, pE714, DOI 10.1542/peds.2008-2838
   Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181
   Kaur R, 2014, INFECT IMMUN, V82, P5069, DOI 10.1128/IAI.02124-14
   Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5
   Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023
   Leroux-Roels G, 2014, VACCINE, V32, P6838, DOI 10.1016/j.vaccine.2014.02.052
   Levy C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211712
   Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488
   Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451
   Mendy AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185824
   Norhayati MN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010089.pub2
   O'Brien KL, 2008, PEDIATR INFECT DIS J, V27, P71, DOI 10.1097/INF.0b013e318159228f
   O'Brien KL, 2004, AM J EPIDEMIOL, V159, P634, DOI 10.1093/aje/kwh082
   Odutola A, 2016, HUM VACC IMMUNOTHER, V12, P393, DOI 10.1080/21645515.2015.1111496
   Odutola A, 2017, VACCINE, V35, P2531, DOI 10.1016/j.vaccine.2017.03.071
   Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9
   Prymula R, 2017, VACCINE, V35, P4603, DOI 10.1016/j.vaccine.2017.07.008
   Prymula R, 2014, VACCINE, V32, P3025, DOI 10.1016/j.vaccine.2014.03.066
   Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0
   Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11
   Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657
   Van Dyke MK, 2017, PEDIATR INFECT DIS J, V36, P274, DOI 10.1097/INF.0000000000001420
   Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X
   Watt JP, 2004, CLIN INFECT DIS, V38, P496, DOI 10.1086/381198
   Weatherholtz R, 2018, 11 INT S PNUM PNEUM
   Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680
   Xu Q, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.01.011
   Xu QF, 2017, VACCINE, V35, P337, DOI 10.1016/j.vaccine.2016.11.046
NR 46
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7482
EP 7492
DI 10.1016/j.vaccine.2019.09.076
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000006
PM 31629570
OA Other Gold
DA 2020-05-12
ER

PT J
AU Modanloo, S
   Stacey, D
   Dunn, S
   Choueiry, J
   Harrison, D
AF Modanloo, Shokoufeh
   Stacey, Dawn
   Dunn, Sandra
   Choueiry, Juliana
   Harrison, Denise
TI Parent resources for early childhood vaccination: An online
   environmental scan
SO VACCINE
LA English
DT Article
DE Vaccination; Immunization; Internet; Parents; Child
ID HEALTH INFORMATION; PAIN-MANAGEMENT; REDUCING PAIN; IMMUNIZATION; TOOL;
   INTERVENTIONS; VIDEOS; WEB
AB Background: Early childhood vaccination is one of the most important public health interventions. However, the injections are usually painful. Clinical practice guidelines recommend using pain management strategies for infants during vaccination. Public access to online health information has increased due to the advent of intemet. Parents are likely to find thousands of websites, and online video platforms of variable quality. This study aims to identify and critically appraise the quality of online parent-targeted resources concerning early childhood vaccination and determine inclusion of recommended infant pain management strategies.
   Methods: An environmental scan of two main internet sources was conducted: (a) Google, (b) Social Media networks. Resources including information relating to infant vaccination and available to Canadians were included. Characteristics of resources were collected. Resource quality was evaluated using the CDC Clear Communication Index. A CDC index score of 90% and above indicates the resource is as an acceptable public communication material. Means and standard deviations were used for normally distributed data; median and interquartile range (IQR) or numbers and proportions were used for data not normally distributed or presented in categorical format.
   Results: We found 55 online resources in website format and 10 resources in video format. Overall, the mean score for the quality of resources was 60% +/- 0.19. Most resources were scored as moderate to low quality (33-87%). Only 5% of material scored as acceptable quality. In terms of content, 30 (46%) resources presented information about pain management strategies during vaccination, including breastfeeding (24, 37%), holding (27, 42%), and sweet solutions (22, 34%). The remaining 35 (54%) resources made no clear statement regarding any pain management strategies during vaccination.
   Conclusion: Most publicly accessible online parent-targeted vaccination resources were of poor quality and did not contain information related to the use of recommended pain management strategies during vaccination. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Modanloo, Shokoufeh; Stacey, Dawn; Dunn, Sandra; Choueiry, Juliana; Harrison, Denise] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada.
   [Modanloo, Shokoufeh; Dunn, Sandra; Choueiry, Juliana; Harrison, Denise] CHEO, Res Inst, Ottawa, ON, Canada.
   [Stacey, Dawn] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
   [Dunn, Sandra] BORN, Ottawa, ON, Canada.
RP Modanloo, S (reprint author), Univ Ottawa, Sch Nursing, Ottawa, ON, Canada.
EM smoda044@uottawa.ca
RI Harrison, Denise/N-6684-2017
OI Harrison, Denise/0000-0001-7549-7742
FU School of Nursing, Faculty of Health Sciences, University of Ottawa,
   Ottawa, Ontario
FX The first author was supported by International Admission Scholarship
   and International Doctoral Scholarship at School of Nursing, Faculty of
   Health Sciences, University of Ottawa, Ottawa, Ontario.
CR Basch CH, 2017, CHILD CARE HLTH DEV, V43, P499, DOI 10.1111/cch.12442
   Baur C, 2014, HEALTH PROMOT PRACT, V15, P629, DOI 10.1177/1524839914538969
   Centers for Disease Control and Prevention, 2014, CDC NHSN SURV DEF SP, V2014, P1
   Cerminara C, 2014, EPILEPSY BEHAV, V41, P119, DOI 10.1016/j.yebeh.2014.09.053
   Chambers CT, 2009, CLIN THER, V31, pS77, DOI 10.1016/j.clinthera.2009.07.023
   Chan S, 2013, PAED CHILD HEALT-CAN, V18, P367, DOI 10.1093/pch/18.7.367
   Charnock D, 2004, HEALTH EDUC RES, V19, P440, DOI 10.1093/her/cyg046
   Chen SL, 2016, EFFICACY SWEET SOLUT, V18, P534
   Dol J, 2019, HEALTH INFORM J, V25, P1265, DOI 10.1177/1460458217752564
   Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691
   Farkas C, 2015, CLIN J PAIN, V31, P591, DOI [10.1097/AJP.0000000000000197, 10.1097/AJP.0000000000000263]
   Franck LS, 2015, CLIN PEDIATR, V54, P228, DOI 10.1177/0009922814561593
   Ghidiu M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6850
   Harrison D, 2018, J NEONATAL NURS, V24, P325
   Harrison D, 2014, BE SWEET BABIES
   Harrison D, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011248.pub2
   Harrison D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164123
   Harrison D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008408.pub3
   Harrison D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-134
   Harrison D, 2013, J PAEDIATR CHILD H, V49, P313, DOI 10.1111/jpc.12161
   Hatch TF, 1998, J CONTIN EDUC HEALTH, V18, P179
   Kaicker J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-59
   Kassab M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008411.pub2
   Kumar VS, 2014, J PEDIATR ORTHOP B, V23, P135, DOI 10.1097/BPB.0000000000000000
   McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006
   Riddell RRP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006275.pub2
   Russell Kathryn, 2015, Nurs N Z, V21, P22
   Sampson M, 2013, PEERJ, V1, DOI 10.7717/peerj.147
   Shah Vibhuti, 2015, Clin J Pain, V31, pS38, DOI 10.1097/AJP.0000000000000281
   Strikas RA, 2015, MMWR-MORBID MORTAL W, V64, P93
   Taddio A, 2015, CAN MED ASSOC J, V187, P975, DOI 10.1503/cmaj.150391
   Taddio A, 2014, CLIN J PAIN, V30, P987, DOI 10.1097/AJP.0000000000000051
   Taddio A, 2014, PAIN, V155, P1288, DOI 10.1016/j.pain.2014.03.024
   Taddio A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-23
   Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011
   Wiley KE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3933-9
   World Health Organization, 2015, WER, V90, P505
NR 37
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7493
EP 7500
DI 10.1016/j.vaccine.2019.09.075
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000007
PM 31590931
DA 2020-05-12
ER

PT J
AU Fu, M
   Hu, K
   Hu, HM
   Ni, FF
   Du, T
   Shattock, RJ
   Hu, QX
AF Fu, Ming
   Hu, Kai
   Hu, Huimin
   Ni, Fengfeng
   Du, Tao
   Shattock, Robin J.
   Hu, Qinxue
TI Antigenicity and immunogenicity of HIV-1 gp140 with different
   combinations of glycan mutation and V1/V2 region or V3 crown deletion
SO VACCINE
LA English
DT Article
DE HIV-1; gp140; Glycan; Variable region; Antigenicity; Immunogenicity
ID ENVELOPE GLYCOPROTEINS; ANTIBODY-RESPONSES; DESIGN; LENGTH; TRIMER;
   CELLS; SITE
AB The carbohydrate moieties on HIV-1 envelope glycoprotein (Env) act as shields to mask conserved neutralizing epitopes, while the hyperimmunogenic variable regions are immunodominant in inducing non-neutralizing antibodies, representing the major challenge for using Env as a vaccine candidate to induce broadly neutralizing antibodies (bNAbs). In this study, we designed a series of HIV-1 gp140 constructs with the removal of N276/N463 glycans, deletion of the V1/V2 region and the V3 crown, alone or in combination. We first demonstrated that all the constructs had a comparable level of expression and were mainly expressed as trimers. Following purification of gp140s from mammalian cells, we measured their binding to bNAbs and non-NAbs in vitro and capability in inducing bNAbs in vivo. Antibody binding assay showed that removal of N276/N463 glycans together with the deletion of V1/V2 region enhanced the binding of gp140s to CD4-binding site-targeting bNAbs VRC01 and 3BNC117, and CD4-induced epitopes-targeting non-NAbs A32, 17b and F425 A1g8, whereas further deletion of V3 crown in the gp140 mutants demonstrated slightly compromised binding capability to these Abs. Immunogenicity study showed that the above mutations did not lead to the induction of a higher Env-specific IgG response via either DNA-DNA or DNA-protein prime-boost strategies in mice, while neutralization assay did not show an apparent difference between wild type and mutated gp140s. Taken together, our results indicate that removal of glycans at N276/N463 and deletion of the V1/V2 region can expose the CD4-binding site and CD4-induced epitopes, but such exposure alone appears incapable of enhancing the induction of bNAbs in mice, informing that additional modification or/and immunization strategies are needed. In addition, the strategies which we established for producing gp140 proteins and for analyzing the antigenicity and immunogenicity of gp140 provide useful means for further vaccine design and assessment. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fu, Ming; Hu, Kai; Hu, Huimin; Ni, Fengfeng; Du, Tao; Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, 44 Xiaohongshan Zhongqu, Wuhan 430071, Hubei, Peoples R China.
   [Fu, Ming; Hu, Huimin; Ni, Fengfeng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Hu, Kai; Hu, Qinxue] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England.
   [Shattock, Robin J.] Imperial Coll London, Fac Med, Sect Infect Dis, St Marys Campus, London W2 1PG, England.
RP Hu, QX (reprint author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, 44 Xiaohongshan Zhongqu, Wuhan 430071, Hubei, Peoples R China.; Hu, QX (reprint author), St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England.
EM qhu@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215
FU National Mega-Projects against Infectious Diseases [2018ZX10301406-002,
   2018ZX10301405-003]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81772192]; Hotung
   Trust
FX This work was supported by the National Mega-Projects against Infectious
   Diseases (2018ZX10301406-002 and 2018ZX10301405-003), the National
   Natural Science Foundation of China (81772192), and the Hotung Trust. We
   thank Ding Gao at the Core Facility and Technical Support, Wuhan
   Institute of Virology, for his technical support with Bio-layer
   interferometry, and Xuefang An and Fan Zhang for their assistance with
   mouse immunizations.
CR Arias MA, 2011, VACCINE, V29, P1258, DOI 10.1016/j.vaccine.2010.11.084
   Borst AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37688
   Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158
   Cheng C, 2016, J VIROL, V90, P2740, DOI 10.1128/JVI.02380-15
   Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6
   Cosgrove CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152038
   Davis-Gardner ME, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006786
   de Taeye SW, 2018, J BIOL CHEM, V293, P1688, DOI 10.1074/jbc.RA117.000709
   Gift SK, 2017, J VIROL, V91, DOI 10.1128/JVI.01216-17
   Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512
   Hu K, 2013, J IMMUNOL, V191, P1935, DOI 10.4049/jimmunol.1300120
   Huang X, 2012, VIROLOGY, V423, P97, DOI 10.1016/j.virol.2011.11.023
   Ivanov II, 2005, J IMMUNOL, V174, P7773, DOI 10.4049/jimmunol.174.12.7773
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195
   Kmieciak D, 1998, J IMMUNOL, V160, P5676
   Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109
   Laakso MM, 2007, PLOS PATHOG, V3, P1118, DOI 10.1371/journal.ppat.0030117
   Lee WS, 2017, J VIROL, V91, DOI 10.1128/JVI.00603-17
   Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165
   Liu LX, 2007, AIDS RES HUM RETROV, V23, P1396, DOI 10.1089/aid.2007.0131
   Mann JK, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0221-0
   Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075
   McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206
   McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824
   Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160
   Medina-Ramirez M, 2017, CURR OPIN HIV AIDS, V12, P241, DOI 10.1097/COH.0000000000000363
   Medina-Ramirez M, 2014, EXPERT REV VACCINES, V13, P449, DOI 10.1586/14760584.2014.894469
   Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14
   Rouers A, 2017, EBIOMEDICINE, V21, P158, DOI 10.1016/j.ebiom.2017.05.029
   Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618
   Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005
   Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002
   Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047
   Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006
   Trovato M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041241
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Visciano ML, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00677
   WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102
   WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993
   Yang ZH, 2018, 2018 INTERNATIONAL CONFERENCE ON INTELLIGENT AUTONOMOUS SYSTEMS (ICOIAS), P9, DOI 10.1109/ICoIAS.2018.8494031
   Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007
   Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150
NR 43
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7501
EP 7508
DI 10.1016/j.vaccine.2019.09.073
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000008
PM 31564450
DA 2020-05-12
ER

PT J
AU Heinimaki, S
   Hankaniemi, MM
   Sioofy-Khojine, AB
   Laitinen, OH
   Hyoty, H
   Hytonen, VP
   Vesikari, T
   Blazevic, V
AF Heinimaki, Suvi
   Hankaniemi, Minna M.
   Sioofy-Khojine, Amir-Babak
   Laitinen, Olli H.
   Hyoty, Heikki
   Hytonen, Vesa P.
   Vesikari, Timo
   Blazevic, Vesna
TI Combination of three virus-derived nanoparticles as a vaccine against
   enteric pathogens; enterovirus, norovirus and rotavirus
SO VACCINE
LA English
DT Article
DE Enterovirus; Coxsackievirus B; Norovirus; Rotavirus; Virus-like
   particle; VP6
ID VP6 PROTEIN; INTRANASAL IMMUNIZATION; IMMUNE-RESPONSES; PARTICLES;
   IMMUNOGENICITY; PURIFICATION; PROTECTION; VLPS; MICE; INFECTION
AB y Enteric viruses cause diverse infections with substantial morbidity and mortality in children, rotavirus (RV) and norovirus (NoV) being the leading agents of severe pediatric gastroenteritis. Coxsackie B viruses (CVB) are common enteroviruses (EV), associated with increased incidence of severe neonatal CVB disease with potentially fatal consequences. To prevent majority of childhood gastroenteritis, we have developed a non-live NoV-RV combination vaccine consisting of NoV virus-like particles (VLPs) and RV oligomeric rVP6 protein that induced protective immune responses to NoV and RV in mice. Moreover, rVP6 acted as an adjuvant for NoV VLPs. Here, we investigated a possibility to include a third enteric virus-derived antigen in the candidate NoV-RV vaccine, by adding recombinant nanoparticles derived from EV CVB1. To examine immunogenicity of EV-NoV-RV vaccine, BALB/c mice were immunized intramuscularly twice with 10 mu g CVB1 VLPs, GII.4 VLPs and rVP6 nanotubes, either separately or combined. To evaluate the adjuvant effect of rVP6 on EV responses, mice received 0.3 mu g CVB1 VLPs with or without 10 mu g rVP6. Comparable serum IgG antibodies were detected whether the antigens were administered separately or in combination. Each formulation generated IgG1 and IgG2a antibodies, indicating a mixed Th2/Th1-type response. CVB1 VLPs skewed the isotype distribution slightly towards IgG1 subtype, while EV-NoV-RV combination vaccine induced unbiased Th1/Th2 responses to CVB1. Each antigen also induced T cell mediated immunity measured by IFN-gamma secretion to specific stimulants ex vivo. Antisera raised by single antigens and combined formulation also exhibited strong neutralizing ability against CVB1 and NoV GII.4. Further, rVP6 showed an adjuvant effect on CVB1 responses, sparing the VLP dose and homogenizing the responses. Finally, the results support inclusion of additional antigens in the candidate NoV-RV combination vaccine to combat severe childhood infections and confirm adjuvant effect of rVP6 nanostructures. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Heinimaki, Suvi; Vesikari, Timo; Blazevic, Vesna] Tampere Univ, Fac Med & Hlth Technol, Vaccine Res Ctr, Tampere, Finland.
   [Hankaniemi, Minna M.; Laitinen, Olli H.; Hytonen, Vesa P.] Tampere Univ, Fac Med & Hlth Technol, Prot Dynam Grp, Tampere, Finland.
   [Sioofy-Khojine, Amir-Babak; Hyoty, Heikki] Tampere Univ, Fac Med & Hlth Technol, Dept Virol, Tampere, Finland.
   [Hyoty, Heikki; Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland.
RP Blazevic, V (reprint author), Tampere Univ, Vaccine Res Ctr, Biokatu 10, FI-33520 Tampere, Finland.
EM vesna.blazevic@tuni.fi
RI ; Hytonen, Vesa/E-8855-2013
OI Laitinen, Olli/0000-0002-3751-9952; Heinimaki, Suvi/0000-0001-9374-4583;
   Hytonen, Vesa/0000-0002-9357-1480; Hankaniemi,
   Minna/0000-0001-6463-1248; Sioofy-Khojine,
   Amir-Babak/0000-0001-5538-5153
FU Business Finland [THERDIAB 1843/31/2014]; ArcDia Ltd.; Vactech Ltd.;
   JILab Ltd.; FimLab Ltd.
FX We gratefully acknowledge the Electron Microscopy Unit of the Institute
   of Biotechnology, University of Helsinki. Special thanks are due to Dr.
   Helena Vihinen and Mervi Lindman for the guidance and technical help in
   transmission electron microscopy. The technical assistance given by the
   personnel of Vaccine Research Center and Ulla Kiiskinen from Protein
   Dynamics group of Tampere University is acknowledged. We also express
   our gratitude to members of the animal facility at Tampere University.
   We acknowledge Business Finland (project THERDIAB 1843/31/2014) for
   financial support and the partners of the THERDIAB project (ArcDia Ltd.,
   Vactech Ltd., JILab Ltd., FimLab Ltd.) for their support. Finally, we
   acknowledge Biocenter Finland for infrastructure support.
CR Afchangi A, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2027
   Aiyegbo MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061101
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297
   Blazevic V, 2016, HUM VACC IMMUNOTHER, V12, P740, DOI 10.1080/21645515.2015.1099772
   Blazevic V, 2011, VACCINE, V29, P8126, DOI 10.1016/j.vaccine.2011.08.026
   Brito LA, 2011, J PHARM SCI-US, V100, P34, DOI 10.1002/jps.22267
   Cao L, 2015, MOL MED REP, V12, P2473, DOI 10.3892/mmr.2015.3680
   Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024
   Clark A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183392
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Hankaniemi MM, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104595
   Hankaniemi MM, 2017, VACCINE, V35, P3718, DOI 10.1016/j.vaccine.2017.05.057
   Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002
   Heinimaki S, 2018, ANTIVIR RES, V157, P1, DOI 10.1016/j.antiviral.2018.06.012
   Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18
   Koho T, 2014, ANTIVIR RES, V104, P93, DOI 10.1016/j.antiviral.2014.01.013
   Koho T, 2012, J VIROL METHODS, V181, P6, DOI 10.1016/j.jviromet.2012.01.003
   Koho T, 2012, J VIROL METHODS, V179, P1, DOI 10.1016/j.jviromet.2011.05.009
   Lappalainen S, 2016, ARCH VIROL, V161, P3219, DOI 10.1007/s00705-016-2991-8
   Lappalainen S, 2015, ARCH VIROL, V160, P2075, DOI 10.1007/s00705-015-2461-8
   Lappalainen S, 2014, HUM VACC IMMUNOTHER, V10, P2039, DOI 10.4161/hv.28858
   Lappalainen S, 2013, HUM VACC IMMUNOTHER, V9, P1991, DOI 10.4161/hv.25249
   Lepault J, 2001, EMBO J, V20, P1498, DOI 10.1093/emboj/20.7.1498
   Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11
   Lindesmith LC, 2010, J VIROL, V84, P1800, DOI 10.1128/JVI.02179-09
   Malm M, 2017, CLIN EXP IMMUNOL, V189, P331, DOI 10.1111/cei.12977
   Malm M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01570
   Malm M, 2016, J IMMUNOL RES, DOI 10.1155/2016/9171632
   Malm M, 2014, J INFECT DIS, V210, P1755, DOI 10.1093/infdis/jiu361
   Mattison CP, 2018, EXPERT REV VACCINES, V17, P773, DOI 10.1080/14760584.2018.1510327
   McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002
   McNeal MM, 2007, VIROLOGY, V363, P410, DOI 10.1016/j.virol.2007.01.041
   Parra GI, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006136
   Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022
   REDMOND MJ, 1991, MOL IMMUNOL, V28, P269, DOI 10.1016/0161-5890(91)90073-S
   Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364
   Sioofy-Khojine AB, 2018, DIABETOLOGIA, V61, P1193, DOI 10.1007/s00125-018-4561-y
   Skibinski DAG, 2011, J GLOB INFECT DIS, V3, P63, DOI 10.4103/0974-777X.77298
   Tamminen K, 2016, VIRAL IMMUNOL, V29, P315, DOI 10.1089/vim.2015.0141
   Tamminen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070409
   Tamminen K, 2012, IMMUNOLOGY, V135, P89, DOI 10.1111/j.1365-2567.2011.03516.x
   Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1
   Verma NA, 2009, CLIN INFECT DIS, V49, P759, DOI 10.1086/605089
   Wahid R, 2005, J VIROL, V79, P5988, DOI 10.1128/JVI.79.10.5988-5995.2005
   Wang XL, 2015, VACCINE, V33, P5779, DOI 10.1016/j.vaccine.2015.09.043
   Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090
   XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992
   Zhang W, 2018, EMERG MICROBES INFEC, V7, DOI [10.1038/S41426-018-0094-1, 10.1038/s41426-018-0094-1]
NR 49
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 3
PY 2019
VL 37
IS 51
BP 7509
EP 7518
DI 10.1016/j.vaccine.2019.09.072
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4AO
UT WOS:000501620000009
PM 31585726
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Martinez, A
   Robles, CA
   Roper, JM
   Gardner, DR
   Neyaz, MS
   Joelson, NZ
   Cook, D
AF Martinez, Agustin
   Robles, Carlos A.
   Roper, Jessie M.
   Gardner, Dale R.
   Neyaz, Marwah S.
   Joelson, Natalia Z.
   Cook, Daniel
TI Detection of swainsonine-producing endophytes in Patagonian Astragalus
   species
SO TOXICON
LA English
DT Article
DE Swainsonine; Endophyte; Alternaria; Astragalus; South America; Patagonia
ID ALKALOID SWAINSONINE; FUNGAL ENDOPHYTES; EMBELLISIA-OXYTROPIS; AMERICAN
   ASTRAGALUS; ALPHA-MANNOSIDASE; UNDIFILUM; LOCOWEEDS; CATTLE; SHEEP
AB Swainsonine has been identified as the toxin in legumes belonging to the genera Astragalus and Oxytropis throughout the world including China, North America, and South America. Several South American Astragalus species have been reported to contain swainsonine; however, data is lacking to support the presence of a fungal symbiont in South American Astragalus species as has been shown for North American and Chinese Astragalus and Oxytropis species. The objective of this study was to investigate several South American species that have been reported to contain swainsonine for the presence of the fungal symbiont using culturing and PCR. Swainsonine was detected in field collections of A. pehuenches, A. illinii and A. chamissonis but not A. moyanoi, which is consistent with reports of toxicity regarding these species. The symbiont Alternaria section Undifilum was detected by PCR in all three species that contained swainsonine but not in A. moyanoi. A fungal symbiont was isolated from seeds of Astragalus pehuenches and A. illinii. The isolated symbiont from both respective species produced swainsonine in vitro, and was demonstrated to belong to the genus Alternaria section Undifilum by analysis of the nuclear ribosomal DNA. It is highly likely that Alternaria section Undifilum isolates will be associated with other South American Astragalus species that are reported to contain swainsonine.
C1 [Martinez, Agustin; Robles, Carlos A.] INTA Bariloche, Natl Inst Agr Technol, Anim Hlth Grp, Modesta Victoria 4450, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.
   [Roper, Jessie M.; Gardner, Dale R.; Cook, Daniel] USDA ARS, Poisonous Plant Res Lab, Logan, UT 84341 USA.
   [Neyaz, Marwah S.] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA.
   [Joelson, Natalia Z.] Univ Nacl Comahue, Pasantia Estudiantil, San Carlos De Bariloche, Rio Negro, Argentina.
RP Martinez, A (reprint author), INTA Bariloche, Natl Inst Agr Technol, Anim Hlth Grp, Modesta Victoria 4450, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.
EM martinez.agustin@inta.gob.ar
OI Martinez, Agustin/0000-0002-1917-1104
FU National Institute for Agricultural Technology (INTA), Argentina;
   Regional Animal Health System -SIRSA-INTA Bariloche; Argentinian
   National Agency for Technology and Science Promotion (ANPCyT) PICT
   [20170900]
FX We thank MSc. Juan Pablo Mikuc and Dr. Alejandro Mogni from Chos Malal
   Rural Extension Agency of INTA who collected samples at Neuquen farms.
   We thank Dr. Donaldo Bran who identified the Astragalus species and
   Tech. Fernando Umaria who edited the map. This work was supported by the
   National Institute for Agricultural Technology (INTA), Argentina, with
   funds from the Regional Animal Health System -SIRSA-INTA Bariloche; and
   by grants from Argentinian National Agency for Technology and Science
   Promotion (ANPCyT) PICT #20170900.
CR Baucom DL, 2012, BOTANY, V90, P866, DOI [10.1139/B2012-056, 10.1139/b2012-056]
   Braun K, 2003, MYCOL RES, V107, P980, DOI 10.1017/S095375620300813X
   Burrows G.R., 2001, TOXIC PLANTS N AM
   COLEGATE SM, 1979, AUST J CHEM, V32, P2257, DOI 10.1071/CH9792257
   Colodel EM, 2002, PESQUI VET BRASIL, V22, P51, DOI 10.1590/S0100-736X2002000200004
   Cook D, 2017, TOXICON, V139, P54, DOI 10.1016/j.toxicon.2017.09.014
   Cook D, 2016, TOXICON, V118, P104, DOI 10.1016/j.toxicon.2016.04.033
   Cook D, 2014, J AGR FOOD CHEM, V62, P7326, DOI 10.1021/jf501674r
   Cook D, 2013, J AGR FOOD CHEM, V61, P3797, DOI 10.1021/jf4008423
   Cook D, 2011, J AGR FOOD CHEM, V59, P1281, DOI 10.1021/jf103551t
   Cook D, 2009, J CHEM ECOL, V35, P1272, DOI 10.1007/s10886-009-9710-9
   DORLING PR, 1980, BIOCHEM J, V191, P649, DOI 10.1042/bj1910649
   Gao XL, 2012, BIOCHEM SYST ECOL, V45, P79, DOI 10.1016/j.bse.2012.07.012
   Gardner DR, 2011, PHYTOCHEM ANALYSIS, V22, P124, DOI 10.1002/pca.1257
   Gardner DR, 2001, J AGR FOOD CHEM, V49, P4573, DOI 10.1021/jf010596p
   Grum DS, 2013, J NAT PROD, V76, P1984, DOI 10.1021/np400274n
   Huang Y. Q, 2003, SHANDONG SCI, V16, P34
   Lawrence DP, 2016, MYCOL PROG, V15, DOI 10.1007/s11557-015-1144-x
   LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994
   Marsh C.D., 1909, USDA BUREAU ANIMAL I, V112
   Martínez A, 2018, RIA. Rev. investig. agropecu., V44, P378
   Martinez A, 2019, TOXICON, V157, P84, DOI 10.1016/j.toxicon.2018.11.303
   Molyneux R. J., 1991, B SOC ARGENT BOT, V27, P59
   MOLYNEUX RJ, 1982, SCIENCE, V216, P190, DOI 10.1126/science.6801763
   MOLYNEUX RJ, 1994, PLANT-ASSOCIATION TOXINS, P107
   Pfister JA, 2003, J ANIM SCI, V81, P2285
   Pryor BM, 2009, BOTANY, V87, P178, DOI 10.1139/B08-130
   Ralphs MH, 2008, J CHEM ECOL, V34, P32, DOI 10.1007/s10886-007-9399-6
   Ralphs MH, 2011, FUNGAL ECOL, V4, P251, DOI 10.1016/j.funeco.2011.03.001
   Robles C. A., 2000, Revista de Medicina Veterinaria (Buenos Aires), V81, P380
   Stegelmeier BL, 2005, VET PATHOL, V42, P566, DOI 10.1354/vp.42-5-566
   Stegelmeier BL, 1999, J VET DIAGN INVEST, V11, P448, DOI 10.1177/104063879901100510
   Takeda S, 2014, J VET MED SCI, V76, P839, DOI 10.1292/jvms.14-0023
   TULSIANI DRP, 1988, ARCH BIOCHEM BIOPHYS, V264, P607, DOI 10.1016/0003-9861(88)90327-X
   Wang Q, 2006, MYCOTAXON, V95, P255
   Woudenberg JHC, 2013, STUD MYCOL, P171, DOI 10.3114/sim0015
   Yu YT, 2010, TOXICON, V56, P330, DOI 10.1016/j.toxicon.2010.03.020
NR 37
TC 0
Z9 0
U1 12
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 1
EP 6
DI 10.1016/j.toxicon.2019.09.020
PG 6
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300001
PM 31568759
DA 2020-05-12
ER

PT J
AU Diaz, C
   Rivera, J
   Lomonte, B
   Bonilla, F
   Diego-Garcia, E
   Camacho, E
   Tytgat, J
   Sasa, M
AF Diaz, Cecilia
   Rivera, Jennifer
   Lomonte, Bruno
   Bonilla, Fabian
   Diego-Garcia, Elia
   Camacho, Erika
   Tytgat, Jan
   Sasa, Mahmood
TI Venom characterization of the bark scorpion Centruroides edwardsii
   (Gervais 1843): Composition, biochemical activities and in vivo toxicity
   for potential prey
SO TOXICON
LA English
DT Article
DE Scorpion venom; Peptides; Hyaluronidase; Paralysis; Toxins
ID CORAL SNAKE MICRURUS; BETA-NEUROTOXIN; TOXINS; HYALURONIDASE;
   PURIFICATION; INHIBITION; DIVERSITY; EVOLUTION; CHANNELS; PANAMA
AB In this study, we characterize the venom of Centruroides edwardsii, one of the most abundant scorpions in urban and rural areas of Costa Rica, in terms of its biochemical constituents and their biological activities. C. edwardsii venom is rich in peptides but also contains some higher molecular weight protein components. No phospholipase A(2), hemolytic or fibrinogenolytic activities were found, but the presence of proteolytic and hyaluronidase enzymes was evidenced by zymography.
   Venom proteomic analysis indicates the presence of a hyaluronidase, several cysteine-rich secretory proteins, metalloproteinases and a peptidylglycine alpha-hydroxylating monooxygenase like-enzyme. It also includes peptides similar to the K+-channel blocker margatoxin, a dominant toxin in the venom of the related scorpion C. margaritatus. MS and N-terminal sequencing analysis also reveals the presence of Natchannel-modulating peptides with sequence similarity to orthologs present in other scorpion species of the genera Centruroides and Tityus. We purified the hyaluronidase (which co-eluted with an allergen 5-like CRISP) and sequenced similar to 60% of this enzyme. We also sequenced some venom gland transcripts that include other cysteine-containing peptides and a Non-Disulfide Bridged Peptide (NDBP).
   Our in vivo experiments characterizing the effects on potential predators and prey show that C. edwardsii venom induces paralysis in several species of arthropods and geckos; crickets being the most sensitive and cockroaches and scorpions the most resistant organisms tested. Envenomation signs were also observed in mice, but no lethality was reached by intraperitoneal administration of this venom up to 120 mu g/g body weight.
C1 [Diaz, Cecilia; Rivera, Jennifer; Lomonte, Bruno; Bonilla, Fabian; Camacho, Erika; Sasa, Mahmood] Inst Clodomiro Picado, Fac Microbiol, San Jose, Costa Rica.
   [Diaz, Cecilia] Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica.
   [Diego-Garcia, Elia; Tytgat, Jan] Univ Leuven, KU Leuven, Toxicol & Pharmacol, Leuven, Belgium.
   [Sasa, Mahmood] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.
   [Rivera, Jennifer] Refugio Nacl Vida Silvestre Punta Rio Claro, Parque Nacl Corcovado, Puntarenas, Costa Rica.
   [Diego-Garcia, Elia] CONACYT El Colegio Frontera Sur ECOSUR, Tapachula, Chiapas, Mexico.
RP Diaz, C (reprint author), Univ Costa Rica, Inst Clodomiro Picado, Fac Microbiol, San Jose 11501, Costa Rica.
EM cecilia.diaz@ucr.ac.cr
RI ; Lomonte, Bruno/B-8862-2019
OI Diego-Garcia, Elia/0000-0003-2408-4248; Lomonte,
   Bruno/0000-0003-2419-6469; Sasa, Mahmood/0000-0003-0118-5142
FU Vicerrectoria de InvestigaciOn (Universidad de Costa Rica) [741-A5-048]
FX This study was partially supported by Vicerrectoria de InvestigaciOn
   (Universidad de Costa Rica) through project No. 741-A5-048.
CR Acosta-Chaves Victor, 2015, Mesoamerican Herpetology, V2, P202
   An S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031920
   Armas L.F, 2008, B SOC ENTOMOL ARAGON, V4, P7
   Armas LF, 2011, EUSCORPIUS, V132, P1
   Barth T, 2019, J PROTEOMICS, V192, P102, DOI 10.1016/j.jprot.2018.08.012
   Batista CVF, 2002, TOXICON, V40, P557, DOI 10.1016/S0041-0101(01)00252-5
   Bende NS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5350
   Bordon KCF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0042-7
   Borges Adolfo, 2004, Invest. clín, V45, P269
   Brenes E, 2016, REV BIOL TROP, V64, P1019, DOI 10.15517/rbt.v64i3.21138
   Carmo AO, 2014, TOXICON, V90, P45, DOI 10.1016/j.toxicon.2014.07.014
   CEVALLOS MA, 1992, TOXICON, V30, P925, DOI 10.1016/0041-0101(92)90392-I
   Chippaux JP, 2012, DRUG DES DEV THER, V6, P165, DOI 10.2147/DDDT.S24754
   Coelho VA, 2014, TOXICON, V83, P15, DOI 10.1016/j.toxicon.2014.02.010
   de Armas L. F., 2012, B SOC ENTOMOLOGICA A, V50, P105
   DEARAUJO AL, 1987, TOXICON, V25, P1181, DOI 10.1016/0041-0101(87)90136-X
   Delafontaine M, 2017, TOXINS, V9, DOI 10.3390/toxins9080244
   Delgado-Prudencio G, 2019, TOXINS, V11, DOI 10.3390/toxins11070425
   Dias NB, 2018, J PROTEOMICS, V170, P70, DOI 10.1016/j.jprot.2017.09.006
   DSUZE G, 1995, TOXICON, V33, P333, DOI 10.1016/0041-0101(94)00171-4
   Duenas-Cuellar RA, 2015, PROTEIN PEPTIDE LETT, V22, P164
   Esposito LA, 2018, ARTHROPOD SYST PHYLO, V76, P87
   Estrada-Gomez S, 2014, TOXINS, V6, P2082, DOI 10.3390/toxins6072082
   Finney D.J., 1971, PROBIT ANAL
   FRIEDEL T, 1989, TOXICON, V27, P305, DOI 10.1016/0041-0101(89)90178-5
   GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866
   Gervais P.M, 1843, CR HEBD ACAD SCI, V5, P129
   Girish KS, 2006, LIFE SCI, V78, P1433, DOI 10.1016/j.lfs.2005.07.015
   Guerrero-Vargas JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030478
   GUTIERREZ JM, 1986, BRIT J EXP PATHOL, V67, P1
   Harris RJ, 2019, TOXINS, V11, DOI 10.3390/toxins11020060
   HERRON GS, 1986, J BIOL CHEM, V261, P2814
   Hjelle J.T., 1990, P9
   Jablonsky MJ, 1999, BIOCHEM BIOPH RES CO, V254, P406, DOI 10.1006/bbrc.1998.9904
   Jami S, 2018, TOXINS, V10, DOI 10.3390/toxins10010015
   Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261
   King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022
   Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009
   Kuzmenkov AI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1764, DOI 10.1134/S0006297915130118
   Langenegger N, 2018, J BIOL CHEM, V293, P2079, DOI 10.1074/jbc.M117.810911
   Laxme RRS, 2019, TOXICON, V158, P84, DOI 10.1016/j.toxicon.2018.11.433
   Lourenco WR, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-017-0138-3
   Mahadeswaraswamy YH, 2011, CURR TOP MED CHEM, V11, P2556
   Manzoli-Palma M. F., 2003, J. Venom. Anim. Toxins incl. Trop. Dis, V9, P174, DOI 10.1590/S1678-91992003000200004
   Miranda Roberto J., 2015, Revista Iberica de Aracnologia, V27, P115
   Mora-Obando D, 2014, PEERJ, V2, DOI 10.7717/peerj.569
   Mullen GR, 2019, MEDICAL AND VETERINARY ENTOMOLOGY, 3RD EDITION, P489, DOI 10.1016/B978-0-12-814043-7.00023-6
   Oliveira-Mendes BBR, 2019, PLOS NEGLECTED TROP, V13
   Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34
   Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121
   Pimenta AMC, 2001, TOXICON, V39, P1009, DOI 10.1016/S0041-0101(00)00240-3
   Ramirez K. L., 2016, SINGLE CELL BIOL, V5, P2, DOI [10.4172/2168-9431.1000138, DOI 10.4172/2168-9431.1000138]
   Ramirez-Dominguez ME, 2002, J EXP BIOL, V205, P869
   Rates B, 2008, TOXICON, V52, P611, DOI 10.1016/j.toxicon.2008.07.010
   Horta CCR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002693
   Rey-Suarez P, 2016, J PROTEOMICS, V136, P262, DOI 10.1016/j.jprot.2016.02.006
   Robertson DO, 2007, CRIT BLACK STUD SER, P39
   Rojas-Azofeifa D, 2019, COMP BIOCHEM PHYS C, V217, P54, DOI 10.1016/j.cbpc.2018.11.021
   Rucavado A, 1998, INT J EXP PATHOL, V79, P245
   Rungsa P, 2016, TOXICON, V119, P159, DOI 10.1016/j.toxicon.2016.06.005
   Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851
   Salazar MH, 2018, TOXICON, V141, P79, DOI 10.1016/j.toxicon.2017.11.013
   Santibanez-Lopez CE, 2016, TOXINS, V8, DOI 10.3390/toxins8010002
   SISSOM WD, 1987, J ARACHNOL, V15, P11
   Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456
   TREVORS JT, 1986, B ENVIRON CONTAM TOX, V37, P18, DOI 10.1007/BF01607723
   Ul-Hasan S, 2013, TOXICON, V74, P215, DOI 10.1016/j.toxicon.2013.08.054
   van der Meijden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078955
   Vandendriessche T, 2010, TOXICON, V56, P613, DOI 10.1016/j.toxicon.2010.06.008
   Ward MJ, 2018, TOXICON, V142, P14, DOI 10.1016/j.toxicon.2017.12.042
NR 70
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 7
EP 19
DI 10.1016/j.toxicon.2019.09.021
PG 13
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300002
PM 31585140
DA 2020-05-12
ER

PT J
AU Nunes, LD
   Stegelmeier, BL
   Cook, D
   Pfister, JA
   Gardner, DR
   Riet-Correa, F
   Welch, KD
AF Nunes, Louisiane de Carvalho
   Stegelmeier, Bryan L.
   Cook, Daniel
   Pfister, James A.
   Gardner, Dale R.
   Riet-Correa, Franklin
   Welch, Kevin D.
TI Clinical and pathological comparison of Astragalus lentiginosus and
   Ipomoea carnea poisoning in goats
SO TOXICON
LA English
DT Article
DE Swainsonine; Calystegines; Ipomoea; Astragalus; Locoweed
ID GLYCOSIDASE INHIBITORS SWAINSONINE; LOCOWEED ASTRAGALUS; CEREBELLAR
   DEGENERATION; ALKALOID SWAINSONINE; ALPHA-MANNOSIDASE; STORAGE DISEASE;
   CALYSTEGINES; SOLANUM; SHEEP; CASTANOSPERMINE
AB The indolizidine alkaloid swainsonine, found in some Astragalus and Oxytropis (i.e., locoweed) species, is a potent cellular glycosidase inhibitor that often poisons livestock. Other toxic genera such as some Ipomoea species also contain swainsonine as well as calystegines which are similar polyhydroxy alkaloids. The toxicity of calystegines is poorly characterized; however, they are also potent glycoside inhibitors capable of intestinal and cellular glycoside dysfunction. The objective of this study was to directly compare A. lentiginosus and I. cornea poisoning in goats to better characterize the role of the calystegines. Three groups of four goats each were treated with ground alfalfa (control), I. carnea or A. lentiginosus to obtain daily doses of 0.0, 1.5, and 1.5 mg swainsonine/kg bw per day, respectively, for 45 days. Animals were observed daily and weekly body weights, serum enzyme activities, and serum swainsonine concentrations were determined. At day 45 all animals were euthanized and necropsied. Goats treated with A. lentiginosus and I. cornea developed clinical disease characterized by mild intention tremors and proprioceptive deficits. Goats treated with A. lentiginosus developed clinical disease sooner and with greater consistency. No differences in body weight, serum swainsonine concentrations and serum enzyme activity were observed between goats treated with A. lentiginosus and L cornea. Additionally, there were no differences in the microscopic and histochemical studies of the visceral and neurologic lesions observed between goats treated with A. lentiginosus and I. carnea. These findings suggest that I. cornea-induced clinical signs and lesions are due to swainsonine and that calystegines contribute little or nothing to toxicity in goats in the presence of swainsonine.
C1 [Nunes, Louisiane de Carvalho] Univ Fed Espirito Santo, Dept Vet Sci, Alegre, ES, Brazil.
   [Stegelmeier, Bryan L.; Cook, Daniel; Pfister, James A.; Gardner, Dale R.; Welch, Kevin D.] USDA ARS, Poisonous Plant Res Lab, 1150 E 1400 N, Logan, UT 84341 USA.
   [Riet-Correa, Franklin] Inst Nacl Invest Agr, La Estanzuela, Colonia, Uruguay.
   [Riet-Correa, Franklin] Univ Fed Campina Grande, Ctr Hlth & Rural Technol, Vet Hosp, Patos Campus, Patos de Minas, Brazil.
RP Stegelmeier, BL; Cook, D (reprint author), USDA ARS, Poisonous Plant Res Lab, 1150 E 1400 N, Logan, UT 84341 USA.
EM Daniel.Cook@usda.gov
FU CAPESCAPES
FX We thank Kermit Price, Edward Knoppel, Joseph Jacobson, and Scott Larsen
   for their technical assistance. Louisiane de Carvalho Nunes was funded
   by a fellowship from CAPES.
CR ADAM SEI, 1973, J COMP PATHOL, V83, P531, DOI 10.1016/0021-9975(73)90011-X
   Armien AG, 2007, VET PATHOL, V44, P170, DOI 10.1354/vp.44-2-170
   Armien AG, 2011, J VET DIAGN INVEST, V23, P221, DOI 10.1177/104063871102300205
   Asano N, 1997, GLYCOBIOLOGY, V7, P1085, DOI 10.1093/glycob/7.8.1085
   BOWEN D, 1993, ANTICANCER RES, V13, P841
   Braun K, 2003, MYCOL RES, V107, P980, DOI 10.1017/S095375620300813X
   Burrows G.R., 2001, TOXIC PLANTS N AM
   CARSON FL, 1997, HISTOTECHNOLOGY SELF
   COLEGATE SM, 1979, AUST J CHEM, V32, P2257, DOI 10.1071/CH9792257
   Colodel EM, 2002, VET HUM TOXICOL, V44, P177
   Cook D, 2015, TOXICON, V95, P62, DOI 10.1016/j.toxicon.2015.01.002
   Cook D, 2014, J AGR FOOD CHEM, V62, P7326, DOI 10.1021/jf501674r
   Cook D, 2013, J AGR FOOD CHEM, V61, P3797, DOI 10.1021/jf4008423
   Cook D, 2011, J AGR FOOD CHEM, V59, P1281, DOI 10.1021/jf103551t
   DAMIR HA, 1987, VET HUM TOXICOL, V29, P316
   de Balogh KKIM, 1999, J VET DIAGN INVEST, V11, P266, DOI 10.1177/104063879901100310
   DEBARROS SS, 1987, PESQUISA VET BRASIL, V7, P1
   DORLING PR, 1980, BIOCHEM J, V191, P649, DOI 10.1042/bj1910649
   Eich E., 2008, SOLANACEAE CONVOLVUL, P213
   ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393
   Gardner DR, 2016, J AGR FOOD CHEM, V64, P6156, DOI 10.1021/acs.jafc.6b02390
   Gardner DR, 2011, PHYTOCHEM ANALYSIS, V22, P124, DOI 10.1002/pca.1257
   Gardner DR, 2001, J AGR FOOD CHEM, V49, P4573, DOI 10.1021/jf010596p
   GOTO N, 1987, STAIN TECHNOL, V62, P305, DOI 10.3109/10520298709108015
   Grum DS, 2013, J NAT PROD, V76, P1984, DOI 10.1021/np400274n
   Haraguchi M, 2003, J AGR FOOD CHEM, V51, P4995, DOI 10.1021/jf0341722
   Hueza IM, 2005, EXP TOXICOL PATHOL, V57, P53, DOI 10.1016/j.etp.2005.02.004
   Idris O.F., 1973, ANIM HLTH PROD, V5, P119
   JAMES LF, 1970, PATHOL VET, V7, P116, DOI 10.1177/030098587000700203
   Jockovic N, 2013, J AGR FOOD CHEM, V61, P5550, DOI 10.1021/jf4010737
   Salinas LM, 2019, TOXICON, V157, P8, DOI 10.1016/j.toxicon.2018.11.291
   Verdes JM, 2006, J VET DIAGN INVEST, V18, P299, DOI 10.1177/104063870601800314
   MOLYNEUX RJ, 1982, SCIENCE, V216, P190, DOI 10.1126/science.6801763
   MOLYNEUX RJ, 1995, J NAT PRODUCTS, V58, P878, DOI 10.1021/np50120a009
   MOLYNEUX RJ, 1994, PLANT-ASSOCIATION TOXINS, P107
   NASH RJ, 1993, PHYTOCHEMISTRY, V34, P1281, DOI 10.1016/0031-9422(91)80016-T
   Oliveira CA, 2015, CIENC RURAL, V45, P1634, DOI 10.1590/0103-8478cr20141668
   Pienaar J.G, 1976, BR ONDERSTEPOORT J V, V43, P67
   RIETCORREA F, 1983, CORNELL VET, V73, P240
   Schimming T, 2005, PHYTOCHEMISTRY, V66, P469, DOI 10.1016/j.phytochem.2004.12.024
   Stegelmeier BL, 1998, J ANIM SCI, V76, P1140
   STEGELMEIER BL, 1995, VET PATHOL, V32, P289, DOI 10.1177/030098589503200311
   Stegelmeier BL, 2005, VET PATHOL, V42, P566, DOI 10.1354/vp.42-5-566
   Stegelmeier BL, 1999, J VET DIAGN INVEST, V11, P448, DOI 10.1177/104063879901100510
   Stegelmeier BL, 1999, J NAT TOXINS, V8, P35
   Stegelmeier BL, 2008, TOXICOL PATHOL, V36, P651, DOI 10.1177/0192623308317420
   TARTOUR G, 1973, Tropical Animal Health and Production, V5, P284, DOI 10.1007/BF02240431
   TIRKEY K, 1987, INDIAN J ANIM SCI, V57, P1019
   WEIBEL ER, 1963, LAB INVEST, V12, P131
   YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x
NR 50
TC 0
Z9 0
U1 2
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 20
EP 28
DI 10.1016/j.toxicon.2019.09.016
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300003
PM 31542469
DA 2020-05-12
ER

PT J
AU Cochran, C
   Hax, S
   Hayes, WK
AF Cochran, Chip
   Hax, Scott
   Hayes, William K.
TI Case reports of envenomation and venom composition differences between
   two Arizona populations of the Southwestern Speckled Rattlesnake,
   Crotalus pyrrhus (Cope, 1867)
SO TOXICON
LA English
DT Article
DE Crotalus pyrrhus; Snake bite; Envenomation; Antivenom; CroFab; AnaVip
ID MOJAVE RATTLESNAKE; VIRIDIS-HELLERI; SNAKEBITE; NEUROTOXICITY;
   EPIDEMIOLOGY; ANTIVENOM
AB Envenomations by the Southwestern Speckled Rattlesnake (Crotalus pyrrhus) are fairly rare. Previous descriptions in the literature do not include locality, an important factor in the clinical symptoms or syndromes of snakebites resulting from geographic variation in venom composition. Here, we describe two cases of envenoming by C. pyrrhus from two Arizona localities (Tinajas Altas Mountains, Yuma County, and Phoenix Mountains, Maricopa County). Both patients experienced swelling, but neither demonstrated coagulopathy, thrombocytopenia, or hypofibrinogenemia. The Phoenix Mountains patient developed hemorrhagic bullae and tissue damage in his bitten extremity, necessitating the amputation of the distal portion of his middle finger. Treatment for both consisted of medication for pain, isotonic crystalloid, and antivenom therapy with recovery in each case. Based on visual inspection of 1D-gels and RP-HPLC chromatograms, venom samples were largely similar but appeared to differ quantitatively for several toxin families between and within populations.
C1 [Cochran, Chip; Hayes, William K.] Loma Linda Univ, Dept Earth & Biol Sci, Loma Linda, CA 92350 USA.
   [Hax, Scott] Air Methods Corp, C NPT, FP C, NR P, Mesa, AZ 84204 USA.
   [Hax, Scott] Mesa Community Coll, Mesa, AZ 85202 USA.
RP Cochran, C (reprint author), Loma Linda Univ, Dept Earth & Biol Sci, Loma Linda, CA 92350 USA.
EM rcochran@llu.edu
RI Hayes, William/L-1284-2013
OI Hayes, William/0000-0002-0903-0519
FU National Science FoundationNational Science Foundation (NSF) [1343166];
   Chicago Herpetological Society; SciFund crowdfunders; Loma Linda
   University Department of Earth and Biological Sciences
FX We would like to thank both of the bite victims for providing us with
   their medical records and photographs. Research was approved by the Loma
   Linda University Institutional Animal Care and Use Committee (IACUC
   protocols #8110041, #8140057, #818007) and conducted under permits
   issued by Arizona Game and Fish Department (SP730815, SPS551534,
   SP621268, SP667726, SP714735, SP743315, SP509441) and the City of
   Phoenix Parks and Recreation Department. This material is based upon
   work supported by the National Science Foundation Graduate Research
   Fellowship under Award Number 1343166 to CC. Any opinion, findings, and
   conclusions or recommendations expressed in this material are those of
   the authors and do not necessarily reflect the views of the National
   Science Foundation. The Chicago Herpetological Society, SciFund
   crowdfunders, and the Loma Linda University Department of Earth and
   Biological Sciences also financially supported CC in this research.
CR Arnold R.E., 1982, RATTLESNAKE VENOMS T, P315
   AZEVEDOMARQUES MM, 1985, TOXICON, V23, P631, DOI 10.1016/0041-0101(85)90367-8
   Boyer L, 2015, VENOMOUS REPTILES TH, P32
   Bush SP, 2015, CLIN TOXICOL, V53, P37, DOI 10.3109/15563650.2014.974263
   Bush SP, 2002, ANN EMERG MED, V40, P619, DOI 10.1067/mem.2002.129939
   Bush SP, 1999, WILD ENVIRON MED, V10, P247, DOI 10.1580/1080-6032(1999)010[0247:NAWSSP]2.3.CO;2
   Campbell JA, 2004, VENOMOUS REPTILES W, V2
   CAMPBELL JA, 2004, VENOMOUS REPTILES W, V1
   Casewell N.R., 2015, VENOMOUS REPTILES TH, P347
   Cochran C., 2019, THESIS
   Cope E.D., 1867, P ACAD NAT SCI PHILA, V18, P300
   Corbit A.G., 2015, THESIS, P20
   Dart RC, 1996, ANN EMERG MED, V27, P321, DOI 10.1016/S0196-0644(96)70267-6
   Fowlie J. A., 1965, SNAKES ARIZONA THEIR
   Fox Jay W., 2010, P95
   GLENN JL, 1985, TOXICON, V23, P769, DOI 10.1016/0041-0101(85)90007-8
   GLENN JL, 1977, TOXICON, V16, P81
   Gutierrez Jose Maria, 2010, P115
   HARDY DL, 1982, TOXICON, V20, P487, DOI 10.1016/0041-0101(82)90012-5
   Hartnett W.G., 1931, OHIO STATE MED J, V27, P636
   Hayes WK, 2010, WILD ENVIRON MED, V21, P35, DOI 10.1016/j.wem.2010.01.006
   JANSEN PW, 1992, ANN EMERG MED, V21, P322, DOI 10.1016/S0196-0644(05)80898-4
   Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218
   Klauber L. M, 1997, RATTLESNAKES THEIR H
   Klauber L.M., 1936, T SAN DIEGO SOC NAT, V7, P149
   LOWE CH, 1986, VENOMOUS REPTILES AR
   MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927
   MACKESSY SP, 2008, BIOL RATTLESNAKES, P495
   Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035
   O'Neil ME, 2007, WILD ENVIRON MED, V18, P281, DOI 10.1580/06-WEME-OR-080R1.1
   Ownby C.L., 1982, RATTLESNAKE VENOMS T, P163
   Pitts SL, 2017, WEST N AM NATURALIST, V77, P309, DOI 10.3398/064.077.0304
   Ruha AM, 2017, J MED TOXICOL, V13, P309, DOI 10.1007/s13181-017-0633-5
   RUSSELL FE, 1969, TOXICON, V7, P33, DOI 10.1016/0041-0101(69)90160-3
   Sunagar K, 2014, J PROTEOMICS, V99, P68, DOI [10.1016/j.jprot.2014.01.013, 10.1016]
   Tanen DA, 2001, ACAD EMERG MED, V8, P177, DOI 10.1111/j.1553-2712.2001.tb01284.x
   Tokish JT, 2001, J ORTHOP TRAUMA, V15, P5, DOI 10.1097/00005131-200101000-00002
   Wilkinson J.A., 1991, DISTRIBUTION GENETIC, P54
   Yoshida-Kanashiro Erika, 2003, Rev Cubana Med Trop, V55, P38
NR 39
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 29
EP 34
DI 10.1016/j.toxicon.2019.09.022
PG 6
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300004
PM 31585139
DA 2020-05-12
ER

PT J
AU Hassan, AA
   Abu Hafsa, SH
   Elghandour, MMMY
   Reddy, PRK
   Monroy, JC
   Salem, AZM
AF Hassan, Ayman A.
   Abu Hafsa, Salma H.
   Elghandour, Mona M. M. Y.
   Reddy, Poonooru Ravi Kanth
   Monroy, Jose Cedillo
   Salem, Abdelfattah Z. M.
TI Dietary Supplementation with sodium bentonite and coumarin alleviates
   the toxicity of aflatoxin B-1 in rabbits
SO TOXICON
LA English
DT Article
DE Rabbits; Aflatoxin; Sodium bentonite; Coumarin; Toxicity
ID NUTRIENT DIGESTIBILITY; GROWTH-PERFORMANCE; GENE-EXPRESSION; BROILER;
   EFFICACY; HISTOPATHOLOGY; GLUTATHIONE; METABOLISM; RESIDUES; RUMEN
AB Eighty-four male New Zealand White rabbits with average body weight 778 +/- 65 g were blocked into four groups to evaluate the ability of sodium bentonite and coumarin in alleviating the toxicity of aflatoxin B1. The first group was fed on a diet without any treatment (CON), while the remaining three diets were added with aflatoxin B1 at 0.25 ppm diet. Diet fed to the third and fourth group of rabbits were further supplemented with sodium bentonite at 5 g/kg (SOB) and coumarin at 5 g/kg (COL) of the diet, respectively. Feeding aflatoxin-contaminated diet (AFL) caused necrosis of liver tissue and reduced the weight gain, average daily gain, feed conversion ratio, nutrient digestibility coefficients, and nitrogen balance of rabbits. This, in turn, was reflected as a reduction in carcass characteristics. The serum collected from rabbits fed aflatoxin-contaminated diet showed decreased levels of total protein, albumin, globulin, glucose, total cholesterol, and triglycerides, and increased concentrations of urea, creatinine, and liver enzymes. Further, aflatoxin diet increased the cecal pH, and decreased the ammonia nitrogen, total volatile fatty acids, and individual fatty acids proportion of cecal fluid. Supplementing sodium bentonite and coumarin at 5 g/kg diet reduced the negative effects of aflatoxin B1 on growth performance, digestibility of nutrients, biochemical parameters, carcass characteristics, and cecal fermentation profile. Furthermore, the coumarin-supplemented group showed better body weight gains and carcass weights compared to the rabbits fed with diets containing sodium bentonite. In conclusion, both sodium bentonite and coumarin supplementation was beneficial in ameliorating the toxicity of aflatoxin B1. Further, the increased body weight gains and better-feed conversion in coumarin-supplemented rabbits project the coumarin as a better anti-aflatoxigenic supplement.
C1 [Hassan, Ayman A.] Minist Agr, Anim Prod Res Inst, Dokki, Gizza, Egypt.
   [Abu Hafsa, Salma H.] City Sci Res & Technol Applicat, Livestock Dept, Alexandria, Egypt.
   [Elghandour, Mona M. M. Y.; Salem, Abdelfattah Z. M.] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Toluca, Mexico.
   [Reddy, Poonooru Ravi Kanth] Sri Venkateswara Vet Univ, Coll Vet Sci, Dept Livestock Farm Complex, Proddatur 516360, Andhra Pradesh, India.
   [Monroy, Jose Cedillo] Univ Autonoma Estado Mexico, Ctr Univ UAEM Temascaltepec, Toluca, Mexico.
RP Salem, AZM (reprint author), Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Toluca, Mexico.
EM asalem70@yahoo.com
RI Salem, A.Z.M./K-1495-2014
OI Salem, A.Z.M./0000-0001-7418-4170
CR Abbasi F, 2018, ASIAN AUSTRAL J ANIM, V31, P91, DOI 10.5713/ajas.17.0383
   Abdel-Wahhab MA, 2010, FOOD CHEM TOXICOL, V48, P733, DOI 10.1016/j.fct.2009.12.006
   Amer SA, 2018, ENVIRON SCI POLLUT R, V25, P1340, DOI 10.1007/s11356-017-0578-x
   AOAC, 1990, 97417 AOAC, P1199
   AOAC, 2005, OFFICIAL METHODS ANA
   Barati M, 2017, J APPL ANIM RES, V46, P707, DOI 10.1080/09712119.2017.1388243
   Bbosa GS, 2013, AFLATOXINS - RECENT ADVANCES AND FUTURE PROSPECTS, P239, DOI 10.5772/51201
   Brahmi D, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-111
   Chandra H., 2015, J MIC IMMUN BIOTECH, V2, P5
   CHANEY AL, 1962, CLIN CHEM, V8, P130
   Danicke S, 2003, BRIT POULTRY SCI, V44, P113, DOI 10.1080/0007166031000085300
   Devienne KF, 2005, PHYTOMEDICINE, V12, P378, DOI 10.1016/j.phymed.2003.09.010
   Devreese M, 2012, FOOD ADDIT CONTAM A, V29, P1101, DOI 10.1080/19440049.2012.671788
   EADIE JM, 1967, ANIM PROD, V9, P247, DOI 10.1017/S0003356100038514
   EFSA, 2010, EFSA J, V8, P1963, DOI DOI 10.2903/J.EFSA.2010.1693
   Elzaki MEA, 2019, PESTIC BIOCHEM PHYS, V157, P211, DOI 10.1016/j.pestbp.2019.03.020
   Feddern V, 2013, AFLATOXINS - RECENT ADVANCES AND FUTURE PROSPECTS, P171, DOI 10.5772/51952
   Furniss B.S., 1978, TXB PARTICAL ORGANIC
   Guilford FT, 2014, TOXINS, V6, P608, DOI 10.3390/toxins6020608
   Gul H, 2017, KAFKAS UNIV VET FAK, V23, P31, DOI 10.9775/kvfd.2016.15714
   Hahn D.Y., 1966, J PHARM SOC KOREA, V10, P25
   Hassan A.A., 2016, INT J CURRENT RES, V8, P25547
   He J, 2013, LIVEST SCI, V152, P192, DOI 10.1016/j.livsci.2012.12.019
   Helal A.A.A., 2014, ZAGAZIG J AGR RES, V41, P803
   Hussain Z, 2016, PAK VET J, V36, P477
   Hussain Z, 2010, FOOD CHEM TOXICOL, V48, P3304, DOI 10.1016/j.fct.2010.08.016
   Jacobson LH, 2002, MEAT SCI, V62, P93, DOI 10.1016/S0309-1740(01)00233-9
   Jedziniak P, 2019, J SEP SCI, V42, P1240, DOI 10.1002/jssc.201801113
   Karaca A, 2019, ARCH PHYSIOL BIOCHEM, DOI 10.1080/13813455.2019.1648516
   Kelly VP, 2000, CANCER RES, V60, P957
   Ko YD, 2006, ANIM FEED SCI TECH, V125, P99, DOI 10.1016/j.anifeedsci.2005.05.014
   Kumar P., 2017, FRONT MICROBIOL, V7
   Liew WPP, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00060
   Ma QG, 2015, TOXINS, V7, P5435, DOI 10.3390/toxins7124879
   Mathew S, 1997, INDIAN J ANIM SCI, V67, P805
   Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004
   Meshreky S.Z., 2007, HOT CLIM, P287
   Mezes M., 2008, P 9 WORLD RABB C JUN, P491
   Miazzo R, 2005, POULTRY SCI, V84, P1, DOI 10.1093/ps/84.1.1
   Mirabdolbagi J., 2007, P 2 C AN SCI SEAF MA, P942
   Nazarizadeh H, 2019, J APPL ANIM RES, V47, P135, DOI 10.1080/09712119.2019.1584106
   Pandey I, 2007, BRIT POULTRY SCI, V48, P713, DOI 10.1080/00071660701713534
   Pasha TN, 2007, ANIM FEED SCI TECH, V132, P103, DOI 10.1016/j.anifeedsci.2006.03.014
   Qu DF, 2017, ITAL J ANIM SCI, V16, P573, DOI [10.1080/1828051X.2017.1302822, 10.1080/1828051x.2017.1302822]
   Rohini K., 2014, J THERMODYN CATAL, V5, P5, DOI DOI 10.4172/2157-7544.1000130
   Rotimi OA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00467
   Rotimi OA, 2017, TOXICOL REP, V4, P408, DOI 10.1016/j.toxrep.2017.07.006
   Shehata S. A., 2010, Egyptian Journal of Nutrition and Feeds, V13, P137
   Shehata S. A., 2012, Egyptian Journal of Nutrition and Feeds, V15, P185
   Tavcar-Kalcher G, 2007, FOOD CONTROL, V18, P333, DOI 10.1016/j.foodcont.2005.10.016
   Tulayakul P, 2007, TOXICON, V50, P339, DOI 10.1016/j.toxicon.2007.04.005
   Yaman T, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1217-7
   Yunus AW, 2011, TOXINS, V3, P566, DOI 10.3390/toxins3060566
NR 53
TC 1
Z9 1
U1 8
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 35
EP 42
DI 10.1016/j.toxicon.2019.09.014
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300005
PM 31526810
DA 2020-05-12
ER

PT J
AU Al-Jaal, B
   Salama, S
   Al-Qasmi, N
   Jaganjac, M
AF Al-Jaal, Beiges
   Salama, Sofia
   Al-Qasmi, Noof
   Jaganjac, Morana
TI Mycotoxin contamination of food and feed in the Gulf Cooperation Council
   countries and its detection
SO TOXICON
LA English
DT Review
DE Mycotoxins; Food and feed; GCC countries
ID AFLATOXIN CONTAMINATION; JEDDAH MARKET; FUNGAL FLORA; ZEARALENONE;
   FUMONISIN; PRODUCTS; TRICHOTHECENES; EXPOSURE; UPDATE; WHEAT
AB Mycotoxins are secondary metabolites produced by different fungal spices and are found in diverse agricultural crops worldwide; they pose a severe threat to public health. Mycotoxins can cause either acute or chronic symptoms, depending on the type and dose of mycotoxin one has been exposed to. Thus, a continuous monitoring of mycotoxins is needed. Since the discovery of mycotoxins, numerous countries, including the Gulf Cooperation Council (GCC) countries, have established mycotoxin-specific regulations for feed and food. Although a number of studies in GCC countries have investigated the presence of mycotoxins, till date, there are no reviews focusing on the mycotoxin contamination of the food and feed from this region. This review is the first study to present an up-to-date overview of the occurrence of mycotoxins in feed and food in the GCC countries and to discuss the techniques used for mycotoxin analysis.
C1 [Al-Jaal, Beiges; Salama, Sofia; Al-Qasmi, Noof; Jaganjac, Morana] Antidoping Lab Qatar, Sport City St, Doha, Qatar.
RP Jaganjac, M (reprint author), Anti Doping Lab Qatar, Qatar Analyt & Biores Lab, Sect Head Generat Metabolites, POB 27775, Doha, Qatar.
EM mjaganjac@adlqatar.qa
OI Jaganjac, Morana/0000-0001-5051-1843
FU Qatar National Research Fund [NPRP8-1472-3-290]
FX The study was supported by the Qatar National Research Fund (Grant No.
   NPRP8-1472-3-290).
CR ABDELGAWAD KM, 1993, MYCOPATHOLOGIA, V124, P55, DOI 10.1007/BF01103057
   Abdulkadar AHW, 2004, FOOD CONTROL, V15, P543, DOI 10.1016/j.foodcont.2003.08.008
   Abdulkadar AHW, 2000, FOOD CONTROL, V11, P157, DOI 10.1016/S0956-7135(99)00088-2
   Abudabos AM, 2017, ENVIRON SCI POLLUT R, V24, P15401, DOI 10.1007/s11356-017-9130-2
   Adhikari M, 2017, ONCOTARGET, V8, P33933, DOI 10.18632/oncotarget.15422
   Al Jaal BA, 2019, FOOD CHEM TOXICOL, V129, P211, DOI 10.1016/j.fct.2019.04.047
   Al Jabir M, 2019, TOXICOL REP, V6, P975, DOI 10.1016/j.toxrep.2019.09.009
   Al-Hazmi N A, 2010, Saudi J Biol Sci, V17, P353, DOI 10.1016/j.sjbs.2010.06.006
   Al-Hazmi NA, 2010, AFR J MICROBIOL RES, V4, P2513
   Al-Hazmi NA, 2011, AFR J BIOTECHNOL, V10, P168
   Al-Julaifi MZ, 2001, J FOOD PROTECT, V64, P1603, DOI 10.4315/0362-028X-64.10.1603
   Alhussaini M. S., 2012, The Journal of American Science, V8, P525
   Alshannaq A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060632
   Beg MU, 2006, ARCH ENVIRON CON TOX, V50, P594, DOI 10.1007/s00244-005-2094-0
   Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003
   Berthiller F, 2018, WORLD MYCOTOXIN J, V11, P5, DOI 10.3920/WMJ2017.2250
   Bhat R, 2017, FOOD CHEM, V215, P425, DOI 10.1016/j.foodchem.2016.07.161
   Bokhari Fardos M., 2010, Saudi Journal of Biological Sciences, V17, P73, DOI 10.1016/j.sjbs.2009.12.011
   Bokhari Fardos M., 2007, Mycobiology, V35, P47, DOI 10.4489/MYCO.2007.35.2.047
   CHU FS, 1994, APPL ENVIRON MICROB, V60, P847, DOI 10.1128/AEM.60.3.847-852.1994
   Dashti B, 2009, FOOD CONTROL, V20, P686, DOI 10.1016/j.foodcont.2009.01.001
   EFSA, 2005, EFSA J, V235, P1, DOI DOI 10.2903/J.EFSA.2005.235
   Egbuta MA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070719
   Elshafie AE, 2002, MYCOPATHOLOGIA, V155, P155, DOI 10.1023/A:1020427527963
   Elzupir AO, 2019, REV FR ALLERGOL, V59, P15, DOI 10.1016/j.reval.2018.09.009
   Garcia-Cela E, 2012, FOOD CONTROL, V25, P797, DOI 10.1016/j.foodcont.2011.12.009
   Gashlan HM, 2009, SCI RES ESSAYS, V4, P69
   Gherbawy Y, 2018, FOOD SCI TECHNOL RES, V24, P87, DOI 10.3136/fstr.24.87
   GSO, 1997, 8411997 GSO GCC
   Hammami W, 2017, J INFECT DEV COUNTR, V11, P343, DOI 10.3855/jidc.9043
   Hammami W, 2014, FOOD CONTROL, V37, P177, DOI 10.1016/j.foodcont.2013.09.027
   Hassan ZU, 2018, FOOD CONTROL, V84, P389, DOI 10.1016/j.foodcont.2017.08.032
   Hooper DG, 2009, INT J MOL SCI, V10, P1465, DOI 10.3390/ijms10041465
   Hueza IM, 2014, TOXINS, V6, P1080, DOI 10.3390/toxins6031080
   IARC, 2014, WORLD CANC REPORT 20
   IARC Monographs on the evaluation of carcinogenic risks to humans, 2002, IARC MON EV CARC RIS, V82
   Jaganjac M, 2016, FRONT BIOSCI-LANDMRK, V21, P839, DOI 10.2741/4423
   Jaganjac M, 2012, CROAT MED J, V53, P304, DOI 10.3325/cmj.2012.53.304
   Kew MC, 2013, J GASTROINTEST LIVER, V22, P305
   KOK WT, 1986, J CHROMATOGR, V367, P231, DOI 10.1016/S0021-9673(00)94838-6
   Koszegi T, 2016, TOXINS, V8, DOI 10.3390/toxins8040111
   Kuiper-Goodman T, 1989, Biomed Environ Sci, V2, P179
   Li FH, 2015, FOOD ADDIT CONTAM B, V8, P169, DOI 10.1080/19393210.2015.1028480
   Lock EA, 2004, CRIT REV TOXICOL, V34, P211, DOI 10.1080/10408440490265210
   Loi M, 2017, TOXINS, V9, DOI 10.3390/toxins9040111
   Malir F, 2016, TOXINS, V8, DOI 10.3390/toxins8070191
   Mannaa M, 2017, MYCOBIOLOGY, V45, P240, DOI 10.5941/MYCO.2017.45.4.240
   Marin S, 2013, FOOD CHEM TOXICOL, V60, P218, DOI 10.1016/j.fct.2013.07.047
   Mathuria N, 2008, FERTIL STERIL, V90, P775, DOI 10.1016/j.fertnstert.2007.07.1300
   Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P2587, DOI 10.3748/wjg.v19.i17.2587
   Milicevic DR, 2010, TOXINS, V2, P572, DOI 10.3390/toxins2040572
   Musaiger AO, 2008, FOOD CONTROL, V19, P854, DOI 10.1016/j.foodcont.2007.08.011
   Osman N, 1999, Mycotoxin Res, V15, P39, DOI 10.1007/BF02945213
   Peraica M, 1999, B WORLD HEALTH ORGAN, V77, P754
   Peraica Maja, 2001, Arhiv za Higijenu Rada i Toksikologiju, V52, P23
   Pierron A, 2016, ANIM NUTR, V2, P63, DOI 10.1016/j.aninu.2016.03.001
   Piotrowska M., 2013, SOYBEAN PEST RESISTA, P185
   Qing-Hua W., 2014, MIL MED SCI LETT, V83, P114, DOI [10.31482/mms1.2014.021, DOI 10.31482/MMS1.2014.021]
   Roseanu Anca, 2010, Romanian Journal of Biochemistry, V47, P79
   Saad A M, 1989, Mycotoxin Res, V5, P57, DOI 10.1007/BF03192122
   Smith LE, 2017, AM J TROP MED HYG, V96, P770, DOI 10.4269/ajtmh.16-0730
   Smith MC, 2016, TOXINS, V8, DOI 10.3390/toxins8040094
   Stockmann-Juvala H, 2008, HUM EXP TOXICOL, V27, P799, DOI 10.1177/0960327108099525
   Sweeney MJ, 1998, INT J FOOD MICROBIOL, V43, P141, DOI 10.1016/S0168-1605(98)00112-3
   Tittlemier SA, 2019, WORLD MYCOTOXIN J, V12, P3, DOI [10.3920/WMJ2018.2398, 10.3920/WMJ2019.2535]
   Turner NW, 2015, ANAL CHIM ACTA, V901, P12, DOI 10.1016/j.aca.2015.10.013
   Turner NW, 2009, ANAL CHIM ACTA, V632, P168, DOI 10.1016/j.aca.2008.11.010
   Ul Hassan Z, 2018, FOOD CONTROL, V92, P25, DOI 10.1016/j.foodcont.2018.04.038
   Ul Hassan Z, 2018, FOOD ADDIT CONTAM B, V11, P191, DOI 10.1080/19393210.2018.1437785
   Urusov AE, 2015, TOXINS, V7, P238, DOI 10.3390/toxins7020238
   van Egmond HP, 2007, ANAL BIOANAL CHEM, V389, P147, DOI 10.1007/s00216-007-1317-9
   Voss K.A, 2013, FOOD SAFETY, V1
   Wacoo A.P., 2014, J APPL CHEM-USSR, V15, P706291, DOI [DOI 10.1155/2014/706291, 10.1155/2014/706291]
   Wang YK, 2014, FOOD CONTROL, V40, P41, DOI 10.1016/j.foodcont.2013.11.025
   Warth B, 2012, J AGR FOOD CHEM, V60, P9352, DOI 10.1021/jf302003n
   Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264
   Williams JH, 2004, AM J CLIN NUTR, V80, P1106
   Wu QH, 2010, DRUG METAB REV, V42, P250, DOI [10.1080/03602530903125807, 10.3109/03602530903125807]
   Wu WD, 2015, TOXICOL REP, V2, P238, DOI 10.1016/j.toxrep.2014.12.010
   Yazar S, 2008, INT J MOL SCI, V9, P2062, DOI 10.3390/ijms9112062
   Zain ME, 2011, J SAUDI CHEM SOC, V15, P129, DOI 10.1016/j.jscs.2010.06.006
   Zarkovic N, 2013, J PROTEOMICS, V92, P239, DOI 10.1016/j.jprot.2013.02.004
   Zhang L, 2018, TOXINS, V10, DOI 10.3390/toxins10020065
   Zheng MZ, 2006, MYCOPATHOLOGIA, V161, P261, DOI 10.1007/s11046-006-0215-6
NR 84
TC 1
Z9 1
U1 19
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 43
EP 50
DI 10.1016/j.toxicon.2019.10.003
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300006
PM 31586556
DA 2020-05-12
ER

PT J
AU Rzymski, P
   Evans, DM
   Murphy, PJ
   Kokociriski, M
AF Rzymski, Piotr
   Evans, Daniel M.
   Murphy, Patrick J.
   Kokociriski, Mikolaj
TI A study of polymethoxy-1-alkenes in Raphidiopsis (Cylindrospermopsis)
   raciborskii and Aphanizomenon gracile isolated in Poland
SO TOXICON
LA English
DT Article
DE Polymethoxy-1-alkenes; Cyanobacteria; Cylindrospermopsis raciborskii;
   Aphanizomenon gracile
ID ISOTACTIC POLYMETHOXY-1-ALKENES; HUMAN HEALTH; GREEN-ALGAE;
   CYANOBACTERIA; TOXICITY; OVALISPORUM; STRAINS; THREAT; RISK
AB Previous studies indicated that teratogenic polymethoxy-1-alkenes (PMAs) are produced by phylogenetically diverse cyanobacteria taxa, however corresponding studies on the occurrence of PMAs in European cyanobacteria are lacking. Herein, the presence of PMAs in strains of Raphidiopsis raciborskii and Aphanizomenon gracile isolated from surface waters in Poland was studied using nuclear magnetic resonance and mass spectrometry. No PMAs were detected in any of the strains investigated, indicating that production of these compounds may be geographically diversified. Further studies are necessary to elucidate mechanisms of cyanobacterial PMAs synthesis.
C1 [Rzymski, Piotr] Poznan Univ Med Sci, Dept Environm Med, Poznan, Poland.
   [Evans, Daniel M.; Murphy, Patrick J.] Bangor Univ, Sch Nat Sci, Alun Roberts Bldg Chem, Bangor LL57 2DG, Gwynedd, Wales.
   [Kokociriski, Mikolaj] Adam Mickiewicz Univ, Dept Hydrobiol, Poznan, Poland.
RP Rzymski, P (reprint author), Poznan Univ Med Sci, Dept Environm Med, Poznan, Poland.
EM rzymskipiotr@ump.edu.pl
FU Beacon+; European Regional Development Fund through the Welsh
   Government; EUEuropean Union (EU)
FX This study has been partly funded by Beacon+. Beacon + has been
   part-funded by the European Regional Development Fund through the Welsh
   Government. EU Funds: Investing in Wales.
CR Acs A, 2013, TOXICON, V70, P98, DOI 10.1016/j.toxicon.2013.04.019
   Antal O, 2011, TOXICON, V57, P831, DOI 10.1016/j.toxicon.2011.02.007
   Banker R, 2000, J NAT PROD, V63, P387, DOI 10.1021/np990498m
   Bernard C, 2003, ENVIRON TOXICOL, V18, P176, DOI 10.1002/tox.10112
   Buratti FM, 2017, ARCH TOXICOL, V91, P1049, DOI 10.1007/s00204-016-1913-6
   Chernoff N, 2017, J TOXICOL ENV HEAL B, V20, P183, DOI 10.1080/10937404.2017.1297592
   Falfushynska H, 2019, AQUAT TOXICOL, V206, P105, DOI 10.1016/j.aquatox.2018.11.012
   Fastner J, 2003, TOXICON, V42, P313, DOI 10.1016/S0041-0101(03)00150-8
   GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x
   Jaja-Chimedza A, 2017, CHEMOSPHERE, V174, P478, DOI 10.1016/j.chemosphere.2017.01.145
   Jaja-Chimedza A, 2015, HARMFUL ALGAE, V49, P156, DOI 10.1016/j.hal.2015.09.010
   Jaja-Chimedza A, 2012, MAR DRUGS, V10, P2322, DOI 10.3390/md10102322
   Kokocinski M, 2013, ENVIRON SCI POLLUT R, V20, P5243, DOI 10.1007/s11356-012-1426-7
   MORI Y, 1991, J ORG CHEM, V56, P631, DOI 10.1021/jo00002a027
   MORI Y, 1991, TETRAHEDRON, V47, P4889, DOI 10.1016/S0040-4020(01)80955-8
   MYNDERSE JS, 1979, PHYTOCHEMISTRY, V18, P1181, DOI 10.1016/0031-9422(79)80130-2
   Poniedzialek B, 2015, TOXICOL IN VITRO, V29, P926, DOI 10.1016/j.tiv.2015.03.023
   Poniedzialek B, 2012, ENVIRON TOXICOL PHAR, V34, P651, DOI 10.1016/j.etap.2012.08.005
   Rzymski Piotr, 2017, Limnological Review, V17, P23, DOI 10.1515/limre-2017-0003
   Rzymski P, 2017, ALGAL RES, V24, P72, DOI 10.1016/j.algal.2017.02.011
   Rzymski P, 2014, WATER RES, V66, P320, DOI 10.1016/j.watres.2014.08.029
   Rzymski P, 2014, HARMFUL ALGAE, V35, P1, DOI 10.1016/j.hal.2014.03.002
   Testai E, 2016, CRIT REV TOXICOL, V46, P385, DOI 10.3109/10408444.2015.1137865
   Vehovszky A, 2015, ENVIRON TOXICOL, V30, P501, DOI 10.1002/tox.21927
   Wu XQ, 2012, P NATL ACAD SCI USA, V109, P9477, DOI 10.1073/pnas.1200062109
NR 25
TC 2
Z9 2
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 51
EP 53
DI 10.1016/j.toxicon.2019.10.002
PG 3
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300007
PM 31586555
DA 2020-05-12
ER

PT J
AU Amano, M
   Amiya, N
   Takaoka, M
   Sato, H
   Takatani, T
   Arakawa, O
   Sakakura, Y
AF Amano, Masafumi
   Amiya, Noriko
   Takaoka, Minami
   Sato, Haruka
   Takatani, Tomohiro
   Arakawa, Osamu
   Sakakura, Yoshitaka
TI Tetrodotoxin functions as a stress relieving substance in juvenile tiger
   puffer Takifugu rubripes
SO TOXICON
LA English
DT Article
DE TTX; CRH; ACTH; Cortisol; Stress; Tiger puffer
ID HATCHERY-REARED JUVENILES; HORMONE CRH; FISH; WILD; PITUITARY; TOXICITY;
   PREDATION; RESPONSES; GOLDFISH; SEA
AB We tested whether tetrodotoxin (TTX) functions as a stress relieving substance in puffer fish. We orally administered TTX to the juveniles of hatchery-reared non-toxic tiger puffer Takifugu rubripes and measured the effects of TTX on brain corticotropin-releasing hormone (CRH) mRNA expression and plasma cortisol levels in comparison with effects in non-toxic juveniles. Firstly, the reciprocal connections of CRH and adrenocorticotropic hormone (ACTH) were confirmed by dual-label immunohistochemistry. CRH-immunoreactive (ir) cell bodies were detected in the hypothalamus and CRH-ir fibers were observed to project to ACTH-ir cells in the rostral pars distalis of the pituitary. Next, a TTX-containing diet (2.35 mouse units (517 ng)/g diet) or a non-toxic diet were fed to the fish for 28 days under a recirculating system. Standard length and body weight became significantly larger in the TTX-treated group. The degree of loss of the caudal fin, which is an indicator of the degree of agonistic interactions, where high values show a higher loss of caudal fin of a fish due to nipping by other individuals, was significantly lower in the TTX-treated group. Relative CRH mRNA expression levels in the brain and cortisol levels in the plasma were significantly lower in the TTX-treated group. These results indicate that TTX functions as a stress relieving substance by affecting the CRH-ACTH-cortisol axis and reducing agonistic interactions in tiger puffer juveniles.
C1 [Amano, Masafumi; Amiya, Noriko; Takaoka, Minami] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan.
   [Sato, Haruka] Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan.
   [Takatani, Tomohiro; Arakawa, Osamu; Sakakura, Yoshitaka] Nagasaki Univ, Inst Integrated Sci & Technol, Grad Sch Fisheries & Environm Sci, Nagasaki 8528521, Japan.
RP Amano, M (reprint author), Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan.
EM amanoma@kitasato-u.ac.jp
RI Sakakura, Yoshitaka/AAL-9491-2020
OI Sakakura, Yoshitaka/0000-0003-0205-8364
FU Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [15K07581, 19K06225]; Nagasaki University
   Priority Research Project Based on Mid-term Goals and Plans
FX This study was supported in part by Grants-in-Aid for Scientific
   Research (C) (15K07581 and 19K06225) from Japan Society for the
   Promotion of Science to M. A., Y. S., and M. A., T. T., Y. S.,
   respectively. 0. A., T. T., and Y. S. were supported by Nagasaki
   University Priority Research Project Based on Mid-term Goals and Plans.
   We thank Mr. Ryo Shirato of the School of Marine Biosciences, Kitasato
   University, for his help in immunohistochemistry. We would like to thank
   Editage (www.editage.com) for English language editing.
CR Amano M, 2016, GEN COMP ENDOCR, V236, P174, DOI 10.1016/j.ygcen.2016.07.018
   Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016
   Bernier NJ, 2005, AM J PHYSIOL-REG I, V289, pR982, DOI 10.1152/ajpregu.00668.2004
   Bernier NJ, 2001, COMP BIOCHEM PHYS B, V129, P639, DOI 10.1016/S1096-4959(01)00360-8
   Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591
   Carpenter RE, 2007, HORM BEHAV, V52, P600, DOI 10.1016/j.yhbeh.2007.07.012
   Clements S, 2002, GEN COMP ENDOCR, V125, P319, DOI 10.1006/gcen.2001.7707
   Conde-Sieira M, 2014, DOMEST ANIM ENDOCRIN, V46, P26, DOI 10.1016/j.domaniend.2013.10.001
   Fabbri E, 1998, COMP BIOCHEM PHYS C, V120, P177, DOI 10.1016/S0742-8413(98)10017-8
   Flik G, 2006, GEN COMP ENDOCR, V146, P36, DOI 10.1016/j.ygcen.2005.11.005
   Gao W, 2019, TOXINS, V11, DOI 10.3390/toxins11080470
   Han K., 1994, SUISANZOSHOKU, V42, P507, DOI DOI 10.11233/AQUACULTURESCIL9
   Itoi S, 2014, TOXICON, V78, P35, DOI 10.1016/j.toxicon.2013.11.003
   [Japan Food Hygiene Association Environmental Health Bureau Ministry of Health and Welfare], 2015, SHOK EIS KENS SHISH, P813
   Katamachi D., 2013, MARINE FISHERIES STO, P1589
   Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006
   Maruyama K, 2006, PEPTIDES, V27, P1820, DOI 10.1016/j.peptides.2006.01.013
   Matsuda K, 2013, GEN COMP ENDOCR, V188, P118, DOI 10.1016/j.ygcen.2013.01.001
   MATSUI T, 1982, B JPN SOC SCI FISH, V48, P253
   Matsunari H, 2008, AQUACULTURE, V274, P142, DOI 10.1016/j.aquaculture.2007.11.002
   Nakashima K, 2004, TOXICON, V43, P207, DOI 10.1016/j.toxicon.2003.05.001
   Noguchi T, 2008, MAR DRUGS, V6, P220, DOI 10.3390/md20080011
   Noguchi T, 2006, COMP BIOCHEM PHYS D, V1, P153, DOI 10.1016/j.cbd.2005.11.003
   Ohgami H., 1982, B SHIZUOKA PREFECTUR, V16, P79
   Okita K, 2013, TOXICON, V71, P128, DOI 10.1016/j.toxicon.2013.05.018
   Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017
   SAITO T, 1984, B JPN SOC SCI FISH, V50, P1573
   Saito T, 2002, J SCH MAR SCI TECH T, V55, P79
   Sakakura Y, 2017, FISHERIES SCI, V83, P191, DOI 10.1007/s12562-016-1046-0
   Shimizu D, 2008, REV FISH SCI, V16, P195, DOI 10.1080/10641260701681755
   Shimizu D, 2007, NIPPON SUISAN GAKK, V73, P461, DOI 10.2331/suisan.73.461
   Shimizu D, 2006, NIPPON SUISAN GAKK, V72, P886, DOI 10.2331/suisan.72.886
   Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8
   Yamada H, 2002, ZOOL SCI, V19, P891, DOI 10.2108/zsj.19.891
   YAMAMORI K, 1988, CAN J FISH AQUAT SCI, V45, P2182, DOI 10.1139/f88-253
NR 35
TC 1
Z9 1
U1 10
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 54
EP 61
DI 10.1016/j.toxicon.2019.09.024
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300008
PM 31580836
DA 2020-05-12
ER

PT J
AU Smith, J
   Lie, AAY
   Seubert, EL
   Crowley, N
   Robertson, G
   Caron, DA
AF Smith, Jayme
   Lie, Alle A. Y.
   Seubert, Erica L.
   Crowley, Noelle
   Robertson, George
   Caron, David A.
TI Co-occurring dissolved algal toxins observed at multiple coastal sites
   in southern California via solid phase adsorption toxin tracking
SO TOXICON
LA English
DT Article
DE Harmful algal blooms; Coastal monitoring; Domoic acid; Okadaic acid;
   Saxitoxin; Southern California Bight; Passive samplers
ID LAND-SEA INTERFACE; DOMOIC ACID; FRESH-WATER; BLOOMS; BAY; PHYCOTOXINS;
   SAXITOXIN; DYNAMICS; SPATT; BEACH
AB Algal toxins (domoic acid, saxitoxin, okadaic acid) were monitored at seven locations off southern California using Solid Phase Adsorption Toxin Tracking. At least two types of toxins were found at all locations, with co-occurrence of two and three toxins in 12% and 10% of samples, respectively. This study expands our limited understanding of the simultaneous presence of multiple algal toxins along the coast and raises questions regarding the potential health ramifications of such co-occurrences.
C1 [Smith, Jayme; Lie, Alle A. Y.; Seubert, Erica L.; Crowley, Noelle; Caron, David A.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.
   [Smith, Jayme] Southern Calif Coastal Water Res Project, Costa Mesa, CA 92626 USA.
   [Robertson, George] Orange Cty Sanitat Dist, 10844 Ellis Ave, Fountain Valley, CA 92708 USA.
RP Smith, J (reprint author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.
EM jaymes@sccwrp.org
FU Southern California Coastal Ocean Observing System; USC Sea Grant
   Program [NA060AR4170012]; National Oceanic and Atmospheric
   AdministrationNational Oceanic Atmospheric Admin (NOAA) - USA
   [NA11NOS4780052]
FX We thank Orange County Sanitation District and the crew of MN Nerissa
   for help with moorings. This research was supported by grants from the
   Southern California Coastal Ocean Observing System, the USC Sea Grant
   Program (NA060AR4170012) and the National Oceanic and Atmospheric
   Administration (NA11NOS4780052). This is ECOHAB publication number
   EC0942.
CR Brooks BW, 2017, ENVIRON TOXICOL CHEM, V36, P1125, DOI 10.1002/etc.3801
   Burkholder J.M, 2006, ECOLOGY HARMFUL ALGA, V189
   Caron DA, 2010, WATER RES, V44, P385, DOI 10.1016/j.watres.2009.06.051
   Dwight RH, 2007, OCEAN COAST MANAGE, V50, P847, DOI 10.1016/j.ocecoaman.2007.04.002
   Garneau ME, 2011, APPL ENVIRON MICROB, V77, P7669, DOI 10.1128/AEM.06174-11
   Gibble CM, 2016, HARMFUL ALGAE, V59, P59, DOI 10.1016/j.hal.2016.09.007
   Gibble CM, 2014, HARMFUL ALGAE, V39, P146, DOI 10.1016/j.hal.2014.07.004
   Gilbert PM, 2017, MAR POLLUT BULL, V124, P591, DOI 10.1016/j.marpolbul.2017.04.027
   Gobler CJ, 2017, P NATL ACAD SCI USA, V114, P4975, DOI 10.1073/pnas.1619575114
   Howard MDA, 2017, ESTUAR COAST SHELF S, V186, P163, DOI 10.1016/j.ecss.2016.06.028
   Jester R, 2009, HARMFUL ALGAE, V8, P291, DOI 10.1016/j.hal.2008.07.001
   Kudela RM, 2017, COMP ANAL C, V78, P379, DOI 10.1016/bs.coac.2017.08.006
   Lane JQ, 2010, LIMNOL OCEANOGR-METH, V8, P645, DOI 10.4319/lom.2010.8.0645
   Li AF, 2012, TOXICON, V60, P420, DOI 10.1016/j.toxicon.2012.04.339
   MacKenzie L, 2004, TOXICON, V44, P901, DOI 10.1016/j.toxicon.2004.08.020
   Paerl HW, 2018, ENVIRON SCI TECHNOL, V52, P5519, DOI 10.1021/acs.est.7b05950
   Peacock MB, 2018, HARMFUL ALGAE, V73, P138, DOI 10.1016/j.hal.2018.02.005
   Seubert EL, 2013, ENVIRON SCI POLLUT R, V20, P6878, DOI 10.1007/s11356-012-1420-0
   Seubert EL, 2012, WATER RES, V46, P6563, DOI 10.1016/j.watres.2012.09.042
   Shipe RF, 2008, CONT SHELF RES, V28, P2584, DOI 10.1016/j.csr.2008.08.003
   Shultz D, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.101641
   Smith J, 2018, HARMFUL ALGAE, V79, P87, DOI 10.1016/j.hal.2018.07.007
   Smith J, 2018, J PLANKTON RES, V40, P29, DOI 10.1093/plankt/fbx069
   Tatters A.O, 2019, ESTUAR COAST, P1
   Tatters AO, 2017, TOXINS, V9, DOI 10.3390/toxins9030095
   Trainer VL, 2013, MAR DRUGS, V11, P1815, DOI 10.3390/md11061815
   Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133
   Wells ML, 2015, HARMFUL ALGAE, V49, P68, DOI 10.1016/j.hal.2015.07.009
   ZHOU J, 1994, PHYCOLOGIA, V33, P455, DOI 10.2216/i0031-8884-33-6-455.1
NR 29
TC 0
Z9 0
U1 17
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 62
EP 65
DI 10.1016/j.toxicon.2019.10.005
PG 4
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300009
PM 31614156
DA 2020-05-12
ER

PT J
AU da Silva, AM
   Colombini, M
   Moura-da-Silva, AM
   de Souza, RM
   Monteiro, WM
   Bernarde, PS
AF da Silva, Ageane Mota
   Colombini, Monica
   Moura-da-Silva, Ana Maria
   de Souza, Rodrigo Medeiros
   Monteiro, Wuelton Marcelo
   Bernarde, Paulo Sergio
TI Ethno-knowledge and attitudes regarding snakebites in the Alto Jurua
   region, Western Brazilian Amazonia
SO TOXICON
LA English
DT Article
DE Snakebite; Snakes; Envenomation; Ophidism; South America
ID BOTHROPS; STATE; SNAKES; BITES; ACRE; ENVENOMATION; COMMUNITIES;
   VIPERIDAE; CRUZEIRO; FOREST
AB Background: The Alto Jurua region, located in the extreme western part of the Brazilian Amazonia, possesses an indigenous and riverine population which is involved in agricultural and forest extraction activities, and is a region that stands out for its high incidence of snakebites.
   Objectives: To assess the attitudes of the victims, the characteristics of the snakes and the circumstances of the snakebites which occurred in a region where human populations are highly exposed to snakes.
   Methods: The study was conducted at the Regional Hospital of Jurua in the Municipality of Cruzeiro do Sul (Acre), which regularly attends victims of snakebites in the Alto Jurua region. The snakes that caused the envenomations were identified from clinical and epidemiological diagnosis of the symptoms and signs that patients presented during hospital, and by enzyme immunoassay for venom detection using serum samples of the patients, or by identification of the snake responsible for the envenomation when it was taken to the hospital or photographed. People who suffered or witnessed the snakebite were interviewed to assess the circumstances of the bite, the attitude adopted after the accident and whether they recognized the species of snake that caused the envenomation.
   Results: There were 133 cases of snakebite (76.24/100.000 inhabitants), mainly involving male individuals living in the rural area and who had a low level of education. The most affected groups were farmers (48%) and children and teenagers (39%). It was observed that 8.3% of them presented a history of recurrence for bites. The lower limbs were the most affected anatomical region (84%). The Bothrops atrox snake, mainly small specimens (mostly juveniles), was the main species involved in the envenomations (83.4%). Snakebites occurred mainly in forest areas, backyards of houses in rural areas and near to aquatic environments, during activities (walking, farming, extractivism, hunting). Most of the time, the snake was on the ground and the bite occurred because of the approximation of the individual, either by trampling or by approximation of a hand. Half of the victims performed some kind of inadequate first aid (not drinking water, use of tourniquet, incision at the site of the bite, use of black stone, drinking a compound "Especifico Pessoa").
   Conclusions: Snakebite is an important cause of morbidity in the Alto Jurua region. Bothrops bites are mostly caused by small-sized specimens, probably due to the greater abundance of B. atrox juveniles, and also because small snakes are more difficult for people to see. People are more often bitten on the lower limbs probably due to the size of B. atrox (small and medium) and because the snakes are usually on the ground in most situations. Many victims resort to ineffective actions that can cause complications and also delay serotherapy. A low level of education is a factor that may contribute to worse outcomes in snakebites since it is associated with a lack of knowledge of preventive and first aid measures.
C1 [da Silva, Ageane Mota] Inst Fed Acre, Campus Cruzeiro Sul, Cruzeiro Do Sul, Acre, Brazil.
   [da Silva, Ageane Mota] Univ Fed Acre, Programa Posgrad Bionorte, Campus Univ, BR 364 Rio Branco, Acre, Brazil.
   [Colombini, Monica; Moura-da-Silva, Ana Maria] Inst Butantan, Lab Imunopatol, Sao Paulo, SP, Brazil.
   [de Souza, Rodrigo Medeiros] Univ Fed Acre, Ctr Multidisciplinar, Lab Microbiol Imunol & Parasitol, Campus Floresta, Cruzeiro Do Sul, AC, Brazil.
   [Monteiro, Wuelton Marcelo] Univ Estado Amazonas, Manaus, AM, Brazil.
   [Monteiro, Wuelton Marcelo] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, AM, Brazil.
   [Bernarde, Paulo Sergio] Univ Fed Acre, Ctr Multidisciplinar, Lab Herpetol, Campus Floresta, Cruzeiro Do Sul, AC, Brazil.
RP Bernarde, PS (reprint author), Univ Fed Acre, Lab Herpetol, Campus Floresta,Estr Canela Fina S-N, BR-69980000 Cruzeiro Do Sul, Acre, Brazil.
EM snakebernarde@hotmail.com
OI Moura-da-Silva, Ana Maria/0000-0003-1787-6634
CR Almeida-Santos SM, 2002, BIOL VIPERS, P445
   Araújo MS., 2007, Braz. J. Biol., V67, P327, DOI 10.1590/S1519-69842007000200019
   Arruda NM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00213816, 10.1590/0102-311x00213816]
   Barros FB, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-37
   Bemarde P.S., 2018, S A J BAS ED TEC TEC, V5, P289
   Bemarde P.S., 2017, SERPENTES ALTO JURUA
   Bernarde Paulo Sérgio, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000200010
   Bernarde Paulo Sergio, 2006, South American Journal of Herpetology, V1, P102, DOI 10.2994/1808-9798(2006)1[102:ASCAED]2.0.CO;2
   Bernarde PS, 2018, SALAMANDRA, V54, P249
   Bernarde Paulo Sérgio, 2012, Acta Amaz., V42, P65, DOI 10.1590/S0044-59672012000100008
   Bertolozzi MR, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005839
   Bisneto PF, 2019, ACTA AMAZON, V49, P105, DOI 10.1590/1809-4392201802371
   Blessmann J, 2018, TOXICON, V156, P61, DOI 10.1016/j.toxicon.2018.11.009
   Borges C.C., 1996, REV U AMAZONAS, V1, P97
   Bucaretchi F, 2016, CLIN TOXICOL, V54, P222, DOI 10.3109/15563650.2015.1135337
   Chippaux JP, 2007, TOXICON, V49, P717, DOI 10.1016/j.toxicon.2006.11.002
   Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662
   Chippaux JP, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0011-1
   Colombini M, 2001, TOXICON, V39, P711, DOI 10.1016/S0041-0101(00)00201-4
   Costa Henrique Caldeira, 2018, Herpetologia Brasileira, V7, P11
   da Fonseca Wirven Lima, 2019, Herpetology Notes, V12, P365
   da Silva AM, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0120-2019
   da Silva AM, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0471-2018
   De Fraga R, 2013, COPEIA, P684, DOI 10.1643/CE-11-098
   de Moura MR, 2010, BIOTA NEOTROP, V10, P133, DOI 10.1590/S1676-06032010000400018
   Pardal PPD, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0052-5
   Pardal PPD, 2010, REV INST MED TROP SP, V52, P333, DOI 10.1590/S0036-46652010000600009
   Dixon J.R., 1986, REPTILES UPPER AMAZO
   Moreira JGD, 2016, NATIVA, V4, P97, DOI 10.14583/2318-7670.v04n02a08
   Santos-Filho Manoel, 2006, Mastozool. neotrop., V13, P217
   DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1
   Fan HW, 2018, TOXICON, V151, P15, DOI 10.1016/j.toxicon.2018.06.070
   Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013
   Fita DS, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-13
   FLECK DW, 1995, J MAMMAL, V76, P809, DOI 10.2307/1382749
   Vasquez SPF, 2014, ACTA AMAZON, V44, P457, DOI 10.1590/1809-4392201400423
   Franca DPF, 2017, IHERINGIA SER ZOOL, V107, DOI 10.1590/1678-4766e2017023
   Fry BG, 2018, TOXINS, V10, DOI 10.3390/toxins10040170
   Haad J.S., 1980, MEM I BUTANTAN, V44, P403
   Huntington HP, 1998, ARCTIC, V51, P237, DOI 10.14430/arctic1065
   IBGE, 2019, CENS DEM
   Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218
   Kasturiratne A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005647
   Martins Marcio, 1999, Herpetological Natural History, V6, P78
   Michael GC, 2018, T ROY SOC TROP MED H, V112, P47, DOI 10.1093/trstmh/try028
   Michael GC, 2011, T ROY SOC TROP MED H, V105, P95, DOI 10.1016/j.trstmh.2010.09.005
   Miranda DB, 2015, ZOOLOGIA-CURITIBA, V32, P93, DOI 10.1590/S1984-46702015000200001
   Mise YF, 2019, AM J TROP MED HYG, V100, P150, DOI 10.4269/ajtmh.18-0579
   MOREIRA JGV, 2019, RBG, V12, P705
   Moreno E, 2005, REV SOC BRAS MED TRO, V38, P15, DOI 10.1590/S0037-86822005000100004
   Mota-da-Silva A., 2019, REV SOC BRAS MED TRO, V52, DOI [10.1590/0037-8682-0195-2018e-20180195, DOI 10.1590/0037-8682-0195-2018E-20180195]
   Mota-da-Silva A., 2019, REV SOC BRAS MED TRO, V52, DOI [10.1590/0037-8682-0140-2018e-20180140, DOI 10.1590/0037-8682-0140-2018E-20180140]
   Mota-da-Silva A., 2019, TOXICON, V166, P34, DOI [10.1016/j.toxicon.2019.05.008, DOI 10.1016/J.TOXICON.2019.05.008]
   Nicoleti AF, 2010, REV SOC BRAS MED TRO, V43, P657, DOI 10.1590/S0037-86822010000600011
   Oliveira HFA, 2013, REV BRAS EPIDEMIOL, V16, P633, DOI DOI 10.1590/S1415-790X2013000300008
   Oliveira M. Ermelinda, 2001, Herpetological Natural History, V8, P101
   Oliveira S.S., 2018, CLIN TOXINOLOGY AUST, V1, P73, DOI DOI 10.1007/978-94-007-6288-6_61-2
   Pandey DP, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0092-0
   Pardal PPD, 2004, T ROY SOC TROP MED H, V98, P28, DOI 10.1016/S0035-9203(03)00005-1
   Roriz KRPS, 2018, REV SOC BRAS MED TRO, V51, P338, DOI 10.1590/0037-8682-0489-2017
   Pierini SV, 1996, TOXICON, V34, P225, DOI 10.1016/0041-0101(95)00125-5
   PINHEIRO BF, 2013, NATUREZA ON LINE, V11, P68
   Prudente A.L.C., 2017, CENSO BIODIVERSIDADE
   Ribeiro LA, 2001, T ROY SOC TROP MED H, V95, P630, DOI 10.1016/S0035-9203(01)90101-4
   Saboia C.O., 2019, J HUM GROWTH DEV, V29, P117, DOI [10.7322/jhgd.157760, DOI 10.7322/JHGD.157760]
   SALOMAO MD, 1995, STUD NEOTROP FAUNA E, V30, P101, DOI 10.1080/01650529509360946
   SAZIMA I, 1988, Memorias do Instituto Butantan (Sao Paulo), V50, P83
   Sazima Ivan, 1992, P199
   Schioldann E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006299
   Silva E.O., 2018, REV PAN AMAZ SAUDE, V9, P57, DOI [10.5123/s2176-62232018000300007, DOI 10.5123/S2176-62232018000300007]
   SILVEIRA PVP, 1992, REV I MED TROP, V34, P499, DOI 10.1590/S0036-46651992000600002
   Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129
   Souza AD, 2018, TOXICON, V145, P15, DOI 10.1016/j.toxicon.2018.02.041
   Strauch MA, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0148-9
   Turci Luiz Carlos Batista, 2009, Biota Neotrop., V9, P197, DOI 10.1590/S1676-06032009000300020
   Magalhes SFV, 2019, T ROY SOC TROP MED H, V113, P143, DOI 10.1093/trstmh/try121
   Waldez Fabiano, 2009, Acta Amaz., V39, P681, DOI 10.1590/S0044-59672009000300025
   Williams DJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007059
   WOODMAN N, 1995, ZOOL J LINN SOC-LOND, V113, P1, DOI 10.1016/S0024-4082(05)80002-0
NR 79
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 66
EP 77
DI 10.1016/j.toxicon.2019.10.238
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300010
PM 31628968
DA 2020-05-12
ER

PT J
AU Kazemi-Lomedasht, F
   Yamabhai, M
   Sabatier, JM
   Behdani, M
   Zareinejad, MR
   Shahbazzadeh, D
AF Kazemi-Lomedasht, Fatemeh
   Yamabhai, Montarop
   Sabatier, Jean-Marc
   Behdani, Mandi
   Zareinejad, Mohammad Reza
   Shahbazzadeh, Delavar
TI Development of a human scFv antibody targeting the lethal Iranian cobra
   (Naja oxiana) snake venom
SO TOXICON
LA English
DT Article
DE Naja oxiana; Snake venom; Human antibody; Phage display
ID AMINO-ACID-SEQUENCE; SINGLE-CHAIN FV; DISPLAY LIBRARIES; ANTIVENOM;
   IMMUNOGLOBULIN; TOXICITY; PURIFICATION; COMPONENTS; NEUTRALIZE;
   DISCOVERY
AB Snakebite is one of the health concerns worldwide. Naja oxiana is one of the venomous snakes with a high mortality rate. Anti-serum therapy is the only treatment of the victims. However, in some cases, antiserum injection leads to some side effects in host like serum sickness and anaphylactic shock. It is crucial to develop a neutralizing agent with low side effects. The human antibody library (non-immunized library) was used to isolate specific antibodies against N.oxiana venom components. Four rounds of biopanning were performed to enrich scFv-displaying phages against the venom of N. oxiana. Enrichment of scFv-displaying phages against N. oxiana venom was analyzed by polyclonal Enzyme-Linked Immunosorbent Assay (ELISA). Specific antibody fragments against N. oxiana venom were selected through monoclonal ELISA, and were expressed in E. coli bacterial cells. Purification of the selected clones was performed by using nickel affinity chromatography. Neutralization and protective capacity of specific antibody fragments were analyzed in C57BL/6 mice (i.v. injection). Results of biopanning and polyclonal ELISA demonstrate a successful enrichment process. Five specific antibody fragments with the highest signal in monoclonal ELISA were selected, expressed, and purified. The purity of expressed antibody fragments was monitored by SDS-PAGE and Western blot. The selected antibody fragments were able to neutralize two LD50 of N. oxiana venom and protected all mice when injected 15 min post-envenomation. The data indicate that such selected antibodies are promising tools for further studies and in the development of novel protective agents against N. oxiana venom.
C1 [Kazemi-Lomedasht, Fatemeh; Behdani, Mandi; Zareinejad, Mohammad Reza; Shahbazzadeh, Delavar] Pasteur Inst Iran, Venom & Biotherapeut Mol Lab, Biotechnol Res Ctr, Tehran, Iran.
   [Yamabhai, Montarop] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Mol Biotechnol Lab, Nakhon Ratchasima 30000, Thailand.
   [Sabatier, Jean-Marc] Fac Med Secteur Nord Marseille, Inst Neurophysiopathol, UMR 7051, 51 Blvd Pierre Dramard,CS80011, F-13344 Marseille 15, France.
RP Kazemi-Lomedasht, F; Shahbazzadeh, D (reprint author), Pasteur Inst Iran, Venom & Biotherapeut Mol Lab, Biotechnol Res Ctr, Tehran, Iran.
EM fa_kazemi@pasteur.ac.ir; shahbazzadeh@pasteur.ac.ir
RI Kazemi-Lomedasht, Fatemeh/J-9157-2017
OI Kazemi-Lomedasht, Fatemeh/0000-0002-5832-1822
FU Pasteur Institute of Iran, Tehran, Iran [974]
FX This work was financially supported by Pasteur Institute of Iran,
   Tehran, Iran (to Fatemeh Kazemi-Lomedasht; grant number 974).
CR Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250
   Amaral CFS, 1997, TOXICON, V35, P699, DOI 10.1016/S0041-0101(96)00181-X
   Bai X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141045
   Bates A, 2019, ANTIBODIES, V8, DOI 10.3390/antib8020028
   Bawaskar H S, 2004, J Assoc Physicians India, V52, P11
   BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6
   Danpaiboon W, 2014, TOXINS, V6, P1526, DOI 10.3390/toxins6051526
   Dehghani R, 2014, TOXICON, V90, P291, DOI 10.1016/j.toxicon.2014.08.063
   Firouz E, 2005, COMPLETE FAUNA IRAN
   Gold BS, 2002, NEW ENGL J MED, V347, P347, DOI 10.1056/NEJMra013477
   GRISHIN EV, 1974, FEBS LETT, V45, P118, DOI 10.1016/0014-5793(74)80825-2
   GRISHIN EV, 1973, FEBS LETT, V36, P77, DOI 10.1016/0014-5793(73)80340-0
   HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004
   Homayouni V, 2016, IRAN J BASIC MED SCI, V19, P1201
   HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879
   ICazemi-Lomedasht F., 2019, ANTITUMOR ACTIVITY I
   Kaplon IL, 2019, ANTIBODIES WATCH 201, P219
   Kazemi-Lomedasht F., 2018, TOXIN REV, P1
   Kazemi-Lomedasht F, 2017, IRAN J BASIC MED SCI, V20, P489, DOI 10.22038/IJBMS.2017.8672
   Kazemi-Lomedasht Fatemeh, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P167, DOI 10.1089/mab.2016.0001
   Kazemi-Lomedasht Fatemeh, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P201, DOI 10.1089/mab.2014.0086
   Kazemi-Lomedasht F, 2015, MOL IMMUNOL, V65, P58, DOI 10.1016/j.molimm.2015.01.010
   Khamehchian S, 2014, HUM VACC IMMUNOTHER, V10, P1633, DOI 10.4161/hv.28531
   Kulkeaw K, 2009, J PROTEOMICS, V72, P270, DOI 10.1016/j.jprot.2008.12.007
   Laustsen AH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06086-4
   Laustsen AH, 2018, TOXICON, V146, P151, DOI 10.1016/j.toxicon.2018.03.004
   Laustsen AH, 2016, CURR PHARM DESIGN, V22, P5270, DOI 10.2174/1381612822666160623073438
   Laustsen AH, 2015, TOXICON, V104, P43, DOI 10.1016/j.toxicon.2015.07.334
   Li KY, 2015, PROTEIN ENG DES SEL, V28, P307, DOI 10.1093/protein/gzv024
   Makhija I. K., 2010, Der Pharmacia Lettre, V2, P399
   Marcinkiewicz C, 2013, INT J BIOCHEM CELL B, V45, P1974, DOI 10.1016/j.biocel.2013.06.009
   MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0
   Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028
   Oghalaie A., 2017, CYTOTOXICITY ANTIADH
   Okamoto T, 2004, BIOCHEM BIOPH RES CO, V323, P583, DOI 10.1016/j.bbrc.2004.08.131
   Oriuchi N, 2005, ANN NUCL MED, V19, P355, DOI 10.1007/BF03027399
   Otten E.J., 1998, EMERGENCY MED CONCEP, P924
   Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6
   Pourhashem Z., 2018, SILICO STUDY FIND AN
   Pucca MB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02090
   Pucca MB, 2014, J IMMUNOTOXICOL, V11, P133, DOI 10.3109/1547691X.2013.809175
   Rami A, 2017, ASIAN PAC J TROP BIO, V7, P599, DOI 10.1016/j.apjtb.2017.06.001
   Shashidharamurthy R, 2002, MOL CELL BIOCHEM, V229, P93, DOI 10.1023/A:1017972511272
   Silva LC, 2018, ACTA TROP, V177, P66, DOI 10.1016/j.actatropica.2017.09.001
   Taherian A, 2018, TROP J PHARM RES, V17, P409, DOI 10.4314/tjpr.v17i3.4
   Vazirianzadeh B., 2008, Journal of Experimental Zoology India, V11, P497
   Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305
   Winthrop MD, 2003, CLIN CANCER RES, V9, p3845S
   Wong KY, 2016, AM J TROP MED HYG, V94, P1392, DOI 10.4269/ajtmh.15-0871
   YOKOTA T, 1992, CANCER RES, V52, P3402
   Zhao AZ, 2016, CRIT REV BIOTECHNOL, V36, P276, DOI 10.3109/07388551.2014.958978
NR 51
TC 0
Z9 0
U1 6
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 5
PY 2019
VL 171
BP 78
EP 85
DI 10.1016/j.toxicon.2019.10.006
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA JQ2BK
UT WOS:000498756300011
PM 31622638
DA 2020-05-12
ER

PT J
AU Dull, P
   Friede, M
   Hwang, A
   Hall, BF
AF Dull, Peter
   Friede, Martin
   Hwang, Angela
   Hall, B. Fenton
TI Meeting report: Global vaccine and immunization research forum, 2018
SO VACCINE
LA English
DT Article
DE GVIRF; GVAP
ID INFLUENZA VACCINE; CHALLENGES; DISEASE; BURDEN
AB Every two years, the Global Vaccine and Immunization Research Forum takes stock of global research in vaccines and immunization. As in prior years, the 2018 meeting addressed vaccine discovery, development, decision-making, and deployment. This time, however, it also featured two overarching themes: Innovating for Equity" and "End-to-End Integration." Significant advances have been made in the last two years, but participants noted that some important goals of the Global Vaccine Action Plan are not being met and called urgently for innovation in improving access to vaccines. Two factors were highlighted as crucial to improving coverage: a focus on equity and sustainability throughout the immunization ecosystem, and an enabling political environment that prioritizes health and immunization. Published by Elsevier Ltd.
C1 [Dull, Peter] Bill & Melinda Gates Fdn, POB 23350, Seattle, WA 98102 USA.
   [Friede, Martin] WHO, Dept Immunizat Vaccines & Biol, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
   [Hwang, Angela] Angela Hwang Consulting, POB 6601, Albany, CA 94706 USA.
   [Hall, B. Fenton] NIAID, Parasitol & Int Programs Branch, Div Microbiol & Infect Dis, NIH, MSC 9825, Bethesda, MD 20892 USA.
RP Hwang, A (reprint author), Angela Hwang Consulting, POB 6601, Albany, CA 94706 USA.
EM peter.dull@gatesfoundation.org; friedem@who.int; angela@ahwang.net;
   lhall@niaid.nih.gov
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01A1108543]; Bill & Melinda Gates
   FoundationGates Foundation [OPP1128274]
FX This forum was supported in part by a NIAID cooperative agreement [grant
   number U01A1108543] and a grant from the Bill & Melinda Gates Foundation
   [grant number OPP1128274].
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P145
   [Anonymous], 2018, 2018 ANN REV DIS PRI
   Bartsch SM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004922
   Batson A., 2016, GLOBAL VACCINE MARKE
   Burnett E, 2017, J INFECT DIS, V215, P1666, DOI 10.1093/infdis/jix186
   Coughlan L, 2018, CELL HOST MICROBE, V24, P18, DOI 10.1016/j.chom.2018.06.016
   Dauner A, 2017, VACCINE, V35, P5487, DOI 10.1016/j.vaccine.2017.03.099
   Diemert DJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005574
   Drake D., 2018, GLOBAL VACCINE IMMUN
   Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103
   Farrell M, 2017, J INFECT DIS, V216, pS193, DOI 10.1093/infdis/jiw558
   Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517
   Food and Drug Administration, 2017, CLIN DEV PLAN PFIZ I
   Ford AQ, 2018, VACCINE, V36, P915, DOI 10.1016/j.vaccine.2017.12.013
   Ford AQ, 2016, VACCINE, V34, P1489, DOI 10.1016/j.vaccine.2015.11.038
   Fruh K, 2017, CURR OPIN IMMUNOL, V47, P52, DOI 10.1016/j.coi.2017.06.010
   Gessner BD, 2017, VACCINE, V35, P6255, DOI 10.1016/j.vaccine.2017.09.048
   Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976
   Goldblatt D, 2018, LANCET INFECT DIS, V18, P171, DOI 10.1016/S1473-3099(17)30654-0
   Grohmann G, 2016, VACCINE, V34, P5420, DOI 10.1016/j.vaccine.2016.07.047
   Hsu DC, 2017, HUM VACC IMMUNOTHER, V13, P1018, DOI 10.1080/21645515.2016.1276138
   Jefferys R, 2017, HIV RES ERA PREP IMP
   Jorba J, 2017, MMWR-MORBID MORTAL W, V66, P1185, DOI 10.15585/mmwr.mm6643a6
   Lin L., 2018, USE MULTIPLE MEASURE
   Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16
   O'Brien KL, 2018, LANCET INFECT DIS, V18, P127, DOI 10.1016/S1473-3099(17)30684-9
   O'Brien VP, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0013-2012
   Postovoitova A., 2018, SOCIAL MEDIA INITIAT
   Rello J, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1601-9
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Schrager L, 2018, GLOBAL REPORT TUBERC
   Simoni Y, 2018, CURR OPIN IMMUNOL, V51, P187, DOI 10.1016/j.coi.2018.03.023
   Sparrow E, 2016, VACCINE, V34, P5442, DOI 10.1016/j.vaccine.2016.08.057
   Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Voss Gerald, 2018, F1000Res, V7, P199, DOI 10.12688/f1000research.13588.1
   Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X
   World Health Organization, R D BLUEPR KEY ACT
   World Health Organization, Q A MAL VACC IMPL PR
   World Health Organization, 2017, PAND INFL RISK MAN
   World Health Organization, 2012, WEEKLY EPIDEMIOL REC, V21, P421
   World Health Organization, WHO VACC PIP TRACK
   World Health Organization, IMM VACC BIOL VACC D
   World Health Organization, 2016, R D BLUEPR ACT PREV
   World Health Organization, 2018, GLOB OBS HLTH R D HL
   World Health Organization, 2017, GLOB HEP REP 2017
   World Health Organization, 2015, GLOB ACT PLAN ANT RE
   World Health Organization, 2013, GLOB VACC ACT PLAN 2
   World Health Organization, IMM COV KEY FACTS
   World Health Organization, RAINB TABL
   World Health Organization Strategic Advisory Group of Experts on Immunization, 2017, 2017 ASS REP GLOB VA
   World Health Organization Strategic Advisory Group of Experts on Immunization, 2016, MIDT REV GLOB VACC A
   World Health Organization (WHO), 2013, POL ER ENDG STRAT PL
   Zipursky S, 2017, J INFECT DIS, V216, pS15, DOI 10.1093/infdis/jix185
NR 55
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7519
EP 7526
DI 10.1016/j.vaccine.2019.10.011
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600001
PM 31623915
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU McCallum, AD
   Kanagarajah, S
   Ford, L
   Patel, D
AF McCallum, Andrew D.
   Kanagarajah, Sanch
   Ford, Lisa
   Patel, Dipti
TI To err is human: Clinical incident calls to a national travel health
   advice line
SO VACCINE
LA English
DT Article
DE Vaccine; Adverse events; Yellow fever; MMR
AB The National Travel Health Network and Centre (NaTHNaC) offers a telephone advice line for travel health practitioners in the UK. In this study we review clinical incidents concerning vaccines or malaria prophylaxis reported between 2016 and 2018.
   Two-hundred-and-fifty-one clinical incident calls were recorded, and commonly concerned scheduling or dosing errors. Vaccine scheduling errors accounted for 103 calls (41%), predominantly due to hepatitis A or hepatitis B vaccination either alone or in combination (65/103, 63%). Administration of yellow fever vaccine within 28 days of measles, mumps and rubella accounted for a further 15 (15%) calls. Twenty-six (10%) calls reported administration of a vaccine that was not recommended either for the destination or contraindicated in the traveller. Yellow fever was the commonest single vaccine discussed in 28.4% of vaccine clinical incidents reported. By highlighting common mistakes, we hope to raise awareness of common issues and improve practice in travel health. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [McCallum, Andrew D.] Hosp Trop Dis, 2nd Floor,Capper St, London WC1E 6JB, England.
   [Kanagarajah, Sanch; Ford, Lisa; Patel, Dipti] UCLH NHS Fdn Trust, Natl Travel Hlth Network & Ctr, 250 Euston Rd, London NW1 2PG, England.
   [Ford, Lisa] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
RP McCallum, AD (reprint author), Hosp Trop Dis, 2nd Floor,Capper St, London WC1E 6JB, England.
EM andrew.mccallum@nhs.net
CR [Anonymous], 2019, PROMED
   Boddington NL, 2012, J TRAVEL MED, V19, P84, DOI 10.1111/j.1708-8305.2011.00587.x
   Boyne LC, 2018, COMPETENCIES TRAVEL
   Chiodini JH, 2012, TRAVEL MED INFECT DI, V10, P109, DOI 10.1016/j.tmaid.2012.05.002
   Core R. Team R, 2017, LANG ENV STAT COMP
   Evans D, 2019, TRAVEL MED INFECT DI, V32, DOI 10.1016/j.tmaid.2019.101497
   Evans D, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6030064
   Lalloo DG, 2016, J INFECTION, V72, P635, DOI 10.1016/j.jinf.2016.02.001
   Lang Sarah, 2014, Qual Prim Care, V22, P139
   Lindsey NP, 2016, J TRAVEL MED, V5, P23
   Maurer W, 2014, EXPERT REV VACCINES, V13, P545, DOI 10.1586/14760584.2014.892833
   Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
   National Travel Health Network and Centre, TRAV HLTH PRO 2019
   National Travel Health Network and Centre, YELL FEV ZON 2019
   National Travel Health Network and Centre, YELL FEV REP TRAV RE
   Public Health England, 2017, IMMUNISATION INFECT
   Public Health England, 2019, VACC INC GUID RESP E
   Public Health England, 2018, NAT MIN STAND COR CU
   Wilson K, 2016, AM J TROP MED HYG, V94, P485, DOI 10.4269/ajtmh.15-0510
NR 19
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7535
EP 7538
DI 10.1016/j.vaccine.2019.10.007
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600006
PM 31611096
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Spicher, VM
   Weiss, MG
AF Spicher, Virginie Masserey
   Weiss, Mitchell G.
TI Policy and socio-cultural differences between cantons in Switzerland
   with high and low adolescent vaccination coverage for hepatitis B and
   HPV
SO VACCINE
LA English
DT Article
DE Vaccination coverage; Vaccine hesitancy; HPV vaccine; Hepatitis B
   vaccine; Adolescent health; Health system; School health
ID MIDDLE-INCOME COUNTRIES; PUBLISHED LITERATURE; CHILDREN; INTERVENTIONS;
   ATTITUDES; HESITANCY; VACCINES
AB Vaccination recommendations in Switzerland are national, but vaccine coverage varies greatly from one canton to another, particularly for vaccinations recommended in adolescence. To explain these differences, we studied vaccination practices and socio-cultural views from the vantage points of policy makers, healthcare providers and community adolescents and parents in 4 cantons with low (LVC) and 4 cantons with high (HVC) vaccination coverage for hepatitis B (HBV) and human papillomavirus (HPV) vaccines. In-depth semi-structured interviews were administered to a policy maker, a private practitioner and 4 to 7 community members (adolescents and parents of adolescents) from each of the 8 cantons. LVCs were notable for less government involvement in vaccination issues, more autonomy of municipalities for school health, lower density of pediatricians, less information about these vaccines, greater emphasis on individual rather than government responsibility for vaccinations and for anticipated community hesitancy. Doctors in HVCs more actively advocated for vaccines. Community views in HVCs were more collectivistic and reliant on schools as a source of information than in LVCs. In both groups, hesitancy and concerns about efficacy were greater for HPV than for HBV vaccine. Findings suggest more systematic involvement of health and school authorities will be appreciated by adolescents and their parents, and will improve vaccination coverage. Interventions focused only on community awareness and hesitancy are likely to be inadequate without efforts to reach policy makers and doctors. (C) 2019 Elsevier Ltd. All rights reserved.
C1 Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.
   Univ Basel, CH-4007 Basel, Switzerland.
RP Spicher, VM (reprint author), Fed Off Publ Hlth, Communicable Dis Div, Schwarzenburgstr 157, CH-3003 Bern, Switzerland.
EM virginie.masserey@bag.admin.ch; mitchell-g.weiss@unibas.ch
FU Swiss School of Public Health (SSPH+)
FX This work was supported by a sabbatical scholarship from the Swiss
   School of Public Health (SSPH+).
CR Adam T, 2012, HEALTH POLICY PLANN, V27, P9, DOI 10.1093/heapol/czs086
   Blanco NB, 2011, JAIDS-J ACQ IMM DEF, V58, P472, DOI 10.1097/QAI.0b013e318237915e
   Bourquin C, 1998, SOZ PRAVENTIV MED, V43, pS72, DOI 10.1007/BF02042181
   Bundesamt fur Gesundheit, 2008, B BAG, V8, P152
   Bundesamt fur Gesundheit, 2010, BULL BAG, V43, P949
   Bundesamt fur Gesundheit, 2015, B BAG, V23, P405
   DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1
   Gross K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1716-3
   Gugelmann RJ, 1998, SOZ PRAVENTIV MED, V43, pS57, DOI 10.1007/BF02042177
   Hawkes S, 2014, VACCINE, V32, P1610, DOI 10.1016/j.vaccine.2013.09.039
   Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370
   Lang P, 2011, PUBLIC HEALTH REP, V126, P97, DOI 10.1177/00333549111260S212
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Mays RM, 2004, SOC SCI MED, V58, P1405, DOI 10.1016/S0277-9536(03)00335-6
   Mikkelsen-Lopez I, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-13
   Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002
   Office federal de la sante publique, COUV VACC ENF AG 2 A
   Office federal de la sante publique Commission federale pour les vaccinations, 2018, PLAN VACC SUISS 2018
   Posfay-Barbe KM, 2005, PEDIATRICS, V116, pE623, DOI 10.1542/peds.2005-0885
   Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096
   Riesen M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021006
   Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013
   Schuler M, 2017, PEDIATR INFECT DIS J, V36, pE167, DOI 10.1097/INF.0000000000001522
   Tauil MD, 2016, VACCINE, V34, P2635, DOI 10.1016/j.vaccine.2016.04.016
   Theeten H, 2007, VACCINE, V25, P4940, DOI 10.1016/j.vaccine.2007.03.032
   WHO IVIR-AC, 2018, IMM VACC REL IMPL RE
   Wymann MN, 2018, INT J PUBLIC HEALTH, V63, P105, DOI 10.1007/s00038-017-1050-x
NR 28
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7539
EP 7546
DI 10.1016/j.vaccine.2019.09.085
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600007
PM 31630937
DA 2020-05-12
ER

PT J
AU Constenla, D
   Liu, T
AF Constenla, D.
   Liu, T.
TI Estimating the economic impact of pneumococcal conjugate, Haemophilus
   influenzae type b and rotavirus vaccines in India: National and
   state-level analyses
SO VACCINE
LA English
DT Article
DE Pneumonia; Meningitis; Diarrhea; Vaccination; Economics; Savings; India
ID STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; BURDEN;
   VACCINATION; MULTICENTER; DIARRHEA; STRAINS
AB Background: To support vaccine decision-making we estimated from the societal perspective the potential health impact and costs averted through immunization with three vaccines - Haemophilus influenzae type b (Hib), pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RW). Methods: Based on variability in disease burden, strength of health system and economic status, we selected four states in India: Bihar, New Delhi, Maharashtra and Tamil Nadu. We used secondary data sources to estimate the number of under-5 deaths averted from Hib, pneumococcus and rotavirus in each state and back-calculated the total cases averted. We synthesized available data to estimate the disease burden, treatment cost, caretaker productivity loss and vaccine coverage in each state. A Delphi Survey and roundtable among Indian experts was conducted to reach consensus on model inputs. Results: By scaling up coverage of Hib, PCV and RW, India could save over US$1 billion (uncertainty range: US$0.9-US$2.4 billion) in economic benefits and avert more than 90,000 needless child deaths each year. An estimated US$1 billion (US$0.9-US$2 billion) or 88% of the total amount of cost savings would be attributable to lost productivity due to premature pneumococcal death. Another US$112.8 million (US$105-297 million), or 10% of the total cost would be accounted by costs related to loss of productivity due to disability as a result of these diseases. Treatment costs of Hib, pneumococcal disease and rotavirus gastroenteritis, would account for US$8.4 million (US$4-12 million) or <1% of the total costs of these diseases. Finally, caretaker productivity loss from seeking care would represent US$1.5 million (US$ 1-4.9 million). Cost savings varied by vaccine, coverage scenarios and states. Conclusions: Hib, PCV and RVV vaccine introduction in India can result in immediate benefits to the government and households in terms of savings. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Constenla, D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21231 USA.
   [Liu, T.] Minist Hlth, China Natl Hlth Dev Res Ctr, Beijing, Peoples R China.
   [Liu, T.] Hlth Sci Ctr, Peking Univ, 38 Xueyuan Rd,POB 218, Beijing 100191, Peoples R China.
RP Constenla, D (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, 415 N Washington St,Off 537, Baltimore, MD 21231 USA.
EM dconste1@jhu.edu
FU Gavi The Vaccine Alliance
FX This work was supported by Gavi The Vaccine Alliance, as part of a
   collaborative effort to make information about vaccine economics more
   readily available to decision-makers in India.
CR Anand K, 2001, I MED SCI
   Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088
   Cherukupally SR, 2004, OTOLARYNG HEAD NECK, V130, P339, DOI 10.1016/j.otohns.2003.11.017
   Clark A, 2013, CHILDHOOD-SER, P163
   Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094
   Government of India planning commission, 2013, PRESS NOT POV EST 20
   Griffiths UK, 2012, EPIDEMIOL INFECT, V140, P1343, DOI 10.1017/S0950268812000957
   IRS, 2015, YEARL AV CURR EXCH R
   John J, 2014, VACCINE, V32, pA5, DOI 10.1016/j.vaccine.2014.03.004
   Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348
   Kang G, 2013, VACCINE, V31, P2879, DOI 10.1016/j.vaccine.2013.04.030
   Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031
   Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Krishnan A, 2001, DETERMINING COSTS AS
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8
   LUCERO MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2
   Mani R, 2007, Indian J Med Microbiol, V25, P108
   Moisi JC, 2009, CLIN INFECT DIS, V48, pS49, DOI 10.1086/596481
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381
   Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952
   Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401
   UNICEF, 2018, COV EV SURV 2009 CES, P8
   United states advisory committee on immunization practices (ACIP), 2013, ACIP JUN 2013 M
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4
   World Health Organization (WHO), 2013, INT GLOB ACT PLAN PN
NR 28
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7547
EP 7559
DI 10.1016/j.vaccine.2019.09.084
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600008
PM 31607600
DA 2020-05-12
ER

PT J
AU Koike, ME
   Gattas, VL
   Lucchesi, MBB
   de Oliveira, MMM
   Vanni, T
   Thome, BD
   Menang, O
   Socquet, M
   Precioso, AR
AF Koike, Marcelo E.
   Gattas, Vera L.
   Lucchesi, Maria Beatriz B.
   Moura de Oliveira, Mayra M.
   Vanni, Tazio
   Thome, Beatriz da C.
   Menang, Olga
   Socquet, Muriel
   Precioso, Alexander R.
TI Pharmacovigilance capacity strengthening for WHO prequalification: The
   case of the trivalent influenza vaccine manufactured by Institute
   Butantan
SO VACCINE
LA English
DT Article
DE Trivalent influenza vaccine; WHO prequalification; Pharmacovigilance;
   Instituto Butantan
AB Institute Butantan is a biomedical research center and vaccine manufacturer affiliated with the Sao Paulo State Secretary of Health in Brazil. In 2013, Institute Butantan successfully licensed its trivalent influenza vaccine, in order to support the Brazilian National Immunization Program's influenza vaccination strategy, which was introduced in 1999. In order to respond to the increasing influenza vaccine demand worldwide, Institute Butantan is undergoing prequalification of its trivalent influenza vaccine by the World Health Organization (WHO). A key requirement of the prequalification review was the submission of a pharmacovigilance plan, including an active surveillance evaluation, for the trivalent influenza vaccine, and proof of a functional pharmacovigilance system at Institute Butantan. The aim of this paper is to describe the capacity strengthening process of the pharmacovigilance system at Instituto Butantan for the WHO prequalification of the trivalent influenza vaccine. This process was supported by PATH and the U.S. Federal Government Biomedical Advanced Research and Development Authority (BARDA). The key strategic axes for this capacity strengthening process included the improvement of organizational structure, human resources training, internal processes and procedures, appropriate documentation, and acquisition of an E2B compliant pharmacovigilance database. The project led to the establishment of a functional pharmacovigilance system compliant with international regulatory requirements. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Koike, Marcelo E.; Gattas, Vera L.; Lucchesi, Maria Beatriz B.; Moura de Oliveira, Mayra M.; Vanni, Tazio; Thome, Beatriz da C.; Precioso, Alexander R.] Inst Butantan, Div Clin Trials & Pharmacovigilance, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
   [Menang, Olga; Socquet, Muriel] PATH, Ctr Vaccine Innovat & Access, Geneva, Switzerland.
   [Precioso, Alexander R.] Univ Sao Paulo, Sch Med, Pediat Dept, Sao Paulo, SP, Brazil.
RP Koike, ME (reprint author), Inst Butantan, Div Clin Trials & Pharmacovigilance, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM marcelo.koike@butantan.gov.br
RI Koike, Marcelo/C-1652-2018; thome, beatriz/B-7337-2018; Precioso,
   Alexander/A-9712-2013
OI Koike, Marcelo/0000-0002-4608-8365; thome, beatriz/0000-0002-3941-3756;
   Precioso, Alexander/0000-0001-8657-9292
FU Federal funds from the U.S. Department of Health and Human Services;
   Office of the Assistant Secretary for Preparedness and Response;
   Biomedical Advanced Research and Development Authority (BARDA)
   [IDSEP130018]
FX This project has been funded in whole or in part with Federal funds from
   the U.S. Department of Health and Human Services; Office of the
   Assistant Secretary for Preparedness and Response; Biomedical Advanced
   Research and Development Authority (BARDA), under Grant No. IDSEP130018.
CR Agenda Nacional de Vigilancia Sanitaria (BR), 2009, DIARIO OFICIAL UNIAO, P42
   European Medicines Agency, 2017, GUID GOOD PHARM PRAC
   European Medicines Agency, 2018, GUID FORM RISK MAN P
   European Medicines Agency, 2012, GUID GOOD PHARM PRAC
   European Medicines Agency; Heads of Medicines Agencies, 2015, GUID GOOD PHARM PRAC
   Francis DP, 2014, VACCINE, V32, P5259, DOI 10.1016/j.vaccine.2014.07.069
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Ministerio da saude (BR), 2018, COORD GER PROGR NAC
   Miyaki C, 2011, VACCINE, V29, pA12, DOI 10.1016/j.vaccine.2011.04.127
   The Uppsala Monitoring Centre, US WHO UMC SYST STAN
   World Health Organization, 2013, WHO EXP COMM BIOL ST
   World Health Organization, 2018, CAUSALITY ASSESSMENT
NR 12
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7560
EP 7565
DI 10.1016/j.vaccine.2019.09.082
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600009
PM 31590933
DA 2020-05-12
ER

PT J
AU Ball, C
   Forrester, A
   Herrmann, A
   Lemier, S
   Ganapathy, K
AF Ball, Christopher
   Forrester, Anne
   Herrmann, Andreas
   Lemier, Stephane
   Ganapathy, Kannan
TI Comparative protective immunity provided by live vaccines of Newcastle
   disease virus or avian metapneumovirus when co-administered alongside
   classical and variant strains of infectious bronchitis virus in day-old
   broiler chicks
SO VACCINE
LA English
DT Article
DE Day-old vaccination; Newcastle Disease virus; Avian metapneumovirus;
   Infectious bronchitis viruses; Broiler chicken
ID MOLECULAR CHARACTERIZATION; RESPIRATORY-TRACT; VACCINATION; RESPONSES;
   PNEUMOVIRUS; SELECTION; SINGLE; FIELD; HEMAGGLUTINATION; DIFFERENTIATION
AB This study reports on the simultaneous administration of live NDV or aMPV subtype B vaccines alongside two live IBV (Massachusetts-HI 20 and 793B-CR88) vaccines in day-old maternal-antibody positive commercial broiler chicks. In the first experiment, chicks were divided into four groups; one unvaccinated and three groups vaccinated with live NDV VG/GA-Avinew, live H120 + CR88, or VC/GA-Avinew + H120 + CR88. In the second experiment, live aMPV subtype B vaccine was used in place of NDV. Clinical signs were monitored daily and oropharyngeal swabs were taken at regular intervals for vaccine virus detection. Blood was collected at 21 dpv for serology. 10 chicks from each group were challenged with virulent strains of M41 or QX or aMPV subtype B. For IBV, after 5 days post challenge (dpc), tracheal ciliary protection was assessed. For aMPV, clinical scores were recorded up to 10 dpc. For NDV, haemagglutination inhibition (HI) antibody titres were assayed as an indicator of protective immunity. In both experiments, ciliary protection for IBV vaccinated groups was maintained above 90%. The protection against virulent aMPV challenge was not compromised when aMPV, H120 and CR88 were co-administered. NDV HI mean titres in single and combined NDV-vaccinated groups remained above the protective titre (>3 log(2)). Both experiments demonstrated that simultaneous administration of live NDV VG/GA-Avinew or aMPV subtype B alongside H120 and CR88 vaccines does not interfere with protection conferred against NDV, IBV or aMPV. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Ball, Christopher; Forrester, Anne; Ganapathy, Kannan] Univ Liverpool, Inst Infect & Global Hlth, Leahurst Campus, Neston CH64 7TE, Cheshire, England.
   [Herrmann, Andreas; Lemier, Stephane] Boehringer Ingelheim GmbH & Co KG, 29 Ave Tony Gamier, F-69007 Lyon, France.
RP Ganapathy, K (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Leahurst Campus, Neston CH64 7TE, Cheshire, England.
EM gana@liverpool.ac.uk
CR Abdel-Sabour MA, 2017, AVIAN DIS, V61, P307, DOI 10.1637/11566-121516-RegR
   Abdelwhab EM, 2011, J VIROL METHODS, V174, P120, DOI 10.1016/j.jviromet.2011.03.017
   Al-Garib SO, 2003, WORLD POULTRY SCI J, V59, P185, DOI 10.1079/WPS20030011
   Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783
   Aldous EW, 2001, AVIAN PATHOL, V30, P117, DOI 10.1080/03079450120044515
   ALEXANDER DJ, 1977, AVIAN PATHOL, V6, P9, DOI 10.1080/03079457708418208
   Amarasinghe GK, 2019, ARCH VIROL, V164, P1967, DOI 10.1007/s00705-019-04247-4
   Awad F, 2015, VET REC OPEN, V2
   Awad F, 2016, AVIAN PATHOL, V45, P169, DOI 10.1080/03079457.2015.1137866
   Awad F, 2015, RES VET SCI, V98, P127, DOI 10.1016/j.rvsc.2014.11.004
   Ball C, 2017, AVIAN PATHOL, V46, P309, DOI 10.1080/03079457.2016.1268675
   Ball C, 2016, J GEN VIROL, V97, P3232, DOI 10.1099/jgv.0.000628
   BRACEWELL CD, 1972, VET REC, V90, P248, DOI 10.1136/vr.90.9.248
   Cardoso WM, 2005, Rev. Bras. Cienc. Avic., V7, P181, DOI 10.1590/S1516-635X2005000300008
   Catelli E, 2006, VACCINE, V24, P6476, DOI 10.1016/j.vaccine.2006.06.076
   Cavanagh D, 2005, AVIAN PATHOL, V34, P20, DOI 10.1080/03079450400025414
   Cavanagh D, 1999, AVIAN PATHOL, V28, P593, DOI 10.1080/03079459994399
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   Chhabra R, 2018, DEV COMP IMMUNOL, V87, P16, DOI 10.1016/j.dci.2018.04.026
   Chhabra R, 2015, CLIN VACCINE IMMUNOL, V22, P1050, DOI 10.1128/CVI.00368-15
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   COOK JKA, 1989, AVIAN PATHOL, V18, P523, DOI 10.1080/03079458908418624
   Cook JKA, 1999, AVIAN PATHOL, V28, P477, DOI 10.1080/03079459994506
   Cook JKA, 2001, AVIAN PATHOL, V30, P233, DOI 10.1080/03079450120054640
   De Wit JJ, 2015, AVIAN PATHOL, V44, P352, DOI 10.1080/03079457.2015.1058916
   Diallo IS, 2010, AVIAN PATHOL, V39, P25, DOI 10.1080/03079450903447412
   Fan WQ, 2012, BIOSCI BIOTECH BIOCH, V76, P2255, DOI 10.1271/bbb.120521
   FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270
   Ganapathy K, 2007, AVIAN PATHOL, V36, P313, DOI 10.1080/03079450701460781
   Ganapathy K, 2005, AVIAN PATHOL, V34, P297, DOI 10.1080/03079450500178824
   Ganapathy K, 2015, VIRUS RES, V210, P198, DOI 10.1016/j.virusres.2015.07.019
   Ganapathy K, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3227
   Ganapathy K, 2010, VACCINE, V28, P3944, DOI 10.1016/j.vaccine.2010.03.065
   Gelb J, 2007, AVIAN DIS, V51, P924, DOI 10.1637/7930-020807-REGR.1
   GODDARD RD, 1988, VACCINE, V6, P530, DOI 10.1016/0264-410X(88)90106-5
   Grgic H, 2008, CAN J VET RES, V72, P403
   Guionie O, 2007, J VIROL METHODS, V139, P150, DOI 10.1016/j.jviromet.2006.09.022
   Han ZX, 2011, INFECT GENET EVOL, V11, P190, DOI 10.1016/j.meegid.2010.09.002
   Jackwood MW, 2013, INFECT BRONCHITIS
   Jakhesara SJ, 2018, ACTA TROP, V183, P57, DOI 10.1016/j.actatropica.2018.04.004
   Jeong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083161
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Jones RM, 2011, TRANSBOUND EMERG DIS, V58, P411, DOI 10.1111/j.1865-1682.2011.01222.x
   Jones RC, 2010, BRIT POULTRY SCI, V51, P1, DOI 10.1080/00071660903541378
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Marangon S, 2007, REV SCI TECH OIE, V26, P265, DOI 10.20506/rst.26.1.1742
   McKinley ET, 2008, VACCINE, V26, P1274, DOI 10.1016/j.vaccine.2008.01.006
   Miller P, 2013, DIS POULTRY, P89, DOI DOI 10.1002/9781119421481.CH3
   Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1
   Naqi S, 2003, AVIAN DIS, V47, P594, DOI 10.1637/6087
   Nei M, 2000, MOL EVOLUTION PHYLOG
   Nielsen R, 1998, GENETICS, V148, P929
   Okino CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172275
   Purvis LB, 2006, J VIROL METHODS, V138, P66, DOI 10.1016/j.jviromet.2006.07.021
   RAGGI LG, 1964, AVIAN DIS, V8, P471, DOI 10.2307/1587936
   Raghul J, 2006, VET RES COMMUN, V30, P95, DOI 10.1007/s11259-005-3141-z
   Raj GD, 1996, AVIAN PATHOL, V25, P481, DOI 10.1080/03079459608419157
   Raue R, 1998, J VIROL METHODS, V73, P211, DOI 10.1016/S0166-0934(98)00065-2
   Rubbenstroth D, 2009, AVIAN PATHOL, V38, P427, DOI 10.1080/03079450903349204
   SAINI SS, 1990, COMP IMMUNOL MICROB, V13, P1, DOI 10.1016/0147-9571(90)90002-B
   Senne DA, 2004, DEV BIOLOGICALS, V119, P165
   Shokri S, 2018, IRAN J MICROBIOL, V10, P65
   Smith J., 37 NAT M POULTR HLTH, P31
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Toro H, 2010, BRAZ J POULTRY SCI, V12, P79, DOI 10.1590/S1516-635X2010000200002
   Tucciarone CM, 2018, POULTRY SCI, V97, P503, DOI 10.3382/ps/pex350
   van Santen VL, 2008, AVIAN PATHOL, V37, P293, DOI 10.1080/03079450802043783
   Wang YuDong, 1998, Chinese Journal of Animal Quarantine, V15, P1
   Worthington KJ, 2008, AVIAN PATHOL, V37, P247, DOI 10.1080/03079450801986529
   Yu L, 2001, AVIAN DIS, V45, P416, DOI 10.2307/1592981
NR 71
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7566
EP 7575
DI 10.1016/j.vaccine.2019.09.081
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600010
PM 31607602
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Maltezou, HC
   Botelho-Nevers, E
   Brantsaeter, AB
   Carlsson, RM
   Heininger, U
   Hubschen, JM
   Josefsdottir, KS
   Kassianos, G
   Kyncl, J
   Ledda, C
   Medic, S
   Nitsch-Osuch, A
   de Lejarazu, RO
   Theodoridou, M
   Van Damme, P
   van Essen, GA
   Wicker, S
   Wiedermann, U
   Poland, GA
   Bino, S
   Filipova, R
   Drazenovic, V
   Koliou, M
   Fabianova, K
   Jensen, LH
   Filippova, I
   Elonsalo, U
   Molnar, Z
   Josefsdottir, KS
   Sisson, L
   Perevoscikovs, J
   Savrasova, L
   Caplinskas, S
   Berthet, F
   Hbschen, JM
   Borg, M
   Cirstea, O
   Brantsaeer, AB
   Graca, S
   Falup-Pecurariu, O
   Mikheeva, I
   Kollarova, D
   Mrvic, T
   Roth, A
   Chernyshova, L
   Lapiy, F
AF Maltezou, Helena C.
   Botelho-Nevers, Elisabeth
   Brantsaeter, Arne B.
   Carlsson, Rose-Marie
   Heininger, Ulrich
   Hubschen, Judith M.
   Josefsdottir, Kamilla S.
   Kassianos, George
   Kyncl, Jan
   Ledda, Caterina
   Medic, Snezana
   Nitsch-Osuch, Aneta
   Ortiz de Lejarazu, Raul
   Theodoridou, Maria
   Van Damme, Pierre
   van Essen, Gerrit A.
   Wicker, Sabine
   Wiedermann, Ursula
   Poland, Gregory A.
   Bino, Silvia
   Filipova, Radosveta
   Drazenovic, Vladimir
   Koliou, Maria
   Fabianova, Katerina
   Jensen, Lise Heilmann
   Filippova, Irina
   Elonsalo, Ulpu
   Molnar, Zsuzsanna
   Josefsdottir, Kamilla Sigridur
   Sisson, Lynda
   Perevoscikovs, Jurijs
   Savrasova, Larisa
   Caplinskas, Saulius
   Berthet, Francoise
   Hbschen, Judith M.
   Borg, Michael
   Cirstea, Olga
   Brantsaeter, Arne B.
   Graca, Silva
   Falup-Pecurariu, Oana
   Mikheeva, Irina
   Kollarova, Dagmar
   Mrvic, Tatjana
   Roth, Adam
   Chernyshova, Liudmyla
   Lapiy, Fedir
CA Vaccination Policies HCP Europe St
TI Vaccination of healthcare personnel in Europe: Update to current
   policies
SO VACCINE
LA English
DT Article
DE Vaccination; Healthcare personnel; Occupational; Policies; Europe
ID TUBERCULOSIS PREVENTION; WORKERS; PERTUSSIS; HESITANCY; MEASLES
AB We investigated and compared current national vaccination policies for health-care personnel (HCP) in Europe with results from our previous survey. Data from 36 European countries were collected using the same methodology as in 2011. National policies for HCP immunization were in place in all countries. There were significant differences in terms of number of vaccinations, target HCP and healthcare settings, and implementation regulations (recommended or mandatory vaccinations). Vaccination policies against hepatitis B and seasonal influenza were present in 35 countries each. Policies for vaccination of HCP against measles, mumps, rubella and varicella existed in 28, 24, 25 and 19 countries, respectively; and against tetanus, diphtheria, pertussis and poliomyelitis in 21, 20, 19, and 18 countries, respectively. Recommendations for hepatitis A immunization existed in 17 countries, and against meningococcus B, meningococcus C, meningococcus A, C, W, Y, and tuberculosis in 10, 8, 17, and 7 countries, respectively. Mandatory vaccination policies were found in 13 countries and were a pre-requisite for employment in ten. Comparing the vaccination programs of the 30 European countries that participated in the 2011 survey, we found that more countries had national vaccination policies against measles, mumps, rubella, hepatitis A, diphtheria, tetanus, poliomyelitis, pertussis, meningococcus C and/or meningococcus A, C, W, Y; and more of these implemented mandatory vaccination policies for HCP. In conclusion, European countries now have more comprehensive national vaccination programs for HCP, however there are still gaps. Given the recent large outbreaks of vaccine-preventable diseases in Europe and the occupational risk for HCP, vaccination policies need to be expanded and strengthened in several European countries. Overall, vaccination policies for HCP in Europe should be periodically re-evaluated in order to provide optimal protection against vaccine-preventable diseases and infection control within healthcare facilities for HCP and patients. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Maltezou, Helena C.] Hellen Ctr Dis Control & Prevent, Dept Intervent Hlth Care Facil, 3-5 Agrafon St, Athens 15123, Greece.
   [Botelho-Nevers, Elisabeth] Univ Hosp St Etienne, Clin Trial Ctr, INSERM CICEC 1408, F-42055 St Etienne, France.
   [Botelho-Nevers, Elisabeth] Univ Hosp St Etienne, Infect Dis Dept, F-42055 St Etienne, France.
   [Brantsaeter, Arne B.] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.
   [Brantsaeter, Arne B.] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway.
   [Carlsson, Rose-Marie; Roth, Adam] Publ Hlth Agcy Sweden, Solna, Sweden.
   [Heininger, Ulrich] Univ Basel, Childrens Hosp, Basel, Switzerland.
   [Hubschen, Judith M.; Hbschen, Judith M.] Luxembourg Inst Hlth, Luxembourg, Luxembourg.
   [Josefsdottir, Kamilla S.] Directorate Hlth, Ctr Hlth Secur & Communicable Dis Control, Reykjavik, Iceland.
   [Kassianos, George] Royal Coll Gen Practitioners, Wokingham, England.
   [Kyncl, Jan] Natl Inst Publ Hlth, Dept Infect Dis Epidemiol, Prague, Czech Republic.
   [Kyncl, Jan] Charles Univ Prague, Fac Med 3, Dept Epidemiol & Biostat, Prague, Czech Republic.
   [Ledda, Caterina] Univ Catania, Dept Clin & Expt Med, Occupat Med, Catania, Italy.
   [Medic, Snezana] Univ Novi Sad, Fac Med, Dept Epidemiol, Novi Sad, Serbia.
   [Medic, Snezana] Ctr Dis Control & Prevent, Inst Publ Hlth Vojvodina, Novi Sad, Serbia.
   [Nitsch-Osuch, Aneta] Med Univ Warsaw, Dept Social Med & Publ Hlth, Warsaw, Poland.
   [Ortiz de Lejarazu, Raul] Hosp Clin Univ, Natl Influenza Ctr, Sch Med, Microbiol & Immunol Dept, Valladolid, Spain.
   [Theodoridou, Maria] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece.
   [Van Damme, Pierre] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Antwerp, Belgium.
   [Wicker, Sabine] Univ Hosp Frankfurt, Occupat Hlth Serv, Frankfurt, Germany.
   [Wiedermann, Ursula] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.
   [Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN USA.
   [Bino, Silvia] Inst Publ Hlth, Tirana, Albania.
   [Wiedermann, Ursula] Med Univ Vienna, Vienna, Austria.
   [Van Damme, Pierre] Univ Antwerp, Antwerp, Belgium.
   [Filipova, Radosveta] Minist Hlth, Sofia, Bulgaria.
   [Drazenovic, Vladimir] Croatian Natl Inst Publ Hlth, Zagreb, Croatia.
   [Koliou, Maria] Univ Cyprus, Med Sch, Nicosia, Cyprus.
   [Kyncl, Jan; Fabianova, Katerina] Natl Inst Publ Hlth, Prague, Czech Republic.
   [Jensen, Lise Heilmann] Roskilde Univ Hosp, Roskilde, Denmark.
   [Filippova, Irina] Ctr Dis Surveillance & Control, Tallinn, Estonia.
   [Elonsalo, Ulpu] Natl Inst Hlth & Welf, Helsinki, Finland.
   [Botelho-Nevers, Elisabeth] Univ Hosp St Etienne, St Etienne, France.
   [Wicker, Sabine] Univ Hosp Frankfurt, Frankfurt, Germany.
   [Maltezou, Helena C.] Hellen Ctr Dis Control & Prevent, Athens, Greece.
   [Theodoridou, Maria] Univ Athens, Athens, Greece.
   [Molnar, Zsuzsanna] Minist Human Capac, Budapest, Hungary.
   [Josefsdottir, Kamilla Sigridur] Directorate Hlth, Reykjavik, Iceland.
   [Sisson, Lynda] Workpl Hlth & Wellbeing Unit, Dublin, Ireland.
   [Ledda, Caterina] Univ Catania, Catania, Italy.
   [Perevoscikovs, Jurijs; Savrasova, Larisa] Ctr Dis Prevent & Control, Riga, Latvia.
   [Caplinskas, Saulius] Ctr Communicable Dis & AIDS, Vilnius, Lithuania.
   [Berthet, Francoise] Minist Hlth, Luxembourg, Luxembourg.
   [Borg, Michael] Univ Malta, Msida, Malta.
   [Cirstea, Olga] State Univ Med & Pharm Nicolae Testemitanu, Kishinev, Moldova.
   [Brantsaeter, Arne B.] Oslo Univ Hosp, Oslo, Norway.
   [Nitsch-Osuch, Aneta] Med Univ Warsaw, Warsaw, Poland.
   [Graca, Silva] Natl Hlth Inst, Lisbon, Portugal.
   [Falup-Pecurariu, Oana] Transilvania Univ, Fac Med, Brasov, Romania.
   [Mikheeva, Irina] Cent Res Inst Epidemiol, Moscow, Russia.
   [Medic, Snezana] Univ Novi Sad, Novi Sad, Serbia.
   [Kollarova, Dagmar] Slovak Med Univ, Bratislava, Slovakia.
   [Mrvic, Tatjana] Infect Control UMC, Ljubljana, Slovenia.
   [Ortiz de Lejarazu, Raul] Natl Influenza Ctr, Valladolid, Spain.
   [Chernyshova, Liudmyla; Lapiy, Fedir] Natl Med Acad Postgrad Educ, Kiev, Ukraine.
RP Maltezou, HC (reprint author), Hellen Ctr Dis Control & Prevent, Dept Intervent Hlth Care Facil, 3-5 Agrafon St, Athens 15123, Greece.
EM helen-maltezou@ath.forthnet.gr
RI Ledda, Caterina/A-1118-2011; Hubschen, Judith/AAF-5113-2020
OI Ledda, Caterina/0000-0003-0739-8798; Heininger,
   Ulrich/0000-0001-8901-6778
FU European Union's Health Programme (2014-2020)European Union (EU)
FX Part of the Belgian research was funded by the European Union's Health
   Programme (2014-2020).
CR Bo M, 2016, HUM VACC IMMUNOTHER, V12, P2753, DOI 10.1080/21645515.2016.1200776
   Boulanger RF, 2016, CLIN INFECT DIS, V62, pS268, DOI 10.1093/cid/ciw013
   Dube E, 2017, CLIN MICROBIOL INFEC, V23, P279, DOI 10.1016/j.cmi.2016.11.007
   Eichner M, 2013, LANCET, V382, P1777, DOI 10.1016/S0140-6736(13)62220-5
   European Centre for Disease Prevention and Control, MEN VACC REC VACC
   European Centre for Disease Prevention and Control, EP UPD HEP OUTBR EU
   European Centre for Disease Prevention and Control, MEASL
   European Centre for Disease Prevention and Control, 2018, MONTHL MEASL RUB MON
   European Commission, 20091019EU EUR COMM
   Fiebelkorn AP, 2014, VACCINE, V32, P4823, DOI 10.1016/j.vaccine.2013.11.005
   Gagneux-Brunon A, 2018, EXPERT REV VACCINES, V17, P421, DOI 10.1080/14760584.2018.1470507
   Heininger U, 2014, VACCINE, V32, P4840, DOI 10.1016/j.vaccine.2013.10.062
   Jussi Sane, 2015, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.2.30105, DOI 10.2807/1560-7917.ES.2016.21.2.30105]
   Levy-Bruhl D, 2018, EUROSURVEILLANCE, V23, P11, DOI 10.2807/1560-7917.ES.2018.23.17.18-00048
   Maltezou HC, 2013, J HOSP INFECT, V85, P243, DOI 10.1016/j.jhin.2013.09.009
   Maltezou HC, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030047
   Maltezou HC, 2013, AM J INFECT CONTROL, V41, P661, DOI 10.1016/j.ajic.2012.09.017
   Maltezou HC, 2011, VACCINE, V29, P9557, DOI 10.1016/j.vaccine.2011.09.076
   Paterson P, 2016, VACCINE, V34, P6700, DOI 10.1016/j.vaccine.2016.10.042
   Pavli A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax016
   Sejvar JJ, 2005, J CLIN MICROBIOL, V43, P4811, DOI 10.1128/JCM.43.9.4811-4814.2005
   Sydnor E, 2014, VACCINE, V32, P4814, DOI 10.1016/j.vaccine.2014.03.097
   van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400
   Verger P, 2016, EUROSURVEILLANCE, V21, P14, DOI 10.2807/1560-7917.ES.2016.21.47.30406
   WHO, 2018, STATE VACCINE CONFID
   Wicker S, 2014, VACCINE, V32, P4844, DOI 10.1016/j.vaccine.2013.09.062
   World Health Organization, 18 M EUR TECHN ADV G
   World Health Organization, TABL 4 SUMM WHO POS
NR 28
TC 5
Z9 5
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7576
EP 7584
DI 10.1016/j.vaccine.2019.09.061
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600011
PM 31623916
DA 2020-05-12
ER

PT J
AU Rouse, CE
   Eckert, LO
   Munoz, FM
   Stringer, JSA
   Kochhar, S
   Bartlett, L
   Sanicas, M
   Dudley, DJ
   Harper, DM
   Bittaye, M
   Meller, L
   Jehan, F
   Maltezou, HC
   Subelj, M
   Bardaji, A
   Kachikis, A
   Beigi, R
   Gravett, MG
AF Rouse, C. E.
   Eckert, L. O.
   Munoz, F. M.
   Stringer, J. S. A.
   Kochhar, S.
   Bartlett, L.
   Sanicas, M.
   Dudley, D. J.
   Harper, D. M.
   Bittaye, M.
   Meller, L.
   Jehan, F.
   Maltezou, H. C.
   Subelj, M.
   Bardaji, A.
   Kachikis, A.
   Beigi, R.
   Gravett, M. G.
CA Global Alignment Immunization Safe
TI Postpartum endometritis and infection following incomplete or complete
   abortion: Case definition & guidelines for data collection, analysis,
   and presentation of maternal immunization safety data
SO VACCINE
LA English
DT Article
ID ADVERSE EVENTS; COMPLICATIONS; MORBIDITY; SEPSIS; RISK; CULTURE; BURDEN;
   WOMEN; CARE
C1 [Rouse, C. E.] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN USA.
   [Eckert, L. O.; Kachikis, A.; Gravett, M. G.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Eckert, L. O.; Gravett, M. G.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Munoz, F. M.] Baylor Coll Med, Dept Pediat, Sect Infect Dis, Houston, TX 77030 USA.
   [Stringer, J. S. A.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA.
   [Kochhar, S.] Univ Washington, Global Healthcare Consulting, Seattle, WA 98195 USA.
   [Kochhar, S.] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands.
   [Bartlett, L.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA.
   [Sanicas, M.] Sanofi Pasteur, Singapore, Singapore.
   [Dudley, D. J.] Univ Virginia, Dept Obstet & Gynecol, Charlottesville, VA USA.
   [Harper, D. M.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.
   [Harper, D. M.] Univ Michigan, Dept Obstet & Gynecol, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Bittaye, M.] Univ Gambia, Edward Francis Small Teaching Hosp, Serekunda, Gambia.
   [Bittaye, M.] MRC, Serekunda, Gambia.
   [Bittaye, M.] London Sch Hyg & Trop Med, London, England.
   [Meller, L.] Syneos Hlth, Safety & Pharmacovigilance, Raleigh, NC USA.
   [Jehan, F.] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan.
   [Maltezou, H. C.] Hellen Ctr Dis Control & Prevent, Dept Intervent Healthcare Facil, Athens, Greece.
   [Subelj, M.] Natl Inst Publ Hlth, Ljubljana, Slovenia.
   [Bardaji, A.] Barcelona Inst Global Hlth, Barcelona, Spain.
   [Kachikis, A.] Univ Washington, Global Hlth, Seattle, WA 98195 USA.
   [Beigi, R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
RP Gravett, MG (reprint author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gravett, MG (reprint author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM secretariat@brightoncollaboration.org
RI Harper, Diane M./I-2180-2014; Bardaji, Azucena/AAE-9145-2019; Sanicas,
   Melvin/AAJ-5606-2020
OI Harper, Diane M./0000-0001-7648-883X; Bardaji,
   Azucena/0000-0002-5135-0540; Sanicas, Melvin/0000-0002-2933-0666; Munoz,
   Flor/0000-0002-0457-7689; Eckert, Linda/0000-0002-1357-8405
FU Bill and Melinda Gates FoundationGates Foundation
FX The authors are grateful for the support and helpful comments provided
   by the Brighton Collaboration Steering Committee and Reference group, as
   well as members of an external review panel. other experts consulted as
   part of the process. The authors are also grateful to names of the
   Brighton Collaboration Secretariat for final revisions of the final
   document. Finally, we would like to acknowledge the Global Alignment of
   Immunization Safety Assessment in Pregnancy (GALA) project, funded by
   the Bill and Melinda Gates Foundation.
CR Albright CM, 2017, OBSTET GYNECOL, V130, P747, DOI 10.1097/AOG.0000000000002260
   Albright CM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.010
   [Anonymous], 2017, STAT MAT SEPS
   Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014
   Axelsson D, 2014, ACTA OBSTET GYN SCAN, V93, P1065, DOI 10.1111/aogs.12455
   Bonet M, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0451-5
   BURKMAN RT, 1977, AM J OBSTET GYNECOL, V128, P556, DOI 10.1016/0002-9378(77)90041-2
   Burrows LJ, 2004, OBSTET GYNECOL, V103, P907, DOI 10.1097/01.AOG.0000124568.71597.ce
   CHOW AW, 1977, J INFECT DIS, V135, pS35, DOI 10.1093/infdis/135.Supplement.S35
   Cleland K, 2013, OBSTET GYNECOL, V121, P166, DOI [10.1097/AOG.0b013e3182755763, http://10.1097/AOG.0b013e3182755763]
   Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803
   DOLEA C, 2003, GLOBAL BURDEN MATERN
   DUFF P, 1983, OBSTET GYNECOL, V61, P217
   Eschenbach DA, 2015, OBSTET GYNECOL, V125, P1042, DOI 10.1097/AOG.0000000000000795
   Faro S, 2005, CLIN PERINATOL, V32, P803, DOI 10.1016/j.clp.2005.04.005
   Fischer M, 2005, NEW ENGL J MED, V353, P2352, DOI 10.1056/NEJMoa051620
   Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4
   GRIMES DA, 1981, OBSTET GYNECOL, V57, P739
   Hussein J., 2010, MATERNAL INFANT DEAT, P131
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Kachikis A, CHORIOAMNIONITIS CAS
   Kinaro J, 2009, REPROD HEALTH MATTER, V17, P71, DOI 10.1016/S0968-8080(09)34476-6
   Kohl KS, 2007, VACCINE, V25, P5671, DOI 10.1016/j.vaccine.2007.02.063
   Leber A. L., 2016, CLIN MICROBIOLOGY PR
   Locksmith G J, 1994, Infect Dis Obstet Gynecol, V2, P111, DOI 10.1155/S1064744994000487
   Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07
   Mackeen AD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001067.pub3
   Maharaj D, 2007, OBSTET GYNECOL SURV, V62, P400, DOI 10.1097/01.ogx.0000266063.84571.fb
   Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007
   Mayi-Tsonga S, 2009, REPROD HEALTH MATTER, V17, P65, DOI 10.1016/S0968-8080(09)34465-1
   Melese T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166287
   Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044
   Motherhood S., 1994, FHEMSM94
   Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2
   National Academies of Sciences Engineering and Medicine Health and Medicine Division Board on Health Care Services Board on Population Health and Public Health Practice Committee on Reproductive Health Services: Assessing the Safety and Quality of Abortion Care in the U.S, 2018, COMM REPR HLTH SERV
   Ngonzi J, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1891-1
   O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264
   Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045
   Rahangdale L, 2009, CLIN OBSTET GYNECOL, V52, P198, DOI 10.1097/GRF.0b013e3181a2b6dd
   Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X
   ROSENE K, 1986, J INFECT DIS, V153, P1028, DOI 10.1093/infdis/153.6.1028
   Rouse CE, 2017, VACCINE, V35, P6563, DOI 10.1016/j.vaccine.2017.01.047
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Seale AC, 2017, CLIN INFECT DIS, V65, pS200, DOI 10.1093/cid/cix664
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4
   Shannon C, 2004, CONTRACEPTION, V70, P183, DOI 10.1016/j.contraception.2004.04.009
   Spandorfer SD, 1996, J REPROD MED, V41, P797
   STEVENSON MM, 1995, INT J STD AIDS, V6, P305, DOI 10.1177/095646249500600501
   Upadhyay UD, 2015, OBSTET GYNECOL, V125, P175, DOI 10.1097/AOG.0000000000000603
   van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c
   White K, 2015, CONTRACEPTION, V92, P422, DOI 10.1016/j.contraception.2015.07.013
NR 52
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7585
EP 7595
DI 10.1016/j.vaccine.2019.09.101
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600012
PM 31783980
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Pellegrin, S
   Munoz, FM
   Padula, M
   Heath, PT
   Meller, L
   Top, K
   Wilmshurst, J
   Wiznitzer, M
   Das, MK
   Hahn, CD
   Kucuku, M
   Oleske, J
   Vinayan, KP
   Yozawitz, E
   Aneja, S
   Bhat, N
   Boylan, G
   Sesay, S
   Shrestha, A
   Soul, JS
   Tagbo, B
   Joshi, J
   Soe, A
   Maltezou, HC
   Gidudu, J
   Kochhar, S
   Pressler, RM
AF Pellegrin, Serena
   Munoz, Flor M.
   Padula, Michael
   Heath, Paul T.
   Meller, Lee
   Top, Karina
   Wilmshurst, Jo
   Wiznitzer, Max
   Das, Manoja Kumar
   Hahn, Cecil D.
   Kucuku, Merita
   Oleske, James
   Vinayan, Kollencheri Puthenveettil
   Yozawitz, Elissa
   Aneja, Satinder
   Bhat, Niranjan
   Boylan, Geraldine
   Sesay, Sanie
   Shrestha, Anju
   Soul, Janet S.
   Tagbo, Beckie
   Joshi, Jyoti
   Soe, Aung
   Maltezou, Helena C.
   Gidudu, Jane
   Kochhar, Sonali
   Pressler, Ronit M.
CA Brighton Collaboration Neonatal Se
TI Neonatal seizures: Case definition & guidelines for data collection,
   analysis, and presentation of immunization safety data
SO VACCINE
LA English
DT Article
DE Neonatal seizures; Adverse event; Immunization; Guidelines; Case
   definition
ID NEUROPHYSIOLOGY SOCIETY GUIDELINE; NONEPILEPTIC MOTOR PHENOMENA;
   ELECTROGRAPHIC SEIZURES; EPILEPTIC SEIZURES; INTERNATIONAL-LEAGUE;
   CLINICAL-FEATURES; ILAE COMMISSION; POSITION PAPER; BRAIN-INJURY;
   PRETERM
C1 [Pellegrin, Serena; Pressler, Ronit M.] UCL Inst Child Hlth, Clin Neurosci, London, England.
   [Pellegrin, Serena] Univ Verona, Dept Child Neuropsychiat, Verona, Italy.
   [Munoz, Flor M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Padula, Michael] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   [Heath, Paul T.] St Georges Univ London, Vaccine Inst, London, England.
   [Meller, Lee] Syneos Hlth Safety & Pharmacovigilance, Raleigh, NC USA.
   [Top, Karina] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.
   [Wilmshurst, Jo] Univ Cape Town, Red Cross War Mem Childrens Hosp, Neurosci Inst, Dept Paediat Neurol, Cape Town, South Africa.
   [Wiznitzer, Max] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA.
   [Das, Manoja Kumar] INCLEN Trust Int, New Delhi, India.
   [Hahn, Cecil D.] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON, Canada.
   [Hahn, Cecil D.] Univ Toronto, Dept Paediat, Toronto, ON, Canada.
   [Kucuku, Merita] Natl Agcy Med & Med Devices, Tirana, Albania.
   [Oleske, James] Rutgers New Jersey Med Sch, Dept Pediat, Newark, NJ USA.
   [Vinayan, Kollencheri Puthenveettil] Amrita Inst Med Sci, Dept Neurol, Div Pediat Neurol, Cochin, Kerala, India.
   [Yozawitz, Elissa] Albert Einstein Coll Med, Dept Pediat, Saul R Korey Dept Neurol, Bronx, NY 10467 USA.
   [Aneja, Satinder] Sharda Univ, Sch Med Sci & Res, Dept Pediat, Gr Noida, India.
   [Bhat, Niranjan] Ctr Vaccine Innovat & Access PATH, Seattle, WA USA.
   [Boylan, Geraldine] Univ Coll Cork, INFANT Res Ctr, Cork, Ireland.
   [Sesay, Sanie] Sanofi Pasteur, Clin Sci, Marcy Letoile, France.
   [Shrestha, Anju] Global Pharmacovigilance, Sanofi Pasteur, Prussia, PA USA.
   [Soul, Janet S.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.
   [Tagbo, Beckie] Univ Nigeria Teaching Hosp, Inst Child Hlth, Enugu, Nigeria.
   [Joshi, Jyoti] Ctr Dis Dynam Econ & Policy, New Delhi, India.
   [Soe, Aung] Medway NHS Fdn Trust, Gillingham, Kent, England.
   [Maltezou, Helena C.] Hellenic Ctr Dis Control & Prevent, Dept Intervent Healthcare Facil, Athens, Greece.
   [Gidudu, Jane] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA.
   [Kochhar, Sonali] Global Healthcare Consulting, New Delhi, India.
   [Kochhar, Sonali] Erasmus MC, Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.
   [Kochhar, Sonali] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Pressler, Ronit M.] Great Ormond St Hosp Children NHS Fdn Trust, London, England.
RP Pressler, RM (reprint author), UCL Inst Child Hlth, London, England.
EM contact@brightoncollaboration.org
OI Top, Karina/0000-0002-9981-368X; Munoz, Flor/0000-0002-0457-7689;
   Boylan, Geraldine/0000-0003-0920-5291
CR Abend NS, 2018, VOLPES NEUROLOGY NEW, P275
   Anand V, 2014, J PEDIATR NEUROSCI, V9, P97, DOI 10.4103/1817-1745.139261
   Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002
   [Anonymous], 1981, Epilepsia, V22, P489
   Armentrout D C, 2001, J Pediatr Health Care, V15, P147, DOI 10.1067/mph.2001.114820
   Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077
   Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008
   BOOTH D, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004218.PUB2
   Boylan GB, 2002, ARCH DIS CHILD-FETAL, V86, P165
   Boylan GB, 1999, DEV MED CHILD NEUROL, V41, P819, DOI 10.1017/S0012162299001632
   BRAY PF, 1977, JAMA-J AM MED ASSOC, V237, P1342, DOI 10.1001/jama.237.13.1342
   BYE AME, 1995, EPILEPSIA, V36, P1009, DOI 10.1111/j.1528-1157.1995.tb00960.x
   CLANCY RR, 1987, EPILEPSIA, V28, P537, DOI 10.1111/j.1528-1157.1987.tb03685.x
   CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x
   CONNOLLY AM, 1990, CLIN PERINATOL, V17, P371
   Cross JH, 2013, SEMIN FETAL NEONAT M, V18, P192, DOI 10.1016/j.siny.2013.04.003
   de Vries LS, 2005, ARCH DIS CHILD-FETAL, V90, P201, DOI 10.1136/adc.2004.062745
   Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670
   Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550
   Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x
   Ghanshyambhai P, 2016, J MATERN-FETAL NEO M, V29, P554, DOI 10.3109/14767058.2015.1010199
   Glass HC, 2018, SEMIN FETAL NEONAT M, V23, P218, DOI 10.1016/j.siny.2018.02.001
   Glass HC, 2017, PEDIATR NEUROL, V72, P19, DOI 10.1016/j.pediatrneurol.2017.04.016
   Glass HC, 2016, J PEDIATR-US, V174, P98, DOI 10.1016/j.jpeds.2016.03.035
   Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008
   Hahn CD, 2004, NEONATAL SEIZURES EE
   Heljic Suada, 2016, Med Arch, V70, P182, DOI 10.5455/medarh.2016.70.182-185
   Holanda MRR, 2006, ARQ NEURO-PSIQUIAT, V64, P45, DOI 10.1590/S0004-282X2006000100010
   Huntsman RJ, 2008, PAED CHILD HEALT-CAN, V13, P680, DOI 10.1093/pch/13.8.680
   Institute of Medicine, 2013, CHILDH IMM SCHED SAF
   Janackova S, 2016, CLIN NEUROPHYSIOL, V127, P2721, DOI 10.1016/j.clinph.2016.05.006
   Jones CE, 2016, VACCINE, V34, P5998, DOI 10.1016/j.vaccine.2016.07.032
   Kabakus N, 2006, PEDIATR INT, V48, P622, DOI 10.1111/j.1442-200X.2006.02280.x
   Katsarou AM, 2018, SEMIN FETAL NEONAT M, V23, P159, DOI 10.1016/j.siny.2017.12.004
   Kharoshankaya L, 2016, DEV MED CHILD NEUROL, V58, P1242, DOI 10.1111/dmcn.13215
   Kohl KS, 2007, VACCINE, V25, P5671, DOI 10.1016/j.vaccine.2007.02.063
   Kuratani J, 2016, J CLIN NEUROPHYSIOL, V33, P320, DOI 10.1097/WNP.0000000000000321
   Lanska MJ, 1996, NEUROEPIDEMIOLOGY, V15, P117, DOI 10.1159/000109898
   LANSKA MJ, 1995, NEUROLOGY, V45, P724, DOI 10.1212/WNL.45.4.724
   Lateef TM, 2015, J PEDIATR-US, V166, P576, DOI 10.1016/j.jpeds.2014.10.054
   Lewis E, 2001, PEDIATR INFECT DIS J, V20, P1049, DOI 10.1097/00006454-200111000-00009
   Malik AR, 2013, PAK J MED SCI, V29, P1128
   Malone A, 2009, EPILEPSIA, V50, P2097, DOI 10.1111/j.1528-1167.2009.02132.x
   Maurer VO, 2010, PEDIATRICS, V125, pE919, DOI 10.1542/peds.2009-1839
   MIZRAHI EM, 1987, NEUROLOGY, V37, P1837, DOI 10.1212/WNL.37.12.1837
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314
   Mwaniki M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-16
   Nagarajan L, 2012, EUR J PAEDIATR NEURO, V16, P118, DOI 10.1016/j.ejpn.2011.11.005
   Orivoli S, 2015, BRAIN DEV-JPN, V37, P833, DOI 10.1016/j.braindev.2015.01.002
   Pinchefsky EF, 2017, CURR OPIN NEUROL, V30, P156, DOI 10.1097/WCO.0000000000000425
   Pisani F, 2007, NEUROLOGY, V69, P2177, DOI 10.1212/01.wnl.0000295674.34193.9e
   Pisani F, 2012, J CHILD NEUROL, V27, P1264, DOI 10.1177/0883073811435244
   Pisani F, 2012, PEDIATR RES, V72, P186, DOI 10.1038/pr.2012.66
   Plouin P, 2013, HAND CLINIC, V111, P467, DOI 10.1016/B978-0-444-52891-9.00051-8
   Pressler RM, 2017, PEDIAT EPILEPSY
   Pressler RM, 2018, ILAE CLASSIFICATION
   Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045
   Rakshasbhuvankar A, 2015, SEIZURE-EUR J EPILEP, V33, P90, DOI 10.1016/j.seizure.2015.09.014
   Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205
   Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c
   Ronen GM, 1999, J PEDIATR-US, V134, P71, DOI 10.1016/S0022-3476(99)70374-4
   Sabzehei MK, 2014, IRAN J CHILD NEUROL, V8, P26
   Sadeghian Afsaneh, 2012, Acta Med Iran, V50, P760
   Saliba RM, 1999, AM J EPIDEMIOL, V150, P763, DOI 10.1093/oxfordjournals.aje.a010079
   Sands TT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0694-x
   Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709
   SCHER MS, 1993, PEDIATRICS, V91, P128
   Scher MS, 2003, PEDIATR NEUROL, V28, P277, DOI 10.1016/S0887-8994(02)00621-5
   Schulz KF, 2010, BMJ-BRIT MED J, V340, pc332, DOI DOI 10.1136/BMJ.C332
   Shah DK, 2010, PEDIATR RES, V67, P102, DOI 10.1203/PDR.0b013e3181bf5914
   Shellhaas RA, 2011, J CLIN NEUROPHYSIOL, V28, P611, DOI 10.1097/WNP.0b013e31823e96d7
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178
   Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1
   Top KA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1112-0
   Tsuchida TN, 2013, J CLIN NEUROPHYSIOL, V30, P161, DOI 10.1097/WNP.0b013e3182872b24
   Vasudevan C, 2013, SEMIN FETAL NEONAT M, V18, P185, DOI 10.1016/j.siny.2013.05.008
   Vesoulis ZA, 2014, PEDIATR RES, V75, P564, DOI 10.1038/pr.2013.245
   VOLPE J, 1973, NEW ENGL J MED, V289, P413, DOI 10.1056/NEJM197308232890807
   VOLPE JJ, 1989, PEDIATRICS, V84, P422
   VOLPE JJ, 2001, NEUROLOGY NEWBORN, P178
   Volpe JJ, 2008, ANN NEUROL, V64, P232, DOI 10.1002/ana.21466
   Weeke LC, 2017, CLIN NEUROPHYSIOL, V128, P2428, DOI 10.1016/j.clinph.2017.08.035
   Weeke LC, 2015, DEV MED CHILD NEUROL, V57, P248, DOI 10.1111/dmcn.12629
   WEINER SP, 1991, PEDIATR NEUROL, V7, P363, DOI 10.1016/0887-8994(91)90067-U
   Wikstrom S, 2012, ACTA PAEDIATR, V101, P719, DOI 10.1111/j.1651-2227.2012.02677.x
   Winter K, 2017, CLIN INFECT DIS, V64, P9, DOI 10.1093/cid/ciw633
   World Health Organisation, 2011, GUID NEON SEIZ
   World Health Organization, 2018, CAUS ASS ADV EV FOLL
   World Health Organization, 2006, NEON PER MORT COUNTR
   World Health Organization, 2004, ICD 10 INT STAT CLAS
   Yildiz EP, 2012, PEDIATR NEUROL, V47, P186, DOI 10.1016/j.pediatrneurol.2012.05.015
   Yozawitz E, 2017, PEDIATR DRUGS, V19, P553, DOI 10.1007/s40272-017-0250-4
NR 94
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7596
EP 7609
DI 10.1016/j.vaccine.2019.05.031
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600013
PM 31783981
OA Other Gold, Green Accepted, Green Published
DA 2020-05-12
ER

PT J
AU Kachikis, A
   Eckert, LO
   Walker, C
   Bardaji, A
   Varricchio, F
   Lipkind, HS
   Diouf, K
   Huang, WT
   Mataya, R
   Bittaye, M
   Cutland, C
   Boghossian, NS
   Moore, TM
   McCall, R
   King, J
   Mundle, S
   Munoz, FM
   Rouse, C
   Gravett, M
   Katikaneni, L
   Ault, K
   Klein, NP
   Roberts, DJ
   Kochhar, S
   Chescheir, N
AF Kachikis, Alisa
   Eckert, Linda O.
   Walker, Christie
   Bardaji, Azucena
   Varricchio, Frederick
   Lipkind, Heather S.
   Diouf, Khady
   Huang, Wan-Ting
   Mataya, Ronald
   Bittaye, Mustapha
   Cutland, Clare
   Boghossian, Nansi S.
   Moore, Tamala Mallett
   McCall, Rebecca
   King, Jay
   Mundle, Shuchita
   Munoz, Flor M.
   Rouse, Caroline
   Gravett, Michael
   Katikaneni, Lakshmi
   Ault, Kevin
   Klein, Nicola P.
   Roberts, Drucilla J.
   Kochhar, Sonali
   Chescheir, Nancy
CA Brighton Collaboration Chorioamnio
TI Chorioamnionitis: Case definition & guidelines for data collection,
   analysis, and presentation of immunization safety data
SO VACCINE
LA English
DT Article
ID FETAL INFLAMMATORY RESPONSE; AMNIOTIC-FLUID; HISTOLOGIC
   CHORIOAMNIONITIS; PLACENTAL INFLAMMATION; PERTUSSIS VACCINATION;
   RISK-FACTORS; PRETERM; INFECTION; PREGNANCY; WOMEN
C1 [Kachikis, Alisa; Eckert, Linda O.; Walker, Christie; Gravett, Michael; Kochhar, Sonali] Univ Washington, Seattle, WA 98195 USA.
   [Bardaji, Azucena] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.
   [Lipkind, Heather S.] Yale Univ, Sch Med, New Haven, CT USA.
   [Diouf, Khady] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Huang, Wan-Ting] Taiwan Ctr Dis Control, Taipei, Taiwan.
   [Mataya, Ronald] Loma Linda Univ, Loma Linda, CA 92350 USA.
   [Mataya, Ronald] Univ Malawi, Coll Med, Zomba, Malawi.
   [Bittaye, Mustapha] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Bittaye, Mustapha] London Sch Hyg & Trop Med, Med Res Council Gambia, Fajara, Gambia.
   [Bittaye, Mustapha] Univ Gambia Sch Med & Allied Hlth Sci, Banjul, Gambia.
   [Cutland, Clare] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Cutland, Clare] Univ Witwatersrand, Fac Hlth Sci, Vaccine Preventable Dis, Dept Sci & Technol,Natl Res Fdn, Johannesburg, South Africa.
   [Boghossian, Nansi S.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.
   [Moore, Tamala Mallett; King, Jay] Sanofi Pasteur, Swiftwater, PA USA.
   [McCall, Rebecca; Chescheir, Nancy] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Mundle, Shuchita] Govt Med Coll, Nagpur, Maharashtra, India.
   [Munoz, Flor M.] Baylor Coll Med, Houston, TX 77030 USA.
   [Rouse, Caroline] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Katikaneni, Lakshmi] Med Univ South Carolina, Charleston, SC 29425 USA.
   [Ault, Kevin] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.
   [Klein, Nicola P.] Kaiser Permanents Vaccine Study Ctr, Oakland, CA USA.
   [Roberts, Drucilla J.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Kochhar, Sonali] Global Healthcare Consulting, Bengaluru, India.
   [Kochhar, Sonali] Erasmus MC, Rotterdam, Netherlands.
RP Chescheir, N (reprint author), Univ N Carolina, Chapel Hill, NC 27515 USA.
EM secretariat@brightoncollaboration.org
RI Bardaji, Azucena/AAE-9145-2019
OI Bardaji, Azucena/0000-0002-5135-0540; Huang,
   Wan-Ting/0000-0002-4344-9567
FU Brighton Collaboration Steering Committee
FX The authors are grateful for the support and helpful comments provided
   by the Brighton Collaboration Steering Committee (Jorgen Bauwens and Jan
   Bonhoeffer), as well as other experts consulted as part of the process.
   We would also like to thank Jan Hamanishi, Medical Illustrator/Graphic
   Designer, in the University of Washington Department of Obstetrics and
   Gynecology for her assistance in creating the figure for our literature
   search. Many thanks also to Karalee Sheaffer in Scientific Intelligence
   at Sanofi Pasteur for her expertise in conducting our second literature
   search.
CR AbeleHorn M, 1997, INFECTION, V25, P286, DOI 10.1007/BF01720398
   Andrys C, 2010, NEUROENDOCRINOL LETT, V31, P857
   [Anonymous], 2018, Obstet Gynecol, V131, pe214, DOI 10.1097/AOG.0000000000002662
   Apantaku O, 2007, J OBSTET GYNAECOL, V27, P12, DOI 10.1080/01443610601016644
   Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001
   Berenson AB, 2016, HUM VACC IMMUNOTHER, V12, P1965, DOI 10.1080/21645515.2016.1157241
   Blanc W A, 1981, Monogr Pathol, P67
   Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8
   Bonhoeffer J, 2016, VACCINE, V34, P5993, DOI 10.1016/j.vaccine.2016.07.006
   Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018
   CDC, 2016, GUID VACC PREGN WOM
   Committee on Obstetric Practice, 2017, Obstet Gynecol, V130, pe95, DOI 10.1097/AOG.0000000000002236
   Dashe JS, 1999, OBSTET GYNECOL, V93, P341, DOI 10.1016/S0029-7844(98)00415-3
   Datwani H, 2015, VACCINE, V33, P3110, DOI 10.1016/j.vaccine.2015.04.097
   GIBBS RS, 1991, AM J OBSTET GYNECOL, V164, P1317, DOI 10.1016/0002-9378(91)90707-X
   GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007
   Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696
   Hassan S, 2006, J PERINAT MED, V34, P13, DOI 10.1515/JPM.2006.002
   Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246
   Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669
   Holzman C, 2007, AM J EPIDEMIOL, V166, P786, DOI 10.1093/aje/kwm168
   Kharbanda EO, 2014, JAMA-J AM MED ASSOC, V312, P1897, DOI 10.1001/jama.2014.14825
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040
   Krohn M A, 1993, Ann Epidemiol, V3, P78
   Maeda K, 1997, GYNECOL OBSTET INVES, V43, P225, DOI 10.1159/000291862
   Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007
   Mark SP, 2000, OBSTET GYNECOL, V95, P909, DOI 10.1016/S0029-7844(00)00816-4
   McMillan M, 2017, OBSTET GYNECOL, V129, P560, DOI 10.1097/AOG.0000000000001888
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Morales W J, 1987, J Perinatol, V7, P105
   Morgan JL, 2015, OBSTET GYNECOL, V125, P1433, DOI 10.1097/AOG.0000000000000862
   National Institute for Health and Care Excellence, 2015, PRET LAB BIRTH NICE
   NEWTON ER, 1993, CLIN OBSTET GYNECOL, V36, P795, DOI 10.1097/00003081-199312000-00004
   Newton ER, 1997, AM J OBSTET GYNECOL, V176, P672, DOI 10.1016/S0002-9378(97)70568-4
   Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/713605804
   Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445
   Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23
   Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045
   Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y
   Rickert VI, 1998, OBSTET GYNECOL, V92, P254, DOI 10.1016/S0029-7844(98)00135-5
   Roberts DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031819
   Rouse CE, 2017, VACCINE, V35, P6563, DOI 10.1016/j.vaccine.2017.01.047
   Rouse DJ, 2004, AM J OBSTET GYNECOL, V191, P211, DOI 10.1016/j.ajog.2004.03.003
   SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Seaward PG, 1997, AM J OBSTET GYNECOL, V177, P1024, DOI 10.1016/S0002-9378(97)70007-3
   Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040
   SOPER DE, 1989, AM J OBSTET GYNECOL, V161, P562, DOI 10.1016/0002-9378(89)90356-6
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003
   van de Laar R, 2009, EUR J OBSTET GYN R B, V147, P124, DOI 10.1016/j.ejogrb.2009.09.017
   van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c
   Vazquez-Benitez G, 2016, AM J EPIDEMIOL, V184, P176, DOI 10.1093/aje/kww043
   WHO, 2014, SAF IMM PREGN REV EV
   World Health Organization, INT CLASS DIS MORT M
   World Health Organization, 2015, WHO REC PREV TREATM
   Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1
   Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680
   YUE D, 1987, OBSTET GYNECOL, V70, P175
NR 61
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7610
EP 7622
DI 10.1016/j.vaccine.2019.05.030
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600014
PM 31783982
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Villagomez, AN
   Munoz, FM
   Peterson, RL
   Colbert, AM
   Gladstone, M
   MacDonald, B
   Wilson, R
   Fairlie, L
   Gerner, GJ
   Patterson, J
   Boghossian, NS
   Burton, VJ
   Cortes, M
   Katikaneni, LD
   Larson, JCG
   Angulo, AS
   Joshi, J
   Nesin, M
   Padula, MA
   Kochhar, S
   Connery, AK
   Bonhoeffer, J
   Bauwens, J
   Laughton, B
   Herz, SM
   Chabanon, AL
   Jafri, SK
   McCathern, A
   Pathirana, J
   Neveu, D
   Spiegel, H
AF Villagomez, Adrienne N.
   Munoz, Flor M.
   Peterson, Robin L.
   Colbert, Alison M.
   Gladstone, Melissa
   MacDonald, Beatriz
   Wilson, Rebecca
   Fairlie, Lee
   Gerner, Gwendolyn J.
   Patterson, Jackie
   Boghossian, Nansi S.
   Burton, Vera Joanna
   Cortes, Margarita
   Katikaneni, Lakshmi D.
   Larson, Jennifer C. G.
   Angulo, Abigail S.
   Joshi, Jyoti
   Nesin, Mirjana
   Padula, Michael A.
   Kochhar, Sonali
   Connery, Amy K.
   Bonhoeffer, Jan
   Bauwens, Jorgen
   Laughton, Barbara
   Herz, Susanne Martin
   Chabanon, Anne-Laure
   Jafri, Sidra Kaleem
   McCathern, Alexis
   Pathirana, Jayani
   Neveu, David
   Spiegel, Hans
CA Brighton Collaboration Neurodev De
TI Neurodevelopmental delay: Case definition & guidelines for data
   collection, analysis, and presentation of immunization safety data
SO VACCINE
LA English
DT Article
DE Neurodevelopmental delay; Adverse event; Maternal immunization;
   Guidelines; Case definition
ID EARLY-CHILDHOOD DEVELOPMENT; MIDDLE-INCOME COUNTRIES; B STREPTOCOCCUS
   VACCINE; SUB-SAHARAN AFRICA; LOW-BIRTH-WEIGHT; YOUNG-CHILDREN;
   DEVELOPMENTAL DELAY; VISUAL IMPAIRMENT; MATERNAL IMMUNIZATION;
   MENTAL-DEVELOPMENT
C1 [Villagomez, Adrienne N.; Peterson, Robin L.; Colbert, Alison M.; Wilson, Rebecca; Angulo, Abigail S.; Connery, Amy K.] Univ Colorado, Sch Med, Aurora, CO 80045 USA.
   [Villagomez, Adrienne N.; Peterson, Robin L.; Colbert, Alison M.; Wilson, Rebecca; Burton, Vera Joanna; Angulo, Abigail S.; Connery, Amy K.] Childrens Hosp Colorado, Aurora, CO 80045 USA.
   [Munoz, Flor M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Gladstone, Melissa] Univ Liverpool, Inst Translat Med, Dept Women & Childrens Hlth, Liverpool, Merseyside, England.
   [MacDonald, Beatriz] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.
   [Fairlie, Lee] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.
   [Gerner, Gwendolyn J.] Kennedy Krieger Inst, Baltimore, MD USA.
   [Gerner, Gwendolyn J.; Burton, Vera Joanna] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Patterson, Jackie] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA.
   [Boghossian, Nansi S.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.
   [Cortes, Margarita] Sanofi Pasteur, Clin Sci Latam, Bogota, Colombia.
   [Katikaneni, Lakshmi D.] Med Univ South Carolina, Charleston, SC 29425 USA.
   [Larson, Jennifer C. G.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA.
   [Joshi, Jyoti] Amity Univ, Ctr Dis Dynam Econ & Policy, Amity Inst Publ Hlth, Noida, India.
   [Nesin, Mirjana] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Padula, Michael A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.
   [Kochhar, Sonali] Global Healthcare Consulting, New Delhi, India.
   [Kochhar, Sonali] Univ Washington, Seattle, WA 98195 USA.
   [Kochhar, Sonali] Erasmus Univ, Med Ctr, Rotterdam, Netherlands.
RP Connery, AK (reprint author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.; Connery, AK (reprint author), Childrens Hosp Colorado, Aurora, CO 80045 USA.
EM secretariat@brightoncollaboration.org
RI Spiegel, Hans/AAC-4220-2020; Gladstone, Melissa/L-6535-2018
OI Munoz, Flor/0000-0002-0457-7689; Gladstone, Melissa/0000-0002-2579-9301
CR ABOUD FE, 1995, SOC SCI MED, V41, P725, DOI 10.1016/0277-9536(94)00377-6
   Abubakar A, 2008, TROP MED INT HEALTH, V13, P880, DOI 10.1111/j.1365-3156.2008.02079.x
   Accardo PJ, 2005, CAPUTE SCALES COGNIT
   Ainsworth M. D., 2015, PATTERNS ATTACHMENT
   Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199
   Anastasi A, 1997, PSYCHOL TEST, V7, P113
   [Anonymous], 2013, DIAGN STAT MAN MENT
   [Anonymous], 2001, CHILD DEV SHOULD WE
   August A., 2015, 21 FIG WORLD C GYN O
   Australian Bureau of Statistics, 2009, SURV DIS
   Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574
   Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0
   Baron IS, 2010, NEUROPSYCHOL REV, V20, P430, DOI 10.1007/s11065-010-9132-z
   Bayley N., 2006, BAYLEY SCALES INFANT
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Becerra-Culqui TA, 2018, PEDIATRICS
   Bednarczyk RA, 2012, AM J OBSTET GYNECOL, V207, pS38, DOI 10.1016/j.ajog.2012.07.002
   Bitta Mary, 2017, Wellcome Open Res, V2, P121, DOI 10.12688/wellcomeopenres.13540.3
   Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   BLOKHUIS C, 2016, NEUROBEHAV HIV MED, V7, P1, DOI DOI 10.2147/NBHIV.S68954
   Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055
   Boivin MJ, 2011, TROP MED INT HEALTH, V16, P263, DOI 10.1111/j.1365-3156.2010.02704.x
   Bracken B. A., 1987, J PSYCHOEDUCATIONAL, V5, P313, DOI DOI 10.1177/073428298700500402
   Brand RA, 2009, STANDARDS REPORTING
   Callaghan T, 2011, MONOGR SOC RES CHILD
   Carlson SM, 2009, SYMBOLS TOOLS DEV EX
   Cassepp-Borges V, 2010, TRADUCAO VALIDACAO C, P506
   Chaithongwongwatthana S, 2012, COCHRANE DB SYST REV, P7
   Chernoff MC, 2018, J PEDIAT INFECT DIS
   Chiang SS, 2014, LANCET INFECT DIS, V14, P947, DOI 10.1016/S1473-3099(14)70852-7
   Cicchetti D., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [DOI 10.1037/1040-3590.6.4.284, 10.1037/1040-3590.6.4.284]
   COSTELLO EJ, 1986, PEDIATRICS, V78, P1044
   Dale N, 2007, CHILD CARE HLTH DEV, V33, P684, DOI 10.1111/j.1365-2214.2007.00798.x
   Daley TC, 2004, SOC SCI MED, V58, P1323, DOI 10.1016/S0277-9536(03)00330-7
   Daley TC, 2002, J AUTISM DEV DISORD, V32, P13, DOI 10.1023/A:1017947922349
   DAVIDSON L, 2012, [No title captured], V56, P768
   Demicheli V, 2015, VACCINES WOMEN PREVE
   Demirci A, 2016, CHILD CARE HLTH DEV, V42, P213, DOI 10.1111/cch.12289
   Desai PP, 2011, J DEV BEHAV PEDIATR, V32, P69, DOI 10.1097/DBP.0b013e3181f46e0b
   Donders GGG, 2016, OBSTET GYNECOL, V127, P213, DOI 10.1097/AOG.0000000000001190
   Drachler MD, 2005, ACTA PAEDIATR, V94, P1137, DOI 10.1080/08035250510036534
   Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078
   Eapen V, 2006, J PSYCHOSOM RES, V61, P321, DOI 10.1016/j.jpsychores.2006.05.012
   Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1
   Eppig C, 2010, P ROY SOC B-BIOL SCI, V277, P3801, DOI 10.1098/rspb.2010.0973
   Eriksson M, 2010, RES DEV DISABIL, V31, P943, DOI 10.1016/j.ridd.2010.04.019
   Ertem IO, 2007, CHILD CARE HLTH DEV, V33, P728, DOI 10.1111/j.1365-2214.2007.00751.x
   Ertem IO, 2008, PEDIATRICS, V121, pE581, DOI 10.1542/peds.2007-1771
   Ertem IO, 2018, LANCET GLOB HEALTH, V6, pE279, DOI 10.1016/S2214-109X(18)30003-2
   Ertem IO Organization WH, 2012, DEV DIFFICULTIES EAR
   Fernald L. C., 2009, EXAMINING EARLY CHIL
   Fernald L. C. H., 2017, TOOLKIT MEASURING EA
   Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x
   Fitzpatrick JP, 2017, RES DEV DISABIL, V65, P114, DOI 10.1016/j.ridd.2017.04.001
   Flanagan NM, 2003, CHILD CARE HLTH DEV, V29, P493, DOI 10.1046/j.1365-2214.2003.00369.x
   Fluegge K, 2016, ENVIRON TOXICOL PHAR, V47, P6, DOI 10.1016/j.etap.2016.08.013
   Geisinger K. F., 1994, PSYCHOL ASSESSMENT, V6, P304, DOI [10.1037/1040-3590.6.4.304, DOI 10.1037/1040-3590.6.4.304]
   Gillberg Christopher, 2003, Neural Plasticity, V10, P59, DOI 10.1155/NP.2003.59
   Gladstone M, 2010, ANN TROP PAEDIATR, V30, P181, DOI 10.1179/146532810X12786388978481
   Gladstone M, 2017, 2 INT DEV PED ASS C
   Gladstone M, 2017, G492 WHO 0 3 DEV IND
   Gladstone MJ, 2008, ARCH DIS CHILD, V93, P23, DOI 10.1136/adc.2006.095471
   GLASCOE FP, 1992, PEDIATRICS, V89, P1221
   Glascoe FP, 2012, J DEV BEHAV PEDIATR, V33, P87, DOI 10.1097/DBP.0b013e3182362265
   Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x
   Graf WD, 2013, PEDIAT NEUROLOGY 1, V111
   Graf WD, 2013, HAND CLINIC, V111, P143, DOI 10.1016/B978-0-444-52891-9.00014-2
   Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4
   GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6
   Green M., 1994, ERIC
   Hambleton R. K., 1999, J APPL TESTING TECHN, V1, P1, DOI DOI 10.1186/1471-2288-10-13
   Hambleton R.K., 2004, ADAPTING ED PSYCHOL, P15
   He MX, 2015, INFANCY, V20, P283, DOI 10.1111/infa.12071
   Hebbeler K, 2008, EXCEPTIONALITY, V16, P48, DOI 10.1080/09362830701796792
   Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327
   Heyderman RS, 2016, LANCET INFECT DIS, V16, P546, DOI 10.1016/S1473-3099(15)00484-3
   Holding P, 2018, APPL NEUROPSYCH-CHIL, V7, P1, DOI 10.1080/21622965.2016.1206823
   Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4
   Howe SH, 2016, RES DEV DISABIL, V48, P231, DOI 10.1016/j.ridd.2015.11.003
   Jerome Sattler P., 2008, ASSESSMENT CHILDREN
   Johnson MH, 2005, DEV PSYCHOBIOL, V46, P287, DOI 10.1002/dev.20057
   Jones CE, 2016, VACCINE, V34, P5998, DOI 10.1016/j.vaccine.2016.07.032
   Judge MP, 2016, NUTR REV, V74, P411, DOI 10.1093/nutrit/nuw006
   Jurewicz J, 2013, ANN AGR ENV MED, V20, P465
   KAGAN J, 1979, MONOGR SOC RES CHILD, V44, P1, DOI 10.2307/1165916
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Keunen K, 2012, J MATERN-FETAL NEO M, V25, P89, DOI 10.3109/14767058.2012.664343
   Kirkwood M. W., 2015, VALIDITY TESTING CHI
   Kohl KS, 2005, BRIGHTON COLLABORATI, V2
   Kohli-Lynch M, 2017, CLIN INFECT DIS, V65, pS190, DOI 10.1093/cid/cix663
   Kristjansson Elizabeth A, 2003, Can J Nurs Res, V35, P127
   Kvestad I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121743
   Lancy D., 2014, ANTHR CHILDHOOD CHER
   Lansdown RG, 1996, B WORLD HEALTH ORGAN, V74, P283
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Le Doare K, 2012, PEDIATRICS
   Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8
   Leroux-Roels G, 2016, VACCINE, V34, P1786, DOI 10.1016/j.vaccine.2016.02.044
   Li Y, 2000, J DEV BEHAV PEDIATR, V21, P114, DOI 10.1097/00004703-200004000-00005
   Lieberman AF, 2005, J AM ACAD CHILD PSY, V44, P1241, DOI 10.1097/01.chi.0000181047.59702.58
   Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]
   Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3
   Marques RC, 2009, COGN BEHAV NEUROL, V22, P134, DOI 10.1097/WNN.0b013e3181a72248
   Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B
   McCay V, 2005, J DEAF STUD DEAF EDU, V10, P225, DOI 10.1093/deafed/eni024
   Mccoy DC, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0122-8
   McCoy DC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002034
   MEISELS SJ, 1989, PEDIATRICS, V83, P578
   Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102
   Meredith RM, 2015, NEUROSCI BIOBEHAV R, V50, P180, DOI 10.1016/j.neubiorev.2014.12.001
   Min H, 2016, MOL NEUROBIOL, V53, P1613, DOI 10.1007/s12035-015-9101-x
   Mitchell JM, 2017, S AFRICAN J PSYCHOL
   Moeschler JB, 2014, PEDIATRICS, P2014
   Moro PL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.047
   Mullen E. M., 1995, MULLEN SCALES EARLY
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9
   Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435
   Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8
   Neisworth JT, 2004, INFANT YOUNG CHILD, V17, P198, DOI 10.1097/00001163-200407000-00002
   Newborg J., 2005, BATTELLE DEV INVENTO
   Noble Y, 2012, DEV MED CHILD NEUROL, V54, P129, DOI 10.1111/j.1469-8749.2010.03903.x
   Oh W, 2010, ACTA PAEDIATR, V99, P673, DOI 10.1111/j.1651-2227.2010.01688.x
   Oudgenoeg-Paz O, 2012, INFANT BEHAV DEV, V35, P733, DOI 10.1016/j.infbeh.2012.07.010
   Parsons S, 2013, DISABILITY YOUNG CHI
   Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x
   Phillips D. A., 2000, NEURONS NEIGHBORHOOD
   Pitt MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3939
   Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045
   ROGOFF B, 1982, CHILD DEV, V53, P1224, DOI 10.2307/1129009
   Rogoff B., 2003, CULTURAL NATURE HUMA
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Sabanathan S, 2015, ARCH DIS CHILD, V100, P482, DOI 10.1136/archdischild-2014-308114
   Salam RA, 2012, COCHRANE DB SYST REV, P7
   Salas AA, 2016, ARCH DIS CHILD-FETAL, V101, pF494, DOI 10.1136/archdischild-2015-309670
   Sangkomkamhang US, 2011, COCHRANE DB SYST REV, P3
   Schady N, 2006, ECONOMIA, V6, P185, DOI 10.1353/eco.2006.0021
   Scherzer AL, 2012, DEV MED CHILD NEUROL, V54, P1079, DOI 10.1111/j.1469-8749.2012.04348.x
   Schlaudecker EP, 2017, VACCINE, V35, P6518, DOI 10.1016/j.vaccine.2017.01.040
   Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7
   Semrud-Clikeman M, 2017, CHILD NEUROPSYCHOL, V23, P761, DOI 10.1080/09297049.2016.1216536
   Serenius F, 2016, JAMA PEDIATR, V170, P954, DOI 10.1001/jamapediatrics.2016.1210
   Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775
   Sireci SG, 2006, J CROSS CULT PSYCHOL, V37, P557, DOI 10.1177/0022022106290478
   Slobin DI, 1985, THEORETICAL ISSUES
   Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782
   Spinazzola J, 2005, PSYCHIAT ANN, V35, P433, DOI 10.3928/00485713-20050501-09
   Squires VR, 2009, RANGELAND DEGRADATION AND RECOVERY IN CHINA'S PASTORAL LANDS, P3, DOI 10.1079/9781845934965.0003
   Stadskleiv K, 2017, J DEV PHYS DISABIL, V29, P663, DOI 10.1007/s10882-017-9549-x
   Stoltzfus RJ, 2013, LANCET, V382, P380, DOI 10.1016/S0140-6736(13)61567-6
   Stolwijk LJ, 2017, J PEDIATR-US, V182, P335, DOI 10.1016/j.jpeds.2016.11.080
   Tanzer NK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P235
   Tchamo ME, 2016, J DEV ORIG HLTH DIS, V7, P408, DOI 10.1017/S2040174416000131
   Tervo RC, 2006, CLIN PEDIATR, V45, P509, DOI 10.1177/0009922806290566
   Valla L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0528-z
   Van de Vijver F. J., 1997, METHODS DATA ANAL CR, V1
   Van Rie A, 2008, PEDIATRICS, V122, pE123, DOI 10.1542/peds.2007-2558
   Verrall C, 2016, HEART LUNG CIRCULAT, V25, pS311
   VERSI E, 1992, BRIT MED J, V305, P187, DOI 10.1136/bmj.305.6846.187-b
   Visser L, 2012, J COGN EDUC PSYCHOL, V11, P102, DOI 10.1891/1945-8959.11.2.102
   Visser L, 2013, RES DEV DISABIL, V34, P3736, DOI 10.1016/j.ridd.2013.07.027
   Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2
   Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2
   Walle E, 2015, COGSCI
   Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085760
   Wassner AJ, 2017, PEDIATR DRUGS, V19, P291, DOI 10.1007/s40272-017-0238-0
   Wei QW, 2015, PUBLIC HEALTH, V129, P1610, DOI 10.1016/j.puhe.2015.07.036
   Wijnhoven Trudy M, 2004, Food Nutr Bull, V25, pS37
   World Health Organization, 2004, INT STAT CLASS DIS R, V1
   Yaghini O, 2015, IRAN J CHILD NEUROL, V9, P17
   Yamasmit W, 2005, COCHRANE DB SYST REV, P3
   Yousafzai AK, 2014, ARCH DIS CHILD, V99, P840, DOI 10.1136/archdischild-2012-302066
   Zablotsky Benjamin, 2017, NCHS Data Brief, P1
   2011, WORLD REP DIS, P1
NR 175
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 10
PY 2019
VL 37
IS 52
BP 7623
EP 7641
DI 10.1016/j.vaccine.2019.05.027
PG 19
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU4IZ
UT WOS:000501642600015
PM 31783983
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Diercks, G
AF Diercks, Gijs
TI Lost in translation: How legacy limits the OECD in promoting new policy
   mixes for sustainability transitions
SO RESEARCH POLICY
LA English
DT Article
DE Policy mixes; Sustainability transitions; System innovation; Discourse
   institutionalisation; Legacy effects; OECD
ID INNOVATION POLICY; MULTILEVEL PERSPECTIVE; CLIMATE-CHANGE; SCIENCE;
   EVOLUTIONARY; MANAGEMENT; NETWORKS; JOURNEYS; SOCIETY; IDEAS
AB The OECD has a strong legacy in shaping innovation policy mixes. The purpose of this paper is therefore to provide a better understanding of how the OECD is currently shaping new policy mixes for sustainability transitions. It provides a detailed account of the uptake of system innovation thinking, a key concept in transition studies, at the OECD. It takes an ethnographic approach combining desk research with participant observation, allowing to study 'discourse in the making'. The paper traces the different translation and inscription strategies pursued. It finds that despite purposeful efforts, system innovation has not been institutionalised in the core activities of the organisation, thus can be considered 'lost in translation'. It concludes that legacy effects created a number of sticking points that can be categorised under three main categories: (1) institutional, arising from previous ways of working; (2) cognitive, arising from ways of framing and knowing and (3) political, arising from pre-existing power relations. Suggestions are made for both innovation policy academics and practitioners interested in promoting a transformative innovation agenda.
C1 [Diercks, Gijs] Imperial Coll London, Ctr Environm Policy, 16-18 Princes Gardens, London SW7 1NE, England.
RP Diercks, G (reprint author), Imperial Coll London, Ctr Environm Policy, 16-18 Princes Gardens, London SW7 1NE, England.
EM g.diercks@rathenau.nl
FU Climate-IUC
FX The work was supported by Climate-IUC. The author wants to thank Fred
   Steward for his constructive feedback throughout the process. The author
   also thanks Karoline Rogge, Florian Kern, Mike Howlett and participants
   at a workshop on policy mixes for sustainability transitions (hosted by
   CIED in January 2017) for valuable comments on an earlier version of
   this paper. Last but not least, the openness of the OECD and its staff
   members have been crucial for this work, and the author is very grateful
   for this.
CR BILLIG M, 1987, ARGUING THINKING RHE
   Busby A., 2011, YOURE NOT GOING WRIT, DOI [10.1017/C1309781107415324.004, DOI 10.1017/C1309781107415324.004]
   Carson M., 2009, PARADIGMS PUBLIC POL
   Cervantes M., 2016, CLIMATEKIC TRANS HUB
   Diercks G.A., 2018, TRANSFORMATIVE INNOV
   Edmondson DL, 2019, RES POLICY, V48, DOI 10.1016/j.respol.2018.03.010
   Elzen Boelie, 2004, SYSTEM INNOVATION TR
   Fischer F., 1993, ARGUMENTATIVE TURN P
   Flanagan K, 2016, IND INNOV, V23, P177, DOI 10.1080/13662716.2016.1146126
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foray D, 2012, RES POLICY, V41, P1697, DOI 10.1016/j.respol.2012.07.011
   Garud R, 2007, ORGAN STUD, V28, P957, DOI 10.1177/0170840607078958
   Garud R, 2012, RES POLICY, V41, P980, DOI 10.1016/j.respol.2011.07.009
   Geels F.W., 2013, SYSTEM INNOVATION CO
   Geels FW, 2010, RES POLICY, V39, P495, DOI 10.1016/j.respol.2010.01.022
   Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8
   Godin B., 2009, MAKING SCI TECHNOLOG
   Godin B., 2002, RHETORICAL NUMBERS O
   Godin Dore, 2004, HIST SOCIOL S T STAT, P1
   Greener I., 2005, POLITICS, V25, P62, DOI DOI 10.1111/J.1467-9256.2005.00230.X
   Hajer M. A., 1995, POLITICS ENV DISCOUR
   Hajer M. A., 2006, WORDS MATTER POLICY, P65, DOI DOI 10.1063/1.3033202
   Hajera M., 2005, J ENVIRON POL PLAN, V7, P175, DOI DOI 10.1080/15239080500339646
   Henriques L, 2013, RES POLICY, V42, P801, DOI 10.1016/j.respol.2012.09.004
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Hyett N, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23606
   Innovation Policy Platform, 2016, SYST INN OECD PROJ
   Jensen MB, 2007, RES POLICY, V36, P680, DOI 10.1016/j.respol.2007.01.006
   Kallerud E., 2010, ENZYK MIK TECHNIK, P1
   Kawulich Barbara, 2006, FORUM QUALITATIVE SO, V6, P1
   Kemp R., 2011, 10 THEMES ECOINNOVAT
   Kern F, 2011, ENVIRON PLANN C, V29, P1116, DOI 10.1068/c1142
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Kuhlmann S., 2014, CHALLENGE ADDRESSING
   Latour B., 2005, REASSEMBLING SOCIAL
   LAW J, 1992, SYST PRACTICE, V5, P379, DOI 10.1007/BF01059830
   Leach M, 2010, GLOBAL ENVIRON CHANG, V20, P369, DOI 10.1016/j.gloenvcha.2009.11.008
   Lehtonen M, 2009, ECOL ECON, V69, P389, DOI 10.1016/j.ecolecon.2009.08.013
   Liedtke C, 2015, J CLEAN PROD, V97, P106, DOI 10.1016/j.jclepro.2014.04.070
   Loorbach D, 2017, ANNU REV ENV RESOUR, V42, P599, DOI 10.1146/annurev-environ-102014-021340
   Loorbach D, 2010, GOVERNANCE, V23, P161, DOI 10.1111/j.1468-0491.2009.01471.x
   Lundvall Borth S., 2005, OXFORD HDB INNOVATIO, P599
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Mazzucato M, 2013, ENTREPRENEURIAL STAT
   Mazzucato M., 2015, MISSION ORIENTED FIN
   Merriam S., 2009, QUALITATIVE RES GUID
   Mulgan G., 2013, SYSTEM INNOVATION DI
   Mulgan G, 2012, SOCIAL INNOVATION BL, P33, DOI DOI 10.1057/9780230367098
   Mytelka LK, 2002, RES POLICY, V31, P1467, DOI 10.1016/S0048-7333(02)00076-8
   Nay O, 2012, J PUBLIC POLICY, V32, P53, DOI 10.1017/S0143814X11000183
   Niinikoski ML, 2014, TECHNOL FORECAST SOC, V85, P69, DOI 10.1016/j.techfore.2013.07.011
   OECD, 2015, M 21 CENT CHALL SCI
   OECD, 2008, OECD ORG EC COOP DEV
   OECD, 2016, EN NEXT PROD REV FUT
   OECD, 2015, GREEN GROWTH
   OECD, 2015, AL POL LOW CARB EC A, DOI [10.1787/9789264233294-en, DOI 10.1787/9789264233294-EN]
   OECD, 2011, FOST INN GREEN GROWT, DOI [10.1787/9789264119925-en, DOI 10.1787/9789264119925-EN]
   OECD, 2010, OECD INN STRAT GETT
   OECD, 2014, REV TERMS REF TIP PR
   OECD, 2014, OECD SCI TECHN IND O
   OECD, 2015, INN IMP CONTR PROD G
   OECD, 2010, OECD SCI TECHN IND O, DOI [10.1787/sti_outlook-2010-en, DOI 10.1787/STI_OUTLOOK-2010-EN]
   OECD, 2015, FRASC MAN 2015 GUID, DOI [10.1787/9789264239012-en, DOI 10.1787/9789264239012-EN]
   OECD, 2015, SYSTEM INNOVATION SY
   OECD, 2015, DAEJ DECL SCI TECHN
   OECD, 2016, INN POL SYST TRANSF
   OECD, 2016, OECD SCI TECHN INN O, DOI [10.1787/sti_in_outlook-2016-6-en, DOI 10.1787/STI_IN_OUTLOOK-2016-6-EN]
   OECD, 2015, SYST TRANSF INN TECH
   OECD, 2016, GREEN GROWTH SUST DE
   OECD, 2012, M GLOB CHALL BETT G, DOI [10.1787/9789264178700-12-en, DOI 10.1787/9789264178700-12-EN]
   Owen R, 2012, SCI PUBL POLICY, V39, P751, DOI 10.1093/scipol/scs093
   Pelto P. J., 2013, APPL ETHNOGRAPHY GUI
   Perez C., 2012, WORKING PAPERS TECHN
   Pohle J., 2013, IAMCR C
   Richardson T., 2001, J ENVIRON POL PLAN, V3, P193, DOI DOI 10.1002/JEPP.88
   Rogge K.S., 2016, SYSTEM INNOVATION SY, P101, DOI [10.1016/j.eist.2016.05.001, DOI 10.1016/J.EIST.2016.05.001]
   Rogge KS, 2018, RES POLICY, V47, P1639, DOI 10.1016/j.respol.2018.05.011
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rutland T, 2008, ENVIRON PLANN D, V26, P627, DOI 10.1068/d6907
   Saurugger S, 2013, J EUR PUBLIC POLICY, V20, P888, DOI 10.1080/13501763.2013.781826
   Schot J, 2008, TECHNOL ANAL STRATEG, V20, P537, DOI 10.1080/09537320802292651
   Schot Johan, 2018, 3 FRAMES INNOVATION
   Sengers F, 2019, TECHNOL FORECAST SOC, V145, P153, DOI 10.1016/j.techfore.2016.08.031
   Skogstad G., 2011, POLICY PARADIGMS TRA
   Smith A, 2016, GOTHIC DEATH 1740-1914: A LITERARY HISTORY, P11
   Smits R.-J., 2010, THEORY PRACTICE INNO
   Stake RE, 1995, ART CASE STUDY RES
   Stegmaier P., 2014, GOVERNANCE SOCIOTECH, P111, DOI DOI 10.4337/9781784710194.00015
   Steward F, 2012, TECHNOL ANAL STRATEG, V24, P331, DOI 10.1080/09537325.2012.663959
   Swaans K., 2014, INNOVATION DEV, V4, P239, DOI DOI 10.1080/2157930X.2014.925246
   Sydow J, 2009, ACAD MANAGE REV, V34, P689, DOI 10.5465/AMR.2009.44885978
   TIPC, 2016, TRANSF INN POL CONS
   van den Bergh JCJM, 2011, ENVIRON INNOV SOC TR, V1, P1, DOI 10.1016/j.eist.2011.04.010
   Vergragt PJ, 2011, TECHNOL FORECAST SOC, V78, P747, DOI 10.1016/j.techfore.2011.03.010
   Veugelers R, 2012, RES POLICY, V41, P1770, DOI 10.1016/j.respol.2012.06.012
   Von Hippel E., 2005, DEMOCRATIZING INNOVA
   Voytenko Y, 2016, J CLEAN PROD, V123, P45, DOI 10.1016/j.jclepro.2015.08.053
   Waylen KA, 2015, ECOL SOC, V20, DOI 10.5751/ES-07594-200221
   Weber KM, 2012, RES POLICY, V41, P1037, DOI 10.1016/j.respol.2011.10.015
NR 100
TC 1
Z9 1
U1 10
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103667
DI 10.1016/j.respol.2018.09.002
PG 12
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200004
DA 2020-05-12
ER

PT J
AU Edmondson, DL
   Kern, F
   Rogge, KS
AF Edmondson, Duncan L.
   Kern, Florian
   Rogge, Karoline S.
TI The co-evolution of policy mixes and socio-technical systems: Towards a
   conceptual framework of policy mix feedback in sustainability
   transitions
SO RESEARCH POLICY
LA English
DT Article
DE Policy mix; Sustainability transitions; Policy processes; Policy
   feedback; Socio-technical system
ID TECHNOLOGICAL-INNOVATION SYSTEMS; ZERO-CARBON HOMES; RENEWABLE ENERGY;
   OFFSHORE WIND; MULTILEVEL PERSPECTIVE; CREATIVE DESTRUCTION;
   POLITICAL-ECONOMY; GERMAN; DYNAMICS; INSTRUMENTS
AB Understanding how policymaking processes can influence the rate and direction of socio-technical change towards sustainability is an important, yet underexplored research agenda in the field of sustainability transitions. Some studies have sought to explain how individual policy instruments can influence transitions, and the politics surrounding this process. We argue that such individual policy instruments can cause wider feedback mechanisms that influence not only their own future development, but also other instruments in the same area. Consequently, by extending the scope of analysis to that of a policy mix allows us to account for multiple policy effects on socio-technical change and resultant feedback mechanisms influencing the policy processes that underpin further policy mix change. This paper takes a first step in this regard by combining policy studies and innovation studies literatures to conceptualise the co-evolutionary dynamics of policy mixes and socio-technical systems. We focus on policy processes to help explain how policy mixes influence socio-technical change, and how changes in the socio-technical system also shape the evolution of the policy mix. To do so we draw on insights from the policy feedback literature, and propose a novel conceptual framework. The framework highlights that policy mixes aiming to foster sustainability transitions need to be designed to create incentives for beneficiaries to mobilise further support, while overcoming a number of prevailing challenges which may undermine political support over time. In the paper, we illustrate the framework using the example of the zero carbon homes policy mix in the UK. We conclude with deriving research and policy implications for analysing and designing dynamic policy mixes for sustainability transitions.
C1 [Edmondson, Duncan L.; Kern, Florian; Rogge, Karoline S.] Univ Sussex, SPRU Sci Policy Res Unit, Jubilee Bldg, Brighton BN1 9SL, E Sussex, England.
   [Rogge, Karoline S.] Fraunhofer Inst Syst & Innovat Res Fraunhofer ISI, Breslauer Str 48, D-76139 Karlsruhe, Germany.
RP Edmondson, DL (reprint author), Univ Sussex, SPRU Sci Policy Res Unit, Jubilee Bldg, Brighton BN1 9SL, E Sussex, England.
EM d.edmondson@sussex.ac.uk
OI Kern, Florian/0000-0002-3968-330X
FU Research Council UK's EUED Programme [EP/K011790/1]
FX The research on which this paper is based was partly enabled through the
   Centre on Innovation and Energy Demand which is funded by the Research
   Council UK's EUED Programme (grant number EP/K011790/1). This funding is
   gratefully acknowledged.
CR Alkemade F, 2011, ENVIRON INNOV SOC TR, V1, P125, DOI 10.1016/j.eist.2011.04.009
   [Anonymous], TOP 20 HOUSEBUILDERS
   [Anonymous], 2013, HOME ENERGY EFFICIEN
   Arnold A.D., 1990, LOGIC C ACTION
   Arrow K. J., 2000, EUROPEAN J HIST EC T, V7, P171
   Avelino F., 2011, POWER TRANSITION EMP
   Avelino F, 2009, EUR J SOC THEORY, V12, P543, DOI 10.1177/1368431009349830
   Baker L, 2014, NEW POLIT ECON, V19, P791, DOI 10.1080/13563467.2013.849674
   Baranzini A, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.462
   Beland D, 2010, ADMIN SOC, V42, P568, DOI 10.1177/0095399710377444
   Bergek A, 2008, RES POLICY, V37, P407, DOI 10.1016/j.respol.2007.12.003
   Borras S, 2013, TECHNOL FORECAST SOC, V80, P1513, DOI 10.1016/j.techfore.2013.03.002
   Borras S, 2011, SCI PUBL POLICY, V38, P725, DOI 10.3152/030234211X13070021633323
   Cairney P, 2014, THEORIES POLICY PROC
   Campbell AL, 2012, ANNU REV POLIT SCI, V15, P333, DOI 10.1146/annurev-polisci-012610-135202
   David M, 2017, ENERGY RES SOC SCI, V33, P138, DOI 10.1016/j.erss.2017.09.023
   DCLG, 2008, DEF ZER CARB HOM NON
   del Rio P, 2010, ENERG POLICY, V38, P4978, DOI 10.1016/j.enpol.2010.04.003
   ENDS report, 2006, ROAD ZERO CARBON DEV
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foxon T, 2008, J CLEAN PROD, V16, pS148, DOI 10.1016/j.jclepro.2007.10.011
   Foxon TJ, 2011, ECOL ECON, V70, P2258, DOI 10.1016/j.ecolecon.2011.07.014
   Foxon TJ, 2005, ENERG POLICY, V33, P2123, DOI 10.1016/j.enpol.2004.04.011
   Geels FW, 2007, RES POLICY, V36, P399, DOI 10.1016/j.respol.2007.01.003
   Geels FW, 2016, RES POLICY, V45, P896, DOI 10.1016/j.respol.2016.01.015
   Geels FW, 2014, THEOR CULT SOC, V31, P21, DOI 10.1177/0263276414531627
   Geels FW, 2004, RES POLICY, V33, P897, DOI 10.1016/j.respol.2004.01.015
   Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8
   Geels FW, 2005, TECHNOL FORECAST SOC, V72, P681, DOI 10.1016/j.techfore.2004.08.014
   Geels FW, 2010, TRANSITIONS SUSTAINA, P11
   Gibbs D, 2015, GEOFORUM, V59, P133, DOI 10.1016/j.geoforum.2014.12.004
   GONZALEZ PD, 2006, MITIG ADAPT STRAT GL, V12, P1363, DOI DOI 10.1007/S11027-006-9069-Y
   GOULD S J, 1977, Paleobiology, V3, P115
   Greenwood D, 2015, ENVIRON POLIT, V24, P423, DOI 10.1080/09644016.2015.1008227
   Greenwood D, 2012, ENVIRON PLANN C, V30, P162, DOI 10.1068/c1146
   Guerzoni M, 2015, RES POLICY, V44, P726, DOI 10.1016/j.respol.2014.10.009
   Hafeneth T., 2017, REFORMING FOSSIL FUE
   Heffernan E., 2015, ZERO CARBON HOMES PE
   Hekkert MP, 2007, TECHNOL FORECAST SOC, V74, P413, DOI 10.1016/j.techfore.2006.03.002
   Hess D.J., 2015, ENVIRON INNOV SOC TR, P1, DOI DOI 10.1016/J.EIST2015.09.002
   Hess DJ, 2014, RES POLICY, V43, P278, DOI 10.1016/j.respol.2013.10.008
   HM Government, 2009, UK LOW CARB TRANS PL
   Hoppmann J, 2014, RES POLICY, V43, P1422, DOI 10.1016/j.respol.2014.01.014
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2017, POLITICS GOV, V5, P69, DOI 10.17645/pag.v5i2.928
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   Jacobs AM, 2015, GOVERNANCE, V28, P441, DOI 10.1111/gove.12101
   Jacobsson S, 2006, ENERG POLICY, V34, P256, DOI 10.1016/j.enpol.2004.08.029
   Jacobsson S, 2011, ENVIRON INNOV SOC TR, V1, P41, DOI 10.1016/j.eist.2011.04.006
   Johnstone P, 2017, ENERGY RES SOC SCI, V33, P147, DOI 10.1016/j.erss.2017.09.005
   Jordan A, 2014, POLICY SCI, V47, P227, DOI 10.1007/s11077-014-9201-x
   Jordan G., 2004, BRIT J POLIT INT REL, V6, P195, DOI DOI 10.1111/J.1467-856X.2004.00134.X
   Kemp R, 2004, SYSTEM INNOVATION TR, P137
   Kemp R., 1997, ENV POLICY TECHNICAL
   Kemp R, 2011, ECOL ECON, V72, P28, DOI 10.1016/j.ecolecon.2011.09.014
   Kern F, 2017, ENERGY RES SOC SCI, V23, P11, DOI 10.1016/j.erss.2016.11.002
   Kern F, 2018, ENVIRON INNOV SOC TR, V27, P102, DOI 10.1016/j.eist.2017.11.001
   Kern F, 2016, ENERGY RES SOC SCI, V22, P13, DOI 10.1016/j.erss.2016.08.016
   Kern F, 2011, ENVIRON PLANN C, V29, P1116, DOI 10.1068/c1142
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Lauber V, 2016, ENVIRON INNOV SOC TR, V18, P147, DOI 10.1016/j.eist.2015.06.005
   Lehmann P., 2010, THESIS
   Loorbach D, 2010, GOVERNANCE, V23, P161, DOI 10.1111/j.1468-0491.2009.01471.x
   Markard J., 2014, INT TIMBER TRADE WOR, P1
   Markard J, 2016, ENVIRON INNOV SOC TR, V18, P215, DOI 10.1016/j.eist.2015.05.003
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   May PJ, 2013, POLICY STUD J, V41, P426, DOI 10.1111/psj.12024
   Meadowcroft J, 2009, CACHING THE CARBON:THE POLITICS AND POLICY OF CARBON CAPTURE AND STORAGE, P1
   Meadowcroft J, 2011, ENVIRON INNOV SOC TR, V1, P70, DOI 10.1016/j.eist.2011.02.003
   Meadowcroft J, 2009, POLICY SCI, V42, P323, DOI 10.1007/s11077-009-9097-z
   Meckling J, 2017, NAT ENERGY, V2, P918, DOI 10.1038/s41560-017-0025-8
   Mettler S, 2002, AM POLIT SCI REV, V96, P351
   Mettler Suzanne, 2004, PERSPECTIVES POLITIC, V2, P55, DOI DOI 10.1017/S1537592704000623
   Mourik R., 2006, PRACTIONERS VIEW STR, P37
   Nauwelaers C., 2009, POLICY MIXES R D EUR
   Norman H.E., 2017, TECHNOL FORECASTING
   Normann HE, 2015, ENVIRON INNOV SOC TR, V15, P180, DOI 10.1016/j.eist.2014.11.002
   Oberlander J, 2015, FORUM-J APPL RES CON, V13, P37, DOI 10.1515/for-2015-0010
   Osmani M, 2009, BUILD ENVIRON, V44, P1917, DOI 10.1016/j.buildenv.2009.01.005
   Ossenbrink J., DELINEATING PO UNPUB
   Patashnik E., 2009, ANNU M AM POLIT SCI, P1
   Patashnik EM, 2013, PERSPECT POLIT, V11, P1071, DOI 10.1017/S1537592713002831
   Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011
   Pierson P, 2007, COMP POLIT STUD, V40, P145, DOI 10.1177/0010414006296347
   Pierson Paul, 1993, WORLD POLIT, V45, P595, DOI DOI 10.2307/2950710
   PIERSON Paul, 2004, POLITICS TIME HIST I
   Podewils C., 2018, RECORDS RENEWABLES O
   Quitzow R, 2015, ENVIRON INNOV SOC TR, V17, P126, DOI 10.1016/j.eist.2014.12.002
   Quitzow R, 2015, RES POLICY, V44, P233, DOI 10.1016/j.respol.2014.09.003
   Raven R, 2016, ENVIRON INNOV SOC TR, V18, P164, DOI 10.1016/j.eist.2015.02.002
   Reichardt K, 2017, RENEW SUST ENERG REV, V80, P1217, DOI 10.1016/j.rser.2017.05.280
   Reichardt K, 2016, ENVIRON INNOV SOC TR, V18, P62, DOI 10.1016/j.eist.2015.08.001
   Reichardt K, 2016, TECHNOL FORECAST SOC, V106, P11, DOI 10.1016/j.techfore.2016.01.029
   Rogge K, 2018, DO POLICY MIX CHARAC
   Rogge K.S., 2017, SPRU WORKING PAPER S, V23, P1
   Rogge KS, 2017, ENERGY RES SOC SCI, V33, P128, DOI 10.1016/j.erss.2017.10.004
   Rogge KS, 2017, ENERGY RES SOC SCI, V33, P1, DOI 10.1016/j.erss.2017.09.025
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rosenow J, 2013, ENERG EFFIC, V6, P219, DOI 10.1007/s12053-012-9181-7
   Rotmans J., 2010, NEW DIRECTIONS STUDY, P105
   Sabatier PA, 2014, THEORIES POLICY PROC
   Schmidt TS, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.84
   Schneider A, 2009, POLICY STUD J, V37, P103, DOI 10.1111/j.1541-0072.2008.00298.x
   Schweber L., 2015, BUILD RES INF, V3218, P37
   Scrase I, 2009, ENVIRON POLIT, V18, P707, DOI 10.1080/09644010903157008
   Seager A., 2007, GUARDIAN
   Shove E, 2007, ENVIRON PLANN A, V39, P763, DOI 10.1068/a39310
   Skocpol Theda, 1992, PROTECTING SOLDIERS
   Skogstad G., 2016, POLICY FEEDBACK SELF
   Smith A, 2014, TECHNOL FORECAST SOC, V81, P115, DOI 10.1016/j.techfore.2013.02.001
   Smith A, 2012, RES POLICY, V41, P1025, DOI 10.1016/j.respol.2011.12.012
   Sovacool BK, 2016, ENERGY RES SOC SCI, V13, P202, DOI 10.1016/j.erss.2015.12.020
   Stenzel T, 2008, ENERG POLICY, V36, P2645, DOI 10.1016/j.enpol.2008.03.007
   Turnheim B, 2015, GLOBAL ENVIRON CHANG, V35, P239, DOI 10.1016/j.gloenvcha.2015.08.010
   UK-GBC, 2015, COMMUNICATION
   UK-GBC, 2015, UK GBC NEWS
   Unruh GC, 2000, ENERG POLICY, V28, P817, DOI 10.1016/S0301-4215(00)00070-7
   Weaver RK, 2010, J PUBLIC POLICY, V30, P137, DOI 10.1017/S0143814X10000061
   Weber KM, 2012, RES POLICY, V41, P1037, DOI 10.1016/j.respol.2011.10.015
   Weible C., 2014, THEORIES POLICY PROC
   White W, 2013, BIOMASS BIOENERG, V57, P97, DOI 10.1016/j.biombioe.2012.12.035
   Wieczorek AJ, 2012, SCI PUBL POLICY, V39, P74, DOI 10.1093/scipol/scr008
   Wolsink M, 2007, RENEW SUST ENERG REV, V11, P1188, DOI 10.1016/j.rser.2005.10.005
NR 124
TC 13
Z9 13
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103555
DI 10.1016/j.respol.2018.03.010
PG 14
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200009
OA Other Gold
DA 2020-05-12
ER

PT J
AU Huang, P
AF Huang, Ping
TI The verticality of policy mixes for sustainability transitions: A case
   study of solar water heating in China
SO RESEARCH POLICY
LA English
DT Article
DE Multilevel policy mix; Verticality; Resource anchoring; Coevolution;
   Sustainability transitions; China
ID TECHNOLOGICAL-INNOVATION SYSTEMS; OFFSHORE WIND; RENEWABLE ENERGY; PATH
   CREATION; MULTILEVEL GOVERNANCE; INDUSTRY; EMERGENCE; DYNAMICS;
   ACTIVISM; DEZHOU
AB Climate change and sustainable development are the defining challenges of the modern era. The field of sustainability transitions seeks systematic solutions for fundamental transformations of socio-technical systems towards sustainability, and exploring the role of policy mixes has been a central research agenda within the field. In the extant literature, there exists a lack of both conceptual and empirical research on the vertical dimension of policy mixes for sustainability transitions. This study provides a multilevel and evolutionary interpretation of the vertical interactions of policy mixes in the process of industrial path development towards sustainability transitions. An exemplary case of solar water heating (SWH) technology in Shandong Province in China is presented, capturing both the bottom-up and top-down processes of interactions. On the one hand, urban-level policy initiatives can inform higher-level policymaking; on the other hand, national-level priorities can greatly configure policy strategies for lower-level governments. Moreover, as the industry matures, the interactions of multilevel policy mixes evolve from simpler, unidirectional patterns to more complex, bidirectional ones through a vertical policy-learning feedback mechanism. This study generates two important policy implications that extend beyond the Chinese context: first, dynamic vertical interactions between multilevel governments indicate the need to develop more nuanced perspectives on the design of policy mixes; second, policy makers need to hold a more dynamic view of policy mixes by recognizing their temporal and coevolutionary nature through the policy learning process.
C1 [Huang, Ping] UCL, Bartlett Dev Planning Unit, London WC1H 9EZ, England.
   [Huang, Ping] Tufts Univ, Ctr Int Environm & Resource Policy, Fletcher Sch, Climate Policy Lab, Medford, MA 02155 USA.
RP Huang, P (reprint author), Tufts Univ, Ctr Int Environm & Resource Policy, Fletcher Sch, Climate Policy Lab, Medford, MA 02155 USA.
EM ping.huang@tufts.edu
RI Huang, Ping/W-1953-2017
OI Huang, Ping/0000-0002-7573-715X
FU UCL Bartlett Faculty of the Built Environment (Bartlett Synergy Grants)
FX This work was supported by The UCL Bartlett Faculty of the Built
   Environment (Bartlett Synergy Grants). I would like to thank 'Solar
   Vision' for providing us with many valuable materials on China's SWH
   development, and all the interviewees who participated in this study and
   shared their thoughts with us. I would especially like to thank my wife
   and colleague, Dr Ying Liu, for her wisdom in conversations about this
   manuscript, as well as her editorial support. Finally, I also thank the
   editors and anonymous reviewers for their constructive and insightful
   comments that greatly contributed to improving this manuscript.
CR [Anonymous], 2010, JINAN DAILY
   [Anonymous], 2013, CHINA SECURITIES J
   [Anonymous], 2019, RES POLICY
   [Anonymous], 2010, QILU EVENING NEWS
   [Anonymous], 2012, CHINA SECURITIES J
   [Anonymous], 2009, JINAN XINHUA NEWS
   [Anonymous], 2012, DAZHONG DAILY
   [Anonymous], 2010, DEZHOU DAILY
   [Anonymous], 2019, RES POLICY
   [Anonymous], 2006, DEZHOU DAILY
   [Anonymous], 2008, JINAN DAILY
   Asheim BT, 2005, OXFORD HDB INNOVATIO, P291, DOI DOI 10.1093/OXFORDHB/9780199286805.003.0011
   Bai XM, 2009, TECHNOL FORECAST SOC, V76, P255, DOI 10.1016/j.techfore.2008.03.022
   Bergek A, 2008, RES POLICY, V37, P407, DOI 10.1016/j.respol.2007.12.003
   Binz C, 2016, ECON GEOGR, V92, P172, DOI 10.1080/00130095.2015.1103177
   Bressers H, 2005, DESIGNING GOVT INSTR, P132
   Bridge G, 2013, ENERG POLICY, V53, P331, DOI 10.1016/j.enpol.2012.10.066
   Buker MS, 2015, RENEW SUST ENERG REV, V51, P327, DOI 10.1016/j.rser.2015.06.009
   Cheng H.Z., 2009, SOLAR VISION, V7, P16
   Corn Dazhong, 2008, 4 RULES SOLAR WATER
   Corn Dazhong, 2012, LIANCHUANG ENERGY SA
   Crevoisier O, 2009, EUR PLAN STUD, V17, P1223, DOI 10.1080/09654310902978231
   Dawley S, 2015, CAMB J REG ECON SOC, V8, P257, DOI 10.1093/cjres/rsu036
   Dawley S, 2014, ECON GEOGR, V90, P91, DOI 10.1111/ecge.12028
   De Propris L, 2011, HANDBOOK OF REGIONAL INNOVATION AND GROWTH, P167
   del Rio P, 2014, POLICY SCI, V47, P267, DOI 10.1007/s11077-013-9189-7
   Department of Construction of Shandong, 2008, NOT ISS DEV PLAN APP
   Essletzbichler J, 2012, EUR PLAN STUD, V20, P791, DOI 10.1080/09654313.2012.667926
   Feldman M., 2003, IND INNOV, V10, P311, DOI DOI 10.1080/1366271032000141661
   Flanagan K., 2010, 599 MANCH BUS SCH
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Gibbs D, 2014, GEOGR ANN B, V96, P201, DOI 10.1111/geob.12046
   Goess S, 2015, ENERG POLICY, V86, P684, DOI 10.1016/j.enpol.2015.08.018
   Guo Y.M., 2014, SOLAR VISION, V53, P20
   Hekkert MP, 2007, TECHNOL FORECAST SOC, V74, P413, DOI 10.1016/j.techfore.2006.03.002
   Hoppmann J, 2014, RES POLICY, V43, P1422, DOI 10.1016/j.respol.2014.01.014
   Howlett M, 2017, POLITICS GOV, V5, P69, DOI 10.17645/pag.v5i2.928
   Hu RQ, 2012, ENERG POLICY, V51, P46, DOI 10.1016/j.enpol.2012.03.081
   Huang P, 2018, ENERGY RES SOC SCI, V36, P156, DOI 10.1016/j.erss.2017.10.028
   Huang P, 2018, J CLEAN PROD, V180, P222, DOI 10.1016/j.jclepro.2018.01.053
   Huang P, 2016, RENEW SUST ENERG REV, V64, P777, DOI 10.1016/j.rser.2016.06.061
   Islam MR, 2013, RENEW SUST ENERG REV, V17, P1, DOI 10.1016/j.rser.2012.09.011
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Lanahan L, 2015, RES POLICY, V44, P1387, DOI 10.1016/j.respol.2015.04.002
   Lehmann P., 2010, THESIS
   Li Jing, 2009, China Vegetables, P30
   Li W, 2011, ENERG POLICY, V39, P5909, DOI 10.1016/j.enpol.2011.06.044
   Liu Y.J., 2006, CONSTR SCI TECHNOL, V86
   Luo, 2003, SOL ENERGY, V2, P6
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Matti C, 2017, ENVIRON PLAN C-POLIT, V35, P661, DOI 10.1177/0263774X16663933
   Ministry of Industry and Information Technology (MIIT), 2013, GUID IMPL HLTH DEV S
   Negro SO, 2007, ENERG POLICY, V35, P925, DOI 10.1016/j.enpol.2006.01.027
   Reichardt K, 2016, ENVIRON INNOV SOC TR, V18, P62, DOI 10.1016/j.eist.2015.08.001
   Reichardt K, 2016, TECHNOL FORECAST SOC, V106, P11, DOI 10.1016/j.techfore.2016.01.029
   Richardson J, 1982, POLICY STYLES W EURO, P1
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Schmidt TS, 2016, GLOBAL ENVIRON CHANG, V38, P8, DOI 10.1016/j.gloenvcha.2016.02.005
   Schmidt TS, 2012, ENVIRON INNOV SOC TR, V2, P23, DOI 10.1016/j.eist.2011.12.002
   Smith A, 2005, RES POLICY, V34, P1491, DOI 10.1016/j.respol.2005.07.005
   Smith A, 2007, ENERG POLICY, V35, P6266, DOI 10.1016/j.enpol.2007.07.023
   Strambo C, 2015, ENERGY RES SOC SCI, V8, P1, DOI 10.1016/j.erss.2015.04.004
   Tanner AN, 2014, ECON GEOGR, V90, P403, DOI 10.1111/ecge.12055
   Trippl M, 2018, PROG HUM GEOG, V42, P687, DOI 10.1177/0309132517700982
   Truffer B, 2010, ENVIRON POLICY GOV, V20, P258, DOI 10.1002/eet.550
   Turnheim B, 2015, GLOBAL ENVIRON CHANG, V35, P239, DOI 10.1016/j.gloenvcha.2015.08.010
   UNFCCC, 2017, UN CLIM CHANG ANN RE
   Vale M, 2013, REG STUD, V47, P1018, DOI 10.1080/00343404.2011.644237
   Vision Solar, 2011, SOLAR VISION, V33, P24
   Wang Y., 2010, SURFACE ENHANCED RAM, P39, DOI DOI 10.1002/9783527632756.CH2
   Wang ZY, 2015, RENEW SUST ENERG REV, V41, P68, DOI 10.1016/j.rser.2014.08.026
   Weber KM, 2012, RES POLICY, V41, P1037, DOI 10.1016/j.respol.2011.10.015
   Weiss W, 2017, SOLAR HEAT WORLDWIDE
   Yu Z, 2018, ENERGY RES SOC SCI, V46, P236, DOI 10.1016/j.erss.2018.07.029
   Yu Z, 2018, REG STUD, V52, P68, DOI 10.1080/00343404.2016.1260706
   Zhao ZY, 2013, RENEW SUST ENERG REV, V21, P229, DOI 10.1016/j.rser.2012.12.066
NR 76
TC 1
Z9 1
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103758
DI 10.1016/j.respol.2019.02.009
PG 12
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200010
DA 2020-05-12
ER

PT J
AU Ingold, K
   Stadelmann-Steffen, I
   Kammermann, L
AF Ingold, Karin
   Stadelmann-Steffen, Isabelle
   Kammermann, Lorenz
TI The acceptance of instruments in instrument mix situations: Citizens'
   perspective on Swiss energy transition
SO RESEARCH POLICY
LA English
DT Article
DE Social acceptance; Energy transition; Instrument mix; Citizens'
   perspective; Political science
ID PROSPECT-THEORY; ADVOCACY COALITIONS; POLICY INSTRUMENTS;
   POLITICAL-SCIENCE; SOCIAL ACCEPTANCE; PUBLIC ACCEPTANCE; CLIMATE-CHANGE;
   ATTITUDES; TECHNOLOGIES; ELECTRICITY
AB Citizens are the target group of sustainability policies, and their acceptance and subsequent behavioral change are key in transition processes. But what drives citizens to accept new instruments that will be added to a preexisting instrument mix? To answer this question, we suggest an innovative combination of sustainability transitions and social acceptance research, and examine the case of Swiss energy turnaround. We rely on data from a representative sample of the Swiss resident population. By estimating logistic multi-response models, we disentangle individual and context-related factors that drive instrument preferences in a instrument mix situation. We conclude that it is mainly individual factors (values in favor of nuclear phasing out and climate mitigation) that positively impact the acceptance of instruments that promote the larger energy transitions through renewables. Additionally, the self-contribution of citizens (energy pro-sumers) seems to shape preferences more than current policies of their own jurisdiction.
C1 [Ingold, Karin; Kammermann, Lorenz] ETH Domain, Swiss Fed Inst Aquat Sci, Eawag, Zurich, Switzerland.
   [Ingold, Karin; Stadelmann-Steffen, Isabelle; Kammermann, Lorenz] Univ Bern, Inst Polit Sci, Fabrikstr 8, CH-3012 Bern, Switzerland.
   [Ingold, Karin] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland.
RP Ingold, K (reprint author), Univ Bern, Inst Polit Sci, Fabrikstr 8, CH-3012 Bern, Switzerland.
EM karin.ingold@ipw.unibe.ch
OI Kammermann, Lorenz/0000-0003-4274-6719
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [NRP 71]; Eawag discretionary fund
FX This work was supported by the Swiss National Science Foundation within
   the National Research Programme Managing Energy Consumption"(NRP 71);
   and was partially funded by the Eawag discretionary fund.
CR Batel S, 2015, PUBLIC UNDERST SCI, V24, P311, DOI 10.1177/0963662513514165
   Batel S, 2013, ENERG POLICY, V58, P1, DOI 10.1016/j.enpol.2013.03.018
   Bell D, 2005, ENVIRON POLIT, V14, P460, DOI 10.1080/09644010500175833
   BIRKLAND TA, 1998, J PUBLIC POLICY, V18, P53, DOI DOI 10.1017/S0143814X98000038
   Borras S., 2015, GOVERNANCE SOCIOTECH, P23
   Bressers H., 2005, DESIGNING GOVT INSTR
   Browne WJ, 2006, BAYESIAN ANAL, V1, P473, DOI 10.1214/06-BA117
   Burke MJ, 2017, ENERGY RES SOC SCI, V33, P35, DOI 10.1016/j.erss.2017.09.024
   Carattini S., 2016, 273 GRANTH RES I CLI
   del Rio P, 2017, ENERGY RES SOC SCI, V33, P49, DOI 10.1016/j.erss.2017.09.010
   Dermont C., 2018, ENV POLIT, V21
   Dermont C, 2017, ENERG POLICY, V108, P359, DOI 10.1016/j.enpol.2017.05.062
   Devine-Wright P, 2005, LOCAL ENVIRON, V10, P57, DOI 10.1080/1354983042000309315
   Dreyer SJ, 2015, NAT CLIM CHANGE, V5, P1064, DOI 10.1038/NCLIMATE2756
   Edmondson DL, 2019, RES POLICY, V48, DOI 10.1016/j.respol.2018.03.010
   Ek K, 2005, ENERG POLICY, V33, P1677, DOI 10.1016/j.enpol.2004.02.005
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8
   Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02
   Holzinger K., 2006, EUR LAW J, V12, P403, DOI [DOI 10.1111/j.1468-0386.2006.00323.x, DOI 10.1111/EULJ.2006.12.ISSUE-3]
   Howlett M., 2009, STUDYING PUBLIC POLI
   Howlett M., 2012, ADMIN SOC, VXX, P1
   Huijts NMA, 2012, RENEW SUST ENERG REV, V16, P525, DOI 10.1016/j.rser.2011.08.018
   Ingold K., 2016, UMWELTPOLITIK SCHWEI
   Ingold K, 2011, POLICY STUD J, V39, P435, DOI 10.1111/j.1541-0072.2011.00416.x
   Jenkins-Smith H, 2014, POLICY STUD J, V42, P484, DOI 10.1111/psj.12071
   KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185
   Kammermann L, 2018, ENERGY RES SOC SCI, V43, P48, DOI 10.1016/j.erss.2018.05.010
   Kammermann L, 2018, REV POLICY RES, V35, P213, DOI 10.1111/ropr.12274
   Karlstrom H, 2014, ENERG POLICY, V67, P656, DOI 10.1016/j.enpol.2013.11.049
   Kirchgassner G, 2003, PUBLIC CHOICE, V115, P369, DOI 10.1023/A:1024289627887
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Knill Christoph, 2012, PUBLIC POLICY NEW IN
   Landry R., 2005, DESIGNING GOVT INSTR
   Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728
   Linder S. H., 1988, POLICY STUDIES REV, V7, P738, DOI DOI 10.1111/J.1541-1338.1988.TB00892.X
   Loukopoulos P, 2005, ENVIRON SCI POLICY, V8, P57, DOI 10.1016/j.envsci.2004.07.008
   Lutz G., 2016, WAHLTEILNAHME WAHLEN
   Markard J., RES POLICY
   Markard J, 2016, ENVIRON INNOV SOC TR, V18, P215, DOI 10.1016/j.eist.2015.05.003
   Markard J, 2016, RES POLICY, V45, P330, DOI 10.1016/j.respol.2015.10.009
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Martin BR, 2016, IND INNOV, V23, P157, DOI 10.1080/13662716.2016.1146125
   McDermott R, 2004, POLIT PSYCHOL, V25, P289, DOI 10.1111/j.1467-9221.2004.00372.x
   Mercer J, 2005, ANNU REV POLIT SCI, V8, P1, DOI 10.1146/annurev.polisci.8.082103.104911
   Metz F., 2017, NETWORK STRUCTURE PO
   Mills C. Wright, 1956, POWER ELITE
   Poortinga W, 2003, J ECON PSYCHOL, V24, P49, DOI 10.1016/S0167-4870(02)00154-X
   Ricci M, 2008, INT J HYDROGEN ENERG, V33, P5868, DOI 10.1016/j.ijhydene.2008.07.106
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rosenow J, 2017, ENERGY RES SOC SCI, V33, P95, DOI 10.1016/j.erss.2017.09.013
   SABATIER P, 1986, J PUBLIC POLICY, V6, P21, DOI DOI 10.1017/S0143814X00003846
   Sabatier PA, 1993, POLICY CHANGE LEARNI
   Sager F, 2009, POLIT STUD-LONDON, V57, P537, DOI 10.1111/j.1467-9248.2008.00743.x
   Schaffrin A, 2015, POLICY STUD J, V43, P257, DOI 10.1111/psj.12095
   Schuitema G, 2011, SOC JUSTICE RES, V24, P66, DOI 10.1007/s11211-011-0124-9
   Shi J, 2015, RISK ANAL, V35, P2183, DOI 10.1111/risa.12406
   Smith A, 2005, RES POLICY, V34, P1491, DOI 10.1016/j.respol.2005.07.005
   Sovacool BK, 2009, ENERG POLICY, V37, P1529, DOI 10.1016/j.enpol.2008.12.016
   Stadelmann-Steffen I, 2018, PUBLIC CHOICE, V175, P37, DOI 10.1007/s11127-018-0513-9
   Steg L, 2005, J ENVIRON PSYCHOL, V25, P415, DOI 10.1016/j.jenvp.2005.08.003
   Stegmueller D, 2013, AM J POLIT SCI, V57, P748, DOI 10.1111/ajps.12001
   STERNER T, 2003, POLICY INSTRUMENTS E
   Subramanian SV, 2005, J EPIDEMIOL COMMUN H, V59, P664, DOI 10.1136/jech.2004.025742
   Swiss Confederation, 2013, BOTSCH ZUM ERST MASS
   Swiss Federal Office of Energy SFOE, 2013, EN 2050
   Tabi A., 2015, BEFRAGUNG ANWOHNER M
   Thalmann P, 2004, PUBLIC CHOICE, V119, P179, DOI 10.1023/B:PUCH.0000024165.18082.db
   Vedung E., 1998, CARROTS STICKS SERMO
   Warren C. R., 2005, J ENVIRON PLANN MAN, V48, P853, DOI DOI 10.1080/09640560500294376
   Wolsink M, 2006, T I BRIT GEOGR, V31, P85, DOI 10.1111/j.1475-5661.2006.00191.x
   Wolsink M, 2000, RENEW ENERG, V21, P49, DOI 10.1016/S0960-1481(99)00130-5
   Wolsink M., 2013, EDI Q, V5, P10
   Wolsink M, 2012, RENEW SUST ENERG REV, V16, P822, DOI 10.1016/j.rser.2011.09.006
   Wustenhagen R, 2007, ENERG POLICY, V35, P2683, DOI 10.1016/j.enpol.2006.12.001
   Zoellner J, 2008, ENERG POLICY, V36, P4136, DOI 10.1016/j.enpol.2008.06.026
NR 76
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103694
DI 10.1016/j.respol.2018.10.018
PG 11
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200007
DA 2020-05-12
ER

PT J
AU Kern, F
   Rogge, KS
   Howlett, M
AF Kern, Florian
   Rogge, Karoline S.
   Howlett, Michael
TI Policy mixes for sustainability transitions: New approaches and insights
   through bridging innovation and policy studies
SO RESEARCH POLICY
LA English
DT Article
DE Policy mix; Innovation policy; Sustainability transitions; Innovation
   studies; Policy studies; Public policy
ID RESEARCH-AND-DEVELOPMENT; CREATIVE DESTRUCTION; OFFSHORE WIND; SYSTEMS;
   INSTRUMENTS; TECHNOLOGY; POLITICS; CLIMATE; CHOICE; IMPACT
AB There has been an increasing interest in science, technology and innovation policy studies in the topic of policy mixes. While earlier studies conceptualised policy mixes mainly in terms of combinations of instruments to support innovation, more recent literature extends the focus to how policy mixes can foster sustainability transitions. For this, broader policy mix conceptualisations have emerged which also include considerations of policy goals and policy strategies; policy mix characteristics such as consistency, coherence, credibility and comprehensiveness; as well as policy making and implementation processes. It is these broader conceptualisations of policy mixes which are the subject of the special issue introduced in this article. We aim at supporting the emergence of a new strand of interdisciplinary social science research on policy mixes which combines approaches, methods and insights from innovation and policy studies to further such broader policy mix research with a specific focus on fostering sustainability transitions. In this article we introduce this topic and present a bibliometric analysis of the literature on policy mixes in both fields as well as their emerging connections. We also introduce five major themes in the policy mix literature and summarise the contributions made by the articles in the special issue to these: methodological advances; policy malting and implementation; actors and agency; evaluating policy mixes; and the co-evolution of policy mixes and socio-technical systems. We conclude by summarising key insights for policy making.
C1 [Kern, Florian] Inst Ecol Econ Res, Berlin, Germany.
   [Rogge, Karoline S.] Univ Sussex, SPRU, Brighton, E Sussex, England.
   [Rogge, Karoline S.] Fraunhofer Inst Syst & Innovat Res ISI, Karlsruhe, Germany.
   [Howlett, Michael] Simon Fraser Univ, Dept Polit Sci, Burnaby, BC, Canada.
RP Kern, F (reprint author), Inst Ecol Econ Res, Berlin, Germany.
OI Kern, Florian/0000-0002-3968-330X; Howlett, Michael/0000-0003-4689-740X
FU Research Council UK's EUED Programme [EP/K011790/1]
FX We would like to thank Larissa Gross for excellent research assistance
   with the bibliometric analysis. For Karoline Rogge and Florian Kern the
   guest-editing of this special issue has been enabled through the Centre
   on Innovation and Energy Demand which is funded by the Research Council
   UK's EUED Programme (grant number EP/K011790/1). This funding is
   gratefully acknowledged. We are also grateful to the Research Policy
   lead editor for this special issue for very helpful comments on an
   earlier version of this introduction. This study did not create new data
   but only re-analysed existing bibliometric data available at locations
   cited in the paper.
CR Arnold E, 2004, RES EVALUAT, V13, P3, DOI 10.3152/147154404781776509
   Arnold E, 2018, SHOULD WE EVALUATE C
   Avelino F, 2016, J ENVIRON POL PLAN, V18, P557, DOI 10.1080/1523908X.2016.1216782
   Boni A., 2019, KEY PRINCIPLES FORMA
   Borras S, 2019, RES POLICY, V48, P312, DOI 10.1016/j.respol.2018.08.020
   Borras S, 2013, TECHNOL FORECAST SOC, V80, P1513, DOI 10.1016/j.techfore.2013.03.002
   Costantini V, 2017, RES POLICY, V46, P799, DOI 10.1016/j.respol.2017.02.004
   del Rio P, 2017, ENERGY RES SOC SCI, V33, P49, DOI 10.1016/j.erss.2017.09.010
   Di Stefano G, 2012, RES POLICY, V41, P1283, DOI 10.1016/j.respol.2012.03.021
   Doremus H, 2003, ENVIRON SCI POLICY, V6, P217, DOI 10.1016/S1462-9011(03)00036-4
   Duygan M., 2019, ENV INNOV SOC
   Farla J, 2012, TECHNOL FORECAST SOC, V79, P991, DOI 10.1016/j.techfore.2012.02.001
   Fischer LB, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050476
   Fisher R, 2018, MISSION ORIENTED RES
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foray D, 2012, RES POLICY, V41, P1697, DOI 10.1016/j.respol.2012.07.011
   Goulder LH, 2008, REV ENV ECON POLICY, V2, P152, DOI 10.1093/reep/ren005
   Gunningham Neil, 1999, LAW POLY, V21, P49, DOI DOI 10.1111/1467-9930.00065
   Hoppmann J, 2014, RES POLICY, V43, P1422, DOI 10.1016/j.respol.2014.01.014
   Howlett M., 2009, STUDYING PUBLIC POLI
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2015, ENVIRON PLANN C, V33, P1233, DOI 10.1177/0263774X15610059
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   International Energy Agency, 2017, REAL WORLD POL PACK
   Kemp R, 2011, ECOL ECON, V72, P28, DOI 10.1016/j.ecolecon.2011.09.014
   Kern F, 2017, ENERGY RES SOC SCI, V23, P11, DOI 10.1016/j.erss.2016.11.002
   Kern F, 2018, ENVIRON INNOV SOC TR, V27, P102, DOI 10.1016/j.eist.2017.11.001
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kivimaa P, 2017, ENERGY RES SOC SCI, V33, P115, DOI 10.1016/j.erss.2017.09.002
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Kivimaa P, 2014, RES POLICY, V43, P1370, DOI 10.1016/j.respol.2014.02.007
   Kohler J, 2019, ENVIRON INNOV SOC TR, V31, P1, DOI 10.1016/j.eist.2019.01.004
   Luederitz C, 2017, J CLEAN PROD, V169, P61, DOI 10.1016/j.jclepro.2016.09.005
   Magro E, 2013, RES POLICY, V42, P1647, DOI 10.1016/j.respol.2013.06.005
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   McLaughlin M. W., 1987, EDUC EVAL POLICY AN, V9, P171, DOI DOI 10.3102/01623737009002171
   Meckling J, 2017, NAT ENERGY, V2, P918, DOI 10.1038/s41560-017-0025-8
   Molas-Gallart J, 2006, AM J EVAL, V27, P64, DOI 10.1177/1098214005281701
   Nauwelaers C, 2002, TECHNOL ANAL STRATEG, V14, P201, DOI 10.1080/09537320220133866
   Nauwelaers C., 2009, POLICY MIXES R D EUR
   Nieminen M, 2015, EVALUATION-US, V21, P448, DOI 10.1177/1356389015606540
   OECD, 2015, SYST INN SYNTH REP
   OECD, 2016, POL MIX BUS R D INN, DOI [10.1787/sti_in_outlook-2016-22-en, DOI 10.1787/STI_IN_OUTLOOK-2016-22-EN]
   Reichardt K, 2017, RENEW SUST ENERG REV, V80, P1217, DOI 10.1016/j.rser.2017.05.280
   Reichardt K, 2016, TECHNOL FORECAST SOC, V106, P11, DOI 10.1016/j.techfore.2016.01.029
   Roberts C, 2018, ENERGY RES SOC SCI, V44, P304, DOI 10.1016/j.erss.2018.06.001
   Rogge KS, 2018, RES POLICY, V47, P1639, DOI 10.1016/j.respol.2018.05.011
   Rogge KS, 2018, ENVIRON SCI POLICY, V87, P74, DOI 10.1016/j.envsci.2018.05.009
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Sabatier PA, 2014, THEORIES POLICY PROC
   Schaffrin A, 2015, POLICY STUD J, V43, P257, DOI 10.1111/psj.12095
   Schmidt TS, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.84
   Schot J, 2018, RES POLICY, V47, P1554, DOI 10.1016/j.respol.2018.08.011
   Schot J, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.54
   Seyfang G, 2012, ENVIRON PLANN C, V30, P381, DOI 10.1068/c10222
   Smink MM., 2013, BUS STRATEG ENVIRON, DOI [10.1002/bse.1808.n/a-n/a, DOI 10.1002/BSE.1808.N/A-N/A]
   Smits R., 2004, International Journal of Foresight and Innovation Policy, V1, P4, DOI 10.1504/IJFIP.2004.004621
   Sorrell S, 2003, OXFORD REV ECON POL, V19, P420, DOI 10.1093/oxrep/19.3.420
   Sterner T., 2012, POLICY INSTRUMENTS E
   van Eck N.J., 2017, GETTING STARTED CITN
   van Eck N. J., 2017, VOSVIEWER MANUAL, DOI [10.3402/jac.v8.30072, DOI 10.3402/JAC.V8.30072]
   van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7
   Vedung E., 2017, PUBLIC POLICY PROGRA, DOI [10.4324/9781315127767, DOI 10.4324/9781315127767]
   Veugelers R, 2012, RES POLICY, V41, P1770, DOI 10.1016/j.respol.2012.06.012
   Weber KM, 2012, RES POLICY, V41, P1037, DOI 10.1016/j.respol.2011.10.015
   Wieczorek AJ, 2012, SCI PUBL POLICY, V39, P74, DOI 10.1093/scipol/scr008
   Wittmayer JM, 2017, ENVIRON INNOV SOC TR, V24, P45, DOI 10.1016/j.eist.2016.10.003
NR 67
TC 3
Z9 3
U1 10
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103832
DI 10.1016/j.respol.2019.103832
PG 15
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200001
OA Green Accepted, Other Gold
DA 2020-05-12
ER

PT J
AU Lindberg, MB
   Markard, J
   Andersen, AD
AF Lindberg, Marie Byskov
   Markard, Jochen
   Andersen, Allan Dahl
TI Policies, actors and sustainability transition pathways: A study of the
   EU's energy policy mix
SO RESEARCH POLICY
LA English
DT Article
DE Sustainability transitions; Policy mix; Transition pathways; Actor
   preferences; Energy policy; European Union
ID MULTILEVEL ANALYSIS; OFFSHORE WIND; INNOVATION; POLITICS; GERMAN;
   GOVERNANCE; TYPOLOGY; SYSTEMS; LIBERALIZATION; DESTRUCTION
AB Policies and politics are crucial elements of sustainability transitions. Transition pathways unfold as a result of continuous struggles of actors over policy goals and instruments. Taking a policy mix perspective, we study policies and policy preferences of key industry actors in the ongoing energy transition at the level of the European Union. We introduce two central analytical dimensions for transition pathways: the degree of sustainability (here: renewable energy ambition) and the degree of disruption (here: whether to pursue centralized or decentralized energy system configurations). We find that the current EU energy policy mix is heterogeneous with respect to the issue of (de-)centralization, whereas most policies and actors express high or moderate ambitions for renewable energy. Our paper makes three contributions. It demonstrates how actors and policy preferences can be explicitly included in the study of policy mixes. To the literature on transition pathways, we introduce sustainability as another key dimension in addition to disruption. Lastly, we propose a novel methodology for analyzing the politics of transition pathways.
C1 [Lindberg, Marie Byskov; Andersen, Allan Dahl] Univ Oslo UiO, TIK Ctr Innovat Technol & Culture, Oslo, Norway.
   [Markard, Jochen] Swiss Fed Inst Technol, Grp Sustainabil & Technol, Swiss Fed Inst Technol Zurich, Zurich, Switzerland.
RP Lindberg, MB (reprint author), Univ Oslo UiO, TIK Ctr Innovat Technol & Culture, Oslo, Norway.
EM m.b.lindberg@tik.uio.no
RI ; Markard, Jochen/L-5338-2013
OI Dahl Andersen, Allan/0000-0002-2703-293X; Markard,
   Jochen/0000-0002-6470-7211
FU Norwegian Research CouncilResearch Council of Norway [24 3994/E20];
   Swiss Competence Center for Energy Research (SCCER CREST) - Innosuisse
   [KTI 1155000154]
FX We gratefully acknowledge the funding for this research from the
   Norwegian Research Council as a part of the project on the "Integration
   of Power Transmission Grids" (InGrid, Grant number 24 3994/E20). One
   author has also received funding from the Swiss Competence Center for
   Energy Research (SCCER CREST), financially supported by Innosuisse under
   Grant No. KTI 1155000154.
CR Agora Energiewende, 2017, COST REN EN CRIT ASS
   Airtricity, 2006, EUR OFFSH SUP PROP
   Alkemade F, 2011, ENVIRON INNOV SOC TR, V1, P125, DOI 10.1016/j.eist.2011.04.009
   Andersen A.D., 2017, TIK WORKING PAPERS I
   Andersen AD, 2014, ENVIRON INNOV SOC TR, V13, P75, DOI 10.1016/j.eist.2014.09.004
   Bergek A, 2013, RES POLICY, V42, P1210, DOI 10.1016/j.respol.2013.02.009
   Berggren C, 2015, RES POLICY, V44, P1017, DOI 10.1016/j.respol.2014.11.009
   Bohringer C, 2010, J REGUL ECON, V37, P316, DOI 10.1007/s11149-010-9116-1
   Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009
   del Rio P, 2014, POLICY SCI, V47, P267, DOI 10.1007/s11077-013-9189-7
   Dijk M, 2016, TECHNOL FORECAST SOC, V105, P77, DOI 10.1016/j.techfore.2016.01.013
   Dolata U, 2009, RES POLICY, V38, P1066, DOI 10.1016/j.respol.2009.03.006
   Edmondson D.L., RES POLICY, DOI [10.1016/jaespol.2018.03.010, DOI 10.1016/JAESPOL.2018.03.010]
   European Commission, 2015, ACH 10 EL INT TARG
   Fagan-Watson B., 2015, LOBBYING TRADE ASS E
   Fankhauser S, 2010, CLIM CHANG ECON, V1, P209, DOI 10.1142/S2010007810000169
   Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1
   Fitch-Roy O.W.F., 2017, NEGOTIATING EUS 2030
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foxon TJ, 2013, ENERG POLICY, V52, P10, DOI 10.1016/j.enpol.2012.04.001
   Franceschini S, 2016, ENVIRON INNOV SOC TR, V21, P56, DOI 10.1016/j.eist.2016.04.003
   FRENCH RM, 1969, J POLIT, V31, P818, DOI 10.2307/2128502
   Funcke S, 2016, UTIL POLICY, V40, P67, DOI 10.1016/j.jup.2016.03.005
   Garlach B., 2017, HDB TRANSITIONS ENER, P79
   Geels FW, 2011, TECHNOL FORECAST SOC, V78, P910, DOI 10.1016/j.techfore.2010.12.004
   Geels FW, 2007, RES POLICY, V36, P399, DOI 10.1016/j.respol.2007.01.003
   Geels FW, 2016, RES POLICY, V45, P896, DOI 10.1016/j.respol.2016.01.015
   Geels FW, 2005, TECHNOL ANAL STRATEG, V17, P445, DOI 10.1080/09537320500357319
   Geels FW, 2004, RES POLICY, V33, P897, DOI 10.1016/j.respol.2004.01.015
   Girod B, 2016, J CLEAN PROD, V128, P209, DOI 10.1016/j.jclepro.2015.07.010
   Glachant JM, 2014, UTIL POLICY, V31, P221, DOI 10.1016/j.jup.2014.03.006
   Goulder LH, 2013, J ECON PERSPECT, V27, P87, DOI 10.1257/jep.27.1.87
   Gullberg AT, 2013, REV POLICY RES, V30, P611, DOI 10.1111/ropr.12049
   Haley B, 2017, ENVIRON INNOV SOC TR, V25, P107, DOI 10.1016/j.eist.2017.01.002
   Hansen T, 2015, ENVIRON INNOV SOC TR, V17, P92, DOI 10.1016/j.eist.2014.11.001
   Hess D.J., 2015, ENVIRON INNOV SOC TR, P1, DOI DOI 10.1016/J.EIST2015.09.002
   Hess DJ, 2014, RES POLICY, V43, P278, DOI 10.1016/j.respol.2013.10.008
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   IEA, 2014, EN POL IEA COUNTR EU
   Jacobsson S, 2011, ENVIRON INNOV SOC TR, V1, P41, DOI 10.1016/j.eist.2011.04.006
   Jamasb T, 2005, ENERGY J, P11
   Jerks J., 2017, J ENVIRON ECON MANAG, V84, P1, DOI [10.1016/j.jeern.2017.01.004, DOI 10.1016/J.JEERN.2017.01.004]
   Kemp R, 2006, REFLEXIVE GOVERNANCE FOR SUSTAINABLE DEVELOPMENT, P103
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Kivimaa P, 2014, ENVIRON POLICY GOV, V24, P28, DOI 10.1002/eet.1629
   Koch N, 2014, ENERG POLICY, V73, P676, DOI 10.1016/j.enpol.2014.06.024
   Konrad K, 2012, TECHNOL FORECAST SOC, V79, P1084, DOI 10.1016/j.techfore.2011.09.008
   Kungl G, 2015, ENERGY RES SOC SCI, V8, P13, DOI 10.1016/j.erss.2015.04.009
   Laes E, 2014, SUSTAINABILITY-BASEL, V6, P1129, DOI 10.3390/su6031129
   Lauber V, 2016, ENVIRON INNOV SOC TR, V18, P147, DOI 10.1016/j.eist.2015.06.005
   Lazard, 2017, LAZ LEV COST EN AN V
   Leach M., 2010, DYNAMIC SUSTAINABILI
   Lerum Boasson E., 2013, EU CLIMATE POLICY IN
   Lilliestam J, 2016, ENERGY RES SOC SCI, V17, P20, DOI 10.1016/j.erss.2016.03.011
   Magnusson T, 2005, IND CORP CHANGE, V14, P1, DOI 10.1093/icc/dth042
   Makitie T, 2018, J CLEAN PROD, V177, P813, DOI 10.1016/j.jclepro.2017.12.209
   Markard J, 2006, RES POLICY, V35, P609, DOI 10.1016/j.respol.2006.02.008
   Markard J, 2018, NAT ENERGY, V3, P628, DOI 10.1038/s41560-018-0171-7
   Markard J, 2016, ENVIRON INNOV SOC TR, V18, P215, DOI 10.1016/j.eist.2015.05.003
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Markard J, 2009, ENERG POLICY, V37, P3545, DOI 10.1016/j.enpol.2009.04.015
   Matches F.C., 2010, NUCL SAFETY, V49, P1
   Meadowcroft J, 2011, ENVIRON INNOV SOC TR, V1, P70, DOI 10.1016/j.eist.2011.02.003
   Meckling J, 2011, GLOBAL ENVIRON POLIT, V11, P26, DOI 10.1162/GLEP_a_00052
   Mitchell C, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.30
   Raven R, 2016, ENVIRON INNOV SOC TR, V18, P101, DOI 10.1016/j.eist.2015.06.008
   Reichardt K, 2016, ENVIRON INNOV SOC TR, V18, P62, DOI 10.1016/j.eist.2015.08.001
   Reichardt K, 2016, TECHNOL FORECAST SOC, V106, P11, DOI 10.1016/j.techfore.2016.01.029
   Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263
   REN21, 2017, REN 2017 GLOB STAT R, DOI DOI 10.1016/J.RSER.2016.09.082
   Richter M, 2013, ENERG POLICY, V62, P1226, DOI 10.1016/j.enpol.2013.05.038
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rosenbloom D, 2017, GLOBAL ENVIRON CHANG, V43, P37, DOI 10.1016/j.gloenvcha.2016.12.011
   Sabatier PA, 2007, THEORIES POLICY PROC, P189
   Scheer H., 2006, ENERGY AUTONOMY EC S
   Schlaile MP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9122253
   Schmid E, 2016, ENERGY RES SOC SCI, V11, P263, DOI 10.1016/j.erss.2015.11.002
   Schmidt TS, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.84
   Skjaerseth J.B., 2016, LINKING EU CLIMATE E
   Smink MM, 2015, BUS STRATEG ENVIRON, V24, P86, DOI 10.1002/bse.1808
   Smith A, 2005, RES POLICY, V34, P1491, DOI 10.1016/j.respol.2005.07.005
   Smith A, 2010, ECOL SOC, V15
   Stirling A, 2014, ENERGY RES SOC SCI, V1, P83, DOI 10.1016/j.erss.2014.02.001
   UNEP, 2016, EM GAP REP 2016
   Van den Bergh K, 2013, ENERG POLICY, V63, P1021, DOI 10.1016/j.enpol.2013.09.003
   Verbong GPJ, 2010, TECHNOL FORECAST SOC, V77, P1214, DOI 10.1016/j.techfore.2010.04.008
   Verbruggen A, 2012, ENERG POLICY, V45, P635, DOI 10.1016/j.enpol.2012.03.014
   Wesseling JH, 2014, TRANSPORT RES D-TR E, V33, P196, DOI 10.1016/j.trd.2014.06.006
   Wittneben BBF, 2012, ENVIRON SCI POLICY, V15, P1, DOI 10.1016/j.envsci.2011.09.002
   Ydersbond L. M., 2016, 32016 FNI
NR 91
TC 9
Z9 9
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103668
DI 10.1016/j.respol.2018.09.003
PG 15
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200006
DA 2020-05-12
ER

PT J
AU Magro, E
   Wilson, JR
AF Magro, Edurne
   Wilson, James R.
TI Policy-mix evaluation: Governance challenges from new place-based
   innovation policies
SO RESEARCH POLICY
LA English
DT Article
DE Regional innovation policy; Policy mix; Policy evaluation; Governance;
   Smart specialisation strategies; Sustainable transitions
ID SMART SPECIALIZATION; SYSTEMS; STRATEGY; FAILURE; REGIONS; ISSUES;
   ENERGY; SPACES
AB The policy mix concept has become popular in innovation policy literature. It is particularly relevant for complex challenges such as sustainable industrial transitions that require joined-up interventions from different policy domains. Yet finding the right policy mix for a given challenge is strongly conditioned by the governance context in which individual policies emerge and evolve over time. In particular, the evaluation of policy mixes in a regional context is often neglected.
   This paper aims to deepen understanding of the interaction between governance processes and policy mix evaluation in the specific context of smart specialisation strategies. These newly popular regional innovation strategies are ideal laboratories for analysing policy mixes due to their place-based nature, their directionality, their experimental character and potential orientation towards grand societal challenges, and their complex governance context.
   The paper builds on the smart specialisation literature, the innovation policy and policy evaluation literature, and the literature on governance in pluralistic contexts to build a conceptual framework for analysing the governance of policy-mix evaluation. The conceptual arguments are illustrated by the Basque Country case in Spain, providing insights on the establishment of a strategic innovation policy mix evaluation process in a complex setting of institutions and actors.
C1 [Magro, Edurne] Univ Deusto, Orkestra Basque Inst Competitiveness, Mundaiz 50, San Sebastian 20012, Spain.
   Univ Deusto, Deusto Business Sch, Mundaiz 50, San Sebastian 20012, Spain.
RP Magro, E (reprint author), Univ Deusto, Orkestra Basque Inst Competitiveness, Mundaiz 50, San Sebastian 20012, Spain.
EM edurne.magro@orkestra.deusto.es; jwilson@orkestra.deusto.es
CR Amanatidou E, 2014, MINERVA, V52, P419, DOI 10.1007/s11024-014-9258-x
   Aranguren M.-J., 2016, CUADEMOS ORKESTRA 20
   Aranguren M.-J., 2017, HDB REGIONS COMPETIT
   Arnold E, 2004, RES EVALUAT, V13, P3, DOI 10.3152/147154404781776509
   Barca F., 2009, AGENDA REFORMED COHE
   BENNETT CJ, 1992, POLICY SCI, V25, P275, DOI 10.1007/BF00138786
   Bevir M., 2012, GOVERNANCE VERY SHOR, P147
   Borras S., 2009, CIRCLE ELECT WORKING
   Borras S, 2013, TECHNOL FORECAST SOC, V80, P1513, DOI 10.1016/j.techfore.2013.03.002
   Capello R, 2016, EUR PLAN STUD, V24, P1393, DOI 10.1080/09654313.2016.1156058
   Carnahan L., 2015, RES POLICY, V44, P1387
   Coenen L, 2012, RES POLICY, V41, P968, DOI 10.1016/j.respol.2012.02.014
   Coenen L, 2012, EUR PLAN STUD, V20, P367, DOI 10.1080/09654313.2012.651802
   Cooke P., 2000, GOVERNANCE INNOVATIO
   Davoudi S, 2008, B ASOC GEOGR ESP, P33
   del Rio P, 2014, POLICY SCI, V47, P267, DOI 10.1007/s11077-013-9189-7
   Fetterman D. M., 1994, EVALUATION PRACTICE, V15, P1, DOI DOI 10.1016/0886-1633(94)90055-8
   Flanagan K, 2016, IND INNOV, V23, P177, DOI 10.1080/13662716.2016.1146126
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foray D., 2013, EKONOMIAZ, V83, P54
   Foray D., 2012, GUIDE RES INNOVATION
   Foray D., 2015, USCIRE CRISI CITTA C
   Foray D., 2017, GOVERNING SMART SPEC
   Gianelle C., 2016, IMPLEMENTING SMART S
   Gil N., 2017, COMPLEXITY PLURALISM
   Guba E, 1989, 4 GENERATION EVALUAT
   Hansen MB, 2010, AM J EVAL, V31, P295, DOI 10.1177/1098214010366174
   Hansen T, 2015, ENVIRON INNOV SOC TR, V17, P92, DOI 10.1016/j.eist.2014.11.001
   Hodson M, 2012, EUR PLAN STUD, V20, P421, DOI 10.1080/09654313.2012.651804
   Hodson M, 2010, RES POLICY, V39, P477, DOI 10.1016/j.respol.2010.01.020
   Howlett M, 2014, POLICY SOC, V33, P317, DOI 10.1016/j.polsoc.2014.10.002
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2015, ENVIRON PLANN C, V33, P1233, DOI 10.1177/0263774X15610059
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   Jarzabkowski P, 2006, LONG RANGE PLANN, V39, P631, DOI 10.1016/j.lrp.2006.11.002
   Jessop B, 1998, INT SOC SCI J, V50, P29, DOI 10.1111/1468-2451.00107
   Aranguren MJ, 2019, REG STUD, V53, P451, DOI 10.1080/00343404.2018.1462484
   Aranguren MJ, 2017, ENVIRON PLAN C-POLIT, V35, P703, DOI 10.1177/0263774X16662469
   Kern F, 2017, ENERGY RES SOC SCI, V23, P11, DOI 10.1016/j.erss.2016.11.002
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Kuhlmann S, 2001, RES POLICY, V30, P953, DOI 10.1016/S0048-7333(00)00167-0
   Loorbach D, 2010, FUTURES, V42, P237, DOI 10.1016/j.futures.2009.11.009
   Lynn L. E., 2012, OXFORD HDB GOVERNANC
   Maassen A, 2012, EUR PLAN STUD, V20, P441, DOI 10.1080/09654313.2012.651807
   Magro E., 2015, STRATEGIES SHAPING T
   Magro E, 2014, REV POLICY RES, V31, P367, DOI 10.1111/ropr.12090
   Magro E, 2013, RES POLICY, V42, P1647, DOI 10.1016/j.respol.2013.06.005
   Marinelli E., 2017, S3 WORKING PAPER SER
   Marques P., 2018, NEW AVENUES REGIONAL
   Martin BR, 2016, IND INNOV, V23, P157, DOI 10.1080/13662716.2016.1146125
   Matti C, 2017, ENVIRON PLAN C-POLIT, V35, P661, DOI 10.1177/0263774X16663933
   Mccann P, 2015, REG STUD, V49, P1291, DOI 10.1080/00343404.2013.799769
   McCann P, 2016, EUR PLAN STUD, V24, P1407, DOI 10.1080/09654313.2016.1166177
   McCann P, 2014, EUR J INNOV MANAG, V17, P409, DOI 10.1108/EJIM-05-2014-0052
   Morgan K., 2013, BASQUE COUNTRY RIS3
   Morgan K, 2017, ENVIRON PLAN C-POLIT, V35, P569, DOI 10.1177/0263774X16645106
   OECD, 2011, OECD REV REG INN BAS
   Patton MQ, 2012, EVALUATION-US, V18, P364, DOI 10.1177/1356389012449523
   Pawson R., 1997, REALISTIC EVALUATION
   Peters B.G., 2009, STUDYING EUROPEAN UN
   Pierre Jon, 2000, GOVERNANCE POLITICS
   Radosevic S., 2017, ADV THEORY PRACTICE
   Reid A., 2017, ADV THEORY PRACTICE
   Risse T., 2012, SFB GOVERNANCE WORKI, V32
   Rodriguez-Pose A., 2017, GOVERNING SMART SPEC
   Rodrik D., 2004, RWP04047 HARV U KENN
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Shove E, 2010, RES POLICY, V39, P471, DOI 10.1016/j.respol.2010.01.019
   Stame N., 2004, EVALUATION, V10, P58, DOI DOI 10.1177/1356389004043135
   Streek W., 2005, CONTINUITY I CHANGE
   Todtling F, 2005, RES POLICY, V34, P1203, DOI 10.1016/j.respol.2005.01.018
   Truffer B., 2016, GEOGRAPHY SUSTAINABI
   Uyarra E, 2017, ENVIRON PLAN C-POLIT, V35, P828, DOI 10.1177/2399654417694620
   Uyarra E, 2010, ENVIRON PLANN C, V28, P681, DOI 10.1068/c0961
   Walendoski J., 2011, 2010 ANN REPORT
NR 75
TC 6
Z9 6
U1 20
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103612
DI 10.1016/j.respol.2018.06.010
PG 10
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200008
DA 2020-05-12
ER

PT J
AU Mavrot, C
   Hadorn, S
   Sager, F
AF Mavrot, Celine
   Hadorn, Susanne
   Sager, Fritz
TI Mapping the mix: Linking instruments, settings and target groups in the
   study of policy mixes
SO RESEARCH POLICY
LA English
DT Article
DE Policy mix; Policy Instrument; Setting; Target group; Behavioural
   change; Sustainability transition
ID SUSTAINABILITY TRANSITIONS; HEALTH; CHALLENGES; PREVENTION; MANAGEMENT;
   GOVERNMENT; SYSTEM
AB This article proposes the extension of a conceptual framework aimed at analysing policy mixes and their outcomes and demonstrates its value added for the study of sustainability transitions. The argument is that policy mixes research should not focus only on the form of policy instruments, but also on their implementation context. Policy mix form designates the specific policy instruments that are involved according to a policy strategy. Policy mix context includes the specific setting where each policy measure is implemented, such as enterprise or family. It also includes the specific target group of each measure, such as youth or smokers. We apply this conceptual framework to the policy concept and implementation of tobacco control policies in Switzerland, which are an exemplary case for analysing transitions as they are geared towards behavioural change. In a mixed method approach, we triangulate different sets of quantitative and qualitative indicators in order to assess the implementation of eleven subnational policy mixes. Our findings show that taking into account the moderating role of settings between policy instruments and target groups allows for a more in depth analysis of policy processes. Observing the interactions between the four elements policy instruments, policy strategy, the implementation settings and the target groups allows capturing the complexity of policy mixes, at the crossroads of policy design, policy implementation and policy outcomes. Taking implementation settings and target groups into account in the analysis of policy mixes allows for a refined understanding of policy compliance and thus, from a broader perspective, of sustainability transitions.
C1 [Mavrot, Celine; Hadorn, Susanne; Sager, Fritz] Univ Bern, KPM Ctr Publ Management, Schanzeneckstr 1, CH-3001 Bern, Switzerland.
RP Mavrot, C (reprint author), Univ Bern, KPM Ctr Publ Management, Schanzeneckstr 1, CH-3001 Bern, Switzerland.
EM celine.mavrot@kpm.unibe.ch; susanne.hadom@kpm.unibe.ch;
   fritz.sager@kpm.unibe.ch
RI Mavrot, Celine/K-7546-2015
OI Mavrot, Celine/0000-0001-9603-5790; Sager, Fritz/0000-0001-5099-6676
FU Tobacco Control Fund of the Swiss Federal Office of Public Health
FX This research received funding from the Tobacco Control Fund of the
   Swiss Federal Office of Public Health D (public agency).
CR BABOR T, 2003, ALCOHOL NO ORDINARY
   Befani B., 2007, EVALUATION, V13, P171, DOI DOI 10.1177/1356389007075222
   Bemelmans-Videc Marie-Louise, 1998, CARROTS STICKS SERMO
   Borras S, 2013, TECHNOL FORECAST SOC, V80, P1513, DOI 10.1016/j.techfore.2013.03.002
   Burke MJ, 2017, ENERGY RES SOC SCI, V33, P35, DOI 10.1016/j.erss.2017.09.024
   Bussmann W., 1997, EINFUHRUNG POLITIKEV
   Chung CC, 2013, RES POLICY, V42, P1053, DOI 10.1016/j.respol.2013.01.007
   de Andrade M, 2016, HEXAG SER HUM ENVIRO, V10, P705, DOI 10.1007/978-3-319-43884-9_33
   Dooris M, 2006, HEALTH PROMOT INT, V21, P55, DOI 10.1093/heapro/dai030
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Foray D, 2012, RES POLICY, V41, P1697, DOI 10.1016/j.respol.2012.07.011
   Greenhalgh T, 2009, MILBANK Q, V87, P391, DOI 10.1111/j.1468-0009.2009.00562.x
   Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10
   Hall Peter A, 1988, COMP POLIT, V25, P275
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   Janssen M, 2013, TECHNOL FORECAST SOC, V80, P1360, DOI 10.1016/j.techfore.2012.12.003
   Kemm J, 2001, HEALTH PROMOT INT, V16, P79, DOI 10.1093/heapro/16.1.79
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kickbusch Ilona, 2012, GOVERNANCE HLTH 21 C
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Kivimaa P, 2014, RES POLICY, V43, P1370, DOI 10.1016/j.respol.2014.02.007
   Kivisaari S., 2004, SYSTEM INNOVATION TR, P223
   Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185
   Ledermann S, 2009, Z EVAL, V8, P7
   Levesque L, 2005, HEALTH PROMOT PRACT, V6, P64, DOI 10.1177/1524839903260156
   Loorbach D, 2010, FUTURES, V42, P237, DOI 10.1016/j.futures.2009.11.009
   Mavrot C, 2018, POLICY POLIT, V46, P391, DOI 10.1332/030557316X14788733118252
   McGuire M, 2006, PUBLIC ADMIN REV, V66, P33, DOI 10.1111/j.1540-6210.2006.00664.x
   McMeekin A, 2012, TECHNOL ANAL STRATEG, V24, P345, DOI 10.1080/09537325.2012.663960
   Merkur S., 2013, PROMOTING HLTH PREVE, V6
   Moser L, 2015, SWISS POLIT SCI REV, V21, P437, DOI 10.1111/spsr.12168
   Mullen PD, 1995, HEALTH EDUC QUART, V22, P329, DOI 10.1177/109019819402200306
   Pawson R., 1997, REALISTIC EVALUATION
   Peters D, 2016, HEALTH PROMOT INT, V31, P290, DOI 10.1093/heapro/dau104
   Provan KG, 2008, J PUBL ADM RES THEOR, V18, P229, DOI 10.1093/jopart/mum015
   Ravindran T K S, 2008, Glob Public Health, V3 Suppl 1, P121, DOI 10.1080/17441690801900761
   Reichardt K, 2016, ENVIRON INNOV SOC TR, V18, P62, DOI 10.1016/j.eist.2015.08.001
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rosenow J, 2017, ENERGY RES SOC SCI, V33, P95, DOI 10.1016/j.erss.2017.09.013
   Sager F, 2017, POLICY ANAL SCHWEIZ
   Sager F., 2015, EUROPEAN POLICY ANAL, V1, P90
   Sager F, 2017, J PUBLIC POLICY, V37, P287, DOI 10.1017/S0143814X1600009X
   Sager F, 2012, AM J EVAL, V33, P60, DOI 10.1177/1098214011411574
   Shove E, 2010, ENVIRON PLANN A, V42, P1273, DOI 10.1068/a42282
   Shove E, 2010, RES POLICY, V39, P471, DOI 10.1016/j.respol.2010.01.019
   Smith A, 2010, RES POLICY, V39, P435, DOI 10.1016/j.respol.2010.01.023
   Weber M., 1980, WIRTSCHAFT GESELLSCH
   Wong G, 2012, MED EDUC, V46, P89, DOI 10.1111/j.1365-2923.2011.04045.x
NR 49
TC 2
Z9 2
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103614
DI 10.1016/j.respol.2018.06.012
PG 9
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200005
DA 2020-05-12
ER

PT J
AU Ossenbrink, J
   Finnsson, S
   Bening, CR
   Hoffmann, VH
AF Ossenbrink, Jan
   Finnsson, Sveinbjoern
   Bening, Catharina R.
   Hoffmann, Volker H.
TI Delineating policy mixes: Contrasting top-down and bottom-up approaches
   to the case of energy-storage policy in California
SO RESEARCH POLICY
LA English
DT Article
DE Policy mix; Sustainability transitions; Technological change;
   Innovation; Actor networks
ID RENEWABLE ENERGY; TECHNOLOGIES; TRANSITIONS; PERFORMANCE; SIMULATION;
   DEPLOYMENT; SYSTEMS; DESIGN; SECTOR; WIND
AB In the light of pressing societal challenges such as climate change and resource scarcity, scholars are increasingly interested in studying policy mixes in the context of sustainability transitions. However, despite numerous conceptual advances and empirical insights, researchers still lack universal criteria or accepted heuristics for delineating policy mixes in these complex policy spaces. We address this gap by conducting an extensive review of the literature, synthesizing best practices, and developing an analytical framework that provides researchers with two archetypical methodological approaches. The top-down approach builds on the idea that the elements of a policy mix originate from an overarching strategic intent. By contrast, the bottom-up approach starts from the definition of a focal impact domain that is affected by a range of policy instruments. For each approach, we outline a systematic analytical procedure, then implement it to scrutinize how policy affects the emerging technological domain of energy storage in California. We find that each approach has particular advantages that render it useful for certain policy mix analyses. Discussing how researchers may choose between the two approaches or leverage their complementarities, we seek to provide the basis for a consistent research program building on the policy mix framework.
C1 [Ossenbrink, Jan; Finnsson, Sveinbjoern; Bening, Catharina R.; Hoffmann, Volker H.] Swiss Fed Inst Technol, Dept Management Technol & Econ, Weinbergstr 56-58, CH-8092 Zurich, Switzerland.
   [Ossenbrink, Jan] Stanford Univ, Stanford Grad Sch Business, 655 Knight Way, Stanford, CA 94305 USA.
RP Ossenbrink, J (reprint author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Weinbergstr 56-58, CH-8092 Zurich, Switzerland.
EM jan.ossenbrink@gmail.com
FU Swiss Commission for Technology and Innovation (CTI) [KTI.1155000154]
FX The authors would like to thank the attendees of the Bits & Watts
   seminar at Stanford University in August 2016, and the participants of
   the Policy Mixes for Sustainability Transitions workshop organized by
   the Science Policy Research Unit (SPRU) at University of Sussex in
   February 2017, as well as Stephen D. Cornello Diane Grueneich, and
   Stefan J. Reichelstein for their valuable inputs, and three anonymous
   reviewers for their constructive feedback. All errors remain our own.
   This research is part of the activities of SCCER CREST (Swiss Competence
   Center for Energy Research), which is financially supported by the Swiss
   Commission for Technology and Innovation (CTI) under Grant No.
   KTI.1155000154.
CR AEE, 2016, POW
   ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208
   Blunden J., 2015, CASE LONG DURATION S
   BMWi, 2016, OV LEG GOV GERM EN S
   CAISO/CPUC/CEC, 2014, ADV MAX VAL EN STOR
   CAISO/CPUC/CEC, 2014, REL CPUC CEC CAISO P
   Carl J., 2012, RENEWABLE DISTRIBUTE
   CSE SCE PG&E SDG&E SoCalGas, 2016, 2016 SELF GEN INC PR
   Darghouth NR, 2011, ENERG POLICY, V39, P5243, DOI 10.1016/j.enpol.2011.05.040
   Del Rio P., 2013, ANN REV POLICY DESIG, P1
   Del Rio P., 2016, TECHNOECONOMIC ANAL
   EC/OECD, 2016, SCI TECHN INN POL DA
   EDQUIST C, 1997, SYSTEMS INNOVATION T
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   Fitzgerald G., 2015, EC BATTERY ENERGY ST
   Flanagan K, 2016, IND INNOV, V23, P177, DOI 10.1080/13662716.2016.1146126
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Flick U., 2009, INTRO QUALITATIVE RE
   Fouquet R., 2008, HEAT POWER LIGHT REV
   Fuhrs M., 2015, PV MAGAZINE, P82
   Gallagher KS, 2012, ANNU REV ENV RESOUR, V37, P137, DOI 10.1146/annurev-environ-060311-133915
   Gallagher KS, 2011, WIRES CLIM CHANGE, V2, P373, DOI 10.1002/wcc.112
   Grumm J.J., 1975, POLICIES POLICY MAKI, P439
   Hoppmann J, 2014, RENEW SUST ENERG REV, V39, P1101, DOI 10.1016/j.rser.2014.07.068
   Hosseus D, 1997, CAN PUBLIC POL, V23, P399, DOI 10.2307/3552071
   Howlett M., 2006, REV POLICY RES, V23
   Howlett M, 2009, J COMP POLICY ANAL, V11, P33, DOI 10.1080/13876980802648144
   Huang P., 2018, RES POLICY
   Huenteler J, 2016, RES POLICY, V45, P1195, DOI 10.1016/j.respol.2016.03.014
   Huenteler J, 2016, TECHNOL FORECAST SOC, V104, P102, DOI 10.1016/j.techfore.2015.09.022
   IEA, 2012, POL MEAS DAT
   IEA/IRENA, 2017, IEA IRENA JOINT GLOB
   IPCC, 2014, CLIMATE CHANGE 2014
   Kergroach S., 2017, OECD SCI TECHNOLOGY
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kiss B., 2012, GLOBAL ENERGY ASSESS, DOI [10.1017/CB09781139150880.013, DOI 10.1017/CB09781139150880.013]
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Hood C, 2014, ENERGY SECTOR TRANFO
   Luthander R, 2015, APPL ENERG, V142, P80, DOI 10.1016/j.apenergy.2014.12.028
   Malhotra A, 2016, RENEW SUST ENERG REV, V56, P705, DOI 10.1016/j.rser.2015.11.085
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Markard J, 2011, J INFRASTRUCT SYST, V17, P107, DOI 10.1061/(ASCE)IS.1943-555X.0000056
   Mowery DC, 2010, RES POLICY, V39, P1011, DOI 10.1016/j.respol.2010.05.008
   Murphy L, 2012, ENERG POLICY, V45, P459, DOI 10.1016/j.enpol.2012.02.056
   Nalwelaers C., 2009, POLICY MIXES R D EUR
   Negro SO, 2012, RENEW SUST ENERG REV, V16, P3836, DOI 10.1016/j.rser.2012.03.043
   Nill J, 2009, RES POLICY, V38, P668, DOI 10.1016/j.respol.2009.01.011
   Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564
   OECD, 2015, AL POL LOW CARB EC A, DOI [10.1787/9789264233294-en, DOI 10.1787/9789264233294-EN]
   Osscribrink J., 2017, THESIS
   Ossenbrink J, 2017, ENERG POLICY, V108, P239, DOI 10.1016/j.enpol.2017.05.030
   Proudlove A., 2016, 50 STATES SOLAR Q2 2
   Purtado A.T., 2018, RES POLICY
   Quilzow R, 2015, RES POLICY, V44, P233, DOI [10.1016/j.respol.2014.09.003, DOI 10.1016/J.RESPOL.2014.09.003]
   Reichardt K, 2016, TECHNOL FORECAST SOC, V106, P11, DOI 10.1016/j.techfore.2016.01.029
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rose R., 1988, COMP PLURALIST DEMOC, P219
   Schmidt TS, 2019, RES POLICY, V48, DOI 10.1016/j.respol.2018.03.012
   Schmidt TS, 2016, RES POLICY, V45, P1965, DOI 10.1016/j.respol.2016.07.001
   Shmidt Y., 2012, RENEWABLE JUNGLE GUI
   Shove E, 2007, ENVIRON PLANN A, V39, P763, DOI 10.1068/a39310
   Sivaraman D, 2012, ENERG POLICY, V49, P274, DOI 10.1016/j.enpol.2012.06.019
   Sorrell S., 2003, INTERACTION EU CLIMA
   Sovacool BK, 2009, ENERG POLICY, V37, P1529, DOI 10.1016/j.enpol.2008.12.016
   Trencher G., 2018, RES POLICY
   Unruh GC, 2000, ENERG POLICY, V28, P817, DOI 10.1016/S0301-4215(00)00070-7
   Vedung F., 1998, CARROTS STICKS SERMO
   von Appen J, 2015, 2015 INTERNATIONAL SYMPOSIUM ON SMART ELECTRIC DISTRIBUTION SYSTEMS AND TECHNOLOGIES (EDST), P612, DOI 10.1109/SEDST.2015.7315280
   Weimer D.L., 2017, POLICY ANAL CONCEPTS
   Yin R., 2009, CASE STUDY RES DESIG
NR 70
TC 5
Z9 5
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103582
DI 10.1016/j.respol.2018.04.014
PG 25
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200002
DA 2020-05-12
ER

PT J
AU Schmidt, TS
   Sewerin, S
AF Schmidt, Tobias S.
   Sewerin, Sebastian
TI Measuring the temporal dynamics of policy mixes - An empirical analysis
   of renewable energy policy mixes' balance and design features in nine
   countries
SO RESEARCH POLICY
LA English
DT Article
DE Policy mix; Policy design; Energy policy; Index of policy activity
   (IPA); Policy output measurement; Technological change
ID DEPLOYMENT POLICIES; EUROPEAN-UNION; TECHNOLOGICAL-INNOVATION; CLIMATE
   POLICY; SUSTAINABILITY; TRANSITIONS; SUPPORT; MARKET; INSTRUMENTS;
   EFFICIENCY
AB Complex societal or environmental problems require fast and substantial socio-technical transitions. For instance, in the case of climate change, these transitions need to take place in the energy, transport and several industry sectors. To induce and accelerate such transitions, numerous policy interventions are required, which interact with each other in policy mixes. While several conceptual studies on policy mixes have been published recently, there is very little empirical research apart from single case or small-n studies. It has been prominently argued that the debate about policy mixes has reached an impasse partly due to this lack of empirical work. This paper addresses this gap by providing a first analysis of the temporal dynamics of complex policy mixes. To do so, we develop a conceptualization and measurement of policy mix balance across instrument types as well as policy mix design features (in the form of intensity as a general and technology specificity as a technology-focused design feature). This allows us to answer the question how temporal dynamics of policy mixes differ between countries regarding their balance and design features. Our measurement approach is developed bottom-up, i.e., policies are assessed individually and then aggregated systematically at the policy mix level. This enables overcoming the 'dependent variable problem in the study of policy change', i.e., the problem of measuring policy output. More specifically, we develop a comparative dataset of 522 renewable energy policies in nine OECD countries. Our analysis shows that countries' policy mix dynamics vary strongly regarding some variables (e.g., technology specificity) but less regarding others (e.g., balance). As a validity check, we also test the effects of these mix dynamics on policy outcome in the form of renewable energy technology diffusion. We reflect our findings in light of the theoretical debates around policy mixes and policy design and discuss how our results provoke an agenda for the new generation of research on policy mixes. We specifically discuss avenues for future research with a particular focus on the 'politics of policy mixes'.
C1 [Schmidt, Tobias S.; Sewerin, Sebastian] Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Energy Polit Grp, Haldeneggsteig 4, CH-8092 Zurich, Switzerland.
RP Schmidt, TS (reprint author), Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Energy Polit Grp, Haldeneggsteig 4, CH-8092 Zurich, Switzerland.
EM tobiasschmidt@ethz.ch
OI Schmidt, Tobias/0000-0002-7971-2187; Sewerin,
   Sebastian/0000-0002-0349-948X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PYAPP1_166905]
FX We gratefully acknowledge the financial support by the Swiss National
   Science Foundation (Project number PYAPP1_166905). Earlier versions of
   this paper were presented at the SPRU 50 conference 2016, the
   Environmental Politics and Governance Conference 2016, the International
   Sustainability Transitions Conference 2017, and the International
   Conference on Public Policy 2017. We thank the participants for their
   feedback. We also want to acknowledge the research support by Blair
   Bateson and Geraldine Sznek Alvarez.
CR Al-Mansour F, 2010, BIOMASS BIOENERG, V34, P620, DOI 10.1016/j.biombioe.2010.01.004
   Albadi MH, 2010, ELECTR POW SYST RES, V80, P627, DOI 10.1016/j.epsr.2009.10.035
   Ashford N.A., 1993, ENV STRATEGIES IND I, P277
   ASHFORD NA, 1985, HARVARD ENVIRON LAW, V9, P419
   Azar C, 2011, ENVIRON INNOV SOC TR, V1, P135, DOI 10.1016/j.eist.2011.03.003
   Bauer M.W., 2012, DISMANTLING PUBLIC P, P30
   Bauer MW, 2014, J COMP POLICY ANAL, V16, P28, DOI 10.1080/13876988.2014.885186
   Beland D, 2007, SOC SCI QUART, V88, P20, DOI 10.1111/j.1540-6237.2007.00444.x
   Beland D, 2016, GOVERNANCE, V29, P393, DOI 10.1111/gove.12179
   Bergek A, 2008, RES POLICY, V37, P407, DOI 10.1016/j.respol.2007.12.003
   Borras S, 2013, TECHNOL FORECAST SOC, V80, P1513, DOI 10.1016/j.techfore.2013.03.002
   Burer MJ, 2009, ENERG POLICY, V37, P4997, DOI 10.1016/j.enpol.2009.06.071
   Carley S, 2012, POLICY STUD J, V40, P730, DOI 10.1111/j.1541-0072.2012.00471.x
   Daugbjerg C, 2016, GOVERNANCE, V29, P265, DOI 10.1111/gove.12171
   Gonzalez PD, 2008, ECOL ECON, V65, P292, DOI 10.1016/j.ecolecon.2007.06.013
   del Rio P, 2017, RENEW SUST ENERG REV, V74, P824, DOI 10.1016/j.rser.2017.01.122
   Del Rio P, 2009, CLIM POLICY, V9, P119, DOI 10.3763/cpol.2007.0424
   Edenhofer O., 2011, IPCC SPECIAL REPORT
   Farla J, 2012, TECHNOL FORECAST SOC, V79, P991, DOI 10.1016/j.techfore.2012.02.001
   Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1
   Fischer C., 2010, COMBINING POLICIES R, P10
   Flanagan K, 2011, RES POLICY, V40, P702, DOI 10.1016/j.respol.2011.02.005
   Gawel E, 2017, ENERG POLICY, V102, P16, DOI 10.1016/j.enpol.2016.12.007
   Geels FW, 2002, RES POLICY, V31, P1257, DOI 10.1016/S0048-7333(02)00062-8
   Gerring J., 2007, CASE STUDY RES PRINC
   Gillingham K, 2010, HARNESSING RENEWABLE ENERGY IN ELECTRIC POWER SYSTEMS: THEORY, PRACTICE, POLICY, P69
   Gravey V, 2016, J EUR PUBLIC POLICY, V23, P1180, DOI 10.1080/13501763.2016.1186208
   Hacker JS, 2004, BRIT J POLIT SCI, V34, P693, DOI 10.1017/S0007123404000250
   HALL PA, 1993, COMP POLIT, V25, P275, DOI 10.2307/422246
   Heffron RJ, 2015, ENERG POLICY, V87, P168, DOI 10.1016/j.enpol.2015.08.033
   Hekkert MP, 2009, TECHNOL FORECAST SOC, V76, P584, DOI 10.1016/j.techfore.2008.04.013
   HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352
   Holzinger K, 2011, ENVIRON POLIT, V20, P20, DOI 10.1080/09644016.2011.538163
   Hoppmann J, 2013, RES POLICY, V42, P989, DOI 10.1016/j.respol.2013.01.002
   Howlett M., 2007, POLICY SOC, V26, P1, DOI DOI 10.1016/S1449-4035(07)70118-2
   Howlett M, 2018, POLICY POLIT, V46, P101, DOI 10.1332/030557317X15053060139376
   Howlett M, 2015, ENVIRON PLANN C, V33, P1233, DOI 10.1177/0263774X15610059
   Howlett M, 2013, POLITICS GOV, V1, P170, DOI 10.17645/pag.v1i2.95
   Howlett M, 2014, POLICY SCI, V47, P187, DOI 10.1007/s11077-014-9199-0
   Howlett M, 2009, J COMP POLICY ANAL, V11, P33, DOI 10.1080/13876980802648144
   Jaffe AB, 2005, ECOL ECON, V54, P164, DOI 10.1016/j.ecolecon.2004.12.027
   Jenner S, 2013, ENERG POLICY, V52, P385, DOI 10.1016/j.enpol.2012.09.046
   Johnstone N, 2005, SUSTAIN INNOV, P21, DOI 10.1007/3-7908-1620-5_2
   Kemp R, 2011, ECOL ECON, V72, P28, DOI 10.1016/j.ecolecon.2011.09.014
   Kern F, 2017, ENERGY RES SOC SCI, V23, P11, DOI 10.1016/j.erss.2016.11.002
   Kern F, 2009, POLICY SCI, V42, P391, DOI 10.1007/s11077-009-9099-x
   Kivimaa P, 2016, RES POLICY, V45, P205, DOI 10.1016/j.respol.2015.09.008
   Knill C, 2012, REGUL GOV, V6, P427, DOI 10.1111/j.1748-5991.2012.01150.x
   Lascoumes P, 2007, GOVERNANCE, V20, P1, DOI 10.1111/j.1468-0491.2007.00342.x
   Lehmann P., 2016, UFZ DISCUSSION PAPER
   Levin K, 2012, POLICY SCI, V45, P123, DOI 10.1007/s11077-012-9151-0
   Lewis JI, 2014, BUS POLIT, V16, P511, DOI 10.1515/bap-2014-0012
   Lijphart A., 2012, PATTERNS DEMOCRACY G
   Malhotra A, 2017, ENERG POLICY, V108, P657, DOI 10.1016/j.enpol.2017.06.037
   Markard J, 2012, RES POLICY, V41, P955, DOI 10.1016/j.respol.2012.02.013
   Norberg-Bohm V, 1999, POLICY SCI, V32, P13, DOI 10.1023/A:1004384913598
   Parris TM, 2003, P NATL ACAD SCI USA, V100, P8068, DOI 10.1073/pnas.1231336100
   Patashnik E, 2003, GOVERNANCE, V16, P203, DOI 10.1111/1468-0491.00214
   Polzin F, 2015, ENERG POLICY, V80, P98, DOI 10.1016/j.enpol.2015.01.026
   Popp D, 2011, ENERG ECON, V33, P648, DOI 10.1016/j.eneco.2010.08.007
   Rogge KS, 2016, RES POLICY, V45, P132, DOI 10.1016/j.respol.2016.04.004
   Rogge KS, 2011, ECOL ECON, V70, P513, DOI 10.1016/j.ecolecon.2010.09.032
   Rohlfing, 2012, RES METHODS SER, P176
   Sanden BA, 2005, ENERG POLICY, V33, P1557, DOI 10.1016/j.enpol.2004.01.012
   Schaffrin A, 2015, POLICY STUD J, V43, P257, DOI 10.1111/psj.12095
   Schaffrin A, 2014, ENVIRON POLIT, V23, P860, DOI 10.1080/09644016.2014.924206
   Schmidt TS, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.84
   Schmidt TS, 2016, RES POLICY, V45, P1965, DOI 10.1016/j.respol.2016.07.001
   Schmidt TS, 2016, GLOBAL ENVIRON CHANG, V38, P8, DOI 10.1016/j.gloenvcha.2016.02.005
   Schmidt TS, 2014, NAT CLIM CHANGE, V4, P237, DOI 10.1038/nclimate2112
   Schmidt TS, 2012, ENVIRON INNOV SOC TR, V2, P23, DOI 10.1016/j.eist.2011.12.002
   Schmidt TS, 2012, ENERG POLICY, V43, P466, DOI 10.1016/j.enpol.2012.01.041
   Seawright J, 2008, POLIT RES QUART, V61, P294, DOI 10.1177/1065912907313077
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Smith A, 2012, RES POLICY, V41, P1025, DOI 10.1016/j.respol.2011.12.012
   THELEN K, 2003, COMP HIST ANAL SOCIA, P208, DOI DOI 10.1017/CBO9780511803963
   Tinbergen Jan, 1952, THEORY EC POLICY
   van Benthem A, 2008, ENERG J, V29, P131
   van der Heijden J, 2011, POLITICS-OXFORD, V31, P9, DOI 10.1111/j.1467-9256.2010.01397.x
   van der Zwaan BCC, 2002, ENERG ECON, V24, P1, DOI 10.1016/S0140-9883(01)00073-1
   Vogt-Schilb A, 2014, ENERG POLICY, V66, P645, DOI 10.1016/j.enpol.2013.11.045
   Waissbein O., 2013, DERISKING RENEWABLE
   Yin HT, 2010, ENERG POLICY, V38, P1140, DOI 10.1016/j.enpol.2009.10.067
NR 83
TC 18
Z9 18
U1 13
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-7333
EI 1873-7625
J9 RES POLICY
JI Res. Policy
PD DEC 10
PY 2019
VL 48
IS 10
SI SI
AR UNSP 103557
DI 10.1016/j.respol.2018.03.012
PG 13
WC Management
SC Business & Economics
GA JW5KQ
UT WOS:000503091200003
OA Other Gold, Green Published
HC Y
HP N
DA 2020-05-12
ER

PT J
AU Ashraf, S
   Phirani, J
AF Ashraf, Shabina
   Phirani, Jyoti
TI A generalized model for spontaneous imbibition in a horizontal,
   multi-layered porous medium
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Capillary displacement; Spontaneous imbibition; Multi-layered porous
   medium; Heterogeneous porous medium; Generalized model
ID NUMERICAL-SIMULATION; CAPILLARY IMBIBITION; LIQUID ABSORPTION; OIL;
   RECOVERY; FLOW; DISPLACEMENT; MATRIX; SCALE; TUBES
AB Spontaneous imbibition of a wetting fluid in a homogeneous porous medium follows Washburn's diffusive law. For heterogeneous porous media, the imbibition phenomenon deviates from the diffusive dynamics. A Washburn-like model, developed in the past predicts the imbibition in a three-layered porous medium. In this work, we use experiments to establish the applicability of the model for a horizontal three-layered porous medium. The model is dependent on a scaling law to determine the relative positions of the fronts in the layers. In a multi-layered porous medium, the scaling law cannot predict the relative front advancements. We use a five layered porous medium to develop a strategy and generalize the model for multi-layered porous medium. We show that, the layering pattern, capillary pressure and permeability contrasts among the layers impacts the imbibition behavior significantly and leads to different travel times of the fronts of the invading fluid in the layers. (C) 2019 Published by Elsevier Ltd.
C1 [Ashraf, Shabina; Phirani, Jyoti] Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
RP Phirani, J (reprint author), Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
EM jphirani@chemical.iitd.ac.in
FU Science and Engineering Board (SERB), India [SERB/F/1297/2017-1,
   ECR/2017/000257]
FX The authors acknowledge the financial support granted by Science and
   Engineering Board (SERB), India (Diary No. SERB/F/1297/2017-1, File No.
   ECR/2017/000257).
CR Adkins JA, 2016, ANAL CHEM, V88, P10639, DOI 10.1021/acs.analchem.6b03010
   Ashraf S, 2017, EUR PHYS J E, V40, DOI 10.1140/epje/i2017-11530-8
   Ashraf S, 2019, SOFT MATTER, V15, P2057, DOI 10.1039/c8sm02114g
   Ashraf S, 2018, CHEM ENG SCI, V192, P218, DOI 10.1016/j.ces.2018.07.036
   Babadagli T, 2005, J COLLOID INTERF SCI, V282, P162, DOI 10.1016/j.jcis.2004.08.149
   Bear J, 1972, DYNAMICS FLUIDS PORO
   Beyhaghi S, 2014, AICHE J, V60, P1930, DOI 10.1002/aic.14353
   Bico J, 2003, EUROPHYS LETT, V61, P348, DOI 10.1209/epl/i2003-00196-9
   Breisig H, 2017, CHEM ENG J, V307, P143, DOI 10.1016/j.cej.2016.08.024
   Cate DM, 2015, ANAL CHEM, V87, P19, DOI 10.1021/ac503968p
   Das A, 2009, INDIAN J FIBRE TEXT, V34, P144
   DAVID C, 1993, TRANSPORT POROUS MED, V11, P161, DOI 10.1007/BF01059632
   DAWE RA, 1992, TRANSPORT POROUS MED, V7, P83, DOI 10.1007/BF00617318
   de Laplace P.S., 1806, SUPPLEMENT DIXIEME L
   Dudek M, 2018, CHEM ENG SCI, V191, P448, DOI 10.1016/j.ces.2018.07.006
   Ersland G, 2010, CHEM ENG J, V158, P32, DOI 10.1016/j.cej.2008.11.049
   Fuisz R.C., 1988, US Patent, Patent No. [4,778,459, 4778459]
   Geiger S, 2012, CURR OPIN COLLOID IN, V17, P147, DOI 10.1016/j.cocis.2012.01.003
   Glass RJ, 2001, CURR OPIN COLLOID IN, V6, P223, DOI 10.1016/S1359-0294(01)00086-3
   Gruener S, 2012, P NATL ACAD SCI USA, V109, P10245, DOI 10.1073/pnas.1119352109
   Hahn J.L., 1994, US Patent, Patent No. [5,306,267, 5306267]
   HAMMECKER C, 1994, TRANSPORT POROUS MED, V17, P285, DOI 10.1007/BF00613588
   HAMMECKER C, 1993, TRANSPORT POROUS MED, V12, P125, DOI 10.1007/BF00616976
   Ji XB, 2017, APPL THERM ENG, V117, P782, DOI 10.1016/j.applthermaleng.2017.01.084
   Lamb Jr K.A., 1986, US Patent, Patent No. [4,573,987, 4573987]
   Li KW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14085
   Li YK, 2016, CHEM ENG J, V293, P182, DOI 10.1016/j.cej.2016.02.074
   Liu ZY, 2019, CHEM ENG SCI, V197, P404, DOI 10.1016/j.ces.2019.01.001
   Lucas R, 1918, KOLLOID Z, V23, P15, DOI 10.1007/BF01461107
   Masoodi R, 2007, AICHE J, V53, P2769, DOI 10.1002/aic.11322
   Masoodi R, 2011, AICHE J, V57, P1132, DOI 10.1002/aic.12343
   Morris M.A, 1955, TEXT RES J, V46, P766, DOI DOI 10.1177/004051755502500904
   Morrow NR, 2001, CURR OPIN COLLOID IN, V6, P321, DOI 10.1016/S1359-0294(01)00100-5
   Neading R.R., 2003, US Patent, Patent No. [6,515,194, 6515194]
   Reyssat M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/56002
   Ringrose PS, 1993, J PETROL SCI ENG, V9, P103, DOI 10.1016/0920-4105(93)90071-L
   Schaetzl R. J., 2015, SOILS
   STAUFFER F, 1986, J HYDROL, V84, P9, DOI 10.1016/0022-1694(86)90042-9
   Tavangarrad AH, 2018, TRANSPORT POROUS MED, V122, P203, DOI 10.1007/s11242-018-0999-0
   Trivedi JJ, 2009, CHEM ENG J, V146, P194, DOI 10.1016/j.cej.2008.05.032
   Unsal E, 2007, J COLLOID INTERF SCI, V315, P200, DOI 10.1016/j.jcis.2007.06.070
   Unsal E, 2007, J COLLOID INTERF SCI, V306, P105, DOI 10.1016/j.jcis.2006.10.042
   Walji N, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7050073
   Wang DD, 2015, INT J HEAT MASS TRAN, V89, P33, DOI 10.1016/j.ijheatmasstransfer.2015.05.042
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Xu JY, 2014, INT J HEAT MASS TRAN, V72, P378, DOI 10.1016/j.ijheatmasstransfer.2014.01.016
   Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rst1.1805.0005, DOI 10.1098/RSTL.1805.0005]
   Zarandi MAF, 2018, AICHE J, V64, P294, DOI 10.1002/aic.15965
NR 48
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115175
DI 10.1016/j.ces.2019.115175
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500002
DA 2020-05-12
ER

PT J
AU Attarakih, M
   Bart, HJ
   Abu-Khader, M
AF Attarakih, Menwer
   Bart, Hans-Jorg
   Abu-Khader, Mazen
TI On the solution of the population balance equation: From global to local
   constrained maximum entropy method
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Local maximum entropy; Population balances; Extraction columns;
   Numerical modelling; Orthogonal polynomials
ID ROTATING-DISC CONTACTOR; NUMERICAL-SOLUTION; MASS-TRANSFER; SIZE
   DISTRIBUTION; SIMULATION; COLUMNS; HYDRODYNAMICS; PREDICTION; OPOSPM;
   MODELS
AB We propose continuous approximations to the population balance equation based on maximization of the Shannon entropy subject to the expected properties of the particle size distribution (PSD). This solution is used to close the source term of the PBE with careful sampling of the PSD at prescribed points as roots of the N-th-degree Legendre polynomial. Being a maximum entropy functional, the solution is unique and converges to the exact solution as the number of sampling points increases with accurate calculation of PSD integral properties. The accuracy and efficiency of the method are demonstrated by trying different analytical case studies (particle aggregation, aggregation and growth, and particle breakage) where we show it is not restricted to prespecified particle kinetics and functional forms. As practical case study, we modelled the coupled hydrodynamics and mass transfer in different liquid extraction columns and compared the calculated results with published steady state experimental data. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Attarakih, Menwer; Bart, Hans-Jorg] Tech Univ Kaiserslautern, Fac Mech & Proc Engn, Therm Verfahrenstech TVT, D-67663 Kaiserslautern, Germany.
   [Attarakih, Menwer] Univ Jordan, Chem Engn Dept, Sch Engn, Amman 11942, Jordan.
   [Abu-Khader, Mazen] Al Balqa Appl Univ, Fac Engn Technol, Chem Engn Dept, Amman 11191, Jordan.
RP Attarakih, M (reprint author), Tech Univ Kaiserslautern, Fac Mech & Proc Engn, Therm Verfahrenstech TVT, D-67663 Kaiserslautern, Germany.; Attarakih, M (reprint author), Univ Jordan, Chem Engn Dept, Sch Engn, Amman 11942, Jordan.
EM m.attarakih@ju.edu.jo
RI Attarakih, Menwer/G-2867-2015
OI Attarakih, Menwer/0000-0003-0717-1374
CR Ahrens R, 2018, J COMPUT APPL MATH, V338, P280, DOI 10.1016/j.cam.2018.02.013
   Alzyod S, 2018, COMPUT-AIDED CHEM EN, V43, P451, DOI 10.1016/B978-0-444-64235-6.50081-4
   Alzyod S, 2017, COMPUT-AIDED CHEM EN, V40A, P61, DOI 10.1016/B978-0-444-63965-3.50012-X
   Angelov G, 2012, CHEM ENG RES DES, V90, P877, DOI 10.1016/j.cherd.2011.10.011
   Asadollahzadeh M, 2015, RSC ADV, V5, P95967, DOI 10.1039/c5ra18385e
   Attarakih M. M., 2008, OPEN CHEM ENG J, V2, P10, DOI DOI 10.2174/1874123
   Attarakih M, 2018, COMPUT-AIDED CHEM EN, V43, P427, DOI 10.1016/B978-0-444-64235-6.50077-2
   Attarakih M, 2017, COMPUT-AIDED CHEM EN, V40C, P2053, DOI 10.1016/B978-0-444-63965-3.50344-5
   Attarakih M, 2017, COMPUT-AIDED CHEM EN, V40A, P67, DOI 10.1016/B978-0-444-63965-3.50013-1
   Attarakih M, 2015, COMPUT-AIDED CHEM EN, V37, P203
   Attarakih M, 2015, COMPUT-AIDED CHEM EN, V37, P197
   Attarakih M, 2015, APPL MATH MODEL, V39, P5105, DOI 10.1016/j.apm.2015.04.006
   Attarakih M, 2014, COMPUT-AIDED CHEM EN, V33, P901
   Attarakih M, 2014, CHEM ENG SCI, V108, P123, DOI 10.1016/j.ces.2013.12.031
   Attarakih M, 2013, CHEM ENG SCI, V91, P180, DOI 10.1016/j.ces.2013.01.032
   Attarakih M, 2013, COMPUT CHEM ENG, V48, P1, DOI 10.1016/j.compchemeng.2012.08.001
   Attarakih M, 2012, COMPUT-AIDED CHEM EN, V31, P1216
   Attarakih MM, 2006, CHEM ENG SCI, V61, P113, DOI 10.1016/j.ces.2004.12.055
   Attarakih MM, 2004, CHEM ENG SCI, V59, P2547, DOI 10.1016/j.ces.2004.03.004
   Dreier NA, 2018, INT J NUMER METH FL, V88, P100, DOI 10.1002/fld.4513
   Durr R, 2018, IFAC PAPERSONLINE, V51, P290, DOI 10.1016/j.ifacol.2018.03.050
   Favero JL, 2014, COMPUT CHEM ENG, V60, P41, DOI 10.1016/j.compchemeng.2013.08.006
   Ferreira GGS, 2017, POWDER TECHNOL, V322, P301, DOI 10.1016/j.powtec.2017.09.017
   Foley C, 2009, J MATH BIOL, V58, P285, DOI 10.1007/s00285-008-0165-3
   Gan LP, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814018775897
   Garthe D., 2006, THESIS
   GELBARD F, 1978, J COMPUT PHYS, V28, P357, DOI 10.1016/0021-9991(78)90058-X
   Godfrey J. C., 1994, LIQUID LIQUID EXTRAC
   Greco F, 2016, COMPUT METHOD APPL M, V306, P1, DOI 10.1016/j.cma.2016.03.047
   Grinbaum B, 2006, SOLVENT EXTR ION EXC, V24, P795, DOI 10.1080/07366290600952691
   Guo JB, 2018, STRUCT MULTIDISCIP O, V58, P1187, DOI 10.1007/s00158-018-1961-z
   Ho YK, 2018, CAN J CHEM ENG, V96, P800, DOI 10.1002/cjce.22957
   Jaradat M, 2011, CHEM ENG RES DES, V89, P2752, DOI 10.1016/j.cherd.2011.05.009
   JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620
   Jun-Ichi Y., 2017, J ATMOS SCI, V73, P95
   Kamp J, 2017, REV CHEM ENG, V33, P1, DOI 10.1515/revce-2015-0071
   Kang J., 2018, COMP AIDED CHEM ENG, V44, P559
   KARMESHU, 2003, ENTROPY MEASURES MAX
   Kislik VS, 2012, SOLVENT EXTRACTION: CLASSICAL AND NOVEL APPROACHES, P1
   KLEE AJ, 1956, AICHE J, V2, P444, DOI 10.1002/aic.690020405
   KRONIG R, 1950, APPL SCI RES, V2, P142
   Kumar A, 1999, CHEM ENG RES DES, V77, P372, DOI 10.1205/026387699526359
   Kumar J., 2006, THESIS
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   Liao Y, 2018, INT J NUMER METH FL, V87, P202, DOI 10.1002/fld.4491
   Liao YX, 2010, CHEM ENG SCI, V65, P2851, DOI 10.1016/j.ces.2010.02.020
   Lin FB, 2018, COMMUN NONLINEAR SCI, V59, P255, DOI 10.1016/j.cnsns.2017.11.022
   Lin TL, 2005, ADV POWDER TECHNOL, V16, P231, DOI 10.1163/1568552053750189
   Lobry E, 2013, CHEM ENG J, V233, P24, DOI 10.1016/j.cej.2013.08.020
   Ma CY, 2016, PARTICUOLOGY, V26, P1, DOI 10.1016/j.partic.2015.09.014
   Mahoney AW, 2002, CHEM ENG SCI, V57, P1107, DOI 10.1016/S0009-2509(01)00427-4
   Mantzaris NV, 2001, COMPUT CHEM ENG, V25, P1411, DOI 10.1016/S0098-1354(01)00709-8
   MEAD LR, 1984, J MATH PHYS, V25, P2404, DOI 10.1063/1.526446
   Mickler M, 2014, CAN J CHEM ENG, V92, P307, DOI 10.1002/cjce.21893
   Modes G., 2000, THESIS
   Mohanty S, 1997, CHEM ENG PROCESS, V36, P385, DOI 10.1016/S0255-2701(97)00010-X
   Nissen K, 2016, INT J NUMER METH FL, V82, P35, DOI 10.1002/fld.4205
   Omar HM, 2017, CRYST GROWTH DES, V17, P4028, DOI 10.1021/acs.cgd.7b00645
   Ommi F, 2009, PROCEEDINGS OF THE ASME FLUIDS ENGINEERING DIVISION SUMMER CONFERENCE, VOL 1, PTS A-C, P1009
   Pigou M, 2017, CHEM ENG SCI, V171, P218, DOI 10.1016/j.ces.2017.05.026
   RAMKRISHNA D, 2000, POPULATION BALANCES
   Ramkrishna D, 2014, ANNU REV CHEM BIOMOL, V5, P123, DOI 10.1146/annurev-chembioeng-060713-040241
   Schmidt SA, 2006, CHEM ENG SCI, V61, P246, DOI 10.1016/j.ces.2005.02.075
   Sewerin F, 2018, COMBUST FLAME, V189, P62, DOI 10.1016/j.combustflame.2017.09.045
   Sewerin F, 2017, CHEM ENG SCI, V168, P250, DOI 10.1016/j.ces.2017.01.054
   Singh M, 2016, J COMPUT APPL MATH, V308, P83, DOI 10.1016/j.cam.2016.04.037
   Sobczyk K, 1999, COMPUT METHOD APPL M, V168, P91, DOI 10.1016/S0045-7825(98)00135-2
   Sobrino C, 2015, CHEM ENG J, V262, P628, DOI 10.1016/j.cej.2014.10.014
   Steinmetz J.T., 2007, THESIS
   Strumendo M, 2008, CHEM ENG SCI, V63, P2624, DOI 10.1016/j.ces.2008.02.010
   Szilagyi B, 2016, COMPUT CHEM ENG, V91, P167, DOI 10.1016/j.compchemeng.2016.03.023
   Treybal R. E., 1963, LIQUID EXTRACTION
   Upadhyay RR, 2012, J AEROSOL SCI, V44, P11, DOI 10.1016/j.jaerosci.2011.09.005
   Vie A, 2013, J COMPUT PHYS, V237, P177, DOI 10.1016/j.jcp.2012.11.043
   Vignes A., 1965, GENIE CHIM, V93
   Vikhansky A, 2006, AICHE J, V52, P1441, DOI 10.1002/aic.10735
   Weber M.E., 1978, BUBBLES DROPS PARTIC
   Wesselingh JA, 1999, CHEM ENG RES DES, V77, P89, DOI 10.1205/026387699525954
   Zong Z, 2009, CH CRC APPL MATH NON, P1
NR 79
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115168
DI 10.1016/j.ces.2019.115168
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500029
DA 2020-05-12
ER

PT J
AU Bai, Y
   Moo-Young, M
   Anderson, WA
AF Bai, Yun
   Moo-Young, Murray
   Anderson, William A.
TI Characterization of power input and its impact on mass transfer in a
   rocking disposable bioreactor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Wave bioreactor; Oxygen transfer; Mixing time; Cyclic power input
ID LOOP AIRLIFT BIOREACTOR; SINGLE-USE; ENGINEERING CHARACTERISTICS;
   TRANSFER COEFFICIENT; PROTEIN EXPRESSION; STIRRED BIOREACTOR; WAVE
   BIOREACTOR; OXYGEN-TRANSFER; CELL-DENSITY; MIXING TIME
AB The impact of specific power input on gas-liquid mass transfer and mixing has not been extensively reported for rocking disposable bioreactors. An electrical method was applied for measuring the specific power input into a disposable rocking (Wave) bioreactor at benchtop scales. The peak power input was shown to be suitable for characterizing the impact of operational parameters including rocking frequency, rocking angle and liquid volume. The average power inputs ranged from 66.5 W/m(3) to 680.1 W/m(3) which were comparable to those for stirred tank and orbitally-shaken disposable bioreactors. The gas-liquid oxygen mass transfer coefficient was shown to correlate with the peak power input in a power law model, confirming that the mass transfer capacity rapidly increased with power input, especially at 600 W/m(3) and greater. The correlation between mixing time and power input indicated that power input at higher than 400 W/m(3) was sufficient to induce relatively rapid mixing. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bai, Yun; Moo-Young, Murray; Anderson, William A.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
RP Anderson, WA (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM wanderson@uwaterloo.ca
RI Anderson, William A./L-8599-2019
OI Anderson, William A./0000-0003-3580-8635
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada; GE Healthcare
   Canada
FX This work was supported by the Natural Sciences and Engineering Research
   Council of Canada. The donation of the rocking bioreactor and bags by GE
   Healthcare Canada is greatly appreciated.
CR Ascanio G, 2004, CHEM ENG RES DES, V82, P1282, DOI 10.1205/cerd.82.9.1282.44164
   Bai Y, 2019, BIOTECHNOL BIOENG, V116, P1986, DOI 10.1002/bit.27000
   BANDYOPA.B, 1967, BIOTECHNOL BIOENG, V9, P533, DOI 10.1002/bit.260090408
   Buchs J, 2001, BIOCHEM ENG J, V7, P135, DOI 10.1016/S1369-703X(00)00113-3
   Chisti Y, 2002, BIOCHEM ENG J, V10, P143, DOI 10.1016/S1369-703X(01)00174-7
   Cires S, 2015, BIOTECHNOL BIOENG, V112, P621, DOI 10.1002/bit.25455
   Clincke MF, 2013, BIOTECHNOL PROGR, V29, P754, DOI 10.1002/btpr.1704
   Clincke MF, 2013, BIOTECHNOL PROGR, V29, P768, DOI 10.1002/btpr.1703
   Dorival-Garcia N, 2017, J CHROMATOGR A, V1513, P69, DOI 10.1016/j.chroma.2017.06.066
   Dreher T, 2013, CHEM-ING-TECH, V85, P162, DOI 10.1002/cite.201200122
   Dustdar S, 2013, 2013 2ND INTERNATIONAL WORKSHOP ON GREEN AND SUSTAINABLE SOFTWARE (GREENS), P1, DOI 10.1109/GREENS.2013.6606415
   Eibl D., 2009, P55, DOI 10.1007/978-3-540-68182-3_3
   Eibl R., 2008, PLAN TISSUE CULTURE, P203, DOI [10.1007/978-1-4020-3694-1_12, DOI 10.1007/978-1-4020-3694-1_12]
   Eibl R, 2010, APPL MICROBIOL BIOT, V86, P41, DOI 10.1007/s00253-009-2422-9
   Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006
   Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023
   Ghasemi A, 2019, BIOCHEM ENG J, V143, P121, DOI 10.1016/j.bej.2018.12.011
   Gottschalk U, 2012, NAT BIOTECHNOL, V30, P489, DOI 10.1038/nbt.2263
   Hadjiev D, 2006, BIOCHEM ENG J, V27, P323, DOI 10.1016/j.bej.2005.08.009
   Hammond M, 2014, BIOTECHNOL PROGR, V30, P332, DOI 10.1002/btpr.1869
   Hammond Matthew, 2013, PDA J Pharm Sci Technol, V67, P123, DOI 10.5731/pdajpst.2013.00905
   Jones SMJ, 2017, ALGAL RES, V24, P317, DOI 10.1016/j.algal.2017.03.001
   Junne S, 2013, CHEM-ING-TECH, V85, P57, DOI 10.1002/cite.201200149
   Kaiser SC, 2017, ENG LIFE SCI, V17, P500, DOI 10.1002/elsc.201600096
   Kaiser SC, 2011, ENG LIFE SCI, V11, P359, DOI 10.1002/elsc.201000171
   Kalmbach A, 2011, BIOTECHNOL PROGR, V27, P402, DOI 10.1002/btpr.516
   KAWASE Y, 1989, J CHEM TECHNOL BIOT, V44, P63
   Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448
   Kim JC, 2013, BIOTECHNOL BIOPROC E, V18, P801, DOI 10.1007/s12257-012-0558-4
   Klockner W, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-28
   Klockner W, 2012, BIOCHEM ENG J, V65, P63, DOI 10.1016/j.bej.2012.04.007
   Langer ES, 2014, ENG LIFE SCI, V14, P238, DOI 10.1002/elsc.201300090
   Lehmann N, 2013, CHEM-ING-TECH, V85, P197, DOI 10.1002/cite.201200137
   Li GL, 2018, CHEM ENG SCI, V192, P665, DOI 10.1016/j.ces.2018.08.025
   Loffelholz C, 2014, ADV BIOCHEM ENG BIOT, V138, P1, DOI 10.1007/10_2013_187
   Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004
   Lopes AG, 2015, FOOD BIOPROD PROCESS, V93, P98, DOI 10.1016/j.fbp.2013.12.002
   Mahajan E, 2010, BIOTECHNOL PROGR, V26, P1200, DOI 10.1002/btpr.414
   Marsh DTJ, 2017, AICHE J, V63, P4177, DOI 10.1002/aic.15734
   Mikola M, 2007, BIOPROC BIOSYST ENG, V30, P231, DOI 10.1007/s00449-007-0119-y
   Nikakhtari H, 2005, BIOCHEM ENG J, V27, P138, DOI 10.1016/j.bej.2005.08.014
   Nikakhtari H, 2005, IND ENG CHEM RES, V44, P1067, DOI 10.1021/ie0494925
   Oncul AA, 2010, BIOTECHNOL PROGR, V26, P101, DOI 10.1002/btpr.312
   Ozbek B, 2001, PROCESS BIOCHEM, V36, P729, DOI 10.1016/S0032-9592(00)00272-7
   Pilarek M, 2018, CHEM ENG RES DES, V136, P1, DOI 10.1016/j.cherd.2018.04.012
   Shukla AA, 2013, TRENDS BIOTECHNOL, V31, P147, DOI 10.1016/j.tibtech.2012.10.004
   Singh V, 1999, CYTOTECHNOLOGY, V30, P149, DOI 10.1023/A:1008025016272
   Tao YW, 2012, BIOTECHNOL LETT, V34, P1453, DOI 10.1007/s10529-012-0915-6
   Terrier B, 2007, BIOTECHNOL BIOENG, V96, P914, DOI 10.1002/bit.21187
   Timmins NE, 2011, TISSUE ENG PART C-ME, V17, P1131, DOI [10.1089/ten.tec.2011.0207, 10.1089/ten.TEC.2011.0207]
   TRIBE LA, 1995, BIOTECHNOL BIOENG, V46, P388, DOI 10.1002/bit.260460412
   Weber W, 2002, CYTOTECHNOLOGY, V38, P77, DOI 10.1023/A:1021102015070
   Zhan CJ, 2019, CHEM ENG SCI, V193, P53, DOI 10.1016/j.ces.2018.08.017
   Zhang XW, 2009, ADV BIOCHEM ENG BIOT, V115, P33, DOI 10.1007/10_2008_18
NR 54
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115183
DI 10.1016/j.ces.2019.115183
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500005
DA 2020-05-12
ER

PT J
AU Bouaniche, A
   Vervisch, L
   Domingo, P
AF Bouaniche, Alexandre
   Vervisch, Luc
   Domingo, Pascale
TI A hybrid stochastic/fixed-sectional method for solving the population
   balance equation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Aerosol modelling; Sectional method; Stochastic method; Hybrid modeling;
   Particle size distribution; Population balance equation; Probability
   density function; Monte Carlo solution
ID MONTE-CARLO METHOD; SOOT FORMATION; NUMERICAL-SOLUTION; MODEL; GROWTH;
   DISCRETIZATION; COAGULATION; NUCLEATION; PARTICLES; SIMULATION
AB The dynamics of flowing non-inertial particles undergoing nucleation, surface growth/loss, agglomeration and sometimes breakage, is usually characterised by the particle size distribution function. This distribution evolves according to a population balance equation. A novel approach combining Monte Carlo and fixed-sectional methods is proposed to minimise the discretisation errors when solving the surface growth/loss term of the population balance equation. The approach relies on a fixed number of stochastic particles and sections, with a numerical algorithm organised to minimise errors even for a moderate number of stochastic particles and sections. Canonical test cases featuring nucleation, agglomeration, and surface growth/loss are simulated. Results against the analytical solutions confirm the improvement in accuracy of the novel approach compared with fixed-sectional methods for the same computational effort. The hybrid method is thus of particular interest for simulating problems where surface growth/ loss dominates the particles physics. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bouaniche, Alexandre; Vervisch, Luc; Domingo, Pascale] Normandie Univ, CNRS, CORIA, INSA Rouen, Technopole Madrillet,BP 8, F-76801 St Etienne Du Rouvray, France.
RP Vervisch, L (reprint author), Normandie Univ, CNRS, CORIA, INSA Rouen, Technopole Madrillet,BP 8, F-76801 St Etienne Du Rouvray, France.
EM vervisch@coria.fr
RI VERVISCH, Luc/S-5440-2016
OI VERVISCH, Luc/0000-0003-0313-2060; Domingo, Pascale/0000-0001-5658-0604
FU European UnionEuropean Union (EU) [690724]
FX The authors gratefully acknowledge the financial support of the European
   Union under the project SOPRANO, Horizon 2020 Grant Agreement No.
   690724. The authors also benefited from discussion with Nicolas Perret
   and Matthieu Oullion from SOLVAY R&I.
CR Aubagnac-Karkar D, 2018, COMBUST FLAME, V189, P190, DOI 10.1016/j.combustflame.2017.10.027
   Balthasar A, 2003, COMBUST FLAME, V133, P289, DOI 10.1016/S0010-21800(03)00003-8
   Das SK, 2016, CHEM ENG SCI, V152, P140, DOI 10.1016/j.ces.2016.05.039
   Desgroux P, 2017, COMBUST FLAME, V184, P153, DOI 10.1016/j.combustflame.2017.05.034
   DOPAZO C, 1979, PHYS FLUIDS, V22, P20, DOI 10.1063/1.862431
   Dopazo C, 1997, INT J MOD PHYS B, V11, P2975, DOI 10.1142/S0217979297001453
   Eberle C, 2017, COMBUST FLAME, V179, P63, DOI 10.1016/j.combustflame.2017.01.019
   Falope GO, 2001, CHEM ENG SCI, V56, P2567, DOI 10.1016/S0009-2509(00)00437-1
   Ferziger J.H., 1996, COMPUTATIONAL METHOD
   Filbet F, 2004, SIAM J SCI COMPUT, V25, P2004, DOI 10.1137/S1064827503429132
   FOX RO, 2003, COMPUTATIONAL MODELS
   Franzelli B, 2019, P COMBUST INST, V37, P5411, DOI 10.1016/j.proci.2018.05.061
   Frenklach M, 2002, CHEM ENG SCI, V57, P2229, DOI 10.1016/S0009-2509(02)00113-6
   GELBARD F, 1978, J COMPUT PHYS, V28, P357, DOI 10.1016/0021-9991(78)90058-X
   Haworth DC, 2010, PROG ENERG COMBUST, V36, P168, DOI 10.1016/j.pecs.2009.09.003
   HOUNSLOW MJ, 1988, AICHE J, V34, P1821, DOI 10.1002/aic.690341108
   Hu M, 2018, AAPS J, V20, DOI 10.1208/s12248-018-0212-y
   HULBURT HM, 1964, CHEM ENG SCI, V19, P555, DOI 10.1016/0009-2509(64)85047-8
   Kollmann W., 1990, THEOR COMP FLUID DYN, V1, P285
   Kumar S, 1997, CHEM ENG SCI, V52, P4659, DOI 10.1016/S0009-2509(97)00307-2
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   Kumar S, 1996, CHEM ENG SCI, V51, P1333, DOI 10.1016/0009-2509(95)00355-X
   Lee KF, 2015, J COMPUT PHYS, V303, P1, DOI 10.1016/j.jcp.2015.09.031
   LEUNG KM, 1991, COMBUST FLAME, V87, P289, DOI 10.1016/0010-2180(91)90114-Q
   Li TS, 2001, CHEM ENG SCI, V56, P2511, DOI 10.1016/S0009-2509(00)00451-6
   Lindstedt RP, 2005, P COMBUST INST, V30, P775, DOI 10.1016/j.proci.2004.08.080
   LITSTER JD, 1995, AICHE J, V41, P591
   LUNDGREN TS, 1967, PHYS FLUIDS, V10, P969, DOI 10.1063/1.1762249
   Ma G, 2005, COMBUST SCI TECHNOL, V177, P1567, DOI 10.1080/00102200590956786
   Marchisio D.L., 2007, MULTIPHASE REACTING, V492
   Mueller ME, 2009, COMBUST FLAME, V156, P1143, DOI 10.1016/j.combustflame.2009.01.025
   Nguyen TT, 2016, J COMPUT PHYS, V325, P129, DOI 10.1016/j.jcp.2016.08.017
   Oullion M, 2009, CHEM ENG SCI, V64, P673, DOI 10.1016/j.ces.2008.08.014
   Park SH, 2004, J AEROSOL SCI, V35, P1385, DOI 10.1016/j.jaerosci.2004.05.010
   Patterson RIA, 2007, COMBUST FLAME, V151, P160, DOI 10.1016/j.combustflame.2007.04.012
   Patterson RIA, 2011, J COMPUT PHYS, V230, P7456, DOI 10.1016/j.jcp.2011.06.011
   Pesmazoglou I, 2016, INT J MULTIPHAS FLOW, V80, P118, DOI 10.1016/j.ijmultiphaseflow.2015.12.004
   POPE SB, 1981, COMBUST SCI TECHNOL, V25, P159, DOI 10.1080/00102208108547500
   Qamar S, 2007, COMPUT CHEM ENG, V31, P1296, DOI 10.1016/j.compchemeng.2006.10.014
   RAMABHADRAN TE, 1976, AICHE J, V22, P840, DOI 10.1002/aic.690220505
   RAMKRISHNA D, 2000, POPULATION BALANCES
   Ramkrishna D., 1985, REV CHEM ENG, V3, P49
   Rigopoulos S, 2003, AICHE J, V49, P1127, DOI 10.1002/aic.690490507
   Rodrigues P, 2018, COMBUST FLAME, V190, P477, DOI 10.1016/j.combustflame.2017.12.009
   Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701
   Salenbauch S, 2019, J AEROSOL SCI, V128, P34, DOI 10.1016/j.jaerosci.2018.11.009
   Schiener MA, 2019, P COMBUST INST, V37, P1049, DOI 10.1016/j.proci.2018.06.088
   SCOTT WT, 1968, J ATMOS SCI, V25, P54, DOI 10.1175/1520-0469(1968)025<0054:ASOCDC>2.0.CO;2
   Sewerin F, 2017, CHEM ENG SCI, V168, P250, DOI 10.1016/j.ces.2017.01.054
   Smith M, 1998, CHEM ENG SCI, V53, P1777, DOI 10.1016/S0009-2509(98)00045-1
   Smoluchowski M. V., 1917, Z PHYS CHEM, V92, P129, DOI DOI 10.1515/ZPCH-1918-9209
   Solsvik J, 2015, J DISPER SCI TECHNOL, V36, P510, DOI 10.1080/01932691.2014.909318
   Tsantilis S, 2002, CHEM ENG SCI, V57, P2139, DOI 10.1016/S0009-2509(02)00107-0
   Urbanek S, 2012, PACKAGE EMDIST
   Zhao HB, 2013, COMPUT FLUIDS, V71, P196, DOI 10.1016/j.compfluid.2012.09.025
   Zucca A, 2006, CHEM ENG SCI, V61, P87, DOI 10.1016/j.ces.2004.11.061
NR 56
TC 2
Z9 2
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115198
DI 10.1016/j.ces.2019.115198
PG 15
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500003
DA 2020-05-12
ER

PT J
AU Boutikos, P
   Zak, A
   Koci, P
AF Boutikos, Panagiotis
   Zak, Adrian
   Koci, Petr
TI CO and hydrocarbon light-off inhibition by pre-adsorbed NOx on
   Pt/CeO2/Al2O3 and Pd/CeO2/Al2O3 diesel oxidation catalysts
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Automotive exhaust gas aftertreatment; NOx adsorption; Catalyst; NOx
   adsorber; Inhibition; CO and C3H16 oxidation
ID OXYGEN STORAGE; REDUCTION; PD; CERIA; N2O; ADSORPTION; DYNAMICS; O-2;
   N-2
AB Diesel oxidation catalysts (DOC) for abatement of CO and hydrocarbon (HC) emissions are commonly based on PtPd/CeO2/Al2O3 formulations. PdPt/CeO2 -ZrO2 or Pd/zeolite materials are also used in passive NOx adsorbers (PNA) that capture nitrogen oxides during cold start. The DOC and PNA functions can be integrated into one catalytic device. However, the adsorbed NOx species may inhibit the CO and HC light-off. Aim of this work is to investigate this inhibition effect on model Pt/CeO2/Al2O3 and Pd/CeO2/Al2O3 oxidation catalysts. Isothermal NO R adsorption experiments were performed at 80 degrees C, 120 degrees C and 160 degrees C, followed by temperature programmed desorption. Comparative CO and C3H6 light-off experiments on a catalyst with pre-adsorbed NOx revealed an increase of the light-off temperature by up to 30 degrees C relative to that of a pre-reduced and pre-oxidized catalyst. The inhibition effect was stronger on PtPd/CeO2/Al(2)O(3)than on PtPd/CeO2/Al2O3 and its extent depended on the amount of adsorbed NOx. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Boutikos, Panagiotis; Zak, Adrian; Koci, Petr] Univ Chem & Technol, Dept Chem Engn, Tech 5, Prague 16628, Czech Republic.
RP Koci, P (reprint author), Univ Chem & Technol, Dept Chem Engn, Tech 5, Prague 16628, Czech Republic.
EM petr.koci@vscht.cz
RI Koci, Petr/AAG-8076-2020
OI Koci, Petr/0000-0002-1310-6862
FU Czech Science FoundationGrant Agency of the Czech Republic [GA
   17-26018S]
FX This work was financially supported by the Czech Science Foundation
   (project GA 17-26018S).
CR Arvajova A, 2016, APPL CATAL B-ENVIRON, V181, P644, DOI 10.1016/j.apcatb.2015.08.004
   Auvray X, 2015, APPL CATAL B-ENVIRON, V168, P342, DOI 10.1016/j.apcatb.2014.12.035
   Bartova S, 2014, CATAL TODAY, V231, P145, DOI 10.1016/j.cattod.2013.11.050
   Bernal S, 2004, TOP CATAL, V28, P31, DOI 10.1023/B:TOCA.0000024332.95053.0a
   Boutikos P, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.08.040
   Brandenberger S, 2008, CATAL REV, V50, P492, DOI 10.1080/01614940802480122
   Chen H., 2013010535 SAE
   Chen HY, 2016, CATAL LETT, V146, P1706, DOI 10.1007/s10562-016-1794-6
   Cole JA, 1997, US Patent, Patent No. [5656,244, 5656244]
   Coulson J.E., 2008, Patent Application, WO, Patent No. [2008/047170, 047170]
   Di Monte R, 2004, TOP CATAL, V28, P47
   Dubbe H, 2016, TOP CATAL, V59, P1054, DOI 10.1007/s11244-016-0589-8
   Duprez D, 2001, TOP CATAL, V16, P49, DOI 10.1023/A:1016622612521
   Epling WS, 2004, CATAL REV, V46, P163, DOI 10.1081/CR-200031932
   Gu YT, 2019, APPL CATAL A-GEN, V570, P1, DOI 10.1016/j.apcata.2018.10.036
   Jarvis M., 2001, U.S. Patent, Patent No. [6,182,443, 6182443]
   Jones S, 2016, CATAL LETT, V146, P909, DOI 10.1007/s10562-016-1704-y
   Koci P, 2009, CATAL TODAY, V147, pS257, DOI 10.1016/j.cattod.2009.07.036
   Lambert C., 2014, DEV 2010 FORD DIESEL
   Lietti L., 2018, NOX TRAP CATALYSTS T
   Luo JY, 2012, CATAL LETT, V142, P946, DOI 10.1007/s10562-012-0847-8
   Millo F., 2012020373 SAE
   Mracek D, 2016, APPL CATAL B-ENVIRON, V182, P109, DOI 10.1016/j.apcatb.2015.09.002
   Mracek D, 2015, APPL CATAL B-ENVIRON, V166, P509, DOI 10.1016/j.apcatb.2014.12.002
   Mulla SS, 2006, J CATAL, V241, P389, DOI 10.1016/j.jcat.2006.05.016
   Murata Y., 2015011002 SAE
   Oh H, 2011, CATAL LETT, V141, P1746, DOI 10.1007/s10562-011-0714-z
   Olsson L, 2002, J CATAL, V210, P340, DOI 10.1006/jcat.2002.3698
   Philipp S, 2004, TOP CATAL, V30-1, P235, DOI 10.1023/B:TOCA.0000029755.35282.00
   Piacentini M, 2007, APPL CATAL B-ENVIRON, V72, P105, DOI 10.1016/j.apcatb.2006.10.022
   Plat F, 2010, IND ENG CHEM RES, V49, P10348, DOI 10.1021/ie100590s
   Theis J.R., SAE PAPER
   Theis JR, 2019, CATAL TODAY, V320, P181, DOI 10.1016/j.cattod.2017.12.014
   Theis JR, 2016, CATAL TODAY, V267, P93, DOI 10.1016/j.cattod.2016.01.032
   Theis JR, 2015, CATAL TODAY, V258, P367, DOI 10.1016/j.cattod.2015.01.031
   Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464
   Vaclavik M, 2016, CATAL TODAY, V273, P112, DOI 10.1016/j.cattod.2016.03.013
   Zheng Y, 2017, J PHYS CHEM C, V121, P15793, DOI 10.1021/acs.jpcc.7b04312
NR 38
TC 0
Z9 0
U1 25
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115201
DI 10.1016/j.ces.2019.115201
PG 7
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500007
DA 2020-05-12
ER

PT J
AU Chao, C
   Jin, XQ
   Fan, XF
AF Chao, Cong
   Jin, Xiaoqiang
   Fan, Xianfeng
TI Effect of network structure on the bubble dislodgment and pressure
   distribution in microfluidic networks with multiple bifurcations
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Dislodging pressure; Network structure; Bifurcating angle; Multiple
   bifurcations; Bubble motion; Microfluidic devices
ID SECONDARY FLOW; EMBOLISM; FLUID; MICROCHANNELS; TRANSPORT; ADHESION;
   SYSTEM; MODEL; DROP
AB Bubble lodgment in a network with multiple bifurcations, such as blood vessels and microfluidic networks, is a crucial issue in many biological and chemical processes. However, it has not been quantitatively investigated, particularly the impact of the network structure on the bubble dislodgment, and the distribution of the applied overall pressure in each channel. In this study, 'point-volume-point' networks with multiple bifurcations are designed with smoothly-changed flowpath. Over 500 experiments were conducted to characterize the effect of network structure on the bubble dislodgment. The distribution of the overall pressure in an individual channel j is characterized through a parameter C-j where a bubble is lodged in microchannel j. The results indicate that the C-j value is smaller for the channel with complicated surrounding networks. A higher bifurcating angle of microchannel j results in a larger C-j value of the microchannel j and a lower C-j value of the proximal microchannel. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Chao, Cong; Jin, Xiaoqiang; Fan, Xianfeng] Univ Edinburgh, Sch Engn, Inst Mat & Proc, Kings Bldg,Robert Stevenson Rd, Edinburgh EH9 3JL, Midlothian, Scotland.
RP Fan, XF (reprint author), Univ Edinburgh, Sch Engn, Inst Mat & Proc, Kings Bldg,Robert Stevenson Rd, Edinburgh EH9 3JL, Midlothian, Scotland.
EM x.fan@ed.ac.uk
RI CHAO, CONG/P-4390-2017; Fan, Xianfeng/E-4381-2016
OI CHAO, CONG/0000-0001-6738-5732; Fan, Xianfeng/0000-0002-6811-953X
FU UK-India Education and Research Initiative and Engineering and Physical
   Sciences Research Council (EPSRC) of the UKEngineering & Physical
   Sciences Research Council (EPSRC) [EP/N024672/1]
FX Authors gratefully acknowledge the UK-India Education and Research
   Initiative and Engineering and Physical Sciences Research Council
   (EPSRC) of the UK [grant number EP/N024672/1].
CR Ahn YC, 2008, LAB CHIP, V8, P125, DOI 10.1039/b713626a
   Bassett M.D., 2003, SAE T, P565
   Blackmore B, 2001, J COLLOID INTERF SCI, V241, P514, DOI 10.1006/jcis.2001.7755
   Blanckaert K, 2004, J FLUID MECH, V498, P353, DOI 10.1017/S0022112003006979
   Blanckaert K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001137
   Calderon AJ, 2005, J APPL PHYSIOL, V99, P479, DOI 10.1152/japplphysiol.00656.2004
   Calderon AJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402898
   Cavanagh DP, 1999, J FLUID MECH, V398, P225, DOI 10.1017/S0022112099006230
   CHANG HK, 1981, J APPL PHYSIOL, V51, P1002
   Chao C, 2019, LANGMUIR, V35, P3194, DOI 10.1021/acs.langmuir.8b03323
   Chnafa C, 2017, J BIOMECH, V51, P83, DOI 10.1016/j.jbiomech.2016.12.004
   Cho H, 2007, J COLLOID INTERF SCI, V306, P379, DOI 10.1016/j.jcis.2006.10.077
   Cygan ZT, 2005, LANGMUIR, V21, P3629, DOI 10.1021/la0471137
   Dean WR, 1927, PHILOS MAG, V4, P208
   Di Carlo D, 2009, LAB CHIP, V9, P3038, DOI 10.1039/b912547g
   DUKOVIC J, 1987, J ELECTROCHEM SOC, V134, P331, DOI 10.1149/1.2100456
   Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/NCHEM.1753, 10.1038/nchem.1753]
   Fuerstman MJ, 2007, LAB CHIP, V7, P1479, DOI 10.1039/b706549c
   Gosselin L, 2007, INT J THERM SCI, V46, P434, DOI 10.1016/j.ijthermalsci.2006.06.006
   Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010
   Kim D, 2006, LAB CHIP, V6, P639, DOI 10.1039/b517054k
   Kuppusamy NR, 2014, INT J HEAT MASS TRAN, V78, P216, DOI 10.1016/j.ijheatmasstransfer.2014.06.072
   Kwok DY, 2000, J ADHES SCI TECHNOL, V14, P719, DOI 10.1163/156856100742843
   Lorente S, 2002, INT J HEAT MASS TRAN, V45, P3299, DOI 10.1016/S0017-9310(02)00051-0
   Mark D, 2010, NATO SCI PEACE SEC A, P305, DOI 10.1007/978-90-481-9029-4_17
   Marshall I, 2004, J BIOMECH, V37, P679, DOI 10.1016/j.jbiomech.2003.09.032
   Metz T, 2010, MICROFLUID NANOFLUID, V9, P341, DOI 10.1007/s10404-009-0551-1
   Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505
   Mohammadi M, 2015, J FLUID ENG-T ASME, V137, DOI 10.1115/1.4029033
   Murakami M., 1969, Bulletin of the Japan Society of Mechanical Engineers, V12, P1369
   Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207
   Mynard JP, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2717
   Oh KW, 2012, LAB CHIP, V12, P515, DOI 10.1039/c2lc20799k
   Prabhakarpandian B, 2011, MICROCIRCULATION, V18, P380, DOI 10.1111/j.1549-8719.2011.00099.x
   Sudarsan AP, 2006, LAB CHIP, V6, P74, DOI 10.1039/b511524h
   Suzuki A, 2004, ANESTHESIOLOGY, V101, P97, DOI 10.1097/00000542-200407000-00016
   Tadjfar M, 2004, J FLUID MECH, V519, P1, DOI 10.1017/s0022112004000606
   Valassis DT, 2012, BIOMED MICRODEVICES, V14, P131, DOI 10.1007/s10544-011-9591-x
   van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P237
   Varner VD, 2017, SEMIN CELL DEV BIOL, V67, P170, DOI 10.1016/j.semcdb.2016.06.003
   Vertti-Quintero N, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4739072
   Wang XQ, 2006, INT J THERM SCI, V45, P1103, DOI 10.1016/j.ijthermalsci.2006.01.010
   Wang XQ, 2007, J APPL PHYS, V102, DOI 10.1063/1.2794379
   Wechsatol W, 2001, INT J HEAT MASS TRAN, V44, P3111, DOI 10.1016/S0017-9310(00)00338-0
   Wong CW, 2005, J ELECTROCHEM SOC, V152, pA1600, DOI 10.1149/1.1949067
   Yang S, 2006, LAB CHIP, V6, P871, DOI 10.1039/b516401j
   You LX, 2002, INT J HEAT MASS TRAN, V45, P2277, DOI 10.1016/S0017-9310(01)00322-2
   Zhang J, 2016, LAB CHIP, V16, P10, DOI 10.1039/c5lc01159k
   Zheng WF, 2010, LAB CHIP, V10, P2906, DOI 10.1039/c005274d
NR 49
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115176
DI 10.1016/j.ces.2019.115176
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500013
DA 2020-05-12
ER

PT J
AU Chen, Z
   Zhou, YW
   Wang, YD
   Xu, JH
AF Chen, Zhuo
   Zhou, Yi-Wei
   Wang, Yun-Dong
   Xu, Jian-Hong
TI Regulation and scaling law of gas-liquid-liquid three-phase flow in a
   dual-coaxial microchannel
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hollow droplet; Dual-coaxial; Microchannel; Liquid-liquid; Gas-liquid
ID CONTROLLABLE MICROFLUIDIC PRODUCTION; DROPLET FORMATION; DOUBLE
   EMULSIONS; EXTRACTION; WATER; PRESSURE; PATTERN
AB The one-step dual-coaxial microchannel exhibits wide range of regulation and simple operations in the preparation of hollow droplets. However, the scaling law of preparing hollow droplet and the prediction of hollow droplet size are insufficient. Herein, it was found that the growth stage of the hollow droplets behaves similarly to that of the liquid-liquid system, while the neck-collapse stage is similar to the gas-liquid system. Besides the neck-collapse time of hollow droplets accounts for less than 5% of the total generation time, and thus the effect of the neck-collapse process on the droplet size is negligible. A semi-empirical model based on the Ca number of the continuous phase for predicting the size of hollow droplets is established, and the relative error is within 5%. Furthermore, such a model is also applied to different systems and the model established in our work has good feasibility in predicting the hollow droplet size. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Chen, Zhuo; Zhou, Yi-Wei; Wang, Yun-Dong; Xu, Jian-Hong] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
RP Wang, YD; Xu, JH (reprint author), Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
EM wangyd@mail.tsinghua.edu.cn; xujianhong@tsinghua.edu.cn
OI Zhou, Yiwei/0000-0001-5354-3234
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21636004, 21322604]; Key Research and Development
   Project of Ningxia [2018BDE02057]
FX The authors gratefully acknowledge the support of the National Natural
   Science Foundation of China (21636004, 21322604), the Key Research and
   Development Project of Ningxia (2018BDE02057) for this work.
CR Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519
   Castro-Hernandez E, 2011, LAB CHIP, V11, P2023, DOI 10.1039/c0lc00731e
   Chen R, 2012, LAB CHIP, V12, P3858, DOI 10.1039/c2lc40387k
   Chen Z, 2017, SEP PURIF TECHNOL, V174, P352, DOI 10.1016/j.seppur.2016.10.059
   Cramer C, 2004, CHEM ENG SCI, V59, P3045, DOI 10.1016/j.ces.2004.04.006
   Garstecki P, 2006, LAB CHIP, V6, P693
   Hashimoto M, 2007, SMALL, V3, P1792, DOI 10.1002/smll.200700238
   Kashid M, 2011, CHEM ENG PROCESS, V50, P972, DOI 10.1016/j.cep.2011.07.003
   Khan SA, 2009, LAB CHIP, V9, P1840, DOI 10.1039/b904119b
   Nie ZH, 2008, MICROFLUID NANOFLUID, V5, P585, DOI 10.1007/s10404-008-0271-y
   Nightingale AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4777
   Nisisako T, 2005, SOFT MATTER, V1, P23, DOI 10.1039/b501972a
   Nunes JK, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/11/114002
   Onal Y, 2005, CHEM ENG TECHNOL, V28, P972, DOI 10.1002/ceat.200500147
   Rajesh VM, 2012, CHEM ENG J, V207, P832, DOI 10.1016/j.cej.2012.07.082
   Sang FN, 2018, AICHE J, V64, P730, DOI 10.1002/aic.15930
   Steegmans MLJ, 2009, CHEM ENG SCI, V64, P3042, DOI 10.1016/j.ces.2009.03.010
   Su YH, 2009, AICHE J, V55, P1948, DOI 10.1002/aic.11787
   Tan J, 2012, IND ENG CHEM RES, V51, P1834, DOI 10.1021/ie2010302
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Tice JD, 2004, ANAL CHIM ACTA, V507, P73, DOI 10.1016/j.aca.2003.11.024
   TORZA S, 1969, SCIENCE, V163, P813, DOI 10.1126/science.163.3869.813
   van der Graaf S, 2006, LANGMUIR, V22, P4144, DOI 10.1021/la052682f
   van Steijn V, 2010, LAB CHIP, V10, P2513, DOI 10.1039/c002625e
   Wan J, 2008, ADV MATER, V20, P3314, DOI 10.1002/adma.200800628
   Wang K, 2010, MICROFLUID NANOFLUID, V8, P813, DOI 10.1007/s10404-009-0514-6
   Wang K, 2015, RSC ADV, V5, P6470, DOI 10.1039/c4ra14489a
   Wang WT, 2015, RSC ADV, V5, P82056, DOI 10.1039/c5ra15769b
   Ward T, 2005, ELECTROPHORESIS, V26, P3716, DOI 10.1002/elps.200500173
   Xu JH, 2012, LAB CHIP, V12, P2029, DOI 10.1039/c2lc21193a
   Yue J, 2014, LAB CHIP, V14, P1632, DOI 10.1039/c3lc51307f
   Zhao CX, 2011, CHEM ENG SCI, V66, P1394, DOI 10.1016/j.ces.2010.08.038
   Zheng B, 2005, ANGEW CHEM INT EDIT, V44, P2520, DOI 10.1002/anie.200462857
NR 33
TC 1
Z9 1
U1 15
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115172
DI 10.1016/j.ces.2019.115172
PG 8
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500035
DA 2020-05-12
ER

PT J
AU Cooper, JD
   Liu, L
   Ramskill, NP
   Watling, TC
   York, APE
   Stitt, EH
   Sederman, AJ
   Gladden, LF
AF Cooper, J. D.
   Liu, L.
   Ramskill, N. P.
   Watling, T. C.
   York, A. P. E.
   Stitt, E. H.
   Sederman, A. J.
   Gladden, L. F.
TI Numerical and experimental studies of gas flow in a particulate filter
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Particulate filter; Flow; Magnetic resonance imaging; Computational
   fluid dynamics; Modelling
ID SINGLE-PHASE FLOW; REGENERATION; SIMULATION; MODEL; COMBUSTION;
   TRANSPORT; BEDS
AB Predicted gas flow fields in wall-flow particulate filters, used for vehicular emissions abatement, from both one- and three-dimensional numerical models have been validated for the first time. This has been achieved using experimental measurements made using magnetic resonance imaging (MRI). Two-dimensional MRI velocity images of isotropic spatial resolution 140 mu m px (1) were acquired perpendicular to the filter channels at multiple points, allowing measurement of the gas axial velocity in both the inlet and outlet channels along the length of the filter. Consideration of the mass balance between data points permitted the through-wall (i.e. filtration) velocity to also be calculated. These velocity data were acquired at six flow rates, corresponding to channel Reynolds numbers in the range 102-1251, and compared with the predictions from both an open source three-dimensional CFD code and a recent one-dimensional model. Good agreement was observed for both models at low flow rates, but the three-dimensional model outperformed the one-dimensional model at higher flow rates. The validation of the 3D CFD method allowed its use to probe local gas hydrodynamics, specifically calculating the variation of the momentum convection correction factor and wall friction factor. Comparisons of the calculated factors and literature correlations showed the effects of flow development are significant and have not previously been considered. When these correlations were used with the 1D model, the velocity predictions were coincident with those of the 3D CFD. Hence, with the appropriate flow descriptors, the 1D model can be used to give accurate gas velocity predictions but at a fraction of the computational time required to run CFD code. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cooper, J. D.; Ramskill, N. P.; Sederman, A. J.; Gladden, L. F.] Univ Cambridge, Dept Chem Engn & Biotechnol, West Cambridge Site,Philippa Fawcett Dr, Cambridge CB3 0AS, England.
   [Liu, L.; Stitt, E. H.] Johnson Matthey Technol Ctr, Belasis Ave, Billingham TS23 1LB, Cleveland, England.
   [Watling, T. C.; York, A. P. E.] Johnson Matthey Technol Ctr, Reading RG4 9NH, Berks, England.
RP York, APE (reprint author), Johnson Matthey Technol Ctr, Reading RG4 9NH, Berks, England.
EM andrew.york@matthey.com
OI Watling, Timothy/0000-0003-2050-6183
FU EPSRCEngineering & Physical Sciences Research Council (EPSRC) [1628588];
   Johnson Matthey [1628588]
FX JDC would like to thank the EPSRC and Johnson Matthey for a CASE award
   (reference 1628588).
CR Allouche MH, 2017, CHEM ENG RES DES, V117, P681, DOI 10.1016/j.cherd.2016.11.014
   Benning M, 2014, J MAGN RESON, V238, P26, DOI 10.1016/j.jmr.2013.10.003
   Bensaid S, 2009, CHEM ENG J, V154, P211, DOI 10.1016/j.cej.2009.03.043
   Bensaid S, 2010, CHEM ENG SCI, V65, P357, DOI 10.1016/j.ces.2009.06.051
   Bissett EJ, 2012, CHEM ENG SCI, V84, P255, DOI 10.1016/j.ces.2012.08.012
   BISSETT EJ, 1984, CHEM ENG SCI, V39, P1233, DOI 10.1016/0009-2509(84)85084-8
   Boyce CM, 2014, CHEM ENG SCI, V116, P611, DOI 10.1016/j.ces.2014.05.041
   Cooper JD, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.08.076
   Di Sarli V, 2015, CHEM ENG SCI, V137, P69, DOI 10.1016/j.ces.2015.06.011
   Gladden LF, 2017, ANNU REV CHEM BIOMOL, V8, P227, DOI 10.1146/annurev-chembioeng-061114-123222
   Gunjal PR, 2005, AICHE J, V51, P365, DOI 10.1002/aic.10314
   Haralampous O, 2002, CHEM ENG SCI, V57, P2345, DOI 10.1016/S0009-2509(02)00135-5
   Joshi A., 2018, EMISS CONTROL SCI TE, DOI [DOI 10.1007/s40825-018-0101-y, 10.1007/s40825-018-0101-y]
   Koci P, 2019, CATAL TODAY, V320, P165, DOI 10.1016/j.cattod.2017.12.025
   Koltsakis GC, 2005, 2005010953 SAE
   Koltsakis G, 2013, REV CHEM ENG, V29, P1, DOI 10.1515/revce-2012-0008
   Konstandopoulos A.G., 1999, 1999010468 SAE
   Konstandopoulos A. G., 2000, 2000011016 SAE
   Konstandopoulos A.G., 2001, 2001010909 SAE
   Konstandopoulos AG, 2000, COMBUST FLAME, V121, P488, DOI 10.1016/S0010-2180(99)00156-X
   Konstandopoulos AG, 1989, 890405 SAE
   Koptyug IV, 2000, J MAGN RESON, V147, P36, DOI 10.1006/jmre.2000.2186
   Koptyug IV, 2000, CHEM ENG SCI, V55, P1559, DOI 10.1016/S0009-2509(99)00404-2
   Kostoglou M, 2012, IND ENG CHEM RES, V51, P13062, DOI 10.1021/ie3011098
   Lao CT, 2017, ENRGY PROCED, V142, P3560, DOI 10.1016/j.egypro.2017.12.245
   Liu Z.G., 2002, SAE TECHNICAL PAPER
   Mantle MD, 2002, AICHE J, V48, P909, DOI 10.1002/aic.690480425
   Masoudi M., 2002, 2002011016 SAE
   Newling B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.154503
   Newling B, 2008, PROG NUCL MAG RES SP, V52, P31, DOI 10.1016/j.pnmrs.2007.08.002
   Peters B.J., 2003, SPRING TECHN C ASME
   Piscaglia F, 2009, ENERGY, V34, P2051, DOI 10.1016/j.energy.2008.08.022
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Ramskill NP, 2017, CHEM ENG SCI, V158, P497, DOI 10.1016/j.ces.2016.10.017
   Robbins DJ, 2012, AICHE J, V58, P3904, DOI 10.1002/aic.13767
   Sankey MH, 2009, J MAGN RESON, V196, P142, DOI 10.1016/j.jmr.2008.10.021
   Sbrizzai F, 2005, CHEM ENG SCI, V60, P6551, DOI 10.1016/j.ces.2005.05.038
   Schejbal M, 2009, CHEM ENG J, V154, P219, DOI 10.1016/j.cej.2009.04.056
   Sederman AJ, 2003, MAGN RESON IMAGING, V21, P359, DOI 10.1016/S0730-725X(03)00138-3
   Torregrosa AJ, 2011, ENERGY, V36, P671, DOI 10.1016/j.energy.2010.09.047
   Twigg MV, 2011, CATAL TODAY, V163, P33, DOI 10.1016/j.cattod.2010.12.044
   van Setten BAAL, 2001, CATAL REV, V43, P489, DOI 10.1081/CR-120001810
   Watling TC, 2017, SAE INT J ENGINES, V10, P1765, DOI 10.4271/2017-01-0974
   Watling TC, 2012, CATAL TODAY, V188, P32, DOI 10.1016/j.cattod.2012.02.007
   Williams JL, 2001, CATAL TODAY, V69, P3, DOI 10.1016/S0920-5861(01)00348-0
   Yang S., 2016, ADV MECH ENG, V8, P1
   York APE, 2009, SAE INT J FUELS LUBR, V2, P578, DOI 10.4271/2009-01-1266
   Yu MT, 2013, CHEM ENG J, V232, P541, DOI 10.1016/j.cej.2013.08.006
NR 48
TC 1
Z9 1
U1 8
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115179
DI 10.1016/j.ces.2019.115179
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500027
DA 2020-05-12
ER

PT J
AU Ghayur, A
   Verheyen, TV
AF Ghayur, Adeel
   Verheyen, T. Vincent
TI Modelling a biorefinery concept producing carbon fibre-polybutylene
   succinate composite foam
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Biorefinery; Circular economy; Carbon negative; Carbon fibre;
   Simulation; Succinic acid
ID SEMIBATCH REACTIVE DISTILLATION; ACETIC-ACID; POLY(BUTYLENE SUCCINATE);
   MECHANICAL-PROPERTIES; FERMENTATION BROTHS; ORGANOSOLV LIGNIN;
   CRYSTALLIZATION; ESTERIFICATION; 1,4-BUTANEDIOL; HYDROGENATION
AB In this study, a novel biorefinery concept producing carbon fibre-poly(butylene succinate) composite foam (CPC foam) from lignocellulose and CO2 is modelled. The biodegradable nature of poly(butylene succinate) would allow for easy carbon fibre recovery from the CPC foam for reuse at the end of product lifecycle, thus allowing for a circular materials flow. Technical simulation results show the biorefinery consumes 417 kg of biomass, 33 kg of CO2, 86 kg of methanol, 23 kg of acetic anhydride, 130 kWh of electricity and 1166 kW of heat per hour. The facility generates 72 kg of CPC foam, 82 kg of carbon fibre, 24 kg of tetrahydrofuran and 50 kg of dimethyl ether (DME). DME is used to fulfil parasitic electricity requirement. These results demonstrate the technical viability of this biorefinery although, research is needed to reduce parasitic energy demand. This carbon negative biorefinery avoids carcinogens and halogens for polymeric materials synthesis by utilising green chemistry principles and lignocellulose feedstock. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ghayur, Adeel; Verheyen, T. Vincent] Federat Univ Australia, Carbon Technol Res Ctr, Churchill, Vic 3842, Australia.
RP Ghayur, A (reprint author), Federat Univ Australia, Carbon Technol Res Ctr, Churchill, Vic 3842, Australia.
EM adeel.ghayur@federation.edu.au
OI Ghayur, Adeel/0000-0002-9093-846X
FU Brown Coal Innovation Australia Limited; Australian National Low
   Emissions Coal Research and Development Ltd (ANLEC RD); Victorian State
   Government; Australian GovernmentAustralian Government; RTP Fee-Offset
   Scholarship through Federation University Australia
FX This work was supported by the financial assistance of Brown Coal
   Innovation Australia Limited, a private member-based company with
   funding contracts through Australian National Low Emissions Coal
   Research and Development Ltd (ANLEC R&D) and the Victorian State
   Government; and by an Australian Government Research Training Program
   (RTP) Stipend and RTP Fee-Offset Scholarship through Federation
   University Australia.
CR Akkaravathasinp SS, 2015, ENRGY PROCED, V79, P778, DOI 10.1016/j.egypro.2015.11.566
   Baker DA, 2013, J APPL POLYM SCI, V130, P713, DOI 10.1002/app.39273
   Balasubramanian N, 2001, APPL BIOCHEM BIOTECH, V91-3, P367, DOI 10.1385/ABAB:91-93:1-9:367
   BARKER HA, 1945, P NATL ACAD SCI USA, V31, P219, DOI 10.1073/pnas.31.8.219
   Cachet N, 2014, IND CROP PROD, V58, P287, DOI 10.1016/j.indcrop.2014.03.039
   Chung DDL, 1994, CARBON FIBER COMPOSI
   Dekker R. F. H., 1987, Biocatalysis, V1, P47, DOI 10.3109/10242428709040130
   Dekker R. F. H., 1987, Biocatalysis, V1, P63, DOI 10.3109/10242428709040131
   Ehsanipour M, 2016, J IND MICROBIOL BIOT, V43, P807, DOI 10.1007/s10295-016-1756-4
   Ghayan A., 2018, FLEXINERY
   Ghayan A., 2018, ORYCYCLE
   Ghayur A., 2018, 14 GREENH GAS CONTR
   Ghayur A., 2019, INT C INN APPL ENG O
   Ghayur A, 2019, J CLEAN PROD, V230, P1165, DOI 10.1016/j.jclepro.2019.05.180
   Ghayur A, 2018, INT J HYDROGEN ENERG, V43, P13852, DOI 10.1016/j.ijhydene.2018.02.069
   Ghayur A, 2019, J ENVIRON MANAGE, V241, P514, DOI 10.1016/j.jenvman.2018.07.033
   GRASSIE N, 1962, J POLYM SCI, V56, P189, DOI 10.1002/pol.1962.1205616316
   Han HY, 2013, J CHEM TECHNOL BIOT, V88, P1200, DOI 10.1002/jctb.3956
   Hosseinaei O, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071410
   Hoyme C.A., 2003, US Patent, Patent No. 6518465
   Humbird D, 2011, NRELTP510047764
   Jacquel N, 2011, J POLYM SCI POL CHEM, V49, P5301, DOI 10.1002/pola.25009
   Jeong H, 2012, FIBER POLYM, V13, P1310, DOI 10.1007/s12221-012-1310-6
   Jiang Y, 2013, ELECTROCHIM ACTA, V91, P173, DOI 10.1016/j.electacta.2012.12.032
   Johann S., 1938, U.S. Patent No, Patent No. [2,108,829, 2108829]
   Kang KH, 2016, APPL CATAL A-GEN, V524, P206, DOI 10.1016/j.apcata.2016.06.037
   Kang KH, 2015, APPL CATAL A-GEN, V490, P153, DOI 10.1016/j.apcata.2014.11.029
   Kim DY, 2003, APPL MICROBIOL BIOT, V61, P300, DOI 10.1007/s00253-002-1205-3
   Kuang TR, 2018, COMPOS SCI TECHNOL, V159, P171, DOI 10.1016/j.compscitech.2018.02.021
   Li Q, 2010, SEP PURIF TECHNOL, V72, P294, DOI 10.1016/j.seppur.2010.02.021
   Liang JC, 2015, POLYM COMPOSITE, V36, P1335, DOI 10.1002/pc.23038
   Liang JC, 2014, J THERM ANAL CALORIM, V115, P209, DOI 10.1007/s10973-013-3184-2
   Liu YD, 2012, POLYM REV, V52, P234, DOI 10.1080/15583724.2012.705410
   Luque R, 2009, GREEN CHEM, V11, P193, DOI 10.1039/b813409j
   Lv HS, 2013, CHEM ENG TECHNOL, V36, P1899, DOI 10.1002/ceat.201300183
   Mallard W.G., 2018, 69 NISTSRD
   Masson-Delmotte V, 2018, IPCC SPECIAL REPORT
   Meek N, 2016, COMPOS SCI TECHNOL, V137, P60, DOI 10.1016/j.compscitech.2016.10.016
   Monteil-Rivera F, 2015, IND CROP PROD, V65, P446, DOI 10.1016/j.indcrop.2014.10.060
   Murray EP, 2002, J ELECTROCHEM SOC, V149, pA1127, DOI 10.1149/1.1496484
   OTANI S, 1969, Patent No. 3461082
   PADMANABHAN N, 1968, IND ENG CHEM PROC DD, V7, P511, DOI 10.1021/i260028a006
   Pateraki C, 2016, BIOCHEM ENG J, V112, P285, DOI 10.1016/j.bej.2016.04.005
   Prapainainar C, 2014, ENRGY PROCED, V52, P559, DOI 10.1016/j.egypro.2014.07.110
   Pruckmayr G., 1996, KIRK OTHMER ENCY CHE, P757
   Pu YQ, 2005, CAN J CHEM, V83, P2132, DOI 10.1139/V05-231
   Qu JP, 2011, POLYM-PLAST TECHNOL, V50, P1405, DOI 10.1080/03602559.2011.593081
   Qu WD, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.45736
   Schulze P, 2016, BIORESOURCE TECHNOL, V199, P128, DOI 10.1016/j.biortech.2015.09.040
   Shih YF, 2007, MACROMOL THEOR SIMUL, V16, P101, DOI 10.1002/mats.200600059
   Su C, 2011, J POWER SOURCES, V196, P7601, DOI 10.1016/j.jpowsour.2011.04.056
   SUDO K, 1992, J APPL POLYM SCI, V44, P127, DOI 10.1002/app.1992.070440113
   SUDO K, 1993, J APPL POLYM SCI, V48, P1485, DOI 10.1002/app.1993.070480817
   Tong LW, 2014, CHEM ENG SCI, V106, P190, DOI 10.1016/j.ces.2013.11.036
   Tong LW, 2013, CHEM ENG PROCESS, V67, P111, DOI 10.1016/j.cep.2012.10.014
   URAKI Y, 1995, HOLZFORSCHUNG, V49, P343, DOI 10.1515/hfsg.1995.49.4.343
   Wan CY, 2013, J APPL POLYM SCI, V127, P5094, DOI 10.1002/app.38136
   Wong K, 2017, SCI CHINA TECHNOL SC, V60, P1291, DOI 10.1007/s11431-016-9028-7
   Xu J, 2010, BIOTECHNOL J, V5, P1149, DOI 10.1002/biot.201000136
   Zhang M, 2014, CARBON, V69, P626, DOI 10.1016/j.carbon.2013.12.015
NR 60
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115169
DI 10.1016/j.ces.2019.115169
PG 7
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500025
DA 2020-05-12
ER

PT J
AU Granata, G
   Onoguchi, A
   Tokoro, C
AF Granata, Giuseppe
   Onoguchi, Aina
   Tokoro, Chiharu
TI Preparation of copper nanoparticles for metal-metal bonding by aqueous
   reduction with D-glucose and PVP
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Copper nanoparticles; D-glucose; PVP; Kinetics; XAFS; Sintering
ID CU NANOPARTICLES; SILVER NANOPARTICLES; ASCORBIC-ACID; DIE-ATTACH;
   OZONATION; POWDER
AB Copper nanoparticles (CuNPs) for metal-metal bonding were prepared by aqueous reduction with D-glucose and polyvinylpirrolidone (PVP). Increasing the cupric concentration in the range 0.1-1.0 M resulted in a progressive increase in CuNPs size from 30 nm to 200 nm. Fourier-transform infrared spectroscopy (FTIR) revealed as the PVP groups responsible for capping were C-N and C=O at low cupric concentration and only C=O at higher concentration. X-ray absorption fine structure (XAFS) revealed as the reduction occurred in two steps, with a fast reduction of CuO to Cu2O and a slower reduction of Cu2O. The reaction kinetics was modeled as a series of two irreversible first order reactions based on XAFS results. LC-MS highlighted as D-glucose oxidized to gluconate, glycerate, glycolate and oxalate. Increasing the D-glucose concentration did not affect the kinetics but resulted in smaller CuNPs. The electrical resistivity of the CuNPs material sintered at 300 degrees C was 36 mu Omega cm. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Granata, Giuseppe; Tokoro, Chiharu] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
   [Onoguchi, Aina] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
RP Granata, G (reprint author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
EM giuseppe.granata@aoni.waseda.jp
FU MITSUBISHI MATERIAL CORPORATION (Japan)
FX This work was financially supported by MITSUBISHI MATERIAL CORPORATION
   (Japan). The synchrotron radiation experiments were performed using a
   BL5S1 beamline courtesy of the Aichi Synchrotron Radiation Center, Aichi
   Science & Technology Foundation, Aichi, Japan (Proposal No. 2018P4103).
CR Behera M, 2014, APPL NANOSCI, V4, P247, DOI 10.1007/s13204-013-0198-9
   Bicer M, 2010, POWDER TECHNOL, V198, P279, DOI 10.1016/j.powtec.2009.11.022
   Blosi M, 2011, J NANOPART RES, V13, P127, DOI 10.1007/s11051-010-0010-7
   Bonet F, 2000, B MATER SCI, V23, P165, DOI 10.1007/BF02719903
   Cheon J, 2012, THIN SOLID FILMS, V520, P2639, DOI 10.1016/j.tsf.2011.11.021
   Durand C, 2016, MICROELECTRON RELIAB, V66, P122, DOI 10.1016/j.microrel.2016.10.002
   Gao RH, 2017, J ELECTRON MATER, V46, P6388, DOI 10.1007/s11664-017-5669-4
   Gawande MB, 2016, CHEM REV, V116, P3722, DOI 10.1021/acs.chemrev.5b00482
   Granata G, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3438-6
   Granata G, 2015, APPL SURF SCI, V331, P463, DOI 10.1016/j.apsusc.2015.01.101
   Hu RK, 2017, SCI TOTAL ENVIRON, V603, P8, DOI [10.1016/j.scitotenv.2017.06.033, 10.1016/j.scitotenv.2017.0a033]
   Ishizaki T, 2012, J MATER CHEM, V22, P25198, DOI 10.1039/c2jm34954j
   Jeong S, 2008, ADV FUNCT MATER, V18, P679, DOI 10.1002/adfm.200700902
   Jiu JT, 2016, J MATER SCI, V51, P3422, DOI 10.1007/s10853-015-9659-8
   Khodashenas B, 2014, KOREAN J CHEM ENG, V31, P1105, DOI 10.1007/s11814-014-0127-y
   Kobayashi Y, 2016, APPL NANOSCI, V6, P883, DOI 10.1007/s13204-015-0489-4
   Komeily-Nia Z, 2013, COLLOID SURFACE A, V439, P167, DOI 10.1016/j.colsurfa.2013.03.003
   Lee BS, 2017, MET MATER INT, V23, P958, DOI 10.1007/s12540-017-6908-1
   Lee Y, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/41/415604
   Lemeune S, 2000, OZONE-SCI ENG, V22, P447, DOI 10.1080/01919510009408789
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Li CB, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0875-8
   Li JH, 2013, BIOSENS BIOELECTRON, V42, P198, DOI 10.1016/j.bios.2012.10.029
   Liu QM, 2012, T NONFERR METAL SOC, V22, P2198, DOI 10.1016/S1003-6326(11)61449-0
   Magdassi S, 2010, MATERIALS, V3, P4626, DOI 10.3390/ma3094626
   Mamun AA, 2018, APPL CLAY SCI, V165, P205, DOI 10.1016/j.clay.2018.08.022
   Marcq O, 2009, CARBOHYD RES, V344, P1303, DOI 10.1016/j.carres.2009.05.012
   Minagawa M, 2018, ADV POWDER TECHNOL, V29, P471, DOI 10.1016/j.apt.2017.11.031
   Mittu R., 2016, INT ADV RES J SCI EN, V3, P37, DOI DOI 10.17148/IARJSET
   Morita T, 2015, MATER TRANS, V56, P878, DOI 10.2320/matertrans.M2014399
   Moulder JF, 1979, HDB XRAY PHOTOELECTR
   Obraztsova II, 2006, RUSS J APPL CHEM+, V79, P1605, DOI 10.1134/S1070427206100089
   Onoguchi A, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.182147
   Pagnanelli F, 2014, J IND ENG CHEM, V20, P3201, DOI 10.1016/j.jiec.2013.11.066
   Pagnanelli F, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1887-8
   Pal J, 2012, INDIAN J CHEM A, V51, P821
   Panigrahi S, 2006, POLYHEDRON, V25, P1263, DOI 10.1016/j.poly.2005.09.006
   Park BK, 2007, J COLLOID INTERF SCI, V311, P417, DOI 10.1016/j.jcis.2007.03.039
   Siow KS, 2012, J ALLOY COMPD, V514, P6, DOI 10.1016/j.jallcom.2011.10.092
   Stapley JA, 2007, CARBOHYD RES, V342, P610, DOI 10.1016/j.carres.2006.12.011
   Sun YG, 2002, CHEM MATER, V14, P4736, DOI 10.1021/cm020587b
   Usman MS, 2012, MOLECULES, V17, P14928, DOI 10.3390/molecules171214928
   Wang HS, 2005, MATER CHEM PHYS, V94, P449, DOI 10.1016/j.matchemphys.2005.05.005
   Wang Y, 2014, MICROELECTRON RELIAB, V54, P1911, DOI 10.1016/j.microrel.2014.07.037
   Wu CW, 2006, J NANOPART RES, V8, P965, DOI 10.1007/s11051-005-9065-2
   Wu SH, 2004, J COLLOID INTERF SCI, V273, P165, DOI 10.1016/j.jcis.2004.01.071
   Xu SL, 2010, MATER CHEM PHYS, V120, P1, DOI 10.1016/j.matchemphys.2009.10.049
   Yan JF, 2013, MATER TRANS, V54, P879, DOI 10.2320/matertrans.MD201222
   Yan JF, 2011, J MATER CHEM, V21, P15981, DOI 10.1039/c1jm12108a
   Yang JG, 2007, J MATER SCI, V42, P7638, DOI 10.1007/s10853-007-1899-9
   Yao GD, 2011, RES CHEM INTERMEDIAT, V37, P351, DOI 10.1007/s11164-011-0258-2
   Yoon JW, 2018, MATERIALS, V11, DOI 10.3390/ma11112105
   Zhang ZT, 1996, J SOLID STATE CHEM, V121, P105, DOI 10.1006/jssc.1996.0015
NR 53
TC 0
Z9 0
U1 17
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115210
DI 10.1016/j.ces.2019.115210
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500033
DA 2020-05-12
ER

PT J
AU Guo, ZH
   Sun, ZN
   Zhang, N
   Ding, M
AF Guo, Zehua
   Sun, Zhongning
   Zhang, Nan
   Ding, Ming
TI Influence of confining wall on pressure drop and particle-to-fluid heat
   transfer in packed beds with small D/d ratios under high Reynolds number
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Packed bed; Small tube-to-particle diameter ratio; Influence of
   confining wall; Empirical correlation; Pressure drop; Particle-to-fluid
   heat transfer
ID MASS-TRANSFER; EXPERIMENTAL VALIDATION; CFD SIMULATIONS; FIXED-BEDS;
   SMALL TUBE; DISPERSION COEFFICIENTS; FLOW CHARACTERISTICS; LAMINAR-FLOW;
   GAS-FLOW; VERY-LOW
AB The presence of the confining wall exerts critical influences on packing structure, as well as transport properties of packed beds with small D/d ratios. In the present work, the variations of pressure drop and particle-to-fluid convective heat transfer in the packed beds of strong wall interference were evaluated under the high Reynolds number regime (Re-m similar to 10(4)) by using the CFD simulation combined with the DEM method for random packing generation. The variations upon the D/d ratios were discussed, and the applicability of empirical correlations was examined. It found that the lower D/d ratios, the lower pressure drop and heat transfer performance, and the Carman correlation and the Wakao correlation provided predictions of better accuracy for the two parameters respectively than the other empirical correlations. Then, the discussion was extended to the packing structure and fluid flow distribution. A packed bed with distinct features-the quasi-regular packed bed-was encountered at D/d = 4, in which the packing structure regularity from the wall extents over the entire bed. Accordingly, much uniform flow velocity and temperature distributions were observed in the bed. Finally, some literature results in the range of 1 < D/d < 4 were revisited in conjunction with the present findings to reach a complete picture of the confining wall influence on the packing structure and related transport properties. It suggests that the studies for packed beds in the range of D/d < similar to 4 should be isolated from the other packed beds of higher D/d ratios and the related analysis should be developed on a case-by-case basis. These findings may provide a new perspective to address the confining wall influence in packed beds with small Did ratios. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhang, Nan] Harbin Engn Univ, Fundamental Sci Nucl Safety & Simulat Technol Lab, Harbin 150001, Heilongjiang, Peoples R China.
   Harbin Engn Univ, Coll Nucl Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.
RP Zhang, N (reprint author), Harbin Engn Univ, Fundamental Sci Nucl Safety & Simulat Technol Lab, Harbin 150001, Heilongjiang, Peoples R China.
EM gzh0391@hrbeu.edu.cn; zhangnan11@hrbeu.edu.cn
FU Ph.D. Student Research and Innovation Fund of the Fundamental Research
   Funds for the Central Universities [HEUGIP2018021]
FX The authors acknowledge the financial support provided by the Ph.D.
   Student Research and Innovation Fund of the Fundamental Research Funds
   for the Central Universities (HEUGIP2018021).
CR Abdulmohsin RS, 2017, NUCL TECHNOL, V198, P17, DOI 10.1080/00295450.2017.1292818
   Abdulmohsin RS, 2015, NUCL ENG DES, V284, P143, DOI 10.1016/j.nucengdes.2014.11.041
   ACHENBACH E, 1995, EXP THERM FLUID SCI, V10, P17, DOI 10.1016/0894-1777(94)00077-L
   Achenbach E., 1981, HELIUM COOLED SYSTEM, P381
   Atmakidis T, 2012, CHEM ENG SCI, V81, P77, DOI 10.1016/j.ces.2012.06.048
   Bai H, 2009, IND ENG CHEM RES, V48, P4060, DOI 10.1021/ie801548h
   Bardet P., 2009, INT C ADV NUCL POWER
   Behnam M, 2013, IND ENG CHEM RES, V52, P15244, DOI 10.1021/ie4000568
   Bey O, 2001, INT J THERM SCI, V40, P152, DOI 10.1016/S1290-0729(00)01204-7
   Bu SS, 2014, NUCL ENG DES, V270, P21, DOI 10.1016/j.nucengdes.2014.01.001
   Calis HPA, 2001, CHEM ENG SCI, V56, P1713, DOI 10.1016/S0009-2509(00)00400-0
   Carman P.C., 1937, T I CHEM ENG-LOND, V15, P17, DOI [10.1016/S0263-8762(97)80003-2, DOI 10.1016/S0263-8762(97)80003-2]
   CD-adapco, 2016, STARCCM1104
   Cheng NS, 2011, POWDER TECHNOL, V210, P261, DOI 10.1016/j.powtec.2011.03.026
   COHEN Y, 1981, AICHE J, V27, P705, DOI 10.1002/aic.690270502
   Dai Z., 2013, SHANGH I APPL PHYS
   Dasgupta S, 2018, CHEM ENG PROCESS, V128, P149, DOI 10.1016/j.cep.2018.04.025
   de Klerk A, 2003, AICHE J, V49, P2022, DOI 10.1002/aic.690490812
   DIXON AG, 1988, CAN J CHEM ENG, V66, P705, DOI 10.1002/cjce.5450660501
   Dixon AG, 1997, IND ENG CHEM RES, V36, P3053, DOI 10.1021/ie9605950
   Dixon AG, 2013, COMPUT CHEM ENG, V48, P135, DOI 10.1016/j.compchemeng.2012.08.011
   Dixon AG, 2012, CHEM ENG J, V200, P344, DOI 10.1016/j.cej.2012.06.065
   Dixon AG, 2011, COMPUT CHEM ENG, V35, P1171, DOI 10.1016/j.compchemeng.2010.12.006
   Dong Y, 2017, CHEM ENG J, V317, P204, DOI 10.1016/j.cej.2017.02.063
   Duan YJ, 2014, PARTICUOLOGY, V17, P125, DOI 10.1016/j.partic.2013.07.010
   Eisfeld B, 2001, CHEM ENG SCI, V56, P4321, DOI 10.1016/S0009-2509(00)00533-9
   Eppinger T, 2011, CHEM ENG J, V166, P324, DOI 10.1016/j.cej.2010.10.053
   Erdim E, 2015, POWDER TECHNOL, V283, P488, DOI 10.1016/j.powtec.2015.06.017
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   FAND RM, 1990, J FLUID ENG-T ASME, V112, P84, DOI 10.1115/1.2909373
   Ferrua MJ, 2008, INT J REFRIG, V31, P242, DOI 10.1016/j.ijrefrig.2007.05.013
   FOUMENY EA, 1993, INT J HEAT MASS TRAN, V36, P536, DOI 10.1016/0017-9310(93)80028-S
   Giese M, 1998, AICHE J, V44, P484, DOI 10.1002/aic.690440225
   Gnielinski V., 2010, VDI HEAT ATLAS, P743
   Guardo A, 2005, CHEM ENG SCI, V60, P1733, DOI 10.1016/j.ces.2004.10.034
   Guo ZH, 2019, POWDER TECHNOL, V354, P842, DOI 10.1016/j.powtec.2019.07.001
   Guo ZH, 2019, INT J HEAT MASS TRAN, V134, P489, DOI 10.1016/j.ijheatmasstransfer.2019.01.066
   Guo ZH, 2019, POWDER TECHNOL, V344, P463, DOI 10.1016/j.powtec.2018.11.101
   Guo ZH, 2019, CHEM ENG SCI, V197, P357, DOI 10.1016/j.ces.2018.12.034
   Guo ZH, 2017, POWDER TECHNOL, V321, P286, DOI 10.1016/j.powtec.2017.08.024
   Guo ZH, 2017, CHEM ENG SCI, V173, P578, DOI 10.1016/j.ces.2017.08.022
   Guo ZH, 2017, POWDER TECHNOL, V319, P445, DOI 10.1016/j.powtec.2017.06.061
   Harrison LD, 2013, AICHE J, V59, P703, DOI 10.1002/aic.14034
   Hassan YA, 2012, NUCL TECHNOL, V180, P159, DOI 10.13182/NT12-A14631
   Hu YX, 2018, ENERGY, V155, P909, DOI 10.1016/j.energy.2018.05.018
   Huang AYL, 2009, J CHIN INST ENG, V32, P421, DOI 10.1080/02533839.2009.9671523
   INABA H, 1984, WARME STOFFUBERTRAG, V18, P109, DOI 10.1007/BF01006606
   Jiang B., 2014, HEAT MASS T WAERME U, V51, P67
   JONES DP, 1983, J FLUID ENG-T ASME, V105, P168, DOI 10.1115/1.3240959
   KTA, 1983, REACT COR DES HIGH T
   KTA, 1981, REACT COR DES HIGH T
   Kuo K.K., 1978, J BALLISTICS, V2, P1
   Lee DY, 2019, INT COMMUN HEAT MASS, V103, P64, DOI 10.1016/j.icheatmasstransfer.2019.02.004
   Liu LM, 2018, APPL THERM ENG, V145, P48, DOI 10.1016/j.applthermaleng.2018.09.017
   Liu LM, 2016, PROG NUCL ENERG, V86, P1, DOI 10.1016/j.pnucene.2015.09.011
   Mariani NJ, 2000, CAN J CHEM ENG, V78, P1133, DOI 10.1002/cjce.5450780614
   Mehrabian R, 2014, FUEL, V122, P164, DOI 10.1016/j.fuel.2014.01.027
   MEHTA D, 1969, IND ENG CHEM PROC DD, V8, P280, DOI 10.1021/i260030a021
   Meng X.G., 2013, THESIS
   [孟现珂 Meng Xianke], 2012, [哈尔滨工程大学学报, Journal of Harbin Engineering University], V33, P1122
   Meng XK, 2012, NUCL ENG DES, V252, P121, DOI 10.1016/j.nucengdes.2012.05.041
   Montillet A, 2007, CHEM ENG PROCESS, V46, P329, DOI 10.1016/j.cep.2006.07.002
   Mueller GE, 2019, POWDER TECHNOL, V342, P607, DOI 10.1016/j.powtec.2018.10.030
   MUELLER GE, 1992, POWDER TECHNOL, V72, P269, DOI 10.1016/0032-5910(92)80045-X
   Mueller GE, 1999, CAN J CHEM ENG, V77, P132, DOI 10.1002/cjce.5450770122
   Nguyen N, 2018, GEOTECH SP, P59
   Ookawara S., 2007, P EUR C CHEM ENG ECC
   Pavlisic A, 2018, POWDER TECHNOL, V328, P130, DOI 10.1016/j.powtec.2018.01.029
   Qian P, 2019, ENERG CONVERS MANAGE, V193, P39, DOI 10.1016/j.enconman.2019.04.052
   Rebughini S, 2016, CHEM ENG SCI, V141, P240, DOI 10.1016/j.ces.2015.11.013
   REICHELT W, 1972, CHEM-ING-TECH, V44, P1068, DOI 10.1002/cite.330441806
   Ren XH, 2005, CHEM ENG TECHNOL, V28, P219, DOI 10.1002/ceat.200407092
   Romkes SJP, 2003, CHEM ENG J, V96, P3, DOI 10.1016/j.cej.2003.08.026
   Schroder E, 2006, EXP THERM FLUID SCI, V30, P545, DOI 10.1016/j.expthermflusci.2005.11.002
   Shoji E, 2019, CHEM ENG SCI, V196, P425, DOI 10.1016/j.ces.2018.11.021
   Singhal A, 2017, CHEM ENG SCI, V172, P1, DOI 10.1016/j.ces.2017.06.003
   Suzuki M, 2008, ADV POWDER TECHNOL, V19, P183, DOI 10.1163/156855208X293817
   TALLMADGE JA, 1970, AICHE J, V16, P1092, DOI 10.1002/aic.690160639
   Tidona B, 2012, INT J HEAT MASS TRAN, V55, P522, DOI 10.1016/j.ijheatmasstransfer.2011.11.012
   TSOTSAS E, 1990, WARME STOFFUBERTRAG, V25, P245, DOI 10.1007/BF01785411
   van Antwerpen W, 2010, NUCL ENG DES, V240, P1803, DOI 10.1016/j.nucengdes.2010.03.009
   WAKAO N, 1978, CHEM ENG SCI, V33, P1375, DOI 10.1016/0009-2509(78)85120-3
   WAKAO N, 1979, CHEM ENG SCI, V34, P325, DOI 10.1016/0009-2509(79)85064-2
   Wang J, 2017, APPL ENERGY
   WHITAKER S, 1972, AICHE J, V18, P361, DOI 10.1002/aic.690180219
   WHITE SM, 1987, WARME STOFFUBERTRAG, V21, P291, DOI 10.1007/BF01009290
   Zhang MH, 2019, ADV POWDER TECHNOL, V30, P1226, DOI 10.1016/j.apt.2019.03.019
   Zobel N, 2012, CHEM ENG SCI, V71, P212, DOI 10.1016/j.ces.2011.12.029
NR 88
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115200
DI 10.1016/j.ces.2019.115200
PG 22
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500023
DA 2020-05-12
ER

PT J
AU Gupta, S
   Chokshi, P
AF Gupta, Supriya
   Chokshi, Paresh
TI Interaction potential between polymer grafted nanosheets in an
   architecturally dissimilar polymer matrix
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Polymer nanocomposites; Clay nanosheets; Dispersion; Exfoliation;
   Self-consistent field theory
ID BRUSH; NANOCOMPOSITES; STABILIZATION; PARTICLES; SURFACES; MELT
AB We examine the polymer mediated interaction between two brush coated nanosheets to address the quality of dispersion of clay sheets in a polymer matrix. The distance dependent potential curve for a pair of interacting nanosheets is constructed using self-consistent field theory. We study the role of polymer chain architecture, in addition to the size and chemical dissimilarities between free and grafted chains, in controlling the nature of interaction between finite sized nanosheets. By replacing linear polymeric chains of the matrix polymer with multi-armed star polymer of same degree of polymerization, the strength of attraction is found to be weakened and is completely eliminated for high degree of branching. The compactness of star molecule overcomes entropy driven depletion between nanosheets leading to wetting of brush with purely repulsive potential, indicative of exfoliated dispersion. Thus, the quality of dispersion can be improved by altering the architecture of free and grafted polymeric chains. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Gupta, Supriya; Chokshi, Paresh] Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
RP Chokshi, P (reprint author), Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
EM paresh@chemical.iitd.ac.in
CR ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Balazs AC, 1998, MACROMOLECULES, V31, P8370, DOI 10.1021/ma980727w
   Borukhov I, 2002, MACROMOLECULES, V35, P5171, DOI 10.1021/ma011351g
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   DOLAN AK, 1974, P ROY SOC LOND A MAT, V337, P509, DOI 10.1098/rspa.1974.0063
   Drolet F, 1999, PHYS REV LETT, V83, P4317, DOI 10.1103/PhysRevLett.83.4317
   Ferreira PG, 1998, MACROMOLECULES, V31, P3994, DOI 10.1021/ma9712460
   Gay C, 1997, MACROMOLECULES, V30, P5939, DOI 10.1021/ma970107f
   Giannelis EP, 1999, ADV POLYM SCI, V138, P107
   Gupta S, 2019, SOFT MATTER, V15, P7623, DOI 10.1039/c9sm01240k
   Hasegawa R, 1996, MACROMOLECULES, V29, P6656, DOI 10.1021/ma960365x
   HONG KM, 1981, MACROMOLECULES, V14, P727, DOI 10.1021/ma50004a051
   Kim B, 2009, MACROMOLECULES, V42, P7919, DOI 10.1021/ma9013498
   LEIBLER L, 1994, ORDERING IN MACROMOLECULAR SYSTEMS, P301
   Manias E, 2001, CHEM MATER, V13, P3516, DOI 10.1021/cm0110627
   MATSEN MW, 1994, PHYS REV LETT, V72, P2660, DOI 10.1103/PhysRevLett.72.2660
   Robello DR, 2004, J AM CHEM SOC, V126, P8118, DOI 10.1021/ja048211h
   Singh C, 2000, POLYM INT, V49, P469, DOI 10.1002/(SICI)1097-0126(200005)49:5<469::AID-PI433>3.3.CO;2-U
   VAIA RA, 1995, ADV MATER, V7, P154, DOI 10.1002/adma.19950070210
   Wang R, 2003, J CHEM PHYS, V118, P9447, DOI 10.1063/1.1568339
   Xu JJ, 2006, J POLYM SCI POL PHYS, V44, P2811, DOI 10.1002/polb.20884
   YANO K, 1993, J POLYM SCI POL CHEM, V31, P2493, DOI 10.1002/pola.1993.080311009
   Zhulina E, 1999, LANGMUIR, V15, P3935, DOI 10.1021/la981406g
NR 23
TC 3
Z9 3
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115184
DI 10.1016/j.ces.2019.115184
PG 17
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500024
DA 2020-05-12
ER

PT J
AU Huang, SS
   Zhao, JR
   Wu, CH
   Wang, X
   Fei, SM
   Zhang, Q
   Wang, Q
   Chen, ZW
   Uvdal, K
   Hu, ZJ
AF Huang, Shoushuang
   Zhao, Junru
   Wu, Chenghao
   Wang, Xin
   Fei, Siming
   Zhang, Qian
   Wang, Qing
   Chen, Zhiwen
   Uvdal, Kajsa
   Hu, Zhangjun
TI ZIF-assisted construction of magnetic multiple core-shell
   Fe3O4@ZnO@N-doped carbon composites for effective photocatalysis
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fe3O4; ZnO; ZIF-8; Nitrogen-doped carbon; Photocatalysis; Magnetic
   recovery
ID REDUCED GRAPHENE OXIDE; IN-SITU FABRICATION; HYDROTHERMAL SYNTHESIS;
   ZNO; NANOPARTICLES; DEGRADATION; PERFORMANCE; WATER; HETEROSTRUCTURES;
   DYE
AB Magnetic Fe3O4@ZnO@nitrogen-doped carbon (Fe3O4@ZnO@N-C) composites with multiple core-shell structures have been successfully synthesized by calcination of ZIF-8 coated Fe3O4@ZnO core-shell nanocrystals. The morphologies and microstructural characteristics are investigated by X-ray diffraction, Fourier-transform infrared spectrometer, transmission electron microscopy, X-ray photoelectron spectroscopy, physical adsorption of nitrogen, and UV-vis diffuse reflectance spectroscopy. The photocatalytic performances are tested by degrading methylene blue (MB) in aqueous solutions under the irradiation of imitative sunlight. The photocatalytic trials indicate that the Fe3O4@ZnO@N-C composites exhibit improved degradation efficiency compared to the Fe3O4@ZnO precursor. The photocatalytic efficiencies of the as-prepared Fe3O4@ZnO@N-C composites towards MB are 93% under irradiation of imitative sunlight for 90 min and still maintained to be 87% after 6 recycles, which shows very good stability and recyclability. Nitrogen-doped carbon is believed to extend the absorption spectra to the visible-light region. The photodegradation kinetics via using the as-prepared Fe3O4@ZnO@N-C composite as a novel photocatalyst are systematically investigated. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Huang, Shoushuang; Zhao, Junru; Wu, Chenghao; Wang, Xin; Fei, Siming; Zhang, Qian; Wang, Qing; Chen, Zhiwen; Hu, Zhangjun] Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.
   [Uvdal, Kajsa; Hu, Zhangjun] Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
RP Chen, ZW; Hu, ZJ (reprint author), Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.; Hu, ZJ (reprint author), Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
EM zwchen@shu.edu.cn; zhangjun.hu@liu.se
RI Hu, Zhangjun/E-7297-2013
OI Hu, Zhangjun/0000-0001-9905-0881
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21601120, 11375111]; Science and Technology
   Commission of Shanghai MunicipalityScience & Technology Commission of
   Shanghai Municipality (STCSM) [17ZR1410500, 19ZR1418100]; Swedish
   Government strategic faculty grant in material sciencee (SFO, MATLIU) in
   Advanced Functional Materials (AFM) [5.1-2015-5959]
FX The work was supported by the National Natural Science Foundation of
   China (21601120 and 11375111), the Science and Technology Commission of
   Shanghai Municipality (17ZR1410500 and 19ZR1418100), and Swedish
   Government strategic faculty grant in material science (SFO, MATLIU) in
   Advanced Functional Materials (AFM) (VR Dnr. 5.1-2015-5959).
CR Acuna K, 2017, SOL ENERGY, V157, P335, DOI 10.1016/j.solener.2017.07.054
   Atla SB, 2018, MATER CHEM PHYS, V216, P380, DOI 10.1016/j.matchemphys.2018.06.020
   Azarang M, 2015, RSC ADV, V5, P21888, DOI 10.1039/c4ra16767h
   Chang YC, 2016, J ALLOY COMPD, V664, P538, DOI 10.1016/j.jallcom.2016.01.010
   Chen DM, 2014, J PHYS CHEM C, V118, P15300, DOI 10.1021/jp5033349
   Cheng YW, 2017, J CLEAN PROD, V162, P205, DOI 10.1016/j.jclepro.2017.06.023
   Cui Y, 2012, ANAL METHODS-UK, V4, P3095, DOI 10.1039/c2ay25656h
   Ding YH, 2018, DALTON T, V47, P684, DOI 10.1039/c7dt03256k
   Foteinis S, 2018, J CLEAN PROD, V182, P8, DOI 10.1016/j.jclepro.2018.02.038
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Ghanbarnezhad S, 2017, MAT SCI SEMICON PROC, V72, P85, DOI 10.1016/j.mssp.2017.09.015
   Gilja V, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7120412
   Guo M, 2017, SMALL, V13, DOI 10.1002/smll.201701275
   Guo YX, 2016, APPL SURF SCI, V384, P83, DOI 10.1016/j.apsusc.2016.04.036
   Huang YH, 2015, SENSOR ACTUAT B-CHEM, V212, P165, DOI 10.1016/j.snb.2015.02.013
   Jiang M, 2016, ELECTROCHIM ACTA, V196, P699, DOI 10.1016/j.electacta.2016.02.094
   Jiang TF, 2018, J ALLOY COMPD, V769, P605, DOI 10.1016/j.jallcom.2018.07.328
   Karunakaran C, 2014, LANGMUIR, V30, P15031, DOI 10.1021/la5039409
   Kaur M, 2015, MATER LETT, V154, P90, DOI 10.1016/j.matlet.2015.04.070
   Kaur S, 2016, SUPERLATTICE MICROST, V98, P86, DOI 10.1016/j.spmi.2016.08.011
   Kuo CH, 2012, J AM CHEM SOC, V134, P14345, DOI 10.1021/ja306869j
   Liang P, 2016, RSC ADV, V6, P95903, DOI 10.1039/c6ra20667k
   Lin L, 2015, NANOSCALE, V7, P7615, DOI 10.1039/c5nr00257e
   Liu JY, 2016, SENSOR ACTUAT B-CHEM, V234, P84, DOI 10.1016/j.snb.2016.04.073
   Low JX, 2015, J PHYS CHEM LETT, V6, P4244, DOI 10.1021/acs.jpclett.5b01610
   Lu B, 2018, CARBON, V132, P191, DOI 10.1016/j.carbon.2018.02.038
   Peng YG, 2018, CHEM ENG J, V333, P678, DOI 10.1016/j.cej.2017.09.138
   Qi Q, 2017, J SOLID STATE CHEM, V255, P108, DOI 10.1016/j.jssc.2017.08.004
   Sampaio MJ, 2017, CHEM ENG J, V318, P95, DOI 10.1016/j.cej.2016.05.105
   Shi PC, 2017, J MATER CHEM A, V5, P12322, DOI 10.1039/c7ta02999c
   Shinde SS, 2012, J PHOTOCH PHOTOBIO B, V113, P70, DOI 10.1016/j.jphotobiol.2012.05.008
   Song C, 2012, RSC ADV, V2, P7400, DOI 10.1039/c2ra20874a
   Song JK, 2016, ELECTROCHIM ACTA, V222, P1, DOI 10.1016/j.electacta.2016.11.011
   Tian XL, 2016, GLOBAL ENVIRON CHANG, V39, P244, DOI 10.1016/j.gloenvcha.2016.05.014
   Wang J, 2016, PHYSICA E, V75, P66, DOI 10.1016/j.physe.2015.08.040
   Wang LJ, 2017, PHYS CHEM CHEM PHYS, V19, P16576, DOI 10.1039/c7cp01687e
   Wang XB, 2016, ACS APPL MATER INTER, V8, P9080, DOI 10.1021/acsami.6b00028
   Wang Y, 2019, CHEM ENG J, V356, P746, DOI 10.1016/j.cej.2018.09.015
   Wang YY, 2018, APPL CATAL B-ENVIRON, V237, P633, DOI 10.1016/j.apcatb.2018.06.013
   Winter A, 2011, ADV MATER, V23, P5728, DOI 10.1002/adma.201103612
   Xu SZ, 2017, CHEM ENG J, V323, P502, DOI 10.1016/j.cej.2017.04.093
   Yang H, 2017, SUPERLATTICE MICROST, V111, P687, DOI 10.1016/j.spmi.2017.07.025
   Yang SJ, 2011, J HAZARD MATER, V186, P376, DOI 10.1016/j.jhazmat.2010.11.019
   Yang Y, 2018, J ALLOY COMPD, V769, P257, DOI 10.1016/j.jallcom.2018.07.366
   Yao YJ, 2018, J COLLOID INTERF SCI, V529, P100, DOI 10.1016/j.jcis.2018.05.077
   Yildirim OA, 2016, APPL SURF SCI, V390, P111, DOI 10.1016/j.apsusc.2016.08.069
   Zhan WW, 2013, J AM CHEM SOC, V135, P1926, DOI 10.1021/ja311085e
   Zhang CY, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/35/355402
   Zhang HD, 2017, J PHYS CHEM C, V121, P24000, DOI 10.1021/acs.jpcc.7b06405
   Zhang JJ, 2018, ACS SUSTAIN CHEM ENG, V6, P12893, DOI 10.1021/acssuschemeng.8b02264
   Zhang XP, 2018, ANALYST, V143, P2837, DOI 10.1039/c8an00515j
   Zhao SW, 2017, J ALLOY COMPD, V695, P1029, DOI 10.1016/j.jallcom.2016.10.226
NR 52
TC 1
Z9 1
U1 24
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115185
DI 10.1016/j.ces.2019.115185
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500042
DA 2020-05-12
ER

PT J
AU Hutfles, J
   Lumley, C
   Chen, X
   Ren, ZJ
   Pellegrino, J
AF Hutfles, Jacob
   Lumley, Connor
   Chen, Xi
   Ren, Zhiyong Jason
   Pellegrino, John
TI Graphene-integrated polymeric membrane as a flexible, multifunctional
   electrode
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Graphene transfer; Polysulfone membrane; Supercapacitor; Electrolysis;
   Electrode; UV surface treatment
ID LAYERED GRAPHENE; OXIDE; TRANSPORT; CARBON; WATER; SEPARATION;
   EVOLUTION; TRANSPARENT; MECHANISMS; FILMS
AB Herein, we report on the fabrication of a graphene-based, semi-permeable membrane electrode (gr-ME) using non-solvent phase inversion to confine a packed-layer of graphene nanosheets into a <= 1 mu m thick surface layer that smoothly transitions into the microporous membrane, primarily using polysulfone. The gr-MEs have: (i) gas permeance on the order of 100-1000 GPU with similar to 0.3 CO2/N-2 ideal selectivity (lower than Knudsen diffusion expectations); (ii) salt water permeance (similar to 5 LMH/bar) with NaCl rejection 20-40%, on the order of nanofiltration membranes, as well as, (iii) high electronic surface conductivity, with a sheet resistance as low as similar to 18 Omega/sq. We've characterized the durability using tensile testing and it retains electrical conductivity when stretched until fracture at 9.5%. Electrochemical activity for these gr-MEs have been demonstrated for both the hydrogen evolution reaction, and as electrochemical capacitors. Finally, we illustrate that the capacitance can be increased by UV surface treatment of the graphene layer. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hutfles, Jacob; Lumley, Connor; Pellegrino, John] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   [Chen, Xi; Ren, Zhiyong Jason] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA.
   [Chen, Xi; Ren, Zhiyong Jason] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.
   [Chen, Xi; Ren, Zhiyong Jason] Princeton Univ, Andlinger Ctr Energy & Environm, Princeton, NJ 08544 USA.
RP Pellegrino, J (reprint author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
EM john.pellegino@colorado.edu
CR Ahmed F, 2016, DESALINATION, V391, P1, DOI 10.1016/j.desal.2016.01.030
   Anderko A, 2002, FLUID PHASE EQUILIBR, V194, P123, DOI 10.1016/S0378-3812(01)00645-8
   Baker R.W., 2004, MEMBRANE TECHNOLOGY
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   de Lannoy CF, 2012, J MEMBRANE SCI, V415, P718, DOI 10.1016/j.memsci.2012.05.061
   De S, 2010, SMALL, V6, P458, DOI 10.1002/smll.200901162
   Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Duan WY, 2016, ACS APPL MATER INTER, V8, P22574, DOI 10.1021/acsami.6b07196
   Dudchenko AV, 2014, J MEMBRANE SCI, V468, P1, DOI 10.1016/j.memsci.2014.05.041
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Guo XT, 2017, ENERGY STORAGE MATER, V9, P150, DOI 10.1016/j.ensm.2017.07.006
   Gupta A, 2006, NANO LETT, V6, P2667, DOI 10.1021/nl061420a
   Han Y, 2013, ADV FUNCT MATER, V23, P3693, DOI 10.1002/adfm.201202601
   Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215
   Hou DX, 2018, ENVIRON SCI TECHNOL, V52, P8930, DOI 10.1021/acs.est.8b01349
   Hu M, 2013, ENVIRON SCI TECHNOL, V47, P3715, DOI 10.1021/es400571g
   Huang HB, 2013, CHEM COMMUN, V49, P5963, DOI 10.1039/c3cc41953c
   HULL TR, 1987, VACUUM, V37, P327, DOI 10.1016/0042-207X(87)90018-2
   Hutfles J, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.45993
   Johnson DW, 2015, CURR OPIN COLLOID IN, V20, P367, DOI 10.1016/j.cocis.2015.11.004
   Khan U, 2011, LANGMUIR, V27, P9077, DOI 10.1021/la201797h
   Kidambi PR, 2018, ACS APPL MATER INTER, V10, P10369, DOI 10.1021/acsami.8b00846
   Kim HW, 2013, SCIENCE, V342, P91, DOI 10.1126/science.1236098
   Kim H, 2010, MACROMOLECULES, V43, P6515, DOI 10.1021/ma100572e
   Kim JH, 1998, J MEMBRANE SCI, V138, P153, DOI 10.1016/S0376-7388(97)00224-X
   Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/nnano.2012.162, 10.1038/NNANO.2012.162]
   Lan R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01145
   Lawrence J, 2008, J MEMBRANE SCI, V325, P633, DOI 10.1016/j.memsci.2008.08.027
   Li HY, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601847
   Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b
   Liu GP, 2015, CHEM SOC REV, V44, P5016, DOI 10.1039/c4cs00423j
   Liu YB, 2014, J MATER CHEM A, V2, P16554, DOI 10.1039/c4ta04006f
   Lu GL, 2016, J POWER SOURCES, V315, P302, DOI 10.1016/j.jpowsour.2016.03.028
   Lu L, 2016, ELECTROCHIM ACTA, V206, P381, DOI 10.1016/j.electacta.2016.04.167
   Majumder M, 2007, LANGMUIR, V23, P8624, DOI 10.1021/la700686k
   Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694
   Pei SF, 2012, CARBON, V50, P3210, DOI 10.1016/j.carbon.2011.11.010
   Pellegrino J, 2003, ANN NY ACAD SCI, V984, P289, DOI 10.1111/j.1749-6632.2003.tb06007.x
   Qin YZ, 2017, ACS APPL MATER INTER, V9, P9239, DOI 10.1021/acsami.7b00504
   Ronen A, 2016, REV CHEM ENG, V32, P533, DOI 10.1515/revce-2015-0060
   Rupiasih N. N., 2013, OPEN J ORG POLYM MAT, V3, P12, DOI DOI 10.4236/OJOPM.2013.31003
   Shi Y, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/2/024004
   Soldano C, 2010, CARBON, V48, P2127, DOI 10.1016/j.carbon.2010.01.058
   Teo EYL, 2016, ELECTROCHIM ACTA, V192, P110, DOI 10.1016/j.electacta.2016.01.140
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   Verdejo R, 2011, J MATER CHEM, V21, P3301, DOI 10.1039/c0jm02708a
   Wahyudi W, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802244
   Wan WB, 2017, PROG CHEM, V29, P833, DOI 10.7536/PC170501
   Wang GK, 2012, SMALL, V8, P452, DOI 10.1002/smll.201101719
   Wang LD, 2015, NAT NANOTECHNOL, V10, P785, DOI [10.1038/NNANO.2015.158, 10.1038/nnano.2015.158]
   Weng Z, 2011, ADV ENERGY MATER, V1, P917, DOI 10.1002/aenm.201100312
   Woods J, 2011, J MEMBRANE SCI, V368, P124, DOI 10.1016/j.memsci.2010.11.041
   Wu Q, 2010, ACS NANO, V4, P1963, DOI 10.1021/nn1000035
   Wu ZS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3487
   Xie AZ, 2017, ACS APPL MATER INTER, V9, P4643, DOI 10.1021/acsami.6b14732
   Yang TS, 2019, CHEM MATER, V31, P1829, DOI 10.1021/acs.chemmater.8b03820
   Yoon HW, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0024
   Yoon Y, 2002, DESALINATION, V147, P11, DOI 10.1016/S0011-9164(02)00564-7
   Yoon YM, 2004, SEP SCI TECHNOL, V39, P2105, DOI 10.1081/SS-120039304
   Zhang QY, 2014, J MEMBRANE SCI, V459, P143, DOI 10.1016/j.memsci.2014.02.017
   Zhang SL, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401401
   Zhong C, 2015, CHEM SOC REV, V44, P7484, DOI 10.1039/c5cs00303b
NR 62
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115221
DI 10.1016/j.ces.2019.115221
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500019
DA 2020-05-12
ER

PT J
AU Ilic, D
   Roberts, A
   Wheeler, C
AF Ilic, D.
   Roberts, A.
   Wheeler, C.
TI Modelling bulk solid interactions in transfer chutes: Accelerated flow
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Transfer chute design; Continuum; DEM; Accelerated flow; Belt conveying
ID STRESS CALCULATIONS; GRANULAR-MATERIALS; ROLLING FRICTION; GRAVITY FLOW;
   FORCE MODELS; DISCRETE; DEM; CALIBRATION; ASSEMBLIES; SIMULATION
AB The continuum method is an approach to model transfer chutes characterised by accelerated flow conditions, with origins stemming from free flowing materials. Physical bulk solid properties obtained through laboratory tests are incorporated and the focus is to maintain a rapidly moving stream, with minimum variation in velocity across the burden depth.
   Due to structural elements, it is difficult to quantify flow occurring inside and as such, accurate site validation is scarce. Discrete Element Modelling (DEM) provides a solution enabling flow visualisation, and a unique means of both qualitative and quantitative analyses.
   This paper presents application of both methods in a real high throughput installation comprising a bifurcated chute arrangement transferring coal from one delivery conveyor to two receiving conveyors. The results show that both methods can model the type of flow exhibited and presented is a comparison between qualitative site observations and material flow profiles calculated using each method. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ilic, D.; Roberts, A.; Wheeler, C.] Univ Newcastle, Newcastle Inst Energy & Resources, Sch Engn, Callaghan, NSW, Australia.
RP Ilic, D (reprint author), Univ Newcastle, Newcastle Inst Energy & Resources, Sch Engn, Callaghan, NSW, Australia.
EM dusan.ilic@newcastle.edu.au
RI Ilic, Dusan/O-4457-2016
OI Ilic, Dusan/0000-0002-5880-0233
CR Ai J, 2011, POWDER TECHNOL, V206, P269, DOI 10.1016/j.powtec.2010.09.030
   [Anonymous], 1977, DUNL CONV MAN
   BATHURST RJ, 1988, J APPL MECH-T ASME, V55, P17, DOI 10.1115/1.3173626
   CHARLTON WH, 1970, J AGR ENG RES, V15, P292, DOI 10.1016/0021-8634(70)90125-3
   Chiarella C., 1973, J ENG IND, P1
   Cleary PW, 2004, ENG COMPUTATION, V21, P169, DOI 10.1108/02644400410519730
   Coetzee CJ, 2017, POWDER TECHNOL, V310, P104, DOI 10.1016/j.powtec.2017.01.015
   Conveyor Equipment Manufacturers Association (CEMA), 2005, BELT CONV BULK MAT
   Cundall P.A., 1971, ROCK FRACT P INT S R, V1
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Dewicki G., 2002, P 3 INT C DISCR EL M
   Di Renzo A, 2004, CHEM ENG SCI, V59, P525, DOI 10.1016/j.ces.2003.09.037
   Donohue T.J., 2010, AUST BULK HANDLING R, V11, P62
   Easo L.A., 2013, AICHE ANN C
   Grima A.P., 2011, THESIS
   Grima AP, 2011, GRANUL MATTER, V13, P127, DOI 10.1007/s10035-010-0197-4
   Groger T, 2003, POWDER TECHNOL, V133, P203, DOI 10.1016/S0032-5910(03)00093-7
   Gutierrez Alejandro, 2014, ASME INT MECH ENG C
   Hastie D.B., 2010, THESIS
   Hustrulid A.I., 1998, P ANN M SOC MIN ENG, P33
   Hustrulid AI, 1996, BULK MATERIAL HANDLING BY CONVEYOR BELT, P9
   Ilic D, 2019, POWDER TECHNOL, V354, P30, DOI 10.1016/j.powtec.2019.05.058
   Ilic D., 2013, THESIS
   Ilic D., 2007, 9 INT C BULK MAT STO
   Ilic D, 2019, WEAR, V434, DOI 10.1016/j.wear.2019.202986
   Ilic D, 2017, ADV POWDER TECHNOL, V28, P2410, DOI 10.1016/j.apt.2017.06.024
   Katterfeld A., 2008, C P CD
   Katterfeld A., 2010, BULK SOLIDS INDIA
   Katterfeld A., 2009, CHOPS ICBMH 09
   Katterfeld A., 2007, BULK SOLIDS POWDER S, V2
   Kessler F, 2009, FME TRANS, V37, P185
   KORZEN Z, 1988, [No title captured], V8, P689
   Kruggel-Emden H, 2007, POWDER TECHNOL, V171, P157, DOI 10.1016/j.powtec.2006.10.004
   Li YJ, 2005, POWDER TECHNOL, V160, P219, DOI 10.1016/j.powtec.2005.09.002
   LUDING S, 2006, BEHAV GRANULAR MEDIA, P137
   Max Stein F., 1980, J MATH ASS AM, V11, P239
   Nordell L. K., 1994, BULK SOLIDS HANDLING, V14, P739
   Potapov A., 2013, COMPUTER SIMULATION
   Roberts A.W., 2004, FLOW DYNAMICS WEAR C, P330
   Roberts A.W., 1998, BULK SOLIDS HANDLING, V18, P49
   Roberts A.W., 1998, BASIC PRINCIPLES BUL
   Roberts AW, 2005, CHARACTERISATION OF BULK SOLIDS, P85, DOI 10.1002/9781444305456.ch3
   Roberts AW, 2003, CHEM ENG TECHNOL, V26, P163, DOI 10.1002/ceat.200390024
   ROBERTS AW, 1969, J ENG IND, V91, P373, DOI 10.1115/1.3591575
   ROBERTS AW, 1971, T ASAE, V14, P304
   ROBERTS AW, 1981, BULK SOLIDS HANDLING, V1, P715
   Roessler T, 2019, PARTICUOLOGY, V45, P105, DOI 10.1016/j.partic.2018.08.005
   Russell A, 2014, CHEM ENG SCI, V114, P70, DOI 10.1016/j.ces.2014.04.016
   Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129
   SCOTT OJ, 1993, TRIBOL INT, V26, P353, DOI 10.1016/0301-679X(93)90072-9
   Teffo VB, 2013, J S AFR I MIN METALL, V113, P351
   Thakur SC, 2014, GRANUL MATTER, V16, P383, DOI 10.1007/s10035-014-0506-4
   Walton O.R., 1994, FORCE MODELS PARTICL, P1
   Walton O.R., 1990, INT S SCI C P FORM, P175
   WALTON OR, 1986, J RHEOL, V30, P949, DOI 10.1122/1.549893
   WALTON OR, 1986, ACTA MECH, V63, P73, DOI 10.1007/BF01182541
   Walton OR, 1993, PARTICULATE 2 PHASE, P884
   Wassgren C, 2008, PSL LECT 06 INTR S 1
   Wassgren C., 2008, PSL LECT 09 TANG CON
   Wassgren C., 2008, PSL LECT 07 NORM C 2
   Wensrich CM, 2012, POWDER TECHNOL, V217, P409, DOI 10.1016/j.powtec.2011.10.057
   Zhou C, 2009, MECH MATER, V41, P707, DOI 10.1016/j.mechmat.2009.01.017
   Zhou YC, 2002, POWDER TECHNOL, V125, P45, DOI 10.1016/S0032-5910(01)00520-4
   Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006
NR 64
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115197
DI 10.1016/j.ces.2019.115197
PG 18
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500026
DA 2020-05-12
ER

PT J
AU Janbazi, H
   Karakaya, Y
   Kasper, T
   Schulz, C
   Wlokas, I
   Peukert, S
AF Janbazi, H.
   Karakaya, Y.
   Kasper, T.
   Schulz, C.
   Wlokas, I.
   Peukert, S.
TI Development and evaluation of a chemical kinetics reaction mechanism for
   tetramethylsilane-doped flames
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Tetramethylsilane; Reaction mechanisms; Genetic algorithm;
   Flame-synthesized nanoparticles; Molecular-beam mass spectrometry;
   Quantum-chemical calculations
ID TEMPERATURE RATE CONSTANTS; THERMODYNAMIC PROPERTIES; PHASE SYNTHESIS;
   SILICON; THERMOCHEMISTRY; OXIDATION; DECOMPOSITION; PYROLYSIS;
   MOLECULES; HYDROGEN
AB Tetramethysilane (TMS) is a precursor for flame synthesis of silica (SiO2) nanoparticles. A chemical reaction mechanism was developed for the oxidation of TMS in a lean low-pressure (p approximate to 30 mbar) H-2/O-2/Ar flame using species mole fractions, obtained from molecular-beam mass spectrometry (MBMS) measurements in a matrix-supported flat flame doped with 600 ppm TMS. The thermodynamic data of Si-containing species were determined from quantum-chemical calculations at the G4 level of theory. The formation and subsequent consumption of Si(OH)(4), one of the main products of TMS oxidation, and the formation of Si4O10H4 clusters are hypothesized to be the primary pathway in the synthesis of silica nanoparticles. The reaction rate coefficients are either estimated via an algorithmic optimization procedure or are assumed based on analogies to similar reactions in the literature. The mechanism was further validated based on MBMS measurements with the same base flame doped with 400 and 800 ppm TMS. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Janbazi, H.; Wlokas, I.] Univ Duisburg Essen, Inst Combust & Gas Dynam Fluid Dynam IVG, D-47048 Duisburg, Germany.
   [Karakaya, Y.; Kasper, T.] Univ Duisburg Essen, Inst Combust & Gas Dynam Thermodynam IVG, D-47048 Duisburg, Germany.
   [Schulz, C.] Univ Duisburg Essen, Inst Combust & Gas Dynam React Fluids IVG, D-47048 Duisburg, Germany.
   [Kasper, T.; Schulz, C.; Wlokas, I.; Peukert, S.] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CENIDE, D-47048 Duisburg, Germany.
RP Janbazi, H (reprint author), Univ Duisburg Essen, Inst Combust & Gas Dynam Fluid Dynam, D-47048 Duisburg, Germany.
EM hossein.janbazi@uni-due.de
RI ; Schulz, Christof/A-5711-2010; Kasper, Tina/A-2975-2017
OI Wlokas, Irenaeus/0000-0003-0390-1106; Schulz,
   Christof/0000-0002-6879-4826; Kasper, Tina/0000-0003-3993-5316
FU German Research Foundation (DFG)German Research Foundation (DFG) [FOR
   2284, 262219004, WL 63/1, KA 3871/4, SCHU 1369/25]
FX The authors gratefully acknowledge the financial support by the German
   Research Foundation (DFG, FOR 2284, project number: 262219004, within WL
   63/1, KA 3871/4, and SCHU 1369/25). We would like to thank Andreas
   Kempf, Robin Chrystie, and Thomas Dreier for helpful discussions.
CR ALLENDORF MD, 1995, J PHYS CHEM-US, V99, P15285, DOI 10.1021/j100041a052
   Bahlawane N, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2426876
   BALDWIN AC, 1978, J CHEM SOC FARAD T 1, V74, P2171, DOI 10.1039/f19787402171
   BENAMOTZ D, 1993, J PHYS CHEM-US, V97, P7736, DOI 10.1021/j100131a051
   BRITTEN JA, 1991, S INT COMB P, V23, P195, DOI DOI 10.1016/S0082-0784(06)80259-6
   BRIX T, 1989, J PHYS CHEM-US, V93, P8193, DOI 10.1021/j100362a011
   Canneaux S, 2014, J COMPUT CHEM, V35, P82, DOI 10.1002/jcc.23470
   Chagger HK, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P1859
   Chase J. M. W., 1985, J PHYS CHEM REFER S1, V14, P1, DOI DOI 10.1021/AC00209A714
   CHASE MW, 1998, J PHYS CHEM
   Chaussende D, 2005, CRYST GROWTH DES, V5, P1539, DOI 10.1021/cg050009i
   Chen J, 2018, J NON-CRYST SOLIDS, V481, P33, DOI 10.1016/j.jnoncrysol.2017.10.014
   Chrystie RSM, 2019, APPL PHYS B-LASERS O, V125, DOI 10.1007/s00340-019-7137-8
   Chrystie RSM, 2019, P COMBUST INST, V37, P1221, DOI 10.1016/j.proci.2018.07.024
   CLIFFORD RP, 1972, J ORGANOMET CHEM, V34, P53, DOI 10.1016/S0022-328X(00)88670-2
   COHEN N, 1991, J PHYS CHEM REF DATA, V20, P1211, DOI 10.1063/1.555901
   Cool TA, 2005, P COMBUST INST, V30, P1681, DOI 10.1016/j.proci.2004.08.103
   Curran HJ, 2006, INT J CHEM KINET, V38, P250, DOI 10.1002/kin.20153
   Curtiss LA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2436888
   DAVIDSON IMT, 1976, J CHEM SOC FARAD T 1, V72, P1088, DOI 10.1039/f19767201088
   DAVIDSON IMT, 1981, J CHEM SOC CHEM COMM, P52, DOI 10.1039/c39810000052
   Deng L, 2015, COMBUST FLAME, V162, P1737, DOI 10.1016/j.combustflame.2014.11.035
   DONCASTER AM, 1986, J CHEM SOC FARAD T 2, V82, P707, DOI 10.1039/f29868200707
   Feroughi OM, 2017, P COMBUST INST, V36, P1045, DOI 10.1016/j.proci.2016.07.131
   Glumac NG, 2001, COMBUST FLAME, V124, P702, DOI 10.1016/S0010-2180(00)00247-9
   Goodwin D., 2009, CANTERA OBJECT ORIEN
   GUNN SR, 1961, J PHYS CHEM-US, V65, P779, DOI 10.1021/j100823a018
   GUNN SR, 1964, J PHYS CHEM-US, V68, P946, DOI 10.1021/j100786a501
   GUSELNIKOV LE, 1979, J ORGANOMET CHEM, V169, P155, DOI 10.1016/S0022-328X(00)81154-7
   Hartlieb AT, 2000, COMBUST FLAME, V121, P610, DOI 10.1016/S0010-2180(99)00176-5
   Janbazi H, 2018, INT J CHEM KINET, V50, P681, DOI 10.1002/kin.21192
   Karakaya Y, 2018, J PHYS CHEM A, V122, P7131, DOI 10.1021/acs.jpca.8b06510
   Kee R. J., 2000, CHEMKIN COLLECTION R
   KHABASHESKU VN, 1988, J ORGANOMET CHEM, V347, P277, DOI 10.1016/0022-328X(88)80151-7
   Li J, 2007, INT J CHEM KINET, V39, P109, DOI 10.1002/kin.20218
   Lindackers D, 1997, COMBUST SCI TECHNOL, V123, P287, DOI 10.1080/00102209708935632
   Ma HK, 2003, J THERM SCI, V12, P89, DOI 10.1007/s11630-003-0014-z
   Miyoshi A., 2017, GPOP PROGRAM SUITE
   Nurkowski D, 2016, COMBUST FLAME, V166, P243, DOI 10.1016/j.combustflame.2016.01.025
   Nurkowski D, 2015, P COMBUST INST, V35, P2291, DOI 10.1016/j.proci.2014.06.093
   O Conaire M, 2004, INT J CHEM KINET, V36, P603, DOI 10.1002/kin.20036
   Ochterski JW, 2000, THERMOCHEMISTRY GAUS, P1
   Peukert S, 2018, INT J CHEM KINET, V50, P57, DOI 10.1002/kin.21140
   Phadungsukanan W, 2009, J PHYS CHEM A, V113, P9041, DOI 10.1021/jp905494s
   Pitzer KS, 1942, J CHEM PHYS, V10, P428, DOI 10.1063/1.1723744
   Plane JMC, 2016, J GEOPHYS RES-ATMOS, V121, P3718, DOI 10.1002/2015JD024691
   Pratsinis SE, 1998, PROG ENERG COMBUST, V24, P197, DOI 10.1016/S0360-1285(97)00028-2
   Ranzi E, 2015, COMBUST FLAME, V162, P1679, DOI 10.1016/j.combustflame.2014.11.030
   Reed M.A., 1973, THERMAL REACTION TET
   Schulz C, 2019, P COMBUST INST, V37, P83, DOI 10.1016/j.proci.2018.06.231
   Sela P, 2019, P COMBUST INST, V37, P1133, DOI 10.1016/j.proci.2018.05.084
   Sela P, 2018, PHYS CHEM CHEM PHYS, V20, P10686, DOI 10.1039/c7cp06827a
   Shekar S, 2012, CHEM ENG SCI, V70, P54, DOI 10.1016/j.ces.2011.06.010
   Sikalo N, 2014, INT J CHEM KINET, V46, P41, DOI 10.1002/kin.20826
   Sikalo N, 2015, INT J CHEM KINET, V47, P695, DOI 10.1002/kin.20942
   Simmie JM, 2016, J PHYS CHEM A, V120, P7370, DOI 10.1021/acs.jpca.6b07503
   Sivaramakrishnan R, 2009, P COMBUST INST, V32, P107, DOI 10.1016/j.proci.2008.05.018
   SMITH GP, 1978, INT J CHEM KINET, V10, P489, DOI 10.1002/kin.550100507
   Srinivasan NK, 2003, J PHYS CHEM A, V107, P1532, DOI 10.1021/jp027224j
   Struckmeier U, 2009, Z PHYS CHEM, V223, P503, DOI 10.1524/zpch.2009.6049
   Suh SM, 2001, J VAC SCI TECHNOL A, V19, P940, DOI 10.1116/1.1355757
   TAYLOR JE, 1978, J PHYS CHEM-US, V82, P847, DOI 10.1021/j100497a001
   Timoshkin A.Y., 2001, HIGH TEMPERATURE COR, P262
   Varga T, 2016, INT J CHEM KINET, V48, P407, DOI 10.1002/kin.21006
   WALSH R, 1989, CHEM ORGANIC SILICON
   Wegner K, 2005, POWDER TECHNOL, V150, P117, DOI 10.1016/j.powtec.2004.11.022
   Xu C, 2000, J PHYS CHEM A, V104, P9518, DOI 10.1021/jp002695w
   Yeh C. L., 2001, J THERM SCI, V10, P92
   ZACHARIAH MR, 1994, J AEROSOL SCI, V25, P487, DOI 10.1016/0021-8502(94)90066-3
   ZACHARIAH MR, 1990, J APPL PHYS, V68, P311, DOI 10.1063/1.347134
   ZACHARIAH MR, 1995, J PHYS CHEM-US, V99, P5308, DOI 10.1021/j100015a012
   ZACHARIAH MR, 1989, HIGH TEMP SCI, V28, P113
NR 72
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115209
DI 10.1016/j.ces.2019.115209
PG 17
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500012
DA 2020-05-12
ER

PT J
AU Jiao, L
   Wang, ZB
   Chen, R
   Zhu, X
   Liao, Q
   Ye, DD
   Zhang, B
   Li, W
   Li, DL
AF Jiao, Long
   Wang, Zhibin
   Chen, Rong
   Zhu, Xun
   Liao, Qiang
   Ye, Dingding
   Zhang, Biao
   Li, Wei
   Li, Dongliang
TI Simulation on the Marangoni flow and heat transfer in a laser-heated
   suspended droplet
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Suspended droplet; Photothermal effect; Non-uniform temperature
   distribution; Marangoni flow; Temperature control
ID REAL-TIME PCR; TEMPERATURE; EVAPORATION; MANIPULATION; ABSORPTION;
   CONVECTION
AB In this study, the Marangoni flow and heat transfer inside a laser-heated water droplet suspended in the immiscible oil phase is numerically investigated. It is shown that the Marangoni flow is induced by non-uniform temperature distribution across the droplet interface caused by the localized heating source. Effects of the laser power, laser beam size and surface tension temperature coefficient are investigated. Simulation results show that the temperature rising rate and average temperature rising linearly increase with laser power due to more heat generated by photothermal effect and the Marangoni flow is intensified due to larger interface temperature gradient. With increasing laser beam diameter, the temperature distribution becomes more uniform due to more uniform laser energy distribution. The Marangoni flow is reverse when the surface tension temperature coefficient changes from the positive to the negative and vice versa, resulting in the transformation of the Marangoni flow and temperature distribution. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Chen, Rong] Chongqing Univ, Key Lab Low Grade Energy Utilizat Technol & Syst, Minist Educ, Chongqing 400030, Peoples R China.
   Chongqing Univ, Sch Energy & Power Engn, Inst Engn Thermophys, Chongqing 400030, Peoples R China.
RP Chen, R (reprint author), Chongqing Univ, Key Lab Low Grade Energy Utilizat Technol & Syst, Minist Educ, Chongqing 400030, Peoples R China.
EM rchen@cqu.edu.cn
RI Zhu, Xun/AAL-6459-2020
OI Jiao, Long/0000-0001-9595-228X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51576021, 51620105011]; Program for Back-up Talent
   Development of Chongqing University [CQU2017HBRC1A01]; Fundamental
   Research Funds for the Central UniversitiesFundamental Research Funds
   for the Central Universities [2018CDXYDL0001]
FX The authors acknowledge the financial supports of the National Natural
   Science Foundation of China (Nos. 51576021 and 51620105011), the Program
   for Back-up Talent Development of Chongqing University (No.
   CQU2017HBRC1A01) and the Fundamental Research Funds for the Central
   Universities (No. 2018CDXYDL0001).
CR Albernaz DL, 2016, INT J HEAT MASS TRAN, V97, P853, DOI 10.1016/j.ijheatmasstransfer.2016.02.073
   Antonakakis T, 2013, INT J HEAT MASS TRAN, V62, P314, DOI 10.1016/j.ijheatmasstransfer.2013.02.061
   Baigl D, 2012, LAB CHIP, V12, P3637, DOI 10.1039/c2lc40596b
   Baret JC, 2012, LAB CHIP, V12, P422, DOI 10.1039/c1lc20582j
   Chakraborty N, 2007, INT J HEAT MASS TRAN, V50, P1805, DOI 10.1016/j.ijheatmasstransfer.2006.10.030
   Chen R, 2018, APPL THERM ENG, V144, P945, DOI 10.1016/j.applthermaleng.2018.09.011
   Dressler OJ, 2014, J BIOMOL SCREEN, V19, P483, DOI 10.1177/1087057113510401
   Fradet E, 2011, LAB CHIP, V11, P4228, DOI 10.1039/c1lc20541b
   Hettiarachchi K, 2012, MICROFLUID NANOFLUID, V13, P967, DOI 10.1007/s10404-012-1016-5
   Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633
   Jiao L., 2019, SENSOR ACTUAT B-CHEM, V191, P305
   Jung YC, 2009, LANGMUIR, V25, P14165, DOI 10.1021/la901906h
   Keskin S, 2012, ANALYST, V137, P2651, DOI 10.1039/c2an16296b
   Khwaja TS, 2019, APPL OPTICS, V58, P1048, DOI 10.1364/AO.58.001048
   Ki H, 2002, METALL MATER TRANS A, V33, P1817, DOI 10.1007/s11661-002-0190-6
   Kim H, 2009, OPT EXPRESS, V17, P218, DOI 10.1364/OE.17.000218
   Kolluri N, 2018, LAB CHIP, V18, P75, DOI 10.1039/c7lc00758b
   Kou HB, 2019, FLUID PHASE EQUILIBR, V484, P53, DOI 10.1016/j.fluid.2018.11.024
   Li ZY, 2013, OPT EXPRESS, V21, P1281, DOI 10.1364/OE.21.001281
   Lignos I, 2016, NANO LETT, V16, P1869, DOI 10.1021/acs.nanolett.5b04981
   Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046
   Miralles V, 2013, DIAGNOSTICS, V3, P33, DOI 10.3390/diagnostics3010033
   Mullick S, 2011, APPL OPTICS, V50, P6319, DOI 10.1364/AO.50.006319
   Nguyen NT, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8060186
   Neto AI, 2014, ADV FUNCT MATER, V24, P5096, DOI 10.1002/adfm.201400503
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Raghuram S, 2012, INT J HEAT MASS TRAN, V55, P7949, DOI 10.1016/j.ijheatmasstransfer.2012.08.025
   Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601
   Son JH, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.53
   Song C, 2014, SOFT MATTER, V10, P2679, DOI 10.1039/c2sm27207e
   Tan JL, 2018, MRS COMMUN, V8, P1178, DOI 10.1557/mrc.2018.180
   Tang ZL, 2012, BIOMATERIALS, V33, P7405, DOI 10.1016/j.biomaterials.2012.06.077
   Venancio-Marques A, 2014, LANGMUIR, V30, P4207, DOI 10.1021/la5001254
   Walsh T, 2015, ANALYST, V140, P1535, DOI 10.1039/c4an01750a
   Wang ZB, 2017, INT J HEAT MASS TRAN, V113, P975, DOI 10.1016/j.ijheatmasstransfer.2017.05.123
   Wei JF, 2013, APPL PHYS B-LASERS O, V110, P573, DOI 10.1007/s00340-012-5294-0
NR 36
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115202
DI 10.1016/j.ces.2019.115202
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500037
DA 2020-05-12
ER

PT J
AU Jourshabani, M
   Dominic, JA
   Achari, G
   Shariatinia, Z
AF Jourshabani, Milad
   Dominic, John Albino
   Achari, Gopal
   Shariatinia, Zahra
TI Synergetic photocatalytic ozonation using modified graphitic carbon
   nitride for treatment of emerging contaminants under UVC, UVA and
   visible irradiation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Carbon nitride-based photocatalysts; Degradation; Mineralization;
   Emerging contaminants; Irradiation wavelengths
ID LIGHT-DRIVEN PHOTODEGRADATION; IN-SITU CONSTRUCTION; BISPHENOL-A;
   NANOCOMPOSITE PHOTOCATALYSTS; G-C3N4 NANOCOMPOSITES; DOPED G-C3N4;
   DEGRADATION; EFFICIENT; WATER; HETEROJUNCTION
AB This work unmask the ability of modified graphitic carbon nitride photocatalysts in terms of both degradation and mineralization of bisphenol A (BPA, 50 mg/L) as well as carbamazepine (CBZ, 10 mg/L) as visible-light insensitive pollutants by integrated photocatalytic ozonation treatment. The effects of different light irradiation wavelengths i.e., 80 W UVC (lambda= 254 nm), 80 W UVA (lambda= 352 nm) as well as 3 W LED (lambda = 460 nm) on the mineralization/degradation of BPA were also discussed in detail. A series of Fe2O3 (x)/ S-doped g-C3N4, Fe(x)CNS, nanocomposites with diverse Fe2O3 contents (x = 0.5, 4.3, and 14.8 wt%) were synthesized using an one-step process. It was found that the treatment technique Fe(4.3)CNS/O-3/LED did not selectively mineralize BPA because it also showed a high mineralization efficiency for degradation of the CBZ contaminant. These findings suggest superior treatment processes with various advantages and provide an insight to graphitic carbon nitride-based photocatalysts and their use in pilot scale. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jourshabani, Milad; Shariatinia, Zahra] Amirkabir Univ Technol, Tehran Polytech, Dept Chem, Tehran, Iran.
   [Jourshabani, Milad; Dominic, John Albino; Achari, Gopal] Univ Calgary, Dept Civil Engn, 2500 Univ Dr NW, Calgary, AB, Canada.
RP Jourshabani, M; Achari, G; Shariatinia, Z (reprint author), Amirkabir Univ Technol, Tehran Polytech, Dept Chem, Tehran, Iran.
EM milad.shabani@aut.ac.ir; gachari@ucalgary.ca; shariatic@aut.ac.ir
FU National Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
FX The authors thank the National Sciences and Engineering Research Council
   of Canada (NSERC) for funding this research project.
CR Ang TP, 2011, J PHYS CHEM C, V115, P15965, DOI 10.1021/jp200324v
   Asadzadeh-Khaneghah S, 2018, J COLLOID INTERF SCI, V530, P642, DOI 10.1016/j.jcis.2018.07.024
   Behzadifard Z, 2018, J MOL LIQ, V262, P533, DOI 10.1016/j.molliq.2018.04.126
   Cabana H, 2007, CHEMOSPHERE, V67, P770, DOI 10.1016/j.chemosphere.2006.10.037
   Chang C, 2013, APPL CATAL B-ENVIRON, V142, P553, DOI 10.1016/j.apcatb.2013.05.044
   Chen HY, 2014, RSC ADV, V4, P22491, DOI 10.1039/c4ra01519c
   Chen XF, 2009, CHEM MATER, V21, P4093, DOI 10.1021/cm902130z
   Cheng NY, 2013, ACS APPL MATER INTER, V5, P6815, DOI 10.1021/am401802r
   Christoforidis KC, 2016, APPL CATAL B-ENVIRON, V187, P171, DOI 10.1016/j.apcatb.2016.01.013
   Dai K, 2014, APPL CATAL B-ENVIRON, V156, P331, DOI 10.1016/j.apcatb.2014.03.039
   Dong F, 2013, ACS APPL MATER INTER, V5, P11392, DOI 10.1021/am403653a
   Dong SY, 2015, RSC ADV, V5, P14610, DOI 10.1039/c4ra13734e
   Feng LL, 2014, INT J HYDROGEN ENERG, V39, P15373, DOI 10.1016/j.ijhydene.2014.07.160
   Gao XY, 2019, CHEM ENG J, V360, P1320, DOI 10.1016/j.cej.2018.10.216
   Gao XY, 2018, J ALLOY COMPD, V757, P455, DOI 10.1016/j.jallcom.2018.05.081
   Hong JD, 2012, J MATER CHEM, V22, P15006, DOI 10.1039/c2jm32053c
   Ikehata K, 2006, OZONE-SCI ENG, V28, P353, DOI 10.1080/01919510600985937
   Izadifard M, 2018, CHEMOSPHERE, V197, P535, DOI 10.1016/j.chemosphere.2018.01.072
   Jourshabani M, 2018, J MATER CHEM A, V6, P13448, DOI 10.1039/c8ta03068e
   Jourshabani M, 2018, J MATER SCI TECHNOL, V34, P1511, DOI 10.1016/j.jmst.2017.12.020
   Jourshabani M, 2017, J MOL LIQ, V248, P688, DOI 10.1016/j.molliq.2017.10.110
   Jourshabani M, 2018, APPL SURF SCI, V427, P375, DOI 10.1016/j.apsusc.2017.08.051
   Jourshabani M, 2017, J PHYS CHEM C, V121, P19239, DOI 10.1021/acs.jpcc.7b05556
   Jourshabani M, 2017, J COLLOID INTERF SCI, V507, P59, DOI 10.1016/j.jcis.2017.07.106
   Jourshabani M, 2017, LANGMUIR, V33, P7062, DOI 10.1021/acs.langmuir.7b01767
   Katsumata K, 2013, J HAZARD MATER, V260, P475, DOI 10.1016/j.jhazmat.2013.05.058
   Kumar A, 2017, J CLEAN PROD, V165, P431, DOI 10.1016/j.jclepro.2017.07.117
   Kumar S, 2013, J PHYS CHEM C, V117, P26135, DOI 10.1021/jp409651g
   Lam SM, 2016, MAT SCI SEMICON PROC, V47, P62, DOI 10.1016/j.mssp.2016.02.019
   Li JH, 2012, CHEM COMMUN, V48, P12017, DOI 10.1039/c2cc35862j
   Li TT, 2013, APPL CATAL B-ENVIRON, V129, P255, DOI 10.1016/j.apcatb.2012.09.031
   Liang Q, 2016, APPL CATAL A-GEN, V519, P107, DOI 10.1016/j.apcata.2016.03.033
   Liao GZ, 2016, OZONE-SCI ENG, V38, P312, DOI 10.1080/01919512.2016.1151349
   Ma XG, 2012, J PHYS CHEM C, V116, P23485, DOI 10.1021/jp308334x
   McDowell DC, 2005, ENVIRON SCI TECHNOL, V39, P8014, DOI 10.1021/es050043l
   Mehrabani-Zeinabad M., 2016, J ENVIRON ENG SCI, V10, P92, DOI [10.1680/jenes.15.00015.JEESAX1496-2551, DOI 10.1680/JENES.15.00015.JEESAX1496-2551]
   Mehrabani-Zeinabad M, 2016, J ENVIRON ENG SCI, V11, P44, DOI DOI 10.1680/JENES.16.00014
   Ong WJ, 2016, CHEM REV, V116, P7159, DOI 10.1021/acs.chemrev.6b00075
   Palo P, 2012, WATER AIR SOIL POLL, V223, P5999, DOI 10.1007/s11270-012-1334-y
   Rosenfeldt EJ, 2004, ENVIRON SCI TECHNOL, V38, P5476, DOI 10.1021/es035413p
   Soltanabadi Y, 2018, SEP PURIF TECHNOL, V202, P227, DOI 10.1016/j.seppur.2018.03.019
   Somathilake P, 2018, OZONE-SCI ENG, V40, P113, DOI 10.1080/01919512.2017.1398635
   Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f
   Tijani Jimoh O., 2017, Advances in Natural Sciences: Nanoscience & Nanotechnology, V8, DOI 10.1088/2043-6254/aa7714
   Wang K, 2015, APPL CATAL B-ENVIRON, V176, P44, DOI 10.1016/j.apcatb.2015.03.045
   Wang XC, 2009, NAT MATER, V8, P76, DOI 10.1038/NMAT2317
   Wang Y, 2010, CHEM MATER, V22, P5119, DOI 10.1021/cm1019102
   Wang Y, 2010, ANGEW CHEM INT EDIT, V49, P3356, DOI 10.1002/anie.201000120
   Wang ZY, 2015, NANOSCALE, V7, P2471, DOI 10.1039/c4nr05732e
   Xu L, 2014, J POWER SOURCES, V245, P866, DOI 10.1016/j.jpowsour.2013.07.014
   Yang YX, 2013, APPL CATAL B-ENVIRON, V142, P828, DOI 10.1016/j.apcatb.2013.06.026
   Ye S, 2013, J MATER CHEM A, V1, P3008, DOI 10.1039/c2ta01069k
   Zang YP, 2014, CHEM ENG J, V246, P277, DOI 10.1016/j.cej.2014.02.068
   Zhang GG, 2012, J MATER CHEM, V22, P8083, DOI 10.1039/c2jm00097k
   Zhang X, 2013, CRYSTENGCOMM, V15, P8166, DOI 10.1039/c3ce41269e
   Zhang YJ, 2010, J AM CHEM SOC, V132, P6294, DOI 10.1021/ja101749y
   Zhang YW, 2012, NANOSCALE, V4, P5300, DOI 10.1039/c2nr30948c
   Zhang YJ, 2016, J ALLOY COMPD, V685, P84, DOI 10.1016/j.jallcom.2016.05.220
   Zhao ZW, 2015, NANOSCALE, V7, P15, DOI 10.1039/c4nr03008g
NR 59
TC 0
Z9 0
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115181
DI 10.1016/j.ces.2019.115181
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500039
DA 2020-05-12
ER

PT J
AU Khoso, SA
   Lyu, F
   Meng, XS
   Hu, YH
   Sun, W
AF Khoso, Sultan Ahmed
   Lyu, Fei
   Meng, Xiangsong
   Hu, Yuehua
   Sun, Wei
TI Selective separation of chalcopyrite and pyrite with a novel and
   non-hazardous depressant reagent scheme
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Tricarboxylate sodium starch; TCSS; Biopolymer; Calcium oxide;
   Depression; Flotation
ID LIGNOSULFONATE-BASED BIOPOLYMERS; XANTHATE ADSORPTION; SULFIDE MINERALS;
   ACTIVATED PYRITE; ZARD KOH; FLOTATION; COPPER; OXIDATION; CALCIUM;
   SURFACE
AB Pyrite depression in xanthate flotation of multiple sulphide minerals has become a serious problem in every mineral industry. The present study introduces a novel and non-hazardous depressant reagent scheme in selective flotation of chalcopyrite from pyrite with sodium butyl xanthate (SBX) as the collector. The combined inhibitory effect of an organic polymer, tricarboxylate sodium starch (TCSS), and calcium oxide (CaO) depressed the flotation of pyrite more strongly than that of the chalcopyrite in a wide pH range of 7-12. The synergistic effect of CaO and TCSS achieved an improved selective flotation separation of chalcopyrite from pyrite at low alkaline pH of 9, for which the recovery of chalcopyrite was over 80% and that of pyrite was less than 19%. The IR spectral, XPS spectral, UV-vis spectral and zeta potential measurements indicated that the surface of pyrite adsorbed significantly more amount of CaO and TCSS than that of the chalcopyrite. The dissolved calcium species preferentially adsorbed on the pyrite surface decreasing its negative charge and promoting TCSS adsorption. The findings of this research are of great significance in reducing the consumption of larger doses of lime in conventional Cu-Fe flotation circuits of the copper industry. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hu, Yuehua; Sun, Wei] Cent S Univ, Sch Minerals Proc & Bioengn, Changsha 410083, Hunan, Peoples R China.
   Cent S Univ, Key Lab Hunan Prov Clean & Efficient Utilizat Str, Changsha 410083, Hunan, Peoples R China.
RP Hu, YH; Sun, W (reprint author), Cent S Univ, Sch Minerals Proc & Bioengn, Changsha 410083, Hunan, Peoples R China.
EM huyuehuacsu@126.com; sunmenghu@csu.edu.cn
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [51634009]; Innovation Driven Plan of Central South University
   [2015CX005]; National 111 Projects [B14034]; Collaborative Innovation
   Centre for Clean and Efficient Utilization of Strategic Metal Mineral
   Resources; Key Laboratory of Hunan Province for Clean and Efficient
   Utilization of Strategic Calcium-containing Mineral Resources
   [2018TP1002]; Fundamental Research Funds for the Central Universities of
   Central South University [2018zzts227]
FX This research was supported by the Natural Science Foundation of China
   (No. 51634009); Innovation Driven Plan of Central South University (No.
   2015CX005); National 111 Projects (No. B14034); Collaborative Innovation
   Centre for Clean and Efficient Utilization of Strategic Metal Mineral
   Resources; Key Laboratory of Hunan Province for Clean and Efficient
   Utilization of Strategic Calcium-containing Mineral Resources (No.
   2018TP1002); Fundamental Research Funds for the Central Universities of
   Central South University (No. 2018zzts227).
CR Agheli S, 2018, INT J MIN SCI TECHNO, V28, P167, DOI 10.1016/j.ijmst.2017.12.002
   Agorhom EA, 2014, MINER ENG, V57, P36, DOI 10.1016/j.mineng.2013.12.010
   Ando D.J., 2005, INFRARED SPECTROSCOP
   Bidari E, 2018, T NONFERR METAL SOC, V28, P1433, DOI 10.1016/S1003-6326(18)64782-X
   Cao Z, 2018, MINER ENG, V119, P93, DOI 10.1016/j.mineng.2018.01.029
   Chandra AP, 2009, ADV COLLOID INTERFAC, V145, P97, DOI 10.1016/j.cis.2008.09.001
   Chandra AP, 2012, INT J MINER PROCESS, V114, P16, DOI 10.1016/j.minpro.2012.08.003
   Chen JH, 2011, MINER ENG, V24, P58, DOI 10.1016/j.mineng.2010.09.021
   Chen X., 2014, 24 INT MIN PROC C IM
   Chen X., 2015, EFFECT REGRINDING CH
   Chen XM, 2014, MINER ENG, V58, P64, DOI 10.1016/j.mineng.2014.01.010
   Chen XM, 2013, INT J MINER PROCESS, V125, P129, DOI 10.1016/j.minpro.2013.08.007
   Davila-Pulido GI, 2015, MINER ENG, V71, P113, DOI 10.1016/j.mineng.2014.09.004
   FORNASIERO D, 1992, J COLLOID INTERF SCI, V151, P225, DOI 10.1016/0021-9797(92)90253-I
   Fu YF, 2018, COLLOID SURFACE A, V558, P88, DOI 10.1016/j.colsurfa.2018.08.056
   Fuerstenau M.C., 1985, CHEM FLOTATION
   Guan CP, 2018, MINERALS-BASEL, V8, DOI 10.3390/min8040142
   Guo B, 2017, INT J MINER PROCESS, V158, P85, DOI 10.1016/j.minpro.2016.11.021
   Guo ZQ, 2018, J CLEAN PROD, V199, P891, DOI 10.1016/j.jclepro.2018.07.203
   Hirajima T, 2017, MINER ENG, V100, P83, DOI 10.1016/j.mineng.2016.10.007
   Huang HJ, 2012, INT J MIN SCI TECHNO, V22, P63, DOI 10.1016/j.ijmst.2011.07.007
   Huang P, 2013, MINER ENG, V46-47, P45, DOI 10.1016/j.mineng.2013.03.027
   Jia L., 2016, CHIN J NONFERR MET, V26
   Jiang CL, 1998, COLLOID SURFACE A, V136, P51, DOI 10.1016/S0927-7757(97)00250-1
   Kaniki AT, 2019, J CLEAN PROD, V210, P1406, DOI 10.1016/j.jclepro.2018.11.131
   KARTHE S, 1993, APPL SURF SCI, V72, P157, DOI 10.1016/0169-4332(93)90007-X
   KHOSLA NK, 1984, COLLOID SURFACE, V8, P321, DOI 10.1016/0166-6622(84)80127-4
   Khoso SA, 2019, MINER ENG, V135, P55, DOI 10.1016/j.mineng.2019.02.044
   Khoso SA, 2018, MEHRAN UNIV RES J EN, V37, P569, DOI 10.22581/muet1982.1804.11
   Khoso SA, 2017, MEHRAN UNIV RES J EN, V36, P1017, DOI 10.22581/muet1982.1704.26
   KOCABAG D, 1990, INT J MINER PROCESS, V29, P211, DOI 10.1016/0301-7516(90)90054-3
   Kocabag D., 1983, OLEOPHILICITY HYDROP
   Li YQ, 2012, MINER ENG, V26, P64, DOI 10.1016/j.mineng.2011.11.001
   LIU Q, 1989, J COLLOID INTERF SCI, V130, P101, DOI 10.1016/0021-9797(89)90081-7
   Luo N, 2018, J MATER RES TECHNOL, V7, P96, DOI 10.1016/j.jmrt.2017.04.007
   Max JJ, 2004, J PHYS CHEM A, V108, P3324, DOI 10.1021/jp036401t
   Aguado JMM, 2006, POWDER TECHNOL, V170, P153, DOI 10.1016/j.powtec.2006.09.004
   Meng XS, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118371
   Mikhlin Y, 2016, NEW J CHEM, V40, P3059, DOI 10.1039/c6nj00098c
   Moran CJ, 2014, J CLEAN PROD, V84, P1, DOI 10.1016/j.jclepro.2014.09.016
   Moslemi H, 2017, J IND ENG CHEM, V47, P1, DOI 10.1016/j.jiec.2016.12.012
   Mu YF, 2018, MINER ENG, V122, P91, DOI 10.1016/j.mineng.2018.03.048
   Mu YF, 2016, MINER ENG, V96-97, P143, DOI 10.1016/j.mineng.2016.06.018
   Mu YF, 2016, MINER ENG, V96-97, P113, DOI 10.1016/j.mineng.2016.06.011
   Mu YF, 2016, MINER ENG, V92, P37, DOI 10.1016/j.mineng.2016.02.007
   Mu YF, 2015, ELECTROCHIM ACTA, V174, P133, DOI 10.1016/j.electacta.2015.05.150
   Nara M, 2008, BIOCHEM BIOPH RES CO, V369, P225, DOI 10.1016/j.bbrc.2007.11.188
   Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010
   Peng HQ, 2017, RESULTS PHYS, V7, P3567, DOI 10.1016/j.rinp.2017.09.028
   Sarquis PE, 2014, J CLEAN PROD, V84, P723, DOI 10.1016/j.jclepro.2014.08.025
   Shrimali K, 2018, COLLOID SURFACE A, V546, P194, DOI 10.1016/j.colsurfa.2018.03.001
   Somasundaran P., 2006, SOLUTION CHEM MINERA
   Stuart B. H, 2004, EXPT THERMODYNAMICS, V41, P325, DOI DOI 10.1002/0470011149.CH7
   Todd EC, 2003, GEOCHIM COSMOCHIM AC, V67, P2137, DOI 10.1016/S0016-7037(02)01371-6
   Valdivieso AL, 2004, MINER ENG, V17, P1001, DOI 10.1016/j.mineng.2004.04.003
   Wang Z, 2015, MINER ENG, V74, P86, DOI 10.1016/j.mineng.2015.01.008
   Xian YJ, 2015, MINER ENG, V72, P94, DOI 10.1016/j.mineng.2014.12.016
   Yang BC, 2016, J FUNCT SPACE, DOI 10.1155/2016/9197476
   Yin WZ, 2018, MINER ENG, V115, P142, DOI 10.1016/j.mineng.2017.10.016
   Yuniati MD, 2015, MATER TRANS, V56, P123, DOI 10.2320/matertrans.M-M2015821
   Zhao KL, 2017, INT J MINER PROCESS, V161, P78, DOI 10.1016/j.minpro.2017.02.015
NR 61
TC 1
Z9 1
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115204
DI 10.1016/j.ces.2019.115204
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500036
DA 2020-05-12
ER

PT J
AU Kim, JM
   Kim, SH
   Park, SY
   Kim, SS
   Lee, SJ
AF Kim, Jae-Min
   Kim, Sung-Hyun
   Park, Sung-Youl
   Kim, Seong-Soo
   Lee, Seung-Jae
TI Effects of preparation conditions on the CO methanation performance of
   Co-Mo carbide catalysts
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cobalt molybdenum carbide; Activated charcoal; Wet impregnation; pH;
   Initial Co/Mo molar ratio
ID SUPPORTED MOLYBDENUM CARBIDE; MIXED ALCOHOLS SYNTHESIS; ACTIVATED
   CARBON; SURFACE-AREA; CHEMICAL-STATE; COBALT; ADSORPTION; POTASSIUM;
   HYDRODENITROGENATION; HYDRODESULFURIZATION
AB We prepared activated charcoal-supported Co-Mo carbide catalysts to investigate the effects of solution pH and initial Co/Mo molar ratio. In the absence of Co, no Mo adsorption was observed at pH above the pH(zpc) of AC, whereas the introduction of Co at pH > 6 resulted in the co-precipitation of Mo and Co and facilitated Mo adsorption. CO conversions for CO methanation at 400 degrees C and 30 bar achieved over samples prepared at pH 3 were initially high but decreased with increasing reaction time, whereas CO conversions were maintained at >90% with increasing reaction time for samples prepared at pH > 6. XPS analysis of these high-performance catalysts revealed that the predominant state of surface Mo was Mo-0 rather than Mo4+ and Mo6+. Catalysts with maximum methanation activity, i.e., those with the highest surface Mo-0 content, were obtained at pH 7 and an initial Co/Mo molar ratio of 1.0. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kim, Jae-Min; Kim, Sung-Hyun] Korea Univ, Dept Chem & Biol Engn, 145 Anam Ro, Seoul 02841, South Korea.
   [Park, Sung-Youl; Kim, Seong-Soo; Lee, Seung-Jae] Korea Inst Energy Res, Biomass & Wastes Energy Lab, 152 Gajeong Ro, Daejeon 34129, South Korea.
RP Kim, SH (reprint author), Korea Univ, Dept Chem & Biol Engn, 145 Anam Ro, Seoul 02841, South Korea.; Lee, SJ (reprint author), Korea Inst Energy Res, Biomass & Wastes Energy Lab, 152 Gajeong Ro, Daejeon 34129, South Korea.
EM kimsh@korea.ac.kr; seungjae@kier.re.kr
FU R&D Convergence Program [CAP-16-11-KAERI]; NST (National Research
   Council of Science & Technology) of the Republic of Korea
FX We acknowledge financial support from the R&D Convergence Program
   (CAP-16-11-KAERI) funded by the NST (National Research Council of
   Science & Technology) of the Republic of Korea.
CR Al-Megren HA, 2007, APPL CATAL A-GEN, V329, P36, DOI 10.1016/j.apcata.2007.06.013
   Antoniak K, 2012, APPL CATAL A-GEN, V423, P114, DOI 10.1016/j.apcata.2012.02.028
   Aoki Y, 2013, CATAL TODAY, V215, P169, DOI 10.1016/j.cattod.2013.05.007
   Baltrusaitis J, 2015, APPL SURF SCI, V326, P151, DOI 10.1016/j.apsusc.2014.11.077
   Chen Y, 2011, MAT SCI APPL, V2, P1313
   Cheng JM, 2010, FUEL PROCESS TECHNOL, V91, P185, DOI 10.1016/j.fuproc.2009.09.011
   CHOI JG, 1995, J CATAL, V154, P33, DOI 10.1006/jcat.1995.1143
   DAI MG, 1994, J COLLOID INTERF SCI, V164, P223, DOI 10.1006/jcis.1994.1160
   Dai MG, 1998, J COLLOID INTERF SCI, V198, P6, DOI 10.1006/jcis.1997.5254
   Dang J, 2015, HIGH TEMP MAT PR-ISR, V34, P417, DOI 10.1515/htmp-2014-0064
   DEBOER M, 1993, APPL CATAL A-GEN, V102, P35, DOI 10.1016/0926-860X(93)85153-G
   Griboval-Constant A, 2004, APPL CATAL A-GEN, V260, P35, DOI 10.1016/j.apcata.2003.10.031
   Hu MH, 2004, J CATAL, V225, P230, DOI 10.1016/j.jcat.2004.04.013
   Huang JH, 2004, HYDROMETALLURGY, V75, P77, DOI 10.1016/j.hydromet.2004.06.008
   KASZTELAN S, 1983, APPL CATAL, V7, P91, DOI 10.1016/0166-9834(83)80241-3
   Kim MY, 2013, CATAL COMMUN, V35, P68, DOI 10.1016/j.catcom.2013.02.004
   Klimova TE, 2013, J CATAL, V304, P29, DOI 10.1016/j.jcat.2013.03.027
   LEARY KJ, 1986, J CATAL, V101, P301, DOI 10.1016/0021-9517(86)90257-5
   LEE JS, 1988, J CATAL, V112, P44, DOI 10.1016/0021-9517(88)90119-4
   Leofanti G, 1998, CATAL TODAY, V41, P207, DOI 10.1016/S0920-5861(98)00050-9
   Liang CH, 2003, CARBON, V41, P1833, DOI 10.1016/S0008-6223(03)00169-6
   Liang CH, 2002, CHEM MATER, V14, P3148, DOI 10.1021/cm020202p
   Mir RA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03197-8
   Mo T, 2016, CATAL TODAY, V261, P101, DOI 10.1016/j.cattod.2015.07.014
   Nagai M, 2006, J CATAL, V238, P489, DOI 10.1016/j.jcat.2006.01.003
   Oyama ST, 1999, J CATAL, V184, P535, DOI 10.1006/jcat.1999.2464
   Patt J, 2000, CATAL LETT, V65, P193, DOI 10.1023/A:1019098112056
   Puello-Polo E, 2008, J MOL CATAL A-CHEM, V281, P85, DOI 10.1016/j.molcata.2007.09.015
   Scanlon DO, 2010, J PHYS CHEM C, V114, P4636, DOI 10.1021/jp9093172
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Tominaga H, 2012, APPL CATAL A-GEN, V423, P192, DOI 10.1016/j.apcata.2012.02.041
   Vrubel H, 2012, ANGEW CHEM INT EDIT, V51, P12703, DOI 10.1002/anie.201207111
   WAN C, 2014, ANGEW CHEM, V126, P6525, DOI DOI 10.1002/ANGE.201402998
   Wang HM, 2007, CHEM MATER, V19, P1801, DOI 10.1021/cm0615471
   Wang XQ, 2010, METALL MATER TRANS B, V41, P1067, DOI 10.1007/s11663-010-9409-x
   Wang XH, 2008, CATAL TODAY, V131, P111, DOI 10.1016/j.cattod.2007.10.070
   Wang XH, 2007, DALTON T, P5165, DOI 10.1039/b708363g
   Xiang ML, 2007, CATAL COMMUN, V8, P513, DOI 10.1016/j.catcom.2006.07.028
   Xiang ML, 2010, J NAT GAS CHEM, V19, P151, DOI 10.1016/S1003-9953(09)60051-7
   Xiao TC, 2001, J CATAL, V202, P100, DOI 10.1006/jcat.2001.3247
   Xiao TC, 2000, CR ACAD SCI II C, V3, P451, DOI 10.1016/S1387-1609(00)01154-3
   Yu J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3054164
   Yuezer H, 2008, J HAZARD MATER, V151, P33, DOI 10.1016/j.jhazmat.2007.05.052
NR 43
TC 1
Z9 1
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115219
DI 10.1016/j.ces.2019.115219
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500014
DA 2020-05-12
ER

PT J
AU Korchagin, OV
   Bogdanovskaya, VA
   Tripachev, OV
   Radina, MV
   Andreev, VN
AF Korchagin, Oleg V.
   Bogdanovskaya, Vera A.
   Tripachev, Oleg V.
   Radina, Marina V.
   Andreev, Vladimir N.
TI Oxygen reduction/evolution reactions engineering for lithium-oxygen
   battery scaling-up
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Lithium-oxygen battery; ORR/OER; Electrochemical reaction engineering;
   Power source scaling-up
ID FUEL-CELLS; LI-O-2; ELECTROLYTE; DISTRIBUTIONS; BEHAVIOR; SOLVENTS; AREA
AB Oxygen reduction/evolution reactions (ORR/OER) engineering is the crucial problem of lithium-oxygen battery (LOB) R&D. This work shows that the influence of the pore structure of an active material exceeds the influence of its catalytic properties in ORR/OER in terms of LOB capacity. An original approach to the LOB scaling-up is suggested that is partially based on the principles of the cathode operation in hydrogen-oxygen fuel cell. The discharge capacity of the scaled-up LOB reaches 0.375 A h at the positive electrode surface area of 25 cm(2), which is at the level of the best results for LOBs with an aprotic electrolyte described earlier. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Korchagin, Oleg V.; Bogdanovskaya, Vera A.; Tripachev, Oleg V.; Radina, Marina V.; Andreev, Vladimir N.] Russian Acad Sci, Frumkin Inst Phys Chem & Electrochem, Moscow 119071, Russia.
RP Bogdanovskaya, VA (reprint author), Russian Acad Sci, Frumkin Inst Phys Chem & Electrochem, Moscow 119071, Russia.
EM bogd@elchem.ac.ru
FU Ministry of Science and Higher Education of Russian Federation
FX The work was performed with support of Ministry of Science and Higher
   Education of Russian Federation.
CR Avcioglu GS, 2018, INT J HYDROGEN ENERG, V43, P10779, DOI 10.1016/j.ijhydene.2017.12.055
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Belhadj M, 2018, CHEM ENG SCI, V185, P18, DOI 10.1016/j.ces.2018.03.055
   Bogdanovskaya VA, 2018, PROT MET PHYS CHEM+, V54, P373, DOI 10.1134/S207020511803005X
   Bogdanovskaya VA, 2016, RUSS J ELECTROCHEM+, V52, P723, DOI 10.1134/S1023193516080036
   Imanishi N, 2014, LITHIUM AIR BATTERY
   Izutsu K., 2009, ELECTROCHEMISTRY NON
   Johnson L, 2014, NAT CHEM, V6, P1091, DOI [10.1038/NCHEM.2101, 10.1038/nchem.2101]
   Korchagin OV, 2018, ELECTROCHEM COMMUN, V90, P43, DOI 10.1016/j.elecom.2018.03.005
   Kwak WJ, 2016, ENERG ENVIRON SCI, V9, P2334, DOI 10.1039/c6ee00700g
   Kwak WJ, 2015, J MATER CHEM A, V3, P8855, DOI 10.1039/c5ta01399b
   Laoire CO, 2010, J PHYS CHEM C, V114, P9178, DOI 10.1021/jp102019y
   Liu QC, 2016, ADV MATER, V28, P8413, DOI 10.1002/adma.201602800
   Liu T, 2015, SCIENCE, V350, P530, DOI 10.1126/science.aac7730
   Liu T, 2016, SMALL, V12, P3101, DOI 10.1002/smll.201600540
   Lyu ZY, 2017, CHEM SOC REV, V46, P6046, DOI 10.1039/c7cs00255f
   Meini S, 2012, J ELECTROCHEM SOC, V159, pA2135, DOI 10.1149/2.011301jes
   Soboleva T, 2010, ACS APPL MATER INTER, V2, P375, DOI 10.1021/am900600y
   Srinivasan S, 2006, FUEL CELLS FUNDAMENT
   Tang SK, 2014, RSC ADV, V4, P11251, DOI 10.1039/c3ra47191h
   Tarasevich MR, 2014, RUSS J ELECTROCHEM+, V50, P737, DOI 10.1134/S1023193514080126
   Yang XY, 2017, ADV MATER, V29, DOI 10.1002/adma.201700378
   Yin YB, 2018, ADV MATER, V30, DOI 10.1002/adma.201703791
   Zhang P, 2018, CHEM SOC REV, V47, P2921, DOI 10.1039/c8cs00009c
NR 24
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115164
DI 10.1016/j.ces.2019.115164
PG 4
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500030
DA 2020-05-12
ER

PT J
AU Kumar, A
   Mandal, A
AF Kumar, Amit
   Mandal, Ajay
TI Critical investigation of zwitterionic surfactant for enhanced oil
   recovery from both sandstone and carbonate reservoirs: Adsorption,
   wettability alteration and imbibition studies
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Zwitterionic surfactant; Sandstone; Carbonate; Surfactant adsorption;
   Wettability alteration; Spontaneous imbibition
ID ANIONIC SURFACTANT; INTERFACIAL-TENSION; NONIONIC SURFACTANTS; IFT
   REDUCTION; WET; WATER; BEHAVIOR; MECHANISMS; RETENTION; EQUATION
AB Surfactant flooding, a proven method of oil recovery from conventional reservoirs, is limited due to its adsorption on reservoir rocks. Surfactant adsorption leads to modification of wetting state of reservoirs, but it is dependent on the type of surfactant. In present study, a zwitterionic surfactant was selected to study its wettability alteration and adsorption behavior on sandstone and carbonate samples. The adsorption profile was fitted to isotherm models and best-fitted model was determined by R2 values. Zeta potential suggested hydrophilic interaction between the surface and surfactant. Increase in salinity and alkalinity had opposite effects on surfactant adsorption. Surfactant was found effective in altering the wetting state of rock surface. Increase in salinity and alkalinity was found to improve the wettability alteration effectiveness. Effective wettability alteration was also tested by spontaneous imbibition into core samples. Thus, zwitterionic surfactant was found suitable for application in both sandstone and carbonate reservoirs. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kumar, Amit; Mandal, Ajay] Indian Sch Mines, Indian Inst Technol, Dept Petr Engn, Dhanbad 826004, Bihar, India.
RP Mandal, A (reprint author), Indian Sch Mines, Indian Inst Technol, Dept Petr Engn, Dhanbad 826004, Bihar, India.
EM ajay@iitism.ac.in
RI Mandal, Ajay/I-2955-2019
OI Mandal, Ajay/0000-0003-2947-4261; Kumar, Amit/0000-0001-9818-2866
CR Abdulkadir I., 2016, NIG J BASIC APPL SCI, V24, P47, DOI [10.4314/njbas.v24i1.8, DOI 10.4314/NJBAS.V24I1.8]
   Ahmadi MA, 2012, IND ENG CHEM RES, V51, P9894, DOI 10.1021/ie300269c
   Arabloo M, 2016, FUEL, V185, P199, DOI 10.1016/j.fuel.2016.06.088
   Ayawei N., 2015, OPEN J PHYS CHEM, V5, P56, DOI DOI 10.4236/0JPC.2015.53007
   Azam MR, 2013, J PET EXPLOR PROD TE, V3, P195, DOI 10.1007/s13202-013-0057-y
   Belhaj AF, 2020, J PET EXPLOR PROD TE, V10, P125, DOI 10.1007/s13202-019-0685-y
   Bera A, 2013, APPL SURF SCI, V284, P87, DOI 10.1016/j.apsusc.2013.07.029
   Boparai HK, 2011, J HAZARD MATER, V186, P458, DOI 10.1016/j.jhazmat.2010.11.029
   Chang ZY, 2018, MINER ENG, V121, P66, DOI 10.1016/j.mineng.2018.03.002
   CHATZIS I, 1984, SOC PETROL ENG J, V24, P555, DOI 10.2118/10114-PA
   Curbelo FDS, 2007, COLLOID SURFACE A, V293, P1, DOI 10.1016/j.colsurfa.2006.06.038
   Dada A.O., 2012, J APPL CHEM-USSR, V3, P38, DOI DOI 10.9790/5736-0313845
   Demissie H., 2016, J SCI INNOVATIVE RES, V5, P208
   Elias S.D., 2016, ONLINE J SCI TECHNOL, V6, P6
   Esmaeilzadeh P, 2011, PHYSCS PROC, V22, P63, DOI 10.1016/j.phpro.2011.11.009
   Gandomkar A, 2013, ENERG SOURCE PART A, V35, P58, DOI 10.1080/15567036.2010.501368
   Ghandi E, 2019, PETROL SCI, V16, P1361, DOI 10.1007/s12182-019-0355-1
   Goloub TP, 1996, LANGMUIR, V12, P3188, DOI 10.1021/la9505475
   Guo H, 2017, J CHEM-NY, DOI 10.1155/2017/8509563
   Gupta R, 2008, SPE DOE S IMPR OIL R, DOI [10.2118/113407-MS, DOI 10.2118/113407-MS]
   Hakiki F., 2017, WELL INFLOW PERFORMA, P1, DOI [10.2118/186187-ms, DOI 10.2118/186187-MS]
   Halder E, 2006, INDIAN J CHEM A, V45, P2591
   Haq Z. U., 2017, J MAT, V8, P1029, DOI DOI 10.1038/451414A
   HARWELL JH, 1985, LANGMUIR, V1, P251, DOI 10.1021/la00062a013
   Hernandez-Soriano MC, 2007, SCI TOTAL ENVIRON, V378, P109, DOI 10.1016/j.scitotenv.2007.01.011
   Hoeiland S, 2001, J PETROL SCI ENG, V30, P91, DOI 10.1016/S0920-4105(01)00106-1
   Hou BF, 2015, J DISPER SCI TECHNOL, V36, P1264, DOI 10.1080/01932691.2014.971808
   Hou BF, 2015, APPL SURF SCI, V330, P56, DOI 10.1016/j.apsusc.2014.12.185
   Hu X, 2017, COLLOID SURFACE A, V535, P75, DOI 10.1016/j.colsurfa.2017.09.021
   Jian GQ, 2018, J COLLOID INTERF SCI, V513, P684, DOI 10.1016/j.jcis.2017.11.041
   KALLAY N, 1986, ACTA CHEM SCAND A, V40, P257, DOI 10.3891/acta.chem.scand.40a-0257
   Kamal MS, 2017, ENERG FUEL, V31, P7701, DOI 10.1021/acs.energyfuels.7b00353
   Karakashev S, 2004, ADV COLLOID INTERFAC, V112, P31, DOI 10.1016/j.cis.2004.06.002
   Karimi M, 2016, J PETROL SCI ENG, V147, P560, DOI 10.1016/j.petrol.2016.09.015
   KRUMRINE PH, 1982, SOC PETROL ENG J, V22, P503, DOI 10.2118/8998-PA
   Kumar A, 2018, COLLOID SURFACE A, V549, P1, DOI 10.1016/j.colsurfa.2018.04.001
   Kumar S, 2017, AICHE J, V63, P2731, DOI 10.1002/aic.15651
   Kumar S, 2016, J IND ENG CHEM, V43, P106, DOI 10.1016/j.jiec.2016.07.055
   Li N, 2011, ENERG FUEL, V25, P4430, DOI 10.1021/ef200616b
   Li PX, 2016, SOIL SCI PLANT NUTR, V62, P223, DOI 10.1080/00380768.2016.1191969
   Mackenzie F. T., 2003, ENCY EARTH SCI SEDIM, P147, DOI DOI 10.1007/978-1-4020-3609-5_35
   Madani M, 2019, FUEL, V238, P186, DOI 10.1016/j.fuel.2018.10.105
   Mohajeri E, 2012, E-J CHEM, V9, P2268, DOI 10.1155/2012/961739
   Mohammed MA, 2016, SPE RESERV EVAL ENG, V19, P633, DOI 10.2118/170034-PA
   Murray HH, 1961, CLAYS CLAY MINER, V10, P291, DOI 10.1346/CCMN.1961.0100124
   Nakama Y, 2017, COSMETIC SCI TECHNOL, P231, DOI [10.1016/B978-0-12-802005-0.00015-X, DOI 10.1016/B978-0-12-802005-0.00015-X]
   Negin Chegenizadeh, 2017, Petroleum, V3, P197, DOI 10.1016/j.petlm.2016.11.007
   Nowak S, 2018, TALANTA, V186, P133, DOI 10.1016/j.talanta.2018.03.059
   Okeola F. O., 2010, Advances in Environmental Biology, V4, P329
   Pal S, 2018, PETROL SCI, V15, P77, DOI 10.1007/s12182-017-0198-6
   Paria S, 2004, ADV COLLOID INTERFAC, V110, P75, DOI 10.1016/j.cis.2004.03.001
   Prathapan R, 2016, COLLOID SURFACE A, V509, P11, DOI 10.1016/j.colsurfa.2016.08.075
   Putra W, 2019, J PET EXPLOR PROD TE, V9, P2353, DOI 10.1007/s13202-019-0635-8
   Reig FB, 2002, TALANTA, V58, P811, DOI 10.1016/S0039-9140(02)00372-7
   Repo E, 2010, CHEM ENG J, V161, P73, DOI 10.1016/j.cej.2010.04.030
   RezaeiDoust A, 2011, ENERG FUEL, V25, P2151, DOI 10.1021/ef200215y
   Rhein L., 2007, HDB CLEANING DECONTA, P305, DOI 10.1016/B978-044451664-0/50009-7
   Riley BJ, 2016, FORENSIC SCI INT, V266, P555, DOI 10.1016/j.forsciint.2016.07.018
   Ruessink B., 1992, P SOC PETR ENG FORM, P533, DOI [10.2118/23828-MS, DOI 10.2118/23828-MS]
   Saha R, 2018, J IND ENG CHEM, V59, P286, DOI 10.1016/j.jiec.2017.10.034
   Salehi M, 2008, LANGMUIR, V24, P14099, DOI 10.1021/la802464u
   Sampranpiboon Panida, 2014, WSEAS Transactions on Environment and Development, V10, P35
   Saxena N, 2019, J PETROL SCI ENG, V173, P1264, DOI 10.1016/j.petrol.2018.11.002
   SCAMEHORN JF, 1982, J COLLOID INTERF SCI, V85, P463, DOI 10.1016/0021-9797(82)90013-3
   Shamsijazeyi H., 2013, P SPE INT S OILF CHE, P8, DOI [10.2118/164061-MS, DOI 10.2118/164061-MS]
   ShamsiJazeyi H, 2014, COLLOID SURFACE A, V453, P168, DOI 10.1016/j.colsurfa.2014.02.021
   Shehata A.M., 2014, INT PETR TECHN C INT, P10, DOI [10.2523/18176-MS, DOI 10.2523/18176-MS]
   Sheng JJ, 2013, ENHANCED OIL RECOVERY FIELD CASE STUDIES, P143
   Sheng JJ, 2013, ASIA-PAC J CHEM ENG, V8, P154, DOI 10.1002/apj.1640
   Sivakumar S., 2013, J PURE APPL CHEM, V3, P366
   Souayeh M, 2018, ENERG FUEL, V32, P11222, DOI 10.1021/acs.energyfuels.8b02373
   Standnes DC, 2000, J PETROL SCI ENG, V28, P123, DOI 10.1016/S0920-4105(00)00084-X
   Standnes DC, 2002, ENERG FUEL, V16, P1557, DOI 10.1021/ef0201127
   Vatanparast H, 2011, PETROL SCI TECHNOL, V29, P1873, DOI 10.1080/10916461003610389
   Viana RB, 2012, ADV PHYS CHEM, DOI 10.1155/2012/903272
   Wang GW, 2015, J PETROL SCI ENG, V131, P184, DOI 10.1016/j.petrol.2015.04.011
   Wang YF, 2011, PETROL SCI, V8, P463, DOI 10.1007/s12182-011-0164-7
   Wu FC, 2010, CHEM ENG J, V162, P21, DOI 10.1016/j.cej.2010.03.006
   Xie DH, 2016, J PETROL SCI ENG, V147, P528, DOI 10.1016/j.petrol.2016.09.013
   Xie W., 2018, OPEN J YANGTZE OIL G, V03, P207, DOI [10.4236/ojogas.2018.33018, DOI 10.4236/OJOGAS.2018.33018]
   Xu DR, 2019, FUEL, V244, P110, DOI 10.1016/j.fuel.2019.01.118
   Zhang JY, 2009, SPE RESERV EVAL ENG, V12, P912, DOI 10.2118/113453-PA
   Zhang R, 2012, APPL SURF SCI, V258, P7943, DOI 10.1016/j.apsusc.2012.04.139
   Zor S, 2004, J SERB CHEM SOC, V69, P25, DOI 10.2298/JSC0401025Z
NR 84
TC 2
Z9 2
U1 8
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115222
DI 10.1016/j.ces.2019.115222
PG 14
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500010
DA 2020-05-12
ER

PT J
AU Kuznetsov, GV
   Shlegel, NE
   Solomatin, Y
   Strizhak, PA
AF Kuznetsov, G. V.
   Shlegel, N. E.
   Solomatin, Ya.
   Strizhak, P. A.
TI Combined techniques of secondary atomization of multi-component droplets
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Secondary droplet atomization; Droplet collision; Wall impact; Incoming
   gas jet; Micro-explosive breakup; Combined atomization schemes
ID WATER SPRAY; NUMERICAL-SIMULATION; BINARY COLLISIONS; AIR-FLOW; BREAKUP;
   SURFACE; VISCOSITY; ETHANOL; IMPACT; DIESEL
AB In this paper, we present the experimental results of a secondary droplet atomization study by combining four schemes: droplet collisions with each other, with a solid surface, with a gas flow, as well as micro-explosive breakup of highly inhomogeneous liquid exposed to extensive heating. For each of the four schemes, we show the droplets sizes reduction range, atomization time, and the measured growth of liquid surface area. The latter parameter describes the intensity of the heat exchange and phase transitions at the liquid - gas interface. The experiments are conducted for water and water-based slurries and emulsions, including high-potential fuels. Basing on the experimental results for isolated droplets, we propose a technique for the experimental study of aerosol flows. We determine the droplets sizes that does not lead to its drastic increase due to coalescence or decrease due to disruption during aerosol cloud intermixing. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kuznetsov, G. V.; Shlegel, N. E.; Solomatin, Ya.; Strizhak, P. A.] Natl Res Tomsk Polytech Univ, 30 Lenin Ave, Tomsk 634050, Russia.
RP Strizhak, PA (reprint author), Natl Res Tomsk Polytech Univ, 30 Lenin Ave, Tomsk 634050, Russia.
EM pavelspa@tpu.ru
OI Strizhak, Pavel/0000-0003-1707-5335
FU Russian Science FoundationRussian Science Foundation (RSF) [18-71-10002]
FX Research was supported by the Russian Science Foundation (project
   18-71-10002).
CR Alkhedhair A, 2013, APPL THERM ENG, V61, P416, DOI 10.1016/j.applthermaleng.2013.08.012
   Antonov DV, 2019, EXP THERM FLUID SCI, V109, DOI 10.1016/j.expthermflusci.2019.109862
   Arogeti M, 2019, CHEM ENG SCI, V193, P89, DOI 10.1016/j.ces.2018.08.013
   ASHGRIZ N, 1990, J FLUID MECH, V221, P183, DOI 10.1017/S0022112090003536
   Avulapati MM, 2016, FUEL, V166, P59, DOI 10.1016/j.fuel.2015.10.107
   Bertola V, 2015, INT J HEAT MASS TRAN, V85, P430, DOI 10.1016/j.ijheatmasstransfer.2015.01.084
   Biance AL, 2006, J FLUID MECH, V554, P47, DOI 10.1017/S0022112006009189
   Boulet P, 2013, APPL THERM ENG, V50, P1164, DOI 10.1016/j.applthermaleng.2012.08.039
   Buck B, 2018, CHEM ENG RES DES, V135, P21, DOI 10.1016/j.cherd.2018.05.014
   Cao XK, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2723154
   Cen CZ, 2018, INT J HEAT MASS TRAN, V123, P129, DOI 10.1016/j.ijheatmasstransfer.2018.02.059
   Chen RH, 2007, APPL THERM ENG, V27, P604, DOI 10.1016/j.applthermaleng.2006.05.025
   Chen RH, 2016, EUR J MECH B-FLUID, V60, P62, DOI 10.1016/j.euromechflu.2016.07.009
   Cossali GE, 2005, EXP THERM FLUID SCI, V29, P937, DOI 10.1016/j.expthermflusci.2004.12.003
   Davanlou A, 2015, CHEM ENG SCI, V131, P243, DOI 10.1016/j.ces.2015.03.057
   Feng SQ, 2019, INT J HEAT MASS TRAN, V129, P936, DOI 10.1016/j.ijheatmasstransfer.2018.10.023
   Flock AK, 2012, INT J MULTIPHAS FLOW, V47, P37, DOI 10.1016/j.ijmultiphaseflow.2012.06.008
   Focke C, 2013, INT J MULTIPHAS FLOW, V56, P81, DOI 10.1016/j.ijmultiphaseflow.2013.05.008
   Fujimoto H, 2001, INT J MULTIPHAS FLOW, V27, P1227, DOI 10.1016/S0301-9322(00)00075-6
   Fujimoto H, 2010, INT J MULTIPHAS FLOW, V36, P620, DOI 10.1016/j.ijmultiphaseflow.2010.04.004
   Glushkov DO, 2016, FUEL PROCESS TECHNOL, V143, P60, DOI 10.1016/j.fuproc.2015.11.014
   Hu CB, 2017, INT J HEAT MASS TRAN, V113, P569, DOI 10.1016/j.ijheatmasstransfer.2017.05.094
   Jung SJ, 2011, J NON-NEWTON FLUID, V166, P297, DOI 10.1016/j.jnnfm.2010.12.006
   Kachhwaha SS, 1998, INT J HEAT MASS TRAN, V41, P465, DOI 10.1016/S0017-9310(97)00131-2
   Kekesi T, 2016, CHEM ENG SCI, V140, P319, DOI 10.1016/j.ces.2015.10.019
   Ko GH, 2005, J AEROSOL SCI, V36, P1300, DOI 10.1016/j.jaerosci.2005.02.005
   Ko GH, 2005, INT J MULTIPHAS FLOW, V31, P723, DOI 10.1016/j.ijmultiphaseflow.2005.02.004
   Kohno JY, 2013, CHEM PHYS LETT, V578, P15, DOI 10.1016/j.cplett.2013.06.010
   Komrakova AE, 2015, CHEM ENG SCI, V126, P150, DOI 10.1016/j.ces.2014.12.012
   Kuznetsov GV, 2016, INT J THERM SCI, V108, P218, DOI 10.1016/j.ijthermalsci.2016.05.019
   Lee CH, 2000, INT J MULTIPHAS FLOW, V26, P229, DOI 10.1016/S0301-9322(99)00020-8
   Liu M, 2016, J FLUID MECH, V789, P785, DOI 10.1017/jfm.2015.725
   Liu XD, 2018, CHEM ENG SCI, V183, P215, DOI 10.1016/j.ces.2018.03.003
   Luo HL, 2018, FUEL, V219, P467, DOI 10.1016/j.fuel.2018.01.059
   Meng KS, 2019, J ENERGY INST, V92, P1527, DOI 10.1016/j.joei.2018.07.021
   Moqaddam AM, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4942017
   Nabi MN, 2013, PROCEDIA ENGINEER, V56, P401, DOI 10.1016/j.proeng.2013.03.139
   Pasandideh-Fard M, 2001, INT J HEAT FLUID FL, V22, P201, DOI 10.1016/S0142-727X(00)00086-2
   Pawar SK, 2016, POWDER TECHNOL, V300, P157, DOI 10.1016/j.powtec.2016.06.005
   Planchette C, 2010, COLLOID SURFACE A, V365, P89, DOI 10.1016/j.colsurfa.2009.12.011
   Raoult F, 2019, APPL THERM ENG, V149, P960, DOI 10.1016/j.applthermaleng.2018.12.063
   Sazhin SS, 2019, INT J HEAT MASS TRAN, V131, P815, DOI 10.1016/j.ijheatmasstransfer.2018.11.065
   Solsvik J, 2016, CHEM ENG SCI, V149, P249, DOI 10.1016/j.ces.2016.04.037
   Tang CL, 2017, INT J MULTIPHAS FLOW, V96, P56, DOI 10.1016/j.ijmultiphaseflow.2017.07.002
   Tarlet D, 2016, INT J THERM SCI, V107, P179, DOI 10.1016/j.ijthermalsci.2016.04.008
   Tarlet D, 2016, INT J HEAT MASS TRAN, V95, P689, DOI 10.1016/j.ijheatmasstransfer.2015.12.054
   Tarlet D, 2014, INT J HEAT MASS TRAN, V77, P1043, DOI 10.1016/j.ijheatmasstransfer.2014.06.054
   Tissot J, 2012, INT J THERM SCI, V60, P23, DOI 10.1016/j.ijthermalsci.2012.06.005
   Tissot J, 2011, INT J THERM SCI, V50, P2122, DOI 10.1016/j.ijthermalsci.2011.06.004
   Wang CH, 2003, COMBUST FLAME, V134, P289, DOI 10.1016/S0010-2180(03)00087-7
   Xu YL, 2018, FUEL, V225, P426, DOI 10.1016/j.fuel.2018.03.166
   Zhang XQ, 2018, ENERGY, V154, P535, DOI 10.1016/j.energy.2018.04.176
   Zhang YZ, 2018, INT J MULTIPHAS FLOW, V107, P67, DOI 10.1016/j.ijmultiphaseflow.2018.05.016
   Zhang Z, 2016, APPL THERM ENG, V95, P1, DOI 10.1016/j.applthermaleng.2015.10.137
NR 54
TC 2
Z9 2
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115199
DI 10.1016/j.ces.2019.115199
PG 17
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500008
DA 2020-05-12
ER

PT J
AU Lan, WJ
   Wang, ZH
   Wang, M
   Liu, D
   Guo, XQ
   Sun, Q
   Li, XX
   Li, SW
AF Lan, Wenjie
   Wang, Zhihui
   Wang, Miao
   Liu, Dan
   Guo, Xuqiang
   Sun, Qiang
   Li, Xingxun
   Li, Shaowei
TI Determination of transient interfacial tension in a microfluidic device
   using a Laplace sensor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Transient interfacial tension; Laplace sensor; Microfluidic device; Mass
   transfer; Two-phase dispersion
ID MASS-TRANSFER; EXTRACTION; FLOW; ENHANCEMENT
AB In two-phase dispersion processes coupled with interphase mass transfer, the interfacial tension varies with the mass transfer and significantly affects the dispersion. Determination of the transient interfacial tension (TIFT) in such processes could facilitate better understanding and optimization of the existing processes. In this study, a microfluidic device in which a Laplace sensor was used as a pressure probe was developed to determine the TIFT. The developed Laplace sensor was shown to allow accurate measurement of the local pressure in a micro-device, and to be superior to a commercial pressure sensor. The new method can be used to precisely determine the interfacial tension when the dispersion rate was not higher than 1.5 Hz, and to have a measurement range not narrower than 0.17-58.53 mPa.s. The TIFTs of several systems were then determined, and a mathematical model was established to predict the results. The main factors governing the TIFT were analyzed based on both the experimental and theoretical results. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Lan, Wenjie; Wang, Zhihui; Wang, Miao; Liu, Dan; Guo, Xuqiang; Sun, Qiang; Li, Xingxun] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
   [Li, Shaowei] Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.
   [Li, Shaowei] Tsinghua Univ, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
RP Lan, WJ (reprint author), China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.; Li, SW (reprint author), Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.
EM lanwj@cup.edu.cn; lsw@tsinghua.edu.cn
OI Sun, Qiang/0000-0002-9336-7375; Guo, Xuqiang/0000-0001-5198-9064
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21776151, 21406266]; Science Foundation of China
   University of Petroleum, Beijing [2462018BJC004]
FX We gratefully acknowledge the support of the National Natural Science
   Foundation of China (21776151, 21406266) and the Science Foundation of
   China University of Petroleum, Beijing (No. 2462018BJC004).
CR Ahmadi F, 2019, LAB CHIP, V19, P524, DOI 10.1039/c8lc01170b
   Ashrafmansouri SS, 2016, AICHE J, V62, P852, DOI 10.1002/aic.15084
   Cabral JT, 2006, LAB CHIP, V6, P427, DOI 10.1039/b511976f
   Chen Z, 2018, J RARE EARTH, V36, P851, DOI 10.1016/j.jre.2018.02.001
   Glawdel T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026308
   Gomez-Diaz D, 2009, IND ENG CHEM RES, V48, P2671, DOI 10.1021/ie8009523
   Gunther A, 2006, LAB CHIP, V6, P1487, DOI 10.1039/b609851g
   Huang K, 2015, AICHE J, V61, P3889, DOI 10.1002/aic.14904
   Hudson SD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2034098
   Kiljanski T, 2004, AICHE J, V50, P1636, DOI 10.1002/aic.10155
   Kunding AH, 2018, LAB CHIP, V18, P2797, DOI 10.1039/c8lc00608c
   Lade VG, 2014, IND ENG CHEM RES, V53, P4812, DOI 10.1021/ie401384j
   Lan WJ, 2018, AICHE J, V64, P367, DOI 10.1002/aic.15932
   Lan WJ, 2016, AICHE J, V62, P2542, DOI 10.1002/aic.15217
   Li SW, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/1/015035
   Li SW, 2009, J COLLOID INTERF SCI, V331, P127, DOI 10.1016/j.jcis.2008.11.017
   Perro A, 2011, LANGMUIR, V27, P9034, DOI 10.1021/la1037102
   Raimondi ND, 2014, CHEM ENG SCI, V105, P169, DOI 10.1016/j.ces.2013.11.009
   Steegmans MLJ, 2009, LANGMUIR, V25, P9751, DOI 10.1021/la901103r
   Wang K, 2009, LANGMUIR, V25, P2153, DOI 10.1021/la803049s
   WANG K, 2015, [No title captured], V47, P163
   Wang K, 2016, LANGMUIR, V32, P3174, DOI 10.1021/acs.langmuir.6b00271
   Wang XY, 2015, MICROFLUID NANOFLUID, V18, P503, DOI 10.1007/s10404-014-1449-0
   Xu JH, 2008, LANGMUIR, V24, P11287, DOI 10.1021/la801526n
   Xu JH, 2008, CHEM ENG J, V141, P242, DOI 10.1016/j.cej.2007.12.030
   Zhao CX, 2011, CHEM ENG SCI, V66, P1394, DOI 10.1016/j.ces.2010.08.038
NR 26
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115207
DI 10.1016/j.ces.2019.115207
PG 9
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500011
DA 2020-05-12
ER

PT J
AU Liu, Y
   Wang, FL
   Chang, YQ
   Gao, FR
   He, DK
AF Liu, Yan
   Wang, Fuli
   Chang, Yuqing
   Gao, Furong
   He, Dakuo
TI Performance-relevant kernel independent component analysis based
   operating performance assessment for nonlinear and non-Gaussian
   industrial processes
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Comprehensive economic index; Industrial processes; Nonoptimal cause
   identification; Operating performance assessment; Performance-relevant
   kernel independent components
ID NONOPTIMAL CAUSE IDENTIFICATION; FISHER DISCRIMINANT-ANALYSIS;
   OPTIMALITY ASSESSMENT; FAULT-DIAGNOSIS; QUALITY-RELEVANT; OPTIMIZATION;
   ALGORITHMS; PROJECTION; MODEL
AB The operating performance assessment of industrial processes becomes increasingly important in manufacturing production. A novel operating performance assessment method based on performance-relevant kernel independent component analysis is proposed here for nonlinear and non-Gaussian processes. The proposed method accounts for the comprehensive economic index, and the objectives are simultaneously to maximize the non-Gaussianity of independent components as well as the correlations between them and the comprehensive economic index. When applying it to online assessment, it demonstrates stronger robustness and higher sensitivity than the traditional methods do, which is attributed to its capacity in highlighting the performance-relevant variation information in modeling. Furthermore, both the performance grades and the conversions can be evaluated, which enhances the interpretability of the results. For the nonoptimality, the variable contributions are used to find the possible cause. Finally, the efficiency of the proposed method is illustrated by a case of gold hydrometallurgy process. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Liu, Yan; Wang, Fuli; Chang, Yuqing; He, Dakuo] Northeastern Univ, Coll Informat Sci & Engn, 3 Lane 11,Wenhua Rd, Shenyang 110819, Liaoning, Peoples R China.
   [Wang, Fuli; Chang, Yuqing; He, Dakuo] Northeastern Univ, State Key Lab Synthet Automat Proc Ind, Shenyang 110819, Liaoning, Peoples R China.
   [Liu, Yan; Gao, Furong] Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.
RP Liu, Y (reprint author), Northeastern Univ, Coll Informat Sci & Engn, 3 Lane 11,Wenhua Rd, Shenyang 110819, Liaoning, Peoples R China.
EM liuyan@ise.neu.edu.cn
OI Liu, Yan/0000-0002-8003-8222
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [61703078, 61533007, 61873053, 61773105, 61973057];
   Natural Foundation Funding Schemes of Liaoning Province of China
   [2019-MS-115]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [N180404009]; Hong Kong Research Grant Council (RGC) on Synchronized
   Process Control of Hot-Runner Temperatures [16233316]; Funds for
   Creative Research Groups of ChinaScience Fund for Creative Research
   Groups [61621004]; Stat Key Laboratory of Synthetical Automation for
   Process Industries Fundamental Research Funds [2013ZCX02-04]
FX This work was supported by the National Natural Science Foundation of
   China [grant numbers 61703078, 61533007, 61873053, 61773105, and
   61973057]; Natural Foundation Funding Schemes of Liaoning Province of
   China [grant number 2019-MS-115]; the Fundamental Research Funds for the
   Central Universities [grant number N180404009]; the Hong Kong Research
   Grant Council (RGC) on Synchronized Process Control of Hot-Runner
   Temperatures [grant number 16233316]; the Funds for Creative Research
   Groups of China [grant number 61621004]; and the Stat Key Laboratory of
   Synthetical Automation for Process Industries Fundamental Research Funds
   [grant number 2013ZCX02-04].
CR ABBRUZZESE C, 1995, HYDROMETALLURGY, V39, P265, DOI 10.1016/0304-386X(95)00035-F
   Chiang LH, 2000, CHEMOMETR INTELL LAB, V50, P243, DOI 10.1016/S0169-7439(99)00061-1
   Chiang LH, 2004, COMPUT CHEM ENG, V28, P1389, DOI 10.1016/j.compchemeng.2003.10.002
   Chu F, 2018, CHINESE J CHEM ENG, V26, P775, DOI 10.1016/j.cjche.2017.06.019
   del Rio-Chanona EA, 2016, CHEM ENG SCI, V142, P289, DOI 10.1016/j.ces.2015.11.043
   Du M, 2013, CHEM ENG SCI, V104, P294, DOI 10.1016/j.ces.2013.08.009
   Dunia R, 1996, AICHE J, V42, P2797, DOI 10.1002/aic.690421011
   EDGAR TF, 2001, OPTIMIZATION CHEM PR
   Haghani A, 2014, IEEE T IND ELECTRON, V61, P6446, DOI 10.1109/TIE.2014.2311409
   Hampel F.R., 1986, ROBUST STAT
   Hwang JH, 2013, COMPUT CHEM ENG, V49, P25, DOI 10.1016/j.compchemeng.2012.09.008
   Hyvarinen A, 1998, SIGNAL PROCESS, V64, P301, DOI 10.1016/S0165-1684(97)00197-7
   Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722
   Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5
   Jackson E., 1986, HYDROMETALLURGICAL E
   Jackson J. E., 1991, USERS GUIDE PRINCIPA
   Kim IY, 2005, STRUCT MULTIDISCIP O, V29, P149, DOI 10.1007/s00158-004-0465-1
   Kocsor A., 2001, SOFSEM 2001 THEORY P, V2234, P271
   Kourti T, 1996, J QUAL TECHNOL, V28, P409
   Kumar A, 2001, AICHE J, V47, P328, DOI 10.1002/aic.690470211
   Leao VA, 2000, SOLVENT EXTR ION EXC, V18, P567, DOI 10.1080/07366290008934698
   Lee JM, 2007, CAN J CHEM ENG, V85, P526
   Lee JM, 2006, AICHE J, V52, P3501, DOI 10.1002/aic.10978
   Li QK, 2019, INT J CONTROL, V92, P1870, DOI 10.1080/00207179.2017.1415464
   Liu XQ, 2008, AICHE J, V54, P2379, DOI 10.1002/aic.11526
   Liu Y, 2017, CHEM ENG RES DES, V117, P472, DOI 10.1016/j.cherd.2016.11.001
   Liu Y, 2016, J PROCESS CONTR, V39, P11, DOI 10.1016/j.jprocont.2015.12.008
   Liu Y, 2015, CHEM ENG SCI, V137, P106, DOI 10.1016/j.ces.2015.06.016
   Liu Y, 2014, J PROCESS CONTR, V24, P1548, DOI 10.1016/j.jprocont.2014.08.001
   Liu Y, 2013, IND ENG CHEM RES, V52, P18022, DOI 10.1021/ie402243s
   Luenberger D. G., 1969, OPTIMIZATION VECTOR
   Mardia K. V., 1977, MULTIVARIATE ANAL, V4, P495
   Mejdell T., 1991, IND ENG CHEM RES, V30, P384
   Mnassri B, 2015, J PROCESS CONTR, V33, P60, DOI 10.1016/j.jprocont.2015.06.004
   Peng KX, 2013, CONTROL ENG PRACT, V21, P360, DOI 10.1016/j.conengprac.2012.11.013
   PIOVOSO MJ, 1994, INT J CONTROL, V59, P743
   Qin SJ, 2013, AICHE J, V59, P496, DOI 10.1002/aic.13959
   Qin SJ, 2003, J CHEMOMETR, V17, P480, DOI 10.1002/cem.800
   Qin SJ, 2001, J CHEMOMETR, V15, P715, DOI 10.1002/cem.667
   Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467
   Sedghi S, 2017, ENGINEERING-PRC, V3, P214, DOI 10.1016/J.ENG.2017.02.004
   Srour MH, 2008, CHEM ENG SCI, V63, P4257, DOI 10.1016/j.ces.2008.05.043
   Szekely GJ, 2013, J STAT PLAN INFER, V143, P1249, DOI 10.1016/j.jspi.2013.03.018
   Tsionas MG, 2019, EUR J OPER RES, V276, P364, DOI 10.1016/j.ejor.2018.12.042
   VAPNIK V. N., 1998, STAT LEARNING THEORY
   Wang J, 2017, IND ENG CHEM RES, V56, P7009, DOI 10.1021/acs.iecr.7b00248
   Wang JQ, 2017, INT J TURBO JET ENG, V34, P141, DOI 10.1515/tjj-2015-0061
   Wang Q, 2005, PHYSICA D, V200, P287, DOI 10.1016/j.physd.2004.11.001
   YANG MS, 1993, MATH COMPUT MODEL, V18, P1, DOI 10.1016/0895-7177(93)90202-A
   Ye LB, 2009, IND ENG CHEM RES, V48, P10912, DOI 10.1021/ie801870g
   Yin S, 2015, IEEE T IND ELECTRON, V62, P1651, DOI 10.1109/TIE.2014.2345331
   ZADEH LA, 1963, IEEE T AUTOMAT CONTR, VAC 8, P59, DOI 10.1109/TAC.1963.1105511
   Zhang SM, 2016, IND ENG CHEM RES, V55, P1642, DOI 10.1021/acs.iecr.5b03525
   Zhang XM, 2018, COMPUT CHEM ENG, V115, P141, DOI 10.1016/j.compchemeng.2018.04.006
   Zhang YW, 2008, IND ENG CHEM RES, V47, P6961, DOI 10.1021/ie071496x
   Zhou DH, 2010, AICHE J, V56, P168, DOI 10.1002/aic.11977
   Zou XY, 2017, CHEM ENG RES DES, V120, P348, DOI 10.1016/j.cherd.2017.02.022
NR 57
TC 1
Z9 1
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115167
DI 10.1016/j.ces.2019.115167
PG 20
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500031
DA 2020-05-12
ER

PT J
AU Ma, KY
   Sun, XL
   Shao, YY
   Liu, MY
   Zhu, J
AF Ma, Keying
   Sun, Xiliang
   Shao, Yuanyuan
   Liu, Mingyan
   Zhu, Jesse
TI Hydrodynamic characteristics of bubble-induced three-phase inverse
   fluidized bed (BIFB)
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Three-phase inverse fluidized bed; Hydrodynamic characteristics; Flow
   regimes; Fluidization ratio; Phase holdup
ID WASTE-WATER; GAS; BEHAVIOR; VELOCITY; REACTORS; 2-PHASE
AB A new bubble-induced three-phase inverse fluidized bed (BIFB) is proposed, where particles lighter than water are fluidized downwards by upward flowing gas without net liquid flow due to the reduced net gas-liquid mixture density and the turbulence caused by bubble flow. Key advantages include uniform fluidization of particles, zero or low liquid flowrate, low energy consumption and easy re-fluidization, showing great potential in biochemical, bioprocess, food, environmental and petrochemical industry. In a 0.33 m diameter pilot-scale BIFB column, four flow regimes; initial fluidization gas velocity and complete fluidization gas velocity were identified, using particles of different diameters and densities. A new concept, the fluidization ratio, is devised to best describe the fluidization quality in BIFB. (C) 2019 Published by Elsevier Ltd.
C1 [Ma, Keying; Shao, Yuanyuan; Liu, Mingyan; Zhu, Jesse] Tianjin Univ, Sch Chem Engn Technol, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
   [Sun, Xiliang; Zhu, Jesse] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 3K7, Canada.
   [Shao, Yuanyuan] Tianjin Key Lab Membrane Sci & Desalinat Technol, Tianjin 300072, Peoples R China.
RP Shao, YY (reprint author), Tianjin Univ, Sch Chem Engn Technol, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.; Zhu, J (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 3K7, Canada.
EM keyingma@tju.edu.cn; yshao@tju.edu.cn; myliu@tju.edu.cn; jzhu@uwo.ca
RI ; Zhu, Jesse/E-4048-2017
OI Shao, Yuanyuan/0000-0003-2434-1259; Zhu, Jesse/0000-0001-7749-8917
CR Arnaiz C, 2003, ENVIRON TECHNOL, V24, P1431, DOI 10.1080/09593330309385687
   Arun N, 2013, CHEM ENG COMMUN, V200, P1260, DOI 10.1080/00986445.2012.744747
   Bandaru KSVSR, 2007, CHINA PART, V5, P351, DOI 10.1016/j.cpart.2007.06.002
   BANERJEE J, 1999, INDIAN CHEM ENG, V41, P35
   Begum SS, 2014, KOREAN J CHEM ENG, V31, P436, DOI 10.1007/s11814-013-0260-z
   Briens CL, 1999, CHEM ENG SCI, V54, P4975, DOI 10.1016/S0009-2509(99)00220-1
   Buffiere P, 1999, CHEM ENG SCI, V54, P1233, DOI 10.1016/S0009-2509(98)00436-9
   CHERN SH, 1983, CHEM ENG SCI, V38, P1167, DOI 10.1016/0009-2509(83)80038-4
   Choi HS, 1999, KOREAN J CHEM ENG, V16, P670, DOI 10.1007/BF02708150
   Comte MP, 1997, CHEM ENG SCI, V52, P3971, DOI 10.1016/S0009-2509(97)00240-6
   DAVISON BH, 1992, BIOTECHNOL BIOENG, V39, P365, DOI 10.1002/bit.260390317
   FAN LS, 1982, CHEM ENG J BIOCH ENG, V24, P143, DOI 10.1016/0300-9467(82)80029-4
   GRACE JR, 1986, CAN J CHEM ENG, V64, P353, DOI 10.1002/cjce.5450640301
   Han HD, 2003, KOREAN J CHEM ENG, V20, P163, DOI 10.1007/BF02697203
   Ibrahim YAA, 1996, AICHE J, V42, P1889, DOI 10.1002/aic.690420710
   KRISHNAIAH K, 1993, CHEM ENG J BIOCH ENG, V51, P109, DOI 10.1016/0300-9467(93)80017-I
   Lakshmi ACV, 2000, BIOPROCESS ENG, V22, P461
   Lee DH, 2000, KOREAN J CHEM ENG, V17, P684, DOI 10.1007/BF02699118
   Liang WG, 1997, POWDER TECHNOL, V90, P95, DOI 10.1016/S0032-5910(96)03198-1
   Ma K., 2019, THESIS
   MUROYAMA K, 1985, AICHE J, V31, P1, DOI 10.1002/aic.690310102
   Myre D, 2010, CHEM ENG PROCESS, V49, P523, DOI 10.1016/j.cep.2010.04.002
   Nam W, 2002, CHEMOSPHERE, V47, P1019, DOI 10.1016/S0045-6535(01)00327-7
   Nelson MJ, 2017, ENGINEERING, V3, P330, DOI 10.1016/J.ENG.2017.03.021
   NIKOLOV L, 1987, CAN J CHEM ENG, V65, P214, DOI 10.1002/cjce.5450650204
   Renganathan T, 2003, CAN J CHEM ENG, V81, P853
   Schugerl K, 1997, CHEM ENG SCI, V52, P3661, DOI 10.1016/S0009-2509(97)88926-9
   Shin IS, 2007, J IND ENG CHEM, V13, P971
   Son SM, 2004, J CHEM ENG JPN, V37, P990, DOI 10.1252/jcej.37.990
   Son SM, 2007, CHEM ENG PROCESS, V46, P736, DOI 10.1016/j.cep.2006.10.002
   Zhu JX, 2000, CAN J CHEM ENG, V78, P82, DOI 10.1002/cjce.5450780113
NR 31
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115177
DI 10.1016/j.ces.2019.115177
PG 9
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500021
DA 2020-05-12
ER

PT J
AU Panyaram, S
   Wu, XC
   Slivensky, D
   Hampton, K
   Wilhite, B
AF Panyaram, Srikanth
   Wu Xianchun
   Slivensky, David
   Hampton, Ken
   Wilhite, Ben
TI Fixed bed structures for mono and poly-disperse mixtures of spherical
   particles using different loading methods
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fixed-beds; Loading methods; Spherical; Simulation
ID VOID FRACTION DISTRIBUTION; PACKED-BEDS; HEAT-TRANSFER; PACKING
   STRUCTURE; PRESSURE-DROP; TERNARY MIXTURES; SIZED SPHERES; FLUID-FLOW;
   LOW TUBE; REACTORS
AB Fixed beds comprising of monodsiperse and polydisperse spherical particles were generated using discrete element method (DEM) to study the impact of varying loading methods on the bed structure. The model used generated reproducible structures with good match between the predicted voidage profiles and correlations from literature. Three different loading methodologies-uniform, sock and wall were simulated by varying the initial loading positions from which the particles are introduced into the bed, with bulk voidage calculated using geometric computations and radial voidage patterns obtained by edge-based technique. Additionally, the tortuosity values were calculated for different loading strategies using the PathFinder algorithm. The bulk voidage values stabilized to 0.39 with increase in bed-particle diameter ratio. Increase in the polydispersity of the particle samples dampens the oscillations in radial voidage compared to monodisperse particle samples. Beds generated with varying loading methods demonstrated similar tortuosity values as well. For the case of polydisperse particles, particle segregation behavior varied with loading methodology employed. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Panyaram, Srikanth; Wilhite, Ben] Texas A&M Univ, Dwight Look Coll Engn, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.
   [Wu Xianchun; Slivensky, David; Hampton, Ken] Eastman Chem Co, Longview, TX USA.
RP Wilhite, B (reprint author), Texas A&M Univ, Dwight Look Coll Engn, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.
EM benjaminwilhite@exchange.tamu.edu
FU Eastman Chemical Company, Longview, TX, USA [C4690]; Artie McFerrin
   Department of Chemical Engineering,Dwight Look College of Engineering
FX This work was sponsored by The Eastman Chemical Company, Longview, TX,
   USA through project number C4690. The authors also acknowledge the
   support of High Performance Research Computing facility at Texas A&M
   University for providing the super computing facility which were used
   for the simulation studies. The authors are thankful to Texas A&M
   University for provision of STAR-CCM + license used in this study.
   Additional financial support was provided by the Artie McFerrin
   Department of Chemical Engineering,Dwight Look College of Engineering.
CR Abreu CRA, 2003, POWDER TECHNOL, V134, P167, DOI 10.1016/S0032-5910(03)00151-7
   Afandizadeh S, 2001, APPL THERM ENG, V21, P669, DOI 10.1016/S1359-4311(00)00072-7
   Agrawal N, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.08.206
   Agrawal R, 2007, CHEM ENG SCI, V62, P4926, DOI 10.1016/j.ces.2006.11.057
   ALDAHHAN MH, 1995, IND ENG CHEM RES, V34, P741, DOI 10.1021/ie00042a005
   Bai H, 2009, IND ENG CHEM RES, V48, P4060, DOI 10.1021/ie801548h
   Bazmi M, 2013, TRANSPORT POROUS MED, V99, P535, DOI 10.1007/s11242-013-0199-x
   Bazmi M, 2013, TRANSPORT POROUS MED, V97, P119, DOI 10.1007/s11242-012-0114-x
   BENENATI RF, 1962, AICHE J, V8, P359, DOI 10.1002/aic.690080319
   Benyahia F, 2005, PARTICUL SCI TECHNOL, V23, P169, DOI 10.1080/02726350590922242
   Benyahia F, 1996, PARTICUL SCI TECHNOL, V14, P221, DOI 10.1080/02726359608906697
   Caulkin R, 2006, COMPUT CHEM ENG, V30, P1178, DOI 10.1016/j.compchemeng.2006.02.019
   Caulkin R, 2009, IND ENG CHEM RES, V48, P202, DOI 10.1021/ie800033a
   CHAN SK, 1986, CHEM ENG COMMUN, V48, P215, DOI 10.1080/00986448608911788
   CHOUDHARY M, 1976, AICHE J, V22, P1021, DOI 10.1002/aic.690220611
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Das S, 2017, CHEM ENG SCI, V160, P1, DOI 10.1016/j.ces.2016.11.008
   de Klerk A, 2003, AICHE J, V49, P2022, DOI 10.1002/aic.690490812
   Dixon A. G., 1978, ACS SYM SER, V65, P238
   DIXON AG, 1988, CHEM ENG COMMUN, V71, P217, DOI 10.1080/00986448808940426
   Dixon AG, 2014, CHEM ENG RES DES, V92, P1279, DOI 10.1016/j.cherd.2013.11.018
   Dudukovic MP, 2002, CATAL REV, V44, P123, DOI 10.1081/CR-120001460
   Dziugys A, 2001, GRANUL MATTER, V3, P231, DOI 10.1007/PL00010918
   Eigenberger G., 2000, CATALYTIC FIXED BED
   Eppinger T, 2011, CHEM ENG J, V166, P324, DOI 10.1016/j.cej.2010.10.053
   Eppinger T., 2014, 10 INT C CFD OIL GAS
   FOUMENY EA, 1991, HEAT RECOV SYST CHP, V11, P127, DOI 10.1016/0890-4332(91)90126-O
   Guo Y, 2011, CHEM ENG SCI, V66, P661, DOI 10.1016/j.ces.2010.11.017
   Guo ZH, 2019, CHEM ENG SCI, V197, P357, DOI 10.1016/j.ces.2018.12.034
   Hannaoui R, 2015, CHEM ENG J, V262, P334, DOI 10.1016/j.cej.2014.09.098
   HAUGHEY DP, 1969, CAN J CHEM ENG, V47, P130, DOI 10.1002/cjce.5450470206
   Ismail JH, 2002, CHEM ENG RES DES, V80, P645, DOI 10.1205/026387602760312854
   Ismail JH, 2002, CHEM ENG RES DES, V80, P637, DOI 10.1205/026387602760312845
   Jiang Y, 2002, AICHE J, V48, P716, DOI 10.1002/aic.690480407
   Kodam M, 2010, CHEM ENG SCI, V65, P5863, DOI 10.1016/j.ces.2010.08.007
   Kruggel-Emden H, 2008, COMPUT CHEM ENG, V32, P2263, DOI 10.1016/j.compchemeng.2007.11.002
   Larachi F, 2014, CHEM ENG J, V240, P290, DOI 10.1016/j.cej.2013.11.077
   Li MS, 2000, J CHEM ENG JPN, V33, P811, DOI 10.1252/jcej.33.811
   Li TQ, 2017, MATERIALS, V10, DOI 10.3390/ma10050520
   Lommen S, 2014, PARTICUOLOGY, V12, P107, DOI 10.1016/j.partic.2013.03.006
   Marek M, 2013, CHEM PROCESS ENG-INZ, V34, P347, DOI 10.2478/cpe-2013-0028
   Mathias MF, 2000, CHEM ENG SCI, V55, P4981, DOI 10.1016/S0009-2509(00)00133-0
   McWhirter JD, 1997, TRANSPORT POROUS MED, V27, P99, DOI 10.1023/A:1006576012179
   Mueller GE, 2019, POWDER TECHNOL, V342, P607, DOI 10.1016/j.powtec.2018.10.030
   Mueller GE, 2012, POWDER TECHNOL, V229, P90, DOI 10.1016/j.powtec.2012.06.013
   MUELLER GE, 1992, POWDER TECHNOL, V72, P269, DOI 10.1016/0032-5910(92)80045-X
   Nandakumar K, 1999, AICHE J, V45, P2286, DOI 10.1002/aic.690451104
   Niegodajew P, 2016, POWDER TECHNOL, V297, P193, DOI 10.1016/j.powtec.2016.04.024
   O'Sullivan C, 2004, ENG COMPUTATION, V21, P278, DOI 10.1108/02644400410519794
   Ookawara S., 2007, P EUR C CHEM ENG ECC, P16
   PATERSON WR, 1983, CHEM ENG SCI, V38, P175, DOI 10.1016/0009-2509(83)80149-3
   Peng B., 2014, THESIS
   Pottbacker J, 2017, CHEM-ING-TECH, V89, P454, DOI 10.1002/cite.201600151
   Ranade VV, 2011, TRICKLE BED REACTORS: REACTOR ENGINEERING & APPLICATIONS, P1
   Reimann J, 2017, POWDER TECHNOL, V318, P471, DOI 10.1016/j.powtec.2017.05.033
   ROBLEE LHS, 1958, AICHE J, V4, P460, DOI 10.1002/aic.690040415
   Rougier E, 2004, INT J NUMER METH ENG, V61, P856, DOI 10.1002/nme.1092
   Salvat WI, 2005, CATAL TODAY, V107-08, P513, DOI 10.1016/j.cattod.2005.07.108
   Schulze S, 2015, PARTICUL SCI TECHNOL, V33, P23, DOI 10.1080/02726351.2014.923960
   Shi Y, 2008, APPL PHYS A-MATER, V92, P621, DOI 10.1007/s00339-008-4547-6
   SHYR YS, 1980, J CATAL, V63, P425, DOI 10.1016/0021-9517(80)90096-2
   Smid J, 1993, CHEM ENG TECH, V16, P114
   Sobieski W., 2016, GRANUL MATTER, V3, P1
   Sobieski W., 2016, NEW APPROACH OBTAINI, P165
   Sobieski W, 2012, TRANSPORT POROUS MED, V93, P431, DOI 10.1007/s11242-012-9961-8
   Srivastava A., 2018, CHEM ENG J
   Strack O. D. L., 1978, DISTINCT ELEMENT MET
   Suzuki M, 2008, ADV POWDER TECHNOL, V19, P183, DOI 10.1163/156855208X293817
   Tang P, 2004, PARTICUL SCI TECHNOL, V22, P321, DOI 10.1080/02726350490501420
   Tangri H, 2017, POWDER TECHNOL, V317, P72, DOI 10.1016/j.powtec.2017.03.058
   THADANI MC, 1966, IND ENG CHEM PROC DD, V5, P265, DOI 10.1021/i260019a012
   Theuerkauf J, 2006, POWDER TECHNOL, V165, P92, DOI 10.1016/j.powtec.2006.03.022
   Wang GQ, 2005, IND ENG CHEM RES, V44, P8715, DOI 10.1021/ie050017w
   Wehinger GD, 2017, IND ENG CHEM RES, V56, P87, DOI 10.1021/acs.iecr.6b03596
   Wehinger GD, 2015, CHEM-ING-TECH, V87, P734, DOI 10.1002/cite.201400153
   Yang J, 2016, NUCL ENG DES, V300, P85, DOI 10.1016/j.nucengdes.2015.10.030
   Zobel N, 2012, CHEM ENG SCI, V71, P212, DOI 10.1016/j.ces.2011.12.029
NR 77
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115165
DI 10.1016/j.ces.2019.115165
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500018
DA 2020-05-12
ER

PT J
AU Schulte, MJ
   Robinett, M
   Weidle, N
   Duran, CJ
   Flickinger, MC
AF Schulte, Mark J.
   Robinett, Michael
   Weidle, Nick
   Duran, Christopher J.
   Flickinger, Michael C.
TI Experiments and finite element modeling of hydrodynamics and mass
   transfer for continuous gas-to-liquid biocatalysis using a biocomposite
   falling film reactor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Falling film; Computational fluid dynamics; Gas-to-liquid mass transfer;
   Biocomposite biocatalyst; Process intensification; Immobilized cells in
   biocomposites
ID CLOSTRIDIUM-LJUNGDAHLII OTA1; NUMERICAL-SIMULATION; SYNGAS FERMENTATION;
   ETHANOL-PRODUCTION; BIOFILM; FLOW; COATINGS; WAVY; MICROREACTOR;
   ABSORPTION
AB We investigated the hydrodynamics and mass transfer performance of falling liquid films over a rough, hydrophilic paper surface with experiments and finite element modeling. These results are critical for designing a novel gas-to-liquid continuous bioreactor with cells immobilized on the vertical surface of a paper biocomposite. The paper substrate allows investigations at very low Reynolds numbers while maintaining an unbroken liquid film. A finite element model was developed to give 10 fold faster simulation result for designing a prototype laboratory scale bioreactor. Excellent agreement was found in both the film properties and mass transfer performance between experiments and simulations. At Re < 100, mass transfer coefficients k(L) and k(L)a were similar to 1E-4 m/s and similar to 1000 h(-1), respectively, at similar to 10 W/m(3). That power input is 10-1000 fold less than most gas stripping bioreactors. This work highlights the potential of this finite element method for falling film, gas absorbing, bioreactor design and analysis. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Schulte, Mark J.; Robinett, Michael; Weidle, Nick; Duran, Christopher J.; Flickinger, Michael C.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
RP Flickinger, MC (reprint author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
EM mcflicki@ncsu.edu
FU National Institutes of Health Molecular Biotechnology Training
   ProgramUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32 GM008776-11]; Department of
   Energy, Office of Energy Efficiency and Renewable Energy (EERE)United
   States Department of Energy (DOE) [DE-EE0006877]; Golden LEAF
   Biotechnology Training and Education Center (BTEC) at NCSU
FX This research was supported by the National Institutes of Health
   Molecular Biotechnology Training Program (T32 GM008776-11), the
   Department of Energy, Office of Energy Efficiency and Renewable Energy
   (EERE) under Award Number DE-EE0006877, and the Golden LEAF
   Biotechnology Training and Education Center (BTEC) at NCSU. We would
   like to acknowledge Dr. Edward Cussler and Dr. Jack Edwards for their
   input at critical decision points and AltaSim Technologies for help
   constructing a preliminary model.
CR Albert C, 2014, INT J HEAT MASS TRAN, V69, P343, DOI 10.1016/j.ijheatmasstransfer.2013.10.025
   Albert C, 2012, INT J MULTIPHAS FLOW, V43, P66, DOI 10.1016/j.ijmultiphaseflow.2012.02.011
   Andersson B., 2012, COMPUTATIONAL FLUID
   Azzopardi BJ, 2011, HYDRODYNAMICS OF GAS-LIQUID REACTORS: NORMAL OPERATION AND UPSET CONDITIONS, P91
   Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747
   Bernal O.I., 2014, THESIS
   Bernal OI, 2017, LANGMUIR, V33, P5304, DOI 10.1021/acs.langmuir.7b00335
   Bernal OI, 2014, BIOTECHNOL BIOENG, V111, P1993, DOI 10.1002/bit.25280
   Bolivar JM, 2016, BIOTECHNOL BIOENG, V113, P1862, DOI 10.1002/bit.25969
   Broniarz-Press L., 2007, THIN FILM FLOW LIQUI
   CHANG HC, 2002, COMPLEX WAVE DYNAMIC
   Cheremisinoff N.P., 1989, HDB HEAT MASS TRANSF
   CHERRY RS, 1992, BIOTECHNOL PROGR, V8, P11, DOI 10.1021/bp00013a003
   Chisti Y, 2000, TRENDS BIOTECHNOL, V18, P420, DOI 10.1016/S0167-7799(00)01474-8
   Chisti Y., 2013, UPSTREAM IND BIOTECH, P1719
   Chisti Y., 2007, KIRK OTHMER ENCY CHE
   Cortez S., 2008, Reviews in Environmental Science and Bio/Technology, V7, P155, DOI 10.1007/s11157-008-9127-x
   Cussler E. L., 2009, DIFFUSION MASS TRANS
   DAWSON DA, 1972, INT J HEAT MASS TRAN, V15, P1317, DOI 10.1016/0017-9310(72)90015-4
   De Beer D., 2013, PROKARYOTES, P343
   Dietze GF, 2009, J FLUID MECH, V637, P73, DOI 10.1017/S0022112009008155
   Ercan D, 2015, CRIT REV BIOTECHNOL, V35, P1, DOI 10.3109/07388551.2013.793170
   Fidaleo M, 2006, BIOTECHNOL BIOENG, V95, P446, DOI 10.1002/bit.21051
   Flickinger MC, 2007, BIOTECHNOL PROGR, V23, P2, DOI 10.1021/bp060347r
   Flickinger MC, 2017, J COAT TECHNOL RES, V14, P791, DOI 10.1007/s11998-017-9933-6
   FOUAD MG, 1969, ELECTROCHIM ACTA, V14, P909, DOI 10.1016/0013-4686(69)87012-X
   Garny K, 2009, CHEM ENG SCI, V64, P2723, DOI 10.1016/j.ces.2009.03.009
   Gosse JL, 2010, BIOTECHNOL PROGR, V26, P907, DOI 10.1002/btpr.406
   Halan B., 2012, TRENDS BIOTECHNOL
   Hassard F, 2015, PROCESS SAF ENVIRON, V94, P285, DOI 10.1016/j.psep.2014.07.003
   Hessel V, 2005, IND ENG CHEM RES, V44, P9750, DOI 10.1021/ie0503139
   Hu JG, 2014, CHEM ENG SCI, V116, P243, DOI 10.1016/j.ces.2014.05.002
   Hu WW, 2011, CYTOTECHNOLOGY, V63, P445, DOI 10.1007/s10616-011-9368-3
   Illner S, 2014, CHEMCATCHEM, V6, P1748, DOI 10.1002/cctc.201400028
   Kalliadasis S, 2012, APPL MATH SCI, V176, P1, DOI 10.1007/978-1-84882-367-9
   Kapitza P.L., 1964, ANONYMOUS, P662
   KAWASE Y, 1994, CAN J CHEM ENG, V72, P798, DOI 10.1002/cjce.5450720505
   Mohammadi M, 2011, RENEW SUST ENERG REV, V15, P4255, DOI 10.1016/j.rser.2011.07.124
   Abubackar HN, 2011, BIOFUEL BIOPROD BIOR, V5, P93, DOI 10.1002/bbb.256
   Nienow AW, 2006, CYTOTECHNOLOGY, V50, P9, DOI 10.1007/s10616-006-9005-8
   Scheper T., 2000, INFLUENCE STRESS CEL
   Schulte MJ, 2016, BIOTECHNOL BIOENG, V113, P1913, DOI 10.1002/bit.25966
   Shen YW, 2014, APPL ENERG, V136, P68, DOI 10.1016/j.apenergy.2014.08.117
   Shen YW, 2014, BIOCHEM ENG J, V85, P21, DOI 10.1016/j.bej.2014.01.010
   Todhanakasem T, 2017, BIOCATAL BIOTRANSFOR, V35, P86, DOI 10.1080/10242422.2017.1295230
   Trifonov Y, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4984005
   Warneck P, 2012, ATMOSPHERIC CHEM COM
   Whitham JM, 2017, APPL MICROBIOL BIOT, V101, P1615, DOI 10.1007/s00253-016-7978-6
   Xu ZF, 2008, CHEM ENG SCI, V63, P2559, DOI 10.1016/j.ces.2008.02.014
   YIH SM, 1982, CHEM ENG COMMUN, V17, P123, DOI 10.1080/00986448208911620
   Yu YQ, 2014, PROG NUCL ENERG, V77, P176, DOI 10.1016/j.pnucene.2014.07.001
   Yu YQ, 2014, INT J HEAT MASS TRAN, V79, P561, DOI 10.1016/j.ijheatmasstransfer.2014.08.035
   Ziegenbalg D, 2010, CHEM ENG SCI, V65, P3557, DOI 10.1016/j.ces.2010.02.039
   Zimmerman WB, 2013, CHEM ENG SCI, V101, P865, DOI 10.1016/j.ces.2013.05.026
NR 54
TC 0
Z9 0
U1 6
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115163
DI 10.1016/j.ces.2019.115163
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500017
DA 2020-05-12
ER

PT J
AU Shi, WD
   Wang, J
   You, SM
   Yan, WC
AF Shi, Wei-Dong
   Wang, Jian
   You, Siming
   Yan, Wei-Cheng
TI Numerical simulation of particle focusing dynamics of DNA-laden fluids
   in a microtube
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Particle focusing; DNA-laden fluid; Microfluidics; CFD simulation;
   Microparticle manipulation
ID GRADIENT INDUCED MIGRATION; CONCENTRATED SUSPENSIONS; SUSPENDING LIQUID;
   MOLECULAR-WEIGHT; FINES MIGRATION; HEAT-TRANSFER; FLOW; VISCOELASTICITY;
   MICROFLUIDICS; POLYMERS
AB A CFD model considering inertial, elastic and drag forces was developed to simulate the focusing effect of microparticles in a dilute DNA solution passing through a microtube. The Oldroyd-B fluid model coupled with Lagrangian model was employed to describe the flow behavior of DNA solution and particle trajectory. The model was validated by comparing the patterns of particle beam and its width with experimental results. Particle focusing dynamics was investigated by analyzing the focusing behaviors, flow and particle velocity, and force distributions throughout the whole tube. The results indicated that particles far away from the centerline migrate faster than those near centerline. Investigations on the effect of DNA concentration, particle diameter and flow rate showed that increasing DNA concentration and particle diameter benefited the focusing efficiency while larger flow rate weakened the particle focusing. This computational model could serve as an effective tool to investigate the particle focusing dynamics. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shi, Wei-Dong; Wang, Jian; Yan, Wei-Cheng] Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang 212013, Jiangsu, Peoples R China.
   [You, Siming] Univ Glasgow, Sch Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [Yan, Wei-Cheng] Jiangsu Univ, Res Ctr Fluid Machinery Engn & Technol, Zhenjiang 212013, Jiangsu, Peoples R China.
RP Yan, WC (reprint author), Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang 212013, Jiangsu, Peoples R China.; Yan, WC (reprint author), Jiangsu Univ, Res Ctr Fluid Machinery Engn & Technol, Zhenjiang 212013, Jiangsu, Peoples R China.
EM yanwc@ujs.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21808088]; startup funding for young researchers of
   Jiangsu University of China [18JDG022]; Innovation and Entrepreneurship
   program of Jiangsu province of China (2018); Natural Science Foundation
   of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu
   Province [BK20180868]
FX This project is supported by the National Natural Science Foundation of
   China (21808088) and the startup funding for young researchers of
   Jiangsu University of China (18JDG022). The authors also acknowledge the
   support from the Innovation and Entrepreneurship program of Jiangsu
   province of China (2018) and the Natural Science Foundation of Jiangsu
   Province of China (BK20180868). Acknowledgements are also given to the
   high performance computing center and school of energy and power
   engineering in Jiangsu University for the platform supports in
   simulation.
CR Ahn SW, 2015, CHEM ENG SCI, V126, P237, DOI 10.1016/j.ces.2014.12.019
   Bahiraei M, 2015, J MOL LIQ, V209, P531, DOI 10.1016/j.molliq.2015.06.030
   Bhat PP, 2010, NAT PHYS, V6, P625, DOI 10.1038/NPHYS1682
   Brust M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078305
   Cha S, 2014, RHEOL ACTA, V53, P927, DOI 10.1007/s00397-014-0808-9
   D'Avino G, 2019, J NON-NEWTON FLUID, V263, P33, DOI 10.1016/j.jnnfm.2018.11.003
   D'Avino G, 2017, ANNU REV FLUID MECH, V49, P341, DOI 10.1146/annurev-fluid-010816-060150
   D'Avino G, 2012, LAB CHIP, V12, P1638, DOI 10.1039/c2lc21154h
   Dannhauser D, 2014, ANALYST, V139, P5239, DOI 10.1039/c4an01033g
   Del Giudice F, 2015, MICROFLUID NANOFLUID, V19, P95, DOI 10.1007/s10404-015-1552-x
   Di Carlo D, 2009, LAB CHIP, V9, P3038, DOI 10.1039/b912547g
   Dimakopoulos Y, 2012, J NON-NEWTON FLUID, V187, P16, DOI 10.1016/j.jnnfm.2012.09.001
   Dimakopoulos Y, 2009, J NON-NEWTON FLUID, V159, P95, DOI 10.1016/j.jnnfm.2009.02.001
   Godin J, 2008, J BIOPHOTONICS, V1, P355, DOI 10.1002/jbio.200810018
   GRAESSLEY WW, 1980, POLYMER, V21, P258, DOI 10.1016/0032-3861(80)90266-9
   Hur SC, 2010, LAB CHIP, V10, P274, DOI 10.1039/b919495a
   Kang K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3567
   LEAL LG, 1979, J NON-NEWTON FLUID, V5, P33, DOI 10.1016/0377-0257(79)85004-1
   LEIGHTON D, 1987, J FLUID MECH, V177, P109, DOI 10.1017/S0022112087000880
   Leshansky AM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.234501
   Lim EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5120
   Lim H, 2014, MICROFLUID NANOFLUID, V17, P683, DOI 10.1007/s10404-014-1353-7
   Lin JZ, 2018, CHEM ENG SCI, V176, P270, DOI 10.1016/j.ces.2017.10.047
   Lu XY, 2017, J COLLOID INTERF SCI, V500, P182, DOI 10.1016/j.jcis.2017.04.019
   Masaeli M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031017
   McKinley G.H., 2002, STEADY TRANSIENT MOT
   Merkak O, 2009, AICHE J, V55, P2515, DOI 10.1002/aic.11852
   MOLERUS O, 1995, CHEM ENG SCI, V50, P871, DOI 10.1016/0009-2509(94)00445-W
   Nam J, 2012, LAB CHIP, V12, P1347, DOI 10.1039/c2lc21304d
   Oakey J, 2010, ANAL CHEM, V82, P3862, DOI 10.1021/ac100387b
   PHILLIPS RJ, 1992, PHYS FLUIDS A-FLUID, V4, P30, DOI 10.1063/1.858498
   Ritz JB, 2000, CHEM ENG SCI, V55, P4857, DOI 10.1016/S0009-2509(00)00106-8
   Seo KW, 2014, RSC ADV, V4, P3512, DOI 10.1039/c3ra43522a
   SHARMA MM, 1987, AICHE J, V33, P1654, DOI 10.1002/aic.690331009
   Song HY, 2016, RHEOL ACTA, V55, P889, DOI 10.1007/s00397-016-0962-3
   Tirtaatmadja V, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2190469
   Tsouka S, 2016, J NON-NEWTON FLUID, V228, P79, DOI 10.1016/j.jnnfm.2015.12.011
   Tsouka S, 2014, J RHEOL, V58, P911, DOI 10.1122/1.4880245
   Villone MM, 2011, J NON-NEWTON FLUID, V166, P1396, DOI 10.1016/j.jnnfm.2011.09.003
   Xie Q, 2017, INT J GREENH GAS CON, V65, P32, DOI 10.1016/j.ijggc.2017.08.011
   Xuan XC, 2010, MICROFLUID NANOFLUID, V9, P1, DOI 10.1007/s10404-010-0602-7
   Yang S, 2012, SOFT MATTER, V8, P5011, DOI 10.1039/c2sm07469a
   Yuan PP, 2015, MATER DESIGN, V82, P46, DOI 10.1016/j.matdes.2015.05.041
NR 43
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115213
DI 10.1016/j.ces.2019.115213
PG 12
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500028
DA 2020-05-12
ER

PT J
AU Sun, HY
   Zhang, XY
   He, Y
   Zhang, DD
   Feng, X
   Zhao, YP
   Chen, L
AF Sun, Heyu
   Zhang, Xiaoye
   He, Yang
   Zhang, Dongdong
   Feng, Xia
   Zhao, Yiping
   Chen, Li
TI Preparation of PVDF-g-PAA-PAMAM membrane for efficient removal of copper
   ions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE PAMAM; PVDF; PAA; Membranes; Copper ions adsorption
ID HOLLOW-FIBER MEMBRANES; HEAVY-METALS REMOVAL; WATER-TREATMENT; GRAPHENE
   OXIDE; WASTE-WATER; SILICA-GEL; ADSORPTION; NANOPARTICLES;
   THERMODYNAMICS; ADSORBENTS
AB In this work, PVDF-g-PAA-PAMAM membranes were prepared by surface grafting different generation polyamide-amine (PAMAM) onto PVDF-g-PAA membranes. The structures of membranes were characterized by Fourier transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), energy dispersive X-ray spectrometer (EDX), field-emission scanning electron microscopy (SEM) and atomic force microscope (AFM). The adsorption properties of membranes to copper ions were studied, and the results found that PAMAM was successfully grafted onto the surface of PVDF-g-PAA membranes, and their hydrophilicity were significantly improved. The adsorption properties of PVDF-g-PAA-PAMAM membranes to copper ions were effectively improved. The PVDF-g-PAA-G3.0 PAMAM membrane has the best adsorption properties, and the adsorption capacity of copper ion can reach 100.98 mg/g, which was higher than that of pure membrane. At the same time, it can be found from the desorption experiments that the PVDF-g-PAA-PAMAM membrane can be recycled with high adsorption capacity, and the regeneration rate was higher than 90%. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sun, Heyu; Zhang, Xiaoye; He, Yang; Zhang, Dongdong; Feng, Xia; Zhao, Yiping] Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Natl Ctr Int Joint Res Separat Membranes, Tianjin 300387, Peoples R China.
   [Chen, Li] Tianjin Univ Technol, Sch Mat Sci & Engn, Tianjin 300384, Peoples R China.
RP Zhao, YP (reprint author), Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Natl Ctr Int Joint Res Separat Membranes, Tianjin 300387, Peoples R China.
FU Science and Technology Plans of Tianjin [17YFZCSF01230, 17PTSYJC00040,
   18JCYBJC18100, 18PTSYJC00180]; Program for Innovative Research Team in
   University of Ministry of Education of China [IRT-17R80]; Program for
   Innovative Research Team in University of Tianjin [TD13-5044]
FX This work was financially sponsored by the Science and Technology Plans
   of Tianjin (No. 17YFZCSF01230, 17PTSYJC00040, 18JCYBJC18100 and
   18PTSYJC00180), and Program for Innovative Research Team in University
   of Ministry of Education of China (No. IRT-17R80) Program for Innovative
   Research Team in University of Tianjin (No. TD13-5044).
CR Adeleye AS, 2016, CHEM ENG J, V286, P640, DOI 10.1016/j.cej.2015.10.105
   Al-Rashdi B, 2011, SEP PURIF REV, V40, P209, DOI 10.1080/15422119.2011.558165
   Barakat MA, 2010, DESALINATION, V256, P90, DOI 10.1016/j.desal.2010.02.008
   Bu J, 2004, MACROMOLECULES, V37, P6687, DOI 10.1021/ma040055b
   Camarillo R, 2012, DESALINATION, V286, P193, DOI 10.1016/j.desal.2011.11.021
   Cao ZP, 2017, CHEM ENG J, V309, P30, DOI 10.1016/j.cej.2016.10.013
   Chen M, 2018, CHEM ENG J, V344, P155, DOI 10.1016/j.cej.2018.03.054
   Chen QZ, 2018, ENVIRON SCI TECHNOL, V52, P4464, DOI 10.1021/acs.est.7b06701
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Deng B, 2010, J MEMBRANE SCI, V350, P252, DOI 10.1016/j.memsci.2009.12.035
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Gao J, 2014, WATER RES, V63, P252, DOI 10.1016/j.watres.2014.06.006
   Gao XL, 2013, J MEMBRANE SCI, V445, P146, DOI 10.1016/j.memsci.2013.05.026
   Hashim NA, 2009, J MEMBRANE SCI, V345, P134, DOI 10.1016/j.memsci.2009.08.032
   He YR, 2018, J MEMBRANE SCI, V555, P299, DOI 10.1016/j.memsci.2018.03.055
   Hernandez-Rivera D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051009
   Hou XB, 2018, PART PART SYST CHAR, V35, DOI 10.1002/ppsc.201700438
   Huang XP, 2017, J ENVIRON MANAGE, V204, P264, DOI 10.1016/j.jenvman.2017.09.007
   Li L, 2018, APPL CLAY SCI, V161, P225, DOI 10.1016/j.clay.2018.04.002
   Li T, 2018, WATER RES, V143, P87, DOI 10.1016/j.watres.2018.06.031
   Liang S, 2013, ACS APPL MATER INTER, V5, P6694, DOI 10.1021/am401462e
   Mukherjee R, 2016, CHEM ENG J, V292, P284, DOI 10.1016/j.cej.2016.02.015
   Neghlani PK, 2011, J HAZARD MATER, V186, P182, DOI 10.1016/j.jhazmat.2010.10.121
   Nongbe MC, 2018, CELLULOSE, V25, P4043, DOI 10.1007/s10570-018-1833-0
   Ren J, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.45697
   Silvestri S, 2016, ECOTOX ENVIRON SAFE, V134, P280, DOI 10.1016/j.ecoenv.2016.07.040
   Sunil K, 2018, CHEM ENG J, V348, P678, DOI 10.1016/j.cej.2018.05.017
   Wan SL, 2018, CHEM ENG J, V350, P1135, DOI 10.1016/j.cej.2018.06.068
   Wu H, 2013, J MEMBRANE SCI, V433, P135, DOI 10.1016/j.memsci.2013.01.029
   Wu RX, 2018, J NANOSCI NANOTECHNO, V18, P5624, DOI 10.1166/jnn.2018.15433
   Yuliwati E, 2011, DESALINATION, V283, P206, DOI 10.1016/j.desal.2011.02.037
   Zhou SY, 2015, APPL CLAY SCI, V107, P220, DOI 10.1016/j.clay.2015.01.032
   Zhu WP, 2015, J MEMBRANE SCI, V487, P117, DOI 10.1016/j.memsci.2015.03.033
   Zhu Y, 2018, ECOTOX ENVIRON SAFE, V162, P253, DOI 10.1016/j.ecoenv.2018.06.094
NR 34
TC 2
Z9 2
U1 24
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115186
DI 10.1016/j.ces.2019.115186
PG 11
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500034
DA 2020-05-12
ER

PT J
AU Sun, SQ
   Zhang, XQ
   Feng, SX
   Wang, HB
   Wang, Y
   Luo, JH
   Li, CL
   Hu, SQ
AF Sun, Shuangqing
   Zhang, Xiqiang
   Feng, Shengxiang
   Wang, Hongbing
   Wang, Yan
   Luo, Jianhui
   Li, Chunling
   Hu, Songqing
TI CO2/N-2 switchable aqueous foam stabilized by SDS/C(12)A surfactants:
   Experimental and molecular simulation studies
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE CO2/N-2 switchable; Aqueous foam; CO2-responsive surfactant; Molecular
   simulation; Electrostatic attraction; Hydrophilicity
ID SILICA NANOPARTICLES; CO2 FOAM; IN-SITU; OIL; DESTRUCTION; EMULSIONS;
   DYNAMICS; TENSION; FILM
AB A novel CO2/N-2 switchable aqueous foam was developed using a CO2-responsive surfactant N,N-dimethylN-dodecyl amine (C(12)A) and a conventional surfactant sodium dodecyl sulfate (SDS). The performance and mechanism of this switchable foam were studied by both experiment and molecular simulation methods. Experimental results demonstrate that the foam stabilized by SDS/C(12)A surfactants has better stability and water carrying capacity than single C12A foam. The foam could be rapidly switched between stable and unstable states at ambient temperature with CO2 or N-2 as the triggers. Simulation results shows that when CO2 was introduced, most of SDS and C(12)A molecules aggregated in the water phase, instead of adsorbing at the air-water interface to stabilize the foam films. The strong electrostatic attraction between protonated C(12)A and SDS molecules could account for the aggregation. Due to the presence of limited surfactants located at the air-water interface after introducing CO2, the foam bursts quickly. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sun, Shuangqing; Zhang, Xiqiang; Feng, Shengxiang; Wang, Hongbing; Wang, Yan; Li, Chunling; Hu, Songqing] China Univ Petr East China, Sch Mat Sci, Qingdao 266580, Shandong, Peoples R China.
   [Sun, Shuangqing; Zhang, Xiqiang; Feng, Shengxiang; Wang, Hongbing; Wang, Yan; Li, Chunling; Hu, Songqing] China Univ Petr East China, Sch Engn, Qingdao 266580, Shandong, Peoples R China.
   [Luo, Jianhui] PetroChina, RIPED, Beijing 100083, Peoples R China.
RP Li, CL; Hu, SQ (reprint author), China Univ Petr East China, Sch Mat Sci, Qingdao 266580, Shandong, Peoples R China.; Li, CL; Hu, SQ (reprint author), China Univ Petr East China, Sch Engn, Qingdao 266580, Shandong, Peoples R China.
EM lichunling@upc.edu.cn; songqinghu@upc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51874331]; PetroChina Innovation Foundation
   [2018D-5007-0213]; Shandong Provincial Natural Science FoundationNatural
   Science Foundation of Shandong Province [ZR2017MEE028]; Fundamental
   Research Funds for the Central UniversitiesFundamental Research Funds
   for the Central Universities [17CX05023, 19CX06002A]
FX This work was supported by the "National Natural Science Foundation of
   China" (51874331), the "PetroChina Innovation Foundation"
   (2018D-5007-0213), the "Shandong Provincial Natural Science Foundation"
   (ZR2017MEE028), and the "Fundamental Research Funds for the Central
   Universities" (17CX05023 and 19CX06002A).
CR Berry JD, 2015, J COLLOID INTERF SCI, V454, P226, DOI 10.1016/j.jcis.2015.05.012
   Binks BP, 2007, LANGMUIR, V23, P8691, DOI 10.1021/la700444a
   Chevallier E, 2012, LANGMUIR, V28, P2308, DOI 10.1021/la204200z
   Denkov ND, 2004, LANGMUIR, V20, P9463, DOI 10.1021/la049676o
   Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253
   Fameau AL, 2015, CHEMPHYSCHEM, V16, P66, DOI 10.1002/cphc.201402580
   Fameau AL, 2013, CHEM SCI, V4, P3874, DOI 10.1039/c3sc51774h
   Fameau AL, 2011, ANGEW CHEM INT EDIT, V50, P8264, DOI 10.1002/anie.201102115
   FORDHAM S, 1948, PROC R SOC LON SER-A, V194, P1, DOI 10.1098/rspa.1948.0063
   Fujii S, 2015, SOFT MATTER, V11, P572, DOI 10.1039/c4sm02236j
   Gao FF, 2017, APPL SURF SCI, V407, P156, DOI 10.1016/j.apsusc.2017.02.087
   Garrett P.R., 2016, SCI DEFOAMING THEORY
   Garrett PR, 2015, CURR OPIN COLLOID IN, V20, P81, DOI 10.1016/j.cocis.2015.03.007
   Guo F, 2016, FUEL, V186, P430, DOI 10.1016/j.fuel.2016.08.058
   Heeres AS, 2016, CHEM ENG SCI, V145, P31, DOI 10.1016/j.ces.2016.02.011
   Hill C, 2018, J COLLOID INTERF SCI, V530, P686, DOI 10.1016/j.jcis.2018.07.023
   HUANG YT, 1987, J FOOD SCI, V52, P1684, DOI 10.1111/j.1365-2621.1987.tb05906.x
   Huangfu ZC, 2018, J IND ENG CHEM, V61, P12, DOI 10.1016/j.jiec.2017.11.041
   Jochum FD, 2013, CHEM SOC REV, V42, P7468, DOI 10.1039/c2cs35191a
   Jones SA, 2016, COLLOID SURFACE A, V500, P166, DOI 10.1016/j.colsurfa.2016.03.072
   Kumar S, 2017, APPL SURF SCI, V420, P9, DOI 10.1016/j.apsusc.2017.05.126
   Lam S, 2011, J AM CHEM SOC, V133, P13856, DOI 10.1021/ja205065w
   Lei L, 2017, LANGMUIR, V33, P7908, DOI 10.1021/acs.langmuir.7b00934
   Li CL, 2016, COLLOID SURFACE A, V489, P423, DOI 10.1016/j.colsurfa.2015.11.012
   Li CX, 2013, LANGMUIR, V29, P5418, DOI 10.1021/la4011373
   Li HH, 2016, COLLOID SURFACE A, V502, P107, DOI 10.1016/j.colsurfa.2016.05.013
   Liu YX, 2006, SCIENCE, V313, P958, DOI 10.1126/science.1128142
   Miller CA, 2008, CURR OPIN COLLOID IN, V13, P177, DOI 10.1016/j.cocis.2007.11.007
   Panhuis MIH, 1998, MOL PHYS, V94, P963, DOI 10.1080/002689798167539
   Patino JMR, 2008, ADV COLLOID INTERFAC, V140, P95, DOI 10.1016/j.cis.2007.12.007
   RUDIN AD, 1957, J I BREWING, V63, P506, DOI DOI 10.1002/J.2050-0416.1957.TB06291.X
   Schnurbus M, 2018, LANGMUIR, V34, P6028, DOI 10.1021/acs.langmuir.8b00587
   STAUFFER CE, 1965, J PHYS CHEM-US, V69, P1933, DOI 10.1021/j100890a024
   Sun YG, 2015, COLLOID SURFACE A, V480, P138, DOI 10.1016/j.colsurfa.2015.02.042
   Wang HB, 2018, J PHYS CHEM C, V122, P26438, DOI 10.1021/acs.jpcc.8b08151
   Wang J, 2018, J COLLOID INTERF SCI, V523, P65, DOI 10.1016/j.jcis.2018.03.090
   Wang L, 2017, ENERG FUEL, V31, P1512, DOI 10.1021/acs.energyfuels.6b03186
   Wang L, 2016, CHEM ENG SCI, V155, P167, DOI 10.1016/j.ces.2016.08.012
   Wang ZZ, 2019, J COLLOID INTERF SCI, V536, P381, DOI 10.1016/j.jcis.2018.10.040
   Wu G, 2017, CHEM ENG SCI, V166, P313, DOI 10.1016/j.ces.2017.03.011
   Wu JW, 2016, PETROL EXPLOR DEV+, V43, P695, DOI 10.1016/S1876-3804(16)30081-7
   Yan H, 2011, LANGMUIR, V27, P5762, DOI 10.1021/la1049869
   Yang WP, 2017, ENERG FUEL, V31, P4721, DOI 10.1021/acs.energyfuels.6b03217
   Zhang YM, 2016, LANGMUIR, V32, P11861, DOI 10.1021/acs.langmuir.6b03034
   Zhang YM, 2016, GREEN CHEM, V18, P392, DOI 10.1039/c5gc01411e
   Zhang YM, 2014, GREEN MATER, V2, P95, DOI 10.1680/gmat.13.00016
   Zhu Y, 2014, SOFT MATTER, V10, P9739, DOI 10.1039/c4sm01970a
NR 47
TC 0
Z9 0
U1 10
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115218
DI 10.1016/j.ces.2019.115218
PG 9
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500006
DA 2020-05-12
ER

PT J
AU Tripathi, NM
   Portnikov, D
   Levy, A
   Kalman, H
AF Tripathi, Naveen Mani
   Portnikov, Dmitry
   Levy, Avi
   Kalman, Haim
TI Bend pressure drop in horizontal and vertical dilute phase pneumatic
   conveying systems
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Pneumatic conveying; Dilute phase; Bend; Pressure drop; Horizontal and
   vertical pipeline; Particle velocity
ID PARTICLE-VELOCITY; ACCELERATION; TRANSPORT; SOLIDS; FLOW; COAL
AB This paper presents a detailed investigation into the modeling of the total bend pressure drop (TBPD) for all three orientations: horizontal-horizontal (H-H), horizontal-vertical (H-V), and vertical-horizontal (V-H) in dilute phase flow. Different types of materials were fed with a screw feeder and conveyed through two different sets of galvanized steel pipeline. The TBPD (all orientations) is the summation of the pressure drop due to the momentum change (reacceleration), the air only flow along the bend, and a function of the pressure drop due to the particles, which contributes to the bend only. A qualitative comparison was performed for blind-T and a radius bend (R/D = 10) using a particular material property. This comparison helped in obtaining a comprehensive understanding of TBPD. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tripathi, Naveen Mani; Portnikov, Dmitry; Levy, Avi; Kalman, Haim] Ben Gurion Univ Negev, Dept Mech Engn, Lab Conveying & Handling Particulate Solids CHoP, Beer Sheva, Israel.
   [Kalman, Haim] Aaron Fish Chair Mech Engn Fracture Mech, Beer Sheva, Israel.
   [Tripathi, Naveen Mani] GranuTools, Rue Jean Lambert Defrene 107, B-4340 Awans, Belgium.
RP Tripathi, NM (reprint author), Ben Gurion Univ Negev, Dept Mech Engn, Lab Conveying & Handling Particulate Solids CHoP, Beer Sheva, Israel.; Tripathi, NM (reprint author), GranuTools, Rue Jean Lambert Defrene 107, B-4340 Awans, Belgium.
EM naveen@post.bgu.ac.il
RI LEVY, AVI/F-1974-2012; Tripathi, Naveen Mani/G-1338-2017
OI LEVY, AVI/0000-0002-1665-0265; Tripathi, Naveen Mani/0000-0001-8336-1511
CR Barth W, 1954, CHEM-ING-TECH, V26, P29
   Bradley M.S.A., 1989, 3 INT C BULK MAT STO
   Chambers A.J., 1986, P 2 INT C BULK MAT S, P49
   CHISHOLM D, 1980, INT J MULTIPHAS FLOW, V6, P363, DOI 10.1016/0301-9322(80)90028-2
   Cornish G.K., 1966, PRESSURE DROP ELBOWS, P29
   Das PK, 2002, PARTICUL SCI TECHNOL, V20, P253, DOI 10.1080/02726350216186
   Dhodapkar S., 2009, CHEM ENG, V116, P46
   GHOSH DP, 1970, J AGR ENG RES, V15, P117, DOI 10.1016/0021-8634(70)90084-3
   He CH, 2012, POWDER TECHNOL, V227, P51, DOI 10.1016/j.powtec.2012.02.014
   Ito H., 1960, T ASME D, V82, P131, DOI DOI 10.1115/1.3662501
   Jones MG, 2003, PARTICUL SCI TECHNOL, V21, P45, DOI 10.1080/02726350307495
   Kalman H, 2019, POWDER TECHNOL, V356, P808, DOI 10.1016/j.powtec.2019.08.081
   Kalman H, 2019, POWDER TECHNOL, V354, P485, DOI 10.1016/j.powtec.2019.06.022
   Knudsen, 1996, LOSS ELB
   Kovacs L., 1999, PERIODICA POLYTEC ME, V43, P3
   Liang C, 2014, EXP THERM FLUID SCI, V57, P11, DOI 10.1016/j.expthermflusci.2014.03.016
   Mallick SS, 2009, POWDER TECHNOL, V194, P181, DOI 10.1016/j.powtec.2009.04.003
   Mason DJ, 1998, ADV POWDER TECHNOL, V9, P197, DOI 10.1016/S0921-8831(08)60572-5
   MICHAELIDES EE, 1987, INT J MULTIPHAS FLOW, V13, P433, DOI 10.1016/0301-9322(87)90061-9
   Naveh R, 2017, POWDER TECHNOL, V321, P355, DOI 10.1016/j.powtec.2017.08.029
   Pan R., 1998, P 6 INT C BULK MAT S, P183
   Pan R., 1992, IMPROVING SCALE UP P
   Rabinovich E, 2008, POWDER TECHNOL, V183, P304, DOI 10.1016/j.powtec.2007.07.030
   Rossetti J.S., 1983, HDB FLUIDS MOTION, P635
   Santo N, 2018, POWDER TECHNOL, V339, P368, DOI 10.1016/j.powtec.2018.07.074
   Santo N, 2018, CHEM ENG SCI, V187, P354, DOI 10.1016/j.ces.2018.04.058
   Santo N, 2017, POWDER TECHNOL, V321, P347, DOI 10.1016/j.powtec.2017.08.004
   SCHUCHART P, 1968, CHEM-ING-TECH, V40, P1060, DOI 10.1002/cite.330402107
   SINGH B, 1972, T ASAE, V15, P246
   Spedding P. L., 2004, DEV CHEM ENG MIN PRO, V12, P107, DOI DOI 10.1002/APJ.5500120109
   Tan S., 2007, P 9 INT C BULK MAT S
   Tripathi N, 2015, PARTICUOLOGY, V21, P65, DOI 10.1016/j.partic.2014.09.003
   Tripathi NM, 2019, POWDER TECHNOL, V345, P190, DOI 10.1016/j.powtec.2019.01.001
   Tripathi NM, 2018, POWDER TECHNOL, V330, P239, DOI 10.1016/j.powtec.2018.02.017
   Tripathi NM, 2018, POWDER TECHNOL, V327, P43, DOI 10.1016/j.powtec.2017.12.045
   Zhou Y, 2011, CHEM ENG TECHNOL, V34, P75, DOI 10.1002/ceat.201000307
NR 36
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115228
DI 10.1016/j.ces.2019.115228
PG 20
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500004
DA 2020-05-12
ER

PT J
AU Wang, H
   Su, YL
   Wang, WD
   Sheng, GL
AF Wang, Han
   Su, Yuliang
   Wang, Wendong
   Sheng, Guanglong
TI Hydrodynamic resistance model of oil flow in nanopores coupling oil-wall
   molecular interactions and the pore-throat structures effect
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Enhanced oil flow behaviors; Pore-throat structures; Hydrodynamic
   resistance; Molecular interaction; Entrance effect; Slip length
ID APPARENT PERMEABILITY; LIQUID PERMEABILITY; SHALE RESERVOIRS; WATER
   TRANSPORT; WETTABILITY; SLIP; VISCOSITY; INTERFACES; DYNAMICS; GRAPHENE
AB Clarifying enhanced oil flow behaviors is crucial because of the large number of pore-throat structures and the complex oil-wall molecular interactions in shale/tight reservoirs. According to the single pore model with pore-throat structures, total hydrodynamic resistance and enhanced oil flow models are established by coupling the molecular interaction effect and the entrance effect (caused by pore-throat structures). The results show that, with decreasing oil-wall molecular interactions, the total hydrodynamic resistance decreases because of increasing slip length and decreasing near-wall oil viscosity and the hydrodynamic resistance of the entrance effect gradually dominates. Additionally, the enhanced flow capacity when considering the entrance effect can be several times smaller than that without considering it. With decreasing minimum pore radius and increasing variation trend of radius, the hydrodynamic resistance of the entrance effect increases, and the enhanced oil flow capacity decreases with increase of minimum pore radius and variation trend of radius. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Han; Su, Yuliang; Wang, Wendong] China Univ Petr East China, Key Lab Unconvent Oil & Gas Dev, Minist Educ, Qingdao 266580, Shandong, Peoples R China.
   [Wang, Han; Su, Yuliang; Wang, Wendong] China Univ Petr East China, Sch Petr Engn, Qingdao 266580, Shandong, Peoples R China.
   [Sheng, Guanglong] Yangtze Univ, Sch Petr Engn, Wuhan 430100, Hubei, Peoples R China.
RP Su, YL (reprint author), China Univ Petr East China, Key Lab Unconvent Oil & Gas Dev, Minist Educ, Qingdao 266580, Shandong, Peoples R China.; Su, YL (reprint author), China Univ Petr East China, Sch Petr Engn, Qingdao 266580, Shandong, Peoples R China.
EM sylupc@gmail.com
OI Wang, Han/0000-0002-4341-8453
FU National Science FoundationNational Science Foundation (NSF) [51674279,
   51804328]; Major National Science and Technology Project
   [2017ZX05009-001, 2017ZX05069, 2017ZX05072]; Shandong Province Key
   Research and Development Program [2018GSF116004]; Shandong Province
   Natural Science FoundationNatural Science Foundation of Shandong
   Province [ZR2018BEE008, ZR2018BEE018]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities [18CX02168A]; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2018 M630813, 2019 T120616];
   Postdoctoral Applied Research Project Foundation of Qingdao city
   [BY201802003]
FX This study was supported by the National Science Foundation (51674279,
   51804328), Major National Science and Technology Project
   (2017ZX05009-001, 2017ZX05069, 2017ZX05072) Shandong Province Key
   Research and Development Program (2018GSF116004), Shandong Province
   Natural Science Foundation (ZR2018BEE008, ZR2018BEE018), Fundamental
   Research Funds for the Central Universities (18CX02168A), China
   Postdoctoral Science Foundation (2018 M630813, 2019 T120616), and
   Postdoctoral Applied Research Project Foundation of Qingdao city
   (BY201802003).
CR Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804
   BLAKE TD, 1990, COLLOID SURFACE, V47, P135, DOI 10.1016/0166-6622(90)80068-F
   Cao BY, 2009, INT J MOL SCI, V10, P4638, DOI 10.3390/ijms10114638
   Chiavazzo E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4565
   Cho JHJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166102
   Choi CH, 2003, PHYS FLUIDS, V15, P2897, DOI 10.1063/1.1605425
   Cui JF, 2017, FUEL, V202, P426, DOI 10.1016/j.fuel.2017.04.057
   Das R, 2014, DESALINATION, V336, P97, DOI 10.1016/j.desal.2013.12.026
   Ebrahimi F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26072-6
   Fan HM, 2019, FRACTALS, V27, DOI 10.1142/S0218348X19500889
   Glavatskiy KS, 2016, LANGMUIR, V32, P3400, DOI 10.1021/acs.langmuir.6b00375
   Gravelle S., 2013, P NATL ACAD SCI USA
   Gravelle S, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.033123
   Gravelle S, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897253
   Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298
   Jain R, 2017, LANGMUIR, V33, P7181, DOI 10.1021/acs.langmuir.7b01524
   Jiang FJ, 2017, ENERG FUEL, V31, P2669, DOI 10.1021/acs.energyfuels.6b03313
   Jiang WB, 2017, TRANSPORT POROUS MED, V117, P5, DOI 10.1007/s11242-016-0817-5
   Joly L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2397677
   Kannam SK, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793396
   Kannam SK, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4730167
   Kannam SK, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3675904
   Kucala A, 2017, WATER RESOUR RES, V53, P7281, DOI 10.1002/2016WR020059
   Li Y, 2019, J PETROL SCI ENG, V174, P821, DOI 10.1016/j.petrol.2018.12.003
   Lichter S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.226001
   Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a
   Mattia D, 2012, MICROFLUID NANOFLUID, V13, P125, DOI 10.1007/s10404-012-0949-z
   Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694
   Navier C. L. M. H., 1827, MEM ACAD SCI I FR, V6, P389, DOI DOI 10.1017/CBO9781107415324.004
   Neek-Amal M, 2016, ACS NANO, V10, P3685, DOI 10.1021/acsnano.6b00187
   Nelson PH, 2009, AAPG BULL, V93, P329, DOI 10.1306/10240808059
   Pasquier S, 2017, CHEM ENG SCI, V165, P131, DOI 10.1016/j.ces.2017.01.063
   Priezjev NV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.018302
   Qin Z, 2015, NANO LETT, V15, P3939, DOI 10.1021/acs.nanolett.5b00809
   Qiu Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257002
   Sampson R. A., 1891, PHILOS T R SOC A, V182, P449, DOI DOI 10.1098/RSTA.1891.0012
   Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315
   Sendner C, 2009, LANGMUIR, V25, P10768, DOI 10.1021/la901314b
   Singh H, 2018, ADV MATER SCI ENG, V2018, DOI 10.1155/2018/9565240
   Sondergeld C.H., 2010, 131771MS SPE
   SUN M, 1992, PHYS REV LETT, V69, P3491, DOI 10.1103/PhysRevLett.69.3491
   Tao JB, 2018, CHEM ENG SCI, V192, P1252, DOI 10.1016/j.ces.2018.05.018
   Thomas JA, 2008, NANO LETT, V8, P2788, DOI 10.1021/nl8013617
   Tocci G, 2014, NANO LETT, V14, P6872, DOI 10.1021/nl502837d
   Wang H, 2019, FUEL, V253, P1351, DOI 10.1016/j.fuel.2019.05.098
   Wang H, 2019, J PETROL SCI ENG, V176, P1041, DOI 10.1016/j.petrol.2019.02.027
   Wang S, 2016, FUEL, V171, P74, DOI 10.1016/j.fuel.2015.12.071
   Wei N, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012113
   Whitby M, 2008, NANO LETT, V8, P2632, DOI 10.1021/nl080705f
   Wilson MJ, 2016, EARTH-SCI REV, V158, P31, DOI 10.1016/j.earscirev.2016.04.004
   Wu K., 2019, LANGMUIR
   Wu KL, 2017, P NATL ACAD SCI USA, V114, P3358, DOI 10.1073/pnas.1612608114
   Zhang Q, 2017, INT J HEAT MASS TRAN, V115, P224, DOI 10.1016/j.ijheatmasstransfer.2017.08.024
   Zhang T, 2018, CHEM ENG SCI, V187, P280, DOI 10.1016/j.ces.2018.05.016
   Zhang T, 2017, CHEM ENG SCI, V174, P1, DOI 10.1016/j.ces.2017.08.023
NR 55
TC 0
Z9 0
U1 8
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115166
DI 10.1016/j.ces.2019.115166
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500022
DA 2020-05-12
ER

PT J
AU Wang, QG
   Li, L
   Gu, JP
   Weng, N
AF Wang, Qinggong
   Li, Long
   Gu, Junping
   Weng, Ning
TI A dynamic model for the oscillatory regime of liquid rise in capillaries
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Capillary; Oscillatory regime; Dynamic model; End effect; Dynamic
   contact angle
ID CONTACT-ANGLE; KINETICS; SURFACE; FLOW; DIFFERENCE; INTERFACE; MENISCUS;
   DRIVEN; TUBES; LINE
AB The oscillatory regime for liquid rise in vertical capillaries has been observed but the analytical solution that can be applied for this regime is still in shortage. Some lack terms in the existing analytical solutions make them show deviations when predicting the oscillatory behavior of liquid rise. An improved dynamic model is built in this work for the oscillatory regime. Two main contributions are made, concerning the non-equal pressure losses at the entrance for liquid rise and fall, and the receding dynamic contact angle for the regions with negative capillary numbers. Experiments are performed to correlate the empirical parameters in the submodels and to validate the combined dynamic model. Good accuracies of the present model are obtained by comparing with the experimental data both in literature and from the present study. Inclusion of the non-equal pressure loss equations for the end effect makes the model well capture the high asymmetry of oscillations, while the two-stage dynamic contact angle models correct the local bouncing of the meniscus. The dynamics of liquid in the oscillatory regime is discussed by comparing the contribution of each pressure force. Occurrence criteria of the oscillatory regime is obtained through a non-dimensional analysis. It is shown that the oscillatory regime is affected not only by the combined parameter (omega), but also by the immersed height of tube (H-0) and the pressure head loss coefficients (xi). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Qinggong; Li, Long; Gu, Junping; Weng, Ning] China Acad Space Technol, Qian Xuesen Lab Space Technol, Beijing 100094, Peoples R China.
   [Gu, Junping] Tsinghua Univ, Dept Energy & Power Engn, Minist Educ, Key Lab Thermal Sci & Power Engn, Beijing 100084, Peoples R China.
RP Wang, QG (reprint author), 104 Youyi Rd, Beijing 100094, Peoples R China.
EM wangqinggong@qxslab.cn
OI Wang, Qinggong/0000-0002-9408-6006
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [51606211]
FX Financial support of this work by the National Nature Science Foundation
   of China (Grants No. 51606211) is gratefully acknowledged.
CR Al-Shareef A, 2013, CHEM ENG SCI, V99, P113, DOI 10.1016/j.ces.2013.05.052
   BLAKE TD, 1969, J COLLOID INTERF SCI, V30, P421, DOI 10.1016/0021-9797(69)90411-1
   Blake TD, 2004, COLLOID SURFACE A, V250, P395, DOI 10.1016/j.colsurfa.2004.05.024
   Bosanquet CH, 1923, PHILOS MAG, V45, P525, DOI 10.1080/14786442308634144
   BRITTIN WE, 1946, J APPL PHYS, V17, P37, DOI 10.1063/1.1707633
   Cheong BHP, 2011, LANGMUIR, V27, P11925, DOI 10.1021/la202800s
   COX RG, 1986, J FLUID MECH, V168, P169, DOI 10.1017/S0022112086000332
   Das AK, 2010, CHEM ENG SCI, V65, P4027, DOI 10.1016/j.ces.2010.03.043
   Das S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.063005
   DREYER M, 1993, MICROGRAVITY SCI TEC, V4, P203
   DUSSAN VEB, 1976, J FLUID MECH, V75, P609
   Fries N., 2010, CAPILLARY TRANSPORT
   Hamdan MO, 2018, COMMUN NONLINEAR SCI, V57, P449, DOI 10.1016/j.cnsns.2017.11.004
   Hamraoui A, 2000, J COLLOID INTERF SCI, V226, P199, DOI 10.1006/jcis.2000.6830
   HOFFMAN RL, 1983, J COLLOID INTERF SCI, V94, P470, DOI 10.1016/0021-9797(83)90287-4
   JIANG TS, 1979, J COLLOID INTERF SCI, V69, P74, DOI 10.1016/0021-9797(79)90081-X
   JOOS P, 1990, J COLLOID INTERF SCI, V136, P189, DOI 10.1016/0021-9797(90)90089-7
   Katoh K, 2015, EXP THERM FLUID SCI, V60, P354, DOI 10.1016/j.expthermflusci.2014.05.006
   Levine S., 2012, COLLOID INTERFACE SC, V3, P403
   Li XX, 2014, CHEM ENG SCI, V117, P137, DOI 10.1016/j.ces.2014.06.024
   Li XX, 2013, CHEM ENG SCI, V104, P988, DOI 10.1016/j.ces.2013.10.026
   Lorenceau E, 2002, PHYS FLUIDS, V14, P1985, DOI 10.1063/1.1476670
   Lucas R, 1918, KOLLOID Z, V23, P15, DOI 10.1007/BF01461107
   Maggi F, 2012, INT J MULTIPHAS FLOW, V42, P62, DOI 10.1016/j.ijmultiphaseflow.2012.01.011
   Martic G, 2004, J COLLOID INTERF SCI, V270, P171, DOI 10.1016/j.jcis.2003.08.049
   Martic G, 2003, J COLLOID INTERF SCI, V263, P213, DOI 10.1016/S0021-9797(03)00283-2
   Martic G, 2002, LANGMUIR, V18, P7971, DOI 10.1021/la020068n
   Masoodi R, 2013, J COLLOID INTERF SCI, V389, P268, DOI 10.1016/j.jcis.2012.09.004
   Munson B. R., 2014, FUNDAMENTALS FLUID M
   PETROV PG, 1992, LANGMUIR, V8, P1762, DOI 10.1021/la00043a013
   Quere D, 1999, LANGMUIR, V15, P3679, DOI 10.1021/la9801615
   Rame E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031608
   Rame E, 1996, J COLLOID INTERF SCI, V177, P234, DOI 10.1006/jcis.1996.0026
   Schaffer E, 2000, PHYS REV E, V61, P5257, DOI 10.1103/PhysRevE.61.5257
   SEEBERGH JE, 1992, CHEM ENG SCI, V47, P4455, DOI 10.1016/0009-2509(92)85123-S
   SPARROW EM, 1964, PHYS FLUIDS, V7, P338, DOI 10.1063/1.1711204
   Stange M, 2003, PHYS FLUIDS, V15, P2587, DOI 10.1063/1.1596913
   SZEKELY J, 1971, J COLLOID INTERF SCI, V35, P273, DOI 10.1016/0021-9797(71)90120-2
   Voinov O. V., 1976, FLUID DYNAM, V11, P714, DOI DOI 10.1007/BF01012963
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Wu PK, 2017, LANGMUIR, V33, P7862, DOI 10.1021/acs.langmuir.7b01762
   Wu PK, 2017, ADV COLLOID INTERFAC, V243, P114, DOI 10.1016/j.cis.2017.02.004
   Xiao Y, 2006, J COLLOID INTERF SCI, V298, P880, DOI 10.1016/j.jcis.2006.01.005
   Zhmud BV, 2000, J COLLOID INTERF SCI, V228, P263, DOI 10.1006/jcis.2000.6951
NR 44
TC 1
Z9 1
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115220
DI 10.1016/j.ces.2019.115220
PG 12
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500001
DA 2020-05-12
ER

PT J
AU Wang, SY
   Wang, SL
   Yang, YR
   Wang, XD
   Lee, DJ
AF Wang, Shao-Yu
   Wang, Shuo-Lin
   Yang, Yan-Ru
   Wang, Xiao-Dong
   Lee, Duu-Jong
TI High-temperature reactive wetting systems: Role of lattice constant
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE High temperature; Spreading mechanism; Dissolution; Dynamic contact
   angle; Molecular dynamics simulations
ID MOLECULAR-DYNAMICS SIMULATIONS; DROPS; AG; CU; KINETICS; NI
AB The high-temperature spreading dynamics of Al-Cu(l)/Ni(s) and Al-Ni(l)/Ni(s) wetting systems was studied using molecular dynamics simulations. Accompanied with spreading, a significant dissolution reaction was noted to take place for the two studied systems. The dissolution reaction involves both diffusion of solid atoms into the droplet and incorporation of liquid atoms into the substrate. No precursor film is generated during spreading, since its formation is suppressed by the dissolution reaction. The dissolution reaction induces an enhanced spreading rate, and spreading becomes faster when droplets contain less Cu or Ni atoms. The dissolution of solid atoms into the droplet is faster than that of liquid atoms into the substrate, so that the dissolution of the former is the dominant driving force for the spreading enhancement. The spreading of Al-Cu droplets correlates with that of Al-Ni droplets so long as the Cu concentration in Al-Cu droplets is equal to the Ni concentration in Al-Ni droplets, since both Cu and Ni atoms have the identical lattice constants. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Shao-Yu; Wang, Shuo-Lin; Yang, Yan-Ru; Wang, Xiao-Dong] North China Elect Power Univ, State Key Lab Alternate Elect Power Syst Renewabl, Beijing 102206, Peoples R China.
   [Wang, Shao-Yu; Wang, Shuo-Lin; Yang, Yan-Ru; Wang, Xiao-Dong] North China Elect Power Univ, Res Ctr Engn Thermophys, Beijing 102206, Peoples R China.
   [Wang, Shao-Yu; Wang, Shuo-Lin; Yang, Yan-Ru; Wang, Xiao-Dong] North China Elect Power Univ, Minist Educ, Key Lab Condit Monitoring & Control Power Plant E, Beijing 102206, Peoples R China.
   [Lee, Duu-Jong] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   [Lee, Duu-Jong] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 10607, Taiwan.
RP Wang, XD; Lee, DJ (reprint author), North China Elect Power Univ, State Key Lab Alternate Elect Power Syst Renewabl, Beijing 102206, Peoples R China.
EM wangxd99@gmail.com; djlee@ntu.edu.tw
OI Wang, Xiao-Dong/0000-0002-4533-6734
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51936004]; National Science Fund for Distinguished
   Young Scholars of ChinaNational Natural Science Foundation of
   ChinaNational Science Fund for Distinguished Young Scholars [51525602];
   Science Fund for Creative Research Groups of the National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [51821004]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [2017ZZD006]
FX This study was partially supported by National Natural Science
   Foundation of China (No. 51936004), National Science Fund for
   Distinguished Young Scholars of China (No. 51525602), Science Fund for
   Creative Research Groups of the National Natural Science Foundation of
   China (No. 51821004), and Fundamental Research Funds for the Central
   Universities (No. 2017ZZD006).
CR Benhassine M, 2011, ACTA MATER, V59, P1087, DOI 10.1016/j.actamat.2010.10.039
   Benhassine M, 2010, ACTA MATER, V58, P2068, DOI 10.1016/j.actamat.2009.11.049
   Benhassine M, 2009, LANGMUIR, V25, P11450, DOI 10.1021/la902958k
   BLAKE TD, 1969, J COLLOID INTERF SCI, V30, P421, DOI 10.1016/0021-9797(69)90411-1
   Bonn D, 2009, REV MOD PHYS, V81, P739, DOI 10.1103/RevModPhys.81.739
   FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983
   Heine DR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107801
   Hsieh JY, 2010, NANO-MICRO LETT, V2, P60, DOI 10.1007/BF03353620
   Kim C, 2008, J APPL PHYS, V104, DOI 10.1063/1.2964118
   Kohler MH, 2019, CHEM ENG SCI, V203, P54, DOI 10.1016/j.ces.2019.03.062
   Kubo A, 2005, J MATER SCI, V40, P2395, DOI 10.1007/s10853-005-1965-0
   Lin L, 2017, CHEM ENG SCI, V174, P127, DOI 10.1016/j.ces.2017.09.008
   Lin L, 2017, J TAIWAN INST CHEM E, V75, P51, DOI 10.1016/j.jtice.2017.03.035
   Liu CY, 2019, CHEM ENG SCI, V195, P74, DOI 10.1016/j.ces.2018.11.015
   Lu G, 2017, CHEM PHYS LETT, V687, P91, DOI 10.1016/j.cplett.2017.09.009
   Lu G, 2016, ADV COLLOID INTERFAC, V236, P43, DOI 10.1016/j.cis.2016.07.004
   Moon J, 2002, COMP MATER SCI, V25, P503, DOI 10.1016/S0927-0256(02)00327-0
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Qiu F, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.120203
   Samsonov VM, 2014, TECH PHYS LETT+, V40, P1014, DOI 10.1134/S1063785014110261
   STAROV VM, 1994, ADV COLLOID INTERFAC, V50, P187, DOI 10.1016/0001-8686(94)80030-8
   Straumal BB, 2012, J MATER SCI, V47, P8352, DOI 10.1007/s10853-012-6618-5
   Su S, 2009, ACTA MATER, V57, P3110, DOI 10.1016/j.actamat.2009.03.015
   Sun Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/46/464135
   Swiler TP, 2000, ACTA MATER, V48, P4775, DOI 10.1016/S1359-6454(00)00274-3
   TANNER LH, 1979, J PHYS D APPL PHYS, V12, P1473, DOI 10.1088/0022-3727/12/9/009
   Timoshenko V, 2012, J MATER ENG PERFORM, V21, P575, DOI 10.1007/s11665-012-0184-5
   Wang XD, 2007, LANGMUIR, V23, P9258, DOI 10.1021/la700232y
   Wang XD, 2007, LANGMUIR, V23, P8042, DOI 10.1021/la0701125
   Webb EB, 2005, J MATER SCI, V40, P2281, DOI 10.1007/s10853-005-1946-3
   Webb EB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.236102
   Webb EB, 2005, ACTA MATER, V53, P3163, DOI 10.1016/j.actamat.2005.03.021
   Webb EB, 2005, CURR OPIN SOLID ST M, V9, P174, DOI 10.1016/j.cossms.2006.03.003
   Webb WB, 2002, SCRIPTA MATER, V47, P393, DOI 10.1016/S1359-6462(02)00155-0
   Yost FG, 1998, ACTA MATER, V46, P5143, DOI 10.1016/S1359-6454(98)00146-3
NR 35
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115206
DI 10.1016/j.ces.2019.115206
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500020
DA 2020-05-12
ER

PT J
AU Whyte, HE
   Subrenat, A
   Raillard, C
   Hequet, V
AF Whyte, Henrietta Essie
   Subrenat, Albert
   Raillard, Cecile
   Hequet, Valerie
TI Understanding the influence of media geometry on the degradation of
   acrylonitrile: Experimental and CFD analysis
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Photocatalytic oxidation; Indoor air treatment; Acrylonitrile;
   Single-pass removal efficiency; Computational fluid dynamics;
   Photocatalytic media geometry
ID PHOTOCATALYTIC OXIDATION; AIR-TREATMENT; REACTOR; FORMALDEHYDE; TIO2;
   PHOTODEGRADATION; PURIFICATION; HUMIDITY; KINETICS; SURFACE
AB The media geometry design is a parameter that influences the efficiency of PCO device for indoor air treatment. However, there is little information in the literature to show how it impacts degradation efficiency. In this work, media geometry influence on the degradation of acrylonitrile is investigated experimentally and with numerical simulations. The experiments were conducted in a laboratory closed loop multi-pass reactor with the aim of comparing degradation efficiencies using plane and pleated media geometries. The experimental results showed a higher removal efficiency for the pleated media. Numerical simulations provided some information to better connect the increase in efficiency to the change in media geometry considering and modeling the media as a porous zone. The simulation results showed that pollutants had lower velocity in pleated media thus contact time was increased by 76%. Additionally, the more heterogeneous distribution of velocity and irradiance in the pleated media could counteract the influence of the contact time and possibly explain the lower than expected experimental results. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Whyte, Henrietta Essie; Subrenat, Albert; Raillard, Cecile; Hequet, Valerie] CNRS, UMR 6144, IMT Atlantique, GEPEA, 4 Rue Alfred Kastler CS 20722, F-44307 Nantes 3, France.
RP Whyte, HE (reprint author), CNRS, UMR 6144, IMT Atlantique, GEPEA, 4 Rue Alfred Kastler CS 20722, F-44307 Nantes 3, France.
EM whytehenrietta@yahoo.com
FU ATA Medical; IMT Atlantique
FX The authors would like to express their gratitude to ATA Medical and IMT
   Atlantique for their financial support and also to Eric Chevrel, Patrick
   Brion, Francois-Xavier Blanchet, Yvan Gouriou and Katell Chaillou for
   their invaluable technical assistance and to Eric Dumont for his help
   with the modeling.
CR ANSYS, 2013, ANSYS CFX SOLV MOD G
   Ao CH, 2004, APPL CATAL B-ENVIRON, V54, P41, DOI 10.1016/j.apcatb.2004.06.004
   Barrett WL, 2003, SURG ENDOSC, V17, P979, DOI 10.1007/s00464-002-8584-5
   Batault F., 2014, LILLE, V1
   Batault F, 2017, CHEM ENG J, V307, P766, DOI 10.1016/j.cej.2016.08.118
   Bergeron V, 2007, INFECT CONT HOSP EP, V28, P1181, DOI 10.1086/520733
   Berni L.A., 2013, INT SOC OPTICS PHOTO, DOI 10.1117/12.2282841
   Birnie M, 2006, INT J LOW-CARBON TEC, V1, P47, DOI 10.1093/ijlct/1.1.47
   Boyjoo Y, 2017, CHEM ENG J, V310, P537, DOI 10.1016/j.cej.2016.06.090
   Boyjoo Y, 2014, CHEM ENG SCI, V111, P34, DOI 10.1016/j.ces.2014.02.023
   Boyjoo Y, 2013, CHEM ENG SCI, V101, P764, DOI 10.1016/j.ces.2013.06.035
   Castrillon SRV, 2006, CHEM ENG SCI, V61, P3343, DOI 10.1016/j.ces.2005.11.039
   Chen W., 2016, J ADV OXID TECHNOL, V11, P163, DOI [10.1515/jaots-2008-0123, DOI 10.1515/JA0TS-2008-0123]
   Chong SH, 2011, AICHE J, V57, P724, DOI 10.1002/aic.12295
   Dascalaki EG, 2008, BUILD ENVIRON, V43, P1945, DOI 10.1016/j.buildenv.2007.11.015
   Destaillats H, 2012, APPL CATAL B-ENVIRON, V128, P159, DOI 10.1016/j.apcatb.2012.03.014
   Dillert R, 2012, J HAZARD MATER, V211, P240, DOI 10.1016/j.jhazmat.2011.11.041
   Dumont E, 2017, MOLECULES, V22, DOI 10.3390/molecules22030407
   Feister U, 1997, SOL ENERGY, V60, P313, DOI 10.1016/S0038-092X(97)00030-3
   Holdich R., 2002, FUNDAMENTALS PARTICL, P21
   Kozlov D.V., 2011, DEV MULTISTAGE PHOTO
   Kozlov DV, 2003, RUSS CHEM B+, V52, P1100, DOI 10.1023/A:1024796905146
   Larason TC, 2001, J RES NATL INST STAN, V106, P649, DOI 10.6028/jres.106.030
   Martin-Somer M, 2017, APPL CATAL B-ENVIRON, V215, P1, DOI 10.1016/j.apcatb.2017.05.048
   Maudhuit A, 2011, CHEM ENG J, V170, P464, DOI 10.1016/j.cej.2011.02.040
   MICHALSKY JJ, 1995, SOL ENERGY, V54, P397, DOI 10.1016/0038-092X(95)00017-L
   Mohseni M, 2004, CHEM ENG SCI, V59, P1601, DOI 10.1016/j.ces.2004.01.017
   Passalia C, 2012, J HAZARD MATER, V211, P357, DOI 10.1016/j.jhazmat.2011.10.007
   PERRAUD M, 1992, NOUV REV FR HEMATOL, V34, P295
   Pichat P, 2010, APPL CATAL B-ENVIRON, V99, P428, DOI 10.1016/j.apcatb.2010.07.022
   Queffeulou A, 2010, CHEM ENG SCI, V65, P5067, DOI 10.1016/j.ces.2010.05.024
   Raillard C, 2004, J PHOTOCH PHOTOBIO A, V163, P425, DOI 10.1016/j.jphotochem.2004.01.014
   Raillard C, 2014, INT J CHEM REACT ENG, V12, DOI 10.1515/ijcre-2014-0012
   Rosenbaum RA, 2004, ANN EMERG MED, V44, P628, DOI 10.1016/j.annemergmed.2004.03.012
   Salvado-Estivill I, 2007, ENVIRON SCI TECHNOL, V41, P2028, DOI 10.1021/es061569o
   SAUER ML, 1994, J CATAL, V149, P81, DOI 10.1006/jcat.1994.1274
   Schoenleber T., 2007, HYGIENES, V15, P158
   Sleiman M, 2009, APPL CATAL B-ENVIRON, V86, P159, DOI 10.1016/j.apcatb.2008.08.003
   Le TS, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/1/015016
   Wang X, 2014, IND ENG CHEM RES, V53, P18402, DOI 10.1021/ie5016427
   Whyte HE, 2018, CHEM ENG J, V352, P441, DOI 10.1016/j.cej.2018.07.059
   Ye XJ, 2006, J PHOTOCH PHOTOBIO A, V183, P35, DOI 10.1016/j.jphotochem.2006.02.019
   Yu QL, 2009, APPL CATAL B-ENVIRON, V92, P454, DOI 10.1016/j.apcatb.2009.09.004
   Zibordi G, 2007, APPL OPTICS, V46, P5529, DOI 10.1364/AO.46.005529
NR 44
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115217
DI 10.1016/j.ces.2019.115217
PG 14
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500041
OA Green Published
DA 2020-05-12
ER

PT J
AU Yang, FF
   Chu, QF
   Liu, Q
   Duan, YY
   Yang, Z
AF Yang, Fufang
   Chu, Qingfu
   Liu, Qiang
   Duan, Yuanyuan
   Yang, Zhen
TI The cubic-plus-association equation of state for hydrofluorocarbons,
   hydrofluoroolefins, and their binary mixtures
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hydrofluorocarbon; Hydrofluoroolefin; Cubic-plus-association equation of
   state; Vapor-liquid equilibria; Density
ID VAPOR-LIQUID-EQUILIBRIA; 2ND VIRIAL-COEFFICIENTS; BUBBLE-POINT
   PRESSURES; 1,1,1-TRIFLUOROETHANE (HFC-143A)+1,1,1,2-TETRAFLUOROETHANE
   HFC-134A; INTERNATIONAL STANDARD FORMULATION; ALTERNATIVE REFRIGERANT
   MIXTURES; ISOTHERMAL VLE MEASUREMENTS; ORGANIC RANKINE-CYCLE;
   THERMODYNAMIC PROPERTIES; DIFLUOROMETHANE HFC-32
AB Hydrofluorocarbons, hydrofluoroolefins, and their mixtures are widely used as working fluids in energy systems. Weak hydrogen bond exists in these fluids and thus contribute to their thermodynamic properties. In this work, we account for the contribution of the weak hydrogen bond by tailoring the cubic-plus-association (CPA) equation of state (EoS) and its parameter fitting procedure. Overfitting to the liquid properties is avoided by introducing the saturated vapor density into the fitting objective function. The EoS is extended to binary mixtures using the van der Waals mixing rules and Elliot combining rule in which process solving the cross-association fraction is reduced from an equation set consisting of 4 nonlinear equations to a single nonlinear equation. The performance of the present model is investigated in terms of the vapor-liquid equilibria (VLE) and volumetric properties of 15 pure fluids and 40 binary mixtures using fitted and zero binary interaction parameter, and is compared with the reference data, a CPA EoS that uses the traditional parameter fitting procedure, the Soave-Redlich-Kwong (SRK) EoS, and a volume-translated SRK EoS. The present model (including the EoS and fitting procedure) accurately reproduces the vapor pressure, density, and second virial coefficient for the pure fluids and binary mixtures, and is the only valid model among the investigated models for both the VLE and the volumetric properties in both liquid and vapor phases. The contribution of the association term to the pressure is also shown in the temperature-density diagram, presenting a similar behavior as that in water in which the effect of the hydrogen bond is comparatively more pronounced. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yang, Fufang; Chu, Qingfu; Duan, Yuanyuan; Yang, Zhen] Tsinghua Univ, Key Lab Thermal Sci & Power Engn, Minist Educ, Beijing Key Lab CO2 Utilizat & Reduct Technol, Beijing 100084, Peoples R China.
   [Liu, Qiang] China Univ Petr, Coll Mech & Transportat Engn, State Key Lab Petr Resources & Prospecting, Beijing 102249, Peoples R China.
RP Duan, YY (reprint author), Tsinghua Univ, Key Lab Thermal Sci & Power Engn, Minist Educ, Beijing Key Lab CO2 Utilizat & Reduct Technol, Beijing 100084, Peoples R China.
EM yyduan@tsinghua.edu.cn
OI Duan, Yuanyuan/0000-0002-4117-7545; Liu, Qiang/0000-0001-6010-2795
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51736005, 51506223, 51621062]
FX The work was supported by the National Natural Science Foundation of
   China (Nos. 51736005, 51506223, and 51621062).
CR An BL, 2018, J CHEM ENG DATA, V63, P2075, DOI 10.1021/acs.jced.8b00090
   An BL, 2017, J CHEM ENG DATA, V62, P328, DOI 10.1021/acs.jced.6b00673
   BECKERMANN W, 1995, INT J THERMOPHYS, V16, P455
   Bell IH, 2016, J CHEM ENG DATA, V61, P3752, DOI 10.1021/acs.jced.6b00257
   Benade W., 1994, JOINT M IIR COMM B1
   BIGNELL CM, 1993, J CHEM PHYS, V98, P4889, DOI 10.1063/1.464943
   Bobbo S, 2000, HIGH TEMP-HIGH PRESS, V32, P441, DOI 10.1068/htwu123
   Bobbo S, 2000, INT J THERMOPHYS, V21, P781, DOI 10.1023/A:1006649704594
   Bobbo S, 1999, J CHEM ENG DATA, V44, P349, DOI 10.1021/je980195e
   Bobbo S, 1998, FLUID PHASE EQUILIBR, V150, P343, DOI 10.1016/S0378-3812(98)00334-3
   Bobbo S, 2000, J CHEM ENG DATA, V45, P276, DOI 10.1021/je990162e
   Bobbo S, 2001, FLUID PHASE EQUILIBR, V185, P255, DOI 10.1016/S0378-3812(01)00475-7
   Cabral BJC, 2001, PHYS CHEM CHEM PHYS, V3, P4200, DOI 10.1039/b102879k
   CHAPMAN WG, 1990, IND ENG CHEM RES, V29, P1709, DOI 10.1021/ie00104a021
   Chen LX, 2015, FLUID PHASE EQUILIBR, V392, P19, DOI 10.1016/j.fluid.2015.02.014
   Chung EY, 1997, J CHEM ENG DATA, V42, P1126, DOI 10.1021/je970071m
   Cui XL, 2006, FLUID PHASE EQUILIBR, V249, P97, DOI 10.1016/j.fluid.2006.09.017
   Dang YG, 2015, J CHEM THERMODYN, V89, P183, DOI 10.1016/j.jct.2015.05.009
   Deiters UK, 1997, FLUID PHASE EQUILIBR, V132, P265, DOI 10.1016/S0378-3812(96)03232-3
   Deiters UK, 2001, INT J THERMOPHYS, V22, P1869, DOI 10.1023/A:1013107520858
   Derawi SO, 2004, FLUID PHASE EQUILIBR, V225, P107, DOI 10.1016/j.fluid.2004.08.021
   Dong XQ, 2008, J CHEM ENG DATA, V53, P2193, DOI 10.1021/je800505y
   Dressner M., 1993, THERMODYNAMIC MEASUR
   El Ahmar E, 2012, INT J REFRIG, V35, P2297, DOI 10.1016/j.ijrefrig.2012.05.016
   Fujimine T, 1999, INT J THERMOPHYS, V20, P911, DOI 10.1023/A:1022643404972
   Fujiwara K., 1992, 13 JAP S THERM PROP
   GOODWIN ARH, 1990, J CHEM PHYS, V93, P2741, DOI 10.1063/1.458913
   Han XH, 2006, J CHEM ENG DATA, V51, P1232, DOI 10.1021/je050539i
   Han XH, 2010, FLUID PHASE EQUILIBR, V299, P116, DOI 10.1016/j.fluid.2010.09.016
   Han XH, 2007, J CHEM ENG DATA, V52, P2112, DOI 10.1021/je700011a
   Higashi Y, 1999, J CHEM ENG DATA, V44, P333, DOI 10.1021/je980266+
   Holcomb C.D., 1997, SELECTED THERMODYNAM
   Hou SX, 2007, IND ENG CHEM RES, V46, P9274, DOI 10.1021/ie070911i
   Hou SX, 2010, FLUID PHASE EQUILIBR, V298, P106, DOI 10.1016/j.fluid.2010.07.018
   Hou SX, 2010, FLUID PHASE EQUILIBR, V290, P121, DOI 10.1016/j.fluid.2009.09.008
   Hu P, 2014, FLUID PHASE EQUILIBR, V379, P59, DOI 10.1016/j.fluid.2014.07.014
   Hu P, 2014, FLUID PHASE EQUILIBR, V373, P80, DOI 10.1016/j.fluid.2014.04.015
   Hu P, 2013, FLUID PHASE EQUILIBR, V360, P293, DOI 10.1016/j.fluid.2013.09.056
   Hu XZ, 2017, INT J REFRIG, V79, P49, DOI 10.1016/j.ijrefrig.2017.04.019
   Hu XZ, 2017, FLUID PHASE EQUILIBR, V438, P10, DOI 10.1016/j.fluid.2017.01.024
   Hu XZ, 2017, FLUID PHASE EQUILIBR, V431, P58, DOI 10.1016/j.fluid.2016.10.011
   HUANG SH, 1990, IND ENG CHEM RES, V29, P2284, DOI 10.1021/ie00107a014
   Jaubert JN, 2016, FLUID PHASE EQUILIBR, V419, P88, DOI 10.1016/j.fluid.2016.03.012
   JHAVERI BS, 1988, SPE RESERVOIR ENG, V3, P1033, DOI DOI 10.2118/13118-PA
   Kaarsholm M, 2005, IND ENG CHEM RES, V44, P4406, DOI 10.1021/ie0490029
   Kamiaka T, 2013, INT J REFRIG, V36, P965, DOI 10.1016/j.ijrefrig.2012.08.016
   Kang K, 2018, IND ENG CHEM RES, V57, P17289, DOI 10.1021/acs.iecr.8b04813
   Karamoddin M, 2013, INT J REFRIG, V36, P1681, DOI 10.1016/j.ijrefrig.2013.04.013
   Kim CN, 1999, INT J THERMOPHYS, V20, P519, DOI 10.1023/A:1022605104490
   Kim CN, 2000, J CHEM ENG DATA, V45, P34, DOI 10.1021/je9901379
   Kim CN, 2000, INT J THERMOPHYS, V21, P871, DOI 10.1023/A:1006610223852
   Kleemis M., 1997, THERMODYNAMIC PROPER
   Kleiner M, 2007, FLUID PHASE EQUILIBR, V260, P190, DOI 10.1016/j.fluid.2007.04.015
   Kobayashi M, 1998, FLUID PHASE EQUILIBR, V144, P191, DOI 10.1016/S0378-3812(97)00257-4
   KOHLER F, 1993, MOL PHYS, V80, P795, DOI 10.1080/00268979300102651
   Kontogeorgis GM, 2006, IND ENG CHEM RES, V45, P4855, DOI 10.1021/ie051305v
   Kontogeorgis GM, 2006, IND ENG CHEM RES, V45, P4869, DOI 10.1021/ie051306n
   Kontogeorgis GM, 1996, IND ENG CHEM RES, V35, P4310, DOI 10.1021/ie9600203
   Kraska T, 1998, IND ENG CHEM RES, V37, P4889, DOI 10.1021/ie980206x
   Kryachko E, 2004, J PHYS CHEM A, V108, P2527, DOI 10.1021/jp0365108
   KUBOTA H, 1993, J CHEM ENG JPN, V26, P320, DOI 10.1252/jcej.26.320
   Kumar R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2742385
   Kunz O, 2012, J CHEM ENG DATA, V57, P3032, DOI 10.1021/je300655b
   Lee BG, 1999, J CHEM ENG DATA, V44, P190, DOI 10.1021/je980180g
   Lemmon EW, 2006, J CHEM ENG DATA, V51, P785, DOI 10.1021/je050186n
   Lemmon EW, 2015, J CHEM ENG DATA, V60, P3745, DOI 10.1021/acs.jced.5b00684
   Lemmon EW, 2005, J PHYS CHEM REF DATA, V34, P69, DOI 10.1063/1.1797813
   Lemmon EW, 2003, INT J THERMOPHYS, V24, P991, DOI 10.1023/A:1025048800563
   Lemmon EW, 2000, J PHYS CHEM REF DATA, V29, P521, DOI 10.1063/1.1318909
   Lim JS, 2002, FLUID PHASE EQUILIBR, V193, P29, DOI 10.1016/S0378-3812(01)00632-X
   Lim JS, 2000, INT J THERMOPHYS, V21, P1339, DOI 10.1023/A:1006653309953
   Lin H, 2006, IND ENG CHEM RES, V45, P1829, DOI 10.1021/ie051058v
   Lin H, 2005, FLUID PHASE EQUILIBR, V233, P194, DOI 10.1016/j.fluid.2005.05.008
   Liu Q, 2013, ENERGY, V63, P123, DOI 10.1016/j.energy.2013.10.035
   Madani H, 2016, FLUID PHASE EQUILIBR, V415, P158, DOI 10.1016/j.fluid.2016.02.005
   Mahmoudjanloo H, 2013, CHEM ENG SCI, V98, P152, DOI 10.1016/j.ces.2013.04.002
   Pendas AM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2378807
   Matsuguchi A, 2010, INT J THERMOPHYS, V31, P727, DOI 10.1007/s10765-010-0766-0
   Matsuguchi A, 2008, INT J THERMOPHYS, V29, P1929, DOI 10.1007/s10765-008-0535-5
   McLinden MO, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14476
   Meng XY, 2018, J CHEM THERMODYN, V118, P43, DOI 10.1016/j.jct.2017.10.015
   Montzka SA, 2015, J PHYS CHEM A, V119, P4439, DOI 10.1021/jp5097376
   Lai NA, 2014, APPL THERM ENG, V70, P1, DOI 10.1016/j.applthermaleng.2014.04.042
   Nishiumi H, 1997, KOREAN J CHEM ENG, V14, P359, DOI 10.1007/BF02707052
   Outcalt SL, 1996, J PHYS CHEM REF DATA, V25, P605, DOI 10.1063/1.555979
   Pan J, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-16
   Park JY, 2001, INT J THERMOPHYS, V22, P901, DOI 10.1023/A:1010735318011
   Penoncello SG, 2003, J PHYS CHEM REF DATA, V32, P1473, DOI 10.1063/1.1559671
   Pitts CR, 2017, J ORG CHEM, V82, P3996, DOI 10.1021/acs.joc.7b00268
   Qi HY, 2016, INT J THERMOPHYS, V37, DOI 10.1007/s10765-016-2061-1
   QIAN ZY, 1992, FLUID PHASE EQUILIBR, V78, P323, DOI 10.1016/0378-3812(92)87044-N
   Ramos A, 2018, APPL ENERG, V228, P755, DOI 10.1016/j.apenergy.2018.06.059
   Richter M, 2011, J CHEM ENG DATA, V56, P3254, DOI 10.1021/je200369m
   Rui XF, 2013, FLUID PHASE EQUILIBR, V341, P78, DOI 10.1016/j.fluid.2012.12.026
   Schilling J, 2017, CHEM ENG SCI, V159, P217, DOI 10.1016/j.ces.2016.04.048
   SCHRAMM B, 1992, BER BUNSEN PHYS CHEM, V96, P745, DOI 10.1002/bbpc.19920960602
   Shi Y., 1995, HUADONG LIGONG DAXUE, V21, P613
   Shimawaki S, 2002, INT J THERMOPHYS, V23, P801, DOI 10.1023/A:1015407205188
   SOAVE G, 1972, CHEM ENG SCI, V27, P1197, DOI 10.1016/0009-2509(72)80096-4
   Sousa JMMV, 2013, FLUID PHASE EQUILIBR, V337, P60, DOI 10.1016/j.fluid.2012.09.013
   Su W, 2019, ENERGY, V166, P414, DOI 10.1016/j.energy.2018.10.083
   Su W, 2017, FLUID PHASE EQUILIBR, V432, P28, DOI 10.1016/j.fluid.2016.10.016
   SURESH SJ, 1992, IND ENG CHEM RES, V31, P2783, DOI 10.1021/ie00012a025
   Takagi T, 1999, FLUID PHASE EQUILIBR, V162, P171, DOI 10.1016/S0378-3812(99)00174-0
   Takagi T, 2001, HIGH TEMP-HIGH PRESS, V33, P303, DOI 10.1068/htwu186
   Thol M, 2016, INT J THERMOPHYS, V37, DOI 10.1007/s10765-016-2040-6
   TillnerRoth R, 1997, J PHYS CHEM REF DATA, V26, P1273, DOI 10.1063/1.556002
   TILLNERROTH R, 1994, J PHYS CHEM REF DATA, V23, P657, DOI 10.1063/1.555958
   TILLNERROTH R, 1992, J CHEM THERMODYN, V24, P413, DOI 10.1016/S0021-9614(05)80159-4
   TILLNERROTH R, 1993, J CHEM THERMODYN, V25, P1419, DOI 10.1006/jcht.1993.1144
   Velders GJM, 2012, SCIENCE, V335, P922, DOI 10.1126/science.1216414
   Velders GJM, 2009, P NATL ACAD SCI USA, V106, P10949, DOI 10.1073/pnas.0902817106
   Wang Q, 2010, FLUID PHASE EQUILIBR, V297, P67, DOI 10.1016/j.fluid.2010.06.006
   Wang Q, 2010, J CHEM ENG DATA, V55, P2990, DOI 10.1021/je100160d
   Weber F, 1996, PTB-MITT, V106, P17
   Widiatmo JV, 1997, J CHEM ENG DATA, V42, P270, DOI 10.1021/je9602327
   Widiatmo JV, 1999, J CHEM ENG DATA, V44, P1315, DOI 10.1021/je9900732
   WIDIATMO JV, 1995, INT J THERMOPHYS, V16, P801, DOI 10.1007/BF01438865
   WONG DSH, 1992, AICHE J, V38, P671, DOI 10.1002/aic.690380505
   Xu XH, 2010, FLUID PHASE EQUILIBR, V290, P148, DOI 10.1016/j.fluid.2009.11.015
   Yang FB, 2017, APPL ENERG, V205, P1100, DOI 10.1016/j.apenergy.2017.08.127
   Yang FF, 2018, CHEM ENG SCI, V192, P565, DOI 10.1016/j.ces.2018.08.014
   Yang LX, 2015, J CHEM THERMODYN, V91, P414, DOI 10.1016/j.jct.2015.08.024
   Yang T, 2018, J CHEM ENG DATA, V63, P771, DOI 10.1021/acs.jced.7b00950
   Yang Z, 2013, FLUID PHASE EQUILIBR, V355, P99, DOI 10.1016/j.fluid.2013.06.017
   Zhao YX, 2017, IND ENG CHEM RES, V56, P7384, DOI 10.1021/acs.iecr.7b00941
   Zhou Y, 2016, CANCER GENE THER, V23, P1, DOI 10.1038/cgt.2015.56
NR 127
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115182
DI 10.1016/j.ces.2019.115182
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500040
DA 2020-05-12
ER

PT J
AU Yao, YJ
   Yin, HY
   Gao, MX
   Hu, Y
   Hu, HH
   Yu, MJ
   Wang, SB
AF Yao, Yunjin
   Yin, Hongyu
   Gao, Mengxue
   Hu, Yi
   Hu, Huanhuan
   Yu, Maojing
   Wang, Shaobin
TI Electronic structure modulation of covalent organic frameworks by
   single-atom Fe doping for enhanced oxidation of aqueous contaminants
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Iron; Covalent organic framework; Peroxymono sulfate; Organic Pollutant;
   Single Atom
ID OXYGEN REDUCTION; PEROXYMONOSULFATE ACTIVATION; CARBON NANOTUBES; DOPED
   CARBON; DEGRADATION; CATALYST; INSIGHTS; SITES; BORON
AB A strategy for confining single-atom Fe in porous carbon (Fe@COF) from covalent organic framework (COF) was proposed and the Fe@COF catalysts were tested as peroxymonosulfate (PMS) activators for organic pollutants abatement. Iron doping preferentially generated effective single-atom Fe-N-x active sites into the carbon framework with electronic structure modulation, endowing prominent catalytic properties. Both in-situ electron paramagnetic resonance spectrometry and quenching measurements revealed that singlet oxygen (O-1(2)) generated by the Fe@COF/PMS system was primarily responsible for organic degradation rather than sulfate and hydroxyl radicals. The abundant single-atom Fe-N-x active sites with optimized binding energy were found to successfully activate PMS to produce O-1(2), while the rich pyrrolic nitrogen may act as the adsorption site of organic molecules, giving rise to remarkable catalytic activity in a broad pH range. The present investigation offers a new strategy to the construction of various COF-immobilized catalysts for an efficient environmental cleanup. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yao, Yunjin; Yin, Hongyu; Gao, Mengxue; Hu, Yi; Hu, Huanhuan; Yu, Maojing] Hefei Univ Technol, Sch Chem & Chem Engn, Anhui Prov Key Lab Adv Catalyt Mat & React Engn, Tunxi Rd 193, Hefei 230009, Anhui, Peoples R China.
   [Wang, Shaobin] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia.
RP Yao, YJ (reprint author), Hefei Univ Technol, Sch Chem & Chem Engn, Anhui Prov Key Lab Adv Catalyt Mat & React Engn, Tunxi Rd 193, Hefei 230009, Anhui, Peoples R China.; Wang, SB (reprint author), Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia.
EM yaoyunjin@hfut.edu.cn; shaobin.wang@adelaide.edu.au
RI Wang, Shaobin/AAL-9581-2020; Wang, Shaobin/C-5507-2008
OI Wang, Shaobin/0000-0002-1751-9162; Wang, Shaobin/0000-0002-1751-9162
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21876039]; Anhui Provincial Natural Science
   FoundationNatural Science Foundation of Anhui Province [1708085MB41];
   China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2015M570547, 2016T90585]; Australian Research
   CouncilAustralian Research Council [DP190103548]
FX Financial supports from the National Natural Science Foundation of China
   (NO. 21876039), the Anhui Provincial Natural Science Foundation (NO.
   1708085MB41), and the China Postdoctoral Science Foundation (NO.
   2015M570547, 2016T90585) are acknowledged. A partial support from the
   Australian Research Council for DP190103548 is also acknowledged.
CR AHN SH, 2017, ADV MATER, V29, DOI DOI 10.1002/ADMA.201606534
   Biswal BP, 2013, J AM CHEM SOC, V135, P5328, DOI 10.1021/ja4017842
   Chandra S, 2016, CHEM MATER, V28, P1489, DOI 10.1021/acs.chemmater.5b04947
   Chen FF, 2019, ACS CENTRAL SCI, V5, P176, DOI 10.1021/acscentsci.8b00805
   Chen GJ, 2018, INORG CHEM, V57, P2678, DOI 10.1021/acs.inorgchem.7b03077
   Cheng QQ, 2017, ACS CATAL, V7, P6864, DOI 10.1021/acscatal.7b02326
   Cheng X, 2017, WATER RES, V113, P80, DOI 10.1016/j.watres.2017.02.016
   Choi S., 2019, ANGEW CHEM, V131, P876
   Cui KX, 2019, SMALL, V15, DOI 10.1002/smll.201804419
   Dai QG, 2018, ENVIRON SCI TECHNOL, V52, P13430, DOI 10.1021/acs.est.8b05002
   Ding SM, 2018, CHEM COMMUN, V54, P5058, DOI 10.1039/c8cc02966k
   Fang QR, 2014, ANGEW CHEM INT EDIT, V53, P2878, DOI 10.1002/anie.201310500
   Gao YW, 2018, ENVIRON SCI TECHNOL, V52, P14371, DOI 10.1021/acs.est.8b05246
   Gao Y, 2018, ACS CATAL, V8, P10364, DOI 10.1021/acscatal.8b02360
   Huang N, 2015, ANGEW CHEM INT EDIT, V54, P2986, DOI 10.1002/anie.201411262
   Jia QY, 2016, NANO ENERGY, V29, P65, DOI 10.1016/j.nanoen.2016.03.025
   Li DG, 2017, CARBON, V115, P649, DOI 10.1016/j.carbon.2017.01.058
   Li HC, 2018, ENVIRON SCI TECHNOL, V52, P2197, DOI 10.1021/acs.est.7b05563
   Li QQ, 2018, ENVIRON SCI TECHNOL, V52, P13351, DOI 10.1021/acs.est.8b03789
   Li XL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05462-4
   Li XN, 2018, J AM CHEM SOC, V140, P12469, DOI 10.1021/jacs.8b05992
   Li ZP, 2015, CHEM-EUR J, V21, P12079, DOI 10.1002/chem.201501206
   Liu Y, 2019, CHEM ENG J, V361, P416, DOI 10.1016/j.cej.2018.12.105
   Lu SL, 2017, J AM CHEM SOC, V139, P17082, DOI 10.1021/jacs.7b07918
   Ma WJ, 2019, ACS SUSTAIN CHEM ENG, V7, P2718, DOI 10.1021/acssuschemeng.8b05801
   Ma WJ, 2019, CHEM COMMUN, V55, P159, DOI 10.1039/c8cc08116f
   Peng YW, 2016, CHEM MATER, V28, P5095, DOI 10.1021/acs.chemmater.6b01954
   Shao PH, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201705295
   Tang JT, 2018, ENVIRON SCI TECHNOL, V52, P5367, DOI 10.1021/acs.est.8b00092
   Wang DG, 2018, ACS APPL MATER INTER, V10, P42233, DOI 10.1021/acsami.8b14213
   Wang YB, 2018, CARBON, V135, P238, DOI 10.1016/j.carbon.2018.01.106
   Wang Z, 2018, ENVIRON SCI TECHNOL, V52, P11276, DOI 10.1021/acs.est.8b02266
   Xiao ML, 2018, ACS CATAL, V8, P2824, DOI 10.1021/acscatal.8b00138
   Yan JF, 2018, ENVIRON SCI TECHNOL, V52, P14302, DOI 10.1021/acs.est.8b03340
   Yang Y, 2018, ACS OMEGA, V3, P15870, DOI 10.1021/acsomega.8b02581
   Yao YJ, 2018, J COLLOID INTERF SCI, V529, P100, DOI 10.1016/j.jcis.2018.05.077
   Yao YJ, 2017, J HAZARD MATER, V338, P265, DOI 10.1016/j.jhazmat.2017.05.026
   Yao YJ, 2016, WATER RES, V101, P281, DOI 10.1016/j.watres.2016.05.065
   Yao YJ, 2016, J HAZARD MATER, V314, P129, DOI 10.1016/j.jhazmat.2016.03.089
   Yun ET, 2018, ENVIRON SCI TECHNOL, V52, P7032, DOI 10.1021/acs.est.8b00959
   Zhang J, 2015, J MATER CHEM A, V3, P10851, DOI 10.1039/c5ta00547g
   Zhang ZP, 2018, ANGEW CHEM INT EDIT, V57, P9038, DOI 10.1002/anie.201804958
   Zhang Z, 2018, ACS APPL MATER INTER, V10, P22023, DOI 10.1021/acsami.8b03742
   Zhao R, 2019, ANGEW CHEM INT EDIT, V58, P1975, DOI 10.1002/anie.201811126
   Zhu M, 2018, ACS SUSTAIN CHEM ENG, V6, P15737, DOI 10.1021/acssuschemeng.8b04289
   Zhu SS, 2019, ENVIRON SCI TECHNOL, V53, P307, DOI 10.1021/acs.est.8b04669
   Zhu SS, 2018, ENVIRON SCI TECHNOL, V52, P8649, DOI 10.1021/acs.est.8b01817
NR 47
TC 0
Z9 0
U1 42
U2 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115211
DI 10.1016/j.ces.2019.115211
PG 13
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500015
DA 2020-05-12
ER

PT J
AU Yi, J
   Xing, HL
   Wang, JJ
   Xia, ZH
   Jing, Y
AF Yi, Jie
   Xing, Huilin
   Wang, Junjian
   Xia, Zhaohui
   Jing, Yu
TI Pore-scale study of the effects of surface roughness on relative
   permeability of rock fractures using lattice Boltzmann method
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Pore-scale; Lattice Boltzmann method; Fracture roughness; Relative
   permeability
ID 2-PHASE FLOW; POROUS-MEDIA; CAPILLARY-PRESSURE; MULTIPHASE FLOW;
   CONTACT-ANGLE; FLUID-FLOW; WETTABILITY HETEROGENEITY; HEAT-TRANSFER;
   MIXED-WET; GAS-FLOW
AB Two-phase flow in fractured geo-material plays a significant role in various subsurface processes. Despite some success in studying two-phase flow in ideal smooth-walled fractures, the more realistic issues regarding two-phase flow in rough-walled fractures are still not well understood. In this study, an improved approach based on free energy lattice Boltzmann model is proposed to analyze the two-phase immiscible flow in the rough-walled fracture and to further estimate the relative permeability curves. The proposed model is validated by comparison with analytical results of individual fracture, and good agreement is achieved in general. Then it is used to investigate the effects of wall roughness and the initial phase distribution patterns on the co-current flow of two immiscible fluids. The simulation results demonstrate that roughness impacts phase distribution, flow patterns and relative permeability curves in a single rough-walled fracture. Rough surface increases two-phase interference and flow resistance, and an unsteady flow state appears for the non-wetting phase (NWP) when the wetting phase (WP) saturation is small. In addition, the NWP flow can either be lubricated or be resisted by the WP depending on the flow patterns and the WP saturation. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yi, Jie; Xia, Zhaohui] Petrochina Res Inst Petr Explorat & Dev, Beijing 100083, Peoples R China.
   [Xing, Huilin] Ocean Univ China, Coll Marine Geosci, Key Lab Submarine Geosci & Prospecting Tech, Minist Educ,Inst Adv Ocean Study, Qingdao 266100, Shandong, Peoples R China.
   [Xing, Huilin] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld 4072, Australia.
   [Wang, Junjian] China Univ Geosci Beijing, Sch Energy Resources, Beijing 100083, Peoples R China.
   [Jing, Yu] Univ New South Wales, Sch Mineral & Energy Resources Engn, Sydney, NSW 2003, Australia.
RP Yi, J (reprint author), Petrochina Res Inst Petr Explorat & Dev, Beijing 100083, Peoples R China.
EM yiyanjie1@gmail.com
OI Wang, Junjian/0000-0001-6708-8754
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [51804281]; Fundamental Research Funds for the
   Central UniversitiesFundamental Research Funds for the Central
   Universities [53200759598, 53200759626]
FX This work was supported by National Nature Science Foundation of China
   (Grants No. 51804281) and the Fundamental Research Funds for the Central
   Universities (Grants No. 53200759598 and No. 53200759626).
CR AlRatrout A, 2017, ADV WATER RESOUR, V109, P158, DOI 10.1016/j.advwatres.2017.07.018
   Amiri HAA, 2013, INT J MULTIPHAS FLOW, V52, P22, DOI 10.1016/j.ijmultiphaseflow.2012.12.006
   Arns JY, 2004, TRANSPORT POROUS MED, V55, P21, DOI 10.1023/B:TIPM.0000007252.68488.43
   Ba Y, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.023310
   Babadagli T, 2015, INT J MULTIPHAS FLOW, V68, P40, DOI 10.1016/j.ijmultiphaseflow.2014.10.004
   Bennion DB, 2008, SPE RESERV EVAL ENG, V11, P487, DOI 10.2118/99326-PA
   Blunt MJ, 2001, CURR OPIN COLLOID IN, V6, P197, DOI 10.1016/S1359-0294(01)00084-X
   Bryant SL, 2008, SPE J, V13, P447, DOI 10.2118/99938-PA
   CACAS MC, 1990, WATER RESOUR RES, V26, P479, DOI 10.1029/WR026i003p00479
   CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102
   Chen CY, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003837
   Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08089
   Cousins TA, 2018, TRANSPORT POROUS MED, V122, P527, DOI 10.1007/s11242-017-0938-5
   Cui J, 2015, ENERGIES, V8, P5704, DOI 10.3390/en8065704
   Cui J, 2011, COMPUT MATH APPL, V61, P3678, DOI 10.1016/j.camwa.2010.07.037
   Das DB, 2006, CHEM ENG SCI, V61, P6786, DOI 10.1016/j.ces.2006.07.028
   Di Rienzo AF, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/34001
   Dicarlo DA, 2000, TRANSPORT POROUS MED, V39, P347, DOI 10.1023/A:1006653323374
   Ghanbarian B, 2016, WATER RESOUR RES, V52, P2045, DOI 10.1002/2015WR017857
   GUNSTENSEN AK, 1991, PHYS REV A, V43, P4320, DOI 10.1103/PhysRevA.43.4320
   He XY, 1999, J COMPUT PHYS, V152, P642, DOI 10.1006/jcph.1999.6257
   Honarpour M.M., 2018, RELATIVE PERMEABILIT
   Jing Y, 2017, FUEL, V191, P442, DOI 10.1016/j.fuel.2016.11.094
   Jing Y, 2016, FUEL, V181, P286, DOI 10.1016/j.fuel.2016.04.127
   Joekar-Niasar V, 2008, TRANSPORT POROUS MED, V74, P201, DOI 10.1007/s11242-007-9191-7
   Juanes R, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004806
   Kang QJ, 2010, ADV APPL MATH MECH, V2, P545, DOI 10.4208/aamm.10-m10S02
   Kang QJ, 2004, ADV WATER RESOUR, V27, P13, DOI 10.1016/j.advwatres.2003.10.002
   Krevor SCM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010859
   Lake L.W., 2014, FUNDAMENTALS ENHANCE
   Landry CJ, 2014, WATER RESOUR RES, V50, P3672, DOI 10.1002/2013WR015148
   Lei G, 2015, J CAN PETROL TECHNOL, V54, P36, DOI 10.2118/173897-PA
   Lichtner P. C., 2000, GEOPHYS MONOGR SER, V122, P281, DOI DOI 10.1029/GM122P0281
   Liu HH, 2016, COMPUTAT GEOSCI, V20, P777, DOI 10.1007/s10596-015-9542-3
   Madadi M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026309
   Mahoney SA, 2017, INT J COAL GEOL, V179, P302, DOI 10.1016/j.coal.2017.07.001
   Masalmeh SK, 2003, J PETROL SCI ENG, V39, P399, DOI 10.1016/S0920-4105(03)00078-0
   McCracken ME, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046704
   Ni XM, 2017, INT J MIN SCI TECHNO, V27, P693, DOI 10.1016/j.ijmst.2017.05.021
   Nowamooz A, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007315
   PERSOFF P, 1995, WATER RESOUR RES, V31, P1175, DOI 10.1029/95WR00171
   PRUESS K, 1990, WATER RESOUR RES, V26, P1915, DOI 10.1029/WR026i009p01915
   Qian JZ, 2011, HYDROL PROCESS, V25, P614, DOI 10.1002/hyp.7849
   Qiu J, 2019, IEEE T FUZZY SYST
   Rutqvist J, 2002, INT J ROCK MECH MIN, V39, P429, DOI 10.1016/S1365-1609(02)00022-9
   Schwarzkopf J. D., 2011, MULTIPHASE FLOWS DRO
   SHAN XW, 1993, PHYS REV E, V47, P1815, DOI 10.1103/PhysRevE.47.1815
   Shao JY, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.033309
   Singh K, 2016, WATER RESOUR RES, V52, P1716, DOI 10.1002/2015WR018072
   Sun K, 2018, IEEE T FUZZY SYST
   Swift MR, 1996, PHYS REV E, V54, P5041, DOI 10.1103/PhysRevE.54.5041
   Tzelepis V, 2015, J HYDROL, V521, P108, DOI 10.1016/j.jhydrol.2014.11.054
   Wang JJ, 2016, FUEL, V181, P478, DOI 10.1016/j.fuel.2016.05.032
   Wang JJ, 2016, INT J HEAT MASS TRAN, V95, P94, DOI 10.1016/j.ijheatmasstransfer.2015.12.009
   Wu Y.-S., 2000, AGU GEOPHYS MONOGR, P122
   Yang WL, 2019, WATER RESOUR MANAG, V33, P4865, DOI 10.1007/s11269-019-02412-7
   Yi JE, 2017, CHEM ENG SCI, V161, P57, DOI 10.1016/j.ces.2016.12.016
   Yiotis AG, 2007, COLLOID SURFACE A, V300, P35, DOI 10.1016/j.colsurfa.2006.12.045
   Zhang CB, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016319
   Zhao JL, 2018, WATER RESOUR RES, V54, P1295, DOI 10.1002/2017WR021443
   Zhao YL, 2018, J NAT GAS SCI ENG, V53, P153, DOI 10.1016/j.jngse.2018.03.001
   Zheng HW, 2006, J COMPUT PHYS, V218, P353, DOI 10.1016/j.jcp.2006.02.015
NR 62
TC 1
Z9 1
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115178
DI 10.1016/j.ces.2019.115178
PG 15
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500032
DA 2020-05-12
ER

PT J
AU Yu, JL
   Wu, CL
   Li, YH
   Ghosh, S
   Joshi, JB
   Tyagi, M
   Nandakumar, K
AF Yu, Jielin
   Wu, Chunliang
   Li, Yuehao
   Ghosh, Shankar
   Joshi, J. B.
   Tyagi, Mayank
   Nandakumar, K.
TI Study of granular self-organization inside a cylinder driven by an
   orbital-shaker using discrete element method
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Granular flow mixing; Self-organization; Discrete Element Method (DEM);
   Non-linear dynamics; Mixing in Orbital shaker
ID 8-LEG LOOP REACTOR; CUTTINGS TRANSPORT; FLOW; SEGREGATION; DESIGN
AB In this work, we applied discrete element method (DEM) based simulations to investigate the granular organization phenomenon recently observed in an orbital shaker. The simulation results capture the complex motion and self-organizing patterns of particles. When a single particle descends along the wall of an orbiting cylinder, the centrifugal and frictional forces acting on the particle lead to an oscillating trajectory. In contrast, when multiple particles descend from the top, they form a monolayer of a reproducible trapezoidal robust shape on the inner wall, being supported by particles from below and sides, while rotating with the cylinder. The simulation results confirm the hypothesis of auto-tuning of friction and reveal that there are three distinct regions in the monolayer with varying states of particle motion. Also, it explains the observation that the varying intensity of particle interactions induces the auto-tuning of friction. Particles dissipate the rolling energy through particle interactions and transition their state gradually from rolling to sliding within the monolayer, which subsequently increases the friction forces acting on the particles and balances the overall centrifugal force with the frictional force. This work is the first successful attempt to understand the granular organization phenomenon in orbital shaking by DEM simulations, and it may be beneficial to the design and operation of industrial equipment involving such granular systems. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yu, Jielin; Li, Yuehao; Joshi, J. B.; Tyagi, Mayank; Nandakumar, K.] Louisiana State Univ, Baton Rouge, LA 70803 USA.
   [Wu, Chunliang] ANSYS Inc, 10 Cavendish Court, Lebanon, NH 03766 USA.
   [Ghosh, Shankar] Tata Inst Fundamental Res, Mumbai, Maharashtra, India.
RP Nandakumar, K (reprint author), Louisiana State Univ, Baton Rouge, LA 70803 USA.
EM nandakumar@lsu.edu
CR Akhshik S, 2018, J PETROL SCI ENG, V160, P229, DOI 10.1016/j.petrol.2017.05.012
   Aranson IS, 2006, REV MOD PHYS, V78, P641, DOI 10.1103/RevModPhys.78.641
   Ayeni OO, 2015, POWDER TECHNOL, V283, P549, DOI 10.1016/j.powtec.2015.06.038
   Borzsonyi T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.178302
   Boote OAM, 1999, PHYS FLUIDS, V11, P2020, DOI 10.1063/1.870065
   Elghannay HA, 2018, PARTICUL SCI TECHNOL, V36, P438, DOI 10.1080/02726351.2017.1352638
   Epelle EI, 2018, CHEM ENG RES DES, V131, P520, DOI 10.1016/j.cherd.2017.11.023
   Faraday M., 1831, PHILOS T R SOC LONDO, V121, P299, DOI DOI 10.1098/RSTL.1831.0018
   Gualtieri M, 2006, AM J PHYS, V74, P497, DOI 10.1119/1.2180281
   Hu KW, 2014, SOFT MATTER, V10, P4348, DOI 10.1039/c3sm53190b
   Jia DN, 2014, CAN J CHEM ENG, V92, P176, DOI 10.1002/cjce.21811
   Krengel D, 2013, GRANUL MATTER, V15, P377, DOI 10.1007/s10035-013-0411-2
   Kumar D., 2015, FRICTION INDUCED ORG
   Kumar D, 2015, P NATL ACAD SCI USA, V112, P11443, DOI 10.1073/pnas.1500665112
   Li YH, 2018, IND ENG CHEM RES, V57, P6068, DOI 10.1021/acs.iecr.8b00100
   Li YH, 2017, POWDER TECHNOL, V319, P452, DOI 10.1016/j.powtec.2017.07.014
   Li YH, 2015, POWDER TECHNOL, V284, P95, DOI 10.1016/j.powtec.2015.06.031
   Mitarai N, 2012, EUR PHYS J-SPEC TOP, V204, P5, DOI 10.1140/epjst/e2012-01548-8
   Pujol O, 2007, EUR J PHYS, V28, P379, DOI 10.1088/0143-0807/28/2/024
   Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129
   Schmelzle S, 2018, GRANUL MATTER, V20, DOI 10.1007/s10035-018-0792-3
   Squires AM, 2007, POWDER TECHNOL, V175, P55, DOI 10.1016/j.powtec.2006.06.019
   Squires A.M., 2017, US Patent, Patent No. [9636846 B1, 9636846]
   TSUJI Y, 1992, POWDER TECHNOL, V71, P239, DOI 10.1016/0032-5910(92)88030-L
   Weis D., 2015, DEM SIMULATIONS PART
   Wu CL, 2014, CHEM ENG SCI, V118, P221, DOI 10.1016/j.ces.2014.07.043
   Yu ZY, 2015, INT J MULTIPHAS FLOW, V77, P260, DOI 10.1016/j.ijmultiphaseflow.2015.08.010
   Zhou Y.C., 2002, PHYS REV E
NR 28
TC 0
Z9 0
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115194
DI 10.1016/j.ces.2019.115194
PG 10
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500038
DA 2020-05-12
ER

PT J
AU Zhang, JP
   Liu, W
   Luo, Y
   Chu, GW
   Zou, HK
   Chen, JF
AF Zhang, Jing-Peng
   Liu, Wei
   Luo, Yong
   Chu, Guang-Wen
   Zou, Hai-Kui
   Chen, Jian-Feng
TI Enhancing liquid droplet breakup by hydrophobic wire mesh: Visual study
   and application in a rotating packed bed
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Droplet breakup; Rotating packed bed; Hydrophobicity; Mass transfer
ID MASS-TRANSFER; IMPACTING DROPLETS; FLOW; INTENSIFICATION; DIAMETER
AB Liquid droplet breakup significantly affects the mass transfer performance in chemical reactors. For example, in a rotating packed bed (RPB) reactor, several studies focused on the structure innovations of packing and rotor to enhance liquid droplet breakup. However, using the surface-modification packing with hydrophobicity to intensify the liquid droplet breakup has scarcely been assessed. In this work, a hydrophobic surface-modified stainless steel wire mesh (SSM) was employed to investigate the breakup behaviors of liquid droplet when the mother droplet passed through a single-layer SSM by using a high-speed camera. Different regimes were observed when the mother droplet passed through the single-layer SSM and non-surface-modified stainless steel wire mesh (NSM). The mean daughter droplet diameter obtained by SSM was smaller than that by NSM. Correlations of the mean daughter droplet diameters were proposed, and the predicted values were in a good agreement with the experimental values, having a deviation of +/- 15%. Experimental and modeling results showed smaller dissipation energy of SSM resulted in more energy for mother droplet breakup. Due to the droplet breakup enhancement, the mass transfer performance of a RPB with SSM loaded in the cavity zone was intensified. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Luo, Yong; Chu, Guang-Wen] Beijing Univ Chem Technol, Minist Educ High Grav Engn & Technol, Res Ctr, Beijing 100029, Peoples R China.
   Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China.
RP Luo, Y; Chu, GW (reprint author), Beijing Univ Chem Technol, Minist Educ High Grav Engn & Technol, Res Ctr, Beijing 100029, Peoples R China.
EM luoyong@mail.buct.edu.cn; chugw@mail.buct.edu.cn
FU National Key Research and Development Program of China [2017YFA0206801];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21725601, 21406009, 21436001]
FX This work was supported by the National Key Research and Development
   Program of China (No. 2017YFA0206801) and the National Natural Science
   Foundation of China (Nos. 21725601, 21406009, and 21436001).
CR Aussillous P, 2001, NATURE, V411, P924, DOI 10.1038/35082026
   Brunet P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3275709
   Bucher TM, 2015, SURF COAT TECH, V277, P117, DOI 10.1016/j.surfcoat.2015.07.032
   Burns JR, 1996, CHEM ENG SCI, V51, P1347, DOI 10.1016/0009-2509(95)00367-3
   Chu GW, 2015, IND ENG CHEM RES, V54, P1697, DOI 10.1021/ie504407a
   Chu GW, 2014, IND ENG CHEM RES, V53, P18580, DOI 10.1021/ie503579q
   Chu GW, 2014, IND ENG CHEM RES, V53, P15731, DOI 10.1021/ie502519v
   Delbos A, 2010, J COLLOID INTERF SCI, V341, P171, DOI 10.1016/j.jcis.2009.09.016
   Gao JS, 2001, AICHE J, V47, P677, DOI 10.1002/aic.690470315
   Guo DW, 2015, SMALL, V11, P4491, DOI 10.1002/smll.201501023
   Josserand C, 2016, ANNU REV FLUID MECH, V48, P365, DOI 10.1146/annurev-fluid-122414-034401
   Kumar A, 2018, SOFT MATTER, V14, P1571, DOI 10.1039/c7sm02145c
   Li XG, 2019, SEP PURIF TECHNOL, V216, P74, DOI 10.1016/j.seppur.2019.01.073
   Lin CC, 2012, CHEM ENG PROCESS, V53, P76, DOI 10.1016/j.cep.2011.12.007
   Liu J, 2016, ANGEW CHEM INT EDIT, V55, P4265, DOI 10.1002/anie.201600224
   Liu YZ, 2016, CATAL TODAY, V273, P34, DOI 10.1016/j.cattod.2016.03.017
   Luo Y, 2017, CHEM ENG SCI, V170, P347, DOI 10.1016/j.ces.2016.10.023
   Luo Y, 2012, IND ENG CHEM RES, V51, P9164, DOI 10.1021/ie300466f
   Pan C.Q., 2005, J S CHINA U TECHNOL, V33, P48
   PasandidehFard M, 1996, PHYS FLUIDS, V8, P650, DOI 10.1063/1.868850
   Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a
   Sang L, 2017, CHEM ENG SCI, V170, P355, DOI 10.1016/j.ces.2016.12.041
   Sang L, 2017, CHEM ENG SCI, V158, P429, DOI 10.1016/j.ces.2016.10.044
   Shi X, 2013, CHEM ENG J, V228, P1040, DOI 10.1016/j.cej.2013.05.081
   Shivhare MK, 2013, CHEM ENG PROCESS, V71, P115, DOI 10.1016/j.cep.2013.01.009
   Su YH, 2010, CHEM ENG SCI, V65, P3947, DOI 10.1016/j.ces.2010.03.034
   Ukiwe C, 2005, LANGMUIR, V21, P666, DOI 10.1021/la0481288
   Wang ST, 2015, CHEM REV, V115, P8230, DOI 10.1021/cr400083y
   Xu JL, 2017, EXP THERM FLUID SCI, V82, P83, DOI 10.1016/j.expthermflusci.2016.11.006
   Yan P, 2018, CHEM ENG SCI, V176, P220, DOI 10.1016/j.ces.2017.10.023
   Yang YC, 2016, CHEM ENG J, V294, P111, DOI 10.1016/j.cej.2016.02.054
   Zhang GN, 2018, SOFT MATTER, V14, P8182, DOI 10.1039/c8sm01082j
   Zhang JP, 2017, CHEM ENG SCI, V170, P204, DOI 10.1016/j.ces.2017.03.058
   Zheng XH, 2016, CHEM ENG J, V285, P236, DOI 10.1016/j.cej.2015.09.083
NR 34
TC 2
Z9 2
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115180
DI 10.1016/j.ces.2019.115180
PG 8
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500016
DA 2020-05-12
ER

PT J
AU Zhou, YW
   Huang, JP
   Chen, Z
   Wang, YD
   Xu, JH
AF Zhou, Yiwei
   Huang, Jinpei
   Chen, Zhuo
   Wang, Yundong
   Xu, Jianhong
TI Controlled retention of droplets and the enhancement of mass transfer in
   microchannel with multi-groove structure
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Droplet-based microfluidic device; Multi-groove structure; Mass transfer
   intensification
ID LIQUID-LIQUID-EXTRACTION; PROCESS INTENSIFICATION; COALESCENCE; FLOW
AB A simple and novel droplet-based microfluidic device with multi-groove structure has been developed to achieve stay-collision-transfer process of droplets. After summarizing the scaling law of droplet diameter and formation frequency with two phase flow rates, we got the optimum operating range of continuous phase flow. During the retention of droplet in groove, the existence of internal vortex was observed, which lead to the homogeneity of internal concentration field. For the process of solvent-microextraction with high phase ratio, due to multi-groove structure, the actual volume phase ratio in microchannel can be much smaller than injection phase ratio to improve extraction efficiency. And two-phase acid-base reaction and fluorescence extraction experiments further validate the enhancement of mass transfer process by this kind of microchannel. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhou, Yiwei; Huang, Jinpei; Chen, Zhuo; Wang, Yundong; Xu, Jianhong] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
RP Xu, JH (reprint author), Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
EM xujianhong@tsinghua.edu.cn
OI Zhou, Yiwei/0000-0001-5354-3234
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21476121, 21636004]
FX The authors gratefully acknowledge the supports of the National Natural
   Science Foundation of China (21476121, 21636004) for this work.
CR Abbyad P, 2011, LAB CHIP, V11, P813, DOI 10.1039/c01c00104j
   Ahn B, 2011, LAB CHIP, V11, P3915, DOI 10.1039/c1lc20729f
   Akartuna I, 2015, LAB CHIP, V15, P1140, DOI 10.1039/c4lc01285b
   Amselem G, 2015, PHYS REV APPL, V3, DOI 10.1103/PhysRevApplied.3.054006
   Bowden SA, 2006, LAB CHIP, V6, P740, DOI 10.1039/b518162c
   Ciceri D, 2014, J CHEM TECHNOL BIOT, V89, P771, DOI 10.1002/jctb.4318
   Dangla R, 2013, P NATL ACAD SCI USA, V110, P853, DOI 10.1073/pnas.1209186110
   Flett DS, 2005, J ORGANOMET CHEM, V690, P2426, DOI 10.1016/j.jorganchem.2004.11.037
   Kentish SE, 2001, CHEM ENG J, V84, P149, DOI 10.1016/S1385-8947(01)00199-1
   Kokosa JM, 2013, TRAC-TREND ANAL CHEM, V43, P2, DOI 10.1016/j.trac.2012.09.020
   Li GX, 2019, AICHE J, V65, P334, DOI 10.1002/aic.16211
   Li GX, 2018, AICHE J, V64, P1106, DOI 10.1002/aic.15973
   Maruyama T, 2007, ANAL SCI, V23, P763, DOI 10.2116/analsci.23.763
   Mary P, 2008, ANAL CHEM, V80, P2680, DOI 10.1021/ac800088s
   Nagel M, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4867251
   Nisisako T, 2002, LAB CHIP, V2, P24, DOI 10.1039/b108740c
   Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007
   Tan J, 2011, SEP PURIF TECHNOL, V80, P225, DOI 10.1016/j.seppur.2011.04.030
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Toprakcioglu Z, 2018, LAB CHIP, V18, P3303, DOI 10.1039/c8lc00862k
   Wagli P, 2013, ANAL CHEM, V85, P7558, DOI 10.1021/ac401606p
   Wang WT, 2015, RSC ADV, V5, P82056, DOI 10.1039/c5ra15769b
   Xiong QQ, 2018, CHEM ENG SCI, V185, P157, DOI 10.1016/j.ces.2018.04.022
   Xu JH, 2008, CHEM ENG J, V141, P242, DOI 10.1016/j.cej.2007.12.030
   Xu JH, 2006, AICHE J, V52, P3005, DOI 10.1002/aic.10924
   Yoon DH, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100513
   Zha L, 2019, CHEM ENG SCI, V195, P62, DOI 10.1016/j.ces.2018.11.043
   Zhou QQ, 2016, SOFT MATTER, V12, P1674, DOI 10.1039/c5sm02924d
NR 28
TC 0
Z9 0
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 14
PY 2019
VL 209
AR 115223
DI 10.1016/j.ces.2019.115223
PG 7
WC Engineering, Chemical
SC Engineering
GA JV0WA
UT WOS:000502087500009
DA 2020-05-12
ER

PT J
AU Agrawal, R
AF Agrawal, Rakesh
TI Chemical engineering for a solar economy (2017 P. V. Danckwerts Lecture)
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Solar economy; Systems engineering; Energy storage; Aglectric farms;
   Cogeneration of hydrogen and electricity; Photovoltaic
ID THERMALLY COUPLED DISTILLATION; LIQUID FUEL; RENEWABLE POWER;
   CARBON-DIOXIDE; GRAIN-GROWTH; ENERGY; EFFICIENT; FOOD; NANOCRYSTAL;
   SYSTEMS
AB Chemical engineering evolved in the twentieth century with rise in the use of fossil resources and the myriad of products derived from them. Those products required great innovations and had a huge impact on the human race. Going forward as we transition from fossil resources to renewable resources such as solar energy, we again have unprecedented opportunities for innovation that would not only make great impact but redefine chemical engineering. My Danckwerts lecture focused on my own experiences with challenges and opportunities presented to us as chemical engineers in the emerging solar economy. In particular, the importance of careful energy systems engineering for identifying optimal solutions that seeks synergy between different applications of solar energy is emphasized. The need to acquire and use knowledge beyond our traditional chemical engineering discipline to create new solutions is also discussed. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Agrawal, Rakesh] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.
RP Agrawal, R (reprint author), Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.
EM agrawalr@purdue.edu
CR Adams RA, 2017, ACS APPL MATER INTER, V9, P17872, DOI 10.1021/acsami.7b02476
   Agrawal R, 2000, AICHE J, V46, P2198, DOI 10.1002/aic.690461112
   Agrawal R, 1996, IND ENG CHEM RES, V35, P3607, DOI 10.1021/ie960160c
   Agrawal R, 2003, AICHE J, V49, P379, DOI 10.1002/aic.690490210
   Agrawal R, 1998, IND ENG CHEM RES, V37, P3444, DOI 10.1021/ie980062m
   Agrawal R, 1998, AICHE J, V44, P2565, DOI 10.1002/aic.690441124
   Agrawal R, 1996, IND ENG CHEM RES, V35, P1059, DOI 10.1021/ie950323h
   Agrawal R, 1992, Liquefied natural gas refrigeration transfer to a cryogenics air separation unit using high pressure nitrogen stream, Patent No. [US5137558A, 5137558A]
   Agrawal R, 2007, P NATL ACAD SCI USA, V104, P4828, DOI 10.1073/pnas.0609921104
   Agrawal R, 2010, AICHE J, V56, P2762, DOI 10.1002/aic.12435
   Agrawal R, 2010, ANNU REV CHEM BIOMOL, V1, P343, DOI 10.1146/annurev-chembioeng-073009-100955
   Agrawal R, 2009, AICHE J, V55, P1898, DOI 10.1002/aic.11785
   Al-Musleh EI, 2014, APPL ENERG, V122, P83, DOI 10.1016/j.apenergy.2014.02.015
   AMUNDSON NR, 1986, CHEM ENG SCI, V41, P1947, DOI 10.1016/0009-2509(86)87111-1
   Armstrong A, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074016
   Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586
   Capellan-Perez I, 2017, RENEW SUST ENERG REV, V77, P760, DOI 10.1016/j.rser.2017.03.137
   Carter NJ, 2015, J MATER CHEM C, V3, P7128, DOI 10.1039/c5tc01139f
   Carter NJ, 2014, SOL ENERG MAT SOL C, V123, P189, DOI 10.1016/j.solmat.2014.01.016
   Chen HS, 2009, PROG NAT SCI-MATER, V19, P291, DOI 10.1016/j.pnsc.2008.07.014
   Cormier T. E., 1991, Production of ultra-high purity oxygen from cryogenic air separation plants, Patent No. [US5049173, 5049173]
   Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007
   Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741
   Gencer E, 2018, RESOUR CONSERV RECY, V133, P331, DOI 10.1016/j.resconrec.2018.01.030
   Gencer E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03437-x
   Gencer E, 2017, ENERG CONVERS MANAGE, V133, P486, DOI 10.1016/j.enconman.2016.10.068
   Gencer E, 2015, P NATL ACAD SCI USA, V112, P15821, DOI 10.1073/pnas.1513488112
   Gencer E, 2014, CURR OPIN CHEM ENG, V5, P29, DOI 10.1016/j.coche.2014.04.001
   Grossmann IE, 2000, AICHE J, V46, P1700, DOI 10.1002/aic.690460902
   Guo Q, 2008, NANO LETT, V8, P2982, DOI 10.1021/nl802042g
   Guo Q, 2010, J AM CHEM SOC, V132, P17384, DOI 10.1021/ja108427b
   Guo QJ, 2009, J AM CHEM SOC, V131, P11672, DOI 10.1021/ja904981r
   Guo Q, 2009, NANO LETT, V9, P3060, DOI 10.1021/nl901538w
   Hages CJ, 2016, CHEM MATER, V28, P7703, DOI 10.1021/acs.chemmater.6b02733
   Hages CJ, 2016, J APPL PHYS, V119, DOI 10.1063/1.4939487
   Hages CJ, 2015, COPPER ZINC TIN SULFIDE-BASED THIN-FILM SOLAR CELLS, P239
   Hages CJ, 2014, J APPL PHYS, V115, DOI 10.1063/1.4882119
   Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103
   Hischier I., 2012, J SOLAR ENERGY ENG, V134, P1
   Ho CK, 2014, RENEW SUST ENERG REV, V29, P835, DOI 10.1016/j.rser.2013.08.099
   Hong T, 2016, ENRGY PROCED, V88, P408, DOI 10.1016/j.egypro.2016.06.013
   Imenes AG, 2004, SOL ENERG MAT SOL C, V84, P19, DOI 10.1016/j.solmat.2004.01.038
   Izquierdo S, 2011, SOL ENERGY, V85, P208, DOI 10.1016/j.solener.2010.11.003
   Jiang SL, 2010, SOL ENERG MAT SOL C, V94, P1686, DOI 10.1016/j.solmat.2010.05.029
   Johnson M, 2014, ENERG ENVIRON SCI, V7, P1931, DOI 10.1039/c3ee44130j
   Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x
   Koeper MJ, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.4996283
   Lackner KS, 2009, EUR PHYS J-SPEC TOP, V176, P93, DOI 10.1140/epjst/e2009-01150-3
   Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103
   Macilwain C, 2010, NATURE, V468, P624, DOI 10.1038/468624a
   MacKay DJC, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0431
   Mallapragada DS, 2014, AICHE J, V60, P2533, DOI 10.1002/aic.14456
   Mallapragada DS, 2014, INT J HYDROGEN ENERG, V39, P62, DOI 10.1016/j.ijhydene.2013.10.075
   Mallapragada DS, 2013, IND ENG CHEM RES, V52, P5136, DOI 10.1021/ie301125c
   Marrou H, 2013, AGR FOREST METEOROL, V177, P117, DOI 10.1016/j.agrformet.2013.04.012
   Miskin CK, 2019, NAT SUSTAIN, V2, P972, DOI 10.1038/s41893-019-0388-x
   Miskin CK, 2015, PROG PHOTOVOLTAICS, V23, P654, DOI 10.1002/pip.2472
   Nickerson C., 2011, MAJOR USES LAND US
   NRC, 2004, HYDR EC OPP COSTBA
   Ong S., 2013, NRELTP6A2056290
   Ordonez J, 2010, RENEW SUST ENERG REV, V14, P2122, DOI 10.1016/j.rser.2010.01.001
   Parsell T, 2015, GREEN CHEM, V17, P1492, DOI 10.1039/c4gc01911c
   Perkins C, 2009, AICHE J, V55, P286, DOI 10.1002/aic.11810
   Perlack RD, 2005, BIOMASS FEEDSTOCK BI
   Reddy VS, 2013, RENEW SUST ENERG REV, V27, P258, DOI 10.1016/j.rser.2013.06.037
   ROBERTS MJ, 2001, Patent No. 6308531
   Scheffe JR, 2014, MATER TODAY, V17, P341, DOI 10.1016/j.mattod.2014.04.025
   Sheehan J., 1998, LOOK BACK US DEP ENE
   Singh NR, 2010, ENVIRON SCI TECHNOL, V44, P5298, DOI 10.1021/es100316z
   Smil V., 2015, POWER DENSITY KEY UN
   Steinhagen C, 2009, J AM CHEM SOC, V131, P12554, DOI 10.1021/ja905922j
   Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001
   Tilman D, 2015, DAEDALUS-US, V144, P5, DOI 10.1162/DAED_e_00349
   Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108
   Venkatakrishnan VK, 2015, GREEN CHEM, V17, P178, DOI 10.1039/c4gc01746c
   Venkatakrishnan VK, 2014, GREEN CHEM, V16, P792, DOI 10.1039/c3gc41558a
   Weyer KM, 2010, BIOENERG RES, V3, P204, DOI 10.1007/s12155-009-9046-x
   Xu JG, 1996, CHEM ENG SCI, V51, P365, DOI 10.1016/0009-2509(95)00262-6
   Yang WC, 2014, CHEM MATER, V26, P6955, DOI 10.1021/cm502930d
   Yohe SL, 2016, J CATAL, V344, P535, DOI 10.1016/j.jcat.2016.10.009
NR 80
TC 2
Z9 2
U1 54
U2 54
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115215
DI 10.1016/j.ces.2019.115215
PG 13
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400003
DA 2020-05-12
ER

PT J
AU Basati, Y
   Mohammadipour, OR
   Niazmand, H
AF Basati, Yaser
   Mohammadipour, Omid Reza
   Niazmand, Hamid
TI Numerical and analytical analysis of a robust flow regulator in
   electroosmotic microfluidic networks
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Electroosmotic flow (EOF); Switching process; Flow regulator;
   Nernst-Planck equation; Lattice Boltzmann Method (LBM); Lab-on-a-chip
   (LOC)
ID LATTICE BOLTZMANN METHOD; NERNST-PLANCK MODEL; ELECTROKINETIC FLOW; FLAT
   MICROCHANNELS; SIMULATION; PRESSURE; ELECTROPHORESIS; OPTIMIZATION
AB This paper proposes a three-way electrokinetic flow regulator to control flow direction independent of the electrolyte solution and regulator material. In this two-dimensional regulator, the flow direction is simply controlled by varying the applied electrical voltage at microfluidic network ends. The performance of the regulator is discussed based on full detailed numerical simulations using the Nernst-Plank equation and a simplified semi-analytical approach. Numerical simulations revealed that the cut off voltage ratio required for switching flow direction is almost independent of the electrical double-layer (EDL) thickness and strongly depends on regulator geometry. A semi-analytical approach is introduced to determine the regulation voltage ratio and dimensionless flow rate during the regulation. It is showed that for thin EDLs, the presented approach can adequately predict the overall performance of the regulator with considerably lower computational efforts. Numerical and analytical approaches introduced in this paper, can be extended to more complex networks e.g. four-way networks. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Basati, Yaser] Ferdowsi Univ Mashhad, Dept Mech Engn, Azadi Sq, Mashhad, Razavi Khorasan, Iran.
   [Mohammadipour, Omid Reza] Payame Noor Univ, Dept Mech Engn, Tehran, Iran.
   [Niazmand, Hamid] Ferdowsi Univ Mashhad, Fac Engn, Dept Mech Engn, Mashhad, Razavi Khorasan, Iran.
RP Niazmand, H (reprint author), Ferdowsi Univ Mashhad, Dept Mech Engn, Azadi Sq, Mashhad, Razavi Khorasan, Iran.
EM niazmand@um.ac.ir
RI Niazmand, Hamid/AAA-6000-2020
OI Niazmand, Hamid/0000-0002-1638-4075; Mohammadipour, Omid
   Reza/0000-0002-7755-9094
FU Ferdowsi University of Mashhad [2/45869]
FX The authors would like to acknowledge the financial support provided by
   the Ferdowsi University of Mashhad under the grant No. 2/45869.
CR Ashraf MW, 2011, INT J MOL SCI, V12, P3648, DOI 10.3390/ijms12063648
   Au AK, 2011, MICROMACHINES-BASEL, V2, P179, DOI 10.3390/mi2020179
   Basati Y, 2019, INT J HEAT MASS TRAN, V133, P786, DOI 10.1016/j.ijheatmasstransfer.2018.12.159
   Berli CLA, 2008, MICROFLUID NANOFLUID, V4, P391, DOI 10.1007/s10404-007-0191-2
   Berli CLA, 2007, COLLOID SURFACE A, V301, P271, DOI 10.1016/j.colsurfa.2006.12.066
   Brask A, 2003, SENSOR ACTUAT B-CHEM, V92, P127, DOI 10.1016/S0925-4005(03)00130-8
   Capuani F, 2004, J CHEM PHYS, V121, P973, DOI 10.1063/1.1760739
   Chai ZH, 2008, APPL MATH MODEL, V32, P2050, DOI 10.1016/j.apm.2007.06.033
   Chai ZH, 2007, PHYS LETT A, V364, P183, DOI 10.1016/j.physleta.2006.12.006
   Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329
   Collino RR, 2013, LAB CHIP, V13, P3668, DOI 10.1039/c3lc50481f
   Damiri HS, 2015, LAB CHIP, V15, P4187, DOI 10.1039/c5lc00578g
   Dutta P, 2002, J MICROELECTROMECH S, V11, P36, DOI 10.1109/84.982861
   Erickson D, 2003, LAB CHIP, V3, P141, DOI 10.1039/b306158b
   Ginzburg I, 2005, ADV WATER RESOUR, V28, P1171, DOI 10.1016/j.advwatres.2005.03.004
   Guo Z., 2013, LATTICE BOLTZMANN ME
   Guo ZL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1874813
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   He XY, 1998, PHYS REV E, V57, pR13, DOI 10.1103/PhysRevE.57.R13
   He XY, 2000, COMPUT PHYS COMMUN, V129, P158, DOI 10.1016/S0010-4655(00)00103-X
   Heo YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23273
   Jacobson SC, 1999, ANAL CHEM, V71, P3273, DOI 10.1021/ac990059s
   Karlinsey JM, 2012, ANAL CHIM ACTA, V725, P1, DOI 10.1016/j.aca.2012.02.052
   Kruger T, 2017, SPRINGER INT PUBL, V10, P978
   Laser DJ, 2004, J MICROMECH MICROENG, V14, pR35, DOI 10.1088/0960-1317/14/6/R01
   Li BM, 2003, INT J HEAT MASS TRAN, V46, P4235, DOI 10.1016/S0017-9310(03)00218-7
   Medina I, 2018, CHEM ENG SCI, V184, P259, DOI 10.1016/j.ces.2018.03.051
   Mirbozorgi SA, 2007, J FLUID ENG-T ASME, V129, P1346, DOI 10.1115/1.2776967
   Mirbozorgi SA, 2006, J FLUID ENG-T ASME, V128, P1133, DOI 10.1115/1.2353261
   Mohammadipoor OR, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013309
   Mohammadipoor OR, 2014, ARAB J SCI ENG, V39, P1291, DOI 10.1007/s13369-013-0679-x
   Mohammadipour OR, 2015, INT J MOD PHYS C, V26, DOI 10.1142/S0129183115500783
   Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01
   Park HM, 2007, J COLLOID INTERF SCI, V315, P731, DOI 10.1016/j.jcis.2007.07.007
   Phillips RH, 2016, LAB CHIP, V16, P3260, DOI 10.1039/c6lc00738d
   Qiao R, 2002, J MICROMECH MICROENG, V12, P625, DOI 10.1088/0960-1317/12/5/318
   Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942
   Succi S., 2001, LATTICE BOLTZMANN EQ
   Wang CF, 2016, J MICROMECH MICROENG, V26, DOI 10.1088/0960-1317/26/7/075002
   Wang MR, 2010, J COMPUT PHYS, V229, P728, DOI 10.1016/j.jcp.2009.10.006
   Yang RJ, 2005, J MICROMECH MICROENG, V15, P2141, DOI 10.1088/0960-1317/15/11/021
   Yang XG, 2014, J SCI COMPUT, V61, P222, DOI 10.1007/s10915-014-9820-6
   Zou QS, 1997, PHYS FLUIDS, V9, P1591, DOI 10.1063/1.869307
NR 43
TC 0
Z9 0
U1 29
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115232
DI 10.1016/j.ces.2019.115232
PG 15
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400015
DA 2020-05-12
ER

PT J
AU Bian, W
   Chen, XZ
   Wang, JW
AF Bian, Wei
   Chen, Xizhong
   Wang, Junwu
TI A critical comparison of two-fluid model, discrete particle method and
   direct numerical simulation for modeling dense gas-solid flow of rough
   spheres
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Drag force; Direct numerical simulation; Discrete particle method;
   Two-fluid model; Fluidization; Multiphase flow
ID COMPUTATIONAL FLUID-DYNAMICS; THEORY-BASED PREDICTIONS; EMMS DRAG MODEL;
   KINETIC-THEORY; REYNOLDS-NUMBER; GRANULAR TEMPERATURE; HEAT-TRANSFER;
   EULERIAN SIMULATION; BIDISPERSE ARRAYS; PAST MONODISPERSE
AB Interphase drag coefficient is a critical input in two-fluid model (TFM) and discrete particle method (DPM). In this study, extensive TFM and DPM simulations were carried out to study of the hydrodynamics of gas-solid flows of monodisperse, rough particles in a dense fluidized bed using fourteen drag coefficient correlations available in literature, the simulation results were then compared to the direct numerical simulation (DNS) and experimental data of Tang et al. (2016). It was shown that (i) all TFM and DPM simulations result in a lower bed expansion rate than those of DNS and experiment, which indicates that the true interphase drag force is underestimated by all fourteen drag coefficient correlations; (ii) all DPM simulations can correctly capture, at least in a qualitative sense, the main hydrodynamic features obtained from DNS, but some TFM simulations with the exactly same drag coefficients show anomalous phenomena. This is not an indicator of the failure of the used drag coefficients but might be a sign of the deficiency of the used particle phase stress model in this specific situation; (iii) the time-averaged differential pressure drops of DPM and TFM simulations agree well with DNS results, but the characteristic frequency of pressure fluctuation found in DNS is overestimated by a factor of 2-3 by all DPM and TFM simulations; and (iv) the magnitude of local and global granular temperatures of TFM, DPM and DNS are all in a fair agreement, but the degree of the anisotropy of both local and global granular temperature found in DNS is systematically underestimated by DPM and TFM, especially, the local granular temperature in TFM simulations is inherently isotropic due to the fundamental assumption of the used kinetic theory. This study highlights the need of a better interphase drag coefficient and a better particle phase stress model for modeling dense gas-solid flow. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bian, Wei; Chen, Xizhong; Wang, Junwu] Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, POB 353, Beijing 100190, Peoples R China.
   [Bian, Wei; Wang, Junwu] Univ Chinese Acad Sci, Sch Chem Engn, Beijing 100049, Peoples R China.
RP Wang, JW (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, POB 353, Beijing 100190, Peoples R China.
EM jwwang@ipe.ac.cn
RI Wang, Junwu/P-5040-2019; Wang, Junwu/C-6591-2009
OI Wang, Junwu/0000-0003-3988-1477; Wang, Junwu/0000-0003-3988-1477
FU Innovation Academy for Green Manufacture, Chinese Academy of Sciences
   [IAGM-2019-A13]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [21978295, 91834303]; Key Research
   Program of Frontier Science, Chinese Academy of Sciences
   [QYZDJ-SSW-JSC029]; Transformational Technologies for Clean Energy and
   Demonstration, Strategic Priority Research Program of the Chinese
   Academy of Sciences [XDA21030700]; Fund of State Key Laboratory of
   Multiphase Complex Systems [MPCS-2019A-07, MPCS-2019-D-10]
FX We thank Professor Hans Kuipers for allowing the usage of his 3D-DPM
   code, on which the 3D-DMM code is based. This study is financially
   supported by Innovation Academy for Green Manufacture, Chinese Academy
   of Sciences (IAGM-2019-A13), National Natural Science Foundation of
   China (21978295, 91834303), Key Research Program of Frontier Science,
   Chinese Academy of Sciences (QYZDJ-SSW-JSC029), the Transformational
   Technologies for Clean Energy and Demonstration, Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDA21030700) and
   the Fund of State Key Laboratory of Multiphase Complex Systems
   (MPCS-2019A-07, MPCS-2019-D-10).
CR ANDERSON TB, 1967, IND ENG CHEM FUND, V6, P527, DOI 10.1021/i160024a007
   Beetstra R, 2007, AICHE J, V53, P489, DOI 10.1002/aic.11065
   Benyahia S, 2006, POWDER TECHNOL, V162, P166, DOI 10.1016/j.powtec.2005.12.014
   Bi HTT, 2007, CHEM ENG SCI, V62, P3473, DOI 10.1016/j.ces.2006.12.092
   Bogner S, 2015, INT J MULTIPHAS FLOW, V68, P71, DOI 10.1016/j.ijmultiphaseflow.2014.10.001
   Cello F, 2010, CHEM ENG SCI, V65, P3128, DOI 10.1016/j.ces.2010.02.006
   Chen XZ, 2018, CHEM ENG SCI, V192, P864, DOI 10.1016/j.ces.2018.08.019
   Chen XZ, 2017, AICHE J, V63, P3681, DOI 10.1002/aic.15723
   Chen XZ, 2016, POWDER TECHNOL, V304, P177, DOI 10.1016/j.powtec.2016.08.017
   Chen XZ, 2015, PROCEDIA ENGINEER, V102, P661, DOI 10.1016/j.proeng.2015.01.160
   Chen XZ, 2014, POWDER TECHNOL, V254, P94, DOI 10.1016/j.powtec.2013.12.056
   Chiesa M, 2005, COMPUT CHEM ENG, V29, P291, DOI 10.1016/j.compchemeng.2004.09.002
   Cloete S, 2013, POWDER TECHNOL, V239, P21, DOI 10.1016/j.powtec.2013.01.036
   Coroneo M, 2011, CHEM ENG SCI, V66, P2317, DOI 10.1016/j.ces.2011.02.019
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Dan S, 2009, CHEM ENG SCI, V64, P5013, DOI 10.1016/j.ces.2009.08.005
   Deen NG, 2007, CHEM ENG SCI, V62, P28, DOI 10.1016/j.ces.2006.08.014
   Deen NG, 2014, CURR OPIN CHEM ENG, V5, P84, DOI 10.1016/j.coche.2014.05.005
   Deen NG, 2014, CHEM ENG SCI, V116, P710, DOI 10.1016/j.ces.2014.05.039
   DIFELICE R, 1994, INT J MULTIPHAS FLOW, V20, P153, DOI 10.1016/0301-9322(94)90011-6
   Fevrier P, 2005, J FLUID MECH, V533, P1, DOI 10.1017/S0022112005004088
   Fullmer WD, 2018, CHEM ENG SCI, V186, P84, DOI 10.1016/j.ces.2018.04.035
   Fullmer WD, 2017, J FLUID MECH, V823, P433, DOI 10.1017/jfm.2017.295
   Fullmer WD, 2016, AICHE J, V62, P11, DOI 10.1002/aic.15052
   Garzo V, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4798824
   Ge W, 2019, CHEM ENG SCI, V198, P198, DOI 10.1016/j.ces.2018.12.037
   Ge W, 2017, REV CHEM ENG, V33, P551, DOI 10.1515/revce-2015-0079
   GIBILARO LG, 1985, CHEM ENG SCI, V40, P1817, DOI 10.1016/0009-2509(85)80116-0
   Gidaspow D, 2004, POWDER TECHNOL, V148, P123, DOI 10.1016/j.powtec.2004.09.025
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   Goldschmidt MJV, 2004, POWDER TECHNOL, V142, P23, DOI 10.1016/j.powtec.2004.02.020
   Goldschmidt MJV, 2002, CHEM ENG SCI, V57, P2059, DOI 10.1016/S0009-2509(02)00082-9
   Gu YL, 2019, J FLUID MECH, V860, P318, DOI 10.1017/jfm.2018.856
   Hill RJ, 2001, J FLUID MECH, V448, P213, DOI 10.1017/S0022112001005948
   Hoomans BPB, 1996, CHEM ENG SCI, V51, P99, DOI 10.1016/0009-2509(95)00271-5
   Huang ZQ, 2017, POWDER TECHNOL, V321, P435, DOI 10.1016/j.powtec.2017.08.035
   Ibsen CH, 2004, POWDER TECHNOL, V149, P29, DOI 10.1016/j.powtec.2004.09.042
   Jackson R., 2000, DYNAMICS FLUIDIZED P
   Jenkins JT, 2002, PHYS FLUIDS, V14, P1228, DOI 10.1063/1.1449466
   JENKINS JT, 1985, ARCH RATION MECH AN, V87, P355
   JOHNSON PC, 1987, J FLUID MECH, V176, P67, DOI 10.1017/S0022112087000570
   Jung J, 2005, IND ENG CHEM RES, V44, P1329, DOI 10.1021/ie0496838
   Kravets B, 2019, POWDER TECHNOL, V345, P438, DOI 10.1016/j.powtec.2019.01.028
   Kriebitzsch SHL, 2013, AICHE J, V59, P316, DOI 10.1002/aic.13804
   Kriebitzsch SHL, 2013, CHEM ENG SCI, V91, P1, DOI 10.1016/j.ces.2012.12.038
   Kunii D., 1969, FLUIDIZATION ENG
   Li J., 2013, MULTISCALE MODELING
   Li JH, 2016, ENGINEERING, V2, P276, DOI 10.1016/J.ENG.2016.03.001
   Li TW, 2012, AICHE J, V58, P2058, DOI 10.1002/aic.12728
   Li TW, 2010, POWDER TECHNOL, V203, P447, DOI 10.1016/j.powtec.2010.06.005
   Liu X, 2018, POWDER TECHNOL, V338, P79, DOI 10.1016/j.powtec.2018.06.039
   Lu HL, 2007, CHEM ENG SCI, V62, P301, DOI 10.1016/j.ces.2006.08.031
   Lu LQ, 2019, POWDER TECHNOL, V349, P109, DOI 10.1016/j.powtec.2018.10.055
   Lu LQ, 2017, POWDER TECHNOL, V321, P301, DOI 10.1016/j.powtec.2017.08.034
   Luo K, 2016, AICHE J, V62, P1917, DOI 10.1002/aic.15186
   Ma JS, 2006, CHEM ENG SCI, V61, P7096, DOI 10.1016/j.ces.2006.07.042
   Nelson MJ, 2017, ENGINEERING, V3, P330, DOI 10.1016/J.ENG.2017.03.021
   OGAWA S, 1980, Z ANGEW MATH PHYS, V31, P483, DOI 10.1007/BF01590859
   Olaofe OO, 2011, CHEM ENG SCI, V66, P2764, DOI 10.1016/j.ces.2011.03.030
   Qin ZY, 2019, CHEM ENG SCI, V207, P358, DOI 10.1016/j.ces.2019.06.037
   Radl S, 2014, CHEM ENG SCI, V117, P416, DOI 10.1016/j.ces.2014.07.011
   Rong LW, 2013, CHEM ENG SCI, V99, P44, DOI 10.1016/j.ces.2013.05.036
   Sande PC, 2016, IND ENG CHEM RES, V55, P2623, DOI 10.1021/acs.iecr.5b03565
   Santos A, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3558876
   Sheikh B, 2018, COMPUT FLUIDS, V171, P15, DOI 10.1016/j.compfluid.2018.05.029
   Shu Z, 2014, IND ENG CHEM RES, V53, P3378, DOI 10.1021/ie403496a
   Srivastava A, 2003, POWDER TECHNOL, V129, P72, DOI 10.1016/S0032-5910(02)00132-8
   Srivastava A, 2002, POWDER TECHNOL, V124, P45, DOI 10.1016/S0032-5910(01)00471-5
   Sundaresan S, 2018, ANNU REV CHEM BIOMOL, V9, P61, DOI 10.1146/annurev-chembioeng-060817-084025
   Syamlal M., 1987, DERIVATION DRAG COEF
   Tang Y, 2016, CHEM ENG SCI, V143, P166, DOI 10.1016/j.ces.2015.12.026
   Tang Y, 2015, AICHE J, V61, P688, DOI 10.1002/aic.14645
   Tang YL, 2016, AICHE J, V62, P1958, DOI 10.1002/aic.15197
   Tenneti S, 2011, INT J MULTIPHAS FLOW, V37, P1072, DOI 10.1016/j.ijmultiphaseflow.2011.05.010
   Tenneti S, 2014, ANNU REV FLUID MECH, V46, P199, DOI 10.1146/annurev-fluid-010313-141344
   Third JR, 2016, COMPUT PART MECH, V3, P373, DOI 10.1007/s40571-015-0086-z
   TSINONTIDES SC, 1993, J FLUID MECH, V255, P237, DOI 10.1017/S0022112093002472
   Tsuji Y, 1998, POWDER TECHNOL, V95, P254, DOI 10.1016/S0032-5910(97)03349-4
   TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7
   van der Hoef MA, 2008, ANNU REV FLUID MECH, V40, P47, DOI 10.1146/annurev.fluid.40.111406.102130
   van der Hoef M.A., 2006, ADV CHEM ENG, P65, DOI DOI 10.1016/S0065-2377(06)31002-2
   Van der Hoef MA, 2005, J FLUID MECH, V528, P233, DOI 10.1017/S0022112004003295
   Wang J, 2019, J FLUID MECH, V866, P776, DOI 10.1017/jfm.2019.156
   Wang JW, 2008, CHEM ENG SCI, V63, P1553, DOI 10.1016/j.ces.2007.11.023
   Wang JW, 2017, CHEM ENG SCI, V168, P11, DOI 10.1016/j.ces.2017.04.031
   Wang JW, 2013, CHEM ENG SCI, V97, P264, DOI 10.1016/j.ces.2013.04.028
   Wang JW, 2013, CHEM-ING-TECH, V85, P290, DOI 10.1002/cite.201200101
   Wang JW, 2010, CHEM ENG SCI, V65, P3772, DOI 10.1016/j.ces.2010.03.023
   Wang JW, 2010, CHEM ENG SCI, V65, P2125, DOI 10.1016/j.ces.2009.12.004
   Wang JW, 2009, IND ENG CHEM RES, V48, P5567, DOI 10.1021/ie900247t
   Wang JW, 2009, CHEM ENG SCI, V64, P622, DOI 10.1016/j.ces.2008.09.028
   Wen C.Y., 1966, CHEM ENG PROGR S SER, V62, P100, DOI DOI 10.1016/S0032-0633(98)00014-2
   Werther J., 1973, INT J MULTIPHASE FLO, V1, P103
   Werther J., 1974, AICHE S SER, V70, P53
   Werther J, 1973, INT J MULTIPHASE FLO, V1, P123
   Wylie JJ, 2003, J FLUID MECH, V480, P95, DOI 10.1017/S0022112002003531
   Xiong QG, 2012, CHEM ENG SCI, V71, P422, DOI 10.1016/j.ces.2011.10.059
   Xu J, 2015, CHEM ENG SCI, V121, P200, DOI 10.1016/j.ces.2014.09.051
   Ye M, 2005, CHEM ENG RES DES, V83, P833, DOI 10.1205/cherd.04341
   Zaidi AA, 2018, CHEM ENG RES DES, V132, P714, DOI 10.1016/j.cherd.2018.02.013
   Zaidi AA, 2014, ADV POWDER TECHNOL, V25, P1860, DOI 10.1016/j.apt.2014.07.019
   Zhang YH, 2003, CHEM ENG SCI, V58, P1641, DOI 10.1016/S0009-2509(02)00659-0
   Zhao YH, 2016, IND ENG CHEM RES, V55, P1439, DOI 10.1021/acs.iecr.5b03792
   Zhou Q, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4927552
   Zhou Q, 2015, CHEM ENG SCI, V122, P637, DOI 10.1016/j.ces.2014.10.025
   Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006
   Zhu LT, 2018, CHEM ENG SCI, V192, P759, DOI 10.1016/j.ces.2018.08.026
   Zhu LT, 2016, IND ENG CHEM RES, V55, P11887, DOI 10.1021/acs.iecr.6b02819
NR 108
TC 1
Z9 1
U1 39
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115233
DI 10.1016/j.ces.2019.115233
PG 17
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400002
DA 2020-05-12
ER

PT J
AU Cao, JY
   Pan, J
   Cui, ZL
   Wang, ZH
   Wang, XZ
   Drioli, E
AF Cao, Jingyi
   Pan, Jun
   Cui, Zhaoliang
   Wang, Zhaohui
   Wang, Xiaozu
   Drioli, Enrico
TI Improving efficiency of PVDF membranes for recovering water from
   humidified gas streams through membrane condenser
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Membrane condenser; Composite membrane; Gas dehydration; Hydrophobicity
ID FLUE-GAS; OSMOSIS MEMBRANES; GASEOUS STREAMS; HEAT-RECOVERY; TRANSPORT;
   DEHYDRATION; COMPOSITE; ENERGY; REUSE
AB Membrane condenser (MC) is a novel and promising operation to recover evaporated water from highly humid gas discharged from industrial production. By means of hydrophobic membrane surface, water vapor condensed on membrane retention side, finally be collected. The aim of this paper is to enhance the recovery efficiency of poly(vinylidene fluoride) (PVDF) membrane in MC process. Significantly, coating three kinds of Hyflon ADs onto PVDF membranes effectively improved hydrophobicity of original ones. Among them, Hyflon AD40L/PVDF membrane showed the best membrane and MC performance, the LEPw and water contact angle of which reached 0.43 MPa and 126 degrees, respectively. In terms of dehydration performance in MC, by coated with Hyflon AD40L, water recovery was increased from 7.92% to 18.85%, and condensate water flow (0.35 kg.m(-2).h(-1)) was twice that of pristine ones (0.15 kg.m(-2).h(-1)). These results indicate that Hyflon AD composite membrane is a promising candidate for MC process with high efficiency. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cao, Jingyi; Pan, Jun; Cui, Zhaoliang; Wang, Zhaohui; Wang, Xiaozu] Nanjing Tech Univ, Coll Chem Engn, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Cao, Jingyi; Pan, Jun; Cui, Zhaoliang; Wang, Zhaohui] Nanjing Tech Univ, Natl Engn Res Ctr Special Separat Membrane, Nanjing 210009, Jiangsu, Peoples R China.
   [Cui, Zhaoliang] Nanjing Tech Univ, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 210009, Jiangsu, Peoples R China.
   [Drioli, Enrico] ITM CNR, Res Inst Membrane Technol, Via PietroBucci 17-C, I-87036 Arcavacata Di Rende, Italy.
RP Cui, ZL (reprint author), Nanjing Tech Univ, Coll Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.
EM zcui@njtech.edu.cn
OI Drioli, Enrico/0000-0003-1092-5368
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21606125]; Natural Science Foundation of Jiangsu
   ProvinceJiangsu Planned Projects for Postdoctoral Research FundsNatural
   Science Foundation of Jiangsu Province [BK20160984]; National Key R&D
   Program of China [2017YFC0403702]; Materials-Oriented Chemical
   Engineering State Key Laboratory Program [KL16-09]; Priority Academic
   Program Development of Jiangsu Higher Education Institution (PAPD)
FX The authors would like to express their appreciation for the National
   Natural Science Foundation of China (Grant No. 21606125), the Natural
   Science Foundation of Jiangsu Province (Grant No. BK20160984), the
   financial support of the National Key R&D Program of China
   (2017YFC0403702), Materials-Oriented Chemical Engineering State Key
   Laboratory Program (KL16-09), and the Priority Academic Program
   Development of Jiangsu Higher Education Institution (PAPD).
CR Ang WL, 2015, DESALINATION, V363, P2, DOI 10.1016/j.desal.2014.03.008
   Bassila J., 2017, INT C TECHN MAT REN
   Brunetti A, 2014, CLEAN-SOIL AIR WATER, V42, P1145, DOI 10.1002/clen.201300104
   Cui ZL, 2018, DESALINATION, V440, P68, DOI 10.1016/j.desal.2017.12.038
   Drioli E, 2014, REACT FUNCT POLYM, V79, P1, DOI 10.1016/j.reactfunctpolym.2014.03.003
   Du JR, 2010, CHEM ENG SCI, V65, P4672, DOI 10.1016/j.ces.2010.05.005
   Figoli A, 2017, J MEMBRANE SCI, V522, P192, DOI 10.1016/j.memsci.2016.08.066
   Folkedahl B.C., 2006, WATER EXTRACTION COA
   Fujioka T, 2014, DESALINATION, V350, P28, DOI 10.1016/j.desal.2014.07.002
   Giljean S, 2011, APPL SURF SCI, V257, P9631, DOI 10.1016/j.apsusc.2011.06.088
   Hu H.W., 2016, SCI REPORTS, V6
   Huang Y, 2014, J MEMBRANE SCI, V463, P33, DOI 10.1016/j.memsci.2014.03.016
   Jeong K, 2010, INT J HEAT MASS TRAN, V53, P2361, DOI 10.1016/j.ijheatmasstransfer.2010.02.004
   Judd S., 2003, CONTRIBUTORS, pxiii
   Kijlstra J, 2002, COLLOID SURFACE A, V206, P521, DOI 10.1016/S0927-7757(02)00089-4
   Kim JF, 2018, ACS SUSTAIN CHEM ENG, V6, P6425, DOI 10.1021/acssuschemeng.8b00204
   Lin CX, 2013, INT J HEAT MASS TRAN, V60, P41, DOI 10.1016/j.ijheatmasstransfer.2012.12.053
   Macedonio F, 2017, SEP PURIF TECHNOL, V181, P60, DOI 10.1016/j.seppur.2017.03.009
   Macedonio F, 2014, CHEM ENG PROCESS, V86, P196, DOI 10.1016/j.cep.2014.08.008
   Macedonio F, 2013, IND ENG CHEM RES, V52, P1160, DOI 10.1021/ie203031b
   Metz SJ, 2005, J MEMBRANE SCI, V251, P29, DOI 10.1016/j.memsci.2004.08.036
   Miller GW, 2006, DESALINATION, V187, P65, DOI 10.1016/j.desal.2005.04.068
   Sijbesma H, 2008, J MEMBRANE SCI, V313, P263, DOI 10.1016/j.memsci.2008.01.024
   Tong DQ, 2016, SEP PURIF TECHNOL, V157, P1, DOI 10.1016/j.seppur.2015.11.026
   Wang DX, 2012, APPL ENERG, V91, P341, DOI 10.1016/j.apenergy.2011.10.003
   Wang TT, 2015, J MEMBRANE SCI, V484, P10, DOI 10.1016/j.memsci.2015.03.007
   Xiao TT, 2018, CHEM ENG SCI, V190, P140, DOI 10.1016/j.ces.2018.06.028
   Xie WN, 2016, CHEM ENG SCI, V152, P323, DOI 10.1016/j.ces.2016.06.018
   Xiong YY, 2017, J CLEAN PROD, V161, P1416, DOI 10.1016/j.jclepro.2017.06.081
   Zhang YX, 2017, DESALINATION, V415, P58, DOI 10.1016/j.desal.2017.04.011
   Zhao SF, 2017, APPL THERM ENG, V113, P843, DOI 10.1016/j.applthermaleng.2016.11.101
NR 31
TC 1
Z9 1
U1 53
U2 53
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115234
DI 10.1016/j.ces.2019.115234
PG 10
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400009
DA 2020-05-12
ER

PT J
AU Fabian-Anguiano, JA
   Mendoza-Serrato, CG
   Gomez-Yanez, C
   Zeifert, B
   Ma, XL
   Ortiz-Landeros, J
AF Fabian-Anguiano, J. A.
   Mendoza-Serrato, C. G.
   Gomez-Yanez, C.
   Zeifert, B.
   Ma, Xiaoli
   Ortiz-Landeros, J.
TI Simultaneous CO2 and O-2 separation coupled to oxy-dry reforming of CH4
   by means of a ceramic-carbonate membrane reactor for in situ syngas
   production
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Inorganic membrane; Gas permeation; Ceramic-carbonate membrane; Oxy-CO2
   reforming of methane; Syngas production
ID DUAL-PHASE MEMBRANE; DIOXIDE PERMEATION; CAPTURE; GAS; METHANE;
   STABILITY; OXIDATION; DESIGN; FLUX
AB It is reported the use of a ceramic-carbonate membrane exhibiting CO2 and O-2 permeation, coupled with the oxy-carbon dioxide reforming of methane to produce syngas in a membrane reactor arrangement. The studied membrane is made of a porous fluorite/perovskite mixed conducting ceramic infiltrated with molten carbonates. The CO2 and O-2 gas mixture used to perform the oxy-dry reforming process is the membrane's permeate, which reacts with CH4 supplied in the sweep gas with the assistance of a catalyst. The reactor converts from 74 to 99% of CH4 under the studied separation and reaction conditions. The total rate of syngas production reaches 6.25 mL.min(-1).cm(-2) at 875 degrees C and a H-2/CO ratio ranging from 2.1 to 1.3 between 800 and 875 degrees C. A long-term test shows a stable performance for 300 h. This work suggests the feasibility of this capture-conversion concept for the valorization of CO2 by the efficient production of syngas. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fabian-Anguiano, J. A.; Mendoza-Serrato, C. G.; Gomez-Yanez, C.; Zeifert, B.; Ortiz-Landeros, J.] Inst Politecn Nacl, Escuela Super Ingn Quim & Ind Extract, Dept Ingn Met & Mat, UPALM Zacatenco, IPN Ave, Mexico City 07738, DF, Mexico.
   [Ma, Xiaoli] Univ Wisconsin, Dept Mat Sci & Engn, Milwaukee, WI 53211 USA.
RP Ortiz-Landeros, J (reprint author), Inst Politecn Nacl, Escuela Super Ingn Quim & Ind Extract, Dept Ingn Met & Mat, UPALM Zacatenco, IPN Ave, Mexico City 07738, DF, Mexico.
EM jortizla@ipn.mx
FU Proyectos de Investigacion Cientifica y Desarrollo Tecnologico SIP-IPN
   [20190014]
FX This work was supported by Proyectos de Investigacion Cientifica y
   Desarrollo Tecnologico SIP-IPN No. 20190014. J.A. Fabian thanks to
   Proyectos de Desarrollo Tecnologico o Innovacion para Alumnos 2019,
   SIP-IPN. Finally, the authors wish to express their appreciation for the
   SIBE-IPN, EDI-IPN, BEIFI-IPN and PNPC-CONACYT programs.
CR Al-Fatesh A, 2018, INT J HYDROGEN ENERG, V43, P12069, DOI 10.1016/j.ijhydene.2018.04.152
   Anderson M, 2010, J MEMBRANE SCI, V357, P122, DOI 10.1016/j.memsci.2010.04.009
   Bale C, 2002, CALPHAD, V26, P189, DOI 10.1016/S0364-5916(02)00035-4
   Chen TJ, 2019, J MEMBRANE SCI, V581, P72, DOI 10.1016/j.memsci.2019.03.021
   Chen TJ, 2017, J MEMBRANE SCI, V540, P477, DOI 10.1016/j.memsci.2017.06.063
   Chung SJ, 2005, IND ENG CHEM RES, V44, P7999, DOI 10.1021/ie0503141
   Chung W, 2018, INT J GREENH GAS CON, V74, P259, DOI 10.1016/j.ijggc.2018.05.009
   Dong XL, 2016, J MEMBRANE SCI, V520, P907, DOI 10.1016/j.memsci.2016.08.036
   Espinal L, 2013, ENVIRON SCI TECHNOL, V47, P11960, DOI 10.1021/es402622q
   Ghoneim S.A., 2016, WORLD J ENG TECHNOL, V4, P116, DOI DOI 10.4236/WJET.2016.41011
   Giordano L, 2019, J MEMBRANE SCI, V575, P229, DOI 10.1016/j.memsci.2018.12.063
   Giordano L, 2018, INT J GREENH GAS CON, V68, P146, DOI 10.1016/j.ijggc.2017.11.008
   Gude U, 2019, SEP PURIF TECHNOL, V215, P378, DOI 10.1016/j.seppur.2019.01.020
   Koytsoumpa EI, 2018, J SUPERCRIT FLUID, V132, P3, DOI 10.1016/j.supflu.2017.07.029
   Lan R, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00035
   Li YD, 2009, CATAL TODAY, V148, P303, DOI 10.1016/j.cattod.2009.08.009
   Lu B, 2013, J MEMBRANE SCI, V444, P402, DOI 10.1016/j.memsci.2013.05.046
   Mutch G.A., 2019, J MAT CHEM A
   Norton TT, 2014, J MEMBRANE SCI, V467, P244, DOI 10.1016/j.memsci.2014.05.026
   Norton TT, 2014, IND ENG CHEM RES, V53, P2432, DOI 10.1021/ie4033523
   Ortiz-Landeros J, 2013, CHEM ENG SCI, V104, P891, DOI 10.1016/j.ces.2013.09.027
   Ovalle-Encinia O, 2018, J MEMBRANE SCI, V547, P11, DOI 10.1016/j.memsci.2017.10.021
   Ovalle-Encinia O, 2019, ACS APPL ENERG MATER, V2, P1380, DOI 10.1021/acsaem.8b01947
   Ovalle-Encinia O, 2018, IND ENG CHEM RES, V57, P9261, DOI 10.1021/acs.iecr.8b01570
   Pan SY, 2018, CRIT REV ENV SCI TEC, V48, P471, DOI 10.1080/10643389.2018.1469943
   Shen J, 2019, INT J HYDROGEN ENERG, V44, P4616, DOI 10.1016/j.ijhydene.2019.01.027
   Sherman SR, 2012, J MEMBRANE SCI, V401, P323, DOI 10.1016/j.memsci.2012.02.024
   Wu TH, 2007, J NAT GAS CHEM, V16, P316, DOI 10.1016/S1003-9953(07)60065-6
   Xu NS, 2012, J MEMBRANE SCI, V401, P190, DOI 10.1016/j.memsci.2012.02.001
   Zhang LL, 2014, J MEMBRANE SCI, V455, P162, DOI 10.1016/j.memsci.2013.12.077
   Zhang LL, 2014, J MEMBRANE SCI, V453, P36, DOI 10.1016/j.memsci.2013.10.067
   Zhang P, 2019, ACS SUSTAIN CHEM ENG, V7, P6889, DOI 10.1021/acssuschemeng.8b06430
   Zhang P, 2018, ACS SUSTAIN CHEM ENG, V6, P14162, DOI 10.1021/acssuschemeng.8b02776
   Zhang P, 2016, ACS SUSTAIN CHEM ENG, V4, P7056, DOI 10.1021/acssuschemeng.6b01960
NR 34
TC 0
Z9 0
U1 73
U2 73
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115250
DI 10.1016/j.ces.2019.115250
PG 8
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400020
DA 2020-05-12
ER

PT J
AU Felischak, M
   Wolff, T
   Perea, LA
   Seidel-Morgenstern, A
   Hamel, C
AF Felischak, Matthias
   Wolff, Tanya
   Alvarado Perea, Leo
   Seidel-Morgenstern, Andreas
   Hamel, Christof
TI Influence of process parameters on single bed Ni/(Al)MCM-41 for the
   production of propene from ethene feedstock
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Catalytic cycle; Ethene; Propene; Nickel catalysts; AlMCM-41; Reaction
   kinetics
ID CATALYTIC CRACKING; ETHYLENE DIMERIZATION; HETEROGENEOUS
   OLIGOMERIZATION; DIRECT CONVERSION; METATHESIS; OLEFINS; PROPYLENE;
   ZEOLITES; ALKENES; ISOMERIZATION
AB A Ni aluminized mesoporous MCM-41 catalyst was prepared and applied for the direct conversion of ethene to propene. Suitable ethene conversion and good selectivity for the desired molecule propene were achieved. The catalyst placed in a packed tubular reactor was stable for more than 2000 h with time on stream. A reaction network analysis was performed evaluating the product spectrum observed covering a large range of operating conditions. Thereby, temperature and feed concentration can be considered as significant influence parameters on the product distribution. Based on the product spectra, a modified reaction network including a catalytic cycle is suggested, which adds cracking of long-chain olefins to the conventionally considered dimerization/oligomerization and isomerization steps. Following previous publications, the catalyst presented strong deactivation behavior. It was observed that the regeneration conditions (oxygen concentration and regeneration time) are crucial parameters concerning long-time stability. Finally, a cycling reactor operation of deactivation-regeneration steps is suggested. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Felischak, Matthias; Seidel-Morgenstern, Andreas; Hamel, Christof] Otto Von Guericke Univ, Inst Proc Engn, D-39106 Magdeburg, Germany.
   [Wolff, Tanya; Seidel-Morgenstern, Andreas] Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany.
   [Alvarado Perea, Leo] Univ Autonoma Zacatecas, Zacatecas 98000, Mexico.
   [Hamel, Christof] Anhalt Univ Appl Sci, D-06366 Kothen, Germany.
   [Felischak, Matthias] Otto von Guericke Univ, Univ Pl 2,Postfach 4120, D-39106 Magdeburg, Germany.
RP Felischak, M (reprint author), Otto Von Guericke Univ, Inst Proc Engn, D-39106 Magdeburg, Germany.; Felischak, M (reprint author), Otto von Guericke Univ, Univ Pl 2,Postfach 4120, D-39106 Magdeburg, Germany.
EM matthias.felischak@ovgu.de
FU DAAD (Germany)Deutscher Akademischer Austausch Dienst (DAAD); CONACYT
   (Mexico)Consejo Nacional de Ciencia y Tecnologia (CONACyT)
FX We would like to acknowledge and thank the DAAD (Germany) and CONACYT
   (Mexico) for their funding of the international exchange of knowledge.
   Further, we would especially like to thank Jutta Wilke for supporting
   the experimental realization and the colleagues at the OvGU for helpful
   discussions.
CR Perea LA, 2017, APPL CATAL A-GEN, V533, P121, DOI 10.1016/j.apcata.2016.12.022
   Alvarado Perea L, 2014, DIRECT CONVERSION ET
   Amakawa K, 2012, J AM CHEM SOC, V134, P11462, DOI 10.1021/ja3011989
   Amin N.A.S., 2003, J NAT GAS CHEM, V12, P123
   Andrei RD, 2016, NEW J CHEM, V40, P4146, DOI 10.1039/c5nj02586a
   Andrei RD, 2015, J CATAL, V323, P76, DOI 10.1016/j.jcat.2014.12.027
   Argyle MD, 2015, CATALYSTS, V5, P145, DOI 10.3390/catal5010145
   BAIRD MJ, 1972, J CATAL, V26, P440, DOI 10.1016/0021-9517(72)90105-4
   BONNEVIOT L, 1983, J MOL CATAL, V21, P415, DOI 10.1016/0304-5102(93)80138-K
   Bortnovsky O, 2005, APPL CATAL A-GEN, V287, P203, DOI 10.1016/j.apcata.2005.03.037
   Broene RD, 2005, J AM CHEM SOC, V127, P17194, DOI 10.1021/ja056655n
   Buchanan JS, 1996, J CATAL, V158, P279, DOI 10.1006/jcat.1996.0027
   Cavani F, 2007, CATAL TODAY, V127, P113, DOI 10.1016/j.cattod.2007.05.009
   Chen CJ, 2014, ACS CATAL, V4, P2319, DOI 10.1021/cs500119n
   Corma A, 2000, MICROPOR MESOPOR MAT, V35-6, P21, DOI 10.1016/S1387-1811(99)00205-X
   Corma A, 2005, APPL CATAL A-GEN, V287, P34, DOI 10.1016/j.apcata.2005.03.032
   Dai WL, 2014, J CATAL, V314, P10, DOI 10.1016/j.jcat.2014.03.006
   DEJAIFVE P, 1980, J CATAL, V63, P331, DOI 10.1016/0021-9517(80)90086-X
   Ding X, 2009, J NAT GAS CHEM, V18, P156, DOI 10.1016/S1003-9953(08)60100-0
   Frey AS, 2012, MICROPOR MESOPOR MAT, V164, P164, DOI 10.1016/j.micromeso.2012.07.015
   Hartmann M, 1996, J PHYS CHEM-US, V100, P9906, DOI 10.1021/jp9602181
   Henkel A.S, 2013, THESIS
   Huang SJ, 2005, J MOL CATAL A-CHEM, V226, P61, DOI 10.1016/j.molcata.2004.09.026
   Iwamoto M, 2008, CATAL SURV ASIA, V12, P28, DOI 10.1007/s10563-007-9036-y
   Iwamoto M, 2011, MOLECULES, V16, P7844, DOI 10.3390/molecules16097844
   Kiedorf G, 2014, CHEM ENG SCI, V115, P31, DOI 10.1016/j.ces.2013.06.027
   Kogan S.B., 2001, CATAL COMMUN, V2, P179, DOI DOI 10.1016/S1566-7367(01)00029-2
   Lavrenov AV, 2016, CATAL IND, V8, P316, DOI 10.1134/S2070050416040061
   Lavrenov AV, 2015, CATAL IND, V7, P175, DOI 10.1134/S2070050415030083
   Lehmann T, 2012, MICROPOR MESOPOR MAT, V151, P113, DOI 10.1016/j.micromeso.2011.11.006
   Lehmann T, 2011, CATAL COMMUN, V12, P368, DOI 10.1016/j.catcom.2010.10.018
   Li L, 2013, TOP CATAL, V56, P783, DOI 10.1007/s11244-013-0036-z
   Lin BM, 2009, IND ENG CHEM RES, V48, P10788, DOI 10.1021/ie901227p
   Liu SL, 2004, CATAL TODAY, V93-5, P471, DOI 10.1016/j.cattod.2004.06.062
   Lu JY, 2006, CATAL LETT, V109, P65, DOI 10.1007/s10562-006-0058-2
   Mol JC, 2004, J MOL CATAL A-CHEM, V213, P39, DOI 10.1016/j.molcata.2003.10.049
   Norena-Franco L, 2002, CATAL TODAY, V75, P189, DOI 10.1016/S0920-5861(02)00067-6
   Oikawa H, 2006, APPL CATAL A-GEN, V312, P181, DOI 10.1016/j.apcata.2006.06.045
   Perea LA, 2013, J CATAL, V305, P154, DOI 10.1016/j.jcat.2013.05.007
   Rabeah J, 2016, ACS CATAL, V6, P8224, DOI 10.1021/acscatal.6b02331
   Sohn JR, 2006, J MOL CATAL A-CHEM, V256, P156, DOI 10.1016/j.molcata.2006.04.069
   Sohn JR, 2000, KOREAN J CHEM ENG, V17, P727, DOI 10.1007/BF02699125
   Taoufik M, 2007, ANGEW CHEM INT EDIT, V46, P7202, DOI 10.1002/anie.200701199
   Wang B, 2004, APPL CATAL A-GEN, V274, P167, DOI 10.1016/j.apcata.2004.06.037
   Wittcoff H. A., 2013, IND ORGANIC CHEM
   Zhu XX, 2009, CATAL SURV ASIA, V13, P1, DOI 10.1007/s10563-008-9055-3
   Zhu XX, 2005, CATAL LETT, V103, P201, DOI 10.1007/s10562-005-7155-5
   Zhu XX, 2005, APPL CATAL A-GEN, V290, P191, DOI 10.1016/j.apcata.2005.05.028
   Zhu XX, 2005, APPL CATAL A-GEN, V288, P134, DOI 10.1016/j.apcata.2005.04.050
NR 49
TC 1
Z9 1
U1 30
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115246
DI 10.1016/j.ces.2019.115246
PG 9
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400010
DA 2020-05-12
ER

PT J
AU Glas, J
   Drandev, S
   Pupkevich, V
   Karamanev, D
AF Glas, Jason
   Drandev, Stanimir
   Pupkevich, Victor
   Karamanev, Dimitre
TI Energy balance of an airlift bioreactor used for electrical power
   generation in energy storage
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE BioGenerator; Airlift bioreactor; Energy storage; Oxygen mass transfer;
   Energy balance; Hydrogen-to-electricity conversion
ID BIOELECTROCHEMICAL TECHNOLOGY; MASS-TRANSFER; STIRRED-TANK; HYDROGEN
AB A study of energy losses in the bioreactor component of the BioGenerator as a fraction of the electricity produced is reported in this work. An essential factor in the economic feasibility of the system is the assessment of energy consumption necessary to maintain biological processes, with the oxygen mass transfer rate determined to be the limiting factor of maximum steady state substrate conversion. Using an air-water system, it was shown that the internal energy consumption of the BioGenerator depends mostly on the superficial gas velocity in the bioreactor and its values are within 32-51% of the electrical power generation. Moreover, there was a good fit between the proposed mathematical description of energy efficiency and the experimental results. The results obtained with water as a liquid phase were compared with those of real BioGenerator liquid in two scales of rectangular airlift bioreactors having volumes of 2.2 L and 600 L, respectively. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Glas, Jason; Drandev, Stanimir; Pupkevich, Victor; Karamanev, Dimitre] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Karamanev, D (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
EM dkaramanev@eng.uwo.ca
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [R2815A19]; Ontario
   Centers of Excellence [R2815A17]; University of Western Ontario
   [R2815000]; BioGenerator Energy Solutions Inc. [R2815A18]
FX This work was supported financially by Natural Sciences and Engineering
   Research Council of Canada [grant number R2815A19], Ontario Centers of
   Excellence [grant number R2815A17], University of Western Ontario [grant
   number R2815000] and BioGenerator Energy Solutions Inc. [grant number
   R2815A18].
CR Abou Jarboua T, 2019, J ENERGY STORAGE, V21, P328, DOI 10.1016/j.est.2018.12.004
   Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781
   BAILEY J, 1986, BIOCH ENG FUNDAMENTA
   Barnes FS, 2011, MECH ENG SER TXB REF, P1
   Benyahia F, 1997, J CHEM TECHNOL BIOT, V69, P301, DOI 10.1002/(SICI)1097-4660(199707)69:3<301::AID-JCTB716>3.0.CO;2-Z
   CHANG CM, 1994, PROCESS BIOCHEM, V29, P133, DOI 10.1016/0032-9592(94)80006-5
   Comello S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09988-z
   Drandev S, 2016, CHEM ENG SCI, V146, P180, DOI 10.1016/j.ces.2016.02.041
   Erickson L.E., 1990, CAN J CHEM ENG, V68, P349, DOI DOI 10.1002/CJCE.5450680228
   Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006
   Geankoplis C.J., 2018, TRANSPORT PROCESSES
   Gur TM, 2018, ENERG ENVIRON SCI, V11, P2696, DOI 10.1039/c8ee01419a
   JOSHI JB, 1990, CAN J CHEM ENG, V68, P705, DOI 10.1002/cjce.5450680501
   Karamanev D., 2003, Biofuel cell, Patent No. [CA 2530914, 2530914]
   Marchenko OV, 2015, INT J HYDROGEN ENERG, V40, P3801, DOI 10.1016/j.ijhydene.2015.01.132
   MARGARITIS A, 1981, BIOTECHNOL BIOENG, V23, P2117, DOI 10.1002/bit.260230915
   MERCHUK JC, 1990, TRENDS BIOTECHNOL, V8, P66, DOI 10.1016/0167-7799(90)90138-N
   Pang YP, 2016, INT J HYDROGEN ENERG, V41, P18072, DOI 10.1016/j.ijhydene.2016.08.018
   Polo AM, 2011, BIODEGRADATION, V22, P751, DOI 10.1007/s10532-010-9448-7
   Pupkevich V, 2018, INT J HYDROGEN ENERG, V43, P19305, DOI 10.1016/j.ijhydene.2018.08.170
   Pupkevich V, 2014, SCALE UP STUDY BIOGE
   SCHUGERL K, 1990, J BIOTECHNOL, V13, P251, DOI 10.1016/0168-1656(90)90073-K
   Veras TD, 2017, INT J HYDROGEN ENERG, V42, P2018, DOI 10.1016/j.ijhydene.2016.08.219
NR 23
TC 0
Z9 0
U1 21
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115208
DI 10.1016/j.ces.2019.115208
PG 9
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400006
DA 2020-05-12
ER

PT J
AU Gong, Y
   Guo, QH
   Zhu, HW
   Yu, GS
AF Gong, Yan
   Guo, Qinghua
   Zhu, Huiwen
   Yu, Guangsuo
TI Refractory failure in entrained-flow gasifier: Investigation of
   partitioned erosion characteristics in an industrial opposed
   multi-burner gasifier
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Entrained-flow gasification; Opposed multi-burner (OMB); Refractory
   failure; Partitioned erosion; Erosion characteristics
ID COAL-WATER SLURRY; DEPOSITION CHARACTERISTICS; FLAME CHARACTERISTICS
AB Based on an industrial opposed multi-burner (OMB) gasification plant, a complete review of spent refractory materials inside a gasifier, including a study of the macrostructure and partitioned erosion characteristics, is reported based on systemic industrial data. The results are compared with those from a bench-scale gasification platform as well as numerical simulation. Five heavily eroded regions of the refractory were observed in the industrial OMB gasifier: two in the impinging up-flow zone, one in the burner plane, one in the impinging down-flow zone, and one in the cone zone. The erosion of the refractory material in the dome zone and the plug-flow zone is mild. The spalling on the lower side wall is uneven; therefore, the bricks below the region between two adjacent burners are more eroded in the longitudinal direction. Herein, the results can be used for the development of new refractory structure and the optimization of ultra-large-scale gasifiers. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Gong, Yan; Guo, Qinghua; Zhu, Huiwen; Yu, Guangsuo] East China Univ Sci & Technol, POB 272, Shanghai 200237, Peoples R China.
   [Yu, Guangsuo] Ningxia Univ, State Key Lab High Efficiency Coal Utilizat & Gre, Yinchuan 750021, Peoples R China.
RP Yu, GS (reprint author), East China Univ Sci & Technol, Minist Educ, Key Lab Coal Gasificat & Energy Chem Engn, POB 272, Shanghai 200237, Peoples R China.
EM gsyu@ecust.edu.cn
FU National Key R&D Program of China [2017YFB0602601]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [21878094, U1604252]
FX This work has been supported by the National Key R&D Program of China
   (2017YFB0602601) and the National Natural Science Foundation of China
   (21878094, U1604252).
CR Bennett J., 2006, DOENETLIR2006, P183
   Bennett James P., 2010, Advances in Science and Technology, V70, P179, DOI 10.4028/www.scientific.net/AST.70.179
   Bennett JP, 2011, METALL MATER TRANS A, V42A, P888, DOI 10.1007/s11661-011-0635-x
   Biedermann H, 2008, VDI-BUCH, P1
   Cai BL, 2018, CERAM INT, V44, P4592, DOI 10.1016/j.ceramint.2017.11.023
   Chen D, 2015, CERAM INT, V41, P14748, DOI 10.1016/j.ceramint.2015.07.202
   Gong Y, 2017, ENRGY PROCED, V142, P1089, DOI 10.1016/j.egypro.2017.12.361
   Gong Y, 2017, APPL ENERG, V205, P1091, DOI 10.1016/j.apenergy.2017.08.095
   Gong Y, 2015, CHEM ENG SCI, V138, P291, DOI 10.1016/j.ces.2015.08.013
   Gong Y, 2014, CHEM ENG SCI, V117, P93, DOI 10.1016/j.ces.2014.05.053
   Gong Y, 2013, IND ENG CHEM RES, V52, P3007, DOI 10.1021/ie3027857
   HEBSUR MG, 1983, APPL ENERG, V15, P99, DOI 10.1016/0306-2619(83)90038-7
   Higman C, 2014, CHEM REV, V114, P1673, DOI 10.1021/cr400202m
   Kim HB, 2008, CERAM INT, V34, P2107, DOI 10.1016/j.ceramint.2007.08.010
   Kwong K, 2007, INT J APPL CERAM TEC, V4, P503, DOI 10.1111/j.1744-7402.2007.02175.x
   Li C., 2013, THESIS
   Ni JJ, 2011, CHEM ENG SCI, V66, P448, DOI 10.1016/j.ces.2010.11.005
   Sun Z., 2012, THESIS
   Sun ZH, 2012, IND ENG CHEM RES, V51, P2560, DOI 10.1021/ie201542q
   Williford RE, 2008, CERAM INT, V34, P2085, DOI 10.1016/j.ceramint.2007.08.011
   Xue ZC, 2019, CHEM ENG SCI, V198, P85, DOI 10.1016/j.ces.2019.01.016
   Xue ZC, 2018, CHEM ENG SCI, V190, P248, DOI 10.1016/j.ces.2018.06.039
   Yu Z. H., 2011, U.S. Patent, Patent No. [7,862,632B2, 7862632]
NR 23
TC 0
Z9 0
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115227
DI 10.1016/j.ces.2019.115227
PG 9
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400018
DA 2020-05-12
ER

PT J
AU Heisel, S
   Holtkotter, J
   Wohlgemuth, K
AF Heisel, Stefan
   Holtkoetter, Jonas
   Wohlgemuth, Kerstin
TI Measurement of agglomeration during crystallization: Is the
   differentiation of aggregates and agglomerates via ultrasonic
   irradiation possible?
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Aggregation; Agglomeration; Disaggregation; Crystallization; Particle
   classification; Ultrasonic irradiation
ID PARTICLE-SIZE DISTRIBUTIONS; IMAGE-ANALYSIS; GASSING CRYSTALLIZATION;
   CRYSTAL MORPHOLOGY; ONLINE MEASUREMENT; SINGLE-CRYSTALS; SHAPE;
   DISCRIMINATION; CLASSIFICATION; IDENTIFICATION
AB An online measurement setup is presented to measure the agglomeration processes occurring during batch cooling crystallization of adipic acid from aqueous solution. Quantification of agglomeration is enabled by image analysis and particle classification using a highly accurate artificial neural network. This model system has a strong tendency to agglomerate during crystallization and therefore a strong tendency to aggregate, too. Aggregates and agglomerates are visually indistinguishable though and, therefore, falsify the measurement by aggregates superimposing agglomerates. To counteract this phenomenon during measurement, it is tested whether ultrasonic irradiation can be used to disaggregate the particles before being measured.
   It was found that ultrasonic treatment of the sample at various frequencies and input powers resulted in particle breakage (low frequency, high input power) or disaggregation of very large particles that would lead to clogging of the setup. Complete disaggregation of the sample was not feasible as the frequency and input power variation of the ultrasonic setup has shown. However, it was concluded that continuous treatment with ultrasonic irradiation might be a way to reduce impurity inclusions within the agglomerates due to the continuous destruction of the particles. (C) 2019 Published by Elsevier Ltd.
C1 [Heisel, Stefan; Holtkoetter, Jonas; Wohlgemuth, Kerstin] TU Dortmund Univ, Lab Plant & Proc Design, Emil Figge Str 70, D-44227 Dortmund, Germany.
RP Heisel, S (reprint author), TU Dortmund Univ, Lab Plant & Proc Design, Emil Figge Str 70, D-44227 Dortmund, Germany.
OI Wohlgemuth, Kerstin/0000-0001-7914-4303
CR Alander EM, 2004, IND ENG CHEM RES, V43, P629, DOI 10.1021/ie0301280
   Blandin AP, 2000, PART PART SYST CHAR, V17, P16, DOI 10.1002/(SICI)1521-4117(200003)17:1<16::AID-PPSC16>3.0.CO;2-I
   Borchert C, 2014, CRYST GROWTH DES, V14, P952, DOI 10.1021/cg401098x
   Borchert C, 2011, CHEM ENG TECHNOL, V34, P545, DOI 10.1002/ceat.201000465
   Brunsteiner M, 2005, CRYST GROWTH DES, V5, P3, DOI 10.1021/cg049837m
   DAVID R, 1995, CHEM ENG TECHNOL, V18, P302, DOI 10.1002/ceat.270180503
   De Anda JC, 2005, J PROCESS CONTR, V15, P785, DOI 10.1016/j.jprocont.2005.02.002
   De Anda JC, 2005, AICHE J, V51, P1406, DOI 10.1002/aic.10410
   Eggers J, 2009, CHEM ENG SCI, V64, P163, DOI 10.1016/j.ces.2008.09.025
   Eisenschmidt H, 2015, CRYST GROWTH DES, V15, P219, DOI 10.1021/cg501251e
   Eisenschmidt H, 2016, CRYST GROWTH DES, V16, P3297, DOI 10.1021/acs.cgd.6b00288
   Ferreira A, 2011, IND ENG CHEM RES, V50, P6990, DOI 10.1021/ie2001499
   Gao ZG, 2018, CRYST GROWTH DES, V18, P4275, DOI 10.1021/acs.cgd.8b00883
   Gielen B, 2017, CRYSTALS, V7, DOI 10.3390/cryst7020040
   Guo Z, 2007, POWDER TECHNOL, V171, P146, DOI 10.1016/j.powtec.2006.10.026
   Heisel S, 2019, POWDER TECHNOL, V345, P425, DOI 10.1016/j.powtec.2019.01.018
   Heisel S, 2018, CHEM ENG TECHNOL, V41, P1218, DOI 10.1002/ceat.201700651
   Heisel S, 2017, CHEM ENG SCI, V173, P131, DOI 10.1016/j.ces.2017.07.030
   Helmdach L, 2012, CHEM ENG TECHNOL, V35, P1017, DOI 10.1002/ceat.201100719
   Huo Y, 2017, IND ENG CHEM RES, V56, P11257, DOI 10.1021/acs.iecr.7b02439
   Huo Y, 2016, CHEM ENG SCI, V148, P126, DOI 10.1016/j.ces.2016.03.039
   Jordens J, 2016, CRYST GROWTH DES, V16, P6167, DOI 10.1021/acs.cgd.6b00088
   Kim JM, 2011, COLLOID SURFACE A, V375, P193, DOI 10.1016/j.colsurfa.2010.11.084
   Kleetz T, 2016, CRYST GROWTH DES, V16, P1320, DOI 10.1021/acs.cgd.5b01428
   Kordylla A, 2008, J CRYST GROWTH, V310, P4177, DOI 10.1016/j.jcrysgro.2008.06.057
   Kuhn S, 2011, LAB CHIP, V11, P2488, DOI 10.1039/c1lc20337a
   Lee J, 2014, ULTRASON SONOCHEM, V21, P60, DOI 10.1016/j.ultsonch.2013.07.005
   Lobnitz L, 2018, CHEM-ING-TECH, V90, P464, DOI 10.1002/cite.201700110
   Markovic S, 2008, ULTRASON SONOCHEM, V15, P16, DOI 10.1016/j.ultsonch.2007.07.008
   Narducci O, 2011, CRYST GROWTH DES, V11, P1742, DOI 10.1021/cg1016593
   Nichols G, 2002, J PHARM SCI, V91, P2103, DOI 10.1002/jps.10191
   Ochsenbein DR, 2015, CRYST GROWTH DES, V15, P4296, DOI 10.1021/acs.cgd.5b00604
   Papageorgiou CD, 2016, ORG PROCESS RES DEV, V20, P1500, DOI 10.1021/acs.oprd.6b00201
   Patience DB, 2001, AICHE J, V47, P2125, DOI 10.1002/aic.690470922
   Qu HY, 2006, J CRYST GROWTH, V289, P286, DOI 10.1016/j.jcrysgro.2005.11.108
   Ratsimba B, 1999, KONA, V17, P38, DOI DOI 10.14356/KONA.1999010
   Sander JRG, 2014, ULTRASON SONOCHEM, V21, P1908, DOI 10.1016/j.ultsonch.2014.02.005
   Schorsch S, 2014, CHEM ENG SCI, V105, P155, DOI 10.1016/j.ces.2013.11.003
   Schorsch S, 2012, CHEM ENG SCI, V77, P130, DOI 10.1016/j.ces.2011.11.029
   Terdenge LM, 2017, POWDER TECHNOL, V320, P386, DOI 10.1016/j.powtec.2017.07.044
   Terdenge LM, 2017, CHEM ENG SCI, V167, P88, DOI 10.1016/j.ces.2017.04.003
   Terdenge LM, 2016, CRYST RES TECHNOL, V51, P513, DOI 10.1002/crat.201600125
   Wieckhusen D, 2006, CHIMIA, V60, P598, DOI 10.2533/chimia.2006.598
   Wohgemuth K, 2009, CHEM ENG SCI, V64, P4155, DOI 10.1016/j.ces.2009.06.041
   Yu ZQ, 2007, CHEM ENG RES DES, V85, P893, DOI 10.1205/cherd06234
   Zhang R, 2015, CHEM ENG SCI, V137, P9, DOI 10.1016/j.ces.2015.05.053
NR 46
TC 1
Z9 1
U1 20
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115214
DI 10.1016/j.ces.2019.115214
PG 10
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400012
DA 2020-05-12
ER

PT J
AU Jiang, CH
   Li, KJ
   Zhang, JL
   Liu, ZJ
   Niu, LL
   Liang, W
   Sun, MM
   Ma, HB
   Wang, ZM
AF Jiang, Chunhe
   Li, Kejiang
   Zhang, Jianliang
   Liu, Zhengjian
   Niu, Lele
   Liang, Wang
   Sun, Minmin
   Ma, Hengbao
   Wang, Ziming
TI The effect of CaO and MgO on the structure and properties of coal ash in
   the blast furnace: A molecular dynamics simulation and thermodynamic
   calculation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Coal ash; Molecular dynamics; Structural unit; CaO; MgO; Viscosity
ID MOLTEN COKE ASH; LOCAL STRUCTURES; SLAG; VISCOSITY; GASIFICATION;
   PREDICTION; FLUIDITY; BEHAVIOR; SODIUM; SYSTEM
AB The influence of ash composition on the structure and properties of coal ash in the blast furnace was studied using molecular dynamics simulation and thermodynamic calculation. The change in the relative content of CaO and MgO does not cause a large variation of bond length between different ion-oxygen bonds. In the process of increasing the CaO content, more tricluster oxygen are converted into bridge oxygen and non-Bridge oxygen, which reduces the degree of structural complexity of the system. In addition, Ca(2+)ions could provide more charge compensation than Mg2+ ions. The ternary phase diagram proved that during the change of relative content of CaO and MgO, there is only a mineral transformation process in which the spinel changes to CaAl2Si2O8. Finally, it is found that in the blast furnace tuyere, the ability of CaO to improve the viscosity of coal ash is obviously better than that of MgO. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jiang, Chunhe; Li, Kejiang; Zhang, Jianliang; Liu, Zhengjian; Niu, Lele; Liang, Wang; Sun, Minmin; Ma, Hengbao; Wang, Ziming] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China.
   [Zhang, Jianliang] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia.
RP Li, KJ (reprint author), Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China.
EM likejiang@ustb.edu.cn
FU Canada Foundation for Innovation under the Compute Canada; Government of
   Ontario; University of TorontoUniversity of Toronto; National Science
   Foundation for Young Scientists of China [51804025]; National Science
   Foundation of ChinaNational Natural Science Foundation of China
   [51774032]; National Key Research and Development Program of China
   [2017YFB0304300, 2017YFB0304303]; Chinese Fundamental Research Funds for
   the Central Universities [FRF-TP-17-086A1]; Ontario Research Fund -
   Research Excellence
FX Computations were performed on the Niagara supercomputer at the SciNet
   HPC Consortium in the Compute/Calcul Canada national computing platform.
   SciNet is funded by the Canada Foundation for Innovation under the
   auspices of Compute Canada, the Government of Ontario, Ontario Research
   Fund - Research Excellence, and the University of Toronto. The authors
   acknowledge the support of the National Science Foundation for Young
   Scientists of China (51804025), the National Science Foundation of China
   (51774032), the National Key Research and Development Program of China
   (2017YFB0304300 & 2017YFB0304303), and the Chinese Fundamental Research
   Funds for the Central Universities (FRF-TP-17-086A1).
CR Bale CW, 2016, CALPHAD, V54, P35, DOI 10.1016/j.calphad.2016.05.002
   Barroso J, 2006, FUEL PROCESS TECHNOL, V87, P737, DOI 10.1016/j.fuproc.2006.02.004
   Browning GJ, 2003, ENERG FUEL, V17, P731, DOI 10.1021/ef020165o
   Chapman MW, 2008, METALL MATER TRANS B, V39, P418, DOI 10.1007/s11663-008-9145-7
   Chen XD, 2017, FUEL, V202, P175, DOI 10.1016/j.fuel.2017.04.001
   Dai X, 2019, FUEL, V237, P163, DOI 10.1016/j.fuel.2018.09.127
   Ding J, 2018, APPL ENERG, V227, P555, DOI 10.1016/j.apenergy.2017.07.019
   Ding J, 2018, APPL ENERG, V220, P536, DOI 10.1016/j.apenergy.2018.03.116
   Ding L, 2017, APPL ENERG, V195, P713, DOI 10.1016/j.apenergy.2017.03.098
   Gao YM, 2014, INT J MIN MET MATER, V21, P353, DOI 10.1007/s12613-014-0916-7
   Jabraoui H, 2016, J NON-CRYST SOLIDS, V448, P16, DOI 10.1016/j.jnoncrysol.2016.06.030
   Jakse N, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766920
   Jiang C., 2018, J NONCRYST SOLIDS
   Jiang CH, 2018, J MOL LIQ, V268, P762, DOI 10.1016/j.molliq.2018.07.123
   Kim H, 2010, STEEL RES INT, V81, P261, DOI 10.1002/srin.201000019
   Le Roux S, 2010, J APPL CRYSTALLOGR, V43, P181, DOI [10.1107/S0021889809051929, 10.1107/S00218898090511929]
   Lee S, 2018, MATER TEST, V60, P163, DOI 10.3139/120.111138
   Li KJ, 2017, ENERG FUEL, V31, P13466, DOI 10.1021/acs.energyfuels.7b02795
   Li KJ, 2017, CHEM ENG J, V313, P1184, DOI 10.1016/j.cej.2016.11.011
   Li KJ, 2016, FUEL, V186, P561, DOI 10.1016/j.fuel.2016.08.107
   Li KJ, 2015, METALL MATER TRANS B, V46, P1104, DOI 10.1007/s11663-015-0335-9
   Liu YP, 2007, THERMOCHIM ACTA, V454, P64, DOI 10.1016/j.tca.2006.10.026
   Matsui M, 1996, PHYS CHEM MINER, V23, P345, DOI 10.1007/BF00199500
   Oboirien BO, 2014, APPL ENERG, V129, P207, DOI 10.1016/j.apenergy.2014.04.091
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Sasi T, 2018, FUEL PROCESS TECHNOL, V176, P64, DOI 10.1016/j.fuproc.2018.03.018
   Shao YY, 2011, APPL ENERG, V88, P2635, DOI 10.1016/j.apenergy.2011.02.006
   Song WJ, 2010, ENERG FUEL, V24, P182, DOI 10.1021/ef900537m
   van Dyk JC, 2009, FUEL, V88, P67, DOI 10.1016/j.fuel.2008.07.034
   Wang DC, 2017, FUEL, V189, P15, DOI 10.1016/j.fuel.2016.10.050
   Wu T, 2016, J NON-CRYST SOLIDS, V450, P23, DOI 10.1016/j.jnoncrysol.2016.07.024
   Wu T, 2015, J NON-CRYST SOLIDS, V411, P145, DOI 10.1016/j.jnoncrysol.2014.12.030
NR 32
TC 1
Z9 1
U1 41
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115226
DI 10.1016/j.ces.2019.115226
PG 10
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400023
DA 2020-05-12
ER

PT J
AU Jourdan, N
   Neveux, T
   Potier, O
   Kanniche, M
   Wicks, J
   Nopens, I
   Rehman, U
   Le Moullec, Y
AF Jourdan, Nicolas
   Neveux, Thibaut
   Potier, Olivier
   Kanniche, Mohamed
   Wicks, Jim
   Nopens, Ingmar
   Rehman, Usman
   Le Moullec, Yann
TI Compartmental Modelling in chemical engineering: A critical review
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Review
DE Compartmental Modelling; Hydrodynamics; Multi-scale; CFD; Systemic model
ID RESIDENCE TIME DISTRIBUTION; PARTICLE-SIZE DISTRIBUTION; HYBRID
   MULTIZONAL/CFD MODELS; PREDICTING NOX EMISSIONS; FLUID-DYNAMICS;
   MASS-TRANSFER; GENERAL METHODOLOGY; FUTURE CHALLENGES; NETWORK MODEL;
   MIXING MODEL
AB Compartmental modelling is a hybrid way to model complex systems in Chemical Engineering. This modelling approach offers numerous advantages because it aggregates information from both local and system scale models. Compartmental models allow multi-scale modelling with low computational time compared to a full coupled model (e.g. reactive numerical simulations). Thanks to these main characteristics, compartmental models are able to model complex full-size industrial systems.
   For the last decades, various approaches of compartmental models were developed for different applications. In this article, a critical review and analyses are carried out to classify these different approaches. A unified definition is proposed, and important guidelines are pointed out to assist with constructing a Compartmental Model.
   Finally, some perspectives for the future of Compartmental Modelling are identified and discussed: compartmental modelling for larger and more complex systems, the inclusion of new phenomena modelling and automation of compartmental models with the improvement of numerical methods. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jourdan, Nicolas; Potier, Olivier] Univ Lorraine, LRGP, CNRS, UMR 7274, F-54001 Nancy, France.
   [Jourdan, Nicolas; Neveux, Thibaut; Kanniche, Mohamed] EDF Lab Chatou, EDF R&D, 6 Quai Watier, F-78401 Chatou, France.
   [Wicks, Jim] Magdalen Ctr, Fluid Grp, Robert Robinson Ave,Oxford Sci Pk, Oxford 0X4 4GA, England.
   [Nopens, Ingmar] Univ Ghent, Dept Data Anal & Math Modelling, BIOMATH, Coupure Links 653, B-9000 Ghent, Belgium.
   [Rehman, Usman] AM TEAM, Oktrooipl 1 Box 601, B-9000 Ghent, Belgium.
   [Le Moullec, Yann] EDF China, EDF China R&D Ctr, Beijing 100005, Peoples R China.
RP Potier, O (reprint author), Univ Lorraine, LRGP, CNRS, UMR 7274, F-54001 Nancy, France.
EM olivier.potier@univ-lorraine.fr
RI ; Neveux, Thibaut/N-4187-2018; Wicks, James/G-2024-2016
OI Potier, Olivier/0000-0003-3143-4015; Neveux,
   Thibaut/0000-0002-7460-702X; Wicks, James/0000-0003-4539-7884
FU EDF; ANRT association (Association Nationale de la Recherche et de la
   Technologie)
FX We would like to thank EDF and the ANRT association (Association
   Nationale de la Recherche et de la Technologie) for their support.
CR Alex J, 2002, WATER SCI TECHNOL, V45, P325
   Alex J, 1999, WATER SCI TECHNOL, V39, P55, DOI 10.1016/S0273-1223(99)00053-0
   Alexopoulos AH, 2002, CHEM ENG SCI, V57, P1735, DOI 10.1016/S0009-2509(02)00053-2
   Alopaeus V, 2009, AICHE J, V55, P2545, DOI 10.1002/aic.11850
   Alvarado A, 2012, WATER RES, V46, P521, DOI 10.1016/j.watres.2011.11.038
   Angermann L, 2010, NUMERICAL SIMULATION
   Bashiri H, 2016, CHEM ENG J, V297, P277, DOI 10.1016/j.cej.2016.03.102
   Bashiri H, 2014, CAN J CHEM ENG, V92, P1070, DOI 10.1002/cjce.21955
   Bauer M, 1999, CHEM ENG SCI, V54, P5109, DOI 10.1016/S0009-2509(99)00264-X
   Bauer M, 2001, CHEM ENG SCI, V56, P1067, DOI 10.1016/S0009-2509(00)00323-7
   Baur R, 2001, CHEM ENG SCI, V56, P1721, DOI 10.1016/S0009-2509(00)00401-2
   BENALLOU A, 1986, AICHE J, V32, P1067, DOI 10.1002/aic.690320703
   Bermingham S.K., 1999, P 14 INT S IND CRYST
   Bermingham SK, 1998, COMPUT CHEM ENG, V22, pS355, DOI 10.1016/S0098-1354(98)00075-1
   Bezzo F, 2004, COMPUT CHEM ENG, V28, P513, DOI 10.1016/j.compchemeng.2003.08.010
   Bezzo F, 2004, COMPUT CHEM ENG, V28, P501, DOI 10.1016/j.compchemeng.2003.08.004
   Bezzo F, 2003, AICHE J, V49, P2133, DOI 10.1002/aic.690490821
   Bezzo F, 2000, COMPUT CHEM ENG, V24, P653, DOI 10.1016/S0098-1354(00)00372-0
   Chen GY, 1998, ENERG BUILDINGS, V28, P137
   Cui YQ, 1996, CHEM ENG RES DES, V74, P261
   DANCKWERTS PV, 1953, CHEM ENG SCI, V2, P1, DOI 10.1016/0009-2509(53)80001-1
   Dani A, 2007, CHEM ENG SCI, V62, P7245, DOI 10.1016/j.ces.2007.08.047
   Delafosse A, 2014, CHEM ENG SCI, V106, P76, DOI 10.1016/j.ces.2013.11.033
   Delafosse A, 2010, BIOTECHNOL AGRON SOC, V14, P517
   Demirel SE, 2017, COMPUT CHEM ENG, V105, P2, DOI 10.1016/j.compchemeng.2017.01.044
   DEROSNAY J, 1979, MACROSCOPE NEW WORLD
   Du YP, 2015, IND ENG CHEM RES, V54, P8732, DOI 10.1021/acs.iecr.5b02109
   Dudukovic MP, 2010, CHEM ENG SCI, V65, P3, DOI 10.1016/j.ces.2009.09.018
   Faravelli T, 2001, COMPUT CHEM ENG, V25, P613, DOI 10.1016/S0098-1354(01)00641-X
   Fichet V, 2010, FUEL, V89, P2202, DOI 10.1016/j.fuel.2010.02.010
   Ge W, 2007, CHEM ENG SCI, V62, P3346, DOI 10.1016/j.ces.2007.02.049
   Goldstein R J, 1996, FLUID MECH MEASUREME
   Gresch M, 2009, ENVIRON SCI TECHNOL, V43, P2381, DOI 10.1021/es801651j
   Guha D, 2006, AICHE J, V52, P1836, DOI 10.1002/aic.10772
   Haag J, 2018, INT J CHEM REACT ENG, V16, DOI 10.1515/ijcre-2017-0172
   Hocine S, 2008, COMPUT CHEM ENG, V32, P3112, DOI 10.1016/j.compchemeng.2008.05.002
   Iliuta I, 2004, CHEM ENG SCI, V59, P879, DOI 10.1016/j.ces.2003.11.020
   Iliuta I, 2007, AICHE J, V53, P2062, DOI 10.1002/aic.11242
   Irizarry R, 2012, IND ENG CHEM RES, V51, P15484, DOI 10.1021/ie3011116
   Irizarry-Rivera R, 1997, J CRYST GROWTH, V178
   IrizarryRivera R, 1997, J CRYST GROWTH, V178, P612, DOI 10.1016/S0022-0248(97)00086-9
   Jourdan N., 2017, P SFGP 2017 C, P467
   Kagoshima M, 2006, CHEM ENG SCI, V61, P2852, DOI 10.1016/j.ces.2005.11.054
   Kaur G, 2018, PROCESSES, V6, DOI 10.3390/pr6100195
   Khdhiri H, 2014, WATER RES, V55, P194, DOI 10.1016/j.watres.2014.02.022
   Khowinij S, 2005, SEP PURIF TECHNOL, V46, P95, DOI 10.1016/j.seppur.2005.05.001
   Kougoulos E, 2005, CHEM ENG RES DES, V83, P30, DOI 10.1205/cherd.04080
   Laakkonen M, 2006, AICHE J, V52, P1673, DOI 10.1002/aic.10782
   Laakkonen M, 2006, CHEM ENG SCI, V61, P218, DOI 10.1016/j.ces.2004.11.066
   Laakkonen M, 2007, CHEM ENG SCI, V62, P721, DOI 10.1016/j.ces.2006.10.006
   Lainez-Aguirre JM, 2017, COMPUT CHEM ENG, V107, P92, DOI 10.1016/j.compchemeng.2017.05.027
   Laquerbe C, 2001, CHEM ENG SCI, V56, P5727, DOI 10.1016/S0009-2509(01)00292-5
   Lateb M, 2016, ENVIRON POLLUT, V208, P271, DOI 10.1016/j.envpol.2015.07.039
   LAUNDER BE, 1975, J FLUID MECH, V68, P537, DOI 10.1017/S0022112075001814
   Laurence DR, 2004, FLOW TURBUL COMBUST, V73, P169, DOI 10.1007/s10494-005-1974-8
   Laurent J, 2015, CHEM ENG J, V264, P389, DOI 10.1016/j.cej.2014.11.073
   Le Moullec Y, 2011, WATER RES, V45, P3085, DOI 10.1016/j.watres.2011.03.019
   Le Moullec Y, 2010, CHEM ENG SCI, V65, P492, DOI 10.1016/j.ces.2009.03.021
   Le Moullec Y, 2010, CHEM ENG SCI, V65, P343, DOI 10.1016/j.ces.2009.06.035
   Le Moullec Y, 2008, THESIS
   Le Moullec Y, 2008, CHEM ENG SCI, V63, P2436, DOI 10.1016/j.ces.2008.01.029
   Lee E. R., 2002, MICRODROP GENERATION
   LEVENSPIEL O, 1998, CHEM REACTION ENG
   Li J., 1988, CIRCULATING FLUIDIZE, P89
   Li JP, 2018, AICHE J, V64, P3082, DOI 10.1002/aic.16219
   Li JH, 2010, PARTICUOLOGY, V8, P634, DOI 10.1016/j.partic.2010.09.007
   Maggioris D, 1998, COMPUT CHEM ENG, V22, pS315, DOI 10.1016/S0098-1354(98)00070-2
   Maggioris D, 2000, CHEM ENG SCI, V55, P4611, DOI 10.1016/S0009-2509(00)00100-7
   MAYR B, 1993, BIOPROCESS ENG, V9, P1, DOI 10.1007/BF00389534
   MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149
   Moin P, 1998, ANNU REV FLUID MECH, V30, P539, DOI 10.1146/annurev.fluid.30.1.539
   Morin E., 1990, COMPLEXITY
   Nauha EK, 2018, CHEM ENG J, V334, P2319, DOI 10.1016/j.cej.2017.11.182
   Nauha EK, 2015, CHEM ENG J, V259, P945, DOI 10.1016/j.cej.2014.08.073
   Nauha EK, 2013, CHEM ENG J, V229, P559, DOI 10.1016/j.cej.2013.06.065
   Neveux T, 2011, IND ENG CHEM RES, V50, P7579, DOI 10.1021/ie102239q
   Norregaard A, 2019, CHEM ENG J, V356, P161, DOI 10.1016/j.cej.2018.08.191
   Nunez-Ramirez DM, 2012, J MICROBIOL BIOTECHN, V22, P1494, DOI 10.4014/jmb.1204.04029
   ONER M, 2018, COMPUT AIDED CHEM EN, V44, P181
   PATTERSON GK, 1981, CHEM ENG COMMUN, V8, P25, DOI 10.1080/00986448108912575
   Pavurala N, 2013, COMPUT CHEM ENG, V57, P196, DOI 10.1016/j.compchemeng.2013.06.002
   Peng X, 2012, SEP PURIF TECHNOL, V98, P280, DOI 10.1016/j.seppur.2012.06.028
   Pigou M, 2015, CHEM ENG SCI, V126, P267, DOI 10.1016/j.ces.2014.11.035
   Pitsch H, 2006, ANNU REV FLUID MECH, V38, P453, DOI 10.1146/annurev.fluid.38.050304.092133
   Potier O, 2005, WATER RES, V39, P4454, DOI 10.1016/j.watres.2005.08.024
   Potier O, 2015, CHEM ENG RES DES, V103, P108, DOI 10.1016/j.cherd.2015.05.040
   Preisig HA, 2010, COMPUT CHEM ENG, V34, P1543, DOI 10.1016/j.compchemeng.2010.02.023
   Rehman U, 2015, WATER SCI TECHNOL, V71, P700, DOI 10.2166/wst.2014.525
   Rehman U., 2018, WRRMOD SEM
   Rehman U., 2016, THESIS
   Rehman U, 2017, WATER SCI TECHNOL, V76, P1950, DOI 10.2166/wst.2017.330
   Reuss M, 1993, C BIOR PERF HELS DEN, P63
   Rigopoulos S, 2003, CHEM ENG SCI, V58, P3077, DOI 10.1016/S0009-2509(03)00179-9
   SAPRE AV, 1995, IND ENG CHEM RES, V34, P2202, DOI 10.1021/ie00046a002
   Scott-Pomerantz C.D., 2004, THESIS
   Seppala M., 2008, 6 INT C COMP FLUID D
   Simcik M, 2012, CHEM ENG RES DES, V90, P1739, DOI 10.1016/j.cherd.2012.03.014
   Stropky D, 2007, WATER SCI TECHNOL, V55, P29, DOI 10.2166/wst.2007.346
   Tajsoleiman T, 2019, COMPUT CHEM ENG, V123, P236, DOI 10.1016/j.compchemeng.2018.12.015
   Takagaki N, 2014, INT J MULTIPHAS FLOW, V60, P30, DOI 10.1016/j.ijmultiphaseflow.2013.11.006
   Tibirica CB, 2010, EXP THERM FLUID SCI, V34, P463, DOI 10.1016/j.expthermflusci.2009.03.009
   Versteeg H. K., 2007, INTRO COMPUTATIONAL
   VILLERMAUX J, 1993, CHEM ENG SCI, V48, P2525, DOI 10.1016/0009-2509(93)80265-R
   VILLERMAUX J, 1995, CHEM ENG RES DES, V73, P105
   Villermaux J, 1984, CHEM ENG PROCESS, V18, P123
   Vivaldo-Lima E, 1998, CAN J CHEM ENG, V76, P495, DOI 10.1002/cjce.5450760320
   von Bertalanffy L., 1968, GEN SYSTEM THEORY FD
   Vrabel P, 2001, CHEM ENG J, V84, P463, DOI 10.1016/S1385-8947(00)00271-0
   Vrabel P, 2000, CHEM ENG SCI, V55, P5881, DOI 10.1016/S0009-2509(00)00175-5
   Vrabel P, 1999, CHEM ENG RES DES, V77, P291, DOI 10.1205/026387699526223
   Wells GJ, 2005, AICHE J, V51, P1508, DOI 10.1002/aic.10407
   Wizman V, 1996, INT J HEAT FLUID FL, V17, P255, DOI 10.1016/0142-727X(96)00031-8
   Yu LX, 1999, INT J PHARMACEUT, V186, P119, DOI 10.1016/S0378-5173(99)00147-7
   Yu X, 2017, AICHE J, V63, P438, DOI 10.1002/aic.15401
   Zhang LF, 2007, IND ENG CHEM RES, V46, P3538, DOI 10.1021/ie060567+
   Zhao WL, 2017, AICHE J, V63, P378, DOI 10.1002/aic.15567
NR 116
TC 1
Z9 1
U1 35
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115196
DI 10.1016/j.ces.2019.115196
PG 20
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400005
DA 2020-05-12
ER

PT J
AU Kannan, AS
   Naserentin, V
   Mark, A
   Maggiolo, D
   Sardina, G
   Sasic, S
   Strom, H
AF Kannan, Ananda Subramani
   Naserentin, Vasileios
   Mark, Andreas
   Maggiolo, Dario
   Sardina, Gaetano
   Sasic, Srdjan
   Strom, Henrik
TI A continuum-based multiphase DNS method for studying the Brownian
   dynamics of soot particles in a rarefied gas
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Brownian dynamics; DNS; Rarefied flow; Immersed boundary method;
   Langevin dynamics; Nanoparticles
ID IMMERSED BOUNDARY METHOD; HYDRODYNAMIC INTERACTIONS; NANOPARTICLE
   SYNTHESIS; NUMERICAL-SIMULATION; SPHERICAL-PARTICLES; AXISYMMETRIC BODY;
   AEROSOL-PARTICLES; KINETIC-THEORY; FLOW; MOTION
AB In the mitigation of particulate matter (PM) using filters, the interplay between particle motion, geometry and flow conditions determines the overall performance. In such flows, molecular effects on the particle motion manifest as impeded momentum transfer and a meandering Brownian motion. Other particles and walls induce hydrodynamic interactions, which may further influence PM nucleation, growth and aggregation. Here, we formulate a multiphase direct numerical simulation framework to investigate these complex flows by including the molecular interactions in a consistent manner.
   The basis for this framework is a coupling between the Langevin description of particle motion with a mirroring immersed boundary method. We show that the method is able to capture the diffusion dynamics of a Brownian particle, including its transition from a particle-inertia dominated, correlated ballistic regime to a non-correlated diffusive one, and that the method also can be used to reproduce the meandering motion of realistic soot particles. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kannan, Ananda Subramani; Maggiolo, Dario; Sardina, Gaetano; Sasic, Srdjan; Strom, Henrik] Chalmers Univ Technol, Dept Mech & Maritime Sci, Div Fluid Dynam, S-41296 Gothenburg, Sweden.
   [Naserentin, Vasileios; Mark, Andreas] Fraunhofer Chalmers Res Ctr, S-41288 Gothenburg, Sweden.
   [Naserentin, Vasileios] Chalmers Univ Technol, Div Appl Math & Stat, S-41296 Gothenburg, Sweden.
   [Naserentin, Vasileios] Aristotle Univ Thessaloniki, Dept Chem Engn, Thessaloniki 54124, Greece.
RP Strom, H (reprint author), Chalmers Univ Technol, Dept Mech & Maritime Sci, Div Fluid Dynam, S-41296 Gothenburg, Sweden.
EM ananda@chalmers.se; henrik.strom@chalmers.se
RI ; /H-4779-2011
OI Kannan, Ananda Subramani/0000-0001-7619-6562; /0000-0002-8581-5174;
   Mark, Andreas/0000-0003-0038-3307; Sardina, Gaetano/0000-0002-9172-6311
FU Swedish Research Council (Vetenskapsradet)Swedish Research Council [Dnr
   2015-04809]
FX This work has been financed by the Swedish Research Council
   (Vetenskapsradet, Dnr 2015-04809). We would also like to thank the Swiss
   National Supercomputing Centre for providing us with computational
   resources.
CR Aftosmis M.J., 1997, LECT NOTES SOLUTION
   ALLEN MD, 1985, AEROSOL SCI TECH, V4, P269, DOI 10.1080/02786828508959055
   Bailey C.L., 2004, EUR C COMP METH APPL
   Banchio AJ, 2003, J CHEM PHYS, V118, P10323, DOI 10.1063/1.1571819
   Barber RW, 2006, HEAT TRANSFER ENG, V27, P3, DOI 10.1080/01457630500522271
   Bensaid S, 2010, CHEM ENG SCI, V65, P357, DOI 10.1016/j.ces.2009.06.051
   BERESNEV SA, 1990, J FLUID MECH, V219, P405, DOI 10.1017/S0022112090003007
   BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511
   Bird G., 2013, DSMC METHOD
   Bird G. A., 1994, MOL GAS DYNAMICS DIR
   Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171
   BRADY JF, 1988, ANNU REV FLUID MECH, V20, P111, DOI 10.1146/annurev.fl.20.010188.000551
   Breugem WP, 2012, J COMPUT PHYS, V231, P4469, DOI 10.1016/j.jcp.2012.02.026
   Bunde A., 2018, DIFFUSIVE SPREADING, DOI [10.1007/978-3-319-67798-9, DOI 10.1007/978-3-319-67798-9]
   CERCIGNA.C, 1968, PHYS FLUIDS, V11, P1399, DOI 10.1063/1.1692121
   CERCIGNA.C, 1968, PHYS FLUIDS, V11, P1395, DOI 10.1063/1.1692120
   CERCIGNANI C, 2000, RAREFIED GAS DYNAMIC
   Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1
   Corson J, 2018, J FLUID MECH, V855, P535, DOI 10.1017/jfm.2018.632
   Corson J, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.013103
   Cunningham E, 1910, P R SOC LOND A-CONTA, V83, P357, DOI 10.1098/rspa.1910.0024
   DAVIES CN, 1945, P PHYS SOC LOND, V57, P259, DOI 10.1088/0959-5309/57/4/301
   Di Sarli V, 2015, CHEM ENG SCI, V137, P69, DOI 10.1016/j.ces.2015.06.011
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806
   Epstein PS, 1924, PHYS REV, V23, P710, DOI 10.1103/PhysRev.23.710
   ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761
   ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001
   Gad-El-Hak M, 2006, HEAT TRANSFER ENG, V27, P13, DOI 10.1080/01457630500522305
   Gopalakrishnan R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3617251
   Gopinath A, 1999, PHYS FLUIDS, V11, P2772, DOI 10.1063/1.870136
   Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784
   Hauge E. H., 1973, J STAT PHYS, V7, P259, DOI DOI 10.1007/BF01030307
   HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102
   HOCKING LM, 1973, J ENG MATH, V7, P207, DOI 10.1007/BF01535282
   Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]
   HUBBARD JB, 1993, PHYS REV E, V47, pR2983, DOI 10.1103/PhysRevE.47.R2983
   Ito K., 1973, STOCHASTIC INTEGRATI, P141, DOI [10.1016/B978-0-12-702450-9.50020-8, DOI 10.1016/B978-0-12-702450-9.50020-8]
   Jiang H, 2019, COMBUST FLAME, V199, P204, DOI 10.1016/j.combustflame.2018.10.030
   Kishore N, 2016, INT J THERM SCI, V105, P206, DOI 10.1016/j.ijthermalsci.2016.03.009
   Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4
   Konstandopoulos AG, 2008, KONA POWDER PART J, V26, P36, DOI 10.14356/kona.2008007
   Kostoglou M, 2003, CHEM ENG SCI, V58, P3273, DOI 10.1016/S0009-2509(03)00178-7
   KOYLU UO, 1995, COMBUST FLAME, V100, P621, DOI 10.1016/0010-2180(94)00147-K
   Kruis FE, 1998, J AEROSOL SCI, V29, P511, DOI 10.1016/S0021-8502(97)10032-5
   La Torre F, 2011, COMPUT FLUIDS, V49, P312, DOI 10.1016/j.compfluid.2011.06.008
   Landau L. D., 1987, FLUID MECH, P227, DOI DOI 10.1016/B978-0-08-033933-7.50014-3
   Langevin P, 1908, CR HEBD ACAD SCI, V146, P530
   LeTallec P, 1997, J COMPUT PHYS, V136, P51, DOI 10.1006/jcph.1997.5729
   Mark A, 2013, INT J HEAT MASS TRAN, V56, P424, DOI 10.1016/j.ijheatmasstransfer.2012.09.010
   Mark A, 2011, FLUID DYN MATER PROC, V7, P241
   Mark A, 2008, J COMPUT PHYS, V227, P6660, DOI 10.1016/j.jcp.2008.03.031
   Martirosyan KS, 2010, CHEM ENG SCI, V65, P42, DOI 10.1016/j.ces.2009.01.058
   Matsuoka Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051403
   MAXEY MR, 1983, PHYS FLUIDS, V26, P883, DOI 10.1063/1.864230
   Millikan RA, 1911, PHYS REV, V32, P0349, DOI 10.1103/PhysRevSeriesI.32.349
   Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743
   MOUNTAIN RD, 1986, J COLLOID INTERF SCI, V114, P67, DOI 10.1016/0021-9797(86)90241-9
   Mueller R, 2003, CHEM ENG SCI, V58, P1969, DOI 10.1016/S0009-2509(03)00022-8
   Naumov M, 2015, SIAM J SCI COMPUT, V37, pS602, DOI 10.1137/140980260
   Newmark N, 1959, J ENG MECHANICS DIVI, V85, P67
   NOETINGER B, 1990, PHYSICA A, V163, P545, DOI 10.1016/0378-4371(90)90144-H
   OUNIS H, 1990, AEROSOL SCI TECH, V13, P47, DOI 10.1080/02786829008959423
   OUNIS H, 1990, J FLUID ENG-T ASME, V112, P114, DOI 10.1115/1.2909358
   Park M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35398-0
   PESKIN CS, 1982, ANNU REV FLUID MECH, V14, P235, DOI 10.1146/annurev.fl.14.010182.001315
   Popov SP, 2005, AIP CONF PROC, V762, P82
   RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405
   RHIE CM, 1983, AIAA J, V21, P1525, DOI 10.2514/3.8284
   ROGAK SN, 1993, AEROSOL SCI TECH, V18, P25, DOI 10.1080/02786829308959582
   Roveda R, 2000, J SPACECRAFT ROCKETS, V37, P753, DOI 10.2514/2.3647
   Rovenskaya O, 2014, VACUUM, V109, P266, DOI 10.1016/j.vacuum.2014.04.018
   Rovenskaya OI, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-016-1746-x
   Scanlon TJ, 2010, COMPUT FLUIDS, V39, P2078, DOI 10.1016/j.compfluid.2010.07.014
   Schwartzentruber TE, 2006, J COMPUT PHYS, V215, P402, DOI 10.1016/j.jcp.2005.10.023
   SIMO JC, 1991, INT J NUMER METH ENG, V31, P19, DOI 10.1002/nme.1620310103
   SITARSKI M, 1977, J COLLOID INTERF SCI, V61, P261, DOI 10.1016/0021-9797(77)90389-7
   Sjoblom J, 2014, IND ENG CHEM RES, V53, P3749, DOI 10.1021/ie404046y
   Skorupski K, 2014, PHYSICA A, V404, P106, DOI 10.1016/j.physa.2014.02.072
   Sone Y., 1977, Rarefied Gas Dynamics, P417
   Sorensen CM, 1998, PHYS REV LETT, V80, P1782, DOI 10.1103/PhysRevLett.80.1782
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   Stefanov SK, 2011, SIAM J SCI COMPUT, V33, P677, DOI 10.1137/090751864
   Stokes G.G., 1848, T CAMBRIDGE PHILOS S, V7, P439
   Strom H, 2011, INT J MULTIPHAS FLOW, V37, P906, DOI 10.1016/j.ijmultiphaseflow.2011.03.011
   TORQUATO S, 1991, J CHEM PHYS, V95, P6477, DOI 10.1063/1.461519
   Tripathi G, 2018, ENERGY ENV SUSTAIN, P159, DOI 10.1007/978-981-10-7575-9_8
   Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823
   Uhlmann M, 2005, J COMPUT PHYS, V209, P448, DOI 10.1016/j.jcp.2005.03.017
   VANDOORMAAL JP, 1984, NUMER HEAT TRANSFER, V7, P147, DOI 10.1080/10407798408546946
   von Smoluchowski M, 1906, ANN PHYS-BERLIN, V21, P756
   Wegner K, 2003, CHEM ENG SCI, V58, P4581, DOI 10.1016/j.ces.2003.07.010
   Welander P, ARK FYSIK
   Wijesinghe HS, 2004, J FLUID ENG-T ASME, V126, P768, DOI 10.1115/1.1792275
   YAMAMOTO K, 1985, PHYS FLUIDS, V28, P1286, DOI 10.1063/1.865012
   Yang J, 2009, CHEM ENG SCI, V64, P1625, DOI 10.1016/j.ces.2008.12.011
   YING RX, 1989, J FLUID MECH, V207, P353, DOI 10.1017/S0022112089002612
   Zhang CL, 2012, AEROSOL SCI TECH, V46, P1065, DOI 10.1080/02786826.2012.690543
NR 97
TC 1
Z9 1
U1 14
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115229
DI 10.1016/j.ces.2019.115229
PG 15
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400001
DA 2020-05-12
ER

PT J
AU Ma, R
   Yang, TX
   Sun, JH
   He, YF
   Feng, JT
   Miller, JT
   Li, DQ
AF Ma, Rui
   Yang, Tianxing
   Sun, Jianhua
   He, Yufei
   Feng, Junting
   Miller, Jeffrey T.
   Li, Dianqing
TI Nanoscale surface engineering of PdCo/Al2O3 catalyst via segregation for
   efficient purification of ethene feedstock
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE PdCo/Al2O3 catalyst; Surface segregation; Composition dependency;
   Redispersion; Acetylene selective hydrogenation
ID SELECTIVE HYDROGENATION; OXYGEN REDUCTION; ACETYLENE HYDROGENATION; PD
   CATALYST; PHASE; CARBON; CO; NANOCATALYSTS; ADSORPTION; STABILITY
AB Surface engineering of bimetallic nanoparticles are crucial for harnessing the true catalytic potential. Herein, H-2-induced segregation of palladium was employed to tune the surface structure of PdCo/Al2O3 catalysts with different Pd/Co atomic ratios. The composition dependency of segregation was demonstrated by XRD, XPS, and HAADF-STEM characterization. The results from in situ CO-FTIR analysis show that Pd ensemble sites were formed on Pd75Co23/Al2O3, while, isolated Pd sites were formed on Pd15Co85/Al2O3 after 700 degrees C hydrogen post-treatment. The post-treated catalysts exhibited significantly increased activity for acetylene selective hydrogenation due to Pd segregation on the surface. In addition, the Pd15Co85-700 catalyst displayed 88% ethene selectivity at similar to 100% conversion of acetylene, which was related to the redispersion of Pd and Co during the H-2 treatment. Kinetic analysis provided valuable insight into the nature of the active sites resulting from the surface segregation. The Pd15Co85-700 catalyst also showed favorable stability during 100 h reaction. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ma, Rui; Yang, Tianxing; He, Yufei; Feng, Junting; Li, Dianqing] Beijing Univ Chem Technol, State Key Lab Chem Engn, Beijing 100029, Peoples R China.
   [Ma, Rui; Yang, Tianxing; He, Yufei; Feng, Junting; Li, Dianqing] Beijing Univ Chem Technol, Beijing Engn Ctr Hierarch Catalysts, Beijing 100029, Peoples R China.
   [Sun, Jianhua] Guangxi Univ, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
   [Miller, Jeffrey T.] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.
RP He, YF; Li, DQ (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Engn, Beijing 100029, Peoples R China.
EM yfhe@mail.buct.edu.cn; lidq@mail.buct.edu.cn
OI Sun, JianHua/0000-0001-9968-2846
FU National Key R&D Program of China [2016YFB0301600]; National Natural
   Science FoundationNational Natural Science Foundation of China;
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [BUCTRC201725, JD1816]; Dean
   Project of Guangxi Key Laboratory of Petrochemical Resource Processing
   and Process Intensification Technology
FX This work was supported by the National Key R&D Program of China
   (2016YFB0301600), the National Natural Science Foundation, the
   Fundamental Research Funds for the Central Universities (BUCTRC201725,
   JD1816) and the Dean Project of Guangxi Key Laboratory of Petrochemical
   Resource Processing and Process Intensification Technology.
CR An H, 2017, NANOSCALE, V9, P12077, DOI 10.1039/c7nr04435f
   Bakala PC, 2008, J CATAL, V258, P61, DOI 10.1016/j.jcat.2008.05.026
   Balmes O, 2012, PHYS CHEM CHEM PHYS, V14, P4796, DOI 10.1039/c2cp22873d
   Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051
   BOND GC, 1966, J CATAL, V5, P65, DOI 10.1016/S0021-9517(66)80126-4
   BRONGERSMA HH, 1978, SURF SCI, V71, P657, DOI 10.1016/0039-6028(78)90453-3
   Chen TY, 2016, ACS CATAL, V6, P4025, DOI 10.1021/acscatal.6b00714
   Chen Z, 2012, J PHYS CHEM C, V116, P14986, DOI 10.1021/jp303992g
   Christoffersen E, 2002, SURF SCI, V505, P200, DOI 10.1016/S0039-6028(02)01158-5
   Collins SE, 2012, J CATAL, V292, P90, DOI 10.1016/j.jcat.2012.05.005
   Cui CH, 2014, J AM CHEM SOC, V136, P4813, DOI 10.1021/ja4124658
   Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]
   FAGHERAZZI G, 1995, CATAL LETT, V32, P293, DOI 10.1007/BF00813223
   Feng JT, 2013, DALTON T, V42, P14498, DOI 10.1039/c3dt51855h
   Feng QC, 2017, J AM CHEM SOC, V139, P7294, DOI 10.1021/jacs.7b01471
   Ferreira AP, 2005, CATAL TODAY, V107-08, P181, DOI 10.1016/j.cattod.2005.07.089
   Gislason J, 2002, J PHYS CHEM A, V106, P767, DOI 10.1021/jp011238s
   Han BC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205409
   Han YF, 2004, CATAL LETT, V94, P131, DOI 10.1023/B:CATL.0000020537.33875.46
   HARRIS J, 1985, PHYS REV LETT, V55, P1583, DOI 10.1103/PhysRevLett.55.1583
   He YF, 2012, ACS CATAL, V2, P1703, DOI 10.1021/cs300224j
   Huang DC, 1998, CATAL LETT, V53, P155, DOI 10.1023/A:1019022326090
   Huang W, 2007, J CATAL, V246, P40, DOI 10.1016/j.jcat.2006.11.013
   Hwang SJ, 2012, J AM CHEM SOC, V134, P19508, DOI 10.1021/ja307951y
   Khalfaoui M, 2003, J COLLOID INTERF SCI, V263, P350, DOI 10.1016/S0021-9797(03)00139-5
   Kim DS, 2012, J CATAL, V290, P65, DOI 10.1016/j.jcat.2012.03.001
   Kim WJ, 2004, J CATAL, V226, P226, DOI 10.1016/j.jcat.2004.05.017
   Kronawitter CX, 2011, NANO LETT, V11, P3855, DOI 10.1021/nl201944h
   Lamberov AA, 2007, KINET CATAL+, V48, P136, DOI 10.1134/S0023158407010181
   Lee TJ, 2003, APPL CATAL B-ENVIRON, V41, P115, DOI 10.1016/S0926-3373(02)00197-2
   Leppert L, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.241403
   Li ZP, 2016, J POWER SOURCES, V310, P41, DOI 10.1016/j.jpowsour.2016.01.105
   Lucci FR, 2016, J PHYS CHEM LETT, V7, P480, DOI 10.1021/acs.jpclett.5b02400
   Mani P, 2008, J PHYS CHEM C, V112, P2770, DOI 10.1021/jp0776412
   McCue AJ, 2016, J CATAL, V340, P10, DOI 10.1016/j.jcat.2016.05.002
   McCue AJ, 2014, J CATAL, V319, P127, DOI 10.1016/j.jcat.2014.08.016
   McKenna FM, 2012, CATAL SCI TECHNOL, V2, P632, DOI 10.1039/c2cy00479h
   McKenna FM, 2011, J CATAL, V281, P231, DOI 10.1016/j.jcat.2011.05.003
   MEARS DE, 1971, IND ENG CHEM PROC DD, V10, P541, DOI 10.1021/i260040a020
   Mei DH, 2009, J CATAL, V268, P181, DOI 10.1016/j.jcat.2009.09.004
   Nie Y, 2015, CHEM SOC REV, V44, P2168, DOI 10.1039/c4cs00484a
   Niquille-Rothlisberger A, 2006, J CATAL, V242, P207, DOI 10.1016/j.jcat.2006.06.009
   Osswald J, 2008, J CATAL, V258, P219, DOI 10.1016/j.jcat.2008.06.014
   Ota A, 2011, J PHYS CHEM C, V115, P1368, DOI 10.1021/jp109226r
   Oyama ST, 2008, J CATAL, V257, P1, DOI 10.1016/j.jcat.2008.04.023
   Pei GX, 2017, ACS CATAL, V7, P1491, DOI 10.1021/acscatal.6b03293
   Pei GX, 2015, ACS CATAL, V5, P3717, DOI 10.1021/acscatal.5b00700
   Peng HL, 2014, ACS CATAL, V4, P3797, DOI 10.1021/cs500744x
   Peng LX, 2015, PHYS CHEM CHEM PHYS, V17, P27940, DOI 10.1039/c5cp01492a
   Popova N.M., 2008, REACT KINET CATAL LE, V319, P187
   Prinz J, 2014, J AM CHEM SOC, V136, P11792, DOI 10.1021/ja505936b
   Qin YL, 2015, CHEMSUSCHEM, V8, P260, DOI 10.1002/cssc.201402926
   Ramirez-Caballero GE, 2010, PHYS CHEM CHEM PHYS, V12, P2209, DOI 10.1039/b917899f
   Riyapan S, 2016, CATAL SCI TECHNOL, V6, P5608, DOI 10.1039/c6cy00121a
   Rodriguez JC, 1997, J CATAL, V171, P268, DOI 10.1006/jcat.1997.1815
   Shin EW, 1998, CATAL TODAY, V44, P137, DOI 10.1016/S0920-5861(98)00184-9
   Shiratori N, 2009, LANGMUIR, V25, P7631, DOI 10.1021/la9000347
   Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476
   Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170
   Tao F, 2012, CHEM SOC REV, V41, P7980, DOI 10.1039/c2cs35185d
   Vasquez Y, 2005, J AM CHEM SOC, V127, P12504, DOI 10.1021/ja054442s
   Wang DS, 2011, ADV MATER, V23, P1044, DOI 10.1002/adma.201003695
   Wang X, 2000, APPL CATAL B-ENVIRON, V26, pL227, DOI 10.1016/S0926-3373(00)00125-9
   WEISZ PB, 1954, ADV CATAL, V6, P143, DOI 10.1016/S0360-0564(08)60390-9
   Xiao S, 2006, EUR PHYS J B, V54, P479, DOI 10.1140/epjb/e2007-00018-6
   Xue HR, 2016, ACS APPL MATER INTER, V8, P20766, DOI 10.1021/acsami.6b05856
   Yang B, 2013, J CATAL, V305, P264, DOI 10.1016/j.jcat.2013.05.027
   Zhang J, 2009, J AM CHEM SOC, V131, P18543, DOI 10.1021/ja908245r
   Zhang ZC, 2017, NANO ENERGY, V34, P224, DOI 10.1016/j.nanoen.2017.02.023
   Zhou HR, 2016, ACS CATAL, V6, P1054, DOI 10.1021/acscatal.5b01933
   Zou LF, 2017, J PHYS CHEM LETT, V8, P6035, DOI 10.1021/acs.jpclett.7b02947
NR 71
TC 1
Z9 1
U1 53
U2 53
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115216
DI 10.1016/j.ces.2019.115216
PG 12
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400014
DA 2020-05-12
ER

PT J
AU Mondal, R
   Mondal, S
   Kurada, KV
   Bhattacharjee, S
   Sengupta, S
   Mondal, M
   Karmakar, S
   De, S
   Griffiths, IM
AF Mondal, Raka
   Mondal, Sourav
   Kurada, Krishnasri, V
   Bhattacharjee, Saikat
   Sengupta, Sourav
   Mondal, Mrinmoy
   Karmakar, Sankha
   De, Sirshendu
   Griffiths, Ian M.
TI Modelling the transport and adsorption dynamics of arsenic in a soil bed
   filter
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Arsenic removal; Mathematical modelling; Computational fluid dynamics;
   Intra-particle dynamics; Asymptotic analysis; India and Bangladesh
ID AQUEOUS-SOLUTIONS; LATERITE; KINETICS; SORPTION; REMOVAL
AB Arsenic is among the most hazardous contaminants present in drinking water. Recent increase in agricultural growth and fertiliser use in India and Bangladesh has led to the release of naturally occurring arsenic from the rocks, creating a major public health issue. A novel technology has been developed using naturally abundant laterite soil to filter arsenic, providing potable water to more than 5000 people. To upscale this technology and realise its full potential, a comprehensive understanding of the dependence of filter life on operating regime (flow rate, arsenic concentration and filter size) is essential. We present a mathematical model that characterises arsenic removal, circumventing the need for time-consuming experiments. The model incorporates inter- and intra-particle mass transport within the filter medium. The resulting model enables prediction of a filter lifetime in a specified role, such as on a domestic or community scale, and should assist in future filter deployment and maintenance. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mondal, Raka; Mondal, Sourav; Griffiths, Ian M.] Univ Oxford, Math Inst, Oxford OX2 6GG, England.
   [Kurada, Krishnasri, V; Bhattacharjee, Saikat; Sengupta, Sourav; Mondal, Mrinmoy; Karmakar, Sankha; De, Sirshendu] Indian Inst Technol Kharagpur, Dept Chem Engn, Kharagpur 721302, W Bengal, India.
RP Griffiths, IM (reprint author), Univ Oxford, Math Inst, Oxford OX2 6GG, England.
EM ian.griffiths@maths.ox.ac.uk
FU Royal SocietyRoyal Society of London; EPSRCEngineering & Physical
   Sciences Research Council (EPSRC)
FX The collaborative work between the two institutions was initiated by the
   Global Challenges Research Fund. IMG gratefully acknowledges support
   from the Royal Society through a University Research Fellowship. The
   authors acknowledge helpful discussions with Lucy Auton, Graham Baird
   and Doireann O'Kiely. RM gratefully acknowledges support from the Royal
   Society through a Challenge Grant. SM gratefully acknowledges support
   from the Royal Society and EPSRC. The group from the Indian Institute of
   Technology Kharagpur gratefully acknowledges the inter-disciplinary
   collaborative initiative taken up by the Mathematical Institute at the
   University of Oxford.
CR [Anonymous], 2000, EPASABDWC1001 WHO US
   [Anonymous], 2011, WHO CHRON, V38, P104, DOI DOI 10.1016/S1462-0758(00)00006-6
   Bohart GS, 1920, J AM CHEM SOC, V42, P523, DOI 10.1021/ja01448a018
   Coulson J.M., 1968, CHEM ENG, V1
   COULSON JM, 1968, CHEM ENG, V2
   GARNER FH, 1958, CHEM ENG SCI, V9, P119, DOI 10.1016/0009-2509(58)80003-2
   Gupta S, 2009, BIORESOURCE TECHNOL, V100, P5633, DOI 10.1016/j.biortech.2009.06.025
   Tran HN, 2017, WATER RES, V120, P88, DOI 10.1016/j.watres.2017.04.014
   Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1
   Leist M, 2000, J HAZARD MATER, V76, P125, DOI 10.1016/S0304-3894(00)00188-6
   Liu Y, 2008, LANGMUIR, V24, P11625, DOI 10.1021/la801839b
   Lunt M, 2015, RHEUMATOLOGY, V54, P1137, DOI 10.1093/rheumatology/ket146
   Maiti A, 2008, IND ENG CHEM RES, V47, P1620, DOI 10.1021/ie070908z
   Maiti A, 2012, CHEM ENG J, V191, P1, DOI 10.1016/j.cej.2010.01.031
   Maiti A, 2009, J HAZARD MATER, V172, P928, DOI 10.1016/j.jhazmat.2009.07.140
   Maji SK, 2007, J ENVIRON SCI HEAL A, V42, P989, DOI 10.1080/10934520701373059
   Mondal S, 2017, SCI TOTAL ENVIRON, V583, P142, DOI 10.1016/j.scitotenv.2017.01.042
   Ng JC, 2003, CHEMOSPHERE, V52, P1353, DOI 10.1016/S0045-6535(03)00470-3
   Persons B.S., 2012, LATERITE GENESIS LOC
   Tsiberkin K, 2018, TRANSPORT POROUS MED, V121, P109, DOI 10.1007/s11242-017-0951-8
   WOLBORSKA A, 1989, WATER RES, V23, P85, DOI 10.1016/0043-1354(89)90066-3
NR 21
TC 0
Z9 0
U1 27
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115205
DI 10.1016/j.ces.2019.115205
PG 12
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400013
DA 2020-05-12
ER

PT J
AU Pronczuk, M
   Bizon, K
AF Pronczuk, Mateusz
   Bizon, Katarzyna
TI Investigation of the liquid mixing characteristic of an external-loop
   hybrid fluidized-bed airlift reactor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hybrid airlift reactor; Three-phase reactor; Dispersion; Mixing time
ID RESIDENCE TIME DISTRIBUTION; MASS-TRANSFER; HYDRODYNAMICS; BIOREACTOR;
   DISPERSION; FLOW
AB The paper presents the results of experimental investigation of the mixing characteristics of an external-loop hybrid fluidized-bed airlift reactor. Stimulus-response tracer experiments were carried out using KCl solution as a tracer. Based on the obtained tracer residence time distribution (RTD) curves, values of the Peclet number for the entire apparatus and its selected zones i.e. fluidization, bubbling, bottom and degassing zones were determined. The values of Pe were calculated using three different methods, i.e. method of moments, optimization method combined with numerical solution of the axial dispersion model and by fitting the experimental data to a special solution of the axial dispersion model describing the response of the loop apparatus to the impulse of tracer. The mixing time was determined both from the experimental RTDs and through using the proposed theoretically derived expression that permits an estimation of the values of mixing time based on a single liquid circulation. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Pronczuk, Mateusz; Bizon, Katarzyna] Cracow Univ Technol, Dept Chem & Proc Engn, Ul Warszawska 24, PL-31155 Krakow, Poland.
RP Pronczuk, M (reprint author), Cracow Univ Technol, Dept Chem & Proc Engn, Ul Warszawska 24, PL-31155 Krakow, Poland.
EM mpronczuk@chemia.pk.edu.pl
OI Bizon, Katarzyna/0000-0001-7600-4452; Pronczuk,
   Mateusz/0000-0001-8808-0129
CR Behin J, 2010, CHEM ENG RES DES, V88, P919, DOI 10.1016/j.cherd.2010.01.004
   Behin J, 2015, CHEM ENG TECHNOL, V38, P2207, DOI 10.1002/ceat.201500432
   Behin J, 2013, EXP THERM FLUID SCI, V51, P244, DOI 10.1016/j.expthermflusci.2013.08.004
   Behin J, 2010, KOREAN J CHEM ENG, V27, P1226, DOI 10.1007/s11814-010-0184-9
   BELLO RA, 1984, CAN J CHEM ENG, V62, P573, DOI DOI 10.1002/CJCE.5450620501
   Essadki AH, 2011, CHEM ENG SCI, V66, P3125, DOI 10.1016/j.ces.2011.02.063
   Farhadian N, 2018, COMPUT FLUIDS, V167, P221, DOI 10.1016/j.compfluid.2018.02.030
   Gavrilescu M, 1999, CHEM ENG PROCESS, V38, P225, DOI 10.1016/S0255-2701(99)00005-7
   Gavrilescu M, 1997, CHEM ENG J, V66, P97, DOI 10.1016/S1385-8947(96)03177-4
   Guo YX, 1997, CHEM ENG J, V67, P205, DOI 10.1016/S1385-8947(97)00043-0
   Hamood-ur-Rehman M, 2012, CHEM ENG J, V213, P50, DOI 10.1016/j.cej.2012.09.106
   KHANG SJ, 1976, CHEM ENG SCI, V31, P569, DOI 10.1016/0009-2509(76)80020-6
   Lechowska J, 2019, CHEM ENG J, V362, P298, DOI 10.1016/j.cej.2019.01.037
   LEVENSPIEL O, 1957, CHEM ENG SCI, V6, P227, DOI 10.1016/0009-2509(57)85021-0
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   LIN CH, 1976, BIOTECHNOL BIOENG, V18, P1557, DOI 10.1002/bit.260181106
   Moudoud N, 2018, CHEM ENG PROCESS, V129, P118, DOI 10.1016/j.cep.2018.05.005
   Olivieri G, 2010, CAN J CHEM ENG, V88, P574, DOI 10.1002/cjce.20314
   ONKEN U, 1980, EUR J APPL MICROBIOL, V10, P31, DOI 10.1007/BF00504725
   Petrovic DL, 1995, CHEM ENG COMMUN, V133, P1, DOI 10.1080/00986449508936308
   Pronczuk M, 2017, CHEM ENG RES DES, V126, P188, DOI 10.1016/j.cherd.2017.08.028
   Pronczuk M, 2016, PRZEM CHEM, V95, P2003, DOI 10.15199/62.2016.10.31
   Shampine L. F., 1994, NUMER METH PART D E, V10, P739, DOI DOI 10.1002/NUM.1690100608
   Tabis B, 2014, PRZEM CHEM, V93, P1379
   TAKAO M, 1982, CHEM ENG SCI, V37, P796, DOI 10.1016/0009-2509(82)85044-6
   VERLAAN P, 1989, CHEM ENG SCI, V44, P1139, DOI 10.1016/0009-2509(89)87013-7
   VONCKEN RM, 1964, CHEM ENG SCI, V19, P209, DOI 10.1016/0009-2509(64)85031-4
NR 27
TC 0
Z9 0
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115231
DI 10.1016/j.ces.2019.115231
PG 11
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400011
DA 2020-05-12
ER

PT J
AU Qin, ZZ
   Wang, XD
   Dong, LH
   Su, TM
   Li, B
   Zhou, YW
   Jiang, YX
   Luo, X
   Ji, HB
AF Qin, Zuzeng
   Wang, Xiaodi
   Dong, Lihui
   Su, Tongming
   Li, Bin
   Zhou, Yuwen
   Jiang, Yuexiu
   Luo, Xuan
   Ji, Hongbing
TI CO2 methanation on Co/TiO2 catalyst: Effects of Y on the support
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE CO2 hydrogenation; Methanation; Co3O4 catalyst; Y doped TiO2 support;
   Oxygen vacancy
ID CARBON-DIOXIDE; PHOTOCATALYTIC REDUCTION; TIO2 PHOTOCATALYST;
   LOW-TEMPERATURE; PARTICLE-SIZE; PERFORMANCE; NANOPARTICLES; PHASE; LA;
   NI
AB The Y was used for improving the structural performance of TiO2 support. The results showed that the BET surface area was increased by doping Y, and more oxygen vacancies were generated in the TiO2 support, which would promote the activation of CO2. The reduction temperature of the Co3O4 was decreased and more Co3O4 can be reduced into Co for the Y doped Co/TiO2 samples compared to that of the Co/TiO2. Furthermore, the doped Y enhanced the basicity of the catalysts and the adsorption capacity of the CO2 was greatly increased, which was beneficial to the activation of the CO2 and the CO2 methanation reaction. The activity test indicated that the CO2 conversion and CH4 selectivity was highest when using the 20% Co/2%Y-TiO2 catalyst. The 20% Co/2%Y-TiO2 catalyst exhibited the highest CO2 conversion of 85.9%, and CH4 selectivity of 99.5% at 350 degrees C, and kept stable in 40 h. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Qin, Zuzeng; Wang, Xiaodi; Dong, Lihui; Su, Tongming; Li, Bin; Zhou, Yuwen; Jiang, Yuexiu; Luo, Xuan; Ji, Hongbing] Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
   [Ji, Hongbing] Sun Yat Sen Univ, Sch Chem, Guangzhou 510275, Guangdong, Peoples R China.
RP Ji, HB (reprint author), Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
EM qinzuzeng@gxu.edu.cn; jihb@mail.sysu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21566005]; Natural Science Foundation of Guangxi
   ProvinceNational Natural Science Foundation of Guangxi Province
   [2016GXNSFFA380015]; Open Project of Guangxi Key Laboratory of
   Petrochemical Resource Processing and Process Intensification Technology
   [2018K002]
FX This work was supported by National Natural Science Foundation of China
   (21566005), Natural Science Foundation of Guangxi Province
   (2016GXNSFFA380015), and the Open Project of Guangxi Key Laboratory of
   Petrochemical Resource Processing and Process Intensification Technology
   (2018K002).
CR Abdelsayed V, 2010, J PHYS CHEM LETT, V1, P2804, DOI 10.1021/jz1011143
   Aldana PAU, 2013, CATAL TODAY, V215, P201, DOI 10.1016/j.cattod.2013.02.019
   Aziz MAA, 2014, APPL CATAL A-GEN, V486, P115, DOI 10.1016/j.apcata.2014.08.022
   Aziz MAA, 2014, APPL CATAL B-ENVIRON, V147, P359, DOI 10.1016/j.apcatb.2013.09.015
   Gnanakumar ES, 2019, CHEM ENG SCI, V194, P2, DOI 10.1016/j.ces.2018.08.038
   Hwang S, 2012, CATAL LETT, V142, P860, DOI 10.1007/s10562-012-0842-0
   Karelovic A, 2012, APPL CATAL B-ENVIRON, V113, P237, DOI 10.1016/j.apcatb.2011.11.043
   Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v
   Kim A, 2018, APPL CATAL B-ENVIRON, V220, P615, DOI 10.1016/j.apcatb.2017.08.058
   Kruse N, 2011, APPL CATAL A-GEN, V391, P367, DOI 10.1016/j.apcata.2010.05.039
   Lais A, 2018, INT J ENERG RES, V42, P2031, DOI 10.1002/er.3965
   Landau MV, 2017, IND ENG CHEM RES, V56, P13335, DOI 10.1021/acs.iecr.7b01817
   Lee B, 2017, KOREAN J CHEM ENG, V34, P199, DOI 10.1007/s11814-016-0227-y
   Liang CF, 2019, INT J HYDROGEN ENERG, V44, P8197, DOI 10.1016/j.ijhydene.2019.02.014
   Lin QQ, 2014, CATAL SCI TECHNOL, V4, P2058, DOI 10.1039/c4cy00030g
   Liu C, 2012, J PHYS CHEM C, V116, P5681, DOI 10.1021/jp210480c
   Ma HB, 2019, CHEM ENG SCI, V194, P10, DOI 10.1016/j.ces.2018.05.019
   Ma W, 1998, APPL PHYS A-MATER, V66, P621, DOI 10.1007/s003390050723
   Manzoli M, 2018, CATALYSTS, V8, DOI 10.3390/catal8070262
   Mota FM, 2019, CHEM SOC REV, V48, P205, DOI 10.1039/c8cs00527c
   Nagaoka K, 2003, APPL CATAL A-GEN, V255, P13, DOI 10.1016/S0926-860X(03)00631-8
   Narayan H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/25/255601
   Olajire AA, 2018, J CO2 UTIL, V24, P522, DOI 10.1016/j.jcou.2018.02.012
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pinkaew K, 2013, KOREAN J CHEM ENG, V30, P50, DOI 10.1007/s11814-012-0094-0
   Plata JJ, 2011, TOP CATAL, V54, P219, DOI 10.1007/s11244-011-9639-4
   Podila S, 2017, INT J HYDROGEN ENERG, V42, P24213, DOI 10.1016/j.ijhydene.2017.07.112
   Porosoff MD, 2016, ENERG ENVIRON SCI, V9, P62, DOI 10.1039/c5ee02657a
   Qin ZZ, 2016, RSC ADV, V6, P52665, DOI 10.1039/c6ra03340g
   Riva R, 2000, APPL CATAL A-GEN, V196, P111, DOI 10.1016/S0926-860X(99)00460-3
   Samiee L, 2013, APPL SURF SCI, V265, P214, DOI 10.1016/j.apsusc.2012.10.173
   Shayegan Z, 2018, CHEM ENG J, V334, P2408, DOI 10.1016/j.cej.2017.09.153
   Soled SL, 2003, TOP CATAL, V26, P101, DOI 10.1023/B:TOCA.0000012990.83630.f9
   Su TM, 2017, APPL CATAL B-ENVIRON, V202, P364, DOI 10.1016/j.apcatb.2016.09.035
   Sun Y, 2019, J NANOSCI NANOTECHNO, V19, P3097, DOI 10.1166/jnn.2019.16588
   Takano H, 2016, APPL SURF SCI, V388, P653, DOI 10.1016/j.apsusc.2015.11.187
   Vargas S, 1999, J MATER RES, V14, P3932, DOI 10.1557/JMR.1999.0532
   Wang F, 2015, J CATAL, V329, P177, DOI 10.1016/j.jcat.2015.05.014
   Wang W, 2016, INT J HYDROGEN ENERG, V41, P967, DOI 10.1016/j.ijhydene.2015.11.133
   Wang W, 2011, CHEM SOC REV, V40, P3703, DOI 10.1039/c1cs15008a
   Wang WC, 2008, ACTA PHYS-CHIM SIN, V24, P1761, DOI 10.1016/S1872-1508(08)60072-8
   Wierzbicki D, 2016, CATAL COMMUN, V83, P5, DOI 10.1016/j.catcom.2016.04.021
   Wu YT, 2017, J ALLOY COMPD, V695, P1462, DOI 10.1016/j.jallcom.2016.10.284
   Zanella R, 2012, ACS CATAL, V2, P1, DOI 10.1021/cs200332v
   Zhang WJ, 2009, CHEM ENG J, V155, P83, DOI 10.1016/j.cej.2009.06.039
   Zhi GJ, 2011, CATAL COMMUN, V16, P56, DOI 10.1016/j.catcom.2011.08.037
   Zhou GL, 2013, INT J HYDROGEN ENERG, V38, P10012, DOI 10.1016/j.ijhydene.2013.05.130
   Zhou XH, 2016, CHEM ENG SCI, V153, P10, DOI 10.1016/j.ces.2016.07.007
   Zhou YW, 2018, CHINESE J CHEM ENG, V26, P768, DOI 10.1016/j.cjche.2017.10.014
   [周郁文 Zhou Yuwen], 2018, [精细化工, Fine Chemicals], V35, P72
   Zhu HW, 2012, CATAL COMMUN, V23, P43, DOI 10.1016/j.catcom.2012.02.029
   Zhu Y, 2012, ACS CATAL, V2, P2403, DOI 10.1021/cs3005242
NR 52
TC 1
Z9 1
U1 117
U2 117
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115245
DI 10.1016/j.ces.2019.115245
PG 10
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400004
DA 2020-05-12
ER

PT J
AU Rizkin, BA
   Hartman, RL
AF Rizkin, Benjamin A.
   Hartman, Ryan L.
TI Supervised machine learning for prediction of zirconocene-catalyzed
   alpha-olefin polymerization
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Polymerization; Process development; Machine learning; Neural networks;
   Metallocene catalysis; Olefins
ID ARTIFICIAL NEURAL-NETWORKS; 1-HEXENE POLYMERIZATION; PROPENE
   POLYMERIZATION; METALLOCENE CATALYSTS; CHIRAL ZIRCONOCENE; GENETIC
   ALGORITHMS; MOLECULAR-WEIGHT; KINETICS; ETHYLENE; PROPYLENE
AB A new approach is demonstrated in which an Artificial Neural Network (ANN) was trained with first-principles data to predict the chain length, polydispersity (D) and adiabatic temperature for a zirconocene-catalyzed polymerization reaction. The ANN-generated data shows good agreement with the theoretical results, with an overall R-2 of 0.9987. Using its significantly enhanced computational speed, the ANN was used to analyze the reaction space, providing insights into trends seen in molecular weight and D with various combinations of kinetic parameters, particularly pointing out regions of desirable and undesirable operation. The network was trained in reverse and used to generate reaction rate constants from chain length and D, enabling a new form of kinetic deduction for polymerization reactions. This training was used to derive potential rate constants for different catalysts reported in the literature. Overall, this data indicates that ANNs are a plausible tool for analyzing data from complex metallocene-catalyzed olefin polymerizations. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Rizkin, Benjamin A.; Hartman, Ryan L.] NYU, Dept Chem & Biomol Engn, 6 Metrotech Ctr, Brooklyn, NY 11201 USA.
RP Hartman, RL (reprint author), NYU, Dept Chem & Biomol Engn, 6 Metrotech Ctr, Brooklyn, NY 11201 USA.
EM ryan.hartman@nyu.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CBET-1701393]
FX This material is based upon work supported by the National Science
   Foundation under Grant Number CBET-1701393. Any opinions, findings, and
   conclusions or recommendations expressed in this material are those of
   the authors and do not necessarily reflect the views of the National
   Science Foundation.
CR Ahmadi M, 2009, MACROMOL THEOR SIMUL, V18, P195, DOI 10.1002/mats.200800088
   Ali JM, 2015, EXPERT SYST APPL, V42, P5915, DOI 10.1016/j.eswa.2015.03.023
   BOCHMANN M, 1994, ORGANOMETALLICS, V13, P2235, DOI 10.1021/om00018a017
   CHAN WM, 1994, J APPL POLYM SCI, V53, P1277, DOI 10.1002/app.1994.070531002
   Charoenpanich T, 2016, MACROMOL REACT ENG, V10, P215, DOI 10.1002/mren.201500048
   Chen EYX, 2000, CHEM REV, V100, P1391, DOI 10.1021/cr980462j
   Christianson MD, 2010, J AM CHEM SOC, V132, P11461, DOI 10.1021/ja105107y
   Christopher JN, 1996, ORGANOMETALLICS, V15, P4038, DOI 10.1021/om960104b
   Cruz V, 2004, POLYMER, V45, P2061, DOI 10.1016/j.polymer.2003.12.059
   Cruz VL, 2007, POLYMER, V48, P7672, DOI 10.1016/j.polymer.2007.11.011
   Cruz VL, 2007, POLYMER, V48, P4663, DOI 10.1016/j.polymer.2007.05.081
   Cruz VL, 2014, ORGANOMETALLICS, V33, P2944, DOI 10.1021/om400721v
   Cruz VL, 2005, ORGANOMETALLICS, V24, P5095, DOI 10.1021/om050458f
   Curteanu Silvia, 2014, Proceedings. 4th International Congress on Simulation and Modelling Methodologies, Technologies and Applications (SIMULTECH 2014), P43
   Curteanu S, 2008, INT J QUANTUM CHEM, V108, P617, DOI 10.1002/qua.21376
   D 'Agnillo L, 1998, MACROMOL CHEM PHYSIC, V199, P955, DOI 10.1002/macp.1998.021990605
   Dare EO, 2004, B CHEM SOC ETHIOPIA, V18, P131
   DIWEKAR UM, 1991, IND ENG CHEM RES, V30, P713, DOI 10.1021/ie00052a014
   Drummond ML, 2007, INORG CHEM, V46, P8613, DOI 10.1021/ic700670s
   EWEN JA, 1984, J AM CHEM SOC, V106, P6355, DOI 10.1021/ja00333a041
   Fazilat H, 2012, POLYMER, V53, P2255, DOI 10.1016/j.polymer.2012.03.053
   Galli P., 2011, MET CATAL SYNTH POLY, P14, DOI [10.1007/978-3-642-60178-1_2, DOI 10.1007/978-3-642-60178-1_2]
   Ghiotto F, 2013, DALTON T, V42, P9040, DOI 10.1039/c3dt00107e
   Giro Ronaldo, 2003, Mat. Res., V6, P523, DOI 10.1590/S1516-14392003000400017
   Gonzalez-Ruiz RA, 2006, AICHE J, V52, P1824, DOI 10.1002/aic.10758
   Guo YT, 2017, J POLYM SCI POL CHEM, V55, P867, DOI 10.1002/pola.28439
   HERRMANN WA, 1989, ANGEW CHEM INT EDIT, V28, P1511, DOI 10.1002/anie.198915111
   HILDENBRAND P, 1982, J MACROMOL SCI CHEM, VA17, P1093, DOI 10.1080/00222338208066469
   Himmelblau DM, 2000, KOREAN J CHEM ENG, V17, P373, DOI 10.1007/BF02706848
   Holscher M, 2002, MACROMOLECULES, V35, P8194, DOI 10.1021/ma020413f
   Hough BR, 2017, COMPUT CHEM ENG, V104, P56, DOI 10.1016/j.compchemeng.2017.04.012
   Hutley T.J., 2016, POLYOLEFINS HIST EC, DOI [10.1007/978-3-319-25982-6_2, DOI 10.1007/978-3-319-25982-6_2]
   Ibrehem AS, 2008, CHINESE J CHEM ENG, V16, P84, DOI 10.1016/S1004-9541(08)60042-7
   Inkson NJ, 2006, MACROMOLECULES, V39, P4920, DOI 10.1021/ma060654d
   Irfan MF, 2012, FUEL, V93, P245, DOI 10.1016/j.fuel.2011.09.043
   KAMINSKY W, 1989, MAKROMOL CHEM, V190, P515
   KAMINSKY W, 1988, POLYHEDRON, V7, P2375, DOI 10.1016/S0277-5387(00)86355-X
   KAMINSKY W, 1985, ANGEW CHEM INT EDIT, V24, P507, DOI 10.1002/anie.198505071
   KAMINSKY W, 1994, CATAL TODAY, V20, P257, DOI 10.1016/0920-5861(94)80005-7
   Kaminsky W, 2011, METALORGANIC CATALYS, DOI [10.1007/978-3-642-60178-1, DOI 10.1007/978-3-642-60178-1]
   KAWAMURAKURIBAYASHI H, 1992, J AM CHEM SOC, V114, P8687, DOI 10.1021/ja00048a049
   Kim I, 1998, J MACROMOL SCI PURE, VA35, P1987, DOI 10.1080/10601329808000992
   KITO S, 1994, APPL CATAL A-GEN, V114, pL173
   KOLTHAMMER BWS, 1992, J POLYM SCI POL CHEM, V30, P1017, DOI 10.1002/pola.1992.080300607
   KRAULEDAT H, 1990, ANGEW CHEM INT EDIT, V29, P1412, DOI 10.1002/anie.199014121
   Leite M.S., 2007, APPL ARTIFICIAL INTE
   Lenton TN, 2013, J AM CHEM SOC, V135, P10710, DOI 10.1021/ja403170u
   Lin S, 2000, J AM CHEM SOC, V122, P11275, DOI 10.1021/ja002003h
   Liu ZX, 2001, J AM CHEM SOC, V123, P11193, DOI 10.1021/ja016072n
   MacGregor J.F, 1986, IFAC P, V19, P31, DOI [10.1016/S1474-6670(17)59395-7, DOI 10.1016/S1474-6670(17)59395-7]
   Maltarollo Vinicius, 2013, ARTIFICIAL NEURAL NE, P203, DOI [DOI 10.5772/3409, 10.5772/51275]
   Martinez S, 2012, ORGANOMETALLICS, V31, P1673, DOI 10.1021/om2007776
   Mohring PC, 2006, COORDIN CHEM REV, V250, P18, DOI 10.1016/j.ccr.2005.01.024
   Molga EJ, 2000, CHEM ENG PROCESS, V39, P323, DOI 10.1016/S0255-2701(99)00093-8
   Moscato BM, 2012, ORGANOMETALLICS, V31, P2097, DOI 10.1021/om3000955
   Moscato BM, 2010, J AM CHEM SOC, V132, P14352, DOI 10.1021/ja105775r
   NAKAZAKI Y, 1989, IND ENG CHEM RES, V28, P1285, DOI 10.1021/ie00093a003
   Nandi S, 2002, IND ENG CHEM RES, V41, P2159, DOI 10.1021/ie010414g
   Nayak A, 2004, MACROMOL THEOR SIMUL, V13, P73, DOI 10.1002/mats.200350033
   Paass G., 1993, ADV NEURAL INFORMATI, V5, P196
   Papes AC, 2010, CHEM ENG J, V157, P501, DOI 10.1016/j.cej.2009.12.045
   Pletcher PD, 2016, ACS CATAL, V6, P5138, DOI 10.1021/acscatal.6b00974
   Polikar R, 2001, SENSOR ACTUAT B-CHEM, V80, P243, DOI 10.1016/S0925-4005(01)00903-0
   Prakash N, 2013, KINETIC MODELING SIM
   Resconi L., 1999, POLYM MAT SCI ENG, V80, P421, DOI 10.1021/cr940442r
   RIEGER B, 1994, ANGEW MAKROMOL CHEM, V215, P35, DOI 10.1002/apmc.1994.052150104
   Ruiz D, 2000, COMPUT CHEM ENG, V24, P777, DOI 10.1016/S0098-1354(00)00371-9
   Sadiku M.N.O., 2017, INT J ADV SCI RES EN, V4, P4618, DOI [10.7324/ijasre.2017.32524, DOI 10.7324/IJASRE.2017.32524]
   SASAKI M, 1995, APPL CATAL A-GEN, V132, P261, DOI 10.1016/0926-860X(95)00171-9
   Schwaller P, 2018, CHEM SCI, V9, P6091, DOI 10.1039/c8sc02339e
   SOGA K, 1993, MAKROMOL CHEM, V194, P1745
   Song FQ, 2004, MACROMOL SYMP, V213, P173, DOI 10.1002/masy.200450917
   Song FQ, 2004, CHEM COMMUN, P542, DOI 10.1039/b314845a
   Song FQ, 2003, J AM CHEM SOC, V125, P7641, DOI 10.1021/ja029150v
   Subramanyam U, 2007, J POLYM SCI POL CHEM, V45, P1093, DOI 10.1002/pola.21852
   Switzer JM, 2012, MACROMOLECULES, V45, P4978, DOI 10.1021/ma300129n
   Valeh-e-Sheyda P, 2010, IND ENG CHEM RES, V49, P4620, DOI 10.1021/ie9020705
   Wang BQ, 2005, CHEM-EUR J, V11, P669, DOI 10.1002/chem.200400750
   WOO HG, 1989, J AM CHEM SOC, V111, P8043, DOI 10.1021/ja00202a070
   Yasin T, 2005, POLYHEDRON, V24, P1262, DOI 10.1016/j.poly.2005.02.013
   Young MJ, 2002, POLYM-PLAST TECHNOL, V41, P601, DOI 10.1081/PPT-120006436
   Yu Y, 2019, ACS CATAL, V9, P3098, DOI 10.1021/acscatal.8b04624
   Zhang Z, 2003, COMPOS SCI TECHNOL, V63, P2029, DOI 10.1016/S0266-3538(03)00106-4
   Zhao X, 2000, J POLYM SCI POL CHEM, V38, P3802, DOI 10.1002/1099-0518(20001015)38:20<3802::AID-POLA110>3.0.CO;2-N
NR 84
TC 2
Z9 2
U1 39
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115224
DI 10.1016/j.ces.2019.115224
PG 12
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400022
DA 2020-05-12
ER

PT J
AU Roy, S
   Pant, HJ
   Roy, S
AF Roy, Sangram
   Pant, Harish Jagat
   Roy, Shantanu
TI Solids flow pattern in cold flow mockup of fluidized bed gasifier
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Coal gasification; Fluidized bed; Radioactive Particle Tracking (RPT)
ID RADIOACTIVE PARTICLE TRACKING; AGGLOMERATE BEHAVIOR; COAL-GASIFICATION;
   SCALE-UP; MOTION; SHEDS; HYDRODYNAMICS; DYNAMICS; REACTORS; FLUX
AB We report solids flow pattern in a laboratory-scale fluidized bed of coal and ash mixtures. Suitable tracers were designed and deployed to determine the solids flow path of a typical particle through Radioactive Particle Tracking (RPT). Experiments were conducted in a cylindrical bed of 0.1 m in i.d. with two inventory compositions, namely, 70% Coal + 30% Bottom Ash (Composition I) and 20% Coal + 80% Bottom Ash (Composition II). Comparative analysis of RPT measurements yielded overall bed behavior, which was quantified in terms of time-averaged mean velocity, solids flux, RMS velocity, and kinetic energy per unit volume of the coal - bottom ash mixture. The mean axial velocity and solids flux profile indicated the influence of strong slugs on the solids flow patterns. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Roy, Sangram; Roy, Shantanu] Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
   [Pant, Harish Jagat] Bhabha Atom Res Ctr, Isototpe & Radiat Applicat Div, Mumbai 400076, Maharashtra, India.
RP Roy, S (reprint author), Indian Inst Technol Delhi, Dept Chem Engn, New Delhi 110016, India.
EM roys@chemical.iitd.ac.in
FU Bharat Heavy Electricals Limited (BHEL) RD; Board for Research in
   Nuclear Sciences (BRNS), Department of Atomic Energy (DAE), Government
   of India [2012/35/13/BRNS]
FX Partial financial and logistical support for this work was provided by
   Bharat Heavy Electricals Limited (BHEL) R&D, vide their project
   agreement with IIT Delhi, signed in August 2013 and by Board for
   Research in Nuclear Sciences (BRNS), Department of Atomic Energy (DAE),
   Government of India vide project no. 2012/35/13/BRNS. The authors
   gratefully acknowledge the support of the sponsors.
CR Ali N, 2017, PARTICUOLOGY, V34, P48, DOI 10.1016/j.partic.2016.11.005
   Ali N, 2017, EXP THERM FLUID SCI, V80, P90, DOI 10.1016/j.expthermflusci.2016.08.002
   Alizadeh E, 2013, AICHE J, V59, P1894, DOI 10.1002/aic.13982
   Azizi S, 2017, CHEM ENG SCI, V170, P320, DOI 10.1016/j.ces.2017.02.015
   Basu P, 1999, CHEM ENG SCI, V54, P5547, DOI 10.1016/S0009-2509(99)00285-7
   Bhusarapu S, 2005, IND ENG CHEM RES, V44, P9739, DOI 10.1021/ie050297f
   Bhusarapu S, 2004, POWDER TECHNOL, V148, P158, DOI 10.1016/j.powtec.2004.09.007
   Bhusarapu S, 2007, INT J MULTIPHAS FLOW, V33, P164, DOI 10.1016/j.ijmultiphaseflow.2006.08.006
   Bhusarapu S, 2006, POWDER TECHNOL, V163, P98, DOI 10.1016/j.powtec.2006.01.013
   Careaga FJS, 2018, ADV POWDER TECHNOL, V29, P1758, DOI 10.1016/j.apt.2018.04.011
   Careaga FJS, 2018, PARTICUOLOGY, V38, P143, DOI 10.1016/j.partic.2017.10.008
   Careaga FJS, 2018, POWDER TECHNOL, V325, P31, DOI 10.1016/j.powtec.2017.10.061
   Careaga FJS, 2015, POWDER TECHNOL, V275, P263, DOI 10.1016/j.powtec.2015.01.034
   CASSANELLO M, 1995, IND ENG CHEM RES, V34, P2971, DOI 10.1021/ie00048a007
   Chaouki J, 1997, IND ENG CHEM RES, V36, P4476, DOI 10.1021/ie970210t
   Chikkatur AP, 2009, ENERGY, V34, P942, DOI 10.1016/j.energy.2008.12.014
   Dube O, 2014, APPL RADIAT ISOTOPES, V89, P109, DOI 10.1016/j.apradiso.2014.02.019
   Dube O, 2013, CHEM ENG SCI, V101, P486, DOI 10.1016/j.ces.2013.07.011
   Efhaima A, 2017, CAN J CHEM ENG, V95, P744, DOI 10.1002/cjce.22757
   Fotovat F, 2015, CHEM ENG J, V280, P26, DOI 10.1016/j.cej.2015.05.130
   Fotovat F, 2015, CHEM ENG SCI, V126, P543, DOI 10.1016/j.ces.2014.12.022
   Hagemeier T, 2015, CHEM ENG SCI, V131, P63, DOI 10.1016/j.ces.2015.03.045
   Higman C, 2014, CHEM REV, V114, P1673, DOI 10.1021/cr400202m
   Jain V, 2017, PARTICUOLOGY, V33, P112, DOI 10.1016/j.partic.2016.07.011
   Khane V, 2016, NUCL ENG DES, V302, P1, DOI 10.1016/j.nucengdes.2016.03.031
   Khanna P, 2008, CAN J CHEM ENG, V86, P563, DOI 10.1002/cjce.20073
   Kivi AR, 2019, SENS IMAGING, V20, DOI 10.1007/s11220-019-0229-z
   Larachi F, 1996, AICHE J, V42, P2439, DOI 10.1002/aic.690420905
   LARACHI F, 1994, NUCL INSTRUM METH A, V338, P568, DOI 10.1016/0168-9002(94)91343-9
   LARACHI F, 1995, AICHE J, V41, P439, DOI 10.1002/aic.690410226
   Mahinpey N, 2016, CHEM ENG SCI, V148, P14, DOI 10.1016/j.ces.2016.03.037
   Minchener AJ, 2005, FUEL, V84, P2222, DOI 10.1016/j.fuel.2005.08.035
   Mostoufi N, 2001, POWDER TECHNOL, V114, P23, DOI 10.1016/S0032-5910(00)00258-8
   NOORDERGRAAF IW, 1987, POWDER TECHNOL, V52, P59, DOI 10.1016/0032-5910(87)80007-4
   Rasouli M, 2016, AICHE J, V62, P2622, DOI 10.1002/aic.15235
   Rasouli M, 2015, AICHE J, V61, P384, DOI 10.1002/aic.14644
   Roy S, 2005, AICHE J, V51, P802, DOI 10.1002/aic.10447
   Roy S, 2002, APPL RADIAT ISOTOPES, V56, P485, DOI 10.1016/S0969-8043(01)00142-7
   Roy S, 2017, AICHE J, V63, P314, DOI 10.1002/aic.15559
   Roy Shantanu, 2016, P FLUID 15
   SATIJA S, 1985, AICHE J, V31, P1554, DOI 10.1002/aic.690310919
   Shabanian J, 2016, POWDER TECHNOL, V299, P98, DOI 10.1016/j.powtec.2016.05.027
   Shabanian J, 2014, CHEM ENG SCI, V119, P261, DOI 10.1016/j.ces.2014.08.037
   SINCLAIR JL, 1989, AICHE J, V35, P1473, DOI 10.1002/aic.690350908
   Stewart P. S. B., 1967, POWDER TECHNOL, V1, P61, DOI 10.1016/0032-5910(67)80014-7
   Tebianian S, 2016, CHEM ENG J, V306, P306, DOI 10.1016/j.cej.2016.07.058
   Tebianian S, 2016, POWDER TECHNOL, V296, P45, DOI 10.1016/j.powtec.2015.08.040
   Upadhyay RK, 2010, CAN J CHEM ENG, V88, P601, DOI 10.1002/cjce.20334
   van Putten IC, 2007, CHEM ENG SCI, V62, P2522, DOI 10.1016/j.ces.2005.10.025
   Werther J, 1999, POWDER TECHNOL, V102, P15, DOI 10.1016/S0032-5910(98)00202-2
   Yadav A, 2017, AICHE J, V63, P2850, DOI 10.1002/aic.15596
NR 51
TC 0
Z9 0
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115225
DI 10.1016/j.ces.2019.115225
PG 13
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400021
DA 2020-05-12
ER

PT J
AU Sprakel, LM
   Keijsper, DJ
   Nikolova, AL
   Schuur, B
AF Sprakel, Lisette Mj
   Keijsper, Dylan J.
   Nikolova, Anna L.
   Schuur, Boelo
TI Predicting solvent effects on relative volatility behavior in extractive
   distillation using isothermal titration calorimetry (ITC) and molecular
   modeling (MM)
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Extractive distillation; Solvent regeneration; Solvent screening;
   Isothermal titration calorimetry (ITC); Molecular modeling (MM)
ID LIQUID-LIQUID-EXTRACTION; EQUILIBRIUM DATA; ACTIVITY-COEFFICIENTS;
   SEPARATION; SELECTION; DESIGN; COMPLEXATION; THIOPHENOL; PHENOL; OXIDES
AB A solvent screening approach for extractive distillation, combining isothermal titration calorimetry (ITC) and molecular modeling (MM), was investigated based on three close-boiling mixture cases. The investigated mixtures are octanoic acid (HOct) and levulinic acid (HLev); diethylmethylamine (DEMA) and diisopropylether (DIPE); 2-butanol (2-BuOH) and 2-butanone (2-BuO). Solvent effects were predicted based on ITC and MM. The correlation between the interaction energy of the solvent and mixture constituents and the effect on the relative volatility (validated with VLE experiments) was shown. Successful solvents showed moderate interactions (between binary mixture interaction energy and -60 kJ/mol, with MM calculated). Too low interaction energy lacks effect and too high interaction energy compromised regeneration. For mixtures without strong intermolecular interactions (e.g. 2-BuOH and 2-BuO), a preferential exothermic interaction with the high-boiling component is needed. The developed method with solvent selection guidelines offers an effective approach for systems with strong non-idealities. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sprakel, Lisette Mj; Keijsper, Dylan J.; Nikolova, Anna L.; Schuur, Boelo] Univ Twente, Fac Sci & Technol, Sustainable Proc Technol Grp, Enschede, Netherlands.
RP Schuur, B (reprint author), Drienerlolaan 5,Meander 221, NL-7522 NB Enschede, Netherlands.
EM b.schuur@utwente.nl
CR BASTOS JC, 1985, IND ENG CHEM PROC DD, V24, P420, DOI 10.1021/i200029a035
   Blahusiak M, 2018, SEP PURIF TECHNOL, V194, P301, DOI 10.1016/j.seppur.2017.10.026
   BUNCH DW, 1963, IND ENG CHEM PROC DD, V2, P282, DOI 10.1021/i260008a005
   Chen G., 1990, INVESTIGAT APPL
   Cuypers R, 2008, J PHYS CHEM A, V112, P11714, DOI 10.1021/jp801605y
   Cuypers R, 2010, CHEMPHYSCHEM, V11, P3465, DOI 10.1002/cphc.201000482
   Cuypers R, 2010, CHEMPHYSCHEM, V11, P2230, DOI 10.1002/cphc.201000084
   Doherty M.F., 2004, KIRK OTHMER ENCY CHE
   Eckert F, 2002, AICHE J, V48, P369, DOI 10.1002/aic.690480220
   Falconer RJ, 2016, J MOL RECOGNIT, V29, P504, DOI 10.1002/jmr.2550
   FREDENSLUND A, 1975, AICHE J, V21, P1086, DOI 10.1002/aic.690210607
   Gerbaud V, 2019, CHEM ENG RES DES, V141, P229, DOI 10.1016/j.cherd.2018.09.020
   Gutierrez JP, 2012, IND ENG CHEM RES, V51, P11518, DOI 10.1021/ie301506n
   Harper PM, 2000, COMPUT CHEM ENG, V24, P677, DOI 10.1016/S0098-1354(00)00410-5
   Hoell Detlef, 2009, ULLMANNS ENCY IND CH, V2
   Hu YJ, 2019, SEP PURIF TECHNOL, V211, P723, DOI 10.1016/j.seppur.2018.10.030
   Jongmans MTG, 2012, SEP PURIF TECHNOL, V98, P206, DOI 10.1016/j.seppur.2012.06.040
   KAMLET MJ, 1983, J ORG CHEM, V48, P2877, DOI 10.1021/jo00165a018
   Kiss A., 2013, DISTILLATION EXTRACT
   Kossack S, 2008, CHEM ENG RES DES, V86, P781, DOI 10.1016/j.cherd.2008.01.008
   Krzyzaniak A, 2011, CHEM ENGINEER TRANS, V24, P709, DOI 10.3303/CET1124119
   Laurence C., 2009, LEWIS BASICITY AFFIN
   Laurence C, 2011, J CHEM EDUC, V88, P1651, DOI 10.1021/ed200057b
   Lei ZG, 2003, SEP PURIF REV, V32, P121, DOI 10.1081/SPM-120026627
   Lek-utaiwan P, 2011, COMPUT CHEM ENG, V35, P1088, DOI 10.1016/j.compchemeng.2010.12.005
   Liebergesell B, 2017, FLUID PHASE EQUILIBR, V446, P36, DOI 10.1016/j.fluid.2017.04.014
   Luther SK, 2015, ANAL CHEM, V87, P8165, DOI 10.1021/acs.analchem.5b00699
   Falleiro RMM, 2010, J CHEM THERMODYN, V42, P70, DOI 10.1016/j.jct.2009.07.008
   Meindersma GW, 2005, FUEL PROCESS TECHNOL, V87, P59, DOI 10.1016/j.fuproc.2005.06.002
   ROBBINS LA, 1980, CHEM ENG PROG, V76, P58
   de Rivera MR, 2009, INT J MOL SCI, V10, P2911, DOI 10.3390/ijms10072911
   Seader J.D., 2011, SEPARATION PROCESS P
   Sprakel L.M.J., 2018, CHEM ENG T, V69, P529
   Sprakel LMJ, 2019, J MOL LIQ, V283, P312, DOI 10.1016/j.molliq.2019.03.060
   Sprakel LMJ, 2019, CHEM ENG RES DES, V144, P123, DOI 10.1016/j.cherd.2019.01.024
   Sprakel LMJ, 2019, J IND ENG CHEM, V72, P364, DOI 10.1016/j.jiec.2018.12.038
   Sprakel LMJ, 2018, IND ENG CHEM RES, V57, P12574, DOI 10.1021/acs.iecr.8b03066
   TAFT RW, 1985, J SOLUTION CHEM, V14, P153, DOI 10.1007/BF00647061
   van Dyk B, 2000, IND ENG CHEM RES, V39, P1423, DOI 10.1021/ie9904753
   White WC, 2007, CHEM-BIOL INTERACT, V166, P10, DOI 10.1016/j.cbi.2007.01.009
   YEH A, 1988, CHEM ENG COMMUN, V68, P69, DOI 10.1080/00986448808940398
   Zhou T., 2019, IND ENG CHEM RES
NR 42
TC 0
Z9 0
U1 27
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115203
DI 10.1016/j.ces.2019.115203
PG 15
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400016
DA 2020-05-12
ER

PT J
AU Tailleur, RG
AF Tailleur, Roberto Galiasso
TI Hydrogenation and hydrodesulfurization in gas phase of light
   hydrocarbons from hydrocracking, desulfurization and delayed coking. I
   catalyst deactivation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Kinetic and deactivation rates; Hydrogenation; Coke deposition; Reactor
   simulation; Coke composition
ID SELECTIVE HYDROGENATION; FCC GASOLINE; HYDROTREATING CATALYSTS; COKE
   DEPOSITION; LOW-SULFUR; OLEFINS; REACTORS; NAPHTHA; REACTIVITY
AB Hydrogenation and hydrodesulfurization reactions of hydrocarbons in gas phase was studied in a fluidized-bed reactor using PdNiW/TiO2-Al2O3 and NiMo/TiO2Al2O3 catalysts. Catalyst deactivation was performed at different temperatures and using hydrocracking product with and without delayed coking naphtha feeds. Delta of species and catalysts activities were measured, and catalyst characterized by physical and chemical properties, metals and carbon dispersion, acid sites content and benzene diffusivity in hydrogen. Coke was extracted by CS2 and analyzed by MAS C-13 NMR. There are different rates of sites deactivation when processing gas feed with or without olefinic hydrocarbons on these catalysts. Olefins and diolefins produce carbon deposits fast; carbon distribution across the radius of particle depend on temperature and amounts of aromatics in the feed. Reaction and deactivation rates constants were obtained for each of catalysts. The simulation model used only predicted well products properties without olefins and diolefins. The mechanism of reaction are discusses based on solid characterizations. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tailleur, Roberto Galiasso] Univ Simon Bolivar, Dept Thermodynam, Baruta 8900, Miranda, Venezuela.
   [Tailleur, Roberto Galiasso] HyPro Consultant, 4250 Corrine Dr,Suite 204, Orlando, FL 32814 USA.
RP Tailleur, RG (reprint author), Univ Simon Bolivar, Dept Thermodynam, Baruta 8900, Miranda, Venezuela.; Tailleur, RG (reprint author), HyPro Consultant, 4250 Corrine Dr,Suite 204, Orlando, FL 32814 USA.
EM roberto.galiasso@gmail.com
OI Galiasso Tailleur, Roberto Emilio/0000-0002-7631-3674
CR Alzaid A, 2018, FUEL, V221, P206, DOI 10.1016/j.fuel.2018.02.030
   Argyle MD, 2015, CATALYSTS, V5, P145, DOI 10.3390/catal5010145
   Badawi M, 2010, J MOL CATAL A-CHEM, V320, P34, DOI 10.1016/j.molcata.2009.12.012
   Bartholomew CH, 2001, APPL CATAL A-GEN, V212, P17, DOI 10.1016/S0926-860X(00)00843-7
   Betti C, 2016, REACT KINET MECH CAT, V117, P283, DOI 10.1007/s11144-015-0910-8
   Brussaneze A, 2001, CAN J CHEM ENG, V79, P524
   Bunyard E., 1999, GAS OIL J, P17
   Butt J. B., 1988, ACTIVATION DEACTIVAT
   Chernysheva EA, 2005, CHEM TECH FUELS OIL+, V41, P146, DOI 10.1007/s10553-005-0037-0
   Diao SG, 2005, APPL CATAL A-GEN, V286, P30, DOI 10.1016/j.apcata.2005.02.026
   DIEZ F, 1990, IND ENG CHEM RES, V29, P1999, DOI 10.1021/ie00106a004
   Farina C, 2019, CHEM ENG SCI
   Farina C, 2019, APPL CAT UNPUB
   Forzatti P, 1999, CATAL TODAY, V52, P165, DOI 10.1016/S0920-5861(99)00074-7
   FROMENT GF, 1961, CHEM ENG SCI, V16, P189, DOI 10.1016/0009-2509(61)80030-4
   GALIASSO R, 1983, FUEL, V62, P817, DOI 10.1016/0016-2361(83)90034-0
   Galiasso Tailleur R, 2007, P EUR C CHEM ENG ECC
   Galiasso Tailleur R, 2010, AICHE M MARCH 21 201
   Tailleur RG, 2017, FUEL, V199, P299, DOI 10.1016/j.fuel.2017.02.058
   Tailleur RG, 2014, CATAL TODAY, V220, P133, DOI 10.1016/j.cattod.2013.10.006
   Guisnet M, 2001, APPL CATAL A-GEN, V212, P83, DOI 10.1016/S0926-860X(00)00845-0
   Kim JS, 2001, KOREAN J CHEM ENG, V18, P463, DOI 10.1007/BF02698291
   Lengyel A, 2010, PETROL SCI TECHNOL, V28, P946, DOI 10.1080/10916460902937059
   Magyar S, 2008, FUEL PROCESS TECHNOL, V89, P736, DOI 10.1016/j.fuproc.2007.12.005
   Marafi M, 2001, PETROL SCI TECHNOL, V19, P697, DOI 10.1081/LFT-100105284
   Miller JT, 2000, J CATAL, V193, P123, DOI 10.1006/jcat.2000.2873
   Moulijn JA, 2001, APPL CATAL A-GEN, V212, P3, DOI 10.1016/S0926-860X(00)00842-5
   Pacheco ME, 2011, IND ENG CHEM RES, V50, P5975, DOI 10.1021/ie1023595
   Palmisano E., 2002, US patent, Patent No. [6444116 us, 6444116]
   Ramirez J, 2008, DESULFURIZACION HIDR
   Tailleur RG, 2008, FUEL, V87, P3694, DOI 10.1016/j.fuel.2008.07.012
   Tailleur RG, 2005, COMPUT CHEM ENG, V29, P2404, DOI 10.1016/j.compchemeng.2005.05.012
   Tailleur RG, 2005, APPL CATAL A-GEN, V282, P227, DOI 10.1016/j.apcata.2004.12.014
   Tailleur RG, 2008, FUEL PROCESS TECHNOL, V89, P808, DOI 10.1016/j.fuproc.2008.01.012
   Tailleur RG, 2008, CATAL TODAY, V130, P492, DOI 10.1016/j.cattod.2007.10.074
   Tailleur RG, 2006, FUEL PROCESS TECHNOL, V87, P759, DOI 10.1016/j.fuproc.2005.12.005
   Toba M, 2005, CATAL TODAY, V104, P64, DOI 10.1016/j.cattod.2005.03.027
   Toba M, 2007, APPL CATAL B-ENVIRON, V70, P542, DOI 10.1016/j.apcatb.2005.12.026
   Vogelaar BM, 2007, FUEL, V86, P1122, DOI 10.1016/j.fuel.2006.10.002
   Wen X, 2013, APPL CATAL A-GEN, V468, P204, DOI 10.1016/j.apcata.2013.08.040
   Wivel P., 1991, STUDIES SURFACE SCI, V68, P257
   Wood J, 2003, APPL CATAL A-GEN, V249, P241, DOI 10.1016/S0926-860X(03)00200-X
   Xin Q, 2018, ENERG FUEL, V32, P6167, DOI 10.1021/acs.energyfuels.8b00344
   ZEUTHEN P, 1994, STUD SURF SCI CATAL, V88, P199
   Zhou ZM, 2007, CHEM ENG TECHNOL, V30, P105, DOI 10.1002/ceat.200600293
NR 45
TC 2
Z9 2
U1 38
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115195
DI 10.1016/j.ces.2019.115195
PG 21
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400007
DA 2020-05-12
ER

PT J
AU Torraga, MGF
   Colman, MME
   Giudici, R
AF Torraga, Maria G. F.
   Colman, Maria M. E.
   Giudici, Reinaldo
TI Hydrolysis of acetic anhydride: In situ, real-time monitoring using NIR
   and UV-Vis spectroscopy
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Acetic anhydride; Monitoring; NIR; UV-Vis; Kinetics
ID NONADIABATIC CALORIMETRIC DETERMINATION; KINETICS; ACID; TEMPERATURE;
   REACTOR; PARAMETERS
AB Hydrolysis of acetic anhydride is a fast and very exothermic reaction that has been studied with different analytical techniques to account for the reaction progress. This work presents the real-time monitoring of the hydrolysis of acetic anhydride using in situ NIR and UV-Vis spectroscopy, under non-isothermal and non-adiabatic conditions. The experimental apparatus consists of a reaction vessel equipped with a magnetic stirrer, NIR and UV-Vis immersion probes and a thermocouple. Two multivariate models are proposed to account for the conversion of acetic anhydride as a function of time, one for NIR and other for UV-Vis. The calibration data were generated by calorimetry. The external validation permits the assessment of the adherence of the model to data not used for calibration. The results show that both models can be useful to monitor this hydrolysis, employing a simple and intuitive apparatus. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Torraga, Maria G. F.; Colman, Maria M. E.; Giudici, Reinaldo] Univ Sao Paulo, Dept Chem Engn, Escola Politecn, Av Prof Luciano Gualberto Travessa 3,380, BR-05508010 Sao Paulo, SP, Brazil.
RP Giudici, R (reprint author), Univ Sao Paulo, Dept Chem Engn, Escola Politecn, Av Prof Luciano Gualberto Travessa 3,380, BR-05508010 Sao Paulo, SP, Brazil.
EM rgiudici@usp.br
RI Giudici, Reinaldo/C-3467-2012
OI Giudici, Reinaldo/0000-0001-6544-7098; Torraga, Maria Giuliana
   Fontanelli/0000-0003-1000-9060
FU FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/50684-9]; CNPq -
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [309444/2016-0]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - BrasilCAPES [001]
FX This study was financed in part by FAPESP - Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (grant number 15/50684-9), CNPq -
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant
   number 309444/2016-0), and CAPES - Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (Finance Code 001).
CR Ampelli C, 2003, J THERM ANAL CALORIM, V72, P875, DOI 10.1023/A:1025074400414
   Asprey SP, 1996, CHEM ENG SCI, V51, P4681, DOI 10.1016/0009-2509(96)00306-5
   Assirelli M, 2011, ORG PROCESS RES DEV, V15, P610, DOI 10.1021/op100337v
   Bell WC, 1998, ANAL CHEM, V70, P332, DOI 10.1021/ac9707141
   BUNTON CA, 1962, J CHEM SOC, P4478, DOI 10.1039/jr9620004478
   BUNTON CA, 1966, J ORG CHEM, V31, P3764, DOI 10.1021/jo01349a064
   Chicoma D, 2010, MACROMOL SYMP, V289, P140, DOI 10.1002/masy.200900018
   Chicoma DL, 2011, MACROMOL REACT ENG, V5, P150, DOI 10.1002/mren.201000049
   CLELAND FA, 1956, AICHE J, V2, P489, DOI 10.1002/aic.690020414
   Colman MME, 2014, BRAZ J CHEM ENG, V31, P925, DOI 10.1590/0104-6632.20140314s00002719
   Giudici R, 2016, CHEM ENG SCI, V144, P446, DOI 10.1016/j.ces.2016.01.012
   GLASSER D, 1971, IND ENG CHEM FUND, V10, P516, DOI 10.1021/i160039a027
   GOLDING JA, 1978, CAN J CHEM ENG, V56, P564, DOI 10.1002/cjce.5450560507
   Haji S., 2005, CHEM ENG EDUC, V39, P1
   Hirota WH, 2010, CHEM ENG SCI, V65, P3849, DOI 10.1016/j.ces.2010.03.028
   JANSSEN HJ, 1957, IND ENG CHEM, V49, P197, DOI 10.1021/ie50566a028
   Kralj AK, 2007, J IND ENG CHEM, V13, P631
   Orton KJP, 1912, J CHEM SOC, V101, P1708, DOI 10.1039/ct9120101708
   Puxty G, 2005, J CHEMOMETR, V19, P329, DOI 10.1002/cem.936
   Wiseman FL, 2017, RSC ADV, V7, P28965, DOI 10.1039/c7ra05260j
   Wiseman FL, 2012, J PHYS ORG CHEM, V25, P1105, DOI 10.1002/poc.2945
   Zogg A, 2004, CHEMOMETR INTELL LAB, V71, P165, DOI 10.1016/j.chemolab.2004.01.025
NR 22
TC 0
Z9 0
U1 16
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115244
DI 10.1016/j.ces.2019.115244
PG 9
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400008
DA 2020-05-12
ER

PT J
AU Yan, D
   Li, HZ
   Hu, CQ
   Zhu, QS
   Xie, ZH
AF Yan, Dong
   Li, Hongzhong
   Hu, Chaoquan
   Zhu, Qingshan
   Xie, Zhaohui
TI Simulation of mass transfer in downer fluidized beds with a
   structure-based consideration
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Mass transfer; Downer reactor; Heterogeneous structure; Computational
   fluid dynamics
ID SOLID RISER FLOWS; TRANSFER MODEL; GAS; DOWNFLOW; HYDRODYNAMICS;
   REACTOR; PERFORMANCE
AB The gas-solid mass transfer in the downer fluidized bed is analyzed theoretically in this work. Compared to the homogeneous assumption in each calculating grid, a structure-based model was proposed that the process was divided into the mass transfer in the cluster and dispersed phases. Simulations were performed with the cooperation of the Euler-Euler two-fluid method. The model predictions are in good agreement with the previous reported experimental measurements under a wide range of operating conditions. Simulated ozone profiles show a sharp conversion in the acceleration region, and a gentle conversion in the fully developed region. The transition point is well consistent with the boundary measured experimentally. These results show that the consideration of the heterogeneous structure results in a better understanding and prediction of mass transfer in downers. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yan, Dong; Li, Hongzhong; Hu, Chaoquan; Zhu, Qingshan; Xie, Zhaohui] Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, POB 353, Beijing 100190, Peoples R China.
   [Zhu, Qingshan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Li, HZ; Zhu, QS (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, POB 353, Beijing 100190, Peoples R China.
EM hzli@ipe.ac.cn; qszhu@ipe.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21736010]; State Key Development Program for Basic
   Research of China (973 Program)National Basic Research Program of
   ChinaState Key Development Program for Basic Research of China
   [2015CB251402]; Center for Mesoscience, Institute of Process Engineering
   (IPE), Chinese Academy of Sciences (CAS) [COM2016A001, MPCS-2017-A-02]
FX The authors are grateful to the National Natural Science Foundation of
   China under Grant No. 21736010 and the State Key Development Program for
   Basic Research of China (973 Program) under Grant No. 2015CB251402. We
   would also like to acknowledge the funding provided by the Center for
   Mesoscience, Institute of Process Engineering (IPE), Chinese Academy of
   Sciences (CAS), via Grant COM2016A001 and MPCS-2017-A-02.
CR Abbasi A, 2013, AICHE J, V59, P1635, DOI 10.1002/aic.13956
   Bolland O, 2001, CHEM ENG COMMUN, V187, P1, DOI 10.1080/00986440108912877
   Cao CS, 2000, AICHE J, V46, P515, DOI 10.1002/aic.690460310
   Chalermsinsuwan B, 2009, CHEM ENG SCI, V64, P1212, DOI 10.1016/j.ces.2008.11.006
   Chen HZ, 2005, POWDER TECHNOL, V158, P115, DOI 10.1016/j.powtec.2005.04.023
   Cheng Y, 2008, POWDER TECHNOL, V183, P364, DOI 10.1016/j.powtec.2008.01.022
   Dong WG, 2008, CHEM ENG SCI, V63, P2798, DOI 10.1016/j.ces.2008.01.038
   Dong WG, 2008, CHEM ENG SCI, V63, P2811, DOI 10.1016/j.ces.2008.01.039
   Fan C, 2008, STUDY REACTION HYDRO
   Fan C, 2008, CHEM ENG J, V140, P539, DOI 10.1016/j.cej.2007.11.040
   Fan CG, 2008, CAN J CHEM ENG, V86, P436, DOI 10.1002/cjce.20066
   FRYER C, 1976, AICHE J, V22, P38, DOI 10.1002/aic.690220104
   Higbie R, 1935, T AM INST CHEM ENG, V31, P365
   Hou B, 2011, BASIC RES RELATIONSH
   Hou BL, 2013, CHEM ENG SCI, V102, P354, DOI 10.1016/j.ces.2013.06.050
   Hou BL, 2010, CHEM ENG J, V163, P108, DOI 10.1016/j.cej.2010.07.028
   Hou BL, 2010, CHEM ENG J, V157, P509, DOI 10.1016/j.cej.2009.12.047
   Jung K., 1983, SHERWOOD NUMBERS BUR, P427
   KIM JM, 1983, AICHE J, V29, P353, DOI 10.1002/aic.690290302
   Krol S, 2000, POWDER TECHNOL, V108, P6, DOI 10.1016/S0032-5910(99)00196-5
   LANAUZE RD, 1984, CHEM ENG SCI, V39, P1623, DOI 10.1016/0009-2509(84)80089-5
   Li DB, 2011, CHEM ENG SCI, V66, P4615, DOI 10.1016/j.ces.2011.06.027
   Li HZ, 2010, PARTICUOLOGY, V8, P631, DOI 10.1016/j.partic.2010.07.018
   Li S., 2003, CHINA PART, V1, P258
   Liu CF, 2015, CHEM ENG SCI, V122, P114, DOI 10.1016/j.ces.2014.09.002
   Liu F., 2006, CHINA PART, V4, P160
   Liu WM, 2017, POWDER TECHNOL, V314, P367, DOI 10.1016/j.powtec.2016.09.087
   Lu XS, 2005, CHEM ENG J, V112, P23, DOI 10.1016/j.cej.2005.06.002
   Luo BL, 2007, CHEM ENG J, V132, P9, DOI 10.1016/j.cej.2007.01.008
   Lv XL, 2016, POWDER TECHNOL, V292, P323, DOI 10.1016/j.powtec.2016.02.001
   OUYANG S, 1995, AICHE J, V41, P1534, DOI 10.1002/aic.690410617
   Prajongkan Y, 2012, CHEM ENG PROCESS, V59, P22, DOI 10.1016/j.cep.2012.05.002
   RICHARDSON JF, 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8
   Sun G, 1991, INFLUENCE PARTICLE S
   Wang JW, 2008, CHEM ENG SCI, V63, P1553, DOI 10.1016/j.ces.2007.11.023
   Wei F, 1996, CHEM ENG J, V64, P345, DOI 10.1016/S0923-0467(96)85016-0
   Yan D, 2018, PARTICUOLOGY, V39, P40, DOI 10.1016/j.partic.2017.09.003
   Zhang DZ, 2002, INT J MULTIPHAS FLOW, V28, P805, DOI 10.1016/S0301-9322(02)00005-8
   Zhang H, 1999, CHEM ENG SCI, V54, P5461, DOI 10.1016/S0009-2509(99)00284-5
   Zhang H, 2001, AICHE J, V47, P2000, DOI 10.1002/aic.690470911
   ZHU JX, 1995, CAN J CHEM ENG, V73, P662, DOI 10.1002/cjce.5450730510
   Zimmermann S, 2005, IND ENG CHEM RES, V44, P9818, DOI 10.1021/ie050490+
NR 42
TC 1
Z9 1
U1 10
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115235
DI 10.1016/j.ces.2019.115235
PG 9
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400019
DA 2020-05-12
ER

PT J
AU Yu, P
   Wong, HW
AF Yu, Peng
   Wong, Hsi-Wu
TI Propane pyrolysis facilitated by phenyl radicals: A combined
   experimental and kinetic modeling study
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Propane pyrolysis; Phenyl radicals; Olefin production; Kinetic modeling;
   Hydrogen abstraction
ID HYDROGEN-ATOM ABSTRACTION; OXIDATIVE DEHYDROGENATION; ALKOXY RADICALS;
   N-BUTANE; OXIDE; CATALYSTS; MECHANISM; ALKANES; DECOMPOSITION; SUPPORTS
AB Phenyl radicals generated from nitrobenzene were introduced as hydrogen abstraction agents to accelerate propylene formation from propane pyrolysis. Neat propane pyrolysis and propane pyrolysis facilitated by phenyl radicals were carried out between 550 degrees C and 650 degrees C. Our experiments showed that phenyl facilitated pyrolysis gave higher propane conversion over neat reactions, with yields of all main products increased. However, propylene selectivity in phenyl facilitated pyrolysis decreased in favor of methane and ethylene. Results from detailed kinetic modeling showed that the formation of normal propyl and isopropyl radicals was accelerated due to increased hydrogen abstraction of propane by phenyl radicals. Decreased propylene selectivity in phenyl facilitated pyrolysis was resulted from the increased rates of secondary reactions converting propylene into ethylene and methane. Our work demonstrates that a suitable free radical could facilitate propane pyrolysis for higher propylene yields. However, the balance between propylene yields and selectivity remains a major challenge. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yu, Peng; Wong, Hsi-Wu] Univ Massachusetts Lowell, Dept Chem Engn, One Univ Ave, Lowell, MA 01854 USA.
RP Wong, HW (reprint author), Univ Massachusetts Lowell, Dept Chem Engn, One Univ Ave, Lowell, MA 01854 USA.
EM hsiwu_wong@uml.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CBET-1842101]; UMass Lowell Faculty Startup Funds
FX Funding supports from the National Science Foundation (CBET-1842101) and
   UMass Lowell Faculty Startup Funds are greatly appreciated.
CR Altarawneh M, 2011, J COMPUT CHEM, V32, P1725, DOI 10.1002/jcc.21756
   Bhasin MM, 2001, APPL CATAL A-GEN, V221, P397, DOI 10.1016/S0926-860X(01)00816-X
   Bruijnincx PCA, 2013, ANGEW CHEM INT EDIT, V52, P11980, DOI 10.1002/anie.201305058
   Craig R, 1986, HDB PETROLEUM REFINI, P4
   Curran HJ, 1998, COMBUST FLAME, V114, P149, DOI 10.1016/S0010-2180(97)00282-4
   Deng L, 2014, CATAL TODAY, V232, P33, DOI 10.1016/j.cattod.2013.10.064
   DROEGE AT, 1986, J PHYS CHEM-US, V90, P5937, DOI 10.1021/j100280a096
   EON JG, 1994, J CATAL, V145, P318, DOI 10.1006/jcat.1994.1040
   Francisco CG, 2002, ORG LETT, V4, P1959, DOI 10.1021/ol025981u
   GONZALEZ AC, 1985, J PHYS CHEM-US, V89, P4809, DOI 10.1021/j100268a030
   GRILLER D, 1974, J AM CHEM SOC, V96, P630, DOI 10.1021/ja00809a076
   HIDAKA Y, 1989, INT J CHEM KINET, V21, P689, DOI 10.1002/kin.550210808
   Jibril BY, 2004, APPL CATAL A-GEN, V264, P193, DOI 10.1016/j.apcata.2003.12.054
   Kerr R.A, 2010, NATURAL GAS SHALE BU
   Khodakov A, 1998, J CATAL, V177, P343, DOI 10.1006/jcat.1998.2143
   Kruse TM, 2001, CHEM ENG SCI, V56, P971, DOI 10.1016/S0009-2509(00)00312-2
   LAYOKUN SK, 1979, IND ENG CHEM PROC DD, V18, P232, DOI 10.1021/i260070a008
   Lee MH, 2014, CATAL TODAY, V232, P53, DOI 10.1016/j.cattod.2013.10.011
   Li W, 2018, COMBUST FLAME, V191, P126, DOI 10.1016/j.combustflame.2018.01.002
   Luo Y.R., 2012, CRC HDB CHEM PHYS, P89
   MCCARTHY E, 1980, J ORG CHEM, V45, P2086, DOI 10.1021/jo01299a010
   Mentasty LR, 1999, IND ENG CHEM RES, V38, P396, DOI 10.1021/ie9802562
   Michorczyk P, 2003, APPL CATAL A-GEN, V251, P425, DOI 10.1016/S0926-860X(03)00368-5
   National Academies of Sciences Engineering and Medicine, 2016, CHANG LANDSC HYDR FE
   Nawaz Z, 2015, REV CHEM ENG, V31, P413, DOI 10.1515/revce-2015-0012
   Park J, 2004, INT J CHEM KINET, V36, P49, DOI 10.1002/kin.10171
   PAUL H, 1978, J AM CHEM SOC, V100, P4520, DOI 10.1021/ja00482a033
   Qi W, 2014, ACS CATAL, V4, P3212, DOI 10.1021/cs500723v
   Sattler JJHB, 2014, CHEM REV, V114, P10613, DOI 10.1021/cr5002436
   Sattler JJHB, 2014, ANGEW CHEM INT EDIT, V53, P9251, DOI 10.1002/anie.201404460
   Schweitzer NM, 2014, ACS CATAL, V4, P1091, DOI 10.1021/cs401116p
   Smith G, 1999, GRI MECH 3 0
   Stevens P., 2012, SHALE GAS REVOLUTION
   Tuazon EC, 2003, INT J CHEM KINET, V35, P415, DOI 10.1002/kin.10143
   TULLY FP, 1986, J PHYS CHEM-US, V90, P691, DOI 10.1021/j100276a042
   Wang Q, 2014, RENEW SUST ENERG REV, V30, P1, DOI 10.1016/j.rser.2013.08.065
   Wittcoff H.A, 2004, IND ORGANIC CHEM, P168
   Zhang YW, 2014, J MOL CATAL A-CHEM, V381, P138, DOI 10.1016/j.molcata.2013.10.007
   Zhao J, 2003, CHEM PHYS LETT, V369, P204, DOI 10.1016/S0009-2614(02)02006-7
   ZOU RJ, 1986, IND ENG CHEM PROC DD, V25, P828, DOI 10.1021/i200034a040
NR 40
TC 0
Z9 0
U1 25
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 31
PY 2019
VL 210
AR UNSP 115243
DI 10.1016/j.ces.2019.115243
PG 8
WC Engineering, Chemical
SC Engineering
GA JG3EF
UT WOS:000491956400017
DA 2020-05-12
ER

PT J
AU AL-Washali, T
   Sharma, S
   Lupoja, R
   AL-Nozaily, F
   Haidera, M
   Kennedy, M
AF AL-Washali, Taha
   Sharma, Saroj
   Lupoja, Robert
   AL-Nozaily, Fadhl
   Haidera, Mansour
   Kennedy, Maria
TI Assessment of water losses in distribution networks: Methods,
   applications, uncertainties, and implications in intermittent supply
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Water loss; Water balance; Leakage; Real losses; Apparent losses;
   Intermittent supply
ID LEAKAGE; SYSTEMS; BALANCE; COSTS
AB Reducing all water loss components to zero is neither technically possible nor economically viable. The water loss components should be accurately assessed and prioritised for a reduction. This paper investigates all methods that break down the water losses in distribution networks into apparent and real losses. Their accuracies and uncertainties are discussed and applications to three case studies in developing countries are presented. The results show that different methods estimate the water loss components differently. Consequently, different reduction measures are planned and prioritised. Interestingly, the least accurate methods have a low level of uncertainty, but more realistic assumptions yield higher uncertainties. This suggests that the uncertainty analysis only assists in improving the outputs of each of the methods but does not demonstrate their accuracy. The cost of water loss varies depending on the used assessment method and the economic feasibility of the reduction measures is significantly influenced. The water loss components should therefore be assessed for the whole network using at least two methods to reasonably model and monitor the loss reduction in water distribution networks.
C1 [AL-Washali, Taha; Kennedy, Maria] Delft Univ Technol, Dept Civil Engn & Geosci, Stevinweg 1, NL-2628 CN Delft, Netherlands.
   [AL-Washali, Taha; Sharma, Saroj; Kennedy, Maria] IHE Delft Inst Water Educ, Dept Environm Engn & Water Technol, Westvest 7, NL-2611 AX Delft, Netherlands.
   [AL-Washali, Taha; AL-Nozaily, Fadhl; Haidera, Mansour] Sanaa Univ, Water & Environm Ctr, Sanaa, Yemen.
   [Lupoja, Robert] Mwanza Urban Water Supply & Sanitat Author, Mwanza, Tanzania.
RP AL-Washali, T (reprint author), IHE Delft Inst Water Educ, Westvest 7, NL-2611 AX Delft, Netherlands.
EM t.alwashali@un-ihe.org
FU Niche 27 Project of the Dutch Organisation for Internationalisation in
   Education (NUFFIC), the NetherlandsNetherlands Government; Water and
   Environment Centre of the Sana'a University, Yemen; MetaMeta Research,
   the NetherlandsNetherlands Government
FX This work was funded by the Niche 27 Project of the Dutch Organisation
   for Internationalisation in Education (NUFFIC), the Netherlands; Water
   and Environment Centre of the Sana'a University, Yemen; and MetaMeta
   Research, the Netherlands. The authors thank the water utilities for
   their support during the field work and for providing detailed data
   necessary for the analyses.
CR AL-Washali T, IMPACT FLOAT V UNPUB
   AL-Washali T, 2019, WATER-SUI, V11, DOI 10.3390/w11010048
   AL-Washali T, 2016, WATER RESOUR MANAG, V30, P4985, DOI 10.1007/s11269-016-1503-7
   AL-Washali TM, 2018, J WATER RES PLAN MAN, V144, DOI [10.1061/(asce)wr.1943-5452.0000925, 10.1061/(ASCE)WR.1943-5452.0000925]
   Alegre H., 2016, PERFORMANCE INDICATO
   Alegre H., 2000, PERFORMANCE INDICATO
   ALWASHALI T, 2019, [No title captured], V11, DOI DOI 10.3390/W11061220
   Arregui F., 2007, INTEGRATED WATER MET
   AWWA, 2009, LOSS CONTR PROGR MAN
   AWWA, 2016, M36 WAT AUD LOSS CON
   Connor R, 2017, 9231002015 UN WORLD
   Deuerlein JW, 2008, J HYDRAUL ENG-ASCE, V134, P822, DOI 10.1061/(ASCE)0733-9429(2008)134:6(822)
   Dighade R. R., 2014, INT J INNOVATIVE RES, V3, P13838
   Eugine M., 2017, AM J WATER RESOUR, V5, P1
   European Commission, 2015, EU REF DOC GOOD PRAC
   Fanner P, 2005, P IWA WAT LOSS 2005
   Fantozzi M, 2012, P IWA WAT LOSS C MAN, P26
   Farah E, 2017, WATER RESOUR MANAG, V31, P4821, DOI 10.1007/s11269-017-1780-9
   Farley M, 2008, MANAGERS NONREVENUE
   Farley M., 2003, LOSSES WATER DISTRIB
   Frauendorfer R., 2010, ISSUES CHALLENGES RE
   Galdiero E, 2016, J HYDROINFORM, V18, P49, DOI 10.2166/hydro.2015.023
   Hamilton S, 2014, WATER MANAGEMENT AND WATER LOSS, P1
   Hope VS, 2001, URBAN WATER, V3, P261, DOI DOI 10.1016/S1462-0758(01)00046-2
   Kanakoudis V, 2014, URBAN WATER J, V11, P348, DOI 10.1080/1573062X.2013.806563
   Kanakoudis V, 2012, WATER-SUI, V4, P45, DOI 10.3390/w4010045
   Kesavan H., 1972, J HYDRAULICS DIVISIO, V98, P345
   LAMBERT A, 1994, J INST WATER ENV MAN, V8, P205
   Lambert A., 2017, IWA WAT EFF 2017 C 1
   Lambert A., 2010, WATER LOSS GUIDELINE
   Lambert A., 2005, P IWA SPEC C LEAK 20, P310
   Lambert A, 2019, IWA C SYST APPR LEAK
   Lambert A., 2014, P IWA SPEC C WAT LOS
   Lambert A., 2000, LOSSES WATER SUPPLY
   Lambert AO, 2005, WA SCI TECHNOL, V5, P263
   Lambert AO, 1999, J WATER SERV RES TEC, V48, P227
   Liemberger R, 2019, WATER SCI TECH-W SUP, V19, P831, DOI 10.2166/ws.2018.129
   Liemberger R., 2004, P IWA SPEC C 4 IWA W
   May J., 1994, PRESSURE DEPENDENT L
   McKenzie R.S, 2003, WATER DEMAND MANAGEM
   Molinos-Senante M, 2016, SCI TOTAL ENVIRON, V568, P180, DOI 10.1016/j.scitotenv.2016.06.020
   Morrison J, 2007, DISTRICT METERED ARE
   Mutikanga HE, 2011, WATER ENVIRON J, V25, P327, DOI 10.1111/j.1747-6593.2010.00225.x
   Mutikanga H.E., 2012, THESIS
   Mutikanga HE, 2013, J WATER RES PLAN MAN, V139, P166, DOI 10.1061/(ASCE)WR.1943-5452.0000245
   Pearson D., 2005, IWA WAT LOSS 2005 C
   Puust R, 2010, URBAN WATER J, V7, P25, DOI 10.1080/15730621003610878
   Rubinstein R. Y., 2016, SIMULATION MONTE CAR
   Seago C, 2004, WATER SA, V30, P573
   Sturm R., 2014, REAL LOSS COMPONENT
   Taylor J., 1997, INTRO ERROR ANAL STU
   Thornton J., 2008, WATER LOSS CONTROL
   van Zyl JE, 2017, J HYDRAUL ENG, V143, DOI 10.1061/(ASCE)HY.1943-7900.0001346
   van Zyl JE, 2014, J HYDRAUL ENG, V140, P182, DOI 10.1061/(ASCE)HY.1943-7900.0000813
   Vasconcellos AB, 2009, 2009 BRAZILIAN POWER ELECTRONICS CONFERENCE, VOLS 1 AND 2, P189
   Vermersch M., 2016, GUIDANCE NOTES APPAR
   Vermersch M., 2008, WATER, V10, P39
   Wyatt A.S, 2010, NONREVENUE WATER FIN
NR 58
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104515
DI 10.1016/j.resconrec.2019.104515
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700012
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Bag, S
   Wood, LC
   Mangla, SK
   Luthra, S
AF Bag, Surajit
   Wood, Lincoln C.
   Mangla, Sachin K.
   Luthra, Sunil
TI Procurement 4.0 and its implications on business process performance in
   a circular economy
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Business process; Circular economy; Dynamic capability view theory;
   Optimization; Procurement 4.0
ID SUPPLY CHAIN MANAGEMENT; BIG DATA ANALYTICS; DYNAMIC CAPABILITIES;
   IMPLEMENTATION; INFORMATION; IMPACT; SUSTAINABILITY; TIME; BARRIERS;
   STRATEGY
AB The purpose of this study is to identify how Procurement 4.0 and digital transformations are related and how digital transformation impacts the intention to optimize the procurement process in the circular economy. The moderating effect of information processing capability is also investigated. We survey South African manufacturers and analyze survey results using the Partial Least Squares Structural Equation Modelling (PLS-SEM) approach to test the research hypotheses and our theoretical framework. Finally, a sample business process is simulated to evaluate how Industry 4.0 automation can influence organizational procurement process optimization and circular economy performance. The findings of this empirical study indicate that Procurement 4.0 strategy positively influences buyers' intention to optimize business processes. Second, Procurement 4.0 performance review positively influences buyers' intention to optimize business processes. Third, information processing capability moderates the effect of Procurement 4.0 performance review on buyers' intention to optimize business processes. Finally, buyers' intention to optimize business processes plays a key role in enhancing circular economy performance. The simulation results demonstrate the potential benefits from industry 4.0 applications in the procurement function in a circular economy.
C1 [Bag, Surajit] Univ Johannesburg, Post Grad Sch Engn Management, Fac Engn & Built Environm, Johannesburg, South Africa.
   [Wood, Lincoln C.] Univ Otago, Dunedin, New Zealand.
   [Mangla, Sachin K.] Univ Plymouth, Plymouth Business Sch, Plymouth, Devon, England.
   [Luthra, Sunil] State Inst Engn & Technol, Dept Mech Engn, Nilokheri 132117, Haryana, India.
RP Mangla, SK (reprint author), Univ Plymouth, Plymouth Business Sch, Plymouth, Devon, England.
EM surajit.bag@gmail.com; lincoln.wood@otago.ac.nz; sachinmangl@gmail.com;
   sunilluthra1977@gmail.com
RI Bag, Surajit/AAF-4874-2020; Luthra, Sunil/D-4135-2014
OI Luthra, Sunil/0000-0001-7571-1331; BAG, SURAJIT/0000-0002-2344-9551;
   KUMAR MANGLA, SACHIN/0000-0001-7166-5315
CR [Anonymous], 2016, PROCUREMENT 4 0 ARE
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Bag S, 2017, INT J INF SYST SUPPL, V10, P66, DOI 10.4018/IJISSCM.2017040104
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Barreto I, 2010, J MANAGE, V36, P256, DOI 10.1177/0149206309350776
   Bell JE, 2013, INT J PHYS DISTR LOG, V43, P351, DOI 10.1108/IJPDLM-03-2012-0092
   Beske P, 2012, INT J PHYS DISTR LOG, V42, P372, DOI 10.1108/09600031211231344
   Bienhaus F, 2018, BUS PROCESS MANAG J, V24, P965, DOI 10.1108/BPMJ-06-2017-0139
   Breidbach CF, 2015, SERV IND J, V35, P5, DOI 10.1080/02642069.2014.979404
   Brennan L, 2015, INT J OPER PROD MAN, V35, P1253, DOI 10.1108/IJOPM-03-2015-0135
   Brinch M, 2018, INT J OPER PROD MAN, V38, P1589, DOI 10.1108/IJOPM-05-2017-0268
   Carlucci D, 2015, PROD PLAN CONTROL, V26, P363, DOI 10.1080/09537287.2014.906678
   Cavusgil E, 2007, J MARKET THEORY PRAC, V15, P159, DOI 10.2753/MTP1069-6679150205
   Cecconet D, 2018, INT J HYDROGEN ENERG, V43, P500, DOI 10.1016/j.ijhydene.2017.07.231
   Cegielski CG, 2012, INT J LOGIST MANAG, V23, P184, DOI 10.1108/09574091211265350
   Chiang CY, 2012, INT J OPER PROD MAN, V32, P49, DOI 10.1108/01443571211195736
   Dahiru Tukur, 2008, Ann Ib Postgrad Med, V6, P21
   de Burca S, 2006, INT J OPER PROD MAN, V26, P1240, DOI 10.1108/01443570610705845
   Del Giudice M, 2016, BUS PROCESS MANAG J, V22, P263, DOI 10.1108/BPMJ-12-2015-0173
   Domenech T, 2019, RESOUR CONSERV RECY, V141, P76, DOI 10.1016/j.resconrec.2018.09.016
   Dubey R, 2015, INT J PROD RES, V53, P371, DOI 10.1080/00207543.2014.933909
   Easterby-Smith M, 2009, BRIT J MANAGE, V20, pS1, DOI 10.1111/j.1467-8551.2008.00609.x
   Ellen MacArthur Foundation, 2016, GROWTH CIRC EC VIS C
   Fatorachian H, 2018, PROD PLAN CONTROL, V29, P633, DOI 10.1080/09537287.2018.1424960
   Feger ALR, 2014, INT J OPER PROD MAN, V34, P941, DOI 10.1108/IJOPM-08-2012-0299
   Flynn B, 2018, J SUPPLY CHAIN MANAG, V54, P1, DOI 10.1111/jscm.12161
   Garcia-Rodriguez FJ, 2013, INT J PROD ECON, V141, P582, DOI 10.1016/j.ijpe.2012.09.015
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059
   Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005
   Glas A., 2016, INT J BUSINESS MANAG, V5, P55
   Hair J.F., 2014, PRIMER PARTIAL LEAST
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Huang YY, 2015, INT J OPER PROD MAN, V35, P2, DOI 10.1108/IJOPM-07-2013-0341
   Jabbour ABLD, 2019, J CLEAN PROD, V235, P1525, DOI 10.1016/j.jclepro.2019.06.349
   Janda S, 2001, J BUS IND MARK, V16, P294, DOI 10.1108/EUM0000000005502
   Kache F, 2017, INT J OPER PROD MAN, V37, P10, DOI 10.1108/IJOPM-02-2015-0078
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Klotzer C, 2015, PROCEEDINGS 2015 5TH INTERNATIONAL CONFERENCE ON THE INTERNET OF THINGS (IOT), P12, DOI 10.1109/IOT.2015.7356543
   Kock N, 2014, INT J E-COLLAB, V10, P1, DOI 10.4018/ijec.2014100101
   Kock N, 2010, INT PRO COM, P175, DOI 10.1109/IPCC.2010.5529831
   Kusiak A, 2018, INT J PROD RES, V56, P508, DOI 10.1080/00207543.2017.1351644
   Leslie L.L, 1972, SOC SCI RES, V1, P323, DOI DOI 10.1016/0049-089X(72)90080-4
   Leyer M, 2019, INT J OPER PROD MAN, V39, P24, DOI 10.1108/IJOPM-05-2017-0294
   Amui LBL, 2017, J CLEAN PROD, V142, P308, DOI 10.1016/j.jclepro.2016.07.103
   Lieder M, 2016, J CLEAN PROD, V115, P36, DOI 10.1016/j.jclepro.2015.12.042
   Jabbour ABLD, 2018, ANN OPER RES, V270, P273, DOI 10.1007/s10479-018-2772-8
   Majeed M., 2017, INT J SUPPLY CHAIN M, V6, P25
   Mangla S.K., 2018, ACHIEVING SUSTAINABI
   Mangla SK, 2018, PROD PLAN CONTROL, V29, P551, DOI 10.1080/09537287.2018.1449265
   Moeuf A, 2018, INT J PROD RES, V56, P1118, DOI 10.1080/00207543.2017.1372647
   Ng B, 1997, INT J OPER PROD MAN, V17, P574, DOI 10.1108/01443579710167267
   Nicoletti B, 2018, AGILE PROCUREMENT, P189, DOI DOI 10.1007/978-3-319-61085-6_8
   Nunnally J.C., 1978, PSYCHOMETRIC THEORY
   Peng DX, 2011, INT J OPER PROD MAN, V31, P1022, DOI 10.1108/01443571111182173
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Prange C, 2011, J WORLD BUS, V46, P126, DOI 10.1016/j.jwb.2010.05.024
   Raman S, 2018, INT J LOGIST-RES APP, V21, P579, DOI 10.1080/13675567.2018.1459523
   Raut RD, 2019, J CLEAN PROD, V224, P10, DOI 10.1016/j.jclepro.2019.03.181
   Reh L, 2013, PARTICUOLOGY, V11, P119, DOI 10.1016/j.partic.2012.11.001
   Reike D, 2018, RESOUR CONSERV RECY, V135, P246, DOI 10.1016/j.resconrec.2017.08.027
   Reuter C, 2010, J SUPPLY CHAIN MANAG, V46, P45, DOI 10.1111/j.1745-493X.2010.03189.x
   Ronkko M, 2016, J OPER MANAG, V47-48, P9, DOI 10.1016/j.jom.2016.05.002
   Saidani M, 2018, RESOUR CONSERV RECY, V135, P108, DOI 10.1016/j.resconrec.2017.06.017
   Sarstedt M, 2014, LONG RANGE PLANN, V47, P132, DOI 10.1016/j.lrp.2014.02.008
   Schiele Holger, 2007, Journal of Purchasing and Supply Management, V13, P274, DOI 10.1016/j.pursup.2007.10.002
   Schroeder P, 2019, J IND ECOL, V23, P77, DOI 10.1111/jiec.12732
   Simon B, 2019, RESOUR CONSERV RECY, V141, P299, DOI 10.1016/j.resconrec.2018.10.044
   Srai JS, 2019, J PURCH SUPPLY MANAG, V25, P78, DOI 10.1016/j.pursup.2018.07.001
   Teece D., 1994, IND CORP CHANGE, V3, P537, DOI DOI 10.1093/ICC/3.3.537-A
   Teece DJ, 2007, STRATEG MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Telukdarie A, 2018, PROCESS SAF ENVIRON, V118, P316, DOI 10.1016/j.psep.2018.06.030
   Tersine RJ, 1995, INT J OPER PROD MAN, V15, P8, DOI 10.1108/01443579510080382
   Tezel A, 2018, PROD PLAN CONTROL, V29, P247, DOI 10.1080/09537287.2017.1412522
   Tham CK, 2013, IEEE T SYST MAN CY-S, V43, P773, DOI 10.1109/TSMCA.2012.2224337
   Themistocleus M., 2000, 7 EUR C EV INF TECHN
   Tortorella GL, 2018, INT J PROD RES, V56, P2975, DOI 10.1080/00207543.2017.1391420
   Tseng ML, 2018, RESOUR CONSERV RECY, V131, P146, DOI 10.1016/j.resconrec.2017.12.028
   Tura N, 2019, J CLEAN PROD, V212, P90, DOI 10.1016/j.jclepro.2018.11.202
   Vanegas P, 2018, RESOUR CONSERV RECY, V135, P323, DOI 10.1016/j.resconrec.2017.06.022
   Vanpoucke E, 2017, INT J OPER PROD MAN, V37, P510, DOI 10.1108/IJOPM-07-2015-0441
   Vickery SK, 2003, J OPER MANAG, V21, P523, DOI 10.1016/j.jom.2003.02.002
   Virolainen VM, 1998, INT J PROD ECON, V56-7, P677, DOI 10.1016/S0925-5273(98)00009-7
   Wang CL, 2007, INT J MANAG REV, V9, P31, DOI 10.1111/j.1468-2370.2007.00201.x
   Wood LC, 2018, J MACROMARKETING, V38, P364, DOI 10.1177/0276146718781915
   Wood LC, 2017, INT J LOGIST-RES APP, V20, P426, DOI 10.1080/13675567.2016.1267126
   Wu SJ, 2010, DECISION SCI, V41, P721, DOI 10.1111/j.1540-5915.2010.00294.x
   Yang CL, 2013, INT J OPER PROD MAN, V33, P49, DOI 10.1108/01443571311288048
   Zhang JT, 2018, PROD PLAN CONTROL, V29, P773, DOI 10.1080/09537287.2018.1470268
   Zhang M, 2018, PROD PLAN CONTROL, V29, P802, DOI 10.1080/09537287.2018.1474394
   Zhou L, 2015, INT J PROD ECON, V159, P1, DOI 10.1016/j.ijpe.2014.11.014
NR 95
TC 1
Z9 1
U1 37
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104502
DI 10.1016/j.resconrec.2019.104502
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700002
OA Bronze
DA 2020-05-12
ER

PT J
AU Bolea, L
   Duarte, R
   Sanchez-Choliz, J
AF Bolea, Lucia
   Duarte, Rosa
   Sanchez-Choliz, Julio
TI Exploring carbon emissions and international inequality in a globalized
   world: A multiregional-multisectoral perspective
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE EEMRIO; Environmental inequality; Emissions; Globalization
ID INPUT-OUTPUT DATABASE; DIOXIDE EMISSIONS; CONVERGENCE; DECOMPOSITION;
   TRADE; DIVERGENCE
AB The phenomenon of economic convergence has been investigated from different perspectives, aiming to analyze whether economies move towards a common growth path or tend to diverge over time, and the consequences of this for economic cohesion. However, these consequences for the evolution of CO2 emissions in the study of global convergence of CO2 emissions, and the implications in terms of pollution, inequality, and income-dependence have received less attention in the literature of convergence. The increasing globalization of economies and the rising fragmentation of supply chains imply many countries involved in the production chains and, in consequence, a vision is needed of worldwide emissions associated with these processes. In this paper, we use the multisectoral and multiregional perspective provided by a multiregional input-output model (MRIO), and the associated databases, to analyze the evolution of inequality in CO2 emissions, paying attention to the roles played by regional specificities and/or productive structures. MRIO models and indicators presented, provide the basis to assess to what extent countries and/or sectors are walking towards a common path or, on the contrary, tend to be more unequal over time. Given the role that structure, final demands and international trade play in these models, we can offer a novel structural view of the convergence issue. Moreover, MRIO models also allow analyzing this question combining the perspectives of production and consumption, and their relationship through international trade. Moreover, our paper attempts to shed light on the discussion about the global and regional process of generation of emissions, paying special attention to cluster analysis and to the existence of common trends by groups of countries. Empirically, the information provided by the most recent edition of the World Input-Output Database (WIOD) and environmental accounts compatible with this database, is used. In our view, the results contribute new dimensions and insights to the issue of international inequality in terms of environmental pressures and opens new debates on the relocation of environmental damage, comparative advantage, and the environmental footprint.
C1 [Bolea, Lucia; Duarte, Rosa; Sanchez-Choliz, Julio] Univ Zaragoza, Econ Anal Dept, Gran Via 2, Zaragoza 50005, Spain.
RP Bolea, L (reprint author), Univ Zaragoza, Econ Anal Dept, Gran Via 2, Zaragoza 50005, Spain.
EM lbolea@unizar.es
FU Spanish Ministry of Economy and Competitiveness [BES-2017-080087]
FX This work would not have been possible without the financial support of
   the Spanish Ministry of Economy and Competitiveness, grant number
   BES-2017-080087.
CR Aldy JE, 2006, ENVIRON RESOUR ECON, V33, P533, DOI 10.1007/s10640-005-6160-x
   Aldy JE, 2007, LAND ECON, V83, P353, DOI 10.3368/le.83.3.353
   [Anonymous], 2019, WIOD ENV ACCOUNTS
   Duro JA, 2016, ENVIRON RESOUR ECON, V63, P57, DOI 10.1007/s10640-014-9840-6
   BARRO RJ, 1991, Q J ECON, V106, P407, DOI 10.2307/2937943
   BARRO RJ, 1992, J POLIT ECON, V100, P223, DOI 10.1086/261816
   Brock WA, 2010, J ECON GROWTH, V15, P127, DOI 10.1007/s10887-010-9051-0
   Criado CO, 2011, RESOUR ENERGY ECON, V33, P637, DOI 10.1016/j.reseneeco.2011.01.003
   de Oliveira G, 2017, J ENVIRON MANAGE, V196, P402, DOI 10.1016/j.jenvman.2017.03.034
   Dietzenbacher E, 2009, APPL ECON, V41, P3337, DOI 10.1080/00036840701439355
   Duarte R, 2018, ECON SYST RES, V30, P545, DOI 10.1080/09535314.2018.1450226
   El-Montasser G, 2015, APPL ECON, V47, P6543, DOI 10.1080/00036846.2015.1080809
   Fagerberg J, 2014, UNU MERIT WORKING PA
   Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379
   Isard W, 1951, REV ECON STAT, V33, P318, DOI 10.2307/1926459
   Keller W, 2002, J ECON GROWTH, V7, P5, DOI 10.1023/A:1013461025733
   Kjeldgaard D, 2006, J CONSUM RES, V33, P231, DOI 10.1086/506304
   Lein-Rupprecht S, 2007, ECB WORKING PAPER SE
   Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938
   Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x
   Li XH, 2013, RENEW SUST ENERG REV, V24, P357, DOI 10.1016/j.rser.2013.03.048
   Miller R.E., 2009, INPUT OUTPUT ANAL FD
   Mitry DJ, 2009, INT J CONSUM STUD, V33, P316, DOI 10.1111/j.1470-6431.2009.00746.x
   Ozcan B, 2016, EURASIAN J BUS EC, V9, P113
   Romero-Avila D, 2008, ENERG ECON, V30, P2265, DOI 10.1016/j.eneco.2007.06.003
   Sala-i-Martin X., 1994, ECON J, V106, P1019
   Serrano M, 2010, ECOL ECON, V69, P2224, DOI 10.1016/j.ecolecon.2010.06.008
   Teixido-Figueras J, 2016, ECOL INDIC, V62, P163, DOI 10.1016/j.ecolind.2015.11.041
   Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178
   WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967
   Westerlund J, 2008, ENVIRON RESOUR ECON, V40, P109, DOI 10.1007/s10640-007-9143-2
   Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003
   Xu Y, 2014, ECOL ECON, V101, P10, DOI 10.1016/j.ecolecon.2014.02.015
NR 33
TC 0
Z9 0
U1 33
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104516
DI 10.1016/j.resconrec.2019.104516
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700024
OA Bronze
DA 2020-05-12
ER

PT J
AU Boundy, T
AF Boundy, Thomas
TI How much material can a recycling facility source? A business-incentive
   Check based model for secondary material sourcing applied to waste LCD
   screen material
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Reverse logistics; Liquid crystal displays; Recycling; Economies of
   scale
ID LOGISTICS NETWORK DESIGN; ECONOMIES; SCALE; RECOVERY
AB For low value waste materials, the ability to economically recycle scrap can be inhibited by the transportation costs associated with collecting sufficient material at a central location to reach a threshold economy of scale. Waste liquid crystal display (LCD) screen, once removed from their host devices, are an example of such a material. An economic model has been developed for estimating the amount of material that could be consolidated at a central recycling facility for processing by optimizing for the internal rate of return (IRR) for constructing and operating such a facility. The results show that the population density and high landfill tipping fees of the northeastern United States make New York and New Jersey the states associated with the highest IRR. Process sensitivity analyses reveal that for standard grade commodities produced from LCD glass, only nine states - all in the northeastern US - exhibit an IRR greater than 10% and only process about one third of the US and Canada's LCD screen waste. For a recycler producing a high value liquid crystal product and a value-added glass product from the same waste, the impact of transportation costs becomes negligible and a facility could be operated in a state of one's choosing to process all of the US and Canada's waste with little impact on IRR. For the principal processing flow sheet investigated, the optimal plant capacity is estimated to be about 11,000 tonnes per year.
C1 [Boundy, Thomas] Colorado Sch Mines, Dept Met & Mat Engn, 1500 Illinois St, Golden, CO 80401 USA.
RP Boundy, T (reprint author), Colorado Sch Mines, Dept Met & Mat Engn, 1500 Illinois St, Golden, CO 80401 USA.
EM tiboundy@mines.edu
OI Boundy, Thomas/0000-0003-4877-6097
FU Critical Materials Institute, an Energy Innovation Hub - U.S. Department
   of Energy, Office of Energy Efficiency and Renewable Energy, Advanced
   Manufacturing OfficeUnited States Department of Energy (DOE)
FX This research is supported by the Critical Materials Institute, an
   Energy Innovation Hub funded by the U.S. Department of Energy, Office of
   Energy Efficiency and Renewable Energy, Advanced Manufacturing Office.
CR Anderson C.S., 2018, MINERAL COMMODIY SUM
   Balde C.P., 2015, GLOBAL E WASTE MONIT
   Boundy T, 2017, J CLEAN PROD, V154, P436, DOI 10.1016/j.jclepro.2017.04.038
   Cotton A., 2018, DEV UNVEIL LCD WASTE
   Cruz-Rivera R, 2009, EUR J OPER RES, V196, P930, DOI 10.1016/j.ejor.2008.04.041
   Cucchiella F, 2015, RENEW SUST ENERG REV, V51, P263, DOI 10.1016/j.rser.2015.06.010
   Dahmus JB, 2007, ENVIRON SCI TECHNOL, V41, P7543, DOI 10.1021/es062254b
   E-Waste Facts and Figures, 2014, FACTS FIGURES E WAST
   Eccheveria A., 2015, EXPERT COMMENTARY IO
   Graedel TE, 2015, P NATL ACAD SCI USA, V112, P6295, DOI 10.1073/pnas.1312752110
   Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x
   Gregory JR, 2009, ENVIRON SCI TECHNOL, V43, P9245, DOI 10.1021/es901341n
   Grether C.H., 2016, REPORT SOLID WASTE L
   GUILTINAN JP, 1975, INT J PHYS DISTRIB, V6, P28, DOI 10.1108/eb014359
   Hopson Eric, 2016, SCAM RECYCLING E DUM
   Jin H, 2019, J CLEAN PROD, V211, P257, DOI 10.1016/j.jclepro.2018.11.101
   Jordan BW, 2017, RESOUR ENERGY ECON, V49, P233, DOI 10.1016/j.reseneeco.2017.05.003
   Kirchherr J., 2017, BREAKING BARRIERS CI
   Lang H.J., 1948, CHEM ENG, V55, P112
   Lee DH, 2008, TRANSPORT RES E-LOG, V44, P455, DOI 10.1016/j.tre.2006.11.003
   Leinart J, 2017, ESTIMATING CMC
   MOORE FT, 1959, Q J ECON, V73, P232, DOI 10.2307/1883722
   Ponce-cueto E., 2011, SUPPLY CHAIN UM I, V12, P104
   Research and Markets, 2019, TFT LCD PAN MARK GLO
   Salhofer S., 2011, RECYCLING LCD SCREEN, P454, DOI [10.1007/978-3-642-19692-8_78, DOI 10.1007/978-3-642-19692-8_78]
   Sheu JB, 2014, TRANSPORT RES B-METH, V65, P65, DOI 10.1016/j.trb.2014.03.008
   Shih LH, 2001, RESOUR CONSERV RECY, V32, P55, DOI 10.1016/S0921-3449(00)00098-7
   Staley B., 2018, ANAL MSW LANDFILL TI
   Ueberschaar M., 2017, RECYCLING, V2, P7, DOI DOI 10.3390/RECYCLING2010007
   US EPA, MERC CONS PROD
   Wang RX, 2015, ENVIRON SCI TECHNOL, V49, P5999, DOI 10.1021/acs.est.5b00104
   Wang X, 2014, RESOUR CONSERV RECY, V83, P53, DOI 10.1016/j.resconrec.2013.11.009
NR 32
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104528
DI 10.1016/j.resconrec.2019.104528
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700016
OA Bronze
DA 2020-05-12
ER

PT J
AU De Almeida, ST
   Borsato, M
AF De Almeida, Sergio Tadeu
   Borsato, Milton
TI Extending the RIPEx exergy-based method for selecting End of Life
   strategy
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Design for reuse; End-of-Life strategy; Exergy; Recycling; Waste to
   energy
ID WASTE-TO-ENERGY; SUSTAINABILITY ASSESSMENT; TRIBOELECTRIC SEPARATION;
   THERMODYNAMIC APPROACH; ELECTRONIC EQUIPMENT; MANAGEMENT-SYSTEMS;
   SHREDDER RESIDUES; CYCLE ASSESSMENT; PLASTIC WASTE; EFFICIENCY
AB The decision process to cope with waste coming from End of Life (EoL) products is not often achievable in a sustainable way. Most of the current methods rely on environmental criteria, demanding hundreds of variables, frequently resulting in late and biased interpretation with EoL scenarios chosen with high levels of uncertainties. This paper aims to propose a method able to quantitatively identify clear best EoL strategies and thus, focus the recyclers' efforts during the waste treatment of industrial products. The method relies on energy and material flows quantified in terms of exergy, depicting environmental impact, energy efficiency, cost and technical efficiency. To extend the original method, the Design Science Research Methodology (DSRM) is adopted. The case study quantifies and strongly reiterates the classical hierarchy of EFVs concerning the importance of Reuse, however, challenging the traditional order proposed for other EoL. Hence, materials with high calorific content, such as plastics, are more sustainable by incineration than from recycling. Therefore, the extended method may contribute to decision practices that favour circular economy, waste to energy. An exergy-based approach would drive EoL decision and suggests where to make efforts on more in-depth LCA assessments, disassembly and energy-recovery technologies.
C1 [De Almeida, Sergio Tadeu; Borsato, Milton] UTFPR, Rua Joao Antonio Prosdocimo,551 S2, BR-81560020 Curitiba, Parana, Brazil.
RP De Almeida, ST (reprint author), UTFPR, Rua Joao Antonio Prosdocimo,551 S2, BR-81560020 Curitiba, Parana, Brazil.
EM stadeua@gmail.com
RI Almeida, Sergio/AAH-4086-2020; Borsato, Milton/H-5937-2012
OI de Almeida, Sergio Tadeu/0000-0002-6397-2654; Borsato,
   Milton/0000-0002-3607-8315
CR Ahmed N, 2014, WASTE MANAGE, V34, P1279, DOI 10.1016/j.wasman.2014.03.017
   Andritz, 2016, WEEE TREATM FAC
   [Anonymous], 2006, 14040 ISO
   [Anonymous], 2006, 14044 ISO
   Aragones-Beltran P, 2010, RENEW SUST ENERG REV, V14, P249, DOI 10.1016/j.rser.2009.07.012
   Araujo C., 2001, ACQUISITION PRODUCT, P211
   Awasthi AK, 2018, SCI TOTAL ENVIRON, V613, P46, DOI 10.1016/j.scitotenv.2017.08.288
   Balkenende A., 2015, P 22 ISPE INC INT C, P3
   Bosch ME, 2007, INT J LIFE CYCLE ASS, V12, P181, DOI 10.1065/lca2006.11.282
   Bok C., 1998, ISEE 1998 P 1998 IEE, P19
   Borsato M, 2017, J CLEAN PROD, V140, P1626, DOI 10.1016/j.jclepro.2016.09.185
   Brunner PH, 2015, WASTE MANAGE, V37, P3, DOI 10.1016/j.wasman.2014.02.003
   Buekens A, 2014, J MATER CYCLES WASTE, V16, P415, DOI 10.1007/s10163-014-0241-2
   Buekens A, 2014, J MATER CYCLES WASTE, V16, P398, DOI 10.1007/s10163-014-0244-z
   Castaldi M, 2017, WASTE BIOMASS VALORI, V8, P1875, DOI 10.1007/s12649-017-0049-0
   Castro MBG, 2004, RESOUR CONSERV RECY, V43, P1, DOI 10.1016/j.resconrec.2004.04.011
   Chen GQ, 2009, ENERGY, V34, P1127, DOI 10.1016/j.energy.2009.04.023
   Ciegis R., 2015, ENG ECON, V62, P37
   Cross N., 2008, ENG DESIGN METHODS S
   Cui JR, 2003, J HAZARD MATER, V99, P243, DOI 10.1016/S0304-3894(03)00061-X
   Dahl AL, 2012, ECOL INDIC, V17, P14, DOI 10.1016/j.ecolind.2011.04.032
   De Almeida Sergio Tadeu, 2017, International Journal of Agile Systems and Management, V10, P137
   de Almeida ST, 2017, J CLEAN PROD, V168, P876, DOI 10.1016/j.jclepro.2017.09.034
   De Almeida ST, 2019, RESOUR CONSERV RECY, V140, P189, DOI 10.1016/j.resconrec.2018.09.020
   Deng WJ, 2006, ATMOS ENVIRON, V40, P6945, DOI 10.1016/j.atmosenv.2006.06.032
   Devoldere Tom, 2009, International Journal of Sustainable Manufacturing, V1, P265
   Dewulf J, 2007, ENVIRON SCI TECHNOL, V41, P8477, DOI 10.1021/es0711415
   Dewulf J, 2005, RESOUR CONSERV RECY, V43, P419, DOI 10.1016/j.resconrec.2004.09.006
   Dewulf J, 2008, ENVIRON SCI TECHNOL, V42, P2221, DOI 10.1021/es071719a
   Dewulf JP, 2002, ENVIRON SCI TECHNOL, V36, P1130, DOI 10.1021/es010140o
   Dincer I, 2012, EXERGY ENERGY ENV SU
   Dincer L, 2014, PROGR EXERGY ENERGY
   Dodbiba G, 2005, MINER ENG, V18, P1350, DOI 10.1016/j.mineng.2005.02.015
   Doka G, 2007, LIFE CYCLE INVENTORI
   Duflou JR, 2008, CIRP ANN-MANUF TECHN, V57, P583, DOI 10.1016/j.cirp.2008.09.009
   Duflou JR, 2012, CIRP ANN-MANUF TECHN, V61, P587, DOI 10.1016/j.cirp.2012.05.002
   Ecoinvent, 2018, EC DAT
   Ecoinvent C.D, 2016, EC DAT
   Favi C., 2016, INT J SUSTAIN ENG, P1
   Favi C, 2017, INT J SUSTAIN ENG, V10, P136, DOI 10.1080/19397038.2016.1270369
   Fijal T, 2007, J CLEAN PROD, V15, P914, DOI 10.1016/j.jclepro.2005.11.019
   Fiksel J, 2014, CLEAN TECHNOL ENVIR, V16, P691, DOI 10.1007/s10098-013-0696-1
   Finnveden G, 2016, RESOURCES-BASEL, V5, DOI 10.3390/resources5030023
   Frischknecht R., 2007, ECOINVENT REP, P237
   Frischknecht R., 2007, IMPLEMENTATION LIFE
   Fukushige S., 2012, J REMANUF, V2, P1, DOI DOI 10.1186/2210-4690-2-1
   GaBi, 2019, LIF CYCL ASS LCA SOF
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Glenn J.C, 2003, INTRO FUTURES RES ME
   Gloria T, 2017, J IND ECOL, V21, P1449, DOI 10.1111/jiec.12711
   Goe M, 2015, J ENVIRON MANAGE, V160, P154, DOI 10.1016/j.jenvman.2015.05.038
   Gutowski TG, 2009, ENVIRON SCI TECHNOL, V43, P1584, DOI 10.1021/es8016655
   Hamut HS, 2014, J CLEAN PROD, V67, P187, DOI 10.1016/j.jclepro.2013.12.041
   Henriksen T, 2018, J IND ECOL, V22, P1039, DOI 10.1111/jiec.12709
   Hicks CC, 2016, SCIENCE, V352, P38, DOI 10.1126/science.aad4977
   Hillary R, 2004, J CLEAN PROD, V12, P561, DOI 10.1016/j.jclepro.2003.08.006
   Hischier R, 2007, LIFE CYCLE INVENTORI
   Hrinyak M.J., 1996, P ASME DET CIE C
   Ignatenko O, 2007, MINER ENG, V20, P862, DOI 10.1016/j.mineng.2007.03.005
   Ishii K., 1994, J MAT DESIGN, V15, P225
   Jawad H, 2015, J CLEAN PROD, V105, P64, DOI 10.1016/j.jclepro.2014.06.079
   Jody B., 2011, END OF LIFE VEHICLE
   Juran J., 1999, QUALITY HDB
   Kinoshita Y, 2016, PROC CIRP, V40, P162, DOI 10.1016/j.procir.2016.01.092
   LCA A.e, 2019, LIF CYCL ASS ENV IMP
   Maes D, 2014, ENVIRON IMPACT ASSES, V45, P19, DOI 10.1016/j.eiar.2013.11.002
   Marques JC, 2009, MAR POLLUT BULL, V58, P1773, DOI 10.1016/j.marpolbul.2009.08.020
   Mathieux F., 2002, P 9 INT SEM LIF CYCL, P9
   Medyna G., 2009, P ICED 09 17 INT C E
   Mirabile D, 2002, WASTE MANAGE, V22, P841, DOI 10.1016/S0956-053X(02)00071-5
   Nourreddine M, 2007, J HAZARD MATER, V139, P481, DOI 10.1016/j.jhazmat.2006.02.054
   Ouda Omar K. M., 2017, Journal of King Saud University - Engineering Sciences, V29, P212, DOI 10.1016/j.jksues.2015.02.002
   Pahl G, 2007, ENG DESIGN SYSTEMATI, P632
   PARETO V, 1896, COURS EC POLITIQUE P
   Passarini F, 2012, J CLEAN PROD, V23, P28, DOI 10.1016/j.jclepro.2011.10.028
   Pathak P, 2017, RENEW SUST ENERG REV, V78, P220, DOI 10.1016/j.rser.2017.04.062
   Peffers K, 2007, J MANAGE INFORM SYST, V24, P45, DOI 10.2753/MIS0742-1222240302
   PRe, 2014, SIMAPRO DATABASE MAN, P82
   Priarone PC, 2016, PROC CIRP, V48, P194, DOI 10.1016/j.procir.2016.03.044
   Rant Z, 1956, FORSCH INGENIEURWES, V22, P36, DOI DOI 10.1007/BF02592661
   Rebitzer G, 2004, ENVIRON INT, V30, P701, DOI 10.1016/j.envint.2003.11.005
   Gent MR, 2009, WASTE MANAGE RES, V27, P175, DOI 10.1177/0734242X08096950
   Rigamonti L, 2014, RESOUR CONSERV RECY, V85, P42, DOI 10.1016/j.resconrec.2013.12.012
   Ritzen S, 2000, INTEGRATION ENV ASPE
   Rocco MV, 2014, APPL ENERG, V113, P1405, DOI 10.1016/j.apenergy.2013.08.080
   Rose C.M., 2000, DESIGN ENV METHOD FO
   Rose CM, 2002, J ELECTRON MANUF, V11, P185, DOI 10.1142/S0960313102000369
   Rossi M, 2016, J CLEAN PROD, V129, P361, DOI 10.1016/j.jclepro.2016.04.051
   Saaty Thomas L., 2012, MODELS METHODS CONCE
   SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I
   Saaty TL, 1980, ANAL HIERARCHY PROCE
   Sampaio CH, 2016, CONSTR BUILD MATER, V109, P63, DOI 10.1016/j.conbuildmat.2016.01.058
   Santolaria M, 2011, J CLEAN PROD, V19, P1315, DOI 10.1016/j.jclepro.2011.03.009
   Schandl H, 2016, J CLEAN PROD, V132, P45, DOI 10.1016/j.jclepro.2015.06.100
   Seckin C, 2013, J CLEAN PROD, V47, P422, DOI 10.1016/j.jclepro.2012.07.008
   Sewalt M., 2001, INT J APPL THERMODYN, V4, P35
   SimaPro, 2019, SOFTW MEAS IMPR IMP
   Stougie L, 2018, INT J ENERG RES, V42, P2916, DOI 10.1002/er.4037
   Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002
   Szargut J, 2002, ENERG CONVERS MANAGE, V43, P1149, DOI 10.1016/S0196-8904(02)00005-5
   Szargut J., 2005, EXERGY METHOD TECHNI
   Taelman SE, 2014, RESOUR CONSERV RECY, V91, P1, DOI 10.1016/j.resconrec.2014.07.009
   Tani T, 1999, FIRST INTERNATIONAL SYMPOSIUM ON ENVIRONMENTALLY CONSCIOUS DEGIGN AND INVERSE MANUFACTURING, PROCEEDINGS, P294, DOI 10.1109/ECODIM.1999.747627
   Tebert C, 2006, ENERGY EFFICIENCY FO
   Tojo N., 2011, EUROPE RECYCLING SOC
   Nhu TT, 2015, J CLEAN PROD, V100, P170, DOI 10.1016/j.jclepro.2015.03.030
   Umberto, 2019, LCA SOFTWARE
   Umeda Y, 2012, CIRP ANN-MANUF TECHN, V61, P681, DOI 10.1016/j.cirp.2012.05.004
   Valentinov V, 2014, SYST RES BEHAV SCI, V31, P14, DOI 10.1002/sres.2146
   Valero A., 1998, P INT WORKSH ADV EN, P415
   Valero A, 2013, J IND ECOL, V17, P43, DOI 10.1111/j.1530-9290.2012.00529.x
   Valero A, 2010, RESOUR CONSERV RECY, V54, P1074, DOI 10.1016/j.resconrec.2010.02.010
   van Hemel C, 2002, J CLEAN PROD, V10, P439, DOI 10.1016/S0959-6526(02)00013-6
   Vandermeersch T, 2014, RESOUR CONSERV RECY, V87, P57, DOI 10.1016/j.resconrec.2014.03.008
   Vigon B, 2011, GLOBAL GUIDANCE PRIN, P158
   Wall G, 2002, ENERG CONVERS MANAGE, V43, P1235, DOI 10.1016/S0196-8904(02)00010-9
   Wall G., 2013, EXERGY USEFUL CONCEP, P477
   Wang JJ, 2008, ENERG POLICY, V36, P3823, DOI 10.1016/j.enpol.2008.07.002
   Weidema B.P., 2013, OVERVIEW METHODOLOGY
   Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8
   Wilts H, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8070622
   Wong YC, 2018, J CLEAN PROD, V190, P285, DOI 10.1016/j.jclepro.2018.04.145
   Zhang GW, 2017, WASTE MANAGE, V60, P42, DOI 10.1016/j.wasman.2016.08.010
   Zhang LG, 2016, J CLEAN PROD, V127, P19, DOI 10.1016/j.jclepro.2016.04.004
NR 124
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104536
DI 10.1016/j.resconrec.2019.104536
PG 16
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700027
OA Bronze
DA 2020-05-12
ER

PT J
AU Debbarma, S
   Ransinchung, RNGD
   Singh, S
   Sahdeo, SK
AF Debbarma, Solomon
   Ransinchung, G. D. R. N.
   Singh, Surender
   Sahdeo, Surya Kant
TI Utilization of industrial and agricultural wastes for productions of
   sustainable roller compacted concrete pavement mixes containing
   reclaimed asphalt pavement aggregates
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE RAP; RCCP; Wastes; Strength; Durability; Sustainability
ID PORTLAND-CEMENT CONCRETE; LIFE-CYCLE ASSESSMENT; FLY-ASH; SUGARCANE
   BAGASSE; SILICA FUME; MECHANICAL-PROPERTIES; DURABILITY PROPERTIES;
   DIFFERENT FRACTIONS; ROAD BASES; PERFORMANCE
AB Asphalt pavement recycling has become a common practice across the globe and has been successfully employed in construction of new pavements. While several studies considered utilization of reclaimed asphalt pavement (RAP) aggregates for flexible and rigid pavements, very few attempted its possibility for roller compacted concrete pavements (RCCP). Additionally, studies on the possibility of enhancing the proportion of RAP for RCCP are very scanty. The present study is an attempt to increase the potential of RCCP mixes containing 50% RAP (dust contaminated & stiffened asphalt coated: SCRAP via including various industrial and agricultural wastes such as Silica Fume, Fly ash, and Sugarcane ash as partial replacement of conventional cement. It was observed that the inclusion of the stated admixtures had an insignificant effect on the density of the fresh RCCP mixes, however, increased the moisture demand considerably. In fact, the results firmly indicated the potential of silica fume for RAP-RCCP blends, as, it not only enhanced the physical and mechanical properties, but found to improve the durability of RCCP mixes considerably. Also, utilization of silica fume was found to be economical & environmentally friendly amongst all wastes: with reduced initial construction cost & CO2 emissions by up to 8.4% & 9.7%. As far as the other industrial wastes are concerned, 15% fly ash could also be utilized for producing sustainable RCCP mixes, whereas, higher dosage of fly ash (30%) and sugarcane ash (10 & 15%) may be employed as base layer material of conventional concrete pavements.
C1 [Debbarma, Solomon; Ransinchung, G. D. R. N.; Sahdeo, Surya Kant] Indian Inst Technol Roorkee, Dept Civil Engn, Roorkee 247667, Uttar Pradesh, India.
   [Singh, Surender] Indian Inst Technol Madras, Dept Civil Engn, Transportat Engn Div, Chennai 600036, Tamil Nadu, India.
RP Ransinchung, RNGD (reprint author), Indian Inst Technol Roorkee, Dept Civil Engn, Roorkee 247667, Uttar Pradesh, India.
EM gollu.dce2017@iitr.ac.in; gdranfce@iitr.ac.in; surender@iitm.ac.in;
   ssahdeo@ce.iitr.ac.in
CR Abou Sleiman C.N, 2019, TRANSPORT RES REC
   ACI (American Concrete Institute), 2001, 32595 ACI
   ALKAN C, 1995, RESOUR CONSERV RECY, V13, P147, DOI 10.1016/0921-3449(94)00014-V
   American Society for Testing and Materials, 2013, C1747C1747M ASTM
   American Society for Testing and Materials, 2012, C26712 ASTM
   American Society of Testing and Material (ASTM), 2012, D1557 ASTM
   [Anonymous], 2019, C61819 ASTM
   Arulrajah A, 2014, J MATER CIVIL ENG, V26, P349, DOI 10.1061/(ASCE)MT.1943-5533.0000850
   ASTM, 2013, C1585 ASTM
   ASTM (American Society for Testing and Materials), 2011, C64213 ASTM
   ASTM (American Society for Testing and Materials), 2017, 0217217 ASTM
   ASTM (American Society for Testing and Materials), 2015, C124015 ASTM
   Aurangzeb Q, 2014, RESOUR CONSERV RECY, V83, P77, DOI 10.1016/j.resconrec.2013.12.004
   Avirneni D, 2016, CONSTR BUILD MATER, V121, P198, DOI 10.1016/j.conbuildmat.2016.05.162
   Bahurudeen A, 2015, CEMENT CONCRETE COMP, V59, P77, DOI 10.1016/j.cemconcomp.2015.03.004
   Bahurudeen A, 2015, CEMENT CONCRETE COMP, V56, P32, DOI 10.1016/j.cemconcomp.2014.11.002
   Bajwa A, 2016, J ENVIRON CHEM ENG, V4, P1561, DOI 10.1016/j.jece.2016.02.022
   Baykal G, 2000, RESOUR CONSERV RECY, V30, P59, DOI 10.1016/S0921-3449(00)00042-2
   Baykal G, 2004, RESOUR CONSERV RECY, V42, P209, DOI 10.1016/j.resconrec.2004.04.002
   BIS (Bureau of Indian Standards), 2013, IS8112
   BIS (Bureau of Indian Standards), 1963, IS2386 4
   BIS (Bureau of Indian Standards), 1999, IS5816
   BIS (Bureau of Indian Standards), 1963, IS2386 3
   BIS (Bureau of Indian Standards), 1959, IS516
   Brand A.S., 2015, THESIS
   Brand AS, 2017, CONSTR BUILD MATER, V130, P182, DOI 10.1016/j.conbuildmat.2016.10.013
   Brand AS, 2017, CONSTR BUILD MATER, V130, P171, DOI 10.1016/j.conbuildmat.2016.10.019
   Brand AS, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001403
   Brand AS, 2015, ACI MATER J, V112, P155
   Cai XH, 2016, CONSTR BUILD MATER, V127, P804, DOI 10.1016/j.conbuildmat.2016.09.117
   Cetin B, 2010, RESOUR CONSERV RECY, V54, P878, DOI 10.1016/j.resconrec.2010.01.007
   Cordeiro GC, 2009, CEMENT CONCRETE RES, V39, P110, DOI 10.1016/j.cemconres.2008.11.005
   Courard L, 2010, CONSTR BUILD MATER, V24, P390, DOI 10.1016/j.conbuildmat.2009.08.040
   CPWD (Central Public Works Department), 2016, AN RAT DELH 1
   Debbarma S, 2019, TRANSPORT RES REC, V2673, P652, DOI 10.1177/0361198119849585
   Debbarma S, 2019, CONSTR BUILD MATER, V199, P508, DOI 10.1016/j.conbuildmat.2018.12.047
   Delwar M, 1997, ACI MATER J, V94, P251
   Fakhri M, 2017, ENG FRACT MECH, V180, P43, DOI 10.1016/j.engfracmech.2017.05.011
   Fakhri M, 2017, CONSTR BUILD MATER, V137, P470, DOI 10.1016/j.conbuildmat.2017.01.136
   Harbec D, 2017, CONSTR BUILD MATER, V134, P142, DOI 10.1016/j.conbuildmat.2016.12.018
   Harrington D., 2010, GUIDE ROLLER COMPACT
   Hasanbeigi A, 2012, RENEW SUST ENERG REV, V16, P6220, DOI 10.1016/j.rser.2012.07.019
   Hossiney Nabil, 2010, INT J PAVEMENT RES T, V3, P251, DOI DOI 10.3141/2164-15
   Huang B, 2006, MAG CONCRETE RES, V58, P313, DOI 10.1680/macr.2006.58.5.313
   Huang BS, 2005, CEMENT CONCRETE RES, V35, P2008, DOI 10.1016/j.cemconres.2005.05.002
   IRC (Indian Roads Congress), 2005, IRCSP68
   Khan MI, 2011, RESOUR CONSERV RECY, V57, P30, DOI 10.1016/j.resconrec.2011.09.016
   Kourti I, 2010, RESOUR CONSERV RECY, V54, P769, DOI 10.1016/j.resconrec.2009.12.006
   Kumari M, 2018, CONSTR BUILD MATER, V191, P655, DOI 10.1016/j.conbuildmat.2018.10.017
   Liu HB, 2010, RESOUR CONSERV RECY, V54, P1331, DOI 10.1016/j.resconrec.2010.05.005
   Loh YR, 2013, RESOUR CONSERV RECY, V75, P14, DOI 10.1016/j.resconrec.2013.03.002
   Maddalena R, 2018, J CLEAN PROD, V186, P933, DOI 10.1016/j.jclepro.2018.02.138
   Ministry of Environment Forest and Climate Change, 2010, IND GREENH GAS EM 20
   Modarres A, 2014, MATER DESIGN, V64, P227, DOI 10.1016/j.matdes.2014.07.072
   Moises MP, 2013, MATER LETT, V108, P243, DOI 10.1016/j.matlet.2013.06.086
   Monu K, 2019, CONSTR BUILD MATER, V206, P483, DOI 10.1016/j.conbuildmat.2019.02.087
   Mukhopadhyay A., 2017, FHWATX17068551
   Mukhopadhyay A, 2019, AM SOC TEST MATER, V1613, P187, DOI 10.1520/STP161320180008
   Palmer W.D., 1987, ROLLER COMPACTED CON, P40
   Pongpat P, 2017, J CLEAN PROD, V142, P1138, DOI 10.1016/j.jclepro.2016.07.178
   Pryor SW, 2017, J CLEAN PROD, V141, P137, DOI 10.1016/j.jclepro.2016.09.069
   Robinson GR, 2004, RESOUR CONSERV RECY, V42, P275, DOI 10.1016/j.resconrec.2004.04.006
   Settari C, 2015, CONSTR BUILD MATER, V101, P617, DOI 10.1016/j.conbuildmat.2015.10.039
   Shi X., 2019, TRANSPORT RES REC
   Shi X, 2018, INT J PAVEMENT ENG, P1
   Shi XJ, 2019, ROAD MATER PAVEMENT, DOI 10.1080/14680629.2019.1616604
   Shi XJ, 2019, J CLEAN PROD, V225, P414, DOI 10.1016/j.jclepro.2019.03.288
   Shi XJ, 2019, CEMENT CONCRETE COMP, V95, P56, DOI 10.1016/j.cemconcomp.2018.10.013
   Shi XJ, 2018, J CLEAN PROD, V192, P569, DOI 10.1016/j.jclepro.2018.05.004
   Shi XJ, 2017, CONSTR BUILD MATER, V152, P756, DOI 10.1016/j.conbuildmat.2017.06.174
   Siddique R, 2011, RESOUR CONSERV RECY, V55, P923, DOI 10.1016/j.resconrec.2011.06.012
   Siddique R, 2011, RESOUR CONSERV RECY, V55, P739, DOI 10.1016/j.resconrec.2011.03.004
   Singh NB, 2000, CEMENT CONCRETE RES, V30, P1485, DOI 10.1016/S0008-8846(00)00324-0
   Singh S.K., 2018, THESIS
   Singh SB, 2020, INT J OBESITY, V44, P23, DOI [10.1038/s41366-018-0273-0, 10.1080/00207454.2019.1667799]
   Singh S, 2019, CONSTR BUILD MATER, V209, P619, DOI 10.1016/j.conbuildmat.2019.03.122
   Singh S, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002408
   Singh S, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002316
   Singh S, 2018, ADV CIV ENG MATER, V7, P271, DOI [10.1520/ACEM20180012, 10.1007/s40003-018-0309-7]
   Singh S, 2018, CONSTR BUILD MATER, V166, P808, DOI 10.1016/j.conbuildmat.2018.01.131
   Singh S, 2019, ROAD MATER PAVEMENT, V20, P151, DOI 10.1080/14680629.2017.1380071
   Singh S, 2018, J CLEAN PROD, V174, P42, DOI 10.1016/j.jclepro.2017.10.179
   Singh S, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002124
   Singh S, 2017, CONSTR BUILD MATER, V156, P19, DOI 10.1016/j.conbuildmat.2017.08.144
   Singh S, 2017, CONSTR BUILD MATER, V148, P734, DOI 10.1016/j.conbuildmat.2017.05.030
   Su K, 2009, RESOUR CONSERV RECY, V54, P37, DOI 10.1016/j.resconrec.2009.06.003
   Taha R, 2004, RESOUR CONSERV RECY, V41, P293, DOI 10.1016/j.resconrec.2003.10.005
   Taha R, 2002, J MATER CIVIL ENG, V14, P239, DOI 10.1061/(ASCE)0899-1561(2002)14:3(239)
   Taha R, 1999, TRANSPORT RES REC, P264, DOI 10.3141/1652-33
   Turner LK, 2013, CONSTR BUILD MATER, V43, P125, DOI 10.1016/j.conbuildmat.2013.01.023
   Yang KH, 2015, J CLEAN PROD, V103, P774, DOI 10.1016/j.jclepro.2014.03.018
   Zeng Q, 2012, CONSTR BUILD MATER, V27, P560, DOI 10.1016/j.conbuildmat.2011.07.007
NR 92
TC 1
Z9 1
U1 19
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104504
DI 10.1016/j.resconrec.2019.104504
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700003
OA Bronze
DA 2020-05-12
ER

PT J
AU Donati, F
   Aguilar-Hernandez, GA
   Siguenza-Sanchez, CP
   de Koning, A
   Rodrigues, JFD
   Tukker, A
AF Donati, Franco
   Aguilar-Hernandez, Glenn A.
   Siguenza-Sanchez, Carlos Pablo
   de Koning, Arjan
   Rodrigues, Joao F. D.
   Tukker, Arnold
TI Modeling the circular economy in environmentally extended input-output
   tables: Methods, software and case study
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Interventions; EEIOA; Software; Policy; Scenarios
ID DECISION-MAKING; WASTE
AB A circular economy is an industrial system that is restorative or regenerative by intention or design. During the last decade, the circular economy became an attractive paradigm to increase global welfare while minimizing the environmental impacts of economic activities. Although several studies concerning the potential benefits and drawbacks of policies that implement the new paradigm have been performed, there is currently no standardized theoretical model or software to execute such assessment. In order to fill this gap, in the present paper we show how to perform these analyses using Environmentally Extended Input-Output Analysis. We also describe a python package (pycirk) for modeling Circular Economy scenarios in the context of the Environmentally Extended Multi-Regional Input-Output database EXIOBASE V3.3, for the year 2011. We exemplify the methods and software through a what-if zero-cost case study on two circular economy strategies (Resource Efficiency and Product Lifetime Extension), four environmental pressures and two socio-economic factors.
C1 [Donati, Franco; Aguilar-Hernandez, Glenn A.; Siguenza-Sanchez, Carlos Pablo; de Koning, Arjan; Rodrigues, Joao F. D.; Tukker, Arnold] Leiden Univ, Inst Environm Sci CML, Dept Ind Ecol, Einsteinweg 2, NL-2333 CC Leiden, Netherlands.
   [Tukker, Arnold] Netherlands Org Appl Sci Res TNO, NL-2595 DA The Hague, Netherlands.
RP Donati, F (reprint author), Leiden Univ, Inst Environm Sci CML, Dept Ind Ecol, Einsteinweg 2, NL-2333 CC Leiden, Netherlands.
EM f.donati@cml.leidenuniv.nl
OI Donati, Franco/0000-0002-8287-2413; Rodrigues, Joao/0000-0002-1437-0059;
   Aguilar-Hernandez, Glenn Alonso/0000-0003-3740-8221
FU European Union through EIT RawMaterials in the scope of the project
   RaMa-Scene [16380]
FX This study was funded by the European Union through EIT RawMaterials in
   the scope of the project RaMa-Scene under grant agreement No. 16380. We
   thank the researchers of the scenario group at UL-CML for their
   insightful suggestions and dr. Hale cetinay Iyicil for grammar and
   layout corrections in the first drafts of this research.
CR Aguilar-Hernandez G.A., 2018, J EC STRUCT, V7, P14, DOI [10.1186/s40008-018-0113-3, DOI 10.1186/S40008-018-0113-3]
   Allwood JM, 2015, SUSTAINABLE MAT HOT
   Bocken NMP, 2016, J IND PROD ENG, V33, P308, DOI 10.1080/21681015.2016.1172124
   Cooper DR, 2017, J IND ECOL, V21, P38, DOI 10.1111/jiec.12388
   de Koning A, 2018, THESIS
   Donati F, 2019, PYCIRK READ DOCS
   Duchin F., 2012, J EC STRUCT, V1, P1, DOI [10.1186/2193-2409-1-3, DOI 10.1186/2193-2409-1-3]
   Duchin F, 2019, RESOUR CONSERV RECY, V145, P422, DOI 10.1016/j.resconrec.2018.10.028
   Eisenmenger N, 2014, DEV SYSTEM INDICATOR, P12
   European Commission, 2018, SWD201836 EUR COMM
   Eurostat, 2008, METHODOLOGIES WORKIN
   FAUCHEUX S, 1995, ECOL ECON, V15, P29, DOI 10.1016/0921-8009(95)00018-5
   Faure E, 2017, EUR J FUTURES RES, V5, DOI 10.1007/s40309-017-0121-9
   FIEC, 2019, KEY FIG ACT 2018
   Fraunhofer-Gesellschaft, 2018, EFF US RES MAN MET C
   Geng Y., 2016, SCIENCE, P76, DOI 10.1038/sc.2012.55
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Homrich AS, 2018, J CLEAN PROD, V175, P525, DOI 10.1016/j.jclepro.2017.11.064
   Iacovidou E, 2017, J CLEAN PROD, V166, P910, DOI 10.1016/j.jclepro.2017.07.100
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Knights AM, 2014, ENVIRON SCI POLICY, V39, P56, DOI 10.1016/j.envsci.2014.02.010
   Kronen M, 2010, MAR POLICY, V34, P1135, DOI 10.1016/j.marpol.2010.03.013
   LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294
   Leontief W.W., 1951, STRUCTURE AM EC 1919
   Li SL, 2012, PROCEDIA ENVIRON SCI, V12, P65, DOI 10.1016/j.proenv.2012.01.248
   Litman T, 2019, EVALUATING ACTIVE TR
   MacArthur E., 2013, CIRCULAR EC EC BUSIN
   MacArthur E., 2015, GROWTH CIRCULAR EC V
   McCarthy A, 2018, MACROECONOMICS CIRCU, P130, DOI [10.1787/af983f9a-en, DOI 10.1787/AF983F9A-EN]
   Merciai S, 2018, J IND ECOL, V22, P516, DOI 10.1111/jiec.12713
   Miller R.E., 2009, INPUT OUTPUT ANAL FD
   Mount I, 2016, FORTUNE
   Nakamura S, 2009, WASTE INPUT OUTPUT A, DOI [10.1007/978-1-4020-9902-1, DOI 10.1007/978-1-4020-9902-1]
   Rizos V, 2017, 20178 CEPS
   Solomon S, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19
   Stadler K, 2018, J IND ECOL, V22, P502, DOI 10.1111/jiec.12715
   Suh S., 2010, ECOEFFICIENCY IND SC, V23, DOI [10.1007/978-1-4020-5737-3, DOI 10.1007/978-1-4020-5737-3]
   Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178
   Tisserant A, 2017, J IND ECOL, V21, P628, DOI 10.1111/jiec.12562
   Tukker A, 2013, ECON SYST RES, V25, P50, DOI 10.1080/09535314.2012.761952
   UNEP, 2011, DECOUPLING NATURAL R
   Wiebe KS, 2019, ENVIRON SCI TECHNOL, V53, P6362, DOI 10.1021/acs.est.9b01208
   Wijkman A, 2015, CIRCULAR EC BENEFITS
   Winning M., 2017, INT EC EC POLICY, DOI [10.1007/s10368-017-0385-3, DOI 10.1007/S10368-017-0385-3]
   Wood R, 2018, J IND ECOL, V22, P540, DOI 10.1111/jiec.12702
   Wood R, 2015, SUSTAINABILITY-BASEL, V7, P138, DOI 10.3390/su7010138
   WRAP, 2015, EMPL CIRC EC, P2
   Yifang L, 2007, 16 INT INP OUTP C 2
   Zhou Y, 2006, HEAT TREATING, P1
NR 49
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104508
DI 10.1016/j.resconrec.2019.104508
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700007
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Feng, JX
   Feng, LY
   Wang, JL
   King, CW
AF Feng, Jingxuan
   Feng, Lianyong
   Wang, Jianliang
   King, Carey W.
TI Evaluation of the onshore wind energy potential in mainland China-Based
   on GIS modeling and EROI analysis
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE GIS; Wind energy potential; Land use and land cover; Geographical
   constraints; EROI
ID LIFE-CYCLE ASSESSMENT; GENERATED ELECTRICITY; POWER; SYSTEM; RETURN;
   SCALE; INVESTMENT; OPTIONS; RATIO
AB Due to the advantages of relatively mature technologies and low greenhouse gas pollution, wind energy represents a vital energy alternative for electricity generation. Using onshore wind power has become increasingly important in China. Currently, wind energy faces energy return on investment (EROI) and geographical constraints, which both have significant impacts on net wind energy potential. This study combines GIS modeling, wind turbine performance, and the wind speed distribution with a large daily dataset to estimate onshore technical and net wind energy potential in China and to visualize the available wind energy potential. In this study, more detailed local topographic effects (changing air density, surface roughness, air density, array placement efficiency) were considered despite the complexity of applying them at a country level. The results show that the technical potential of China's onshore wind energy could reach 2560 TW h/yr in a 0% agriculture land scenario and 3501 TW h/yr in a 70% agriculture land scenario, and the net energy potential could reach 2335 TW h/yr and 3194 TW h/yr when EROI = 11.4:1 (when averaging performance of turbines across geographic areas) in these two different scenarios.
C1 [Feng, Jingxuan; Feng, Lianyong; Wang, Jianliang] China Univ Petr, Sch Econ & Management, Beijing 102249, Peoples R China.
   [Feng, Jingxuan] China Natl Petr Corp, Beijing 100007, Peoples R China.
   [King, Carey W.] Univ Texas Austin, Energy Inst, 1849 Whitis Ave,C2400, Austin, TX 78712 USA.
RP Feng, LY (reprint author), 18 Fuxue Rd, Beijing, Peoples R China.
EM fengjxenergy@163.com; fenglyenergy@163.com; wangjianliang305@163.com;
   careyking@energy.utexas.edu
RI Wang, Jianliang/D-9149-2019
OI Wang, Jianliang/0000-0001-7037-9368; Feng, Lianyong/0000-0003-0953-5784
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71874202/71874201/71373285]
FX This study was supported by the National Natural Science Foundation of
   China (Grant No. 71874202/71874201/71373285).
CR Ardente F, 2008, RENEW SUST ENERG REV, V12, P200, DOI 10.1016/j.rser.2006.05.013
   AWEA, 2015, US WIND IND ANN MARK
   Bosch J, 2017, ENERGY, V131, P207, DOI 10.1016/j.energy.2017.05.052
   Cavazzi S, 2016, RENEW ENERG, V87, P212, DOI 10.1016/j.renene.2015.09.021
   Chang TP, 2014, ENERGY, V73, P88, DOI 10.1016/j.energy.2014.05.091
   China Electricity Council, 2017, 2016 STAT B EL POW I
   China Energy Research Society, 2016, CHIN EN OUTL 2030
   China Meteorological Administration, 2006, CHIN WIND EN RES ASS
   Climate Forecast System Reanalysis, 2017, GLOB WEATH DAT SWAT
   COUNIHAN J, 1975, ATMOS ENVIRON, V9, P871, DOI 10.1016/0004-6981(75)90088-8
   Crawford RH, 2009, RENEW SUST ENERG REV, V13, P2653, DOI 10.1016/j.rser.2009.07.008
   Dale M., 2010, GLOBAL ENERGY MODELL
   Davidson MR, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.86, 10.1038/nenergy.2016.86]
   Dupont E, 2018, APPL ENERG, V209, P322, DOI 10.1016/j.apenergy.2017.09.085
   Energy Research Institute, 2014, CHIN WIND EN ROADM 2
   Energy Research Institute, 2010, 2030 CHIN WIND DEV O
   European Wind Energy Association, 2009, EC WIND ENERGY
   Felix E, 2009, ENERGY, V34, P410, DOI 10.1016/j.energy.2008.10.013
   Feng JX, 2018, ENERGIES, V11, DOI 10.3390/en11020313
   Feng JX, 2018, ENERGY, V144, P232, DOI 10.1016/j.energy.2017.11.061
   Gagnon L, 2002, ENERG POLICY, V30, P1267, DOI 10.1016/S0301-4215(02)00088-5
   Gagnon L, 2008, ENERG POLICY, V36, P3317, DOI 10.1016/j.enpol.2008.05.012
   Goldwind, 2017, GOLDW SUST REP
   Goldwind 3.0MW(S), 2017, DIRECT DRIVE PERMANE
   GOV.CN, 2015, CHIN INT NAT D UNPUB
   GUSTAVSON MR, 1979, SCIENCE, V204, P13, DOI 10.1126/science.204.4388.13
   Hall C. A. S., 2017, ENERGY RETURN INVEST
   Hall CAS, 2009, ENERGIES, V2, P25, DOI 10.3390/en20100025
   Hau E, 2006, WIND TURBINES FUNDAM
   He G, 2014, ENERG POLICY, V74, P116, DOI 10.1016/j.enpol.2014.07.003
   Heller MC, 2004, RENEW ENERG, V29, P1023, DOI 10.1016/j.renene.2003.11.018
   IEC, 2005, 6140012 IEC
   IUCN and UNEP-WCMC, 2016, WORLD DAT PROT AR WD
   Kubiszewski I, 2010, RENEW ENERG, V35, P218, DOI 10.1016/j.renene.2009.01.012
   Li LY, 2018, RENEW SUST ENERG REV, V82, P156, DOI 10.1016/j.rser.2017.06.114
   Lissaman PBS, 1982, NUMERIC MODELING SEN
   Liu CY, 2017, RESOUR CONSERV RECY, V121, P33, DOI 10.1016/j.resconrec.2016.10.001
   Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106
   Lund C., 2008, Bulletin of Science, Technology and Society, V28, P200, DOI 10.1177/0270467608315920
   Manwell J.F., 2009, WIND ENERGY EXPLAINE
   Martinez E, 2009, INT J LIFE CYCLE ASS, V14, P52, DOI 10.1007/s11367-008-0033-9
   Mathew S, 2006, WIND ENERGY FUNDAMEN
   Mathur J, 2002, ENERG SOURCE, V24, P19, DOI 10.1080/00908310252712271
   Mathur J, 2001, ENERG SOURCE, V23, P877, DOI 10.1080/009083101317071324
   McElroy MB, 2009, SCIENCE, V325, P1378, DOI 10.1126/science.1175706
   McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016
   Mearns E, 2008, GLOBAL ENERGY CRISES
   Meier P.J, 2002, LIFE CYCLE ASSESSMEN
   Mentis D, 2015, RENEW ENERG, V83, P110, DOI 10.1016/j.renene.2015.03.072
   Moller B, 2012, ENERGY, V48, P314, DOI 10.1016/j.energy.2012.01.029
   Moriarty P, 2016, ENERG POLICY, V93, P3, DOI 10.1016/j.enpol.2016.02.051
   Murphy DJ, 2011, SUSTAINABILITY-BASEL, V3, P1888, DOI 10.3390/su3101888
   Musial W., 2010, LARGE SCALE OFFSHORE
   National Energy Administration, 2016, 13 FYP POW DEV PLANN
   NDRC, 2017, EN REV STRAT 2016 20
   NDRC N.E.A, 2016, 13 FYP EN PLANN
   RESDC, 2018, RES ENV DAT CLOUD PL
   Schallenberg-Rodriguez J, 2013, RENEW SUST ENERG REV, V21, P272, DOI 10.1016/j.rser.2012.12.032
   Schillings C, 2012, ENERG POLICY, V49, P541, DOI 10.1016/j.enpol.2012.06.056
   Sherman P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16073-2
   Siyal SH, 2015, ENERGY, V83, P447, DOI 10.1016/j.energy.2015.02.044
   Sorensen B, 2017, RENEWABLE ENERGY: PHYSICS, ENGINEERING, ENVIRONMENTAL IMPACTS, ECONOMICS AND PLANNING, 5TH EDITION, P1
   Sorensen B, 2017, INT J GREEN ENERGY, V14, P39, DOI 10.1080/15435075.2016.1175355
   Spindler D, 2011, INITIAL LOOK CFSR RE
   State Administration for Market Regulation, 2002, 187102002 GBT STAT A
   Van Wijk A.J.M, 1993, WIND POWER POTENTIAL
   Voss A, 2001, ENERGY POLICY EXTERN, P163
   Wagner HJ, 2004, ENERGY, V29, P2289, DOI 10.1016/j.energy.2004.03.038
   Walmsley TG, 2017, J CLEAN PROD, V167, P885, DOI 10.1016/j.jclepro.2017.08.040
   Wan J.P, 2015, INVESTMENT OUTLOOK E
   Weissbach D, 2013, ENERGY, V52, P210, DOI 10.1016/j.energy.2013.01.029
   White S.W, 1998, NET ENERGY PAYBACK C
   White SW, 2000, FUSION ENG DES, V48, P473, DOI 10.1016/S0920-3796(00)00158-7
   Wind Energy Programmatic EIS, 2016, WIND EN BAS
   Xinhuanet, 2014, XINHUANET
   Zhang SF, 2012, RENEW SUST ENERG REV, V16, P1110, DOI 10.1016/j.rser.2011.11.007
NR 76
TC 1
Z9 1
U1 15
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104484
DI 10.1016/j.resconrec.2019.104484
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700004
OA Bronze
DA 2020-05-12
ER

PT J
AU Foster, G
AF Foster, Gillian
TI Circular economy strategies for adaptive reuse of cultural heritage
   buildings to reduce environmental impacts
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Adaptive reuse; Cultural heritage; Sustainability;
   Urban planning; Buildings
ID SUSTAINABLE DEVELOPMENT; URBAN; CARBON; CONSERVATION; BARRIERS; DRIVERS;
   RENEWAL; WASTE; LIFE
AB Circular economy strategies seek to reduce the total resources extracted from the environment and reduce the wastes that human activities generate in pursuit of human wellbeing. Circular Economy concepts are well suited to the building and construction sector in cities. For example, refurbishing and adaptively reusing underutilized or abandoned buildings can revitalize neighborhoods whilst achieving environmental benefits. Cultural heritage buildings hold a unique niche in the urban landscape. In addition to shelter, they embody the local cultural and historic characteristics that define communities. Therefore, extending their useful lifespan has multiple benefits that extend beyond the project itself to the surrounding area, contributing to economic and social development. To explore this complex issue, the research applies systematic literature review and synthesis methods. Decision makers lack knowledge of the environmental benefits of adaptive reuse of cultural heritage buildings and lack tools to implement these projects. A new comprehensive circular economy framework for the adaptive reuse of cultural heritage buildings to reduce environmental impacts intends to meet these needs. The framework integrates methods and techniques from the building and construction literature that aim to reduce lifecycle environmental impact of buildings with a circular product supply chain approach.
C1 [Foster, Gillian] Vienna Univ Econ & Business, Inst Ecol Econ, Dept Socioecon, Welthandelspl 1-D5, A-1020 Vienna, Austria.
RP Foster, G (reprint author), Vienna Univ Econ & Business, Inst Ecol Econ, Dept Socioecon, Welthandelspl 1-D5, A-1020 Vienna, Austria.
EM gillian.foster@wu.ac.at
FU European UnionEuropean Union (EU) [776758]; CLIC - Circular models
   Leveraging Investments in Cultural heritage adaptive reuse
FX This research was funded by the European Union Horizon 2020 Project ID:
   776758, CLIC - Circular models Leveraging Investments in Cultural
   heritage adaptive reuse. The author thanks the anonymous reviewers for
   their helpful comments and Halliki Kreinin for technical assistance with
   Figs. 6 and 7.
CR Aapaoja A., 2014, OPEN J BUSINESS MANA, V2, P43, DOI DOI 10.4236/OJBM.2014.21007
   Adams K., 2017, CIRCULAR EC CONSTRUC
   Alikhani A, 2009, PROCEEDINGS OF THE 7TH IASME/WSEAS INTERNATIONAL CONFERENCE ON HEAT TRANSFER, THERMAL ENGINEERING AND ENVIRONMENT (HTE'09), P239
   Andersson E, 2006, ECOL SOC, V11
   Assefa G, 2017, SUSTAIN CITIES SOC, V28, P146, DOI 10.1016/j.scs.2016.09.011
   Aytac DO, 2016, EUR J SUSTAIN DEV, V5, P523, DOI 10.14207/ejsd.2016.v5n4p523
   Baker H., 2017, DECISION MAKING DEMO
   Barthel-Bouchier Diane, 2016, CULTURAL HERITAGE CH
   Binder M.L, 2003, U CINCINNATI LAW REV
   Boeri A, 2016, TECHNE, V12, P230, DOI 10.13128/Techne-19357
   BRUCE JP, 1996, CLIMATE CHANGE 1995
   Bullen Peter A., 2011, Structural Survey, V29, P411, DOI 10.1108/02630801111182439
   Bullen P.A, 2011, COBRA 2011 P RICS CO, P1652
   Bullen PA, 2010, CITIES, V27, P215, DOI 10.1016/j.cities.2009.12.005
   Cabeza LF, 2013, RENEW SUST ENERG REV, V23, P536, DOI 10.1016/j.rser.2013.03.017
   Camocini B, 2017, DES J, V20, pS1558, DOI 10.1080/14606925.2017.1352680
   Cheong C, 2011, MEASUREMENTS INDICAT
   Cooper DR, 2017, J IND ECOL, V21, P38, DOI 10.1111/jiec.12388
   de Jesus A, 2018, ECOL ECON, V145, P75, DOI 10.1016/j.ecolecon.2017.08.001
   Debacker W, 2016, D1 SYNTHESIS STATE O
   Dessein J., 2015, CULTURE SUSTAINABLE
   Elefante C, 2007, FORUM J NATL TRUST H, V26
   EMF, 2013, CIRC EC EC BUS RAT A
   Forsyth M, 2013, UNDERSTANDING HIST B
   Ghisellini P, 2017, J CLEAN PROD
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Girard L.F., 2014, HOPUE HOUSING POLICI, P1
   Girard L.F, 2018, BOLLETTINO CTR CALZA, V17, P35
   Grazuleviciute-Vileniske I, 2008, LANDSCAPE RES, V33, P425, DOI 10.1080/01426390801946491
   Guzman PC, 2017, CITIES, V60, P192, DOI 10.1016/j.cities.2016.09.005
   Habitat U., 2016, URB DEV EM FUT WORLD
   Hammond GP, 2008, ENERGY, V161, P87, DOI DOI 10.1680/ENER.2008.161.2.87
   Hassan AM, 2015, LAND USE POLICY, V48, P199, DOI 10.1016/j.landusepol.2015.04.029
   Hein M.F., 2008, INT J CONSTR ED RES, V4, P115, DOI [10.1080/15578770802229466, DOI 10.1080/15578770802229466]
   Hill S, 2016, J CULT HERIT MANAG S, V6, P34, DOI 10.1108/JCHMSD-04-2015-0013
   Hobbs G., 2017, REUSE BUILDING PRODU
   Hoornweg D., 2013, BUILDING SUSTAINABIL
   Hosagrahar J., 2016, B CTR CALZA BINI, V16, P37
   ICOMOS I.I.C.o.C.T, 2002, ICOMOS INT CULT TOUR
   Ijla A., 2015, INT INVENT J ARTS SO, V2, P52
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Korhonen J, 2018, ECOL ECON, V143, P37, DOI 10.1016/j.ecolecon.2017.06.041
   Kubbinga B., 2017, FUTURE PROOF BUILT E
   Lehmann S., 2010, SAPI EN S SURVQ PERS, V3, P2
   Lehmann S, 2013, HABITAT INT, V37, P61, DOI 10.1016/j.habitatint.2011.12.014
   Lehmann S, 2011, J GREEN BUILD, V6, P88
   Lewin SS, 2013, J GREEN BUILD, V8, P17, DOI 10.3992/jgb.8.4.17
   Mahpour A, 2018, RESOUR CONSERV RECY, V134, P216, DOI 10.1016/j.resconrec.2018.01.026
   Melo M P, 2012, CULTURAL HERITAGE PR, P139, DOI 10.1007/978-94-007-1869-2_7
   Montgomery J., 2003, PLANNING PRACTICE RE, V18, P293, DOI DOI 10.1080/1561426042000215614
   Moreau V, 2017, J IND ECOL, V21, P497, DOI 10.1111/jiec.12598
   Munarim U, 2016, RENEW SUST ENERG REV, V58, P235, DOI 10.1016/j.rser.2015.12.334
   OECD/IEA, 2017, EN TECHN PERP 2017 C, P12
   Pomponi F, 2016, J ENVIRON MANAGE, V181, P687, DOI 10.1016/j.jenvman.2016.08.036
   Potting J, 2017, CIRCULAR EC MEASURIN
   Qian GQ, 2016, RES SER CHIN DREAM, P169, DOI 10.1007/978-3-662-48153-0_6
   Quintero T., 2013, STUDY URBAN DESIGN C
   Reike D., 2017, RESOUR CONSERV RECYC
   Richards G, 2011, ANN TOURISM RES, V38, P1225, DOI 10.1016/j.annals.2011.07.008
   Rodrigues C, 2017, J CLEAN PROD, V157, P94, DOI 10.1016/j.jclepro.2017.04.104
   Rodwell D., 2011, HIST ENV, V23, P8
   Rogelj J, 2018, GLOBAL WARNING 1 5 C, P95
   Sauve S, 2016, ENVIRON DEV, V17, P48, DOI 10.1016/j.envdev.2015.09.002
   Soini K, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020167
   Thornton BJ, 2011, J GREEN BUILD, V6, P1
   Throsby D., 2009, CULT TOUR SUSTAIN LO, V17
   Throsby D, 2017, INT J CULT POLICY, V23, P133, DOI 10.1080/10286632.2017.1280788
   United_Nations, 2018, WORLD URB PROSP 2018
   Velez G.G., 2016, HERITAGE COUNTS, V2, P65
   WEF, 2016, SHAP FUT CONSTR BREA, P64
   Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017
   Wong L., 2016, ADAPTIVE REUSE EXTEN
   Wright WCC, 2016, ECOL ECON, V130, P277, DOI 10.1016/j.ecolecon.2016.08.001
   Yung ELK, 2017, HABITAT INT, V66, P135, DOI 10.1016/j.habitatint.2017.06.004
   Zhang Y., 2010, I APPROACH SELF GOVE
NR 75
TC 1
Z9 1
U1 30
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104507
DI 10.1016/j.resconrec.2019.104507
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700020
OA Green Accepted, Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU He, XY
   Kim, HC
   Wallington, TJ
   Zhang, SJ
   Shen, W
   De Kleine, R
   Keoleian, GA
   Ma, RY
   Zheng, YL
   Zhou, BY
   Wu, Y
AF He, Xiaoyi
   Kim, Hyung Chul
   Wallington, Timothy J.
   Zhang, Shaojun
   Shen, Wei
   De Kleine, Robb
   Keoleian, Gregory A.
   Ma, Ruoyun
   Zheng, Yali
   Zhou, Boya
   Wu, Ye
TI Cradle-to-gate greenhouse gas (GHG) burdens for aluminum and steel
   production and cradle-to-grave GHG benefits of vehicle lightweighting in
   China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Life cycle assessment; Advanced high-strength steel; Aluminum; Vehicle
   lightweighting; Greenhouse gas emissions
ID LIFE-CYCLE ASSESSMENT; ENERGY-CONSUMPTION; ELECTRIC VEHICLES; PASSENGER
   CARS; MATERIAL SUBSTITUTION; EMISSIONS; ELECTRIFICATION; REDUCTION;
   IMPACTS; STRATEGIES
AB Greenhouse gas (GHG) burdens of steel and aluminum production and life cycle benefits of vehicle lightweighting in China were evaluated. Production of advanced high-strength steel (AHSS) and wrought aluminum (Al) have average cradle-to-gate GHG emissions of 3.9 and 17.5 kg CO(2)eq/kg. Lightweighting benefits for eleven passenger car models over five driving cycles (including real-world and regulatory cycles) were determined. Lightweighting using AHSS to replace conventional steel has cradle-to-grave GHG savings in all cases, mainly attributed to savings in material use. Wrought Al has a much higher GHG production burden than AHSS and requires greater fuel savings in the use phase to achieve net cradle-to-grave GHG savings. Maximum GHG savings occur with Al versus AHSS in cases where the powertrain is resized, travel is congested, or lifetime travel distance is long. A typical Beijing peak-hour driving cycle with low speed and frequent stop-and-go has higher fuel reduction values (FRVs) and GHG savings than other cycles. Congested travel conditions make lightweighting a particularly effective emissions reduction strategy in China.
C1 [He, Xiaoyi; Keoleian, Gregory A.] Univ Michigan, Ctr Sustainable Syst, Sch Environm & Sustainabil, Dana Bldg 440 Church, Ann Arbor, MI 48109 USA.
   [Kim, Hyung Chul; Wallington, Timothy J.; De Kleine, Robb] Ford Motor Co, Dearborn, MI 48121 USA.
   [Zhang, Shaojun; Ma, Ruoyun; Wu, Ye] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.
   [Zhang, Shaojun; Ma, Ruoyun; Wu, Ye] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
   [Shen, Wei] Ford Motor Co, Beijing 100022, Peoples R China.
   [Zheng, Yali] China Soc Automot Engineers, 4F Tianlian Bldg,Lianhuachi East Rd, Beijing 100084, Peoples R China.
   [Zhou, Boya] China Automot Technol & Res Ctr Co Ltd, 68 Xianfeng East Rd, Tianjin 300300, Peoples R China.
   [Wu, Ye] State Environm Protect Key Lab Sources & Control, Beijing 100084, Peoples R China.
RP Wu, Y (reprint author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.; Wu, Y (reprint author), Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.
EM ywu@tsinghua.edu.cn
RI He, Xiaoyi/AAL-3526-2020; Wu, Ye/O-9779-2015; Shen, Wei/AAK-5955-2020;
   De Kleine, Robert/H-8175-2019; Zhang, Shaojun/E-7745-2016
OI He, Xiaoyi/0000-0002-6263-0329; De Kleine, Robert/0000-0002-6510-9336;
   Kim, Hyung Chul/0000-0002-0992-4547; Shen, Wei/0000-0002-1705-6444;
   Zhang, Shaojun/0000-0002-2176-6174
FU National Key Research and Development Program of China [2017YFC0212100];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [91544222]; Ford University Research Programs;
   University of MichiganUniversity of Michigan System; Tsinghua University
FX This study was supported by the National Key Research and Development
   Program of China (2017YFC0212100) and the National Natural Science
   Foundation of China (91544222), and also partially funded by Ford
   University Research Programs with the University of Michigan and Ford
   University Research Programs with Tsinghua University.
CR Alonso E, 2012, ENVIRON SCI TECHNOL, V46, P2893, DOI 10.1021/es202938m
   Automotive Technology & Research Center (ATRC), 2017, CHIN AUT IND YB
   China Aluminum Association (CAA), 2017, AL IND OP DAT
   China Automotive Technology & Research Center (CATARC), 2018, CHIN AUT DRIV CYCL 1
   China Coking Industry Association, 2016, CHIN EL YB
   China Nonferrous Metal Industry Association (CNMIA), 2016, STAT DOC COMP NONF M
   China Society of Automotive Engineers (China SAE), 2016, ROADM EN SAV NEW EN
   Colett JS, 2016, J IND ECOL, V20, P29, DOI 10.1111/jiec.12268
   Department of Energy, 2019, LONG TERM LIGHTW MAT
   Department of Energy, 2015, BANDW STUD EN US POT
   Ding Ning, 2012, Chinese Journal of Nonferrous Metals, V22, P2908
   Gao F, 2009, SCI CHINA SER E, V52, P2161, DOI 10.1007/s11431-009-0165-6
   [郭杰 Guo Jie], 2014, [环境工程学报, Chinese Journal of Environmental Engineering], V8, P4858
   Hao H, 2016, APPL ENERG, V166, P264, DOI 10.1016/j.apenergy.2015.05.056
   He XY, 2016, APPL ENERG, V180, P650, DOI 10.1016/j.apenergy.2016.08.021
   Hein Kaiser, 2012, ENV CONTROL EMISSION
   Hodnebrog O, 2013, REV GEOPHYS, V51, P300, DOI 10.1002/rog.20013
   International Aluminium Institute (IAI), 2017, 2015 LIF CYCL INV EN
   Jimenez-Palacios J.L., 1999, THESIS
   Ke WW, 2017, APPL ENERG, V188, P367, DOI 10.1016/j.apenergy.2016.12.011
   Kelly JC, 2015, ENVIRON SCI TECHNOL, V49, P12535, DOI 10.1021/acs.est.5b03192
   Keoleian G., 2012, LIFE CYCLE MAT DATA
   Keoleian GA, 2012, MRS BULL, V37, P365, DOI 10.1557/mrs.2012.52
   Kim HC, 2015, ENVIRON SCI TECHNOL, V49, P10209, DOI 10.1021/acs.est.5b01655
   Kim HC, 2013, ENVIRON SCI TECHNOL, V47, P14358, DOI 10.1021/es402954w
   Lewis AM, 2014, APPL ENERG, V126, P13, DOI 10.1016/j.apenergy.2014.03.023
   Liu YX, 2019, J CLEAN PROD, V238, DOI 10.1016/j.jclepro.2019.117884
   Liu Z.M., 2016, RES IRON STEEL, V44, P1
   [卢笙 Lu Sheng], 2018, [环境科学学报, Acta Scientiae Circumstantiae], V38, P1783
   Luk JM, 2017, ENVIRON SCI TECHNOL, V51, P8215, DOI 10.1021/acs.est.7b00909
   Lyu B, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061258
   Ma RY, 2019, J CLEAN PROD, V223, P564, DOI 10.1016/j.jclepro.2019.03.002
   McMillan CA, 2009, ENVIRON SCI TECHNOL, V43, P1571, DOI 10.1021/es800815w
   Ministry of Industry and Information Technology of the People's Republic of China, 2012, DEV PLAN EN SAV NEW
   Modaresi R, 2014, ENVIRON SCI TECHNOL, V48, P10776, DOI 10.1021/es502930w
   Palencia JCG, 2015, ENERGY, V93, P1489, DOI 10.1016/j.energy.2015.10.017
   Qiao QY, 2019, ENERGY, V177, P222, DOI 10.1016/j.energy.2019.04.080
   Qiu X., 2007, ENERGY METAL IND, V26, P3
   Raugei M, 2015, J CLEAN PROD, V108, P1168, DOI 10.1016/j.jclepro.2015.05.100
   Schmidt WP, 2004, INT J LIFE CYCLE ASS, V9, P405, DOI 10.1007/BF02979084
   Upadhyayula VKK, 2019, J CLEAN PROD, V209, P1604, DOI 10.1016/j.jclepro.2018.11.153
   Vercammen S., 2017, GROWING IMPORTANCE S
   Wang RJ, 2015, APPL ENERG, V147, P92, DOI [10.1016/j.apenergy.2015.01.107, 10.1016/j.aPenergy.2015.01.107]
   World Steel Association, 2016, LIF CYCL INV REQ
   Wu Y, 2012, ENERG POLICY, V48, P537, DOI 10.1016/j.enpol.2012.05.060
   Zhang SJ, 2014, ENERGY, V69, P247, DOI 10.1016/j.energy.2014.02.103
   Zhou B., 2016, THESIS
NR 47
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104497
DI 10.1016/j.resconrec.2019.104497
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700005
OA Bronze
DA 2020-05-12
ER

PT J
AU Islam, MT
   Huda, N
AF Islam, Md Tasbirul
   Huda, Nazmul
TI Assessing the recycling potential of "unregulated" e-waste in Australia
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Waste electrical and electronic equipment (WEEE); Dynamic material flow
   analysis; Recycling; Generation; Household appliances; Australia
ID MATERIAL FLOW-ANALYSIS; OBSOLETE HOUSEHOLD APPLIANCES; ELECTRONIC
   EQUIPMENT WEEE; PHONES GENERATION; IN-USE; MANAGEMENT; QUANTITIES;
   COMPUTERS; DISPOSAL; METALS
AB Currently, Australian e-waste management system under the National Television and Computer Recycling Scheme (NTCRS) consider television, computer, and IT peripheral products and MobileMuster only considers mobile phones. A large proportion of E-waste from other categories is still unregulated. This study aims to estimate e-waste generation from this "unregulated" e-waste stream by a Weibull distribution-based sales-stock-lifespan model from 2010 to 2030. A total of sixteen unregulated products (eleven electrical appliances and five electronic equipment) were selected for the estimation. The results of this study show that Australia will generate 342 kilo tonnes (kt) of the e-waste in 2020, which is predicted to grow to 461 kt in 2030 with an annual increase rate of around 3.7% from the 16 unregulated electrical and electronic equipment (EEE). Home laundry appliances, air treatment products, refrigeration appliances, large cooking appliances, and heating appliances are the critical items that account for more than 70% of the total e-waste generation. Base metals such as Fe, Cu, and Al will have a sharp increase by the year 2030, accounting 234.27 kt, 31.19 kt, 13.93 kt, respectively from the estimated e-waste quantities. Electronics products (e.g., home audio and visual devices, portable players, video games hardware, and others) will be a significant source of precious and rare-earth elements. By 2030, the estimated economic value of the metals will vary in between 2.74-4.60 billion US$. This study provides suggestion to policymakers in decision making for the future collection and recycling of e-waste in Australia.
C1 [Islam, Md Tasbirul; Huda, Nazmul] Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
RP Huda, N (reprint author), Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
EM nazmul.huda@mq.edu.au
RI Huda, Nazmul/AAI-4807-2020
OI Huda, Nazmul/0000-0002-2349-7019; Islam, Md Tasbirul/0000-0002-6323-2795
FU Macquarie University under the scholarship scheme "International
   Macquarie University Research Training Program (iMQRTP)"
FX The authors would like to thank two anonymous reviewers for their
   constructive comments on the manuscript. The first author acknowledges
   the financial support from Macquarie University under the scholarship
   scheme "International Macquarie University Research Training Program
   (iMQRTP)" for conducting this research.
CR ABC (Australian Broadcasting Commision), 2018, ABC
   Agamuthu P, 2015, RESOUR CONSERV RECY, V105, P177, DOI 10.1016/j.resconrec.2015.09.018
   Ai N, 2019, RESOUR CONSERV RECY, V145, P208, DOI 10.1016/j.resconrec.2019.01.021
   Araujo MG, 2012, WASTE MANAGE, V32, P335, DOI 10.1016/j.wasman.2011.09.020
   Awasthi AK, 2018, SCI TOTAL ENVIRON, V613, P46, DOI 10.1016/j.scitotenv.2017.08.288
   Balde C.P., 2017, GLOBAL E WASTE MONIT
   Brunner P. H., 2016, PRACTICAL HDB MAT FL
   Brunner P. H., 2004, INT J LIFE CYCLE ASS, V9, P337, DOI DOI 10.1007/BF02979426
   Cao RJ, 2019, RESOUR CONSERV RECY, V147, P137, DOI 10.1016/j.resconrec.2019.04.031
   Chen WQ, 2015, P NATL ACAD SCI USA, V112, P6265, DOI 10.1073/pnas.1406866112
   Cucchiella F, 2015, RENEW SUST ENERG REV, V51, P263, DOI 10.1016/j.rser.2015.06.010
   D'Adamo I, 2019, RESOUR CONSERV RECY, V149, P455, DOI 10.1016/j.resconrec.2019.06.012
   Davis G, 2008, RESOUR CONSERV RECY, V52, P1031, DOI 10.1016/j.resconrec.2008.04.001
   De Meester S, 2019, RESOUR CONSERV RECY, V142, P1, DOI 10.1016/j.resconrec.2018.10.015
   Dias P, 2018, J CLEAN PROD, V197, P750, DOI 10.1016/j.jclepro.2018.06.161
   Environment B, 2018, NATL WASTE REPORT 20
   Ford P, 2016, ENVIRON SCI TECHNOL, V50, P4854, DOI 10.1021/acs.est.6b00237
   Forti V., 2018, E WASTE STAT GUIDELI
   Golev A, 2016, WASTE MANAGE, V58, P348, DOI 10.1016/j.wasman.2016.09.025
   Guo XY, 2017, SCI TOTAL ENVIRON, V575, P321, DOI 10.1016/j.scitotenv.2016.10.054
   Gusukuma M, 2018, RESOUR CONSERV RECY, V138, P142, DOI 10.1016/j.resconrec.2018.07.014
   Tran HP, 2018, RESOUR CONSERV RECY, V139, P78, DOI 10.1016/j.resconrec.2018.07.031
   Habuer, 2014, WASTE MANAGE, V34, P489, DOI 10.1016/j.wasman.2013.11.004
   Herat S, 2019, ELECTRONIC WASTE MANAGEMENT AND TREATMENT TECHNOLOGY, P269, DOI 10.1016/B978-0-12-816190-6.00012-1
   Ikhlayel M, 2016, RESOUR CONSERV RECY, V108, P134, DOI 10.1016/j.resconrec.2016.01.015
   Islam M. T, 2018, INT J ENV ECOL ENG, V12, P610
   Islam M.T, 2018, MULT DIG PUBL I P
   Islam MT, 2019, J CLEAN PROD, V237, DOI 10.1016/j.jclepro.2019.117787
   Islam MT, 2019, J ENVIRON MANAGE, V244, P344, DOI 10.1016/j.jenvman.2019.05.062
   Islam MT, 2018, RESOUR CONSERV RECY, V137, P48, DOI 10.1016/j.resconrec.2018.05.026
   Islam MT, 2016, J CLEAN PROD, V137, P728, DOI 10.1016/j.jclepro.2016.07.111
   Johnson M, 2018, RESOUR CONSERV RECY, V131, P1, DOI 10.1016/j.resconrec.2017.11.029
   Kahhat R, 2008, RESOUR CONSERV RECY, V52, P955, DOI 10.1016/j.resconrec.2008.03.002
   Kahhat R, 2012, RESOUR CONSERV RECY, V67, P67, DOI 10.1016/j.resconrec.2012.07.008
   Kalmykova Y, 2017, RESOUR CONSERV RECY, V120, P65, DOI 10.1016/j.resconrec.2017.01.006
   Kalmykova Y, 2015, WASTE MANAGE, V46, P511, DOI 10.1016/j.wasman.2015.08.034
   Li N, 2018, RESOUR CONSERV RECY, V130, P109, DOI 10.1016/j.resconrec.2017.11.008
   Li Z, 2019, RESOUR CONSERV RECY, V149, P20, DOI 10.1016/j.resconrec.2019.05.025
   Lovik AN, 2015, ENVIRON SCI TECHNOL, V49, P5704, DOI 10.1021/acs.est.5b00320
   Morris A, 2016, J ENVIRON MANAGE, V181, P218, DOI 10.1016/j.jenvman.2016.06.013
   Do NT, 2014, RESOUR CONSERV RECY, V88, P67, DOI 10.1016/j.resconrec.2014.04.006
   Ongondo FO, 2011, WASTE MANAGE, V31, P1307, DOI 10.1016/j.wasman.2011.01.032
   Ongondo FO, 2011, WASTE MANAGE, V31, P743, DOI 10.1016/j.wasman.2010.11.005
   Parajuly K, 2017, RESOUR CONSERV RECY, V123, P85, DOI 10.1016/j.resconrec.2016.08.004
   Parajuly K, 2017, J CLEAN PROD, V151, P272, DOI 10.1016/j.jclepro.2017.03.045
   Peeters JR, 2017, RESOUR CONSERV RECY, V120, P14, DOI 10.1016/j.resconrec.2017.01.001
   Polak M, 2012, WASTE MANAGE, V32, P1583, DOI 10.1016/j.wasman.2012.03.028
   Reuter M. A., 2013, METAL RECYCLING OPPO
   Robinson BH, 2009, SCI TOTAL ENVIRON, V408, P183, DOI 10.1016/j.scitotenv.2009.09.044
   Song XX, 2017, J IND ECOL, V21, P57, DOI 10.1111/jiec.12407
   Statista, 2019, DYSPR OX PRIC WORLDW
   Steubing B, 2010, WASTE MANAGE, V30, P473, DOI 10.1016/j.wasman.2009.09.007
   Thiebaud E, 2017, ENVIRON SCI TECHNOL, V51, P4494, DOI 10.1021/acs.est.6b06336
   Torihara K, 2015, PROC CIRP, V26, P746, DOI 10.1016/j.procir.2014.07.088
   UNCOMTRADE, 2018, UN COMTR DAT
   UTS, 2019, ISF HOSTS LAUNCH EW
   Van Eygen E, 2016, RESOUR CONSERV RECY, V107, P53, DOI 10.1016/j.resconrec.2015.10.032
   Wang F, 2013, WASTE MANAGE, V33, P2397, DOI 10.1016/j.wasman.2013.07.005
   Wang MX, 2018, J CLEAN PROD, V187, P730, DOI 10.1016/j.jclepro.2018.03.243
   Zeng XL, 2018, ENVIRON SCI TECHNOL, V52, P4835, DOI 10.1021/acs.est.7b04909
   Zeng XL, 2016, ENVIRON SCI TECHNOL, V50, P1347, DOI 10.1021/acs.est.5b05446
   Zhang L, 2019, RESOUR CONSERV RECY, V143, P210, DOI 10.1016/j.resconrec.2019.01.007
   Zhang L, 2012, WASTE MANAGE RES, V30, P1160, DOI 10.1177/0734242X12441238
   Zhang L, 2011, RESOUR CONSERV RECY, V55, P1087, DOI 10.1016/j.resconrec.2011.06.003
NR 64
TC 2
Z9 2
U1 10
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104526
DI 10.1016/j.resconrec.2019.104526
PG 15
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700015
OA Bronze
DA 2020-05-12
ER

PT J
AU Kapoor, KK
   Dwivedi, YK
AF Kapoor, Kawaljeet K.
   Dwivedi, Yogesh K.
TI Sustainable consumption from the consumer's perspective: Antecedents of
   solar innovation adoption
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Adoption; Behavioral intention; Diffusion of innovations; Green;
   Innovation; Solar
ID MOBILE BANKING ADOPTION; TECHNOLOGY ADOPTION; RESIDENTIAL SOLAR; CARBON
   EMISSIONS; INTERNET BANKING; DECISION-MAKING; HEATING-SYSTEMS;
   MODERATING ROLE; ENERGY; ATTRIBUTES
AB Rising focus on solar power and better world environment have set ambitious plans in motion on the amount of solar power generation, worldwide, for the coming years. In the interest of socially responsible use of energy, both developed and developing countries are exploring their potential of going green. However, low solar adoption rates are a cause of pressing concern for some of these countries. This study investigates consumer intentions to adopt solar innovations, with particular empirical interest in the adoption of solar equipment by Indian households. We use a cross-sectional field survey approach to gather relevant data from four most populous cities in India. Structural equation modelling and logistic regression are employed to deduce results by analyzing data from 320 respondents. Building on characteristics from diffusion of innovation theory, this study finds that relative advantage and compatibility strongly influence consumer intentions, and such behavioral intentions have a positive and significant effect on the adoption of solar equipment.
C1 [Kapoor, Kawaljeet K.] Aston Univ, Birmingham, W Midlands, England.
   [Dwivedi, Yogesh K.] Swansea Univ, Swansea, W Glam, Wales.
RP Dwivedi, YK (reprint author), Swansea Univ, Swansea, W Glam, Wales.
EM ykdwivedi@gmail.com
RI ; Dwivedi, Yogesh/A-5362-2008
OI Kapoor, Kawaljeet/0000-0001-9524-905X; Dwivedi,
   Yogesh/0000-0002-5547-9990
CR Abu Alhaj M, 2016, RESOUR CONSERV RECY, V108, P82, DOI 10.1016/j.resconrec.2015.11.011
   Agarwal R, 1998, P ANN M DIFF INT GRO
   Agnew S, 2018, J CLEAN PROD, V172, P2363, DOI 10.1016/j.jclepro.2017.11.174
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Al-Jabri IM, 2012, J ELECTRON COMMER RE, V13, P373
   Alalwan AA, 2017, INT J INFORM MANAGE, V37, P99, DOI 10.1016/j.ijinfomgt.2017.01.002
   Arambewela R, 2009, ASIA PAC J MARKET LO, V21, P555, DOI 10.1108/13555850910997599
   Arkesteijn K, 2005, ENERG POLICY, V33, P183, DOI 10.1016/S0301-4215(03)00209-X
   Arts JWC, 2011, INT J RES MARK, V28, P134, DOI 10.1016/j.ijresmar.2010.11.002
   Baker JR, 2013, BEHAV RES THER, V51, P31, DOI 10.1016/j.brat.2012.10.005
   Bauer H.H., 2005, J ELECTRON COMMER RE, V6, P181
   Bauner C, 2015, ENERG POLICY, V86, P27, DOI 10.1016/j.enpol.2015.06.009
   Bedenk Stephan, 2018, STRATEGIES FAILURE M, P95
   Bhattacherjee A., 2012, SOCIAL SCI RES PRINC
   Chaurey A, 2009, ENERG POLICY, V37, P115, DOI 10.1016/j.enpol.2008.07.038
   Chen CJ, 2011, J BUS ETHICS, V104, P525, DOI 10.1007/s10551-011-0926-6
   CHEN JC, 2010, [No title captured], V5
   Chiu RK, 2003, J BUS ETHICS, V43, P65, DOI 10.1023/A:1022911215204
   Chou CJ, 2012, INT J HOSP MANAG, V31, P703, DOI 10.1016/j.ijhm.2011.09.006
   Claudy MC, 2011, ENERG POLICY, V39, P1459, DOI 10.1016/j.enpol.2010.12.018
   COOPER RG, 1987, R&D MANAGE, V17, P175, DOI 10.1111/j.1467-9310.1987.tb00052.x
   Cowan K., 2011, TECHN MAN EN SMART W, P1
   Damiano RJ, 2011, INNOVATIONS, V6, P65, DOI 10.1097/IMI.0b013e3182162bcf
   Diamantopoulos A, 2003, J BUS RES, V56, P465, DOI 10.1016/S0148-2963(01)00241-7
   Dillon A., 1996, USER ACCEPTANCE NEW
   Dwivedi YK, 2019, INFORM SYST FRONT, V21, P719, DOI 10.1007/s10796-017-9774-y
   Dwivedi YK, 2017, GOV INFORM Q, V34, P211, DOI 10.1016/j.giq.2017.03.001
   Dwivedi YK, 2013, INT J INDIAN CULT BU, V7, P53, DOI 10.1504/IJICBM.2013.054817
   Dwivedi YK, 2013, INT J INFORM MANAGE, V33, P367, DOI 10.1016/j.ijinfomgt.2012.10.008
   EAI, 2014, IND SOL EN
   Elmustapha H, 2018, J CLEAN PROD, V172, P347, DOI 10.1016/j.jclepro.2017.10.131
   Faiers A, 2006, ENERG POLICY, V34, P1797, DOI 10.1016/j.enpol.2005.01.001
   Faiers A, 2007, ENERG POLICY, V35, P3418, DOI 10.1016/j.enpol.2006.10.029
   Fang JM, 2017, INT J INFORM MANAGE, V37, P269, DOI 10.1016/j.ijinfomgt.2017.03.003
   Fishbein M, 1977, BELIEF ATTITUDE INTE
   Fornell C., 1981, STRUCTURAL EQUATION
   Galbreath J, 2011, J BUS ETHICS, V104, P421, DOI 10.1007/s10551-011-0919-5
   Gefen D., 2000, COMMUN AIS, V4, P1, DOI DOI 10.17705/1CAIS.00407
   Gencer E, 2018, RESOUR CONSERV RECY, V133, P331, DOI 10.1016/j.resconrec.2018.01.030
   Gounaris S, 2008, INT J BANK MARK, V26, P282, DOI 10.1108/02652320810894370
   Ha I, 2009, ADOPTION IPTV CONVER
   Hair J.F., 2010, MULTIVARIATE DATA AN
   Hair JF, 1998, MULTIVARIATE DATA AN
   Hall J, 2008, J BUS ETHICS, V77, P45, DOI 10.1007/s10551-006-9293-0
   Hall J, 2010, INT J HOSP MANAG, V29, P245, DOI 10.1016/j.ijhm.2009.10.012
   Haneem F, 2019, INT J INFORM MANAGE, V45, P25, DOI 10.1016/j.ijinfomgt.2018.10.007
   Harcourt N, 2014, J IMMIGR MINOR HEALT, V16, P450, DOI 10.1007/s10903-012-9766-4
   Harman H.H., 1976, MODERN FACTOR ANAL
   Holmes-Smith P, 2005, STRUCTURAL EQUATION
   Huetink FJ, 2010, TECHNOL FORECAST SOC, V77, P1270, DOI 10.1016/j.techfore.2010.03.012
   Hughes L, 2019, INT J INFORM MANAGE, V49, P114, DOI 10.1016/j.ijinfomgt.2019.02.005
   Inglis R, 2011, ACCOUNT FINANC, V51, P711, DOI 10.1111/j.1467-629X.2011.00429.x
   Iriana R, 2013, J MARKET MANAG-UK, V29, P467, DOI 10.1080/0267257X.2012.732598
   Islam T, 2014, ENERG POLICY, V65, P340, DOI 10.1016/j.enpol.2013.10.004
   Islam T, 2013, ENERG POLICY, V55, P521, DOI 10.1016/j.enpol.2012.12.041
   Jaakkola E, 2007, J MARKET MANAG, V23, P327, DOI 10.1362/026725707X196404
   Jang HY, 2011, INT J INFORM MANAGE, V31, P582, DOI 10.1016/j.ijinfomgt.2011.03.003
   Jung J, 2012, NEW MEDIA SOC, V14, P204, DOI 10.1177/1461444811410407
   Kabir E, 2018, RENEW SUST ENERG REV, V82, P894, DOI 10.1016/j.rser.2017.09.094
   Kapoor K, 2013, ROLE INNOVATION ATTR, P19
   Kapoor KK, 2014, EUR J INNOV MANAG, V17, P327, DOI 10.1108/EJIM-08-2012-0083
   Kapoor KK, 2015, INFORM SYST FRONT, V17, P1039, DOI 10.1007/s10796-014-9484-7
   Kapoor KK, 2015, INFORM SYST MANAGE, V32, P153, DOI 10.1080/10580530.2015.1018776
   Kapoor KK, 2014, INFORM SYST MANAGE, V31, P74, DOI 10.1080/10580530.2014.854103
   Karahanna E, 1999, MIS QUART, V23, P183, DOI 10.2307/249751
   Karan M, 2019, INDIA SHORT PERIOD T
   Karjaluoto H, 2009, J SYST INF TECHNOL
   Khemthong S., 2006, J BUSINESS SYSTEMS G, V1, P47
   Kim H, 2014, RENEW ENERG, V66, P523, DOI 10.1016/j.renene.2013.12.022
   Klepacka AM, 2018, RESOUR CONSERV RECY, V139, P338, DOI 10.1016/j.resconrec.2018.09.004
   Kline RB, 2005, PRINCIPLES PRACTICE
   LABAY DG, 1981, J CONSUM RES, V8, P271, DOI 10.1086/208865
   Lazzarotti Valentina, 2013, International Journal of Entrepreneurship and Innovation Management, V17, P28
   Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018
   Li WY, 2018, RESOUR CONSERV RECY, V136, P337, DOI 10.1016/j.resconrec.2018.04.026
   Lin CY, 2011, J BUS ETHICS, V98, P67, DOI 10.1007/s10551-010-0535-9
   Lin HF, 2011, INT J INFORM MANAGE, V31, P252, DOI 10.1016/j.ijinfomgt.2010.07.006
   Lockett A., 1997, J MARKETING MANAGEME, V13, P791, DOI DOI 10.1080/0267257X.1997.9964512
   Lu J, 2005, J STRATEGIC INF SYST, V14, P245, DOI 10.1016/j.jsis.2005.07.003
   Mascia MB, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12442
   Mehari S, 2013, CONF P INDIUM PHOSPH, P200
   Meuter ML, 2005, J MARKETING, V69, P61, DOI 10.1509/jmkg.69.2.61.60759
   Michelsen C.C, 2011, 92011 FCN, DOI [10.2139/ssrn.1898688, DOI 10.2139/SSRN.1898688]
   Michelsen CC, 2012, ENERG ECON, V34, P1271, DOI 10.1016/j.eneco.2012.06.009
   Mishra PK, 2013, INT J INDIAN CULT BU, V7, P399, DOI 10.1504/IJICBM.2013.056216
   Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192
   Muller S, 2013, ECON INNOV NEW TECH, V22, P519, DOI 10.1080/10438599.2013.804333
   Nandi J, 2013, TIMES INDIA
   Olson EL, 2014, J CLEAN PROD, V64, P73, DOI 10.1016/j.jclepro.2013.07.050
   Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317
   Ozaki R, 2011, BUS STRATEG ENVIRON, V20, P1, DOI 10.1002/bse.650
   Panigrahi R, 2018, INT J INFORM MANAGE, V43, P1, DOI 10.1016/j.ijinfomgt.2018.05.005
   Panopoulos AP, 2013, INT J INFORM MANAGE, V33, P217, DOI 10.1016/j.ijinfomgt.2012.10.003
   Papies D, 2008, J MEDIA ECON, V21, P131, DOI 10.1080/08997760802300530
   Parthasarathy C., 2019, 2019 IEEE MILAN POWE, P1
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Pueschel J, 2010, INT J BANK MARK, V28, P389, DOI 10.1108/02652321011064908
   Purohit I, 2007, INT J AMBIENT ENERGY, V28, P27, DOI 10.1080/01430750.2007.9675021
   Purohit P, 2008, SOL ENERGY, V82, P799, DOI 10.1016/j.solener.2008.02.016
   Ramayah T, 2002, P INT SEM IND MAL RO, P14
   Rana NP, 2016, COMPUT HUM BEHAV, V59, P265, DOI 10.1016/j.chb.2016.02.019
   Rana NP, 2017, INFORM SYST FRONT, V19, P549, DOI 10.1007/s10796-015-9613-y
   Rehman IH, 2010, ENVIRON SCI POLICY, V13, P303, DOI 10.1016/j.envsci.2010.03.012
   Richardson JW, 2011, J INT DEV, V23, P697, DOI 10.1002/jid.1661
   Rogers EM, 2003, DIFFUSION INNOVATION
   Roh M, 2019, INT J INFORM MANAGE, V47, P262, DOI 10.1016/j.ijinfomgt.2018.09.017
   Sasikumar N., 2013, IOSR J BUS MANAGE, V7, P61
   Schmidt-Costa JR, 2019, RESOUR CONSERV RECY, V140, P145, DOI 10.1016/j.resconrec.2018.09.017
   Shareef Mahmud Akhter, 2009, Electronic Government, V6, P70, DOI 10.1504/EG.2009.022594
   Shareef MA, 2017, INT J INFORM MANAGE, V37, P257, DOI 10.1016/j.ijinfomgt.2017.02.003
   Shih YY, 2004, INTERNET RES, V14, P213, DOI 10.1108/10662240410542643
   Shin DH, 2010, TELECOMMUN POLICY, V34, P616, DOI 10.1016/j.telpol.2010.07.001
   Sinha A, 2018, RENEW ENERG, V119, P703, DOI 10.1016/j.renene.2017.12.058
   Solar-Cooking, 2014, SOLAR COOKING SYSTEM
   Solar-Heating, 2014, SOLAR HEATING SYSTEM
   Solar-Lighting, 2014, SOLAR LIGHTING SYSTE
   SolarPanels, 2014, SOLAR PANELS AMAZING
   Song ML, 2015, J CLEAN PROD, V104, P374, DOI 10.1016/j.jclepro.2014.02.028
   Song ML, 2015, J CLEAN PROD, V103, P620, DOI 10.1016/j.jclepro.2014.05.095
   Sopha BM, 2011, RENEW SUST ENERG REV, V15, P2756, DOI 10.1016/j.rser.2011.03.027
   Spector P.E, 2004, SAGE ENCY SOCIAL SCI, V1, P229
   Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017
   Stevens J., 1996, APPL MULTIVARIATE ST
   Straub D, 2004, ISWORLD QUANTITATIVE
   Sun MX, 2018, RENEW SUST ENERG REV, V92, P823, DOI 10.1016/j.rser.2018.04.036
   Suwannaporn P., 2003, Agribusiness (New York), V19, P169, DOI 10.1002/agr.10047
   Tabachnick BG, 2007, USING MULTIVARIATE S
   Talke K, 2013, J PROD INNOVAT MANAG, V30, P732, DOI 10.1111/jpim.12017
   Donnelly TT, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-49
   Tanakinjal G.H., 2010, INT J MARKETING STUD, V2, P36
   Tapaninen A, 2009, CHARACTERISTICS INNO
   Teo TSH, 2003, OMEGA-INT J MANAGE S, V31, P483, DOI 10.1016/j.omega.2003.08.005
   TORNATZKY LG, 1982, IEEE T ENG MANAGE, V29, P28, DOI 10.1109/TEM.1982.6447463
   Tseng ML, 2018, RESOUR CONSERV RECY, V131, P146, DOI 10.1016/j.resconrec.2017.12.028
   Van Slyke C, 2002, COMMUN ACM, V45, P82, DOI 10.1145/545151.545155
   Venkatesh V, 2012, MIS QUART, V36, P157
   Vollink T, 2002, J ENVIRON PSYCHOL, V22, P333, DOI 10.1006/jevp.2001.0237
   Wang YM, 2010, TECHNOL FORECAST SOC, V77, P803, DOI 10.1016/j.techfore.2010.03.006
   WARKOV S, 1985, INT J COMP SOCIOL, V26, P240, DOI 10.1177/002071528502600310
   Weiss MC, 2013, FAM PRACT, V30, P712, DOI 10.1093/fampra/cmt042
   Weniger S, 2010, P INT BLED ECONFEREN
   Winslow KM, 2018, RESOUR CONSERV RECY, V129, P263, DOI 10.1016/j.resconrec.2017.11.001
   Wu JH, 2005, INFORM MANAGE-AMSTER, V42, P719, DOI 10.1016/j.im.2004.07.001
   Wustenhagen R, 2007, ENERG POLICY, V35, P2683, DOI 10.1016/j.enpol.2006.12.001
   Xia D, 2019, RESOUR CONSERV RECY, V143, P99, DOI 10.1016/j.resconrec.2018.12.022
   Zhang LY, 2012, COMPUT HUM BEHAV, V28, P1902, DOI 10.1016/j.chb.2012.05.008
   Zhu JJH, 2002, COMMUN RES, V29, P466, DOI 10.1177/0093650202029004005
NR 147
TC 2
Z9 2
U1 14
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104501
DI 10.1016/j.resconrec.2019.104501
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700001
OA Bronze
DA 2020-05-12
ER

PT J
AU Katta, AK
   Davis, M
   Kumar, A
AF Katta, Anil Kumar
   Davis, Matthew
   Kumar, Amit
TI Development of disaggregated energy use and greenhouse gas emission
   footprints in Canada's iron, gold, and potash mining sectors
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Mining; Energy intensity; Energy demand; Greenhouse gas emissions;
   Sankey diagram
ID LIFE-CYCLE ASSESSMENT; LONG-TERM ENERGY; EFFICIENCY IMPROVEMENT; SANKEY
   DIAGRAM; PRIMARY FUEL; FLOW; IMPACTS; SYSTEM; MAP
AB This study develops the disaggregated energy use and greenhouse gas (GHG) emission footprint for Canada's iron, gold, and potash mining sectors. Currently, only high-level aggregated data at the sectoral and regional levels exists in the literature. Through bottom-up energy demand tree development, we identified end-use processes for each mining operation in these sectors. The energy intensities for each end-user were calculated and used in a bottom-up energy-environmental model to determine the associated end-use process GHG emissions. The results were then used to develop Sankey diagrams that allow us to visualize the energy and GHG emissions flows from resource to end use by energy use sector, fuel type, and various jurisdictions in Canada. The overall energy and GHG emission intensities for iron, gold, and potash mining are 0.7, 149.8, 1.8 GJ/Mg and 33, 4922, 158 kg CO2 eq./Mg, respectively. Firing, ventilation, and product drying and steam generation end-use devices had the highest energy use share of 42%, 20%, and 47% in iron, gold, and potash mining sectors, respectively, in 2016. Firing in iron mining, ore transport in gold mining, and product drying and steam generation in potash mining were responsible for 66%, 22%, and 34% of the respective total sectoral GHG emissions. 56% of the GHG emissions were from Saskatchewan, followed by Quebec (18%), and Newfoundland and Labrador (14%). The results from this study provide benchmarks to develop energy savings and GHG mitigation strategies useful for decision making.
C1 [Katta, Anil Kumar; Davis, Matthew; Kumar, Amit] Univ Alberta, Donadeo Innovat Ctr Engn 10 263, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada.
RP Kumar, A (reprint author), Univ Alberta, Donadeo Innovat Ctr Engn 10 263, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada.
EM Amit.Kumar@ualberta.ca
FU NSERC/Cenovus/Alberta Innovates Associate Industrial Research Chair in
   Energy and Environmental Systems Engineering; Cenovus Energy Endowed
   Chair in Environmental Engineering; Canada First Research Excellence
   Fund (CFREF)
FX We are thankful to the NSERC/Cenovus/Alberta Innovates Associate
   Industrial Research Chair in Energy and Environmental Systems
   Engineering and the Cenovus Energy Endowed Chair in Environmental
   Engineering for providing financial support. We are also grateful to
   representatives from Alberta Innovates (AI), Suncor Energy Inc., Cenovus
   Energy Inc., Natural Resources Canada (NRCan), and Environment and
   Climate Change Canada (ECCC) for their valuable inputs and comments in
   various forms. As a part of the University of Alberta's Future Energy
   Systems (FES) research initiative, this research was made possible in
   part thanks to funding from the Canada First Research Excellence Fund
   (CFREF). The authors are thankful to Astrid Blodgett for editing the
   paper.
CR Brueske S., 2012, US MANUFACTURING ENE
   Cleveland Cliffs Inc, 2017, CLEV CLIFFS INC ANN
   Conliffe J., 2012, MINERAL COMMODITIES
   Cullen JM, 2010, ENERG POLICY, V38, P75, DOI 10.1016/j.enpol.2009.08.054
   Davis M, 2019, INT J GLOBAL WARM, V17, P23
   Davis M, 2018, APPL ENERG, V220, P754, DOI 10.1016/j.apenergy.2018.03.064
   Davis M, 2018, ENERG CONVERS MANAGE, V156, P178, DOI 10.1016/j.enconman.2017.11.012
   Detour Gold Corporation, 2018, DET LAK OP NI 43 101
   Ditsele O, 2012, INT J LIFE CYCLE ASS, V17, P287, DOI 10.1007/s11367-011-0354-y
   Dupere M., 2014, TECHNICAL REPORT
   Eckelman MJ, 2010, RESOUR CONSERV RECY, V54, P256, DOI 10.1016/j.resconrec.2009.08.008
   Ferreira H, 2015, J CLEAN PROD, V108, P1081, DOI 10.1016/j.jclepro.2015.05.140
   Fischedick M, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P739
   Garrett DE, 1996, POTASH DEPOSITS PROC
   Government of Canada, 2003, EN BENCHM CAN POT PR
   Government of Canada, 2018, COD PRACT POT SECT
   Government of Newfoundland and Labrador, 2017, IR LAB IR FLYER
   Griffin P., 2013, IND ENERGY USE BOTTO
   Griffin PW, 2018, APPL THERM ENG, V134, P152, DOI 10.1016/j.applthermaleng.2018.01.126
   Griffing E, 2010, IRON ORE MINING PELL
   Hamburg i, 2019, ESANKEY 3 2
   Haque N, 2015, IRON ORE MINERALOGY, P615, DOI [10.1016/B978-1-78242-156-6.00020-4, DOI 10.1016/B978-1-78242-156-6.00020-4]
   Harkisaari P., 2015, THESIS
   Heaps CG, 2016, LONG RANGE ENERGY AL
   Hsiao I-Chun, 2009, GLOBAL EXERGY CARBON
   International Energy Agency, 2018, WORLD EN BAL 2018
   International Energy Agency, 2019, CO2 EM STAT ESS TOOL
   International Energy Agency, 2019, WORLD BAL SANK
   Jankowska A, 2015, SECOND LANG LEARN, P251, DOI 10.1007/978-3-642-38339-7_16
   Kaarsberg T.M., 2007, 2007 ACEEE SUMMER ST
   Kallio E, 2015, 43101 NI
   Labrador Iron ore Royalty Corporation, 2019, ANN INF FORMS 2010 2
   Lawrence Livermore National Laboratory, 2018, EN FLOW CHARTS CHART
   Leal-Ayala DR, 2015, RESOUR CONSERV RECY, V103, P19, DOI 10.1016/j.resconrec.2015.07.003
   Marsden JO, 2006, MINER METALL PROC, V23, P121, DOI 10.1007/BF03403198
   Mittal Arcelor, 2017, ANN REPORTS 2010 201
   Natural Resources Canada, 2019, ATL CAN MIN MIN
   Natural Resources Canada, 2018, ANN STAT MIN PROD
   Natural Resources Canada, 2018, COMPR EN US DAT
   Natural Resources Canada, 2005, BENCHM EN CONS CAN O
   New Millennium Capital Corp, 2010, TECHN REP FEAS STUD
   Norgate T, 2012, J CLEAN PROD, V29-30, P53, DOI 10.1016/j.jclepro.2012.01.042
   Perez-Lombard L, 2011, APPL ENERG, V88, P5020, DOI 10.1016/j.apenergy.2011.07.003
   Schmidt M, 2008, J IND ECOL, V12, P82, DOI 10.1111/j.1530-9290.2008.00004.x
   Song XX, 2017, J IND ECOL, V21, P57, DOI 10.1111/jiec.12407
   Stockholm Environment Institute, 2018, LEAP APPL
   Subramanyam V, 2017, ENERGY, V118, P795, DOI 10.1016/j.energy.2016.10.115
   Subramanyam V, 2015, ENERG CONVERS MANAGE, V91, P342, DOI 10.1016/j.enconman.2014.12.024
   Talaei A, 2019, ENERGY, V170, P1051, DOI 10.1016/j.energy.2018.12.088
   US Geological Survey, 2016, MIN INF, V1
   US Securities and Exchange Commission, 2018, EDGAR CO FIL ANN REP
   Volk J., 2017, 43101 NI
   Zhao Z, 2016, CHEM ENGINEER TRANS, V52, P37, DOI 10.3303/CET1652007
NR 53
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104485
DI 10.1016/j.resconrec.2019.104485
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700006
OA Bronze
DA 2020-05-12
ER

PT J
AU Li, X
   Mao, HM
   Ma, YS
   Wang, B
   Liu, WS
   Xu, WJ
AF Li, Xi
   Mao, Hongmin
   Ma, Yongsong
   Wang, Bing
   Liu, Wenshi
   Xu, Wenjia
TI Life cycle greenhouse gas emissions of China shale gas
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Shale gas; GHG emission; Life cycle inventory; China
ID NATURAL-GAS; WATER-CONSUMPTION; GHG EMISSIONS; METHANE; COAL; FOOTPRINT
AB Having the largest shale gas reserve in the world, China is vigorously developing its shale gas resources. In this work, a hybrid life cycle inventory is used to estimate upstream greenhouse gas (GHG) emissions and evaluate the atmospheric environmental effects of China's shale gas development. A comprehensive GHG emission model of the preproduction phase is constructed by considering green completion, methane emission from flowback water, indirect emissions from materials upstream material manufacturing, and Monte Carlo simulation. Results indicate that the upstream GHG emission of 230 shale gas wells is 18.8 g CO2 eq/MJ. During the preproduction phase (from well pad preparation to well completion), indirect GHG emissions from upstream material manufacturing are substantial and account for 78%. The estimation of GHG emissions in preproduction phase presents considerable uncertainty (39%-79%) due to the uncertainty of constructing the pad preparation process and the estimated ultimate recovery. In preproduction phase, the GHG emission of China shale gas is estimated to be approximately 4.18 g CO2 eq/MJ (95% CI: 2.57 to 7.47 g CO2 eq/MJ), which is higher than that of the US shale gas.
C1 [Li, Xi; Xu, Wenjia] CNPC Res Inst Safety & Environm Technol, State Key Lab Petr Pollut Control, Beijing 102206, Peoples R China.
   [Li, Xi; Mao, Hongmin; Ma, Yongsong; Wang, Bing; Liu, Wenshi] Southwest Petr Univ, Dept Chem & Chem Engn, Chengdu 610500, Sichuan, Peoples R China.
RP Li, X (reprint author), Southwest Petr Univ, Dept Chem & Chem Engn, Chengdu 610500, Sichuan, Peoples R China.
EM icy124@hotmail.com
FU Open Project Program of State Key Laboratory of Petroleum Pollution
   Control [PPC2016012]; CNPC Research Institute of Safety and
   Environmental Technology; National Key S&T Special Projects "Development
   of large oil and gas fields and coalbed methane" [2016ZX05040-004]
FX This work was supported by the Open Project Program of State Key
   Laboratory of Petroleum Pollution Control (Grant No. PPC2016012), CNPC
   Research Institute of Safety and Environmental Technology, and the
   National Key S&T Special Projects "Development of large oil and gas
   fields and coalbed methane" (2016ZX05040-004).
CR Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3
   Birkved M, 2006, ECOL MODEL, V198, P433, DOI 10.1016/j.ecolmodel.2006.05.035
   Burnham A, 2012, ENVIRON SCI TECHNOL, V46, P619, DOI 10.1021/es201942m
   Chang Y, 2015, ENERGY, V86, P335, DOI 10.1016/j.energy.2015.04.034
   Chang Y, 2014, APPL ENERG, V125, P147, DOI 10.1016/j.apenergy.2014.03.039
   Chen GJ, 2017, SCI TOTAL ENVIRON, V574, P707, DOI 10.1016/j.scitotenv.2016.09.051
   Clark C.E, 2012, TECHNICAL INFORM TEC, DOI [10.2172/1044520, DOI 10.2172/1044520]
   CNPC, 2018, CHANGN SHAL GAS PROD
   CNPC, 2014, SICH SHAL GAS HOR WE
   CNPC, 2014, DRILL WORK REP SICH
   Heath G, 2014, J UNCONV OIL GAS RES, V8, P46, DOI 10.1016/j.juogr.2014.07.002
   Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5
   Hultman N, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044008
   Jia Chengye, 2017, Natural Gas Industry, V37, P80, DOI 10.3787/j.issn.1000-0976.2017.04.010
   Jiang M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034014
   Laurenzi IJ, 2013, ENVIRON SCI TECHNOL, V47, P4896, DOI 10.1021/es305162w
   Limited C.C.D.E, 2016, CHUANQ SHAL GAS DRIL
   National Bureau of Statistic of China (NBSC), 2014, CHIN STAT YB 2013
   National Development and Reform Commission (NDRC), 2017, OP ACC UT NAT GAS
   NBSC, 2015, CHIN STAT YB 2014
   NDRC N.D.A R, 2014, SOM OP EST LONG TERM
   NEA, 2014, STRAT ACT PLAN EN DE
   Oldenburg CM, 2007, ENERG CONVERS MANAGE, V48, P1808, DOI 10.1016/j.enconman.2007.01.010
   Omara M, 2016, ENVIRON SCI TECHNOL, V50, P2099, DOI 10.1021/acs.est.5b05503
   Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108
   Parra R, 2004, SCI TOTAL ENVIRON, V329, P241, DOI 10.1016/j.scitotenv.2004.03.005
   PetroChina, 2016, ENV IMP REP SHAL GAS
   PetroChina-SOC P.S.O.G, 2015, DRILL PROJ ENV IMP A
   PetroChina-SOC P.S.O.G, 2014, DRILL PROJ ENC IMP A
   PetroChina-SOC P.S.O.G, 2014, DRILL PROJ ENV IMP A
   PetroChina-SOC P.S.O.G, 2015, DRILL PROJ ENC IMP A
   Qin Y, 2017, ENVIRON SCI TECHNOL, V51, P2554, DOI 10.1021/acs.est.6b04072
   Saltelli A, 2008, VARIANCE BASED METHO
   Stephenson T, 2011, ENVIRON SCI TECHNOL, V45, P10757, DOI 10.1021/es2024115
   Sun Haifang, 2017, Natural Gas Industry, V37, P105, DOI 10.3787/j.issn.1000-0976.2017.01.013
   Thompson T, 2011, CHEM IND-LONDON, P22
   Tian G, 2018, NAT GAS IND B, V1, P66
   Wang Daofu, 2013, Natural Gas Industry, V33, P8, DOI 10.3787/j.issn.1000-0976.2013.01.002
   Wang JL, 2017, RESOUR CONSERV RECY, V120, P38, DOI 10.1016/j.resconrec.2017.01.005
   Wang Z, 2016, SCI TECHNOL REV
   Weber CL, 2012, ENVIRON SCI TECHNOL, V46, P5688, DOI 10.1021/es300375n
   [吴伟 Wu Wei], 2014, [天然气地球科学, Natural Gas Geoscience], V25, P1994
   Xie Jun, 2017, Natural Gas Industry, V37, P1, DOI 10.3787/j.issn.1000-0976.2017.07.001
   Xue M, 2019, INT PETR TECHN C, DOI [10.2523/IPTC-19367-MS, DOI 10.2523/IPTC-19367-MS]
   Yang G, 2015, PRACTICE UNDERRSTADI
   Yang H, 2013, SCIENCE, V340, P1288, DOI 10.1126/science.340.6138.1288-a
   Zhang D, 2015, PETROL GAOL ENG, V29, P111
   Zhang L, 2015, CHINAS SHALE GAS RES
   Zheng JY, 2010, ATMOS ENVIRON, V44, P1960, DOI 10.1016/j.atmosenv.2010.03.001
NR 49
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104518
DI 10.1016/j.resconrec.2019.104518
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700025
OA Bronze
DA 2020-05-12
ER

PT J
AU Moyo, T
   Chirume, BH
   Petersen, J
AF Moyo, T.
   Chirume, B. H.
   Petersen, J.
TI Assessing alternative pre-treatment methods to promote metal recovery in
   the leaching of printed circuit boards
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE E-waste; Printed circuit board; Pre-treatment; Liberation; Recycling;
   Hydrometallurgy
ID E-WASTE; COPPER RECOVERY; TECHNOLOGIES; MANAGEMENT; SEPARATION
AB Printed circuit boards are a metals rich fraction of e-waste streams and their recycling to recover the metals promotes growth of a secondary resources economy. Reported successful cases of PCB recycling are carried out in large volumes using high-level technology and high capital investment smelter house operations. Hydrometallurgical proceeds have the potential to provide an option for the scalable processing of smaller volumes of PCBs and can be set up at relatively lower capital costs. However, to date, the hydrometallurgical treatment options available rely on precursor communition processes that also require high capital and energy costs. This study evaluates the options of using NaOH pre-treatment, milling, combustion and other alternative PCB pre-treatment methods to promote the leaching of metals which are otherwise inaccessible. A batch of custom-made PCBs of known and consistent metal content has been used to allow effective comparison. The effectiveness of each pre-treatment method is evaluated through carrying out an ammoniacal copper leach and recoveries are compared. X-ray CT scans are used to characterise the boards and map out accessibility of metals for leaching as well as to demonstrate the effectiveness of each pre-treatment method. Results from the X-ray CT scans showed 69% of the copper to be located in the inner layers of the PCB rendering chemical pre-treatment which only exposes metal on the outer surfaces of the board ineffective. It was concluded that an integration of pre-treatment methods effectively liberates metals without the use of heavily mechanised tools and at relatively minimum environmental impacts.
C1 [Moyo, T.; Chirume, B. H.; Petersen, J.] Univ Cape Town, Minerals Met Signat Theme, Dept Chem Engn, Rondebosch, South Africa.
RP Moyo, T (reprint author), Univ Cape Town, Minerals Met Signat Theme, Dept Chem Engn, Rondebosch, South Africa.
EM thandazile.moyo@uct.ac.za
FU NRF Free Standing Postdoctoral Fellowship; Minerals to Metals (MtM)
   research initiative; South African Research Chairs Initiative of the
   Department of Science and Technology; National Research Foundation of
   South Africa, (NRF)National Research Foundation - South Africa
FX This project has been funded through the NRF Free Standing Postdoctoral
   Fellowship and the Minerals to Metals (MtM) research initiative. MtM is
   supported by the South African Research Chairs Initiative of the
   Department of Science and Technology and National Research Foundation of
   South Africa, (NRF). Any opinions, findings and conclusions or
   recommendations expressed in this material is that of the authors and
   the NRF does not accept any liability in this regard.
CR Adhapure NN, 2014, METHODSX, V1, P181, DOI 10.1016/j.mex.2014.08.011
   Agyei-Mensah S, 2012, INT J ENVIRON HEAL R, V22, P500, DOI 10.1080/09603123.2012.667795
   Albertyn P.W, 2017, THESIS
   Amit J, 2008, E WASTE IMPLICATIONS, P3
   [Anonymous], 2015, US ENV PROT AG EPA R
   Chen B, 2019, J HAZARD MATER, V364, P388, DOI 10.1016/j.jhazmat.2018.10.022
   Chien YC, 2000, CHEMOSPHERE, V40, P383, DOI 10.1016/S0045-6535(99)00251-9
   Chirume B, 2019, THESIS
   Cocchiara C, 2019, J CLEAN PROD, V230, P170, DOI 10.1016/j.jclepro.2019.05.112
   Davis JM, 2015, RESOUR CONSERV RECY, V105, P73, DOI 10.1016/j.resconrec.2015.08.001
   Guo C, 2011, WASTE MANAGE, V31, P2161, DOI 10.1016/j.wasman.2011.05.011
   Hageluken C, 2006, P WAST SEC RAW MAT 3
   Hall WJ, 2007, RESOUR CONSERV RECY, V51, P691, DOI 10.1016/j.resconrec.2006.11.010
   He JF, 2017, WASTE MANAGE, V60, P618, DOI 10.1016/j.wasman.2016.11.019
   Huang K, 2009, J HAZARD MATER, V164, P399, DOI 10.1016/j.jhazmat.2008.08.051
   HUANG M, 2016, RESOUR CONSERV RECY, P25
   Huo X, 2007, ENVIRON HEALTH PERSP, V115, P1113, DOI 10.1289/ehp.9697
   Ilankoon IMSK, 2018, WASTE MANAGE, V82, P258, DOI 10.1016/j.wasman.2018.10.018
   Jha MK, 2011, JOM-US, V63, P29, DOI 10.1007/s11837-011-0133-z
   Jha MK, 2012, HYDROMETALLURGY, V121, P28, DOI 10.1016/j.hydromet.2012.04.010
   Koyama K, 2006, MATER TRANS, V47, P1788, DOI 10.2320/matertrans.47.1788t
   Lim Y, 2013, GEOSYSTEM ENG, V16, P216, DOI 10.1080/12269328.2013.833486
   Lin KH, 2014, J HAZARD MATER, V271, P258, DOI 10.1016/j.jhazmat.2014.02.031
   Lv JX, 2019, J CLEAN PROD, V238, DOI 10.1016/j.jclepro.2019.117938
   Lydall M, 2017, PREPROCESSING PROCES
   Oliveira PC, 2013, MATER SCI FORUM, V730-732, P653, DOI 10.4028/www.scientific.net/MSF.730-732.653
   Oteng- Ababio M., 2012, SUSTAINABLE DEV AUTH, VPP, P149, DOI DOI 10.5772/2562
   Robinson BH, 2009, SCI TOTAL ENVIRON, V408, P183, DOI 10.1016/j.scitotenv.2009.09.044
   Sadan Z, 2019, THESIS
   Sun ZHI, 2015, HYDROMETALLURGY, V152, P91, DOI 10.1016/j.hydromet.2014.12.013
   Wang F, 2012, WASTE MANAGE, V32, P2134, DOI 10.1016/j.wasman.2012.03.029
   Wang HM, 2011, ENVIRON INT, V37, P80, DOI 10.1016/j.envint.2010.07.005
   Widmer R, 2005, ENVIRON IMPACT ASSES, V25, P436, DOI 10.1016/j.eiar.2005.04.001
   Wu ZB, 2017, FRONT ENV SCI ENG, V11, P1, DOI 10.1007/s11783-017-0995-6
   Yang HY, 2011, J HAZARD MATER, V187, P393, DOI 10.1016/j.jhazmat.2011.01.051
   Yang JG, 2012, HYDROMETALLURGY, V121, P1, DOI 10.1016/j.hydromet.2012.04.015
   Yildirir E, 2015, WASTE BIOMASS VALORI, V6, P959, DOI 10.1007/s12649-015-9426-8
NR 37
TC 1
Z9 1
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104545
DI 10.1016/j.resconrec.2019.104545
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700030
OA Bronze
DA 2020-05-12
ER

PT J
AU Nansai, K
   Fry, J
   Malik, A
   Takayanagi, W
   Kondo, N
AF Nansai, Keisuke
   Fry, Jacob
   Malik, Arunima
   Takayanagi, Wataru
   Kondo, Naoki
TI Carbon footprint of Japanese health care services from 2011 to 2015
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Input-output analysis; Planetary health; Medical services; Nursing care;
   Unused medicine; Supply chain
ID GREENHOUSE-GAS EMISSIONS; ENVIRONMENTAL IMPACTS; CONSUMPTION; ENERGY
AB The carbon footprint of Japanese health care services, i.e. the domestic greenhouse gas (GHG) emissions caused by health care expenditures, including the associated fixed capital, were calculated using input-output analysis. In 2011 the total carbon footprint of these services was 62.5 x 10(6) metric tons of CO2 equivalent (MtCO(2)e), which is 4.6% of total domestic GHG emissions. Medical services involving hospitalization accounted for the greatest share, at 15.7 MtCO(2)e. The second highest category, Medical services without hospitalization, accounted for only slightly less: 14.2 MtCO(2)e. However, the difference in emissions per patient between these two categories was considerable. On average, emissions per patient for Medical services (hospitalization) were 12 tCO(2)e/patient, whereas for Medical services (non-hospitalization) they were only 2.1 tCO(2)e/patient, or 5.4 times less. In terms of type of medical condition, the greatest annual emissions were associated with cardiovascular disease (6.2 MtCO(2)e) and neoplasm (4.0 MtCO(2)e). In terms of age, emissions attributed to patients aged 65 and over accounted for more than half of total health care emissions. By 2015, the total carbon footprint had increased to 72.0 MtCO(2)e, a rise of over 15% in four years. Although medical care and pharmaceuticals are the main factors responsible for this increase, emissions associated with nursing services have also risen, suggesting that demographic aging may be having a significant impact on GHG emissions. As a countermeasure, the potential annual GHG mitigation achievable through avoidance of unused prescribed medicines resulting in waste was estimated at 1.24 MtCO(2)e, comparable with the total carbon footprint of home medicines. To safeguard planetary health, in addition to implementing technological improvements to the supply chains of health care services, it will be necessary to provide citizens further options for achieving health promotion and GHG mitigation simultaneously.
C1 [Nansai, Keisuke; Takayanagi, Wataru] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   [Nansai, Keisuke; Fry, Jacob; Malik, Arunima] Univ Sydney, Fac Sci, Sch Phys, ISA, Camperdown, NSW 2006, Australia.
   [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Educ & Hlth Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
RP Nansai, K (reprint author), Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
EM nansai.keisuke@nies.go.jp
RI Nansai, Keisuke/C-2516-2008
OI Malik, Arunima/0000-0002-4630-9869; /0000-0002-2449-1874; Fry,
   Jacob/0000-0002-2349-6745
FU Japanese Ministry of Education, Culture, Sports, Science and
   TechnologyMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) [18KT0056]; Environment Research & Technology
   Development Fund of the Environmental Restoration and Conservation
   Agency, Japan [2-1801]
FX This research was supported in part by Grants-in-Aid for Research (No.
   18KT0056) from the Japanese Ministry of Education, Culture, Sports,
   Science and Technology and the Environment Research & Technology
   Development Fund (2-1801) of the Environmental Restoration and
   Conservation Agency, Japan. We thank Nigel Harle of Gronsveld, The
   Netherlands, for brushing up our manuscript.
CR Behrens P, 2017, P NATL ACAD SCI USA, V114, P13412, DOI 10.1073/pnas.1711889114
   Cabinet Office of Japan, 2019, CAB OFF JAP 2018 ANN
   Chung JW, 2009, JAMA-J AM MED ASSOC, V302, P1970, DOI 10.1001/jama.2009.1610
   Eckelman MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002623
   Eckelman MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157014
   GIO, 2019, NAT GREENH GAS INV R
   Japanese Agency for Natural Resources and Energy, 2019, INT EN STAT
   Japanese Ministry of Health Labour and Welfare, 2019, NAT MED EXP
   Japanese Ministry of Health Labour and Welfare, 2017, FY2005 IMPL STAT SPE
   Japanese Ministry of Internal Affairs and Communications, 2016, 2000 2005 2011 LINK
   Kane GM, 2018, RESOUR CONSERV RECY, V135, P38, DOI 10.1016/j.resconrec.2017.07.030
   Law AV, 2015, RES SOC ADMIN PHARM, V11, P571, DOI 10.1016/j.sapharm.2014.10.003
   Lenzen M, 1998, ENERG POLICY, V26, P495, DOI 10.1016/S0301-4215(98)00012-3
   Lenzen M., 2004, J APPL INPUT OUTPUT, V10, P1
   LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294
   Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x
   Malik A, 2018, LANCET PLANET HEALTH, V2, pE27, DOI 10.1016/S2542-5196(17)30180-8
   Masuyama K, 2015, RES INFLUENCE RESIDU
   Minx JC, 2011, ENVIRON SCI TECHNOL, V45, P9144, DOI 10.1021/es201497m
   Nakamura S, 2016, LCA COMPEND, P219, DOI 10.1007/978-94-017-7610-3_6
   Nansai K, 2003, ENVIRON SCI TECHNOL, V37, P2005, DOI 10.1021/es0257669
   Nansai K, 2019, EMBODIED ENERGY EMIS
   Nansai K, 2008, J CLEAN PROD, V16, P538, DOI 10.1016/j.jclepro.2007.01.008
   Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P9146, DOI 10.1021/es2043257
   Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P155, DOI 10.1021/es202007b
   Nansai K, 2009, ECON SYST RES, V21, P267, DOI 10.1080/09535310903541587
   OECD, 2018, OECD HLTH STAT
   OECD, 2017, HLTH GLANC 2017
   Parvatker AG, 2019, ACS SUSTAIN CHEM ENG, V7, P6580, DOI 10.1021/acssuschemeng.8b05473
   Pichler PP, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab19e1
   Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1
   Shigetomi Y, 2018, RESOUR CONSERV RECY, V133, P385, DOI 10.1016/j.resconrec.2017.11.017
   Shigetomi Y, 2014, ENVIRON SCI TECHNOL, V48, P6069, DOI 10.1021/es404939d
   Shimoda A, 2020, INT J ENVIRON HEAL R, V30, P63, DOI 10.1080/09603123.2019.1572871
   Sodersten CJH, 2018, ENVIRON SCI TECHNOL, V52, P13250, DOI 10.1021/acs.est.8b02791
   Sustainable Development Unit, 2016, CARB FOOTPR UPD NHS
   Taylor T, 2017, PLANETARY HLTH, V1, P357
   Toh MR, 2017, PALLIATIVE MED, V31, P35, DOI 10.1177/0269216316639798
   Tukker A, 2011, ECOL ECON, V70, P1776, DOI 10.1016/j.ecolecon.2011.05.001
   UN, 2015, UN SUST DEV GOALS 17
   United Nations, 2019, PRINC RESP INV
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
   Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1
NR 43
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104525
DI 10.1016/j.resconrec.2019.104525
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700022
OA Bronze
DA 2020-05-12
ER

PT J
AU Roychand, R
   Pramanik, BK
   Zhang, GM
   Setunge, S
AF Roychand, Rajeev
   Pramanik, Biplob Kumar
   Zhang, Guomin
   Setunge, Sujeeva
TI Recycling steel slag from municipal wastewater treatment plants into
   concrete applications - A step towards circular economy
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Compressive strength; Municipal wastewater; Phosphorus removal; Slag
   aggregates
ID X-RAY-DIFFRACTION; COAL BOTTOM ASH; PHOSPHORUS REMOVAL;
   MECHANICAL-PROPERTIES; PHOSPHATE REMOVAL; EAF SLAG; FILTERS; STRENGTH;
   EFFLUENT; NITROGEN
AB Municipal wastewater is a major source of the release of phosphorus into the marine environment, and its excessive release could negatively impact marine flora and fauna. In this study, steel slag a by-product from steel industry was used to remove phosphorus content from the municipal wastewater. The Langmuir isotherm model revealed a maximum adsorption capacity of 3.8 mg phosphate/g of steelmaking slag. The results showed that the phosphate removal efficiency of granular slag was about 90%. The wastewater contained a significant amount of iron and manganese content that was filtered out by the slag granules. X-ray fluorescence and x-ray diffraction analysis show that the wastewater treatment process changes the chemical phase composition of slag in addition to the absorption/adsorption of various chemicals within its pore structure. To recycle this waste slag after the water treatment process, that significantly altered its chemical and mineralogical composition, it was used in concrete as a replacement of conventional coarse aggregates. The results show that the treated slag aggregates provide compressive strength improvement of 32.5% and 18% at 7 days and 8.2 and 16.8% improvement at 28 days compared to that of raw slag and conventional aggregates, respectively. In addition, due to the pozzolanic nature of slag both the raw and treated slag aggregates showed a seamless monolithic bond at the interfacial transition zone between the slag and the cement matrix. This study demonstrates that the waste slag generated from the wastewater treatment process has a great potential to be used as a replacement of conventional aggregates in concrete applications.
C1 [Roychand, Rajeev; Pramanik, Biplob Kumar; Zhang, Guomin; Setunge, Sujeeva] RMIT Univ, Sch Engn, Civil & Infrastruct Engn Discipline, Melbourne, Vic, Australia.
RP Pramanik, BK (reprint author), RMIT Univ, Sch Engn, Civil & Infrastruct Engn Discipline, Melbourne, Vic, Australia.
EM biplob.pramanik@rmit.edu.au
RI Roychand, Rajeev/AAG-6323-2020
OI Roychand, Rajeev/0000-0001-9457-1602; Zhang, Guomin
   Kevin/0000-0002-3503-7431; PRAMANIK, BIPLOB/0000-0002-6959-0227
CR Adegoloye G, 2015, CONSTR BUILD MATER, V76, P313, DOI 10.1016/j.conbuildmat.2014.12.007
   AKINMUSURU JO, 1991, RESOUR CONSERV RECY, V5, P73, DOI 10.1016/0921-3449(91)90041-L
   Al-Negheimish Al, 1997, J KING SAUD U ENG SC, V9, P39
   [Anonymous], 2014, AS101291 NSW
   [Anonymous], 2014, AS101281 NSW
   Arribas I, 2015, CONSTR BUILD MATER, V90, P68, DOI 10.1016/j.conbuildmat.2015.05.003
   Barca C, 2014, ECOL ENG, V68, P214, DOI 10.1016/j.ecoleng.2014.03.065
   Bates S, 2006, PHARM RES-DORDR, V23, P2333, DOI 10.1007/s11095-006-9086-2
   Beshr H, 2003, CONSTR BUILD MATER, V17, P97, DOI 10.1016/S0950-0618(02)00097-1
   Bird SC, 2010, WATER-SUI, V2, P484, DOI 10.3390/w2030484
   Blanco I, 2016, WATER RES, V89, P355, DOI 10.1016/j.watres.2015.11.064
   Bowden LI, 2009, ENVIRON SCI TECHNOL, V43, P2476, DOI 10.1021/es801626d
   Coppola L, 2016, CONSTR BUILD MATER, V123, P115, DOI 10.1016/j.conbuildmat.2016.06.142
   Douterelo I, 2016, APPL ENVIRON MICROB, V82, P4155, DOI 10.1128/AEM.00109-16
   Gonzalez S, 2013, TOXICOL ENVIRON CHEM, V95, P870, DOI 10.1080/02772248.2013.840372
   Gurung DP, 2013, AIR SOIL WATER RES, V6, P23, DOI 10.4137/ASWR.S10548
   Hobbie SE, 2017, P NATL ACAD SCI USA, V114, P4177, DOI 10.1073/pnas.1618536114
   Hua GH, 2016, WATER RES, V102, P180, DOI 10.1016/j.watres.2016.06.022
   Kearsley EP, 2002, CEMENT CONCRETE RES, V32, P233, DOI 10.1016/S0008-8846(01)00665-2
   Kim EH, 2006, CHEMOSPHERE, V63, P192, DOI 10.1016/j.chemosphere.2005.08.029
   Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p
   Manso JM, 2006, CEMENT CONCRETE COMP, V28, P528, DOI 10.1016/j.cemconcomp.2006.02.008
   Maslehuddin M, 2003, CONSTR BUILD MATER, V17, P105, DOI 10.1016/S0950-0618(02)00095-8
   Mos YM, 2018, GEOMICROBIOL J, V35, P511, DOI 10.1080/01490451.2017.1401183
   Navarro C, 2010, ENVIRON SCI TECHNOL, V44, P5383, DOI 10.1021/es100690b
   Oguz E, 2004, J HAZARD MATER, V114, P131, DOI 10.1016/j.jhazmat.2004.07.010
   PANalytical, PANALYTICAL BAS XRD
   Pratt C, 2009, WATER RES, V43, P277, DOI 10.1016/j.watres.2008.10.020
   Pratt C, 2010, WATER SCI TECHNOL, V62, P1713, DOI 10.2166/wst.2010.389
   ROSSLER M, 1985, CEMENT CONCRETE RES, V15, P320
   Roychand R, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002220
   Shi CJ, 2004, J MATER CIVIL ENG, V16, P230, DOI 10.1061/(ASCE)0899-1561(2004)16:3(230)
   Shilton AN, 2006, WATER RES, V40, P113, DOI 10.1016/j.watres.2005.11.002
   Shilton A, 2013, ENVIRON TECHNOL, V34, P195, DOI 10.1080/09593330.2012.689365
   Singh N, 2019, RESOUR CONSERV RECY, V144, P240, DOI 10.1016/j.resconrec.2019.01.044
   Singh N, 2018, RESOUR CONSERV RECY, V138, P257, DOI 10.1016/j.resconrec.2018.07.025
   Singh S. P, 2018, EUR J ENV CIV ENG, P1, DOI [10.1080/19648189.1500312, DOI 10.1080/19648189.2018.1500312]
   Subramani T, 2015, IOSR J ENG, V5, P64
   Youssf Osama, 2019, Journal of Composites Science, V3, DOI 10.3390/jcs3020041
   Yu J, 2015, J ENVIRON SCI, V31, P81, DOI 10.1016/j.jes.2014.12.007
   Yuksel I, 2017, ENVIRON DEV SUSTAIN, V19, P369, DOI 10.1007/s10668-016-9759-x
   Zeiser T, 2001, CHEM ENG SCI, V56, P1697, DOI 10.1016/S0009-2509(00)00398-5
   Zhao GY, 2012, ECOL ENG, V42, P107, DOI 10.1016/j.ecoleng.2012.02.007
   Zuo MY, 2018, ENVIRON SCI POLLUT R, V25, P7391, DOI 10.1007/s11356-017-0925-y
NR 44
TC 1
Z9 1
U1 37
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104533
DI 10.1016/j.resconrec.2019.104533
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700028
OA Bronze
DA 2020-05-12
ER

PT J
AU Shuvabrata, C
   Ankit, S
   Omkarprasad, SV
AF Shuvabrata, Chakraborty
   Ankit, Sharma
   Omkarprasad, Vaidya S.
TI Achieving sustainable operational excellence through IT implementation
   in Indian logistics sector: An analysis of barriers
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Unorganized logistics; India; Barriers; IT implementation;
   Fuzzy-Interpretive Structural Modelling (Fuzzy-ISM); Interpretive
   Ranking Process (IRP)
ID EVALUATING BARRIERS; TECHNOLOGY; SELECTION; ADOPTION
AB Information Technology (IT) infrastructure has been integral to operational excellence approaches towards sustainable supply chains. The paper explores the crucial barriers to IT implementation in the largely unorganized logistics sector of an emerging economy, India. Through a comparative study using two separate expert-groups, representing the organized and unorganized logistics sectors respectively, the paper analyses their views on the criticality of barriers in each sector and highlights the sector-specific problems that hinder effective IT implementation. Considering the profiles of the expert groups used, the paper implements Fuzzy-ISM and Fuzzy-MICMAC analysis for one group and IRP for the other to capture and analyze their opinions appropriately. The results obtained from the analyses show that the barriers concerning IT implementation in the unorganized logistics sector (ULS) substantially differ from those concerning the organized logistics sector (OLS) as perceived by the corresponding sector experts. The study ranks the barriers in the two sectors and highlights the focus areas that require immediate attention to strengthen the IT infrastructure of Indian ULS, which suffers mainly from behavioral issues at the organizational level. Focused attention to unorganized sector's requirements can revive the sector and smoothen its transformation to an organized one as exceedingly demanded by the recent e-commerce boom. The work is perhaps the first to address the Indian ULS. It implements a unique approach: seeks inputs from two different expert groups, implements tools appropriate to the respective panel profiles, and compares their opinions to identify the specific and different requirements of the Indian ULS with respect to IT implementation.
C1 [Shuvabrata, Chakraborty; Ankit, Sharma; Omkarprasad, Vaidya S.] Indian Inst Management Lucknow, Lucknow, Uttar Pradesh, India.
RP Shuvabrata, C (reprint author), Indian Inst Management Lucknow, Lucknow, Uttar Pradesh, India.
EM fpm17010@iiml.ac.in; fpm17014@iiml.ac.in; osv@iiml.ac.in
OI Chakraborty, Shuvabrata/0000-0003-2029-0204
CR Agyemang M, 2018, RESOUR CONSERV RECY, V136, P209, DOI 10.1016/j.resconrec.2018.04.011
   Baker P. M. A., 2004, Proceedings of the 37th Annual Hawaii International Conference on System Sciences
   Beamon BM, 1999, INT J OPER PROD MAN, V19, P275, DOI 10.1108/01443579910249714
   Biyani V, 2017, DECODING INDIAN TRAN
   Bouzon M, 2018, RESOUR CONSERV RECY, V128, P315, DOI 10.1016/j.resconrec.2016.11.022
   Bowersox D. J., 1995, J BUSINESS LOGISTICS, V16, P65
   Dawe RL, 1994, J BUSINESS LOGISTICS, V15, P229
   Delfmann W., 2002, INT J PHYS DISTRIB, V32, P203, DOI DOI 10.1108/09600030210426539
   Diabat A, 2011, RESOUR CONSERV RECY, V55, P659, DOI 10.1016/j.resconrec.2010.12.002
   Dinev T, 2007, J ASSOC INF SYST, V8, P386
   Dwivedi G, 2017, INT J PHYS DISTR LOG, V47, P972, DOI 10.1108/IJPDLM-07-2017-0222
   Feng Y, 2008, INT J PROD ECON, V115, P189, DOI 10.1016/j.ijpe.2008.06.002
   Fraccascia L, 2018, RESOUR CONSERV RECY, V136, P473, DOI 10.1016/j.resconrec.2018.03.009
   Geyskens I., 1996, INT J RES MARK, V13, P303, DOI DOI 10.1016/S0167-8116(96)00006-7
   Govindan K, 2012, INT J PROD ECON, V140, P204, DOI 10.1016/j.ijpe.2012.01.043
   Gunasekaran A, 2017, TRANSPORT RES E-LOG, V99, P14, DOI 10.1016/j.tre.2016.12.008
   Haleem A, 2012, PROD PLAN CONTROL, V23, P722, DOI 10.1080/09537287.2011.642134
   Iacovou CL, 1995, MIS QUART, V19, P465, DOI 10.2307/249629
   Kannan G, 2007, INT J PROD RES, V45, P3831, DOI 10.1080/00207540600676676
   Kannan G, 2009, RESOUR CONSERV RECY, V54, P28, DOI 10.1016/j.resconrec.2009.06.004
   Khatwani G., 2015, GLOB J FLEX SYST MAN, V16, P97, DOI DOI 10.1007/S40171-014-0087-4
   Koch V, 2014, IND 4 0 OPPORTUNITIE
   Lai KH, 2005, TRANSPORT J, V44, P1
   Lan SL, 2018, RESOUR CONSERV RECY, V128, P345, DOI 10.1016/j.resconrec.2016.08.017
   Luthra S, 2018, RESOUR CONSERV RECY, V138, P194, DOI 10.1016/j.resconrec.2018.07.005
   Mangla S. K, 2019, RESOUR CONSERV RECY, V142, P277, DOI DOI 10.1016/J.RESCONREC.2018.11.014
   Mangla SK, 2015, RESOUR CONSERV RECY, V104, P375, DOI 10.1016/j.resconrec.2015.01.001
   Mani V, 2016, RESOUR CONSERV RECY, V111, P42, DOI 10.1016/j.resconrec.2016.04.003
   Matt C, 2015, BUS INFORM SYST ENG+, V57, P339, DOI 10.1007/s12599-015-0401-5
   Mitra S., 2006, IIMB MANAGEMENT REV, V18, P159
   Mitra S, 2008, GLOB BUS EC ANTHOL B, P130
   Narkhede BE, 2017, BENCHMARKING, V24, P1597, DOI 10.1108/BIJ-04-2016-0055
   Pfohl HC, 2011, INT J PHYS DISTR LOG, V41, P839, DOI 10.1108/09600031111175816
   Pickup O, 2017, WHY ARE BUSINESSES S
   Raghu K., 2007, BOOMING EC CALLS ORG
   Saaty T.L., 1980, AHP ANAL HIERARCHY P
   Sage A., 1977, METHODOLOGY LARGE SC
   Sahay B. S., 2006, International Journal of Physical Distribution & Logistics Management, V36, P666, DOI 10.1108/09600030610710845
   Sandelands E., 1997, INT J PHYS DISTRIB, V27, P73, DOI DOI 10.1108/09600039710757736
   SAXENA JP, 1992, TECHNOL FORECAST SOC, V41, P121, DOI 10.1016/0040-1625(92)90059-3
   Sharma S.N, 2018, NEW GOVT DIVISION PL
   Sushil D., 2009, GLOBAL J FLEXIBLE SY, V10, P1, DOI DOI 10.1007/S10479-016-2237-X
   WARFIELD JN, 1974, IEEE T SYST MAN CYB, VSMC4, P405, DOI 10.1109/TSMC.1974.4309336
   Yenradee P, 2000, INT J PROD RES, V38, P2689, DOI 10.1080/002075400411439
   Zimmermann H.-J., 2001, FUZZY SET THEORY ITS
NR 45
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104506
DI 10.1016/j.resconrec.2019.104506
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700008
OA Bronze
DA 2020-05-12
ER

PT J
AU Si, HY
   Shi, JG
   Tang, DZ
   Wu, GD
   Lan, J
AF Si, Hongyun
   Shi, Jian-gang
   Tang, Daizhong
   Wu, Guangdong
   Lan, Jing
TI Understanding intention and behavior toward sustainable usage of bike
   sharing by extending the theory of planned behavior
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Bike sharing; Sustainable consumption; Sharing economy; Consumer
   behavior; Theory of planned behavior; Moral obligation
ID STRATEGIC MANAGEMENT RESEARCH; RECYCLING BEHAVIOR; CONSUMPTION
   BEHAVIORS; PSYCHOLOGICAL-FACTORS; REDUCTION BEHAVIOR; MORAL OBLIGATION;
   URBAN RESIDENTS; MODEL; DETERMINANTS; ATTITUDE
AB Bike sharing, especially dockless bike sharing (DBS), plays a key role in enhancing sustainable mobility in Chinese cities. Unsustainable usage modes and user behavior are increasingly serious problems confronting DBS in China that may substantially threaten its profits and supply. While existing studies have mainly focused on how to promote DBS, the issue of the sustainable usage of shared bikes has been largely overlooked. This paper examined the determinants affecting users' sustainable usage intention and behavior by incorporating awareness of consequences and moral obligation into the theory of planned behavior. Based on partial least squares structural equation modeling, the questionnaire data of 705 users (67.92% of all respondents) who had used DBS in sustainable ways were empirically analyzed. The results revealed that perceived behavioral control and moral obligation are the most important factors driving users' sustainable usage intention and behavior and that behavioral attitude and subjective norms also present significant positive effects on sustainable usage intention. In contrast to the hypothesized relationship, the awareness of consequences does not play a significant role in sustainable usage intention. Moreover, the empirical results ascertained that the extended model has stronger interpretation ability than the original model in predicting DBS users' sustainable usage behavior. Eventually, some targeted managerial implications are proposed. This study enhances the current understanding of the sustainable usage behavior of DBS users and provides timely insights for policymakers and operators promoting sustainable bike-sharing practices in China and other countries operating DBS programs.
C1 [Si, Hongyun; Shi, Jian-gang; Tang, Daizhong] Tongji Univ, Sch Econ & Management, Shanghai, Peoples R China.
   [Wu, Guangdong] Chongqing Univ, Sch Publ Affairs, Chongqing, Peoples R China.
   [Lan, Jing] Henan Univ Econ & Law, Sch Econ, Zhengzhou, Henan, Peoples R China.
RP Tang, DZ (reprint author), Tongji Univ, Sch Econ & Management, Shanghai, Peoples R China.
EM tdzhong@126.com
OI si, hong yun/0000-0003-2367-4756
FU National Social Science Foundation of China [19BGL274]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [71473179]
FX This work was supported by the National Social Science Foundation of
   China (19BGL274) and the National Natural Science Foundation of China
   (71473179).
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 1985, INTENTIONS ACTIONS T
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [DOI 10.1007/BF02723327, 10.1007/BF02723327]
   BECK L, 1991, J RES PERS, V25, P285, DOI 10.1016/0092-6566(91)90021-H
   Botetzagias I, 2015, RESOUR CONSERV RECY, V95, P58, DOI 10.1016/j.resconrec.2014.12.004
   Buck D, 2013, TRANSPORT RES REC, P112, DOI 10.3141/2387-13
   Cai SJ, 2019, J CLEAN PROD, V212, P602, DOI 10.1016/j.jclepro.2018.12.072
   Carmines E. G., 1979, RELIABILITY VALIDITY
   Chen MF, 2016, J CLEAN PROD, V112, P1746, DOI 10.1016/j.jclepro.2015.07.043
   Chen MF, 2014, INT J HOSP MANAG, V36, P221, DOI 10.1016/j.ijhm.2013.09.006
   Cristea M, 2016, TRANSPORT RES F-TRAF, V43, P157, DOI 10.1016/j.trf.2016.10.004
   Ding ZH, 2018, RESOUR CONSERV RECY, V132, P3, DOI 10.1016/j.resconrec.2018.01.013
   Dinh DD, 2013, TRANSPORT POLICY, V29, P199, DOI 10.1016/j.tranpol.2013.06.003
   Donald IJ, 2014, J ENVIRON PSYCHOL, V40, P39, DOI 10.1016/j.jenvp.2014.03.003
   Du MY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041244
   Eagly A.H., 1993, PSYCHOL ATTITUDES
   Fang CC, 2019, COMPUT HUM BEHAV, V92, P87, DOI 10.1016/j.chb.2018.10.036
   Fernando Y, 2017, RESOUR CONSERV RECY, V126, P62, DOI 10.1016/j.resconrec.2017.07.023
   Fishbein M, 1977, BELIEF ATTITUDE INTE
   Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612
   Fu BT, 2019, J CLEAN PROD, V209, P595, DOI 10.1016/j.jclepro.2018.10.192
   Gao L, 2017, RESOUR CONSERV RECY, V127, P107, DOI 10.1016/j.resconrec.2017.08.030
   GORSUCH RL, 1983, J PERS SOC PSYCHOL, V44, P1025, DOI 10.1037/0022-3514.44.5.1025
   Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   Hair JF, 2012, LONG RANGE PLANN, V45, P320, DOI 10.1016/j.lrp.2012.09.008
   Hair Jr JF, 2016, PRIMER PARTIAL LEAST
   Han H, 2010, INT J HOSP MANAG, V29, P659, DOI 10.1016/j.ijhm.2010.01.001
   Han H, 2010, TOURISM MANAGE, V31, P325, DOI 10.1016/j.tourman.2009.03.013
   Hansla A, 2008, J ENVIRON PSYCHOL, V28, P1, DOI 10.1016/j.jenvp.2007.08.004
   Hazen BT, 2015, SUSTAINABILITY-BASEL, V7, P14558, DOI 10.3390/su71114558
   Hersey P, 2007, MANAGEMENT ORG BEHAV
   Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z
   Jia N, 2018, TRANSPORT RES A-POL, V111, P108, DOI 10.1016/j.tra.2018.03.010
   Kaiser FG, 2006, PERS INDIV DIFFER, V41, P71, DOI 10.1016/j.paid.2005.11.028
   Kaspi M, 2017, IISE TRANS, V49, P144, DOI 10.1080/0740817X.2016.1224960
   Khan F, 2019, RESOUR CONSERV RECY, V142, P49, DOI 10.1016/j.resconrec.2018.11.020
   Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014
   Kochan CG, 2016, INT J LOGIST MANAG, V27, P52, DOI 10.1108/IJLM-02-2014-0021
   Kumar A, 2019, RESOUR CONSERV RECY, V141, P378, DOI 10.1016/j.resconrec.2018.10.013
   Leonard LNK, 2004, INFORM MANAGE-AMSTER, V42, P143, DOI 10.1016/j.im.2003.12.008
   Li JR, 2018, J CLEAN PROD, V172, P1399, DOI 10.1016/j.jclepro.2017.10.138
   Li Xuefeng, 2018, ENERGIES, V11, P1, DOI [10.3390/en11071664, DOI 10.3390/en11071664]
   Liobikiene G, 2016, J CLEAN PROD, V112, P3413, DOI 10.1016/j.jclepro.2015.10.049
   Liu DY, 2017, TRANSPORT RES A-POL, V105, P42, DOI 10.1016/j.tra.2017.08.004
   Liu JR, 2010, ECOL COMPLEX, V7, P212, DOI 10.1016/j.ecocom.2010.02.003
   Liu JL, 2019, RESOUR CONSERV RECY, V141, P200, DOI 10.1016/j.resconrec.2018.10.030
   Lizin S, 2017, RESOUR CONSERV RECY, V122, P66, DOI 10.1016/j.resconrec.2017.02.003
   llenseler J, 2009, USE PARTIAL LEAST SQ
   Ma L, 2018, TRANSPORT RES A-POL, V118, P14, DOI 10.1016/j.tra.2018.08.040
   Ma YG, 2019, J CLEAN PROD, V208, P1148, DOI 10.1016/j.jclepro.2018.10.135
   Ma YG, 2018, J CLEAN PROD, V188, P942, DOI 10.1016/j.jclepro.2018.03.323
   Manstead A.S.R., 2000, ATTITUDES BEHAV SOCI
   Matthies E, 2012, J ENVIRON PSYCHOL, V32, P277, DOI 10.1016/j.jenvp.2012.04.003
   Lopes JRN, 2019, RESOUR CONSERV RECY, V145, P268, DOI 10.1016/j.resconrec.2019.02.042
   Pappa IC, 2018, J RURAL STUD, V58, P123, DOI 10.1016/j.jrurstud.2018.01.001
   PARKER D, 1995, BRIT J SOC PSYCHOL, V34, P127, DOI 10.1111/j.2044-8309.1995.tb01053.x
   Paul J, 2016, J RETAIL CONSUM SERV, V29, P123, DOI 10.1016/j.jretconser.2015.11.006
   Petter S., 2007, MANAGEMENT INFORM SY, V31, P657, DOI DOI 10.2307/25148814
   POMAZAL RJ, 1976, J PERS SOC PSYCHOL, V33, P317, DOI 10.1037/0022-3514.33.3.317
   Reynolds SJ, 2008, J APPL PSYCHOL, V93, P1027, DOI 10.1037/0021-9010.93.5.1027
   Rong K, 2018, RESOUR CONSERV RECY, V130, P188, DOI 10.1016/j.resconrec.2017.12.001
   Ru XJ, 2019, RESOUR CONSERV RECY, V141, P99, DOI 10.1016/j.resconrec.2018.10.019
   Ru XJ, 2018, RESOUR CONSERV RECY, V134, P91, DOI 10.1016/j.resconrec.2018.03.001
   SCHWARTZ SH, 1972, J PERS SOC PSYCHOL, V24, P225, DOI 10.1037/h0033365
   Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20
   Shen Y, 2018, INT J SUSTAIN TRANSP, V12, P686, DOI 10.1080/15568318.2018.1429696
   Shi HX, 2017, J CLEAN PROD, V147, P603, DOI 10.1016/j.jclepro.2017.01.108
   Shi HX, 2017, J CLEAN PROD, V145, P64, DOI 10.1016/j.jclepro.2016.12.169
   Si HY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152788
   Si HY, 2019, J CLEAN PROD, V213, P415, DOI 10.1016/j.jclepro.2018.12.157
   Spinney J., 2018, APPL MOBILITIES, V3, P66, DOI [10.1080/23800127.2018.1437656, DOI 10.1080/23800127.2018.1437656]
   Taufique KMR, 2018, J CLEAN PROD, V183, P46, DOI 10.1016/j.jclepro.2018.02.097
   Tonglet M, 2004, RESOUR CONSERV RECY, V41, P191, DOI 10.1016/j.resconrec.2003.11.001
   Verma VK, 2018, J CLEAN PROD, V172, P1152, DOI 10.1016/j.jclepro.2017.10.047
   Wall R, 2007, ENVIRON BEHAV, V39, P731, DOI 10.1177/0013916506294594
   Wan C, 2012, FACILITIES, V30, P630, DOI 10.1108/02632771211270595
   Wang B, 2019, RESOUR CONSERV RECY, V143, P218, DOI 10.1016/j.resconrec.2019.01.005
   Wang P, 2014, J CLEAN PROD, V63, P152, DOI 10.1016/j.jclepro.2013.05.007
   Wang YG, 2019, J CLEAN PROD, V208, P869, DOI 10.1016/j.jclepro.2018.10.139
   Wang Y, 2018, TRANSPORT RES D-TR E, V65, P438, DOI 10.1016/j.trd.2018.09.016
   Wang Z, 2018, APPL THERM ENG, V133, P1, DOI 10.1016/j.applthermaleng.2018.01.025
   Yadav R, 2017, ECOL ECON, V134, P114, DOI 10.1016/j.ecolecon.2016.12.019
   YAO Y, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11010127
   Zhang XJ, 2018, RESOUR CONSERV RECY, V134, P121, DOI 10.1016/j.resconrec.2018.03.003
NR 85
TC 5
Z9 5
U1 39
U2 39
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JAN
PY 2020
VL 152
AR UNSP 104513
DI 10.1016/j.resconrec.2019.104513
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA JN4KI
UT WOS:000496867700013
OA Bronze
DA 2020-05-12
ER

EF